entry_number,pmid,title,details,author,url
8890,32215577,Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial,JAMA Oncol. 2020 May 1;6(5):650-659. doi: 10.1001/jamaoncol.2020.0147.,Phillips R,https://www.ncbi.nlm.nih.gov/pubmed/32215577
8891,32086498,Considering the role of radical prostatectomy in 21st century prostate cancer care,Nat Rev Urol. 2020 Mar;17(3):177-188. doi: 10.1038/s41585-020-0287-y. Epub 2020 Feb 21.,Costello AJ,https://www.ncbi.nlm.nih.gov/pubmed/32086498
8892,32130814,"MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis",N Engl J Med. 2020 Mar 5;382(10):917-928. doi: 10.1056/NEJMoa1910038.,Ahdoot M,https://www.ncbi.nlm.nih.gov/pubmed/32130814
8894,31727300,HDR Prostate Brachytherapy,Semin Radiat Oncol. 2020 Jan;30(1):49-60. doi: 10.1016/j.semradonc.2019.08.003.,Crook J,https://www.ncbi.nlm.nih.gov/pubmed/31727300
8896,32409202,Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer,Urol Oncol. 2020 Aug;38(8):661-670. doi: 10.1016/j.urolonc.2020.04.008. Epub 2020 May 11.,Lenfant L,https://www.ncbi.nlm.nih.gov/pubmed/32409202
8897,31935027,"Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer",JAMA. 2020 Jan 14;323(2):149-163. doi: 10.1001/jama.2019.20675.,Hoffman KE,https://www.ncbi.nlm.nih.gov/pubmed/31935027
8898,31739952,Radiation Therapy for Prostate Cancer,Hematol Oncol Clin North Am. 2020 Feb;34(1):45-69. doi: 10.1016/j.hoc.2019.08.017. Epub 2019 Oct 28.,Kamran SC,https://www.ncbi.nlm.nih.gov/pubmed/31739952
8900,32005113,Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?,BMC Urol. 2020 Jan 31;20(1):8. doi: 10.1186/s12894-020-0578-x.,Lin D,https://www.ncbi.nlm.nih.gov/pubmed/32005113
8901,32275187,High-intensity focused ultrasound for prostate cancer,Expert Rev Med Devices. 2020 May;17(5):427-433. doi: 10.1080/17434440.2020.1755258.,Napoli A,https://www.ncbi.nlm.nih.gov/pubmed/32275187
8903,31733323,Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial,Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):537-545. doi: 10.1016/j.ijrobp.2019.11.005. Epub 2019 Nov 13.,Sampath S,https://www.ncbi.nlm.nih.gov/pubmed/31733323
8904,32035581,Salvage Radiotherapy for Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):156-162. doi: 10.1016/j.clon.2020.01.003.,Rans K,https://www.ncbi.nlm.nih.gov/pubmed/32035581
8905,32378083,Pathological features of prostate cancer in men treated with robot-assisted radical prostatectomy in the Middle East,J Robot Surg. 2021 Feb;15(1):125-133. doi: 10.1007/s11701-020-01089-0. Epub 2020 May 6.,Aldousari S,https://www.ncbi.nlm.nih.gov/pubmed/32378083
8906,31653564,Impact of timing on salvage radiation therapy adverse events following radical prostatectomy: A secondary analysis of the RTOG 9601 cohort,Urol Oncol. 2020 Feb;38(2):38.e17-38.e22. doi: 10.1016/j.urolonc.2019.09.012. Epub 2019 Oct 23.,Baumgarten L,https://www.ncbi.nlm.nih.gov/pubmed/31653564
8907,32303478,Intermediate-risk Prostate Cancer: Stratification and Management,Eur Urol Oncol. 2020 Jun;3(3):270-280. doi: 10.1016/j.euo.2020.03.002. Epub 2020 Apr 14.,Preisser F,https://www.ncbi.nlm.nih.gov/pubmed/32303478
8908,31942462,Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study,Investig Clin Urol. 2020 Jan;61(1):42-50. doi: 10.4111/icu.2020.61.1.42. Epub 2019 Dec 17.,Park H,https://www.ncbi.nlm.nih.gov/pubmed/31942462
8909,32202536,Intraductal carcinoma of the prostate,Pathologica. 2020 Mar;112(1):17-24. doi: 10.32074/1591-951X-5-20.,Szentirmai E,https://www.ncbi.nlm.nih.gov/pubmed/32202536
8910,32203071,Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):573-580. doi: 10.1038/s41391-020-0225-3. Epub 2020 Mar 18.,Rosiello G,https://www.ncbi.nlm.nih.gov/pubmed/32203071
8911,31759076,Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets,Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):630-638. doi: 10.1016/j.ijrobp.2019.11.007. Epub 2019 Nov 20.,Pilskog S,https://www.ncbi.nlm.nih.gov/pubmed/31759076
8912,31549770,Low-dose-rate brachytherapy for prostate cancer: A 15-year experience in Japan,Int J Urol. 2020 Jan;27(1):17-23. doi: 10.1111/iju.14098. Epub 2019 Sep 24.,Tanaka N,https://www.ncbi.nlm.nih.gov/pubmed/31549770
8913,32182149,Prostate cancer: more effective use of underutilized postoperative radiation therapy,Expert Rev Anticancer Ther. 2020 Apr;20(4):241-249. doi: 10.1080/14737140.2020.1743183. Epub 2020 Mar 17.,Motterle G,https://www.ncbi.nlm.nih.gov/pubmed/32182149
8914,31727298,Progress in Low Dose Rate Brachytherapy for Prostate Cancer,Semin Radiat Oncol. 2020 Jan;30(1):39-48. doi: 10.1016/j.semradonc.2019.08.002.,McLaughlin PW,https://www.ncbi.nlm.nih.gov/pubmed/31727298
8915,32091336,"Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines",Curr Top Med Chem. 2020;20(10):847-854. doi: 10.2174/1568026620666200224100730.,Bartzatt R,https://www.ncbi.nlm.nih.gov/pubmed/32091336
8916,31977379,Neoadjuvant Approaches Prior To Radical Prostatectomy,Cancer J. 2020 Jan/Feb;26(1):2-12. doi: 10.1097/PPO.0000000000000424.,Ryan ST,https://www.ncbi.nlm.nih.gov/pubmed/31977379
8917,31724996,Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease,Curr Opin Urol. 2020 Jan;30(1):90-97. doi: 10.1097/MOU.0000000000000691.,Heidenreich A,https://www.ncbi.nlm.nih.gov/pubmed/31724996
8919,31395986,Radical prostatectomy and simultaneous penile prosthesis implantation: a narrative review,Int J Impot Res. 2020 May;32(3):274-280. doi: 10.1038/s41443-019-0176-1. Epub 2019 Aug 8.,Cocci A,https://www.ncbi.nlm.nih.gov/pubmed/31395986
8920,31791573,High Dose Rate Brachytherapy in High-Risk Localised Disease - Why Do Anything Else?,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):163-169. doi: 10.1016/j.clon.2019.11.003. Epub 2019 Nov 30.,Morton GC,https://www.ncbi.nlm.nih.gov/pubmed/31791573
8921,32295542,Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer,BMC Cancer. 2020 Apr 15;20(1):324. doi: 10.1186/s12885-020-06812-6.,Lehtonen M,https://www.ncbi.nlm.nih.gov/pubmed/32295542
8922,32015294,Magnetic Resonance Imaging Assessment After Therapy in Prostate Cancer,Top Magn Reson Imaging. 2020 Feb;29(1):47-58. doi: 10.1097/RMR.0000000000000231.,Koopman AGMM,https://www.ncbi.nlm.nih.gov/pubmed/32015294
8924,31712648,Cytoreductive treatment strategies for de novo metastatic prostate cancer,Nat Rev Clin Oncol. 2020 Mar;17(3):168-182. doi: 10.1038/s41571-019-0284-3. Epub 2019 Nov 11.,Connor MJ,https://www.ncbi.nlm.nih.gov/pubmed/31712648
8925,31792431,Financial toxicity associated with treatment of localized prostate cancer,Nat Rev Urol. 2020 Jan;17(1):28-40. doi: 10.1038/s41585-019-0258-3. Epub 2019 Dec 2.,Imber BS,https://www.ncbi.nlm.nih.gov/pubmed/31792431
8926,32157345,Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients,Strahlenther Onkol. 2020 Jul;196(7):647-656. doi: 10.1007/s00066-020-01596-x. Epub 2020 Mar 10.,Böckelmann F,https://www.ncbi.nlm.nih.gov/pubmed/32157345
8928,31811370,The evolution and resurgence of perineal prostatectomy in the robotic surgical era,World J Urol. 2020 Apr;38(4):821-828. doi: 10.1007/s00345-019-03004-1. Epub 2019 Dec 6.,Garisto J,https://www.ncbi.nlm.nih.gov/pubmed/31811370
8929,32475688,Radical retropubic prostatectomy: Origins and evolution of the technique,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):408-416. doi: 10.1016/j.acuro.2020.03.003. Epub 2020 May 29.,Herranz-Amo F,https://www.ncbi.nlm.nih.gov/pubmed/32475688
8930,32293453,microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation,Mol Cancer. 2020 Mar 23;19(1):63. doi: 10.1186/s12943-020-01186-6.,Labbé M,https://www.ncbi.nlm.nih.gov/pubmed/32293453
8931,32211965,Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes,Eur Radiol. 2020 Aug;30(8):4251-4261. doi: 10.1007/s00330-020-06725-9. Epub 2020 Mar 24.,Abreu-Gomez J,https://www.ncbi.nlm.nih.gov/pubmed/32211965
8932,32461073,Techniques and Outcomes of Salvage Robot-Assisted Radical Prostatectomy (sRARP),Eur Urol. 2020 Dec;78(6):885-892. doi: 10.1016/j.eururo.2020.05.003. Epub 2020 May 24.,De Groote R,https://www.ncbi.nlm.nih.gov/pubmed/32461073
8933,32442822,A biochemical definition of cure after brachytherapy for prostate cancer,Radiother Oncol. 2020 Aug;149:64-69. doi: 10.1016/j.radonc.2020.04.038. Epub 2020 Apr 27.,Crook JM,https://www.ncbi.nlm.nih.gov/pubmed/32442822
8934,32051551,Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):232-243. doi: 10.1038/s41391-020-0206-6. Epub 2020 Feb 12.,Connor MJ,https://www.ncbi.nlm.nih.gov/pubmed/32051551
8935,32402143,Transvesical robot-assisted radical prostatectomy: initial experience and surgical outcomes,BJU Int. 2020 Aug;126(2):300-308. doi: 10.1111/bju.15111. Epub 2020 Jun 1.,Zhou X,https://www.ncbi.nlm.nih.gov/pubmed/32402143
8936,31705700,Hemi-ablative low-dose-rate prostate brachytherapy for unilateral localised prostate cancer,BJU Int. 2020 Mar;125(3):383-390. doi: 10.1111/bju.14948. Epub 2019 Dec 23.,Langley S,https://www.ncbi.nlm.nih.gov/pubmed/31705700
8937,31695139,Prostate cancer characteristics and cancer-specific mortality of Native American patients,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):277-285. doi: 10.1038/s41391-019-0184-8. Epub 2019 Nov 6.,Deuker M,https://www.ncbi.nlm.nih.gov/pubmed/31695139
8938,31863617,Salvage radical prostatectomy following focal therapy: functional and oncological outcomes,BJU Int. 2020 Apr;125(4):525-530. doi: 10.1111/bju.14976. Epub 2020 Jan 9.,Herrera-Caceres JO,https://www.ncbi.nlm.nih.gov/pubmed/31863617
8939,32122185,Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016,Acta Oncol. 2020 May;59(5):549-557. doi: 10.1080/0284186X.2020.1730003. Epub 2020 Mar 3.,Beckmann K,https://www.ncbi.nlm.nih.gov/pubmed/32122185
8940,32176456,The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer,BJU Int. 2020 Jun;125(6):792-800. doi: 10.1111/bju.15055. Epub 2020 Apr 7.,Ranasinghe W,https://www.ncbi.nlm.nih.gov/pubmed/32176456
8941,32487352,Oncological control following partial gland ablation for intermediate-risk prostate cancer,Urol Oncol. 2020 Aug;38(8):671-677. doi: 10.1016/j.urolonc.2020.04.017. Epub 2020 May 31.,Becher E,https://www.ncbi.nlm.nih.gov/pubmed/32487352
8942,32074125,Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders,PLoS One. 2020 Feb 19;15(2):e0229263. doi: 10.1371/journal.pone.0229263. eCollection 2020.,Liu JM,https://www.ncbi.nlm.nih.gov/pubmed/32074125
8943,31977387,Pathologically Node-Positive Prostate Cancer: Casting for Cure When the Die Is Cast?,Cancer J. 2020 Jan/Feb;26(1):58-63. doi: 10.1097/PPO.0000000000000426.,Ginsburg KB,https://www.ncbi.nlm.nih.gov/pubmed/31977387
8944,31830312,Histotripsy: The Next Generation of High-Intensity Focused Ultrasound for Focal Prostate Cancer Therapy,J Ultrasound Med. 2020 Jun;39(6):1057-1067. doi: 10.1002/jum.15191. Epub 2019 Dec 12.,Dubinsky TJ,https://www.ncbi.nlm.nih.gov/pubmed/31830312
8945,30850855,Evolution of definitive external beam radiation therapy in the treatment of prostate cancer,World J Urol. 2020 Mar;38(3):565-591. doi: 10.1007/s00345-019-02661-6. Epub 2019 Mar 8.,Daly T,https://www.ncbi.nlm.nih.gov/pubmed/30850855
8946,32295696,Repeat Radiation for Local Recurrence of Head and Neck Tumors and in Prostate Cancer,Dtsch Arztebl Int. 2020 Mar 6;117(10):167-174. doi: 10.3238/arztebl.2020.0167.,Grün A,https://www.ncbi.nlm.nih.gov/pubmed/32295696
8947,31945379,The Development and Validation of Prostate Cancer-specific Physician-Hospital Networks,Urology. 2020 Apr;138:37-44. doi: 10.1016/j.urology.2019.11.049. Epub 2020 Jan 13.,Jacobs BL,https://www.ncbi.nlm.nih.gov/pubmed/31945379
8948,31734604,MRI-based IMPT planning for prostate cancer,Radiother Oncol. 2020 Mar;144:79-85. doi: 10.1016/j.radonc.2019.10.010. Epub 2019 Nov 14.,Depauw N,https://www.ncbi.nlm.nih.gov/pubmed/31734604
8949,31708350,Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Apr;32(4):259-265. doi: 10.1016/j.clon.2019.10.008. Epub 2019 Nov 7.,Chitmanee P,https://www.ncbi.nlm.nih.gov/pubmed/31708350
8951,31714369,"Robot-assisted radical prostatectomy vs. open radical prostatectomy: latest evidences on perioperative, functional and oncological outcomes",Curr Opin Urol. 2020 Jan;30(1):73-78. doi: 10.1097/MOU.0000000000000688.,Dell'Oglio P,https://www.ncbi.nlm.nih.gov/pubmed/31714369
8952,32141699,A fast robust optimizer for intensity modulated proton therapy using GPU,J Appl Clin Med Phys. 2020 Mar;21(3):123-133. doi: 10.1002/acm2.12835. Epub 2020 Mar 6.,Xu Y,https://www.ncbi.nlm.nih.gov/pubmed/32141699
8953,31928867,Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomy,Urol Oncol. 2020 Apr;38(4):184-190. doi: 10.1016/j.urolonc.2019.12.014. Epub 2020 Jan 9.,Knipper S,https://www.ncbi.nlm.nih.gov/pubmed/31928867
8954,31873779,Image-guided dose-escalated radiation therapy for localized prostate cancer with helical tomotherapy,Strahlenther Onkol. 2020 Mar;196(3):229-242. doi: 10.1007/s00066-019-01562-2. Epub 2019 Dec 23.,Barelkowski T,https://www.ncbi.nlm.nih.gov/pubmed/31873779
8956,31512285,Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature,Int J Urol. 2020 Jan;27(1):24-29. doi: 10.1111/iju.14102. Epub 2019 Sep 11.,Kawamura H,https://www.ncbi.nlm.nih.gov/pubmed/31512285
8957,31942652,Focal high-dose-rate brachytherapy for localized prostate cancer: toxicity and preliminary biochemical results,Strahlenther Onkol. 2020 Mar;196(3):222-228. doi: 10.1007/s00066-019-01561-3. Epub 2020 Jan 15.,Prada PJ,https://www.ncbi.nlm.nih.gov/pubmed/31942652
8958,32077006,Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging,Radiol Med. 2020 May;125(5):491-499. doi: 10.1007/s11547-020-01148-4. Epub 2020 Feb 19.,Rigo M,https://www.ncbi.nlm.nih.gov/pubmed/32077006
8959,32756597,Dr. Answer AI for prostate cancer: Clinical outcome prediction model and service,PLoS One. 2020 Aug 5;15(8):e0236553. doi: 10.1371/journal.pone.0236553. eCollection 2020.,Rho MJ,https://www.ncbi.nlm.nih.gov/pubmed/32756597
8960,32004559,Outcomes and Complications After Intervention for Postradiation Prostatic Urethral Stenosis,Urology. 2020 May;139:193-197. doi: 10.1016/j.urology.2019.11.063. Epub 2020 Jan 28.,Smith SM,https://www.ncbi.nlm.nih.gov/pubmed/32004559
8961,32366385,A Review of Stereotactic Body Radiation Therapy in the Management of Oligometastatic Prostate Cancer,Anticancer Res. 2020 May;40(5):2419-2428. doi: 10.21873/anticanres.14211.,Zhang B,https://www.ncbi.nlm.nih.gov/pubmed/32366385
8962,31846391,Associations between Hospital Volume and Outcomes of Robot-Assisted Radical Prostatectomy,J Urol. 2020 May;203(5):926-932. doi: 10.1097/JU.0000000000000698. Epub 2019 Dec 17.,Xia L,https://www.ncbi.nlm.nih.gov/pubmed/31846391
8963,32581061,High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot,J Immunother Cancer. 2020 Jun;8(1):e000792. doi: 10.1136/jitc-2020-000792.,Keam SP,https://www.ncbi.nlm.nih.gov/pubmed/32581061
8964,32068493,"The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis",J Urol. 2022 Oct;208(4):846-854. doi: 10.1097/JU.0000000000000805. Epub 2020 Feb 18.,Oake JD,https://www.ncbi.nlm.nih.gov/pubmed/32068493
8965,32449896,Peritoneal Flap in Robot-Assisted Radical Prostatectomy,Dtsch Arztebl Int. 2020 Apr 3;117(14):243-250. doi: 10.3238/arztebl.2020.0243.,Bründl J,https://www.ncbi.nlm.nih.gov/pubmed/32449896
8967,32013912,Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors,BMC Cancer. 2020 Feb 3;20(1):90. doi: 10.1186/s12885-020-6581-5.,Buwenge M,https://www.ncbi.nlm.nih.gov/pubmed/32013912
8968,32141110,Quality of life in active surveillance for early prostate cancer,Int J Urol. 2020 Apr;27(4):296-306. doi: 10.1111/iju.14202. Epub 2020 Mar 6.,Kato T,https://www.ncbi.nlm.nih.gov/pubmed/32141110
8969,32245911,Patient-reported outcomes after surgery or radiotherapy for localised prostate cancer: a retrospective study,Hong Kong Med J. 2020 Apr;26(2):95-101. doi: 10.12809/hkmj198239. Epub 2020 Apr 2.,Ng CF,https://www.ncbi.nlm.nih.gov/pubmed/32245911
8970,32165116,Neoadjuvant Leuprolide Therapy with Radical Prostatectomy: Long-term Effects on Health-related Quality of Life,Eur Urol Focus. 2021 Jul;7(4):779-787. doi: 10.1016/j.euf.2020.03.001. Epub 2020 Mar 9.,Chen MC,https://www.ncbi.nlm.nih.gov/pubmed/32165116
8971,31742674,Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends,Cancer. 2020 Feb 1;126(3):506-514. doi: 10.1002/cncr.32570. Epub 2019 Nov 19.,Tang C,https://www.ncbi.nlm.nih.gov/pubmed/31742674
8972,31874245,miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA,Cancer Lett. 2020 Mar 31;473:107-117. doi: 10.1016/j.canlet.2019.12.025. Epub 2019 Dec 23.,Ray J,https://www.ncbi.nlm.nih.gov/pubmed/31874245
8973,32418156,Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer,Clin Transl Oncol. 2020 Dec;22(12):2236-2243. doi: 10.1007/s12094-020-02364-0. Epub 2020 May 16.,Ingrosso G,https://www.ncbi.nlm.nih.gov/pubmed/32418156
8975,32518630,Recent advances in de-intensification of radiotherapy in elderly cancer patients,F1000Res. 2020 May 27;9:F1000 Faculty Rev-447. doi: 10.12688/f1000research.21151.1. eCollection 2020.,Desideri I,https://www.ncbi.nlm.nih.gov/pubmed/32518630
8976,31912470,Factors Predicting Prostate Specific Antigen Failure Following Radical Prostatectomy: Experience with 961 Patients,Urol J. 2020 Jan 4;17(5):486-491. doi: 10.22037/uj.v0i0.5670.,Simforoosh N,https://www.ncbi.nlm.nih.gov/pubmed/31912470
8977,32147556,Prostate Cancer Brain Metastases: A Single-Institution Experience,World Neurosurg. 2020 Jun;138:e445-e449. doi: 10.1016/j.wneu.2020.02.152. Epub 2020 Mar 5.,Bhambhvani HP,https://www.ncbi.nlm.nih.gov/pubmed/32147556
8978,32129297,Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy,Indian J Cancer. 2020 Jan-Mar;57(1):70-75. doi: 10.4103/ijc.IJC_465_18.,Yildirim HC,https://www.ncbi.nlm.nih.gov/pubmed/32129297
8979,31977386,Clinically Lymph Node Positive Prostate Cancer: At the Intersection of Focal and Systemic Disease Control,Cancer J. 2020 Jan/Feb;26(1):53-57. doi: 10.1097/PPO.0000000000000421.,Reichert ZR,https://www.ncbi.nlm.nih.gov/pubmed/31977386
8980,33085712,68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer,PLoS One. 2020 Oct 21;15(10):e0240892. doi: 10.1371/journal.pone.0240892. eCollection 2020.,Kalinauskaite G,https://www.ncbi.nlm.nih.gov/pubmed/33085712
8981,32075389,Long-Term Clinical Results of IGRT in Prostate Cancer Treatment,Klin Onkol. 2020 Winter;33(1):49-54. doi: 10.14735/amko202049.,Doležel M,https://www.ncbi.nlm.nih.gov/pubmed/32075389
8982,32001144,Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019,Eur Urol. 2020 Apr;77(4):508-547. doi: 10.1016/j.eururo.2020.01.012. Epub 2020 Jan 27.,Gillessen S,https://www.ncbi.nlm.nih.gov/pubmed/32001144
8983,31977382,Comparing Radiotherapy to Prostatectomy for High-Risk Prostate Cancer: A Narrative Review of Mortality and Quality-of-Life Outcomes,Cancer J. 2020 Jan/Feb;26(1):29-37. doi: 10.1097/PPO.0000000000000420.,Greenberger BA,https://www.ncbi.nlm.nih.gov/pubmed/31977382
8985,32111781,Clinical Outcomes of Dose-escalated Radiotherapy for Localised Prostate Cancer: A Single-institution Experience,In Vivo. 2020 Mar-Apr;34(2):757-765. doi: 10.21873/invivo.11835.,Meng K,https://www.ncbi.nlm.nih.gov/pubmed/32111781
8986,32167866,Prospective Evaluation of Focal High Intensity Focused Ultrasound for Localized Prostate Cancer,J Urol. 2020 Sep;204(3):483-489. doi: 10.1097/JU.0000000000001015. Epub 2020 Mar 13.,Nahar B,https://www.ncbi.nlm.nih.gov/pubmed/32167866
8987,32073662,Validation of a subclassification for high-risk prostate cancer in a prospective cohort,Cancer. 2020 May 15;126(10):2132-2138. doi: 10.1002/cncr.32778. Epub 2020 Feb 19.,Butler SS,https://www.ncbi.nlm.nih.gov/pubmed/32073662
8988,31994469,The Effect of Prostate Cancer Radiotherapy on Testosterone Level: A Systematic Review and Meta-analysis,Anticancer Agents Med Chem. 2020;20(6):636-642. doi: 10.2174/1871520620666200128112558.,Mortezaee K,https://www.ncbi.nlm.nih.gov/pubmed/31994469
8989,31537483,Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors,Urol Oncol. 2020 Jan;38(1):1.e17-1.e23. doi: 10.1016/j.urolonc.2019.08.016. Epub 2019 Sep 16.,Pooli A,https://www.ncbi.nlm.nih.gov/pubmed/31537483
8991,31721011,Influence of the technique and comorbidities in hypofractionated radiotherapy for prostate cancer,Clin Transl Oncol. 2020 Mar;22(3):311-318. doi: 10.1007/s12094-019-02224-6. Epub 2019 Nov 12.,Correa R,https://www.ncbi.nlm.nih.gov/pubmed/31721011
8992,31612318,Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naïve patients,J Cancer Res Clin Oncol. 2020 Jan;146(1):221-227. doi: 10.1007/s00432-019-03049-0. Epub 2019 Oct 14.,Heo JE,https://www.ncbi.nlm.nih.gov/pubmed/31612318
8993,31735619,The Relationship and Psychosocial Impact of Arousal Incontinence After Radical Prostatectomy,J Sex Med. 2020 Jan;17(1):94-98. doi: 10.1016/j.jsxm.2019.09.001. Epub 2019 Nov 15.,Salter CA,https://www.ncbi.nlm.nih.gov/pubmed/31735619
8994,31894469,The ongoing dilemma in pelvic lymph node dissection during radical prostatectomy: who should decide and in which patients?,J Robot Surg. 2020 Aug;14(4):549-558. doi: 10.1007/s11701-019-01041-x. Epub 2020 Jan 1.,Onol FF,https://www.ncbi.nlm.nih.gov/pubmed/31894469
8997,31837989,Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancer,Brachytherapy. 2020 Mar-Apr;19(2):222-227. doi: 10.1016/j.brachy.2019.11.003. Epub 2019 Dec 16.,Bazinet A,https://www.ncbi.nlm.nih.gov/pubmed/31837989
8998,32249178,Cesium-131 prostate brachytherapy: A single institutional long-term experience,Brachytherapy. 2020 May-Jun;19(3):298-304. doi: 10.1016/j.brachy.2020.02.006. Epub 2020 Apr 2.,Benoit RM,https://www.ncbi.nlm.nih.gov/pubmed/32249178
8999,32220891,"Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer",Clin Cancer Res. 2020 Jul 1;26(13):3230-3238. doi: 10.1158/1078-0432.CCR-20-0168. Epub 2020 Mar 27.,Stopsack KH,https://www.ncbi.nlm.nih.gov/pubmed/32220891
9000,32359937,COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation,Brachytherapy. 2020 Jul-Aug;19(4):401-411. doi: 10.1016/j.brachy.2020.04.005. Epub 2020 Apr 21.,Williams VM,https://www.ncbi.nlm.nih.gov/pubmed/32359937
9001,31679137,Clinical characteristics and outcomes of robot-assisted laparoscopic radical prostatectomy in HIV-positive patients: a nationwide population-based analysis,Int Urol Nephrol. 2020 Mar;52(3):481-487. doi: 10.1007/s11255-019-02321-z. Epub 2019 Nov 2.,Han H,https://www.ncbi.nlm.nih.gov/pubmed/31679137
9002,31653565,Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy,Urol Oncol. 2020 Apr;38(4):204-209. doi: 10.1016/j.urolonc.2019.09.018. Epub 2019 Oct 23.,Bravi CA,https://www.ncbi.nlm.nih.gov/pubmed/31653565
9003,31629640,Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy,Brachytherapy. 2020 Jan-Feb;19(1):24-32. doi: 10.1016/j.brachy.2019.09.001. Epub 2019 Oct 16.,Boehle A,https://www.ncbi.nlm.nih.gov/pubmed/31629640
9004,31932660,GLUT1 expression in high-risk prostate cancer: correlation with (18)F-FDG-PET/CT and clinical outcome,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):441-448. doi: 10.1038/s41391-020-0202-x. Epub 2020 Jan 13.,Meziou S,https://www.ncbi.nlm.nih.gov/pubmed/31932660
9007,32229268,Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis,Clin Genitourin Cancer. 2020 Oct;18(5):e517-e522. doi: 10.1016/j.clgc.2020.02.011. Epub 2020 Mar 4.,Lysenko I,https://www.ncbi.nlm.nih.gov/pubmed/32229268
9008,31942457,"Lessons learned from 12,000 robotic radical prostatectomies: Is the journey as important as the outcome?",Investig Clin Urol. 2020 Jan;61(1):1-10. doi: 10.4111/icu.2020.61.1.1. Epub 2020 Jan 2.,Kang SG,https://www.ncbi.nlm.nih.gov/pubmed/31942457
9009,32453443,Patterns of metastases of prostatic ductal adenocarcinoma,Cancer. 2020 Aug 15;126(16):3667-3673. doi: 10.1002/cncr.32957. Epub 2020 May 26.,Ranasinghe WKB,https://www.ncbi.nlm.nih.gov/pubmed/32453443
9011,31610249,External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume,Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):525-533. doi: 10.1016/j.ijrobp.2019.09.044. Epub 2019 Oct 11.,Tharmalingam H,https://www.ncbi.nlm.nih.gov/pubmed/31610249
9012,31361571,The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns,J Urol. 2020 Jan;203(1):128-136. doi: 10.1097/JU.0000000000000471. Epub 2019 Jul 30.,Jacobs BL,https://www.ncbi.nlm.nih.gov/pubmed/31361571
9013,32248613,Single-port robot-assisted radical prostatectomy: a systematic review and pooled analysis of the preliminary experiences,BJU Int. 2020 Jul;126(1):55-64. doi: 10.1111/bju.15069. Epub 2020 May 1.,Checcucci E,https://www.ncbi.nlm.nih.gov/pubmed/32248613
9014,32285740,Work status and work ability after radical prostatectomy or active surveillance for prostate cancer,Scand J Urol. 2020 Jun;54(3):194-200. doi: 10.1080/21681805.2020.1750473. Epub 2020 Apr 14.,Nilsson R,https://www.ncbi.nlm.nih.gov/pubmed/32285740
9015,32220567,Outcomes for Young Men With Localized Intermediate-Risk Prostate Cancer: An Analysis of the NCDB,Clin Genitourin Cancer. 2020 Oct;18(5):e531-e542. doi: 10.1016/j.clgc.2020.02.002. Epub 2020 Feb 22.,Chua S,https://www.ncbi.nlm.nih.gov/pubmed/32220567
9016,31845838,Tumor Seeding after Robot-Assisted Radical Prostatectomy: Literature Review and Experience from a Single Institution,J Urol. 2020 Jun;203(6):1141-1146. doi: 10.1097/JU.0000000000000701. Epub 2020 Mar 17.,Motterle G,https://www.ncbi.nlm.nih.gov/pubmed/31845838
9017,32232450,Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy,JAMA Netw Open. 2020 Mar 2;3(3):e201913. doi: 10.1001/jamanetworkopen.2020.1913.,Martini A,https://www.ncbi.nlm.nih.gov/pubmed/32232450
9018,32377602,Long-term oncologic outcomes after radical prostatectomy in clinically localized prostate cancer: 10-year follow-up in Korea,Investig Clin Urol. 2020 May;61(3):269-276. doi: 10.4111/icu.2020.61.3.269. Epub 2020 Apr 21.,Suh J,https://www.ncbi.nlm.nih.gov/pubmed/32377602
9020,31668729,Erectile Recovery After Radical Pelvic Surgery: Methodological Challenges and Recommendations for Data Reporting,J Sex Med. 2020 Jan;17(1):7-16. doi: 10.1016/j.jsxm.2019.09.013. Epub 2019 Oct 24.,Capogrosso P,https://www.ncbi.nlm.nih.gov/pubmed/31668729
9021,31713121,Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer,Dig Dis Sci. 2020 Jan;65(1):22-30. doi: 10.1007/s10620-019-05934-7. Epub 2019 Nov 11.,Kim J,https://www.ncbi.nlm.nih.gov/pubmed/31713121
9022,31900431,Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatment,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):435-440. doi: 10.1038/s41391-019-0199-1. Epub 2020 Jan 3.,Falzarano SM,https://www.ncbi.nlm.nih.gov/pubmed/31900431
9023,32354962,Lack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate Cancer,In Vivo. 2020 May-Jun;34(3):1555-1563. doi: 10.21873/invivo.11945.,Zwicker F,https://www.ncbi.nlm.nih.gov/pubmed/32354962
9024,30887183,Associations between intraoperative factors and surgeons' self-assessed operative satisfaction,Surg Endosc. 2020 Jan;34(1):61-68. doi: 10.1007/s00464-019-06731-z. Epub 2019 Mar 18.,Erestam S,https://www.ncbi.nlm.nih.gov/pubmed/30887183
9025,32412803,"Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions",Am Soc Clin Oncol Educ Book. 2020 May;40:1-12. doi: 10.1200/EDBK_279459.,McKay RR,https://www.ncbi.nlm.nih.gov/pubmed/32412803
9026,32180511,Response on DCE-MRI predicts outcome of salvage radiotherapy for local recurrence after radical prostatectomy,Tumori. 2021 Feb;107(1):55-63. doi: 10.1177/0300891620908950. Epub 2020 Mar 17.,Sanguineti G,https://www.ncbi.nlm.nih.gov/pubmed/32180511
9027,32132074,Assessment of Daily Replanning and Geometrical Variation of High-dose-rate Brachytherapy for the Prostate,Anticancer Res. 2020 Mar;40(3):1677-1682. doi: 10.21873/anticanres.14119.,Uchida H,https://www.ncbi.nlm.nih.gov/pubmed/32132074
9028,31829902,Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline,J Clin Oncol. 2020 May 1;38(13):1474-1494. doi: 10.1200/JCO.19.02768. Epub 2019 Dec 12.,Eggener SE,https://www.ncbi.nlm.nih.gov/pubmed/31829902
9029,30124773,Causal inference in continuous time: an example on prostate cancer therapy,Biostatistics. 2020 Jan 1;21(1):172-185. doi: 10.1093/biostatistics/kxy036.,Ryalen PC,https://www.ncbi.nlm.nih.gov/pubmed/30124773
9030,31559880,(68)Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases of recurrent prostate cancer after initial surgery,Acta Oncol. 2020 Feb;59(2):149-156. doi: 10.1080/0284186X.2019.1669816. Epub 2019 Sep 27.,Marzec J,https://www.ncbi.nlm.nih.gov/pubmed/31559880
9031,32091305,Perioperative Outcomes of Single vs Multi-Port Robotic Assisted Radical Prostatectomy: A Single Institutional Experience,J Urol. 2020 Sep;204(3):490-495. doi: 10.1097/JU.0000000000000811. Epub 2020 Feb 24.,Saidian A,https://www.ncbi.nlm.nih.gov/pubmed/32091305
9032,32234553,Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial,Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):530-538. doi: 10.1016/j.ijrobp.2020.03.014. Epub 2020 Mar 29.,Keall P,https://www.ncbi.nlm.nih.gov/pubmed/32234553
9033,32151470,Comparison between laparoscopic and open prostatectomy: Postoperative urinary continence analysis,Actas Urol Esp (Engl Ed). 2020 Oct;44(8):535-541. doi: 10.1016/j.acuro.2019.10.002. Epub 2020 Mar 6.,Martínez-Holguín E,https://www.ncbi.nlm.nih.gov/pubmed/32151470
9034,32033148,The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival,Medicina (Kaunas). 2020 Feb 4;56(2):61. doi: 10.3390/medicina56020061.,Bakavi?ius A,https://www.ncbi.nlm.nih.gov/pubmed/32033148
9035,30892691,Endocrine disrupting-chemicals and biochemical recurrence of prostate cancer after prostatectomy: A cohort study in Guadeloupe (French West Indies),Int J Cancer. 2020 Feb 1;146(3):657-663. doi: 10.1002/ijc.32287. Epub 2019 Apr 8.,Brureau L,https://www.ncbi.nlm.nih.gov/pubmed/30892691
9036,32034499,Functional and perioperative outcomes in elderly men after robotic-assisted radical prostatectomy for prostate cancer,World J Urol. 2020 Nov;38(11):2791-2798. doi: 10.1007/s00345-020-03096-0. Epub 2020 Feb 7.,Traboulsi SL,https://www.ncbi.nlm.nih.gov/pubmed/32034499
9037,32278731,The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy,Urol Oncol. 2020 Oct;38(10):794.e17-794.e27. doi: 10.1016/j.urolonc.2020.03.004. Epub 2020 Apr 9.,Bargão Santos P,https://www.ncbi.nlm.nih.gov/pubmed/32278731
9038,32174775,Comparison of Biochemical Recurrence After Robot-assisted Laparoscopic Radical Prostatectomy with Volatile and Total Intravenous Anesthesia,Int J Med Sci. 2020 Feb 4;17(4):449-456. doi: 10.7150/ijms.40958. eCollection 2020.,Kim NY,https://www.ncbi.nlm.nih.gov/pubmed/32174775
9039,31984644,Robot-assisted radical perineal prostatectomy: a review of 95 cases,BJU Int. 2020 Apr;125(4):573-578. doi: 10.1111/bju.15018. Epub 2020 Feb 21.,Tu?cu V,https://www.ncbi.nlm.nih.gov/pubmed/31984644
9040,32028270,Automatic bi-objective parameter tuning for inverse planning of high-dose-rate prostate brachytherapy,Phys Med Biol. 2020 Apr 2;65(7):075009. doi: 10.1088/1361-6560/ab7362.,Maree SC,https://www.ncbi.nlm.nih.gov/pubmed/32028270
9041,32314509,Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer,BJU Int. 2021 Jan;127(1):44-55. doi: 10.1111/bju.15086. Epub 2020 May 14.,Szarvas T,https://www.ncbi.nlm.nih.gov/pubmed/32314509
9042,31828783,A novel (169) Yb-based dynamic-shield intensity modulated brachytherapy delivery system for prostate cancer,Med Phys. 2020 Mar;47(3):859-868. doi: 10.1002/mp.13959. Epub 2019 Dec 30.,Famulari G,https://www.ncbi.nlm.nih.gov/pubmed/31828783
9043,31924529,High-intensity Focused Ultrasound for the Treatment of Prostate Cancer: A National Cohort Study Focusing on the Development of Stricture and Fistulae,Eur Urol Focus. 2021 Mar;7(2):340-346. doi: 10.1016/j.euf.2019.11.014. Epub 2020 Jan 7.,Dosanjh A,https://www.ncbi.nlm.nih.gov/pubmed/31924529
9044,32279904,A Comparison of Perioperative Outcomes Between Single-port and Multiport Robot-assisted Laparoscopic Prostatectomy,Eur Urol. 2020 Jun;77(6):671-674. doi: 10.1016/j.eururo.2020.03.031. Epub 2020 Apr 9.,Vigneswaran HT,https://www.ncbi.nlm.nih.gov/pubmed/32279904
9045,31542882,External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients,Int Urol Nephrol. 2020 Jan;52(1):59-66. doi: 10.1007/s11255-019-02284-1. Epub 2019 Sep 21.,Knipper S,https://www.ncbi.nlm.nih.gov/pubmed/31542882
9046,32471604,Robust treatment planning in whole pelvis pencil beam scanning proton therapy for prostate cancer,Med Dosim. 2020 Winter;45(4):334-338. doi: 10.1016/j.meddos.2020.04.001. Epub 2020 May 26.,Butala AA,https://www.ncbi.nlm.nih.gov/pubmed/32471604
9047,32320130,"Pelvic exenteration surgery in patients with locally advanced castration-naïve and castration-resistant, symptomatic prostate cancer",BJU Int. 2020 Sep;126(3):342-349. doi: 10.1111/bju.15088. Epub 2020 May 16.,Heidenreich A,https://www.ncbi.nlm.nih.gov/pubmed/32320130
9048,32130481,Predictors of the regional variation of prostatectomy or radiotherapy: evidence from German cancer registries,J Cancer Res Clin Oncol. 2020 May;146(5):1197-1204. doi: 10.1007/s00432-020-03140-x. Epub 2020 Mar 4.,Medenwald D,https://www.ncbi.nlm.nih.gov/pubmed/32130481
9051,32173355,Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study,Clin Genitourin Cancer. 2020 Jun;18(3):185-191. doi: 10.1016/j.clgc.2019.10.009. Epub 2019 Oct 16.,Frantellizzi V,https://www.ncbi.nlm.nih.gov/pubmed/32173355
9052,32399639,Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy,Strahlenther Onkol. 2020 Nov;196(11):1006-1017. doi: 10.1007/s00066-020-01629-5. Epub 2020 May 12.,Henkenberens C,https://www.ncbi.nlm.nih.gov/pubmed/32399639
9054,32037859,A Systematic Review and Meta-Analysis of Pelvic Drain Insertion After Robot-Assisted Radical Prostatectomy,J Endourol. 2020 Apr;34(4):401-408. doi: 10.1089/end.2019.0554. Epub 2020 Mar 23.,Zhong W,https://www.ncbi.nlm.nih.gov/pubmed/32037859
9055,32487626,Race Does Not Affect Survival in Patients With Prostate Cancer Treated With Radiation Therapy,Anticancer Res. 2020 Jun;40(6):3307-3314. doi: 10.21873/anticanres.14313.,Kodiyan J,https://www.ncbi.nlm.nih.gov/pubmed/32487626
9056,31551125,A Phase I/II Study of Stereotactic Hypofractionated Once-weekly Radiation Therapy (SHORT) for Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Feb;32(2):e39-e45. doi: 10.1016/j.clon.2019.09.046. Epub 2019 Sep 21.,Mallick I,https://www.ncbi.nlm.nih.gov/pubmed/31551125
9057,32595074,A Nationwide Persistent Underutilization of Adjuvant Radiotherapy in North American Prostate Cancer Patients,Clin Genitourin Cancer. 2020 Dec;18(6):489-499.e6. doi: 10.1016/j.clgc.2020.05.001. Epub 2020 May 16.,Rakic N,https://www.ncbi.nlm.nih.gov/pubmed/32595074
9059,30937571,"Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men???45 years of age",World J Urol. 2020 Jan;38(1):95-101. doi: 10.1007/s00345-019-02740-8. Epub 2019 Apr 2.,Tilki D,https://www.ncbi.nlm.nih.gov/pubmed/30937571
9060,32312661,Challenges in Reporting the Effect of Radiotherapy on Erectile Function,J Sex Med. 2020 Jun;17(6):1053-1059. doi: 10.1016/j.jsxm.2020.03.008. Epub 2020 Apr 17.,Nukala V,https://www.ncbi.nlm.nih.gov/pubmed/32312661
9061,32006609,MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localized Radiorecurrent Prostate Cancer: Updated Results of 50 Patients,Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):126-135. doi: 10.1016/j.ijrobp.2020.01.023. Epub 2020 Jan 30.,van Son MJ,https://www.ncbi.nlm.nih.gov/pubmed/32006609
9063,31587417,Placement of SpaceOAR hydrogel spacer for prostate cancer patients treated with iodine-125 low-dose-rate brachytherapy,Int J Urol. 2020 Jan;27(1):60-66. doi: 10.1111/iju.14123. Epub 2019 Oct 6.,Morita M,https://www.ncbi.nlm.nih.gov/pubmed/31587417
9064,32923125,A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer,Oncoimmunology. 2020 Jun 1;9(1):1762473. doi: 10.1080/2162402X.2020.1762473.,Shao N,https://www.ncbi.nlm.nih.gov/pubmed/32923125
9065,31478610,Impact of time from diagnosis to treatment on erectile function outcomes after radical prostatectomy,Andrology. 2020 Mar;8(2):337-341. doi: 10.1111/andr.12699. Epub 2019 Sep 3.,Schifano N,https://www.ncbi.nlm.nih.gov/pubmed/31478610
9066,32085930,"Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation",Brachytherapy. 2020 Mar-Apr;19(2):228-233. doi: 10.1016/j.brachy.2019.11.002. Epub 2020 Feb 19.,Kahn J,https://www.ncbi.nlm.nih.gov/pubmed/32085930
9067,31981976,Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients,EBioMedicine. 2020 Feb;52:102616. doi: 10.1016/j.ebiom.2019.102616. Epub 2020 Jan 22.,Xu J,https://www.ncbi.nlm.nih.gov/pubmed/31981976
9069,31493108,Comparison of intra- and postoperative analgesia and pain perception in robot-assisted vs. open radical prostatectomy,World J Urol. 2020 Jun;38(6):1451-1457. doi: 10.1007/s00345-019-02938-w. Epub 2019 Sep 6.,Knipper S,https://www.ncbi.nlm.nih.gov/pubmed/31493108
9070,31836682,(18)F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy,J Nucl Med. 2020 May;61(5):696-701. doi: 10.2967/jnumed.119.234914. Epub 2019 Dec 13.,Eiber M,https://www.ncbi.nlm.nih.gov/pubmed/31836682
9071,31948931,"Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre study",Urol Oncol. 2020 Jun;38(6):599.e15-599.e21. doi: 10.1016/j.urolonc.2019.12.017. Epub 2020 Jan 14.,Felber M,https://www.ncbi.nlm.nih.gov/pubmed/31948931
9073,32354921,Dose-volume Histogram-based Predictors for Hematuria and Rectal Hemorrhage in Patients Receiving Radiotherapy After Radical Prostatectomy,In Vivo. 2020 May-Jun;34(3):1289-1295. doi: 10.21873/invivo.11904.,Shirai K,https://www.ncbi.nlm.nih.gov/pubmed/32354921
9074,31411996,Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis,Eur Urol Oncol. 2020 Apr;3(2):183-197. doi: 10.1016/j.euo.2018.12.011. Epub 2019 Jan 24.,Ingrosso G,https://www.ncbi.nlm.nih.gov/pubmed/31411996
9075,31697452,Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancer,Cancer Med. 2020 Jan;9(1):27-34. doi: 10.1002/cam4.2605. Epub 2019 Nov 7.,Yin M,https://www.ncbi.nlm.nih.gov/pubmed/31697452
9077,32382097,Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system,Sci Rep. 2020 May 7;10(1):7722. doi: 10.1038/s41598-020-64693-y.,Alqahtani S,https://www.ncbi.nlm.nih.gov/pubmed/32382097
9078,32269460,Co-morbidities in a Retrospective Cohort of Prostate Cancer Patients,Ethn Dis. 2020 Apr 2;30(Suppl 1):185-192. doi: 10.18865/ed.30.S1.185. eCollection 2020.,Jefferson M,https://www.ncbi.nlm.nih.gov/pubmed/32269460
9079,31680423,Using spatial tracking with magnetic resonance imaging/ultrasound-guided biopsy to identify unilateral prostate cancer,BJU Int. 2020 Mar;125(3):399-406. doi: 10.1111/bju.14943. Epub 2019 Nov 25.,Zhou SR,https://www.ncbi.nlm.nih.gov/pubmed/31680423
9080,31760356,Patient-reported outcome measures after treatment for prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata),Cancer Epidemiol. 2020 Feb;64:101623. doi: 10.1016/j.canep.2019.101623. Epub 2019 Nov 21.,Nguyen-Nielsen M,https://www.ncbi.nlm.nih.gov/pubmed/31760356
9081,32354922,"BIT-ART: Multicentric Comparison of HDR-brachytherapy, Intensity-modulated Radiotherapy and Tomotherapy for Advanced Radiotherapy in Prostate Cancer",In Vivo. 2020 May-Jun;34(3):1297-1305. doi: 10.21873/invivo.11905.,Alitto AR,https://www.ncbi.nlm.nih.gov/pubmed/32354922
9082,31653563,Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis,Urol Oncol. 2020 Mar;38(3):79.e9-79.e14. doi: 10.1016/j.urolonc.2019.09.015. Epub 2019 Oct 23.,Knipper S,https://www.ncbi.nlm.nih.gov/pubmed/31653563
9085,31411965,Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices,Eur Urol Oncol. 2020 Feb;3(1):21-31. doi: 10.1016/j.euo.2018.12.004. Epub 2018 Dec 26.,van Stam MA,https://www.ncbi.nlm.nih.gov/pubmed/31411965
9086,32356465,Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy,Future Oncol. 2020 Jun;16(16):1083-1189. doi: 10.2217/fon-2020-0056. Epub 2020 May 1.,Dirix P,https://www.ncbi.nlm.nih.gov/pubmed/32356465
9087,31610251,Risk of Pelvic Fracture With Radiation Therapy in Older Patients,Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):485-492. doi: 10.1016/j.ijrobp.2019.10.006. Epub 2019 Oct 11.,Vitzthum LK,https://www.ncbi.nlm.nih.gov/pubmed/31610251
9088,32302790,"Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial",Contemp Clin Trials. 2020 Jun;93:105999. doi: 10.1016/j.cct.2020.105999. Epub 2020 Apr 14.,Reddy D,https://www.ncbi.nlm.nih.gov/pubmed/32302790
9089,32044166,Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study,Radiother Oncol. 2020 Feb;143:95-100. doi: 10.1016/j.radonc.2019.12.017. Epub 2020 Feb 7.,Tharmalingam H,https://www.ncbi.nlm.nih.gov/pubmed/32044166
9090,32396911,Prospective Feasibility Study of Single-Shot Antibiotic Prophylaxis in Transrectal Focal Ablation of Prostate Cancer,Urol Int. 2020;104(5-6):378-385. doi: 10.1159/000507123. Epub 2020 May 12.,Westhoff N,https://www.ncbi.nlm.nih.gov/pubmed/32396911
9091,31971494,Nerve Sparing during Robot-Assisted Radical Prostatectomy Increases the Risk of Ipsilateral Positive Surgical Margins,J Urol. 2020 Jul;204(1):91-95. doi: 10.1097/JU.0000000000000760. Epub 2020 Jan 23.,Soeterik TFW,https://www.ncbi.nlm.nih.gov/pubmed/31971494
9092,32350585,Surgery associated with increased survival compared to radiation in clinically localized Gleason 9-10 prostate cancer: a SEER analysis,World J Urol. 2021 Feb;39(2):415-423. doi: 10.1007/s00345-020-03215-x. Epub 2020 Apr 29.,Nemirovsky A,https://www.ncbi.nlm.nih.gov/pubmed/32350585
9093,31797684,Surgical Strategies for Lymphocele Prevention in Minimally Invasive Radical Prostatectomy and Lymph Node Dissection: A Systematic Review,J Endourol. 2020 Feb;34(2):113-120. doi: 10.1089/end.2019.0716.,Motterle G,https://www.ncbi.nlm.nih.gov/pubmed/31797684
9094,32356508,Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic,J Urol. 2020 Oct;204(4):720-725. doi: 10.1097/JU.0000000000001089. Epub 2020 May 1.,Ginsburg KB,https://www.ncbi.nlm.nih.gov/pubmed/32356508
9095,32064552,Exploratory cost-effectiveness analysis of (68)Gallium-PSMA PET/MRI-based imaging in patients with biochemical recurrence of prostate cancer,Clin Exp Metastasis. 2020 Apr;37(2):305-312. doi: 10.1007/s10585-020-10027-1. Epub 2020 Feb 17.,Gordon LG,https://www.ncbi.nlm.nih.gov/pubmed/32064552
9096,31846392,Extraperitoneal versus Transperitoneal Single Port Robotic Radical Prostatectomy: A Comparative Analysis of Perioperative Outcomes,J Urol. 2020 Jun;203(6):1135-1140. doi: 10.1097/JU.0000000000000700. Epub 2019 Dec 17.,Kaouk J,https://www.ncbi.nlm.nih.gov/pubmed/31846392
9098,32451312,PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy,Eur Urol Oncol. 2021 Feb;4(1):73-83. doi: 10.1016/j.euo.2020.04.004. Epub 2020 May 22.,Schiller K,https://www.ncbi.nlm.nih.gov/pubmed/32451312
9099,32078707,Contrast-enhanced ultrasound with dispersion analysis for the localization of prostate cancer: correlation with radical prostatectomy specimens,World J Urol. 2020 Nov;38(11):2811-2818. doi: 10.1007/s00345-020-03103-4. Epub 2020 Feb 20.,Postema AW,https://www.ncbi.nlm.nih.gov/pubmed/32078707
9100,31463559,Analysis of quality of life and late biochemical predictors for localized cancer recurrence following radical prostatectomy,World J Urol. 2020 Jun;38(6):1501-1507. doi: 10.1007/s00345-019-02921-5. Epub 2019 Aug 28.,Friedersdorff F,https://www.ncbi.nlm.nih.gov/pubmed/31463559
9101,31454660,Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer,Urology. 2020 Jan;135:111-116. doi: 10.1016/j.urology.2019.08.014. Epub 2019 Aug 24.,Peng LC,https://www.ncbi.nlm.nih.gov/pubmed/31454660
9102,32151469,Oncologic outcomes in 408 consecutive patient cohort treated with da Vinci robot-assisted radical prostatectomy,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):179-186. doi: 10.1016/j.acuro.2019.11.001. Epub 2020 Mar 6.,Moreno-Sierra J,https://www.ncbi.nlm.nih.gov/pubmed/32151469
9103,31735483,Focal Salvage MR Imaging-Guided Cryoablation for Localized Prostate Cancer Recurrence after Radiotherapy: 12-Month Follow-up,J Vasc Interv Radiol. 2020 Jan;31(1):35-41. doi: 10.1016/j.jvir.2019.07.001. Epub 2019 Nov 15.,Bomers JGR,https://www.ncbi.nlm.nih.gov/pubmed/31735483
9104,32466781,Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer,J Transl Med. 2020 May 28;18(1):214. doi: 10.1186/s12967-020-02370-4.,Ryan ST,https://www.ncbi.nlm.nih.gov/pubmed/32466781
9105,32763123,Survival Outcomes for Metastatic Prostate Cancer Patients Treated With Radical Prostatectomy or Radiation Therapy: A SEER-based Study,Clin Genitourin Cancer. 2020 Dec;18(6):e705-e722. doi: 10.1016/j.clgc.2020.05.005. Epub 2020 May 11.,Jin K,https://www.ncbi.nlm.nih.gov/pubmed/32763123
9106,32427011,Clinical implications of variable relative biological effectiveness in proton therapy for prostate cancer,Acta Oncol. 2020 Oct;59(10):1171-1177. doi: 10.1080/0284186X.2020.1762928. Epub 2020 May 19.,Bertolet A,https://www.ncbi.nlm.nih.gov/pubmed/32427011
9107,31492650,Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis,Eur Urol Oncol. 2020 Feb;3(1):10-20. doi: 10.1016/j.euo.2019.08.001. Epub 2019 Sep 4.,Goel S,https://www.ncbi.nlm.nih.gov/pubmed/31492650
9108,32033834,Whole and hemi-gland cryoablation for primary localized prostate cancer: Short and medium-term oncological and functional outcomes,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):172-178. doi: 10.1016/j.acuro.2019.10.003. Epub 2020 Feb 5.,Bossier R,https://www.ncbi.nlm.nih.gov/pubmed/32033834
9109,31735617,Erectile Function and Sexual Satisfaction: The Importance of Asking About Sexual Desire,J Sex Med. 2020 Feb;17(2):349-352. doi: 10.1016/j.jsxm.2019.09.024. Epub 2019 Nov 15.,Bravi CA,https://www.ncbi.nlm.nih.gov/pubmed/31735617
9111,32265129,A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806),Clin Genitourin Cancer. 2020 Aug;18(4):e410-e415. doi: 10.1016/j.clgc.2019.12.020. Epub 2020 Jan 8.,Isfahanian N,https://www.ncbi.nlm.nih.gov/pubmed/32265129
9112,31439369,Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups,Eur Urol. 2020 Feb;77(2):191-198. doi: 10.1016/j.eururo.2019.07.051. Epub 2019 Aug 19.,van Leenders GJLH,https://www.ncbi.nlm.nih.gov/pubmed/31439369
9113,32330406,Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer,J Urol. 2020 Nov;204(5):934-940. doi: 10.1097/JU.0000000000001091. Epub 2020 Apr 24.,Detsky JS,https://www.ncbi.nlm.nih.gov/pubmed/32330406
9115,31932412,High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes,Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):668-675. doi: 10.1158/1055-9965.EPI-19-0962. Epub 2020 Jan 13.,Hempel Sullivan H,https://www.ncbi.nlm.nih.gov/pubmed/31932412
9116,32233081,Use of psycho-oncological services by prostate cancer patients: A multilevel analysis,Cancer Med. 2020 Jun;9(11):3680-3690. doi: 10.1002/cam4.2999. Epub 2020 Mar 31.,Breidenbach C,https://www.ncbi.nlm.nih.gov/pubmed/32233081
9117,32423389,Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status,BMC Cancer. 2020 May 18;20(1):437. doi: 10.1186/s12885-020-06908-z.,Dudka I,https://www.ncbi.nlm.nih.gov/pubmed/32423389
9118,31959548,Technical Modifications Necessary to Implement the da Vinci Single-port Robotic System,Eur Urol. 2020 Sep;78(3):415-423. doi: 10.1016/j.eururo.2020.01.005. Epub 2020 Jan 17.,Covas Moschovas M,https://www.ncbi.nlm.nih.gov/pubmed/31959548
9119,31690515,Transperineal mapping biopsy improves selection of brachytherapy boost for men with localized prostate cancer,Brachytherapy. 2020 Jan-Feb;19(1):33-37. doi: 10.1016/j.brachy.2019.09.007. Epub 2019 Nov 2.,Stone NN,https://www.ncbi.nlm.nih.gov/pubmed/31690515
9120,31199504,Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial,Int J Cancer. 2020 Jan 1;146(1):161-168. doi: 10.1002/ijc.32509. Epub 2019 Jun 28.,Bowden P,https://www.ncbi.nlm.nih.gov/pubmed/31199504
9121,32349700,Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy,BMC Cancer. 2020 Apr 29;20(1):362. doi: 10.1186/s12885-020-06883-5.,Oehus AK,https://www.ncbi.nlm.nih.gov/pubmed/32349700
9123,32542009,Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomy,PLoS One. 2020 Jun 15;15(6):e0234264. doi: 10.1371/journal.pone.0234264. eCollection 2020.,Shin D,https://www.ncbi.nlm.nih.gov/pubmed/32542009
9124,31944219,Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy,JAMA Oncol. 2020 Mar 1;6(3):409-412. doi: 10.1001/jamaoncol.2019.5690.,Agarwal A,https://www.ncbi.nlm.nih.gov/pubmed/31944219
9125,32228325,Shape Analysis of Peripheral Zone Observations on Prostate DWI: Correlation to Histopathology Outcomes After Radical Prostatectomy,AJR Am J Roentgenol. 2020 Jun;214(6):1239-1247. doi: 10.2214/AJR.19.22318. Epub 2020 Mar 31.,Abreu-Gomez J,https://www.ncbi.nlm.nih.gov/pubmed/32228325
9127,32307017,CBCT evaluation of inter- and intra-fraction motions during prostate stereotactic body radiotherapy: a technical note,Radiat Oncol. 2020 Apr 19;15(1):85. doi: 10.1186/s13014-020-01534-2.,Jmour O,https://www.ncbi.nlm.nih.gov/pubmed/32307017
9128,32367438,Oncologic outcomes of patients with incidental prostate cancer who underwent RARC: a comparison between nerve sparing and non-nerve sparing approach,J Robot Surg. 2021 Feb;15(1):105-114. doi: 10.1007/s11701-020-01081-8. Epub 2020 May 4.,Chessa F,https://www.ncbi.nlm.nih.gov/pubmed/32367438
9129,32289797,Robotic Perineal Radical Prostatectomy: Initial Experience with the da Vinci Si Robotic System,Urol Int. 2020;104(9-10):710-715. doi: 10.1159/000505557. Epub 2020 Apr 14.,Chang Y,https://www.ncbi.nlm.nih.gov/pubmed/32289797
9130,32353851,Factors Affecting Surgical Margin Positivity after Radical Prostatectomy in the Turkish Population: A Multicenter Study of the Urooncology Association,Urol Int. 2020;104(9-10):724-730. doi: 10.1159/000507268. Epub 2020 Apr 30.,Çelik S,https://www.ncbi.nlm.nih.gov/pubmed/32353851
9131,32327264,Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique,Eur Urol. 2020 Sep;78(3):424-431. doi: 10.1016/j.eururo.2020.03.032. Epub 2020 Apr 20.,Mattei A,https://www.ncbi.nlm.nih.gov/pubmed/32327264
9132,32034540,The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages,Cancer Causes Control. 2020 Mar;31(3):283-290. doi: 10.1007/s10552-020-01273-5. Epub 2020 Feb 7.,Knipper S,https://www.ncbi.nlm.nih.gov/pubmed/32034540
9133,31942461,Subclassification of pathologically organ-confined (pT2) prostate cancer does not significantly predict postoperative outcomes in Korean males,Investig Clin Urol. 2020 Jan;61(1):35-41. doi: 10.4111/icu.2020.61.1.35. Epub 2019 Dec 2.,Lee MH,https://www.ncbi.nlm.nih.gov/pubmed/31942461
9135,32211942,PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis,Strahlenther Onkol. 2020 Jul;196(7):637-646. doi: 10.1007/s00066-020-01605-z. Epub 2020 Mar 24.,Schmidt-Hegemann NS,https://www.ncbi.nlm.nih.gov/pubmed/32211942
9136,32027096,Genetic association analysis identifies a role for ANO5 in prostate cancer progression,Cancer Med. 2020 Apr;9(7):2372-2378. doi: 10.1002/cam4.2909. Epub 2020 Feb 6.,Yu CC,https://www.ncbi.nlm.nih.gov/pubmed/32027096
9137,31822128,Robot-Assisted Radical Prostatectomy in Patients with a History of Holmium Laser Enucleation of the Prostate: The Indiana University Experience,J Endourol. 2020 Feb;34(2):163-168. doi: 10.1089/end.2019.0436.,Abedali ZA,https://www.ncbi.nlm.nih.gov/pubmed/31822128
9138,32057461,The relationship between inguinal hernia and minimally-invasive surgery for prostate cancer: A systematic review of the literature,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):131-138. doi: 10.1016/j.acuro.2019.10.005. Epub 2020 Feb 10.,Bertolo R,https://www.ncbi.nlm.nih.gov/pubmed/32057461
9139,32453596,Knockdown of FBP1 enhances radiosensitivity in prostate cancer cells by activating autophagy,Neoplasma. 2020 Sep;67(5):982-991. doi: 10.4149/neo_2020_190807N728. Epub 2020 May 26.,Li XR,https://www.ncbi.nlm.nih.gov/pubmed/32453596
9140,31764016,A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate Cancer,Am J Clin Oncol. 2020 Feb;43(2):87-93. doi: 10.1097/COC.0000000000000631.,Syed S,https://www.ncbi.nlm.nih.gov/pubmed/31764016
9141,32167708,Effect of pelvimetric diameters on success of surgery in patients submitted to robot-assisted perineal radical prostatectomy,Int Braz J Urol. 2020 May-Jun;46(3):425-433. doi: 10.1590/S1677-5538.IBJU.2019.0413.,Yenice MG,https://www.ncbi.nlm.nih.gov/pubmed/32167708
9142,32497131,Comparison of perioperative outcomes in elderly (age ? 75 years) vs. younger men undergoing robot-assisted radical prostatectomy,PLoS One. 2020 Jun 4;15(6):e0234113. doi: 10.1371/journal.pone.0234113. eCollection 2020.,Yamada Y,https://www.ncbi.nlm.nih.gov/pubmed/32497131
9143,31812632,Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy,Urol Oncol. 2020 Feb;38(2):37.e1-37.e9. doi: 10.1016/j.urolonc.2019.10.008. Epub 2019 Dec 4.,Zhai TS,https://www.ncbi.nlm.nih.gov/pubmed/31812632
9144,31721315,Focal salvage low-dose-rate brachytherapy for recurrent prostate cancer based on magnetic resonance imaging/transrectal ultrasound fusion biopsy technique,Int J Urol. 2020 Feb;27(2):149-155. doi: 10.1111/iju.14151. Epub 2019 Nov 13.,Yamada Y,https://www.ncbi.nlm.nih.gov/pubmed/31721315
9145,31437121,Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience,J Urol. 2020 Feb;203(2):320-330. doi: 10.1097/JU.0000000000000506. Epub 2019 Aug 22.,Tourinho-Barbosa RR,https://www.ncbi.nlm.nih.gov/pubmed/31437121
9146,32328779,"Trends in risk-group distribution and Pentafecta outcomes in patients treated with nerve-sparing, robot-assisted radical prostatectomy: a 10-year low-intermediate volume single-center experience",World J Urol. 2021 Feb;39(2):389-397. doi: 10.1007/s00345-020-03206-y. Epub 2020 Apr 23.,Afferi L,https://www.ncbi.nlm.nih.gov/pubmed/32328779
9148,32078119,Sensitivity of CE-MRI in detecting local recurrence after radical prostatectomy,Radiol Med. 2020 Jul;125(7):683-690. doi: 10.1007/s11547-020-01149-3. Epub 2020 Feb 20.,Coppola A,https://www.ncbi.nlm.nih.gov/pubmed/32078119
9149,32189088,Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial,World J Urol. 2021 Jan;39(1):65-72. doi: 10.1007/s00345-020-03154-7. Epub 2020 Mar 18.,Albers P,https://www.ncbi.nlm.nih.gov/pubmed/32189088
9151,31880744,Short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy for oligometastatic prostate cancer: a propensity score matching study,Chin Med J (Engl). 2020 Jan 20;133(2):127-133. doi: 10.1097/CM9.0000000000000590.,Chen H,https://www.ncbi.nlm.nih.gov/pubmed/31880744
9152,32089359,Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT),Eur Urol. 2020 Jun;77(6):713-724. doi: 10.1016/j.eururo.2020.02.009. Epub 2020 Feb 21.,Wilt TJ,https://www.ncbi.nlm.nih.gov/pubmed/32089359
9153,32166451,Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer,Strahlenther Onkol. 2020 Jul;196(7):617-627. doi: 10.1007/s00066-020-01590-3. Epub 2020 Mar 12.,Campostrini F,https://www.ncbi.nlm.nih.gov/pubmed/32166451
9154,31786703,Does time interval between prostate biopsy and surgery affect outcomes of radical prostatectomy? A systematic review and meta-analysis,Int Urol Nephrol. 2020 Apr;52(4):619-631. doi: 10.1007/s11255-019-02344-6. Epub 2019 Nov 30.,Li J,https://www.ncbi.nlm.nih.gov/pubmed/31786703
9155,32150055,Adding radiotherapy to androgen deprivation therapy in men with node-positive prostate cancer after radical prostatectomy: A meta-analysis,Medicine (Baltimore). 2020 Mar;99(10):e19153. doi: 10.1097/MD.0000000000019153.,Guo L,https://www.ncbi.nlm.nih.gov/pubmed/32150055
9157,31089802,Retzius sparing robotic assisted radical prostatectomy vs. conventional robotic assisted radical prostatectomy: a systematic review and meta-analysis,World J Urol. 2020 May;38(5):1123-1134. doi: 10.1007/s00345-019-02798-4. Epub 2019 May 14.,Phukan C,https://www.ncbi.nlm.nih.gov/pubmed/31089802
9158,32063492,Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial,Eur Urol Oncol. 2021 Dec;4(6):948-954. doi: 10.1016/j.euo.2020.01.005. Epub 2020 Feb 13.,Bitting RL,https://www.ncbi.nlm.nih.gov/pubmed/32063492
9159,32298794,Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data,Pract Radiat Oncol. 2020 Jul-Aug;10(4):282-292. doi: 10.1016/j.prro.2020.02.014. Epub 2020 Apr 13.,Tang C,https://www.ncbi.nlm.nih.gov/pubmed/32298794
9160,31866092,"Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)(†)",Eur Urol. 2020 Jun;77(6):689-698. doi: 10.1016/j.eururo.2019.11.023. Epub 2019 Dec 19.,Yokomizo A,https://www.ncbi.nlm.nih.gov/pubmed/31866092
9161,32255317,Influence of sociodemographic factors on treatment's choice for localized prostate cancer in Portugal,Arch Ital Urol Androl. 2020 Apr 6;92(1):45-49. doi: 10.4081/aiua.2020.1.45.,Pereira-Lourenço M,https://www.ncbi.nlm.nih.gov/pubmed/32255317
9163,32092343,Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial,Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):693-702. doi: 10.1016/j.ijrobp.2019.11.415.,Joseph D,https://www.ncbi.nlm.nih.gov/pubmed/32092343
9164,31010600,Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies,Eur Urol. 2020 Mar;77(3):373-379. doi: 10.1016/j.eururo.2019.04.001. Epub 2019 Apr 19.,Agarwal DK,https://www.ncbi.nlm.nih.gov/pubmed/31010600
9165,31586543,Effect of bladder neck sparing at robot-assisted laparoscopic prostatectomy on postoperative continence rates and biochemical recurrence,Urol Oncol. 2020 Jan;38(1):1.e11-1.e16. doi: 10.1016/j.urolonc.2019.09.005. Epub 2019 Oct 2.,Preisser F,https://www.ncbi.nlm.nih.gov/pubmed/31586543
9166,31745702,Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy,J Cancer Res Clin Oncol. 2020 Mar;146(3):687-694. doi: 10.1007/s00432-019-03089-6. Epub 2019 Nov 19.,Shangguan X,https://www.ncbi.nlm.nih.gov/pubmed/31745702
9167,31897875,Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy,Int Urol Nephrol. 2020 Apr;52(4):671-679. doi: 10.1007/s11255-019-02339-3. Epub 2020 Jan 3.,Kodama H,https://www.ncbi.nlm.nih.gov/pubmed/31897875
9168,32093688,The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis,World J Surg Oncol. 2020 Feb 24;18(1):42. doi: 10.1186/s12957-020-01824-9.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/32093688
9169,32317241,Conventional vs machine learning-based treatment planning in prostate brachytherapy: Results of a Phase I randomized controlled trial,Brachytherapy. 2020 Jul-Aug;19(4):470-476. doi: 10.1016/j.brachy.2020.03.004. Epub 2020 Apr 19.,Nicolae A,https://www.ncbi.nlm.nih.gov/pubmed/32317241
9171,32417995,Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by (68)Ga-PSMA-11 PET/CT or (11)C-Choline PET/CT: impact of postoperative treatments,World J Urol. 2021 Feb;39(2):399-406. doi: 10.1007/s00345-020-03220-0. Epub 2020 May 16.,Devos G,https://www.ncbi.nlm.nih.gov/pubmed/32417995
9172,32361876,Limitations of abdominopelvic CT and multiparametric MR imaging for detection of lymph node metastases prior to radical prostatectomy,World J Urol. 2021 Mar;39(3):779-785. doi: 10.1007/s00345-020-03227-7. Epub 2020 May 2.,Peabody H,https://www.ncbi.nlm.nih.gov/pubmed/32361876
9173,31518200,Decision Regret after Radical Prostatectomy does Not Depend on Surgical Approach: 6-Year Followup of a Large German Cohort Undergoing Routine Care,J Urol. 2020 Mar;203(3):554-561. doi: 10.1097/JU.0000000000000541. Epub 2019 Sep 13.,Baunacke M,https://www.ncbi.nlm.nih.gov/pubmed/31518200
9174,31981427,Comparison of statistical machine learning models for rectal protocol compliance in prostate external beam radiation therapy,Med Phys. 2020 Apr;47(4):1452-1459. doi: 10.1002/mp.14044. Epub 2020 Feb 19.,Jones S,https://www.ncbi.nlm.nih.gov/pubmed/31981427
9175,31977261,Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy,J Urol. 2020 Jul;204(1):82-90. doi: 10.1097/JU.0000000000000774. Epub 2020 Jan 24.,Falagario UG,https://www.ncbi.nlm.nih.gov/pubmed/31977261
9176,31964956,Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy,Sci Rep. 2020 Jan 21;10(1):776. doi: 10.1038/s41598-020-57618-2.,Cheng YT,https://www.ncbi.nlm.nih.gov/pubmed/31964956
9177,32001198,The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancer,Urol Oncol. 2020 May;38(5):379-385. doi: 10.1016/j.urolonc.2019.12.027. Epub 2020 Jan 27.,Tilki D,https://www.ncbi.nlm.nih.gov/pubmed/32001198
9178,31843220,The impact of time from biopsy to radical prostatectomy on Gleason score undergrading and other related factors,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):187-195. doi: 10.1016/j.acuro.2019.08.004. Epub 2019 Dec 13.,Virseda Rodríguez AJ,https://www.ncbi.nlm.nih.gov/pubmed/31843220
9179,31828412,MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL),Eur Radiol. 2020 Apr;30(4):2072-2081. doi: 10.1007/s00330-019-06505-0. Epub 2019 Dec 11.,Fischbach F,https://www.ncbi.nlm.nih.gov/pubmed/31828412
9180,32398040,PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial,BMC Cancer. 2020 May 12;20(1):406. doi: 10.1186/s12885-020-06911-4.,De Bruycker A,https://www.ncbi.nlm.nih.gov/pubmed/32398040
9181,32476081,Survival outcomes of Asian younger men (<?55 years) undergoing radical prostatectomy: a review of prostate cancer database in a tertiary hospital in Singapore,Int Urol Nephrol. 2020 Oct;52(10):1885-1891. doi: 10.1007/s11255-020-02518-7. Epub 2020 May 31.,Lu Y,https://www.ncbi.nlm.nih.gov/pubmed/32476081
9182,32367010,Exposure to direct-to-consumer advertising is associated with overestimation of benefits regarding ultrahypofractionated radiation therapy for prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):670-679. doi: 10.1038/s41391-020-0234-2. Epub 2020 May 4.,Caputo JM,https://www.ncbi.nlm.nih.gov/pubmed/32367010
9183,31511970,Outcome of patients with newly diagnosed prostate cancer with low metastatic burden treated with radical prostatectomy: a comparison to STAMPEDE arm H,World J Urol. 2020 Jun;38(6):1459-1464. doi: 10.1007/s00345-019-02950-0. Epub 2019 Sep 11.,Knipper S,https://www.ncbi.nlm.nih.gov/pubmed/31511970
9184,32383303,Anatomical and dosimetric assessment of the prostate apex: A pilot comparison of image-guided transperineal ultrasound to conventional computed tomography simulation,J Med Imaging Radiat Oncol. 2020 Dec;64(6):839-844. doi: 10.1111/1754-9485.13045. Epub 2020 May 7.,Shanker MD,https://www.ncbi.nlm.nih.gov/pubmed/32383303
9185,32156761,"Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study",BMJ Open. 2020 Mar 9;10(3):e032914. doi: 10.1136/bmjopen-2019-032914.,Plym A,https://www.ncbi.nlm.nih.gov/pubmed/32156761
9186,32253928,An Exploratory Study of Dose Escalation vs Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate Cancer,J Endourol. 2020 Jun;34(6):641-646. doi: 10.1089/end.2019.0613. Epub 2020 May 5.,Huber PM,https://www.ncbi.nlm.nih.gov/pubmed/32253928
9187,31694041,Patients with Biopsy Gleason Score 3 + 4 Are Not Appropriate Candidates for Active Surveillance,Urol Int. 2020;104(3-4):199-204. doi: 10.1159/000503888. Epub 2019 Nov 6.,Park J,https://www.ncbi.nlm.nih.gov/pubmed/31694041
9188,32416376,Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT),Radiother Oncol. 2020 Aug;149:8-13. doi: 10.1016/j.radonc.2020.04.039. Epub 2020 Apr 27.,Alayed Y,https://www.ncbi.nlm.nih.gov/pubmed/32416376
9189,31628565,Evaluation of the residual prostate cancer rate on cystoprostatectomy specimen in patients treated with radiotherapy for prostate cancer,Int Urol Nephrol. 2020 Feb;52(2):279-285. doi: 10.1007/s11255-019-02312-0. Epub 2019 Oct 18.,Schlegel J,https://www.ncbi.nlm.nih.gov/pubmed/31628565
9190,31964317,"Is ""extreme"" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure?",Urologia. 2020 Aug;87(3):149-154. doi: 10.1177/0391560319899253. Epub 2020 Jan 22.,Dal Moro F,https://www.ncbi.nlm.nih.gov/pubmed/31964317
9192,31812685,Updating the International Index of Erectile Function: Evaluation of a Large Clinical Data Set,J Sex Med. 2020 Jan;17(1):126-132. doi: 10.1016/j.jsxm.2019.10.020. Epub 2019 Dec 5.,Vickers AJ,https://www.ncbi.nlm.nih.gov/pubmed/31812685
9193,32234896,Stereotactic Body Radiotherapy Using CyberKnife(R) for Localized Low- and Intermediate-risk Prostate Cancer: Initial Report on a Phase I/II Trial,Anticancer Res. 2020 Apr;40(4):2053-2057. doi: 10.21873/anticanres.14162.,Nakamura R,https://www.ncbi.nlm.nih.gov/pubmed/32234896
9194,31910880,Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer,J Transl Med. 2020 Jan 7;18(1):10. doi: 10.1186/s12967-019-02185-y.,Kiebish MA,https://www.ncbi.nlm.nih.gov/pubmed/31910880
9195,32416115,Assessment of Long-term Changes in Lower Urinary Tract Symptoms in Patients With Prostate Cancer Who Underwent Low-dose-rate Prostate Brachytherapy,Urology. 2020 Aug;142:213-220. doi: 10.1016/j.urology.2020.04.106. Epub 2020 May 13.,Iinuma K,https://www.ncbi.nlm.nih.gov/pubmed/32416115
9196,32146259,Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy,Radiother Oncol. 2020 May;146:90-96. doi: 10.1016/j.radonc.2020.02.009. Epub 2020 Mar 5.,Morton G,https://www.ncbi.nlm.nih.gov/pubmed/32146259
9197,31605802,Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer Patients,J Mol Diagn. 2020 Jan;22(1):30-39. doi: 10.1016/j.jmoldx.2019.08.003. Epub 2019 Oct 9.,Savio AJ,https://www.ncbi.nlm.nih.gov/pubmed/31605802
9198,32129447,Health-related quality of life in Japanese patients with prostate cancer following proton beam therapy: an institutional cohort study,Jpn J Clin Oncol. 2020 May 5;50(5):519-527. doi: 10.1093/jjco/hyaa027.,Matsukawa K,https://www.ncbi.nlm.nih.gov/pubmed/32129447
9199,32101696,"Management of erectile dysfunction and LUTS/incontinence: the two most common, long-term side effects of prostate cancer treatment",Can J Urol. 2020 Feb;27(27 Suppl 1):17-24.,Shabataev V,https://www.ncbi.nlm.nih.gov/pubmed/32101696
9200,31904261,A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy,Br J Radiol. 2020 Mar;93(1107):20190845. doi: 10.1259/bjr.20190845. Epub 2020 Jan 6.,Wang T,https://www.ncbi.nlm.nih.gov/pubmed/31904261
9201,31568795,"Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy",Urology. 2020 Jan;135:117-123. doi: 10.1016/j.urology.2019.07.049. Epub 2019 Sep 27.,Alshak MN,https://www.ncbi.nlm.nih.gov/pubmed/31568795
9202,31412114,Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy,Inflamm Bowel Dis. 2020 Apr 11;26(5):728-733. doi: 10.1093/ibd/izz175.,Feagins LA,https://www.ncbi.nlm.nih.gov/pubmed/31412114
9203,31210148,Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer,Asian J Androl. 2020 Mar-Apr;22(2):217-221. doi: 10.4103/aja.aja_54_19.,Jin K,https://www.ncbi.nlm.nih.gov/pubmed/31210148
9204,31648965,Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of Recurrence,Clin Genitourin Cancer. 2020 Apr;18(2):e112-e121. doi: 10.1016/j.clgc.2019.09.007. Epub 2019 Sep 26.,Knipper S,https://www.ncbi.nlm.nih.gov/pubmed/31648965
9205,31802704,Economic burden of illness associated with localized prostate cancer in the United States,Future Oncol. 2020 Jan;16(1):4265-4277. doi: 10.2217/fon-2019-0639. Epub 2019 Dec 5.,Gustavsen G,https://www.ncbi.nlm.nih.gov/pubmed/31802704
9206,32307311,"MR Imaging-Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer: Preliminary Experience from a Single Center in a Prospective, Multi-Center, Single-Arm Clinical Trial",J Vasc Interv Radiol. 2020 May;31(5):740-746.e4. doi: 10.1016/j.jvir.2019.12.802. Epub 2020 Apr 16.,Sundaram KM,https://www.ncbi.nlm.nih.gov/pubmed/32307311
9207,32179961,Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [(68)Ga]PSMA-PET-guided metastasis-directed therapy,Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2328-2338. doi: 10.1007/s00259-020-04760-8. Epub 2020 Mar 16.,Vogel MME,https://www.ncbi.nlm.nih.gov/pubmed/32179961
9208,32201973,"DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy",Prostate. 2020 May;80(8):632-639. doi: 10.1002/pros.23975. Epub 2020 Mar 23.,Carignan D,https://www.ncbi.nlm.nih.gov/pubmed/32201973
9209,31619029,Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsy,Minerva Urol Nefrol. 2020 Jun;72(3):360-368. doi: 10.23736/S0393-2249.19.03367-8. Epub 2019 Oct 10.,De Luca S,https://www.ncbi.nlm.nih.gov/pubmed/31619029
9210,32031685,Downgrading of grade group 2 intermediate-risk prostate cancer from biopsy to radical prostatectomy: Comparison of outcomes and predictors to identify potential candidates for active surveillance,Cancer. 2020 Apr 15;126(8):1632-1639. doi: 10.1002/cncr.32709. Epub 2020 Feb 7.,Su ZT,https://www.ncbi.nlm.nih.gov/pubmed/32031685
9211,31799874,Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis,AJR Am J Roentgenol. 2020 Mar;214(3):597-604. doi: 10.2214/AJR.19.21836. Epub 2019 Dec 4.,Woo S,https://www.ncbi.nlm.nih.gov/pubmed/31799874
9212,31435731,Development of a model to predict prostate cancer at the apex (PCAP model) in patients undergoing robot-assisted radical prostatectomy,World J Urol. 2020 Apr;38(4):813-819. doi: 10.1007/s00345-019-02905-5. Epub 2019 Aug 21.,Cumarasamy S,https://www.ncbi.nlm.nih.gov/pubmed/31435731
9213,32161996,The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy,World J Urol. 2020 Dec;38(12):3091-3099. doi: 10.1007/s00345-020-03147-6. Epub 2020 Mar 11.,Meissner VH,https://www.ncbi.nlm.nih.gov/pubmed/32161996
9214,31291715,Clinical Outcomes of Postoperative Radiotherapy Following Radical Prostatectomy in Patients with Localized Prostate Cancer: A Multicenter Retrospective Study (KROG 18-01) of a Korean Population,Cancer Res Treat. 2020 Jan;52(1):167-180. doi: 10.4143/crt.2019.126. Epub 2019 Jun 25.,Lee SU,https://www.ncbi.nlm.nih.gov/pubmed/31291715
9215,32442334,Early 3-month treatment with comprehensive physical therapy program restores continence in urinary incontinence patients after radical prostatectomy: A randomized controlled trial,Neurourol Urodyn. 2020 Jun;39(5):1529-1537. doi: 10.1002/nau.24389. Epub 2020 May 22.,Soto González M,https://www.ncbi.nlm.nih.gov/pubmed/32442334
9216,31833722,"Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: a large retrospective study",Minerva Urol Nefrol. 2020 Feb;72(1):72-81. doi: 10.23736/S0393-2249.19.03586-0. Epub 2019 Dec 12.,Sebben M,https://www.ncbi.nlm.nih.gov/pubmed/31833722
9217,32343155,"Do negative intrusive thoughts at diagnosis predict impaired quality of life, depressed mood and waking up with anxiety 3, 12 and 24 months after radical prostatectomy? - a longitudinal study",Scand J Urol. 2020 Jun;54(3):220-226. doi: 10.1080/21681805.2020.1754905. Epub 2020 Apr 28.,Bock D,https://www.ncbi.nlm.nih.gov/pubmed/32343155
9218,31812580,Prostate Cancer Nonascitic Peritoneal Carcinomatosis After Robot-assisted Laparoscopic Radical Prostatectomy: 3 Case Reports and Review of the Literature,Urology. 2020 Mar;137:121-125. doi: 10.1016/j.urology.2019.11.035. Epub 2019 Dec 5.,Achard V,https://www.ncbi.nlm.nih.gov/pubmed/31812580
9219,31679107,Is the Recommendation of a Pelvic Lymphadenectomy in Conjunction with Radical Prostatectomy in Prostate Cancer Patients Justified? Report from a Multidisciplinary Expert Panel Meeting,Adv Ther. 2020 Jan;37(1):213-224. doi: 10.1007/s12325-019-01133-y. Epub 2019 Nov 2.,Winter A,https://www.ncbi.nlm.nih.gov/pubmed/31679107
9220,32410119,The impact of surgical margin status on prostate cancer-specific mortality after radical prostatectomy: a systematic review and meta-analysis,Clin Transl Oncol. 2020 Nov;22(11):2087-2096. doi: 10.1007/s12094-020-02358-y. Epub 2020 May 14.,Zhang B,https://www.ncbi.nlm.nih.gov/pubmed/32410119
9221,30946523,"Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trial",BJU Int. 2020 Jun;125(6):810-816. doi: 10.1111/bju.14768. Epub 2020 Mar 2.,Sargos P,https://www.ncbi.nlm.nih.gov/pubmed/30946523
9222,32311600,Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy,Radiother Oncol. 2020 Jul;148:44-50. doi: 10.1016/j.radonc.2020.04.007. Epub 2020 Apr 9.,Yoon S,https://www.ncbi.nlm.nih.gov/pubmed/32311600
9223,31614071,Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial,BJU Int. 2020 Feb;125(2):215-225. doi: 10.1111/bju.14925. Epub 2019 Nov 8.,Macias VA,https://www.ncbi.nlm.nih.gov/pubmed/31614071
9224,31892490,Salvage Focal Cryotherapy Offers Similar Short-term Oncologic Control and Improved Urinary Function Compared With Salvage Whole Gland Cryotherapy for Radiation-resistant or Recurrent Prostate Cancer,Clin Genitourin Cancer. 2020 Jun;18(3):e260-e265. doi: 10.1016/j.clgc.2019.11.009. Epub 2019 Dec 5.,Tan WP,https://www.ncbi.nlm.nih.gov/pubmed/31892490
9226,32249179,Evaluation of the urethral ?/? ratio and tissue repair half-time for iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy,Brachytherapy. 2020 May-Jun;19(3):290-297. doi: 10.1016/j.brachy.2020.02.007. Epub 2020 Apr 2.,Gocho T,https://www.ncbi.nlm.nih.gov/pubmed/32249179
9227,32096413,Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy,Aging Male. 2020 Dec;23(5):1210-1216. doi: 10.1080/13685538.2020.1731450. Epub 2020 Feb 25.,Kato Y,https://www.ncbi.nlm.nih.gov/pubmed/32096413
9228,32007430,The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial,J Sex Med. 2020 Apr;17(4):688-694. doi: 10.1016/j.jsxm.2019.12.024. Epub 2020 Jan 30.,Baccaglini W,https://www.ncbi.nlm.nih.gov/pubmed/32007430
9230,31611160,Racial differences in the PSA bounce in predicting prostate cancer outcomes after brachytherapy: Evidence from the Department of Veterans Affairs,Brachytherapy. 2020 Jan-Feb;19(1):6-12. doi: 10.1016/j.brachy.2019.08.008. Epub 2019 Oct 11.,Slade AN,https://www.ncbi.nlm.nih.gov/pubmed/31611160
9231,32414618,Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?,Eur Urol Focus. 2021 Jul;7(4):807-811. doi: 10.1016/j.euf.2020.04.005. Epub 2020 May 12.,Marra G,https://www.ncbi.nlm.nih.gov/pubmed/32414618
9232,32217038,A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer,Brachytherapy. 2020 May-Jun;19(3):282-289. doi: 10.1016/j.brachy.2020.02.008. Epub 2020 Mar 23.,Den RB,https://www.ncbi.nlm.nih.gov/pubmed/32217038
9233,32146018,Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review,Eur Urol. 2020 May;77(5):614-627. doi: 10.1016/j.eururo.2020.01.033. Epub 2020 Mar 4.,Moris L,https://www.ncbi.nlm.nih.gov/pubmed/32146018
9234,31727561,Development and external validation of a nomogram to predict lymph node invasion after robot assisted radical prostatectomy,Urol Oncol. 2020 Feb;38(2):37.e11-37.e20. doi: 10.1016/j.urolonc.2019.10.001. Epub 2019 Nov 12.,Tosco L,https://www.ncbi.nlm.nih.gov/pubmed/31727561
9235,31388817,Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey,World J Urol. 2020 Jun;38(6):1397-1411. doi: 10.1007/s00345-019-02887-4. Epub 2019 Aug 6.,Stranne J,https://www.ncbi.nlm.nih.gov/pubmed/31388817
9236,32179016,Prevalence and Predictors of Climacturia and Associated Patient/Partner Bother in Patients With History of Definitive Therapy for Prostate Cancer,J Sex Med. 2020 Jun;17(6):1126-1132. doi: 10.1016/j.jsxm.2020.02.016. Epub 2020 Mar 13.,Jimbo M,https://www.ncbi.nlm.nih.gov/pubmed/32179016
9237,32701978,Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: Medium-term results from a single centre,PLoS One. 2020 Jul 23;15(7):e0236026. doi: 10.1371/journal.pone.0236026. eCollection 2020.,Wu YT,https://www.ncbi.nlm.nih.gov/pubmed/32701978
9238,31641931,Acute and late toxicity and preliminary outcomes report of moderately hypofractionated helical tomotherapy for localized prostate cancer: a mono-institutional analysis,Radiol Med. 2020 Feb;125(2):220-227. doi: 10.1007/s11547-019-01095-9. Epub 2019 Oct 22.,Cuccia F,https://www.ncbi.nlm.nih.gov/pubmed/31641931
9240,32396488,Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials,J Clin Oncol. 2020 Sep 10;38(26):3024-3031. doi: 10.1200/JCO.19.03217. Epub 2020 May 12.,Jackson WC,https://www.ncbi.nlm.nih.gov/pubmed/32396488
9241,32130477,Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis,World J Urol. 2020 Dec;38(12):3075-3083. doi: 10.1007/s00345-020-03144-9. Epub 2020 Mar 4.,Kretschmer A,https://www.ncbi.nlm.nih.gov/pubmed/32130477
9242,31347951,"Retzius Sparing Robot-Assisted Radical Prostatectomy Conveys Early Regain of Continence over Conventional Robot-Assisted Radical Prostatectomy: A Propensity Score Matched Analysis of 1,863 Patients",J Urol. 2020 Jan;203(1):137-144. doi: 10.1097/JU.0000000000000461. Epub 2019 Jul 26.,Lee J,https://www.ncbi.nlm.nih.gov/pubmed/31347951
9243,32139288,"A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy",Urol Oncol. 2020 Oct;38(10):794.e1-794.e9. doi: 10.1016/j.urolonc.2020.02.007. Epub 2020 Mar 3.,Caumont F,https://www.ncbi.nlm.nih.gov/pubmed/32139288
9244,31079187,Recovery of pad-free continence in elderly men does not differ from younger men undergoing robot-assisted radical prostatectomy for aggressive prostate cancer,World J Urol. 2020 Feb;38(2):351-360. doi: 10.1007/s00345-019-02797-5. Epub 2019 May 11.,Nyarangi-Dix JN,https://www.ncbi.nlm.nih.gov/pubmed/31079187
9245,32444261,The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series,Eur Urol. 2020 Aug;78(2):155-160. doi: 10.1016/j.eururo.2020.04.068. Epub 2020 May 19.,Stabile A,https://www.ncbi.nlm.nih.gov/pubmed/32444261
9246,32331976,"Acute patient-reported bowel quality of life and rectal bleeding with the combination of prostate external beam radiation, low-dose-rate brachytherapy boost, and SpaceOAR",Brachytherapy. 2020 Jul-Aug;19(4):477-483. doi: 10.1016/j.brachy.2020.03.006. Epub 2020 Apr 21.,Patel AK,https://www.ncbi.nlm.nih.gov/pubmed/32331976
9247,32308085,Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy,Scand J Urol. 2020 Jun;54(3):215-219. doi: 10.1080/21681805.2020.1752795. Epub 2020 Apr 20.,Nair SM,https://www.ncbi.nlm.nih.gov/pubmed/32308085
9248,31820209,Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy,Int J Clin Oncol. 2020 Apr;25(4):713-719. doi: 10.1007/s10147-019-01596-7. Epub 2019 Dec 9.,Aizawa R,https://www.ncbi.nlm.nih.gov/pubmed/31820209
9249,31628038,Prospective multicentre study using high intensity focused ultrasound (HIFU) for the focal treatment of prostate cancer: Safety outcomes and complications,Urol Oncol. 2020 Apr;38(4):225-230. doi: 10.1016/j.urolonc.2019.09.001. Epub 2019 Oct 16.,Schmid FA,https://www.ncbi.nlm.nih.gov/pubmed/31628038
9250,32301194,"Complete puborectalis, puboperinealis muscle and urethral rhabdomyosphincter preservation in laparoscopic radical prostatectomy: Anatomical landmarks to achieve early urinary continence",Int J Urol. 2020 Jun;27(6):525-536. doi: 10.1111/iju.14228. Epub 2020 Apr 16.,Laucirica O,https://www.ncbi.nlm.nih.gov/pubmed/32301194
9251,32035187,Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study,Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):635-643. doi: 10.1016/j.ijrobp.2020.01.026. Epub 2020 Feb 6.,Dinh TT,https://www.ncbi.nlm.nih.gov/pubmed/32035187
9252,31912475,Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study,Urol J. 2020 May 16;17(3):262-270. doi: 10.22037/uj.v0i0.5174.,Murray NP,https://www.ncbi.nlm.nih.gov/pubmed/31912475
9253,31673831,The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy,Int J Clin Oncol. 2020 Feb;25(2):377-383. doi: 10.1007/s10147-019-01561-4. Epub 2019 Oct 31.,Hashimoto T,https://www.ncbi.nlm.nih.gov/pubmed/31673831
9254,32181951,Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen ((68) Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection,BJU Int. 2020 Jun;125(6):876-883. doi: 10.1111/bju.15052. Epub 2020 Apr 23.,Huits TH,https://www.ncbi.nlm.nih.gov/pubmed/32181951
9255,32377600,Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancer,Investig Clin Urol. 2020 May;61(3):250-259. doi: 10.4111/icu.2020.61.3.250. Epub 2020 Apr 17.,Huang-Tiel HJ,https://www.ncbi.nlm.nih.gov/pubmed/32377600
9256,32259466,Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy?,J Urol. 2020 Sep;204(3):476-482. doi: 10.1097/JU.0000000000001070. Epub 2020 Apr 7.,Ahmad AE,https://www.ncbi.nlm.nih.gov/pubmed/32259466
9257,32019501,Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy,BMC Cancer. 2020 Feb 4;20(1):97. doi: 10.1186/s12885-020-6565-5.,Zhou X,https://www.ncbi.nlm.nih.gov/pubmed/32019501
9258,32068483,A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank Specimens,J Urol. 2020 Aug;204(2):289-295. doi: 10.1097/JU.0000000000000808. Epub 2020 Feb 18.,Woon DTS,https://www.ncbi.nlm.nih.gov/pubmed/32068483
9259,32922383,"The Prognostic Value of Indoleamine-2,3-Dioxygenase Gene Expression in Urine of Prostate Cancer Patients Undergoing Radical Prostatectomy as First Treatment of Choice",Front Immunol. 2020 Aug 14;11:1244. doi: 10.3389/fimmu.2020.01244. eCollection 2020.,Thüring M,https://www.ncbi.nlm.nih.gov/pubmed/32922383
9260,32215583,Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer,JAMA Oncol. 2020 May 1;6(5):735-743. doi: 10.1001/jamaoncol.2020.0109.,Dess RT,https://www.ncbi.nlm.nih.gov/pubmed/32215583
9261,32423621,Clinical Outcomes of Stereotactic Body Radiotherapy With Immediate Versus Delayed Hormone Therapy in Men With Oligometastatic Recurrence of Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Aug;32(8):509-517. doi: 10.1016/j.clon.2020.03.008. Epub 2020 May 16.,Chaw CL,https://www.ncbi.nlm.nih.gov/pubmed/32423621
9262,30989489,"Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy",Pathol Oncol Res. 2020 Apr;26(2):1049-1056. doi: 10.1007/s12253-019-00659-4. Epub 2019 Apr 15.,Gasinska A,https://www.ncbi.nlm.nih.gov/pubmed/30989489
9263,32312070,Might definitive local therapy of the primary tumor improve the survival benefits of metastatic prostate cancer?-evidence from a meta-analysis,Ann Palliat Med. 2020 May;9(3):648-660. doi: 10.21037/apm.2020.04.21. Epub 2020 Apr 20.,Xiao M,https://www.ncbi.nlm.nih.gov/pubmed/32312070
9264,32327702,African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):581-588. doi: 10.1038/s41391-020-0230-6. Epub 2020 Apr 23.,Deka R,https://www.ncbi.nlm.nih.gov/pubmed/32327702
9265,30992160,Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis,Eur Urol. 2020 Jan;77(1):3-10. doi: 10.1016/j.eururo.2019.03.022. Epub 2019 Apr 13.,Sandler KA,https://www.ncbi.nlm.nih.gov/pubmed/30992160
9266,32113829,Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):156-163. doi: 10.1016/j.acuro.2019.06.006. Epub 2020 Feb 26.,Garcia-Rodriguez J,https://www.ncbi.nlm.nih.gov/pubmed/32113829
9267,32273183,"The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial",Eur Urol. 2020 Aug;78(2):184-192. doi: 10.1016/j.eururo.2020.03.001. Epub 2020 Apr 6.,Dearnaley DP,https://www.ncbi.nlm.nih.gov/pubmed/32273183
9268,32220141,Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4,Prostate. 2020 May;80(8):653-659. doi: 10.1002/pros.23977. Epub 2020 Mar 27.,Greenland NY,https://www.ncbi.nlm.nih.gov/pubmed/32220141
9269,32114475,Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL),BMJ Open. 2020 Feb 28;10(2):e034623. doi: 10.1136/bmjopen-2019-034623.,Murthy V,https://www.ncbi.nlm.nih.gov/pubmed/32114475
9270,32029346,Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer,Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):939-947. doi: 10.1016/j.ijrobp.2019.11.418. Epub 2020 Feb 3.,Lin J,https://www.ncbi.nlm.nih.gov/pubmed/32029346
9272,31603253,Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men,Prostate. 2020 Jan;80(1):51-56. doi: 10.1002/pros.23916. Epub 2019 Oct 11.,Assel MJ,https://www.ncbi.nlm.nih.gov/pubmed/31603253
9273,31767473,A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer,Radiother Oncol. 2020 Jan;142:62-71. doi: 10.1016/j.radonc.2019.10.017. Epub 2019 Nov 22.,Murray J,https://www.ncbi.nlm.nih.gov/pubmed/31767473
9274,32229186,Ten-year disease progression and mortality rates in men who experience biochemical recurrence versus persistence after radical prostatectomy and undergo salvage radiation therapy: A post-hoc analysis of RTOG 9601 trial data,Urol Oncol. 2020 Jun;38(6):599.e1-599.e8. doi: 10.1016/j.urolonc.2020.02.024. Epub 2020 Mar 27.,Sood A,https://www.ncbi.nlm.nih.gov/pubmed/32229186
9275,32231245,Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):646-653. doi: 10.1038/s41391-020-0226-2. Epub 2020 Mar 30.,Tosoian JJ,https://www.ncbi.nlm.nih.gov/pubmed/32231245
9276,31978853,Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005-2015,Radiother Oncol. 2020 Apr;145:138-145. doi: 10.1016/j.radonc.2019.12.022. Epub 2020 Jan 21.,Morias S,https://www.ncbi.nlm.nih.gov/pubmed/31978853
9277,31711834,Long-lasting prothrombotic state implied by changes of plasma von Willebrand factor parameters after radical prostatectomy for prostate malignancy,Urol Oncol. 2020 Apr;38(4):191-197. doi: 10.1016/j.urolonc.2019.10.007. Epub 2019 Nov 9.,Harsfalvi J,https://www.ncbi.nlm.nih.gov/pubmed/31711834
9278,32098731,"Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation",Eur Urol. 2020 Aug;78(2):248-255. doi: 10.1016/j.eururo.2020.02.007. Epub 2020 Feb 22.,Laviana AA,https://www.ncbi.nlm.nih.gov/pubmed/32098731
9279,31971335,"Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry",BJU Int. 2020 Jun;125(6):853-860. doi: 10.1111/bju.15004. Epub 2020 Feb 11.,Lovegrove CE,https://www.ncbi.nlm.nih.gov/pubmed/31971335
9280,31771797,"Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received",Eur Urol. 2020 Mar;77(3):320-330. doi: 10.1016/j.eururo.2019.10.030. Epub 2019 Nov 24.,Neal DE,https://www.ncbi.nlm.nih.gov/pubmed/31771797
9281,32447033,"Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life",Radiother Oncol. 2020 Aug;149:240-245. doi: 10.1016/j.radonc.2020.05.029. Epub 2020 May 22.,Sanmamed N,https://www.ncbi.nlm.nih.gov/pubmed/32447033
9283,31929596,Urethral realignment with maximal urethral length and bladder neck preservation in robot-assisted radical prostatectomy: Urinary continence recovery,PLoS One. 2020 Jan 13;15(1):e0227744. doi: 10.1371/journal.pone.0227744. eCollection 2020.,Heo JE,https://www.ncbi.nlm.nih.gov/pubmed/31929596
9284,31359337,The impact of PTEN deletion and ERG rearrangement on recurrence after treatment for prostate cancer: a systematic review and meta-analysis,Clin Transl Oncol. 2020 May;22(5):694-702. doi: 10.1007/s12094-019-02170-3. Epub 2019 Jul 29.,Liu R,https://www.ncbi.nlm.nih.gov/pubmed/31359337
9285,32103332,(68)Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy,World J Urol. 2020 Dec;38(12):3085-3090. doi: 10.1007/s00345-020-03131-0. Epub 2020 Feb 26.,Kopp J,https://www.ncbi.nlm.nih.gov/pubmed/32103332
9286,32166768,Automatic prostate segmentation using deep learning on clinically diverse 3D transrectal ultrasound images,Med Phys. 2020 Jun;47(6):2413-2426. doi: 10.1002/mp.14134. Epub 2020 Apr 8.,Orlando N,https://www.ncbi.nlm.nih.gov/pubmed/32166768
9287,31860754,Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients,Prostate. 2020 Feb;80(3):284-290. doi: 10.1002/pros.23942. Epub 2019 Dec 20.,Kato M,https://www.ncbi.nlm.nih.gov/pubmed/31860754
9288,31848818,Facility-Level Variation in Pelvic Lymphadenectomy During Radical Prostatectomy and Effect on Overall Survival in Men with High-Risk Prostate Cancer,Ann Surg Oncol. 2020 Jun;27(6):1929-1936. doi: 10.1245/s10434-019-08110-3. Epub 2019 Dec 17.,Friedlander DF,https://www.ncbi.nlm.nih.gov/pubmed/31848818
9289,32152901,Are we failing to consent to an increasingly common complication? Incisional hernias at robotic prostatectomy,J Robot Surg. 2020 Dec;14(6):861-864. doi: 10.1007/s11701-020-01063-w. Epub 2020 Mar 9.,Timm B,https://www.ncbi.nlm.nih.gov/pubmed/32152901
9290,32527134,"Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis",Ann Palliat Med. 2020 Jul;9(4):1708-1717. doi: 10.21037/apm-19-414. Epub 2020 May 30.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/32527134
9291,32211861,"Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy",J Radiat Res. 2020 May 22;61(3):487-493. doi: 10.1093/jrr/rraa013.,Saito M,https://www.ncbi.nlm.nih.gov/pubmed/32211861
9292,32188426,Urinary continence outcomes of four years of follow-up and predictors of early and late urinary continence in patients undergoing robot-assisted radical prostatectomy,BMC Urol. 2020 Mar 18;20(1):29. doi: 10.1186/s12894-020-00601-w.,Li X,https://www.ncbi.nlm.nih.gov/pubmed/32188426
9293,32217039,Long-term biochemical control and cause-specific survival in men with Gleason grade Group 4 and 5 prostate cancer treated with brachytherapy and external beam irradiation,Brachytherapy. 2020 May-Jun;19(3):275-281. doi: 10.1016/j.brachy.2020.01.008. Epub 2020 Mar 23.,Stone NN,https://www.ncbi.nlm.nih.gov/pubmed/32217039
9294,32209629,Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review,BMJ Open. 2020 Mar 24;10(3):e034612. doi: 10.1136/bmjopen-2019-034612.,John A,https://www.ncbi.nlm.nih.gov/pubmed/32209629
9295,32464368,(18)F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE,Pract Radiat Oncol. 2020 Sep-Oct;10(5):354-362. doi: 10.1016/j.prro.2020.05.007. Epub 2020 May 25.,Solanki AA,https://www.ncbi.nlm.nih.gov/pubmed/32464368
9296,32335059,"Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy",Clin Genitourin Cancer. 2020 Aug;18(4):274-283.e5. doi: 10.1016/j.clgc.2019.11.023. Epub 2020 Mar 19.,Tward JD,https://www.ncbi.nlm.nih.gov/pubmed/32335059
9297,31704459,Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer,Urology. 2020 Feb;136:180-189. doi: 10.1016/j.urology.2019.09.040. Epub 2019 Nov 5.,Goy BW,https://www.ncbi.nlm.nih.gov/pubmed/31704459
9298,31062122,Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters,World J Urol. 2020 Feb;38(2):343-350. doi: 10.1007/s00345-019-02784-w. Epub 2019 May 6.,Hatiboglu G,https://www.ncbi.nlm.nih.gov/pubmed/31062122
9300,31944367,Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy,Histopathology. 2020 Apr;76(5):755-762. doi: 10.1111/his.14064.,Hollemans E,https://www.ncbi.nlm.nih.gov/pubmed/31944367
9301,31267377,Moderate hypofractionated helical tomotherapy for prostate cancer in a cohort of older patients: a mono-institutional report of toxicity and clinical outcomes,Aging Clin Exp Res. 2020 Apr;32(4):747-753. doi: 10.1007/s40520-019-01243-1. Epub 2019 Jul 2.,Cuccia F,https://www.ncbi.nlm.nih.gov/pubmed/31267377
9302,31915143,Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes,Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):676-680. doi: 10.1158/1055-9965.EPI-19-1462. Epub 2020 Jan 8.,Heaphy CM,https://www.ncbi.nlm.nih.gov/pubmed/31915143
9303,31923712,Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial,Radiother Oncol. 2020 Apr;145:71-80. doi: 10.1016/j.radonc.2019.12.006. Epub 2020 Jan 7.,Murthy V,https://www.ncbi.nlm.nih.gov/pubmed/31923712
9304,32248826,"1.5?T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment",Radiat Oncol. 2020 Mar 23;15(1):69. doi: 10.1186/s13014-020-01510-w.,Alongi F,https://www.ncbi.nlm.nih.gov/pubmed/32248826
9305,32049793,Long non-coding RNA small nucleolar RNA host gene 7 expression level in prostate cancer tissues predicts the prognosis of patients with prostate cancer,Medicine (Baltimore). 2020 Feb;99(7):e18993. doi: 10.1097/MD.0000000000018993.,Xia Q,https://www.ncbi.nlm.nih.gov/pubmed/32049793
9307,31547938,"The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy",Eur Urol. 2020 Jun;77(6):733-741. doi: 10.1016/j.eururo.2019.09.005. Epub 2019 Sep 21.,Gandaglia G,https://www.ncbi.nlm.nih.gov/pubmed/31547938
9308,31630864,Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy,Radiother Oncol. 2020 Jan;142:253-260. doi: 10.1016/j.radonc.2019.09.017. Epub 2019 Oct 17.,Pedersen J,https://www.ncbi.nlm.nih.gov/pubmed/31630864
9309,31562222,Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer,J Nucl Med. 2020 Apr;61(4):540-545. doi: 10.2967/jnumed.119.232199. Epub 2019 Sep 27.,Hinsenveld FJ,https://www.ncbi.nlm.nih.gov/pubmed/31562222
9311,31924316,Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study,Eur Urol. 2020 May;77(5):563-572. doi: 10.1016/j.eururo.2019.12.020. Epub 2020 Jan 8.,Lin DW,https://www.ncbi.nlm.nih.gov/pubmed/31924316
9312,31928408,Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound,J Urol. 2020 Apr;203(4):734-742. doi: 10.1097/JU.0000000000000747. Epub 2020 Jan 13.,Huber PM,https://www.ncbi.nlm.nih.gov/pubmed/31928408
9313,32303782,Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer : Long-term results and factors predictive for outcome and toxicity,Strahlenther Onkol. 2020 Jul;196(7):608-616. doi: 10.1007/s00066-020-01619-7. Epub 2020 Apr 17.,Franzese C,https://www.ncbi.nlm.nih.gov/pubmed/32303782
9314,31665352,Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study,Jpn J Clin Oncol. 2020 Jan 24;50(1):66-72. doi: 10.1093/jjco/hyz138.,Enokida H,https://www.ncbi.nlm.nih.gov/pubmed/31665352
9315,32276193,Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer,Radiother Oncol. 2020 Jun;147:123-129. doi: 10.1016/j.radonc.2020.03.033. Epub 2020 Mar 31.,Parzen JS,https://www.ncbi.nlm.nih.gov/pubmed/32276193
9316,32108029,A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2),Clin Cancer Res. 2020 Jun 15;26(12):3035-3043. doi: 10.1158/1078-0432.CCR-19-3873. Epub 2020 Feb 27.,Freedland SJ,https://www.ncbi.nlm.nih.gov/pubmed/32108029
9317,31813740,Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy,Brachytherapy. 2020 Jan-Feb;19(1):43-50. doi: 10.1016/j.brachy.2019.10.005. Epub 2019 Dec 5.,Tom MC,https://www.ncbi.nlm.nih.gov/pubmed/31813740
9318,32000818,Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer - a prospective pilot study,Radiat Oncol. 2020 Jan 30;15(1):27. doi: 10.1186/s13014-020-1474-y.,Schaefer C,https://www.ncbi.nlm.nih.gov/pubmed/32000818
9319,31813810,Comparison of Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy Strategies as Primary Treatment for High-risk Localized Prostate Cancer: A Systematic Review and Meta-analysis,Eur Urol Focus. 2020 Mar 15;6(2):404-418. doi: 10.1016/j.euf.2019.11.007. Epub 2019 Dec 5.,Greenberger BA,https://www.ncbi.nlm.nih.gov/pubmed/31813810
9320,32259468,Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer,J Urol. 2020 Oct;204(4):748-753. doi: 10.1097/JU.0000000000001074. Epub 2020 Apr 7.,Ranasinghe W,https://www.ncbi.nlm.nih.gov/pubmed/32259468
9321,31920063,"Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)",Minerva Urol Nefrol. 2020 Oct;72(5):595-604. doi: 10.23736/S0393-2249.19.03637-3. Epub 2020 Jan 7.,Antonelli A,https://www.ncbi.nlm.nih.gov/pubmed/31920063
9322,31437119,Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study,J Urol. 2020 Feb;203(2):338-343. doi: 10.1097/JU.0000000000000504. Epub 2019 Aug 22.,Preisser F,https://www.ncbi.nlm.nih.gov/pubmed/31437119
9325,31909690,Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center,J Urol. 2020 Jun;203(6):1117-1121. doi: 10.1097/JU.0000000000000742. Epub 2020 Jan 7.,Carlsson S,https://www.ncbi.nlm.nih.gov/pubmed/31909690
9326,31864774,Multiquadrant Combined Robotic Radical Prostatectomy And Left Partial Nephrectomy: A Combined procedure by A Single Approach,Actas Urol Esp (Engl Ed). 2020 Mar;44(2):119-124. doi: 10.1016/j.acuro.2019.06.004. Epub 2019 Dec 18.,Valero R,https://www.ncbi.nlm.nih.gov/pubmed/31864774
9327,32156491,Clinical-genomic Characterization Unveils More Aggressive Disease Features in Elderly Prostate Cancer Patients with Low-grade Disease,Eur Urol Focus. 2021 Jul;7(4):797-806. doi: 10.1016/j.euf.2020.02.008. Epub 2020 Mar 7.,Goldberg H,https://www.ncbi.nlm.nih.gov/pubmed/32156491
9328,30041833,Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes,Eur Urol. 2020 May;77(5):628-635. doi: 10.1016/j.eururo.2018.07.003. Epub 2018 Jul 21.,de Carvalho PA,https://www.ncbi.nlm.nih.gov/pubmed/30041833
9329,31761540,Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial,Pract Radiat Oncol. 2020 Mar-Apr;10(2):e82-e90. doi: 10.1016/j.prro.2019.09.016. Epub 2019 Nov 21.,Gore JL,https://www.ncbi.nlm.nih.gov/pubmed/31761540
9330,31072805,Functional Recovery Following Primary Treatment for Prostate Cancer: Update from the CEASAR Study,Eur Urol Focus. 2020 Mar 15;6(2):205-207. doi: 10.1016/j.euf.2019.04.001. Epub 2019 May 7.,Barocas DA,https://www.ncbi.nlm.nih.gov/pubmed/31072805
9331,31502941,PTEN Loss with ERG Negative Status is Associated with Lethal Disease after Radical Prostatectomy,J Urol. 2020 Feb;203(2):344-350. doi: 10.1097/JU.0000000000000533. Epub 2019 Sep 10.,Haney NM,https://www.ncbi.nlm.nih.gov/pubmed/31502941
9332,31144490,Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression,Minerva Urol Nefrol. 2020 Apr;72(2):214-222. doi: 10.23736/S0393-2249.19.03377-0. Epub 2019 May 28.,Palermo G,https://www.ncbi.nlm.nih.gov/pubmed/31144490
9333,32068488,"Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of (68)Ga-PSMA and (11)C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections",J Urol. 2020 Aug;204(2):296-302. doi: 10.1097/JU.0000000000000800. Epub 2020 Feb 18.,Fossati N,https://www.ncbi.nlm.nih.gov/pubmed/32068488
9334,31959519,Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapy,Brachytherapy. 2020 Mar-Apr;19(2):210-215. doi: 10.1016/j.brachy.2019.12.002. Epub 2020 Jan 17.,Attalla K,https://www.ncbi.nlm.nih.gov/pubmed/31959519
9336,31794085,The clinical predictive factors and postoperative histopathological parameters associated with upgrading after radical prostatectomy: A contemporary analysis with grade groups,Prostate. 2020 Feb;80(2):225-234. doi: 10.1002/pros.23936. Epub 2019 Dec 3.,Erdem S,https://www.ncbi.nlm.nih.gov/pubmed/31794085
9337,30953141,Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy,World J Urol. 2020 Jan;38(1):103-109. doi: 10.1007/s00345-019-02752-4. Epub 2019 Apr 5.,Lu Y,https://www.ncbi.nlm.nih.gov/pubmed/30953141
9338,30413390,Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study),Eur Urol Focus. 2020 Mar 15;6(2):259-266. doi: 10.1016/j.euf.2018.10.013. Epub 2018 Nov 7.,Lista G,https://www.ncbi.nlm.nih.gov/pubmed/30413390
9339,31793211,Urologists' referral and radiation oncologists' treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis,J Med Imaging Radiat Oncol. 2020 Feb;64(1):134-143. doi: 10.1111/1754-9485.12979. Epub 2019 Dec 2.,Egger S,https://www.ncbi.nlm.nih.gov/pubmed/31793211
9340,32158968,Single-port robot-assisted radical prostatectomy with the da Vinci SP system: A single surgeon's experience,Investig Clin Urol. 2020 Mar;61(2):173-179. doi: 10.4111/icu.2020.61.2.173. Epub 2020 Jan 30.,Kim KH,https://www.ncbi.nlm.nih.gov/pubmed/32158968
9341,31959170,The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review,World J Surg Oncol. 2020 Jan 20;18(1):14. doi: 10.1186/s12957-020-1791-5.,Yuan P,https://www.ncbi.nlm.nih.gov/pubmed/31959170
9342,31719663,Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):295-302. doi: 10.1038/s41391-019-0185-7. Epub 2019 Nov 12.,Marascio J,https://www.ncbi.nlm.nih.gov/pubmed/31719663
9343,32002591,Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study,Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1852-1863. doi: 10.1007/s00259-020-04708-y. Epub 2020 Jan 30.,Schmidt-Hegemann NS,https://www.ncbi.nlm.nih.gov/pubmed/32002591
9344,31792635,Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology,Int J Clin Oncol. 2020 Apr;25(4):732-740. doi: 10.1007/s10147-019-01587-8. Epub 2019 Dec 2.,Ito K,https://www.ncbi.nlm.nih.gov/pubmed/31792635
9345,31899654,Histogram analysis from stretched exponential model on diffusion-weighted imaging: evaluation of clinically significant prostate cancer,Br J Radiol. 2020 Feb 1;93(1106):20190757. doi: 10.1259/bjr.20190757. Epub 2020 Jan 9.,Kim E,https://www.ncbi.nlm.nih.gov/pubmed/31899654
9347,31483694,"Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy",J Urol. 2020 Feb;203(2):299-303. doi: 10.1097/JU.0000000000000527. Epub 2019 Sep 4.,Leyh-Bannurah SR,https://www.ncbi.nlm.nih.gov/pubmed/31483694
9348,31705947,"Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a ""Negative Core"" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis",Urology. 2020 Mar;137:102-107. doi: 10.1016/j.urology.2019.10.012. Epub 2019 Nov 6.,Leong JY,https://www.ncbi.nlm.nih.gov/pubmed/31705947
9349,32312641,Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions,Urol Oncol. 2020 Sep;38(9):734.e11-734.e17. doi: 10.1016/j.urolonc.2020.03.023. Epub 2020 Apr 17.,Manceau C,https://www.ncbi.nlm.nih.gov/pubmed/32312641
9350,32481410,Management of locally advanced synchronous colorectal and prostate cancers: A case report,Medicine (Baltimore). 2020 May 29;99(22):e20336. doi: 10.1097/MD.0000000000020336.,Tey YQ,https://www.ncbi.nlm.nih.gov/pubmed/32481410
9351,31796374,Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential,Urol Oncol. 2020 Mar;38(3):78.e15-78.e21. doi: 10.1016/j.urolonc.2019.10.009. Epub 2019 Dec 1.,Waingankar N,https://www.ncbi.nlm.nih.gov/pubmed/31796374
9352,31899229,Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies,Urology. 2020 Mar;137:126-132. doi: 10.1016/j.urology.2019.10.039. Epub 2019 Dec 30.,Ploussard G,https://www.ncbi.nlm.nih.gov/pubmed/31899229
9353,32033909,The Significance of Primary Biopsy Gleason 5 in Patients with Grade Group 5 Prostate Cancer,Eur Urol Focus. 2020 Mar 15;6(2):255-258. doi: 10.1016/j.euf.2020.01.008. Epub 2020 Feb 6.,Tilki D,https://www.ncbi.nlm.nih.gov/pubmed/32033909
9355,32014426,Salvage Radical Prostatectomy After Robot-assisted Laparoscopic Prostatectomy: Case Series,Clin Genitourin Cancer. 2020 Apr;18(2):e202-e207. doi: 10.1016/j.clgc.2019.10.017. Epub 2019 Oct 16.,Ahmed ME,https://www.ncbi.nlm.nih.gov/pubmed/32014426
9356,32150281,Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers,Int J Cancer. 2020 Jul 15;147(2):575-583. doi: 10.1002/ijc.32957. Epub 2020 Mar 18.,Luebke AM,https://www.ncbi.nlm.nih.gov/pubmed/32150281
9359,31782131,Application of Dried Human Amnion Graft to Improve Post-Prostatectomy Incontinence and Potency: A Randomized Exploration Study Protocol,Adv Ther. 2020 Jan;37(1):592-602. doi: 10.1007/s12325-019-01158-3. Epub 2019 Nov 28.,Barski D,https://www.ncbi.nlm.nih.gov/pubmed/31782131
9361,31969336,"CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer",Clin Cancer Res. 2020 Jun 1;26(11):2595-2602. doi: 10.1158/1078-0432.CCR-19-1669. Epub 2020 Jan 22.,Faisal FA,https://www.ncbi.nlm.nih.gov/pubmed/31969336
9362,32429654,The level of myeloid derived-suppressor cells in peripheral blood of patients with prostate cancerafter various types of therapy,Pol J Pathol. 2020;71(1):46-54. doi: 10.5114/pjp.2020.95415.,,https://www.ncbi.nlm.nih.gov/pubmed/32429654
9363,31858823,Does trunk muscle training with an oscillating rod improve urinary incontinence after radical prostatectomy? A prospective randomized controlled trial,Clin Rehabil. 2020 Mar;34(3):320-333. doi: 10.1177/0269215519893096. Epub 2019 Dec 20.,Heydenreich M,https://www.ncbi.nlm.nih.gov/pubmed/31858823
9364,31482413,Whole-Body Integrated [(68)Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference,Mol Imaging Biol. 2020 Jun;22(3):788-796. doi: 10.1007/s11307-019-01424-4.,Guberina N,https://www.ncbi.nlm.nih.gov/pubmed/31482413
9367,31796344,Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry,Clin Genitourin Cancer. 2020 Feb;18(1):e21-e27. doi: 10.1016/j.clgc.2019.10.026. Epub 2019 Nov 6.,Ten Ham RMT,https://www.ncbi.nlm.nih.gov/pubmed/31796344
9368,31243337,Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):102-107. doi: 10.1038/s41391-019-0159-9. Epub 2019 Jun 27.,Canter DJ,https://www.ncbi.nlm.nih.gov/pubmed/31243337
9369,32068113,Effect of (18)F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial,Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):316-324. doi: 10.1016/j.ijrobp.2020.01.050. Epub 2020 Feb 14.,Scarsbrook AF,https://www.ncbi.nlm.nih.gov/pubmed/32068113
9370,31054811,Accuracy of Sampling PI-RADS 4-5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy-naive Patients Undergoing Radical Prostatectomy,Eur Urol Focus. 2020 Mar 15;6(2):249-254. doi: 10.1016/j.euf.2019.04.010. Epub 2019 May 2.,Kilic M,https://www.ncbi.nlm.nih.gov/pubmed/31054811
9372,31604131,A Multicenter Phase 2 study of Hypofractionated Stereostatic Boost in Intermediate Risk Prostate Carcinoma: A 5-Year Analysis of the CKNO-PRO Trial,Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):116-123. doi: 10.1016/j.ijrobp.2019.09.039. Epub 2019 Oct 8.,Pasquier D,https://www.ncbi.nlm.nih.gov/pubmed/31604131
9373,31383954,Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):116-126. doi: 10.1038/s41391-019-0164-z. Epub 2019 Aug 5.,Huang C,https://www.ncbi.nlm.nih.gov/pubmed/31383954
9374,32848525,Detection Rate of (18)F-Fluorethylcholine-PET/CT in relation to PSA Value in PCA Patients Referred with Biochemical Relapse,Contrast Media Mol Imaging. 2020 Aug 11;2020:4320178. doi: 10.1155/2020/4320178. eCollection 2020.,Takesh M,https://www.ncbi.nlm.nih.gov/pubmed/32848525
9377,32357849,"Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model",BMC Cancer. 2020 May 1;20(1):371. doi: 10.1186/s12885-020-06880-8.,Taguchi S,https://www.ncbi.nlm.nih.gov/pubmed/32357849
9383,32119879,Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort,Hum Pathol. 2020 Apr;98:74-80. doi: 10.1016/j.humpath.2020.02.004. Epub 2020 Feb 28.,Haffner MC,https://www.ncbi.nlm.nih.gov/pubmed/32119879
9385,32324906,Response to: Bando et al. Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histological and molecular analyses,Prostate. 2020 Jul;80(10):795-796. doi: 10.1002/pros.23987. Epub 2020 Apr 23.,Sebben M,https://www.ncbi.nlm.nih.gov/pubmed/32324906
9390,32157427,"Interobserver variability, detection rate, and lesion patterns of (68)Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy",Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2339-2347. doi: 10.1007/s00259-020-04718-w. Epub 2020 Mar 10.,Miksch J,https://www.ncbi.nlm.nih.gov/pubmed/32157427
9391,32388444,Dosimetric predictors of patient-reported toxicity after prostate stereotactic body radiotherapy: Analysis of full range of the dose-volume histogram using ensemble machine learning,Radiother Oncol. 2020 Jul;148:181-188. doi: 10.1016/j.radonc.2020.04.013. Epub 2020 Apr 17.,Pan X,https://www.ncbi.nlm.nih.gov/pubmed/32388444
9393,32143901,Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study,Clin Oncol (R Coll Radiol). 2020 Aug;32(8):501-508. doi: 10.1016/j.clon.2020.02.004. Epub 2020 Mar 3.,Sujenthiran A,https://www.ncbi.nlm.nih.gov/pubmed/32143901
9394,31845840,Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer,J Urol. 2020 Jun;203(6):1128-1134. doi: 10.1097/JU.0000000000000704. Epub 2019 Dec 17.,Pak S,https://www.ncbi.nlm.nih.gov/pubmed/31845840
9396,31680398,Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature,BJU Int. 2020 Feb;125(2):206-214. doi: 10.1111/bju.14944. Epub 2019 Nov 29.,Luiting HB,https://www.ncbi.nlm.nih.gov/pubmed/31680398
9397,32152758,"Indoleamine 2,3-dioxygenase expression in the prognosis of the localized prostate cancer",Int Urol Nephrol. 2020 Aug;52(8):1477-1482. doi: 10.1007/s11255-020-02414-0. Epub 2020 Mar 9.,Ferreira JM,https://www.ncbi.nlm.nih.gov/pubmed/32152758
9400,31916185,Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy,Pathol Oncol Res. 2020 Oct;26(4):2115-2121. doi: 10.1007/s12253-019-00762-6. Epub 2020 Jan 8.,Oikawa M,https://www.ncbi.nlm.nih.gov/pubmed/31916185
9401,32124531,Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy,BJU Int. 2020 Jul;126(1):91-96. doi: 10.1111/bju.15042. Epub 2020 Apr 1.,Ahlering TE,https://www.ncbi.nlm.nih.gov/pubmed/32124531
9402,32022878,Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States,JAMA Netw Open. 2020 Feb 5;3(2):e1920471. doi: 10.1001/jamanetworkopen.2019.20471.,Mahase SS,https://www.ncbi.nlm.nih.gov/pubmed/32022878
9404,32400122,"Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression",Cancer Med. 2020 Jul;9(13):4667-4675. doi: 10.1002/cam4.3087. Epub 2020 May 13.,Gutiontov SI,https://www.ncbi.nlm.nih.gov/pubmed/32400122
9405,32421259,Particle therapy toxicity outcomes: A systematic review,J Med Imaging Radiat Oncol. 2020 Oct;64(5):725-737. doi: 10.1111/1754-9485.13036. Epub 2020 May 18.,Hwang EJ,https://www.ncbi.nlm.nih.gov/pubmed/32421259
9407,32464369,Adaptive Strategy for External Beam Radiation Therapy in Prostate Cancer: Management of the Geometrical Uncertainties With Robust Optimization,Pract Radiat Oncol. 2020 Nov-Dec;10(6):e521-e528. doi: 10.1016/j.prro.2020.05.006. Epub 2020 May 25.,Ferrara E,https://www.ncbi.nlm.nih.gov/pubmed/32464369
9408,31679970,Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis,Eur Urol. 2020 Mar;77(3):365-372. doi: 10.1016/j.eururo.2019.09.004. Epub 2019 Nov 1.,Sathianathen NJ,https://www.ncbi.nlm.nih.gov/pubmed/31679970
9409,32227280,Pre-clinical evaluation of an image-guided in-situ Raman spectroscopy navigation system for targeted prostate cancer interventions,Int J Comput Assist Radiol Surg. 2020 May;15(5):867-876. doi: 10.1007/s11548-020-02136-9. Epub 2020 Mar 29.,Shams R,https://www.ncbi.nlm.nih.gov/pubmed/32227280
9410,32415472,Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice,Radiol Med. 2021 Jan;126(1):142-146. doi: 10.1007/s11547-020-01216-9. Epub 2020 May 15.,Barra S,https://www.ncbi.nlm.nih.gov/pubmed/32415472
9411,32321456,"Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level?<?4?ng/ml: a population-based study",BMC Cancer. 2020 Apr 22;20(1):340. doi: 10.1186/s12885-020-06827-z.,Zheng Z,https://www.ncbi.nlm.nih.gov/pubmed/32321456
9412,32413546,RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning,Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):802-812. doi: 10.1016/j.ijrobp.2020.04.045. Epub 2020 May 12.,Mao X,https://www.ncbi.nlm.nih.gov/pubmed/32413546
9413,32399638,Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer,Strahlenther Onkol. 2020 Jul;196(7):628-636. doi: 10.1007/s00066-020-01628-6. Epub 2020 May 12.,Cuccia F,https://www.ncbi.nlm.nih.gov/pubmed/32399638
9414,31872469,Mechanisms of decision-making in preoperative assessment for older adult prostate cancer patients-A qualitative study,J Surg Oncol. 2020 Mar;121(3):561-569. doi: 10.1002/jso.25819. Epub 2019 Dec 23.,Kierkegaard P,https://www.ncbi.nlm.nih.gov/pubmed/31872469
9415,32243242,Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy,J Urol. 2020 Sep;204(3):511-517. doi: 10.1097/JU.0000000000001036. Epub 2020 Apr 3.,Daskivich TJ,https://www.ncbi.nlm.nih.gov/pubmed/32243242
9418,31248850,Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations,Eur Urol Focus. 2020 Mar 15;6(2):231-234. doi: 10.1016/j.euf.2019.06.004. Epub 2019 Jun 24.,Van den Broeck T,https://www.ncbi.nlm.nih.gov/pubmed/31248850
9419,32655718,FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer,Dis Markers. 2020 Jun 18;2020:3904947. doi: 10.1155/2020/3904947. eCollection 2020.,Cao Z,https://www.ncbi.nlm.nih.gov/pubmed/32655718
9421,32123315,Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):61-68. doi: 10.1038/s41391-020-0211-9. Epub 2020 Mar 3.,Gross ME,https://www.ncbi.nlm.nih.gov/pubmed/32123315
9422,32327479,[(18)F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial,BMJ Open. 2020 Apr 22;10(4):e035959. doi: 10.1136/bmjopen-2019-035959.,Glicksman RM,https://www.ncbi.nlm.nih.gov/pubmed/32327479
9423,31593756,"Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial",Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):108-115. doi: 10.1016/j.ijrobp.2019.09.007. Epub 2019 Oct 5.,de Vries KC,https://www.ncbi.nlm.nih.gov/pubmed/31593756
9424,32329227,Simulating the impact of centralization of prostate cancer surgery services on travel burden and equity in the English National Health Service: A national population based model for health service re-design,Cancer Med. 2020 Jun;9(12):4175-4184. doi: 10.1002/cam4.3073. Epub 2020 Apr 23.,Aggarwal A,https://www.ncbi.nlm.nih.gov/pubmed/32329227
9425,31868959,"Overall, specific, and metastasis-free survival of Afro-Caribbean men with pathological Gleason 6 prostate cancer",Prostate. 2020 Mar;80(4):329-335. doi: 10.1002/pros.23947. Epub 2019 Dec 23.,Mollard P,https://www.ncbi.nlm.nih.gov/pubmed/31868959
9426,32299388,Applied anatomy of pelvic lymph nodes and its clinical significance for prostate cancer:a single-center cadaveric study,BMC Cancer. 2020 Apr 16;20(1):330. doi: 10.1186/s12885-020-06833-1.,Chen JJ,https://www.ncbi.nlm.nih.gov/pubmed/32299388
9428,31994151,Robotic perineal radical prostatectomy in a patient with a pre-existing three piece inflatable penile prosthesis,Aktuelle Urol. 2022 Aug;53(4):351-353. doi: 10.1055/a-0945-2489. Epub 2020 Jan 28.,Yenice MG,https://www.ncbi.nlm.nih.gov/pubmed/31994151
9429,31915914,Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer,J Cancer Res Clin Oncol. 2020 Feb;146(2):537-543. doi: 10.1007/s00432-019-03085-w. Epub 2020 Jan 8.,Choi SY,https://www.ncbi.nlm.nih.gov/pubmed/31915914
9430,31985486,"Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study",J Xray Sci Technol. 2020;28(2):243-254. doi: 10.3233/XST-190598.,Soda R,https://www.ncbi.nlm.nih.gov/pubmed/31985486
9431,32665997,Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?,Investig Clin Urol. 2020 Jul;61(4):405-410. doi: 10.4111/icu.2020.61.4.405. Epub 2020 May 25.,Pham DM,https://www.ncbi.nlm.nih.gov/pubmed/32665997
9432,32472391,Retzius-sparing robotic-assisted laparoscopic radical prostatectomy: racial considerations for 250 consecutive cases,J Robot Surg. 2021 Apr;15(2):221-228. doi: 10.1007/s11701-020-01096-1. Epub 2020 May 29.,Sayyid RK,https://www.ncbi.nlm.nih.gov/pubmed/32472391
9434,32088104,External validation of the Martini nomogram for prediction of side-specific extraprostatic extension of prostate cancer in patients undergoing robot-assisted radical prostatectomy,Urol Oncol. 2020 May;38(5):372-378. doi: 10.1016/j.urolonc.2019.12.028. Epub 2020 Feb 19.,Soeterik TFW,https://www.ncbi.nlm.nih.gov/pubmed/32088104
9435,32372146,Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes,J Cancer Res Clin Oncol. 2020 Sep;146(9):2379-2397. doi: 10.1007/s00432-020-03230-w. Epub 2020 May 5.,Mazzola R,https://www.ncbi.nlm.nih.gov/pubmed/32372146
9438,31538243,"Management of low-risk prostate cancer in patients with enlarged glands and lower urinary tract symptoms: robotic total prostatectomy, a novel technique",World J Urol. 2020 Apr;38(4):829-836. doi: 10.1007/s00345-019-02951-z. Epub 2019 Sep 19.,Pathak RA,https://www.ncbi.nlm.nih.gov/pubmed/31538243
9439,31913473,"Clinical utilization of radiation therapy in Korea, 2016",J Radiat Res. 2020 Mar 23;61(2):249-256. doi: 10.1093/jrr/rrz095.,Kim E,https://www.ncbi.nlm.nih.gov/pubmed/31913473
9440,33014247,Treatment of localized prostate cancer and use of nomograms among urologists in the West Africa sub-region,Pan Afr Med J. 2020 Aug 6;36:251. doi: 10.11604/pamj.2020.36.251.21419. eCollection 2020.,Kyei MY,https://www.ncbi.nlm.nih.gov/pubmed/33014247
9441,31987958,Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate Cancer,Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):299-304. doi: 10.1016/j.ijrobp.2020.01.010. Epub 2020 Jan 25.,Vogelius IR,https://www.ncbi.nlm.nih.gov/pubmed/31987958
9442,31784282,"""Real-time"" Assessment of Surgical Margins During Radical Prostatectomy: State-of-the-Art",Clin Genitourin Cancer. 2020 Apr;18(2):95-104. doi: 10.1016/j.clgc.2019.07.012. Epub 2019 Jul 19.,Eissa A,https://www.ncbi.nlm.nih.gov/pubmed/31784282
9443,31924715,Impact of (68)Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study,J Nucl Med. 2020 Aug;61(8):1153-1160. doi: 10.2967/jnumed.119.237602. Epub 2020 Jan 10.,Sonni I,https://www.ncbi.nlm.nih.gov/pubmed/31924715
9444,32307562,Independent external validation of nomogram to predict extracapsular extension in patients with prostate cancer,Eur Radiol. 2020 Sep;30(9):5004-5010. doi: 10.1007/s00330-020-06839-0. Epub 2020 Apr 19.,Alves JR,https://www.ncbi.nlm.nih.gov/pubmed/32307562
9445,32474764,Peri-prostatic adipose tissue measurements using MRI predict prostate cancer aggressiveness in men undergoing radical prostatectomy,J Endocrinol Invest. 2021 Feb;44(2):287-296. doi: 10.1007/s40618-020-01294-6. Epub 2020 May 30.,Zhai T-,https://www.ncbi.nlm.nih.gov/pubmed/32474764
9447,32171650,Volume of Gleason pattern 4 stratifies risk of metastasis and death in patients with Gleason score 3+5=8/5+3=8 positive prostate core biopsies,Hum Pathol. 2020 May;99:62-74. doi: 10.1016/j.humpath.2020.03.001. Epub 2020 Mar 11.,Acosta AM,https://www.ncbi.nlm.nih.gov/pubmed/32171650
9450,31953005,PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapy,Urol Oncol. 2020 Jun;38(6):600.e1-600.e8. doi: 10.1016/j.urolonc.2019.12.015. Epub 2020 Jan 15.,Turchan WT,https://www.ncbi.nlm.nih.gov/pubmed/31953005
9451,32333202,Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer,Int J Clin Oncol. 2020 Jul;25(7):1398-1404. doi: 10.1007/s10147-020-01682-1. Epub 2020 Apr 24.,Morizane S,https://www.ncbi.nlm.nih.gov/pubmed/32333202
9454,31606332,Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study,Eur Urol. 2020 Feb;77(2):180-188. doi: 10.1016/j.eururo.2019.09.027. Epub 2019 Oct 9.,Zelic R,https://www.ncbi.nlm.nih.gov/pubmed/31606332
9455,31591454,United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):179-183. doi: 10.1038/s41391-019-0175-9. Epub 2019 Oct 7.,Butler SS,https://www.ncbi.nlm.nih.gov/pubmed/31591454
9456,32433602,"Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment",Br J Cancer. 2020 Aug;123(3):487-494. doi: 10.1038/s41416-020-0859-x. Epub 2020 May 20.,Butler EN,https://www.ncbi.nlm.nih.gov/pubmed/32433602
9457,32240115,Gasless robotic perineal radical prostatectomy: Experience of the first 12 cases,Arch Esp Urol. 2020 Apr;73(3):236-241.,Tasci AI,https://www.ncbi.nlm.nih.gov/pubmed/32240115
9459,31980875,The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy,World J Urol. 2020 Nov;38(11):2799-2809. doi: 10.1007/s00345-020-03094-2. Epub 2020 Jan 24.,Sebben M,https://www.ncbi.nlm.nih.gov/pubmed/31980875
9460,31780781,Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels???2.0?ng/ml,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):343-348. doi: 10.1038/s41391-019-0194-6. Epub 2019 Nov 28.,Witkowska-Patena E,https://www.ncbi.nlm.nih.gov/pubmed/31780781
9461,31769876,Impact of age at diagnosis of de novo metastatic prostate cancer on survival,Cancer. 2020 Mar 1;126(5):986-993. doi: 10.1002/cncr.32630. Epub 2019 Nov 26.,Bernard B,https://www.ncbi.nlm.nih.gov/pubmed/31769876
9464,31441379,Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study,Urologia. 2020 Feb;87(1):23-28. doi: 10.1177/0391560319867809. Epub 2019 Aug 23.,Della Camera PA,https://www.ncbi.nlm.nih.gov/pubmed/31441379
9465,31895608,Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England,J Clin Oncol. 2020 Mar 1;38(7):744-752. doi: 10.1200/JCO.19.01538. Epub 2020 Jan 2.,Nossiter J,https://www.ncbi.nlm.nih.gov/pubmed/31895608
9466,32158963,Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population,Investig Clin Urol. 2020 Mar;61(2):127-135. doi: 10.4111/icu.2020.61.2.127. Epub 2020 Feb 10.,Suh J,https://www.ncbi.nlm.nih.gov/pubmed/32158963
9467,31784804,Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancer,Strahlenther Onkol. 2020 Feb;196(2):109-116. doi: 10.1007/s00066-019-01553-3. Epub 2019 Nov 29.,Beck M,https://www.ncbi.nlm.nih.gov/pubmed/31784804
9468,32153229,Social Support in Patients With Sexual Dysfunction After Non-Nerve-Sparing Radical Prostatectomy: A Qualitative Study,Am J Mens Health. 2020 Mar-Apr;14(2):1557988320906977. doi: 10.1177/1557988320906977.,Fernández-Sola C,https://www.ncbi.nlm.nih.gov/pubmed/32153229
9469,32026731,Pelvic phased-array mpMRI versus saturation biopsy: a diagnostic performance analysis in men with suspected advanced prostate cancer,Scand J Urol. 2020 Feb;54(1):14-19. doi: 10.1080/21681805.2020.1719193. Epub 2020 Feb 6.,Liu G,https://www.ncbi.nlm.nih.gov/pubmed/32026731
9470,31753604,Cribriform pattern and perineural invasion on MR/US fusion biopsy predict failure of selection criteria for prostatic hemigland ablation,Urol Oncol. 2020 Feb;38(2):38.e1-38.e8. doi: 10.1016/j.urolonc.2019.09.029. Epub 2019 Nov 18.,Mithal P,https://www.ncbi.nlm.nih.gov/pubmed/31753604
9471,31039101,Incidence of Inguinal Hernia after Radical Prostatectomy: A Systematic Review and Meta-Analysis,J Urol. 2020 Feb;203(2):265-274. doi: 10.1097/JU.0000000000000313. Epub 2019 Apr 30.,Alder R,https://www.ncbi.nlm.nih.gov/pubmed/31039101
9472,31249271,Contemporary trends in radical prostatectomy and predictors of recovery of urinary continence in men aged over 70 years: comparisons between cohorts aged over 70 and less than 70 years,Asian J Androl. 2020 May-Jun;22(3):280-286. doi: 10.4103/aja.aja_62_19.,Lee YJ,https://www.ncbi.nlm.nih.gov/pubmed/31249271
9474,31971828,Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases,Br J Radiol. 2020 Apr;93(1108):20190353. doi: 10.1259/bjr.20190353. Epub 2020 Jan 31.,Deantoni CL,https://www.ncbi.nlm.nih.gov/pubmed/31971828
9475,32417965,Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers,Virchows Arch. 2020 Nov;477(5):625-636. doi: 10.1007/s00428-020-02834-4. Epub 2020 May 16.,Möller K,https://www.ncbi.nlm.nih.gov/pubmed/32417965
9476,32231265,Prognostic value of seminal vesicle invasion on preoperative multi-parametric magnetic resonance imaging in pathological stage T3b prostate cancer,Sci Rep. 2020 Mar 30;10(1):5693. doi: 10.1038/s41598-020-62808-z.,Kim JK,https://www.ncbi.nlm.nih.gov/pubmed/32231265
9477,32155646,Impact of Preoperative Magnetic Resonance Imaging Anatomic Features on Urinary Continence Recovery after Laparoscopic Radical Prostatectomy,Urol Int. 2020;104(3-4):239-246. doi: 10.1159/000506021. Epub 2020 Mar 10.,Yang B,https://www.ncbi.nlm.nih.gov/pubmed/32155646
9478,31833113,Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer,Int J Urol. 2020 Feb;27(2):179-185. doi: 10.1111/iju.14161. Epub 2019 Dec 13.,Takeda T,https://www.ncbi.nlm.nih.gov/pubmed/31833113
9480,31868968,Automated approach for estimation of grade groups for prostate cancer based on histological image feature analysis,Prostate. 2020 Feb;80(3):291-302. doi: 10.1002/pros.23943. Epub 2019 Dec 23.,Hossain A,https://www.ncbi.nlm.nih.gov/pubmed/31868968
9481,30773328,"Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis",Eur Urol. 2020 Apr;77(4):403-417. doi: 10.1016/j.eururo.2019.01.049. Epub 2019 Feb 14.,Perera M,https://www.ncbi.nlm.nih.gov/pubmed/30773328
9482,31584841,Practice Patterns in Reporting Tertiary Grades at Radical Prostatectomy: Survey of a Large Group of Experienced Urologic Pathologists,Arch Pathol Lab Med. 2020 Mar;144(3):356-360. doi: 10.5858/arpa.2019-0224-OA. Epub 2019 Oct 4.,Fine SW,https://www.ncbi.nlm.nih.gov/pubmed/31584841
9483,32065865,Continent cutaneous ileocecal cystoplasty in the treatment of refractory bladder neck contracture and urinary incontinence after prostate cancer treatment,Can J Urol. 2020 Feb;27(1):10093-10098.,Shen JK,https://www.ncbi.nlm.nih.gov/pubmed/32065865
9484,31571158,Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study,Int Urol Nephrol. 2020 Feb;52(2):271-278. doi: 10.1007/s11255-019-02300-4. Epub 2019 Sep 30.,Chen C,https://www.ncbi.nlm.nih.gov/pubmed/31571158
9485,32338176,Adherence to guidelines for androgen deprivation therapy after radical prostatectomy: Swedish population-based study,Scand J Urol. 2020 Jun;54(3):208-214. doi: 10.1080/21681805.2020.1750475. Epub 2020 Apr 27.,Lycken M,https://www.ncbi.nlm.nih.gov/pubmed/32338176
9486,31271443,Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer,Int J Cancer. 2020 Jan 15;146(2):577-588. doi: 10.1002/ijc.32551. Epub 2019 Jul 19.,Becker F,https://www.ncbi.nlm.nih.gov/pubmed/31271443
9487,32381585,Management of Active Surveillance-Eligible Prostate Cancer during Pretransplantation Workup of Patients with Kidney Failure: A Simulation Study,Clin J Am Soc Nephrol. 2020 Jun 8;15(6):822-829. doi: 10.2215/CJN.14041119. Epub 2020 May 7.,Bieri U,https://www.ncbi.nlm.nih.gov/pubmed/32381585
9488,31509606,Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate,Int J Cancer. 2020 May 1;146(9):2619-2627. doi: 10.1002/ijc.32679. Epub 2019 Oct 16.,Borkowetz A,https://www.ncbi.nlm.nih.gov/pubmed/31509606
9489,31982182,Clinical and pathological characteristics of bladder cancer in post brachytherapy patients,Pathol Res Pract. 2020 Mar;216(3):152822. doi: 10.1016/j.prp.2020.152822. Epub 2020 Jan 10.,Au S,https://www.ncbi.nlm.nih.gov/pubmed/31982182
9490,31961962,A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy,Prostate. 2020 Apr;80(5):376-387. doi: 10.1002/pros.23952. Epub 2020 Jan 21.,Li X,https://www.ncbi.nlm.nih.gov/pubmed/31961962
9491,32164666,Intraoperative intraocular pressure changes during robot-assisted radical prostatectomy: associations with perioperative and clinicopathological factors,BMC Urol. 2020 Mar 12;20(1):26. doi: 10.1186/s12894-020-00595-5.,Shirono Y,https://www.ncbi.nlm.nih.gov/pubmed/32164666
9492,32324163,Significance of nuclear factor - kappa beta activation on prostate needle biopsy samples in the evaluation of Gleason score 6 prostatic carcinoma indolence,Radiol Oncol. 2020 Apr 21;54(2):194-200. doi: 10.2478/raon-2020-0019.,Zupancic M,https://www.ncbi.nlm.nih.gov/pubmed/32324163
9493,32000716,"Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study ""GUNMA0702""",BMC Cancer. 2020 Jan 30;20(1):75. doi: 10.1186/s12885-020-6570-8.,Kawamura H,https://www.ncbi.nlm.nih.gov/pubmed/32000716
9494,32505965,Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials,Radiother Oncol. 2020 Jul;148:235-242. doi: 10.1016/j.radonc.2020.04.037. Epub 2020 Apr 28.,Lehrer EJ,https://www.ncbi.nlm.nih.gov/pubmed/32505965
9495,32368932,Preoperative Predictive Model of Narrow Pelvis in Laparoscopic Radical Prostatectomy Through Computed Tomography,J Endourol. 2020 Jul;34(7):763-769. doi: 10.1089/end.2020.0005. Epub 2020 May 28.,Xie R,https://www.ncbi.nlm.nih.gov/pubmed/32368932
9496,32149575,Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy,J Urol. 2020 Sep;204(3):503-510. doi: 10.1097/JU.0000000000001012. Epub 2020 Mar 9.,Luiting HB,https://www.ncbi.nlm.nih.gov/pubmed/32149575
9498,31791703,Should all prostate needle biopsy Gleason score 4?+?4?=?8 prostate cancers be high risk? Implications for shared decision-making and patient counselling,Urol Oncol. 2020 Mar;38(3):78.e1-78.e6. doi: 10.1016/j.urolonc.2019.11.002. Epub 2019 Nov 29.,Ginsburg K,https://www.ncbi.nlm.nih.gov/pubmed/31791703
9499,31987962,Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials,Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):136-142. doi: 10.1016/j.ijrobp.2019.12.044. Epub 2020 Jan 25.,Alayed Y,https://www.ncbi.nlm.nih.gov/pubmed/31987962
9500,32160050,MRI of the Prostate With and Without Endorectal Coil at 3 T: Correlation With Whole-Mount Histopathologic Gleason Score,AJR Am J Roentgenol. 2020 Jul;215(1):133-141. doi: 10.2214/AJR.19.22094. Epub 2020 Mar 11.,Dhatt R,https://www.ncbi.nlm.nih.gov/pubmed/32160050
9501,31937423,Nuclear magnetic resonance spectroscopy of human body fluids and in vivo magnetic resonance spectroscopy: Potential role in the diagnosis and management of prostate cancer,Urol Oncol. 2020 Apr;38(4):150-173. doi: 10.1016/j.urolonc.2019.10.019. Epub 2020 Jan 11.,Gholizadeh N,https://www.ncbi.nlm.nih.gov/pubmed/31937423
9502,31923450,Gleason score 5?+?3?=?8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading,Hum Pathol. 2020 Mar;97:40-51. doi: 10.1016/j.humpath.2019.11.002. Epub 2020 Jan 7.,Kryvenko ON,https://www.ncbi.nlm.nih.gov/pubmed/31923450
9504,31732677,Prostate-Specific Membrane Antigen-Guided Surgery,J Nucl Med. 2020 Jan;61(1):6-12. doi: 10.2967/jnumed.119.232330. Epub 2019 Nov 15.,Maurer T,https://www.ncbi.nlm.nih.gov/pubmed/31732677
9505,31670591,Prostatic Remnant After Prostatectomy: MR Findings and Prevalence in Clinical Practice,AJR Am J Roentgenol. 2020 Jan;214(1):W37-W43. doi: 10.2214/AJR.19.21345. Epub 2019 Oct 31.,Yoshida K,https://www.ncbi.nlm.nih.gov/pubmed/31670591
9506,32434560,Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up,BMC Cancer. 2020 May 20;20(1):453. doi: 10.1186/s12885-020-06960-9.,Vuolukka K,https://www.ncbi.nlm.nih.gov/pubmed/32434560
9507,32084522,Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy,Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):305-315. doi: 10.1016/j.ijrobp.2020.01.052. Epub 2020 Feb 19.,Pollack A,https://www.ncbi.nlm.nih.gov/pubmed/32084522
9508,32053149,HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer,JAMA Oncol. 2020 Apr 1;6(4):e196496. doi: 10.1001/jamaoncol.2019.6496. Epub 2020 Apr 9.,Hearn JWD,https://www.ncbi.nlm.nih.gov/pubmed/32053149
9510,32430252,"Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study",Urol Oncol. 2020 Nov;38(11):854.e1-854.e9. doi: 10.1016/j.urolonc.2020.04.029. Epub 2020 May 17.,Lec PM,https://www.ncbi.nlm.nih.gov/pubmed/32430252
9511,31987974,Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy Fractionation,Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):928-938. doi: 10.1016/j.ijrobp.2020.01.003. Epub 2020 Jan 24.,Wilkins A,https://www.ncbi.nlm.nih.gov/pubmed/31987974
9513,32139401,Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients,Clin Cancer Res. 2020 Apr 15;26(8):1915-1923. doi: 10.1158/1078-0432.CCR-19-2659. Epub 2020 Mar 5.,Bhargava HK,https://www.ncbi.nlm.nih.gov/pubmed/32139401
9514,32239219,Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer,JAMA Netw Open. 2020 Apr 1;3(4):e202041. doi: 10.1001/jamanetworkopen.2020.2041.,Kim DW,https://www.ncbi.nlm.nih.gov/pubmed/32239219
9515,32203069,A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):630-637. doi: 10.1038/s41391-020-0221-7. Epub 2020 Mar 13.,Longo J,https://www.ncbi.nlm.nih.gov/pubmed/32203069
9516,31342804,Focused Submission of Tissue for Radical Prostatectomy Following Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-Targeted Biopsy,Int J Surg Pathol. 2020 Feb;28(1):44-50. doi: 10.1177/1066896919865026. Epub 2019 Jul 25.,Fasciano D,https://www.ncbi.nlm.nih.gov/pubmed/31342804
9517,32181985,Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy,J Magn Reson Imaging. 2020 Oct;52(4):1239-1248. doi: 10.1002/jmri.27138. Epub 2020 Mar 17.,Zhang GM,https://www.ncbi.nlm.nih.gov/pubmed/32181985
9518,32432435,A systematic review and meta-analysis of prognostic impact of different Gleason patterns in ISUP grade group 4,Minerva Urol Nephrol. 2021 Feb;73(1):42-49. doi: 10.23736/S2724-6051.20.03778-9. Epub 2020 May 20.,Mori K,https://www.ncbi.nlm.nih.gov/pubmed/32432435
9519,31718960,Patterns of inpatient care for prostate cancer in men with spina bifida,Disabil Health J. 2020 Apr;13(2):100866. doi: 10.1016/j.dhjo.2019.100866. Epub 2019 Nov 6.,Johnston AW,https://www.ncbi.nlm.nih.gov/pubmed/31718960
9520,32040691,Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities,Strahlenther Onkol. 2020 Jul;196(7):598-607. doi: 10.1007/s00066-020-01589-w. Epub 2020 Feb 10.,Vassis S,https://www.ncbi.nlm.nih.gov/pubmed/32040691
9521,32332299,Isolated Intravascular Prostate Carcinoma Recurrence Confirmed With 18F-Fluciclovine PET/CT and MRI,Clin Nucl Med. 2020 Jun;45(6):442-443. doi: 10.1097/RLU.0000000000003011.,Agely A,https://www.ncbi.nlm.nih.gov/pubmed/32332299
9522,32389051,PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness,Int J Biol Markers. 2020 Jun;35(2):82-90. doi: 10.1177/1724600820919969. Epub 2020 May 11.,Raspollini MR,https://www.ncbi.nlm.nih.gov/pubmed/32389051
9523,31487219,The Role of Prostate Specific Antigen Monitoring after Holmium Laser Enucleation of the Prostate,J Urol. 2020 Feb;203(2):304-310. doi: 10.1097/JU.0000000000000530. Epub 2019 Sep 6.,Abedali ZA,https://www.ncbi.nlm.nih.gov/pubmed/31487219
9525,31944823,The effect of anaemia on normal tissue toxicity and survival outcomes in prostate cancer treated with radical radiotherapy and neo-adjuvant androgen deprivation,Br J Radiol. 2020 Apr;93(1108):20190577. doi: 10.1259/bjr.20190577. Epub 2020 Jan 29.,Keenan LG,https://www.ncbi.nlm.nih.gov/pubmed/31944823
9526,31907606,Ex vivo fluorescence confocal microscopy: prostatic and periprostatic tissues atlas and evaluation of the learning curve,Virchows Arch. 2020 Apr;476(4):511-520. doi: 10.1007/s00428-019-02738-y. Epub 2020 Jan 6.,Bertoni L,https://www.ncbi.nlm.nih.gov/pubmed/31907606
9527,31451070,Obesity is a predictor in prostate cancer patients receiving prostatectomy after neoadjuvant hormonal therapy,Tumori. 2020 Apr;106(2):133-138. doi: 10.1177/0300891619868281. Epub 2019 Aug 27.,Sun L,https://www.ncbi.nlm.nih.gov/pubmed/31451070
9528,32003613,Risk of Postoperative Up Staging or Upgrading among Men with Low Risk Familial Prostate Cancer,J Urol. 2020 Jul;204(1):79-81. doi: 10.1097/JU.0000000000000793. Epub 2020 Jan 31.,Jansson F,https://www.ncbi.nlm.nih.gov/pubmed/32003613
9529,31732676,Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of (177)Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer,J Nucl Med. 2020 Jun;61(6):857-865. doi: 10.2967/jnumed.119.236414. Epub 2019 Nov 15.,Violet J,https://www.ncbi.nlm.nih.gov/pubmed/31732676
9530,31430247,Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database,J Urol. 2020 Jan;203(1):120-127. doi: 10.1097/JU.0000000000000494. Epub 2019 Aug 20.,Dambal S,https://www.ncbi.nlm.nih.gov/pubmed/31430247
9531,32083416,Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution,Minerva Urol Nephrol. 2021 Aug;73(4):481-488. doi: 10.23736/S2724-6051.20.03662-0. Epub 2020 Feb 19.,Bravi CA,https://www.ncbi.nlm.nih.gov/pubmed/32083416
9532,32343184,Biopsy core length in white versus African descendant prostate cancer patients,Scand J Urol. 2020 Jun;54(3):188-193. doi: 10.1080/21681805.2020.1754907. Epub 2020 Apr 28.,Azal Neto W,https://www.ncbi.nlm.nih.gov/pubmed/32343184
9533,32034057,Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy,J Clin Pathol. 2020 Oct;73(10):630-635. doi: 10.1136/jclinpath-2019-206300. Epub 2020 Feb 7.,Ström P,https://www.ncbi.nlm.nih.gov/pubmed/32034057
9534,34185293,Integrated Therapeutic Targeting of the Prostate Tumor Microenvironment,Adv Exp Med Biol. 2020;1296:183-198. doi: 10.1007/978-3-030-59038-3_11.,Livas L,https://www.ncbi.nlm.nih.gov/pubmed/34185293
9535,32674729,Do Drugs Work for ??? Following Prostate Cancer Surgery,Curr Drug Targets. 2020;21(15):1515-1526. doi: 10.2174/1389450121666200716202103.,Sakalis V,https://www.ncbi.nlm.nih.gov/pubmed/32674729
9536,32409155,Radical Prostatectomy Without Pelvic Lymph Node Dissection Is Widely Practiced in High-Risk Patients Despite Poorer Survival,Clin Genitourin Cancer. 2020 Oct;18(5):395-401.e8. doi: 10.1016/j.clgc.2020.03.008. Epub 2020 Mar 13.,Kodiyan J,https://www.ncbi.nlm.nih.gov/pubmed/32409155
9537,32060212,Intraoperative (68)Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study,J Nucl Med. 2020 Oct;61(10):1500-1506. doi: 10.2967/jnumed.119.240424. Epub 2020 Feb 14.,Darr C,https://www.ncbi.nlm.nih.gov/pubmed/32060212
9538,31109856,Impact of Tumor Regional Involvement on Active Surveillance Outcomes: Validation of the Cumulative Cancer Location Metric in a US Population,Eur Urol Focus. 2020 Mar 15;6(2):235-241. doi: 10.1016/j.euf.2019.05.001. Epub 2019 May 18.,Leong JY,https://www.ncbi.nlm.nih.gov/pubmed/31109856
9539,31522272,(68)Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):147-159. doi: 10.1007/s00259-019-04511-4. Epub 2019 Sep 14.,Ferraro DA,https://www.ncbi.nlm.nih.gov/pubmed/31522272
9540,31602512,"Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics",Eur Radiol. 2020 Feb;30(2):806-815. doi: 10.1007/s00330-019-06436-w. Epub 2019 Oct 10.,Wildeboer RR,https://www.ncbi.nlm.nih.gov/pubmed/31602512
9541,32150328,"A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings",BJU Int. 2020 Jul;126(1):104-113. doi: 10.1111/bju.15048. Epub 2020 Apr 1.,Luzzago S,https://www.ncbi.nlm.nih.gov/pubmed/32150328
9542,32022528,Extraperitoneal Laparoscopic Radical Prostatectomy and Simultaneously Inguinal Hernia Repair with 3 Trocars,Int Braz J Urol. 2020 Mar-Apr;46(2):294-295. doi: 10.1590/S1677-5538.IBJU.2019.0019.,Akin Y,https://www.ncbi.nlm.nih.gov/pubmed/32022528
9543,31907632,Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer,World J Urol. 2020 Oct;38(10):2513-2521. doi: 10.1007/s00345-019-03066-1. Epub 2020 Jan 6.,Kaufmann S,https://www.ncbi.nlm.nih.gov/pubmed/31907632
9544,32929343,Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy,Theranostics. 2020 Sep 2;10(22):10200-10212. doi: 10.7150/thno.48706. eCollection 2020.,Shao L,https://www.ncbi.nlm.nih.gov/pubmed/32929343
9545,31201249,Prospective Evaluation of PSMA-Targeted (18)F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer,J Nucl Med. 2020 Jan;61(1):58-61. doi: 10.2967/jnumed.119.226514. Epub 2019 Jun 14.,Rowe SP,https://www.ncbi.nlm.nih.gov/pubmed/31201249
9546,32378362,Correlation between lumbar skeletal muscle size and urinary incontinence after radical prostatectomy,Low Urin Tract Symptoms. 2020 Sep;12(3):245-252. doi: 10.1111/luts.12312. Epub 2020 May 6.,Mitsui Y,https://www.ncbi.nlm.nih.gov/pubmed/32378362
9547,31160805,Efficacy and safety of periprostatic nerve block combined with perineal subcutaneous anaesthesia and intrarectal lidocaine gel in transrectal ultrasound guided transperineal prostate biopsy: A Prospective Randomised Controlled Trial,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):74-80. doi: 10.1038/s41391-019-0155-0. Epub 2019 Jun 3.,Lv Z,https://www.ncbi.nlm.nih.gov/pubmed/31160805
9548,31425386,Aerobic Recovery after Radical Prostatectomy: A Case Study,Med Sci Sports Exerc. 2020 Feb;52(2):296-302. doi: 10.1249/MSS.0000000000002130.,Swain DP,https://www.ncbi.nlm.nih.gov/pubmed/31425386
9549,31197523,"Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance",World J Urol. 2020 Mar;38(3):663-671. doi: 10.1007/s00345-019-02848-x. Epub 2019 Jun 13.,Ploussard G,https://www.ncbi.nlm.nih.gov/pubmed/31197523
9550,32327305,The Influence of Normal Tissue Objective in the Treatment of Prostate Cancer,J Med Imaging Radiat Sci. 2020 Jun;51(2):312-316. doi: 10.1016/j.jmir.2020.02.006. Epub 2020 Apr 20.,Caldeira A,https://www.ncbi.nlm.nih.gov/pubmed/32327305
9551,32323003,Effect of a brief physical activity-based presentation by a former patient for men treated with radical prostatectomy for prostate cancer: a mixed methods pilot study,Support Care Cancer. 2021 Jan;29(1):145-154. doi: 10.1007/s00520-020-05455-4. Epub 2020 Apr 22.,Fox L,https://www.ncbi.nlm.nih.gov/pubmed/32323003
9553,31899555,Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histopathological and molecular analyses,Prostate. 2020 Mar;80(4):345-351. doi: 10.1002/pros.23949. Epub 2020 Jan 3.,Bando Y,https://www.ncbi.nlm.nih.gov/pubmed/31899555
9554,32130059,17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort,J Clin Oncol. 2020 May 10;38(14):1549-1557. doi: 10.1200/JCO.19.02267. Epub 2020 Mar 4.,Lin DW,https://www.ncbi.nlm.nih.gov/pubmed/32130059
9556,32065499,Development and randomised controlled trial of a Continence Product Patient Decision Aid for men postradical prostatectomy,J Clin Nurs. 2020 Jul;29(13-14):2251-2259. doi: 10.1111/jocn.15223. Epub 2020 Mar 3.,Murphy C,https://www.ncbi.nlm.nih.gov/pubmed/32065499
9557,32248363,Combined systematic versus stand-alone multiparametric MRI-guided targeted fusion biopsy: nomogram prediction of non-organ-confined prostate cancer,World J Urol. 2021 Jan;39(1):81-88. doi: 10.1007/s00345-020-03176-1. Epub 2020 Apr 5.,Leyh-Bannurah SR,https://www.ncbi.nlm.nih.gov/pubmed/32248363
9558,31905251,Genomic and clinical characterization of stromal infiltration markers in prostate cancer,Cancer. 2020 Apr 1;126(7):1407-1412. doi: 10.1002/cncr.32688. Epub 2020 Jan 6.,Mahal BA,https://www.ncbi.nlm.nih.gov/pubmed/31905251
9559,32298065,Efficacy of modified radical prostatectomy technique for recovery of urinary incontinence in high-grade prostate cancer,Minerva Urol Nefrol. 2020 Oct;72(5):605-614. doi: 10.23736/S0393-2249.20.03633-4. Epub 2020 Apr 16.,Chung JW,https://www.ncbi.nlm.nih.gov/pubmed/32298065
9561,32220548,Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer,Urol Oncol. 2020 Oct;38(10):793.e19-793.e25. doi: 10.1016/j.urolonc.2020.02.025. Epub 2020 Mar 25.,Sanguedolce F,https://www.ncbi.nlm.nih.gov/pubmed/32220548
9562,31977380,Genomic Strategies to Personalize Use of Androgen Deprivation Therapy With Radiotherapy,Cancer J. 2020 Jan/Feb;26(1):13-20. doi: 10.1097/PPO.0000000000000419.,Glicksman RM,https://www.ncbi.nlm.nih.gov/pubmed/31977380
9564,32228027,The Impact of Three Different Bladder Neck Reconstruction Techniques on Urinary Continence after Laparoscopic Radical Prostatectomy,J Endourol. 2020 Jun;34(6):663-670. doi: 10.1089/end.2020.0064. Epub 2020 May 5.,Zhang S,https://www.ncbi.nlm.nih.gov/pubmed/32228027
9565,31479407,Racial Discrepancies in Overall Survival among Men Treated with (223)Radium,J Urol. 2020 Feb;203(2):331-337. doi: 10.1097/JU.0000000000000524. Epub 2019 Sep 3.,Zhao H,https://www.ncbi.nlm.nih.gov/pubmed/31479407
9567,31670596,Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups,AJR Am J Roentgenol. 2020 Mar;214(3):588-596. doi: 10.2214/AJR.19.21828. Epub 2019 Oct 31.,Bakir B,https://www.ncbi.nlm.nih.gov/pubmed/31670596
9568,31893344,Linear extent of positive surgical margin impacts biochemical recurrence after robot-assisted radical prostatectomy in a high-volume center,J Robot Surg. 2020 Aug;14(4):663-675. doi: 10.1007/s11701-019-01039-5. Epub 2020 Jan 1.,Porcaro AB,https://www.ncbi.nlm.nih.gov/pubmed/31893344
9569,31926820,Elective Pelvic Nodal Irradiation With a Simultaneous Hypofractionated Integrated Prostate Boost for Localised Prostate Cancer: Ready for Prime Time?,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):181-188. doi: 10.1016/j.clon.2019.12.002. Epub 2020 Jan 8.,Cheung P,https://www.ncbi.nlm.nih.gov/pubmed/31926820
9570,32334484,"Cyberknife, Helical Tomotherapy and Rapid Arc SIB-SBRT Treatment Plan Comparison for Carcinoma Prostate",Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1149-1154. doi: 10.31557/APJCP.2020.21.4.1149.,T K B,https://www.ncbi.nlm.nih.gov/pubmed/32334484
9571,32368959,Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy,Radiology. 2020 Jul;296(1):87-95. doi: 10.1148/radiol.2020192133. Epub 2020 May 5.,Park KJ,https://www.ncbi.nlm.nih.gov/pubmed/32368959
9572,31297628,Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations,World J Urol. 2020 Mar;38(3):681-693. doi: 10.1007/s00345-019-02872-x. Epub 2019 Jul 11.,Mukherji D,https://www.ncbi.nlm.nih.gov/pubmed/31297628
9573,31549286,A new method in robotic-assisted laparoscopic radical prostatectomy: personalised neuroprotective surgery with neuromonitoring system-randomised controlled study,Int Urol Nephrol. 2020 Feb;52(2):263-269. doi: 10.1007/s11255-019-02295-y. Epub 2019 Sep 23.,Karabulut ?,https://www.ncbi.nlm.nih.gov/pubmed/31549286
9574,32269146,Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer,J Immunother Cancer. 2020 Mar;8(1):e000655. doi: 10.1136/jitc-2020-000655.,Abdul Sater H,https://www.ncbi.nlm.nih.gov/pubmed/32269146
9575,32365088,Fully automated dose prediction using generative adversarial networks in prostate cancer patients,PLoS One. 2020 May 4;15(5):e0232697. doi: 10.1371/journal.pone.0232697. eCollection 2020.,Murakami Y,https://www.ncbi.nlm.nih.gov/pubmed/32365088
9576,31988233,"Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)",BMJ Open. 2020 Jan 26;10(1):e033667. doi: 10.1136/bmjopen-2019-033667.,Scheinberg T,https://www.ncbi.nlm.nih.gov/pubmed/31988233
9577,31862801,(11)C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series,J Nucl Med. 2020 Jun;61(6):827-833. doi: 10.2967/jnumed.119.233098. Epub 2019 Dec 20.,Michaud L,https://www.ncbi.nlm.nih.gov/pubmed/31862801
9579,31542390,Optimization of prostate brachytherapy techniques with polyethylene glycol-based hydrogel spacers: A systematic review,Brachytherapy. 2020 Jan-Feb;19(1):13-23. doi: 10.1016/j.brachy.2019.08.009. Epub 2019 Sep 18.,Afkhami Ardekani M,https://www.ncbi.nlm.nih.gov/pubmed/31542390
9580,32881970,Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients,PLoS One. 2020 Sep 3;15(9):e0238814. doi: 10.1371/journal.pone.0238814. eCollection 2020.,Stroomberg HV,https://www.ncbi.nlm.nih.gov/pubmed/32881970
9581,32187316,Nursing diagnoses and NIC interventions in adult males undergoing radical prostatectomy,Rev Esc Enferm USP. 2020 Mar 16;54:e03541. doi: 10.1590/S1980-220X2018038003541. eCollection 2020.,Kocaçal E,https://www.ncbi.nlm.nih.gov/pubmed/32187316
9583,31977391,Radiotherapy in the Management of Metastatic Hormone-Sensitive Prostate Cancer: What Is the Standard of Care?,Cancer J. 2020 Jan/Feb;26(1):87-93. doi: 10.1097/PPO.0000000000000429.,Deek MP,https://www.ncbi.nlm.nih.gov/pubmed/31977391
9585,31837592,"Determining the cut-off values of tumor diameter, degree of extraprostatic extension, and extent of surgical margin positivity with regard to biochemical recurrence of prostate cancer after radical prostatectomy",Ann Diagn Pathol. 2020 Feb;44:151431. doi: 10.1016/j.anndiagpath.2019.151431. Epub 2019 Nov 22.,Kir G,https://www.ncbi.nlm.nih.gov/pubmed/31837592
9586,30997868,Impact of the introduction of novel hormonal agents on metastatic castration-resistant prostate cancer treatment choice,J Oncol Pharm Pract. 2020 Mar;26(2):293-305. doi: 10.1177/1078155219842329. Epub 2019 Apr 18.,Lahcene H,https://www.ncbi.nlm.nih.gov/pubmed/30997868
9587,32066277,Robot-Assisted Radical Prostatectomy Associated with Decreased Persistent Postoperative Opioid Use,J Endourol. 2020 Apr;34(4):475-481. doi: 10.1089/end.2019.0788. Epub 2020 Mar 26.,Shkolyar E,https://www.ncbi.nlm.nih.gov/pubmed/32066277
9588,32266690,"Evaluation of relationships between the final Gleason score, PI-RADS v2 score, ADC value, PSA level, and tumor diameter in patients that underwent radical prostatectomy due to prostate cancer",Radiol Med. 2020 Sep;125(9):827-837. doi: 10.1007/s11547-020-01183-1. Epub 2020 Apr 7.,Gündo?du E,https://www.ncbi.nlm.nih.gov/pubmed/32266690
9589,31745288,Nonlinear microscopy for detection of prostate cancer: analysis of sensitivity and specificity in radical prostatectomies,Mod Pathol. 2020 May;33(5):916-923. doi: 10.1038/s41379-019-0408-4. Epub 2019 Nov 19.,Cahill LC,https://www.ncbi.nlm.nih.gov/pubmed/31745288
9590,32274889,"Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden",BJU Int. 2020 Jul;126(1):142-151. doi: 10.1111/bju.15077. Epub 2020 May 8.,Orrason AW,https://www.ncbi.nlm.nih.gov/pubmed/32274889
9591,32149792,68Ga-Prostate-Specific Membrane Antigen Uptake in a Pancreatic Neuroendocrine Tumor,Clin Nucl Med. 2020 May;45(5):379-382. doi: 10.1097/RLU.0000000000002997.,Luong TV,https://www.ncbi.nlm.nih.gov/pubmed/32149792
9592,32169590,A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer,Pract Radiat Oncol. 2020 Sep-Oct;10(5):345-353. doi: 10.1016/j.prro.2020.02.013. Epub 2020 Mar 10.,Ritter MA,https://www.ncbi.nlm.nih.gov/pubmed/32169590
9593,30701334,Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5,World J Urol. 2020 Mar;38(3):637-645. doi: 10.1007/s00345-019-02651-8. Epub 2019 Jan 30.,Nitschke K,https://www.ncbi.nlm.nih.gov/pubmed/30701334
9594,31119473,Comparison of longitudinal health-related quality-of-life outcomes between anterior and posterior surgical approaches to robot-assisted radical prostatectomy,J Robot Surg. 2020 Apr;14(2):255-260. doi: 10.1007/s11701-019-00975-6. Epub 2019 May 22.,Maruyama Y,https://www.ncbi.nlm.nih.gov/pubmed/31119473
9595,32374087,Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort,Cancer Med. 2020 Jul;9(13):4613-4621. doi: 10.1002/cam4.3101. Epub 2020 May 6.,Lim J,https://www.ncbi.nlm.nih.gov/pubmed/32374087
9597,30316824,Role of Bed Assistant During Robot-assisted Radical Prostatectomy: The Effect of Learning Curve on Perioperative Variables,Eur Urol Focus. 2020 Mar 15;6(2):397-403. doi: 10.1016/j.euf.2018.10.005. Epub 2018 Oct 11.,Albo G,https://www.ncbi.nlm.nih.gov/pubmed/30316824
9598,32141086,Operating a treatment planning system using a deep-reinforcement learning-based virtual treatment planner for prostate cancer intensity-modulated radiation therapy treatment planning,Med Phys. 2020 Jun;47(6):2329-2336. doi: 10.1002/mp.14114. Epub 2020 Mar 28.,Shen C,https://www.ncbi.nlm.nih.gov/pubmed/32141086
9599,32525914,Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era,PLoS One. 2020 Jun 11;15(6):e0234391. doi: 10.1371/journal.pone.0234391. eCollection 2020.,Chen MM,https://www.ncbi.nlm.nih.gov/pubmed/32525914
9600,31347517,High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection,Asian J Androl. 2020 May-Jun;22(3):323-329. doi: 10.4103/aja.aja_70_19.,Porcaro AB,https://www.ncbi.nlm.nih.gov/pubmed/31347517
9601,32448741,Benefits of positron emission tomography scans for the evaluation of radiotherapy,Cancer Radiother. 2020 Aug;24(5):388-397. doi: 10.1016/j.canrad.2020.02.007. Epub 2020 May 21.,Decazes P,https://www.ncbi.nlm.nih.gov/pubmed/32448741
9603,32232449,Geographic Distribution of Racial Differences in Prostate Cancer Mortality,JAMA Netw Open. 2020 Mar 2;3(3):e201839. doi: 10.1001/jamanetworkopen.2020.1839.,Fletcher SA,https://www.ncbi.nlm.nih.gov/pubmed/32232449
9605,31373142,Retzius-sparing robot-assisted radical prostatectomy vs the standard approach: a systematic review and analysis of comparative outcomes,BJU Int. 2020 Jan;125(1):8-16. doi: 10.1111/bju.14887. Epub 2019 Aug 26.,Checcucci E,https://www.ncbi.nlm.nih.gov/pubmed/31373142
9606,32089495,Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review,Eur Urol Focus. 2021 Jul;7(4):742-751. doi: 10.1016/j.euf.2020.01.017. Epub 2020 Feb 20.,Kretschmer A,https://www.ncbi.nlm.nih.gov/pubmed/32089495
9607,31715511,T-staging of prostate cancer: Identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI,Clin Imaging. 2020 Jan;59(1):1-7. doi: 10.1016/j.clinimag.2019.08.007. Epub 2019 Sep 13.,Pesapane F,https://www.ncbi.nlm.nih.gov/pubmed/31715511
9608,30840115,Perioperative venous thromboembolism prophylaxis in prostate cancer surgery,World J Urol. 2020 Mar;38(3):593-600. doi: 10.1007/s00345-019-02705-x. Epub 2019 Mar 6.,Klaassen Z,https://www.ncbi.nlm.nih.gov/pubmed/30840115
9609,32608338,Delivery of Radiation at the Lowest Dose Rate by a Modern Linear Accelerator is Most Effective in Inhibiting Prostate Cancer Growth,Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820935525. doi: 10.1177/1533033820935525.,Tazat K,https://www.ncbi.nlm.nih.gov/pubmed/32608338
9611,31584849,"Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden",J Urol. 2020 Jan;203(1):145-150. doi: 10.1097/JU.0000000000000451. Epub 2019 Jul 17.,Loeb S,https://www.ncbi.nlm.nih.gov/pubmed/31584849
9614,32587951,Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer,Cancer Rep (Hoboken). 2020 Jun;3(3):e1237. doi: 10.1002/cnr2.1237. Epub 2020 Jan 29.,Carleton NM,https://www.ncbi.nlm.nih.gov/pubmed/32587951
9616,32467601,A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy,Br J Cancer. 2020 Aug;123(4):604-609. doi: 10.1038/s41416-020-0914-7. Epub 2020 May 29.,Haese A,https://www.ncbi.nlm.nih.gov/pubmed/32467601
9617,32487653,Clinical Features of Treatment-related Neuroendocrine Prostate Cancer: A Case Series,Anticancer Res. 2020 Jun;40(6):3519-3526. doi: 10.21873/anticanres.14340.,Suzuki K,https://www.ncbi.nlm.nih.gov/pubmed/32487653
9618,32043791,"A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups",Oncologist. 2020 Feb;25(2):e311-e320. doi: 10.1634/theoncologist.2019-0309. Epub 2019 Oct 10.,Macchia G,https://www.ncbi.nlm.nih.gov/pubmed/32043791
9620,32402544,Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy,Brachytherapy. 2020 Jul-Aug;19(4):484-490. doi: 10.1016/j.brachy.2020.04.001. Epub 2020 May 10.,Bathala TK,https://www.ncbi.nlm.nih.gov/pubmed/32402544
9621,32205538,Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer,Cancer J. 2020 Mar/Apr;26(2):137-143. doi: 10.1097/PPO.0000000000000432.,Deek MP,https://www.ncbi.nlm.nih.gov/pubmed/32205538
9622,31430233,Under Treatment of Prostate Cancer in Rural Locations,J Urol. 2020 Jan;203(1):108-114. doi: 10.1097/JU.0000000000000500. Epub 2019 Aug 20.,Maganty A,https://www.ncbi.nlm.nih.gov/pubmed/31430233
9624,32349927,Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial,Clin Genitourin Cancer. 2020 Dec;18(6):444-451. doi: 10.1016/j.clgc.2020.03.017. Epub 2020 Apr 7.,Dumont C,https://www.ncbi.nlm.nih.gov/pubmed/32349927
9626,30888646,"Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study",Pathol Oncol Res. 2020 Apr;26(2):905-912. doi: 10.1007/s12253-019-00623-2. Epub 2019 Mar 19.,Jorgo K,https://www.ncbi.nlm.nih.gov/pubmed/30888646
9627,31718822,Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials,Eur Urol. 2020 Feb;77(2):201-208. doi: 10.1016/j.eururo.2019.10.008. Epub 2019 Nov 10.,Kishan AU,https://www.ncbi.nlm.nih.gov/pubmed/31718822
9628,31893572,Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients,Cancer Med. 2020 Feb;9(4):1409-1418. doi: 10.1002/cam4.2773. Epub 2020 Jan 1.,Büscheck F,https://www.ncbi.nlm.nih.gov/pubmed/31893572
9629,32469248,Pharmacotherapeutic strategies for castrate-resistant prostate cancer,Expert Opin Pharmacother. 2020 Aug;21(12):1431-1448. doi: 10.1080/14656566.2020.1767069. Epub 2020 May 29.,Moussa M,https://www.ncbi.nlm.nih.gov/pubmed/32469248
9630,30298710,Prostate-specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low-risk prostate cancer,Minerva Urol Nefrol. 2020 Feb;72(1):66-71. doi: 10.23736/S0393-2249.18.03172-7. Epub 2018 Oct 3.,Porcaro AB,https://www.ncbi.nlm.nih.gov/pubmed/30298710
9631,31971829,Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy,Br J Radiol. 2020 Apr;93(1108):20190789. doi: 10.1259/bjr.20190789. Epub 2020 Jan 30.,Devlin L,https://www.ncbi.nlm.nih.gov/pubmed/31971829
9632,32447004,The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study,Int J Surg. 2020 Jul;79:217-221. doi: 10.1016/j.ijsu.2020.05.025. Epub 2020 May 21.,He G,https://www.ncbi.nlm.nih.gov/pubmed/32447004
9633,32430253,Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer,Urol Oncol. 2020 Oct;38(10):795.e1-795.e8. doi: 10.1016/j.urolonc.2020.04.032. Epub 2020 May 17.,Sekino Y,https://www.ncbi.nlm.nih.gov/pubmed/32430253
9635,32111769,Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer,In Vivo. 2020 Mar-Apr;34(2):679-682. doi: 10.21873/invivo.11823.,Haus R,https://www.ncbi.nlm.nih.gov/pubmed/32111769
9636,31584209,"Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue",Prostate. 2020 Jan;80(1):38-50. doi: 10.1002/pros.23914. Epub 2019 Oct 4.,Lu Z,https://www.ncbi.nlm.nih.gov/pubmed/31584209
9638,32320063,Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance,Cancer. 2020 Jul 1;126(13):2986-2990. doi: 10.1002/cncr.32821. Epub 2020 Apr 22.,Shoag JE,https://www.ncbi.nlm.nih.gov/pubmed/32320063
9639,32217041,Inequity in selective referral to high-volume hospitals for genitourinary malignancies,Urol Oncol. 2020 Jun;38(6):582-589. doi: 10.1016/j.urolonc.2020.02.013. Epub 2020 Mar 23.,Berg S,https://www.ncbi.nlm.nih.gov/pubmed/32217041
9640,32247206,Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer,Radiother Oncol. 2020 Jun;147:92-98. doi: 10.1016/j.radonc.2020.03.015. Epub 2020 Apr 1.,Draulans C,https://www.ncbi.nlm.nih.gov/pubmed/32247206
9641,32488311,Dosimetric evaluation of phantoms including metal objects with high atomic number for use in intensity modulated radiation therapy,Radiat Environ Biophys. 2020 Aug;59(3):503-510. doi: 10.1007/s00411-020-00851-0. Epub 2020 Jun 1.,Inal A,https://www.ncbi.nlm.nih.gov/pubmed/32488311
9642,32997692,Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer,PLoS One. 2020 Sep 30;15(9):e0239686. doi: 10.1371/journal.pone.0239686. eCollection 2020.,Carlson AS,https://www.ncbi.nlm.nih.gov/pubmed/32997692
9643,31306199,68Ga-PSMA PET/CT Uptake in the Ureter Caused by Ligand Expression in Urothelial Cancer,Clin Nucl Med. 2020 Jan;45(1):e43-e45. doi: 10.1097/RLU.0000000000002720.,Zacho HD,https://www.ncbi.nlm.nih.gov/pubmed/31306199
9644,32201958,Multi-atlas-based auto-segmentation for prostatic urethra using novel prediction of deformable image registration accuracy,Med Phys. 2020 Jul;47(7):3023-3031. doi: 10.1002/mp.14154. Epub 2020 Apr 27.,Takagi H,https://www.ncbi.nlm.nih.gov/pubmed/32201958
9646,32212232,"Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry",Cancer Med. 2020 May;9(10):3623-3633. doi: 10.1002/cam4.3003. Epub 2020 Mar 25.,Bluethmann SM,https://www.ncbi.nlm.nih.gov/pubmed/32212232
9647,31559480,Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis,Strahlenther Onkol. 2020 Mar;196(3):213-221. doi: 10.1007/s00066-019-01523-9. Epub 2019 Sep 26.,Nicosia L,https://www.ncbi.nlm.nih.gov/pubmed/31559480
9648,32522431,A retrospective evaluation of mixed energy volumetric modulated arc therapy for anal cancers with lymph node involvement,Med Dosim. 2020 Winter;45(4):339-345. doi: 10.1016/j.meddos.2020.04.002. Epub 2020 Jun 7.,Eskens M,https://www.ncbi.nlm.nih.gov/pubmed/32522431
9649,31862575,Automatic VMAT planning for post-operative prostate cancer cases using particle swarm optimization: A proof of concept study,Phys Med. 2020 Jan;69:101-109. doi: 10.1016/j.ejmp.2019.12.007. Epub 2019 Dec 17.,Künzel LA,https://www.ncbi.nlm.nih.gov/pubmed/31862575
9650,31948886,Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer,Eur Urol Oncol. 2020 Apr;3(2):224-230. doi: 10.1016/j.euo.2019.12.003. Epub 2020 Jan 14.,Wu Y,https://www.ncbi.nlm.nih.gov/pubmed/31948886
9651,32277993,A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men,Urology. 2020 Aug;142:166-173. doi: 10.1016/j.urology.2020.01.052. Epub 2020 Apr 8.,Murphy AB,https://www.ncbi.nlm.nih.gov/pubmed/32277993
9653,32087469,Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study,Radiother Oncol. 2020 May;146:21-28. doi: 10.1016/j.radonc.2020.01.029. Epub 2020 Feb 19.,Greco C,https://www.ncbi.nlm.nih.gov/pubmed/32087469
9656,31665354,Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone,Jpn J Clin Oncol. 2020 Jan 24;50(1):58-65. doi: 10.1093/jjco/hyz136.,Nakai Y,https://www.ncbi.nlm.nih.gov/pubmed/31665354
9657,31506877,Effects of lung protective ventilation on postoperative respiratory parameters in patients undergoing robot-assisted radical prostatectomy,J Robot Surg. 2020 Jun;14(3):509-516. doi: 10.1007/s11701-019-01016-y. Epub 2019 Sep 10.,Mølsted M,https://www.ncbi.nlm.nih.gov/pubmed/31506877
9658,31868927,A fast deep learning approach for beam orientation optimization for prostate cancer treated with intensity-modulated radiation therapy,Med Phys. 2020 Mar;47(3):880-897. doi: 10.1002/mp.13986. Epub 2020 Jan 20.,Sadeghnejad Barkousaraie A,https://www.ncbi.nlm.nih.gov/pubmed/31868927
9659,32266979,Secondary bladder and rectal cancer risk estimates following standard fractionated and moderately hypofractionated VMAT for prostate carcinoma,Med Phys. 2020 Jul;47(7):2805-2813. doi: 10.1002/mp.14169. Epub 2020 Apr 30.,Mazonakis M,https://www.ncbi.nlm.nih.gov/pubmed/32266979
9660,31479405,A Nationally Representative Study of Nonindex Hospital Readmissions following Radical Prostatectomy: Implications for Bundled Payment Models,J Urol. 2020 Mar;203(3):546-553. doi: 10.1097/JU.0000000000000522. Epub 2019 Sep 3.,Chappidi MR,https://www.ncbi.nlm.nih.gov/pubmed/31479405
9662,31711843,LacdiNAc-Glycosylated Prostate-specific Antigen Density is a Potential Biomarker of Prostate Cancer,Clin Genitourin Cancer. 2020 Feb;18(1):e28-e36. doi: 10.1016/j.clgc.2019.10.011. Epub 2019 Oct 17.,Inoue T,https://www.ncbi.nlm.nih.gov/pubmed/31711843
9663,32229417,Patients' education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer,Eur J Cancer. 2020 May;130:204-210. doi: 10.1016/j.ejca.2020.02.045. Epub 2020 Mar 28.,Kilpeläinen TP,https://www.ncbi.nlm.nih.gov/pubmed/32229417
9664,32537467,"Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options",J Immunol Res. 2020 May 25;2020:4910595. doi: 10.1155/2020/4910595. eCollection 2020.,Janiczek M,https://www.ncbi.nlm.nih.gov/pubmed/32537467
9665,31965416,Safety of radiotherapy for hemodialysis patients with cancer,Int J Clin Oncol. 2020 May;25(5):978-983. doi: 10.1007/s10147-020-01621-0. Epub 2020 Jan 21.,Hirota H,https://www.ncbi.nlm.nih.gov/pubmed/31965416
9666,31629838,Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT,Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):291-299. doi: 10.1016/j.ijrobp.2019.10.014. Epub 2019 Oct 17.,Fuller D,https://www.ncbi.nlm.nih.gov/pubmed/31629838
9667,32158967,BRCA1-associated protein 1 expression and prognostic role in prostate adenocarcinoma,Investig Clin Urol. 2020 Mar;61(2):166-172. doi: 10.4111/icu.2020.61.2.166. Epub 2020 Feb 21.,Oh H,https://www.ncbi.nlm.nih.gov/pubmed/32158967
9669,31932995,Duration-dependent margins for prostate radiotherapy-a practical motion mitigation strategy,Strahlenther Onkol. 2020 Jul;196(7):657-663. doi: 10.1007/s00066-019-01558-y. Epub 2020 Jan 13.,Pang EPP,https://www.ncbi.nlm.nih.gov/pubmed/31932995
9670,32413530,Cranberry capsules are not superior to placebo capsules in managing acute non-haemorrhagic radiation cystitis in prostate cancer patients: A phase III double blinded randomised placebo controlled clinical trial,Radiother Oncol. 2020 Aug;149:117-123. doi: 10.1016/j.radonc.2020.05.006. Epub 2020 May 13.,Herst PM,https://www.ncbi.nlm.nih.gov/pubmed/32413530
9671,31253741,Matched-Pair Comparison of (68)Ga-PSMA-11 PET/CT and (18)F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy,J Nucl Med. 2020 Jan;61(1):51-57. doi: 10.2967/jnumed.119.229187. Epub 2019 Jun 28.,Rauscher I,https://www.ncbi.nlm.nih.gov/pubmed/31253741
9672,32461072,Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer,Eur Urol. 2020 Sep;78(3):327-332. doi: 10.1016/j.eururo.2020.05.009. Epub 2020 May 24.,Kishan AU,https://www.ncbi.nlm.nih.gov/pubmed/32461072
9673,31640913,"Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?",Clin Genitourin Cancer. 2020 Feb;18(1):50-55. doi: 10.1016/j.clgc.2019.09.018. Epub 2019 Sep 26.,Kim H,https://www.ncbi.nlm.nih.gov/pubmed/31640913
9674,32071439,Copy number alterations are associated with metastatic-lethal progression in prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):494-506. doi: 10.1038/s41391-020-0212-8. Epub 2020 Feb 18.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/32071439
9675,32192919,Retzius-sparing Robotic Radical Prostatectomy for Surgeons in the Learning Curve: A Propensity Score-matching Analysis,Eur Urol Focus. 2021 Jul;7(4):772-778. doi: 10.1016/j.euf.2020.03.002. Epub 2020 Mar 17.,Olivero A,https://www.ncbi.nlm.nih.gov/pubmed/32192919
9677,32361572,Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer,Radiother Oncol. 2020 Jul;148:126-132. doi: 10.1016/j.radonc.2020.04.020. Epub 2020 Apr 21.,Fiandra C,https://www.ncbi.nlm.nih.gov/pubmed/32361572
9678,31644433,Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer,Curr Opin Urol. 2020 Jan;30(1):98-105. doi: 10.1097/MOU.0000000000000685.,Lawal IO,https://www.ncbi.nlm.nih.gov/pubmed/31644433
9679,31676732,(18)F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy,J Nucl Med. 2020 Jun;61(6):881-889. doi: 10.2967/jnumed.119.234799. Epub 2019 Nov 1.,Mena E,https://www.ncbi.nlm.nih.gov/pubmed/31676732
9680,32487218,Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study,Radiat Oncol. 2020 Jun 1;15(1):137. doi: 10.1186/s13014-020-01577-5.,Zapatero A,https://www.ncbi.nlm.nih.gov/pubmed/32487218
9682,32140802,Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617,Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2322-2327. doi: 10.1007/s00259-020-04723-z. Epub 2020 Mar 5.,Ferdinandus J,https://www.ncbi.nlm.nih.gov/pubmed/32140802
9684,32173650,T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer,Clin Cancer Res. 2020 Jul 1;26(13):3182-3192. doi: 10.1158/1078-0432.CCR-19-3372. Epub 2020 Mar 15.,Obradovic AZ,https://www.ncbi.nlm.nih.gov/pubmed/32173650
9685,31984482,Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system,Cancer. 2020 Apr 15;126(8):1683-1690. doi: 10.1002/cncr.32666. Epub 2020 Jan 27.,Riviere P,https://www.ncbi.nlm.nih.gov/pubmed/31984482
9686,32020512,"Robot-assisted orthotopic ""W"" ileal neobladder in male patients: step-by-step video-illustrated technique and preliminary outcomes",J Robot Surg. 2020 Oct;14(5):739-744. doi: 10.1007/s11701-020-01048-9. Epub 2020 Feb 4.,Nouhaud FX,https://www.ncbi.nlm.nih.gov/pubmed/32020512
9690,32134450,Modern development of high-dose-rate brachytherapy,Jpn J Clin Oncol. 2020 May 5;50(5):490-501. doi: 10.1093/jjco/hyaa029.,Itami J,https://www.ncbi.nlm.nih.gov/pubmed/32134450
9691,31957964,Observer uncertainties of soft tissue-based patient positioning in IGRT,J Appl Clin Med Phys. 2020 Feb;21(2):73-81. doi: 10.1002/acm2.12817. Epub 2020 Jan 20.,Hirose TA,https://www.ncbi.nlm.nih.gov/pubmed/31957964
9694,32065277,"Same-day discharge surgery for robot-assisted radical prostatectomy in the era of ERAS and prehabilitation pathways: a contemporary, comparative, feasibility study",World J Urol. 2022 Jun;40(6):1359-1365. doi: 10.1007/s00345-020-03119-w. Epub 2020 Feb 17.,Ploussard G,https://www.ncbi.nlm.nih.gov/pubmed/32065277
9696,31197228,"Role of the DNA damage response in prostate cancer formation, progression and treatment",Prostate Cancer Prostatic Dis. 2020 Mar;23(1):24-37. doi: 10.1038/s41391-019-0153-2. Epub 2019 Jun 13.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/31197228
9697,32247227,A convolution neural network for higher resolution dose prediction in prostate volumetric modulated arc therapy,Phys Med. 2020 Apr;72:88-95. doi: 10.1016/j.ejmp.2020.03.023. Epub 2020 Apr 1.,Sumida I,https://www.ncbi.nlm.nih.gov/pubmed/32247227
9698,32405735,Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer,Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):143-151. doi: 10.1007/s00259-020-04777-z. Epub 2020 May 13.,Stefan A Koerber,https://www.ncbi.nlm.nih.gov/pubmed/32405735
9699,31902566,Controlling heterogeneity within the lymphatic target volume for dose painted treatment of prostate cancer,Med Dosim. 2020 Autumn;45(3):202-205. doi: 10.1016/j.meddos.2019.11.004. Epub 2020 Jan 3.,McDonald AM,https://www.ncbi.nlm.nih.gov/pubmed/31902566
9700,32151466,ECCO Essential Requirements for Quality Cancer Care: Prostate cancer,Crit Rev Oncol Hematol. 2020 Apr;148:102861. doi: 10.1016/j.critrevonc.2019.102861. Epub 2020 Jan 7.,Brausi M,https://www.ncbi.nlm.nih.gov/pubmed/32151466
9701,31842658,Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden,Scand J Urol. 2020 Feb;54(1):20-26. doi: 10.1080/21681805.2019.1702093. Epub 2019 Dec 16.,George G,https://www.ncbi.nlm.nih.gov/pubmed/31842658
9702,32125635,Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients,Radiol Med. 2020 Aug;125(8):777-783. doi: 10.1007/s11547-020-01158-2. Epub 2020 Mar 3.,Onal C,https://www.ncbi.nlm.nih.gov/pubmed/32125635
9703,32404868,Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):680-688. doi: 10.1038/s41391-020-0236-0. Epub 2020 May 13.,Shore N,https://www.ncbi.nlm.nih.gov/pubmed/32404868
9704,31718396,Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection,J Urol. 2020 Apr;203(4):713-718. doi: 10.1097/JU.0000000000000652. Epub 2019 Nov 13.,Draulans C,https://www.ncbi.nlm.nih.gov/pubmed/31718396
9705,32358086,(177)Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer,J Nucl Med. 2020 Dec;61(12):1772-1778. doi: 10.2967/jnumed.120.242263. Epub 2020 May 1.,Zang J,https://www.ncbi.nlm.nih.gov/pubmed/32358086
9706,32245678,Validation of the updated eighth edition of AJCC for prostate cancer: Removal of pT2 substages - Does extent of tumor involvement matter?,Urol Oncol. 2020 Jul;38(7):637.e1-637.e7. doi: 10.1016/j.urolonc.2020.01.005. Epub 2020 Mar 31.,Pompe RS,https://www.ncbi.nlm.nih.gov/pubmed/32245678
9707,32639983,Patient preferences for reducing bowel adverse events following prostate radiotherapy,PLoS One. 2020 Jul 8;15(7):e0235616. doi: 10.1371/journal.pone.0235616. eCollection 2020.,Mishra MV,https://www.ncbi.nlm.nih.gov/pubmed/32639983
9708,31562018,Comparison of dose statistics for bladder wall and rectum wall vs whole organs for VMAT prostate treatment,Med Dosim. 2020 Summer;45(2):140-148. doi: 10.1016/j.meddos.2019.08.003. Epub 2019 Sep 24.,Desrochers A,https://www.ncbi.nlm.nih.gov/pubmed/31562018
9710,32366454,Building a Nomogram for Prediction of Prostate Cancer in Patients With Preoperatively Suspected Prostate Cancer,Anticancer Res. 2020 May;40(5):2995-3002. doi: 10.21873/anticanres.14280.,Ou YC,https://www.ncbi.nlm.nih.gov/pubmed/32366454
9711,32487038,A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS),BMC Cancer. 2020 Jun 1;20(1):492. doi: 10.1186/s12885-020-07000-2.,Hasan H,https://www.ncbi.nlm.nih.gov/pubmed/32487038
9712,32160416,"Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results",Cancer Med. 2020 May;9(9):3097-3106. doi: 10.1002/cam4.2966. Epub 2020 Mar 11.,Zilli T,https://www.ncbi.nlm.nih.gov/pubmed/32160416
9713,31745256,Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):316-323. doi: 10.1038/s41391-019-0188-4. Epub 2019 Nov 19.,Chen WS,https://www.ncbi.nlm.nih.gov/pubmed/31745256
9714,32005115,A cross-sectional study of current work ability after radical prostatectomy,BMC Urol. 2020 Jan 31;20(1):9. doi: 10.1186/s12894-020-0579-9.,Dahl AA,https://www.ncbi.nlm.nih.gov/pubmed/32005115
9715,31977383,Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer,Cancer J. 2020 Jan/Feb;26(1):38-42. doi: 10.1097/PPO.0000000000000425.,Loblaw A,https://www.ncbi.nlm.nih.gov/pubmed/31977383
9716,31723077,"Clinical Evaluation of Onrad, A New Low-cost Version of TomoTherapy that Uses Only Static Beams",Kurume Med J. 2020 Jan 23;65(4):129-136. doi: 10.2739/kurumemedj.MS654004. Epub 2019 Nov 13.,Murai T,https://www.ncbi.nlm.nih.gov/pubmed/31723077
9718,32277679,The effect of radiotherapy and hormone therapy on osteopontin concentrations in prostate cancer patients,J BUON. 2020 Jan-Feb;25(1):527-530.,Wisniewski T,https://www.ncbi.nlm.nih.gov/pubmed/32277679
9719,32191583,Short-Term Outcomes of Active Surveillance for Low Risk Prostate Cancer among Men with Germline DNA Repair Gene Mutations,J Urol. 2020 Oct;204(4):707-713. doi: 10.1097/JU.0000000000001027. Epub 2020 Mar 19.,Halstuch D,https://www.ncbi.nlm.nih.gov/pubmed/32191583
9721,32366119,Evaluating Changes in Immune Function and Bone Microenvironment During Radium-223 Treatment of Patients with Castration-Resistant Prostate Cancer,Cancer Biother Radiopharm. 2020 Sep;35(7):485-489. doi: 10.1089/cbr.2019.3397. Epub 2020 May 5.,Dorff TB,https://www.ncbi.nlm.nih.gov/pubmed/32366119
9722,31611635,A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):184-193. doi: 10.1038/s41391-019-0176-8. Epub 2019 Oct 14.,Ross AE,https://www.ncbi.nlm.nih.gov/pubmed/31611635
9723,31601699,Patients Resistant Against PSMA-Targeting ?-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated Genes,J Nucl Med. 2020 May;61(5):683-688. doi: 10.2967/jnumed.119.234559. Epub 2019 Oct 10.,Kratochwil C,https://www.ncbi.nlm.nih.gov/pubmed/31601699
9724,31630384,Clinical Implications of Peripheral CD3+CD69+ T-Cell And CD8+CD28+ T-Cell Proportions in Patients Prior to Radical Prostatectomy,Urol J. 2020 May 16;17(3):257-261. doi: 10.22037/uj.v0i0.5103.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/31630384
9725,31948932,Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features,Urol Oncol. 2020 May;38(5):386-392. doi: 10.1016/j.urolonc.2019.12.018. Epub 2020 Jan 13.,Roumiguie M,https://www.ncbi.nlm.nih.gov/pubmed/31948932
9727,32144340,Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer,Sci Rep. 2020 Mar 6;10(1):4179. doi: 10.1038/s41598-020-61129-5.,Zhang J,https://www.ncbi.nlm.nih.gov/pubmed/32144340
9728,32358562,Harnessing the potential of multimodal radiotherapy in prostate cancer,Nat Rev Urol. 2020 Jun;17(6):321-338. doi: 10.1038/s41585-020-0310-3. Epub 2020 May 1.,Philippou Y,https://www.ncbi.nlm.nih.gov/pubmed/32358562
9730,32333981,Quantifying the Relationship Between Increasing Life Expectancy and Nonprostate Cancer Mortality After Radical Prostatectomy,Urology. 2020 Aug;142:174-178. doi: 10.1016/j.urology.2020.04.053. Epub 2020 Apr 22.,Froehner M,https://www.ncbi.nlm.nih.gov/pubmed/32333981
9731,32424131,A Pilot retrospective analysis of alpha-blockers on recurrence in men with localised prostate cancer treated with radiotherapy,Sci Rep. 2020 May 18;10(1):8191. doi: 10.1038/s41598-020-65238-z.,Hart J,https://www.ncbi.nlm.nih.gov/pubmed/32424131
9732,32410487,Overweight and obesity in men with prostate cancer do not constitute risk factors for biochemical recurrence,Aging Male. 2020 Dec;23(5):1283-1288. doi: 10.1080/13685538.2020.1764523. Epub 2020 May 15.,Leal-García M,https://www.ncbi.nlm.nih.gov/pubmed/32410487
9733,32278839,Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Oct;18(5):e523-e530. doi: 10.1016/j.clgc.2020.03.009. Epub 2020 Mar 13.,Fujita N,https://www.ncbi.nlm.nih.gov/pubmed/32278839
9734,32347780,[(18)F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer,J Urol. 2020 Oct;204(4):734-740. doi: 10.1097/JU.0000000000001095. Epub 2020 Apr 29.,Alemozaffar M,https://www.ncbi.nlm.nih.gov/pubmed/32347780
9735,31802175,Impact of (68)Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):652-664. doi: 10.1007/s00259-019-04568-1. Epub 2019 Dec 4.,Ferraro DA,https://www.ncbi.nlm.nih.gov/pubmed/31802175
9736,32108043,Genetic Association Analysis of Cell Cycle Regulators Reveals YWHAZ Has Prognostic Significance in Prostate Cancer,Cancer Genomics Proteomics. 2020 Mar-Apr;17(2):209-216. doi: 10.21873/cgp.20181.,Yu CC,https://www.ncbi.nlm.nih.gov/pubmed/32108043
9737,32268944,External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection,Eur Urol. 2020 Aug;78(2):138-142. doi: 10.1016/j.eururo.2020.03.023. Epub 2020 Apr 5.,Gandaglia G,https://www.ncbi.nlm.nih.gov/pubmed/32268944
9739,31755624,A national study of artificial urinary sphincter and male sling implantation after radical prostatectomy in England,BJU Int. 2020 Mar;125(3):467-475. doi: 10.1111/bju.14955. Epub 2020 Jan 16.,Dosanjh A,https://www.ncbi.nlm.nih.gov/pubmed/31755624
9740,32209449,"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study",Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.,Hofman MS,https://www.ncbi.nlm.nih.gov/pubmed/32209449
9741,31780782,Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):349-355. doi: 10.1038/s41391-019-0191-9. Epub 2019 Nov 28.,Malouff TD,https://www.ncbi.nlm.nih.gov/pubmed/31780782
9742,32500805,Stereotactic Body Radiotherapy for Prostate Cancer,Am J Mens Health. 2020 May-Jun;14(3):1557988320927241. doi: 10.1177/1557988320927241.,Parikh NR,https://www.ncbi.nlm.nih.gov/pubmed/32500805
9743,32374476,Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer,Cancer. 2020 Jul 15;126(14):3274-3280. doi: 10.1002/cncr.32933. Epub 2020 May 6.,Patel DN,https://www.ncbi.nlm.nih.gov/pubmed/32374476
9744,32201058,Kilovoltage intrafraction monitoring during normofractionated prostate cancer radiotherapy,Cancer Radiother. 2020 Apr;24(2):99-105. doi: 10.1016/j.canrad.2019.11.001. Epub 2020 Mar 19.,Chasseray M,https://www.ncbi.nlm.nih.gov/pubmed/32201058
9745,31455846,Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):136-143. doi: 10.1038/s41391-019-0167-9. Epub 2019 Aug 27.,Herlemann A,https://www.ncbi.nlm.nih.gov/pubmed/31455846
9746,32333739,How I Do It - MRI-ultrasound fusion prostate biopsy using the Fusion MR and Fusion Bx systems,Can J Urol. 2020 Apr;27(2):10185-10191.,Perlis N,https://www.ncbi.nlm.nih.gov/pubmed/32333739
9747,31899007,"Comparative analysis of the expression of metalloproteases (MMP-2, MMP-9, MMP-11 and MMP-13) and the tissue inhibitor of metalloprotease 3 (TIMP-3) between previous negative biopsies and radical prostatectomies",Actas Urol Esp (Engl Ed). 2020 Mar;44(2):78-85. doi: 10.1016/j.acuro.2019.10.004. Epub 2019 Dec 30.,Medina-González A,https://www.ncbi.nlm.nih.gov/pubmed/31899007
9748,32088139,State-of-the-art Intraoperative Imaging Technologies for Prostate Margin Assessment: A Systematic Review,Eur Urol Focus. 2021 Jul;7(4):733-741. doi: 10.1016/j.euf.2020.02.004. Epub 2020 Feb 20.,Olde Heuvel J,https://www.ncbi.nlm.nih.gov/pubmed/32088139
9749,31909889,Analyses of integrated EPID images for on-treatment quality assurance to account for interfractional variations in volumetric modulated arc therapy,J Appl Clin Med Phys. 2020 Jan;21(1):110-116. doi: 10.1002/acm2.12805. Epub 2020 Jan 7.,Matsushita N,https://www.ncbi.nlm.nih.gov/pubmed/31909889
9751,32165153,Value of (18)F-Choline PET/MRI hybrid technique on the therapeutic approach for patients with prostate cancer treated with prostatectomy and rising prostate specific antigen levels below 1 ng/ml,Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jul-Aug;39(4):197-203. doi: 10.1016/j.remn.2020.01.010. Epub 2020 Mar 9.,García JR,https://www.ncbi.nlm.nih.gov/pubmed/32165153
9752,32460527,Gene Expression-Based Immune Cell Infiltration Analyses of Prostate Cancer and Their Associations with Survival Outcome,DNA Cell Biol. 2020 Jul;39(7):1194-1204. doi: 10.1089/dna.2020.5371. Epub 2020 May 27.,Hu P,https://www.ncbi.nlm.nih.gov/pubmed/32460527
9753,31967521,Evaluating the Trade-Offs Men with Localized Prostate Cancer Make between the Risks and Benefits of Treatments: The COMPARE Study,J Urol. 2020 Aug;204(2):273-280. doi: 10.1097/JU.0000000000000754. Epub 2020 Jan 22.,Watson V,https://www.ncbi.nlm.nih.gov/pubmed/31967521
9754,31250347,Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer,Cell Biol Toxicol. 2020 Apr;36(2):115-130. doi: 10.1007/s10565-019-09483-7. Epub 2019 Jun 27.,Lee CH,https://www.ncbi.nlm.nih.gov/pubmed/31250347
9755,31822909,53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy,Nucleic Acids Res. 2020 Feb 20;48(3):1314-1326. doi: 10.1093/nar/gkz1139.,Eke I,https://www.ncbi.nlm.nih.gov/pubmed/31822909
9756,31757784,Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk,Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):246-253. doi: 10.1158/1055-9965.EPI-19-0407. Epub 2019 Nov 22.,Creed JH,https://www.ncbi.nlm.nih.gov/pubmed/31757784
9757,32473821,Radical retropubic prostatectomy: Vesicourethral anastomosis,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):423-429. doi: 10.1016/j.acuro.2020.02.004. Epub 2020 May 27.,Herranz-Amo F,https://www.ncbi.nlm.nih.gov/pubmed/32473821
9758,32003412,HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate Cancer,J Nutr Health Aging. 2020;24(2):205-209. doi: 10.1007/s12603-019-1294-7.,Couderc AL,https://www.ncbi.nlm.nih.gov/pubmed/32003412
9760,32008885,Optimizing planning CT using past CT images for prostate cancer volumetric modulated arc therapy,Med Dosim. 2020 Autumn;45(3):213-218. doi: 10.1016/j.meddos.2019.12.008. Epub 2020 Jan 31.,Tanabe Y,https://www.ncbi.nlm.nih.gov/pubmed/32008885
9761,32444886,Current state of image-guided focal therapy for prostate cancer,World J Urol. 2021 Mar;39(3):701-717. doi: 10.1007/s00345-020-03254-4. Epub 2020 May 22.,Tourinho-Barbosa RR,https://www.ncbi.nlm.nih.gov/pubmed/32444886
9762,32585020,Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis,JAMA Netw Open. 2020 Jun 1;3(6):e208221. doi: 10.1001/jamanetworkopen.2020.8221.,Miller LE,https://www.ncbi.nlm.nih.gov/pubmed/32585020
9763,31653712,"Response Prediction of (177)Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase",J Nucl Med. 2020 May;61(5):689-695. doi: 10.2967/jnumed.119.231431. Epub 2019 Oct 25.,Rathke H,https://www.ncbi.nlm.nih.gov/pubmed/31653712
9764,31648185,Soluble CD105 is prognostic of disease recurrence in prostate cancer patients,Endocr Relat Cancer. 2020 Jan;27(1):1-9. doi: 10.1530/ERC-19-0370.,Placencio-Hickok VR,https://www.ncbi.nlm.nih.gov/pubmed/31648185
9765,32229093,Penile Prosthesis Implantation and Timing Disparities After Radical Prostatectomy: Results From a Statewide Claims Database,J Sex Med. 2020 Jun;17(6):1175-1181. doi: 10.1016/j.jsxm.2020.02.022. Epub 2020 Mar 28.,Bajic P,https://www.ncbi.nlm.nih.gov/pubmed/32229093
9766,31793443,Epidemiology regarding penile prosthetic surgery,Asian J Androl. 2020 Jan-Feb;22(1):2-7. doi: 10.4103/aja.aja_124_19.,Saavedra-Belaunde JA,https://www.ncbi.nlm.nih.gov/pubmed/31793443
9767,31471138,Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer,Eur Urol. 2020 Mar;77(3):299-308. doi: 10.1016/j.eururo.2019.08.014. Epub 2019 Aug 28.,Gorchakov AA,https://www.ncbi.nlm.nih.gov/pubmed/31471138
9769,32058663,Evaluation of a commercial DIR platform for contour propagation in prostate cancer patients treated with IMRT/VMAT,J Appl Clin Med Phys. 2020 Feb;21(2):14-25. doi: 10.1002/acm2.12787.,Hammers JE,https://www.ncbi.nlm.nih.gov/pubmed/32058663
9771,32581402,Influence of human adipose stem cells on prostate cancer cell growth,Nagoya J Med Sci. 2020 May;82(2):217-224. doi: 10.18999/nagjms.82.2.217.,Tokunori Yamamoto,https://www.ncbi.nlm.nih.gov/pubmed/32581402
9775,32460298,Association between Basal Total Testosterone Levels and Prostate Cancer D'Amico Risk Classes,Urol Int. 2020;104(9-10):716-723. doi: 10.1159/000506525. Epub 2020 May 27.,Tafuri A,https://www.ncbi.nlm.nih.gov/pubmed/32460298
9776,31492993,Prediction nomogram for (68)Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):136-146. doi: 10.1007/s00259-019-04505-2. Epub 2019 Sep 6.,Ceci F,https://www.ncbi.nlm.nih.gov/pubmed/31492993
9778,32241690,Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer,Urol Oncol. 2020 Jun;38(6):601.e1-601.e9. doi: 10.1016/j.urolonc.2020.02.009. Epub 2020 Mar 30.,Qian H,https://www.ncbi.nlm.nih.gov/pubmed/32241690
9779,31640893,Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer,Eur Urol. 2020 Mar;77(3):333-341. doi: 10.1016/j.eururo.2019.09.036. Epub 2019 Oct 20.,Reimers MA,https://www.ncbi.nlm.nih.gov/pubmed/31640893
9780,31893996,BUB1B Promotes Proliferation of Prostate Cancer via Transcriptional Regulation of MELK,Anticancer Agents Med Chem. 2020;20(9):1140-1146. doi: 10.2174/1871520620666200101141934.,Tian JH,https://www.ncbi.nlm.nih.gov/pubmed/31893996
9781,31937084,"""In-bore"" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation",Arch Ital Urol Androl. 2020 Jan 14;91(4):224-229. doi: 10.4081/aiua.2019.4.224.,Porreca A,https://www.ncbi.nlm.nih.gov/pubmed/31937084
9782,31983662,"The Precision Prostatectomy: ""Waiting for Godot""",Eur Urol Focus. 2020 Mar 15;6(2):227-230. doi: 10.1016/j.euf.2020.01.010. Epub 2020 Jan 23.,Sood A,https://www.ncbi.nlm.nih.gov/pubmed/31983662
9783,31725935,Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment,BJU Int. 2020 Mar;125(3):369-378. doi: 10.1111/bju.14951. Epub 2019 Dec 5.,Blazevski A,https://www.ncbi.nlm.nih.gov/pubmed/31725935
9784,31977081,Physician and facility drivers of spending variation in locoregional prostate cancer,Cancer. 2020 Apr 15;126(8):1622-1631. doi: 10.1002/cncr.32719. Epub 2020 Jan 24.,Rodin D,https://www.ncbi.nlm.nih.gov/pubmed/31977081
9785,31401014,Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting,Eur Urol Oncol. 2020 Apr;3(2):231-238. doi: 10.1016/j.euo.2019.07.010. Epub 2019 Aug 8.,Aluwini SS,https://www.ncbi.nlm.nih.gov/pubmed/31401014
9786,31595044,Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):38-52. doi: 10.1038/s41391-019-0174-x. Epub 2019 Oct 8.,Iravani A,https://www.ncbi.nlm.nih.gov/pubmed/31595044
9787,32047296,Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression,Br J Cancer. 2020 Mar;122(7):1068-1076. doi: 10.1038/s41416-020-0749-2. Epub 2020 Feb 12.,Lévesque E,https://www.ncbi.nlm.nih.gov/pubmed/32047296
9788,31883873,Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials,Urol Oncol. 2020 Mar;38(3):78.e7-78.e13. doi: 10.1016/j.urolonc.2019.10.015. Epub 2019 Dec 27.,Trinh QD,https://www.ncbi.nlm.nih.gov/pubmed/31883873
9789,31707924,Bicalutamide-associated hallucinations in a metastatic prostate cancer patient: A case report,J Oncol Pharm Pract. 2020 Jun;26(4):1029-1031. doi: 10.1177/1078155219886918. Epub 2019 Nov 10.,Turkkan G,https://www.ncbi.nlm.nih.gov/pubmed/31707924
9790,32168432,"Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence",J Cell Mol Med. 2020 Apr;24(8):4698-4706. doi: 10.1111/jcmm.15138. Epub 2020 Mar 13.,Huang JB,https://www.ncbi.nlm.nih.gov/pubmed/32168432
9791,32460889,Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer,Radiat Oncol. 2020 May 27;15(1):127. doi: 10.1186/s13014-020-01575-7.,Takakusagi Y,https://www.ncbi.nlm.nih.gov/pubmed/32460889
9792,31321651,Preoperative Prediction of Extracapsular Extension: Radiomics Signature Based on Magnetic Resonance Imaging to Stage Prostate Cancer,Mol Imaging Biol. 2020 Jun;22(3):711-721. doi: 10.1007/s11307-019-01405-7.,Ma S,https://www.ncbi.nlm.nih.gov/pubmed/31321651
9795,32320126,Targeted and systematic cognitive freehand-guided transperineal biopsy: is there still a role for systematic biopsy?,BJU Int. 2020 Aug;126(2):280-285. doi: 10.1111/bju.15092. Epub 2020 May 19.,Neale A,https://www.ncbi.nlm.nih.gov/pubmed/32320126
9796,32080350,Clinicopathological characteristics of glomeruloid architecture in prostate cancer,Mod Pathol. 2020 Aug;33(8):1618-1625. doi: 10.1038/s41379-020-0507-2. Epub 2020 Feb 20.,Hollemans E,https://www.ncbi.nlm.nih.gov/pubmed/32080350
9797,32016908,Endogenous testosterone mirrors prostate cancer aggressiveness: correlation between basal testosterone serum levels and prostate cancer European Urology Association clinical risk classes in a large cohort of Caucasian patients,Int Urol Nephrol. 2020 Jul;52(7):1261-1269. doi: 10.1007/s11255-020-02398-x. Epub 2020 Feb 3.,Tafuri A,https://www.ncbi.nlm.nih.gov/pubmed/32016908
9799,31505246,Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia,Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):61-66. doi: 10.1016/j.ijrobp.2019.08.061. Epub 2019 Sep 7.,Ong WL,https://www.ncbi.nlm.nih.gov/pubmed/31505246
9801,32384491,Loss of DNA mismatch repair proteins in prostate cancer,Medicine (Baltimore). 2020 May;99(19):e20124. doi: 10.1097/MD.0000000000020124.,Sharma M,https://www.ncbi.nlm.nih.gov/pubmed/32384491
9802,31989474,"Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)",Clin Transl Oncol. 2020 Aug;22(8):1378-1389. doi: 10.1007/s12094-019-02274-w. Epub 2020 Jan 27.,Valero J,https://www.ncbi.nlm.nih.gov/pubmed/31989474
9803,31699490,Patterns of stereotactic body radiation therapy: The influence of lung cancer treatment on prostate cancer treatment,Urol Oncol. 2020 Feb;38(2):37.e21-37.e27. doi: 10.1016/j.urolonc.2019.09.031. Epub 2019 Nov 5.,Jacobs BL,https://www.ncbi.nlm.nih.gov/pubmed/31699490
9804,31885207,Utility of Ga(68) prostate-specific membrane antigen positron-emission tomography for pre-operative staging of high-risk prostate cancer in a prospective cohort,J Med Imaging Radiat Oncol. 2020 Feb;64(1):78-86. doi: 10.1111/1754-9485.12988. Epub 2019 Dec 29.,Tarr GP,https://www.ncbi.nlm.nih.gov/pubmed/31885207
9805,32116138,Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori,Tumori. 2020 Oct;106(5):406-412. doi: 10.1177/0300891620905646. Epub 2020 Mar 2.,Raimondi A,https://www.ncbi.nlm.nih.gov/pubmed/32116138
9806,32473820,"Prostate cancer, new treatment advances - immunotherapy",Actas Urol Esp (Engl Ed). 2020 Sep;44(7):458-468. doi: 10.1016/j.acuro.2020.01.009. Epub 2020 May 27.,Silva D,https://www.ncbi.nlm.nih.gov/pubmed/32473820
9808,32233346,Advances in prostate cancer,Aust J Gen Pract. 2020 Apr;49(4):200-205. doi: 10.31128/AJGP-09-19-5055.,Reeves FA,https://www.ncbi.nlm.nih.gov/pubmed/32233346
9809,33156884,Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer,PLoS One. 2020 Nov 6;15(11):e0241636. doi: 10.1371/journal.pone.0241636. eCollection 2020.,Takakusagi Y,https://www.ncbi.nlm.nih.gov/pubmed/33156884
9810,31977390,Treatment of Primary in Metastatic Prostate Cancer: What Is the Standard of Care?,Cancer J. 2020 Jan/Feb;26(1):83-86. doi: 10.1097/PPO.0000000000000430.,Joseph N,https://www.ncbi.nlm.nih.gov/pubmed/31977390
9811,32280037,High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel,Urol Oncol. 2020 Jul;38(7):637.e17-637.e27. doi: 10.1016/j.urolonc.2020.03.001. Epub 2020 Apr 10.,Nientiedt C,https://www.ncbi.nlm.nih.gov/pubmed/32280037
9812,32020826,Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis,Aging Male. 2020 Dec;23(5):1182-1193. doi: 10.1080/13685538.2020.1718637. Epub 2020 Feb 5.,Zhou L,https://www.ncbi.nlm.nih.gov/pubmed/32020826
9813,32174016,Is prospective MRI mapping of the changes in the volume of the prostate gland in prostate cancer patients undergoing 6 months of neo-adjuvant androgen deprivation therapy a step towards a trial to determine those who may benefit from treatment intensification or extended duration?,J Med Imaging Radiat Oncol. 2020 Apr;64(2):287-292. doi: 10.1111/1754-9485.13017. Epub 2020 Mar 15.,Christie DR,https://www.ncbi.nlm.nih.gov/pubmed/32174016
9814,31977381,Next Generation of Androgen Deprivation Therapy Combined With Radiotherapy for N0 M0 Prostate Cancer,Cancer J. 2020 Jan/Feb;26(1):21-28. doi: 10.1097/PPO.0000000000000428.,Barata P,https://www.ncbi.nlm.nih.gov/pubmed/31977381
9815,31714881,Biomarkers for prostate cancer: prostate-specific antigen and beyond,Clin Chem Lab Med. 2020 Feb 25;58(3):326-339. doi: 10.1515/cclm-2019-0693.,Duffy MJ,https://www.ncbi.nlm.nih.gov/pubmed/31714881
9816,31787501,Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):170-174. doi: 10.1016/j.clon.2019.11.004. Epub 2019 Nov 28.,Loblaw A,https://www.ncbi.nlm.nih.gov/pubmed/31787501
9817,32469606,Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer,Future Oncol. 2020 Jul;16(19):1371-1384. doi: 10.2217/fon-2020-0039. Epub 2020 May 29.,Kuppen MC,https://www.ncbi.nlm.nih.gov/pubmed/32469606
9820,32033574,Accuracy of automatic deformable structure propagation for high-field MRI guided prostate radiotherapy,Radiat Oncol. 2020 Feb 7;15(1):32. doi: 10.1186/s13014-020-1482-y.,Christiansen RL,https://www.ncbi.nlm.nih.gov/pubmed/32033574
9821,31983560,VA-Radiation Oncology Quality Surveillance Program,Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):639-647. doi: 10.1016/j.ijrobp.2019.08.064. Epub 2020 Jan 23.,Hagan M,https://www.ncbi.nlm.nih.gov/pubmed/31983560
9822,31829912,Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial,J Clin Oncol. 2020 Feb 20;38(6):593-601. doi: 10.1200/JCO.19.01904. Epub 2019 Dec 12.,Malone S,https://www.ncbi.nlm.nih.gov/pubmed/31829912
9824,32685021,Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving (177)Lu-PSMA-617 Radioligand Therapy,Theranostics. 2020 Jun 19;10(17):7812-7820. doi: 10.7150/thno.47251. eCollection 2020.,Seifert R,https://www.ncbi.nlm.nih.gov/pubmed/32685021
9825,32146249,Measuring up': A comparison of two response expectancy assessment formats completed by men treated with radiotherapy for prostate cancer,J Psychosom Res. 2020 May;132:109979. doi: 10.1016/j.jpsychores.2020.109979. Epub 2020 Feb 29.,Devlin EJ,https://www.ncbi.nlm.nih.gov/pubmed/32146249
9828,32191331,Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer,JAMA Netw Open. 2020 Mar 2;3(3):e201255. doi: 10.1001/jamanetworkopen.2020.1255.,Bagley AF,https://www.ncbi.nlm.nih.gov/pubmed/32191331
9829,32337234,Comparing Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) Category 1 and 2 Groups: Clinical Implication of Negative Multiparametric Magnetic Resonance Imaging,Biomed Res Int. 2020 Mar 31;2020:2819701. doi: 10.1155/2020/2819701. eCollection 2020.,Kim JK,https://www.ncbi.nlm.nih.gov/pubmed/32337234
9830,31430234,Prostate Specific Membrane Antigen Targeted Positron Emission Tomography of Primary Prostate Cancer: Assessing Accuracy with Whole Mount Pathology,J Urol. 2020 Jan;203(1):92-99. doi: 10.1097/JU.0000000000000501. Epub 2019 Aug 20.,Bahler CD,https://www.ncbi.nlm.nih.gov/pubmed/31430234
9831,31809979,Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy,Radiother Oncol. 2020 Mar;144:135-140. doi: 10.1016/j.radonc.2019.11.017. Epub 2019 Dec 3.,Alayed Y,https://www.ncbi.nlm.nih.gov/pubmed/31809979
9832,31730876,A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy,Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):546-555. doi: 10.1016/j.ijrobp.2019.11.001. Epub 2019 Nov 12.,Liu W,https://www.ncbi.nlm.nih.gov/pubmed/31730876
9833,32083417,A systematic review of imaging-guided metastasis-directed therapy for oligorecurrent prostate cancer: revolution or devolution?,Minerva Urol Nefrol. 2020 Jun;72(3):279-291. doi: 10.23736/S0393-2249.20.03675-9. Epub 2020 Feb 19.,Albisinni S,https://www.ncbi.nlm.nih.gov/pubmed/32083417
9835,32112055,All change in the prostate cancer diagnostic pathway,Nat Rev Clin Oncol. 2020 Jun;17(6):372-381. doi: 10.1038/s41571-020-0332-z. Epub 2020 Feb 28.,Lomas DJ,https://www.ncbi.nlm.nih.gov/pubmed/32112055
9836,31077088,Differences of the immune cell landscape between normal and tumor tissue in human prostate,Clin Transl Oncol. 2020 Mar;22(3):344-350. doi: 10.1007/s12094-019-02128-5. Epub 2019 May 10.,Zhang E,https://www.ncbi.nlm.nih.gov/pubmed/31077088
9837,31620808,[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):185-191. doi: 10.1007/s00259-019-04482-6. Epub 2019 Oct 16.,Pasqualetti F,https://www.ncbi.nlm.nih.gov/pubmed/31620808
9838,32378019,Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing (177)Lu-PSMA-617 radioligand therapy,Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):103-112. doi: 10.1007/s00259-020-04828-5. Epub 2020 May 6.,Khreish F,https://www.ncbi.nlm.nih.gov/pubmed/32378019
9839,31386793,Extraperitoneal single-port robot-assisted radical prostatectomy: initial experience and description of technique,BJU Int. 2020 Jan;125(1):182-189. doi: 10.1111/bju.14885. Epub 2019 Sep 11.,Kaouk J,https://www.ncbi.nlm.nih.gov/pubmed/31386793
9840,31501508,Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):172-178. doi: 10.1038/s41391-019-0171-0. Epub 2019 Sep 9.,Baack Kukreja J,https://www.ncbi.nlm.nih.gov/pubmed/31501508
9841,31238766,Combination possibility and deep learning model as clinical decision-aided approach for prostate cancer,Health Informatics J. 2020 Jun;26(2):945-962. doi: 10.1177/1460458219855884. Epub 2019 Jun 26.,Eminaga O,https://www.ncbi.nlm.nih.gov/pubmed/31238766
9843,32208168,CD8(+) T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens,Mol Ther. 2020 May 6;28(5):1238-1250. doi: 10.1016/j.ymthe.2020.02.018. Epub 2020 Mar 3.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32208168
9844,31937614,Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer,Clin Cancer Res. 2020 May 1;26(9):2104-2110. doi: 10.1158/1078-0432.CCR-19-2591. Epub 2020 Jan 14.,Agarwal N,https://www.ncbi.nlm.nih.gov/pubmed/31937614
9845,31786279,Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial,Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):706-714. doi: 10.1016/j.ijrobp.2019.11.027. Epub 2019 Nov 28.,Aksnessæther BY,https://www.ncbi.nlm.nih.gov/pubmed/31786279
9847,31912257,(68)Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is (68)Ga-PSMA PET/CT guided biopsy the future?,Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1843-1851. doi: 10.1007/s00259-019-04620-0. Epub 2020 Jan 7.,Donato P,https://www.ncbi.nlm.nih.gov/pubmed/31912257
9848,32436467,Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer,Acta Oncol. 2020 Aug;59(8):911-917. doi: 10.1080/0284186X.2020.1760349. Epub 2020 May 21.,Outaggarts Z,https://www.ncbi.nlm.nih.gov/pubmed/32436467
9849,31789908,Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients,Clin Nucl Med. 2020 Jan;45(1):19-31. doi: 10.1097/RLU.0000000000002833.,Yadav MP,https://www.ncbi.nlm.nih.gov/pubmed/31789908
9850,32448724,Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer -5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life,Clin Oncol (R Coll Radiol). 2020 Oct;32(10):e177-e187. doi: 10.1016/j.clon.2020.05.002. Epub 2020 May 21.,Jiang XY,https://www.ncbi.nlm.nih.gov/pubmed/32448724
9851,31899081,The Horse is at the Stable Door: Management of N1M0 Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):199-208. doi: 10.1016/j.clon.2019.12.001. Epub 2019 Dec 31.,Thiruthaneeswaran N,https://www.ncbi.nlm.nih.gov/pubmed/31899081
9853,31643128,"Effect of a prospective opioid reduction intervention on opioid prescribing and use after radical prostatectomy: results of the Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (ORIOLES) Initiative",BJU Int. 2020 Mar;125(3):426-432. doi: 10.1111/bju.14932. Epub 2019 Nov 15.,Patel HD,https://www.ncbi.nlm.nih.gov/pubmed/31643128
9854,31977389,Factors to Guide Treatment Selection for Hormone-Sensitive Metastatic Prostate Cancer,Cancer J. 2020 Jan/Feb;26(1):76-82. doi: 10.1097/PPO.0000000000000423.,Tsao PA,https://www.ncbi.nlm.nih.gov/pubmed/31977389
9855,32111687,Early Prostate-Specific Antigen Changes and Clinical Outcome After (177)Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer,J Nucl Med. 2020 Oct;61(10):1476-1483. doi: 10.2967/jnumed.119.240242. Epub 2020 Feb 28.,Gafita A,https://www.ncbi.nlm.nih.gov/pubmed/32111687
9856,32333734,Charlson Comorbidity score influence on prostate cancer survival and radiation-related toxicity,Can J Urol. 2020 Apr;27(2):10154-10161.,Ghanem AI,https://www.ncbi.nlm.nih.gov/pubmed/32333734
9857,32111660,Comparison of Dual-Tracer PET and CT Features to Conventional Risk Categories in Assessing Response to (177)Lu-PSMA-617 Therapy for Metastatic Prostate Adenocarcinoma with Urinary Bladder Involvement,J Nucl Med Technol. 2020 Jun;48(2):148-153. doi: 10.2967/jnmt.119.235960. Epub 2020 Feb 28.,Adnan A,https://www.ncbi.nlm.nih.gov/pubmed/32111660
9858,32192889,Prognostic value of the SPOP mutant genomic subclass in prostate cancer,Urol Oncol. 2020 May;38(5):418-422. doi: 10.1016/j.urolonc.2020.02.011. Epub 2020 Mar 17.,Shoag J,https://www.ncbi.nlm.nih.gov/pubmed/32192889
9859,31742661,Recognizing and minimizing bias: Helping patients make their best choice for prostate cancer management through multidisciplinary clinics,Cancer. 2020 Feb 1;126(3):470-472. doi: 10.1002/cncr.32574. Epub 2019 Nov 19.,Eggener SE,https://www.ncbi.nlm.nih.gov/pubmed/31742661
9860,32250042,SpaceOAR(C) hydrogel rectal dose reduction prediction model: a decision support tool,J Appl Clin Med Phys. 2020 Jun;21(6):15-25. doi: 10.1002/acm2.12860. Epub 2020 Apr 30.,Paetkau O,https://www.ncbi.nlm.nih.gov/pubmed/32250042
9861,31904002,Dosimetric comparison of artificial walls of bladder and rectum with real walls in common prostate IMRT techniques: Patient and Monte Carlo study,J Xray Sci Technol. 2020;28(1):59-70. doi: 10.3233/XST-190592.,Gorji KE,https://www.ncbi.nlm.nih.gov/pubmed/31904002
9862,31830233,Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes: A Meta-analysis of Individual Patient Data From Randomized Clinical Trials,JAMA Oncol. 2020 Feb 1;6(2):206-216. doi: 10.1001/jamaoncol.2019.4097.,Terrisse S,https://www.ncbi.nlm.nih.gov/pubmed/31830233
9864,32196428,Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review,Radiographics. 2020 May-Jun;40(3):709-726. doi: 10.1148/rg.2020190121. Epub 2020 Mar 20.,Tanaka T,https://www.ncbi.nlm.nih.gov/pubmed/32196428
9865,31162261,Complete Regression of Lung Metastases in a Patient With Metastatic Castration-Resistant Prostate Cancer Using 177Lu-PSMA Radioligand Therapy,Clin Nucl Med. 2020 Jan;45(1):e48-e50. doi: 10.1097/RLU.0000000000002655.,Zhang J,https://www.ncbi.nlm.nih.gov/pubmed/31162261
9866,31926489,Efficacy of a hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer,Jpn J Clin Oncol. 2020 Mar 9;50(3):303-309. doi: 10.1093/jjco/hyz171.,Ogita M,https://www.ncbi.nlm.nih.gov/pubmed/31926489
9868,32475745,"Comparative study of surgical orchidectomy and medical castration in treatment efficacy, adverse effects and cost based on a large prospective metastatic prostate cancer registry",Urol Oncol. 2020 Aug;38(8):682.e1-682.e9. doi: 10.1016/j.urolonc.2020.05.005. Epub 2020 May 29.,Tan YG,https://www.ncbi.nlm.nih.gov/pubmed/32475745
9871,32877914,Introduction of a New Score to Assess Surgical Efficiency in Holmium Laser Enucleation of the Prostate,Urol Int. 2020;104(11-12):914-922. doi: 10.1159/000510135. Epub 2020 Sep 2.,Rosenhammer B,https://www.ncbi.nlm.nih.gov/pubmed/32877914
9872,32360049,Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study,Eur Urol. 2020 Sep;78(3):443-451. doi: 10.1016/j.eururo.2020.03.035. Epub 2020 Apr 30.,Stavrinides V,https://www.ncbi.nlm.nih.gov/pubmed/32360049
9875,32213206,Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223,Int Braz J Urol. 2020 Jul-Aug;46(4):599-611. doi: 10.1590/S1677-5538.IBJU.2019.0343. Epub 2020 Mar 15.,Vidal M,https://www.ncbi.nlm.nih.gov/pubmed/32213206
9876,31724081,Locally advanced prostate cancer imaging findings and implications for treatment from the surgical perspective,Abdom Radiol (NY). 2020 Mar;45(3):865-877. doi: 10.1007/s00261-019-02318-3.,Elsherif SB,https://www.ncbi.nlm.nih.gov/pubmed/31724081
9877,32591433,Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial,J Immunother Cancer. 2020 Jun;8(1):e000928. doi: 10.1136/jitc-2020-000928.,Cappuccini F,https://www.ncbi.nlm.nih.gov/pubmed/32591433
9878,32273493,Caveolin-1 regulates the ASMase/ceramide-mediated radiation response of endothelial cells in the context of tumor-stroma interactions,Cell Death Dis. 2020 Apr 9;11(4):228. doi: 10.1038/s41419-020-2418-z.,Ketteler J,https://www.ncbi.nlm.nih.gov/pubmed/32273493
9879,32466877,External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study,Urol Oncol. 2020 Nov;38(11):847.e9-847.e16. doi: 10.1016/j.urolonc.2020.04.011. Epub 2020 May 26.,Diamand R,https://www.ncbi.nlm.nih.gov/pubmed/32466877
9880,32460859,Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation,BMC Med. 2020 May 28;18(1):114. doi: 10.1186/s12916-020-01588-9.,Parry MG,https://www.ncbi.nlm.nih.gov/pubmed/32460859
9882,31103721,Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort,Eur Urol Oncol. 2020 Jun;3(3):283-290. doi: 10.1016/j.euo.2019.04.008. Epub 2019 May 16.,Blazevski A,https://www.ncbi.nlm.nih.gov/pubmed/31103721
9884,32112196,Osteoporosis screening using computed tomography for men with prostate cancer: results of a prospective study,Arch Osteoporos. 2020 Feb 29;15(1):32. doi: 10.1007/s11657-020-0711-1.,McDonald AM,https://www.ncbi.nlm.nih.gov/pubmed/32112196
9885,31992480,Effect of Echo Times on Prostate Cancer Detection on T2-Weighted Images,Acad Radiol. 2020 Nov;27(11):1555-1563. doi: 10.1016/j.acra.2019.12.014. Epub 2020 Jan 26.,Chatterjee A,https://www.ncbi.nlm.nih.gov/pubmed/31992480
9887,32474391,Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis,Crit Rev Oncol Hematol. 2020 Jul;151:102992. doi: 10.1016/j.critrevonc.2020.102992. Epub 2020 May 23.,Buonerba C,https://www.ncbi.nlm.nih.gov/pubmed/32474391
9889,31809327,Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Recurrence: A Meta-analysis,Am J Clin Oncol. 2020 Feb;43(2):73-81. doi: 10.1097/COC.0000000000000635.,Viani GA,https://www.ncbi.nlm.nih.gov/pubmed/31809327
9890,31977385,Surrogate Endpoints in Localized Prostate Cancer,Cancer J. 2020 Jan/Feb;26(1):48-52. doi: 10.1097/PPO.0000000000000422.,Hartman HE,https://www.ncbi.nlm.nih.gov/pubmed/31977385
9891,32444264,Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial,Eur Urol. 2020 Sep;78(3):360-368. doi: 10.1016/j.eururo.2020.05.001. Epub 2020 May 19.,Patel HD,https://www.ncbi.nlm.nih.gov/pubmed/32444264
9892,30953271,Risk factors of positive surgical margins after robot-assisted radical prostatectomy in high-volume center: results in 732 cases,J Robot Surg. 2020 Feb;14(1):167-175. doi: 10.1007/s11701-019-00954-x. Epub 2019 Apr 5.,Porcaro AB,https://www.ncbi.nlm.nih.gov/pubmed/30953271
9893,31664733,Clinical and pathologic characteristics of familial prostate cancer in Asian population,Prostate. 2020 Jan;80(1):57-64. doi: 10.1002/pros.23917. Epub 2019 Oct 30.,Kim M,https://www.ncbi.nlm.nih.gov/pubmed/31664733
9894,32109140,The Relationship Between Total Lesion Activity on (18)F Choline Positron Emission Tomography-Computed Tomography and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Bone Metastases Treated with (223)Radium,Cancer Biother Radiopharm. 2020 Aug;35(6):398-403. doi: 10.1089/cbr.2019.3188. Epub 2020 Feb 28.,Filippi L,https://www.ncbi.nlm.nih.gov/pubmed/32109140
9895,31746656,Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort,J Urol. 2020 May;203(5):933-939. doi: 10.1097/JU.0000000000000684. Epub 2020 Nov 20.,Weiner AB,https://www.ncbi.nlm.nih.gov/pubmed/31746656
9898,32358729,A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223,Aging Clin Exp Res. 2021 Mar;33(3):651-658. doi: 10.1007/s40520-020-01573-5. Epub 2020 May 1.,Frantellizzi V,https://www.ncbi.nlm.nih.gov/pubmed/32358729
9900,31781834,Clinical outcome of standardized (177)Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):713-720. doi: 10.1007/s00259-019-04584-1. Epub 2019 Nov 28.,Rasul S,https://www.ncbi.nlm.nih.gov/pubmed/31781834
9902,32249345,Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223,Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2633-2638. doi: 10.1007/s00259-020-04796-w. Epub 2020 Apr 5.,Caffo O,https://www.ncbi.nlm.nih.gov/pubmed/32249345
9903,32544044,"Prospective evaluation of the value of dynamic contrast enhanced (DCE) imaging for prostate cancer detection, with pathology correlation",Can J Urol. 2020 Jun;27(3):10220-10227.,Al Salmi I,https://www.ncbi.nlm.nih.gov/pubmed/32544044
9904,32353391,Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 Prostate Cancers,Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):982-985. doi: 10.1016/j.ijrobp.2020.04.025. Epub 2020 Apr 27.,Abu-Gheida I,https://www.ncbi.nlm.nih.gov/pubmed/32353391
9905,31385046,Prediction of extraprostatic extension on multi-parametric magnetic resonance imaging in patients with anterior prostate cancer,Eur Radiol. 2020 Jan;30(1):26-37. doi: 10.1007/s00330-019-06340-3. Epub 2019 Aug 5.,Ahn H,https://www.ncbi.nlm.nih.gov/pubmed/31385046
9906,31978591,Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial,Pract Radiat Oncol. 2020 May-Jun;10(3):186-194. doi: 10.1016/j.prro.2019.12.011. Epub 2020 Jan 21.,Quinn TJ,https://www.ncbi.nlm.nih.gov/pubmed/31978591
9909,32273504,Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation,Nat Commun. 2020 Apr 9;11(1):1750. doi: 10.1038/s41467-020-15424-4.,Brady-Nicholls R,https://www.ncbi.nlm.nih.gov/pubmed/32273504
9911,31734020,Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group,Urol Oncol. 2020 Mar;38(3):83-93. doi: 10.1016/j.urolonc.2019.10.006. Epub 2019 Nov 14.,Narayan V,https://www.ncbi.nlm.nih.gov/pubmed/31734020
9912,31714037,Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients,Cancer Med. 2020 Jan;9(1):125-132. doi: 10.1002/cam4.2685. Epub 2019 Nov 12.,Belkora J,https://www.ncbi.nlm.nih.gov/pubmed/31714037
9913,31872571,Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancer,Basic Clin Pharmacol Toxicol. 2020 Jun;126(6):484-491. doi: 10.1111/bcpt.13379. Epub 2020 Jan 8.,Hálfdánarson ÓÖ,https://www.ncbi.nlm.nih.gov/pubmed/31872571
9914,31703155,Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer,Magn Reson Med. 2020 Jun;83(6):2293-2309. doi: 10.1002/mrm.28058. Epub 2019 Nov 8.,Merisaari H,https://www.ncbi.nlm.nih.gov/pubmed/31703155
9915,32209536,Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial,J Med Internet Res. 2020 Mar 25;22(3):e12689. doi: 10.2196/12689.,Tran C,https://www.ncbi.nlm.nih.gov/pubmed/32209536
9916,31266732,Management of cT4 Prostate Cancer,Eur Urol Focus. 2020 Mar 15;6(2):221-226. doi: 10.1016/j.euf.2019.06.012. Epub 2019 Jun 30.,Ranasinghe WKB,https://www.ncbi.nlm.nih.gov/pubmed/31266732
9917,32014912,Expression of Kisspeptin (KISS1) and its Receptor GPR54 (KISS1R) in Prostate Cancer,Anticancer Res. 2020 Feb;40(2):709-718. doi: 10.21873/anticanres.14001.,Xoxakos I,https://www.ncbi.nlm.nih.gov/pubmed/32014912
9918,32069077,Diagnostic Performance of Mass Enhancement on Dynamic Contrast-Enhanced MRI for Predicting Clinically Significant Peripheral Zone Prostate Cancer,AJR Am J Roentgenol. 2020 Apr;214(4):792-799. doi: 10.2214/AJR.19.22072. Epub 2020 Feb 18.,Park SY,https://www.ncbi.nlm.nih.gov/pubmed/32069077
9920,31758224,(225)Ac-PSMA-617/(177)Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):721-728. doi: 10.1007/s00259-019-04612-0. Epub 2019 Nov 22.,Khreish F,https://www.ncbi.nlm.nih.gov/pubmed/31758224
9921,31868556,Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience,J Urol. 2020 Jun;203(6):1122-1127. doi: 10.1097/JU.0000000000000713. Epub 2019 Dec 23.,Carlsson S,https://www.ncbi.nlm.nih.gov/pubmed/31868556
9922,32234933,Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage,Anticancer Res. 2020 Apr;40(4):2323-2329. doi: 10.21873/anticanres.14199.,Ov?ari?ek PP,https://www.ncbi.nlm.nih.gov/pubmed/32234933
9923,32092044,Establishment and characterization of patient-derived xenografts for hormone-naïve and castrate-resistant prostate cancers to improve treatment modality evaluation,Aging (Albany NY). 2020 Feb 24;12(4):3848-3861. doi: 10.18632/aging.102854. Epub 2020 Feb 24.,Wu P,https://www.ncbi.nlm.nih.gov/pubmed/32092044
9924,31411973,There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies,Eur Urol Oncol. 2020 Feb;3(1):112-118. doi: 10.1016/j.euo.2019.03.002. Epub 2019 Mar 27.,Dell'Oglio P,https://www.ncbi.nlm.nih.gov/pubmed/31411973
9925,32388502,Impact of Histopathological Prostate Inflammation on Urine-Based Prostate Cancer Prediction Using the Prostate Cancer Gene 3 Score,Urol Int. 2020;104(5-6):483-488. doi: 10.1159/000506885. Epub 2020 May 8.,Hennenlotter J,https://www.ncbi.nlm.nih.gov/pubmed/32388502
9928,32454797,Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers,Mediators Inflamm. 2020 May 4;2020:8730608. doi: 10.1155/2020/8730608. eCollection 2020.,Jin W,https://www.ncbi.nlm.nih.gov/pubmed/32454797
9930,32144767,Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced insulin-like growth factor-1 secretion by prostate stromal cells,Int J Cancer. 2020 Jun 15;146(12):3474-3484. doi: 10.1002/ijc.32959. Epub 2020 Mar 19.,Ohishi T,https://www.ncbi.nlm.nih.gov/pubmed/32144767
9931,32169910,Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study,J Nucl Med. 2020 Nov;61(11):1602-1606. doi: 10.2967/jnumed.120.241588. Epub 2020 Mar 13.,Derlin T,https://www.ncbi.nlm.nih.gov/pubmed/32169910
9932,32456482,Isolated Intraductal Carcinoma of the Prostate in Prostatectomy Specimens: Report of 2 Cases and Review of the Literature,Int J Surg Pathol. 2020 Dec;28(8):918-924. doi: 10.1177/1066896920920357. Epub 2020 May 26.,Grypari IM,https://www.ncbi.nlm.nih.gov/pubmed/32456482
9933,32048341,Prospective evaluation of visual function in patients with ocular diseases after robot-assisted laparoscopic prostatectomy,Int J Urol. 2020 Apr;27(4):307-312. doi: 10.1111/iju.14183. Epub 2020 Feb 11.,Kakutani S,https://www.ncbi.nlm.nih.gov/pubmed/32048341
9935,31786304,Prostate Cancer in Men With Treated Advanced Heart Failure: Should we Keep Screening?,Urology. 2020 Feb;136:46-50. doi: 10.1016/j.urology.2019.11.022. Epub 2019 Nov 28.,Lee HH,https://www.ncbi.nlm.nih.gov/pubmed/31786304
9936,31806247,"Laparoscopic radical prostatectomy compared to open radical prostatectomy: Comparison between surgical time, complications and length of hospital stay",Actas Urol Esp (Engl Ed). 2020 Jan-Feb;44(1):41-48. doi: 10.1016/j.acuro.2019.06.008. Epub 2019 Dec 2.,Martínez-Holguín E,https://www.ncbi.nlm.nih.gov/pubmed/31806247
9938,31927264,Enhancement of Hounsfield unit distribution in cone-beam CT images for adaptive radiation therapy: Evaluation of a hybrid correction approach,Phys Med. 2020 Jan;69:269-274. doi: 10.1016/j.ejmp.2020.01.002. Epub 2020 Jan 8.,Kidar HS,https://www.ncbi.nlm.nih.gov/pubmed/31927264
9939,31660679,Novel agents for metastatic hormone-sensitive prostate cancer - a practice guide for urologists,BJU Int. 2020 Mar;125(3):342-345. doi: 10.1111/bju.14936. Epub 2019 Nov 15.,Thangasamy IA,https://www.ncbi.nlm.nih.gov/pubmed/31660679
9941,32448171,Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial,BMC Cancer. 2020 May 24;20(1):457. doi: 10.1186/s12885-020-06853-x.,Berghen C,https://www.ncbi.nlm.nih.gov/pubmed/32448171
9942,32957098,Health-Related Quality of Life and Survival in Prostate Cancer Patients in a Real-World Setting,Urol Int. 2020;104(11-12):939-947. doi: 10.1159/000510319. Epub 2020 Sep 21.,Bergius S,https://www.ncbi.nlm.nih.gov/pubmed/32957098
9943,31056859,Declining use of radical prostatectomy and pelvic lymphadenectomy despite more robotics: National population data over 15 years,Asia Pac J Clin Oncol. 2020 Apr;16(2):e118-e124. doi: 10.1111/ajco.13158. Epub 2019 May 6.,Roberts MJ,https://www.ncbi.nlm.nih.gov/pubmed/31056859
9944,32383524,"Challenges, applications and future directions of precision medicine in prostate cancer - the role of organoids and patient-derived xenografts",BJU Int. 2020 Jul;126(1):65-72. doi: 10.1111/bju.15103. Epub 2020 May 30.,Joshi A,https://www.ncbi.nlm.nih.gov/pubmed/32383524
9946,32026664,"Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer",Minerva Urol Nephrol. 2021 Jun;73(3):349-356. doi: 10.23736/S2724-6051.20.03646-2. Epub 2020 Jan 30.,Claps F,https://www.ncbi.nlm.nih.gov/pubmed/32026664
9948,32130049,Imaging Biochemical Recurrence After Prostatectomy: Where Are We Headed?,AJR Am J Roentgenol. 2020 Jun;214(6):1248-1258. doi: 10.2214/AJR.19.21905. Epub 2020 Mar 4.,Bhargava P,https://www.ncbi.nlm.nih.gov/pubmed/32130049
9949,31724209,Comparison of dynamic features of pelvic floor muscle contraction between men with and without incontinence after prostatectomy and men with no history of prostate cancer,Neurourol Urodyn. 2020 Jan;39(1):170-180. doi: 10.1002/nau.24213. Epub 2019 Nov 13.,Stafford RE,https://www.ncbi.nlm.nih.gov/pubmed/31724209
9950,32187859,Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi-institutional analysis,Cancer Med. 2020 May;9(10):3383-3389. doi: 10.1002/cam4.2920. Epub 2020 Mar 18.,Barsky AR,https://www.ncbi.nlm.nih.gov/pubmed/32187859
9952,32340863,Angiographic Findings Relevant to Prostatic Artery Embolization in Patients with Prostate Cancer,J Vasc Interv Radiol. 2020 Jun;31(6):899-902.e1. doi: 10.1016/j.jvir.2020.02.012. Epub 2020 Apr 25.,Xu ZW,https://www.ncbi.nlm.nih.gov/pubmed/32340863
9953,32446432,Imaging and Management of Prostate Cancer,Semin Ultrasound CT MR. 2020 Apr;41(2):207-221. doi: 10.1053/j.sult.2020.02.001. Epub 2020 Feb 18.,Surasi DSS,https://www.ncbi.nlm.nih.gov/pubmed/32446432
9955,32080073,Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report,Medicine (Baltimore). 2020 Feb;99(8):e18889. doi: 10.1097/MD.0000000000018889.,Sharan B,https://www.ncbi.nlm.nih.gov/pubmed/32080073
9956,31476359,Formal methods for prostate cancer Gleason score and treatment prediction using radiomic biomarkers,Magn Reson Imaging. 2020 Feb;66:165-175. doi: 10.1016/j.mri.2019.08.030. Epub 2019 Aug 30.,Brunese L,https://www.ncbi.nlm.nih.gov/pubmed/31476359
9957,32410407,The Diagnostic Performance of the Length of Tumor Capsular Contact on MRI for Detecting Prostate Cancer Extraprostatic Extension: A Systematic Review and Meta-Analysis,Korean J Radiol. 2020 Jun;21(6):684-694. doi: 10.3348/kjr.2019.0842.,Kim TH,https://www.ncbi.nlm.nih.gov/pubmed/32410407
9958,32020032,Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):457-464. doi: 10.1038/s41391-019-0200-z. Epub 2020 Feb 4.,Newton RU,https://www.ncbi.nlm.nih.gov/pubmed/32020032
9959,32060214,Multiphasic (68)Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients,J Nucl Med. 2020 Oct;61(10):1484-1490. doi: 10.2967/jnumed.119.238071. Epub 2020 Feb 14.,Beheshti M,https://www.ncbi.nlm.nih.gov/pubmed/32060214
9960,32436834,A Systematic Review and Meta-Analysis about the Effect of Bisphosphonates on the Risk of Skeletal-Related Event in Men with Prostate Cancer,Anticancer Agents Med Chem. 2020;20(13):1604-1612. doi: 10.2174/1871520620666200521114815.,Wu C,https://www.ncbi.nlm.nih.gov/pubmed/32436834
9962,32004582,Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer,Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):143-151. doi: 10.1016/j.ijrobp.2020.01.022. Epub 2020 Jan 28.,Rasmusson E,https://www.ncbi.nlm.nih.gov/pubmed/32004582
9963,31479563,Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial,BJU Int. 2020 Feb;125(2):226-233. doi: 10.1111/bju.14905. Epub 2019 Sep 27.,Allott EH,https://www.ncbi.nlm.nih.gov/pubmed/31479563
9964,30219709,Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey,Eur Urol Focus. 2020 Mar 15;6(2):273-279. doi: 10.1016/j.euf.2018.09.002. Epub 2018 Sep 13.,Bukavina L,https://www.ncbi.nlm.nih.gov/pubmed/30219709
9965,31702061,Disparities in prostate cancer incidence and mortality rates: Solvable or not?,Prostate. 2020 Jan;80(1):3-16. doi: 10.1002/pros.23923. Epub 2019 Nov 8.,Badal S,https://www.ncbi.nlm.nih.gov/pubmed/31702061
9966,32209576,PSMA-PET/CT-avid metastatic prostate cancer to the penis,BMJ Case Rep. 2020 Mar 24;13(3):e233522. doi: 10.1136/bcr-2019-233522.,Mansbridge MM,https://www.ncbi.nlm.nih.gov/pubmed/32209576
9967,30880374,Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes' Theorem to reduce costs and improve outcomes,Health Care Manag Sci. 2020 Mar;23(1):102-116. doi: 10.1007/s10729-019-09480-6. Epub 2019 Mar 18.,Swersey AJ,https://www.ncbi.nlm.nih.gov/pubmed/30880374
9968,32049940,Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single-centre experience,Nucl Med Commun. 2020 Apr;41(4):300-307. doi: 10.1097/MNM.0000000000001164.,Gazzilli M,https://www.ncbi.nlm.nih.gov/pubmed/32049940
9969,32360668,Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?,Biochim Biophys Acta Mol Cell Res. 2020 Sep;1867(9):118731. doi: 10.1016/j.bbamcr.2020.118731. Epub 2020 Apr 29.,Braglia L,https://www.ncbi.nlm.nih.gov/pubmed/32360668
9970,31810035,Ultra-effective near-infrared Photothermal therapy for the prostate cancer Nursing care through novel intended and surface tailored photo-responsive Ga-Au@MPS nanovesicles,J Photochem Photobiol B. 2020 Jan;202:111685. doi: 10.1016/j.jphotobiol.2019.111685. Epub 2019 Nov 6.,Gu C,https://www.ncbi.nlm.nih.gov/pubmed/31810035
9971,31799745,Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens,Prostate. 2020 Feb;80(2):214-224. doi: 10.1002/pros.23935. Epub 2019 Dec 4.,Ylitalo EB,https://www.ncbi.nlm.nih.gov/pubmed/31799745
9972,31502940,Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop,J Urol. 2020 Jan;203(1):115-119. doi: 10.1097/JU.0000000000000532. Epub 2019 Sep 10.,Weinstock C,https://www.ncbi.nlm.nih.gov/pubmed/31502940
9973,32363988,Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden,Scand J Urol. 2020 Jun;54(3):227-234. doi: 10.1080/21681805.2020.1756402. Epub 2020 May 4.,Franck Lissbrant I,https://www.ncbi.nlm.nih.gov/pubmed/32363988
9974,31825470,Multifocal Extraprostatic Extension of Prostate Cancer,Am J Clin Pathol. 2020 Mar 9;153(4):548-553. doi: 10.1093/ajcp/aqz193.,Farchoukh L,https://www.ncbi.nlm.nih.gov/pubmed/31825470
9975,32375698,ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients,BMC Cancer. 2020 May 6;20(1):387. doi: 10.1186/s12885-020-06899-x.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/32375698
9976,31715513,Incidental dedifferentiated mediastinal liposarcoma on F-18-fluciclovine PET/CT,Clin Imaging. 2020 Jan;59(1):21-24. doi: 10.1016/j.clinimag.2019.08.004. Epub 2019 Sep 13.,Boatright C,https://www.ncbi.nlm.nih.gov/pubmed/31715513
9977,31897602,Navigating systemic therapy for metastatic castration-naïve prostate cancer,World J Urol. 2021 Feb;39(2):339-348. doi: 10.1007/s00345-019-03060-7. Epub 2020 Jan 2.,Kwan EM,https://www.ncbi.nlm.nih.gov/pubmed/31897602
9978,32213502,Adenocarcinoma of an ileal conduit developing 8 years after cystoprostatectomy for locally advanced prostate carcinoma,BMJ Case Rep. 2020 Mar 25;13(3):e227015. doi: 10.1136/bcr-2018-227015.,Boettge KR,https://www.ncbi.nlm.nih.gov/pubmed/32213502
9979,31562225,Head-to-Head Comparison of (68)Ga-PSMA-11 with (18)F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard,J Nucl Med. 2020 Apr;61(4):527-532. doi: 10.2967/jnumed.119.234187. Epub 2019 Sep 27.,Kuten J,https://www.ncbi.nlm.nih.gov/pubmed/31562225
9980,32068492,Tumor Location and Pathological Features of Latent and Incidental Prostate Cancer in Contemporary Japanese Men,J Urol. 2020 Aug;204(2):267-272. doi: 10.1097/JU.0000000000000804. Epub 2020 Feb 18.,Inaba H,https://www.ncbi.nlm.nih.gov/pubmed/32068492
9982,32130741,Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines,Prostate. 2020 May;80(6):527-544. doi: 10.1002/pros.23967. Epub 2020 Mar 4.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32130741
9983,31552575,Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis,Int Urol Nephrol. 2020 Jan;52(1):87-95. doi: 10.1007/s11255-019-02294-z. Epub 2019 Sep 24.,Jin S,https://www.ncbi.nlm.nih.gov/pubmed/31552575
9984,31876300,Fast contour propagation for MR-guided prostate radiotherapy using convolutional neural networks,Med Phys. 2020 Mar;47(3):1238-1248. doi: 10.1002/mp.13994. Epub 2020 Jan 23.,Eppenhof KAJ,https://www.ncbi.nlm.nih.gov/pubmed/31876300
9986,31708295,Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up,Eur Urol. 2020 Mar;77(3):311-317. doi: 10.1016/j.eururo.2019.10.007. Epub 2019 Nov 8.,Klotz L,https://www.ncbi.nlm.nih.gov/pubmed/31708295
9987,31651227,African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study,J Urol. 2020 Apr;203(4):727-733. doi: 10.1097/JU.0000000000000621. Epub 2019 Oct 25.,Schenk JM,https://www.ncbi.nlm.nih.gov/pubmed/31651227
9988,31801152,Effect of Preoperative Dutasteride on Holmium Laser Enucleation of the Prostate,Urol Int. 2020;104(5-6):356-360. doi: 10.1159/000504265. Epub 2019 Dec 4.,Shigemura K,https://www.ncbi.nlm.nih.gov/pubmed/31801152
9989,32268338,Examined and Positive Lymph Node Counts Are Associated with Mortality in Prostate Cancer: A Population-Based Analysis,Urol Int. 2020;104(9-10):699-709. doi: 10.1159/000505410. Epub 2020 Apr 8.,Kamel MG,https://www.ncbi.nlm.nih.gov/pubmed/32268338
9990,31613683,Sex Hormones and Prostate Cancer,Annu Rev Med. 2020 Jan 27;71:33-45. doi: 10.1146/annurev-med-051418-060357. Epub 2019 Oct 15.,Auchus RJ,https://www.ncbi.nlm.nih.gov/pubmed/31613683
9991,31305891,Circulating mRNA signature as a marker for high-risk prostate cancer,Carcinogenesis. 2020 Apr 22;41(2):139-145. doi: 10.1093/carcin/bgz129.,Souza MF,https://www.ncbi.nlm.nih.gov/pubmed/31305891
9992,31558364,An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients,Urol Oncol. 2020 Feb;38(2):39.e1-39.e9. doi: 10.1016/j.urolonc.2019.08.017. Epub 2019 Sep 24.,Jeyapala R,https://www.ncbi.nlm.nih.gov/pubmed/31558364
9993,31937920,Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer,Nat Rev Urol. 2020 Feb;17(2):107-118. doi: 10.1038/s41585-019-0272-5. Epub 2020 Jan 14.,Siva S,https://www.ncbi.nlm.nih.gov/pubmed/31937920
9994,31529265,(68)Ga-PSMA I&T PET/CT for primary staging of prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):168-177. doi: 10.1007/s00259-019-04524-z. Epub 2019 Sep 16.,Cytawa W,https://www.ncbi.nlm.nih.gov/pubmed/31529265
9995,32250727,Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on (18)F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer,J Urol. 2020 Sep;204(3):496-502. doi: 10.1097/JU.0000000000001064. Epub 2020 Apr 6.,Markowski MC,https://www.ncbi.nlm.nih.gov/pubmed/32250727
9996,31868997,"United in Fight against prOstate cancer (UFO) registry: first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia",BJU Int. 2020 Apr;125(4):541-552. doi: 10.1111/bju.14980. Epub 2020 Jan 30.,Uemura H,https://www.ncbi.nlm.nih.gov/pubmed/31868997
9997,32187729,Influence of short-term dexamethasone on the efficacy of (177) Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer,Prostate. 2020 May;80(8):619-631. doi: 10.1002/pros.23974. Epub 2020 Mar 18.,Derlin T,https://www.ncbi.nlm.nih.gov/pubmed/32187729
9999,31642740,"Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer",J Urol. 2020 Apr;203(4):706-712. doi: 10.1097/JU.0000000000000617. Epub 2019 Oct 23.,Bjurlin MA,https://www.ncbi.nlm.nih.gov/pubmed/31642740
10000,31836681,Histologically Confirmed Diagnostic Efficacy of (18)F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer,J Nucl Med. 2020 May;61(5):710-715. doi: 10.2967/jnumed.119.234906. Epub 2019 Dec 13.,Kroenke M,https://www.ncbi.nlm.nih.gov/pubmed/31836681
10001,32444374,(68)Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer,J Nucl Med. 2021 Feb;62(2):214-220. doi: 10.2967/jnumed.120.245605. Epub 2020 May 22.,Klingenberg S,https://www.ncbi.nlm.nih.gov/pubmed/32444374
10003,31129776,Fast prostate retrieval in robot-assisted laparoscopic prostatectomy for next-generation biobanking,J Robot Surg. 2020 Apr;14(2):271-274. doi: 10.1007/s11701-019-00974-7. Epub 2019 May 25.,Petas A,https://www.ncbi.nlm.nih.gov/pubmed/31129776
10004,31719100,Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer,Cancer Res. 2020 Jan 15;80(2):156-162. doi: 10.1158/0008-5472.CAN-19-0201. Epub 2019 Nov 12.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/31719100
10007,30312191,A Patient Decision Aid for Men With Localized Prostate Cancer: A Comparative Case Study of Natural Implementation Approaches,Cancer Nurs. 2020 Jan/Feb;43(1):E10-E21. doi: 10.1097/NCC.0000000000000651.,Stacey D,https://www.ncbi.nlm.nih.gov/pubmed/30312191
10008,32096678,Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer,J Urol. 2020 Sep;204(3):416-426. doi: 10.1097/JU.0000000000000809. Epub 2020 Feb 25.,Saad F,https://www.ncbi.nlm.nih.gov/pubmed/32096678
10010,31977495,Comparison of Diagnostic Utility of Fluciclovine PET/CT Versus Pelvic Multiparametric MRI for Prostate Cancer in the Pelvis in the Setting of Rising PSA After Initial Treatment,Clin Nucl Med. 2020 May;45(5):349-355. doi: 10.1097/RLU.0000000000002963.,Chen B,https://www.ncbi.nlm.nih.gov/pubmed/31977495
10011,31789910,Imaging of Prostate Cancer Recurrence in the Vas Deferens With 68Ga-PSMA PET/CT,Clin Nucl Med. 2020 Jan;45(1):49-51. doi: 10.1097/RLU.0000000000002837.,Priftakis D,https://www.ncbi.nlm.nih.gov/pubmed/31789910
10013,32750695,Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study,Urol Int. 2020;104(9-10):684-691. doi: 10.1159/000509974. Epub 2020 Aug 4.,Çelen S,https://www.ncbi.nlm.nih.gov/pubmed/32750695
10014,31956888,Curcumin derivatives as photosensitizers in photodynamic therapy: photophysical properties and in vitro studies with prostate cancer cells,Photochem Photobiol Sci. 2020 Feb 19;19(2):193-206. doi: 10.1039/c9pp00375d.,Kazantzis KT,https://www.ncbi.nlm.nih.gov/pubmed/31956888
10016,31846064,Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer,Int J Cancer. 2020 Aug 15;147(4):1228-1234. doi: 10.1002/ijc.32832. Epub 2020 Jan 2.,Ersvaer E,https://www.ncbi.nlm.nih.gov/pubmed/31846064
10018,31935026,Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial,JAMA. 2020 Jan 14;323(2):140-148. doi: 10.1001/jama.2019.20207.,Parsons JK,https://www.ncbi.nlm.nih.gov/pubmed/31935026
10019,32451781,Transient renal dysfunction due to rhabdomyolysis after robot-assisted radical prostatectomy,Int Urol Nephrol. 2020 Oct;52(10):1877-1884. doi: 10.1007/s11255-020-02500-3. Epub 2020 May 25.,Onagi A,https://www.ncbi.nlm.nih.gov/pubmed/32451781
10020,32486483,Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential,Cells. 2020 May 31;9(6):1362. doi: 10.3390/cells9061362.,Bjerre MT,https://www.ncbi.nlm.nih.gov/pubmed/32486483
10021,32062682,Radioligand therapy using [(177)Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis,Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2106-2112. doi: 10.1007/s00259-020-04703-3. Epub 2020 Feb 16.,Seifert R,https://www.ncbi.nlm.nih.gov/pubmed/32062682
10022,32159858,Intratumoral heterogeneity and genetic characteristics of prostate cancer,Int J Cancer. 2020 Jun 15;146(12):3369-3378. doi: 10.1002/ijc.32961. Epub 2020 Mar 25.,Wu B,https://www.ncbi.nlm.nih.gov/pubmed/32159858
10023,31911608,Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy,Nat Commun. 2020 Jan 7;11(1):52. doi: 10.1038/s41467-019-13950-4.,Affronti HC,https://www.ncbi.nlm.nih.gov/pubmed/31911608
10024,32314028,(68)Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy,Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2804-2815. doi: 10.1007/s00259-020-04809-8. Epub 2020 Apr 20.,Deandreis D,https://www.ncbi.nlm.nih.gov/pubmed/32314028
10025,31324713,An (18)F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with (18)F-JK-PSMA-7 During the First Year of Application,J Nucl Med. 2020 Feb;61(2):202-209. doi: 10.2967/jnumed.119.229542. Epub 2019 Jul 19.,Dietlein F,https://www.ncbi.nlm.nih.gov/pubmed/31324713
10026,32142780,Bulging Tumor in the Distal Rectum,Gastroenterology. 2020 Jun;158(8):2061-2062. doi: 10.1053/j.gastro.2020.02.049. Epub 2020 Mar 4.,Huang CS,https://www.ncbi.nlm.nih.gov/pubmed/32142780
10028,31690449,Can the addition of clinical information improve the accuracy of PI-RADS version 2 for the diagnosis of clinically significant prostate cancer in positive MRI?,Clin Radiol. 2020 Feb;75(2):157.e1-157.e7. doi: 10.1016/j.crad.2019.09.139. Epub 2019 Nov 2.,Polanec SH,https://www.ncbi.nlm.nih.gov/pubmed/31690449
10029,32152437,Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):69-76. doi: 10.1038/s41391-020-0218-2. Epub 2020 Mar 9.,Finelli A,https://www.ncbi.nlm.nih.gov/pubmed/32152437
10031,31733635,Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naïve Japanese men compared with the standard biopsy,Int J Urol. 2020 Feb;27(2):140-146. doi: 10.1111/iju.14149. Epub 2019 Nov 16.,Fujii S,https://www.ncbi.nlm.nih.gov/pubmed/31733635
10032,32067075,Buccal mucosal graft urethroplasty for radiation-induced urethral strictures: an evaluation using the extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM),World J Urol. 2020 Nov;38(11):2863-2872. doi: 10.1007/s00345-020-03102-5. Epub 2020 Feb 18.,Vetterlein MW,https://www.ncbi.nlm.nih.gov/pubmed/32067075
10033,31977388,Metastatic Hormone-Sensitive Prostate Cancer: A Review of the Current Treatment Landscape,Cancer J. 2020 Jan/Feb;26(1):64-75. doi: 10.1097/PPO.0000000000000418.,Kinsey EN,https://www.ncbi.nlm.nih.gov/pubmed/31977388
10034,31692438,Efficacy and Safety of Non-Steroidal Anti-Androgens in Patients with Metastatic Prostate Cancer: Meta-Analysis of Randomized Controlled Trials,Rev Recent Clin Trials. 2020;15(1):34-47. doi: 10.2174/1574887114666191105152404.,Rashid M,https://www.ncbi.nlm.nih.gov/pubmed/31692438
10036,31991418,Predictive Factors of the Risk of Long-Term Hospital Readmission after Primary Prostate Surgery at a Single Tertiary Referral Center: Preliminary Report,Urol Int. 2020;104(5-6):465-475. doi: 10.1159/000505409. Epub 2020 Jan 28.,Tafuri A,https://www.ncbi.nlm.nih.gov/pubmed/31991418
10037,31713349,Real-world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer: The Singapore experience,Asia Pac J Clin Oncol. 2020 Feb;16(1):75-79. doi: 10.1111/ajco.13241. Epub 2019 Nov 11.,Chan J,https://www.ncbi.nlm.nih.gov/pubmed/31713349
10039,31977466,"99mTc-HDP Bone Scintigraphy, SPECT/CT, and 18F-FDG PET/CT Diagnosis Imaging of Incidental Pleural Mesothelioma in a Patient With Biochemical Recurrences of Prostate Cancer: Is it Really a Coincidence?",Clin Nucl Med. 2020 Mar;45(3):e148-e150. doi: 10.1097/RLU.0000000000002908.,Fernández-Rodríguez P,https://www.ncbi.nlm.nih.gov/pubmed/31977466
10040,31910120,Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine?,Radiat Res. 2020 Mar;193(3):199-208. doi: 10.1667/RR15553.1. Epub 2020 Jan 7.,Prasanna PGS,https://www.ncbi.nlm.nih.gov/pubmed/31910120
10041,31714366,"In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?",Nucl Med Commun. 2020 Feb;41(2):139-146. doi: 10.1097/MNM.0000000000001110.,Kulkarni SC,https://www.ncbi.nlm.nih.gov/pubmed/31714366
10042,32201320,Electromagnetic Transponder Localization and Real-Time Tracking for Prostate Cancer Radiation Therapy: Clinical Impact of Metallic Hip Prostheses,Pract Radiat Oncol. 2020 Nov-Dec;10(6):e538-e542. doi: 10.1016/j.prro.2020.03.003. Epub 2020 Mar 19.,Bottero M,https://www.ncbi.nlm.nih.gov/pubmed/32201320
10043,31065839,Exploring the impact of providing men with information about potential prostate cancer treatment options prior to receiving biopsy results,Support Care Cancer. 2020 Feb;28(2):507-514. doi: 10.1007/s00520-019-04847-5. Epub 2019 May 8.,Pillay B,https://www.ncbi.nlm.nih.gov/pubmed/31065839
10044,31669134,Parameters of 2-Dimensional Perineal Ultrasonography Before and After Male Sling Procedure for Urinary Incontinence After Radical Prostatectomy,Urology. 2020 Feb;136:257-262. doi: 10.1016/j.urology.2019.10.004. Epub 2019 Oct 24.,Costa Cruz DSLD,https://www.ncbi.nlm.nih.gov/pubmed/31669134
10045,32483440,Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with (68)Ga-PSMA-11-PET,Theranostics. 2020 May 15;10(14):6082-6094. doi: 10.7150/thno.44584. eCollection 2020.,Ferraro DA,https://www.ncbi.nlm.nih.gov/pubmed/32483440
10047,32003362,Lower urinary tract symptoms in patients with advanced prostate cancer: What are the outcomes of androgen deprivation therapy?,Niger Postgrad Med J. 2020 Jan-Mar;27(1):49-53. doi: 10.4103/npmj.npmj_146_19.,Akpayak IC,https://www.ncbi.nlm.nih.gov/pubmed/32003362
10048,31411963,Neutrophil-to-lymphocyte Ratio as a Predictive Marker of Response to Abiraterone Acetate: A Retrospective Analysis of the COU302 Study,Eur Urol Oncol. 2020 Jun;3(3):298-305. doi: 10.1016/j.euo.2019.01.009. Epub 2019 Jan 31.,Loubersac T,https://www.ncbi.nlm.nih.gov/pubmed/31411963
10049,31456317,Fully automated localization of prostate peripheral zone tumors on apparent diffusion coefficient map MR images using an ensemble learning method,J Magn Reson Imaging. 2020 Apr;51(4):1223-1234. doi: 10.1002/jmri.26913. Epub 2019 Aug 28.,Zabihollahy F,https://www.ncbi.nlm.nih.gov/pubmed/31456317
10052,32347457,Identification and Design of a Next-Generation Multi Epitopes Bases Peptide Vaccine Candidate Against Prostate Cancer: An In Silico Approach,Cell Biochem Biophys. 2020 Dec;78(4):495-509. doi: 10.1007/s12013-020-00912-7. Epub 2020 Apr 28.,Patra P,https://www.ncbi.nlm.nih.gov/pubmed/32347457
10053,31757845,Diagnostic Value of (68)Ga-PSMA PET/CT for Detection of Phosphatase and Tensin Homolog Expression in Prostate Cancer: A Pilot Study,J Nucl Med. 2020 Jun;61(6):873-880. doi: 10.2967/jnumed.119.236059. Epub 2019 Nov 22.,Wang B,https://www.ncbi.nlm.nih.gov/pubmed/31757845
10055,31711737,Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):175-180. doi: 10.1016/j.clon.2019.10.006. Epub 2019 Nov 8.,Tree AC,https://www.ncbi.nlm.nih.gov/pubmed/31711737
10056,31875956,A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population,Int J Cancer. 2020 Aug 15;147(4):1143-1151. doi: 10.1002/ijc.32851. Epub 2020 Jan 21.,Badrising SK,https://www.ncbi.nlm.nih.gov/pubmed/31875956
10057,31956009,Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer,Clin Genitourin Cancer. 2020 Apr;18(2):e157-e166. doi: 10.1016/j.clgc.2019.09.020. Epub 2019 Sep 26.,Garje R,https://www.ncbi.nlm.nih.gov/pubmed/31956009
10058,30918223,Analysis of Diffusion-weighted MR Images Based on a Gamma Distribution Model to Differentiate Prostate Cancers with Different Gleason Score,Magn Reson Med Sci. 2020 Feb 10;19(1):40-47. doi: 10.2463/mrms.mp.2018-0124. Epub 2019 Mar 26.,Tomita H,https://www.ncbi.nlm.nih.gov/pubmed/30918223
10059,32219979,Tumour location determined by preoperative MRI is an independent predictor for positive surgical margin status after Retzius-sparing robot-assisted radical prostatectomy,BJU Int. 2020 Jul;126(1):152-158. doi: 10.1111/bju.15060. Epub 2020 Apr 17.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32219979
10061,32182086,"Long noncoding RNA CRNDE promotes proliferation, migration and invasion in prostate cancer through miR-101/Rap1A",Neoplasma. 2020 May;67(3):584-594. doi: 10.4149/neo_2020_190621N534. Epub 2020 Mar 18.,Chen JH,https://www.ncbi.nlm.nih.gov/pubmed/32182086
10063,31243870,Experiences of a nutrition intervention-A qualitative study within a randomised controlled trial in men undergoing radiotherapy for prostate cancer,Nutr Diet. 2020 Apr;77(2):223-230. doi: 10.1111/1747-0080.12564. Epub 2019 Jun 27.,Forslund M,https://www.ncbi.nlm.nih.gov/pubmed/31243870
10064,32271960,"Corpora amylacea in benign prostatic acini are associated with concurrent, predominantly low-grade cancer",Prostate. 2020 Jun;80(9):687-697. doi: 10.1002/pros.23980. Epub 2020 Apr 9.,Palangmonthip W,https://www.ncbi.nlm.nih.gov/pubmed/32271960
10065,32003204,Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients,Minerva Urol Nephrol. 2021 Aug;73(4):471-480. doi: 10.23736/S2724-6051.19.03564-1. Epub 2020 Jan 29.,Porcaro AB,https://www.ncbi.nlm.nih.gov/pubmed/32003204
10066,31899150,Identification of Differential Patterns of Oxidative Biomarkers in Prostate Cancer Progression,Clin Genitourin Cancer. 2020 Apr;18(2):e174-e179. doi: 10.1016/j.clgc.2019.09.014. Epub 2019 Sep 26.,Wu T,https://www.ncbi.nlm.nih.gov/pubmed/31899150
10067,32319003,Percutaneous nephrostomy in obstructing pelvic malignancy does not facilitate further oncological treatment,Int Urol Nephrol. 2020 Sep;52(9):1625-1628. doi: 10.1007/s11255-020-02466-2. Epub 2020 Apr 22.,Folkard SS,https://www.ncbi.nlm.nih.gov/pubmed/32319003
10068,31813086,Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer,Adv Ther. 2020 Jan;37(1):501-511. doi: 10.1007/s12325-019-01156-5. Epub 2019 Dec 7.,Chowdhury S,https://www.ncbi.nlm.nih.gov/pubmed/31813086
10069,32036374,Institutional Adoption and Apprenticeship of Fusion Targeted Prostate Biopsy: Does Experience Affect the Cancer Detection Rate?,Urol Int. 2020;104(5-6):476-482. doi: 10.1159/000505654. Epub 2020 Feb 7.,Berg S,https://www.ncbi.nlm.nih.gov/pubmed/32036374
10070,31914846,Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men,Scand J Urol. 2020 Feb;54(1):7-13. doi: 10.1080/21681805.2019.1711161. Epub 2020 Jan 9.,Knaapila J,https://www.ncbi.nlm.nih.gov/pubmed/31914846
10071,32065165,Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts,J Vis Exp. 2020 Feb 3;(156). doi: 10.3791/60367.,Lee S,https://www.ncbi.nlm.nih.gov/pubmed/32065165
10072,31601518,Combined clinical characteristics and multiparametric MRI parameters for prediction of cribriform morphology in intermediate-risk prostate cancer patients,Urol Oncol. 2020 Apr;38(4):216-224. doi: 10.1016/j.urolonc.2019.09.002. Epub 2019 Oct 7.,Gao J,https://www.ncbi.nlm.nih.gov/pubmed/31601518
10073,32407168,Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/?-Catenin Pathway,Cancer Biother Radiopharm. 2020 Nov;35(9):682-695. doi: 10.1089/cbr.2019.3479. Epub 2020 May 14.,Song X,https://www.ncbi.nlm.nih.gov/pubmed/32407168
10074,32043634,Exercise training improves radiotherapy efficiency in a murine model of prostate cancer,FASEB J. 2020 Apr;34(4):4984-4996. doi: 10.1096/fj.201901728R. Epub 2020 Feb 11.,Dufresne S,https://www.ncbi.nlm.nih.gov/pubmed/32043634
10075,32112501,Dose-Dependent Increases in Ellagitannin Metabolites as Biomarkers of Intake in Humans Consuming Standardized Black Raspberry Food Products Designed for Clinical Trials,Mol Nutr Food Res. 2020 May;64(10):e1900800. doi: 10.1002/mnfr.201900800. Epub 2020 Mar 17.,Roberts KM,https://www.ncbi.nlm.nih.gov/pubmed/32112501
10077,33370412,The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients,PLoS One. 2020 Dec 28;15(12):e0244663. doi: 10.1371/journal.pone.0244663. eCollection 2020.,Gevaert T,https://www.ncbi.nlm.nih.gov/pubmed/33370412
10078,32149569,Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation,Int J Radiat Biol. 2020 Jun;96(6):823-835. doi: 10.1080/09553002.2020.1739774. Epub 2020 Mar 23.,Petragnano F,https://www.ncbi.nlm.nih.gov/pubmed/32149569
10080,31733274,Renal Pelvis Metastasis From Prostatic Adenocarcinoma Missed by PSMA PET: A Case Report,Urology. 2020 Feb;136:e3-e4. doi: 10.1016/j.urology.2019.11.005. Epub 2019 Nov 14.,Zhang F,https://www.ncbi.nlm.nih.gov/pubmed/31733274
10081,30941562,"A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients",World J Urol. 2020 Jan;38(1):111-119. doi: 10.1007/s00345-019-02741-7. Epub 2019 Apr 3.,Shore N,https://www.ncbi.nlm.nih.gov/pubmed/30941562
10082,31972568,Systemic Management for Nonmetastatic Castration-resistant Prostate Cancer: A Systematic Review and Network Meta-Analysis,Am J Clin Oncol. 2020 Apr;43(4):288-297. doi: 10.1097/COC.0000000000000660.,Liu Z,https://www.ncbi.nlm.nih.gov/pubmed/31972568
10083,32242253,(68)Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series,Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2624-2632. doi: 10.1007/s00259-020-04783-1. Epub 2020 Apr 2.,Olde Heuvel J,https://www.ncbi.nlm.nih.gov/pubmed/32242253
10085,32631766,Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?,Clin Genitourin Cancer. 2020 Dec;18(6):425-428. doi: 10.1016/j.clgc.2020.05.003. Epub 2020 May 11.,Adashek JJ,https://www.ncbi.nlm.nih.gov/pubmed/32631766
10086,32144327,Second-line Hormonal Therapy for the Management of Metastatic Castration-resistant Prostate Cancer: a Real-World Data Study Using a Claims Database,Sci Rep. 2020 Mar 6;10(1):4240. doi: 10.1038/s41598-020-61235-4.,Liu JM,https://www.ncbi.nlm.nih.gov/pubmed/32144327
10087,32234886,Nucleolin and Nucleophosmin Expression in Gleason 3 and Gleason 4 Prostate Cancer With Seminal Vesicles Invasion (pT3b),Anticancer Res. 2020 Apr;40(4):1973-1979. doi: 10.21873/anticanres.14152.,Masiuk M,https://www.ncbi.nlm.nih.gov/pubmed/32234886
10089,31809312,KPNA2/ERG Coexpression is Associated With Early Recurrence in Advanced Prostate Cancers,Appl Immunohistochem Mol Morphol. 2020 Jan;28(1):62-66. doi: 10.1097/PAI.0000000000000706.,D'Antonio A,https://www.ncbi.nlm.nih.gov/pubmed/31809312
10090,31635491,Examining the technical feasibility of prostate cancer molecular imaging by transrectal photoacoustic tomography with transurethral illumination,Exp Biol Med (Maywood). 2020 Feb;245(4):313-320. doi: 10.1177/1535370219884356. Epub 2019 Oct 21.,Zhang H,https://www.ncbi.nlm.nih.gov/pubmed/31635491
10091,32081564,Lower postoperative natural killer cell activity is associated with positive surgical margins after radical prostatectomy,J Formos Med Assoc. 2020 Nov;119(11):1673-1683. doi: 10.1016/j.jfma.2019.12.015. Epub 2020 Feb 17.,Lu YC,https://www.ncbi.nlm.nih.gov/pubmed/32081564
10093,31210145,Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review,Asian J Androl. 2020 Mar-Apr;22(2):200-207. doi: 10.4103/aja.aja_45_19.,Kong DP,https://www.ncbi.nlm.nih.gov/pubmed/31210145
10094,31411968,A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk,Eur Urol Oncol. 2020 Jun;3(3):262-269. doi: 10.1016/j.euo.2019.03.005. Epub 2019 Mar 29.,Miah S,https://www.ncbi.nlm.nih.gov/pubmed/31411968
10095,31560227,Effects of a Laxation and Probiotic Bowel Preparation Regimen: A Randomized Controlled Trial in Patients Undergoing Prostate Radiation Therapy,Nutr Cancer. 2020;72(6):999-1003. doi: 10.1080/01635581.2019.1669675. Epub 2019 Sep 27.,Weston N,https://www.ncbi.nlm.nih.gov/pubmed/31560227
10096,31628216,Prospective Evaluation of (18)F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management,J Nucl Med. 2020 Apr;61(4):546-551. doi: 10.2967/jnumed.119.231654. Epub 2019 Oct 18.,Song H,https://www.ncbi.nlm.nih.gov/pubmed/31628216
10097,31280463,Visualization of peri-prostatic neurovascular fibers before and after radical prostatectomy by means of diffusion tensor imaging (DTI) with clinical correlations: preliminary report,J Robot Surg. 2020 Apr;14(2):357-363. doi: 10.1007/s11701-019-00998-z. Epub 2019 Jul 6.,Siracusano S,https://www.ncbi.nlm.nih.gov/pubmed/31280463
10098,32049721,Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer: One Center Results,Clin Nucl Med. 2020 Apr;45(4):288-291. doi: 10.1097/RLU.0000000000002942.,Özkan A,https://www.ncbi.nlm.nih.gov/pubmed/32049721
10099,31801961,"Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer",Mod Pathol. 2020 May;33(5):905-915. doi: 10.1038/s41379-019-0418-2. Epub 2019 Dec 4.,Ersvær E,https://www.ncbi.nlm.nih.gov/pubmed/31801961
10100,32671996,A feasibility study of a psycho-educational support intervention for men with prostate cancer on active surveillance,Cancer Rep (Hoboken). 2020 Apr;3(2):e1230. doi: 10.1002/cnr2.1230. Epub 2019 Dec 9.,Hughes JG,https://www.ncbi.nlm.nih.gov/pubmed/32671996
10101,32098770,"Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators",Clin Cancer Res. 2020 Jul 1;26(13):3079-3090. doi: 10.1158/1078-0432.CCR-19-2744. Epub 2020 Feb 25.,Huh JW,https://www.ncbi.nlm.nih.gov/pubmed/32098770
10102,32053990,Beyond PSA: The Role of Prostate Health Index (phi),Int J Mol Sci. 2020 Feb 11;21(4):1184. doi: 10.3390/ijms21041184.,Ferro M,https://www.ncbi.nlm.nih.gov/pubmed/32053990
10103,32094489,Androgen receptor variant-driven prostate cancer II: advances in clinical investigation,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):367-380. doi: 10.1038/s41391-020-0215-5. Epub 2020 Feb 24.,Brown LC,https://www.ncbi.nlm.nih.gov/pubmed/32094489
10104,32387546,Improving 3D ultrasound prostate localisation in radiotherapy through increased automation of interfraction matching,Radiother Oncol. 2020 Aug;149:134-141. doi: 10.1016/j.radonc.2020.04.044. Epub 2020 May 6.,Grimwood A,https://www.ncbi.nlm.nih.gov/pubmed/32387546
10105,31900963,"The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression",BJU Int. 2020 Apr;125(4):506-514. doi: 10.1111/bju.14987. Epub 2020 Feb 12.,Bryant RJ,https://www.ncbi.nlm.nih.gov/pubmed/31900963
10106,31562226,Comparison of 3 Interpretation Criteria for (68)Ga-PSMA11 PET Based on Inter- and Intrareader Agreement,J Nucl Med. 2020 Apr;61(4):533-539. doi: 10.2967/jnumed.119.232504. Epub 2019 Sep 27.,Toriihara A,https://www.ncbi.nlm.nih.gov/pubmed/31562226
10107,31737935,Removing rician bias in diffusional kurtosis of the prostate using real-data reconstruction,Magn Reson Med. 2020 Jun;83(6):2243-2252. doi: 10.1002/mrm.28080. Epub 2019 Nov 18.,Goodburn RJ,https://www.ncbi.nlm.nih.gov/pubmed/31737935
10108,32070055,"Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in Prostate Cancer Cells",Int J Mol Sci. 2020 Feb 13;21(4):1263. doi: 10.3390/ijms21041263.,Hybel TE,https://www.ncbi.nlm.nih.gov/pubmed/32070055
10109,31986318,Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review,Crit Rev Oncol Hematol. 2020 Feb;146:102864. doi: 10.1016/j.critrevonc.2020.102864. Epub 2020 Jan 7.,Cursano MC,https://www.ncbi.nlm.nih.gov/pubmed/31986318
10111,31894256,Cancer?related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction,Int J Mol Med. 2020 Feb;45(2):485-496. doi: 10.3892/ijmm.2019.4435. Epub 2019 Dec 18.,Feng LR,https://www.ncbi.nlm.nih.gov/pubmed/31894256
10112,31953003,Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients,Urol Oncol. 2020 Jun;38(6):600.e9-600.e15. doi: 10.1016/j.urolonc.2019.11.005. Epub 2020 Jan 14.,Stangl-Kremser J,https://www.ncbi.nlm.nih.gov/pubmed/31953003
10113,31689158,New Antiandrogen Compounds Compared to Docetaxel for Metastatic Hormone Sensitive Prostate Cancer: Results from a Network Meta-Analysis,J Urol. 2020 Apr;203(4):751-759. doi: 10.1097/JU.0000000000000636. Epub 2019 Nov 5.,Marchioni M,https://www.ncbi.nlm.nih.gov/pubmed/31689158
10114,31348089,Potential Causes of False-Negative Interpretations in 68Ga-PSMA PET/CT for the Detection of Local and Recurrent Prostate Cancer: An Underexposed Issue,Clin Nucl Med. 2020 Jan;45(1):e32-e35. doi: 10.1097/RLU.0000000000002750.,Yakar D,https://www.ncbi.nlm.nih.gov/pubmed/31348089
10115,33284845,Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool,PLoS One. 2020 Dec 7;15(12):e0240039. doi: 10.1371/journal.pone.0240039. eCollection 2020.,Frendl DM,https://www.ncbi.nlm.nih.gov/pubmed/33284845
10116,32003864,Prediction of radiation-induced malfunction for cardiac implantable electronic devices (CIEDs),Med Phys. 2020 Apr;47(4):1489-1498. doi: 10.1002/mp.14057. Epub 2020 Feb 21.,Matsubara H,https://www.ncbi.nlm.nih.gov/pubmed/32003864
10117,31694438,The influence of errors in small field dosimetry on the dosimetric accuracy of treatment plans,Acta Oncol. 2020 May;59(5):511-517. doi: 10.1080/0284186X.2019.1685127. Epub 2019 Nov 7.,Lechner W,https://www.ncbi.nlm.nih.gov/pubmed/31694438
10118,31361646,18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer,Clin Nucl Med. 2020 Feb;45(2):e96-e97. doi: 10.1097/RLU.0000000000002738.,Meijer D,https://www.ncbi.nlm.nih.gov/pubmed/31361646
10119,32285285,National trends in the management of low-risk prostate cancer: analyzing the impact of Medicaid expansion in the United States,Int Urol Nephrol. 2020 Sep;52(9):1611-1615. doi: 10.1007/s11255-020-02463-5. Epub 2020 Apr 13.,Chipollini J,https://www.ncbi.nlm.nih.gov/pubmed/32285285
10120,32400341,"Folate-Targeted Polyacrylamide/Punicic Acid Nanomicelles for Flutamide Delivery in Prostate Cancer: Characterization, In Vitro Biological Evaluation, and its DFT Study",Recent Pat Nanotechnol. 2020;14(4):360-374. doi: 10.2174/1872210514666200513092614.,Mirsafaei R,https://www.ncbi.nlm.nih.gov/pubmed/32400341
10122,32224316,Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects,Radiother Oncol. 2020 Jun;147:40-49. doi: 10.1016/j.radonc.2020.02.028. Epub 2020 Mar 28.,Mylona E,https://www.ncbi.nlm.nih.gov/pubmed/32224316
10123,31433119,"Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma",Andrology. 2020 Mar;8(2):427-433. doi: 10.1111/andr.12695. Epub 2019 Aug 21.,Bisegna C,https://www.ncbi.nlm.nih.gov/pubmed/31433119
10124,32203427,"Climacturia: a comprehensive review assessing pathophysiology, prevalence, impact, and treatment options regarding the ""leak of pleasure""",Int J Impot Res. 2021 Apr;33(3):259-270. doi: 10.1038/s41443-020-0257-1. Epub 2020 Mar 17.,Mykoniatis I,https://www.ncbi.nlm.nih.gov/pubmed/32203427
10125,32678818,Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study,PLoS One. 2020 Jul 17;15(7):e0234927. doi: 10.1371/journal.pone.0234927. eCollection 2020.,Hong S,https://www.ncbi.nlm.nih.gov/pubmed/32678818
10126,32561036,Shielding implications on secondary radiation doses in prostate cancer treatment,Appl Radiat Isot. 2020 Sep;163:109163. doi: 10.1016/j.apradiso.2020.109163. Epub 2020 Apr 4.,Medeiros MPC,https://www.ncbi.nlm.nih.gov/pubmed/32561036
10127,32132072,Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer,Anticancer Res. 2020 Mar;40(3):1665-1668. doi: 10.21873/anticanres.14117.,Nguyen T,https://www.ncbi.nlm.nih.gov/pubmed/32132072
10130,32101695,"Androgen deprivation therapy: indications, methods of utilization, side effects and their management",Can J Urol. 2020 Feb;27(27 Suppl 1):11-16.,Magee DE,https://www.ncbi.nlm.nih.gov/pubmed/32101695
10131,32190957,Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration-Sensitive Prostate Cancer,Oncologist. 2020 Jul;25(7):e1042-e1050. doi: 10.1634/theoncologist.2019-0495. Epub 2020 Mar 19.,Wei Y,https://www.ncbi.nlm.nih.gov/pubmed/32190957
10132,31599113,Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer,BJU Int. 2020 Jan;125(1):49-55. doi: 10.1111/bju.14916. Epub 2019 Nov 1.,Khoo CC,https://www.ncbi.nlm.nih.gov/pubmed/31599113
10136,32366674,"Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFN?, Resulting in Pronounced Antitumor Systemic Immune Responses",Mol Cancer Res. 2020 Aug;18(8):1232-1243. doi: 10.1158/1541-7786.MCR-19-0836. Epub 2020 May 4.,Udayakumar TS,https://www.ncbi.nlm.nih.gov/pubmed/32366674
10137,32147685,Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer,Jpn J Clin Oncol. 2020 Apr 7;50(4):349-356. doi: 10.1093/jjco/hyaa004.,Tateishi U,https://www.ncbi.nlm.nih.gov/pubmed/32147685
10139,31653572,"Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer",Clin Genitourin Cancer. 2020 Feb;18(1):1-10. doi: 10.1016/j.clgc.2019.09.015. Epub 2019 Sep 26.,Zhang T,https://www.ncbi.nlm.nih.gov/pubmed/31653572
10140,32281264,Can we improve the detection rate of prostate cancer using standard 12-core TRUS-guided prostate biopsy? Focused on the location of prostate biopsy,Cancer Med. 2020 Jun;9(11):3758-3764. doi: 10.1002/cam4.2990. Epub 2020 Apr 12.,Yoo S,https://www.ncbi.nlm.nih.gov/pubmed/32281264
10143,31821185,"Prostate Cancer, Use of Androgen Deprivation Therapy, and Cognitive Impairment: A Population-based Study",Alzheimer Dis Assoc Disord. 2020 Apr-Jun;34(2):118-121. doi: 10.1097/WAD.0000000000000366.,Alonso Quiñones HJ,https://www.ncbi.nlm.nih.gov/pubmed/31821185
10144,31522863,Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer,Urol Oncol. 2020 Mar;38(3):79.e15-79.e22. doi: 10.1016/j.urolonc.2019.08.015. Epub 2019 Sep 12.,George DJ,https://www.ncbi.nlm.nih.gov/pubmed/31522863
10145,31955223,Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries,World J Urol. 2021 Feb;39(2):317-326. doi: 10.1007/s00345-019-03063-4. Epub 2020 Jan 18.,De Bruycker A,https://www.ncbi.nlm.nih.gov/pubmed/31955223
10147,32193798,Evaluation of target volume margins for radiotherapy of prostate implanted with fiducial markers,Radiol Phys Technol. 2020 Jun;13(2):152-159. doi: 10.1007/s12194-020-00563-6. Epub 2020 Mar 19.,Fawzy R,https://www.ncbi.nlm.nih.gov/pubmed/32193798
10149,32145020,Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T,J Natl Cancer Inst. 2020 Jun 1;112(6):562-573. doi: 10.1093/jnci/djaa021.,Madan RA,https://www.ncbi.nlm.nih.gov/pubmed/32145020
10150,31822799,Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer,Oncogene. 2020 Mar;39(10):2187-2201. doi: 10.1038/s41388-019-1116-8. Epub 2019 Dec 10.,Saraç H,https://www.ncbi.nlm.nih.gov/pubmed/31822799
10151,31302638,Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic Management,J Nucl Med. 2020 Jan;61(1):46-50. doi: 10.2967/jnumed.119.227637. Epub 2019 Jul 13.,Koerber SA,https://www.ncbi.nlm.nih.gov/pubmed/31302638
10152,32343628,Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy,JCO Glob Oncol. 2020 Apr;6:667-678. doi: 10.1200/JGO.19.00261.,Irabor OC,https://www.ncbi.nlm.nih.gov/pubmed/32343628
10153,31814454,"Noncanonical Wnt as a prognostic marker in prostate cancer: ""you can't always get what you Wnt""",Expert Rev Mol Diagn. 2020 Feb;20(2):245-254. doi: 10.1080/14737159.2020.1702522. Epub 2019 Dec 12.,Fisher RR,https://www.ncbi.nlm.nih.gov/pubmed/31814454
10154,32272943,MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria,Radiat Oncol. 2020 Apr 9;15(1):77. doi: 10.1186/s13014-020-01513-7.,Persson E,https://www.ncbi.nlm.nih.gov/pubmed/32272943
10155,31825529,Anatomical study of the prostatic urethra using vinyl polysiloxane casts,Prostate. 2020 Feb;80(3):241-246. doi: 10.1002/pros.23937. Epub 2019 Dec 11.,Chen H,https://www.ncbi.nlm.nih.gov/pubmed/31825529
10156,32881870,"Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells",PLoS One. 2020 Sep 3;15(9):e0226056. doi: 10.1371/journal.pone.0226056. eCollection 2020.,Singh JP,https://www.ncbi.nlm.nih.gov/pubmed/32881870
10157,31851457,"Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study",Int Braz J Urol. 2020 Jan-Feb;46(1):42-52. doi: 10.1590/S1677-5538.IBJU.2019.0225.,Johnston AW,https://www.ncbi.nlm.nih.gov/pubmed/31851457
10158,31825653,The FLASH effect depends on oxygen concentration,Br J Radiol. 2020 Feb 1;93(1106):20190702. doi: 10.1259/bjr.20190702. Epub 2019 Dec 20.,Adrian G,https://www.ncbi.nlm.nih.gov/pubmed/31825653
10159,31954695,CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo,Exp Cell Res. 2020 Mar 15;388(2):111850. doi: 10.1016/j.yexcr.2020.111850. Epub 2020 Jan 16.,Ni J,https://www.ncbi.nlm.nih.gov/pubmed/31954695
10161,31851956,Male pelvic multi-organ segmentation aided by CBCT-based synthetic MRI,Phys Med Biol. 2020 Feb 4;65(3):035013. doi: 10.1088/1361-6560/ab63bb.,Lei Y,https://www.ncbi.nlm.nih.gov/pubmed/31851956
10163,31960153,The Emerging Role of Local Therapy in Metastatic Prostate Cancer,Curr Oncol Rep. 2020 Jan 20;22(1):2. doi: 10.1007/s11912-020-0868-1.,Sundahl N,https://www.ncbi.nlm.nih.gov/pubmed/31960153
10167,32685010,Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving (177)Lu-PSMA-617 Radioligand Therapy,Theranostics. 2020 Jun 18;10(17):7645-7655. doi: 10.7150/thno.44556. eCollection 2020.,Kessel K,https://www.ncbi.nlm.nih.gov/pubmed/32685010
10169,32029552,Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer,Cancer Res. 2020 Apr 1;80(7):1564-1577. doi: 10.1158/0008-5472.CAN-18-3637. Epub 2020 Feb 6.,Cerasuolo M,https://www.ncbi.nlm.nih.gov/pubmed/32029552
10170,31734450,Enhanced radiosensitivity of LNCaP prostate cancer cell line by gold-photoactive nanoparticles modified with folic acid,Photodiagnosis Photodyn Ther. 2020 Mar;29:101602. doi: 10.1016/j.pdpdt.2019.101602. Epub 2019 Nov 14.,Changizi O,https://www.ncbi.nlm.nih.gov/pubmed/31734450
10171,33337358,Predictive clinical features for negative histopathology of MRI/Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a urologic outpatient clinic1,Clin Hemorheol Microcirc. 2020;76(4):503-511. doi: 10.3233/CH-209225.,Apfelbeck M,https://www.ncbi.nlm.nih.gov/pubmed/33337358
10173,32055749,The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer,Investig Clin Urol. 2020 Feb;61(Suppl 1):S3-S7. doi: 10.4111/icu.2020.61.S1.S3. Epub 2020 Jan 16.,Parker DC,https://www.ncbi.nlm.nih.gov/pubmed/32055749
10174,31025163,Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer,Mol Imaging Biol. 2020 Feb;22(1):85-93. doi: 10.1007/s11307-019-01354-1.,Pagoto A,https://www.ncbi.nlm.nih.gov/pubmed/31025163
10175,31468514,Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments,FEBS Lett. 2020 Jan;594(2):209-226. doi: 10.1002/1873-3468.13589. Epub 2019 Sep 17.,Packer JR,https://www.ncbi.nlm.nih.gov/pubmed/31468514
10176,31831560,"Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer",Clin Cancer Res. 2020 Apr 15;26(8):1985-1996. doi: 10.1158/1078-0432.CCR-19-2268. Epub 2019 Dec 12.,Hammer S,https://www.ncbi.nlm.nih.gov/pubmed/31831560
10177,31833179,Propensity score-matched comparison of docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant intraductal carcinoma of the prostate,BJU Int. 2020 May;125(5):702-708. doi: 10.1111/bju.14970. Epub 2019 Dec 25.,Yamamoto A,https://www.ncbi.nlm.nih.gov/pubmed/31833179
10179,32250729,Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer,J Urol. 2020 Oct;204(4):691-700. doi: 10.1097/JU.0000000000001066. Epub 2020 Apr 6.,Woo J,https://www.ncbi.nlm.nih.gov/pubmed/32250729
10181,32182733,Decreased Risk of Renal Calculi in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer,Int J Environ Res Public Health. 2020 Mar 9;17(5):1762. doi: 10.3390/ijerph17051762.,Lin CY,https://www.ncbi.nlm.nih.gov/pubmed/32182733
10182,30726506,Evidence-based approach to active surveillance of prostate cancer,World J Urol. 2020 Mar;38(3):555-562. doi: 10.1007/s00345-019-02662-5. Epub 2019 Feb 6.,Witherspoon L,https://www.ncbi.nlm.nih.gov/pubmed/30726506
10184,32057714,Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States,Clin Genitourin Cancer. 2020 Aug;18(4):284-294. doi: 10.1016/j.clgc.2019.12.019. Epub 2020 Jan 7.,George DJ,https://www.ncbi.nlm.nih.gov/pubmed/32057714
10185,32286548,Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):81-87. doi: 10.1038/s41391-020-0228-0. Epub 2020 Apr 14.,Aggarwal R,https://www.ncbi.nlm.nih.gov/pubmed/32286548
10186,32453606,"Examination of the Association Between 3,4-Divanillyltetrahydrofuran Lignan (Urtica dioica Origin) and Prostate Cancer Cells by (131)I Radiolabeling",Cancer Biother Radiopharm. 2021 May;36(4):326-332. doi: 10.1089/cbr.2020.3602. Epub 2020 May 21.,Tekin V,https://www.ncbi.nlm.nih.gov/pubmed/32453606
10187,32156598,TACC3 promotes prostate cancer cell proliferation and restrains primary cilium formation,Exp Cell Res. 2020 May 15;390(2):111952. doi: 10.1016/j.yexcr.2020.111952. Epub 2020 Mar 7.,Qie Y,https://www.ncbi.nlm.nih.gov/pubmed/32156598
10188,31263944,T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation,World J Urol. 2020 Mar;38(3):673-680. doi: 10.1007/s00345-019-02861-0. Epub 2019 Jul 1.,Cerqueira MA,https://www.ncbi.nlm.nih.gov/pubmed/31263944
10189,31706946,Analysis of Magnetic Resonance Imaging-directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis,Eur Urol Oncol. 2020 Feb;3(1):32-41. doi: 10.1016/j.euo.2019.10.001. Epub 2019 Nov 7.,Schoots IG,https://www.ncbi.nlm.nih.gov/pubmed/31706946
10190,32472278,Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies,World J Urol. 2021 Apr;39(4):1153-1159. doi: 10.1007/s00345-020-03277-x. Epub 2020 May 29.,Lantz A,https://www.ncbi.nlm.nih.gov/pubmed/32472278
10191,31364875,"Efficacy of Synbiotics to Reduce Symptoms and Rectal Inflammatory Response in Acute Radiation Proctitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial",Nutr Cancer. 2020;72(4):602-609. doi: 10.1080/01635581.2019.1647254. Epub 2019 Jul 31.,Nascimento M,https://www.ncbi.nlm.nih.gov/pubmed/31364875
10194,31810118,The role of JNK in prostate cancer progression and therapeutic strategies,Biomed Pharmacother. 2020 Jan;121:109679. doi: 10.1016/j.biopha.2019.109679. Epub 2019 Nov 24.,Xu R,https://www.ncbi.nlm.nih.gov/pubmed/31810118
10195,31980741,Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents,Oncogene. 2020 Mar;39(12):2467-2477. doi: 10.1038/s41388-020-1163-1. Epub 2020 Jan 24.,Broustas CG,https://www.ncbi.nlm.nih.gov/pubmed/31980741
10197,32205016,A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer,Ann Oncol. 2020 May;31(5):619-625. doi: 10.1016/j.annonc.2020.01.074. Epub 2020 Feb 21.,Kolinsky MP,https://www.ncbi.nlm.nih.gov/pubmed/32205016
10198,32162868,Age-Adapted Prostate Cancer Gene 3 Score Interpretation - Suggestions for Clinical Use,Clin Lab. 2020 Mar 1;66(3). doi: 10.7754/Clin.Lab.2019.190714.,Hennenlotter J,https://www.ncbi.nlm.nih.gov/pubmed/32162868
10199,32313185,Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer,Mod Pathol. 2020 Sep;33(9):1802-1810. doi: 10.1038/s41379-020-0543-y. Epub 2020 Apr 20.,Chan E,https://www.ncbi.nlm.nih.gov/pubmed/32313185
10200,32058354,PATIENT WITH UNILATERAL CHOROIDAL AND SEROUS RETINAL DETACHMENT WITH A HISTORY OF TREATED PROSTATE CANCER AND UNTREATED SARCOIDOSIS,Retin Cases Brief Rep. 2022 May 1;16(3):344-346. doi: 10.1097/ICB.0000000000000976. Epub 2020 Feb 13.,Schönbach EM,https://www.ncbi.nlm.nih.gov/pubmed/32058354
10202,32003207,The optimal core number and site for MRI-targeted biopsy of prostate? A systematic review and pooled analysis,Minerva Urol Nefrol. 2020 Apr;72(2):144-151. doi: 10.23736/S0393-2249.20.03639-5. Epub 2020 Jan 29.,Tu X,https://www.ncbi.nlm.nih.gov/pubmed/32003207
10203,32424106,"Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance",Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12315-12323. doi: 10.1073/pnas.1922207117. Epub 2020 May 18.,Alumkal JJ,https://www.ncbi.nlm.nih.gov/pubmed/32424106
10204,32236169,"Enhanced selectivity, cellular uptake, and in vitro activity of an intrinsically fluorescent copper-tirapazamine nanocomplex for hypoxia targeted therapy in prostate cancer",Biomater Sci. 2020 May 7;8(9):2420-2433. doi: 10.1039/c9bm01905g. Epub 2020 Apr 1.,Silva VL,https://www.ncbi.nlm.nih.gov/pubmed/32236169
10207,31874726,Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance,Eur Urol. 2020 Apr;77(4):501-507. doi: 10.1016/j.eururo.2019.12.009. Epub 2019 Dec 23.,Chesnut GT,https://www.ncbi.nlm.nih.gov/pubmed/31874726
10208,32088155,Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy,Eur Urol Oncol. 2021 Oct;4(5):821-825. doi: 10.1016/j.euo.2020.01.002. Epub 2020 Feb 20.,Jansen BHE,https://www.ncbi.nlm.nih.gov/pubmed/32088155
10209,33119677,Prostate cancer survivors with symptoms of radiation cystitis have elevated fibrotic and vascular proteins in urine,PLoS One. 2020 Oct 29;15(10):e0241388. doi: 10.1371/journal.pone.0241388. eCollection 2020.,Zwaans BMM,https://www.ncbi.nlm.nih.gov/pubmed/33119677
10211,32124525,Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study,BJU Int. 2020 Jul;126(1):97-103. doi: 10.1111/bju.15039. Epub 2020 Apr 6.,Berry B,https://www.ncbi.nlm.nih.gov/pubmed/32124525
10212,32366670,"Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study",Clin Cancer Res. 2020 Jul 15;26(14):3517-3524. doi: 10.1158/1078-0432.CCR-19-3402. Epub 2020 May 4.,Posadas EM,https://www.ncbi.nlm.nih.gov/pubmed/32366670
10213,31601703,Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy,J Nucl Med. 2020 May;61(5):723-728. doi: 10.2967/jnumed.119.233429. Epub 2019 Oct 10.,Seifert R,https://www.ncbi.nlm.nih.gov/pubmed/31601703
10214,32221791,Retrospective correlation of (68)ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy,Ann Nucl Med. 2020 Jun;34(6):388-396. doi: 10.1007/s12149-020-01462-x. Epub 2020 Mar 27.,Onal C,https://www.ncbi.nlm.nih.gov/pubmed/32221791
10215,31326219,"Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis",Eur Urol. 2020 Jan;77(1):78-94. doi: 10.1016/j.eururo.2019.06.023. Epub 2019 Jul 18.,Drost FH,https://www.ncbi.nlm.nih.gov/pubmed/31326219
10216,32444177,Rise in serum folate after androgen deprivation associated with worse prostate cancer-specific survival,Urol Oncol. 2020 Aug;38(8):682.e21-682.e27. doi: 10.1016/j.urolonc.2020.04.003. Epub 2020 May 20.,Liss MA,https://www.ncbi.nlm.nih.gov/pubmed/32444177
10217,32239889,Transient acantholytic dermatosis in a patient with prostate cancer,Dermatol Online J. 2020 Feb 15;26(2):13030/qt02s0n1zr.,Khan MS,https://www.ncbi.nlm.nih.gov/pubmed/32239889
10218,30832497,Orbital metastasis as presenting symptom from a prostatic adenocarcinoma,Eur J Ophthalmol. 2020 Jan;30(1):NP29-NP32. doi: 10.1177/1120672119832182. Epub 2019 Mar 4.,Pastore MR,https://www.ncbi.nlm.nih.gov/pubmed/30832497
10219,32370911,What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort,Eur Urol. 2020 Aug;78(2):163-170. doi: 10.1016/j.eururo.2020.04.029. Epub 2020 May 1.,Norris JM,https://www.ncbi.nlm.nih.gov/pubmed/32370911
10220,32195681,"Role of metabolic imaging in diagnosis of primary, metastatic, and recurrent prostate cancer",Curr Opin Oncol. 2020 May;32(3):223-231. doi: 10.1097/CCO.0000000000000625.,Hadavand MA,https://www.ncbi.nlm.nih.gov/pubmed/32195681
10221,32040781,"Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities",Int J Clin Oncol. 2020 Apr;25(4):509-520. doi: 10.1007/s10147-020-01627-8. Epub 2020 Feb 10.,Shoji S,https://www.ncbi.nlm.nih.gov/pubmed/32040781
10223,31955497,Prostate cancer in kidney transplant recipients - a nationwide register study,BJU Int. 2020 May;125(5):679-685. doi: 10.1111/bju.15002. Epub 2020 Feb 12.,Bratt O,https://www.ncbi.nlm.nih.gov/pubmed/31955497
10224,32149799,Solitary Penile Metastasis of Prostate Cancer on 18F-Fluciclovine PET/CT Imaging in a Patient With PSA of 1 ng/mL,Clin Nucl Med. 2020 May;45(5):389-391. doi: 10.1097/RLU.0000000000002987.,Salavati A,https://www.ncbi.nlm.nih.gov/pubmed/32149799
10226,32034191,"(68)Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients' disease management and adequacy of impact",Sci Rep. 2020 Feb 7;10(1):2104. doi: 10.1038/s41598-020-58975-8.,Fourquet A,https://www.ncbi.nlm.nih.gov/pubmed/32034191
10227,32424596,"ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training",Eur Radiol. 2020 Oct;30(10):5404-5416. doi: 10.1007/s00330-020-06929-z. Epub 2020 May 19.,de Rooij M,https://www.ncbi.nlm.nih.gov/pubmed/32424596
10228,31485740,Biopsy Grade Group as a reliable prognostic factor for BCR in Afro-Caribbean men with intermediate- and high-risk prostate cancer,World J Urol. 2020 Jun;38(6):1493-1499. doi: 10.1007/s00345-019-02931-3. Epub 2019 Sep 3.,Perrot E,https://www.ncbi.nlm.nih.gov/pubmed/31485740
10229,31994702,Semi-automated prediction approach of target shifts using machine learning with anatomical features between planning and pretreatment CT images in prostate radiotherapy,J Radiat Res. 2020 Mar 23;61(2):285-297. doi: 10.1093/jrr/rrz105.,Kai Y,https://www.ncbi.nlm.nih.gov/pubmed/31994702
10230,31653561,The role of salvage lymph node dissection in nonmetastatic castration-resistant prostate cancer: A single center experience,Urol Oncol. 2020 Feb;38(2):38.e9-38.e16. doi: 10.1016/j.urolonc.2019.09.016. Epub 2019 Oct 23.,Boeri L,https://www.ncbi.nlm.nih.gov/pubmed/31653561
10231,32385837,Unmet expectations in prostate cancer patients and their association with decision regret,J Cancer Surviv. 2020 Oct;14(5):731-738. doi: 10.1007/s11764-020-00888-6. Epub 2020 May 8.,Wollersheim BM,https://www.ncbi.nlm.nih.gov/pubmed/32385837
10232,31846689,Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGF?1/p-Smad2/3 signaling,Cancer Lett. 2020 Mar 1;472:151-164. doi: 10.1016/j.canlet.2019.12.014. Epub 2019 Dec 14.,Xu H,https://www.ncbi.nlm.nih.gov/pubmed/31846689
10233,32143573,Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion,Mol Med. 2020 Mar 6;26(1):24. doi: 10.1186/s10020-020-00148-4.,Fraune C,https://www.ncbi.nlm.nih.gov/pubmed/32143573
10234,31502942,Variation in Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Outcomes in Asian American Men: A Multicenter Study,J Urol. 2020 Mar;203(3):530-536. doi: 10.1097/JU.0000000000000534. Epub 2019 Sep 10.,Gross MD,https://www.ncbi.nlm.nih.gov/pubmed/31502942
10237,32172803,Radium-223 as an Approved Modality for Treatment of Bone Metastases,Semin Nucl Med. 2020 Mar;50(2):177-192. doi: 10.1053/j.semnuclmed.2019.11.005. Epub 2020 Mar 11.,Brito AE,https://www.ncbi.nlm.nih.gov/pubmed/32172803
10238,31732768,The effect of androgen deprivation therapy on (68)Ga-PSMA tracer uptake in non-metastatic prostate cancer patients,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):632-641. doi: 10.1007/s00259-019-04581-4. Epub 2019 Nov 15.,Onal C,https://www.ncbi.nlm.nih.gov/pubmed/31732768
10239,32411286,Mathematical Prostate Cancer Evolution: Effect of Immunotherapy Based on Controlled Vaccination Strategy,Comput Math Methods Med. 2020 Jan 13;2020:7970265. doi: 10.1155/2020/7970265. eCollection 2020.,Ba Dziul D,https://www.ncbi.nlm.nih.gov/pubmed/32411286
10240,32286677,Prognostic value of microRNA-20b expression level in patients with prostate cancer,Histol Histopathol. 2020 Aug;35(8):827-831. doi: 10.14670/HH-18-216. Epub 2020 Apr 14.,Zhang R,https://www.ncbi.nlm.nih.gov/pubmed/32286677
10242,32380981,Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential,BMC Cancer. 2020 May 7;20(1):398. doi: 10.1186/s12885-020-06817-1.,Miller ET,https://www.ncbi.nlm.nih.gov/pubmed/32380981
10244,32194842,Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer,Theranostics. 2020 Feb 3;10(7):2888-2896. doi: 10.7150/thno.38882. eCollection 2020.,Shen CJ,https://www.ncbi.nlm.nih.gov/pubmed/32194842
10245,32086149,Effects of MRI image normalization techniques in prostate cancer radiomics,Phys Med. 2020 Mar;71:7-13. doi: 10.1016/j.ejmp.2020.02.007. Epub 2020 Feb 18.,Isaksson LJ,https://www.ncbi.nlm.nih.gov/pubmed/32086149
10246,31175460,One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis,World J Urol. 2020 Apr;38(4):949-956. doi: 10.1007/s00345-019-02835-2. Epub 2019 Jun 7.,Tafuri A,https://www.ncbi.nlm.nih.gov/pubmed/31175460
10247,31840615,Radio-thermo-sensitivity Induced by Gold Magnetic Nanoparticles in the Monolayer Culture of Human Prostate Carcinoma Cell Line DU145,Anticancer Agents Med Chem. 2020;20(3):315-324. doi: 10.2174/1871520620666191216113052.,Rajaee Z,https://www.ncbi.nlm.nih.gov/pubmed/31840615
10248,31601564,Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer,Clin Chem. 2020 Jan 1;66(1):161-168. doi: 10.1373/clinchem.2019.310912.,Joosse SA,https://www.ncbi.nlm.nih.gov/pubmed/31601564
10249,31874108,Genomics of lethal prostate cancer at diagnosis and castration resistance,J Clin Invest. 2020 Apr 1;130(4):1743-1751. doi: 10.1172/JCI132031.,Mateo J,https://www.ncbi.nlm.nih.gov/pubmed/31874108
10250,32069895,miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression,Cells. 2020 Feb 13;9(2):435. doi: 10.3390/cells9020435.,Rotundo F,https://www.ncbi.nlm.nih.gov/pubmed/32069895
10252,31733275,Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy,Urology. 2020 Mar;137:97-101. doi: 10.1016/j.urology.2019.11.004. Epub 2019 Nov 14.,Schwarzman LS,https://www.ncbi.nlm.nih.gov/pubmed/31733275
10253,30431694,Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting,BJU Int. 2020 Feb;125(2):244-252. doi: 10.1111/bju.14620. Epub 2019 Dec 3.,Kum F,https://www.ncbi.nlm.nih.gov/pubmed/30431694
10254,31564531,Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative,Eur Urol Oncol. 2020 Feb;3(1):80-91. doi: 10.1016/j.euo.2019.08.014. Epub 2019 Sep 26.,Kalapara AA,https://www.ncbi.nlm.nih.gov/pubmed/31564531
10255,32238799,Histone demethylase JMJD1A promotes expression of DNA repair factors and radio-resistance of prostate cancer cells,Cell Death Dis. 2020 Apr 1;11(4):214. doi: 10.1038/s41419-020-2405-4.,Fan L,https://www.ncbi.nlm.nih.gov/pubmed/32238799
10256,31541653,Patient-Centered Outcomes From Multiparametric MRI and MRI-Guided Biopsy for Prostate Cancer: A Systematic Review,J Am Coll Radiol. 2020 Apr;17(4):486-495. doi: 10.1016/j.jacr.2019.08.031. Epub 2019 Sep 18.,Merriel SWD,https://www.ncbi.nlm.nih.gov/pubmed/31541653
10257,32366786,225Ac-PSMA-617 Radioligand Posttherapy Imaging in Metastatic Castrate-Resistant Prostate Cancer Patient Using 3 Photopeaks,Clin Nucl Med. 2020 Jun;45(6):437-438. doi: 10.1097/RLU.0000000000003031.,Vatsa R,https://www.ncbi.nlm.nih.gov/pubmed/32366786
10258,33125383,Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2015 and 2019 at the Uganda Cancer Institute,PLoS One. 2020 Oct 30;15(10):e0236458. doi: 10.1371/journal.pone.0236458. eCollection 2020.,Katongole P,https://www.ncbi.nlm.nih.gov/pubmed/33125383
10259,32768356,Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes,Clin Genitourin Cancer. 2020 Dec;18(6):e739-e753. doi: 10.1016/j.clgc.2020.05.008. Epub 2020 May 22.,Enikeev D,https://www.ncbi.nlm.nih.gov/pubmed/32768356
10260,31876821,68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report,Clin Nucl Med. 2020 Mar;45(3):e151-e153. doi: 10.1097/RLU.0000000000002884.,Pilati E,https://www.ncbi.nlm.nih.gov/pubmed/31876821
10261,31639200,Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts,Cancer. 2020 Feb 1;126(3):583-592. doi: 10.1002/cncr.32557. Epub 2019 Oct 22.,Lange JM,https://www.ncbi.nlm.nih.gov/pubmed/31639200
10262,31893534,Transcriptional regulation of G(2)/M regulatory proteins and perturbation of G(2)/M Cell cycle transition by a traditional Chinese medicine recipe,J Ethnopharmacol. 2020 Apr 6;251:112526. doi: 10.1016/j.jep.2019.112526. Epub 2019 Dec 29.,Hnit SST,https://www.ncbi.nlm.nih.gov/pubmed/31893534
10263,32166568,Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naïve patients,Int Urol Nephrol. 2020 Aug;52(8):1483-1490. doi: 10.1007/s11255-020-02426-w. Epub 2020 Mar 12.,Harraz AM,https://www.ncbi.nlm.nih.gov/pubmed/32166568
10265,31902714,Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization,Clin Genitourin Cancer. 2020 Jun;18(3):192-200.e2. doi: 10.1016/j.clgc.2019.11.017. Epub 2019 Dec 5.,Huynh-Le MP,https://www.ncbi.nlm.nih.gov/pubmed/31902714
10266,31306539,Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy,BJU Int. 2020 Feb;125(2):260-269. doi: 10.1111/bju.14865. Epub 2019 Aug 1.,Hansen NL,https://www.ncbi.nlm.nih.gov/pubmed/31306539
10267,31444628,(68)Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients,Cardiovasc Intervent Radiol. 2020 Jan;43(1):147-154. doi: 10.1007/s00270-019-02312-8. Epub 2019 Aug 23.,van Steenbergen TRF,https://www.ncbi.nlm.nih.gov/pubmed/31444628
10268,31770581,Self-assembling poly(ethylene glycol)-block-polylactide-cabazitaxel conjugate nanoparticles for anticancer therapy with high efficacy and low in vivo toxicity,Int J Pharm. 2020 Jan 25;574:118879. doi: 10.1016/j.ijpharm.2019.118879. Epub 2019 Nov 23.,Shuai Q,https://www.ncbi.nlm.nih.gov/pubmed/31770581
10269,31737920,Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier,Prostate. 2020 Feb;80(2):146-152. doi: 10.1002/pros.23926. Epub 2019 Nov 18.,Taylor AS,https://www.ncbi.nlm.nih.gov/pubmed/31737920
10270,31773273,"Impact of the antifermentative diet during radiotherapy for prostate cancer in elderly, SÃO Paulo, Brazil",Support Care Cancer. 2020 Jun;28(6):2969-2975. doi: 10.1007/s00520-019-05187-0. Epub 2019 Nov 27.,de Oliveira Pedron ÉL,https://www.ncbi.nlm.nih.gov/pubmed/31773273
10271,31758981,How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy,Urology. 2020 Mar;137:133-137. doi: 10.1016/j.urology.2019.11.016. Epub 2019 Nov 20.,Pepe P,https://www.ncbi.nlm.nih.gov/pubmed/31758981
10272,31848297,Aurora B Kinase Promotes CHIP-Dependent Degradation of HIF1? in Prostate Cancer Cells,Mol Cancer Ther. 2020 Apr;19(4):1008-1017. doi: 10.1158/1535-7163.MCT-19-0777. Epub 2019 Dec 17.,Biswas K,https://www.ncbi.nlm.nih.gov/pubmed/31848297
10273,31375566,Detection Rate and Localization of Prostate Cancer Recurrence Using (68)Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ? 0.5 ng/mL,J Nucl Med. 2020 Feb;61(2):194-201. doi: 10.2967/jnumed.118.225276. Epub 2019 Aug 2.,Kranzbühler B,https://www.ncbi.nlm.nih.gov/pubmed/31375566
10274,32357938,Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16,World J Surg Oncol. 2020 May 1;18(1):81. doi: 10.1186/s12957-020-01850-7.,Liao G,https://www.ncbi.nlm.nih.gov/pubmed/32357938
10275,31713278,"Circ-MTO1 correlates with favorable prognosis and inhibits cell proliferation, invasion as well as miR-17-5p expression in prostate cancer",J Clin Lab Anal. 2020 Mar;34(3):e23086. doi: 10.1002/jcla.23086. Epub 2019 Nov 11.,Hu Y,https://www.ncbi.nlm.nih.gov/pubmed/31713278
10276,31786702,MRI-targeted biopsy for detecting prostate cancer: have the guidelines changed our practices and our prostate cancer detection rate?,Int Urol Nephrol. 2020 Apr;52(4):611-618. doi: 10.1007/s11255-019-02353-5. Epub 2019 Nov 30.,Baboudjian M,https://www.ncbi.nlm.nih.gov/pubmed/31786702
10277,32389119,In situ Generated (212)Pb-PSMA Ligand in a (224)Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells,Curr Radiopharm. 2020;13(2):130-141. doi: 10.2174/1874471013666200511000532.,Stenberg VY,https://www.ncbi.nlm.nih.gov/pubmed/32389119
10278,31926808,Evaluation of intrafraction prostate motion tracking using the Clarity Autoscan system for safety margin validation,Z Med Phys. 2020 May;30(2):135-141. doi: 10.1016/j.zemedi.2019.12.004. Epub 2020 Jan 8.,Richter A,https://www.ncbi.nlm.nih.gov/pubmed/31926808
10280,32253231,Mechanistic Insights for Optimizing PSMA Radioligand Therapy,Clin Cancer Res. 2020 Jun 15;26(12):2774-2776. doi: 10.1158/1078-0432.CCR-20-0209. Epub 2020 Apr 6.,Ravi Kumar AS,https://www.ncbi.nlm.nih.gov/pubmed/32253231
10282,32201312,NF-?B signaling promotes castration-resistant prostate cancer initiation and progression,Pharmacol Ther. 2020 Jul;211:107538. doi: 10.1016/j.pharmthera.2020.107538. Epub 2020 Mar 19.,Thomas-Jardin SE,https://www.ncbi.nlm.nih.gov/pubmed/32201312
10285,31997148,Decreasing the prospect of upper extremity neuropraxia during robotic assisted laparoscopic prostatectomy: a novel technique,J Robot Surg. 2020 Oct;14(5):733-738. doi: 10.1007/s11701-020-01047-w. Epub 2020 Jan 29.,Watson MJ,https://www.ncbi.nlm.nih.gov/pubmed/31997148
10286,31614001,Response assessment using [(68) Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer,Prostate. 2020 Jan;80(1):74-82. doi: 10.1002/pros.23919. Epub 2019 Oct 15.,Grubmüller B,https://www.ncbi.nlm.nih.gov/pubmed/31614001
10287,32022514,Can natural killer cell activity help screen patients requiring a biopsy for the diagnosis of prostate cancer?,Int Braz J Urol. 2020 Mar-Apr;46(2):244-252. doi: 10.1590/S1677-5538.IBJU.2019.0268.,Tae BS,https://www.ncbi.nlm.nih.gov/pubmed/32022514
10288,32166495,Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice,Eur Radiol. 2020 Jul;30(7):4039-4049. doi: 10.1007/s00330-020-06782-0. Epub 2020 Mar 12.,Zawaideh JP,https://www.ncbi.nlm.nih.gov/pubmed/32166495
10289,32854102,Elastography Targeted Prostate Biopsy in Patients under Active Surveillance,Urol Int. 2020;104(11-12):948-953. doi: 10.1159/000509256. Epub 2020 Aug 27.,Steinwender T,https://www.ncbi.nlm.nih.gov/pubmed/32854102
10291,31822959,[(18)F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):579-591. doi: 10.1007/s00259-019-04614-y. Epub 2019 Dec 11.,Nanni C,https://www.ncbi.nlm.nih.gov/pubmed/31822959
10292,32034111,(68)Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results,J Nucl Med. 2020 Sep;61(9):1314-1319. doi: 10.2967/jnumed.119.235333. Epub 2020 Feb 7.,Liu C,https://www.ncbi.nlm.nih.gov/pubmed/32034111
10293,30882158,Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy,Urol J. 2020 Jan 26;17(1):42-49. doi: 10.22037/uj.v0i0.4735.,Shimodaira K,https://www.ncbi.nlm.nih.gov/pubmed/30882158
10294,31253744,Preclinical Evaluation of (203/212)Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer,J Nucl Med. 2020 Jan;61(1):80-88. doi: 10.2967/jnumed.119.229393. Epub 2019 Jun 28.,Banerjee SR,https://www.ncbi.nlm.nih.gov/pubmed/31253744
10295,32350606,Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication,J Cancer Res Clin Oncol. 2020 Jul;146(7):1701-1709. doi: 10.1007/s00432-020-03221-x. Epub 2020 Apr 30.,Abdelsalam RA,https://www.ncbi.nlm.nih.gov/pubmed/32350606
10297,32377272,Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer,Dis Markers. 2020 Apr 25;2020:7050146. doi: 10.1155/2020/7050146. eCollection 2020.,Marx A,https://www.ncbi.nlm.nih.gov/pubmed/32377272
10299,31651660,The Risk of Cardiovascular Disease in Prostate Cancer Patients Receiving Androgen Deprivation Therapies,Epidemiology. 2020 May;31(3):432-440. doi: 10.1097/EDE.0000000000001132.,Cardwell CR,https://www.ncbi.nlm.nih.gov/pubmed/31651660
10300,32173766,Exercise intensity prescription in cancer survivors: ventilatory and lactate thresholds are useful submaximal alternatives to VO(2peak),Support Care Cancer. 2020 Nov;28(11):5521-5528. doi: 10.1007/s00520-020-05407-y. Epub 2020 Mar 16.,Schneider J,https://www.ncbi.nlm.nih.gov/pubmed/32173766
10301,31471713,Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):192-217. doi: 10.1007/s00259-019-04475-5. Epub 2019 Aug 30.,Dizdarevic S,https://www.ncbi.nlm.nih.gov/pubmed/31471713
10302,31715025,Comparison of biological properties of [(177) Lu]Lu-ProBOMB1 and [(177) Lu]Lu-NeoBOMB1 for GRPR targeting,J Labelled Comp Radiopharm. 2020 Feb;63(2):56-64. doi: 10.1002/jlcr.3815. Epub 2020 Jan 11.,Rousseau E,https://www.ncbi.nlm.nih.gov/pubmed/31715025
10303,33685193,First experience in the Czech Republic with perirectal hydrogel injection before radiotherapy for prostate cancer,Klin Onkol. 2020 Winter;33(6):440-444.,Vik V,https://www.ncbi.nlm.nih.gov/pubmed/33685193
10304,32685011,TGF-? causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization,Theranostics. 2020 Jun 18;10(17):7656-7670. doi: 10.7150/thno.44567. eCollection 2020.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32685011
10305,31190153,(68)Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study,World J Urol. 2020 Apr;38(4):939-948. doi: 10.1007/s00345-019-02846-z. Epub 2019 Jun 12.,Petersen LJ,https://www.ncbi.nlm.nih.gov/pubmed/31190153
10306,32308757,Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with (177)Lu-PSMA radioligand therapy,Theranostics. 2020 Mar 30;10(11):4900-4902. doi: 10.7150/thno.44568. eCollection 2020.,von Eyben FE,https://www.ncbi.nlm.nih.gov/pubmed/32308757
10307,32813687,"Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series study",PLoS One. 2020 Aug 19;15(8):e0236480. doi: 10.1371/journal.pone.0236480. eCollection 2020.,Li AH,https://www.ncbi.nlm.nih.gov/pubmed/32813687
10308,32345668,Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer,Cancer Genomics Proteomics. 2020 May-Jun;17(3):271-275. doi: 10.21873/cgp.20187.,Lehrer S,https://www.ncbi.nlm.nih.gov/pubmed/32345668
10310,32454387,Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study,Cancer Treat Res Commun. 2020;24:100177. doi: 10.1016/j.ctarc.2020.100177. Epub 2020 May 24.,Natale C,https://www.ncbi.nlm.nih.gov/pubmed/32454387
10311,31552555,CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm,Radiol Med. 2020 Jan;125(1):87-97. doi: 10.1007/s11547-019-01082-0. Epub 2019 Sep 24.,Mostafaei S,https://www.ncbi.nlm.nih.gov/pubmed/31552555
10312,32166452,Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer,Strahlenther Onkol. 2020 Jul;196(7):589-597. doi: 10.1007/s00066-020-01598-9. Epub 2020 Mar 12.,Ghadjar P,https://www.ncbi.nlm.nih.gov/pubmed/32166452
10313,31750988,Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials),J Magn Reson Imaging. 2020 May;51(5):1556-1567. doi: 10.1002/jmri.26975. Epub 2019 Nov 21.,Perez IM,https://www.ncbi.nlm.nih.gov/pubmed/31750988
10314,32468165,Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng/ml improves its performance,Int Urol Nephrol. 2020 Oct;52(10):1811-1819. doi: 10.1007/s11255-020-02517-8. Epub 2020 May 28.,Stojadinovic M,https://www.ncbi.nlm.nih.gov/pubmed/32468165
10316,31020423,Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection,World J Urol. 2020 Feb;38(2):361-369. doi: 10.1007/s00345-019-02695-w. Epub 2019 Apr 24.,Merrick GS,https://www.ncbi.nlm.nih.gov/pubmed/31020423
10317,31247546,Extending the Hybrid Surgical Guidance Concept With Freehand Fluorescence Tomography,IEEE Trans Med Imaging. 2020 Jan;39(1):226-235. doi: 10.1109/TMI.2019.2924254. Epub 2019 Jun 21.,van Oosterom MN,https://www.ncbi.nlm.nih.gov/pubmed/31247546
10318,32319143,ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer,Mol Carcinog. 2020 Aug;59(8):897-907. doi: 10.1002/mc.23201. Epub 2020 Apr 22.,Chen G,https://www.ncbi.nlm.nih.gov/pubmed/32319143
10319,32384317,Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients,Am J Ther. 2020 May 5;28(4):e380-e387. doi: 10.1097/MJT.0000000000001085.,Pathak S,https://www.ncbi.nlm.nih.gov/pubmed/32384317
10320,32296034,PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer,Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y.,Luszczak S,https://www.ncbi.nlm.nih.gov/pubmed/32296034
10322,32279141,Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men,World J Urol. 2021 Jan;39(1):73-80. doi: 10.1007/s00345-020-03177-0. Epub 2020 Apr 11.,Chen R,https://www.ncbi.nlm.nih.gov/pubmed/32279141
10324,32385167,"The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study",J Nucl Med. 2021 Jan;62(1):81-87. doi: 10.2967/jnumed.120.246983. Epub 2020 May 8.,Harsini S,https://www.ncbi.nlm.nih.gov/pubmed/32385167
10325,31801153,Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies,Urol Int. 2020;104(3-4):205-213. doi: 10.1159/000504266. Epub 2019 Dec 4.,Maxeiner A,https://www.ncbi.nlm.nih.gov/pubmed/31801153
10327,32068491,Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate,J Urol. 2020 Jul;204(1):71-78. doi: 10.1097/JU.0000000000000803. Epub 2020 Feb 18.,Stuopelyte K,https://www.ncbi.nlm.nih.gov/pubmed/32068491
10328,32317750,Clinical aspects of mCRPC management in patients treated with radium-223,Sci Rep. 2020 Apr 21;10(1):6681. doi: 10.1038/s41598-020-63302-2.,Rizzini EL,https://www.ncbi.nlm.nih.gov/pubmed/32317750
10329,31995472,Iterative Label Denoising Network: Segmenting Male Pelvic Organs in CT From 3D Bounding Box Annotations,IEEE Trans Biomed Eng. 2020 Oct;67(10):2710-2720. doi: 10.1109/TBME.2020.2969608. Epub 2020 Jan 27.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/31995472
10332,32149800,Eye Symptoms in a Patient With Prostate Cancer,Clin Nucl Med. 2020 May;45(5):370-371. doi: 10.1097/RLU.0000000000002982.,Kairemo K,https://www.ncbi.nlm.nih.gov/pubmed/32149800
10333,31893532,Effect of Diaphragmatic Breathing on Procedural Anxiety During Transrectal Prostate Biopsy,Urology. 2020 Mar;137:26-32. doi: 10.1016/j.urology.2019.12.024. Epub 2019 Dec 29.,Grinberg AS,https://www.ncbi.nlm.nih.gov/pubmed/31893532
10334,32057189,"Synthesis, Labeling and Preclinical Evaluation of a Squaric Acid Containing PSMA Inhibitor Labeled with (68) Ga: A Comparison with PSMA-11 and PSMA-617",ChemMedChem. 2020 Apr 20;15(8):695-704. doi: 10.1002/cmdc.201900559. Epub 2020 Mar 19.,Greifenstein L,https://www.ncbi.nlm.nih.gov/pubmed/32057189
10335,31579967,The value of tumor markers in men with metastatic prostate cancer undergoing [(177) Lu]Lu-PSMA therapy,Prostate. 2020 Jan;80(1):17-27. doi: 10.1002/pros.23912. Epub 2019 Oct 3.,Yordanova A,https://www.ncbi.nlm.nih.gov/pubmed/31579967
10336,31932493,Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer,Clin Cancer Res. 2020 Apr 15;26(8):1965-1976. doi: 10.1158/1078-0432.CCR-19-3023. Epub 2020 Jan 13.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/31932493
10337,32393280,Clinical implementation of MRI-based organs-at-risk auto-segmentation with convolutional networks for prostate radiotherapy,Radiat Oncol. 2020 May 11;15(1):104. doi: 10.1186/s13014-020-01528-0.,Savenije MHF,https://www.ncbi.nlm.nih.gov/pubmed/32393280
10338,32478441,Patterns of infection following transrectal ultrasound-guided biopsy of the prostate in a regional New South Wales Centre,Aust J Rural Health. 2020 Jun;28(3):301-306. doi: 10.1111/ajr.12600. Epub 2020 Jun 1.,Grant A,https://www.ncbi.nlm.nih.gov/pubmed/32478441
10342,31776632,The (68)Ga/(177)Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):695-712. doi: 10.1007/s00259-019-04583-2. Epub 2019 Nov 27.,Maffey-Steffan J,https://www.ncbi.nlm.nih.gov/pubmed/31776632
10343,32220760,Performance of PI-RADS v2 assessment categories assigned prior to MR-US fusion biopsy in a new fusion biopsy program,Clin Imaging. 2020 Aug;64:29-34. doi: 10.1016/j.clinimag.2020.03.004. Epub 2020 Mar 13.,Trent GP,https://www.ncbi.nlm.nih.gov/pubmed/32220760
10344,32172796,Supply and Clinical Application of Actinium-225 and Bismuth-213,Semin Nucl Med. 2020 Mar;50(2):119-123. doi: 10.1053/j.semnuclmed.2020.02.003. Epub 2020 Feb 21.,Morgenstern A,https://www.ncbi.nlm.nih.gov/pubmed/32172796
10345,31742897,Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy,Thorac Cancer. 2020 Jan;11(1):113-119. doi: 10.1111/1759-7714.13244. Epub 2019 Nov 19.,Kuo YH,https://www.ncbi.nlm.nih.gov/pubmed/31742897
10346,31541035,Total-Body (68)Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines,J Nucl Med. 2020 Mar;61(3):405-411. doi: 10.2967/jnumed.119.230318. Epub 2019 Sep 20.,Pomykala KL,https://www.ncbi.nlm.nih.gov/pubmed/31541035
10347,32030484,Polypoidal giant cancer cells in metastatic castration-resistant prostate cancer: observations from the Michigan Legacy Tissue Program,Med Oncol. 2020 Feb 6;37(3):16. doi: 10.1007/s12032-020-1341-6.,Mannan R,https://www.ncbi.nlm.nih.gov/pubmed/32030484
10348,32312701,Prospective Evaluation of (68)Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer Diagnosis,Eur Urol Focus. 2021 Jul;7(4):764-771. doi: 10.1016/j.euf.2020.03.004. Epub 2020 Apr 17.,Lopci E,https://www.ncbi.nlm.nih.gov/pubmed/32312701
10349,31959342,A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer,Ann Oncol. 2020 Feb;31(2):257-265. doi: 10.1016/j.annonc.2019.10.025. Epub 2019 Dec 23.,Sternberg CN,https://www.ncbi.nlm.nih.gov/pubmed/31959342
10350,32476206,Predictors of prostate-specific antigen testing in men aged ?55 years: A cross-sectional study based on patient-reported outcomes,Int J Urol. 2020 Sep;27(9):711-718. doi: 10.1111/iju.14276. Epub 2020 May 31.,Leong JY,https://www.ncbi.nlm.nih.gov/pubmed/32476206
10351,31931431,Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment,Neoplasia. 2020 Feb;22(2):111-119. doi: 10.1016/j.neo.2019.12.003. Epub 2020 Jan 10.,Kregel S,https://www.ncbi.nlm.nih.gov/pubmed/31931431
10353,32444369,The Prognostic Value of Quantitative Bone SPECT/CT Before (223)Ra Treatment in Metastatic Castration-Resistant Prostate Cancer,J Nucl Med. 2021 Jan;62(1):48-54. doi: 10.2967/jnumed.119.240408. Epub 2020 May 22.,Dittmann H,https://www.ncbi.nlm.nih.gov/pubmed/32444369
10354,31940039,"Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial",JAMA Netw Open. 2020 Jan 3;3(1):e1919284. doi: 10.1001/jamanetworkopen.2019.19284.,Kovac E,https://www.ncbi.nlm.nih.gov/pubmed/31940039
10355,32312543,Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study,Eur Urol. 2020 Oct;78(4):503-511. doi: 10.1016/j.eururo.2020.03.002. Epub 2020 Apr 18.,Bosaily AE,https://www.ncbi.nlm.nih.gov/pubmed/32312543
10358,30353474,Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients,J Cancer Educ. 2020 Feb;35(1):28-35. doi: 10.1007/s13187-018-1436-3.,Kushalnagar P,https://www.ncbi.nlm.nih.gov/pubmed/30353474
10359,31586004,Assessing Radiographic Response to (223)Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients,J Nucl Med. 2020 May;61(5):671-675. doi: 10.2967/jnumed.119.231100. Epub 2019 Oct 4.,Anand A,https://www.ncbi.nlm.nih.gov/pubmed/31586004
10362,32191376,DNA Origami-Enabled Engineering of Ligand-Drug Conjugates for Targeted Drug Delivery,Small. 2020 Apr;16(16):e1904857. doi: 10.1002/smll.201904857. Epub 2020 Mar 19.,Ge Z,https://www.ncbi.nlm.nih.gov/pubmed/32191376
10363,31999376,A Pooled Analysis of Fall Incidence From Placebo-Controlled Trials of Denosumab,J Bone Miner Res. 2020 Jun;35(6):1014-1021. doi: 10.1002/jbmr.3972. Epub 2020 Apr 2.,Chotiyarnwong P,https://www.ncbi.nlm.nih.gov/pubmed/31999376
10364,31541034,Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes,J Nucl Med. 2020 Jan;61(1):70-79. doi: 10.2967/jnumed.119.229054. Epub 2019 Sep 20.,Carlos Dos Santos J,https://www.ncbi.nlm.nih.gov/pubmed/31541034
10367,32086346,Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study,Clin Cancer Res. 2020 Jun 1;26(11):2487-2496. doi: 10.1158/1078-0432.CCR-20-0394. Epub 2020 Feb 21.,Abida W,https://www.ncbi.nlm.nih.gov/pubmed/32086346
10368,32342192,Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients,Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2796-2803. doi: 10.1007/s00259-020-04827-6. Epub 2020 Apr 28.,Spohn S,https://www.ncbi.nlm.nih.gov/pubmed/32342192
10369,31987960,Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer,Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):163-171. doi: 10.1016/j.ijrobp.2019.12.040. Epub 2020 Jan 25.,Mitra A,https://www.ncbi.nlm.nih.gov/pubmed/31987960
10370,31482426,First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [(177)Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):123-135. doi: 10.1007/s00259-019-04504-3. Epub 2019 Sep 3.,Kurth J,https://www.ncbi.nlm.nih.gov/pubmed/31482426
10372,32239451,Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice,Endocrine. 2020 Jul;69(1):204-211. doi: 10.1007/s12020-020-02277-6. Epub 2020 Apr 1.,Mazziotti G,https://www.ncbi.nlm.nih.gov/pubmed/32239451
10374,32139878,Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):381-397. doi: 10.1038/s41391-020-0217-3. Epub 2020 Mar 5.,Lu C,https://www.ncbi.nlm.nih.gov/pubmed/32139878
10375,32485222,Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer,Cancer Lett. 2020 Sep 28;488:40-49. doi: 10.1016/j.canlet.2020.05.027. Epub 2020 May 30.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/32485222
10376,32222727,Baseline quality of life predicts overall survival in patients with mCRPC treated with (223)Ra-dichloride,Hell J Nucl Med. 2020 Jan-Apr;23(1):12-20. doi: 10.1967/s002449912001. Epub 2020 Mar 31.,Frantellizzi V,https://www.ncbi.nlm.nih.gov/pubmed/32222727
10377,31292755,Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country,Support Care Cancer. 2020 Apr;28(4):1703-1715. doi: 10.1007/s00520-019-04975-y. Epub 2019 Jul 10.,Ting CY,https://www.ncbi.nlm.nih.gov/pubmed/31292755
10378,32127357,ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer,Cancer Res. 2020 Jun 1;80(11):2094-2100. doi: 10.1158/0008-5472.CAN-19-3126. Epub 2020 Mar 3.,Rafiei S,https://www.ncbi.nlm.nih.gov/pubmed/32127357
10379,32414626,Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic,Eur Urol. 2020 Jul;78(1):29-42. doi: 10.1016/j.eururo.2020.04.063. Epub 2020 May 3.,Wallis CJD,https://www.ncbi.nlm.nih.gov/pubmed/32414626
10380,31773851,The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression,BJU Int. 2020 Mar;125(3):433-441. doi: 10.1111/bju.14961. Epub 2019 Dec 26.,Wollersheim BM,https://www.ncbi.nlm.nih.gov/pubmed/31773851
10382,32483206,The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer,Nat Commun. 2020 Jun 1;11(1):2689. doi: 10.1038/s41467-020-15396-5.,Wang K,https://www.ncbi.nlm.nih.gov/pubmed/32483206
10383,29661690,The History of Testosterone and the Evolution of its Therapeutic Potential,Sex Med Rev. 2020 Apr;8(2):286-296. doi: 10.1016/j.sxmr.2018.03.002. Epub 2018 Apr 13.,Morgentaler A,https://www.ncbi.nlm.nih.gov/pubmed/29661690
10384,31919866,Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [(212) Pb]Pb-NG001 for prostate cancer,J Labelled Comp Radiopharm. 2020 Mar;63(3):129-143. doi: 10.1002/jlcr.3825. Epub 2020 Jan 29.,Stenberg VY,https://www.ncbi.nlm.nih.gov/pubmed/31919866
10386,32278840,A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Oct;18(5):343-350. doi: 10.1016/j.clgc.2020.02.005. Epub 2020 Mar 6.,Hird AE,https://www.ncbi.nlm.nih.gov/pubmed/32278840
10387,32182503,3D dosimetric verification of unity MR-linac treatments by portal dosimetry,Radiother Oncol. 2020 May;146:161-166. doi: 10.1016/j.radonc.2020.02.010. Epub 2020 Mar 19.,Torres-Xirau I,https://www.ncbi.nlm.nih.gov/pubmed/32182503
10388,32323799,PLC? knockdown enhances the radiosensitivity of castration?resistant prostate cancer via the AR/PARP1/DNA?PKcs axis,Oncol Rep. 2020 May;43(5):1397-1412. doi: 10.3892/or.2020.7520. Epub 2020 Feb 26.,Pu J,https://www.ncbi.nlm.nih.gov/pubmed/32323799
10389,31630874,TERT- beyond the territory: Usage of PCR-based TERT promoter assay in defining urothelial carcinoma in a case of long-standing prostatic adenocarcinoma,Pathol Res Pract. 2020 Jan;216(1):152663. doi: 10.1016/j.prp.2019.152663. Epub 2019 Sep 21.,Mannan R,https://www.ncbi.nlm.nih.gov/pubmed/31630874
10390,31115751,Semiquantitative Parameters in PSMA-Targeted PET Imaging with [(18)F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake,Mol Imaging Biol. 2020 Feb;22(1):181-189. doi: 10.1007/s11307-019-01376-9.,Sahakyan K,https://www.ncbi.nlm.nih.gov/pubmed/31115751
10391,32001090,Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer,Bioorg Med Chem. 2020 Mar 1;28(5):115319. doi: 10.1016/j.bmc.2020.115319. Epub 2020 Jan 20.,Yao X,https://www.ncbi.nlm.nih.gov/pubmed/32001090
10393,31082867,Postoperative Venous Thromboembolism and other Complications after Anatomic Total Shoulder Arthroplasty in Patients With a History of Prostate or Breast Cancer,J Am Acad Orthop Surg. 2020 Jan 15;28(2):75-80. doi: 10.5435/JAAOS-D-18-00777.,Chen DQ,https://www.ncbi.nlm.nih.gov/pubmed/31082867
10394,32379495,Examining Absorbed Doses of Indigenously Developed (177)Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy,Cancer Biother Radiopharm. 2021 Apr;36(3):292-304. doi: 10.1089/cbr.2020.3640. Epub 2020 May 5.,Kamaldeep,https://www.ncbi.nlm.nih.gov/pubmed/32379495
10396,32469183,Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer,N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32469183
10397,31986925,Biomarkers of response to advanced prostate cancer therapy,Expert Rev Mol Diagn. 2020 Feb;20(2):195-205. doi: 10.1080/14737159.2020.1707669. Epub 2020 Jan 27.,Iacovelli R,https://www.ncbi.nlm.nih.gov/pubmed/31986925
10398,32347270,Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer,Food Funct. 2020 May 1;11(5):4114-4122. doi: 10.1039/d0fo00565g. Epub 2020 Apr 29.,Henning SM,https://www.ncbi.nlm.nih.gov/pubmed/32347270
10399,31809858,A combination drug delivery system employing thermosensitive liposomes for enhanced cell penetration and improved in vitro efficacy,Int J Pharm. 2020 Jan 25;574:118912. doi: 10.1016/j.ijpharm.2019.118912. Epub 2019 Dec 3.,Eleftheriou K,https://www.ncbi.nlm.nih.gov/pubmed/31809858
10401,32102283,Does Physical Activity Regulate Prostate Carcinogenesis and Prostate Cancer Outcomes? A Narrative Review,Int J Environ Res Public Health. 2020 Feb 24;17(4):1441. doi: 10.3390/ijerph17041441.,Capece M,https://www.ncbi.nlm.nih.gov/pubmed/32102283
10402,31446149,Indications of Online Adaptive Replanning Based On Organ Deformation,Pract Radiat Oncol. 2020 Mar-Apr;10(2):e95-e102. doi: 10.1016/j.prro.2019.08.007. Epub 2019 Aug 22.,Lim SN,https://www.ncbi.nlm.nih.gov/pubmed/31446149
10404,32340289,Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics,Int J Mol Sci. 2020 Apr 23;21(8):2991. doi: 10.3390/ijms21082991.,To PK,https://www.ncbi.nlm.nih.gov/pubmed/32340289
10405,31053567,Focal therapy for localized prostate cancer: Where do we stand?,Eur Urol Focus. 2020 Mar 15;6(2):208-211. doi: 10.1016/j.euf.2019.04.012. Epub 2019 May 1.,Nahar B,https://www.ncbi.nlm.nih.gov/pubmed/31053567
10406,32172641,The challenge of checkpoint inhibitors in prostate cancer: drugs for the many but useful to a few,Immunotherapy. 2020 Mar;12(4):219-221. doi: 10.2217/imt-2019-0221. Epub 2020 Mar 16.,F Slovin S,https://www.ncbi.nlm.nih.gov/pubmed/32172641
10407,31202786,Focal Therapy Should Not Be Considered for Men with Gleason Grade Group 3-5 Prostate Cancer,Eur Urol Focus. 2020 Mar 15;6(2):203-204. doi: 10.1016/j.euf.2019.06.005. Epub 2019 Jun 13.,Johnson DC,https://www.ncbi.nlm.nih.gov/pubmed/31202786
10408,32430583,Dosimetry and safety of (177)Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients,Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3008-3017. doi: 10.1007/s00259-020-04856-1. Epub 2020 May 20.,Paganelli G,https://www.ncbi.nlm.nih.gov/pubmed/32430583
10410,31806774,Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria,J Nucl Med. 2020 May;61(5):678-682. doi: 10.2967/jnumed.119.233817. Epub 2019 Dec 5.,Fanti S,https://www.ncbi.nlm.nih.gov/pubmed/31806774
10411,32124100,X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser,J Biol Inorg Chem. 2020 Mar;25(2):295-303. doi: 10.1007/s00775-020-01761-8. Epub 2020 Mar 2.,Bolitho EM,https://www.ncbi.nlm.nih.gov/pubmed/32124100
10413,32011889,Development of (18)F-Fluoroglycosylated PSMA-Ligands with Improved Renal Clearance Behavior,Mol Pharm. 2020 Mar 2;17(3):933-943. doi: 10.1021/acs.molpharmaceut.9b01179. Epub 2020 Feb 17.,Potemkin R,https://www.ncbi.nlm.nih.gov/pubmed/32011889
10414,32315265,Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel,Radiology. 2020 Jul;296(1):76-84. doi: 10.1148/radiol.2020190646. Epub 2020 Apr 21.,Westphalen AC,https://www.ncbi.nlm.nih.gov/pubmed/32315265
10416,32035580,Targeted and Systematic Biopsy for the Diagnosis and Management of Prostate Cancer - A Case for Lesion Targeted-Only Biopsies,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):136-143. doi: 10.1016/j.clon.2020.01.001.,Tam JO,https://www.ncbi.nlm.nih.gov/pubmed/32035580
10417,31964201,Whole grain consumption and human health: an umbrella review of observational studies,Int J Food Sci Nutr. 2020 Sep;71(6):668-677. doi: 10.1080/09637486.2020.1715354. Epub 2020 Jan 21.,Tieri M,https://www.ncbi.nlm.nih.gov/pubmed/31964201
10419,32052276,Stereotactic robot-assisted transperineal prostate biopsy under local anaesthesia and sedation: moving robotic biopsy from operating theatre to clinic,J Robot Surg. 2020 Oct;14(5):767-772. doi: 10.1007/s11701-020-01052-z. Epub 2020 Feb 12.,Yang X,https://www.ncbi.nlm.nih.gov/pubmed/32052276
10420,31937919,Tumour innervation and neurosignalling in prostate cancer,Nat Rev Urol. 2020 Feb;17(2):119-130. doi: 10.1038/s41585-019-0274-3. Epub 2020 Jan 14.,March B,https://www.ncbi.nlm.nih.gov/pubmed/31937919
10423,31617674,Prostate-specific membrane antigen for the surgical oncologist: interpreting expression beyond the prostate,ANZ J Surg. 2020 May;90(5):715-718. doi: 10.1111/ans.15479. Epub 2019 Oct 16.,Farag M,https://www.ncbi.nlm.nih.gov/pubmed/31617674
10425,31864796,Targeted and Systematic Biopsy for Diagnosis and Management of Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):144-148. doi: 10.1016/j.clon.2019.11.011. Epub 2019 Dec 18.,Chuang RJ,https://www.ncbi.nlm.nih.gov/pubmed/31864796
10427,32255671,Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy,Cancer Biother Radiopharm. 2020 Sep;35(7):497-510. doi: 10.1089/cbr.2020.3568. Epub 2020 Apr 7.,Hagemann UB,https://www.ncbi.nlm.nih.gov/pubmed/32255671
10428,32479115,Emerging Subtypes and New Treatments for Castration-Resistant Prostate Cancer,Am Soc Clin Oncol Educ Book. 2020 May;40:e319-e332. doi: 10.1200/EDBK_100025.,Carneiro BA,https://www.ncbi.nlm.nih.gov/pubmed/32479115
10429,31840434,Patient expectations of benefit from systemic treatments for metastatic prostate cancer,Cancer Med. 2020 Feb;9(3):980-987. doi: 10.1002/cam4.2783. Epub 2019 Dec 16.,Oswald LB,https://www.ncbi.nlm.nih.gov/pubmed/31840434
10430,32014960,Assessment of Factors Predicting Disease Progression in Japanese Patients With Non-Metastatic Castration-resistant Prostate Cancer,Anticancer Res. 2020 Feb;40(2):1101-1106. doi: 10.21873/anticanres.14049.,Miyake H,https://www.ncbi.nlm.nih.gov/pubmed/32014960
10431,32452656,Association between lactate dehydrogenase levels and oncologic outcomes in metastatic prostate cancer: A meta-analysis,Cancer Med. 2020 Oct;9(19):7341-7351. doi: 10.1002/cam4.3108. Epub 2020 May 26.,Li F,https://www.ncbi.nlm.nih.gov/pubmed/32452656
10432,31864524,Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression,Pathology. 2020 Feb;52(2):218-227. doi: 10.1016/j.pathol.2019.10.006. Epub 2019 Dec 18.,Tzelepi V,https://www.ncbi.nlm.nih.gov/pubmed/31864524
10433,32253585,Review article: MRI-targeted biopsies for prostate cancer diagnosis and management,World J Urol. 2021 Jan;39(1):57-63. doi: 10.1007/s00345-020-03182-3. Epub 2020 Apr 6.,Noureldin M,https://www.ncbi.nlm.nih.gov/pubmed/32253585
10434,33307509,Influence of abiraterone and enzalutamide on body composition in patients with metastatic castration resistant prostate cancer,Cancer Treat Res Commun. 2020;25:100256. doi: 10.1016/j.ctarc.2020.100256. Epub 2020 Dec 1.,Fischer S,https://www.ncbi.nlm.nih.gov/pubmed/33307509
10435,31914111,Sessile Serrated Polyposis: Not an Inherited Syndrome?,Dis Colon Rectum. 2020 Feb;63(2):183-189. doi: 10.1097/DCR.0000000000001537.,Cauley CE,https://www.ncbi.nlm.nih.gov/pubmed/31914111
10436,32088746,Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results,World J Urol. 2020 Dec;38(12):3101-3111. doi: 10.1007/s00345-020-03127-w. Epub 2020 Feb 22.,Shore N,https://www.ncbi.nlm.nih.gov/pubmed/32088746
10437,31359096,Rectal wall saline displacement for improved margin during MRI-guided cryoablation of primary and recurrent prostate cancer,Abdom Radiol (NY). 2020 Apr;45(4):1155-1161. doi: 10.1007/s00261-019-02147-4.,Lomas DJ,https://www.ncbi.nlm.nih.gov/pubmed/31359096
10438,32243728,Review of the accuracy of multi-parametric MRI prostate in detecting prostate cancer within a local reporting service,J Med Imaging Radiat Oncol. 2020 Jun;64(3):379-384. doi: 10.1111/1754-9485.13029. Epub 2020 Apr 3.,Tsai WC,https://www.ncbi.nlm.nih.gov/pubmed/32243728
10439,31954170,Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation,Urology. 2020 Apr;138:98-105. doi: 10.1016/j.urology.2020.01.005. Epub 2020 Jan 15.,Al Hussein Al Awamlh B,https://www.ncbi.nlm.nih.gov/pubmed/31954170
10440,31834623,A computer-aided diagnosis system for differentiation and delineation of malignant regions on whole-slide prostate histopathology image using spatial statistics and multidimensional DenseNet,Med Phys. 2020 Mar;47(3):1021-1033. doi: 10.1002/mp.13964. Epub 2020 Jan 6.,Chen CM,https://www.ncbi.nlm.nih.gov/pubmed/31834623
10443,32440696,Revisiting the penoscrotal approach to artificial urinary sphincter surgery: how does it compare to a perineal incision for initial implantation?,World J Urol. 2021 Mar;39(3):871-876. doi: 10.1007/s00345-020-03244-6. Epub 2020 May 21.,Staniorski CJ,https://www.ncbi.nlm.nih.gov/pubmed/32440696
10447,32367009,PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):549-560. doi: 10.1038/s41391-020-0233-3. Epub 2020 May 4.,Ratta R,https://www.ncbi.nlm.nih.gov/pubmed/32367009
10448,30632450,Rubber Band Ligation of Hemorrhoids is often a Necessary Complement in the Management of Hemorrhagic Radiation Proctitis,Scand J Surg. 2020 Jun;109(2):108-114. doi: 10.1177/1457496918822619. Epub 2019 Jan 11.,De Robles MS,https://www.ncbi.nlm.nih.gov/pubmed/30632450
10449,32275845,Use of multiparametric magnetic resonance imaging (mpMRI) in localized prostate cancer,Expert Rev Med Devices. 2020 May;17(5):435-442. doi: 10.1080/17434440.2020.1755257. Epub 2020 Apr 26.,O'Connor L,https://www.ncbi.nlm.nih.gov/pubmed/32275845
10450,32164507,Real-World Evidence of Clinical Outcomes in Precision Radionuclide Oncology: The NIGHTCAP Study of 177Lu-PSMA in Metastatic Prostate Cancer,Curr Pharm Des. 2020;26(31):3799-3803. doi: 10.2174/1381612826666200312141347.,Turner JH,https://www.ncbi.nlm.nih.gov/pubmed/32164507
10451,31787484,Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database,Eur J Cancer. 2020 Jan;125:153-163. doi: 10.1016/j.ejca.2019.10.030. Epub 2019 Nov 29.,Delanoy N,https://www.ncbi.nlm.nih.gov/pubmed/31787484
10452,31992607,Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis,BMJ Open. 2020 Jan 27;10(1):e034611. doi: 10.1136/bmjopen-2019-034611.,Norris JM,https://www.ncbi.nlm.nih.gov/pubmed/31992607
10453,32273196,Systematic Review of Efficacy and Health Economic Implications of Real-world Treatment Sequencing in Prostate Cancer: Where Do the Newer Agents Enzalutamide and Abiraterone Fit in?,Eur Urol Focus. 2021 Jul;7(4):752-763. doi: 10.1016/j.euf.2020.03.003. Epub 2020 Apr 6.,Pereira-Salgado A,https://www.ncbi.nlm.nih.gov/pubmed/32273196
10454,32054151,Diagnostic Accuracy and Value of Magnetic Resonance Imaging-Ultrasound Fusion Transperineal Targeted and Template Systematic Prostate Biopsy Based on Bi-parametric Magnetic Resonance Imaging,Cancer Res Treat. 2020 Jul;52(3):714-721. doi: 10.4143/crt.2019.716. Epub 2020 Feb 10.,Noh TI,https://www.ncbi.nlm.nih.gov/pubmed/32054151
10455,32389443,Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence,Eur Urol. 2020 Sep;78(3):304-306. doi: 10.1016/j.eururo.2020.04.016. Epub 2020 May 7.,Vickers A,https://www.ncbi.nlm.nih.gov/pubmed/32389443
10456,31712325,Can Intraoperative Fluorescence Imaging Identify All Lesions While the Road Map Created by Preoperative Nuclear Imaging Is Masked?,J Nucl Med. 2020 Jun;61(6):834-841. doi: 10.2967/jnumed.119.235234. Epub 2019 Nov 11.,Meershoek P,https://www.ncbi.nlm.nih.gov/pubmed/31712325
10458,31870703,The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility?,Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188336. doi: 10.1016/j.bbcan.2019.188336. Epub 2019 Dec 21.,Chun JN,https://www.ncbi.nlm.nih.gov/pubmed/31870703
10459,31420248,Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities,Eur Urol. 2020 Feb;77(2):158-166. doi: 10.1016/j.eururo.2019.07.031. Epub 2019 Aug 13.,Lu-Yao G,https://www.ncbi.nlm.nih.gov/pubmed/31420248
10461,31609177,Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Naïve Men: A Systematic Review and Meta-Analysis,J Urol. 2020 Jun;203(6):1085-1093. doi: 10.1097/JU.0000000000000595. Epub 2019 Oct 14.,Goldberg H,https://www.ncbi.nlm.nih.gov/pubmed/31609177
10464,32139297,Epigenetic modulations and lineage plasticity in advanced prostate cancer,Ann Oncol. 2020 Apr;31(4):470-479. doi: 10.1016/j.annonc.2020.02.002. Epub 2020 Feb 13.,Ge R,https://www.ncbi.nlm.nih.gov/pubmed/32139297
10465,33544809,Primary prostate cancer synchronous with renal cell carcinoma: clinical experience and literature review,Rom J Morphol Embryol. 2020 Apr-Jun;61(2):555-561. doi: 10.47162/RJME.61.2.27.,Li ZY,https://www.ncbi.nlm.nih.gov/pubmed/33544809
10466,32538039,Thymidine Kinase-1 as Additional Diagnostic Marker of Prostate Cancer,Clin Lab. 2020 Jun 1;66(6). doi: 10.7754/Clin.Lab.2019.191026.,Hanousková L,https://www.ncbi.nlm.nih.gov/pubmed/32538039
10467,31235801,Contemporary national trends in prostate cancer risk profile at diagnosis,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):81-87. doi: 10.1038/s41391-019-0157-y. Epub 2019 Jun 24.,Fletcher SA,https://www.ncbi.nlm.nih.gov/pubmed/31235801
10468,31822000,miR-1231 Is Downregulated in Prostate Cancer with Prognostic and Functional Implications,Oncol Res Treat. 2020;43(3):78-86. doi: 10.1159/000504606. Epub 2019 Dec 10.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/31822000
10469,31545701,Prostate cancer pathology: What has changed in the last 5 years,Urologia. 2020 Feb;87(1):3-10. doi: 10.1177/0391560319876821. Epub 2019 Sep 23.,Cimadamore A,https://www.ncbi.nlm.nih.gov/pubmed/31545701
10470,32192907,Standardization of acquisition protocols using PET/CT with (18)F-Choline in prostate cancer,Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jul-Aug;39(4):204-211. doi: 10.1016/j.remn.2020.01.007. Epub 2020 Mar 16.,Garcia JR,https://www.ncbi.nlm.nih.gov/pubmed/32192907
10471,31617025,Pre-treatment ratio of periprostatic to subcutaneous fat thickness on MRI is an independent survival predictor in hormone-naïve men with advanced prostate cancer,Int J Clin Oncol. 2020 Feb;25(2):370-376. doi: 10.1007/s10147-019-01559-y. Epub 2019 Oct 15.,Sasaki T,https://www.ncbi.nlm.nih.gov/pubmed/31617025
10472,31902712,Targeted and Systematic Prostate Biopsy in Biopsy-naive Men With Positive Multiparameter Magnetic Resonance Imaging Findings: A Meta-analysis,Clin Genitourin Cancer. 2020 Apr;18(2):105-110.e5. doi: 10.1016/j.clgc.2019.10.004. Epub 2019 Oct 17.,Jiang G,https://www.ncbi.nlm.nih.gov/pubmed/31902712
10474,31468158,Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network,Eur Radiol. 2020 Feb;30(2):1243-1253. doi: 10.1007/s00330-019-06417-z. Epub 2019 Aug 29.,Aldoj N,https://www.ncbi.nlm.nih.gov/pubmed/31468158
10475,31874447,Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer,Crit Rev Oncol Hematol. 2020 Jan;145:102860. doi: 10.1016/j.critrevonc.2019.102860. Epub 2019 Dec 19.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/31874447
10476,31886567,Prognostic implication and functional annotations of Rad50 expression in patients with prostate cancer,J Cell Biochem. 2020 Jun;121(5-6):3124-3134. doi: 10.1002/jcb.29580. Epub 2019 Dec 30.,Xu WH,https://www.ncbi.nlm.nih.gov/pubmed/31886567
10477,31833612,RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression,Cancer Sci. 2020 Feb;111(2):369-382. doi: 10.1111/cas.14280. Epub 2020 Jan 4.,Zhao J,https://www.ncbi.nlm.nih.gov/pubmed/31833612
10478,31918957,Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort,Eur Urol. 2020 Jun;77(6):675-682. doi: 10.1016/j.eururo.2019.12.017. Epub 2020 Jan 7.,Tosoian JJ,https://www.ncbi.nlm.nih.gov/pubmed/31918957
10479,31760357,Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort,Cancer Epidemiol. 2020 Feb;64:101631. doi: 10.1016/j.canep.2019.101631. Epub 2019 Nov 21.,Seikkula H,https://www.ncbi.nlm.nih.gov/pubmed/31760357
10480,32620227,MRI in the Management of Prostate Cancer,Semin Ultrasound CT MR. 2020 Aug;41(4):366-372. doi: 10.1053/j.sult.2020.04.003. Epub 2020 May 7.,Stempel CV,https://www.ncbi.nlm.nih.gov/pubmed/32620227
10481,32104968,Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy,BJU Int. 2020 Sep;126 Suppl 1:6-11. doi: 10.1111/bju.14974. Epub 2020 Feb 27.,Franklin A,https://www.ncbi.nlm.nih.gov/pubmed/32104968
10482,31791623,Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy,Eur Urol. 2020 Apr;77(4):481-490. doi: 10.1016/j.eururo.2019.10.009. Epub 2019 Nov 30.,Venderink W,https://www.ncbi.nlm.nih.gov/pubmed/31791623
10483,31937083,MRI/TRUS FUSION guided biopsy as first approach in ambulatory setting: Feasibility and performance of a new fusion device,Arch Ital Urol Androl. 2020 Jan 13;91(4):211-217. doi: 10.4081/aiua.2019.4.211.,D'Agostino D,https://www.ncbi.nlm.nih.gov/pubmed/31937083
10484,32088189,B7-H4 is a potential prognostic biomarker of prostate cancer,Exp Mol Pathol. 2020 Jun;114:104406. doi: 10.1016/j.yexmp.2020.104406. Epub 2020 Feb 20.,Li H,https://www.ncbi.nlm.nih.gov/pubmed/32088189
10485,32146725,Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression,J Diabetes Investig. 2020 Sep;11(5):1137-1149. doi: 10.1111/jdi.13247. Epub 2020 Apr 9.,Shigeoka T,https://www.ncbi.nlm.nih.gov/pubmed/32146725
10487,31119294,Vasectomy and Prostate Cancer Risk: A 38-Year Nationwide Cohort Study,J Natl Cancer Inst. 2020 Jan 1;112(1):71-77. doi: 10.1093/jnci/djz099.,Husby A,https://www.ncbi.nlm.nih.gov/pubmed/31119294
10488,31837907,Impact of progression at baseline and on-treatment progression events in three large prostate cancer trials,Eur J Cancer. 2020 Jan;125:142-152. doi: 10.1016/j.ejca.2019.10.029. Epub 2019 Dec 11.,Robbrecht DG,https://www.ncbi.nlm.nih.gov/pubmed/31837907
10489,31677880,Transrectal ultrasound-guided targeted biopsy of transition zone prostate cancer under cognitive registration with prebiopsy MRI and sonographic findings,Clin Radiol. 2020 Feb;75(2):157.e21-157.e27. doi: 10.1016/j.crad.2019.10.001. Epub 2019 Oct 31.,Won SY,https://www.ncbi.nlm.nih.gov/pubmed/31677880
10490,32241385,Race differences in mobility status among prostate cancer survivors: The role of socioeconomic status,Adv Cancer Res. 2020;146:103-114. doi: 10.1016/bs.acr.2020.01.006. Epub 2020 Feb 24.,Thorpe RJ Jr,https://www.ncbi.nlm.nih.gov/pubmed/32241385
10491,32775459,Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection,Biomed Res Int. 2020 Jul 21;2020:9872146. doi: 10.1155/2020/9872146. eCollection 2020.,Barisiene M,https://www.ncbi.nlm.nih.gov/pubmed/32775459
10492,31912363,Subcapsular orchiectomy versus total orchiectomy and LHRH analogue in the treatment of hormone-sensitive metastatic prostate cancer: a different perspective in evaluation of the psychosocial effects,Support Care Cancer. 2020 Sep;28(9):4313-4326. doi: 10.1007/s00520-019-05266-2. Epub 2020 Jan 7.,Selvi I,https://www.ncbi.nlm.nih.gov/pubmed/31912363
10493,31651228,External Validation and Comparison of Prostate Cancer Risk Calculators Incorporating Multiparametric Magnetic Resonance Imaging for Prediction of Clinically Significant Prostate Cancer,J Urol. 2020 Apr;203(4):719-726. doi: 10.1097/JU.0000000000000622. Epub 2019 Oct 25.,Saba K,https://www.ncbi.nlm.nih.gov/pubmed/31651228
10495,31843335,Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study,Eur Urol. 2020 Apr;77(4):494-500. doi: 10.1016/j.eururo.2019.11.021. Epub 2019 Dec 13.,Matsubara N,https://www.ncbi.nlm.nih.gov/pubmed/31843335
10496,31147265,"Screening, Active Surveillance, and Treatment of Localized Prostate Cancer Among Carriers of Germline BRCA Mutations",Eur Urol Focus. 2020 Mar 15;6(2):212-214. doi: 10.1016/j.euf.2019.05.009. Epub 2019 May 27.,Halstuch D,https://www.ncbi.nlm.nih.gov/pubmed/31147265
10497,31335254,Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS Trial,J Urol. 2020 Jan;203(1):100-107. doi: 10.1097/JU.0000000000000455. Epub 2019 Jul 23.,Lovegrove CE,https://www.ncbi.nlm.nih.gov/pubmed/31335254
10498,31919691,Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan,Int J Clin Oncol. 2020 May;25(5):912-920. doi: 10.1007/s10147-019-01614-8. Epub 2020 Jan 9.,Narita S,https://www.ncbi.nlm.nih.gov/pubmed/31919691
10499,32521919,"Castration aggravates insulin resistance, reduces immune function and improves quality of life of prostate cancer patients",J BUON. 2020 Mar-Apr;25(2):1148-1154.,Ma Z,https://www.ncbi.nlm.nih.gov/pubmed/32521919
10500,31843064,Targeted Radionuclide Therapy: A Historical and Personal Review,Semin Nucl Med. 2020 Jan;50(1):87-97. doi: 10.1053/j.semnuclmed.2019.07.006. Epub 2019 Nov 6.,Goldsmith SJ,https://www.ncbi.nlm.nih.gov/pubmed/31843064
10501,32314932,Prostate Mapping for Cancer Diagnosis: The Madrid Protocol. Transperineal Prostate Biopsies Using Multiparametric Magnetic Resonance Imaging Fusion and Micro-Ultrasound Guided Biopsies,J Urol. 2020 Oct;204(4):726-733. doi: 10.1097/JU.0000000000001083. Epub 2020 Apr 21.,Rodríguez Socarrás ME,https://www.ncbi.nlm.nih.gov/pubmed/32314932
10502,32008343,Histogram analysis in prostate cancer: a comparison of diffusion kurtosis imaging model versus monoexponential model,Acta Radiol. 2020 Oct;61(10):1431-1440. doi: 10.1177/0284185120901504. Epub 2020 Feb 2.,Jiang Y,https://www.ncbi.nlm.nih.gov/pubmed/32008343
10503,31430244,"Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml",J Urol. 2020 Jan;203(1):83-91. doi: 10.1097/JU.0000000000000495. Epub 2019 Aug 20.,Ito K,https://www.ncbi.nlm.nih.gov/pubmed/31430244
10504,31637636,MRI for clinically suspected prostate cancer-the disparity between private and public sectors,Ir J Med Sci. 2020 May;189(2):461-465. doi: 10.1007/s11845-019-02103-7. Epub 2019 Oct 22.,Yap LC,https://www.ncbi.nlm.nih.gov/pubmed/31637636
10505,32265090,The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillance,Urol Oncol. 2020 Jun;38(6):599.e9-599.e13. doi: 10.1016/j.urolonc.2020.03.002. Epub 2020 Apr 4.,Yaguchi G,https://www.ncbi.nlm.nih.gov/pubmed/32265090
10507,31389764,Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells,J Urol. 2020 Jan;203(1):73-82. doi: 10.1097/JU.0000000000000475. Epub 2019 Aug 7.,Xu L,https://www.ncbi.nlm.nih.gov/pubmed/31389764
10508,31734078,Prevalence and correlates of non-tissue prostate cancer diagnosis in the United States,J Geriatr Oncol. 2020 Jun;11(5):885-892. doi: 10.1016/j.jgo.2019.11.003. Epub 2019 Nov 13.,Aksenov LI,https://www.ncbi.nlm.nih.gov/pubmed/31734078
10509,32035807,Role of the neutrophil/lymphocyte ratio in patients with metastatic castration-resistant prostate cancer treated first-line with abiraterone,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):164-171. doi: 10.1016/j.acuro.2019.11.003. Epub 2020 Feb 5.,Nieblas-Toscano D,https://www.ncbi.nlm.nih.gov/pubmed/32035807
10510,32113858,Histomorphological analysis of false positive PI-RADS 4 and 5 lesions,Urol Oncol. 2020 Jul;38(7):636.e7-636.e12. doi: 10.1016/j.urolonc.2020.01.017. Epub 2020 Feb 27.,Hupe MC,https://www.ncbi.nlm.nih.gov/pubmed/32113858
10511,31640441,An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer,Expert Rev Mol Diagn. 2020 Feb;20(2):207-217. doi: 10.1080/14737159.2019.1684265. Epub 2019 Oct 29.,Mollica V,https://www.ncbi.nlm.nih.gov/pubmed/31640441
10512,31825927,Diagnostic Role of Magnetic Resonance Imaging-Targeted Biopsy for Prostate Cancer in Biopsy-Naïve Men: A Meta-Analysis,Urol Int. 2020;104(3-4):187-198. doi: 10.1159/000504028. Epub 2019 Dec 11.,Tu X,https://www.ncbi.nlm.nih.gov/pubmed/31825927
10513,32072326,Adopting a collaborative approach in developing a prehabilitation program for patients with prostate cancer utilising experience-based co-design methodology,Support Care Cancer. 2020 Nov;28(11):5195-5202. doi: 10.1007/s00520-020-05341-z. Epub 2020 Feb 18.,Tang CY,https://www.ncbi.nlm.nih.gov/pubmed/32072326
10514,31644434,Developments in MRI-targeted prostate biopsy,Curr Opin Urol. 2020 Jan;30(1):1-8. doi: 10.1097/MOU.0000000000000683.,Norris JM,https://www.ncbi.nlm.nih.gov/pubmed/31644434
10516,31309290,Impact of using 29 MHz high-resolution micro-ultrasound in real-time targeting of transrectal prostate biopsies: initial experience,World J Urol. 2020 May;38(5):1201-1206. doi: 10.1007/s00345-019-02863-y. Epub 2019 Jul 15.,Abouassaly R,https://www.ncbi.nlm.nih.gov/pubmed/31309290
10518,31577907,Clinical utility of emerging biomarkers in prostate cancer liquid biopsies,Expert Rev Mol Diagn. 2020 Feb;20(2):219-230. doi: 10.1080/14737159.2019.1675515. Epub 2019 Oct 11.,Boerrigter E,https://www.ncbi.nlm.nih.gov/pubmed/31577907
10519,32131560,Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer,Nutrients. 2020 Mar 2;12(3):679. doi: 10.3390/nu12030679.,Abd Wahab NA,https://www.ncbi.nlm.nih.gov/pubmed/32131560
10520,32307329,Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population,Urol Oncol. 2020 Oct;38(10):794.e11-794.e16. doi: 10.1016/j.urolonc.2020.03.024. Epub 2020 Apr 17.,Zahalka AH,https://www.ncbi.nlm.nih.gov/pubmed/32307329
10521,31876229,Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ?3?ng/ml,Scand J Urol. 2020 Feb;54(1):1-6. doi: 10.1080/21681805.2019.1703806. Epub 2019 Dec 26.,Chandra Engel J,https://www.ncbi.nlm.nih.gov/pubmed/31876229
10523,32466878,Apalutamide in combination with autophagy inhibitors improves treatment effects in prostate cancer cells,Urol Oncol. 2020 Aug;38(8):683.e19-683.e26. doi: 10.1016/j.urolonc.2020.04.030. Epub 2020 May 25.,Eberli D,https://www.ncbi.nlm.nih.gov/pubmed/32466878
10524,32428663,GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers,Cancer Lett. 2020 Aug 10;485:45-55. doi: 10.1016/j.canlet.2020.05.007. Epub 2020 May 16.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32428663
10526,32424261,"Association between metformin medication, genetic variation and prostate cancer risk",Prostate Cancer Prostatic Dis. 2021 Mar;24(1):96-105. doi: 10.1038/s41391-020-0238-y. Epub 2020 May 18.,Lee MJ,https://www.ncbi.nlm.nih.gov/pubmed/32424261
10527,31169140,Establishment of two new predictive models for prostate cancer to determine whether to require prostate biopsy when the PSA level is in the diagnostic gray zone (4-10 ng ml(-1)),Asian J Androl. 2020 Mar-Apr;22(2):213-216. doi: 10.4103/aja.aja_46_19.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/31169140
10528,32313142,Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):638-645. doi: 10.1038/s41391-020-0231-5. Epub 2020 Apr 20.,Martini A,https://www.ncbi.nlm.nih.gov/pubmed/32313142
10530,32344931,"Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer",Cells. 2020 Apr 25;9(5):1073. doi: 10.3390/cells9051073.,Montironi R,https://www.ncbi.nlm.nih.gov/pubmed/32344931
10531,32065691,Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome study,Psychooncology. 2020 May;29(5):886-893. doi: 10.1002/pon.5362. Epub 2020 Feb 26.,Wilding S,https://www.ncbi.nlm.nih.gov/pubmed/32065691
10532,31797427,"Effects of gametogenetin-binding protein 2 on proliferation, invasion and migration of prostate cancer PC-3 cells",Andrologia. 2020 Mar;52(2):e13488. doi: 10.1111/and.13488. Epub 2019 Dec 3.,Yang Z,https://www.ncbi.nlm.nih.gov/pubmed/31797427
10534,30962017,"Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia",Asian J Surg. 2020 Jan;43(1):87-94. doi: 10.1016/j.asjsur.2019.02.014. Epub 2019 Apr 5.,Yii RSL,https://www.ncbi.nlm.nih.gov/pubmed/30962017
10535,31870724,A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy,Urol Oncol. 2020 May;38(5):401-409. doi: 10.1016/j.urolonc.2019.12.006. Epub 2019 Dec 23.,Sun J,https://www.ncbi.nlm.nih.gov/pubmed/31870724
10536,31931827,Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report,Diagn Pathol. 2020 Jan 13;15(1):5. doi: 10.1186/s13000-019-0916-z.,Hongo H,https://www.ncbi.nlm.nih.gov/pubmed/31931827
10537,32500294,Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry,Target Oncol. 2020 Jun;15(3):301-315. doi: 10.1007/s11523-020-00720-2.,Chowdhury S,https://www.ncbi.nlm.nih.gov/pubmed/32500294
10538,32458625,Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer,Asian Pac J Cancer Prev. 2020 May 1;21(5):1221-1226. doi: 10.31557/APJCP.2020.21.5.1221.,Rahimi N,https://www.ncbi.nlm.nih.gov/pubmed/32458625
10539,31914996,DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation,BMC Med Genomics. 2020 Jan 8;13(1):6. doi: 10.1186/s12920-020-0657-6.,Rauluseviciute I,https://www.ncbi.nlm.nih.gov/pubmed/31914996
10540,32356095,Multiple instance learning combined with label invariant synthetic data for guiding systematic prostate biopsy: a feasibility study,Int J Comput Assist Radiol Surg. 2020 Jun;15(6):1023-1031. doi: 10.1007/s11548-020-02168-1. Epub 2020 Apr 30.,Javadi G,https://www.ncbi.nlm.nih.gov/pubmed/32356095
10541,32089744,Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis,Theranostics. 2020 Jan 16;10(5):2309-2326. doi: 10.7150/thno.39486. eCollection 2020.,Pang B,https://www.ncbi.nlm.nih.gov/pubmed/32089744
10542,31687881,High RSF1 protein expression is an independent prognostic feature in prostate cancer,Acta Oncol. 2020 Mar;59(3):268-273. doi: 10.1080/0284186X.2019.1686537. Epub 2019 Nov 5.,Höflmayer D,https://www.ncbi.nlm.nih.gov/pubmed/31687881
10544,31783311,Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets,Int J Med Inform. 2020 Jan;133:104014. doi: 10.1016/j.ijmedinf.2019.104014. Epub 2019 Nov 17.,Murtojärvi M,https://www.ncbi.nlm.nih.gov/pubmed/31783311
10545,32484704,Metastasis-free survival as a new endpoint in castration- -resistant prostate cancer,Bratisl Lek Listy. 2020;121(6):411-414. doi: 10.4149/BLL_2020_066.,Kuzma M,https://www.ncbi.nlm.nih.gov/pubmed/32484704
10546,32451769,Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy,Int J Clin Oncol. 2021 Jan;26(1):18-25. doi: 10.1007/s10147-020-01704-y. Epub 2020 May 26.,Fukuhara H,https://www.ncbi.nlm.nih.gov/pubmed/32451769
10547,32372384,Improving detection of prostate cancer foci via information fusion of MRI and temporal enhanced ultrasound,Int J Comput Assist Radiol Surg. 2020 Jul;15(7):1215-1223. doi: 10.1007/s11548-020-02172-5. Epub 2020 May 5.,Sedghi A,https://www.ncbi.nlm.nih.gov/pubmed/32372384
10548,32317175,High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer,Pathology. 2020 Jun;52(4):421-430. doi: 10.1016/j.pathol.2020.03.001. Epub 2020 Apr 18.,Eichenauer T,https://www.ncbi.nlm.nih.gov/pubmed/32317175
10549,31762182,A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection,BJU Int. 2020 Apr;125(4):531-540. doi: 10.1111/bju.14957. Epub 2019 Dec 23.,Wajswol E,https://www.ncbi.nlm.nih.gov/pubmed/31762182
10550,32243384,A randomized controlled trial for acupuncture combined with conventional therapy in the treatment of pain caused by prostate cancer: Study protocol clinical trial (SPIRIT compliant),Medicine (Baltimore). 2020 Apr;99(14):e19609. doi: 10.1097/MD.0000000000019609.,Lei Y,https://www.ncbi.nlm.nih.gov/pubmed/32243384
10551,32083576,The accuracy of prostate lesion localization in cognitive fusion,Clin Hemorheol Microcirc. 2020;74(3):223-229. doi: 10.3233/CH-180423.,Xu G,https://www.ncbi.nlm.nih.gov/pubmed/32083576
10553,31648903,Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer,Eur Urol. 2020 Feb;77(2):170-177. doi: 10.1016/j.eururo.2019.08.020. Epub 2019 Oct 21.,Graf RP,https://www.ncbi.nlm.nih.gov/pubmed/31648903
10554,32341031,Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer,Clin Cancer Res. 2020 Aug 1;26(15):4143-4153. doi: 10.1158/1078-0432.CCR-19-4100. Epub 2020 Apr 27.,Malihi PD,https://www.ncbi.nlm.nih.gov/pubmed/32341031
10555,32248987,Study structure may compromise understanding of longitudinal decision regret stability: A systematic review,Patient Educ Couns. 2020 Aug;103(8):1507-1517. doi: 10.1016/j.pec.2020.03.011. Epub 2020 Mar 12.,Aarhus RT,https://www.ncbi.nlm.nih.gov/pubmed/32248987
10556,31865531,Automatic cancer tissue detection using multispectral photoacoustic imaging,Int J Comput Assist Radiol Surg. 2020 Feb;15(2):309-320. doi: 10.1007/s11548-019-02101-1. Epub 2019 Dec 21.,Jnawali K,https://www.ncbi.nlm.nih.gov/pubmed/31865531
10557,32107089,Targeted Biopsy With Reduced Number of Cores: Optimal Sampling Scheme in Patients Undergoing Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Prostate Biopsy,Ultrasound Med Biol. 2020 May;46(5):1197-1207. doi: 10.1016/j.ultrasmedbio.2020.01.017. Epub 2020 Feb 24.,Shen WW,https://www.ncbi.nlm.nih.gov/pubmed/32107089
10558,32480269,Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives,Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24.,Leone G,https://www.ncbi.nlm.nih.gov/pubmed/32480269
10559,31641011,Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database,Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):236-245. doi: 10.1158/1055-9965.EPI-19-0619. Epub 2019 Oct 22.,Cook MB,https://www.ncbi.nlm.nih.gov/pubmed/31641011
10560,31733173,Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial,BJU Int. 2020 Mar;125(3):391-398. doi: 10.1111/bju.14953. Epub 2019 Dec 11.,Eldred-Evans D,https://www.ncbi.nlm.nih.gov/pubmed/31733173
10562,31583692,Chronic oral anticoagluation and risk of prostate cancer: Evidence of detection bias,Int J Cancer. 2020 Jun 1;146(11):3022-3025. doi: 10.1002/ijc.32712. Epub 2019 Oct 23.,Ward MM,https://www.ncbi.nlm.nih.gov/pubmed/31583692
10563,31135342,Open Source Platform for Transperineal In-Bore MRI-Guided Targeted Prostate Biopsy,IEEE Trans Biomed Eng. 2020 Feb;67(2):565-576. doi: 10.1109/TBME.2019.2918731. Epub 2019 May 23.,Herz C,https://www.ncbi.nlm.nih.gov/pubmed/31135342
10565,31273290,Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong's perspective,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):108-115. doi: 10.1038/s41391-019-0161-2. Epub 2019 Jul 4.,Chiang CL,https://www.ncbi.nlm.nih.gov/pubmed/31273290
10566,32299423,Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study,BMC Med. 2020 Apr 17;18(1):95. doi: 10.1186/s12916-020-01548-3.,Kim L,https://www.ncbi.nlm.nih.gov/pubmed/32299423
10567,32163676,Preliminary results of targeted prostate-specific membrane antigen imaging in evaluating the efficacy of a novel hormone agent in metastatic castration-resistant prostate cancer,Cancer Med. 2020 May;9(10):3278-3286. doi: 10.1002/cam4.2964. Epub 2020 Mar 12.,Liu C,https://www.ncbi.nlm.nih.gov/pubmed/32163676
10568,31588646,Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions,J Magn Reson Imaging. 2020 Apr;51(4):1235-1246. doi: 10.1002/jmri.26933. Epub 2019 Oct 6.,van Houdt PJ,https://www.ncbi.nlm.nih.gov/pubmed/31588646
10569,32268584,Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention,Nutrients. 2020 Apr 6;12(4):1010. doi: 10.3390/nu12041010.,Izzo S,https://www.ncbi.nlm.nih.gov/pubmed/32268584
10571,31736000,Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study,Support Care Cancer. 2020 Jun;28(6):2875-2885. doi: 10.1007/s00520-019-05120-5. Epub 2019 Nov 18.,Adam S,https://www.ncbi.nlm.nih.gov/pubmed/31736000
10572,31605663,Exercise-induced attenuation of treatment side-effects in patients with newly diagnosed prostate cancer beginning androgen-deprivation therapy: a randomised controlled trial,BJU Int. 2020 Jan;125(1):28-37. doi: 10.1111/bju.14922. Epub 2019 Oct 31.,Ndjavera W,https://www.ncbi.nlm.nih.gov/pubmed/31605663
10575,31851456,Prostate cancer screening among elderly men in Brazil: should we diagnose or not?,Int Braz J Urol. 2020 Jan-Feb;46(1):34-41. doi: 10.1590/S1677-5538.IBJU.2019.0022.,Mori RR,https://www.ncbi.nlm.nih.gov/pubmed/31851456
10576,32342705,Robotic-assisted surgery for the treatment of urologic cancers: recent advances,Expert Rev Med Devices. 2020 Jun;17(6):579-590. doi: 10.1080/17434440.2020.1762487. Epub 2020 May 13.,Falagario U,https://www.ncbi.nlm.nih.gov/pubmed/32342705
10577,32091322,Feasibility and efficacy of sequential systemic therapy for metastatic castration-resistant prostate cancer in a rural health care setting,Scand J Urol. 2020 Apr;54(2):110-114. doi: 10.1080/21681805.2020.1730435. Epub 2020 Feb 24.,Nieder C,https://www.ncbi.nlm.nih.gov/pubmed/32091322
10578,31773467,Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy,Mol Cell Biochem. 2020 Jan;464(1-2):153-167. doi: 10.1007/s11010-019-03657-x. Epub 2019 Nov 27.,Shatnawi A,https://www.ncbi.nlm.nih.gov/pubmed/31773467
10579,31762400,Psychosocial mechanisms of a behavioral treatment for urinary incontinence of prostate cancer survivors,J Psychosoc Oncol. 2020 Mar-Apr;38(2):210-227. doi: 10.1080/07347332.2019.1678547. Epub 2019 Nov 24.,Zhang AY,https://www.ncbi.nlm.nih.gov/pubmed/31762400
10580,32132043,Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer,Anticancer Res. 2020 Mar;40(3):1459-1462. doi: 10.21873/anticanres.14088.,Vidal AC,https://www.ncbi.nlm.nih.gov/pubmed/32132043
10581,31951037,The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: A systematic review and meta-analysis,J Clin Pharm Ther. 2020 Jun;45(3):488-495. doi: 10.1111/jcpt.13092. Epub 2020 Jan 17.,Yang H,https://www.ncbi.nlm.nih.gov/pubmed/31951037
10582,31399825,Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?,World J Urol. 2020 Mar;38(3):531-545. doi: 10.1007/s00345-019-02899-0. Epub 2019 Aug 9.,Schoots IG,https://www.ncbi.nlm.nih.gov/pubmed/31399825
10584,32487321,Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer,Eur Urol. 2020 Aug;78(2):173-180. doi: 10.1016/j.eururo.2020.03.044. Epub 2020 May 30.,Fettke H,https://www.ncbi.nlm.nih.gov/pubmed/32487321
10585,32044790,Acute Disseminated Intravascular Coagulation After Prophylactic Nailing of the Femur in a Patient with Metastatic Prostate Cancer: A Case Report,JBJS Case Connect. 2020 Jan-Mar;10(1):e0370. doi: 10.2106/JBJS.CC.19.00370.,You DZ,https://www.ncbi.nlm.nih.gov/pubmed/32044790
10586,33101546,Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer,Dis Markers. 2020 Oct 9;2020:8860788. doi: 10.1155/2020/8860788. eCollection 2020.,Liu B,https://www.ncbi.nlm.nih.gov/pubmed/33101546
10587,32189394,Is it worth carrying out ultrasound-magnetic resonance imaging fusion targeted biopsy on Prostate Imaging Reporting and Data System score 3 prostate lesions?,Int J Urol. 2020 May;27(5):431-438. doi: 10.1111/iju.14213. Epub 2020 Mar 18.,Kim KH,https://www.ncbi.nlm.nih.gov/pubmed/32189394
10588,31002873,Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer,Semin Cancer Biol. 2020 Feb;60:132-137. doi: 10.1016/j.semcancer.2019.04.002. Epub 2019 Apr 16.,Salvi S,https://www.ncbi.nlm.nih.gov/pubmed/31002873
10589,31899651,Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study,J Urol. 2020 Jun;203(6):1109-1116. doi: 10.1097/JU.0000000000000714. Epub 2020 Jan 3.,Leong DP,https://www.ncbi.nlm.nih.gov/pubmed/31899651
10590,32456413,"The role of magnetic resonance imaging-guided biopsy for diagnosis of prostate cancer; comparison between FUSION and ""IN-BORE"" approaches",Minerva Urol Nephrol. 2021 Feb;73(1):90-97. doi: 10.23736/S2724-6051.20.03550-X. Epub 2020 May 26.,D'Agostino D,https://www.ncbi.nlm.nih.gov/pubmed/32456413
10591,31512007,Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer,Int J Clin Oncol. 2020 Mar;25(3):479-485. doi: 10.1007/s10147-019-01541-8. Epub 2019 Sep 11.,Mori K,https://www.ncbi.nlm.nih.gov/pubmed/31512007
10592,32240336,Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer,Cancer Chemother Pharmacol. 2020 May;85(5):863-868. doi: 10.1007/s00280-020-04063-7. Epub 2020 Apr 2.,Kushnir I,https://www.ncbi.nlm.nih.gov/pubmed/32240336
10593,31139906,Accuracy of the preoperative PSA level for predicting clinically significant incidental transitional zone-prostate cancer before endoscopic enucleation of very large adenoma,World J Urol. 2020 Apr;38(4):993-1000. doi: 10.1007/s00345-019-02823-6. Epub 2019 May 28.,Misraï V,https://www.ncbi.nlm.nih.gov/pubmed/31139906
10596,31176623,Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer,Eur Urol. 2020 Jan;77(1):14-21. doi: 10.1016/j.eururo.2019.05.032. Epub 2019 Jun 5.,Isaacsson Velho P,https://www.ncbi.nlm.nih.gov/pubmed/31176623
10597,31487220,Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer,J Urol. 2020 Mar;203(3):537-545. doi: 10.1097/JU.0000000000000531. Epub 2019 Sep 6.,van Kalmthout LWM,https://www.ncbi.nlm.nih.gov/pubmed/31487220
10598,31081564,Molecular imaging of the prostate: Comparing total sodium concentration quantification in prostate cancer and normal tissue using dedicated (13) C and (23) Na endorectal coils,J Magn Reson Imaging. 2020 Jan;51(1):90-97. doi: 10.1002/jmri.26788. Epub 2019 May 13.,Barrett T,https://www.ncbi.nlm.nih.gov/pubmed/31081564
10599,31420496,(18)F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies,J Nucl Med. 2020 Mar;61(3):337-343. doi: 10.2967/jnumed.119.225789. Epub 2019 Aug 16.,Davenport MS,https://www.ncbi.nlm.nih.gov/pubmed/31420496
10600,31821099,Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer,J Urol. 2020 May;203(5):918-925. doi: 10.1097/JU.0000000000000692. Epub 2019 Dec 10.,Claros OR,https://www.ncbi.nlm.nih.gov/pubmed/31821099
10601,31899231,Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection,Urology. 2020 Apr;138:106-112. doi: 10.1016/j.urology.2019.12.025. Epub 2019 Dec 30.,Gupta I,https://www.ncbi.nlm.nih.gov/pubmed/31899231
10603,31940221,Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline,J Clin Oncol. 2020 Jun 10;38(17):1963-1996. doi: 10.1200/JCO.19.02757. Epub 2020 Jan 15.,Trabulsi EJ,https://www.ncbi.nlm.nih.gov/pubmed/31940221
10604,33290430,Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer,PLoS One. 2020 Dec 8;15(12):e0243386. doi: 10.1371/journal.pone.0243386. eCollection 2020.,Cunningham J,https://www.ncbi.nlm.nih.gov/pubmed/33290430
10605,32362422,EphrinB2 expression in prostate adenocarcinoma: Implications for targeted therapy,Pathol Res Pract. 2020 Jun;216(6):152967. doi: 10.1016/j.prp.2020.152967. Epub 2020 Apr 19.,Gupta C,https://www.ncbi.nlm.nih.gov/pubmed/32362422
10606,32284527,Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide,Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.,Buttigliero C,https://www.ncbi.nlm.nih.gov/pubmed/32284527
10607,31327752,Diet and lifestyle considerations for patients with prostate cancer,Urol Oncol. 2020 Mar;38(3):105-117. doi: 10.1016/j.urolonc.2019.06.018. Epub 2019 Jul 18.,Zuniga KB,https://www.ncbi.nlm.nih.gov/pubmed/31327752
10608,32534948,Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: A pilot randomised control trial,Clin Nutr. 2021 Jan;40(1):245-254. doi: 10.1016/j.clnu.2020.05.016. Epub 2020 May 25.,Baguley BJ,https://www.ncbi.nlm.nih.gov/pubmed/32534948
10609,32531720,Optimizing size thresholds for detection of clinically significant prostate cancer on MRI: Peripheral zone cancers are smaller and more predictable than transition zone tumors,Eur J Radiol. 2020 Aug;129:109071. doi: 10.1016/j.ejrad.2020.109071. Epub 2020 May 17.,Mahjoub S,https://www.ncbi.nlm.nih.gov/pubmed/32531720
10611,33017413,Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: Impact on diagnostic accuracy and inter-reader agreement,PLoS One. 2020 Oct 5;15(10):e0239975. doi: 10.1371/journal.pone.0239975. eCollection 2020.,Hötker AM,https://www.ncbi.nlm.nih.gov/pubmed/33017413
10612,31925552,Long short-term memory artificial neural network model for prediction of prostate cancer survival outcomes according to initial treatment strategy: development of an online decision-making support system,World J Urol. 2020 Oct;38(10):2469-2476. doi: 10.1007/s00345-020-03080-8. Epub 2020 Jan 10.,Koo KC,https://www.ncbi.nlm.nih.gov/pubmed/31925552
10613,32301002,Surgical management of acquired rectourethral fistula: a retrospective analysis of 52 consecutive patients,Tech Coloproctol. 2020 Sep;24(9):927-933. doi: 10.1007/s10151-020-02214-9. Epub 2020 Apr 16.,Bislenghi G,https://www.ncbi.nlm.nih.gov/pubmed/32301002
10614,32191585,Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive Disease,J Urol. 2020 Sep;204(3):466-475. doi: 10.1097/JU.0000000000001020. Epub 2020 Mar 19.,Wang WW,https://www.ncbi.nlm.nih.gov/pubmed/32191585
10615,31916449,"Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy",Future Oncol. 2020 Feb;16(5):75-80. doi: 10.2217/fon-2019-0745. Epub 2020 Jan 9.,Cimadamore A,https://www.ncbi.nlm.nih.gov/pubmed/31916449
10616,31977600,Temperature-Sensitive Frozen-Tissue Imaging for Cryoablation Monitoring Using STIR-UTE MRI,Invest Radiol. 2020 May;55(5):310-317. doi: 10.1097/RLI.0000000000000642.,Tokuda J,https://www.ncbi.nlm.nih.gov/pubmed/31977600
10617,32802197,Efficacy and safety of (225)Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients,Theranostics. 2020 Jul 23;10(20):9364-9377. doi: 10.7150/thno.48107. eCollection 2020.,Yadav MP,https://www.ncbi.nlm.nih.gov/pubmed/32802197
10618,31959547,Leveraging Behavioral Economics to Reduce Low-value Prostate Cancer Screening,Eur Urol. 2020 Apr;77(4):400-402. doi: 10.1016/j.eururo.2020.01.001. Epub 2020 Jan 17.,Hunt TC,https://www.ncbi.nlm.nih.gov/pubmed/31959547
10619,32164671,Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation,BMC Urol. 2020 Mar 12;20(1):25. doi: 10.1186/s12894-020-00593-7.,Seikkula H,https://www.ncbi.nlm.nih.gov/pubmed/32164671
10620,31937094,Solitary prostatic cancer metastasis to the testis: A case report and lessons to learn,Arch Ital Urol Androl. 2020 Jan 14;91(4):265-266. doi: 10.4081/aiua.2019.4.265.,Ismail A,https://www.ncbi.nlm.nih.gov/pubmed/31937094
10621,31686520,Upregulated circZMIZ1 promotes the proliferation of prostate cancer cells and is a valuable marker in plasma,Neoplasma. 2020 Jan;67(1):68-77. doi: 10.4149/neo_2019_190213N116. Epub 2019 Nov 4.,Jiang H,https://www.ncbi.nlm.nih.gov/pubmed/31686520
10622,32317221,(18)F-fluciclovine PET CT detection of biochemical recurrent prostate cancer at specific PSA thresholds after definitive treatment,Urol Oncol. 2020 Jul;38(7):636.e1-636.e6. doi: 10.1016/j.urolonc.2020.03.021. Epub 2020 Apr 18.,Armstrong JM,https://www.ncbi.nlm.nih.gov/pubmed/32317221
10623,32027524,A risk prediction model of DNA methylation improves prognosis evaluation and indicates gene targets in prostate cancer,Epigenomics. 2020 Feb;12(4):333-352. doi: 10.2217/epi-2019-0349. Epub 2020 Feb 6.,Zhang E,https://www.ncbi.nlm.nih.gov/pubmed/32027524
10624,31506748,How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies,World J Urol. 2020 Jun;38(6):1481-1491. doi: 10.1007/s00345-019-02946-w. Epub 2019 Sep 10.,Borque-Fernando Á,https://www.ncbi.nlm.nih.gov/pubmed/31506748
10626,32338277,miR-484 is associated with disease recurrence and promotes migration in prostate cancer,Biosci Rep. 2020 May 29;40(5):BSR20191028. doi: 10.1042/BSR20191028.,Lee D,https://www.ncbi.nlm.nih.gov/pubmed/32338277
10627,31855410,Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers?,Bioconjug Chem. 2020 Feb 19;31(2):375-395. doi: 10.1021/acs.bioconjchem.9b00758. Epub 2020 Jan 6.,Hensbergen AW,https://www.ncbi.nlm.nih.gov/pubmed/31855410
10628,32203215,A novel stratification framework for predicting outcome in patients with prostate cancer,Br J Cancer. 2020 May;122(10):1467-1476. doi: 10.1038/s41416-020-0799-5. Epub 2020 Mar 20.,Luca BA,https://www.ncbi.nlm.nih.gov/pubmed/32203215
10629,31692391,Is Engrailed-2 (EN2) a truly promising biomarker in prostate cancer detection?,Biomarkers. 2020 Feb;25(1):34-39. doi: 10.1080/1354750X.2019.1690047. Epub 2019 Nov 14.,Do Carmo Silva J,https://www.ncbi.nlm.nih.gov/pubmed/31692391
10630,32118378,Targeted prostate biopsy using a cognitive fusion of multiparametric magnetic resonance imaging and transrectal ultrasound in patients with previously negative systematic biopsies and non-suspicious digital rectal exam,Croat Med J. 2020 Feb 29;61(1):49-54. doi: 10.3325/cmj.2020.61.49.,Kuliš T,https://www.ncbi.nlm.nih.gov/pubmed/32118378
10631,31813087,Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer,Adv Ther. 2020 Jan;37(1):512-526. doi: 10.1007/s12325-019-01157-4. Epub 2019 Dec 7.,Chowdhury S,https://www.ncbi.nlm.nih.gov/pubmed/31813087
10632,31913068,MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort,AJR Am J Roentgenol. 2020 Mar;214(3):574-578. doi: 10.2214/AJR.19.21559. Epub 2020 Jan 8.,Washington SL 3rd,https://www.ncbi.nlm.nih.gov/pubmed/31913068
10633,33565519,"Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ?3: Results of a prospective, randomized clinical trial",J Cancer Res Ther. 2020;16(7):1698-1702. doi: 10.4103/jcrt.JCRT_1495_20.,Zhang J,https://www.ncbi.nlm.nih.gov/pubmed/33565519
10634,32447644,PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer,Clin Transl Oncol. 2021 Jan;23(1):172-178. doi: 10.1007/s12094-020-02384-w. Epub 2020 May 23.,Lopci E,https://www.ncbi.nlm.nih.gov/pubmed/32447644
10636,32147365,Combination of Multiparametric Magnetic Resonance Imaging With Elastic-fusion Biopsy Has a High Sensitivity in Detecting Clinically Significant Prostate Cancer in Daily Practice,Clin Genitourin Cancer. 2020 Oct;18(5):e501-e509. doi: 10.1016/j.clgc.2020.02.006. Epub 2020 Feb 8.,Cecchini S,https://www.ncbi.nlm.nih.gov/pubmed/32147365
10638,31907568,Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer,Abdom Radiol (NY). 2020 Feb;45(2):547-555. doi: 10.1007/s00261-019-02281-z.,Wang B,https://www.ncbi.nlm.nih.gov/pubmed/31907568
10639,32387923,Accuracy of ADC ratio in discriminating true and false positives in multiparametric prostatic MRI,Eur J Radiol. 2020 Jul;128:109024. doi: 10.1016/j.ejrad.2020.109024. Epub 2020 Apr 27.,Falaschi Z,https://www.ncbi.nlm.nih.gov/pubmed/32387923
10640,31845837,Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary Therapy,J Urol. 2020 May;203(5):940-948. doi: 10.1097/JU.0000000000000699. Epub 2020 Dec 17.,Pouliot F,https://www.ncbi.nlm.nih.gov/pubmed/31845837
10641,31901895,The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion,Aging (Albany NY). 2020 Jan 5;12(1):397-415. doi: 10.18632/aging.102630. Epub 2020 Jan 5.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/31901895
10642,32162567,End-fire versus side-fire: a randomized controlled study of transrectal ultrasound guided biopsies for prostate cancer detection,Scand J Urol. 2020 Apr;54(2):101-104. doi: 10.1080/21681805.2020.1738544. Epub 2020 Mar 12.,van der Slot MA,https://www.ncbi.nlm.nih.gov/pubmed/32162567
10643,32321689,Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer,Urol Oncol. 2020 Sep;38(9):734.e19-734.e25. doi: 10.1016/j.urolonc.2020.03.020. Epub 2020 Apr 19.,Watts KL,https://www.ncbi.nlm.nih.gov/pubmed/32321689
10644,32157115,Chemokine releasing particle implants for trapping circulating prostate cancer cells,Sci Rep. 2020 Mar 10;10(1):4433. doi: 10.1038/s41598-020-60696-x.,Huang Y,https://www.ncbi.nlm.nih.gov/pubmed/32157115
10645,32450824,Independence of HIF1a and androgen signaling pathways in prostate cancer,BMC Cancer. 2020 May 25;20(1):469. doi: 10.1186/s12885-020-06890-6.,Tran MGB,https://www.ncbi.nlm.nih.gov/pubmed/32450824
10646,32306717,"While Urine and Plasma Decorin Remain Unchanged in Prostate Cancer, Prostatic Tissue Decorin Has a Prognostic Value",Iran Biomed J. 2020 Jul;24(4):229-35. doi: 10.29252/ibj.24.4.229. Epub 2020 Apr 19.,Rezaie R,https://www.ncbi.nlm.nih.gov/pubmed/32306717
10647,31704142,Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer,Urol Oncol. 2020 Jan;38(1):1.e1-1.e10. doi: 10.1016/j.urolonc.2019.09.027. Epub 2019 Nov 5.,Halwani AS,https://www.ncbi.nlm.nih.gov/pubmed/31704142
10649,31733095,Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p,J Cell Mol Med. 2020 Jan;24(1):799-813. doi: 10.1111/jcmm.14791. Epub 2019 Nov 16.,Kong Z,https://www.ncbi.nlm.nih.gov/pubmed/31733095
10650,33029516,The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer,Biomed Res Int. 2020 Sep 24;2020:5395312. doi: 10.1155/2020/5395312. eCollection 2020.,Xiang Q,https://www.ncbi.nlm.nih.gov/pubmed/33029516
10651,31747673,Androgen Deprivation Therapy and the Risk of Stroke in Patients with Prostate Cancer: An Updated Systematic Review and Meta-Analysis,Urol Int. 2020;104(3-4):214-221. doi: 10.1159/000503906. Epub 2019 Nov 20.,Liu R,https://www.ncbi.nlm.nih.gov/pubmed/31747673
10652,31925454,Longitudinal model-based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer,Eur J Clin Pharmacol. 2020 Apr;76(4):589-601. doi: 10.1007/s00228-020-02829-9. Epub 2020 Jan 10.,Chen W,https://www.ncbi.nlm.nih.gov/pubmed/31925454
10653,32219507,Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer,Eur Radiol. 2020 Aug;30(8):4262-4271. doi: 10.1007/s00330-020-06773-1. Epub 2020 Mar 26.,Rudolph MM,https://www.ncbi.nlm.nih.gov/pubmed/32219507
10654,32316077,Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland,Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):653-663. doi: 10.1002/pds.4998. Epub 2020 Apr 21.,Baillie K,https://www.ncbi.nlm.nih.gov/pubmed/32316077
10655,31447087,"""Real-world"" evaluation of (18)F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy",Urol Oncol. 2020 Jan;38(1):2.e1-2.e9. doi: 10.1016/j.urolonc.2019.07.017. Epub 2019 Aug 22.,Niziers V,https://www.ncbi.nlm.nih.gov/pubmed/31447087
10656,32130256,Can online support groups address psychological morbidity of cancer patients? An artificial intelligence based investigation of prostate cancer trajectories,PLoS One. 2020 Mar 4;15(3):e0229361. doi: 10.1371/journal.pone.0229361. eCollection 2020.,Adikari A,https://www.ncbi.nlm.nih.gov/pubmed/32130256
10658,31473884,How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score???3?,Int J Clin Oncol. 2020 Jan;25(1):175-186. doi: 10.1007/s10147-019-01524-9. Epub 2019 Aug 31.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/31473884
10659,32052171,Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1,Eur Radiol. 2020 Jun;30(6):3383-3392. doi: 10.1007/s00330-019-06654-2. Epub 2020 Feb 12.,Brembilla G,https://www.ncbi.nlm.nih.gov/pubmed/32052171
10660,32633348,Elevated CISD2 expression predicts poor diagnosis and promotes invasion and migration of prostate cancer cells,Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6597-6604. doi: 10.26355/eurrev_202006_21645.,Zhu QQ,https://www.ncbi.nlm.nih.gov/pubmed/32633348
10661,32281273,Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel-like factors in prostate cancer,J Cell Mol Med. 2020 May;24(10):5797-5810. doi: 10.1111/jcmm.15242. Epub 2020 Apr 13.,Meng J,https://www.ncbi.nlm.nih.gov/pubmed/32281273
10662,31647166,Active surveillance in intermediate-risk prostate cancer,BJU Int. 2020 Mar;125(3):346-354. doi: 10.1111/bju.14935. Epub 2020 Jan 16.,Klotz L,https://www.ncbi.nlm.nih.gov/pubmed/31647166
10663,31642541,Chronic prostatitis/chronic pelvic pain syndrome and prostate cancer: study of immune cells and cytokines,Fundam Clin Pharmacol. 2020 Apr;34(2):160-172. doi: 10.1111/fcp.12517. Epub 2019 Nov 12.,Liu Y,https://www.ncbi.nlm.nih.gov/pubmed/31642541
10664,31264233,Clinical Value of the Elastographic Q-Analysis Score in Assisting Real-Time Elastography-Guided Prostate Biopsy: A Retrospective Study of 125 Patients,J Ultrasound Med. 2020 Jan;39(1):83-87. doi: 10.1002/jum.15075. Epub 2019 Jul 1.,Ding Z,https://www.ncbi.nlm.nih.gov/pubmed/31264233
10665,30714520,"Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions",Curr Med Chem. 2020;27(19):3187-3249. doi: 10.2174/0929867326666190201142814.,Dash A,https://www.ncbi.nlm.nih.gov/pubmed/30714520
10666,31942460,Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice,Investig Clin Urol. 2020 Jan;61(1):28-34. doi: 10.4111/icu.2020.61.1.28. Epub 2019 Nov 28.,Oh KT,https://www.ncbi.nlm.nih.gov/pubmed/31942460
10667,32058895,The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone,Eur J Radiol. 2020 Apr;125:108865. doi: 10.1016/j.ejrad.2020.108865. Epub 2020 Feb 6.,Chen Z,https://www.ncbi.nlm.nih.gov/pubmed/32058895
10668,33084528,Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis,Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820963578. doi: 10.1177/1533033820963578.,Gong X,https://www.ncbi.nlm.nih.gov/pubmed/33084528
10669,32537065,"Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa",Pan Afr Med J. 2020 Feb 28;35:61. doi: 10.11604/pamj.2020.35.61.21331. eCollection 2020.,Maphayi MR,https://www.ncbi.nlm.nih.gov/pubmed/32537065
10670,32152436,Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):567-572. doi: 10.1038/s41391-020-0223-5. Epub 2020 Mar 9.,Hoge C,https://www.ncbi.nlm.nih.gov/pubmed/32152436
10671,31585778,Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel-A pooled analysis of 3 randomized studies,Urol Oncol. 2020 Apr;38(4):210-215. doi: 10.1016/j.urolonc.2019.09.004. Epub 2019 Oct 1.,Abdel-Rahman O,https://www.ncbi.nlm.nih.gov/pubmed/31585778
10672,31874336,Feasibility of integrating computer-aided diagnosis with structured reports of prostate multiparametric MRI,Clin Imaging. 2020 Mar;60(1):123-130. doi: 10.1016/j.clinimag.2019.12.010. Epub 2019 Dec 13.,Zhu L,https://www.ncbi.nlm.nih.gov/pubmed/31874336
10673,32402819,Cost-Effectiveness Analysis of Prostate-Specific Antigen Screening Among Chinese Men,Value Health Reg Issues. 2020 May;21:272-279. doi: 10.1016/j.vhri.2020.01.005. Epub 2020 May 8.,Zhao G,https://www.ncbi.nlm.nih.gov/pubmed/32402819
10674,31825297,The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies,J Urol. 2020 May;203(5):910-917. doi: 10.1097/JU.0000000000000693. Epub 2019 Dec 11.,Amin A,https://www.ncbi.nlm.nih.gov/pubmed/31825297
10675,32017175,How many bone metastases may be defined as high-volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study,Prostate. 2020 Apr;80(5):432-440. doi: 10.1002/pros.23958. Epub 2020 Feb 3.,Yamada Y,https://www.ncbi.nlm.nih.gov/pubmed/32017175
10676,30868240,Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions,World J Urol. 2020 Mar;38(3):517-529. doi: 10.1007/s00345-019-02707-9. Epub 2019 Mar 13.,Schoots IG,https://www.ncbi.nlm.nih.gov/pubmed/30868240
10677,31154465,Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy,World J Urol. 2020 Apr;38(4):957-964. doi: 10.1007/s00345-019-02830-7. Epub 2019 Jun 1.,Porcaro AB,https://www.ncbi.nlm.nih.gov/pubmed/31154465
10678,30858072,Patient-reported Outcome Measures in Metastatic Urinary Cancers,Eur Urol Focus. 2020 Jan 15;6(1):26-30. doi: 10.1016/j.euf.2019.02.020. Epub 2019 Mar 8.,Bergerot CD,https://www.ncbi.nlm.nih.gov/pubmed/30858072
10679,32862614,Early PSA response to antiandrogen therapy in metastatic castration-resistant prostate carcinoma patients: A predictive marker for progression-free survival?,J BUON. 2020 May-Jun;25(3):1625-1630.,Atakan D,https://www.ncbi.nlm.nih.gov/pubmed/32862614
10680,32067845,Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result,Urol Oncol. 2020 May;38(5):410-417. doi: 10.1016/j.urolonc.2019.12.013. Epub 2020 Feb 15.,Morote J,https://www.ncbi.nlm.nih.gov/pubmed/32067845
10681,32153047,Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancer,Prostate. 2020 May;80(7):547-558. doi: 10.1002/pros.23968. Epub 2020 Mar 9.,Connell SP,https://www.ncbi.nlm.nih.gov/pubmed/32153047
10682,31872280,The management impact of (68)gallium-tris(hydroxypyridinone) prostate-specific membrane antigen ((68)Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):674-686. doi: 10.1007/s00259-019-04643-7. Epub 2019 Dec 23.,Kulkarni M,https://www.ncbi.nlm.nih.gov/pubmed/31872280
10683,31898035,"Interactive, Up-to-date Meta-Analysis of MRI in the Management of Men with Suspected Prostate Cancer",J Digit Imaging. 2020 Jun;33(3):586-594. doi: 10.1007/s10278-019-00312-1.,Becker AS,https://www.ncbi.nlm.nih.gov/pubmed/31898035
10684,31807974,Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy,Int Urol Nephrol. 2020 Apr;52(4):633-638. doi: 10.1007/s11255-019-02354-4. Epub 2019 Dec 5.,Sugano D,https://www.ncbi.nlm.nih.gov/pubmed/31807974
10685,32516098,PD-L1 Inhibitors for the Treatment of Prostate Cancer,Curr Drug Targets. 2020;21(15):1558-1565. doi: 10.2174/1389450121666200609142219.,Santoni M,https://www.ncbi.nlm.nih.gov/pubmed/32516098
10686,32350862,Overall and abdominal obesity and prostate cancer risk in a West African population: An analysis of the Ghana Prostate Study,Int J Cancer. 2020 Nov 15;147(10):2669-2676. doi: 10.1002/ijc.33026. Epub 2020 May 6.,Hurwitz LM,https://www.ncbi.nlm.nih.gov/pubmed/32350862
10687,31593800,Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel,Cancer Lett. 2020 Jan 1;468:88-101. doi: 10.1016/j.canlet.2019.10.006. Epub 2019 Oct 5.,Shen Z,https://www.ncbi.nlm.nih.gov/pubmed/31593800
10689,31440806,Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population,World J Urol. 2020 May;38(5):1207-1214. doi: 10.1007/s00345-019-02889-2. Epub 2019 Aug 22.,Hsieh PF,https://www.ncbi.nlm.nih.gov/pubmed/31440806
10690,31823152,"A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study",Int J Clin Oncol. 2020 Apr;25(4):720-731. doi: 10.1007/s10147-019-01589-6. Epub 2019 Dec 10.,Matsubara N,https://www.ncbi.nlm.nih.gov/pubmed/31823152
10691,32714984,Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study,Biomed Res Int. 2020 Jul 1;2020:7804932. doi: 10.1155/2020/7804932. eCollection 2020.,Kawahara T,https://www.ncbi.nlm.nih.gov/pubmed/32714984
10692,32380831,(1)H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer,J Proteome Res. 2020 Jun 5;19(6):2419-2428. doi: 10.1021/acs.jproteome.0c00091. Epub 2020 May 18.,Bruzzone C,https://www.ncbi.nlm.nih.gov/pubmed/32380831
10693,31952998,Opportunistic prostate cancer screening: A population-based analysis,Urol Oncol. 2020 May;38(5):393-400. doi: 10.1016/j.urolonc.2019.12.009. Epub 2020 Jan 14.,Matti B,https://www.ncbi.nlm.nih.gov/pubmed/31952998
10694,32452292,An Exploration of Precancer and Post-Cancer Diagnosis and Health Communication Among African American Prostate Cancer Survivors and Their Families,Am J Mens Health. 2020 May-Jun;14(3):1557988320927202. doi: 10.1177/1557988320927202.,Dickey SL,https://www.ncbi.nlm.nih.gov/pubmed/32452292
10695,30915900,Development and usability testing of a multi-criteria value clarification methods for patients with localized prostate cancer,Health Informatics J. 2020 Mar;26(1):486-498. doi: 10.1177/1460458219832055. Epub 2019 Mar 27.,de Angst IB,https://www.ncbi.nlm.nih.gov/pubmed/30915900
10696,31225597,Overdiagnosis and Lives Saved by Reflex Testing Men With Intermediate Prostate-Specific Antigen Levels,J Natl Cancer Inst. 2020 Apr 1;112(4):384-390. doi: 10.1093/jnci/djz127.,Gulati R,https://www.ncbi.nlm.nih.gov/pubmed/31225597
10698,32558494,The Identification of Key Gene Expression Signature in Prostate Cancer,Crit Rev Eukaryot Gene Expr. 2020;30(2):153-168. doi: 10.1615/CritRevEukaryotGeneExpr.2020029243.,Huang Y,https://www.ncbi.nlm.nih.gov/pubmed/32558494
10699,32470903,Automated gleason grading on prostate biopsy slides by statistical representations of homology profile,Comput Methods Programs Biomed. 2020 Oct;194:105528. doi: 10.1016/j.cmpb.2020.105528. Epub 2020 May 26.,Yan C,https://www.ncbi.nlm.nih.gov/pubmed/32470903
10700,31596671,Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men,J Urol. 2020 Apr;203(4):699-705. doi: 10.1097/JU.0000000000000587. Epub 2019 Oct 9.,Zhou SR,https://www.ncbi.nlm.nih.gov/pubmed/31596671
10701,32039628,Association of interleukine-18 polymorphisms with susceptibility to prostate cancer in Iranian population,Neoplasma. 2020 May;67(3):644-649. doi: 10.4149/neo_2020_190616N513. Epub 2020 Feb 9.,Abedinzadeh M,https://www.ncbi.nlm.nih.gov/pubmed/32039628
10702,32057513,"Long noncoding RNA TUG1 regulates prostate cancer cell proliferation, invasion and migration via the Nrf2 signaling axis",Pathol Res Pract. 2020 Apr;216(4):152851. doi: 10.1016/j.prp.2020.152851. Epub 2020 Feb 5.,Yang G,https://www.ncbi.nlm.nih.gov/pubmed/32057513
10703,32203070,Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):705-713. doi: 10.1038/s41391-020-0224-4. Epub 2020 Mar 18.,Du M,https://www.ncbi.nlm.nih.gov/pubmed/32203070
10704,31611636,Exposure-response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):244-251. doi: 10.1038/s41391-019-0179-5. Epub 2019 Oct 14.,van Nuland M,https://www.ncbi.nlm.nih.gov/pubmed/31611636
10705,32481312,Efficacy of docetaxel combined carboplatin for the treatment of patients with castration-resistant prostate cancer: A protocol of systematic review and meta-analysis,Medicine (Baltimore). 2020 May 22;99(21):e20297. doi: 10.1097/MD.0000000000020297.,Pu CL,https://www.ncbi.nlm.nih.gov/pubmed/32481312
10706,32315112,"Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy",BJU Int. 2020 Oct;126(4):481-493. doi: 10.1111/bju.15093. Epub 2020 May 13.,Mannaerts CK,https://www.ncbi.nlm.nih.gov/pubmed/32315112
10707,31462701,"The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study",Prostate Cancer Prostatic Dis. 2020 Mar;23(1):144-150. doi: 10.1038/s41391-019-0169-7. Epub 2019 Aug 28.,Nayak JG,https://www.ncbi.nlm.nih.gov/pubmed/31462701
10709,33273988,Systematic Investigation of mRNA N (6)-Methyladenosine Machinery in Primary Prostate Cancer,Dis Markers. 2020 Nov 12;2020:8833438. doi: 10.1155/2020/8833438. eCollection 2020.,Jiang M,https://www.ncbi.nlm.nih.gov/pubmed/33273988
10710,32119574,Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors,Can J Physiol Pharmacol. 2020 Jul;98(7):477-481. doi: 10.1139/cjpp-2019-0668. Epub 2020 Mar 2.,Bakrania A,https://www.ncbi.nlm.nih.gov/pubmed/32119574
10711,30734845,Re: Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study,World J Urol. 2020 Mar;38(3):803-804. doi: 10.1007/s00345-019-02669-y. Epub 2019 Feb 8.,Norris JM,https://www.ncbi.nlm.nih.gov/pubmed/30734845
10712,31830211,Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials,JAMA Oncol. 2020 Feb 1;6(2):217-225. doi: 10.1001/jamaoncol.2019.4636.,Armstrong AJ,https://www.ncbi.nlm.nih.gov/pubmed/31830211
10715,32358695,Central adiposity at diagnosis may reduce prostate cancer-specific mortality in African-Caribbean men with prostate cancer: 10-year follow-up of participants in a case-control study,Cancer Causes Control. 2020 Jul;31(7):651-662. doi: 10.1007/s10552-020-01306-z. Epub 2020 May 1.,Jackson MD,https://www.ncbi.nlm.nih.gov/pubmed/32358695
10716,32027768,"What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing",Prostate. 2020 Apr;80(5):441-450. doi: 10.1002/pros.23959. Epub 2020 Feb 6.,Greenberg S,https://www.ncbi.nlm.nih.gov/pubmed/32027768
10717,32387417,Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype,Ann Oncol. 2020 Sep;31(9):1178-1185. doi: 10.1016/j.annonc.2020.04.473. Epub 2020 May 5.,Lu C,https://www.ncbi.nlm.nih.gov/pubmed/32387417
10718,32619831,Antibody selection influences the detection of AR-V7 in primary prostate cancer,Cancer Treat Res Commun. 2020;24:100186. doi: 10.1016/j.ctarc.2020.100186. Epub 2020 Jun 23.,Kaczorowski A,https://www.ncbi.nlm.nih.gov/pubmed/32619831
10719,32312102,Impact of mandated prospectively reported apparent diffusion coefficient values on the rates of positivity for clinically significant prostate cancer by PI-RADS score,Acta Radiol. 2021 Jan;62(1):139-144. doi: 10.1177/0284185120915617. Epub 2020 Apr 20.,Shaish H,https://www.ncbi.nlm.nih.gov/pubmed/32312102
10720,31954166,Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer,Urology. 2020 Apr;138:84-90. doi: 10.1016/j.urology.2020.01.001. Epub 2020 Jan 15.,Huang MM,https://www.ncbi.nlm.nih.gov/pubmed/31954166
10721,32057540,Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure,Ann Oncol. 2020 Mar;31(3):369-376. doi: 10.1016/j.annonc.2019.12.002. Epub 2020 Feb 11.,Alyamani M,https://www.ncbi.nlm.nih.gov/pubmed/32057540
10722,32306078,Manual prostate cancer segmentation in MRI: interreader agreement and volumetric correlation with transperineal template core needle biopsy,Eur Radiol. 2020 Sep;30(9):4806-4815. doi: 10.1007/s00330-020-06786-w. Epub 2020 Apr 19.,Liechti MR,https://www.ncbi.nlm.nih.gov/pubmed/32306078
10723,31918180,Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model,Cancer Epidemiol. 2020 Feb;64:101657. doi: 10.1016/j.canep.2019.101657. Epub 2020 Jan 7.,Hong JH,https://www.ncbi.nlm.nih.gov/pubmed/31918180
10725,32822968,"Improvement in overall survival with Apalutamide, Darolutamide and Enzalutamide in patients with non-metastatic castration-resistant prostate cancer",Cancer Treat Res Commun. 2020;25:100205. doi: 10.1016/j.ctarc.2020.100205. Epub 2020 Aug 12.,Swami U,https://www.ncbi.nlm.nih.gov/pubmed/32822968
10726,31967522,Predictive Factors of Missed Clinically Significant Prostate Cancers in Men with Negative Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis,J Urol. 2020 Jul;204(1):24-32. doi: 10.1097/JU.0000000000000757. Epub 2020 Jan 22.,Pagniez MA,https://www.ncbi.nlm.nih.gov/pubmed/31967522
10727,31622990,Value of Dynamic Contrast-Enhanced (DCE) MR Imaging in Peripheral Lesions in PI-RADS-4 Patients,Rofo. 2020 May;192(5):441-447. doi: 10.1055/a-1020-4026. Epub 2019 Oct 17.,Ullrich T,https://www.ncbi.nlm.nih.gov/pubmed/31622990
10728,31953243,Algorithms May Assist Expert Pathologists in Prostate Cancer Diagnosis,Cancer Discov. 2020 Mar;10(3):OF1. doi: 10.1158/2159-8290.CD-RW2020-012. Epub 2020 Jan 17.,,https://www.ncbi.nlm.nih.gov/pubmed/31953243
10729,31907633,External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers,World J Urol. 2020 Oct;38(10):2555-2561. doi: 10.1007/s00345-019-03058-1. Epub 2020 Jan 6.,Cindolo L,https://www.ncbi.nlm.nih.gov/pubmed/31907633
10730,32119131,Mutational and transcriptomic landscapes of a rare human prostate basal cell carcinoma,Prostate. 2020 May;80(6):508-517. doi: 10.1002/pros.23965. Epub 2020 Mar 2.,Su X,https://www.ncbi.nlm.nih.gov/pubmed/32119131
10731,31332559,Comparison between pelvic PSMA-PET/MR and whole-body PSMA-PET/CT for the initial evaluation of prostate cancer: a proof of concept study,Eur Radiol. 2020 Jan;30(1):328-336. doi: 10.1007/s00330-019-06353-y. Epub 2019 Jul 22.,Domachevsky L,https://www.ncbi.nlm.nih.gov/pubmed/31332559
10733,32382078,Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10?ng/mL,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):607-614. doi: 10.1038/s41391-020-0237-z. Epub 2020 May 7.,Tutrone R,https://www.ncbi.nlm.nih.gov/pubmed/32382078
10734,31961049,Luminal Water Imaging: Comparison With Diffusion-Weighted Imaging (DWI) and PI-RADS for Characterization of Prostate Cancer Aggressiveness,J Magn Reson Imaging. 2020 Jul;52(1):271-279. doi: 10.1002/jmri.27050. Epub 2020 Jan 21.,Hectors SJ,https://www.ncbi.nlm.nih.gov/pubmed/31961049
10735,31874825,Design and synthesis of a novel BODIPY-labeled PSMA inhibitor,Bioorg Med Chem Lett. 2020 Feb 1;30(3):126894. doi: 10.1016/j.bmcl.2019.126894. Epub 2019 Dec 18.,Son SH,https://www.ncbi.nlm.nih.gov/pubmed/31874825
10737,31241767,"Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer",Int J Cancer. 2020 Mar 1;146(5):1346-1358. doi: 10.1002/ijc.32535. Epub 2019 Jul 9.,Li H,https://www.ncbi.nlm.nih.gov/pubmed/31241767
10738,32441162,The role of insulin-like growth factors in the development of prostate cancer,Expert Rev Endocrinol Metab. 2020 Jul;15(4):237-250. doi: 10.1080/17446651.2020.1764844. Epub 2020 May 22.,Holly JMP,https://www.ncbi.nlm.nih.gov/pubmed/32441162
10739,32406325,How can we predict the active surveillance candidates meeting all Epstein criteria prior to prostate biopsy to avoid overdiagnosis?,Aging Male. 2020 Dec;23(5):1289-1295. doi: 10.1080/13685538.2020.1764524. Epub 2020 May 14.,Avci S,https://www.ncbi.nlm.nih.gov/pubmed/32406325
10740,31710780,Epithelium segmentation and automated Gleason grading of prostate cancer via deep learning in label-free multiphoton microscopic images,J Biophotonics. 2020 Feb;13(2):e201900203. doi: 10.1002/jbio.201900203. Epub 2019 Dec 4.,Yang Q,https://www.ncbi.nlm.nih.gov/pubmed/31710780
10741,32389459,Negative Biopsy Histology in Men With PI-RADS Score 5 in Daily Clinical Practice: Incidence of Granulomatous Prostatitis,Clin Genitourin Cancer. 2020 Dec;18(6):e684-e687. doi: 10.1016/j.clgc.2020.04.001. Epub 2020 Apr 14.,Pepe P,https://www.ncbi.nlm.nih.gov/pubmed/32389459
10744,32006051,Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer,Cell Mol Life Sci. 2020 Oct;77(19):3693-3710. doi: 10.1007/s00018-020-03459-1. Epub 2020 Jan 31.,Jafari S,https://www.ncbi.nlm.nih.gov/pubmed/32006051
10745,32745972,PARP inhibitors in castration-resistant prostate cancer,Cancer Treat Res Commun. 2020;24:100199. doi: 10.1016/j.ctarc.2020.100199. Epub 2020 Jul 22.,Tripathi A,https://www.ncbi.nlm.nih.gov/pubmed/32745972
10746,32407167,CircSMARCA5 Facilitates the Progression of Prostate Cancer Through miR-432/PDCD10 Axis,Cancer Biother Radiopharm. 2021 Feb;36(1):70-83. doi: 10.1089/cbr.2019.3490. Epub 2020 May 14.,Dong C,https://www.ncbi.nlm.nih.gov/pubmed/32407167
10747,32330776,"Biparametric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with ""gray zone"" PSA levels",Eur J Radiol. 2020 Jun;127:108977. doi: 10.1016/j.ejrad.2020.108977. Epub 2020 Apr 10.,Wei CG,https://www.ncbi.nlm.nih.gov/pubmed/32330776
10748,31617161,The X(c)(-) inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism,Cell Oncol (Dordr). 2020 Feb;43(1):95-106. doi: 10.1007/s13402-019-00474-8. Epub 2019 Oct 15.,Zheng Z,https://www.ncbi.nlm.nih.gov/pubmed/31617161
10752,31582290,Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition,Eur Urol. 2020 Apr;77(4):457-468. doi: 10.1016/j.eururo.2019.09.021. Epub 2019 Sep 30.,Engels RRM,https://www.ncbi.nlm.nih.gov/pubmed/31582290
10753,32028831,The Yin Yang Role of Nitric Oxide in Prostate Cancer,Am J Mens Health. 2020 Jan-Feb;14(1):1557988320903191. doi: 10.1177/1557988320903191.,Soni Y,https://www.ncbi.nlm.nih.gov/pubmed/32028831
10754,32448502,Examining the association of health literacy and numeracy with prostate-related knowledge and prostate cancer treatment regret,Urol Oncol. 2020 Aug;38(8):682.e11-682.e19. doi: 10.1016/j.urolonc.2020.04.007. Epub 2020 May 21.,Joyce DD,https://www.ncbi.nlm.nih.gov/pubmed/32448502
10755,33144873,Evaluation of Multimodal Algorithms for the Segmentation of Multiparametric MRI Prostate Images,Comput Math Methods Med. 2020 Oct 20;2020:8861035. doi: 10.1155/2020/8861035. eCollection 2020.,Nai YH,https://www.ncbi.nlm.nih.gov/pubmed/33144873
10757,31307958,Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis,Eur Urol Oncol. 2020 Apr;3(2):176-182. doi: 10.1016/j.euo.2019.06.008. Epub 2019 Jul 13.,Rescigno P,https://www.ncbi.nlm.nih.gov/pubmed/31307958
10759,32198373,Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone,Sci Rep. 2020 Mar 20;10(1):5157. doi: 10.1038/s41598-020-62015-w.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/32198373
10760,32019810,27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells,Mol Cancer Res. 2020 May;18(5):671-684. doi: 10.1158/1541-7786.MCR-19-0974. Epub 2020 Feb 4.,Dambal S,https://www.ncbi.nlm.nih.gov/pubmed/32019810
10762,32277668,"Antiproliferative activities of auraptenol against drug-resistant human prostate carcinoma cells are mediated via programmed cell death, endogenous ROS production, and targeting the JNK/p38 MAPK signal pathways",J BUON. 2020 Jan-Feb;25(1):454-459.,Liu Y,https://www.ncbi.nlm.nih.gov/pubmed/32277668
10764,31980309,"The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations",Eur Urol. 2020 Sep;78(3):335-344. doi: 10.1016/j.eururo.2020.01.009. Epub 2020 Jan 21.,Jeong CW,https://www.ncbi.nlm.nih.gov/pubmed/31980309
10765,32055002,Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):486-493. doi: 10.1038/s41391-020-0210-x. Epub 2020 Feb 13.,Wong RL,https://www.ncbi.nlm.nih.gov/pubmed/32055002
10766,30993586,"Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-?B",Invest New Drugs. 2020 Apr;38(2):246-263. doi: 10.1007/s10637-019-00774-8. Epub 2019 Apr 16.,Erdogan S,https://www.ncbi.nlm.nih.gov/pubmed/30993586
10768,32066750,Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer,Sci Rep. 2020 Feb 17;10(1):2705. doi: 10.1038/s41598-020-59296-6.,Barakat A,https://www.ncbi.nlm.nih.gov/pubmed/32066750
10769,31991773,Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression,Int J Mol Sci. 2020 Jan 25;21(3):787. doi: 10.3390/ijms21030787.,Pietrovito L,https://www.ncbi.nlm.nih.gov/pubmed/31991773
10773,30926960,Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth,Gene Ther. 2020 Feb;27(1-2):15-26. doi: 10.1038/s41434-019-0071-x. Epub 2019 Mar 29.,Tamura RE,https://www.ncbi.nlm.nih.gov/pubmed/30926960
10774,31155953,Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial,Nutr Cancer. 2020;72(1):74-87. doi: 10.1080/01635581.2019.1619783. Epub 2019 Jun 1.,Zhang Z,https://www.ncbi.nlm.nih.gov/pubmed/31155953
10775,31944670,Simultaneous Detection of Zinc and Its Pathway Metabolites Using MALDI MS Imaging of Prostate Tissue,Anal Chem. 2020 Feb 18;92(4):3171-3179. doi: 10.1021/acs.analchem.9b04903. Epub 2020 Jan 28.,Andersen MK,https://www.ncbi.nlm.nih.gov/pubmed/31944670
10776,31794113,Relative Enhanced Diffusivity in Prostate Cancer: Protocol Optimization and Diagnostic Potential,J Magn Reson Imaging. 2020 Jun;51(6):1900-1910. doi: 10.1002/jmri.27011. Epub 2019 Dec 3.,Billdal DC,https://www.ncbi.nlm.nih.gov/pubmed/31794113
10777,31301021,Robotic surgery using Senhance((R)) robotic platform: single center experience with first 100 cases,J Robot Surg. 2020 Apr;14(2):371-376. doi: 10.1007/s11701-019-01000-6. Epub 2019 Jul 12.,Samalavicius NE,https://www.ncbi.nlm.nih.gov/pubmed/31301021
10778,32409115,A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry,Eur Urol. 2020 Sep;78(3):316-320. doi: 10.1016/j.eururo.2020.04.060. Epub 2020 May 12.,Darst BF,https://www.ncbi.nlm.nih.gov/pubmed/32409115
10779,31227306,Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts,Eur Urol. 2020 Feb;77(2):144-155. doi: 10.1016/j.eururo.2019.05.042. Epub 2019 Jun 19.,Lam HM,https://www.ncbi.nlm.nih.gov/pubmed/31227306
10780,32204513,Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells,Cells. 2020 Mar 19;9(3):755. doi: 10.3390/cells9030755.,Eguchi T,https://www.ncbi.nlm.nih.gov/pubmed/32204513
10781,31147628,Performance of [(68)Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):1-10. doi: 10.1038/s41391-019-0156-z. Epub 2019 May 30.,Kimura S,https://www.ncbi.nlm.nih.gov/pubmed/31147628
10782,32573479,Detection of TMPRSS2-ERG Fusion Transcript in Biopsy Specimen of Prostate Cancer Patients: A Single Centre Experience,Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2020 Jun 1;41(1):5-14. doi: 10.2478/prilozi-2020-0018.,Trifunovski A,https://www.ncbi.nlm.nih.gov/pubmed/32573479
10783,32710316,Recent Advances in DNA Repair Pathway and Its Application in Personalized Care of Metastatic Castration-Resistant Prostate Cancer (mCRPC),Methods Mol Biol. 2020;2204:75-89. doi: 10.1007/978-1-0716-0904-0_7.,Xu C,https://www.ncbi.nlm.nih.gov/pubmed/32710316
10786,31960124,Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer,Support Care Cancer. 2020 Oct;28(10):4687-4695. doi: 10.1007/s00520-020-05311-5. Epub 2020 Jan 20.,Banna GL,https://www.ncbi.nlm.nih.gov/pubmed/31960124
10789,31969015,Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses,Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):e55-e64. doi: 10.1161/ATVBAHA.119.313046. Epub 2020 Jan 23.,Hu JR,https://www.ncbi.nlm.nih.gov/pubmed/31969015
10790,32341037,Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance,Cancer Res. 2020 Jul 1;80(13):2927-2939. doi: 10.1158/0008-5472.CAN-19-2549. Epub 2020 Apr 27.,Wu H,https://www.ncbi.nlm.nih.gov/pubmed/32341037
10791,32198407,OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation,Nat Commun. 2020 Mar 20;11(1):1487. doi: 10.1038/s41467-020-15237-5.,Schöpf B,https://www.ncbi.nlm.nih.gov/pubmed/32198407
10793,31893292,The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer,Cancer Chemother Pharmacol. 2020 Mar;85(3):547-553. doi: 10.1007/s00280-019-04011-0. Epub 2020 Jan 1.,Belderbos BPS,https://www.ncbi.nlm.nih.gov/pubmed/31893292
10796,31767941,A polymeric paste-drug formulation for intratumoral treatment of prostate cancer,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):324-332. doi: 10.1038/s41391-019-0190-x. Epub 2019 Nov 25.,Kesch C,https://www.ncbi.nlm.nih.gov/pubmed/31767941
10797,32247852,Metabolically stable diphenylamine derivatives suppress androgen receptor and BET protein in prostate cancer,Biochem Pharmacol. 2020 Jul;177:113946. doi: 10.1016/j.bcp.2020.113946. Epub 2020 Apr 2.,Yu J,https://www.ncbi.nlm.nih.gov/pubmed/32247852
10798,32125228,Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years,J Urol. 2020 Aug;204(2):281-288. doi: 10.1097/JU.0000000000001007. Epub 2020 Mar 3.,Vertosick EA,https://www.ncbi.nlm.nih.gov/pubmed/32125228
10799,31736271,Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer,Mol Oncol. 2020 Jan;14(1):129-138. doi: 10.1002/1878-0261.12597. Epub 2019 Nov 29.,Höflmayer D,https://www.ncbi.nlm.nih.gov/pubmed/31736271
10800,32953881,Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients,Biomed Res Int. 2020 Sep 1;2020:4264291. doi: 10.1155/2020/4264291. eCollection 2020.,Cai J,https://www.ncbi.nlm.nih.gov/pubmed/32953881
10801,32067844,Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative,Urol Oncol. 2020 Jul;38(7):636.e13-636.e19. doi: 10.1016/j.urolonc.2020.01.011. Epub 2020 Feb 14.,Eyrich NW,https://www.ncbi.nlm.nih.gov/pubmed/32067844
10802,31988304,Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction,Sci Rep. 2020 Jan 27;10(1):1216. doi: 10.1038/s41598-020-58118-z.,Yin L,https://www.ncbi.nlm.nih.gov/pubmed/31988304
10803,32360240,Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea,Curr Probl Cancer. 2020 Dec;44(6):100578. doi: 10.1016/j.currproblcancer.2020.100578. Epub 2020 Apr 25.,Kang J,https://www.ncbi.nlm.nih.gov/pubmed/32360240
10804,31316185,Multiparametric MRI for prostate cancer diagnosis: current status and future directions,Nat Rev Urol. 2020 Jan;17(1):41-61. doi: 10.1038/s41585-019-0212-4. Epub 2019 Jul 17.,Stabile A,https://www.ncbi.nlm.nih.gov/pubmed/31316185
10805,32293349,Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer,BMC Cancer. 2020 Apr 15;20(1):302. doi: 10.1186/s12885-020-06844-y.,Matsuda Y,https://www.ncbi.nlm.nih.gov/pubmed/32293349
10806,32234928,Therapeutic Effect of Ethinylestradiol in Castration-resistant Prostate Cancer,Anticancer Res. 2020 Apr;40(4):2291-2296. doi: 10.21873/anticanres.14194.,Nakano T,https://www.ncbi.nlm.nih.gov/pubmed/32234928
10808,31692125,Vorticity in lower urinary tract can be assessed and associates with urinary tract morphology in men,Neurourol Urodyn. 2020 Jan;39(1):286-294. doi: 10.1002/nau.24193. Epub 2019 Nov 6.,Minagawa T,https://www.ncbi.nlm.nih.gov/pubmed/31692125
10809,31326500,Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer,Eur Urol Oncol. 2020 Feb;3(1):104-111. doi: 10.1016/j.euo.2019.06.016. Epub 2019 Jul 18.,Joshi SS,https://www.ncbi.nlm.nih.gov/pubmed/31326500
10811,31955172,AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC,Urol Int. 2020;104(3-4):253-262. doi: 10.1159/000504416. Epub 2020 Jan 17.,Erb HHH,https://www.ncbi.nlm.nih.gov/pubmed/31955172
10812,33338056,"Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial",PLoS One. 2020 Dec 18;15(12):e0243928. doi: 10.1371/journal.pone.0243928. eCollection 2020.,Brady L,https://www.ncbi.nlm.nih.gov/pubmed/33338056
10814,32063483,MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4?10ng/mL: Biparametric versus multiparametric MRI,Diagn Interv Imaging. 2020 Apr;101(4):235-244. doi: 10.1016/j.diii.2020.01.014. Epub 2020 Feb 13.,Han C,https://www.ncbi.nlm.nih.gov/pubmed/32063483
10815,32413498,Effects of estrogen receptor signaling on prostate cancer carcinogenesis,Transl Res. 2020 Aug;222:56-66. doi: 10.1016/j.trsl.2020.04.003. Epub 2020 May 12.,Qu LG,https://www.ncbi.nlm.nih.gov/pubmed/32413498
10817,33626542,Preclinical Quantification of Prostate Cancer-Associated Vascular Alterations in the Bone Microenvironment in vivo,Eur Surg Res. 2020;61(6):188-200. doi: 10.1159/000514224. Epub 2021 Feb 24.,Schroeder M,https://www.ncbi.nlm.nih.gov/pubmed/33626542
10820,32393768,Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies,Mod Pathol. 2020 Oct;33(10):2058-2066. doi: 10.1038/s41379-020-0551-y. Epub 2020 May 11.,Raciti P,https://www.ncbi.nlm.nih.gov/pubmed/32393768
10821,32640460,Current Role of Multiparametric MRI and MRI Targeted Biopsies for Prostate Cancer Diagnosis in Germany: A Nationwide Survey,Urol Int. 2020;104(9-10):731-740. doi: 10.1159/000508755. Epub 2020 Jul 8.,Saar M,https://www.ncbi.nlm.nih.gov/pubmed/32640460
10822,32228820,Epidemiological study on more accurate diagnosis of prostate cancer,Cent Eur J Public Health. 2020 Mar;28(1):65-69. doi: 10.21101/cejph.a5720.,Kopecký J,https://www.ncbi.nlm.nih.gov/pubmed/32228820
10824,32192942,Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review,Eur Urol Oncol. 2020 Apr;3(2):145-167. doi: 10.1016/j.euo.2020.02.005. Epub 2020 Mar 17.,Stabile A,https://www.ncbi.nlm.nih.gov/pubmed/32192942
10825,32035258,Development of (G3-C12)-mediated camptothecin polymeric prodrug targeting to Galectin-3 receptor against androgen-independent prostate cancer,Int J Pharm. 2020 Apr 30;580:119123. doi: 10.1016/j.ijpharm.2020.119123. Epub 2020 Feb 5.,Yuan X,https://www.ncbi.nlm.nih.gov/pubmed/32035258
10826,31943737,On evaluating how well a biomarker can predict treatment response with survival data,Pharm Stat. 2020 Jul;19(4):410-423. doi: 10.1002/pst.2002. Epub 2020 Jan 13.,Mboup B,https://www.ncbi.nlm.nih.gov/pubmed/31943737
10827,32224611,Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies,Urol Int. 2020;104(3-4):181-186. doi: 10.1159/000506262. Epub 2020 Mar 30.,Schulze A,https://www.ncbi.nlm.nih.gov/pubmed/32224611
10828,32040715,Determinants of self-reported functional status (EPIC-26) in prostate cancer patients prior to treatment,World J Urol. 2021 Jan;39(1):27-36. doi: 10.1007/s00345-020-03097-z. Epub 2020 Feb 10.,Roth R,https://www.ncbi.nlm.nih.gov/pubmed/32040715
10830,31408512,Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans,Carcinogenesis. 2020 May 14;41(3):267-273. doi: 10.1093/carcin/bgz139.,Xu J,https://www.ncbi.nlm.nih.gov/pubmed/31408512
10832,32183763,Rectal perforation following endorectal prostate MRI: an unexpected complication,BMC Urol. 2020 Mar 17;20(1):28. doi: 10.1186/s12894-020-00591-9.,Hsu I,https://www.ncbi.nlm.nih.gov/pubmed/32183763
10833,31619598,An ERG Gene Analysis in Two Cases with Metastatic Castration-resistant Prostate Cancer in Which Abiraterone Demonstrated Long-term Efficacy,Intern Med. 2020 Feb 1;59(3):395-399. doi: 10.2169/internalmedicine.3302-19. Epub 2019 Oct 17.,Yoshizawa T,https://www.ncbi.nlm.nih.gov/pubmed/31619598
10834,32012233,Incidence and disease burden of prostate cancer from 1990 to 2017: Results from the Global Burden of Disease Study 2017,Cancer. 2020 Jan 1;126(9):1969-1978. doi: 10.1002/cncr.32733. Epub 2020 Feb 3.,Zhai Z,https://www.ncbi.nlm.nih.gov/pubmed/32012233
10835,32633347,VASN promotes proliferation of prostate cancer through the YAP/TAZ axis,Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6589-6596. doi: 10.26355/eurrev_202006_21644.,Cui FL,https://www.ncbi.nlm.nih.gov/pubmed/32633347
10837,31944447,Contemporary consumer perspectives on prostate cancer survivorship: Fifty voices,Psychooncology. 2020 Mar;29(3):557-563. doi: 10.1002/pon.5306. Epub 2020 Jan 15.,Dunn J,https://www.ncbi.nlm.nih.gov/pubmed/31944447
10838,32437994,Right Parietal Skull Xanthoma Characterized as a Metastatic Deposit,World Neurosurg. 2020 Aug;140:56-59. doi: 10.1016/j.wneu.2020.05.015. Epub 2020 May 11.,Jain S,https://www.ncbi.nlm.nih.gov/pubmed/32437994
10840,31816126,Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxel,Prostate. 2020 Feb;80(3):247-255. doi: 10.1002/pros.23938. Epub 2019 Dec 9.,Ando K,https://www.ncbi.nlm.nih.gov/pubmed/31816126
10841,32410514,Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients,Aging Male. 2020 Dec;23(5):1333-1338. doi: 10.1080/13685538.2020.1766013. Epub 2020 May 15.,Kincius M,https://www.ncbi.nlm.nih.gov/pubmed/32410514
10842,32473650,Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016,BMC Cancer. 2020 May 30;20(1):488. doi: 10.1186/s12885-020-06979-y.,Nilssen Y,https://www.ncbi.nlm.nih.gov/pubmed/32473650
10843,32493676,The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?,Clin Genitourin Cancer. 2020 Dec;18(6):e698-e704. doi: 10.1016/j.clgc.2020.04.006. Epub 2020 May 4.,Roscigno M,https://www.ncbi.nlm.nih.gov/pubmed/32493676
10844,31937854,Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer,Sci Rep. 2020 Jan 14;10(1):227. doi: 10.1038/s41598-019-57101-7.,Zedan AH,https://www.ncbi.nlm.nih.gov/pubmed/31937854
10845,32277006,"Prostate Cancer Incidence and Aggressiveness in Appalachia versus Non-Appalachia Populations in Pennsylvania by Urban-Rural Regions, 2004-2014",Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1365-1373. doi: 10.1158/1055-9965.EPI-19-1232. Epub 2020 Apr 10.,McDonald AC,https://www.ncbi.nlm.nih.gov/pubmed/32277006
10846,32171601,"The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer",Clin Genitourin Cancer. 2020 Jun;18(3):e217-e223. doi: 10.1016/j.clgc.2019.09.019. Epub 2019 Oct 10.,Smith K,https://www.ncbi.nlm.nih.gov/pubmed/32171601
10848,32436074,Comparing a new risk prediction model with prostate cancer risk calculator apps in a Taiwanese population,World J Urol. 2021 Mar;39(3):797-802. doi: 10.1007/s00345-020-03256-2. Epub 2020 May 20.,Chen IHA,https://www.ncbi.nlm.nih.gov/pubmed/32436074
10849,32328763,High spatiotemporal resolution dynamic contrast-enhanced MRI improves the image-based discrimination of histopathology risk groups of peripheral zone prostate cancer: a supervised machine learning approach,Eur Radiol. 2020 Sep;30(9):4828-4837. doi: 10.1007/s00330-020-06849-y. Epub 2020 Apr 23.,Winkel DJ,https://www.ncbi.nlm.nih.gov/pubmed/32328763
10850,32238875,Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization,Mod Pathol. 2020 Sep;33(9):1791-1801. doi: 10.1038/s41379-020-0525-0. Epub 2020 Apr 1.,Dedigama-Arachchige P,https://www.ncbi.nlm.nih.gov/pubmed/32238875
10851,32495863,Circular RNA_LARP4 inhibits cell migration and invasion of prostate cancer by targeting FOXO3A,Eur Rev Med Pharmacol Sci. 2020 May;24(10):5303-5309. doi: 10.26355/eurrev_202005_21312.,Weng XD,https://www.ncbi.nlm.nih.gov/pubmed/32495863
10852,31912360,Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review,Support Care Cancer. 2020 May;28(5):2079-2093. doi: 10.1007/s00520-019-05255-5. Epub 2020 Jan 7.,Edmunds K,https://www.ncbi.nlm.nih.gov/pubmed/31912360
10853,31053766,Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC),Prostate Cancer Prostatic Dis. 2020 Mar;23(1):66-73. doi: 10.1038/s41391-019-0152-3. Epub 2019 May 3.,Ryan CJ,https://www.ncbi.nlm.nih.gov/pubmed/31053766
10854,32338768,Rare germline genetic variants and risk of aggressive prostate cancer,Int J Cancer. 2020 Oct 15;147(8):2142-2149. doi: 10.1002/ijc.33024. Epub 2020 May 8.,Nguyen-Dumont T,https://www.ncbi.nlm.nih.gov/pubmed/32338768
10857,31055625,Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital,World J Urol. 2020 Feb;38(2):371-379. doi: 10.1007/s00345-019-02774-y. Epub 2019 May 4.,Donato P,https://www.ncbi.nlm.nih.gov/pubmed/31055625
10858,31767492,Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation,Eur Urol. 2020 Apr;77(4):469-480. doi: 10.1016/j.eururo.2019.10.024. Epub 2019 Nov 23.,Israël B,https://www.ncbi.nlm.nih.gov/pubmed/31767492
10859,31806540,"Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial",Lancet Oncol. 2020 Jan;21(1):162-174. doi: 10.1016/S1470-2045(19)30684-9. Epub 2019 Dec 2.,Mateo J,https://www.ncbi.nlm.nih.gov/pubmed/31806540
10860,32027071,Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI,J Magn Reson Imaging. 2020 Aug;52(2):552-564. doi: 10.1002/jmri.27075. Epub 2020 Feb 6.,Cui Y,https://www.ncbi.nlm.nih.gov/pubmed/32027071
10861,32111923,Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):517-526. doi: 10.1038/s41391-020-0213-7. Epub 2020 Feb 28.,Sartor O,https://www.ncbi.nlm.nih.gov/pubmed/32111923
10862,32238934,A genomic and epigenomic atlas of prostate cancer in Asian populations,Nature. 2020 Apr;580(7801):93-99. doi: 10.1038/s41586-020-2135-x. Epub 2020 Mar 25.,Li J,https://www.ncbi.nlm.nih.gov/pubmed/32238934
10863,30913093,The association of metabolic syndrome and its components with serum prostate-specific antigen levels,Eur J Cancer Prev. 2020 Jan;29(1):36-41. doi: 10.1097/CEJ.0000000000000508.,Gao X,https://www.ncbi.nlm.nih.gov/pubmed/30913093
10864,32421745,Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer,PLoS One. 2020 May 18;15(5):e0233442. doi: 10.1371/journal.pone.0233442. eCollection 2020.,Macagno A,https://www.ncbi.nlm.nih.gov/pubmed/32421745
10865,31829421,Utility of index lesion volume assessed by multiparametric MRI combined with Gleason grade for assessment of lymph node involvement in patients with high-risk prostate cancer,Jpn J Clin Oncol. 2020 Mar 9;50(3):333-337. doi: 10.1093/jjco/hyz170.,Hatano K,https://www.ncbi.nlm.nih.gov/pubmed/31829421
10866,32448679,Sexual Motivators and Endorsement of Models Describing Sexual Response of Men Undergoing Androgen Deprivation Therapy for Advanced Prostate Cancer,J Sex Med. 2020 Aug;17(8):1538-1543. doi: 10.1016/j.jsxm.2020.04.006. Epub 2020 May 21.,Fode M,https://www.ncbi.nlm.nih.gov/pubmed/32448679
10868,33195694,Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence,Biomed Res Int. 2020 Oct 28;2020:5845374. doi: 10.1155/2020/5845374. eCollection 2020.,Kind S,https://www.ncbi.nlm.nih.gov/pubmed/33195694
10869,31980029,Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis,Cell Commun Signal. 2020 Jan 24;18(1):11. doi: 10.1186/s12964-019-0505-5.,Neuwirt H,https://www.ncbi.nlm.nih.gov/pubmed/31980029
10872,32279066,Active Surveillance of Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: A Review of the Current Role and Future Perspectives,Med Sci Monit. 2020 Apr 12;26:e920252. doi: 10.12659/MSM.920252.,Sklinda K,https://www.ncbi.nlm.nih.gov/pubmed/32279066
10873,32064561,Stimulated-echo diffusion-weighted imaging with moderate b values for the detection of prostate cancer,Eur Radiol. 2020 Jun;30(6):3236-3244. doi: 10.1007/s00330-020-06689-w. Epub 2020 Feb 16.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/32064561
10876,32142374,Ultrasound elastography in characterization of prostatic lesions: correlation with histopathological findings,Br J Radiol. 2020 Jun;93(1110):20200035. doi: 10.1259/bjr.20200035. Epub 2020 Mar 23.,Emara DM,https://www.ncbi.nlm.nih.gov/pubmed/32142374
10877,32150897,DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types,Cells. 2020 Mar 5;9(3):624. doi: 10.3390/cells9030624.,Constâncio V,https://www.ncbi.nlm.nih.gov/pubmed/32150897
10879,32350662,MRI-directed high-frequency (29MhZ) TRUS-guided biopsies: initial results of a single-center study,Eur Radiol. 2020 Sep;30(9):4838-4846. doi: 10.1007/s00330-020-06882-x. Epub 2020 Apr 29.,Cornud F,https://www.ncbi.nlm.nih.gov/pubmed/32350662
10880,32316350,A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types,Int J Mol Sci. 2020 Apr 16;21(8):2783. doi: 10.3390/ijms21082783.,Pastor-Navarro B,https://www.ncbi.nlm.nih.gov/pubmed/32316350
10882,32152435,Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):539-548. doi: 10.1038/s41391-020-0222-6. Epub 2020 Mar 9.,Mori K,https://www.ncbi.nlm.nih.gov/pubmed/32152435
10883,32314873,Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone,EMBO Rep. 2020 Jun 4;21(6):e50162. doi: 10.15252/embr.202050162. Epub 2020 Apr 21.,Owen KL,https://www.ncbi.nlm.nih.gov/pubmed/32314873
10884,32294481,Concordance and Performance of 4Kscore and SelectMDx for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer,Urology. 2020 Jul;141:119-124. doi: 10.1016/j.urology.2020.02.032. Epub 2020 Apr 12.,Wysock JS,https://www.ncbi.nlm.nih.gov/pubmed/32294481
10885,32444265,Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis,Eur Urol. 2020 Sep;78(3):402-414. doi: 10.1016/j.eururo.2020.03.048. Epub 2020 May 20.,Sathianathen NJ,https://www.ncbi.nlm.nih.gov/pubmed/32444265
10886,32303599,Factors Predicting Metastatic Disease in (68)Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer,J Nucl Med. 2020 Dec;61(12):1779-1785. doi: 10.2967/jnumed.119.241174. Epub 2020 Apr 17.,Chiu LW,https://www.ncbi.nlm.nih.gov/pubmed/32303599
10887,30406690,"Excelsanone, a new isoflavonoid from Erythrina excelsa (Fabaceae), with in vitro antioxidant and in vitro cytotoxic effects on prostate cancer cells lines",Nat Prod Res. 2020 Mar;34(5):659-667. doi: 10.1080/14786419.2018.1495639. Epub 2018 Nov 8.,Gbaweng AJY,https://www.ncbi.nlm.nih.gov/pubmed/30406690
10890,32382028,Prostate cancer screening research can benefit from network medicine: an emerging awareness,NPJ Syst Biol Appl. 2020 May 7;6(1):13. doi: 10.1038/s41540-020-0133-0.,Panebianco V,https://www.ncbi.nlm.nih.gov/pubmed/32382028
10891,32016503,Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model,Cancer Immunol Immunother. 2020 Apr;69(4):641-651. doi: 10.1007/s00262-020-02493-z. Epub 2020 Feb 4.,Simons BW,https://www.ncbi.nlm.nih.gov/pubmed/32016503
10893,32232921,Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?,BJU Int. 2020 Jul;126(1):124-132. doi: 10.1111/bju.15065. Epub 2020 Apr 22.,Osses DF,https://www.ncbi.nlm.nih.gov/pubmed/32232921
10894,31980408,Relationship Between Metastasis-free Survival and Overall Survival in Patients With Nonmetastatic Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Apr;18(2):e180-e189. doi: 10.1016/j.clgc.2019.10.030. Epub 2019 Nov 6.,Smith MR,https://www.ncbi.nlm.nih.gov/pubmed/31980408
10895,31125113,"Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study",Int J Cancer. 2020 Mar 1;146(5):1261-1267. doi: 10.1002/ijc.32428. Epub 2019 Jun 4.,Gào X,https://www.ncbi.nlm.nih.gov/pubmed/31125113
10897,31770548,Health Care Disparities in Urologic Oncology: A Systematic Review,Urology. 2020 Feb;136:9-18. doi: 10.1016/j.urology.2019.09.058. Epub 2019 Nov 23.,Das H,https://www.ncbi.nlm.nih.gov/pubmed/31770548
10898,32286386,Effects of orthotopic implantation of rat prostate tumour cells upon components of the N-acylethanolamine and monoacylglycerol signalling systems: an mRNA study,Sci Rep. 2020 Apr 14;10(1):6314. doi: 10.1038/s41598-020-63198-y.,Alhouayek M,https://www.ncbi.nlm.nih.gov/pubmed/32286386
10899,31718392,Functionally modified magnetic nanoparticles for effective siRNA delivery to prostate cancer cells in vitro,J Biomater Appl. 2020 Feb;34(7):952-964. doi: 10.1177/0885328219886953. Epub 2019 Nov 13.,Panday R,https://www.ncbi.nlm.nih.gov/pubmed/31718392
10901,31794091,The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer,Prostate. 2020 Feb;80(2):198-208. doi: 10.1002/pros.23932. Epub 2019 Dec 3.,Pardy L,https://www.ncbi.nlm.nih.gov/pubmed/31794091
10902,32207920,EV-Ident: Identifying Tumor-Specific Extracellular Vesicles by Size Fractionation and Single-Vesicle Analysis,Anal Chem. 2020 Apr 21;92(8):6010-6018. doi: 10.1021/acs.analchem.0c00285. Epub 2020 Apr 7.,Kim D,https://www.ncbi.nlm.nih.gov/pubmed/32207920
10905,31942459,Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting,Investig Clin Urol. 2020 Jan;61(1):19-27. doi: 10.4111/icu.2020.61.1.19. Epub 2019 Dec 10.,Jung SI,https://www.ncbi.nlm.nih.gov/pubmed/31942459
10906,31959826,Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer,Nat Commun. 2020 Jan 20;11(1):384. doi: 10.1038/s41467-019-14184-0.,Tiwari R,https://www.ncbi.nlm.nih.gov/pubmed/31959826
10907,31765989,Increased risk for second primary rectal cancer after pelvic radiation therapy,Eur J Cancer. 2020 Jan;124:142-151. doi: 10.1016/j.ejca.2019.10.022. Epub 2019 Nov 22.,Rombouts AJM,https://www.ncbi.nlm.nih.gov/pubmed/31765989
10908,32440915,Latest progress in molecular biology and treatment in genitourinary tumours,Clin Transl Oncol. 2020 Dec;22(12):2175-2195. doi: 10.1007/s12094-020-02373-z. Epub 2020 May 21.,González-Del-Alba A,https://www.ncbi.nlm.nih.gov/pubmed/32440915
10910,31556911,Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial,JAMA Oncol. 2020 Feb 1;6(2):e193332. doi: 10.1001/jamaoncol.2019.3332. Epub 2020 Feb 13.,Dueck AC,https://www.ncbi.nlm.nih.gov/pubmed/31556911
10911,29571270,Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis,Aging Male. 2020 Jun;23(2):132-138. doi: 10.1080/13685538.2018.1455178. Epub 2018 Mar 23.,Russo GI,https://www.ncbi.nlm.nih.gov/pubmed/29571270
10913,32341393,"Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12?Gy single-dose",Sci Rep. 2020 Apr 27;10(1):7050. doi: 10.1038/s41598-020-64062-9.,Pisani C,https://www.ncbi.nlm.nih.gov/pubmed/32341393
10915,32430485,Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer,Mol Cancer Ther. 2020 Aug;19(8):1708-1718. doi: 10.1158/1535-7163.MCT-20-0015. Epub 2020 May 19.,Zhao J,https://www.ncbi.nlm.nih.gov/pubmed/32430485
10917,31918265,ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D,Biomed Pharmacother. 2020 Feb;122:109557. doi: 10.1016/j.biopha.2019.109557. Epub 2019 Dec 30.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/31918265
10918,32339056,"A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer",Int J Biol Markers. 2020 Jun;35(2):74-81. doi: 10.1177/1724600820914944. Epub 2020 Apr 27.,Wang D,https://www.ncbi.nlm.nih.gov/pubmed/32339056
10919,31705219,Corticosteroid switch after progression on abiraterone acetate plus prednisone,Int J Clin Oncol. 2020 Feb;25(2):240-246. doi: 10.1007/s10147-019-01577-w. Epub 2019 Nov 8.,Roviello G,https://www.ncbi.nlm.nih.gov/pubmed/31705219
10920,32169916,(68)Ga-PSMA-Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer,J Nucl Med. 2020 Nov;61(11):1607-1614. doi: 10.2967/jnumed.119.241109. Epub 2020 Mar 13.,de Jong AC,https://www.ncbi.nlm.nih.gov/pubmed/32169916
10921,32121073,Exosomes are the Driving Force in Preparing the Soil for the Metastatic Seeds: Lessons from the Prostate Cancer,Cells. 2020 Feb 28;9(3):564. doi: 10.3390/cells9030564.,Saber SH,https://www.ncbi.nlm.nih.gov/pubmed/32121073
10922,31808980,Multiparametric MRI-Based Radiomics for Prostate Cancer Screening With PSA in 4-10 ng/mL to Reduce Unnecessary Biopsies,J Magn Reson Imaging. 2020 Jun;51(6):1890-1899. doi: 10.1002/jmri.27008. Epub 2019 Dec 6.,Qi Y,https://www.ncbi.nlm.nih.gov/pubmed/31808980
10926,32359345,Is there a non-linear relationship between dietary protein intake and prostate-specific antigen: proof from the national health and nutrition examination survey (2003-2010),Lipids Health Dis. 2020 May 2;19(1):82. doi: 10.1186/s12944-020-01234-6.,Song J,https://www.ncbi.nlm.nih.gov/pubmed/32359345
10927,31724998,The changing role of lasers in urologic surgery,Curr Opin Urol. 2020 Jan;30(1):24-29. doi: 10.1097/MOU.0000000000000695.,Enikeev D,https://www.ncbi.nlm.nih.gov/pubmed/31724998
10930,31929449,Improvement of Constipation Symptoms in an Older Adult Patient by Defecation Care Based on Using a Handheld Ultrasound Device in Home Care Settings: A Case Report,J Wound Ostomy Continence Nurs. 2020 Jan/Feb;47(1):75-78. doi: 10.1097/WON.0000000000000610.,Matsumoto M,https://www.ncbi.nlm.nih.gov/pubmed/31929449
10932,32421185,Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model,JAMA Netw Open. 2020 May 1;3(5):e205165. doi: 10.1001/jamanetworkopen.2020.5165.,Walker B,https://www.ncbi.nlm.nih.gov/pubmed/32421185
10933,32273234,Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel,Clin Genitourin Cancer. 2020 Jun;18(3):222-229.e2. doi: 10.1016/j.clgc.2019.10.002. Epub 2019 Oct 17.,Ryan CJ,https://www.ncbi.nlm.nih.gov/pubmed/32273234
10934,31925912,SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-? signaling promotes prostate cancer bone metastasis,Mol Oncol. 2020 Apr;14(4):808-828. doi: 10.1002/1878-0261.12634. Epub 2020 Feb 8.,Lang C,https://www.ncbi.nlm.nih.gov/pubmed/31925912
10935,32194866,"Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria",Theranostics. 2020 Feb 10;10(7):3254-3262. doi: 10.7150/thno.39838. eCollection 2020.,Velez EM,https://www.ncbi.nlm.nih.gov/pubmed/32194866
10936,33178832,Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis,Biomed Res Int. 2020 Oct 29;2020:6037434. doi: 10.1155/2020/6037434. eCollection 2020.,Sun Y,https://www.ncbi.nlm.nih.gov/pubmed/33178832
10937,33569050,"Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors",Front Immunol. 2021 Jan 25;11:586126. doi: 10.3389/fimmu.2020.586126. eCollection 2020.,Gallazzi M,https://www.ncbi.nlm.nih.gov/pubmed/33569050
10938,32362484,Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry,Eur Urol Focus. 2021 Jul;7(4):788-796. doi: 10.1016/j.euf.2020.03.009. Epub 2020 Apr 30.,Notohardjo JCL,https://www.ncbi.nlm.nih.gov/pubmed/32362484
10940,31926805,Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study,Lancet Oncol. 2020 Feb;21(2):233-241. doi: 10.1016/S1470-2045(19)30739-9. Epub 2020 Jan 8.,Bulten W,https://www.ncbi.nlm.nih.gov/pubmed/31926805
10941,32930086,MicroRNA-92a Inhibits the Cell Viability and Metastasis of Prostate Cancer by Targeting SOX4,Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820959354. doi: 10.1177/1533033820959354.,Liao G,https://www.ncbi.nlm.nih.gov/pubmed/32930086
10942,32319592,Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10?AS1/CBP/FOXM1 signaling pathway,Int J Oncol. 2020 Jul;57(1):314-324. doi: 10.3892/ijo.2020.5036. Epub 2020 Apr 1.,Zhou Y,https://www.ncbi.nlm.nih.gov/pubmed/32319592
10944,32095882,Infectious complications of prostate biopsy: winning battles but not war,World J Urol. 2020 Nov;38(11):2743-2753. doi: 10.1007/s00345-020-03112-3. Epub 2020 Feb 24.,Derin O,https://www.ncbi.nlm.nih.gov/pubmed/32095882
10946,33217255,Comparison of effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis,J Pharm Pharm Sci. 2020;23:451-461. doi: 10.18433/jpps31003.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/33217255
10948,30862227,Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5-10?ng/mL and 10.1-30?ng/mL?,Aging Male. 2020 Mar;23(1):59-65. doi: 10.1080/13685538.2019.1578741. Epub 2019 Mar 12.,Erdogan A,https://www.ncbi.nlm.nih.gov/pubmed/30862227
10949,32439702,Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression,Mol Cancer Res. 2020 Aug;18(8):1244-1254. doi: 10.1158/1541-7786.MCR-20-0060. Epub 2020 May 21.,Sullivan C,https://www.ncbi.nlm.nih.gov/pubmed/32439702
10950,31767448,Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Feb;18(1):69-76.e4. doi: 10.1016/j.clgc.2019.09.010. Epub 2019 Sep 27.,Caffo O,https://www.ncbi.nlm.nih.gov/pubmed/31767448
10952,32219665,Cross-sectional associations between angiotensin-converting enzyme inhibitor use and cancer diagnosis in US adults,Clin Exp Med. 2020 Aug;20(3):409-416. doi: 10.1007/s10238-020-00622-7. Epub 2020 Mar 26.,Smith L,https://www.ncbi.nlm.nih.gov/pubmed/32219665
10953,31255618,Systemic Treatment of Bone Disease in Metastatic Urinary Malignancies,Eur Urol Focus. 2020 Jan 15;6(1):17-25. doi: 10.1016/j.euf.2019.06.007. Epub 2019 Jun 27.,Patel SH,https://www.ncbi.nlm.nih.gov/pubmed/31255618
10954,32175798,The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility,Cancer Biol Ther. 2020 Jun 2;21(6):533-540. doi: 10.1080/15384047.2020.1736481. Epub 2020 Mar 16.,Zacharopoulou N,https://www.ncbi.nlm.nih.gov/pubmed/32175798
10955,32133742,Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy,Cancer Sci. 2020 May;111(5):1567-1581. doi: 10.1111/cas.14375. Epub 2020 Mar 30.,Cui SZ,https://www.ncbi.nlm.nih.gov/pubmed/32133742
10956,31621172,"Toward (18) F-Labeled Theranostics: A Single Agent that Can Be Labeled with (18) F, (64) Cu, or (177) Lu",Chembiochem. 2020 Apr 1;21(7):943-947. doi: 10.1002/cbic.201900632. Epub 2019 Dec 4.,Lepage ML,https://www.ncbi.nlm.nih.gov/pubmed/31621172
10957,31844959,Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study,Eur Radiol. 2020 Apr;30(4):2082-2090. doi: 10.1007/s00330-019-06557-2. Epub 2019 Dec 16.,Giganti F,https://www.ncbi.nlm.nih.gov/pubmed/31844959
10959,32385116,The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population,Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1381-1388. doi: 10.1158/1055-9965.EPI-19-1560. Epub 2020 May 8.,Darst BF,https://www.ncbi.nlm.nih.gov/pubmed/32385116
10960,31810867,The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study,Clin Genitourin Cancer. 2020 Apr;18(2):e103-e111. doi: 10.1016/j.clgc.2019.09.006. Epub 2019 Sep 27.,Okita K,https://www.ncbi.nlm.nih.gov/pubmed/31810867
10961,32041153,Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma,Int J Mol Sci. 2020 Feb 6;21(3):1078. doi: 10.3390/ijms21031078.,Ostano P,https://www.ncbi.nlm.nih.gov/pubmed/32041153
10962,31892584,Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel,Anticancer Res. 2020 Jan;40(1):335-339. doi: 10.21873/anticanres.13957.,Shiota M,https://www.ncbi.nlm.nih.gov/pubmed/31892584
10964,32196577,Circ PSMC3 inhibits prostate cancer cell proliferation by downregulating DGCR8,Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2264-2270. doi: 10.26355/eurrev_202003_20492.,Dong JS,https://www.ncbi.nlm.nih.gov/pubmed/32196577
10967,32099001,Prostate Cancer Nodal Staging: Using Deep Learning to Predict (68)Ga-PSMA-Positivity from CT Imaging Alone,Sci Rep. 2020 Feb 25;10(1):3398. doi: 10.1038/s41598-020-60311-z.,Hartenstein A,https://www.ncbi.nlm.nih.gov/pubmed/32099001
10968,32355025,Regenerative potential of prostate luminal cells revealed by single-cell analysis,Science. 2020 May 1;368(6490):497-505. doi: 10.1126/science.aay0267.,Karthaus WR,https://www.ncbi.nlm.nih.gov/pubmed/32355025
10969,32336645,"Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study",Eur Urol. 2020 Oct;78(4):603-614. doi: 10.1016/j.eururo.2020.03.019. Epub 2020 Apr 23.,Stenzl A,https://www.ncbi.nlm.nih.gov/pubmed/32336645
10970,32183428,The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert,Genes (Basel). 2020 Mar 15;11(3):312. doi: 10.3390/genes11030312.,Gu Y,https://www.ncbi.nlm.nih.gov/pubmed/32183428
10971,31564004,Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study,Int J Clin Oncol. 2020 Mar;25(3):486-494. doi: 10.1007/s10147-019-01554-3. Epub 2019 Sep 28.,Iguchi T,https://www.ncbi.nlm.nih.gov/pubmed/31564004
10973,32273182,"""PSA Surveillance in the Septuagenarian"": A Proposed New Terminology for Clinical Follow-up to Assess Risk of Prostate Cancer in Men Aged 70 Years and Older",Eur Urol. 2020 Aug;78(2):136-137. doi: 10.1016/j.eururo.2020.03.028. Epub 2020 Apr 6.,Carlsson SV,https://www.ncbi.nlm.nih.gov/pubmed/32273182
10974,32024430,"An Educational Program to Help Patients Manage Androgen Deprivation Therapy Side Effects: Feasibility, Acceptability, and Preliminary Outcomes",Am J Mens Health. 2020 Jan-Feb;14(1):1557988319898991. doi: 10.1177/1557988319898991.,Wibowo E,https://www.ncbi.nlm.nih.gov/pubmed/32024430
10976,31974616,Identification of aberrantly methylated?differentially expressed genes and gene ontology in prostate cancer,Mol Med Rep. 2020 Feb;21(2):744-758. doi: 10.3892/mmr.2019.10876. Epub 2019 Dec 11.,Wang L,https://www.ncbi.nlm.nih.gov/pubmed/31974616
10977,32132214,Knowing what's growing: Why ductal and intraductal prostate cancer matter,Sci Transl Med. 2020 Mar 4;12(533):eaaz0152. doi: 10.1126/scitranslmed.aaz0152.,Lawrence MG,https://www.ncbi.nlm.nih.gov/pubmed/32132214
10978,32330514,The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells,Cancer Lett. 2020 Jul 28;483:12-21. doi: 10.1016/j.canlet.2020.03.030. Epub 2020 Apr 21.,Siddiqui S,https://www.ncbi.nlm.nih.gov/pubmed/32330514
10980,31318977,Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer,Int J Cancer. 2020 May 15;146(10):2694-2702. doi: 10.1002/ijc.32577. Epub 2019 Jul 27.,Hashim D,https://www.ncbi.nlm.nih.gov/pubmed/31318977
10983,32127231,Complications of transrectal prostate biopsy in our context. International multicenter study of 3350 patients,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):196-204. doi: 10.1016/j.acuro.2019.11.004. Epub 2020 Feb 29.,Perán Teruel M,https://www.ncbi.nlm.nih.gov/pubmed/32127231
10984,31926806,"Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study",Lancet Oncol. 2020 Feb;21(2):222-232. doi: 10.1016/S1470-2045(19)30738-7. Epub 2020 Jan 8.,Ström P,https://www.ncbi.nlm.nih.gov/pubmed/31926806
10986,32433882,Sub-zeptomole Detection of Biomarker Proteins Using a Microfluidic Immunoarray with Nanostructured Sensors,Anal Chem. 2020 Jun 16;92(12):8021-8025. doi: 10.1021/acs.analchem.0c01507. Epub 2020 May 27.,Dhanapala L,https://www.ncbi.nlm.nih.gov/pubmed/32433882
10987,32289380,Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer,Ann Oncol. 2020 Jul;31(7):930-941. doi: 10.1016/j.annonc.2020.03.309. Epub 2020 Apr 11.,Halabi S,https://www.ncbi.nlm.nih.gov/pubmed/32289380
10988,32383093,Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [(177)Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial),Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):113-122. doi: 10.1007/s00259-020-04797-9. Epub 2020 May 8.,Ahmadzadehfar H,https://www.ncbi.nlm.nih.gov/pubmed/32383093
10991,31883940,Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands,Clin Genitourin Cancer. 2020 Jun;18(3):e233-e253. doi: 10.1016/j.clgc.2019.11.015. Epub 2019 Dec 5.,Kuppen MCP,https://www.ncbi.nlm.nih.gov/pubmed/31883940
10993,31971823,The effect of capped biparametric magnetic resonance imaging slots on weekly prostate cancer imaging workload,Br J Radiol. 2020 Apr;93(1108):20190929. doi: 10.1259/bjr.20190929. Epub 2020 Feb 3.,Sushentsev N,https://www.ncbi.nlm.nih.gov/pubmed/31971823
10994,31763714,Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment,Prostate. 2020 Feb;80(2):173-185. doi: 10.1002/pros.23929. Epub 2019 Nov 25.,Vickman RE,https://www.ncbi.nlm.nih.gov/pubmed/31763714
10995,32061825,Transperineal Free-hand mpMRI Fusion-targeted Biopsies Under Local Anesthesia: Technique and Feasibility From a Single-center Prospective Study,Urology. 2020 Jun;140:122-131. doi: 10.1016/j.urology.2019.11.078. Epub 2020 Feb 13.,Marra G,https://www.ncbi.nlm.nih.gov/pubmed/32061825
10996,32202923,Targeted ?-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies,Cancer Biother Radiopharm. 2020 Sep;35(7):475-484. doi: 10.1089/cbr.2019.3340. Epub 2020 Mar 23.,Jadvar H,https://www.ncbi.nlm.nih.gov/pubmed/32202923
10998,32702615,Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer,Cancer Treat Res Commun. 2020;24:100193. doi: 10.1016/j.ctarc.2020.100193. Epub 2020 Jul 14.,Moses M,https://www.ncbi.nlm.nih.gov/pubmed/32702615
10999,31239236,Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?,Eur Urol Oncol. 2020 Apr;3(2):216-223. doi: 10.1016/j.euo.2019.06.005. Epub 2019 Jun 22.,Exterkate L,https://www.ncbi.nlm.nih.gov/pubmed/31239236
11000,31993991,Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients,Clin Drug Investig. 2020 Mar;40(3):211-226. doi: 10.1007/s40261-020-00888-5.,Di Nunno V,https://www.ncbi.nlm.nih.gov/pubmed/31993991
11001,32570240,Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy,Oncology. 2020;98(10):743-747. doi: 10.1159/000509434. Epub 2020 Jun 22.,Di Lorenzo G,https://www.ncbi.nlm.nih.gov/pubmed/32570240
11003,32112280,Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone,Adv Ther. 2020 May;37(5):2083-2097. doi: 10.1007/s12325-020-01260-x. Epub 2020 Feb 28.,Ramaswamy K,https://www.ncbi.nlm.nih.gov/pubmed/32112280
11005,32904490,Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer,Biomed Res Int. 2020 Aug 20;2020:7586521. doi: 10.1155/2020/7586521. eCollection 2020.,Li S,https://www.ncbi.nlm.nih.gov/pubmed/32904490
11006,30993424,A critical appraisal of biomarkers in prostate cancer,World J Urol. 2020 Mar;38(3):547-554. doi: 10.1007/s00345-019-02759-x. Epub 2019 Apr 16.,Narayan VM,https://www.ncbi.nlm.nih.gov/pubmed/30993424
11008,31594705,Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study,Eur Urol. 2020 Mar;77(3):380-387. doi: 10.1016/j.eururo.2019.09.019. Epub 2019 Oct 5.,Thiery-Vuillemin A,https://www.ncbi.nlm.nih.gov/pubmed/31594705
11009,31742767,PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study,Prostate. 2020 Jan;80(1):99-108. doi: 10.1002/pros.23922. Epub 2019 Nov 19.,Petrylak DP,https://www.ncbi.nlm.nih.gov/pubmed/31742767
11010,32801692,Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer,Int J Nanomedicine. 2020 Jul 29;15:5333-5344. doi: 10.2147/IJN.S258856. eCollection 2020.,Wan Z,https://www.ncbi.nlm.nih.gov/pubmed/32801692
11011,31659808,Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4,Mol Carcinog. 2020 Jan;59(1):45-55. doi: 10.1002/mc.23127. Epub 2019 Oct 29.,Xiao F,https://www.ncbi.nlm.nih.gov/pubmed/31659808
11012,31677604,Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor,Iran Biomed J. 2020 Mar;24(2):81-8. doi: 10.29252/ibj.24.2.81. Epub 2019 Oct 23.,Hassani M,https://www.ncbi.nlm.nih.gov/pubmed/31677604
11014,31848822,A Novel Prediction Tool Based on Multiparametric Magnetic Resonance Imaging to Determine the Biopsy Strategy for Clinically Significant Prostate Cancer in Patients with PSA Levels Less than 50 ng/ml,Ann Surg Oncol. 2020 Apr;27(4):1284-1295. doi: 10.1245/s10434-019-08111-2. Epub 2019 Dec 17.,He BM,https://www.ncbi.nlm.nih.gov/pubmed/31848822
11015,33370378,Observational study on time on treatment with abiraterone and enzalutamide,PLoS One. 2020 Dec 28;15(12):e0244462. doi: 10.1371/journal.pone.0244462. eCollection 2020.,Fallara G,https://www.ncbi.nlm.nih.gov/pubmed/33370378
11016,31564440,Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1,Cell Metab. 2020 Jan 7;31(1):105-114.e3. doi: 10.1016/j.cmet.2019.08.024. Epub 2019 Sep 26.,Granlund KL,https://www.ncbi.nlm.nih.gov/pubmed/31564440
11018,31471556,Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):160-171. doi: 10.1038/s41391-019-0172-z. Epub 2019 Aug 30.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/31471556
11020,32238575,"Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer",Sci Transl Med. 2020 Apr 1;12(537):eaaz3577. doi: 10.1126/scitranslmed.aaz3577.,Subudhi SK,https://www.ncbi.nlm.nih.gov/pubmed/32238575
11021,31768692,Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis,Int J Clin Oncol. 2020 Feb;25(2):247-257. doi: 10.1007/s10147-019-01578-9. Epub 2019 Nov 25.,Mori K,https://www.ncbi.nlm.nih.gov/pubmed/31768692
11022,32673844,Recent developments in the treatment of non-metastatic castration resistant prostate cancer,Cancer Treat Res Commun. 2020;24:100181. doi: 10.1016/j.ctarc.2020.100181. Epub 2020 May 22.,Esther J,https://www.ncbi.nlm.nih.gov/pubmed/32673844
11024,32289552,Trends in Radiation Fractionation for Bone Metastases: A Contemporary Nationwide Analysis,Pract Radiat Oncol. 2020 Nov-Dec;10(6):402-408. doi: 10.1016/j.prro.2020.03.009. Epub 2020 Apr 11.,Wegner RE,https://www.ncbi.nlm.nih.gov/pubmed/32289552
11025,32669958,The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer,Int J Med Sci. 2020 Jun 21;17(11):1550-1560. doi: 10.7150/ijms.46780. eCollection 2020.,Geng X,https://www.ncbi.nlm.nih.gov/pubmed/32669958
11027,31899283,DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations,Magn Reson Imaging. 2020 Apr;67:50-58. doi: 10.1016/j.mri.2019.12.007. Epub 2019 Dec 30.,Giganti F,https://www.ncbi.nlm.nih.gov/pubmed/31899283
11028,31541465,MTSS1 hypermethylation is associated with prostate cancer progression,J Cell Physiol. 2020 Mar;235(3):2687-2697. doi: 10.1002/jcp.29172. Epub 2019 Sep 20.,Chen J,https://www.ncbi.nlm.nih.gov/pubmed/31541465
11029,32313227,Intratumor ?-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression,Oncogene. 2020 May;39(22):4358-4374. doi: 10.1038/s41388-020-1281-9. Epub 2020 Apr 20.,Li M,https://www.ncbi.nlm.nih.gov/pubmed/32313227
11030,32135040,Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis,Cancer Med. 2020 May;9(9):3142-3152. doi: 10.1002/cam4.2960. Epub 2020 Mar 5.,White-Gilbertson S,https://www.ncbi.nlm.nih.gov/pubmed/32135040
11031,31693255,Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer,J Cell Biochem. 2020 Apr;121(4):2756-2769. doi: 10.1002/jcb.29515. Epub 2019 Nov 6.,Liu WJ,https://www.ncbi.nlm.nih.gov/pubmed/31693255
11032,32952813,Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer,Pan Afr Med J. 2020 Jul 9;36:169. doi: 10.11604/pamj.2020.36.169.21038. eCollection 2020.,Tolani MA,https://www.ncbi.nlm.nih.gov/pubmed/32952813
11033,31943289,Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter?,Prostate. 2020 Apr;80(5):399-406. doi: 10.1002/pros.23954. Epub 2020 Jan 13.,Andrews JR,https://www.ncbi.nlm.nih.gov/pubmed/31943289
11034,31694931,Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis,Mol Cancer Res. 2020 Feb;18(2):240-252. doi: 10.1158/1541-7786.MCR-19-0722. Epub 2019 Nov 6.,Wang H,https://www.ncbi.nlm.nih.gov/pubmed/31694931
11039,32393869,Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression,Nat Ecol Evol. 2020 Jun;4(6):870-884. doi: 10.1038/s41559-020-1157-y. Epub 2020 May 11.,Frankenstein Z,https://www.ncbi.nlm.nih.gov/pubmed/32393869
11040,32094488,Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):507-516. doi: 10.1038/s41391-020-0214-6. Epub 2020 Feb 24.,Gupta S,https://www.ncbi.nlm.nih.gov/pubmed/32094488
11041,32171277,Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report,BMC Cancer. 2020 Mar 14;20(1):215. doi: 10.1186/s12885-020-6657-2.,Simmons AD,https://www.ncbi.nlm.nih.gov/pubmed/32171277
11043,30194031,"ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer",Eur Urol Focus. 2020 Jan 15;6(1):63-70. doi: 10.1016/j.euf.2018.08.022. Epub 2018 Sep 5.,Peltola KJ,https://www.ncbi.nlm.nih.gov/pubmed/30194031
11045,31759831,Sequential Use of Androgen Receptor Axis-targeted Agents in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Retrospective Analysis With 3-Year Follow-up,Clin Genitourin Cancer. 2020 Feb;18(1):e46-e54. doi: 10.1016/j.clgc.2019.09.011. Epub 2019 Sep 26.,Kobayashi T,https://www.ncbi.nlm.nih.gov/pubmed/31759831
11047,31630979,Pharmacokinetic/Pharmacodynamic Relationship of Enzalutamide and Its Active Metabolite N-Desmethyl Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients,Clin Genitourin Cancer. 2020 Apr;18(2):155-160. doi: 10.1016/j.clgc.2019.05.020. Epub 2019 Jun 13.,Joulia ML,https://www.ncbi.nlm.nih.gov/pubmed/31630979
11048,32857787,Inadequate tissue mineralization promotes cancer cell attachment,PLoS One. 2020 Aug 28;15(8):e0237116. doi: 10.1371/journal.pone.0237116. eCollection 2020.,Sariisik E,https://www.ncbi.nlm.nih.gov/pubmed/32857787
11049,32284318,An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer,Clin Cancer Res. 2020 Sep 15;26(18):4717-4722. doi: 10.1158/1078-0432.CCR-19-3835. Epub 2020 Apr 13.,Brave M,https://www.ncbi.nlm.nih.gov/pubmed/32284318
11051,32440711,TGF-?1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44,Cell Mol Life Sci. 2021 Feb;78(3):949-962. doi: 10.1007/s00018-020-03544-5. Epub 2020 May 21.,Chen Q,https://www.ncbi.nlm.nih.gov/pubmed/32440711
11052,32234375,NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway,Exp Cell Res. 2020 May 15;390(2):111981. doi: 10.1016/j.yexcr.2020.111981. Epub 2020 Mar 28.,Luo S,https://www.ncbi.nlm.nih.gov/pubmed/32234375
11053,32371869,An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer,Sci Rep. 2020 May 5;10(1):7535. doi: 10.1038/s41598-020-64282-z.,Barker T,https://www.ncbi.nlm.nih.gov/pubmed/32371869
11056,32025848,Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial,Cancer Immunol Immunother. 2020 May;69(5):847-857. doi: 10.1007/s00262-020-02498-8. Epub 2020 Feb 5.,Noguchi M,https://www.ncbi.nlm.nih.gov/pubmed/32025848
11057,33062666,Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer,Biomed Res Int. 2020 Sep 29;2020:1269624. doi: 10.1155/2020/1269624. eCollection 2020.,Han C,https://www.ncbi.nlm.nih.gov/pubmed/33062666
11058,32343890,Olaparib for Metastatic Castration-Resistant Prostate Cancer,N Engl J Med. 2020 May 28;382(22):2091-2102. doi: 10.1056/NEJMoa1911440. Epub 2020 Apr 28.,de Bono J,https://www.ncbi.nlm.nih.gov/pubmed/32343890
11060,32294305,"miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4",Prostate. 2020 Jun;80(9):674-686. doi: 10.1002/pros.23979. Epub 2020 Apr 15.,Li X,https://www.ncbi.nlm.nih.gov/pubmed/32294305
11061,32879887,The Potential Diagnostic Value of Exosomal Long Noncoding RNAs in Solid Tumors: A Meta-Analysis and Systematic Review,Biomed Res Int. 2020 Aug 15;2020:6786875. doi: 10.1155/2020/6786875. eCollection 2020.,Wu Z,https://www.ncbi.nlm.nih.gov/pubmed/32879887
11062,32266854,Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden,Scand J Urol. 2020 Apr;54(2):115-121. doi: 10.1080/21681805.2020.1739139. Epub 2020 Apr 8.,Aly M,https://www.ncbi.nlm.nih.gov/pubmed/32266854
11065,34185301,Seminal Vesicle Tumor Microenvironment,Adv Exp Med Biol. 2020;1296:309-318. doi: 10.1007/978-3-030-59038-3_19.,Cimadamore A,https://www.ncbi.nlm.nih.gov/pubmed/34185301
11067,31953400,MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer,Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6.,Yasumizu Y,https://www.ncbi.nlm.nih.gov/pubmed/31953400
11068,31562975,The Role of Stabilization-Free Microsurgical Decompression in the Surgical Treatment of Spinal Metastases,World Neurosurg. 2020 Jan;133:e498-e502. doi: 10.1016/j.wneu.2019.09.083. Epub 2019 Sep 25.,Müller M,https://www.ncbi.nlm.nih.gov/pubmed/31562975
11073,32675015,A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer,Clin Genitourin Cancer. 2021 Feb;19(1):22-31.e5. doi: 10.1016/j.clgc.2020.05.013. Epub 2020 May 30.,Spetsieris N,https://www.ncbi.nlm.nih.gov/pubmed/32675015
11075,31610702,The effects of L-NAME on DU145 human prostate cancer cell line: A cytotoxicity-based study,Hum Exp Toxicol. 2020 Feb;39(2):182-193. doi: 10.1177/0960327119880591. Epub 2019 Oct 14.,Kacar S,https://www.ncbi.nlm.nih.gov/pubmed/31610702
11077,31997617,The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study,J Korean Med Sci. 2020 Feb 3;35(4):e47. doi: 10.3346/jkms.2020.35.e47.,Shim M,https://www.ncbi.nlm.nih.gov/pubmed/31997617
11079,32481418,Can docetaxel combined prednisone effectively treat hormone refractory prostate cancer?: A protocol of systematic review and meta-analysis,Medicine (Baltimore). 2020 May 29;99(22):e20367. doi: 10.1097/MD.0000000000020367.,Cheng L,https://www.ncbi.nlm.nih.gov/pubmed/32481418
11080,31957122,"Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer",BJU Int. 2020 Apr;125(4):515-524. doi: 10.1111/bju.14999. Epub 2020 Feb 12.,Amin A,https://www.ncbi.nlm.nih.gov/pubmed/31957122
11081,31721232,Coping with interfraction time trends in tumor setup,Med Phys. 2020 Feb;47(2):331-341. doi: 10.1002/mp.13919. Epub 2019 Dec 10.,Gi?y?ska MK,https://www.ncbi.nlm.nih.gov/pubmed/31721232
11082,33061374,PSMA-Targeting Reduction-Cleavable Hyperbranched Polyamide-Amine Gene Delivery System to Treat the Bone Metastases of Prostate Cancer,Int J Nanomedicine. 2020 Sep 28;15:7173-7184. doi: 10.2147/IJN.S268398. eCollection 2020.,Ye Y,https://www.ncbi.nlm.nih.gov/pubmed/33061374
11083,31462713,BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer,Oncogene. 2020 Jan;39(1):17-29. doi: 10.1038/s41388-019-0966-4. Epub 2019 Aug 28.,Zhu S,https://www.ncbi.nlm.nih.gov/pubmed/31462713
11085,32860394,COVID-19 pandemic: Implications for radionuclide therapy in Nuclear Medicine departments,Hell J Nucl Med. 2020 May-Aug;23 Suppl:31-34.,Koukouraki S,https://www.ncbi.nlm.nih.gov/pubmed/32860394
11086,32461687,Introducing PIONEER: a project to harness big data in prostate cancer research,Nat Rev Urol. 2020 Jun;17(6):351-362. doi: 10.1038/s41585-020-0324-x. Epub 2020 May 27.,Omar MI,https://www.ncbi.nlm.nih.gov/pubmed/32461687
11093,31775939,"U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer",Int J Technol Assess Health Care. 2020;36(1):20-28. doi: 10.1017/S0266462319000813. Epub 2019 Nov 28.,Ribeiro TB,https://www.ncbi.nlm.nih.gov/pubmed/31775939
11095,31505052,A CTGF-RUNX2-RANKL Axis in Breast and Prostate Cancer Cells Promotes Tumor Progression in Bone,J Bone Miner Res. 2020 Jan;35(1):155-166. doi: 10.1002/jbmr.3869. Epub 2019 Oct 31.,Kim B,https://www.ncbi.nlm.nih.gov/pubmed/31505052
11096,32268276,Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer,EBioMedicine. 2020 Apr;54:102728. doi: 10.1016/j.ebiom.2020.102728.,Kohli M,https://www.ncbi.nlm.nih.gov/pubmed/32268276
11097,32167701,Efficacy of Leuprorelide acetate (Eligard(R)) in daily practice in Brazil: a retrospective study with depot formulations in patients with prostate cancer,Int Braz J Urol. 2020 May-Jun;46(3):383-389. doi: 10.1590/S1677-5538.IBJU.2019.0212.,de Freitas CSM,https://www.ncbi.nlm.nih.gov/pubmed/32167701
11098,32080281,Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence,Sci Rep. 2020 Feb 20;10(1):3121. doi: 10.1038/s41598-020-59942-z.,Baur ADJ,https://www.ncbi.nlm.nih.gov/pubmed/32080281
11099,31894265,Ophiopogonin D' induces RIPK1?dependent necroptosis in androgen?dependent LNCaP prostate cancer cells,Int J Oncol. 2020 Feb;56(2):439-447. doi: 10.3892/ijo.2019.4945. Epub 2019 Dec 17.,Lu Z,https://www.ncbi.nlm.nih.gov/pubmed/31894265
11102,31920062,Role of prostate specific antigen and prostate specific antigen density as biomarkers for medical and surgical treatment response in men with lower urinary tract symptoms,Minerva Urol Nefrol. 2020 Apr;72(2):135-143. doi: 10.23736/S0393-2249.19.03585-9. Epub 2020 Jan 7.,Corona G,https://www.ncbi.nlm.nih.gov/pubmed/31920062
11103,32313004,Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model,Nat Commun. 2020 Apr 20;11(1):1884. doi: 10.1038/s41467-020-15426-2.,Faugeroux V,https://www.ncbi.nlm.nih.gov/pubmed/32313004
11104,31250182,An allied health rehabilitation program for patients following surgery for abdomino-pelvic cancer: a feasibility and pilot clinical study,Support Care Cancer. 2020 Mar;28(3):1335-1350. doi: 10.1007/s00520-019-04931-w. Epub 2019 Jun 27.,Frawley HC,https://www.ncbi.nlm.nih.gov/pubmed/31250182
11106,31362683,Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications,Curr Radiopharm. 2020;13(1):63-79. doi: 10.2174/1874471012666190729151540.,Pastorino S,https://www.ncbi.nlm.nih.gov/pubmed/31362683
11112,33378392,Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study,PLoS One. 2020 Dec 30;15(12):e0244660. doi: 10.1371/journal.pone.0244660. eCollection 2020.,Shim M,https://www.ncbi.nlm.nih.gov/pubmed/33378392
11114,32267200,Receipt of Survivorship Care Plans and Self-Reported Health Status among Patients with Genitourinary Malignancy,J Urol. 2020 Sep;204(3):564-569. doi: 10.1097/JU.0000000000001032. Epub 2020 Apr 8.,Linscott JA,https://www.ncbi.nlm.nih.gov/pubmed/32267200
11115,31672485,PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: Multicenter validation in patients from the Chinese Prostate Cancer Consortium,Urol Oncol. 2020 Jan;38(1):2.e11-2.e17. doi: 10.1016/j.urolonc.2019.07.014. Epub 2019 Oct 28.,Pei X,https://www.ncbi.nlm.nih.gov/pubmed/31672485
11119,31613660,Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study,AJR Am J Roentgenol. 2020 Jan;214(1):105-113. doi: 10.2214/AJR.19.21264. Epub 2019 Oct 15.,Turkbey B,https://www.ncbi.nlm.nih.gov/pubmed/31613660
11128,31081133,Peimine inhibits the growth and motility of prostate cancer cells and induces apoptosis by disruption of intracellular calcium homeostasis through Ca(2+) /CaMKII/JNK pathway,J Cell Biochem. 2020 Jan;121(1):81-92. doi: 10.1002/jcb.28870. Epub 2019 May 12.,Tan H,https://www.ncbi.nlm.nih.gov/pubmed/31081133
11129,31723001,Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness,Cancer Res. 2020 Feb 1;80(3):624-638. doi: 10.1158/0008-5472.CAN-19-1840. Epub 2019 Nov 13.,Patel VL,https://www.ncbi.nlm.nih.gov/pubmed/31723001
11131,32445315,Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario,Indian J Cancer. 2020 Apr-Jun;57(2):129-138. doi: 10.4103/ijc.IJC_356_20.,Narain TA,https://www.ncbi.nlm.nih.gov/pubmed/32445315
11132,31797478,Facilitators and barriers to participation in lifestyle modification for men with prostate cancer: A scoping review,Eur J Cancer Care (Engl). 2020 Jan;29(1):e13193. doi: 10.1111/ecc.13193. Epub 2019 Dec 3.,Yannitsos D,https://www.ncbi.nlm.nih.gov/pubmed/31797478
11133,31935634,MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis,Biomed Pharmacother. 2020 Mar;123:109666. doi: 10.1016/j.biopha.2019.109666. Epub 2020 Jan 11.,Hao T,https://www.ncbi.nlm.nih.gov/pubmed/31935634
11135,32049786,Subsequent risk of acute urinary retention and androgen deprivation therapy in patients with prostate cancer: A population-based retrospective cohort study,Medicine (Baltimore). 2020 Feb;99(7):e18842. doi: 10.1097/MD.0000000000018842.,Yang TK,https://www.ncbi.nlm.nih.gov/pubmed/32049786
11141,32194823,Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study,Theranostics. 2020 Feb 3;10(6):2612-2620. doi: 10.7150/thno.42228. eCollection 2020.,Stuparu AD,https://www.ncbi.nlm.nih.gov/pubmed/32194823
11143,32206096,Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy,Theranostics. 2020 Feb 10;10(8):3366-3381. doi: 10.7150/thno.41849. eCollection 2020.,Liao Y,https://www.ncbi.nlm.nih.gov/pubmed/32206096
11151,32015092,Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2,Cancer Res. 2020 Apr 1;80(7):1428-1437. doi: 10.1158/0008-5472.CAN-19-1394. Epub 2020 Feb 3.,Mao N,https://www.ncbi.nlm.nih.gov/pubmed/32015092
11157,32795611,DPHL: A DIA Pan-human Protein Mass Spectrometry Library for Robust Biomarker Discovery,Genomics Proteomics Bioinformatics. 2020 Apr;18(2):104-119. doi: 10.1016/j.gpb.2019.11.008. Epub 2020 Aug 12.,Zhu T,https://www.ncbi.nlm.nih.gov/pubmed/32795611
11159,32397905,Rhabdomyolysis and acute kidney injury induced by the association of rosuvastatin and abiraterone: A case report and review of the literature,J Oncol Pharm Pract. 2021 Jan;27(1):216-219. doi: 10.1177/1078155220923001. Epub 2020 May 12.,Ould-Nana I,https://www.ncbi.nlm.nih.gov/pubmed/32397905
11160,32219437,Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer,J Exp Med. 2020 Jun 1;217(6):e20191787. doi: 10.1084/jem.20191787.,Hermanova I,https://www.ncbi.nlm.nih.gov/pubmed/32219437
11171,32449811,Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals,Prostate. 2020 Jul;80(10):742-752. doi: 10.1002/pros.23988. Epub 2020 May 25.,Tang M,https://www.ncbi.nlm.nih.gov/pubmed/32449811
11176,31587137,Adverse Events Associated with Cumulative Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis,Drug Saf. 2020 Jan;43(1):23-33. doi: 10.1007/s40264-019-00867-6.,Schultz NM,https://www.ncbi.nlm.nih.gov/pubmed/31587137
11182,31591690,Salvage Lymph-Node Percutaneous Cryoablation: Safety Profile and Oncologic Outcomes,Cardiovasc Intervent Radiol. 2020 Feb;43(2):264-272. doi: 10.1007/s00270-019-02341-3. Epub 2019 Oct 7.,Tsoumakidou G,https://www.ncbi.nlm.nih.gov/pubmed/31591690
11183,32115649,Perioperative therapies for urological cancers,Jpn J Clin Oncol. 2020 Apr 7;50(4):357-367. doi: 10.1093/jjco/hyaa013.,Inokuchi J,https://www.ncbi.nlm.nih.gov/pubmed/32115649
11189,31412017,Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients,Eur Urol Oncol. 2020 Feb;3(1):119-127. doi: 10.1016/j.euo.2019.01.008. Epub 2019 Apr 20.,Efstathiou E,https://www.ncbi.nlm.nih.gov/pubmed/31412017
11190,32151941,"Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome",Eur J Cancer. 2020 Apr;129:117-122. doi: 10.1016/j.ejca.2020.01.017. Epub 2020 Mar 6.,Colomba E,https://www.ncbi.nlm.nih.gov/pubmed/32151941
11205,32252729,Men's view on participation in decisions about prostate-specific antigen (PSA) screening: patient and public involvement in development of a survey,BMC Med Inform Decis Mak. 2020 Apr 6;20(1):65. doi: 10.1186/s12911-020-1077-4.,Birkeland S,https://www.ncbi.nlm.nih.gov/pubmed/32252729
11209,32376721,Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies,J Immunother Cancer. 2020 May;8(1):e000368. doi: 10.1136/jitc-2019-000368.,Cham J,https://www.ncbi.nlm.nih.gov/pubmed/32376721
11219,31927166,Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma,J Pharm Biomed Anal. 2020 Mar 20;181:113073. doi: 10.1016/j.jpba.2019.113073. Epub 2019 Dec 27.,Schmidt KT,https://www.ncbi.nlm.nih.gov/pubmed/31927166
11228,32125151,Reversal of Apalutamide and Darolutamide Aldo-Keto Reductase 1C3-Mediated Resistance by a Small Molecule Inhibitor,ACS Chem Biol. 2020 Mar 20;15(3):646-650. doi: 10.1021/acschembio.0c00069. Epub 2020 Mar 9.,Morsy A,https://www.ncbi.nlm.nih.gov/pubmed/32125151
11233,32317029,Recent advances of PET imaging in clinical radiation oncology,Radiat Oncol. 2020 Apr 21;15(1):88. doi: 10.1186/s13014-020-01519-1.,Unterrainer M,https://www.ncbi.nlm.nih.gov/pubmed/32317029
11235,31604889,Radiation Exposure to the Nuclear Medicine Personnel During Preparation and Handling of (213)Bi-Radiopharmaceuticals,J Nucl Med Technol. 2020 Mar;48(1):68-72. doi: 10.2967/jnmt.119.230516. Epub 2019 Oct 11.,Thakral P,https://www.ncbi.nlm.nih.gov/pubmed/31604889
11244,32155108,Automated Big Data Analytics for the Radiation Oncology Alternative Payment Model Proposal Using a Novel Health Care Software Technology,JCO Oncol Pract. 2020 Apr;16(4):e333-e340. doi: 10.1200/JOP.19.00692. Epub 2020 Mar 10.,Thaker NG,https://www.ncbi.nlm.nih.gov/pubmed/32155108
11261,31364100,The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy,Urol J. 2020 Mar 16;17(2):192-197. doi: 10.22037/uj.v0i0.4755.,Korkmaz N,https://www.ncbi.nlm.nih.gov/pubmed/31364100
11266,32277721,TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands,Genes Cells. 2020 Jul;25(7):450-465. doi: 10.1111/gtc.12770. Epub 2020 May 5.,Al Mahmud MR,https://www.ncbi.nlm.nih.gov/pubmed/32277721
11278,31899856,Developing a cancer-specific trigger tool to identify treatment-related adverse events using administrative data,Cancer Med. 2020 Feb;9(4):1462-1472. doi: 10.1002/cam4.2812. Epub 2020 Jan 3.,Weingart SN,https://www.ncbi.nlm.nih.gov/pubmed/31899856
11284,32361681,"MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses",Redox Biol. 2020 Jul;34:101542. doi: 10.1016/j.redox.2020.101542. Epub 2020 Apr 21.,Chatterjee A,https://www.ncbi.nlm.nih.gov/pubmed/32361681
11316,32356572,Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia,Prostate. 2020 Jul;80(10):731-741. doi: 10.1002/pros.23986. Epub 2020 May 1.,Popovics P,https://www.ncbi.nlm.nih.gov/pubmed/32356572
11351,31977462,Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery,Clin Nucl Med. 2020 Mar;45(3):204-205. doi: 10.1097/RLU.0000000000002893.,Gupta M,https://www.ncbi.nlm.nih.gov/pubmed/31977462
11357,32145689,"Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells",Neoplasia. 2020 Apr;22(4):192-202. doi: 10.1016/j.neo.2020.02.002. Epub 2020 Mar 4.,Zhou X,https://www.ncbi.nlm.nih.gov/pubmed/32145689
11359,31967907,Targeted Alpha Therapy with Thorium-227,Cancer Biother Radiopharm. 2020 Aug;35(6):437-445. doi: 10.1089/cbr.2019.3105. Epub 2020 Jan 20.,Frantellizzi V,https://www.ncbi.nlm.nih.gov/pubmed/31967907
11366,32222469,"Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity",Free Radic Biol Med. 2020 May 20;152:255-270. doi: 10.1016/j.freeradbiomed.2020.03.014. Epub 2020 Mar 25.,Shrishrimal S,https://www.ncbi.nlm.nih.gov/pubmed/32222469
11384,31587386,Magnetic resonance imaging-guided targeted prostate biopsy: Comparison between computer-software-based fusion versus cognitive fusion technique in biopsy-naïve patients,Int J Urol. 2020 Jan;27(1):67-71. doi: 10.1111/iju.14127. Epub 2019 Oct 6.,Yamada Y,https://www.ncbi.nlm.nih.gov/pubmed/31587386
11387,31582533,The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models,Mol Cancer Ther. 2020 Jan;19(1):26-38. doi: 10.1158/1535-7163.MCT-19-0019. Epub 2019 Oct 3.,Wengner AM,https://www.ncbi.nlm.nih.gov/pubmed/31582533
11388,31631014,The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease,Curr Res Transl Med. 2020 Apr;68(2):71-76. doi: 10.1016/j.retram.2019.10.001. Epub 2019 Oct 17.,Alsuliman T,https://www.ncbi.nlm.nih.gov/pubmed/31631014
11403,31926329,The 100 most-cited articles in urological surgery: A bibliometric analysis,Int J Surg. 2020 Mar;75:74-79. doi: 10.1016/j.ijsu.2019.12.030. Epub 2020 Jan 8.,He L,https://www.ncbi.nlm.nih.gov/pubmed/31926329
11404,32293366,Association between depression and healthcare expenditures among elderly cancer patients,BMC Psychiatry. 2020 Mar 23;20(1):131. doi: 10.1186/s12888-020-02527-x.,Gu D,https://www.ncbi.nlm.nih.gov/pubmed/32293366
11407,31609776,Biological and therapeutic advances in the pursuit of effective immunotherapy for prostate cancer,Curr Opin Urol. 2020 Jan;30(1):30-35. doi: 10.1097/MOU.0000000000000682.,Hamid AA,https://www.ncbi.nlm.nih.gov/pubmed/31609776
11410,32055753,The human gastrointestinal microbiota and prostate cancer development and treatment,Investig Clin Urol. 2020 Feb;61(Suppl 1):S43-S50. doi: 10.4111/icu.2020.61.S1.S43. Epub 2019 Sep 24.,Sha S,https://www.ncbi.nlm.nih.gov/pubmed/32055753
11411,31825540,Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting,Prostate. 2020 Feb;80(2):113-132. doi: 10.1002/pros.23934. Epub 2019 Dec 11.,Miyahira AK,https://www.ncbi.nlm.nih.gov/pubmed/31825540
11415,32133899,Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly,Scand J Urol. 2020 Apr;54(2):105-109. doi: 10.1080/21681805.2020.1732463. Epub 2020 Mar 5.,Löffeler S,https://www.ncbi.nlm.nih.gov/pubmed/32133899
11419,32209821,Recent progress in treating advanced prostate cancer,Curr Opin Oncol. 2020 May;32(3):210-215. doi: 10.1097/CCO.0000000000000624.,Gourdin T,https://www.ncbi.nlm.nih.gov/pubmed/32209821
11420,32241692,Serum and urine biomarkers for detecting clinically significant prostate cancer,Urol Oncol. 2021 Oct;39(10):686-690. doi: 10.1016/j.urolonc.2020.02.018. Epub 2020 Mar 30.,Becerra MF,https://www.ncbi.nlm.nih.gov/pubmed/32241692
11422,31503032,"The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and Therapy",Adv Anat Pathol. 2020 Jan;27(1):11-19. doi: 10.1097/PAP.0000000000000245.,Faisal FA,https://www.ncbi.nlm.nih.gov/pubmed/31503032
11423,31364489,A different perspective: Can urine pH be important in the diagnosis of prostate cancer?,Urologia. 2020 Feb;87(1):19-22. doi: 10.1177/0391560319865724. Epub 2019 Jul 31.,Ceylan C,https://www.ncbi.nlm.nih.gov/pubmed/31364489
11424,32093338,Influence of Diet and Nutrition on Prostate Cancer,Int J Mol Sci. 2020 Feb 20;21(4):1447. doi: 10.3390/ijms21041447.,Matsushita M,https://www.ncbi.nlm.nih.gov/pubmed/32093338
11425,32067601,Precision Medicine Approach in Prostate Cancer,Curr Pharm Des. 2020;26(31):3783-3798. doi: 10.2174/1381612826666200218104921.,Assadi M,https://www.ncbi.nlm.nih.gov/pubmed/32067601
11426,32481386,Role of long non-coding RNA NEAT1 in the prognosis of prostate cancer patients,Medicine (Baltimore). 2020 May 29;99(22):e20204. doi: 10.1097/MD.0000000000020204.,Bai J,https://www.ncbi.nlm.nih.gov/pubmed/32481386
11427,32253914,Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer,Biomark Med. 2020 Apr;14(5):353-369. doi: 10.2217/bmm-2019-0318. Epub 2020 Apr 7.,Mu HQ,https://www.ncbi.nlm.nih.gov/pubmed/32253914
11428,32471792,Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review,Eur Urol Oncol. 2020 Aug;3(4):400-409. doi: 10.1016/j.euo.2020.03.006. Epub 2020 May 26.,Shevach JW,https://www.ncbi.nlm.nih.gov/pubmed/32471792
11429,32143723,Data-driven translational prostate cancer research: from biomarker discovery to clinical decision,J Transl Med. 2020 Mar 7;18(1):119. doi: 10.1186/s12967-020-02281-4.,Lin Y,https://www.ncbi.nlm.nih.gov/pubmed/32143723
11431,32693761,Nanoparticles for Targeting of Prostate Cancer,Curr Pharm Des. 2020;26(42):5393-5413. doi: 10.2174/1381612826666200721001500.,Yari H,https://www.ncbi.nlm.nih.gov/pubmed/32693761
11432,31343436,Is leisure time sitting associated with mortality rates among men diagnosed with localized prostate cancer?,Eur J Cancer Prev. 2020 Mar;29(2):134-140. doi: 10.1097/CEJ.0000000000000523.,Bonn SE,https://www.ncbi.nlm.nih.gov/pubmed/31343436
11434,31526166,Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study,Acta Oncol. 2020 Jan;59(1):106-111. doi: 10.1080/0284186X.2019.1662084. Epub 2019 Sep 17.,Westerberg M,https://www.ncbi.nlm.nih.gov/pubmed/31526166
11436,32126261,Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy,Semin Cancer Biol. 2022 May;80:107-117. doi: 10.1016/j.semcancer.2020.02.012. Epub 2020 Feb 29.,Levenson AS,https://www.ncbi.nlm.nih.gov/pubmed/32126261
11438,32096986,Dual-Action Ru(II) Complexes with Bulky ?-Expansive Ligands: Phototoxicity without DNA Intercalation,Inorg Chem. 2020 Mar 16;59(6):3919-3933. doi: 10.1021/acs.inorgchem.9b03585. Epub 2020 Feb 25.,Toupin NP,https://www.ncbi.nlm.nih.gov/pubmed/32096986
11439,32085497,Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets,Cells. 2020 Feb 18;9(2):460. doi: 10.3390/cells9020460.,Fontana F,https://www.ncbi.nlm.nih.gov/pubmed/32085497
11440,32015276,Genomics to personalize care of prostate cancer,J Am Assoc Nurse Pract. 2020 Feb;32(2):106-108. doi: 10.1097/JXX.0000000000000390.,Connors LM,https://www.ncbi.nlm.nih.gov/pubmed/32015276
11441,31911085,Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition,Eur Urol Focus. 2020 Nov 15;6(6):1162-1164. doi: 10.1016/j.euf.2019.11.010. Epub 2020 Jan 3.,Izard JP,https://www.ncbi.nlm.nih.gov/pubmed/31911085
11442,31983186,The Effect of Prostate Cancer Educational Program on the level of Knowledge and Intention to Screen among Jordanian Men in Amman,Asian Pac J Cancer Prev. 2020 Jan 1;21(1):211-215. doi: 10.31557/APJCP.2020.21.1.211.,Saleh AM,https://www.ncbi.nlm.nih.gov/pubmed/31983186
11444,32019719,When and How Should Active Surveillance for Prostate Cancer be De-Escalated?,Eur Urol Focus. 2021 Mar;7(2):297-300. doi: 10.1016/j.euf.2020.01.001. Epub 2020 Feb 2.,Rajwa P,https://www.ncbi.nlm.nih.gov/pubmed/32019719
11446,32162861,The Trend of ripk1/ripk3 and mlkl Mediated Necroptosis Pathway in Patients with Different Stages of Prostate Cancer as Promising Progression Biomarkers,Clin Lab. 2020 Mar 1;66(3). doi: 10.7754/Clin.Lab.2019.190439.,Heidaryan F,https://www.ncbi.nlm.nih.gov/pubmed/32162861
11447,32243243,5?-Reductase Inhibitors and Risk of Prostate Cancer Death,J Urol. 2020 Oct;204(4):714-719. doi: 10.1097/JU.0000000000001038. Epub 2020 Apr 3.,Bonde Miranda T,https://www.ncbi.nlm.nih.gov/pubmed/32243243
11448,32481356,Increased expression of microRNA-93 correlates with progression and prognosis of prostate cancer,Medicine (Baltimore). 2020 May 29;99(22):e18432. doi: 10.1097/MD.0000000000018432.,Wang C,https://www.ncbi.nlm.nih.gov/pubmed/32481356
11449,31839379,Why the UK Should Consider Gene Expression Testing in Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Mar;32(3):149-155. doi: 10.1016/j.clon.2019.11.006. Epub 2019 Dec 12.,Dess RT,https://www.ncbi.nlm.nih.gov/pubmed/31839379
11450,31721301,Crosstalk between myeloid-derived suppressor cells and the immune system in prostate cancer: MDSCs and immune system in Prostate cancer,J Leukoc Biol. 2020 Jan;107(1):43-56. doi: 10.1002/JLB.4RU0819-150RR. Epub 2019 Nov 13.,Sanaei MJ,https://www.ncbi.nlm.nih.gov/pubmed/31721301
11454,32045912,Complexity of Neural Component of Tumor Microenvironment in Prostate Cancer,Pathobiology. 2020;87(2):87-99. doi: 10.1159/000505437. Epub 2020 Feb 11.,Sejda A,https://www.ncbi.nlm.nih.gov/pubmed/32045912
11455,32481368,The diagnostic value of miRNA-141 in prostate cancer: A systematic review and PRISMA-compliant meta-analysis,Medicine (Baltimore). 2020 May 29;99(22):e19993. doi: 10.1097/MD.0000000000019993.,Ye Y,https://www.ncbi.nlm.nih.gov/pubmed/32481368
11456,31659799,The role of masculinities in psychological and emotional help seeking by men with prostate cancer,Psychooncology. 2020 Feb;29(2):356-363. doi: 10.1002/pon.5264. Epub 2019 Nov 19.,Goodwin BC,https://www.ncbi.nlm.nih.gov/pubmed/31659799
11458,31928160,"Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study",J Biomol Struct Dyn. 2021 Feb;39(2):621-634. doi: 10.1080/07391102.2020.1715261. Epub 2020 Jan 25.,Selvaraj D,https://www.ncbi.nlm.nih.gov/pubmed/31928160
11459,32204455,"Exosomes in Prostate Cancer Diagnosis, Prognosis and Therapy",Int J Mol Sci. 2020 Mar 19;21(6):2118. doi: 10.3390/ijms21062118.,Lorenc T,https://www.ncbi.nlm.nih.gov/pubmed/32204455
11461,28810471,Gay men's experiences with prostate cancer: Implications for future research,J Health Psychol. 2020 Mar;25(3):298-310. doi: 10.1177/1359105317711491. Epub 2017 Jun 15.,Hoyt MA,https://www.ncbi.nlm.nih.gov/pubmed/28810471
11462,32460795,Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient - a systematic review and meta analysis,BMC Cancer. 2020 May 27;20(1):482. doi: 10.1186/s12885-020-06942-x.,Meyer HJ,https://www.ncbi.nlm.nih.gov/pubmed/32460795
11463,32592348,A Study of Ser217Leu and Ala541Thr Polymorphism in the Men Afflicted with Prostate Cancer and in the Men being Suspicious of Prostate Cancer,Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1551-1557. doi: 10.31557/APJCP.2020.21.6.1551.,Zahiri Z,https://www.ncbi.nlm.nih.gov/pubmed/32592348
11465,30790052,"Lifestyles, health habits, and prostate cancer",J Cancer Res Clin Oncol. 2020 Jun;146(6):1623-1624. doi: 10.1007/s00432-019-02871-w. Epub 2019 Feb 21.,Kawada T,https://www.ncbi.nlm.nih.gov/pubmed/30790052
11466,32483877,High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancer,Prostate. 2020 Aug;80(11):885-894. doi: 10.1002/pros.24022. Epub 2020 Jun 1.,Itsumi M,https://www.ncbi.nlm.nih.gov/pubmed/32483877
11467,31990107,Bacterial signatures and their inflammatory potentials associated with prostate cancer,APMIS. 2020 Feb;128(2):80-91. doi: 10.1111/apm.13021. Epub 2020 Jan 28.,Brüggemann H,https://www.ncbi.nlm.nih.gov/pubmed/31990107
11468,32367257,"Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and ""First Do No Harm"" Part III",Curr Urol Rep. 2020 May 4;21(5):22. doi: 10.1007/s11934-020-00972-5.,Moyad MA,https://www.ncbi.nlm.nih.gov/pubmed/32367257
11469,31594268,Quality of life and functional outcomes after surgery for spinal metastases: Results of a cohort study,Technol Health Care. 2020;28(3):303-314. doi: 10.3233/THC-191727.,Westermann L,https://www.ncbi.nlm.nih.gov/pubmed/31594268
11470,31553489,Prostate cancer in young men: An emerging young adult and older adolescent challenge,Cancer. 2020 Jan 1;126(1):46-57. doi: 10.1002/cncr.32498. Epub 2019 Sep 25.,Bleyer A,https://www.ncbi.nlm.nih.gov/pubmed/31553489
11471,32122268,Stem Cell/Oxygen-Releasing Microparticle Enhances Erectile Function in a Cavernous Nerve Injury Model,Tissue Eng Part A. 2021 Jan;27(1-2):50-62. doi: 10.1089/ten.TEA.2019.0240. Epub 2020 Mar 31.,Jung AR,https://www.ncbi.nlm.nih.gov/pubmed/32122268
11472,31493960,Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates,Eur Urol. 2020 Jan;77(1):38-52. doi: 10.1016/j.eururo.2019.08.005. Epub 2019 Sep 5.,Culp MB,https://www.ncbi.nlm.nih.gov/pubmed/31493960
11474,31964666,Negative recollections regarding doctor-patient interactions among men receiving a prostate cancer diagnosis: a qualitative study of patient experiences in Japan,BMJ Open. 2020 Jan 20;10(1):e032251. doi: 10.1136/bmjopen-2019-032251.,Torishima M,https://www.ncbi.nlm.nih.gov/pubmed/31964666
11475,32290196,Targeted Radionuclide Therapy of Prostate Cancer-From Basic Research to Clinical Perspectives,Molecules. 2020 Apr 10;25(7):1743. doi: 10.3390/molecules25071743.,Czerwi?ska M,https://www.ncbi.nlm.nih.gov/pubmed/32290196
11476,32132040,Polyamine Analogues of Propanediamine Series Inhibit Prostate Tumor Cell Growth and Activate the Polyamine Catabolic Pathway,Anticancer Res. 2020 Mar;40(3):1437-1441. doi: 10.21873/anticanres.14085.,Ploskonos MV,https://www.ncbi.nlm.nih.gov/pubmed/32132040
11477,32063129,"""One stroke, with twenty-two people"": exploring prostate cancer survivors' participation in dragon boating",J Psychosoc Oncol. 2020 Jul-Aug;38(4):375-388. doi: 10.1080/07347332.2020.1725215. Epub 2020 Feb 17.,Cinà IV,https://www.ncbi.nlm.nih.gov/pubmed/32063129
11478,31447293,An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis,Clin Res Hepatol Gastroenterol. 2020 Jun;44(3):302-309. doi: 10.1016/j.clinre.2019.07.003. Epub 2019 Aug 23.,Chen M,https://www.ncbi.nlm.nih.gov/pubmed/31447293
11479,30327280,Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists,Eur Urol Focus. 2020 Mar 15;6(2):267-272. doi: 10.1016/j.euf.2018.10.008. Epub 2018 Oct 14.,Pickersgill NA,https://www.ncbi.nlm.nih.gov/pubmed/30327280
11480,31287731,Silibinin Differentially Decreases the Aggressive Cancer Phenotype in an In Vitro Model of Obesity and Prostate Cancer,Nutr Cancer. 2020;72(2):333-342. doi: 10.1080/01635581.2019.1633363. Epub 2019 Jul 9.,Sherman B,https://www.ncbi.nlm.nih.gov/pubmed/31287731
11482,32358634,Caveola-forming proteins and prostate cancer,Cancer Metastasis Rev. 2020 Jun;39(2):415-433. doi: 10.1007/s10555-020-09874-x.,Nassar ZD,https://www.ncbi.nlm.nih.gov/pubmed/32358634
11483,32366788,FDG Hepatic Superscan Due to Metastatic Infiltration of Prostate Cancer,Clin Nucl Med. 2020 Jun;45(6):474-476. doi: 10.1097/RLU.0000000000003044.,Yildirim N,https://www.ncbi.nlm.nih.gov/pubmed/32366788
11484,32108622,A grading dilemma; Gleason scoring system: Are we sufficiently compatible? A multi center study,Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S25-S29. doi: 10.4103/IJPM.IJPM_288_18.,Dere Y,https://www.ncbi.nlm.nih.gov/pubmed/32108622
11485,31713906,Prostate cancer survivorship priorities for men and their partners: Delphi consensus from a nurse specialist cohort,J Clin Nurs. 2020 Jan;29(1-2):265-273. doi: 10.1111/jocn.15096. Epub 2019 Nov 27.,Ralph N,https://www.ncbi.nlm.nih.gov/pubmed/31713906
11486,32037622,Family history in primary hormone therapy for prostate cancer: Analysis from a community-based multi-institutional Japan-wide database,Int J Urol. 2020 Apr;27(4):313-318. doi: 10.1111/iju.14184. Epub 2020 Feb 10.,Shiota M,https://www.ncbi.nlm.nih.gov/pubmed/32037622
11487,31986004,Programing Assembling/Releasing Multifunctional miRNA Nanomedicine to Treat Prostate Cancer,ACS Appl Mater Interfaces. 2020 Feb 26;12(8):9032-9040. doi: 10.1021/acsami.9b21707. Epub 2020 Feb 7.,Ma D,https://www.ncbi.nlm.nih.gov/pubmed/31986004
11488,32134996,"Survival and prognostic determinants of prostate cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A retrospective cohort study",PLoS One. 2020 Mar 5;15(3):e0229854. doi: 10.1371/journal.pone.0229854. eCollection 2020.,Beksisa J,https://www.ncbi.nlm.nih.gov/pubmed/32134996
11489,32258129,Citral Induced Apoptosis through Modulation of Key Genes Involved in Fatty Acid Biosynthesis in Human Prostate Cancer Cells: In Silico and In Vitro Study,Biomed Res Int. 2020 Mar 18;2020:6040727. doi: 10.1155/2020/6040727. eCollection 2020.,Balusamy SR,https://www.ncbi.nlm.nih.gov/pubmed/32258129
11490,32334481,Prostate Cancer-based Interventions' Efficacy on Knowledge and Adherence Intention to Healthy Lifestyle among Men,Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1129-1134. doi: 10.31557/APJCP.2020.21.4.1129.,Saleh AM,https://www.ncbi.nlm.nih.gov/pubmed/32334481
11491,31895010,Genetic and molecular determinants of prostate cancer among Iranian patients: An update,Crit Rev Clin Lab Sci. 2020 Jan;57(1):37-53. doi: 10.1080/10408363.2019.1657061. Epub 2019 Sep 6.,Ghayour-Mobarhan M,https://www.ncbi.nlm.nih.gov/pubmed/31895010
11493,31673791,Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma,J Bone Miner Metab. 2020 Mar;38(2):254-263. doi: 10.1007/s00774-019-01052-6. Epub 2019 Oct 31.,Jeon HL,https://www.ncbi.nlm.nih.gov/pubmed/31673791
11494,32307327,Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions,Urol Oncol. 2020 Jul;38(7):637.e9-637.e15. doi: 10.1016/j.urolonc.2020.03.019. Epub 2020 Apr 17.,Al Hussein Al Awamlh B,https://www.ncbi.nlm.nih.gov/pubmed/32307327
11498,32343194,Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?,Pharmacogenomics. 2020 May;21(7):487-503. doi: 10.2217/pgs-2019-0123. Epub 2020 Apr 28.,Pinto AR,https://www.ncbi.nlm.nih.gov/pubmed/32343194
11499,32456317,Second-Generation Androgen Receptor Antagonists as Hormonal Therapeutics for Three Forms of Prostate Cancer,Molecules. 2020 May 24;25(10):2448. doi: 10.3390/molecules25102448.,Rajaram P,https://www.ncbi.nlm.nih.gov/pubmed/32456317
11500,32497551,A promising therapeutic combination for metastatic prostate cancer: Chloroquine as autophagy inhibitor and palladium(II) barbiturate complex,Biochimie. 2020 Aug;175:159-172. doi: 10.1016/j.biochi.2020.05.010. Epub 2020 Jun 1.,Erkisa M,https://www.ncbi.nlm.nih.gov/pubmed/32497551
11501,31874106,Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1,J Clin Invest. 2020 Apr 1;130(4):1782-1792. doi: 10.1172/JCI126327.,Wang L,https://www.ncbi.nlm.nih.gov/pubmed/31874106
11502,31239513,Financial implications of biparametric prostate MRI,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):88-93. doi: 10.1038/s41391-019-0158-x. Epub 2019 Jun 25.,Porter KK,https://www.ncbi.nlm.nih.gov/pubmed/31239513
11503,31614208,Intracrinology-revisited and prostate cancer,J Steroid Biochem Mol Biol. 2020 Feb;196:105499. doi: 10.1016/j.jsbmb.2019.105499. Epub 2019 Oct 12.,Penning TM,https://www.ncbi.nlm.nih.gov/pubmed/31614208
11504,32508976,Auxiliary Medical Decision System for Prostate Cancer Based on Ensemble Method,Comput Math Methods Med. 2020 May 18;2020:6509596. doi: 10.1155/2020/6509596. eCollection 2020.,Wu J,https://www.ncbi.nlm.nih.gov/pubmed/32508976
11505,32332316,Hepatic Vascular Malformation Mimics PSMA-Positive Prostate Cancer Metastasis,Clin Nucl Med. 2020 Jun;45(6):e283-e284. doi: 10.1097/RLU.0000000000003032.,Hoberück S,https://www.ncbi.nlm.nih.gov/pubmed/32332316
11506,32446375,Wnt/?-catenin signaling contributes to prostate cancer heterogeneity through reciprocal suppression of H3K27 trimethylation,Biochem Biophys Res Commun. 2020 Jun 18;527(1):242-249. doi: 10.1016/j.bbrc.2020.04.112. Epub 2020 May 4.,Wang F,https://www.ncbi.nlm.nih.gov/pubmed/32446375
11507,32108042,Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics,Cancer Genomics Proteomics. 2020 Mar-Apr;17(2):195-208. doi: 10.21873/cgp.20180.,Kwon OK,https://www.ncbi.nlm.nih.gov/pubmed/32108042
11508,31711637,Head-to-head comparison of prostate MRI using an endorectal coil versus a non-endorectal coil: meta-analysis of diagnostic performance in staging T3 prostate cancer,Clin Radiol. 2020 Feb;75(2):157.e9-157.e19. doi: 10.1016/j.crad.2019.09.142. Epub 2019 Nov 9.,Tirumani SH,https://www.ncbi.nlm.nih.gov/pubmed/31711637
11509,32406055,"Incidence, Gleason Score and Ethnicity Pattern of Prostate Cancer in the Multi-ethnicity Country of Iran During 2008-2010",Urol J. 2020 May 4;17(6):602-606. doi: 10.22037/uj.v0i0.5618.,Basiri A,https://www.ncbi.nlm.nih.gov/pubmed/32406055
11510,31804971,The epigenetic and transcriptional landscape of neuroendocrine prostate cancer,Endocr Relat Cancer. 2020 Feb;27(2):R35-R50. doi: 10.1530/ERC-19-0420.,Davies A,https://www.ncbi.nlm.nih.gov/pubmed/31804971
11512,31740786,BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration,Oncogene. 2020 Feb;39(8):1797-1806. doi: 10.1038/s41388-019-1106-x. Epub 2019 Nov 18.,Loveridge CJ,https://www.ncbi.nlm.nih.gov/pubmed/31740786
11513,32380503,Docetaxel Rechallenge in Patients with Metastatic Prostate Cancer: A Comprehensive Review,Oncol Res Treat. 2020;43(6):299-306. doi: 10.1159/000506693. Epub 2020 May 7.,Assi T,https://www.ncbi.nlm.nih.gov/pubmed/32380503
11514,32343604,Immune Checkpoint Blockade for Prostate Cancer: Niche Role or Next Breakthrough?,Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-18. doi: 10.1200/EDBK_278853.,de Almeida DVP,https://www.ncbi.nlm.nih.gov/pubmed/32343604
11516,32358094,Impact of (68)Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial,J Nucl Med. 2020 Dec;61(12):1793-1799. doi: 10.2967/jnumed.120.242180. Epub 2020 May 1.,Fendler WP,https://www.ncbi.nlm.nih.gov/pubmed/32358094
11517,32217993,The study of multiple diagnosis models of human prostate cancer based on Taylor database by artificial neural networks,J Chin Med Assoc. 2020 May;83(5):471-477. doi: 10.1097/JCMA.0000000000000299.,Jiang FN,https://www.ncbi.nlm.nih.gov/pubmed/32217993
11519,32316767,Prostate Cancer in Latin America: Challenges and Recommendations,Cancer Control. 2020 Jan-Dec;27(1):1073274820915720. doi: 10.1177/1073274820915720.,Reis RBD,https://www.ncbi.nlm.nih.gov/pubmed/32316767
11522,32035100,Methiothepin mesylate causes apoptosis of human prostate cancer cells by mediating oxidative stress and mitochondrial dysfunction,Free Radic Biol Med. 2020 Apr;150:12-22. doi: 10.1016/j.freeradbiomed.2020.01.187. Epub 2020 Feb 5.,Yang C,https://www.ncbi.nlm.nih.gov/pubmed/32035100
11523,31892050,Determination of prostate cancer marker Zn(2+) with a highly selective surface-enhanced Raman scattering probe on liquid-liquid self-assembled Au nanoarrays,Talanta. 2020 Mar 1;209:120569. doi: 10.1016/j.talanta.2019.120569. Epub 2019 Nov 16.,Teng Y,https://www.ncbi.nlm.nih.gov/pubmed/31892050
11524,32267174,miRNA in prostate cancer: challenges toward translation,Epigenomics. 2020 Mar;12(6):543-558. doi: 10.2217/epi-2019-0275. Epub 2020 Apr 8.,Abramovic I,https://www.ncbi.nlm.nih.gov/pubmed/32267174
11526,32424643,How do prostate cancer patients navigate the active surveillance journey? A 3-year longitudinal study,Support Care Cancer. 2021 Feb;29(2):645-651. doi: 10.1007/s00520-020-05524-8. Epub 2020 May 18.,Dordoni P,https://www.ncbi.nlm.nih.gov/pubmed/32424643
11527,33120315,Preference for sleep management strategies among prostate cancer patients: An Aotearoa/New Zealand perspective(?),Cancer Treat Res Commun. 2020;25:100219. doi: 10.1016/j.ctarc.2020.100219. Epub 2020 Oct 7.,Delpachitra S,https://www.ncbi.nlm.nih.gov/pubmed/33120315
11528,32366240,miR-185 inhibits prostate cancer angiogenesis induced by the nodal/ALK4 pathway,BMC Urol. 2020 May 4;20(1):49. doi: 10.1186/s12894-020-00617-2.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32366240
11529,32180450,Granulomatous prostatitis: a challenging differential diagnosis to take into consideration,Future Oncol. 2020 May;16(13):805-806. doi: 10.2217/fon-2020-0185. Epub 2020 Mar 17.,Crocetto F,https://www.ncbi.nlm.nih.gov/pubmed/32180450
11530,32169431,Sex After Prostate Cancer in Gay and Bisexual Men: A Review of the Literature,Sex Med Rev. 2020 Jul;8(3):466-472. doi: 10.1016/j.sxmr.2020.01.004. Epub 2020 Mar 10.,McInnis MK,https://www.ncbi.nlm.nih.gov/pubmed/32169431
11531,32012197,Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells,PLoS One. 2020 Feb 3;15(2):e0228590. doi: 10.1371/journal.pone.0228590. eCollection 2020.,Luo Z,https://www.ncbi.nlm.nih.gov/pubmed/32012197
11533,31652164,Promise of PET imaging in prostate cancer: improvement or waste of money?,Curr Opin Urol. 2020 Jan;30(1):9-16. doi: 10.1097/MOU.0000000000000684.,Morigi JJ,https://www.ncbi.nlm.nih.gov/pubmed/31652164
11534,31776447,Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):333-342. doi: 10.1038/s41391-019-0181-y. Epub 2019 Nov 27.,Ahmed M,https://www.ncbi.nlm.nih.gov/pubmed/31776447
11535,32183314,Polyphenolic Compounds from Lespedeza Bicolor Root Bark Inhibit Progression of Human Prostate Cancer Cells via Induction of Apoptosis and Cell Cycle Arrest,Biomolecules. 2020 Mar 14;10(3):451. doi: 10.3390/biom10030451.,Dyshlovoy SA,https://www.ncbi.nlm.nih.gov/pubmed/32183314
11537,31839360,Liquid biopsy and prostate cancer. Current evidence applied to clinical practice,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):139-147. doi: 10.1016/j.acuro.2019.08.007. Epub 2019 Dec 12.,Puche-Sanz I,https://www.ncbi.nlm.nih.gov/pubmed/31839360
11539,31995611,"Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study",PLoS One. 2020 Jan 29;15(1):e0228447. doi: 10.1371/journal.pone.0228447. eCollection 2020.,Thomsen FB,https://www.ncbi.nlm.nih.gov/pubmed/31995611
11540,31845922,Nurse-Led Supportive Care Intervention for Men With Advanced Prostate Cancer: Healthcare Professionals' Perspectives,Oncol Nurs Forum. 2020 Jan 1;47(1):33-43. doi: 10.1188/20.ONF.33-43.,Ralph N,https://www.ncbi.nlm.nih.gov/pubmed/31845922
11541,31184513,Dietary Glycemic Index and Glycemic Load and the Risk of Prostate Cancer: An Updated Systematic Review and Dose-Response Meta-Analysis,Nutr Cancer. 2020;72(1):5-14. doi: 10.1080/01635581.2019.1621356. Epub 2019 Jun 11.,Sadeghi A,https://www.ncbi.nlm.nih.gov/pubmed/31184513
11542,32039537,Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance,BJU Int. 2020 Jun;125(6):861-866. doi: 10.1111/bju.15033. Epub 2020 Mar 2.,Mamawala MK,https://www.ncbi.nlm.nih.gov/pubmed/32039537
11545,31820217,Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group Practice,J Gen Intern Med. 2020 May;35(5):1368-1374. doi: 10.1007/s11606-019-05561-y. Epub 2019 Dec 9.,Presti J Jr,https://www.ncbi.nlm.nih.gov/pubmed/31820217
11548,32111915,Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery,Sci Rep. 2020 Feb 28;10(1):3716. doi: 10.1038/s41598-020-60616-z.,Lee B,https://www.ncbi.nlm.nih.gov/pubmed/32111915
11549,31973751,PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review,Cancer Imaging. 2020 Jan 23;20(1):10. doi: 10.1186/s40644-020-0290-9.,Petersen LJ,https://www.ncbi.nlm.nih.gov/pubmed/31973751
11550,33544803,Agreement of two pre-trained deep-learning neural networks built with transfer learning with six pathologists on 6000 patches of prostate cancer from Gleason2019 Challenge,Rom J Morphol Embryol. 2020 Apr-Jun;61(2):513-519. doi: 10.47162/RJME.61.2.21.,?erb?nescu MS,https://www.ncbi.nlm.nih.gov/pubmed/33544803
11551,32332147,Semiautomatically Quantified Tumor Volume Using (68)Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer,J Nucl Med. 2020 Dec;61(12):1786-1792. doi: 10.2967/jnumed.120.242057. Epub 2020 Apr 24.,Seifert R,https://www.ncbi.nlm.nih.gov/pubmed/32332147
11552,31899938,Using data from an online health community to examine the impact of prostate cancer on sleep,BJU Int. 2020 May;125(5):634-635. doi: 10.1111/bju.14986. Epub 2020 Jan 23.,Robbins R,https://www.ncbi.nlm.nih.gov/pubmed/31899938
11553,31937425,Decreased protein expression of candidate tumor suppressors TET3 and EPB41L3 in prostate cancers,Pathol Res Pract. 2020 Feb;216(2):152815. doi: 10.1016/j.prp.2020.152815. Epub 2020 Jan 3.,Mo HY,https://www.ncbi.nlm.nih.gov/pubmed/31937425
11554,31403335,Clinicopathologic Diagnostic Approach to Aggressive Variant Prostate Cancer,Arch Pathol Lab Med. 2020 Jan;144(1):18-23. doi: 10.5858/arpa.2019-0124-RA. Epub 2019 Aug 12.,Manucha V,https://www.ncbi.nlm.nih.gov/pubmed/31403335
11556,31974718,Genetic Testing in Prostate Cancer,Curr Oncol Rep. 2020 Jan 23;22(1):5. doi: 10.1007/s11912-020-0863-6.,Sokolova AO,https://www.ncbi.nlm.nih.gov/pubmed/31974718
11557,32183364,Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer,Genes (Basel). 2020 Mar 14;11(3):314. doi: 10.3390/genes11030314.,Rantapero T,https://www.ncbi.nlm.nih.gov/pubmed/32183364
11558,31989173,ADAPT identifies an ESCRT complex composition that discriminates VCaP from LNCaP prostate cancer cell exosomes,Nucleic Acids Res. 2020 May 7;48(8):4013-4027. doi: 10.1093/nar/gkaa034.,Hornung T,https://www.ncbi.nlm.nih.gov/pubmed/31989173
11560,32620228,The Role of PET-CT Imaging in Prostate Cancer,Semin Ultrasound CT MR. 2020 Aug;41(4):373-391. doi: 10.1053/j.sult.2020.04.004. Epub 2020 May 17.,Subesinghe M,https://www.ncbi.nlm.nih.gov/pubmed/32620228
11561,31963450,Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma,Int J Mol Sci. 2020 Jan 17;21(2):602. doi: 10.3390/ijms21020602.,Oliveira-Ferrer L,https://www.ncbi.nlm.nih.gov/pubmed/31963450
11562,32009541,Proscillaridin A slows the prostate cancer progression through triggering the activation of endoplasmic reticulum stress,Cell Cycle. 2020 Mar;19(5):541-550. doi: 10.1080/15384101.2020.1716484. Epub 2020 Feb 2.,Wang F,https://www.ncbi.nlm.nih.gov/pubmed/32009541
11563,31950190,PCaLiStDB: a lifestyle database for precision prevention of prostate cancer,Database (Oxford). 2020 Jan 1;2020:baz154. doi: 10.1093/database/baz154.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/31950190
11564,32065862,Assessment of high-grade prostate cancer risk using prostate cancer biomarkers,Can J Urol. 2020 Feb;27(1):10080-10085.,Stanton WN,https://www.ncbi.nlm.nih.gov/pubmed/32065862
11565,32188381,MiR-493 Induces Cytotoxic Autophagy in Prostate Cancer Cells through Regulation on PHLPP2,Curr Pharm Biotechnol. 2020;21(14):1451-1456. doi: 10.2174/1389201021666200318120733.,Deng J,https://www.ncbi.nlm.nih.gov/pubmed/32188381
11566,31932554,"Eupalinolide J induces apoptosis, cell cycle arrest, mitochondrial membrane potential disruption and DNA damage in human prostate cancer cells",J Toxicol Sci. 2020;45(1):15-23. doi: 10.2131/jts.45.15.,Wu Z,https://www.ncbi.nlm.nih.gov/pubmed/31932554
11568,31957820,Long non-coding RNA BLACAT1 inhibits prostate cancer cell proliferation through sponging miR-361,Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):74-85. doi: 10.26355/eurrev_202001_19897.,Li HY,https://www.ncbi.nlm.nih.gov/pubmed/31957820
11569,32114681,Neutrophils are mediators of metastatic prostate cancer progression in bone,Cancer Immunol Immunother. 2020 Jun;69(6):1113-1130. doi: 10.1007/s00262-020-02527-6. Epub 2020 Feb 29.,Costanzo-Garvey DL,https://www.ncbi.nlm.nih.gov/pubmed/32114681
11572,31939697,Extraprostatic Uptake of (18)F-Fluciclovine: Differentiation of Nonprostatic Neoplasms From Metastatic Prostate Cancer,AJR Am J Roentgenol. 2020 Mar;214(3):641-648. doi: 10.2214/AJR.19.21894. Epub 2020 Jan 15.,Robertson MS,https://www.ncbi.nlm.nih.gov/pubmed/31939697
11573,31604846,IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer,Mol Cancer Res. 2020 Jan;18(1):153-165. doi: 10.1158/1541-7786.MCR-19-0595. Epub 2019 Oct 11.,Maynard JP,https://www.ncbi.nlm.nih.gov/pubmed/31604846
11574,31746380,Screening and identification of key biomarkers in prostate cancer using bioinformatics,Mol Med Rep. 2020 Jan;21(1):311-319. doi: 10.3892/mmr.2019.10799. Epub 2019 Nov 6.,Li S,https://www.ncbi.nlm.nih.gov/pubmed/31746380
11576,32759606,Prostate Cancer Characteristics in the US Preventive Services Task Force Grade D Era: A Single-Center Study and Meta-Analysis,Urol Int. 2020;104(9-10):692-698. doi: 10.1159/000507656. Epub 2020 Aug 6.,Clements MB,https://www.ncbi.nlm.nih.gov/pubmed/32759606
11577,31865349,Impact of a Changing Population Structure and Clustering of Cancer in Prostate Cancer Patients Depending on a First-Degree Family History,Urol Int. 2020;104(3-4):222-229. doi: 10.1159/000504789. Epub 2019 Dec 20.,Meissner VH,https://www.ncbi.nlm.nih.gov/pubmed/31865349
11579,31771935,Can high resolution micro-ultrasound replace MRI in the diagnosis of prostate cancer?,Eur Urol Focus. 2020 Mar 15;6(2):419-423. doi: 10.1016/j.euf.2019.11.006. Epub 2019 Nov 24.,Laurence Klotz CM,https://www.ncbi.nlm.nih.gov/pubmed/31771935
11580,32323805,"p62 promotes proliferation, apoptosis?resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis",Oncol Rep. 2020 May;43(5):1547-1557. doi: 10.3892/or.2020.7527. Epub 2020 Feb 28.,Jiang G,https://www.ncbi.nlm.nih.gov/pubmed/32323805
11581,31481580,Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for (18)F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer,J Nucl Med. 2020 Feb;61(2):210-216. doi: 10.2967/jnumed.118.222513. Epub 2019 Sep 3.,Jansen BHE,https://www.ncbi.nlm.nih.gov/pubmed/31481580
11582,32089542,A Case of Fournier's Gangrene in a Patient Taking Canagliflozin for the Treatment of Type II Diabetes Mellitus,Am J Case Rep. 2020 Feb 24;21:e920115. doi: 10.12659/AJCR.920115.,Elbeddini A,https://www.ncbi.nlm.nih.gov/pubmed/32089542
11583,32391971,Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer,Mol Carcinog. 2020 Aug;59(8):955-966. doi: 10.1002/mc.23214. Epub 2020 May 11.,Shankar E,https://www.ncbi.nlm.nih.gov/pubmed/32391971
11584,32366552,C-reactive Protein Is a Predictor of Prognosis of Prostate Cancer: A Systematic Review and Meta-Analysis,Ann Clin Lab Sci. 2020 Mar;50(2):161-171.,Liao DW,https://www.ncbi.nlm.nih.gov/pubmed/32366552
11585,32436757,Exploring Prostate Cancer Patients' Interest and Preferences for Receiving Genetic Risk Information About Cancer Aggressiveness,Am J Mens Health. 2020 May-Jun;14(3):1557988320919626. doi: 10.1177/1557988320919626.,Roy S,https://www.ncbi.nlm.nih.gov/pubmed/32436757
11586,32189455,"Role of eIF4E on epithelial-mesenchymal transition, invasion, and chemoresistance of prostate cancer cells",Cancer Commun (Lond). 2020 Mar;40(2-3):126-131. doi: 10.1002/cac2.12011. Epub 2020 Mar 18.,Liu X,https://www.ncbi.nlm.nih.gov/pubmed/32189455
11587,31031042,Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance,Eur Urol Focus. 2020 Mar 15;6(2):242-248. doi: 10.1016/j.euf.2019.04.008. Epub 2019 Apr 25.,Macleod LC,https://www.ncbi.nlm.nih.gov/pubmed/31031042
11588,32219716,Transcriptional suppression of androgen receptor by 18?-glycyrrhetinic acid in LNCaP human prostate cancer cells,Arch Pharm Res. 2020 Apr;43(4):433-448. doi: 10.1007/s12272-020-01228-z. Epub 2020 Mar 26.,Sun Y,https://www.ncbi.nlm.nih.gov/pubmed/32219716
11589,31599460,Androgen receptor-related micro RNAs in prostate cancer and their role in antiandrogen drug resistance,J Cell Physiol. 2020 Apr;235(4):3222-3234. doi: 10.1002/jcp.29275. Epub 2019 Oct 10.,Rezaei S,https://www.ncbi.nlm.nih.gov/pubmed/31599460
11590,31892550,Genetic Polymorphisms in IL-10 Promoter Are Associated With Smoking and Prostate Cancer Risk in African Americans,Anticancer Res. 2020 Jan;40(1):27-34. doi: 10.21873/anticanres.13923.,Abbas M,https://www.ncbi.nlm.nih.gov/pubmed/31892550
11591,32458094,"PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions",World J Urol. 2021 Mar;39(3):787-796. doi: 10.1007/s00345-020-03242-8. Epub 2020 May 26.,Deuker M,https://www.ncbi.nlm.nih.gov/pubmed/32458094
11592,31283607,18F-NaF Uptake in Ocular Prosthesis (Implant),Clin Nucl Med. 2020 Jan;45(1):e59-e60. doi: 10.1097/RLU.0000000000002700.,Kothekar E,https://www.ncbi.nlm.nih.gov/pubmed/31283607
11593,32280028,Diagnostic Performance of the Prostate Cancer Antigen 3 Test in Prostate Cancer: Systematic Review and Meta-analysis,Clin Genitourin Cancer. 2020 Oct;18(5):402-408.e5. doi: 10.1016/j.clgc.2020.03.005. Epub 2020 Mar 14.,Lee D,https://www.ncbi.nlm.nih.gov/pubmed/32280028
11594,31907651,Effects of exercise interventions on social and cognitive functioning of men with prostate cancer: a meta-analysis,Support Care Cancer. 2020 May;28(5):2043-2057. doi: 10.1007/s00520-019-05278-y. Epub 2020 Jan 7.,Fang YY,https://www.ncbi.nlm.nih.gov/pubmed/31907651
11595,32033184,Prostate Cancer Incidence in U.S. Counties and Low Levels of Arsenic in Drinking Water,Int J Environ Res Public Health. 2020 Feb 4;17(3):960. doi: 10.3390/ijerph17030960.,Ahn J,https://www.ncbi.nlm.nih.gov/pubmed/32033184
11596,32274755,Divergent Modulation of Proteostasis in Prostate Cancer,Adv Exp Med Biol. 2020;1233:117-151. doi: 10.1007/978-3-030-38266-7_5.,Ballar Kirmizibayrak P,https://www.ncbi.nlm.nih.gov/pubmed/32274755
11597,31802111,"Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian-randomization study based on 79?148 prostate-cancer cases and 61?106 controls",Int J Epidemiol. 2020 Apr 1;49(2):587-596. doi: 10.1093/ije/dyz235.,Kazmi N,https://www.ncbi.nlm.nih.gov/pubmed/31802111
11600,31630993,Ethnic disparities among men with prostate cancer undergoing germline testing,Urol Oncol. 2020 Mar;38(3):80.e1-80.e7. doi: 10.1016/j.urolonc.2019.09.010. Epub 2019 Oct 17.,Kwon DH,https://www.ncbi.nlm.nih.gov/pubmed/31630993
11601,32068456,The addition of apalutamide to ADT in the treatment of metastatic castration-sensitive prostate cancer: safety and efficacy,Expert Rev Anticancer Ther. 2020 Mar;20(3):147-150. doi: 10.1080/14737140.2020.1732212. Epub 2020 Feb 24.,Barata P,https://www.ncbi.nlm.nih.gov/pubmed/32068456
11602,31693605,Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical Response,Clin Nucl Med. 2020 Jan;45(1):81-82. doi: 10.1097/RLU.0000000000002799.,Plouznikoff N,https://www.ncbi.nlm.nih.gov/pubmed/31693605
11605,31652158,Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence,Clin Nucl Med. 2020 Jan;45(1):e63-e64. doi: 10.1097/RLU.0000000000002781.,Nguyen NC,https://www.ncbi.nlm.nih.gov/pubmed/31652158
11607,32072396,On the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer,Arch Sex Behav. 2020 Jul;49(5):1575-1588. doi: 10.1007/s10508-019-01603-y. Epub 2020 Feb 18.,Walker LM,https://www.ncbi.nlm.nih.gov/pubmed/32072396
11608,31780055,Increasing of FKBP9 can predict poor prognosis in patients with prostate cancer,Pathol Res Pract. 2020 Jan;216(1):152732. doi: 10.1016/j.prp.2019.152732. Epub 2019 Nov 11.,Jiang FN,https://www.ncbi.nlm.nih.gov/pubmed/31780055
11609,33280506,B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis,Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820971649. doi: 10.1177/1533033820971649.,Zhou Y,https://www.ncbi.nlm.nih.gov/pubmed/33280506
11610,32384445,Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors: A case report,Medicine (Baltimore). 2020 May;99(19):e19962. doi: 10.1097/MD.0000000000019962.,Lee CH,https://www.ncbi.nlm.nih.gov/pubmed/32384445
11611,32000564,Evaluating liquid biopsies for methylomic profiling of prostate cancer,Epigenetics. 2020 Jun-Jul;15(6-7):715-727. doi: 10.1080/15592294.2020.1712876. Epub 2020 Jan 31.,Silva R,https://www.ncbi.nlm.nih.gov/pubmed/32000564
11612,32364525,TGF-? signaling regulates SPOP expression and promotes prostate cancer cell stemness,Aging (Albany NY). 2020 May 1;12(9):7747-7760. doi: 10.18632/aging.103085. Epub 2020 May 1.,Jiao C,https://www.ncbi.nlm.nih.gov/pubmed/32364525
11613,31926772,The value of endothelin receptor type B promoter methylation as a biomarker for the risk assessment and diagnosis of prostate cancer: A meta-analysis,Pathol Res Pract. 2020 Feb;216(2):152796. doi: 10.1016/j.prp.2019.152796. Epub 2019 Dec 20.,Yuan Y,https://www.ncbi.nlm.nih.gov/pubmed/31926772
11614,31779479,Methodology for the at-home collection of urine samples for prostate cancer detection,Biotechniques. 2020 Feb;68(2):65-71. doi: 10.2144/btn-2019-0092. Epub 2019 Nov 29.,Webb M,https://www.ncbi.nlm.nih.gov/pubmed/31779479
11617,32323148,Urinary microRNAs expression in prostate cancer diagnosis: a systematic review,Clin Transl Oncol. 2020 Nov;22(11):2061-2073. doi: 10.1007/s12094-020-02349-z. Epub 2020 Apr 22.,Paiva RM,https://www.ncbi.nlm.nih.gov/pubmed/32323148
11619,33364756,Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis,Int J Nanomedicine. 2020 Dec 15;15:10241-10256. doi: 10.2147/IJN.S283106. eCollection 2020.,Pang B,https://www.ncbi.nlm.nih.gov/pubmed/33364756
11620,32149736,Genome-wide plasma DNA methylation features of metastatic prostate cancer,J Clin Invest. 2020 Apr 1;130(4):1991-2000. doi: 10.1172/JCI130887.,Wu A,https://www.ncbi.nlm.nih.gov/pubmed/32149736
11621,32451315,"Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators",Eur Urol Focus. 2021 May;7(3):546-553. doi: 10.1016/j.euf.2020.05.002. Epub 2020 May 22.,Mortezavi A,https://www.ncbi.nlm.nih.gov/pubmed/32451315
11622,32213519,Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study,BMJ Open. 2020 Mar 25;10(3):e034202. doi: 10.1136/bmjopen-2019-034202.,Wu FJ,https://www.ncbi.nlm.nih.gov/pubmed/32213519
11623,32949398,Single-Cell Sequencing in Genitourinary Malignancies,Adv Exp Med Biol. 2020;1255:153-164. doi: 10.1007/978-981-15-4494-1_13.,Murphy N,https://www.ncbi.nlm.nih.gov/pubmed/32949398
11624,32232974,Metabolomic effects of androgen deprivation therapy treatment for prostate cancer,Cancer Med. 2020 Jun;9(11):3691-3702. doi: 10.1002/cam4.3016. Epub 2020 Mar 31.,Chi JT,https://www.ncbi.nlm.nih.gov/pubmed/32232974
11625,32314009,The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis,World J Urol. 2021 Feb;39(2):365-376. doi: 10.1007/s00345-020-03202-2. Epub 2020 Apr 20.,Knijnik PG,https://www.ncbi.nlm.nih.gov/pubmed/32314009
11626,32430927,Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer,Cell Biochem Funct. 2020 Dec;38(8):1006-1016. doi: 10.1002/cbf.3531. Epub 2020 May 19.,Xie Y,https://www.ncbi.nlm.nih.gov/pubmed/32430927
11627,32183092,GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk,Medicina (Kaunas). 2020 Mar 13;56(3):128. doi: 10.3390/medicina56030128.,Santric V,https://www.ncbi.nlm.nih.gov/pubmed/32183092
11628,32005612,Amrubicin for Patients With Platinum-refractory Small-cell Prostate Cancer: Two Case Reports,Clin Genitourin Cancer. 2020 Jun;18(3):e324-e329. doi: 10.1016/j.clgc.2019.12.017. Epub 2020 Jan 7.,Suzuki K,https://www.ncbi.nlm.nih.gov/pubmed/32005612
11629,32220973,An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer,Mol Cancer Ther. 2020 Jun;19(6):1373-1382. doi: 10.1158/1535-7163.MCT-19-0531. Epub 2020 Mar 27.,Dawson NA,https://www.ncbi.nlm.nih.gov/pubmed/32220973
11630,31274029,Glycyrrhiza glabra-Enhanced Extract and Adriamycin Antiproliferative Effect on PC-3 Prostate Cancer Cells,Nutr Cancer. 2020;72(2):320-332. doi: 10.1080/01635581.2019.1632357. Epub 2019 Jul 5.,Gioti K,https://www.ncbi.nlm.nih.gov/pubmed/31274029
11631,32252623,Enhanced identification of significant regulators of gene expression,BMC Bioinformatics. 2020 Apr 6;21(1):134. doi: 10.1186/s12859-020-3468-z.,Ehsani R,https://www.ncbi.nlm.nih.gov/pubmed/32252623
11632,31278035,Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men,Eur Urol Oncol. 2020 Jun;3(3):291-297. doi: 10.1016/j.euo.2019.06.010. Epub 2019 Jul 3.,Chandrasekar T,https://www.ncbi.nlm.nih.gov/pubmed/31278035
11633,31882504,Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance,In Vivo. 2020 Jan-Feb;34(1):393-396. doi: 10.21873/invivo.11786.,Pepe P,https://www.ncbi.nlm.nih.gov/pubmed/31882504
11635,32432733,Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p/YY1 axis,Eur Rev Med Pharmacol Sci. 2020 May;24(9):4697-4709. doi: 10.26355/eurrev_202005_21158.,Luo ZF,https://www.ncbi.nlm.nih.gov/pubmed/32432733
11636,32248648,LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer,Cancer Med. 2020 Jun;9(11):3852-3862. doi: 10.1002/cam4.2992. Epub 2020 Apr 5.,Li T,https://www.ncbi.nlm.nih.gov/pubmed/32248648
11638,32038105,Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT,Int J Med Sci. 2020 Jan 14;17(2):214-223. doi: 10.7150/ijms.39542. eCollection 2020.,Regula N,https://www.ncbi.nlm.nih.gov/pubmed/32038105
11639,32566661,Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer,Biomed Res Int. 2020 May 30;2020:1692658. doi: 10.1155/2020/1692658. eCollection 2020.,Cao Z,https://www.ncbi.nlm.nih.gov/pubmed/32566661
11640,32439974,Diagnosing hereditary cancer predisposition in men with prostate cancer,Genet Med. 2020 Sep;22(9):1517-1523. doi: 10.1038/s41436-020-0830-5. Epub 2020 May 22.,Pritzlaff M,https://www.ncbi.nlm.nih.gov/pubmed/32439974
11641,32014658,Prostate and breast cancer cells death induced by xanthohumol investigated with Fourier transform infrared spectroscopy,Spectrochim Acta A Mol Biomol Spectrosc. 2020 Apr 15;231:118112. doi: 10.1016/j.saa.2020.118112. Epub 2020 Jan 25.,Gieroba B,https://www.ncbi.nlm.nih.gov/pubmed/32014658
11642,31929142,Genetic susceptibility of CYP1A1 gene and risk of pesticide exposure in prostate cancer,Cancer Biomark. 2020;29(4):429-440. doi: 10.3233/CBM-190636.,Abhishek A,https://www.ncbi.nlm.nih.gov/pubmed/31929142
11644,33294057,GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity,Dis Markers. 2020 Nov 25;2020:8810756. doi: 10.1155/2020/8810756. eCollection 2020.,He S,https://www.ncbi.nlm.nih.gov/pubmed/33294057
11645,29446325,Behaviour change techniques in physical activity interventions for men with prostate cancer: A systematic review,J Health Psychol. 2020 Jan;25(1):105-122. doi: 10.1177/1359105318756501. Epub 2018 Feb 15.,Hallward L,https://www.ncbi.nlm.nih.gov/pubmed/29446325
11646,32091270,The prognostic impact of tumour NSD2 expression in advanced prostate cancer,Biomarkers. 2020 May;25(3):268-273. doi: 10.1080/1354750X.2020.1734861. Epub 2020 Mar 2.,Stangl-Kremser J,https://www.ncbi.nlm.nih.gov/pubmed/32091270
11647,30859486,YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells,Pathol Oncol Res. 2020 Apr;26(2):867-876. doi: 10.1007/s12253-019-00634-z. Epub 2019 Mar 11.,Collak FK,https://www.ncbi.nlm.nih.gov/pubmed/30859486
11648,32349713,Pretreatment elevated prognostic nutritional index predicts a favorable prognosis in patients with prostate cancer,BMC Cancer. 2020 Apr 29;20(1):361. doi: 10.1186/s12885-020-06879-1.,Li B,https://www.ncbi.nlm.nih.gov/pubmed/32349713
11649,32106418,Roles of Splicing Factors in Hormone-Related Cancer Progression,Int J Mol Sci. 2020 Feb 25;21(5):1551. doi: 10.3390/ijms21051551.,Takeiwa T,https://www.ncbi.nlm.nih.gov/pubmed/32106418
11650,31672619,The role of adrenal derived androgens in castration resistant prostate cancer,J Steroid Biochem Mol Biol. 2020 Mar;197:105506. doi: 10.1016/j.jsbmb.2019.105506. Epub 2019 Oct 28.,Barnard M,https://www.ncbi.nlm.nih.gov/pubmed/31672619
11653,31782573,"Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy",Mol Carcinog. 2020 Feb;59(2):193-201. doi: 10.1002/mc.23140. Epub 2019 Nov 29.,Pham V,https://www.ncbi.nlm.nih.gov/pubmed/31782573
11654,32222730,"Diffusion-weighted MRI, (11)C-choline PET/CT, and (18)F-FDG PET/CT for predicting the Gleason score in prostate cancer",Hell J Nucl Med. 2020 Jan-Apr;23(1):34-39. doi: 10.1967/s002449912004. Epub 2020 Mar 31.,Kitajima K,https://www.ncbi.nlm.nih.gov/pubmed/32222730
11655,32434566,The economic burden of prostate cancer - a Swedish prevalence-based register study,BMC Health Serv Res. 2020 May 20;20(1):448. doi: 10.1186/s12913-020-05265-8.,Hao S,https://www.ncbi.nlm.nih.gov/pubmed/32434566
11656,32130048,Influence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2,AJR Am J Roentgenol. 2020 May;214(5):1101-1111. doi: 10.2214/AJR.19.21608. Epub 2020 Mar 4.,Wibulpolprasert P,https://www.ncbi.nlm.nih.gov/pubmed/32130048
11657,31948677,Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States,Urology. 2020 Mar;137:60-65. doi: 10.1016/j.urology.2019.12.007. Epub 2020 Jan 13.,Al Hussein Al Awamlh B,https://www.ncbi.nlm.nih.gov/pubmed/31948677
11658,31187780,"Prostate cancer risk prediction models in Eastern Asian populations: current status, racial difference, and future directions",Asian J Androl. 2020 Mar-Apr;22(2):158-161. doi: 10.4103/aja.aja_55_19.,He BM,https://www.ncbi.nlm.nih.gov/pubmed/31187780
11660,32102219,Stevia eupatoria and Stevia pilosa Extracts Inhibit the Proliferation and Migration of Prostate Cancer Cells,Medicina (Kaunas). 2020 Feb 23;56(2):90. doi: 10.3390/medicina56020090.,Martínez-Rojo E,https://www.ncbi.nlm.nih.gov/pubmed/32102219
11661,32358065,Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice,J Biol Chem. 2020 Jun 12;295(24):8252-8261. doi: 10.1074/jbc.RA120.013694. Epub 2020 May 1.,Traughber CA,https://www.ncbi.nlm.nih.gov/pubmed/32358065
11663,32394394,Using In Situ Padlock Probe Technology to Detect mRNA Splice Variants in Tumor Cells,Methods Mol Biol. 2020;2148:361-378. doi: 10.1007/978-1-0716-0623-0_23.,Hofmann L,https://www.ncbi.nlm.nih.gov/pubmed/32394394
11664,31836686,"Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, (18)F-rhPSMA-7, in Patients with Prostate Cancer",J Nucl Med. 2020 May;61(5):702-709. doi: 10.2967/jnumed.119.234609. Epub 2019 Dec 13.,Oh SW,https://www.ncbi.nlm.nih.gov/pubmed/31836686
11665,31789914,Detection of Unusual Peritoneal Metastases of Prostate Cancer With 68Ga-Prostate-Specific Membrane Antigen PET/CT,Clin Nucl Med. 2020 Jan;45(1):63-64. doi: 10.1097/RLU.0000000000002843.,Simsek DH,https://www.ncbi.nlm.nih.gov/pubmed/31789914
11666,31490315,Incidental Detection of Pleomorphic Sarcoma on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer,Clin Nucl Med. 2020 Feb;45(2):e120-e121. doi: 10.1097/RLU.0000000000002760.,Mathew B,https://www.ncbi.nlm.nih.gov/pubmed/31490315
11667,31782192,Capsaicin suppressed activity of prostate cancer stem cells by inhibition of Wnt/?-catenin pathway,Phytother Res. 2020 Apr;34(4):817-824. doi: 10.1002/ptr.6563. Epub 2019 Nov 28.,Zhu M,https://www.ncbi.nlm.nih.gov/pubmed/31782192
11670,32094363,Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer,Sci Rep. 2020 Feb 24;10(1):3250. doi: 10.1038/s41598-020-60064-9.,Hennigs JK,https://www.ncbi.nlm.nih.gov/pubmed/32094363
11671,32986714,Multi-ethnic transcriptome-wide association study of prostate cancer,PLoS One. 2020 Sep 28;15(9):e0236209. doi: 10.1371/journal.pone.0236209. eCollection 2020.,Fiorica PN,https://www.ncbi.nlm.nih.gov/pubmed/32986714
11672,32439935,Racial differences in prostate cancer: does timing of puberty play a role?,Br J Cancer. 2020 Aug;123(3):349-354. doi: 10.1038/s41416-020-0897-4. Epub 2020 May 22.,Hur J,https://www.ncbi.nlm.nih.gov/pubmed/32439935
11675,32019811,Histone Demethylase JMJD1A Promotes Tumor Progression via Activating Snail in Prostate Cancer,Mol Cancer Res. 2020 May;18(5):698-708. doi: 10.1158/1541-7786.MCR-19-0889. Epub 2020 Feb 4.,Tang DE,https://www.ncbi.nlm.nih.gov/pubmed/32019811
11676,32208880,Chimeric cytokine receptor enhancing PSMA-CAR-T cell-mediated prostate cancer regression,Cancer Biol Ther. 2020 Jun 2;21(6):570-580. doi: 10.1080/15384047.2020.1739952. Epub 2020 Mar 25.,Weimin S,https://www.ncbi.nlm.nih.gov/pubmed/32208880
11677,32077525,Validation of a 2-gene mRNA urine test for the detection of ?GG2 prostate cancer in an opportunistic screening population,Prostate. 2020 May;80(6):500-507. doi: 10.1002/pros.23964. Epub 2020 Feb 20.,Rubio-Briones J,https://www.ncbi.nlm.nih.gov/pubmed/32077525
11678,30370853,3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues,Curr Comput Aided Drug Des. 2020;16(3):245-256. doi: 10.2174/1573409914666181029123746.,Meng X,https://www.ncbi.nlm.nih.gov/pubmed/30370853
11679,32246247,CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel,Mol Biol Rep. 2020 May;47(5):3691-3703. doi: 10.1007/s11033-020-05411-9. Epub 2020 Apr 3.,Aghajani M,https://www.ncbi.nlm.nih.gov/pubmed/32246247
11680,31647334,Impact of oxidative stress SNPs and dietary antioxidant quality score on prostate cancer,Int J Food Sci Nutr. 2020 Jun;71(4):500-508. doi: 10.1080/09637486.2019.1680958. Epub 2019 Oct 24.,Pascual-Geler M,https://www.ncbi.nlm.nih.gov/pubmed/31647334
11681,32448969,Quality management in (prostate) cancer care: what do European cancer control plans tell us?,World J Urol. 2021 Jan;39(1):37-39. doi: 10.1007/s00345-020-03258-0. Epub 2020 May 24.,Albreht T,https://www.ncbi.nlm.nih.gov/pubmed/32448969
11682,32487245,The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue,BMC Urol. 2020 Jun 1;20(1):61. doi: 10.1186/s12894-020-00635-0.,Li X,https://www.ncbi.nlm.nih.gov/pubmed/32487245
11683,32115854,The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer,BJU Int. 2020 Jul;126(1):191-201. doi: 10.1111/bju.15041. Epub 2020 Mar 29.,Dong L,https://www.ncbi.nlm.nih.gov/pubmed/32115854
11685,31954523,Circulating cell-free DNA: Translating prostate cancer genomics into clinical care,Mol Aspects Med. 2020 Apr;72:100837. doi: 10.1016/j.mam.2019.100837. Epub 2020 Jan 16.,Gasi Tandefelt D,https://www.ncbi.nlm.nih.gov/pubmed/31954523
11686,31704035,Conceptual review of key themes in treating prostate cancer in older adults,J Geriatr Oncol. 2020 Jun;11(5):893-898. doi: 10.1016/j.jgo.2019.10.005. Epub 2019 Nov 5.,Sedhom R,https://www.ncbi.nlm.nih.gov/pubmed/31704035
11687,32255689,What You Need to Know Before Reading Multiparametric MRI for Prostate Cancer,AJR Am J Roentgenol. 2020 Jun;214(6):1211-1219. doi: 10.2214/AJR.19.22751. Epub 2020 Apr 7.,Walker SM,https://www.ncbi.nlm.nih.gov/pubmed/32255689
11688,32017831,PSA cancer screening: a case for shared decision-making,J Fam Pract. 2020 Jan/Feb;69(1):26;28;30;32;46.,Dasarathy J,https://www.ncbi.nlm.nih.gov/pubmed/32017831
11689,32283544,FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer,Aging (Albany NY). 2020 Apr 13;12(7):6352-6369. doi: 10.18632/aging.103030. Epub 2020 Apr 13.,Ma L,https://www.ncbi.nlm.nih.gov/pubmed/32283544
11690,32147352,Results of the spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Update after 21 years of follow-up,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):430-436. doi: 10.1016/j.acuro.2020.01.005. Epub 2020 Mar 5.,Luján Galán M,https://www.ncbi.nlm.nih.gov/pubmed/32147352
11691,32106357,GP experience and understandings of providing follow-up care in prostate cancer survivors in England,Health Soc Care Community. 2020 Sep;28(5):1468-1478. doi: 10.1111/hsc.12969. Epub 2020 Feb 27.,Margariti C,https://www.ncbi.nlm.nih.gov/pubmed/32106357
11693,31337229,Analysis of Inpatient Palliative Care Consultations for Patients With Metastatic Prostate Cancer,Am J Hosp Palliat Care. 2020 Feb;37(2):136-141. doi: 10.1177/1049909119864576. Epub 2019 Jul 24.,Mistry NA,https://www.ncbi.nlm.nih.gov/pubmed/31337229
11694,32279204,A novel palpation-based method for tumor nodule quantification in soft tissue-computational framework and experimental validation,Med Biol Eng Comput. 2020 Jun;58(6):1369-1381. doi: 10.1007/s11517-020-02168-y. Epub 2020 Apr 11.,Palacio-Torralba J,https://www.ncbi.nlm.nih.gov/pubmed/32279204
11695,32071115,Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations,Clin Cancer Res. 2020 Jun 1;26(11):2673-2680. doi: 10.1158/1078-0432.CCR-19-2135. Epub 2020 Feb 18.,Sztupinszki Z,https://www.ncbi.nlm.nih.gov/pubmed/32071115
11697,32015295,Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging,Top Magn Reson Imaging. 2020 Feb;29(1):59-66. doi: 10.1097/RMR.0000000000000229.,Ferraro DA,https://www.ncbi.nlm.nih.gov/pubmed/32015295
11699,31734853,Identifying Expectations of Delayed Return to Work in Patients with Prostate Cancer at the Beginning of a Cancer Rehabilitation Program,J Occup Rehabil. 2020 Jun;30(2):183-193. doi: 10.1007/s10926-019-09860-3.,Ullrich A,https://www.ncbi.nlm.nih.gov/pubmed/31734853
11703,31729886,False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma,Arch Pathol Lab Med. 2020 Mar;144(3):326-334. doi: 10.5858/arpa.2019-0456-RA. Epub 2019 Nov 15.,Yang C,https://www.ncbi.nlm.nih.gov/pubmed/31729886
11704,32997661,Differential anti-proliferative and apoptotic effects of lichen species on human prostate carcinoma cells,PLoS One. 2020 Sep 30;15(9):e0238303. doi: 10.1371/journal.pone.0238303. eCollection 2020.,Goncu B,https://www.ncbi.nlm.nih.gov/pubmed/32997661
11705,31652379,Anxiety and depression symptoms in adult males in Atlantic Canada with or without a lifetime history of prostate cancer,Psychooncology. 2020 Feb;29(2):280-286. doi: 10.1002/pon.5244. Epub 2019 Dec 26.,Ilie G,https://www.ncbi.nlm.nih.gov/pubmed/31652379
11706,32019578,SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer,J Exp Clin Cancer Res. 2020 Feb 4;39(1):28. doi: 10.1186/s13046-019-1516-1.,Ding M,https://www.ncbi.nlm.nih.gov/pubmed/32019578
11707,31732913,Temporal and spatial trends and determinants of aggressive prostate cancer among Black and White men with prostate cancer,Cancer Causes Control. 2020 Jan;31(1):63-71. doi: 10.1007/s10552-019-01249-0. Epub 2019 Nov 15.,Wang M,https://www.ncbi.nlm.nih.gov/pubmed/31732913
11708,32459381,"CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action",J Cell Mol Med. 2020 Jul;24(13):7239-7253. doi: 10.1111/jcmm.15281. Epub 2020 May 27.,Hu C,https://www.ncbi.nlm.nih.gov/pubmed/32459381
11710,32089062,Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1,Cancer Biol Ther. 2020 May 3;21(5):452-462. doi: 10.1080/15384047.2020.1727700. Epub 2020 Feb 23.,Li X,https://www.ncbi.nlm.nih.gov/pubmed/32089062
11711,33029258,eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer,Dis Markers. 2020 Sep 22;2020:8847986. doi: 10.1155/2020/8847986. eCollection 2020.,Zhang X,https://www.ncbi.nlm.nih.gov/pubmed/33029258
11712,32282098,Integrative analysis of AR-mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression,Prostate. 2020 May;80(8):640-652. doi: 10.1002/pros.23976. Epub 2020 Apr 13.,Cheng Y,https://www.ncbi.nlm.nih.gov/pubmed/32282098
11713,32319568,Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF??B pathway (Review),Int J Oncol. 2020 May;56(5):1064-1074. doi: 10.3892/ijo.2020.4990. Epub 2020 Feb 19.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/32319568
11714,32101694,Diagnosis of prostate cancer: the implications and proper utilization of PSA and its variants; indications and use of MRI and biomarkers,Can J Urol. 2020 Feb;27(27 Suppl 1):3-10.,Law KW,https://www.ncbi.nlm.nih.gov/pubmed/32101694
11715,30217630,The U Shape of Prostate-specific Antigen and Prostate Cancer-specific Mortality in High-grade Metastatic Prostate Adenocarcinoma,Eur Urol Focus. 2020 Jan 15;6(1):53-62. doi: 10.1016/j.euf.2018.08.024. Epub 2018 Sep 11.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/30217630
11716,31588660,Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques,J Magn Reson Imaging. 2020 May;51(5):1540-1553. doi: 10.1002/jmri.26945. Epub 2019 Oct 6.,Montoya Perez I,https://www.ncbi.nlm.nih.gov/pubmed/31588660
11717,31977384,Molecular Imaging of Newly Diagnosed Prostate Cancer,Cancer J. 2020 Jan/Feb;26(1):43-47. doi: 10.1097/PPO.0000000000000427.,Williams S,https://www.ncbi.nlm.nih.gov/pubmed/31977384
11718,31794066,Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening,Cancer. 2020 Feb 15;126(4):694-696. doi: 10.1002/cncr.32605. Epub 2019 Dec 3.,Joshi SS,https://www.ncbi.nlm.nih.gov/pubmed/31794066
11719,32674240,"Dietary phosphorus intake and serum prostate-specific antigen in non-prostate cancer American adults: A secondary analysis of the National Health and Nutrition Examination Survey (NHANES), 2003-2010",Asia Pac J Clin Nutr. 2020;29(2):322-333. doi: 10.6133/apjcn.202007_29(2).0015.,Zhu G,https://www.ncbi.nlm.nih.gov/pubmed/32674240
11720,31758936,Development and internal validation of a novel PHI-nomogram to identify aggressive prostate cancer,Clin Chim Acta. 2020 Feb;501:174-178. doi: 10.1016/j.cca.2019.10.039. Epub 2019 Nov 20.,Foj L,https://www.ncbi.nlm.nih.gov/pubmed/31758936
11721,32066566,Revisiting Immunotherapy: A Focus on Prostate Cancer,Cancer Res. 2020 Apr 15;80(8):1615-1623. doi: 10.1158/0008-5472.CAN-19-2948. Epub 2020 Feb 17.,Cha HR,https://www.ncbi.nlm.nih.gov/pubmed/32066566
11722,31473840,Quality of life and fear of disease progression are associated with aspects of health literacy in men with prostate cancer from Germany,Support Care Cancer. 2020 May;28(5):2283-2292. doi: 10.1007/s00520-019-05052-0. Epub 2019 Aug 31.,Haack M,https://www.ncbi.nlm.nih.gov/pubmed/31473840
11723,32876300,"Trends in prostate cancer mortality in the state of São Paulo, 2000 to 2015",Rev Saude Publica. 2020;54:87. doi: 10.11606/s1518-8787.2020054001948. Epub 2020 Aug 28.,Luizaga CTM,https://www.ncbi.nlm.nih.gov/pubmed/32876300
11725,31769890,Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms,Prostate. 2020 Feb;80(2):162-172. doi: 10.1002/pros.23928. Epub 2019 Nov 26.,Elix CC,https://www.ncbi.nlm.nih.gov/pubmed/31769890
11726,32250342,CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo,J Clin Invest. 2020 May 1;130(5):2435-2450. doi: 10.1172/JCI131133.,Alajati A,https://www.ncbi.nlm.nih.gov/pubmed/32250342
11727,32848387,Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer,Int J Nanomedicine. 2020 Aug 5;15:5545-5559. doi: 10.2147/IJN.S257522. eCollection 2020.,Dong W,https://www.ncbi.nlm.nih.gov/pubmed/32848387
11729,31448633,Anthocyanins of Blue Corn and Tortilla Arrest Cell Cycle and Induce Apoptosis on Breast and Prostate Cancer Cells,Nutr Cancer. 2020;72(5):768-777. doi: 10.1080/01635581.2019.1654529. Epub 2019 Aug 26.,Herrera-Sotero MY,https://www.ncbi.nlm.nih.gov/pubmed/31448633
11730,31006341,Safety analysis of long-term phenazopyridine use for radiation cystitis,J Oncol Pharm Pract. 2020 Mar;26(2):306-311. doi: 10.1177/1078155219842646. Epub 2019 Apr 22.,Shore SN,https://www.ncbi.nlm.nih.gov/pubmed/31006341
11731,31402717,Effects of Black Raspberries and Their Constituents on Rat Prostate Carcinogenesis and Human Prostate Cancer Cell Growth In Vitro,Nutr Cancer. 2020;72(4):672-685. doi: 10.1080/01635581.2019.1650943. Epub 2019 Aug 12.,Eskra JN,https://www.ncbi.nlm.nih.gov/pubmed/31402717
11733,32764784,Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype,PLoS One. 2020 Aug 7;15(8):e0237222. doi: 10.1371/journal.pone.0237222. eCollection 2020.,Bou-Dargham MJ,https://www.ncbi.nlm.nih.gov/pubmed/32764784
11734,31066018,"High Concentrations of Boric Acid Trigger Concentration-Dependent Oxidative Stress, Apoptotic Pathways and Morphological Alterations in DU-145 Human Prostate Cancer Cell Line",Biol Trace Elem Res. 2020 Feb;193(2):400-409. doi: 10.1007/s12011-019-01739-x. Epub 2019 May 7.,Hacioglu C,https://www.ncbi.nlm.nih.gov/pubmed/31066018
11735,32347121,Can Isoflavones Influence Prostate Specific Antigen Serum Levels in Localized Prostate Cancer? A Systematic Review,Nutr Cancer. 2021;73(3):361-368. doi: 10.1080/01635581.2020.1759660. Epub 2020 Apr 29.,Ratha P,https://www.ncbi.nlm.nih.gov/pubmed/32347121
11736,30879969,Androgen deprivation therapy and cardiovascular disease,Urol Oncol. 2020 Feb;38(2):45-52. doi: 10.1016/j.urolonc.2019.02.010. Epub 2019 Mar 14.,Melloni C,https://www.ncbi.nlm.nih.gov/pubmed/30879969
11737,32468018,"TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells",Oncol Rep. 2020 Aug;44(2):747-756. doi: 10.3892/or.2020.7616. Epub 2020 May 19.,Lin M,https://www.ncbi.nlm.nih.gov/pubmed/32468018
11738,32462034,Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues,Biomed Res Int. 2020 May 5;2020:9086829. doi: 10.1155/2020/9086829. eCollection 2020.,Ambrozkiewicz F,https://www.ncbi.nlm.nih.gov/pubmed/32462034
11740,31401823,Time Trends for Prostate Cancer Incidence from 2003 to 2013 in South Korea: An Age-Period-Cohort Analysis,Cancer Res Treat. 2020 Jan;52(1):301-308. doi: 10.4143/crt.2019.194. Epub 2019 Aug 1.,Lee HY,https://www.ncbi.nlm.nih.gov/pubmed/31401823
11741,32470500,LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation,Mol Cell Probes. 2020 Oct;53:101607. doi: 10.1016/j.mcp.2020.101607. Epub 2020 May 26.,Hu J,https://www.ncbi.nlm.nih.gov/pubmed/32470500
11742,32377739,p53/PGC?1??mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis,Mol Med Rep. 2020 Jul;22(1):155-164. doi: 10.3892/mmr.2020.11121. Epub 2020 May 5.,Li J,https://www.ncbi.nlm.nih.gov/pubmed/32377739
11743,32444377,PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study,J Nucl Med. 2021 Jan;62(1):88-91. doi: 10.2967/jnumed.120.245456. Epub 2020 May 22.,Weber M,https://www.ncbi.nlm.nih.gov/pubmed/32444377
11744,30937835,Phloretin Inhibits the Human Prostate Cancer Cells Through the Generation of Reactive Oxygen Species,Pathol Oncol Res. 2020 Apr;26(2):977-984. doi: 10.1007/s12253-019-00643-y. Epub 2019 Apr 1.,Kim U,https://www.ncbi.nlm.nih.gov/pubmed/30937835
11745,31849283,Germline variants and response to systemic therapy in advanced prostate cancer,Pharmacogenomics. 2020 Jan;21(1):75-81. doi: 10.2217/pgs-2019-0125.,Johnson E,https://www.ncbi.nlm.nih.gov/pubmed/31849283
11746,32475689,Initial experience with SelectMDx(R) in the diagnosis of prostate cancer in a real-world evidence clinical practice setting,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):400-407. doi: 10.1016/j.acuro.2020.03.005. Epub 2020 May 29.,Quintana LM,https://www.ncbi.nlm.nih.gov/pubmed/32475689
11747,32003504,Stromal-epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells,J Cell Biochem. 2020 Nov;121(11):4406-4418. doi: 10.1002/jcb.29664. Epub 2020 Jan 31.,Fu S,https://www.ncbi.nlm.nih.gov/pubmed/32003504
11748,32015292,Magnetic Resonance Imaging of Prostate Adenocarcinoma: Detection and Staging,Top Magn Reson Imaging. 2020 Feb;29(1):17-30. doi: 10.1097/RMR.0000000000000226.,Ward RD,https://www.ncbi.nlm.nih.gov/pubmed/32015292
11749,31776744,Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer,Eur Radiol. 2020 Mar;30(3):1313-1324. doi: 10.1007/s00330-019-06488-y. Epub 2019 Nov 27.,Bleker J,https://www.ncbi.nlm.nih.gov/pubmed/31776744
11751,29594807,"Genetic Polymorphisms in miR-146a, miR-196a2 and miR-125a Genes and its Association in Prostate Cancer",Pathol Oncol Res. 2020 Jan;26(1):193-200. doi: 10.1007/s12253-018-0412-x. Epub 2018 Mar 29.,Damodaran M,https://www.ncbi.nlm.nih.gov/pubmed/29594807
11752,31630475,The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer,Mol Oncol. 2020 Jan;14(1):105-128. doi: 10.1002/1878-0261.12587. Epub 2019 Nov 28.,Kryza T,https://www.ncbi.nlm.nih.gov/pubmed/31630475
11755,31624316,Tobacco smoking and death from prostate cancer in US veterans,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):252-259. doi: 10.1038/s41391-019-0178-6. Epub 2019 Oct 17.,Riviere P,https://www.ncbi.nlm.nih.gov/pubmed/31624316
11756,31567104,Deep Learning-Based Gleason Grading of Prostate Cancer From Histopathology Images-Role of Multiscale Decision Aggregation and Data Augmentation,IEEE J Biomed Health Inform. 2020 May;24(5):1413-1426. doi: 10.1109/JBHI.2019.2944643. Epub 2019 Sep 30.,Karimi D,https://www.ncbi.nlm.nih.gov/pubmed/31567104
11757,31678450,"Intracranial Metastases from Prostate Carcinoma: Classification, Management, and Prognostication",World Neurosurg. 2020 Feb;134:e559-e565. doi: 10.1016/j.wneu.2019.10.125. Epub 2019 Oct 31.,Ganau M,https://www.ncbi.nlm.nih.gov/pubmed/31678450
11758,31843065,PSMA-Based Theranostics: A Step-by-Step Practical Approach to Diagnosis and Therapy for mCRPC Patients,Semin Nucl Med. 2020 Jan;50(1):98-109. doi: 10.1053/j.semnuclmed.2019.07.003. Epub 2019 Aug 21.,Ahmadzadehfar H,https://www.ncbi.nlm.nih.gov/pubmed/31843065
11760,31492992,Performance of (18)F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):105-114. doi: 10.1007/s00259-019-04506-1. Epub 2019 Sep 6.,Amorim BJ,https://www.ncbi.nlm.nih.gov/pubmed/31492992
11761,32385370,"Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer",Sci Rep. 2020 May 8;10(1):7736. doi: 10.1038/s41598-020-62182-w.,Nair-Shalliker V,https://www.ncbi.nlm.nih.gov/pubmed/32385370
11762,32008114,Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial,World J Urol. 2021 Feb;39(2):357-364. doi: 10.1007/s00345-020-03098-y. Epub 2020 Feb 1.,Bultijnck R,https://www.ncbi.nlm.nih.gov/pubmed/32008114
11765,31625175,Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker,J Cell Biochem. 2020 Mar;121(3):2118-2126. doi: 10.1002/jcb.28239. Epub 2019 Oct 17.,Li T,https://www.ncbi.nlm.nih.gov/pubmed/31625175
11767,31996370,Risk of Prostate Cancer-related Death Following a Low PSA Level in the PLCO Trial,Cancer Prev Res (Phila). 2020 Apr;13(4):367-376. doi: 10.1158/1940-6207.CAPR-19-0397. Epub 2020 Jan 29.,Landy R,https://www.ncbi.nlm.nih.gov/pubmed/31996370
11768,31292837,Dirty deeds done dirt cheap: sensitization of prostate cancer cells to abiraterone treatment using hydroxylated polychlorinated biphenyls,Invest New Drugs. 2020 Apr;38(2):541-545. doi: 10.1007/s10637-019-00833-0. Epub 2019 Jul 11.,Daragan G,https://www.ncbi.nlm.nih.gov/pubmed/31292837
11769,32433780,Does screening for prostate cancer improve cancer-specific mortality in Asian men? Real-world data in Yokosuka City 15 years after introducing PSA-based population screening,Prostate. 2020 Aug;80(11):824-830. doi: 10.1002/pros.23997. Epub 2020 May 20.,Tabei T,https://www.ncbi.nlm.nih.gov/pubmed/32433780
11770,32035002,Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer,Cancer Med. 2020 Apr;9(7):2379-2389. doi: 10.1002/cam4.2862. Epub 2020 Feb 8.,Tan XL,https://www.ncbi.nlm.nih.gov/pubmed/32035002
11773,32102754,CTHRC1 affects malignant tumor cell behavior and is regulated by miR-30e-5p in human prostate cancer,Biochem Biophys Res Commun. 2020 Apr 30;525(2):418-424. doi: 10.1016/j.bbrc.2020.02.098. Epub 2020 Feb 23.,Ma Z,https://www.ncbi.nlm.nih.gov/pubmed/32102754
11774,32363651,Contrast Medium or No Contrast Medium for Prostate Cancer Diagnosis. That Is the Question,J Magn Reson Imaging. 2021 Jan;53(1):13-22. doi: 10.1002/jmri.27180. Epub 2020 May 3.,Padhani AR,https://www.ncbi.nlm.nih.gov/pubmed/32363651
11775,31155933,?-Casein Changes Gene Expression Profiles and Promotes Tumorigenesis of Prostate Cancer Cells,Nutr Cancer. 2020;72(2):239-251. doi: 10.1080/01635581.2019.1622742. Epub 2019 Jun 1.,Kim JY,https://www.ncbi.nlm.nih.gov/pubmed/31155933
11776,31791110,Prostate cancer adverse pathology reclassification in patients undergoing active surveillance in a long-term follow-up series,Prostate. 2020 Feb;80(2):209-213. doi: 10.1002/pros.23933. Epub 2019 Dec 2.,Fernández-Conejo G,https://www.ncbi.nlm.nih.gov/pubmed/31791110
11777,32661204,Promoter polymorphisms of the PCA3 gene are not associated with its overexpression in prostate cancer patients,J Genet. 2020;99:51.,Arámbula-Meraz E,https://www.ncbi.nlm.nih.gov/pubmed/32661204
11778,31964195,The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer,Future Oncol. 2020 Feb;16(6):147-149. doi: 10.2217/fon-2019-0718. Epub 2020 Jan 22.,Mather RL,https://www.ncbi.nlm.nih.gov/pubmed/31964195
11779,32154965,"Associations between self-reported physical activity, quality of life, and emotional well-being in men with prostate cancer on active surveillance",Psychooncology. 2020 Jun;29(6):1044-1050. doi: 10.1002/pon.5375. Epub 2020 Mar 18.,Papadopoulos E,https://www.ncbi.nlm.nih.gov/pubmed/32154965
11780,32029296,Development of a conceptual framework to improve sexual wellbeing communication in routine prostate cancer care,Patient Educ Couns. 2020 Jun;103(6):1150-1160. doi: 10.1016/j.pec.2020.01.014. Epub 2020 Jan 20.,McCaughan E,https://www.ncbi.nlm.nih.gov/pubmed/32029296
11781,31816118,Germline BLM mutations and metastatic prostate cancer,Prostate. 2020 Feb;80(2):235-237. doi: 10.1002/pros.23924. Epub 2019 Nov 5.,Ledet EM,https://www.ncbi.nlm.nih.gov/pubmed/31816118
11782,32322996,Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group,World J Urol. 2020 Oct;38(10):2411-2431. doi: 10.1007/s00345-020-03197-w. Epub 2020 Apr 22.,Jamnadass E,https://www.ncbi.nlm.nih.gov/pubmed/32322996
11783,32393663,A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa,Cancer Res. 2020 Jul 1;80(13):2956-2966. doi: 10.1158/0008-5472.CAN-19-2165. Epub 2020 May 11.,Harlemon M,https://www.ncbi.nlm.nih.gov/pubmed/32393663
11784,31276604,GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer,Int J Cancer. 2020 Mar 1;146(5):1369-1382. doi: 10.1002/ijc.32554. Epub 2019 Jul 22.,Sawada Y,https://www.ncbi.nlm.nih.gov/pubmed/31276604
11785,32385899,Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer,Mol Oncol. 2020 Aug;14(8):1881-1897. doi: 10.1002/1878-0261.12706. Epub 2020 May 31.,Mazzu YZ,https://www.ncbi.nlm.nih.gov/pubmed/32385899
11786,31951873,Artificial intelligence in multiparametric prostate cancer imaging with focus on deep-learning methods,Comput Methods Programs Biomed. 2020 Jun;189:105316. doi: 10.1016/j.cmpb.2020.105316. Epub 2020 Jan 7.,Wildeboer RR,https://www.ncbi.nlm.nih.gov/pubmed/31951873
11787,32407712,"Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer",Arch Biochem Biophys. 2020 Jul 30;688:108407. doi: 10.1016/j.abb.2020.108407. Epub 2020 May 12.,Park S,https://www.ncbi.nlm.nih.gov/pubmed/32407712
11788,31841727,"Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer",Eur J Med Chem. 2020 Feb 1;187:111937. doi: 10.1016/j.ejmech.2019.111937. Epub 2019 Dec 9.,Tokay E,https://www.ncbi.nlm.nih.gov/pubmed/31841727
11789,32102531,Can the Irisin be a Biomarker for Prostate Cancer? A Case Control Study,Asian Pac J Cancer Prev. 2020 Feb 1;21(2):505-509. doi: 10.31557/APJCP.2020.21.2.505.,Aslan R,https://www.ncbi.nlm.nih.gov/pubmed/32102531
11791,31267540,Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR-133b,J Cell Physiol. 2020 Feb;235(2):1235-1246. doi: 10.1002/jcp.29039. Epub 2019 Jul 2.,Cheng G,https://www.ncbi.nlm.nih.gov/pubmed/31267540
11792,32075840,Local and systemic morbidities of de novo metastatic prostate cancer in Singapore: insight from 685 consecutive patients from a large prospective Uro-oncology registry,BMJ Open. 2020 Feb 18;10(2):e034331. doi: 10.1136/bmjopen-2019-034331.,Tan YG,https://www.ncbi.nlm.nih.gov/pubmed/32075840
11793,32000565,Occupation as a predictor of prostate cancer screening behaviour in Canada,J Med Screen. 2020 Dec;27(4):215-222. doi: 10.1177/0969141320902485. Epub 2020 Jan 30.,Peters CE,https://www.ncbi.nlm.nih.gov/pubmed/32000565
11794,32349610,Impact of Pretreatment Total Cholesterol Level Is Associated With Metastasis of Prostate Cancer,Am J Mens Health. 2020 Mar-Apr;14(2):1557988320918788. doi: 10.1177/1557988320918788.,Hirano H,https://www.ncbi.nlm.nih.gov/pubmed/32349610
11795,32327298,Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants,Clin Breast Cancer. 2020 Aug;20(4):300-306. doi: 10.1016/j.clbc.2020.03.005. Epub 2020 Mar 20.,Abdel-Rahman O,https://www.ncbi.nlm.nih.gov/pubmed/32327298
11796,32075054,Sanggenol L Induces Apoptosis and Cell Cycle Arrest via Activation of p53 and Suppression of PI3K/Akt/mTOR Signaling in Human Prostate Cancer Cells,Nutrients. 2020 Feb 14;12(2):488. doi: 10.3390/nu12020488.,Won YS,https://www.ncbi.nlm.nih.gov/pubmed/32075054
11798,32403270,The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells,Molecules. 2020 May 11;25(9):2257. doi: 10.3390/molecules25092257.,Zarmouh NO,https://www.ncbi.nlm.nih.gov/pubmed/32403270
11799,31772313,SOX2 has dual functions as a regulator in the progression of neuroendocrine prostate cancer,Lab Invest. 2020 Apr;100(4):570-582. doi: 10.1038/s41374-019-0343-5. Epub 2019 Nov 26.,Li H,https://www.ncbi.nlm.nih.gov/pubmed/31772313
11800,32060215,Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer,J Nucl Med. 2020 Jun;61(6):792-798. doi: 10.2967/jnumed.119.234971. Epub 2020 Feb 14.,Baratto L,https://www.ncbi.nlm.nih.gov/pubmed/32060215
11801,32183880,Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells,Stem Cell Res Ther. 2020 Mar 17;11(1):123. doi: 10.1186/s13287-020-01634-6.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/32183880
11802,31591455,The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):53-58. doi: 10.1038/s41391-019-0177-7. Epub 2019 Oct 7.,Ge Y,https://www.ncbi.nlm.nih.gov/pubmed/31591455
11803,32307923,Functionalized NIR-II Semiconducting Polymer Nanoparticles for Single-cell to Whole-Organ Imaging of PSMA-Positive Prostate Cancer,Small. 2020 May;16(19):e2001215. doi: 10.1002/smll.202001215. Epub 2020 Apr 20.,Wu J,https://www.ncbi.nlm.nih.gov/pubmed/32307923
11804,31990618,Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline,J Clin Oncol. 2020 May 20;38(15):1736-1743. doi: 10.1200/JCO.19.03148. Epub 2020 Jan 28.,Saylor PJ,https://www.ncbi.nlm.nih.gov/pubmed/31990618
11805,32904557,The Significance of Circular RNA DDX17 in Prostate Cancer,Biomed Res Int. 2020 Aug 20;2020:1878431. doi: 10.1155/2020/1878431. eCollection 2020.,Lin Q,https://www.ncbi.nlm.nih.gov/pubmed/32904557
11806,32123316,Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):527-533. doi: 10.1038/s41391-020-0220-8. Epub 2020 Mar 2.,Beckmann K,https://www.ncbi.nlm.nih.gov/pubmed/32123316
11807,31161221,Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome,J Natl Cancer Inst. 2020 Mar 1;112(3):247-255. doi: 10.1093/jnci/djz112.,Jeon J,https://www.ncbi.nlm.nih.gov/pubmed/31161221
11809,32368817,Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study,Prostate. 2020 Jul;80(10):777-781. doi: 10.1002/pros.23991. Epub 2020 May 5.,Lundgren PO,https://www.ncbi.nlm.nih.gov/pubmed/32368817
11811,32598349,Antihypertensive drug use and prostate cancer-specific mortality in Finnish men,PLoS One. 2020 Jun 29;15(6):e0234269. doi: 10.1371/journal.pone.0234269. eCollection 2020.,Siltari A,https://www.ncbi.nlm.nih.gov/pubmed/32598349
11813,32321776,Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer,Cancer Immunol Res. 2020 Jul;8(7):844-850. doi: 10.1158/2326-6066.CIR-19-0568. Epub 2020 Apr 22.,Wagle MC,https://www.ncbi.nlm.nih.gov/pubmed/32321776
11815,31736422,MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR,Cancer Biol Ther. 2020;21(1):34-42. doi: 10.1080/15384047.2019.1665393. Epub 2019 Nov 17.,Zheng L,https://www.ncbi.nlm.nih.gov/pubmed/31736422
11817,32443915,Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis,Molecules. 2020 May 20;25(10):2380. doi: 10.3390/molecules25102380.,Lin SR,https://www.ncbi.nlm.nih.gov/pubmed/32443915
11818,32077748,Long Noncoding RNA SNHG1 Contributes to the Promotion of Prostate Cancer Cells Through Regulating miR-377-3p/AKT2 Axis,Cancer Biother Radiopharm. 2020 Mar;35(2):109-119. doi: 10.1089/cbr.2019.3177. Epub 2020 Feb 20.,Xie M,https://www.ncbi.nlm.nih.gov/pubmed/32077748
11819,31644322,Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review,Arch Pathol Lab Med. 2020 Mar;144(3):320-325. doi: 10.5858/arpa.2019-0434-RA. Epub 2019 Oct 23.,Hu J,https://www.ncbi.nlm.nih.gov/pubmed/31644322
11820,32434809,The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane,Cancer Prev Res (Phila). 2020 Aug;13(8):661-672. doi: 10.1158/1940-6207.CAPR-20-0054. Epub 2020 May 20.,Hahm ER,https://www.ncbi.nlm.nih.gov/pubmed/32434809
11821,31983247,ONECUT2 is a novel target for treatment of castration-resistant prostate cancer,Expert Opin Ther Targets. 2020 Feb;24(2):89-90. doi: 10.1080/14728222.2020.1723080. Epub 2020 Feb 3.,Joglekar T,https://www.ncbi.nlm.nih.gov/pubmed/31983247
11822,32406281,Treatment in hormone-sensitive metastatic prostate cancer: factors to consider when personalizing therapy,Expert Rev Anticancer Ther. 2020 Jun;20(6):483-490. doi: 10.1080/14737140.2020.1770087. Epub 2020 Jun 21.,Aragon-Ching JB,https://www.ncbi.nlm.nih.gov/pubmed/32406281
11823,32409263,"Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer",Nucl Med Biol. 2021 Jan;92:217-227. doi: 10.1016/j.nucmedbio.2020.04.005. Epub 2020 May 3.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32409263
11824,31746434,Long non?coding RNA HCP5 promotes prostate cancer cell proliferation by acting as the sponge of miR?4656 to modulate CEMIP expression,Oncol Rep. 2020 Jan;43(1):328-336. doi: 10.3892/or.2019.7404. Epub 2019 Nov 8.,Hu R,https://www.ncbi.nlm.nih.gov/pubmed/31746434
11825,32179174,Association of 5'UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis,Gene. 2020 Jun 5;742:144589. doi: 10.1016/j.gene.2020.144589. Epub 2020 Mar 13.,Ozturk K,https://www.ncbi.nlm.nih.gov/pubmed/32179174
11826,32624693,The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study,Int J Med Sci. 2020 May 30;17(10):1366-1374. doi: 10.7150/ijms.45730. eCollection 2020.,Chen S,https://www.ncbi.nlm.nih.gov/pubmed/32624693
11827,31310382,MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1,J Cell Biochem. 2020 Jan;121(1):482-488. doi: 10.1002/jcb.29231. Epub 2019 Jul 16.,Zhao S,https://www.ncbi.nlm.nih.gov/pubmed/31310382
11828,32233011,Integrating the immune microenvironment of prostate cancer induced bone disease,Mol Carcinog. 2020 Jul;59(7):822-829. doi: 10.1002/mc.23192. Epub 2020 Mar 31.,Ihle CL,https://www.ncbi.nlm.nih.gov/pubmed/32233011
11829,30614821,PTEN Loss in a Prostate Cancer Cohort From Jordan,Appl Immunohistochem Mol Morphol. 2020 May/Jun;28(5):389-394. doi: 10.1097/PAI.0000000000000732.,Al Bashir S,https://www.ncbi.nlm.nih.gov/pubmed/30614821
11831,33082840,Texture Feature-Based Classification on Transrectal Ultrasound Image for Prostatic Cancer Detection,Comput Math Methods Med. 2020 Oct 6;2020:7359375. doi: 10.1155/2020/7359375. eCollection 2020.,Huang X,https://www.ncbi.nlm.nih.gov/pubmed/33082840
11832,31866160,Magnetic resonance as imaging diagnostic tool in prostate cancer: New evidences-The EAU Section of Uro-Technology position,Actas Urol Esp (Engl Ed). 2020 Apr;44(3):148-155. doi: 10.1016/j.acuro.2019.08.003. Epub 2019 Dec 19.,Álvarez-Maestro M,https://www.ncbi.nlm.nih.gov/pubmed/31866160
11833,33204318,Urinary glycoproteins associated with aggressive prostate cancer,Theranostics. 2020 Oct 25;10(26):11892-11907. doi: 10.7150/thno.47066. eCollection 2020.,Dong M,https://www.ncbi.nlm.nih.gov/pubmed/33204318
11834,31958077,"METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay",Cancer Biomark. 2020;27(3):377-387. doi: 10.3233/CBM-191001.,Pong YH,https://www.ncbi.nlm.nih.gov/pubmed/31958077
11835,32300100,CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating ?-catenin/STAT3 signaling,Cell Death Dis. 2020 Apr 16;11(4):234. doi: 10.1038/s41419-020-2435-y.,Huang R,https://www.ncbi.nlm.nih.gov/pubmed/32300100
11836,32203935,The role of extracellular vesicles in prostate cancer with clinical applications,Endocr Relat Cancer. 2020 May;27(5):R133-R144. doi: 10.1530/ERC-20-0021.,Tai YL,https://www.ncbi.nlm.nih.gov/pubmed/32203935
11838,32128938,"Illness uncertainty, coping, and quality of life among patients with prostate cancer",Psychooncology. 2020 Jun;29(6):1019-1025. doi: 10.1002/pon.5372. Epub 2020 Mar 13.,Guan T,https://www.ncbi.nlm.nih.gov/pubmed/32128938
11843,32387456,Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532),Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.,Montopoli M,https://www.ncbi.nlm.nih.gov/pubmed/32387456
11844,33013832,Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis,Front Immunol. 2020 Sep 10;11:1820. doi: 10.3389/fimmu.2020.01820. eCollection 2020.,Caputo S,https://www.ncbi.nlm.nih.gov/pubmed/33013832
11845,32013356,Diagnostic Value of Peripheral Blood miR-374b-5p in Patients with Prostate Cancer,Clin Lab. 2020 Jan 1;66(1). doi: 10.7754/Clin.Lab.2019.190620.,Pang C,https://www.ncbi.nlm.nih.gov/pubmed/32013356
11848,32317181,Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics,Eur Urol. 2020 Nov;78(5):671-679. doi: 10.1016/j.eururo.2020.03.024. Epub 2020 Apr 19.,Nguyen B,https://www.ncbi.nlm.nih.gov/pubmed/32317181
11849,31487532,Reference region extraction by clustering for the pharmacokinetic analysis of dynamic contrast-enhanced MRI in prostate cancer,Magn Reson Imaging. 2020 Feb;66:185-192. doi: 10.1016/j.mri.2019.08.034. Epub 2019 Sep 2.,Ikoma Y,https://www.ncbi.nlm.nih.gov/pubmed/31487532
11850,32056135,Do rapid emotional thermometers correlate with multidimensional validated structured questionnaires in low-risk prostate cancer?,Int Urol Nephrol. 2020 Jun;52(6):1073-1078. doi: 10.1007/s11255-020-02399-w. Epub 2020 Feb 13.,Laranja WW,https://www.ncbi.nlm.nih.gov/pubmed/32056135
11851,32242459,Fish Lipid against Prostate Cancer (PC-3) through Apoptosis and Cell Cycle Arrest,Nutr Cancer. 2021;73(2):300-306. doi: 10.1080/01635581.2020.1743872. Epub 2020 Apr 3.,Gupta P,https://www.ncbi.nlm.nih.gov/pubmed/32242459
11852,32101033,Identification of Core Genes and Potential Drugs for Castration-Resistant Prostate Cancer Based on Bioinformatics Analysis,DNA Cell Biol. 2020 May;39(5):836-847. doi: 10.1089/dna.2019.5247. Epub 2020 Feb 26.,Liang X,https://www.ncbi.nlm.nih.gov/pubmed/32101033
11854,32413384,Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer,Mol Cell Endocrinol. 2020 Jul 1;511:110864. doi: 10.1016/j.mce.2020.110864. Epub 2020 May 13.,Nanni S,https://www.ncbi.nlm.nih.gov/pubmed/32413384
11855,32385075,Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer,Cancer Discov. 2020 Sep;10(9):1374-1387. doi: 10.1158/2159-8290.CD-19-1352. Epub 2020 May 8.,Zhao D,https://www.ncbi.nlm.nih.gov/pubmed/32385075
11856,32086850,Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy,Exp Physiol. 2020 May;105(5):793-808. doi: 10.1113/EP088011. Epub 2020 Apr 22.,Fan L,https://www.ncbi.nlm.nih.gov/pubmed/32086850
11858,32375682,"Spatial patterns in prostate Cancer-specific mortality in Pennsylvania using Pennsylvania Cancer registry data, 2004-2014",BMC Cancer. 2020 May 6;20(1):394. doi: 10.1186/s12885-020-06902-5.,Wang M,https://www.ncbi.nlm.nih.gov/pubmed/32375682
11859,32414237,Plasma enabled devices for the selective capture and photodynamic identification of prostate cancer cells,Biointerphases. 2020 May 15;15(3):031002. doi: 10.1116/6.0000047.,Shirazi HS,https://www.ncbi.nlm.nih.gov/pubmed/32414237
11860,32104682,Silencing of ELK3 Induces S-M Phase Arrest and Apoptosis and Upregulates SERPINE1 Expression Reducing Migration in Prostate Cancer Cells,Biomed Res Int. 2020 Feb 13;2020:2406159. doi: 10.1155/2020/2406159. eCollection 2020.,Mao Y,https://www.ncbi.nlm.nih.gov/pubmed/32104682
11861,32014792,Novel multifunctional (18)F-labelled PET tracer with prostate-specific membrane antigen-targeting and hypoxia-sensitive moieties,Eur J Med Chem. 2020 Mar 1;189:112099. doi: 10.1016/j.ejmech.2020.112099. Epub 2020 Jan 25.,Kwon YD,https://www.ncbi.nlm.nih.gov/pubmed/32014792
11862,32376286,Epigenetic regulation of the ITGB4 gene in prostate cancer,Exp Cell Res. 2020 Jul 15;392(2):112055. doi: 10.1016/j.yexcr.2020.112055. Epub 2020 May 4.,Wilkinson EJ,https://www.ncbi.nlm.nih.gov/pubmed/32376286
11863,32003789,Prostate-Specific Antigen Test Utilization in a Major Canadian City,Am J Clin Pathol. 2020 May 5;153(6):776-780. doi: 10.1093/ajcp/aqaa003.,Wang Q,https://www.ncbi.nlm.nih.gov/pubmed/32003789
11864,32386046,Progress in applications of (18)F-fluciclovine in diagnosis of prostate cancer,Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Feb 28;45(2):187-192. doi: 10.11817/j.issn.1672-7347.2020.180549.,Wang K,https://www.ncbi.nlm.nih.gov/pubmed/32386046
11865,31667686,MiR-130b/TNF-?/NF-?B/VEGFA loop inhibits prostate cancer angiogenesis,Clin Transl Oncol. 2020 Jan;22(1):111-121. doi: 10.1007/s12094-019-02217-5. Epub 2019 Oct 30.,Mu HQ,https://www.ncbi.nlm.nih.gov/pubmed/31667686
11866,32306060,Advanced ultrasound in the diagnosis of prostate cancer,World J Urol. 2021 Mar;39(3):661-676. doi: 10.1007/s00345-020-03193-0. Epub 2020 Apr 18.,Correas JM,https://www.ncbi.nlm.nih.gov/pubmed/32306060
11867,32862613,Associations between the expressions of MiR-135 and MiR-92a and pathogenesis of prostate cancer and analysis of their clinical significance,J BUON. 2020 May-Jun;25(3):1619-1624.,He W,https://www.ncbi.nlm.nih.gov/pubmed/32862613
11868,32012234,"Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study ""hits"" in black and white men",Cancer. 2020 Jan 1;126(9):1949-1957. doi: 10.1002/cncr.32734. Epub 2020 Feb 3.,Lynch SM,https://www.ncbi.nlm.nih.gov/pubmed/32012234
11870,32467600,The association of diabetes with risk of prostate cancer defined by clinical and molecular features,Br J Cancer. 2020 Aug;123(4):657-665. doi: 10.1038/s41416-020-0910-y. Epub 2020 May 29.,Feng X,https://www.ncbi.nlm.nih.gov/pubmed/32467600
11871,32790761,The effect of neighborhood social environment on prostate cancer development in black and white men at high risk for prostate cancer,PLoS One. 2020 Aug 13;15(8):e0237332. doi: 10.1371/journal.pone.0237332. eCollection 2020.,Lynch SM,https://www.ncbi.nlm.nih.gov/pubmed/32790761
11872,32198489,Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer,Sci Rep. 2020 Mar 20;10(1):5167. doi: 10.1038/s41598-020-62038-3.,Ganapathy K,https://www.ncbi.nlm.nih.gov/pubmed/32198489
11873,32879636,An Intelligent Decision-Making Support System for the Detection and Staging of Prostate Cancer in Developing Countries,Comput Math Methods Med. 2020 Aug 17;2020:5363549. doi: 10.1155/2020/5363549. eCollection 2020.,Zhang J,https://www.ncbi.nlm.nih.gov/pubmed/32879636
11874,31754047,Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer,Clin Cancer Res. 2020 Mar 1;26(5):1086-1093. doi: 10.1158/1078-0432.CCR-19-2853. Epub 2019 Nov 21.,Allott EH,https://www.ncbi.nlm.nih.gov/pubmed/31754047
11876,32251068,Self-reported Prostate Cancer Progression Status Is Accurate: A Validation Study,Epidemiology. 2020 May;31(3):441-447. doi: 10.1097/EDE.0000000000001170.,Daugherty SE,https://www.ncbi.nlm.nih.gov/pubmed/32251068
11877,32447342,LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop,Cell Death Dis. 2020 May 23;11(5):393. doi: 10.1038/s41419-020-2569-y.,Wu G,https://www.ncbi.nlm.nih.gov/pubmed/32447342
11878,32100577,Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor,Expert Opin Drug Discov. 2020 May;15(5):551-560. doi: 10.1080/17460441.2020.1732920. Epub 2020 Feb 26.,Sadar MD,https://www.ncbi.nlm.nih.gov/pubmed/32100577
11879,31668811,AaHIV a sodium channel scorpion toxin inhibits the proliferation of DU145 prostate cancer cells,Biochem Biophys Res Commun. 2020 Jan 8;521(2):340-346. doi: 10.1016/j.bbrc.2019.10.115. Epub 2019 Oct 24.,BenAissa R,https://www.ncbi.nlm.nih.gov/pubmed/31668811
11880,30830274,Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review,World J Urol. 2020 Mar;38(3):601-611. doi: 10.1007/s00345-019-02704-y. Epub 2019 Mar 4.,Kunath F,https://www.ncbi.nlm.nih.gov/pubmed/30830274
11881,32032355,The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial,PLoS Med. 2020 Feb 7;17(2):e1003033. doi: 10.1371/journal.pmed.1003033. eCollection 2020 Feb.,Fredsøe J,https://www.ncbi.nlm.nih.gov/pubmed/32032355
11882,32107877,MIR-138-5P inhibits the progression of prostate cancer by targeting FOXC1,Mol Genet Genomic Med. 2020 Apr;8(4):e1193. doi: 10.1002/mgg3.1193. Epub 2020 Feb 28.,Huang H,https://www.ncbi.nlm.nih.gov/pubmed/32107877
11883,31816356,Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer,Mol Cell Endocrinol. 2020 Feb 15;502:110659. doi: 10.1016/j.mce.2019.110659. Epub 2019 Dec 7.,Costa BP,https://www.ncbi.nlm.nih.gov/pubmed/31816356
11884,33542717,"Membrane Interactome of a Recombinant Fragment of Human Surfactant Protein D Reveals GRP78 as a Novel Binding Partner in PC3, a Metastatic Prostate Cancer Cell Line",Front Immunol. 2021 Jan 19;11:600660. doi: 10.3389/fimmu.2020.600660. eCollection 2020.,Thakur G,https://www.ncbi.nlm.nih.gov/pubmed/33542717
11885,32037533,Cancer transcriptomic profiling from rapidly enriched circulating tumor cells,Int J Cancer. 2020 May 15;146(10):2845-2854. doi: 10.1002/ijc.32915. Epub 2020 Feb 27.,Morrison GJ,https://www.ncbi.nlm.nih.gov/pubmed/32037533
11886,32521918,FGF-2 and HGF reverse abiraterone's effect ?n intracellular levels of DHT in androgen-dependent and androgen independent prostate cancer cell lines,J BUON. 2020 Mar-Apr;25(2):1141-1147.,Vasileiou C,https://www.ncbi.nlm.nih.gov/pubmed/32521918
11887,32193973,"4,4'-Diisothiocyanatostilbene-2,2'-disulfonate modulates voltage-gated K(+) current and influences cell cycle arrest in androgen sensitive and insensitive human prostate cancer cell lines",Toxicol Mech Methods. 2020 Jun;30(5):358-369. doi: 10.1080/15376516.2020.1745343. Epub 2020 Apr 1.,George K,https://www.ncbi.nlm.nih.gov/pubmed/32193973
11888,32089070,Combined targeting of EGFR and HER2 against prostate cancer stem cells,Cancer Biol Ther. 2020 May 3;21(5):463-475. doi: 10.1080/15384047.2020.1727702. Epub 2020 Feb 23.,Rossini A,https://www.ncbi.nlm.nih.gov/pubmed/32089070
11889,32103725,A scoping review of core outcome sets and their 'mapping' onto real-world data using prostate cancer as a case study,BMC Med Res Methodol. 2020 Feb 27;20(1):41. doi: 10.1186/s12874-020-00928-w.,Meregaglia M,https://www.ncbi.nlm.nih.gov/pubmed/32103725
11890,31634418,Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment,Prostate. 2020 Jan;80(1):83-87. doi: 10.1002/pros.23920. Epub 2019 Oct 21.,Yu H,https://www.ncbi.nlm.nih.gov/pubmed/31634418
11891,32029930,"Associations among statins, preventive care, and prostate cancer mortality",Prostate Cancer Prostatic Dis. 2020 Sep;23(3):475-485. doi: 10.1038/s41391-020-0207-5. Epub 2020 Feb 6.,Kumar A,https://www.ncbi.nlm.nih.gov/pubmed/32029930
11892,32716402,Correlations of the (68)Ga-PSMA PET/CT derived primary prostate tumor PSMA expression parameters and metastatic patterns in patients with Gleason Score >7 prostate cancer,Hell J Nucl Med. 2020 May-Aug;23(2):120-124. doi: 10.1967/s002449912100. Epub 2020 Jul 27.,Karyagar SS,https://www.ncbi.nlm.nih.gov/pubmed/32716402
11893,31226226,A genome-wide association study of prostate cancer in Latinos,Int J Cancer. 2020 Apr 1;146(7):1819-1826. doi: 10.1002/ijc.32525. Epub 2019 Jul 3.,Du Z,https://www.ncbi.nlm.nih.gov/pubmed/31226226
11894,31695151,Nuclear receptor HNF4? performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence,Oncogene. 2020 Feb;39(7):1572-1589. doi: 10.1038/s41388-019-1080-3. Epub 2019 Nov 6.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/31695151
11895,31177307,Urolithin A induces prostate cancer cell death in p53-dependent and in p53-independent manner,Eur J Nutr. 2020 Jun;59(4):1607-1618. doi: 10.1007/s00394-019-02016-2. Epub 2019 Jun 8.,Mohammed Saleem YI,https://www.ncbi.nlm.nih.gov/pubmed/31177307
11896,32385718,Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis,Mol Cell Biochem. 2020 Jun;469(1-2):169-178. doi: 10.1007/s11010-020-03739-1. Epub 2020 May 8.,Yu Z,https://www.ncbi.nlm.nih.gov/pubmed/32385718
11897,31789411,Cholinergic ?5 nicotinic receptor is involved in the proliferation and invasion of human prostate cancer cells,Oncol Rep. 2020 Jan;43(1):159-168. doi: 10.3892/or.2019.7411. Epub 2019 Nov 20.,Qi JC,https://www.ncbi.nlm.nih.gov/pubmed/31789411
11899,32703135,Current Challenges and Implications of Proteogenomic Approaches in Prostate Cancer,Curr Top Med Chem. 2020;20(22):1968-1980. doi: 10.2174/1568026620666200722112450.,Shukla N,https://www.ncbi.nlm.nih.gov/pubmed/32703135
11900,32319606,Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin?releasing hormone receptors (Review),Int J Oncol. 2020 May;56(5):1075-1082. doi: 10.3892/ijo.2020.5008. Epub 2020 Mar 5.,Contreras HR,https://www.ncbi.nlm.nih.gov/pubmed/32319606
11903,32199616,Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer,Biochem Biophys Res Commun. 2020 May 21;526(1):128-134. doi: 10.1016/j.bbrc.2020.03.043. Epub 2020 Mar 18.,Nagasawa M,https://www.ncbi.nlm.nih.gov/pubmed/32199616
11905,32179997,Long-term unmet supportive care needs of prostate cancer survivors: 15-year follow-up from the NSW Prostate Cancer Care and Outcomes Study,Support Care Cancer. 2020 Nov;28(11):5511-5520. doi: 10.1007/s00520-020-05389-x. Epub 2020 Mar 16.,Mazariego CG,https://www.ncbi.nlm.nih.gov/pubmed/32179997
11907,32475711,Online peer-to-peer support for persons affected by prostate cancer: A systematic review,Patient Educ Couns. 2020 Oct;103(10):2107-2115. doi: 10.1016/j.pec.2020.05.009. Epub 2020 May 12.,Ihrig A,https://www.ncbi.nlm.nih.gov/pubmed/32475711
11910,31430659,Extensive serum cytokine analysis in patients with prostate cancer,Cytokine. 2020 Jan;125:154810. doi: 10.1016/j.cyto.2019.154810. Epub 2019 Aug 17.,Gong D,https://www.ncbi.nlm.nih.gov/pubmed/31430659
11911,32522053,"Targeting eIF5A2 inhibits prostate carcinogenesis, migration, invasion and metastasis in vitro and in vivo",Bioengineered. 2020 Jan 1;11(1):619-627. doi: 10.1080/21655979.2020.1774993.,Zhong X,https://www.ncbi.nlm.nih.gov/pubmed/32522053
11912,31790330,Unpacking Trial Offers and Low Accrual Rates: A Qualitative Analysis of Clinic Visits With Physicians and Patients Potentially Eligible for a Prostate Cancer Clinical Trial,JCO Oncol Pract. 2020 Feb;16(2):e124-e131. doi: 10.1200/JOP.19.00444. Epub 2019 Dec 2.,Hamel LM,https://www.ncbi.nlm.nih.gov/pubmed/31790330
11914,31721355,Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction,Cell Prolif. 2020 Jan;53(1):e12718. doi: 10.1111/cpr.12718. Epub 2019 Nov 13.,Liu L,https://www.ncbi.nlm.nih.gov/pubmed/31721355
11917,32334469,The Relationship Between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy,Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1051-1056. doi: 10.31557/APJCP.2020.21.4.1051.,Duran MB,https://www.ncbi.nlm.nih.gov/pubmed/32334469
11918,31992688,Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis,Q J Nucl Med Mol Imaging. 2022 Sep;66(3):280-289. doi: 10.23736/S1824-4785.20.03224-0. Epub 2020 Jan 24.,Rosar F,https://www.ncbi.nlm.nih.gov/pubmed/31992688
11919,32099355,Prostate Cancer Cellular Uptake of Ternary Titanate Nanotubes/CuFe(2)O(4)/Zn-Fe Mixed Metal Oxides Nanocomposite,Int J Nanomedicine. 2020 Jan 30;15:619-631. doi: 10.2147/IJN.S228279. eCollection 2020.,El-Shahawy AA,https://www.ncbi.nlm.nih.gov/pubmed/32099355
11920,32234541,PKMYT1 is associated with prostate cancer malignancy and may serve as a therapeutic target,Gene. 2020 Jun 20;744:144608. doi: 10.1016/j.gene.2020.144608. Epub 2020 Mar 29.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32234541
11921,32173432,Biosensing of prostate specific antigen (PSA) in human plasma samples using biomacromolecule encapsulation into KCC-1-npr-NH(2): A new platform for prostate cancer detection,Int J Biol Macromol. 2020 Jul 1;154:584-595. doi: 10.1016/j.ijbiomac.2020.03.093. Epub 2020 Mar 13.,Abbasy L,https://www.ncbi.nlm.nih.gov/pubmed/32173432
11922,33282964,The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis-Mediated Innate Immune Response,J Immunol Res. 2020 Nov 17;2020:8820355. doi: 10.1155/2020/8820355. eCollection 2020.,Fu W,https://www.ncbi.nlm.nih.gov/pubmed/33282964
11923,31254281,Laminin-derived peptide C16 regulates Tks expression and reactive oxygen species generation in human prostate cancer cells,J Cell Physiol. 2020 Jan;235(1):587-598. doi: 10.1002/jcp.28997. Epub 2019 Jun 28.,Caires-Dos-Santos L,https://www.ncbi.nlm.nih.gov/pubmed/31254281
11924,32219892,BRCA1 and VDR gene polymorphisms are associated with prostate cancer risk in Mexican men,Mol Carcinog. 2020 Jun;59(6):629-639. doi: 10.1002/mc.23187. Epub 2020 Mar 26.,Martínez-Nava GA,https://www.ncbi.nlm.nih.gov/pubmed/32219892
11925,32138787,Pesticide exposure and risk of aggressive prostate cancer among private pesticide applicators,Environ Health. 2020 Mar 5;19(1):30. doi: 10.1186/s12940-020-00583-0.,Pardo LA,https://www.ncbi.nlm.nih.gov/pubmed/32138787
11926,32335733,Early experience with Watson for Oncology: a clinical decision-support system for prostate cancer treatment recommendations,World J Urol. 2021 Feb;39(2):407-413. doi: 10.1007/s00345-020-03214-y. Epub 2020 Apr 25.,Yu SH,https://www.ncbi.nlm.nih.gov/pubmed/32335733
11927,31298931,Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro,Nutr Cancer. 2020;72(3):528-537. doi: 10.1080/01635581.2019.1637442. Epub 2019 Jul 12.,Mani J,https://www.ncbi.nlm.nih.gov/pubmed/31298931
11928,33021980,Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer,PLoS One. 2020 Oct 6;15(10):e0239414. doi: 10.1371/journal.pone.0239414. eCollection 2020.,Meijer D,https://www.ncbi.nlm.nih.gov/pubmed/33021980
11929,32017004,MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1,Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):639-646. doi: 10.26355/eurrev_202001_20040.,Chen JY,https://www.ncbi.nlm.nih.gov/pubmed/32017004
11930,31980895,"Pain, fatigue and depression symptom cluster in survivors of prostate cancer",Support Care Cancer. 2020 Oct;28(10):4813-4824. doi: 10.1007/s00520-019-05268-0. Epub 2020 Jan 24.,Baden M,https://www.ncbi.nlm.nih.gov/pubmed/31980895
11931,32701470,"Improvement of Knowledge, Attitudes, and Beliefs of African American Men Toward Prostate Cancer Screening",J Dr Nurs Pract. 2020 Mar 1;13(1):84-89. doi: 10.1891/2380-9418.13.1.84.,Adams CD,https://www.ncbi.nlm.nih.gov/pubmed/32701470
11932,31879814,Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with (68)Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):665-673. doi: 10.1007/s00259-019-04635-7. Epub 2019 Dec 26.,Ettala O,https://www.ncbi.nlm.nih.gov/pubmed/31879814
11933,32004532,Advances in prostate specific antigen biosensors-impact of nanotechnology,Clin Chim Acta. 2020 May;504:43-55. doi: 10.1016/j.cca.2020.01.028. Epub 2020 Jan 28.,Negahdary M,https://www.ncbi.nlm.nih.gov/pubmed/32004532
11934,32164523,Prediction of tumor location in prostate cancer tissue using a machine learning system on gene expression data,BMC Bioinformatics. 2020 Mar 11;21(Suppl 2):78. doi: 10.1186/s12859-020-3345-9.,Hamzeh O,https://www.ncbi.nlm.nih.gov/pubmed/32164523
11935,31566466,Implementation of a decision aid for localized prostate cancer in routine care: A successful implementation strategy,Health Informatics J. 2020 Jun;26(2):1194-1207. doi: 10.1177/1460458219873528. Epub 2019 Sep 30.,van Tol-Geerdink JJ,https://www.ncbi.nlm.nih.gov/pubmed/31566466
11937,32356434,Investigation of lncRNA H19 in prostate cancer cells and secreted exosomes upon androgen stimulation or androgen receptor blockage,Bratisl Lek Listy. 2020;121(5):362-365. doi: 10.4149/BLL_2020_058.,Ozgur E,https://www.ncbi.nlm.nih.gov/pubmed/32356434
11938,32396449,A qualitative exploration of South African men's perceived effects of Androgen Deprivation Therapy (ADT) as a treatment for advanced prostate cancer,Aging Male. 2020 Dec;23(5):1266-1274. doi: 10.1080/13685538.2020.1762075. Epub 2020 May 12.,Gray PB,https://www.ncbi.nlm.nih.gov/pubmed/32396449
11939,32361091,Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism pathway,J Pharm Biomed Anal. 2020 Jul 15;186:113288. doi: 10.1016/j.jpba.2020.113288. Epub 2020 Apr 4.,Wang K,https://www.ncbi.nlm.nih.gov/pubmed/32361091
11940,32143478,Resveratrol Suppresses Prostate Cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by Prostate Stromal Cells and Upregulation of E-cadherin by Prostate Cancer Epithelial Cells,Int J Mol Sci. 2020 Mar 4;21(5):1760. doi: 10.3390/ijms21051760.,Hsieh TC,https://www.ncbi.nlm.nih.gov/pubmed/32143478
11941,32264962,"No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-? gene and susceptibility to prostate cancer: a comprehensive meta-analysis",Hereditas. 2020 Apr 7;157(1):11. doi: 10.1186/s41065-020-00125-1.,Yin L,https://www.ncbi.nlm.nih.gov/pubmed/32264962
11942,32397189,Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology,Genes (Basel). 2020 May 8;11(5):526. doi: 10.3390/genes11050526.,Farashi S,https://www.ncbi.nlm.nih.gov/pubmed/32397189
11944,31214711,Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls,J Natl Cancer Inst. 2020 Apr 1;112(4):369-376. doi: 10.1093/jnci/djz124.,Momozawa Y,https://www.ncbi.nlm.nih.gov/pubmed/31214711
11945,32343403,Changes in prostate-specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men,Cancer. 2020 Jul 15;126(14):3229-3236. doi: 10.1002/cncr.32930. Epub 2020 Apr 28.,Weiner AB,https://www.ncbi.nlm.nih.gov/pubmed/32343403
11946,31636385,HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer,Oncogene. 2020 Feb;39(6):1335-1346. doi: 10.1038/s41388-019-1065-2. Epub 2019 Oct 21.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/31636385
11947,32292071,Functionalized nano-targeted moieties in management of prostate cancer,Future Oncol. 2020 May;16(13):869-883. doi: 10.2217/fon-2019-0635. Epub 2020 Apr 15.,Salaheldin TA,https://www.ncbi.nlm.nih.gov/pubmed/32292071
11948,32015293,Uncommon Prostate Malignant Neoplasms,Top Magn Reson Imaging. 2020 Feb;29(1):31-45. doi: 10.1097/RMR.0000000000000230.,Horvat N,https://www.ncbi.nlm.nih.gov/pubmed/32015293
11949,32169995,"Long-term Trends in Prostate Cancer Incidence by Stage at Diagnosis in Japan Using the Multiple Imputation Approach, 1993-2014",Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1222-1228. doi: 10.1158/1055-9965.EPI-19-1228. Epub 2020 Mar 13.,Saito E,https://www.ncbi.nlm.nih.gov/pubmed/32169995
11950,32296126,Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):77-80. doi: 10.1038/s41391-020-0227-1. Epub 2020 Apr 15.,Jiang C,https://www.ncbi.nlm.nih.gov/pubmed/32296126
11951,32396918,Impact of Androgen Deprivation Therapy on Non-Alcoholic Fatty Liver Disease in Patients with Prostate Cancer: A CT Evaluation,Urol Int. 2020;104(5-6):425-430. doi: 10.1159/000507351. Epub 2020 May 12.,Sawazaki H,https://www.ncbi.nlm.nih.gov/pubmed/32396918
11952,31876822,99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and Intraobserver Variability in Treatment-Related Longitudinal Tracer Uptake Assessments of Prostate-Specific Membrane Antigen-Positive Lesions,Clin Nucl Med. 2020 Feb;45(2):105-112. doi: 10.1097/RLU.0000000000002880.,Schmidkonz C,https://www.ncbi.nlm.nih.gov/pubmed/31876822
11953,32013257,Cationic Polymer Nanoparticles-Mediated Delivery of miR-124 Impairs Tumorigenicity of Prostate Cancer Cells,Int J Mol Sci. 2020 Jan 29;21(3):869. doi: 10.3390/ijms21030869.,Conte R,https://www.ncbi.nlm.nih.gov/pubmed/32013257
11954,31745707,Holmium laser enucleation of the prostate in Jehovah's Witness patients,Int Urol Nephrol. 2020 Mar;52(3):455-460. doi: 10.1007/s11255-019-02331-x. Epub 2019 Nov 19.,Selim A,https://www.ncbi.nlm.nih.gov/pubmed/31745707
11955,32102477,MiRNA-Based Inspired Approach in Diagnosis of Prostate Cancer,Medicina (Kaunas). 2020 Feb 24;56(2):94. doi: 10.3390/medicina56020094.,Munteanu VC,https://www.ncbi.nlm.nih.gov/pubmed/32102477
11957,32197936,Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC),Prog Urol. 2020 Apr;30(5):252-260. doi: 10.1016/j.purol.2020.02.011. Epub 2020 Mar 18.,Villers A,https://www.ncbi.nlm.nih.gov/pubmed/32197936
11960,32320704,Identification of cofilin-1 as a novel mediator for the metastatic potentials and chemoresistance of the prostate cancer cells,Eur J Pharmacol. 2020 Aug 5;880:173100. doi: 10.1016/j.ejphar.2020.173100. Epub 2020 Apr 19.,Chen L,https://www.ncbi.nlm.nih.gov/pubmed/32320704
11962,32216312,Rapid Prostate Cancer Noninvasive Biomarker Screening Using Segmented Flow Mass Spectrometry-Based Untargeted Metabolomics,J Proteome Res. 2020 May 1;19(5):2080-2091. doi: 10.1021/acs.jproteome.0c00006. Epub 2020 Apr 6.,Pinto FG,https://www.ncbi.nlm.nih.gov/pubmed/32216312
11963,32250065,Phase-Regulated Sensing Mechanism of MoS(2) Based Nanohybrids toward Point-of-Care Prostate Cancer Diagnosis,Small. 2020 May;16(18):e2000307. doi: 10.1002/smll.202000307. Epub 2020 Apr 6.,Ying Z,https://www.ncbi.nlm.nih.gov/pubmed/32250065
11964,31914333,Novel immunotherapy combinations for genitourinary cancers,Expert Opin Biol Ther. 2020 Mar;20(3):253-262. doi: 10.1080/14712598.2020.1713086. Epub 2020 Jan 27.,Al Harthy M,https://www.ncbi.nlm.nih.gov/pubmed/31914333
11965,32076894,"Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM",AAPS J. 2020 Feb 19;22(2):50. doi: 10.1208/s12248-019-0388-9.,Riglet F,https://www.ncbi.nlm.nih.gov/pubmed/32076894
11966,31905248,SIRPB1 promotes prostate cancer cell proliferation via Akt activation,Prostate. 2020 Mar;80(4):352-364. doi: 10.1002/pros.23950. Epub 2020 Jan 6.,Song Q,https://www.ncbi.nlm.nih.gov/pubmed/31905248
11967,31685983,Hyperpolarized (13)C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):269-276. doi: 10.1038/s41391-019-0180-z. Epub 2019 Nov 4.,Chen HY,https://www.ncbi.nlm.nih.gov/pubmed/31685983
11968,32072894,Exploring the Role of Asp1116 in Selective Drug Targeting of CREBcAMP- Responsive Element-binding Protein Implicated in Prostate Cancer,Comb Chem High Throughput Screen. 2020;23(3):178-184. doi: 10.2174/1386207323666200219122057.,Akinsiku OE,https://www.ncbi.nlm.nih.gov/pubmed/32072894
11973,32164448,Diagnostic Value of Transrectal Shear Wave Elastography for Prostate Cancer Detection in Peripheral Zone: Comparison with Magnetic Resonance Imaging,J Endourol. 2020 May;34(5):558-566. doi: 10.1089/end.2019.0902. Epub 2020 Apr 21.,Fu S,https://www.ncbi.nlm.nih.gov/pubmed/32164448
11974,31924729,Repeatability of Quantitative (18)F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer,J Nucl Med. 2020 Sep;61(9):1320-1325. doi: 10.2967/jnumed.119.236075. Epub 2020 Jan 10.,Jansen BHE,https://www.ncbi.nlm.nih.gov/pubmed/31924729
11975,31712163,Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration,Int J Biochem Cell Biol. 2020 Jan;118:105644. doi: 10.1016/j.biocel.2019.105644. Epub 2019 Nov 9.,Khusbu FY,https://www.ncbi.nlm.nih.gov/pubmed/31712163
11976,32494682,Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment,Sci Adv. 2020 Apr 29;6(18):eaaz8031. doi: 10.1126/sciadv.aaz8031. eCollection 2020 May.,Wang L,https://www.ncbi.nlm.nih.gov/pubmed/32494682
11977,32300177,Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians,Oncogene. 2020 May;39(21):4299-4311. doi: 10.1038/s41388-020-1280-x. Epub 2020 Apr 16.,Yadav S,https://www.ncbi.nlm.nih.gov/pubmed/32300177
11978,32314536,Upregulation of PTTG1 is associated with poor prognosis in prostate cancer,Pathol Int. 2020 Jul;70(7):441-451. doi: 10.1111/pin.12938. Epub 2020 Apr 20.,Fraune C,https://www.ncbi.nlm.nih.gov/pubmed/32314536
11979,32066885,Chalcomoracin inhibits cell proliferation and increases sensitivity to radiotherapy in human non-small cell lung cancer cells via inducing endoplasmic reticulum stress-mediated paraptosis,Acta Pharmacol Sin. 2020 Jun;41(6):825-834. doi: 10.1038/s41401-019-0351-4. Epub 2020 Feb 17.,Zhang SR,https://www.ncbi.nlm.nih.gov/pubmed/32066885
11980,32019175,Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies,Int J Mol Sci. 2020 Jan 30;21(3):905. doi: 10.3390/ijms21030905.,Hepburn AC,https://www.ncbi.nlm.nih.gov/pubmed/32019175
11982,32068909,A comparison of prostate cancer cell transcriptomes in 2D monoculture vs 3D xenografts identify consistent gene expression alterations associated with tumor microenvironments,Prostate. 2020 May;80(6):491-499. doi: 10.1002/pros.23963. Epub 2020 Feb 18.,Brady L,https://www.ncbi.nlm.nih.gov/pubmed/32068909
11983,32602285,NANOG as prognostic factor of prostate cancer course,Exp Oncol. 2020 Jun;42(2):94-100. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-2.14673.,Zadvornyi TV,https://www.ncbi.nlm.nih.gov/pubmed/32602285
11984,32593392,How to identify and treat data inconsistencies when eliciting health-state utility values for patient-centered decision making,Artif Intell Med. 2020 Jun;106:101882. doi: 10.1016/j.artmed.2020.101882. Epub 2020 May 26.,Triantaphyllou E,https://www.ncbi.nlm.nih.gov/pubmed/32593392
11985,32247806,Self-assembly of amphiphilic phospholipid peptide dendrimer-based nanovectors for effective delivery of siRNA therapeutics in prostate cancer therapy,J Control Release. 2020 Jun 10;322:416-425. doi: 10.1016/j.jconrel.2020.04.003. Epub 2020 Apr 2.,Dong Y,https://www.ncbi.nlm.nih.gov/pubmed/32247806
11986,31740444,USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair,Cancer Res. 2020 Feb 1;80(3):430-443. doi: 10.1158/0008-5472.CAN-19-1033. Epub 2019 Nov 18.,McCann JJ,https://www.ncbi.nlm.nih.gov/pubmed/31740444
11987,30951192,"Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC",Int J Cancer. 2020 Feb 1;146(3):720-730. doi: 10.1002/ijc.32314. Epub 2019 Apr 29.,Schmidt JA,https://www.ncbi.nlm.nih.gov/pubmed/30951192
11988,31794057,"Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012",Cancer. 2020 Feb 15;126(4):717-724. doi: 10.1002/cncr.32604. Epub 2019 Dec 3.,Butler SS,https://www.ncbi.nlm.nih.gov/pubmed/31794057
11989,32358088,PET Imaging Quantifying (68)Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer,J Nucl Med. 2020 Nov;61(11):1576-1579. doi: 10.2967/jnumed.119.233312. Epub 2020 May 1.,Cuda TJ,https://www.ncbi.nlm.nih.gov/pubmed/32358088
11990,32319589,Neferine treatment enhances the TRAIL?induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway,Int J Oncol. 2020 May;56(5):1152-1161. doi: 10.3892/ijo.2020.5012. Epub 2020 Mar 13.,Nazim UM,https://www.ncbi.nlm.nih.gov/pubmed/32319589
11991,31587305,"Elevating SOX2 in prostate tumor cells upregulates expression of neuroendocrine genes, but does not reduce the inhibitory effects of enzalutamide",J Cell Physiol. 2020 Apr;235(4):3731-3740. doi: 10.1002/jcp.29267. Epub 2019 Oct 6.,Metz EP,https://www.ncbi.nlm.nih.gov/pubmed/31587305
11992,31899232,Granulomatous Prostatitis Mimicking Prostate Cancer,Urology. 2020 Mar;137:e3-e5. doi: 10.1016/j.urology.2019.12.028. Epub 2019 Dec 31.,Moon SK,https://www.ncbi.nlm.nih.gov/pubmed/31899232
11993,31783154,Meta-Analysis of steroid-converting enzymes and related receptors in prostate cancer suggesting novel combined therapies,J Steroid Biochem Mol Biol. 2020 Apr;198:105559. doi: 10.1016/j.jsbmb.2019.105559. Epub 2019 Nov 26.,Zhang WF,https://www.ncbi.nlm.nih.gov/pubmed/31783154
11994,32330852,Machine learning application for incident prostate adenocarcinomas automatic registration in a French regional cancer registry,Int J Med Inform. 2020 Jul;139:104139. doi: 10.1016/j.ijmedinf.2020.104139. Epub 2020 Apr 9.,Fabacher T,https://www.ncbi.nlm.nih.gov/pubmed/32330852
11995,32210104,"Fli-1 Activation through Targeted Promoter Activity Regulation Using a Novel 3', 5'-diprenylated Chalcone Inhibits Growth and Metastasis of Prostate Cancer Cells",Int J Mol Sci. 2020 Mar 23;21(6):2216. doi: 10.3390/ijms21062216.,Ma Y,https://www.ncbi.nlm.nih.gov/pubmed/32210104
11997,32779174,Incidental double neurinoma detected by 18F-choline PET/CT scan in a prostate cancer patient,Nucl Med Rev Cent East Eur. 2020;23(1):40-41. doi: 10.5603/NMR.2020.0006.,Dondi F,https://www.ncbi.nlm.nih.gov/pubmed/32779174
11998,32665998,A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone,Investig Clin Urol. 2020 Jul;61(4):411-418. doi: 10.4111/icu.2020.61.4.411. Epub 2020 May 29.,Kang HW,https://www.ncbi.nlm.nih.gov/pubmed/32665998
11999,32255528,"Atypical gynecomastia mimicking breast malignancy on mammography, sonography, and 18F-fluciclovine PET/CT in the setting of biochemical recurrence of prostate cancer",Breast J. 2020 Sep;26(9):1805-1807. doi: 10.1111/tbj.13828. Epub 2020 Apr 7.,Winter AM,https://www.ncbi.nlm.nih.gov/pubmed/32255528
12000,32355326,The diverse roles of SPOP in prostate cancer and kidney cancer,Nat Rev Urol. 2020 Jun;17(6):339-350. doi: 10.1038/s41585-020-0314-z. Epub 2020 Apr 30.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/32355326
12001,31999078,"Comparison between high definition FT-IR, Raman and AFM-IR for subcellular chemical imaging of cholesteryl esters in prostate cancer cells",J Biophotonics. 2020 May;13(5):e201960094. doi: 10.1002/jbio.201960094. Epub 2020 Feb 13.,Roman M,https://www.ncbi.nlm.nih.gov/pubmed/31999078
12002,33007193,The malignancy index is a robust predictor of prostate cancer,Discov Med. 2020 May-Jun;29(158):181-189.,Serafin AM,https://www.ncbi.nlm.nih.gov/pubmed/33007193
12004,32065282,Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer,Eur Radiol. 2020 Jun;30(6):3083-3093. doi: 10.1007/s00330-019-06515-y. Epub 2020 Feb 17.,Lecouvet FE,https://www.ncbi.nlm.nih.gov/pubmed/32065282
12005,31069946,"Psychological distress among prostate cancer survivors in South Korea: A nationwide population-based, longitudinal study",Asia Pac J Clin Oncol. 2020 Apr;16(2):e125-e130. doi: 10.1111/ajco.13160. Epub 2019 May 8.,Heo J,https://www.ncbi.nlm.nih.gov/pubmed/31069946
12007,31730277,RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model,Prostate. 2020 Feb;80(2):133-145. doi: 10.1002/pros.23925. Epub 2019 Nov 15.,Thomas-Jardin SE,https://www.ncbi.nlm.nih.gov/pubmed/31730277
12009,32646251,FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer,J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620941313. doi: 10.1177/2324709620941313.,Kichloo A,https://www.ncbi.nlm.nih.gov/pubmed/32646251
12012,32479339,Paper-based ITP technology: An application to specific cancer-derived exosome detection and analysis,Biosens Bioelectron. 2020 Sep 15;164:112292. doi: 10.1016/j.bios.2020.112292. Epub 2020 May 15.,Guo S,https://www.ncbi.nlm.nih.gov/pubmed/32479339
12014,32298066,"Androgen deprivation therapy prescription, blood and bone-density testing in a French population-based study exploring adherence to the French prostate cancer guidelines",Minerva Urol Nephrol. 2021 Dec;73(6):845-848. doi: 10.23736/S2724-6051.20.03683-8. Epub 2020 Apr 16.,Scailteux LM,https://www.ncbi.nlm.nih.gov/pubmed/32298066
12015,31553480,Why is prostate cancer incidence rising in young men?,Cancer. 2020 Jan 1;126(1):17-18. doi: 10.1002/cncr.32497. Epub 2019 Sep 25.,Sartor O,https://www.ncbi.nlm.nih.gov/pubmed/31553480
12016,31477840,Centrosome loss results in an unstable genome and malignant prostate tumors,Oncogene. 2020 Jan;39(2):399-413. doi: 10.1038/s41388-019-0995-z. Epub 2019 Sep 2.,Wang M,https://www.ncbi.nlm.nih.gov/pubmed/31477840
12019,32371181,A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients,Eur J Radiol. 2020 Jul;128:109020. doi: 10.1016/j.ejrad.2020.109020. Epub 2020 Apr 19.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/32371181
12020,32132580,A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation,Sci Rep. 2020 Mar 4;10(1):4024. doi: 10.1038/s41598-020-60844-3.,Lafront C,https://www.ncbi.nlm.nih.gov/pubmed/32132580
12021,31279677,Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis,Eur Urol Focus. 2020 May 15;6(3):463-478. doi: 10.1016/j.euf.2019.06.014. Epub 2019 Jul 4.,Maggi M,https://www.ncbi.nlm.nih.gov/pubmed/31279677
12022,31876381,Development of an in vitro screening assay for PIP5K1? lipid kinase and identification of potent inhibitors,FEBS J. 2020 Jul;287(14):3042-3064. doi: 10.1111/febs.15194. Epub 2020 Jan 13.,Strätker K,https://www.ncbi.nlm.nih.gov/pubmed/31876381
12024,32182139,Sorting Through the Maze of Treatment Options for Metastatic Castration-Sensitive Prostate Cancer,Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-10. doi: 10.1200/EDBK_278845.,Schulte B,https://www.ncbi.nlm.nih.gov/pubmed/32182139
12025,32428870,lncRNA OGFRP1 functions as a ceRNA to promote the progression of prostate cancer by regulating SARM1 level via miR-124-3p,Aging (Albany NY). 2020 May 19;12(10):8880-8892. doi: 10.18632/aging.103007. Epub 2020 May 19.,Yan K,https://www.ncbi.nlm.nih.gov/pubmed/32428870
12026,31387780,Epistemic risks in cancer screening: Implications for ethics and policy,Stud Hist Philos Biol Biomed Sci. 2020 Feb;79:101200. doi: 10.1016/j.shpsc.2019.101200. Epub 2019 Aug 3.,Biddle JB,https://www.ncbi.nlm.nih.gov/pubmed/31387780
12027,32884240,Cinnamaldehyde Treatment of Prostate Cancer-Associated Fibroblasts Prevents Their Inhibitory Effect on T Cells Through Toll-Like Receptor 4,Drug Des Devel Ther. 2020 Aug 18;14:3363-3372. doi: 10.2147/DDDT.S241410. eCollection 2020.,Mei J,https://www.ncbi.nlm.nih.gov/pubmed/32884240
12028,31967357,Exendin-4 enhances the sensitivity of prostate cancer to enzalutamide by targeting Akt activation,Prostate. 2020 Apr;80(5):367-375. doi: 10.1002/pros.23951. Epub 2020 Jan 22.,Wenjing H,https://www.ncbi.nlm.nih.gov/pubmed/31967357
12030,31722969,A PSCA/PGRN-NF-?B-Integrin-?4 Axis Promotes Prostate Cancer Cell Adhesion to Bone Marrow Endothelium and Enhances Metastatic Potential,Mol Cancer Res. 2020 Mar;18(3):501-513. doi: 10.1158/1541-7786.MCR-19-0278. Epub 2019 Nov 13.,Zhao Z,https://www.ncbi.nlm.nih.gov/pubmed/31722969
12033,31616997,A core competency framework for prostate cancer peer navigation,Support Care Cancer. 2020 Jun;28(6):2605-2614. doi: 10.1007/s00520-019-05059-7. Epub 2019 Oct 15.,Flora PK,https://www.ncbi.nlm.nih.gov/pubmed/31616997
12034,32478682,Taxane resistance in prostate cancer is mediated by decreased drug-target engagement,J Clin Invest. 2020 Jun 1;130(6):3287-3298. doi: 10.1172/JCI132184.,Gjyrezi A,https://www.ncbi.nlm.nih.gov/pubmed/32478682
12035,32250210,Targeted Delivery of Therapeutics to Urological Cancer Stem Cells,Curr Pharm Des. 2020;26(17):2038-2056. doi: 10.2174/1381612826666200403131514.,Liu Q,https://www.ncbi.nlm.nih.gov/pubmed/32250210
12036,31880242,Recognition of Invasive Prostate Cancer Using a GHRL Polypeptide Probe Targeting GHSR in a Mouse Model In Vivo,Curr Pharm Des. 2020;26(14):1614-1621. doi: 10.2174/1381612826666191227160001.,Ye H,https://www.ncbi.nlm.nih.gov/pubmed/31880242
12037,31674023,PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells,J Cell Physiol. 2020 May;235(5):4618-4630. doi: 10.1002/jcp.29339. Epub 2019 Oct 31.,Afsharzadeh M,https://www.ncbi.nlm.nih.gov/pubmed/31674023
12038,32238563,Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance,Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8515-8523. doi: 10.1073/pnas.1910952117. Epub 2020 Apr 1.,Haldar S,https://www.ncbi.nlm.nih.gov/pubmed/32238563
12039,32747906,Automated Gleason grading of prostate cancer using transfer learning from general-purpose deep-learning networks,Rom J Morphol Embryol. 2020;61(1):149-155. doi: 10.47162/RJME.61.1.17.,?erb?nescu MS,https://www.ncbi.nlm.nih.gov/pubmed/32747906
12040,32282699,Association of finasteride with prostate cancer: A systematic review and meta-analysis,Medicine (Baltimore). 2020 Apr;99(15):e19486. doi: 10.1097/MD.0000000000019486.,Wang L,https://www.ncbi.nlm.nih.gov/pubmed/32282699
12041,31582531,"A Multifunctional Therapy Approach for Cancer: Targeting Raf1- Mediated Inhibition of Cell Motility, Growth, and Interaction with the Microenvironment",Mol Cancer Ther. 2020 Jan;19(1):39-51. doi: 10.1158/1535-7163.MCT-19-0222. Epub 2019 Oct 3.,Zhang L,https://www.ncbi.nlm.nih.gov/pubmed/31582531
12042,32182228,64CuCl2 PET/CT as a potential new imaging method in prostate cancer: illusion or reality?,Minerva Urol Nephrol. 2021 Oct;73(5):668-671. doi: 10.23736/S2724-6051.20.03615-2. Epub 2020 Mar 16.,Cantiello F,https://www.ncbi.nlm.nih.gov/pubmed/32182228
12045,32298604,Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram,J Comput Biol. 2020 Dec;27(12):1656-1667. doi: 10.1089/cmb.2019.0397. Epub 2020 Apr 16.,Hu M,https://www.ncbi.nlm.nih.gov/pubmed/32298604
12046,32723241,Development of Radiofrequency Saturation Amplitude-independent Quantitative Markers for Magnetization Transfer MRI of Prostate Cancer,Curr Med Imaging. 2020;16(6):695-702. doi: 10.2174/1573405615666190318153328.,Huang X,https://www.ncbi.nlm.nih.gov/pubmed/32723241
12047,32076639,Sight and switch off: Nerve density visualization for interventions targeting nerves in prostate cancer,Sci Adv. 2020 Feb 5;6(6):eaax6040. doi: 10.1126/sciadv.aax6040. eCollection 2020 Feb.,You H,https://www.ncbi.nlm.nih.gov/pubmed/32076639
12048,32401013,Sarcosine Prostate Cancer Biomarker Detection by Controlling Oxygen in NiO(x) Membrane on Vertical Silicon Nanowires in Electrolyte-Insulator-Nanowire Structure,Anal Chem. 2020 Jun 16;92(12):8064-8071. doi: 10.1021/acs.analchem.9b04745. Epub 2020 May 28.,Roy A,https://www.ncbi.nlm.nih.gov/pubmed/32401013
12050,32636623,Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on ?-Glucosidase/Amygdalin,Int J Nanomedicine. 2020 Jun 29;15:4639-4657. doi: 10.2147/IJN.S242359. eCollection 2020.,Zhou J,https://www.ncbi.nlm.nih.gov/pubmed/32636623
12051,31749072,Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain,Neurochem Res. 2020 Jun;45(6):1256-1267. doi: 10.1007/s11064-019-02909-y. Epub 2019 Nov 20.,Vornov JJ,https://www.ncbi.nlm.nih.gov/pubmed/31749072
12052,31814446,Gene set based systematic analysis of prostate cancer and its subtypes,Future Oncol. 2020 Jan;16(2):4381-4393. doi: 10.2217/fon-2019-0459. Epub 2019 Dec 9.,Ye S,https://www.ncbi.nlm.nih.gov/pubmed/31814446
12055,32378433,Growth Inhibitory and Pro-Apoptotic Effects of Ornamental Pomegranate Extracts in Du145 Human Prostate Cancer Cells,Nutr Cancer. 2020;72(6):932-938. doi: 10.1080/01635581.2019.1660385. Epub 2019 Sep 5.,Amri Z,https://www.ncbi.nlm.nih.gov/pubmed/32378433
12056,31478797,Impacts of the prostate stem cell antigen (PSCA) and Clostridium perfringens enterotoxin (CPE) on the apoptosis and cell cycle regulatory genes in PC3,Prep Biochem Biotechnol. 2020;50(1):47-55. doi: 10.1080/10826068.2019.1660892. Epub 2019 Sep 3.,Abedi S,https://www.ncbi.nlm.nih.gov/pubmed/31478797
12058,32188493,Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer,Clin Epigenetics. 2020 Mar 18;12(1):48. doi: 10.1186/s13148-020-00836-2.,Lawrence MG,https://www.ncbi.nlm.nih.gov/pubmed/32188493
12059,32413672,Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway,Biomed Pharmacother. 2020 Jul;127:110223. doi: 10.1016/j.biopha.2020.110223. Epub 2020 May 12.,Ye J,https://www.ncbi.nlm.nih.gov/pubmed/32413672
12060,31785779,Phthalate exposure and prostate cancer in a population-based nested case-control study,Environ Res. 2020 Feb;181:108902. doi: 10.1016/j.envres.2019.108902. Epub 2019 Nov 8.,Chuang SC,https://www.ncbi.nlm.nih.gov/pubmed/31785779
12061,33351846,Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort,PLoS One. 2020 Dec 22;15(12):e0244149. doi: 10.1371/journal.pone.0244149. eCollection 2020.,Ishiyama Y,https://www.ncbi.nlm.nih.gov/pubmed/33351846
12062,32790723,Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer,PLoS One. 2020 Aug 13;15(8):e0237248. doi: 10.1371/journal.pone.0237248. eCollection 2020.,Erb HHH,https://www.ncbi.nlm.nih.gov/pubmed/32790723
12064,31915789,BRCA2 gene mutation and prostate cancer risk. Comprehensive review and update,Saudi Med J. 2020 Jan;41(1):9-17. doi: 10.15537/smj.2020.1.24759.,Junejo NN,https://www.ncbi.nlm.nih.gov/pubmed/31915789
12065,32220959,Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG,Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8584-8592. doi: 10.1073/pnas.1922159117. Epub 2020 Mar 27.,Wasmuth EV,https://www.ncbi.nlm.nih.gov/pubmed/32220959
12066,32208461,Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer,PLoS One. 2020 Mar 24;15(3):e0230571. doi: 10.1371/journal.pone.0230571. eCollection 2020.,Zou Y,https://www.ncbi.nlm.nih.gov/pubmed/32208461
12067,32369032,Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid,JMIR Mhealth Uhealth. 2020 May 5;8(5):e15502. doi: 10.2196/15502.,Allen JD,https://www.ncbi.nlm.nih.gov/pubmed/32369032
12068,32606678,"Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer",Int J Nanomedicine. 2020 Jun 17;15:4289-4309. doi: 10.2147/IJN.S243548. eCollection 2020.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32606678
12069,32121075,"Extent of Food Processing and Risk of Prostate Cancer: The PROtEuS Study in Montreal, Canada",Nutrients. 2020 Feb 28;12(3):637. doi: 10.3390/nu12030637.,Trudeau K,https://www.ncbi.nlm.nih.gov/pubmed/32121075
12070,32453797,Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies,PLoS One. 2020 May 26;15(5):e0233260. doi: 10.1371/journal.pone.0233260. eCollection 2020.,Graham LS,https://www.ncbi.nlm.nih.gov/pubmed/32453797
12071,31810132,Total saponins from Paris forrestii (Takht) H. Li. show the anticancer and RNA expression regulating effects on prostate cancer cells,Biomed Pharmacother. 2020 Jan;121:109674. doi: 10.1016/j.biopha.2019.109674. Epub 2019 Nov 27.,Xia C,https://www.ncbi.nlm.nih.gov/pubmed/31810132
12072,32056383,Late-onset hypogonadism: Prostate safety,Andrology. 2020 Nov;8(6):1606-1613. doi: 10.1111/andr.12772. Epub 2020 Feb 28.,Miranda EP,https://www.ncbi.nlm.nih.gov/pubmed/32056383
12073,31730983,Human prostasomes an extracellular vesicle - Biomarkers for male infertility and prostrate cancer: The journey from identification to current knowledge,Int J Biol Macromol. 2020 Mar 1;146:946-958. doi: 10.1016/j.ijbiomac.2019.09.218. Epub 2019 Nov 12.,Vickram AS,https://www.ncbi.nlm.nih.gov/pubmed/31730983
12074,31781737,Stratification of Atypical Intraepithelial Prostatic Lesions Based on Basal Cell and Architectural Patterns,Am J Clin Pathol. 2020 Feb 8;153(3):407-416. doi: 10.1093/ajcp/aqz183.,Xiao GQ,https://www.ncbi.nlm.nih.gov/pubmed/31781737
12075,32251286,8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer,Nat Commun. 2020 Mar 23;11(1):1523. doi: 10.1038/s41467-020-15122-1.,Dupont WD,https://www.ncbi.nlm.nih.gov/pubmed/32251286
12076,31975433,miR-210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells,J Cell Physiol. 2020 Sep;235(9):6194-6203. doi: 10.1002/jcp.29548. Epub 2020 Jan 24.,Angel CZ,https://www.ncbi.nlm.nih.gov/pubmed/31975433
12077,31312936,Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists,Invest New Drugs. 2020 Jun;38(3):746-754. doi: 10.1007/s10637-019-00831-2. Epub 2019 Jul 17.,Muñoz-Moreno L,https://www.ncbi.nlm.nih.gov/pubmed/31312936
12078,32045549,Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to Assess the Value of Abiraterone and Enzalutamide in Advanced Prostate Cancer,JCO Oncol Pract. 2020 Feb;16(2):e201-e210. doi: 10.1200/JOP.19.00421. Epub 2020 Jan 21.,Wong SE,https://www.ncbi.nlm.nih.gov/pubmed/32045549
12080,32831196,Investigation of GSTP1 and epigenetic regulators expression pattern in a population of Iranian patients with prostate cancer,Hum Antibodies. 2020;28(4):327-334. doi: 10.3233/HAB-200424.,Mohammadi M,https://www.ncbi.nlm.nih.gov/pubmed/32831196
12081,31870912,"Bacterial steroid-17,20-desmolase is a taxonomically rare enzymatic pathway that converts prednisone to 1,4-androstanediene-3,11,17-trione, a metabolite that causes proliferation of prostate cancer cells",J Steroid Biochem Mol Biol. 2020 May;199:105567. doi: 10.1016/j.jsbmb.2019.105567. Epub 2019 Dec 20.,Ly LK,https://www.ncbi.nlm.nih.gov/pubmed/31870912
12083,32006205,"Allergy, asthma, and the risk of breast and prostate cancer: a Mendelian randomization study",Cancer Causes Control. 2020 Mar;31(3):273-282. doi: 10.1007/s10552-020-01271-7. Epub 2020 Jan 31.,Jiang X,https://www.ncbi.nlm.nih.gov/pubmed/32006205
12084,32017073,Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial-mesenchymal transition,J Cell Physiol. 2020 Jul;235(7-8):5602-5612. doi: 10.1002/jcp.29490. Epub 2020 Feb 4.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32017073
12085,31628219,Intraindividual Comparison of (18)F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer,J Nucl Med. 2020 May;61(5):729-734. doi: 10.2967/jnumed.119.234898. Epub 2019 Oct 18.,Dietlein F,https://www.ncbi.nlm.nih.gov/pubmed/31628219
12088,32367011,Telomere-based risk models for the early diagnosis of clinically significant prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):88-95. doi: 10.1038/s41391-020-0232-4. Epub 2020 May 4.,Rubio Galisteo JM,https://www.ncbi.nlm.nih.gov/pubmed/32367011
12089,31953000,Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?,Urol Oncol. 2020 Apr;38(4):129-136. doi: 10.1016/j.urolonc.2019.11.007. Epub 2020 Jan 15.,Heidegger I,https://www.ncbi.nlm.nih.gov/pubmed/31953000
12090,31976303,Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis,Ann Glob Health. 2020 Jan 2;86(1):2. doi: 10.5334/aogh.2607.,Hassanipour S,https://www.ncbi.nlm.nih.gov/pubmed/31976303
12091,32164503,Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting Properties,Curr Med Chem. 2020;27(41):7090-7111. doi: 10.2174/0929867327666200312114902.,Mitran B,https://www.ncbi.nlm.nih.gov/pubmed/32164503
12092,32396045,PSMA-targeted Radiotracers versus (18)F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis,Radiology. 2020 Jul;296(1):44-55. doi: 10.1148/radiol.2020191689. Epub 2020 May 12.,Tan N,https://www.ncbi.nlm.nih.gov/pubmed/32396045
12093,33116405,"The Impact of Icariside II on Human Prostate Cancer Cell Proliferation, Mobility, and Autophagy via PI3K-AKT-mTOR Signaling Pathway",Drug Des Devel Ther. 2020 Oct 8;14:4169-4178. doi: 10.2147/DDDT.S268524. eCollection 2020.,Li S,https://www.ncbi.nlm.nih.gov/pubmed/33116405
12094,31753699,"Formation of 5?-dihydrotestosterone from 5?-androstane-3?,17?-diol in prostate cancer LAPC-4 cells - Identifying inhibitors of non-classical pathways producing the most potent androgen",Bioorg Med Chem Lett. 2020 Jan 15;30(2):126783. doi: 10.1016/j.bmcl.2019.126783. Epub 2019 Nov 9.,Boutin S,https://www.ncbi.nlm.nih.gov/pubmed/31753699
12096,32378902,Impact of Increased FUT8 Expression on the Extracellular Vesicle Proteome in Prostate Cancer Cells,J Proteome Res. 2020 Jun 5;19(6):2195-2205. doi: 10.1021/acs.jproteome.9b00578. Epub 2020 May 18.,Clark DJ,https://www.ncbi.nlm.nih.gov/pubmed/32378902
12097,31901103,New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):687-694. doi: 10.1007/s00259-019-04674-0. Epub 2020 Jan 3.,Rosar F,https://www.ncbi.nlm.nih.gov/pubmed/31901103
12099,32429655,"Clinical significance of PON1 L55M, Q192R and I102V polymorphisms and their association with prostate cancer risk in Polish men",Pol J Pathol. 2020;71(1):55-61. doi: 10.5114/pjp.2020.95416.,,https://www.ncbi.nlm.nih.gov/pubmed/32429655
12100,32100392,Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells,J Cell Mol Med. 2020 Apr;24(7):4286-4297. doi: 10.1111/jcmm.15089. Epub 2020 Feb 26.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/32100392
12101,32321673,"Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer",Clin Genitourin Cancer. 2020 Dec;18(6):436-443. doi: 10.1016/j.clgc.2020.03.012. Epub 2020 Mar 27.,Yu EY,https://www.ncbi.nlm.nih.gov/pubmed/32321673
12102,32277669,Prostate 3D ultrasound-guided imaging device (HistoScanning) performance detecting clinically significant prostate cancer,J BUON. 2020 Jan-Feb;25(1):460-463.,Vezelis Alvydas A,https://www.ncbi.nlm.nih.gov/pubmed/32277669
12103,32284256,Role of miRNAs in prostate cancer: Do we really know everything?,Urol Oncol. 2020 Jul;38(7):623-635. doi: 10.1016/j.urolonc.2020.03.007. Epub 2020 Apr 10.,Cochetti G,https://www.ncbi.nlm.nih.gov/pubmed/32284256
12105,31562641,Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5,FEBS Lett. 2020 Feb;594(3):466-476. doi: 10.1002/1873-3468.13624. Epub 2019 Oct 7.,Fan J,https://www.ncbi.nlm.nih.gov/pubmed/31562641
12106,32108699,Incidental Detection of Hypothyroidism on 68Ga-PSMA-HBED-CC PET/CT Imaging,Clin Nucl Med. 2020 Apr;45(4):e217-e218. doi: 10.1097/RLU.0000000000002965.,Sood A,https://www.ncbi.nlm.nih.gov/pubmed/32108699
12107,32277004,Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study,Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1229-1236. doi: 10.1158/1055-9965.EPI-19-1236. Epub 2020 Apr 10.,Khan S,https://www.ncbi.nlm.nih.gov/pubmed/32277004
12113,31732520,Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer,Clin Cancer Res. 2020 Mar 1;26(5):1054-1064. doi: 10.1158/1078-0432.CCR-19-1659. Epub 2019 Nov 15.,Glumac PM,https://www.ncbi.nlm.nih.gov/pubmed/31732520
12114,32280038,The impact of TP53BP1 and MLH1 on metastatic capability in cases of locally advanced prostate cancer and their usefulness in clinical practice,Urol Oncol. 2020 Jun;38(6):600.e17-600.e26. doi: 10.1016/j.urolonc.2020.02.012. Epub 2020 Apr 10.,Gzil A,https://www.ncbi.nlm.nih.gov/pubmed/32280038
12116,32410356,Quantitative Prostate MRI,J Magn Reson Imaging. 2021 Jun;53(6):1632-1645. doi: 10.1002/jmri.27191. Epub 2020 May 15.,Schieda N,https://www.ncbi.nlm.nih.gov/pubmed/32410356
12117,31495749,Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study,Eur Urol. 2020 Jan;77(1):24-35. doi: 10.1016/j.eururo.2019.08.025. Epub 2019 Sep 6.,Nyberg T,https://www.ncbi.nlm.nih.gov/pubmed/31495749
12118,32086567,Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany,Support Care Cancer. 2020 Nov;28(11):5223-5233. doi: 10.1007/s00520-020-05357-5. Epub 2020 Feb 21.,Diel I,https://www.ncbi.nlm.nih.gov/pubmed/32086567
12119,32014455,Identification of retinoid acid induced 16 as a novel androgen receptor target in prostate cancer cells,Mol Cell Endocrinol. 2020 Apr 15;506:110745. doi: 10.1016/j.mce.2020.110745. Epub 2020 Jan 31.,Ding CL,https://www.ncbi.nlm.nih.gov/pubmed/32014455
12121,32366428,Oral dosing of Recombinant Methioninase Is Associated With a 70% Drop in PSA in a Patient With Bone-metastatic Prostate Cancer and 50% Reduction in Circulating Methionine in a High-stage Ovarian Cancer Patient,Anticancer Res. 2020 May;40(5):2813-2819. doi: 10.21873/anticanres.14254.,Han Q,https://www.ncbi.nlm.nih.gov/pubmed/32366428
12122,31982813,Optimization of CHARMM force field parameters of a prostate cancer drug enzalutamide,J Mol Graph Model. 2020 May;96:107541. doi: 10.1016/j.jmgm.2020.107541. Epub 2020 Jan 20.,Baday S,https://www.ncbi.nlm.nih.gov/pubmed/31982813
12125,32168038,Therapeutic targeting of the DNA damage response in prostate cancer,Curr Opin Oncol. 2020 May;32(3):216-222. doi: 10.1097/CCO.0000000000000617.,Marshall CH,https://www.ncbi.nlm.nih.gov/pubmed/32168038
12127,32084293,"A synopsis of prostate organoid methodologies, applications, and limitations",Prostate. 2020 May;80(6):518-526. doi: 10.1002/pros.23966. Epub 2020 Feb 21.,Gleave AM,https://www.ncbi.nlm.nih.gov/pubmed/32084293
12128,33355426,Survival in men diagnosed with prostate cancer in Poland in the years 2000 - 2014 compared to European Countries based on Concord-3,Rocz Panstw Zakl Hig. 2020;71(4):445-453. doi: 10.32394/rpzh.2020.0143.,Gliniewicz A,https://www.ncbi.nlm.nih.gov/pubmed/33355426
12129,32139877,Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases,Oncogene. 2020 Apr;39(18):3666-3679. doi: 10.1038/s41388-020-1243-2. Epub 2020 Mar 5.,De Piano M,https://www.ncbi.nlm.nih.gov/pubmed/32139877
12130,32124938,SNAIL expression correlates with the translocation of syndecan?1 intracellular domain into the nucleus in prostate cancer cell lines,Int J Mol Med. 2020 Apr;45(4):1073-1080. doi: 10.3892/ijmm.2020.4488. Epub 2020 Feb 5.,Farfán N,https://www.ncbi.nlm.nih.gov/pubmed/32124938
12131,32390303,Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance,FASEB J. 2020 Jul;34(7):9087-9101. doi: 10.1096/fj.201802159RRR. Epub 2020 May 11.,Li T,https://www.ncbi.nlm.nih.gov/pubmed/32390303
12133,32197218,"Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGEN",Cancer Genet. 2020 May;243:11-18. doi: 10.1016/j.cancergen.2020.02.007. Epub 2020 Mar 7.,Qu X,https://www.ncbi.nlm.nih.gov/pubmed/32197218
12134,31826492,Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment,Carbohydr Polym. 2020 Feb 1;229:115498. doi: 10.1016/j.carbpol.2019.115498. Epub 2019 Oct 21.,Qu D,https://www.ncbi.nlm.nih.gov/pubmed/31826492
12135,32168400,A CD24-p53 axis contributes to African American prostate cancer disparities,Prostate. 2020 May;80(8):609-618. doi: 10.1002/pros.23973. Epub 2020 Mar 13.,Liu W,https://www.ncbi.nlm.nih.gov/pubmed/32168400
12136,32305266,Development and evaluation of the MiCheck test for aggressive prostate cancer,Urol Oncol. 2020 Aug;38(8):683.e11-683.e18. doi: 10.1016/j.urolonc.2020.03.010. Epub 2020 Apr 16.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32305266
12137,32360904,Thyroid hormone induces cellular senescence in prostate cancer cells through induction of DEC1,J Steroid Biochem Mol Biol. 2020 Jul;201:105689. doi: 10.1016/j.jsbmb.2020.105689. Epub 2020 May 1.,Kotolloshi R,https://www.ncbi.nlm.nih.gov/pubmed/32360904
12138,32456702,The effect of information on prostate cancer screening decision process: a discrete choice experiment,BMC Health Serv Res. 2020 May 26;20(1):467. doi: 10.1186/s12913-020-05327-x.,Charvin M,https://www.ncbi.nlm.nih.gov/pubmed/32456702
12139,32198885,Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element,Nucleic Acids Res. 2020 May 21;48(9):4741-4755. doi: 10.1093/nar/gkaa178.,Kregel S,https://www.ncbi.nlm.nih.gov/pubmed/32198885
12140,31728894,PreView: a Randomized Trial of a Multi-site Intervention in Diverse Primary Care to Increase Rates of Age-Appropriate Cancer Screening,J Gen Intern Med. 2020 Feb;35(2):449-456. doi: 10.1007/s11606-019-05438-0. Epub 2019 Nov 14.,Walsh J,https://www.ncbi.nlm.nih.gov/pubmed/31728894
12141,32438200,Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer,Eur J Med Chem. 2020 Aug 1;199:112414. doi: 10.1016/j.ejmech.2020.112414. Epub 2020 May 8.,Sanz Del Olmo N,https://www.ncbi.nlm.nih.gov/pubmed/32438200
12142,32471499,CCL2/CCR2 signaling in cancer pathogenesis,Cell Commun Signal. 2020 May 29;18(1):82. doi: 10.1186/s12964-020-00589-8.,Hao Q,https://www.ncbi.nlm.nih.gov/pubmed/32471499
12143,32406844,A 1 MHz Miniaturized Electrical Impedance Tomography System for Prostate Imaging,IEEE Trans Biomed Circuits Syst. 2020 Aug;14(4):787-799. doi: 10.1109/TBCAS.2020.2994297. Epub 2020 May 12.,Rao A,https://www.ncbi.nlm.nih.gov/pubmed/32406844
12144,31996731,Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor,Sci Rep. 2020 Jan 29;10(1):1403. doi: 10.1038/s41598-020-58354-3.,Hao Q,https://www.ncbi.nlm.nih.gov/pubmed/31996731
12145,33119680,Prescription-based prediction of baseline mortality risk among older men,PLoS One. 2020 Oct 29;15(10):e0241439. doi: 10.1371/journal.pone.0241439. eCollection 2020.,Gedeborg R,https://www.ncbi.nlm.nih.gov/pubmed/33119680
12149,32198642,Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials,Clin Transl Oncol. 2020 Nov;22(11):2126-2129. doi: 10.1007/s12094-020-02334-6. Epub 2020 Mar 20.,Carretero-González A,https://www.ncbi.nlm.nih.gov/pubmed/32198642
12150,32414345,Upregulation of pERK and c-JUN by ?-tocotrienol and not ?-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells,BMC Cancer. 2020 May 15;20(1):428. doi: 10.1186/s12885-020-06947-6.,Moore C,https://www.ncbi.nlm.nih.gov/pubmed/32414345
12151,31819003,Aberrant activation of hepatocyte growth factor/MET signaling promotes ?-catenin-mediated prostatic tumorigenesis,J Biol Chem. 2020 Jan 10;295(2):631-644. doi: 10.1074/jbc.RA119.011137. Epub 2019 Dec 9.,Aldahl J,https://www.ncbi.nlm.nih.gov/pubmed/31819003
12152,31236756,Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[(18)F] F and [(18)F]FDG: a Focus on Skeletal Lesions,Mol Imaging Biol. 2020 Apr;22(2):397-406. doi: 10.1007/s11307-019-01392-9.,Sonni I,https://www.ncbi.nlm.nih.gov/pubmed/31236756
12153,32130760,Development and validation of hub genes for lymph node metastasis in patients with prostate cancer,J Cell Mol Med. 2020 Apr;24(8):4402-4414. doi: 10.1111/jcmm.15098. Epub 2020 Mar 4.,Xu N,https://www.ncbi.nlm.nih.gov/pubmed/32130760
12155,31784928,Prevalence and clinical significance of incidental findings on multiparametric prostate MRI,Radiol Med. 2020 Feb;125(2):204-213. doi: 10.1007/s11547-019-01106-9. Epub 2019 Nov 29.,Cutaia G,https://www.ncbi.nlm.nih.gov/pubmed/31784928
12156,32024754,TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss,Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3637-3647. doi: 10.1073/pnas.1911673117. Epub 2020 Feb 5.,Pietrzak K,https://www.ncbi.nlm.nih.gov/pubmed/32024754
12157,32175697,Prostate cancer risk in patients with melanoma: A systematic review and meta-analysis,Cancer Med. 2020 May;9(10):3604-3612. doi: 10.1002/cam4.2995. Epub 2020 Mar 16.,Acharya P,https://www.ncbi.nlm.nih.gov/pubmed/32175697
12158,32203305,Cellular rewiring in lethal prostate cancer: the architect of drug resistance,Nat Rev Urol. 2020 May;17(5):292-307. doi: 10.1038/s41585-020-0298-8. Epub 2020 Mar 16.,Carceles-Cordon M,https://www.ncbi.nlm.nih.gov/pubmed/32203305
12159,31969640,Geranylated 4-phenylcoumarins extracted from Mesua elegans induced caspase-independent cell death in prostate cancer cell lines through calpain-2 and cathepsin B,Sci Rep. 2020 Jan 22;10(1):986. doi: 10.1038/s41598-020-57781-6.,Sapili H,https://www.ncbi.nlm.nih.gov/pubmed/31969640
12160,32377599,Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer,Investig Clin Urol. 2020 May;61(3):242-249. doi: 10.4111/icu.2020.61.3.242. Epub 2020 Apr 27.,Kim JW,https://www.ncbi.nlm.nih.gov/pubmed/32377599
12161,31913197,Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study,Anticancer Drugs. 2020 Mar;31(3):298-303. doi: 10.1097/CAD.0000000000000884.,Shiota M,https://www.ncbi.nlm.nih.gov/pubmed/31913197
12162,31473819,"Antiangiogenic therapy with Nintedanib affects hypoxia, angiogenesis and apoptosis in the ventral prostate of TRAMP animals",Cell Tissue Res. 2020 Feb;379(2):407-420. doi: 10.1007/s00441-019-03091-x. Epub 2019 Aug 31.,da Silva RF,https://www.ncbi.nlm.nih.gov/pubmed/31473819
12163,32329523,Long intergenic noncoding RNA 00844 promotes apoptosis and represses proliferation of prostate cancer cells through upregulating GSTP1 by recruiting EBF1,J Cell Physiol. 2020 Nov;235(11):8472-8485. doi: 10.1002/jcp.29690. Epub 2020 Apr 24.,Qiu K,https://www.ncbi.nlm.nih.gov/pubmed/32329523
12164,32220946,Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion,ESMO Open. 2020 Mar;5(2):e000652. doi: 10.1136/esmoopen-2019-000652.,Santini D,https://www.ncbi.nlm.nih.gov/pubmed/32220946
12166,32051423,A predictive model for prostate cancer incorporating PSA molecular forms and age,Sci Rep. 2020 Feb 12;10(1):2463. doi: 10.1038/s41598-020-58836-4.,Oto J,https://www.ncbi.nlm.nih.gov/pubmed/32051423
12167,30446448,Exercise medicine for the management of androgen deprivation therapy-related side effects in prostate cancer,Urol Oncol. 2020 Feb;38(2):62-70. doi: 10.1016/j.urolonc.2018.10.008. Epub 2018 Nov 13.,Cormie P,https://www.ncbi.nlm.nih.gov/pubmed/30446448
12169,32455140,Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia,J Immunol Res. 2020 May 8;2020:5873056. doi: 10.1155/2020/5873056. eCollection 2020.,Jin W,https://www.ncbi.nlm.nih.gov/pubmed/32455140
12170,29974804,"Expertise, advocacy and activism: A qualitative study on the activities of prostate cancer peer support workers",Health (London). 2020 Jan;24(1):21-37. doi: 10.1177/1363459318785711. Epub 2018 Jul 5.,Jones M,https://www.ncbi.nlm.nih.gov/pubmed/29974804
12172,31837464,piR-31470 epigenetically suppresses the expression of glutathione S-transferase pi 1 in prostate cancer via DNA methylation,Cell Signal. 2020 Mar;67:109501. doi: 10.1016/j.cellsig.2019.109501. Epub 2019 Dec 16.,Zhang L,https://www.ncbi.nlm.nih.gov/pubmed/31837464
12173,31913073,Development and External Validation of Multiparametric MRI-Derived Nomogram to Predict Risk of Pathologic Upgrade in Patients on Active Surveillance for Prostate Cancer,AJR Am J Roentgenol. 2020 Apr;214(4):825-834. doi: 10.2214/AJR.19.22196. Epub 2020 Jan 8.,Kim SH,https://www.ncbi.nlm.nih.gov/pubmed/31913073
12174,32102946,Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial,Cancer Prev Res (Phila). 2020 Jun;13(6):521-530. doi: 10.1158/1940-6207.CAPR-19-0413. Epub 2020 Feb 26.,Torkko K,https://www.ncbi.nlm.nih.gov/pubmed/32102946
12176,31392791,Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells,BJU Int. 2020 Jan;125(1):89-102. doi: 10.1111/bju.14893. Epub 2019 Aug 7.,Sakellariou C,https://www.ncbi.nlm.nih.gov/pubmed/31392791
12177,33361638,Study on the SFRP4 gene polymorphism and expression in prostate cancer,J Genet. 2020;99:86.,Natarajan A,https://www.ncbi.nlm.nih.gov/pubmed/33361638
12178,32508166,Non-metastatic castration-resistant prostate cancer: current status and future directions,Expert Rev Anticancer Ther. 2020 Jun;20(6):513-522. doi: 10.1080/14737140.2020.1772759. Epub 2020 Jun 7.,Gupta R,https://www.ncbi.nlm.nih.gov/pubmed/32508166
12179,31222811,"The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90? and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth",J Cell Biochem. 2020 Jan;121(1):407-417. doi: 10.1002/jcb.29195. Epub 2019 Jun 21.,Brünnert D,https://www.ncbi.nlm.nih.gov/pubmed/31222811
12180,31529508,Mechanisms underlying the effect of an oral antihyperglycaemic agent glyburide on calcium ion (Ca(2+) ) movement and its related cytotoxicity in prostate cancer cells,Clin Exp Pharmacol Physiol. 2020 Jan;47(1):111-118. doi: 10.1111/1440-1681.13177. Epub 2019 Oct 1.,Sun GC,https://www.ncbi.nlm.nih.gov/pubmed/31529508
12182,32019859,Double Trouble: Concomitant RB1 and BRCA2 Depletion Evokes Aggressive Phenotypes,Clin Cancer Res. 2020 Apr 15;26(8):1784-1786. doi: 10.1158/1078-0432.CCR-19-4033. Epub 2020 Feb 4.,Mandigo AC,https://www.ncbi.nlm.nih.gov/pubmed/32019859
12183,32051980,Pseudo-branched polyester copolymer: an efficient drug delivery system to treat cancer,Biomater Sci. 2020 Mar 17;8(6):1592-1603. doi: 10.1039/c9bm01475f.,Shaw Z,https://www.ncbi.nlm.nih.gov/pubmed/32051980
12184,31662478,Arrogance of 'but all you need is a good index finger': A narrative ethics exploration of lack of universal funding of PSA screening in Canada,J Med Ethics. 2020 Apr;46(4):249-252. doi: 10.1136/medethics-2019-105742. Epub 2019 Oct 29.,Nisker J,https://www.ncbi.nlm.nih.gov/pubmed/31662478
12185,32313141,The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):661-669. doi: 10.1038/s41391-020-0229-z. Epub 2020 Apr 20.,Cheng S,https://www.ncbi.nlm.nih.gov/pubmed/32313141
12186,31743436,"Assessing the effect of patient navigator assistance for psychosocial support services on health-related quality of life in a randomized clinical trial in Latino breast, prostate, and colorectal cancer survivors",Cancer. 2020 Mar 1;126(5):1112-1123. doi: 10.1002/cncr.32626. Epub 2019 Nov 19.,Ramirez AG,https://www.ncbi.nlm.nih.gov/pubmed/31743436
12187,31899813,Age dependence of modern clinical risk groups for localized prostate cancer-A population-based study,Cancer. 2020 Apr 15;126(8):1691-1699. doi: 10.1002/cncr.32702. Epub 2020 Jan 3.,Huynh-Le MP,https://www.ncbi.nlm.nih.gov/pubmed/31899813
12188,32143562,CNV Radar: an improved method for somatic copy number alteration characterization in oncology,BMC Bioinformatics. 2020 Mar 6;21(1):98. doi: 10.1186/s12859-020-3397-x.,Soong D,https://www.ncbi.nlm.nih.gov/pubmed/32143562
12191,31806771,Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for (18)F-FDG Imaging of PSMA-Suppressed Tumors,J Nucl Med. 2020 Jun;61(6):904-910. doi: 10.2967/jnumed.119.231068. Epub 2019 Dec 5.,Bakht MK,https://www.ncbi.nlm.nih.gov/pubmed/31806771
12192,30855080,Society of Behavior Medicine (SBM) Urges Congress to Ensure Affordable Care Act Coverage of Prostate Cancer Screening Support Services for High-Risk Men,Transl Behav Med. 2020 May 20;10(2):492-494. doi: 10.1093/tbm/ibz034.,Watson K,https://www.ncbi.nlm.nih.gov/pubmed/30855080
12193,32439453,"Identification of a natural compound, sesamin, as a novel TRPM8 antagonist with inhibitory effects on prostate adenocarcinoma",Fitoterapia. 2020 Sep;145:104631. doi: 10.1016/j.fitote.2020.104631. Epub 2020 May 19.,Sui Y,https://www.ncbi.nlm.nih.gov/pubmed/32439453
12194,32039440,Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway,Biosci Rep. 2020 Mar 27;40(3):BSR20192826. doi: 10.1042/BSR20192826.,Cai F,https://www.ncbi.nlm.nih.gov/pubmed/32039440
12195,31743102,Multimodal feature learning and fusion on B-mode ultrasonography and sonoelastography using point-wise gated deep networks for prostate cancer diagnosis,Biomed Tech (Berl). 2020 Jan 28;65(1):87-98. doi: 10.1515/bmt-2018-0136.,Zhang Q,https://www.ncbi.nlm.nih.gov/pubmed/31743102
12196,33329538,"Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells",Front Immunol. 2020 Nov 27;11:574046. doi: 10.3389/fimmu.2020.574046. eCollection 2020.,Niespolo C,https://www.ncbi.nlm.nih.gov/pubmed/33329538
12197,32401357,The association between androgen receptor splice variant 7 status and prognosis of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis,Andrologia. 2020 Aug;52(7):e13642. doi: 10.1111/and.13642. Epub 2020 May 13.,Zhou J,https://www.ncbi.nlm.nih.gov/pubmed/32401357
12199,32301932,"A Qualitative Exploration of Prostate Cancer Survivors Experiencing Psychological Distress: Loss of Self, Function, Connection, and Control",Oncol Nurs Forum. 2020 May 1;47(3):318-330. doi: 10.1188/20.ONF.318-330.,Matheson L,https://www.ncbi.nlm.nih.gov/pubmed/32301932
12200,32421868,THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway,Prostate. 2020 Jul;80(10):753-763. doi: 10.1002/pros.23989. Epub 2020 May 18.,Hou Y,https://www.ncbi.nlm.nih.gov/pubmed/32421868
12201,32394247,Social and clinical determinants of physical activity in prostate cancer survivors,Support Care Cancer. 2021 Jan;29(1):459-465. doi: 10.1007/s00520-020-05482-1. Epub 2020 May 11.,Halbert CH,https://www.ncbi.nlm.nih.gov/pubmed/32394247
12202,31882336,Squamous Transformation of Prostate Adenocarcinoma: A Report of Two Cases With Genomic Profiling,Clin Genitourin Cancer. 2020 Jun;18(3):e289-e292. doi: 10.1016/j.clgc.2019.11.020. Epub 2019 Dec 4.,Dizman N,https://www.ncbi.nlm.nih.gov/pubmed/31882336
12203,32159363,Active vitamin D induces gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance,Am J Physiol Cell Physiol. 2020 May 1;318(5):C836-C847. doi: 10.1152/ajpcell.00522.2019. Epub 2020 Mar 11.,Lai GR,https://www.ncbi.nlm.nih.gov/pubmed/32159363
12204,32363906,In vivo magnetic resonance imaging of orthotopic prostate cancer,Biotechniques. 2020 Jul;69(1):395-403. doi: 10.2144/btn-2020-0021. Epub 2020 May 2.,Ravoori MK,https://www.ncbi.nlm.nih.gov/pubmed/32363906
12205,32224036,Portable Perfusion Phantom Offers Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Accurate Prostate Cancer Grade Stratification: A Pilot Study,Acad Radiol. 2021 Mar;28(3):405-413. doi: 10.1016/j.acra.2020.02.027. Epub 2020 Mar 27.,Kim H,https://www.ncbi.nlm.nih.gov/pubmed/32224036
12207,31758738,External validation of novel magnetic resonance imaging-based models for prostate cancer prediction,BJU Int. 2020 Mar;125(3):407-416. doi: 10.1111/bju.14958. Epub 2019 Dec 20.,Püllen L,https://www.ncbi.nlm.nih.gov/pubmed/31758738
12208,31674708,Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer,Mol Carcinog. 2020 Jan;59(1):62-72. doi: 10.1002/mc.23129. Epub 2019 Nov 1.,Peak TC,https://www.ncbi.nlm.nih.gov/pubmed/31674708
12209,32364250,Interaction between prostate cancer cells and prostate fibroblasts promotes accumulation and proteolytic processing of basement membrane proteins,Prostate. 2020 Jun;80(9):715-726. doi: 10.1002/pros.23985. Epub 2020 May 4.,Ojalill M,https://www.ncbi.nlm.nih.gov/pubmed/32364250
12210,32003227,Geographic-Level Association of Contemporary Changes in Localized and Metastatic Prostate Cancer Incidence in the Era of Decreasing PSA Screening,Cancer Control. 2020 Jan-Dec;27(1):1073274820902267. doi: 10.1177/1073274820902267.,Yang DX,https://www.ncbi.nlm.nih.gov/pubmed/32003227
12211,31123866,Mechanism of selective anticancer activity of isothiocyanates relies on differences in DNA damage repair between cancer and healthy cells,Eur J Nutr. 2020 Jun;59(4):1421-1432. doi: 10.1007/s00394-019-01995-6. Epub 2019 May 23.,Ha? A,https://www.ncbi.nlm.nih.gov/pubmed/31123866
12214,32203167,p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer,Oncogene. 2020 May;39(19):3939-3951. doi: 10.1038/s41388-020-1270-z. Epub 2020 Mar 23.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/32203167
12215,31381135,The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1?/pAKT in prostate cancer,Int J Cancer. 2020 Mar 15;146(6):1686-1699. doi: 10.1002/ijc.32607. Epub 2019 Aug 16.,Larsson P,https://www.ncbi.nlm.nih.gov/pubmed/31381135
12216,32198311,"(18)F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smoothing Filter, and Partial-Volume Correction on PROMISE Criteria",J Nucl Med. 2020 Nov;61(11):1615-1620. doi: 10.2967/jnumed.120.241737. Epub 2020 Mar 20.,Ortega C,https://www.ncbi.nlm.nih.gov/pubmed/32198311
12218,31920048,Multiphoton FLIM imaging of NAD(P)H and FAD with one excitation wavelength,J Biomed Opt. 2020 Jan;25(1):1-16. doi: 10.1117/1.JBO.25.1.014510.,Cao R,https://www.ncbi.nlm.nih.gov/pubmed/31920048
12219,32350277,Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer,Nat Commun. 2020 Apr 29;11(1):2089. doi: 10.1038/s41467-020-15815-7.,Zhang D,https://www.ncbi.nlm.nih.gov/pubmed/32350277
12222,31249268,Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer,Asian J Androl. 2020 Jan-Feb;22(1):76-78. doi: 10.4103/aja.aja_52_19.,Aragon-Ching JB,https://www.ncbi.nlm.nih.gov/pubmed/31249268
12224,31743594,Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta-analysis and systematic review,Andrology. 2020 May;8(3):559-574. doi: 10.1111/andr.12731. Epub 2019 Dec 17.,Liang Z,https://www.ncbi.nlm.nih.gov/pubmed/31743594
12225,31986411,Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer,Biomed Pharmacother. 2020 Apr;124:109863. doi: 10.1016/j.biopha.2020.109863. Epub 2020 Jan 24.,Xia L,https://www.ncbi.nlm.nih.gov/pubmed/31986411
12226,31902674,Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer,EBioMedicine. 2020 Jan;51:102547. doi: 10.1016/j.ebiom.2019.11.008. Epub 2020 Jan 3.,Jiménez-Vacas JM,https://www.ncbi.nlm.nih.gov/pubmed/31902674
12227,31881124,Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing KLF4 promoter methylation,J Cell Mol Med. 2020 Jan;24(2):1878-1892. doi: 10.1111/jcmm.14883. Epub 2019 Dec 27.,Jiang Z,https://www.ncbi.nlm.nih.gov/pubmed/31881124
12228,30241953,Prostate cancer tissues with positive TMPRSS2-ERG-gene-fusion status may display enhanced nerve density,Urol Oncol. 2020 Jan;38(1):3.e7-3.e15. doi: 10.1016/j.urolonc.2018.07.019. Epub 2018 Sep 18.,Hänze J,https://www.ncbi.nlm.nih.gov/pubmed/30241953
12229,31925334,BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation,Oncogene. 2020 Mar;39(11):2391-2407. doi: 10.1038/s41388-020-1153-3. Epub 2020 Jan 10.,Lempiäinen JK,https://www.ncbi.nlm.nih.gov/pubmed/31925334
12230,31932969,The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancer,Med Mol Morphol. 2020 Sep;53(3):156-167. doi: 10.1007/s00795-020-00243-9. Epub 2020 Jan 13.,Umemori M,https://www.ncbi.nlm.nih.gov/pubmed/31932969
12231,32329830,m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1,Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3565-3571. doi: 10.26355/eurrev_202004_20817.,Ma XX,https://www.ncbi.nlm.nih.gov/pubmed/32329830
12232,32333639,Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making,Cancer Med. 2020 Jun;9(12):4039-4058. doi: 10.1002/cam4.3018. Epub 2020 Apr 25.,Van Hemelrijck M,https://www.ncbi.nlm.nih.gov/pubmed/32333639
12233,32084147,Overall survival and second primary malignancies in men with metastatic prostate cancer,PLoS One. 2020 Feb 21;15(2):e0227552. doi: 10.1371/journal.pone.0227552. eCollection 2020.,Mehtälä J,https://www.ncbi.nlm.nih.gov/pubmed/32084147
12234,31147627,"Appetite-regulating hormones-leptin, adiponectin and ghrelin-and the development of prostate cancer: a systematic review and exploratory meta-analysis",Prostate Cancer Prostatic Dis. 2020 Mar;23(1):11-23. doi: 10.1038/s41391-019-0154-1. Epub 2019 May 30.,Angel CZ,https://www.ncbi.nlm.nih.gov/pubmed/31147627
12235,31959023,The influence of androgen deprivation therapy on hip geometric properties and bone mineral density in Japanese men with prostate cancer and its relationship with the visceral fat accumulation,Aging Male. 2020 Dec;23(5):1158-1164. doi: 10.1080/13685538.2020.1713741. Epub 2020 Jan 20.,Watanabe D,https://www.ncbi.nlm.nih.gov/pubmed/31959023
12236,32197590,Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis,BMC Cancer. 2020 Mar 20;20(1):238. doi: 10.1186/s12885-020-06739-y.,Song H,https://www.ncbi.nlm.nih.gov/pubmed/32197590
12237,32176628,The interactome of the prostate-specific protein Anoctamin 7,Cancer Biomark. 2020;28(1):91-100. doi: 10.3233/CBM-190993.,Kaikkonen E,https://www.ncbi.nlm.nih.gov/pubmed/32176628
12238,31719098,Activation of ?-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer,Cancer Res. 2020 Feb 1;80(3):576-590. doi: 10.1158/0008-5472.CAN-19-1684. Epub 2019 Nov 12.,Patel R,https://www.ncbi.nlm.nih.gov/pubmed/31719098
12241,32333736,The role of FSH and LH in prostate cancer and cardiometabolic comorbidities,Can J Urol. 2020 Apr;27(2):10167-10173.,Crawford ED,https://www.ncbi.nlm.nih.gov/pubmed/32333736
12242,31429050,[(68)Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [(68)Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence,Mol Imaging Biol. 2020 Jun;22(3):752-763. doi: 10.1007/s11307-019-01421-7.,Green MA,https://www.ncbi.nlm.nih.gov/pubmed/31429050
12243,31941606,The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer,Biochem Biophys Res Commun. 2020 Mar 12;523(3):588-594. doi: 10.1016/j.bbrc.2019.12.084. Epub 2020 Jan 12.,Ishizuya Y,https://www.ncbi.nlm.nih.gov/pubmed/31941606
12247,31693611,Pulmonary Vein Varix Mimicking Prostate Cancer Metastasis on 68Ga-Prostate Specific Membrane Antigen-11 PET/CT,Clin Nucl Med. 2020 Jan;45(1):e39-e40. doi: 10.1097/RLU.0000000000002803.,Sgard B,https://www.ncbi.nlm.nih.gov/pubmed/31693611
12248,32531722,Prostate MRI radiomics: A systematic review and radiomic quality score assessment,Eur J Radiol. 2020 Aug;129:109095. doi: 10.1016/j.ejrad.2020.109095. Epub 2020 May 30.,Stanzione A,https://www.ncbi.nlm.nih.gov/pubmed/32531722
12249,32066783,Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection,Sci Rep. 2020 Feb 17;10(1):2708. doi: 10.1038/s41598-020-59622-y.,Ideo H,https://www.ncbi.nlm.nih.gov/pubmed/32066783
12250,32048561,Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells,Immunopharmacol Immunotoxicol. 2020 Apr;42(2):93-100. doi: 10.1080/08923973.2020.1725040. Epub 2020 Feb 12.,Deveci Ozkan A,https://www.ncbi.nlm.nih.gov/pubmed/32048561
12251,31796514,Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer,Clin Cancer Res. 2020 Mar 15;26(6):1516-1528. doi: 10.1158/1078-0432.CCR-19-0396. Epub 2019 Dec 3.,Cao Q,https://www.ncbi.nlm.nih.gov/pubmed/31796514
12252,32212356,Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics,J Magn Reson Imaging. 2020 Oct;52(4):1102-1109. doi: 10.1002/jmri.27132. Epub 2020 Mar 25.,Gong L,https://www.ncbi.nlm.nih.gov/pubmed/32212356
12253,30446888,Association Between the Interleukin-17 Gene Polymorphism -197G>A and the Risk of Prostate Cancer in a Galician Population,Pathol Oncol Res. 2020 Jan;26(1):483-489. doi: 10.1007/s12253-018-0537-y. Epub 2018 Nov 16.,Aguín N,https://www.ncbi.nlm.nih.gov/pubmed/30446888
12254,31685982,Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):260-268. doi: 10.1038/s41391-019-0183-9. Epub 2019 Nov 4.,Mazzone E,https://www.ncbi.nlm.nih.gov/pubmed/31685982
12255,31309555,MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1,J Cell Physiol. 2020 Feb;235(2):1588-1600. doi: 10.1002/jcp.29078. Epub 2019 Jul 15.,Wang M,https://www.ncbi.nlm.nih.gov/pubmed/31309555
12256,32109649,Reduced cancer-specific survival of low prostate-specific antigen in high-grade prostate cancer: A population-based retrospective cohort study,Int J Surg. 2020 Apr;76:64-68. doi: 10.1016/j.ijsu.2020.02.024. Epub 2020 Feb 26.,Song P,https://www.ncbi.nlm.nih.gov/pubmed/32109649
12258,31875279,Optimal threshold of the prostate health index in predicting aggressive prostate cancer using predefined cost-benefit ratios and prevalence,Int Urol Nephrol. 2020 May;52(5):893-901. doi: 10.1007/s11255-019-02367-z. Epub 2019 Dec 24.,Stojadinovic M,https://www.ncbi.nlm.nih.gov/pubmed/31875279
12259,31943365,Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre-metastatic niches,Mol Carcinog. 2020 Mar;59(3):323-332. doi: 10.1002/mc.23157. Epub 2020 Jan 14.,Deep G,https://www.ncbi.nlm.nih.gov/pubmed/31943365
12260,32303129,Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis,Klin Onkol. 2020 Spring;33(2):92-100. doi: 10.14735/amko202092.,Abedinzadeh M,https://www.ncbi.nlm.nih.gov/pubmed/32303129
12261,31963946,Advances of Zinc Signaling Studies in Prostate Cancer,Int J Mol Sci. 2020 Jan 19;21(2):667. doi: 10.3390/ijms21020667.,Li D,https://www.ncbi.nlm.nih.gov/pubmed/31963946
12262,31844181,A review of prostate cancer treatment impact on the CNS and cognitive function,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):207-219. doi: 10.1038/s41391-019-0195-5. Epub 2019 Dec 16.,Ryan C,https://www.ncbi.nlm.nih.gov/pubmed/31844181
12263,31939917,Qualitative and quantitative reproducibility of [18]fluoromethycholine PET/computed tomography in prostate cancer,Nucl Med Commun. 2020 Feb;41(2):147-154. doi: 10.1097/MNM.0000000000001129.,Pinto-Leite T,https://www.ncbi.nlm.nih.gov/pubmed/31939917
12264,31676279,Management of bone complications in patients with genitourinary malignancies,Urol Oncol. 2020 Mar;38(3):94-104. doi: 10.1016/j.urolonc.2019.09.028. Epub 2019 Oct 29.,Ballon-Landa E,https://www.ncbi.nlm.nih.gov/pubmed/31676279
12265,30941561,The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literature,World J Urol. 2020 Mar;38(3):657-662. doi: 10.1007/s00345-019-02744-4. Epub 2019 Apr 2.,Offermann A,https://www.ncbi.nlm.nih.gov/pubmed/30941561
12267,32252682,Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer,BMC Cancer. 2020 Apr 6;20(1):289. doi: 10.1186/s12885-020-06776-7.,Chen C,https://www.ncbi.nlm.nih.gov/pubmed/32252682
12268,32155117,PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells,Elife. 2020 Mar 10;9:e51373. doi: 10.7554/eLife.51373.,Jain P,https://www.ncbi.nlm.nih.gov/pubmed/32155117
12270,31846114,Cancer-stromal cell fusion as revealed by fluorescence protein tracking,Prostate. 2020 Feb;80(3):274-283. doi: 10.1002/pros.23941. Epub 2019 Dec 17.,Wang R,https://www.ncbi.nlm.nih.gov/pubmed/31846114
12271,32197509,HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in Prostate Cancer Progression,Biomolecules. 2020 Mar 18;10(3):467. doi: 10.3390/biom10030467.,Anselmino N,https://www.ncbi.nlm.nih.gov/pubmed/32197509
12272,32494663,"miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1",Sci Adv. 2020 Apr 29;6(18):eaay3051. doi: 10.1126/sciadv.aay3051. eCollection 2020 May.,Urabe F,https://www.ncbi.nlm.nih.gov/pubmed/32494663
12273,32851058,Inhibition of Specificity Protein 1 Is Involved in Phloretin-Induced Suppression of Prostate Cancer,Biomed Res Int. 2020 Aug 10;2020:1358674. doi: 10.1155/2020/1358674. eCollection 2020.,Kang D,https://www.ncbi.nlm.nih.gov/pubmed/32851058
12274,33162934,Osteocytes and Bone Metastasis,Front Endocrinol (Lausanne). 2020 Oct 14;11:567844. doi: 10.3389/fendo.2020.567844. eCollection 2020.,Riquelme MA,https://www.ncbi.nlm.nih.gov/pubmed/33162934
12275,31977491,Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer,Clin Nucl Med. 2020 Apr;45(4):e208-e210. doi: 10.1097/RLU.0000000000002938.,Bitar R,https://www.ncbi.nlm.nih.gov/pubmed/31977491
12276,32432734,MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2,Eur Rev Med Pharmacol Sci. 2020 May;24(9):4710-4718. doi: 10.26355/eurrev_202005_21159.,Huang WT,https://www.ncbi.nlm.nih.gov/pubmed/32432734
12277,32925162,Application of texture analysis based on T2-weighted magnetic resonance images in discriminating Gleason scores of prostate cancer,J Xray Sci Technol. 2020;28(6):1207-1218. doi: 10.3233/XST-200695.,Pan R,https://www.ncbi.nlm.nih.gov/pubmed/32925162
12279,32461304,Targeting RET Kinase in Neuroendocrine Prostate Cancer,Mol Cancer Res. 2020 Aug;18(8):1176-1188. doi: 10.1158/1541-7786.MCR-19-1245. Epub 2020 May 27.,VanDeusen HR,https://www.ncbi.nlm.nih.gov/pubmed/32461304
12280,32458006,A microdose clinical trial to evaluate [(18)F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer,Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):95-102. doi: 10.1007/s00259-020-04883-y. Epub 2020 May 26.,Lee I,https://www.ncbi.nlm.nih.gov/pubmed/32458006
12283,32125899,Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets,JCO Glob Oncol. 2020 Mar;6:382-386. doi: 10.1200/JGO.19.00341.,Patel A,https://www.ncbi.nlm.nih.gov/pubmed/32125899
12286,31479397,Reducing Unnecessary Prostate Multiparametric Magnetic Resonance Imaging by Using Clinical Parameters to Predict Negative and Indeterminate Findings,J Urol. 2020 Feb;203(2):292-298. doi: 10.1097/JU.0000000000000518. Epub 2019 Sep 3.,Deniffel D,https://www.ncbi.nlm.nih.gov/pubmed/31479397
12287,32354165,The Role of Crosstalk between AR3 and E2F1 in Drug Resistance in Prostate Cancer Cells,Cells. 2020 Apr 28;9(5):1094. doi: 10.3390/cells9051094.,Xu J,https://www.ncbi.nlm.nih.gov/pubmed/32354165
12288,32295536,Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population,BMC Med Genet. 2020 Apr 15;21(1):81. doi: 10.1186/s12881-020-01014-0.,Beikzadeh B,https://www.ncbi.nlm.nih.gov/pubmed/32295536
12289,32183345,Compliance with the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and Prostate Cancer,Nutrients. 2020 Mar 14;12(3):768. doi: 10.3390/nu12030768.,Olmedo-Requena R,https://www.ncbi.nlm.nih.gov/pubmed/32183345
12290,32841893,Induction of proliferative and mutagenic activity by benzo(a)pyrene in PC-3 cells via JAK2/STAT3 pathway,Mutat Res. 2020 May-Dec;821:111720. doi: 10.1016/j.mrfmmm.2020.111720. Epub 2020 Aug 12.,Gao M,https://www.ncbi.nlm.nih.gov/pubmed/32841893
12292,31522560,"The Prevalence of Zinc Deficiency among Men with and without Prostate Cancer in Port Harcourt, Nigeria",Nutr Cancer. 2020;72(6):1018-1025. doi: 10.1080/01635581.2019.1664600. Epub 2019 Sep 14.,Amadi C,https://www.ncbi.nlm.nih.gov/pubmed/31522560
12293,32411320,Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer,Oxid Med Cell Longev. 2020 Jan 20;2020:2148562. doi: 10.1155/2020/2148562. eCollection 2020.,Barquilha CN,https://www.ncbi.nlm.nih.gov/pubmed/32411320
12294,32096520,Bifunctional Au-templated RNA nanoparticles enable direct cell uptake detection and GRP75 knockdown in prostate cancer,J Mater Chem B. 2020 Mar 11;8(10):2169-2176. doi: 10.1039/c9tb02438g.,Shah SS,https://www.ncbi.nlm.nih.gov/pubmed/32096520
12295,32297439,Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer,Oncologist. 2020 Apr;25(4):327-333. doi: 10.1634/theoncologist.2019-0115. Epub 2019 Nov 11.,Ledet EM,https://www.ncbi.nlm.nih.gov/pubmed/32297439
12296,31472243,Identifying FL11 subtype by characterizing tumor immune microenvironment in prostate adenocarcinoma via Chou's 5-steps rule,Genomics. 2020 Mar;112(2):1500-1515. doi: 10.1016/j.ygeno.2019.08.021. Epub 2019 Aug 28.,Yang L,https://www.ncbi.nlm.nih.gov/pubmed/31472243
12298,32484090,Computerized Tomography (CT) Updates and Challenges in Diagnosis of Bone Metastases During Prostate Cancer,Curr Med Imaging. 2020;16(5):565-571. doi: 10.2174/1573405614666181009144601.,Zhang J,https://www.ncbi.nlm.nih.gov/pubmed/32484090
12299,33238278,Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer,Chemotherapy. 2020;65(5-6):125-133. doi: 10.1159/000511505. Epub 2020 Nov 25.,Qian S,https://www.ncbi.nlm.nih.gov/pubmed/33238278
12300,31794112,Deep learning-based quantification of PET/CT prostate gland uptake: association with overall survival,Clin Physiol Funct Imaging. 2020 Mar;40(2):106-113. doi: 10.1111/cpf.12611. Epub 2019 Dec 20.,Polymeri E,https://www.ncbi.nlm.nih.gov/pubmed/31794112
12301,31655823,Karyomegalic Interstitial Nephritis: Cancer Risk Following Transplantation,Nephron. 2020;144(1):49-54. doi: 10.1159/000503034. Epub 2019 Oct 25.,Murray SL,https://www.ncbi.nlm.nih.gov/pubmed/31655823
12302,32199263,Improved drug delivery and anti-tumor efficacy of combinatorial liposomal formulation of genistein and plumbagin by targeting Glut1 and Akt3 proteins in mice bearing prostate tumor,Colloids Surf B Biointerfaces. 2020 Jun;190:110966. doi: 10.1016/j.colsurfb.2020.110966. Epub 2020 Mar 12.,Song YY,https://www.ncbi.nlm.nih.gov/pubmed/32199263
12303,31909204,Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGF? signaling,Commun Biol. 2020 Jan 3;3:12. doi: 10.1038/s42003-019-0720-z. eCollection 2020.,Thapa D,https://www.ncbi.nlm.nih.gov/pubmed/31909204
12305,32046530,Self-efficacy and importance of participation reasons as predictors for prostate cancer screening intention in African American men,Ethn Health. 2022 Feb;27(2):316-328. doi: 10.1080/13557858.2020.1724269. Epub 2020 Feb 11.,Qin W,https://www.ncbi.nlm.nih.gov/pubmed/32046530
12306,32264916,Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients,J Transl Med. 2020 Apr 7;18(1):160. doi: 10.1186/s12967-020-02323-x.,Hu D,https://www.ncbi.nlm.nih.gov/pubmed/32264916
12307,32457180,Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank,Cancer Epidemiol Biomarkers Prev. 2020 Aug;29(8):1615-1626. doi: 10.1158/1055-9965.EPI-19-1525. Epub 2020 May 26.,Watts EL,https://www.ncbi.nlm.nih.gov/pubmed/32457180
12308,31636091,A Bispecific Antibody Targeting the ?v and ?5?1 Integrins Induces Integrin Degradation in Prostate Cancer Cells and Is Superior to Monospecific Antibodies,Mol Cancer Res. 2020 Jan;18(1):27-32. doi: 10.1158/1541-7786.MCR-19-0442. Epub 2019 Oct 21.,Joshi R,https://www.ncbi.nlm.nih.gov/pubmed/31636091
12309,31733043,Barriers to Prostate Cancer Screening by Men in Sub-Saharan Africa: An Integrated Review,J Nurs Scholarsh. 2020 Jan;52(1):85-94. doi: 10.1111/jnu.12529. Epub 2019 Nov 15.,Baratedi WM,https://www.ncbi.nlm.nih.gov/pubmed/31733043
12310,31937346,IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model,J Transl Med. 2020 Jan 14;18(1):23. doi: 10.1186/s12967-019-02206-w.,Wang D,https://www.ncbi.nlm.nih.gov/pubmed/31937346
12311,32054861,A case report of multiple primary prostate tumors with differential drug sensitivity,Nat Commun. 2020 Feb 13;11(1):837. doi: 10.1038/s41467-020-14657-7.,Wilkinson S,https://www.ncbi.nlm.nih.gov/pubmed/32054861
12313,32235729,ER? and NF?B-Modulators of Zearalenone-Induced Oxidative Stress in Human Prostate Cancer Cells,Toxins (Basel). 2020 Mar 22;12(3):199. doi: 10.3390/toxins12030199.,Kowalska K,https://www.ncbi.nlm.nih.gov/pubmed/32235729
12314,31530650,A Novel Salicylanilide Derivative Induces Autophagy Cell Death in Castration-Resistant Prostate Cancer via ER Stress-Activated PERK Signaling Pathway,Mol Cancer Ther. 2020 Jan;19(1):101-111. doi: 10.1158/1535-7163.MCT-19-0387. Epub 2019 Sep 17.,Hsieh CL,https://www.ncbi.nlm.nih.gov/pubmed/31530650
12319,32108505,Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients,Acta Radiol. 2020 Nov;61(11):1570-1579. doi: 10.1177/0284185120905066. Epub 2020 Feb 28.,Losnegård A,https://www.ncbi.nlm.nih.gov/pubmed/32108505
12320,31985311,"Beneficial effects of genistein in suppression of proliferation, inhibition of metastasis, and induction of apoptosis in PC3 prostate cancer cells",Arch Physiol Biochem. 2022 Jun;128(3):694-702. doi: 10.1080/13813455.2020.1717541. Epub 2020 Jan 27.,Shafiee G,https://www.ncbi.nlm.nih.gov/pubmed/31985311
12321,31977460,Nodular Fat-Sparing Hepatic Parenchyma as 11C-Choline-Avid Finding on PET/CT,Clin Nucl Med. 2020 Mar;45(3):228-229. doi: 10.1097/RLU.0000000000002898.,Nguyen BD,https://www.ncbi.nlm.nih.gov/pubmed/31977460
12323,32371590,Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor,Mol Cancer Ther. 2020 Jul;19(7):1436-1447. doi: 10.1158/1535-7163.MCT-19-0936. Epub 2020 May 5.,Adelaiye-Ogala R,https://www.ncbi.nlm.nih.gov/pubmed/32371590
12324,31518861,Evaluation of statistical techniques to normalize mass spectrometry-based urinary metabolomics data,J Pharm Biomed Anal. 2020 Jan 5;177:112854. doi: 10.1016/j.jpba.2019.112854. Epub 2019 Sep 3.,Cook T,https://www.ncbi.nlm.nih.gov/pubmed/31518861
12328,31816706,On-chip RT-LAMP and colorimetric detection of the prostate cancer 3 biomarker with an integrated thermal and imaging box,Talanta. 2020 Feb 1;208:120407. doi: 10.1016/j.talanta.2019.120407. Epub 2019 Sep 28.,Wang LX,https://www.ncbi.nlm.nih.gov/pubmed/31816706
12332,32388678,Therapeutic ISCOMATRIXTM adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer,Cancer Immunol Immunother. 2020 Oct;69(10):1959-1972. doi: 10.1007/s00262-020-02597-6. Epub 2020 May 9.,Barr AM,https://www.ncbi.nlm.nih.gov/pubmed/32388678
12333,32393102,"Preliminary validation of the Sexual Distress Scale-Short Form: Applications to Women, Men, and Prostate Cancer Survivors",J Sex Marital Ther. 2020;46(6):542-563. doi: 10.1080/0092623X.2020.1761494. Epub 2020 May 12.,Santos-Iglesias P,https://www.ncbi.nlm.nih.gov/pubmed/32393102
12334,31865408,The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):642-651. doi: 10.1007/s00259-019-04552-9. Epub 2019 Dec 21.,Alberts I,https://www.ncbi.nlm.nih.gov/pubmed/31865408
12335,31758937,NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer,Clin Chim Acta. 2020 Feb;501:241-251. doi: 10.1016/j.cca.2019.10.046. Epub 2019 Nov 20.,Zheng H,https://www.ncbi.nlm.nih.gov/pubmed/31758937
12336,31792572,Digital versus analogue PET in [(68)Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):614-623. doi: 10.1007/s00259-019-04630-y. Epub 2019 Dec 2.,Alberts I,https://www.ncbi.nlm.nih.gov/pubmed/31792572
12337,31936346,"Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer",Int J Mol Sci. 2020 Jan 8;21(2):401. doi: 10.3390/ijms21020401.,Costea T,https://www.ncbi.nlm.nih.gov/pubmed/31936346
12338,32191450,From In Silico to Experimental Validation: Tailoring Peptide Substrates for a Serine Protease,Biomacromolecules. 2020 Apr 13;21(4):1636-1643. doi: 10.1021/acs.biomac.0c00240. Epub 2020 Apr 2.,Knaff PM,https://www.ncbi.nlm.nih.gov/pubmed/32191450
12339,32310634,Isoenzyme-Selective Inhibitors of Human Neuraminidases Reveal Distinct Effects on Cell Migration,ACS Chem Biol. 2020 Jun 19;15(6):1328-1339. doi: 10.1021/acschembio.9b00975. Epub 2020 May 6.,Howlader MA,https://www.ncbi.nlm.nih.gov/pubmed/32310634
12341,31986451,A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer,Eur J Cancer. 2020 Mar;127:67-75. doi: 10.1016/j.ejca.2019.12.027. Epub 2020 Jan 24.,Boukovala M,https://www.ncbi.nlm.nih.gov/pubmed/31986451
12342,31997472,Induction of tryptophan hydroxylase in the liver of s.c. tumor model of prostate cancer,Cancer Sci. 2020 Apr;111(4):1218-1227. doi: 10.1111/cas.14333. Epub 2020 Feb 27.,Hagiwara A,https://www.ncbi.nlm.nih.gov/pubmed/31997472
12343,32467000,Diagnostic utility and therapeutic impact of PET/CT [(18)F]F-Fluoromethylcholine -Choline in the biochemical recurrence of prostate cancer,Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Sep-Oct;39(5):284-291. doi: 10.1016/j.remn.2020.03.010. Epub 2020 May 25.,Sánchez N,https://www.ncbi.nlm.nih.gov/pubmed/32467000
12344,32260207,Fatty-Acid Uptake in Prostate Cancer Cells Using Dynamic Microfluidic Raman Technology,Molecules. 2020 Apr 3;25(7):1652. doi: 10.3390/molecules25071652.,Tang NT,https://www.ncbi.nlm.nih.gov/pubmed/32260207
12347,32480236,Stable isotope resolved metabolomics classification of prostate cancer cells using hyperpolarized NMR data,J Magn Reson. 2020 Jul;316:106750. doi: 10.1016/j.jmr.2020.106750. Epub 2020 May 20.,Frahm AB,https://www.ncbi.nlm.nih.gov/pubmed/32480236
12350,31628514,Dynamic patterns of [(68)Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):160-167. doi: 10.1007/s00259-019-04545-8. Epub 2019 Oct 18.,Alberts I,https://www.ncbi.nlm.nih.gov/pubmed/31628514
12351,31209779,[(89)Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model,Mol Imaging Biol. 2020 Apr;22(2):367-376. doi: 10.1007/s11307-019-01386-7.,Zettlitz KA,https://www.ncbi.nlm.nih.gov/pubmed/31209779
12353,31948306,Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin,J Int Med Res. 2020 Jan;48(1):300060519892395. doi: 10.1177/0300060519892395.,Yang F,https://www.ncbi.nlm.nih.gov/pubmed/31948306
12354,31857702,Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer,Cell Death Differ. 2020 Jun;27(6):1938-1951. doi: 10.1038/s41418-019-0473-8. Epub 2019 Dec 19.,Guo F,https://www.ncbi.nlm.nih.gov/pubmed/31857702
12355,31776034,"Discovery and optimization of novel N-benzyl-3,6-dimethylbenzo[d]isoxazol-5-amine derivatives as potent and selective TRIM24 bromodomain inhibitors with potential anti-cancer activities",Bioorg Chem. 2020 Jan;94:103424. doi: 10.1016/j.bioorg.2019.103424. Epub 2019 Nov 9.,Hu Q,https://www.ncbi.nlm.nih.gov/pubmed/31776034
12356,32863961,Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer,Theranostics. 2020 Aug 2;10(21):9808-9829. doi: 10.7150/thno.43631. eCollection 2020.,Wu D,https://www.ncbi.nlm.nih.gov/pubmed/32863961
12357,32454055,"Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis",Toxicol Appl Pharmacol. 2020 Aug 15;401:115071. doi: 10.1016/j.taap.2020.115071. Epub 2020 May 23.,Samy ALPA,https://www.ncbi.nlm.nih.gov/pubmed/32454055
12358,31175458,Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer,World J Urol. 2020 Apr;38(4):981-991. doi: 10.1007/s00345-019-02827-2. Epub 2019 Jun 7.,Moraes MO,https://www.ncbi.nlm.nih.gov/pubmed/31175458
12359,33486495,Appropriate Number of Docetaxel Cycles in Castration-Resistant Prostate Cancer Patients Considering Peripheral Neuropathy and Oncological Control,Chemotherapy. 2020;65(5-6):119-124. doi: 10.1159/000510900. Epub 2021 Jan 22.,Nakai Y,https://www.ncbi.nlm.nih.gov/pubmed/33486495
12360,33063634,ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro,Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820948062. doi: 10.1177/1533033820948062.,Tan G,https://www.ncbi.nlm.nih.gov/pubmed/33063634
12361,31831298,Prostatic carcinoma with neuroendocrine differentiation harboring the EWSR1-FEV fusion transcript in a man with the WRN G327X germline mutation: A new variant of prostatic carcinoma or a member of the Ewing sarcoma family of tumors?,Pathol Res Pract. 2020 Feb;216(2):152758. doi: 10.1016/j.prp.2019.152758. Epub 2019 Nov 22.,Febres-Aldana CA,https://www.ncbi.nlm.nih.gov/pubmed/31831298
12362,32884236,Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study,Drug Des Devel Ther. 2020 Aug 13;14:3315-3324. doi: 10.2147/DDDT.S261027. eCollection 2020.,Zare-Zardini H,https://www.ncbi.nlm.nih.gov/pubmed/32884236
12363,31804970,Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program,Endocr Relat Cancer. 2020 Feb;27(2):67-79. doi: 10.1530/ERC-19-0181.,Stelloo S,https://www.ncbi.nlm.nih.gov/pubmed/31804970
12364,31910313,Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the 'Fry-Turnbull' effect,BJU Int. 2020 Apr;125(4):484-486. doi: 10.1111/bju.14992. Epub 2020 Jan 24.,Lovegrove CE,https://www.ncbi.nlm.nih.gov/pubmed/31910313
12365,31765754,Antitumor effects of pollen polysaccharides from Chinese wolfberry on DU145 cells via the PI3K/AKT pathway in vitro and in vivo,Int J Biol Macromol. 2020 Jun 1;152:1164-1173. doi: 10.1016/j.ijbiomac.2019.10.206. Epub 2019 Nov 22.,Ran L,https://www.ncbi.nlm.nih.gov/pubmed/31765754
12366,31840521,Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer,Mol Pharm. 2020 Jan 6;17(1):98-108. doi: 10.1021/acs.molpharmaceut.9b00788. Epub 2019 Dec 16.,Hapuarachchige S,https://www.ncbi.nlm.nih.gov/pubmed/31840521
12367,31707200,Improving diagnosis of genitourinary cancers: Biomarker discovery strategies through mass spectrometry-based metabolomics,J Pharm Biomed Anal. 2020 Jan 30;178:112905. doi: 10.1016/j.jpba.2019.112905. Epub 2019 Oct 7.,Manzi M,https://www.ncbi.nlm.nih.gov/pubmed/31707200
12368,32337233,Effects of the Bone/Bone Marrow Microenvironments on Prostate Cancer Cells and CD59 Expression,Biomed Res Int. 2020 Apr 6;2020:2753414. doi: 10.1155/2020/2753414. eCollection 2020.,Yan B,https://www.ncbi.nlm.nih.gov/pubmed/32337233
12369,32282865,Darolutamide for treatment of castration-resistant prostate cancer,Drugs Today (Barc). 2020 Mar;56(3):185-193. doi: 10.1358/dot.2020.56.3.3110574.,Rhea LP,https://www.ncbi.nlm.nih.gov/pubmed/32282865
12373,31822380,TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Apr;18(2):148-154. doi: 10.1016/j.clgc.2019.10.022. Epub 2019 Nov 6.,Chapman L,https://www.ncbi.nlm.nih.gov/pubmed/31822380
12375,30554274,Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review,World J Urol. 2020 Mar;38(3):613-635. doi: 10.1007/s00345-018-2574-2. Epub 2018 Dec 15.,Pinart M,https://www.ncbi.nlm.nih.gov/pubmed/30554274
12376,31134918,Integrative molecular characterization of Chinese prostate cancer specimens,Asian J Androl. 2020 Mar-Apr;22(2):162-168. doi: 10.4103/aja.aja_36_19.,Lv SD,https://www.ncbi.nlm.nih.gov/pubmed/31134918
12377,32001316,Molecular mechanisms of plant steroids and study of their interaction with nuclear receptors in prostate cancer cells,Food Chem Toxicol. 2020 Mar;137:111164. doi: 10.1016/j.fct.2020.111164. Epub 2020 Jan 27.,Huskova Z,https://www.ncbi.nlm.nih.gov/pubmed/32001316
12378,32065351,Arctigenin induces necroptosis through mitochondrial dysfunction with CCN1 upregulation in prostate cancer cells under lactic acidosis,Mol Cell Biochem. 2020 Apr;467(1-2):45-56. doi: 10.1007/s11010-020-03699-6. Epub 2020 Feb 17.,Lee YJ,https://www.ncbi.nlm.nih.gov/pubmed/32065351
12379,32040869,Mutation HOXB13 c.853delT in Martinican prostate cancer patients,Prostate. 2020 May;80(6):463-470. doi: 10.1002/pros.23960. Epub 2020 Feb 10.,Marlin R,https://www.ncbi.nlm.nih.gov/pubmed/32040869
12380,31107971,The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA,Int J Cancer. 2020 Jan 15;146(2):475-486. doi: 10.1002/ijc.32422. Epub 2019 Jun 4.,Shi X,https://www.ncbi.nlm.nih.gov/pubmed/31107971
12385,32098730,Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System,Eur Urol. 2020 Jun;77(6):683-686. doi: 10.1016/j.eururo.2020.02.004. Epub 2020 Feb 22.,Loeb S,https://www.ncbi.nlm.nih.gov/pubmed/32098730
12386,32236496,Competence against insufficiency: Why are men mostly safe from a rare and deadly prostate cancer?,J Exp Med. 2020 Jun 1;217(6):e20200087. doi: 10.1084/jem.20200087.,Mathew G,https://www.ncbi.nlm.nih.gov/pubmed/32236496
12387,30950925,Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors: a meta-analysis of observational studies,Eur J Cancer Prev. 2020 Jan;29(1):42-52. doi: 10.1097/CEJ.0000000000000514.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/30950925
12389,31959131,IL-1-conferred gene expression pattern in ER?(+) BCa and AR(+) PCa cells is intrinsic to ER?(-) BCa and AR(-) PCa cells and promotes cell survival,BMC Cancer. 2020 Jan 20;20(1):46. doi: 10.1186/s12885-020-6529-9.,Nawas AF,https://www.ncbi.nlm.nih.gov/pubmed/31959131
12390,32413029,SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models,PLoS One. 2020 May 15;15(5):e0230354. doi: 10.1371/journal.pone.0230354. eCollection 2020.,Brasil da Costa FH,https://www.ncbi.nlm.nih.gov/pubmed/32413029
12392,32217563,Translation and cultural adaptation of a prostate cancer screening decision aid: a qualitative study in Portugal,BMJ Open. 2020 Mar 25;10(3):e034384. doi: 10.1136/bmjopen-2019-034384.,Baptista S,https://www.ncbi.nlm.nih.gov/pubmed/32217563
12393,32406953,Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer,J Cell Physiol. 2020 Dec;235(12):9729-9742. doi: 10.1002/jcp.29784. Epub 2020 May 14.,Guan H,https://www.ncbi.nlm.nih.gov/pubmed/32406953
12394,32066880,MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness,Oncogene. 2020 Apr;39(16):3305-3321. doi: 10.1038/s41388-020-1217-4. Epub 2020 Feb 17.,Li J,https://www.ncbi.nlm.nih.gov/pubmed/32066880
12395,32298325,"Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines",PLoS One. 2020 Apr 16;15(4):e0231409. doi: 10.1371/journal.pone.0231409. eCollection 2020.,Ulyte A,https://www.ncbi.nlm.nih.gov/pubmed/32298325
12397,31486077,Mushroom consumption and incident risk of prostate cancer in Japan: A pooled analysis of the Miyagi Cohort Study and the Ohsaki Cohort Study,Int J Cancer. 2020 May 15;146(10):2712-2720. doi: 10.1002/ijc.32591. Epub 2019 Sep 4.,Zhang S,https://www.ncbi.nlm.nih.gov/pubmed/31486077
12398,32054790,Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models,Mol Cancer Ther. 2020 Apr;19(4):1059-1069. doi: 10.1158/1535-7163.MCT-19-0378. Epub 2020 Feb 13.,Weyer-Czernilofsky U,https://www.ncbi.nlm.nih.gov/pubmed/32054790
12399,32061580,Comparative expression of immunohistochemical biomarkers in cribriform and pattern 4 non-cribriform prostatic adenocarcinoma,Exp Mol Pathol. 2020 Jun;114:104400. doi: 10.1016/j.yexmp.2020.104400. Epub 2020 Feb 12.,Xiao GQ,https://www.ncbi.nlm.nih.gov/pubmed/32061580
12402,31981447,TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway,FEBS Open Bio. 2020 Apr;10(4):515-524. doi: 10.1002/2211-5463.12798. Epub 2020 Mar 3.,Cao H,https://www.ncbi.nlm.nih.gov/pubmed/31981447
12403,32020841,Budget Impact of Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer,J Manag Care Spec Pharm. 2020 Apr;26(4):538-549. doi: 10.18553/jmcp.2020.19329. Epub 2020 Feb 5.,Schultz NM,https://www.ncbi.nlm.nih.gov/pubmed/32020841
12405,32418878,"Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies",Eur Urol Focus. 2021 May;7(3):522-531. doi: 10.1016/j.euf.2020.04.007. Epub 2020 May 14.,Knaapila J,https://www.ncbi.nlm.nih.gov/pubmed/32418878
12406,32120841,Isoform-Specific Lysine Methylation of ROR?2 by SETD7 Is Required for Association of the TIP60 Coactivator Complex in Prostate Cancer Progression,Int J Mol Sci. 2020 Feb 27;21(5):1622. doi: 10.3390/ijms21051622.,Song H,https://www.ncbi.nlm.nih.gov/pubmed/32120841
12409,32361089,"Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [(68)Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies",Nucl Med Biol. 2020 Jul-Aug;86-87:1-8. doi: 10.1016/j.nucmedbio.2020.04.002. Epub 2020 Apr 20.,Doot RK,https://www.ncbi.nlm.nih.gov/pubmed/32361089
12410,31608997,SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5,J Cell Physiol. 2020 Apr;235(4):3916-3927. doi: 10.1002/jcp.29285. Epub 2019 Oct 14.,Wang ZY,https://www.ncbi.nlm.nih.gov/pubmed/31608997
12411,32835628,Psychosocial Barriers and Enablers for Prostate Cancer Patients in Starting a Relationship,J Sex Marital Ther. 2020;46(8):736-746. doi: 10.1080/0092623X.2020.1808549. Epub 2020 Aug 24.,Mathew S,https://www.ncbi.nlm.nih.gov/pubmed/32835628
12413,31552574,Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancer,Int Urol Nephrol. 2020 Jan;52(1):77-85. doi: 10.1007/s11255-019-02281-4. Epub 2019 Sep 24.,Fukuoka K,https://www.ncbi.nlm.nih.gov/pubmed/31552574
12414,32132977,"Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study",Front Endocrinol (Lausanne). 2020 Feb 18;11:60. doi: 10.3389/fendo.2020.00060. eCollection 2020.,Tao H,https://www.ncbi.nlm.nih.gov/pubmed/32132977
12416,32449815,RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer,Prostate. 2020 Aug;80(11):799-810. doi: 10.1002/pros.23994. Epub 2020 May 25.,Linder A,https://www.ncbi.nlm.nih.gov/pubmed/32449815
12417,32066485,YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression,J Exp Clin Cancer Res. 2020 Feb 17;39(1):36. doi: 10.1186/s13046-020-1542-z.,Shen T,https://www.ncbi.nlm.nih.gov/pubmed/32066485
12419,32546299,A critical update on the strategies towards modulators targeting androgen receptors,Bioorg Med Chem. 2020 Jul 1;28(13):115554. doi: 10.1016/j.bmc.2020.115554. Epub 2020 May 12.,Luan H,https://www.ncbi.nlm.nih.gov/pubmed/32546299
12420,31919137,Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer,Clin Cancer Res. 2020 Apr 1;26(7):1678-1689. doi: 10.1158/1078-0432.CCR-19-0098. Epub 2020 Jan 9.,Nouri M,https://www.ncbi.nlm.nih.gov/pubmed/31919137
12421,31317826,"Construction, visualization and application of neutral zone classifiers",Stat Methods Med Res. 2020 May;29(5):1420-1433. doi: 10.1177/0962280219863823. Epub 2019 Jul 18.,Jeske DR,https://www.ncbi.nlm.nih.gov/pubmed/31317826
12422,32389660,Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate,Hum Pathol. 2020 Jul;101:70-79. doi: 10.1016/j.humpath.2020.04.014. Epub 2020 May 7.,Heaphy CM,https://www.ncbi.nlm.nih.gov/pubmed/32389660
12423,31876385,MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression,J Cell Mol Med. 2020 Feb;24(3):2098-2108. doi: 10.1111/jcmm.14050. Epub 2019 Dec 26.,Wu C,https://www.ncbi.nlm.nih.gov/pubmed/31876385
12424,32342655,Structurally unique PARP-1 inhibitors for the treatment of prostate cancer,Pharmacol Res Perspect. 2020 Apr;8(2):e00586. doi: 10.1002/prp2.586.,Divan A,https://www.ncbi.nlm.nih.gov/pubmed/32342655
12425,32103057,Spatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities,Sci Rep. 2020 Feb 26;10(1):3490. doi: 10.1038/s41598-020-60384-w.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32103057
12426,32403427,"Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer",Mar Drugs. 2020 May 11;18(5):251. doi: 10.3390/md18050251.,Dyshlovoy SA,https://www.ncbi.nlm.nih.gov/pubmed/32403427
12427,32634071,"Incidence, prevalence, and outcomes of systemic malignancy with bone metastases",J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(2):2309499020915989. doi: 10.1177/2309499020915989.,Jiang W,https://www.ncbi.nlm.nih.gov/pubmed/32634071
12428,32164378,Radiomics Driven Diffusion Weighted Imaging Sensing Strategies for Zone-Level Prostate Cancer Sensing,Sensors (Basel). 2020 Mar 10;20(5):1539. doi: 10.3390/s20051539.,Dulhanty C,https://www.ncbi.nlm.nih.gov/pubmed/32164378
12430,31917173,Eradication of BRAF K601E Mutation in Metastatic Castrate-resistant Prostate Cancer Treated With Cabazitaxel and Carboplatin: A Case Report,Clin Genitourin Cancer. 2020 Jun;18(3):e312-e314. doi: 10.1016/j.clgc.2019.12.015. Epub 2019 Dec 19.,Steinwald P,https://www.ncbi.nlm.nih.gov/pubmed/31917173
12431,31616062,Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis,Oncogene. 2020 Feb;39(6):1246-1259. doi: 10.1038/s41388-019-1061-6. Epub 2019 Oct 15.,Ali S,https://www.ncbi.nlm.nih.gov/pubmed/31616062
12432,31709706,Exploring the impact of a naturally occurring sapogenin diosgenin on underlying mechanisms of Ca(2+) movement and cytotoxicity in human prostate cancer cells,Environ Toxicol. 2020 Mar;35(3):395-403. doi: 10.1002/tox.22876. Epub 2019 Nov 10.,Sun GC,https://www.ncbi.nlm.nih.gov/pubmed/31709706
12433,32319597,Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo,Int J Oncol. 2020 Jul;57(1):139-150. doi: 10.3892/ijo.2020.5043. Epub 2020 Apr 13.,Yu F,https://www.ncbi.nlm.nih.gov/pubmed/32319597
12435,32052752,Comparison of double inversion recovery magnetic resonance imaging (DIR-MRI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in detection of prostate cancer: A pilot study,Radiography (Lond). 2020 Aug;26(3):234-239. doi: 10.1016/j.radi.2019.12.012. Epub 2020 Jan 6.,Onwuharine EN,https://www.ncbi.nlm.nih.gov/pubmed/32052752
12436,31057123,New Insights into the Binding Mechanism of Co-regulator BUD31 to AR AF2 Site: Structural Determination and Analysis of the Mutation Effect,Curr Comput Aided Drug Des. 2020;16(1):45-53. doi: 10.2174/1573409915666190502153307.,Song T,https://www.ncbi.nlm.nih.gov/pubmed/31057123
12437,32193430,Comparison of (68)Ga-PSMA-11 PET/CT with (11)C-acetate PET/CT in re-staging of prostate cancer relapse,Sci Rep. 2020 Mar 19;10(1):4993. doi: 10.1038/s41598-020-61910-6.,Regula N,https://www.ncbi.nlm.nih.gov/pubmed/32193430
12438,32321981,SEER and Gene Expression Data Analysis Deciphers Racial Disparity Patterns in Prostate Cancer Mortality and the Public Health Implication,Sci Rep. 2020 Apr 22;10(1):6820. doi: 10.1038/s41598-020-63764-4.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/32321981
12439,32143995,Effects of six months of aerobic and resistance training on metabolic markers and bone mineral density in older men on androgen deprivation therapy for prostate cancer,J Geriatr Oncol. 2020 Sep;11(7):1074-1077. doi: 10.1016/j.jgo.2020.02.013. Epub 2020 Mar 3.,Papadopoulos E,https://www.ncbi.nlm.nih.gov/pubmed/32143995
12440,32020225,Variant analysis of prostate cancer in Japanese patients and a new attempt to predict related biological pathways,Oncol Rep. 2020 Mar;43(3):943-952. doi: 10.3892/or.2020.7481. Epub 2020 Jan 27.,Kasajima R,https://www.ncbi.nlm.nih.gov/pubmed/32020225
12441,32371391,The role of the histone H3 variant CENPA in prostate cancer,J Biol Chem. 2020 Jun 19;295(25):8537-8549. doi: 10.1074/jbc.RA119.010080. Epub 2020 May 5.,Saha AK,https://www.ncbi.nlm.nih.gov/pubmed/32371391
12442,32017154,Hypocalcaemia following denosumab in prostate cancer: A clinical review,Clin Endocrinol (Oxf). 2020 Jun;92(6):495-502. doi: 10.1111/cen.14169. Epub 2020 Feb 16.,Lau LH,https://www.ncbi.nlm.nih.gov/pubmed/32017154
12444,32250715,"Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer",J Clin Oncol. 2020 Jun 20;38(18):2018-2027. doi: 10.1200/JCO.19.02185. Epub 2020 Apr 6.,Troeschel AN,https://www.ncbi.nlm.nih.gov/pubmed/32250715
12447,31748715,Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression,Oncogene. 2020 Feb;39(9):1891-1903. doi: 10.1038/s41388-019-1070-5. Epub 2019 Nov 20.,Hu L,https://www.ncbi.nlm.nih.gov/pubmed/31748715
12448,32303533,"Racial/Ethnic Disparities in Prostate Cancer Incidence, Distant Stage Diagnosis, and Mortality by U.S. Census Region and Age Group, 2012-2015",Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1357-1364. doi: 10.1158/1055-9965.EPI-19-1344. Epub 2020 Apr 17.,Iyengar S,https://www.ncbi.nlm.nih.gov/pubmed/32303533
12449,32166512,Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2562-2576. doi: 10.1007/s00259-020-04721-1. Epub 2020 Mar 12.,Konopka CJ,https://www.ncbi.nlm.nih.gov/pubmed/32166512
12451,31977154,"Demethylation of miR-195 suppresses prostate cancer cell proliferation, migration and invasion",FEBS Open Bio. 2020 Apr;10(4):525-534. doi: 10.1002/2211-5463.12799. Epub 2020 Mar 9.,Ma X,https://www.ncbi.nlm.nih.gov/pubmed/31977154
12452,32527560,Production of (64)Cu-labeled monobody for imaging of human EphA2-expressing tumors,Bioorg Med Chem Lett. 2020 Jul 15;30(14):127262. doi: 10.1016/j.bmcl.2020.127262. Epub 2020 May 15.,Pyo A,https://www.ncbi.nlm.nih.gov/pubmed/32527560
12453,31524674,Pituitary Adenoma on 18F-Fluciclovine PET/CT,Clin Nucl Med. 2020 Jan;45(1):e65-e66. doi: 10.1097/RLU.0000000000002777.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/31524674
12454,31425022,Boundary-Weighted Domain Adaptive Neural Network for Prostate MR Image Segmentation,IEEE Trans Med Imaging. 2020 Mar;39(3):753-763. doi: 10.1109/TMI.2019.2935018. Epub 2019 Aug 13.,Zhu Q,https://www.ncbi.nlm.nih.gov/pubmed/31425022
12456,31643114,Multi-atlas segmentation of the skeleton from whole-body MRI-Impact of iterative background masking,Magn Reson Med. 2020 May;83(5):1851-1862. doi: 10.1002/mrm.28042. Epub 2019 Oct 23.,Ceranka J,https://www.ncbi.nlm.nih.gov/pubmed/31643114
12457,32614643,An Overview of Current Alternative Models for Use in the Context of Prostate Cancer Research,Altern Lab Anim. 2020 Mar;48(2):58-69. doi: 10.1177/0261192920929701. Epub 2020 Jul 2.,Nascimento-Gonçalves E,https://www.ncbi.nlm.nih.gov/pubmed/32614643
12458,32415173,ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis,Cell Death Dis. 2020 May 15;11(5):376. doi: 10.1038/s41419-020-2587-9.,Tseng JC,https://www.ncbi.nlm.nih.gov/pubmed/32415173
12459,30674244,Differential Characteristics of HMGB2 Versus HMGB1 and their Perspectives in Ovary and Prostate Cancer,Curr Med Chem. 2020;27(20):3271-3289. doi: 10.2174/0929867326666190123120338.,Cámara-Quílez M,https://www.ncbi.nlm.nih.gov/pubmed/30674244
12460,31876815,68Ga-PMSA Uptake in the Lung: Metastatic Versus Primary Lung Tumor,Clin Nucl Med. 2020 Feb;45(2):e80-e82. doi: 10.1097/RLU.0000000000002870.,Usmani S,https://www.ncbi.nlm.nih.gov/pubmed/31876815
12462,31548294,Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors,Mol Cancer Ther. 2020 Jan;19(1):231-246. doi: 10.1158/1535-7163.MCT-19-0508. Epub 2019 Sep 23.,Udhane V,https://www.ncbi.nlm.nih.gov/pubmed/31548294
12465,32418347,Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study,Int J Urol. 2020 Jul;27(7):610-617. doi: 10.1111/iju.14258. Epub 2020 May 16.,Hatakeyama S,https://www.ncbi.nlm.nih.gov/pubmed/32418347
12467,33137125,LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production,PLoS One. 2020 Nov 2;15(11):e0240801. doi: 10.1371/journal.pone.0240801. eCollection 2020.,Han C,https://www.ncbi.nlm.nih.gov/pubmed/33137125
12468,31554654,A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer,Mol Cancer Ther. 2020 Jan;19(1):75-88. doi: 10.1158/1535-7163.MCT-19-0489. Epub 2019 Sep 25.,Yang Z,https://www.ncbi.nlm.nih.gov/pubmed/31554654
12469,31796516,Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression,Clin Cancer Res. 2020 Apr 15;26(8):2047-2064. doi: 10.1158/1078-0432.CCR-19-1570. Epub 2019 Dec 3.,Chakraborty G,https://www.ncbi.nlm.nih.gov/pubmed/31796516
12470,32862568,Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on muscle and bone health,J BUON. 2020 May-Jun;25(3):1286-1294.,Bargiota A,https://www.ncbi.nlm.nih.gov/pubmed/32862568
12471,32331836,Markers of malignant prostate cancer cells: Golgi localization of ?-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface,Biochem Biophys Res Commun. 2020 Jun 25;527(2):406-410. doi: 10.1016/j.bbrc.2020.03.168. Epub 2020 Apr 22.,Cheng PW,https://www.ncbi.nlm.nih.gov/pubmed/32331836
12473,32133801,Identification of PTPRR and JAG1 as key genes in castration-resistant prostate cancer by integrated bioinformatics methods(),J Zhejiang Univ Sci B. 2020 Mar.;21(3):246-255. doi: 10.1631/jzus.B1900329.,Wang JL,https://www.ncbi.nlm.nih.gov/pubmed/32133801
12474,31900260,Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-?B Activation,Cancer Res. 2020 Mar 1;80(5):950-963. doi: 10.1158/0008-5472.CAN-19-3460. Epub 2020 Jan 3.,Saha S,https://www.ncbi.nlm.nih.gov/pubmed/31900260
12475,32002708,Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain,Cell Biol Toxicol. 2020 Oct;36(5):399-416. doi: 10.1007/s10565-020-09511-x. Epub 2020 Jan 30.,Peng S,https://www.ncbi.nlm.nih.gov/pubmed/32002708
12477,31868960,A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant AR(F876L) nuclear import and function,Prostate. 2020 Mar;80(4):319-328. doi: 10.1002/pros.23945. Epub 2019 Dec 23.,Wu Z,https://www.ncbi.nlm.nih.gov/pubmed/31868960
12478,31770767,Optimal Starting Age and Baseline Level for Repeat Tests: Economic Concerns of PSA Screening for Chinese Men - 10-Year Experience of a Single Center,Urol Int. 2020;104(3-4):230-238. doi: 10.1159/000503733. Epub 2019 Nov 26.,Liu Y,https://www.ncbi.nlm.nih.gov/pubmed/31770767
12481,32166986,miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer,J Invest Surg. 2021 Sep;34(9):984-992. doi: 10.1080/08941939.2020.1738602. Epub 2020 Mar 13.,Ge J,https://www.ncbi.nlm.nih.gov/pubmed/32166986
12482,32319557,"Prostate field cancerization and exosomes: Association between CD9, early growth response 1 and fatty acid synthase",Int J Oncol. 2020 Apr;56(4):957-968. doi: 10.3892/ijo.2020.4980. Epub 2020 Feb 10.,Amirrad F,https://www.ncbi.nlm.nih.gov/pubmed/32319557
12483,31436734,"Reporting of Resistance Training Dose, Adherence, and Tolerance in Exercise Oncology",Med Sci Sports Exerc. 2020 Feb;52(2):315-322. doi: 10.1249/MSS.0000000000002127.,Fairman CM,https://www.ncbi.nlm.nih.gov/pubmed/31436734
12485,31823168,"Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study",Cancer Causes Control. 2020 Feb;31(2):139-151. doi: 10.1007/s10552-019-01252-5. Epub 2019 Dec 10.,Skriver C,https://www.ncbi.nlm.nih.gov/pubmed/31823168
12488,31652161,Asymptomatic Metastasis to Thyroid Cartilage Detected by 18F-Choline and 64Cu-PSMA PET/CT as a Single Site of Disease Relapse in a Patient With Castration-Resistant Prostate Carcinoma,Clin Nucl Med. 2020 Mar;45(3):214-216. doi: 10.1097/RLU.0000000000002786.,Annovazzi A,https://www.ncbi.nlm.nih.gov/pubmed/31652161
12489,31467432,Notch3 promotes prostate cancer-induced bone lesion development via MMP-3,Oncogene. 2020 Jan;39(1):204-218. doi: 10.1038/s41388-019-0977-1. Epub 2019 Aug 29.,Ganguly SS,https://www.ncbi.nlm.nih.gov/pubmed/31467432
12490,31882179,Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer,Pathol Res Pract. 2020 Feb;216(2):152784. doi: 10.1016/j.prp.2019.152784. Epub 2019 Dec 19.,Yan Z,https://www.ncbi.nlm.nih.gov/pubmed/31882179
12491,33091732,"Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation(?,??)",Cancer Treat Res Commun. 2020;25:100212. doi: 10.1016/j.ctarc.2020.100212. Epub 2020 Sep 28.,Loeb S,https://www.ncbi.nlm.nih.gov/pubmed/33091732
12492,32941451,Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study,PLoS One. 2020 Sep 17;15(9):e0238928. doi: 10.1371/journal.pone.0238928. eCollection 2020.,Aladwani M,https://www.ncbi.nlm.nih.gov/pubmed/32941451
12493,31948751,The regulation of HAS3 by miR-10b and miR-29a in neuroendocrine transdifferentiated LNCaP prostate cancer cells,Biochem Biophys Res Commun. 2020 Mar 12;523(3):713-718. doi: 10.1016/j.bbrc.2020.01.026. Epub 2020 Jan 14.,Czyrnik ED,https://www.ncbi.nlm.nih.gov/pubmed/31948751
12494,31677899,Drug-Drug Interactions in Prostate Cancer Treatment,Clin Genitourin Cancer. 2020 Apr;18(2):e71-e82. doi: 10.1016/j.clgc.2019.05.016. Epub 2019 May 27.,Hebenstreit D,https://www.ncbi.nlm.nih.gov/pubmed/31677899
12496,31634807,Fast and accurate segmentation method of active shape model with Rayleigh mixture model clustering for prostate ultrasound images,Comput Methods Programs Biomed. 2020 Feb;184:105097. doi: 10.1016/j.cmpb.2019.105097. Epub 2019 Sep 26.,Bi H,https://www.ncbi.nlm.nih.gov/pubmed/31634807
12497,32134535,Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1,Prostate. 2020 May;80(6):453-462. doi: 10.1002/pros.23946. Epub 2020 Mar 5.,Seo HK,https://www.ncbi.nlm.nih.gov/pubmed/32134535
12498,32797099,Bone metastasis classification using whole body images from prostate cancer patients based on convolutional neural networks application,PLoS One. 2020 Aug 14;15(8):e0237213. doi: 10.1371/journal.pone.0237213. eCollection 2020.,Papandrianos N,https://www.ncbi.nlm.nih.gov/pubmed/32797099
12499,31246686,Low 68Ga-PSMA PET/CT Uptake in Chronic Intramuscular Nodular Fasciitis,Clin Nucl Med. 2020 Jan;45(1):e41-e42. doi: 10.1097/RLU.0000000000002675.,Plouznikoff N,https://www.ncbi.nlm.nih.gov/pubmed/31246686
12500,32017144,Automatic configuration of the reference point method for fully automated multi-objective treatment planning applied to oropharyngeal cancer,Med Phys. 2020 Apr;47(4):1499-1508. doi: 10.1002/mp.14073. Epub 2020 Mar 5.,van Haveren R,https://www.ncbi.nlm.nih.gov/pubmed/32017144
12501,32323921,STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer,Mol Syst Biol. 2020 Apr;16(4):e9247. doi: 10.15252/msb.20199247.,Oberhuber M,https://www.ncbi.nlm.nih.gov/pubmed/32323921
12502,31625599,On Mendelian randomization analysis of case-control study,Biometrics. 2020 Jun;76(2):380-391. doi: 10.1111/biom.13166. Epub 2019 Nov 11.,Zhang H,https://www.ncbi.nlm.nih.gov/pubmed/31625599
12505,32396050,The Impact of Race and Age on Distribution of Metastases in Patients with Prostate Cancer,J Urol. 2020 Nov;204(5):962-968. doi: 10.1097/JU.0000000000001131. Epub 2020 May 12.,Stolzenbach LF,https://www.ncbi.nlm.nih.gov/pubmed/32396050
12506,32315455,Germline and somatic DNA repair gene alterations in prostate cancer,Cancer. 2020 Jul 1;126(13):2980-2985. doi: 10.1002/cncr.32908. Epub 2020 Apr 21.,Dall'Era MA,https://www.ncbi.nlm.nih.gov/pubmed/32315455
12507,31967940,SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex,Mol Biol Cell. 2020 Mar 15;31(6):478-490. doi: 10.1091/mbc.E19-08-0456. Epub 2020 Jan 22.,Watanabe R,https://www.ncbi.nlm.nih.gov/pubmed/31967940
12508,32229180,Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration,J Mol Diagn. 2020 May;22(5):652-669. doi: 10.1016/j.jmoldx.2020.02.012. Epub 2020 Mar 27.,Rao SR,https://www.ncbi.nlm.nih.gov/pubmed/32229180
12509,31685981,Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):199-206. doi: 10.1038/s41391-019-0182-x. Epub 2019 Nov 4.,De Nunzio C,https://www.ncbi.nlm.nih.gov/pubmed/31685981
12511,32451180,Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer,Eur Urol. 2020 Dec;78(6):834-844. doi: 10.1016/j.eururo.2020.04.058. Epub 2020 May 22.,Herberts C,https://www.ncbi.nlm.nih.gov/pubmed/32451180
12513,32196578,LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9,Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2271-2280. doi: 10.26355/eurrev_202003_20493.,Tan SF,https://www.ncbi.nlm.nih.gov/pubmed/32196578
12514,31834633,The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells,Prostate. 2020 Feb;80(3):267-273. doi: 10.1002/pros.23940. Epub 2019 Dec 13.,Gruber M,https://www.ncbi.nlm.nih.gov/pubmed/31834633
12515,31478089,Physiological (68)Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements,Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):115-122. doi: 10.1007/s00259-019-04503-4. Epub 2019 Sep 2.,Baratto L,https://www.ncbi.nlm.nih.gov/pubmed/31478089
12516,33376323,Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer,Int J Nanomedicine. 2020 Dec 17;15:10305-10320. doi: 10.2147/IJN.S282107. eCollection 2020.,Tai Z,https://www.ncbi.nlm.nih.gov/pubmed/33376323
12517,32208047,Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes,J Clin Oncol. 2020 Jun 1;38(16):1807-1813. doi: 10.1200/JCO.19.02808. Epub 2020 Mar 24.,Beebe-Dimmer JL,https://www.ncbi.nlm.nih.gov/pubmed/32208047
12518,32487588,Moving beyond PARP Inhibition in ATM-Deficient Prostate Cancer,Cancer Res. 2020 Jun 1;80(11):2085-2086. doi: 10.1158/0008-5472.CAN-20-0966.,Setton JS,https://www.ncbi.nlm.nih.gov/pubmed/32487588
12519,32915889,#ERROR!,PLoS One. 2020 Sep 11;15(9):e0238999. doi: 10.1371/journal.pone.0238999. eCollection 2020.,Nicholas TR,https://www.ncbi.nlm.nih.gov/pubmed/32915889
12520,31713018,Helping Men Find Their Way: Improving Prostate Cancer Clinic Attendance via Patient Navigation,J Community Health. 2020 Jun;45(3):561-568. doi: 10.1007/s10900-019-00776-w.,Dobbs RW,https://www.ncbi.nlm.nih.gov/pubmed/31713018
12524,32101720,Immune Checkpoint Inhibition in Prostate Cancer,Trends Cancer. 2020 Mar;6(3):174-177. doi: 10.1016/j.trecan.2020.01.003. Epub 2020 Feb 6.,Nicholson LT,https://www.ncbi.nlm.nih.gov/pubmed/32101720
12528,31811435,High homogeneity of mismatch repair deficiency in advanced prostate cancer,Virchows Arch. 2020 May;476(5):745-752. doi: 10.1007/s00428-019-02701-x. Epub 2019 Dec 6.,Fraune C,https://www.ncbi.nlm.nih.gov/pubmed/31811435
12530,31972048,Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer,Prostate. 2020 Apr;80(5):407-411. doi: 10.1002/pros.23955. Epub 2020 Jan 23.,Markowski MC,https://www.ncbi.nlm.nih.gov/pubmed/31972048
12531,31865399,"Modulation of CXC-motif chemokine receptor 7, but not 4, expression is related to migration of the human prostate cancer cell LNCaP: regulation by androgen and inflammatory stimuli",Inflamm Res. 2020 Feb;69(2):167-178. doi: 10.1007/s00011-019-01305-0. Epub 2019 Dec 21.,Yu L,https://www.ncbi.nlm.nih.gov/pubmed/31865399
12532,32324838,"Incidence of prostate cancer in Eritrea: Data from the National Health Laboratory, Orotta Referral Hospital and Sembel Hospital 2011-2018",PLoS One. 2020 Apr 23;15(4):e0232091. doi: 10.1371/journal.pone.0232091. eCollection 2020.,Medhin LB,https://www.ncbi.nlm.nih.gov/pubmed/32324838
12534,31728588,"(18)F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer",Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):592-602. doi: 10.1007/s00259-019-04569-0. Epub 2019 Nov 14.,Sachpekidis C,https://www.ncbi.nlm.nih.gov/pubmed/31728588
12538,31903102,"(18)F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging",Theranostics. 2020 Jan 1;10(1):1-16. doi: 10.7150/thno.37894. eCollection 2020.,Werner RA,https://www.ncbi.nlm.nih.gov/pubmed/31903102
12539,31642565,Adjustment strategies amongst black African and black Caribbean men following treatment for prostate cancer: Findings from the Life After Prostate Cancer Diagnosis (LAPCD) study,Eur J Cancer Care (Engl). 2020 Jan;29(1):e13183. doi: 10.1111/ecc.13183. Epub 2019 Oct 23.,Wagland R,https://www.ncbi.nlm.nih.gov/pubmed/31642565
12540,31685947,DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals,Oncogene. 2020 Feb;39(7):1557-1571. doi: 10.1038/s41388-019-1085-y. Epub 2019 Nov 4.,Chen X,https://www.ncbi.nlm.nih.gov/pubmed/31685947
12541,32088212,Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades,Life Sci. 2020 May 1;248:117449. doi: 10.1016/j.lfs.2020.117449. Epub 2020 Feb 21.,Huang Y,https://www.ncbi.nlm.nih.gov/pubmed/32088212
12542,32941547,"Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience",PLoS One. 2020 Sep 17;15(9):e0239469. doi: 10.1371/journal.pone.0239469. eCollection 2020.,Groarke A,https://www.ncbi.nlm.nih.gov/pubmed/32941547
12544,32123273,Androgen Receptor and Poly(ADP-ribose) Glycohydrolase Inhibition Increases Efficiency of Androgen Ablation in Prostate Cancer Cells,Sci Rep. 2020 Mar 2;10(1):3836. doi: 10.1038/s41598-020-60849-y.,Zhang M,https://www.ncbi.nlm.nih.gov/pubmed/32123273
12545,31813050,Deep neural network for automatic characterization of lesions on (68)Ga-PSMA-11 PET/CT,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):603-613. doi: 10.1007/s00259-019-04606-y. Epub 2019 Dec 7.,Zhao Y,https://www.ncbi.nlm.nih.gov/pubmed/31813050
12546,32045072,Direct Comparison of PI-RADS Version 2 and 2.1 in Transition Zone Lesions for Detection of Prostate Cancer: Preliminary Experience,J Magn Reson Imaging. 2020 Aug;52(2):577-586. doi: 10.1002/jmri.27080. Epub 2020 Feb 11.,Byun J,https://www.ncbi.nlm.nih.gov/pubmed/32045072
12547,32412310,The management of patients with metastatic prostate cancer during the COVID-19 pandemic,Future Oncol. 2020 Jul;16(20):1455-1461. doi: 10.2217/fon-2020-0361. Epub 2020 May 15.,Assi T,https://www.ncbi.nlm.nih.gov/pubmed/32412310
12548,32229215,CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancer,Nanomedicine. 2020 Jul;27:102192. doi: 10.1016/j.nano.2020.102192. Epub 2020 Mar 27.,Tan H,https://www.ncbi.nlm.nih.gov/pubmed/32229215
12550,31190217,The Role of O(6)-methylguanine-DNA Methyltransferase Polymorphisms in Prostate Cancer Susceptibility: a Meta-Analysis,Pathol Oncol Res. 2020 Apr;26(2):1201-1209. doi: 10.1007/s12253-019-00672-7. Epub 2019 Jun 13.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/31190217
12551,32649855,A Sensitive Aptamer-Based Biosensor for Electrochemical Quantification of PSA as a Specific Diagnostic Marker of Prostate Cancer,J Pharm Pharm Sci. 2020;23:243-258. doi: 10.18433/jpps31171.,Hassani S,https://www.ncbi.nlm.nih.gov/pubmed/32649855
12552,33263645,A duplex probe-directed recombinase amplification assay for detection of single nucleotide polymorphisms on 8q24 associated with prostate cancer,Braz J Med Biol Res. 2020 Nov 27;54(2):e9549. doi: 10.1590/1414-431X20209549. eCollection 2020.,Duan Q,https://www.ncbi.nlm.nih.gov/pubmed/33263645
12554,32132383,Digoxin lowers the incidence of prostate cancer: A nationwide population-based study,J Chin Med Assoc. 2020 Apr;83(4):377-381. doi: 10.1097/JCMA.0000000000000288.,Lin TP,https://www.ncbi.nlm.nih.gov/pubmed/32132383
12555,32098919,"Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells",J Biosci. 2020;45:40.,Xu H,https://www.ncbi.nlm.nih.gov/pubmed/32098919
12557,32243332,Prostate cancer awareness and screening practice among Kenyan men,Eur J Cancer Prev. 2020 May;29(3):252-258. doi: 10.1097/CEJ.0000000000000501.,Erena AN,https://www.ncbi.nlm.nih.gov/pubmed/32243332
12558,31941830,A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer,Clin Cancer Res. 2020 Mar 1;26(5):990-999. doi: 10.1158/1078-0432.CCR-19-2389. Epub 2020 Jan 15.,Corn PG,https://www.ncbi.nlm.nih.gov/pubmed/31941830
12559,32172727,Emerging role of transient receptor potential (TRP) channels in cancer progression,BMB Rep. 2020 Mar;53(3):125-132. doi: 10.5483/BMBRep.2020.53.3.016.,Yang D,https://www.ncbi.nlm.nih.gov/pubmed/32172727
12560,32372001,Characterization of a novel automated microfiltration device for the efficient isolation and analysis of circulating tumor cells from clinical blood samples,Sci Rep. 2020 May 5;10(1):7543. doi: 10.1038/s41598-020-63672-7.,Yee-de León JF,https://www.ncbi.nlm.nih.gov/pubmed/32372001
12561,32242968,Using Card Games to study cultural differences in men's social talk about prostate cancer,J Adv Nurs. 2020 Jul;76(7):1840-1849. doi: 10.1111/jan.14373. Epub 2020 Apr 25.,Fry SL,https://www.ncbi.nlm.nih.gov/pubmed/32242968
12562,32299729,Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Aug;18(4):332-339.e2. doi: 10.1016/j.clgc.2019.10.019. Epub 2020 Mar 7.,Smith DC,https://www.ncbi.nlm.nih.gov/pubmed/32299729
12563,32215176,Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1?,Oxid Med Cell Longev. 2020 Mar 6;2020:6724810. doi: 10.1155/2020/6724810. eCollection 2020.,Yang F,https://www.ncbi.nlm.nih.gov/pubmed/32215176
12564,30450971,Two new dammarane triterpenes isolated from Cleome khorassanica Bunge & Bien with cytotoxicity against DU-145 and LNCaP prostate cancer cell lines,J Asian Nat Prod Res. 2020 Jan;22(1):38-46. doi: 10.1080/10286020.2018.1538211. Epub 2018 Nov 17.,Sajjadi SE,https://www.ncbi.nlm.nih.gov/pubmed/30450971
12565,31900277,"""Matching"" the ""Mismatch"" Repair-Deficient Prostate Cancer with Immunotherapy",Clin Cancer Res. 2020 Mar 1;26(5):981-983. doi: 10.1158/1078-0432.CCR-19-3780. Epub 2020 Jan 3.,Schweizer MT,https://www.ncbi.nlm.nih.gov/pubmed/31900277
12567,31918176,From tea to treatment; epigallocatechin gallate and its potential involvement in minimizing the metabolic changes in cancer,Nutr Res. 2020 Feb;74:23-36. doi: 10.1016/j.nutres.2019.12.004. Epub 2019 Dec 10.,Tauber AL,https://www.ncbi.nlm.nih.gov/pubmed/31918176
12568,32273609,Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers,Nat Med. 2020 Apr;26(4):549-557. doi: 10.1038/s41591-020-0800-0. Epub 2020 Apr 7.,Mars N,https://www.ncbi.nlm.nih.gov/pubmed/32273609
12572,32224531,Study of the application of gold nanoparticles for early detection of prostate cancer,Hum Antibodies. 2020;28(3):211-219. doi: 10.3233/HAB-200409.,Ahmadianpour MV,https://www.ncbi.nlm.nih.gov/pubmed/32224531
12573,32475858,Preliminary Evaluation of Astatine-211-Labeled Bombesin Derivatives for Targeted Alpha Therapy,Chem Pharm Bull (Tokyo). 2020;68(6):538-545. doi: 10.1248/cpb.c20-00077.,Aoki M,https://www.ncbi.nlm.nih.gov/pubmed/32475858
12575,32456259,Pharmacological Modulation of Steroid Activity in Hormone-Dependent Breast and Prostate Cancers: Effect of Some Plant Extract Derivatives,Int J Mol Sci. 2020 May 23;21(10):3690. doi: 10.3390/ijms21103690.,Bayala B,https://www.ncbi.nlm.nih.gov/pubmed/32456259
12576,31673789,(68)Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol,Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):624-631. doi: 10.1007/s00259-019-04548-5. Epub 2019 Nov 1.,Haupt F,https://www.ncbi.nlm.nih.gov/pubmed/31673789
12578,31953835,Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer,Urol J. 2020 May 16;17(3):271-275. doi: 10.22037/uj.v0i0.5051.,Khooshemehri P,https://www.ncbi.nlm.nih.gov/pubmed/31953835
12580,32101774,Isolation and characterization of flavonoid derivatives with anti-prostate cancer and hepatoprotective activities from the flowers of Hosta plantaginea (Lam.) Aschers,J Ethnopharmacol. 2020 May 10;253:112685. doi: 10.1016/j.jep.2020.112685. Epub 2020 Feb 23.,Wei R,https://www.ncbi.nlm.nih.gov/pubmed/32101774
12581,32449873,MicroRNA-143 inhibits proliferation and migration of prostate cancer cells,Arch Physiol Biochem. 2022 Oct;128(5):1323-1329. doi: 10.1080/13813455.2020.1769678. Epub 2020 May 25.,Bajhan E,https://www.ncbi.nlm.nih.gov/pubmed/32449873
12583,31895222,Performance of an Automated Workflow for Magnetic Resonance Imaging of the Prostate: Comparison With a Manual Workflow,Invest Radiol. 2020 May;55(5):277-284. doi: 10.1097/RLI.0000000000000635.,Esser M,https://www.ncbi.nlm.nih.gov/pubmed/31895222
12584,32383887,Combined Application of Albumin-Binding [(177)Lu]Lu-PSMA-ALB-56 and Fast-Cleared PSMA Inhibitors: Optimization of the Pharmacokinetics,Mol Pharm. 2020 Jun 1;17(6):2044-2053. doi: 10.1021/acs.molpharmaceut.0c00199. Epub 2020 May 8.,Borgna F,https://www.ncbi.nlm.nih.gov/pubmed/32383887
12585,32448371,microRNA-1271 impedes the development of prostate cancer by downregulating PES1 and upregulating ER?,J Transl Med. 2020 May 24;18(1):209. doi: 10.1186/s12967-020-02349-1.,Jiang Z,https://www.ncbi.nlm.nih.gov/pubmed/32448371
12586,31951590,p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer,Endocr Relat Cancer. 2020 Mar;27(3):187-198. doi: 10.1530/ERC-19-0488.,Gruber M,https://www.ncbi.nlm.nih.gov/pubmed/31951590
12587,32089544,Androgen receptor with short polyglutamine tract preferably enhances Wnt/?-catenin-mediated prostatic tumorigenesis,Oncogene. 2020 Apr;39(16):3276-3291. doi: 10.1038/s41388-020-1214-7. Epub 2020 Feb 24.,He Y,https://www.ncbi.nlm.nih.gov/pubmed/32089544
12588,31933148,"Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies",J Cancer Surviv. 2020 Jun;14(3):386-392. doi: 10.1007/s11764-020-00855-1. Epub 2020 Jan 13.,Coughlin SS,https://www.ncbi.nlm.nih.gov/pubmed/31933148
12589,32011434,Association of 17q24 rs1859962 gene polymorphism with prostate cancer risk: A systematic review and meta-analysis,Medicine (Baltimore). 2020 Jan;99(3):e18398. doi: 10.1097/MD.0000000000018398.,Ren F,https://www.ncbi.nlm.nih.gov/pubmed/32011434
12591,29796873,"Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells",Pathol Oncol Res. 2020 Jan;26(1):209-216. doi: 10.1007/s12253-018-0415-7. Epub 2018 May 24.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/29796873
12592,32931488,Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors,PLoS One. 2020 Sep 15;15(9):e0224414. doi: 10.1371/journal.pone.0224414. eCollection 2020.,Baio G,https://www.ncbi.nlm.nih.gov/pubmed/32931488
12594,32230980,"Differential Targeting of Gr-MDSCs, T Cells and Prostate Cancer Cells by Dactolisib and Dasatinib",Int J Mol Sci. 2020 Mar 27;21(7):2337. doi: 10.3390/ijms21072337.,Liu G,https://www.ncbi.nlm.nih.gov/pubmed/32230980
12595,32376773,Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis,Cancer Discov. 2020 Jul;10(7):1038-1057. doi: 10.1158/2159-8290.CD-19-1242. Epub 2020 May 6.,Leibold J,https://www.ncbi.nlm.nih.gov/pubmed/32376773
12596,31963634,?-Tocotrienol and ?-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells,Molecules. 2020 Jan 18;25(2):398. doi: 10.3390/molecules25020398.,Asay S,https://www.ncbi.nlm.nih.gov/pubmed/31963634
12597,32016963,Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis,Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):619-632. doi: 10.26355/eurrev_202001_20038.,Hao SD,https://www.ncbi.nlm.nih.gov/pubmed/32016963
12598,32112659,Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration-resistant prostate cancer,Cancer Sci. 2020 May;111(5):1692-1698. doi: 10.1111/cas.14366. Epub 2020 Mar 19.,Fujita K,https://www.ncbi.nlm.nih.gov/pubmed/32112659
12599,32447485,"SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis",J Cancer Res Clin Oncol. 2020 Aug;146(8):1953-1969. doi: 10.1007/s00432-020-03247-1. Epub 2020 May 23.,Xu N,https://www.ncbi.nlm.nih.gov/pubmed/32447485
12600,31651568,Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects,Eur J Cancer Prev. 2020 May;29(3):248-251. doi: 10.1097/CEJ.0000000000000539.,Braga R,https://www.ncbi.nlm.nih.gov/pubmed/31651568
12602,31790140,LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2,J Biochem. 2020 Mar 1;167(3):295-301. doi: 10.1093/jb/mvz097.,Zhou Y,https://www.ncbi.nlm.nih.gov/pubmed/31790140
12603,32321698,Direct in vivo comparison of [(18)F]PSMA-1007 with [(68)Ga]Ga-PSMA-11 and [(18)F]AlF-PSMA-11 in mice bearing PSMA-expressing xenografts,Appl Radiat Isot. 2020 Jul;161:109164. doi: 10.1016/j.apradiso.2020.109164. Epub 2020 Apr 2.,Ioppolo JA,https://www.ncbi.nlm.nih.gov/pubmed/32321698
12604,31712637,Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1,Gene Ther. 2020 Apr;27(3-4):143-156. doi: 10.1038/s41434-019-0108-1. Epub 2019 Nov 11.,Jiang Z,https://www.ncbi.nlm.nih.gov/pubmed/31712637
12605,32460179,Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer,Eur J Cancer. 2020 Jul;134:29-40. doi: 10.1016/j.ejca.2020.04.013. Epub 2020 May 24.,Zhou T,https://www.ncbi.nlm.nih.gov/pubmed/32460179
12606,32994029,"LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer",Mater Sci Eng C Mater Biol Appl. 2020 Sep;114:111035. doi: 10.1016/j.msec.2020.111035. Epub 2020 May 1.,Shitole AA,https://www.ncbi.nlm.nih.gov/pubmed/32994029
12608,31583618,"Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged ""no-problems""",Qual Life Res. 2020 Mar;29(3):755-763. doi: 10.1007/s11136-019-02316-4. Epub 2019 Oct 3.,Murasawa H,https://www.ncbi.nlm.nih.gov/pubmed/31583618
12609,31113757,Can Ga-68 PSMA PET/CT replace conventional imaging modalities for primary lymph node and bone staging of prostate cancer?,Eur Urol Focus. 2020 Mar 15;6(2):218-220. doi: 10.1016/j.euf.2019.05.005. Epub 2019 May 18.,Esen T,https://www.ncbi.nlm.nih.gov/pubmed/31113757
12610,31672604,LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p,Cell Signal. 2020 Jan;65:109422. doi: 10.1016/j.cellsig.2019.109422. Epub 2019 Oct 28.,Jiang X,https://www.ncbi.nlm.nih.gov/pubmed/31672604
12611,32183146,Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells,Molecules. 2020 Mar 13;25(6):1320. doi: 10.3390/molecules25061320.,Hwang ST,https://www.ncbi.nlm.nih.gov/pubmed/32183146
12612,32185555,"Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and ""First Do No Harm"" Part II",Curr Urol Rep. 2020 Mar 18;21(3):15. doi: 10.1007/s11934-020-0967-4.,Moyad MA,https://www.ncbi.nlm.nih.gov/pubmed/32185555
12613,33029095,Potential risk of certain cancers among patients with Periodontitis: a supplementary meta-analysis of a large-scale population,Int J Med Sci. 2020 Sep 12;17(16):2531-2543. doi: 10.7150/ijms.46812. eCollection 2020.,Ma H,https://www.ncbi.nlm.nih.gov/pubmed/33029095
12614,32234758,Honing in on PARPi Response in Prostate Cancer: from HR Pathway to Gene-by-Gene Granularity,Clin Cancer Res. 2020 Jun 1;26(11):2439-2440. doi: 10.1158/1078-0432.CCR-20-0707. Epub 2020 Mar 31.,Sokolova AO,https://www.ncbi.nlm.nih.gov/pubmed/32234758
12615,31894360,Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells,Cell Mol Life Sci. 2020 Nov;77(22):4663-4673. doi: 10.1007/s00018-019-03429-2. Epub 2020 Jan 1.,Song IS,https://www.ncbi.nlm.nih.gov/pubmed/31894360
12616,32164292,A Camera Sensors-Based System to Study Drug Effects On In Vitro Motility: The Case of PC-3 Prostate Cancer Cells,Sensors (Basel). 2020 Mar 10;20(5):1531. doi: 10.3390/s20051531.,Comes MC,https://www.ncbi.nlm.nih.gov/pubmed/32164292
12617,32053654,Trajectories in muscular strength and physical function among men with and without prostate cancer in the health aging and body composition study,PLoS One. 2020 Feb 13;15(2):e0228773. doi: 10.1371/journal.pone.0228773. eCollection 2020.,Lucas AR,https://www.ncbi.nlm.nih.gov/pubmed/32053654
12618,32152485,Lineage plasticity in cancer: a shared pathway of therapeutic resistance,Nat Rev Clin Oncol. 2020 Jun;17(6):360-371. doi: 10.1038/s41571-020-0340-z. Epub 2020 Mar 9.,Quintanal-Villalonga Á,https://www.ncbi.nlm.nih.gov/pubmed/32152485
12620,31969643,Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells,Sci Rep. 2020 Jan 22;10(1):980. doi: 10.1038/s41598-020-57932-9.,Nagesh PKB,https://www.ncbi.nlm.nih.gov/pubmed/31969643
12621,31899823,Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy,Prostate. 2020 Mar;80(4):336-344. doi: 10.1002/pros.23948. Epub 2020 Jan 3.,Hawley JE,https://www.ncbi.nlm.nih.gov/pubmed/31899823
12622,32275943,HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression,Cell Signal. 2020 Aug;72:109631. doi: 10.1016/j.cellsig.2020.109631. Epub 2020 Apr 7.,Lei X,https://www.ncbi.nlm.nih.gov/pubmed/32275943
12623,31760076,GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells,Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158573. doi: 10.1016/j.bbalip.2019.158573. Epub 2019 Nov 21.,Cárdenas S,https://www.ncbi.nlm.nih.gov/pubmed/31760076
12624,32006297,"A novel pregnene analogs: synthesis, cytotoxicity on prostate cancer of PC-3 and LNCPa-AI cells and in silico molecular docking study",Mol Divers. 2021 May;25(2):661-671. doi: 10.1007/s11030-020-10038-w. Epub 2020 Jan 31.,Abdul-Rida NA,https://www.ncbi.nlm.nih.gov/pubmed/32006297
12625,32283033,"Incarnatapeptins A and B, Nonribosomal Peptides Discovered Using Genome Mining and (1)H/(15)N HSQC-TOCSY",Org Lett. 2020 Jun 5;22(11):4053-4057. doi: 10.1021/acs.orglett.0c00818. Epub 2020 Apr 13.,Morgan KD,https://www.ncbi.nlm.nih.gov/pubmed/32283033
12626,31912870,Inhibition of hypoxia-inducible factor 1? accumulation by glyceryl trinitrate and cyclic guanosine monophosphate,Biosci Rep. 2020 Jan 31;40(1):BSR20192345. doi: 10.1042/BSR20192345.,Kim J,https://www.ncbi.nlm.nih.gov/pubmed/31912870
12627,31936664,Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells,Int J Mol Sci. 2020 Jan 9;21(2):439. doi: 10.3390/ijms21020439.,Yeo C,https://www.ncbi.nlm.nih.gov/pubmed/31936664
12628,30659302,"Role of androgen receptor splice variants, their clinical relevance and treatment options",World J Urol. 2020 Mar;38(3):647-656. doi: 10.1007/s00345-018-02619-0. Epub 2019 Jan 19.,Wach S,https://www.ncbi.nlm.nih.gov/pubmed/30659302
12629,32804121,"Investigating the relationship between ccfDNA concentration, its integrity, and some individual factors in an Iranian population",Hum Antibodies. 2020;28(4):319-326. doi: 10.3233/HAB-200419.,Khani M,https://www.ncbi.nlm.nih.gov/pubmed/32804121
12630,32078741,The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer,J Racial Ethn Health Disparities. 2020 Oct;7(5):996-1002. doi: 10.1007/s40615-020-00724-8. Epub 2020 Feb 20.,Zuniga KB,https://www.ncbi.nlm.nih.gov/pubmed/32078741
12631,32319599,Gli2 mediates the development of castration?resistant prostate cancer,Int J Oncol. 2020 Jul;57(1):100-112. doi: 10.3892/ijo.2020.5044. Epub 2020 Apr 13.,Xia L,https://www.ncbi.nlm.nih.gov/pubmed/32319599
12632,31832978,The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: a systematic review,Qual Life Res. 2020 Apr;29(4):843-865. doi: 10.1007/s11136-019-02361-z. Epub 2019 Dec 12.,Geerkens MJM,https://www.ncbi.nlm.nih.gov/pubmed/31832978
12633,31843555,Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation,Cancer Lett. 2020 Mar 31;473:118-129. doi: 10.1016/j.canlet.2019.12.018. Epub 2019 Dec 13.,Yang Z,https://www.ncbi.nlm.nih.gov/pubmed/31843555
12634,32216035,A critical review of graphics for subgroup analyses in clinical trials,Pharm Stat. 2020 Sep;19(5):541-560. doi: 10.1002/pst.2012. Epub 2020 Mar 25.,Ballarini NM,https://www.ncbi.nlm.nih.gov/pubmed/32216035
12635,32361642,Factors associated with appropriate and low-value PSA testing,Cancer Epidemiol. 2020 Jun;66:101724. doi: 10.1016/j.canep.2020.101724. Epub 2020 May 8.,Oswald N,https://www.ncbi.nlm.nih.gov/pubmed/32361642
12638,30807653,Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition,Int J Cancer. 2020 Jan 1;146(1):44-57. doi: 10.1002/ijc.32233. Epub 2019 Mar 14.,Perez-Cornago A,https://www.ncbi.nlm.nih.gov/pubmed/30807653
12639,32329252,Associations between prostate cancer-related anxiety and health-related quality of life,Cancer Med. 2020 Jun;9(12):4467-4473. doi: 10.1002/cam4.3069. Epub 2020 Apr 23.,Erim DO,https://www.ncbi.nlm.nih.gov/pubmed/32329252
12640,31544977,Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer,J Cell Physiol. 2020 Mar;235(3):2776-2791. doi: 10.1002/jcp.29182. Epub 2019 Sep 23.,Panda PK,https://www.ncbi.nlm.nih.gov/pubmed/31544977
12641,31868268,DJ-1 inhibits autophagy activity of prostate cancer cells by repressing JNK-Bcl2-Beclin1 signaling,Cell Biol Int. 2020 Apr;44(4):937-946. doi: 10.1002/cbin.11290. Epub 2020 Jan 5.,Qin X,https://www.ncbi.nlm.nih.gov/pubmed/31868268
12642,32188463,Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy,J Nanobiotechnology. 2020 Mar 18;18(1):50. doi: 10.1186/s12951-020-00607-4.,Jiang W,https://www.ncbi.nlm.nih.gov/pubmed/32188463
12644,32402770,Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers,Urol Oncol. 2021 Jun;39(6):312-315. doi: 10.1016/j.urolonc.2020.04.004. Epub 2020 May 8.,Makhov P,https://www.ncbi.nlm.nih.gov/pubmed/32402770
12645,31580749,The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data,J Urol. 2020 Apr;203(4):743-750. doi: 10.1097/JU.0000000000000577. Epub 2019 Oct 3.,Crawford ED,https://www.ncbi.nlm.nih.gov/pubmed/31580749
12646,32139350,Mobilizing serum factors and immune cells through exercise to counteract age-related changes in cancer risk,Exerc Immunol Rev. 2020;26:80-99.,Hwang JH,https://www.ncbi.nlm.nih.gov/pubmed/32139350
12648,32134137,Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer,Prostate. 2020 May;80(7):559-569. doi: 10.1002/pros.23969. Epub 2020 Mar 5.,Yamada Y,https://www.ncbi.nlm.nih.gov/pubmed/32134137
12649,32626928,MicroRNA?137 regulates hypoxia?mediated migration and epithelial?mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway,Int J Oncol. 2020 Aug;57(2):540-549. doi: 10.3892/ijo.2020.5064. Epub 2020 May 14.,Zhang H,https://www.ncbi.nlm.nih.gov/pubmed/32626928
12650,31740783,A NF-?B-Activin A signaling axis enhances prostate cancer metastasis,Oncogene. 2020 Feb;39(8):1634-1651. doi: 10.1038/s41388-019-1103-0. Epub 2019 Nov 18.,Chen L,https://www.ncbi.nlm.nih.gov/pubmed/31740783
12651,32413665,Endosulfan triggers epithelial-mesenchymal transition via PTP4A3-mediated TGF-? signaling pathway in prostate cancer cells,Sci Total Environ. 2020 Aug 20;731:139234. doi: 10.1016/j.scitotenv.2020.139234. Epub 2020 May 7.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32413665
12652,32304760,RETRACTED: MicroRNA-381 facilitates autophagy and apoptosis in prostate cancer cells via inhibiting the RELN-mediated PI3K/AKT/mTOR signaling pathway,Life Sci. 2020 Aug 1;254:117672. doi: 10.1016/j.lfs.2020.117672. Epub 2020 Apr 15.,Liao W,https://www.ncbi.nlm.nih.gov/pubmed/32304760
12653,31481577,Observer Agreement and Accuracy of (18)F-Sodium Fluoride PET/CT in the Diagnosis of Bone Metastases in Prostate Cancer,J Nucl Med. 2020 Mar;61(3):344-349. doi: 10.2967/jnumed.119.232686. Epub 2019 Sep 3.,Zacho HD,https://www.ncbi.nlm.nih.gov/pubmed/31481577
12654,32043710,Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells,J Biochem Mol Toxicol. 2020 May;34(5):e22474. doi: 10.1002/jbt.22474. Epub 2020 Feb 11.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32043710
12656,32327394,Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment,Clin Genitourin Cancer. 2020 Aug;18(4):258-267.e1. doi: 10.1016/j.clgc.2019.11.002. Epub 2020 Mar 29.,Madan RA,https://www.ncbi.nlm.nih.gov/pubmed/32327394
12657,32460015,Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress,Cell Rep. 2020 May 26;31(8):107669. doi: 10.1016/j.celrep.2020.107669.,Nyquist MD,https://www.ncbi.nlm.nih.gov/pubmed/32460015
12658,32196489,IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages,PLoS Negl Trop Dis. 2020 Mar 20;14(3):e0008126. doi: 10.1371/journal.pntd.0008126. eCollection 2020 Mar.,Han IH,https://www.ncbi.nlm.nih.gov/pubmed/32196489
12662,33204367,CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer,Dis Markers. 2020 Nov 1;2020:8899924. doi: 10.1155/2020/8899924. eCollection 2020.,Ma Z,https://www.ncbi.nlm.nih.gov/pubmed/33204367
12663,31760099,CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183,Life Sci. 2020 Jan 15;241:117097. doi: 10.1016/j.lfs.2019.117097. Epub 2019 Nov 21.,Jin C,https://www.ncbi.nlm.nih.gov/pubmed/31760099
12665,31856338,Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration-resistant prostate cancer,Prostate. 2020 Feb;80(3):256-266. doi: 10.1002/pros.23939. Epub 2019 Dec 19.,Chen X,https://www.ncbi.nlm.nih.gov/pubmed/31856338
12666,32100191,Tomato consumption and intake of lycopene as predictors of the incidence of prostate cancer: the Adventist Health Study-2,Cancer Causes Control. 2020 Apr;31(4):341-351. doi: 10.1007/s10552-020-01279-z. Epub 2020 Feb 25.,Fraser GE,https://www.ncbi.nlm.nih.gov/pubmed/32100191
12667,31482294,Metabolic changes with degarelix vs leuprolide plus bicalutamide in patients with prostate cancer: a randomized clinical study,World J Urol. 2020 Jun;38(6):1465-1471. doi: 10.1007/s00345-019-02937-x. Epub 2019 Sep 3.,Sawazaki H,https://www.ncbi.nlm.nih.gov/pubmed/31482294
12668,30007542,Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or ?-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis,Eur Urol Focus. 2020 Mar 15;6(2):370-375. doi: 10.1016/j.euf.2018.06.014. Epub 2018 Jul 13.,Cimino S,https://www.ncbi.nlm.nih.gov/pubmed/30007542
12669,31531888,Upregulation of GRIM-19 augments the sensitivity of prostate cancer cells to docetaxel by targeting Rad23b,Clin Exp Pharmacol Physiol. 2020 Jan;47(1):76-84. doi: 10.1111/1440-1681.13179. Epub 2019 Oct 22.,Lin H,https://www.ncbi.nlm.nih.gov/pubmed/31531888
12671,31964530,Ubiquitin-specific protease 14 promotes prostate cancer progression through deubiquitinating the transcriptional factor ATF2,Biochem Biophys Res Commun. 2020 Mar 26;524(1):16-21. doi: 10.1016/j.bbrc.2019.12.128. Epub 2020 Jan 18.,Geng L,https://www.ncbi.nlm.nih.gov/pubmed/31964530
12672,32198082,Cabazitaxel in patients aged ?80?years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan,J Geriatr Oncol. 2020 Sep;11(7):1067-1073. doi: 10.1016/j.jgo.2020.02.014. Epub 2020 Mar 18.,Matsubara N,https://www.ncbi.nlm.nih.gov/pubmed/32198082
12673,32167698,Special emphasis on bone health management in prostate cancer patients: a prospective longitudinal study,Int Braz J Urol. 2020 May-Jun;46(3):363-373. doi: 10.1590/S1677-5538.IBJU.2019.0023.,Sharma A,https://www.ncbi.nlm.nih.gov/pubmed/32167698
12674,32209447,"DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer",Trends Cancer. 2020 Apr;6(4):337-347. doi: 10.1016/j.trecan.2020.01.015. Epub 2020 Feb 18.,Giguère V,https://www.ncbi.nlm.nih.gov/pubmed/32209447
12675,32127465,SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy,Mol Cancer Ther. 2020 May;19(5):1157-1164. doi: 10.1158/1535-7163.MCT-19-0926. Epub 2020 Mar 3.,Conteduca V,https://www.ncbi.nlm.nih.gov/pubmed/32127465
12677,31999003,Pilot Study of Hyperfractionated Dosing of Lutetium-177-Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 ((177) Lu-J591) for Metastatic Castration-Resistant Prostate Cancer,Oncologist. 2020 Jun;25(6):477-e895. doi: 10.1634/theoncologist.2020-0028. Epub 2020 Jan 30.,Niaz MJ,https://www.ncbi.nlm.nih.gov/pubmed/31999003
12678,31947623,Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer,Cells. 2020 Jan 14;9(1):203. doi: 10.3390/cells9010203.,Marín-Aguilera M,https://www.ncbi.nlm.nih.gov/pubmed/31947623
12679,31738958,FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy,Cancer Lett. 2020 Jan 28;469:481-489. doi: 10.1016/j.canlet.2019.11.014. Epub 2019 Nov 16.,Lin JZ,https://www.ncbi.nlm.nih.gov/pubmed/31738958
12680,31894239,Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer,Endocrinology. 2020 Feb 1;161(2):bqz042. doi: 10.1210/endocr/bqz042.,Park S,https://www.ncbi.nlm.nih.gov/pubmed/31894239
12681,32094298,Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors,Cancer Res. 2020 Jun 15;80(12):2427-2436. doi: 10.1158/0008-5472.CAN-19-3447. Epub 2020 Feb 24.,Hankey W,https://www.ncbi.nlm.nih.gov/pubmed/32094298
12682,31969702,Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer,Nature. 2020 Feb;578(7794):306-310. doi: 10.1038/s41586-020-1930-8. Epub 2020 Jan 22.,Faivre EJ,https://www.ncbi.nlm.nih.gov/pubmed/31969702
12683,31981706,Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate,Int J Pharm. 2020 Mar 15;577:119069. doi: 10.1016/j.ijpharm.2020.119069. Epub 2020 Jan 22.,Schultz HB,https://www.ncbi.nlm.nih.gov/pubmed/31981706
12684,32434918,Enzyme-mediated depletion of serum l-Met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity,Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):13000-13011. doi: 10.1073/pnas.1917362117. Epub 2020 May 20.,Lu WC,https://www.ncbi.nlm.nih.gov/pubmed/32434918
12686,32328032,"Estrogen Receptors Promote Migration, Invasion and Colony Formation of the Androgen-Independent Prostate Cancer Cells PC-3 Through ?-Catenin Pathway",Front Endocrinol (Lausanne). 2020 Apr 9;11:184. doi: 10.3389/fendo.2020.00184. eCollection 2020.,Lombardi APG,https://www.ncbi.nlm.nih.gov/pubmed/32328032
12687,32022719,"Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer",Am J Gastroenterol. 2020 Apr;115(4):526-534. doi: 10.14309/ajg.0000000000000515.,Hammami MB,https://www.ncbi.nlm.nih.gov/pubmed/32022719
12689,32282738,Metastatic castration-resistant prostate cancer: Academic insights and perspectives through bibliometric analysis,Medicine (Baltimore). 2020 Apr;99(15):e19760. doi: 10.1097/MD.0000000000019760.,He L,https://www.ncbi.nlm.nih.gov/pubmed/32282738
12690,32424485,"A prospective intra-individual comparison of [(68)Ga]Ga-PSMA-11 PET/CT, [(68)Ga]Ga-NODAGA(ZOL) PET/CT, and [(99m)Tc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases",Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):134-142. doi: 10.1007/s00259-020-04867-y. Epub 2020 May 18.,Lawal IO,https://www.ncbi.nlm.nih.gov/pubmed/32424485
12692,31727303,Model-Based Dose Calculation Algorithms for Brachytherapy Dosimetry,Semin Radiat Oncol. 2020 Jan;30(1):77-86. doi: 10.1016/j.semradonc.2019.08.006.,Enger SA,https://www.ncbi.nlm.nih.gov/pubmed/31727303
12694,32061305,Targeting the Unfolded Protein Response in Hormone-Regulated Cancers,Trends Cancer. 2020 Feb;6(2):160-171. doi: 10.1016/j.trecan.2019.12.001. Epub 2020 Jan 16.,Jin Y,https://www.ncbi.nlm.nih.gov/pubmed/32061305
12695,31410600,Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany,Support Care Cancer. 2020 May;28(5):2175-2184. doi: 10.1007/s00520-019-05018-2. Epub 2019 Aug 14.,Link H,https://www.ncbi.nlm.nih.gov/pubmed/31410600
12697,31432469,Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects,Clin Pharmacokinet. 2020 Feb;59(2):229-244. doi: 10.1007/s40262-019-00808-7.,Pérez-Ruixo C,https://www.ncbi.nlm.nih.gov/pubmed/31432469
12698,31630010,Semi-supervised mp-MRI data synthesis with StitchLayer and auxiliary distance maximization,Med Image Anal. 2020 Jan;59:101565. doi: 10.1016/j.media.2019.101565. Epub 2019 Oct 1.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/31630010
12699,31806643,Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer,Clin Cancer Res. 2020 Apr 1;26(7):1667-1677. doi: 10.1158/1078-0432.CCR-19-0775. Epub 2019 Dec 5.,Corella AN,https://www.ncbi.nlm.nih.gov/pubmed/31806643
12700,31986176,Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer,PLoS One. 2020 Jan 27;15(1):e0226219. doi: 10.1371/journal.pone.0226219. eCollection 2020.,Nagaya N,https://www.ncbi.nlm.nih.gov/pubmed/31986176
12701,31835965,Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy,J Med Econ. 2020 Apr;23(4):330-346. doi: 10.1080/13696998.2019.1705313. Epub 2020 Jan 6.,Shah A,https://www.ncbi.nlm.nih.gov/pubmed/31835965
12702,31321444,ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs,Cell Mol Life Sci. 2020 Mar;77(6):1135-1152. doi: 10.1007/s00018-019-03226-x. Epub 2019 Jul 18.,Cui X,https://www.ncbi.nlm.nih.gov/pubmed/31321444
12703,31594215,Association between tumor necrosis factor-alpha gene rs1800629 (-308G/A) and rs361525 (-238G > A) polymorphisms and prostate cancer risk in an Iranian cohort,Hum Antibodies. 2020;28(1):65-74. doi: 10.3233/HAB-190397.,Alidoost S,https://www.ncbi.nlm.nih.gov/pubmed/31594215
12704,32001306,Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis,Urology. 2020 May;139:64-70. doi: 10.1016/j.urology.2019.11.062. Epub 2020 Jan 27.,Patel MS,https://www.ncbi.nlm.nih.gov/pubmed/32001306
12706,32048780,Potential biomarkers screening to predict side effects of dexamethasone in different cancers,Mol Genet Genomic Med. 2020 Apr;8(4):e1160. doi: 10.1002/mgg3.1160. Epub 2020 Feb 12.,Jiang D,https://www.ncbi.nlm.nih.gov/pubmed/32048780
12707,31614005,Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer,Prostate. 2020 Jan;80(1):65-73. doi: 10.1002/pros.23918. Epub 2019 Oct 15.,Shao L,https://www.ncbi.nlm.nih.gov/pubmed/31614005
12708,31669704,Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population,Genomics. 2020 Mar;112(2):1746-1753. doi: 10.1016/j.ygeno.2019.09.017. Epub 2019 Oct 31.,Siraj AK,https://www.ncbi.nlm.nih.gov/pubmed/31669704
12709,32724813,Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database,Biomed Res Int. 2020 Jul 16;2020:8341097. doi: 10.1155/2020/8341097. eCollection 2020.,Zheng L,https://www.ncbi.nlm.nih.gov/pubmed/32724813
12710,32459662,Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway,Aging (Albany NY). 2020 May 27;12(10):9948-9958. doi: 10.18632/aging.103260. Epub 2020 May 27.,Li K,https://www.ncbi.nlm.nih.gov/pubmed/32459662
12712,32427840,"2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer",Nat Commun. 2020 May 19;11(1):2508. doi: 10.1038/s41467-020-16126-7.,Blomme A,https://www.ncbi.nlm.nih.gov/pubmed/32427840
12713,32804986,FeAture Explorer (FAE): A tool for developing and comparing radiomics models,PLoS One. 2020 Aug 17;15(8):e0237587. doi: 10.1371/journal.pone.0237587. eCollection 2020.,Song Y,https://www.ncbi.nlm.nih.gov/pubmed/32804986
12714,32162172,"Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen",Cancer Causes Control. 2020 May;31(5):431-449. doi: 10.1007/s10552-020-01291-3. Epub 2020 Mar 11.,Harrison S,https://www.ncbi.nlm.nih.gov/pubmed/32162172
12717,32414694,Low-Dose Enzalutamide in Late-Elderly Patients (? 75 Years Old) Presenting With Metastatic Castration-Resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Dec;18(6):e660-e668. doi: 10.1016/j.clgc.2020.03.019. Epub 2020 Apr 7.,Vinh-Hung V,https://www.ncbi.nlm.nih.gov/pubmed/32414694
12718,32321669,European cancer mortality predictions for the year 2020 with a focus on prostate cancer,Ann Oncol. 2020 May;31(5):650-658. doi: 10.1016/j.annonc.2020.02.009. Epub 2020 Apr 19.,Carioli G,https://www.ncbi.nlm.nih.gov/pubmed/32321669
12719,31783936,Impact of Lifestyle Intervention for Patients with Prostate Cancer,Am J Health Behav. 2020 Jan 1;44(1):90-99. doi: 10.5993/AJHB.44.1.10.,Park S,https://www.ncbi.nlm.nih.gov/pubmed/31783936
12720,32408351,Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study,Clin Chem. 2020 Jun 1;66(6):842-851. doi: 10.1093/clinchem/hvaa095.,Benoist GE,https://www.ncbi.nlm.nih.gov/pubmed/32408351
12722,32097050,Immunotherapy for castration-resistant prostate cancer: has its time arrived?,Expert Opin Biol Ther. 2020 May;20(5):481-487. doi: 10.1080/14712598.2020.1735345. Epub 2020 Mar 5.,Slovin SF,https://www.ncbi.nlm.nih.gov/pubmed/32097050
12723,31971633,CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer,Prostate. 2020 Apr;80(5):388-398. doi: 10.1002/pros.23953. Epub 2020 Jan 23.,Xing Z,https://www.ncbi.nlm.nih.gov/pubmed/31971633
12724,31140110,Semiquantitative Parameters in PSMA-Targeted PET Imaging with [(18)F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake,Mol Imaging Biol. 2020 Feb;22(1):190-197. doi: 10.1007/s11307-019-01375-w.,Werner RA,https://www.ncbi.nlm.nih.gov/pubmed/31140110
12725,32028704,The miR-28-5p Targetome Discovery Identified SREBF2 as One of the Mediators of the miR-28-5p Tumor Suppressor Activity in Prostate Cancer Cells,Cells. 2020 Feb 3;9(2):354. doi: 10.3390/cells9020354.,Fazio S,https://www.ncbi.nlm.nih.gov/pubmed/32028704
12726,31811000,Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing,Clin Chem. 2020 Jan 1;66(1):188-198. doi: 10.1373/clinchem.2019.309633.,Ge G,https://www.ncbi.nlm.nih.gov/pubmed/31811000
12727,32376689,Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity,J Biol Chem. 2020 Jun 19;295(25):8550-8559. doi: 10.1074/jbc.RA120.013794. Epub 2020 May 6.,Cinar B,https://www.ncbi.nlm.nih.gov/pubmed/32376689
12728,32383180,PLC? regulates metabolism and metastasis signaling via HIF-1?/MEK/ERK pathway in prostate cancer,J Cell Physiol. 2020 Nov;235(11):8546-8557. doi: 10.1002/jcp.29698. Epub 2020 May 7.,Fan Y,https://www.ncbi.nlm.nih.gov/pubmed/32383180
12730,31187203,Combined androgen blockade (CAB) versus luteinizing hormone-releasing hormone (LHRH) agonist monotherapy for androgen deprivation therapy,World J Urol. 2020 Apr;38(4):971-979. doi: 10.1007/s00345-019-02847-y. Epub 2019 Jun 11.,Park HS,https://www.ncbi.nlm.nih.gov/pubmed/31187203
12731,31905252,"Ascleposide, a natural cardenolide, induces anticancer signaling in human castration-resistant prostatic cancer through Na(+) /K(+) -ATPase internalization and tubulin acetylation",Prostate. 2020 Mar;80(4):305-318. doi: 10.1002/pros.23944. Epub 2020 Jan 6.,Leu WJ,https://www.ncbi.nlm.nih.gov/pubmed/31905252
12732,32358577,Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):596-606. doi: 10.1038/s41391-020-0235-1. Epub 2020 May 1.,McAllister MJ,https://www.ncbi.nlm.nih.gov/pubmed/32358577
12733,31990543,"Bioconjugates of Chelators with Peptides and Proteins in Nuclear Medicine: Historical Importance, Current Innovations, and Future Challenges",Bioconjug Chem. 2020 Mar 18;31(3):483-491. doi: 10.1021/acs.bioconjchem.0c00015. Epub 2020 Feb 12.,Jackson JA,https://www.ncbi.nlm.nih.gov/pubmed/31990543
12734,31846382,Mitochondrial DNA damage in the hair bulb: can it be used as a noninvasive biomarker of local exposure to low LET ionizing radiation?,Int J Radiat Biol. 2020 Apr;96(4):491-501. doi: 10.1080/09553002.2020.1704910. Epub 2020 Jan 8.,Hargitai R,https://www.ncbi.nlm.nih.gov/pubmed/31846382
12735,32034294,Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):220-231. doi: 10.1038/s41391-020-0209-3. Epub 2020 Feb 7.,Guan Y,https://www.ncbi.nlm.nih.gov/pubmed/32034294
12736,32468257,Negative associations between the has-miR-27a and hsa-miR-125a gene variations and prostate cancer susceptibility,Mol Biol Rep. 2020 Jun;47(6):4209-4214. doi: 10.1007/s11033-020-05548-7. Epub 2020 May 28.,Hakimian M,https://www.ncbi.nlm.nih.gov/pubmed/32468257
12737,31952332,"New Zampanolide Mimics: Design, Synthesis, and Antiproliferative Evaluation",Molecules. 2020 Jan 15;25(2):362. doi: 10.3390/molecules25020362.,Chen G,https://www.ncbi.nlm.nih.gov/pubmed/31952332
12740,32173422,Akt/survivin pathway inhibition enhances the apoptotic cell death-induced by alpha-santalol in human prostate cancer cells,Fitoterapia. 2020 Jun;143:104552. doi: 10.1016/j.fitote.2020.104552. Epub 2020 Mar 12.,Bommareddy A,https://www.ncbi.nlm.nih.gov/pubmed/32173422
12741,31974375,Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer,Nat Commun. 2020 Jan 23;11(1):441. doi: 10.1038/s41467-020-14318-9.,Zhou S,https://www.ncbi.nlm.nih.gov/pubmed/31974375
12742,32399975,"Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study",Int J Cancer. 2020 Nov 15;147(10):2735-2742. doi: 10.1002/ijc.33048. Epub 2020 May 29.,Meyers TJ,https://www.ncbi.nlm.nih.gov/pubmed/32399975
12743,30857458,Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels,Aging Male. 2020 Jun;23(2):112-118. doi: 10.1080/13685538.2019.1578739. Epub 2019 Mar 12.,Zhang X,https://www.ncbi.nlm.nih.gov/pubmed/30857458
12744,32066619,Leveraging Digital Data to Inform and Improve Quality Cancer Care,Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):816-822. doi: 10.1158/1055-9965.EPI-19-0873. Epub 2020 Feb 17.,Hernandez-Boussard T,https://www.ncbi.nlm.nih.gov/pubmed/32066619
12745,32217447,Aspalathin-rich green Aspalathus linearis extract suppresses migration and invasion of human castration-resistant prostate cancer cells via inhibition of YAP signaling,Phytomedicine. 2020 Apr;69:153210. doi: 10.1016/j.phymed.2020.153210. Epub 2020 Mar 18.,Huang SH,https://www.ncbi.nlm.nih.gov/pubmed/32217447
12746,31978674,Detection of prostate cancer by Raman spectroscopy: A multivariate study on patients with normal and altered PSA values,J Photochem Photobiol B. 2020 Mar;204:111801. doi: 10.1016/j.jphotobiol.2020.111801. Epub 2020 Jan 18.,Correia NA,https://www.ncbi.nlm.nih.gov/pubmed/31978674
12747,31780240,"Automatic Quality Assessment of Transperineal Ultrasound Images of the Male Pelvic Region, Using Deep Learning",Ultrasound Med Biol. 2020 Feb;46(2):445-454. doi: 10.1016/j.ultrasmedbio.2019.10.027. Epub 2019 Nov 25.,Camps SM,https://www.ncbi.nlm.nih.gov/pubmed/31780240
12748,32253061,Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer,Bioorg Med Chem Lett. 2020 Jun 1;30(11):127148. doi: 10.1016/j.bmcl.2020.127148. Epub 2020 Mar 28.,Bakthavatsalam S,https://www.ncbi.nlm.nih.gov/pubmed/32253061
12749,31800121,Substituted chloroacetamides as potential cancer stem cell inhibitors: Synthesis and biological evaluation,Drug Dev Res. 2020 May;81(3):356-365. doi: 10.1002/ddr.21628. Epub 2019 Dec 4.,Padhariya KN,https://www.ncbi.nlm.nih.gov/pubmed/31800121
12750,32366400,Androgen-induced Epigenetic Profiles of Polycomb and Trithorax Genes in Prostate Cancer Cells,Anticancer Res. 2020 May;40(5):2559-2565. doi: 10.21873/anticanres.14226.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/32366400
12751,32076807,The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients,Cancer Chemother Pharmacol. 2020 Apr;85(4):753-760. doi: 10.1007/s00280-020-04039-7. Epub 2020 Feb 19.,Benoist GE,https://www.ncbi.nlm.nih.gov/pubmed/32076807
12752,31833002,Effect of Androgen Deprivation Therapy on Metabolic Complications and Cardiovascular Risk,J Cardiovasc Transl Res. 2020 Jun;13(3):451-462. doi: 10.1007/s12265-019-09942-w. Epub 2019 Dec 12.,Melloni C,https://www.ncbi.nlm.nih.gov/pubmed/31833002
12757,32550915,Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer,Theranostics. 2020 May 25;10(15):6959-6976. doi: 10.7150/thno.41792. eCollection 2020.,Lu T,https://www.ncbi.nlm.nih.gov/pubmed/32550915
12758,32374392,Serum and Saliva Concentrations of Biochemical Parameters in Men with Prostate Cancer and Benign Prostate Hyperplasia,Lab Med. 2020 May 6;51(3):243-251. doi: 10.1093/labmed/lmz053.,Farahani H,https://www.ncbi.nlm.nih.gov/pubmed/32374392
12759,31669642,Long non-coding RNA AFAP1-AS1 promotes proliferation and invasion in prostate cancer via targeting miR-512-3p,Gene. 2020 Feb 5;726:144169. doi: 10.1016/j.gene.2019.144169. Epub 2019 Nov 26.,Wang K,https://www.ncbi.nlm.nih.gov/pubmed/31669642
12761,31744831,Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer,Clin Cancer Res. 2020 Mar 1;26(5):1114-1125. doi: 10.1158/1078-0432.CCR-19-1623. Epub 2019 Nov 19.,Ritch E,https://www.ncbi.nlm.nih.gov/pubmed/31744831
12762,32225005,Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells,Cells. 2020 Mar 26;9(4):797. doi: 10.3390/cells9040797.,Chen L,https://www.ncbi.nlm.nih.gov/pubmed/32225005
12763,32356608,CD4(+) T helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion,Prostate. 2020 Jul;80(10):764-776. doi: 10.1002/pros.23990. Epub 2020 May 1.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/32356608
12764,31975155,Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis,Cancer Causes Control. 2020 Mar;31(3):209-220. doi: 10.1007/s10552-019-01263-2. Epub 2020 Jan 23.,Georgantopoulos P,https://www.ncbi.nlm.nih.gov/pubmed/31975155
12766,31892044,Electrochemical nano-genosensor for highly sensitive detection of miR-21 biomarker based on SWCNT-grafted dendritic Au nanostructure for early detection of prostate cancer,Talanta. 2020 Mar 1;209:120595. doi: 10.1016/j.talanta.2019.120595. Epub 2019 Nov 26.,Sabahi A,https://www.ncbi.nlm.nih.gov/pubmed/31892044
12767,32371099,"Small molecule DTDQ exerts anti-metastatic effects in DU145 human castration-resistant prostate cancer cells via modulations of ERK, JNK, p38 and c-Myc signaling pathways",Bioorg Med Chem Lett. 2020 Jul 1;30(13):127223. doi: 10.1016/j.bmcl.2020.127223. Epub 2020 Apr 27.,Son J,https://www.ncbi.nlm.nih.gov/pubmed/32371099
12768,32048059,Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer,Curr Oncol Rep. 2020 Feb 11;22(3):24. doi: 10.1007/s11912-020-0884-1.,Kluger J,https://www.ncbi.nlm.nih.gov/pubmed/32048059
12769,32275162,"Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer",Cancer Biother Radiopharm. 2020 Nov;35(9):661-672. doi: 10.1089/cbr.2019.3123. Epub 2020 Apr 9.,Ma T,https://www.ncbi.nlm.nih.gov/pubmed/32275162
12770,31685432,Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study,Arch Cardiovasc Dis. 2020 Jan;113(1):9-21. doi: 10.1016/j.acvd.2019.09.006. Epub 2019 Nov 2.,Bretagne M,https://www.ncbi.nlm.nih.gov/pubmed/31685432
12772,32086391,Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers,Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5269-5279. doi: 10.1073/pnas.1915975117. Epub 2020 Feb 21.,Phillips JW,https://www.ncbi.nlm.nih.gov/pubmed/32086391
12773,31604898,Characterizing and Mitigating Bladder Radioactivity on (18)F-Fluciclovine PET/CT,J Nucl Med Technol. 2020 Mar;48(1):24-29. doi: 10.2967/jnmt.119.230581. Epub 2019 Oct 11.,Lovrec P,https://www.ncbi.nlm.nih.gov/pubmed/31604898
12774,32929382,LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network,Theranostics. 2020 Aug 29;10(23):10823-10837. doi: 10.7150/thno.47830. eCollection 2020.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/32929382
12775,32194820,Mitochondrial PAK6 inhibits prostate cancer cell apoptosis via the PAK6-SIRT4-ANT2 complex,Theranostics. 2020 Feb 3;10(6):2571-2586. doi: 10.7150/thno.42874. eCollection 2020.,Li T,https://www.ncbi.nlm.nih.gov/pubmed/32194820
12777,31691294,Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk,Med J Aust. 2020 Jan;212(1):17-22. doi: 10.5694/mja2.50376. Epub 2019 Nov 6.,Bach AC,https://www.ncbi.nlm.nih.gov/pubmed/31691294
12778,31477836,TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression,Oncogene. 2020 Jan;39(2):356-367. doi: 10.1038/s41388-019-0991-3. Epub 2019 Sep 2.,Feng T,https://www.ncbi.nlm.nih.gov/pubmed/31477836
12780,32035103,Tumour functional imaging by PET,Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165717. doi: 10.1016/j.bbadis.2020.165717. Epub 2020 Feb 5.,Abrantes AM,https://www.ncbi.nlm.nih.gov/pubmed/32035103
12781,31585016,Brevifoliol ester induces apoptosis in prostate cancer cells by activation of caspase pathway,Chem Biol Drug Des. 2020 Jan;95(1):150-161. doi: 10.1111/cbdd.13631. Epub 2019 Oct 20.,Bhukya B,https://www.ncbi.nlm.nih.gov/pubmed/31585016
12782,31865764,LRP11 activates ?-catenin to induce PD-L1 expression in prostate cancer,J Drug Target. 2020 Jun;28(5):508-515. doi: 10.1080/1061186X.2019.1687710. Epub 2019 Dec 27.,Gan S,https://www.ncbi.nlm.nih.gov/pubmed/31865764
12783,32449823,Prostate penile metastasis: Incidence and imaging pattern on (68) Ga-PSMA PET/CT,J Med Imaging Radiat Oncol. 2020 Aug;64(4):499-504. doi: 10.1111/1754-9485.13052. Epub 2020 May 25.,Tatkovic A,https://www.ncbi.nlm.nih.gov/pubmed/32449823
12785,31919338,"3,6-diazabicyclo[3.3.1]heptanes Induces Apoptosis and Arrests Cell Cycle in Prostate Cancer Cells",Med Sci Monit. 2020 Jan 10;26:e920266. doi: 10.12659/MSM.920266.,Wei H,https://www.ncbi.nlm.nih.gov/pubmed/31919338
12786,32403054,Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4,Neoplasia. 2020 Jun;22(6):253-262. doi: 10.1016/j.neo.2020.04.002. Epub 2020 May 11.,Coleman DJ,https://www.ncbi.nlm.nih.gov/pubmed/32403054
12787,31560992,"Bioguided identification of daucosterol, a compound that contributes to the cytotoxicity effects of Crateva adansonii DC (capparaceae) to prostate cancer cells",J Ethnopharmacol. 2020 Jan 30;247:112251. doi: 10.1016/j.jep.2019.112251. Epub 2019 Sep 24.,Zingue S,https://www.ncbi.nlm.nih.gov/pubmed/31560992
12788,31911497,Hypoxia influences polysome distribution of human ribosomal protein S12 and alternative splicing of ribosomal protein mRNAs,RNA. 2020 Mar;26(3):361-371. doi: 10.1261/rna.070318.119. Epub 2020 Jan 7.,Brumwell A,https://www.ncbi.nlm.nih.gov/pubmed/31911497
12789,32093096,Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis,Int J Environ Res Public Health. 2020 Feb 19;17(4):1345. doi: 10.3390/ijerph17041345.,Rivera-Izquierdo M,https://www.ncbi.nlm.nih.gov/pubmed/32093096
12790,31745255,Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia,Prostate Cancer Prostatic Dis. 2020 Jun;23(2):309-315. doi: 10.1038/s41391-019-0186-6. Epub 2019 Nov 19.,Stangl-Kremser J,https://www.ncbi.nlm.nih.gov/pubmed/31745255
12791,31203805,"Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II)",Med Chem. 2020;16(6):735-749. doi: 10.2174/1573406415666190613162322.,Y?lmaz Ö,https://www.ncbi.nlm.nih.gov/pubmed/31203805
12792,30782054,"Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality",Aging Male. 2020 Mar;23(1):81-92. doi: 10.1080/13685538.2019.1575354. Epub 2019 Feb 20.,Saad F,https://www.ncbi.nlm.nih.gov/pubmed/30782054
12795,32475774,Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Oct;18(5):416-422. doi: 10.1016/j.clgc.2020.02.015. Epub 2020 Apr 18.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32475774
12797,31993719,"A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosumab (PROMADE) study",Osteoporos Int. 2020 Jul;31(7):1251-1259. doi: 10.1007/s00198-019-05271-5. Epub 2020 Jan 28.,Yoshida T,https://www.ncbi.nlm.nih.gov/pubmed/31993719
12798,32427575,"A novel 3',5'-diprenylated chalcone induces concurrent apoptosis and GSDME-dependent pyroptosis through activating PKC?/JNK signal in prostate cancer",Aging (Albany NY). 2020 May 19;12(10):9103-9124. doi: 10.18632/aging.103178. Epub 2020 May 19.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/32427575
12799,32394269,Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?,Ann Nucl Med. 2020 Jul;34(7):476-485. doi: 10.1007/s12149-020-01474-7. Epub 2020 May 11.,Simsek DH,https://www.ncbi.nlm.nih.gov/pubmed/32394269
12801,31373513,Practical Molecular Testing in a Clinical Genitourinary Service,Arch Pathol Lab Med. 2020 Mar;144(3):277-289. doi: 10.5858/arpa.2019-0134-RA. Epub 2019 Aug 2.,Magers MJ,https://www.ncbi.nlm.nih.gov/pubmed/31373513
12802,32416561,"Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles",Biomed Pharmacother. 2020 Jul;127:110181. doi: 10.1016/j.biopha.2020.110181. Epub 2020 May 13.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32416561
12806,31756402,Inhibition of base excision repair by natamycin suppresses prostate cancer cell proliferation,Biochimie. 2020 Jan;168:241-250. doi: 10.1016/j.biochi.2019.11.008. Epub 2019 Nov 19.,Vasquez JL,https://www.ncbi.nlm.nih.gov/pubmed/31756402
12807,31800303,Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p/WISP1 pathway,Biochem Cell Biol. 2020 Jun;98(3):396-404. doi: 10.1139/bcb-2019-0211. Epub 2019 Dec 4.,Zheng Y,https://www.ncbi.nlm.nih.gov/pubmed/31800303
12810,32361788,The near-infrared fluorescent dye IR-780 was coupled with cabazitaxel for castration-resistant prostate cancer imaging and therapy,Invest New Drugs. 2020 Dec;38(6):1641-1652. doi: 10.1007/s10637-020-00934-1. Epub 2020 May 2.,Zheng Y,https://www.ncbi.nlm.nih.gov/pubmed/32361788
12811,31932422,Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1,Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2032-2042. doi: 10.1073/pnas.1905384117. Epub 2020 Jan 13.,Hsu EC,https://www.ncbi.nlm.nih.gov/pubmed/31932422
12812,32420382,"Aptamer-Conjugated Multifunctional Polymeric Nanoparticles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems for Treatment of Castration-Resistant Prostate Cancer",Biomed Res Int. 2020 Apr 25;2020:9186583. doi: 10.1155/2020/9186583. eCollection 2020.,Fang Y,https://www.ncbi.nlm.nih.gov/pubmed/32420382
12813,31439889,Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages,Prostate Cancer Prostatic Dis. 2020 Mar;23(1):127-135. doi: 10.1038/s41391-019-0168-8. Epub 2019 Aug 22.,Liang P,https://www.ncbi.nlm.nih.gov/pubmed/31439889
12815,32279449,(99m) Tc-(EDDA/tricine)-HYNIC-GnRH analogue as a potential imaging probe for diagnosis of prostate cancer,Chem Biol Drug Des. 2020 Aug;96(2):850-860. doi: 10.1111/cbdd.13693. Epub 2020 Apr 28.,Masteri Farahani A,https://www.ncbi.nlm.nih.gov/pubmed/32279449
12816,32431503,A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer,Int J Nanomedicine. 2020 May 1;15:3087-3098. doi: 10.2147/IJN.S241324. eCollection 2020.,Zhou M,https://www.ncbi.nlm.nih.gov/pubmed/32431503
12819,31654872,Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis,Biomaterials. 2020 Jan;227:119558. doi: 10.1016/j.biomaterials.2019.119558. Epub 2019 Oct 18.,Vijayaraghavalu S,https://www.ncbi.nlm.nih.gov/pubmed/31654872
12820,32755252,Statin-Induced Rhabdomyolysis Due to Pharmacokinetic Changes From Biliary Obstruction in a Patient With Metastatic Prostate Cancer,J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620947275. doi: 10.1177/2324709620947275.,Desikan SP,https://www.ncbi.nlm.nih.gov/pubmed/32755252
12822,32184358,Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance,J Biol Chem. 2020 Apr 17;295(16):5470-5483. doi: 10.1074/jbc.RA119.011385. Epub 2020 Mar 17.,Li C,https://www.ncbi.nlm.nih.gov/pubmed/32184358
12824,32497056,Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging,PLoS One. 2020 Jun 4;15(6):e0233443. doi: 10.1371/journal.pone.0233443. eCollection 2020.,Rikkert LG,https://www.ncbi.nlm.nih.gov/pubmed/32497056
12825,32480094,3D porous chitosan-chondroitin sulfate scaffolds promote epithelial to mesenchymal transition in prostate cancer cells,Biomaterials. 2020 Sep;254:120126. doi: 10.1016/j.biomaterials.2020.120126. Epub 2020 May 22.,Xu K,https://www.ncbi.nlm.nih.gov/pubmed/32480094
12826,32718298,Implication of Prophetic Variables and their Impulsive Interplay in CA Prostate Patients Experiencing Osteo-Metastasis,Anticancer Agents Med Chem. 2020;20(17):2106-2113. doi: 10.2174/1871520620666200727094430.,Ashraf MAB,https://www.ncbi.nlm.nih.gov/pubmed/32718298
12827,31712062,Anti-androgen hormonal therapy for cancer and other diseases,Eur J Pharmacol. 2020 Jan 5;866:172783. doi: 10.1016/j.ejphar.2019.172783. Epub 2019 Nov 8.,Student S,https://www.ncbi.nlm.nih.gov/pubmed/31712062
12828,32205868,Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis,Oncogene. 2020 May;39(20):4014-4027. doi: 10.1038/s41388-020-1272-x. Epub 2020 Mar 23.,Goto Y,https://www.ncbi.nlm.nih.gov/pubmed/32205868
12829,32217372,"Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen",Bioorg Chem. 2020 Jun;99:103743. doi: 10.1016/j.bioorg.2020.103743. Epub 2020 Mar 13.,Mosayebnia M,https://www.ncbi.nlm.nih.gov/pubmed/32217372
12830,31914854,The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1,Cell Cycle. 2020 Feb;19(3):363-375. doi: 10.1080/15384101.2019.1711317. Epub 2020 Jan 9.,Singh V,https://www.ncbi.nlm.nih.gov/pubmed/31914854
12831,32097115,Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis,Perm J. 2020;24:19.086. doi: 10.7812/TPP/19.086. Epub 2020 Feb 14.,Dutheil F,https://www.ncbi.nlm.nih.gov/pubmed/32097115
12832,31601704,Evaluation of an Automated Module Synthesis and a Sterile Cold Kit-Based Preparation of (68)Ga-PSMA-11 in Patients with Prostate Cancer,J Nucl Med. 2020 May;61(5):716-722. doi: 10.2967/jnumed.119.231605. Epub 2019 Oct 10.,Calderoni L,https://www.ncbi.nlm.nih.gov/pubmed/31601704
12834,32174789,Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways,Int J Biol Sci. 2020 Feb 10;16(7):1121-1134. doi: 10.7150/ijbs.41686. eCollection 2020.,Lu X,https://www.ncbi.nlm.nih.gov/pubmed/32174789
12835,32132146,"Red and Processed Meat, Poultry, Fish, and Egg Intakes and Cause-Specific and All-Cause Mortality among Men with Nonmetastatic Prostate Cancer in a U.S. Cohort",Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):1029-1038. doi: 10.1158/1055-9965.EPI-19-1426. Epub 2020 Mar 4.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32132146
12837,32251583,Bioinspired Superwettable Microspine Chips with Directional Droplet Transportation for Biosensing,ACS Nano. 2020 Apr 28;14(4):4654-4661. doi: 10.1021/acsnano.0c00324. Epub 2020 Apr 10.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32251583
12841,32059012,Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry,PLoS Genet. 2020 Feb 14;16(2):e1008641. doi: 10.1371/journal.pgen.1008641. eCollection 2020 Feb.,Yuan J,https://www.ncbi.nlm.nih.gov/pubmed/32059012
12843,32091413,Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer,J Clin Invest. 2020 Apr 1;130(4):1653-1668. doi: 10.1172/JCI131041.,Beltran H,https://www.ncbi.nlm.nih.gov/pubmed/32091413
12844,32210729,miR-197-3p Represses the Proliferation of Prostate Cancer by Regulating the VDAC1/AKT/?-catenin Signaling Axis,Int J Biol Sci. 2020 Feb 21;16(8):1417-1426. doi: 10.7150/ijbs.42019. eCollection 2020.,Huang Q,https://www.ncbi.nlm.nih.gov/pubmed/32210729
12847,32201212,Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells,Biochem Pharmacol. 2020 May;175:113920. doi: 10.1016/j.bcp.2020.113920. Epub 2020 Mar 19.,Lee YJ,https://www.ncbi.nlm.nih.gov/pubmed/32201212
12849,32388358,"Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer",Sci Total Environ. 2020 Aug 15;730:138314. doi: 10.1016/j.scitotenv.2020.138314. Epub 2020 Apr 30.,Martinez-Gonzalez LJ,https://www.ncbi.nlm.nih.gov/pubmed/32388358
12850,32229267,Quality of Life and Pain During Treatment of Metastatic Castration-resistant Prostate Cancer With Cabazitaxel In Routine Clinical Practice,Clin Genitourin Cancer. 2020 Oct;18(5):e510-e516. doi: 10.1016/j.clgc.2020.02.003. Epub 2020 Mar 6.,Joly F,https://www.ncbi.nlm.nih.gov/pubmed/32229267
12851,32314732,Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology,Elife. 2020 Apr 21;9:e51019. doi: 10.7554/eLife.51019.,Kerwin J,https://www.ncbi.nlm.nih.gov/pubmed/32314732
12854,31787585,Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4?717?839 people,Lancet Psychiatry. 2020 Jan;7(1):52-63. doi: 10.1016/S2215-0366(19)30414-6. Epub 2019 Nov 29.,Solmi M,https://www.ncbi.nlm.nih.gov/pubmed/31787585
12855,32459967,Hydroxylated Rotenoids Selectively Inhibit the Proliferation of Prostate Cancer Cells,J Nat Prod. 2020 Jun 26;83(6):1829-1845. doi: 10.1021/acs.jnatprod.9b01224. Epub 2020 May 27.,Russell DA,https://www.ncbi.nlm.nih.gov/pubmed/32459967
12856,31555944,Gene expression signatures of site-specificity in cancer metastases,Clin Exp Metastasis. 2020 Feb;37(1):159-171. doi: 10.1007/s10585-019-09995-w. Epub 2019 Sep 25.,Hartung F,https://www.ncbi.nlm.nih.gov/pubmed/31555944
12857,32207938,(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging,J Med Chem. 2020 Apr 9;63(7):3563-3576. doi: 10.1021/acs.jmedchem.9b02031. Epub 2020 Mar 30.,Duan X,https://www.ncbi.nlm.nih.gov/pubmed/32207938
12858,32146726,PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth,Mol Oncol. 2020 May;14(5):974-990. doi: 10.1002/1878-0261.12662. Epub 2020 Apr 1.,Singh N,https://www.ncbi.nlm.nih.gov/pubmed/32146726
12859,31783387,Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblasts,Nanotechnology. 2020 Mar 27;31(13):135102. doi: 10.1088/1361-6528/ab5d82. Epub 2019 Nov 29.,Ivošev V,https://www.ncbi.nlm.nih.gov/pubmed/31783387
12860,32436081,Protein kinase CK2 impact on intracellular calcium homeostasis in prostate cancer,Mol Cell Biochem. 2020 Jul;470(1-2):131-143. doi: 10.1007/s11010-020-03752-4. Epub 2020 May 20.,Afzal M,https://www.ncbi.nlm.nih.gov/pubmed/32436081
12862,32149481,Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastases of prostate cancer,J Pathol Clin Res. 2020 Jul;6(3):171-177. doi: 10.1002/cjp2.160. Epub 2020 Mar 9.,Wen J,https://www.ncbi.nlm.nih.gov/pubmed/32149481
12863,30685298,"Consumption of whole grain/bran rye instead of refined wheat decrease concentrations of TNF-R2, e-selectin, and endostatin in an exploratory study in men with prostate cancer",Clin Nutr. 2020 Jan;39(1):159-165. doi: 10.1016/j.clnu.2019.01.007. Epub 2019 Jan 15.,Zamaratskaia G,https://www.ncbi.nlm.nih.gov/pubmed/30685298
12865,32376654,Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study,BMJ. 2020 May 6;369:m1203. doi: 10.1136/bmj.m1203.,Richardson TG,https://www.ncbi.nlm.nih.gov/pubmed/32376654
12870,32220301,Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation,Cancer Cell. 2020 Apr 13;37(4):584-598.e11. doi: 10.1016/j.ccell.2020.03.001. Epub 2020 Mar 26.,Zhang Z,https://www.ncbi.nlm.nih.gov/pubmed/32220301
12872,32075173,Geographical Disparities in Screening and Cancer-Related Health Behaviour,Int J Environ Res Public Health. 2020 Feb 14;17(4):1246. doi: 10.3390/ijerph17041246.,Goodwin BC,https://www.ncbi.nlm.nih.gov/pubmed/32075173
12873,32276929,TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?,Cancer Discov. 2020 Jun;10(6):779-782. doi: 10.1158/2159-8290.CD-20-0451. Epub 2020 Apr 10.,Stopsack KH,https://www.ncbi.nlm.nih.gov/pubmed/32276929
12876,32243390,Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis,Medicine (Baltimore). 2020 Apr;99(14):e19628. doi: 10.1097/MD.0000000000019628.,Chen X,https://www.ncbi.nlm.nih.gov/pubmed/32243390
12877,31774688,"Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study",J Clin Oncol. 2020 Feb 10;38(5):395-405. doi: 10.1200/JCO.19.01638. Epub 2019 Nov 27.,Antonarakis ES,https://www.ncbi.nlm.nih.gov/pubmed/31774688
12881,32447643,The effects of human sera conditioned by high-intensity exercise sessions and training on the tumorigenic potential of cancer cells,Clin Transl Oncol. 2021 Jan;23(1):22-34. doi: 10.1007/s12094-020-02388-6. Epub 2020 May 23.,Baldelli G,https://www.ncbi.nlm.nih.gov/pubmed/32447643
12884,32226548,Nuclear receptor ERR? contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis,Theranostics. 2020 Mar 4;10(9):4201-4216. doi: 10.7150/thno.35589. eCollection 2020.,Xu Z,https://www.ncbi.nlm.nih.gov/pubmed/32226548
12885,32045360,Abiraterone acetate treatment lowers 11-oxygenated androgens,Eur J Endocrinol. 2020 Apr;182(4):413-421. doi: 10.1530/EJE-19-0905.,Wright C,https://www.ncbi.nlm.nih.gov/pubmed/32045360
12886,33091733,Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study,Cancer Treat Res Commun. 2020;25:100221. doi: 10.1016/j.ctarc.2020.100221. Epub 2020 Oct 13.,Cattrini C,https://www.ncbi.nlm.nih.gov/pubmed/33091733
12887,32251995,"A comparative study of peptide-based imaging agents [(68)Ga]Ga-PSMA-11, [(68)Ga]Ga-AMBA, [(68)Ga]Ga-NODAGA-RGD and [(68)Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models",Nucl Med Biol. 2020 May-Jun;84-85:88-95. doi: 10.1016/j.nucmedbio.2020.03.005. Epub 2020 Mar 30.,Zhang-Yin J,https://www.ncbi.nlm.nih.gov/pubmed/32251995
12888,31451492,Prospective Comparison of PET Imaging with PSMA-Targeted (18)F-DCFPyL Versus Na(18)F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer,J Nucl Med. 2020 Feb;61(2):183-188. doi: 10.2967/jnumed.119.227793. Epub 2019 Aug 26.,Rowe SP,https://www.ncbi.nlm.nih.gov/pubmed/31451492
12889,31742696,Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent,Photochem Photobiol. 2020 May;96(3):718-724. doi: 10.1111/php.13181. Epub 2019 Dec 26.,Overchuk M,https://www.ncbi.nlm.nih.gov/pubmed/31742696
12890,32220972,Novel Dual BET and PLK1 Inhibitor WNY0824 Exerts Potent Antitumor Effects in CRPC by Inhibiting Transcription Factor Function and Inducing Mitotic Abnormality,Mol Cancer Ther. 2020 Jun;19(6):1221-1231. doi: 10.1158/1535-7163.MCT-19-0578. Epub 2020 Mar 27.,Xu Y,https://www.ncbi.nlm.nih.gov/pubmed/32220972
12891,31903637,Extracellular vesicle-derived circ_SLC19A1 promotes prostate cancer cell growth and invasion through the miR-497/septin 2 pathway,Cell Biol Int. 2020 Apr;44(4):1037-1045. doi: 10.1002/cbin.11303. Epub 2020 Jan 16.,Zheng Y,https://www.ncbi.nlm.nih.gov/pubmed/31903637
12893,32152162,Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study,BMJ Open. 2020 Mar 8;10(3):e033532. doi: 10.1136/bmjopen-2019-033532.,Katzke V,https://www.ncbi.nlm.nih.gov/pubmed/32152162
12896,31838085,Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer,Cancer Lett. 2020 Feb 28;471:72-87. doi: 10.1016/j.canlet.2019.12.017. Epub 2019 Dec 12.,Lee YG,https://www.ncbi.nlm.nih.gov/pubmed/31838085
12899,31759982,Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer,Gene. 2020 Mar 10;730:144264. doi: 10.1016/j.gene.2019.144264. Epub 2019 Nov 21.,Basu S,https://www.ncbi.nlm.nih.gov/pubmed/31759982
12900,32253584,Implementing quality metrics in European Cancer Centers (ECCs),World J Urol. 2021 Jan;39(1):49-56. doi: 10.1007/s00345-020-03165-4. Epub 2020 Apr 6.,Griesshammer E,https://www.ncbi.nlm.nih.gov/pubmed/32253584
12901,32568179,GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p,Cancer Biomark. 2020;28(4):483-497. doi: 10.3233/CBM-191271.,Zhang L,https://www.ncbi.nlm.nih.gov/pubmed/32568179
12902,32172196,Concomitant intake of abiraterone acetate and food to increase pharmacokinetic exposure: real life data from a therapeutic drug monitoring programme,Eur J Cancer. 2020 May;130:32-38. doi: 10.1016/j.ejca.2020.02.012. Epub 2020 Mar 13.,Groenland SL,https://www.ncbi.nlm.nih.gov/pubmed/32172196
12906,32433663,Cancer morbidity trends and regional differences in England-A Bayesian analysis,PLoS One. 2020 May 20;15(5):e0232844. doi: 10.1371/journal.pone.0232844. eCollection 2020.,Ar?k A,https://www.ncbi.nlm.nih.gov/pubmed/32433663
12913,31995655,Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells,Prostate. 2020 Apr;80(5):412-423. doi: 10.1002/pros.23956. Epub 2020 Jan 29.,Venugopal SV,https://www.ncbi.nlm.nih.gov/pubmed/31995655
12917,32164534,Dynamic incorporation of prior knowledge from multiple domains in biomarker discovery,BMC Bioinformatics. 2020 Mar 11;21(Suppl 2):77. doi: 10.1186/s12859-020-3344-x.,Guan X,https://www.ncbi.nlm.nih.gov/pubmed/32164534
12919,32484838,The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells,PLoS One. 2020 Jun 2;15(6):e0234078. doi: 10.1371/journal.pone.0234078. eCollection 2020.,Sennoune SR,https://www.ncbi.nlm.nih.gov/pubmed/32484838
12924,31838616,"Pomegranate Juice and Peel Extracts are Able to Inhibit Proliferation, Migration and Colony Formation of Prostate Cancer Cell Lines and Modulate the Akt/mTOR/S6K Signaling Pathway",Plant Foods Hum Nutr. 2020 Mar;75(1):54-62. doi: 10.1007/s11130-019-00776-0.,Chaves FM,https://www.ncbi.nlm.nih.gov/pubmed/31838616
12926,32203405,11-Oxygenated androgens in health and disease,Nat Rev Endocrinol. 2020 May;16(5):284-296. doi: 10.1038/s41574-020-0336-x. Epub 2020 Mar 16.,Turcu AF,https://www.ncbi.nlm.nih.gov/pubmed/32203405
12929,32733447,Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy,Front Immunol. 2020 Jul 8;11:1333. doi: 10.3389/fimmu.2020.01333. eCollection 2020.,Qin L,https://www.ncbi.nlm.nih.gov/pubmed/32733447
12931,31612201,Serum Retinol and Risk of Overall and Site-Specific Cancer in the ATBC Study,Am J Epidemiol. 2020 Jun 1;189(6):532-542. doi: 10.1093/aje/kwz226.,Hada M,https://www.ncbi.nlm.nih.gov/pubmed/31612201
12932,31589086,Total cost of care for castration-resistant prostate cancer in a commercially insured population and a medicare supplemental insured population,J Med Econ. 2020 Jan;23(1):54-63. doi: 10.1080/13696998.2019.1678171. Epub 2019 Oct 18.,Wu B,https://www.ncbi.nlm.nih.gov/pubmed/31589086
12934,32568016,Sumoylation as an Emerging Target in Therapeutics against Cancer,Curr Pharm Des. 2020;26(37):4764-4776. doi: 10.2174/1381612826666200622124134.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/32568016
12941,31909511,Luminescent Pt(II) and Pt(IV) Platinacycles with Anticancer Activity Against Multiplatinum-Resistant Metastatic CRC and CRPC Cell Models,Chemistry. 2020 Feb 11;26(9):1947-1952. doi: 10.1002/chem.201905325. Epub 2020 Jan 30.,Lázaro A,https://www.ncbi.nlm.nih.gov/pubmed/31909511
12945,32283060,"Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line",Eur J Pharmacol. 2020 Jul 5;878:173102. doi: 10.1016/j.ejphar.2020.173102. Epub 2020 Apr 10.,Eftekhari S,https://www.ncbi.nlm.nih.gov/pubmed/32283060
12947,32560611,Evaluation of a New (99m)Tc-labeled GnRH Analogue as a Possible Imaging Agent for Prostate Cancer Detection,Anticancer Agents Med Chem. 2020;20(14):1695-1703. doi: 10.2174/1871520620666200619175352.,Farahani AM,https://www.ncbi.nlm.nih.gov/pubmed/32560611
12950,31468537,Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy,J Cell Physiol. 2020 Mar;235(3):2129-2138. doi: 10.1002/jcp.29117. Epub 2019 Aug 29.,Sha J,https://www.ncbi.nlm.nih.gov/pubmed/31468537
12953,32349746,"Comparison of explicit values clarification method (VCM), implicit VCM and no VCM decision aids for men considering prostate cancer screening: protocol of a randomized trial",BMC Med Inform Decis Mak. 2020 Apr 29;20(1):78. doi: 10.1186/s12911-020-1094-3.,Baptista S,https://www.ncbi.nlm.nih.gov/pubmed/32349746
12954,32226005,DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs,PLoS Genet. 2020 Mar 30;16(3):e1008667. doi: 10.1371/journal.pgen.1008667. eCollection 2020 Mar.,Dai JY,https://www.ncbi.nlm.nih.gov/pubmed/32226005
12958,32057715,A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Jun;18(3):171-178.e2. doi: 10.1016/j.clgc.2019.10.013. Epub 2020 Jan 11.,McHugh DJ,https://www.ncbi.nlm.nih.gov/pubmed/32057715
12961,31912782,Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer,Ann Oncol. 2020 Jan;31(1):103-114. doi: 10.1016/j.annonc.2019.09.007.,Genkinger JM,https://www.ncbi.nlm.nih.gov/pubmed/31912782
12962,32069422,Detecting TRA-1-60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent,Mol Pharm. 2020 Apr 6;17(4):1139-1147. doi: 10.1021/acs.molpharmaceut.9b01181. Epub 2020 Feb 28.,White JM,https://www.ncbi.nlm.nih.gov/pubmed/32069422
12963,32008178,"Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells",Invest New Drugs. 2020 Oct;38(5):1292-1302. doi: 10.1007/s10637-020-00901-w. Epub 2020 Feb 1.,Qu F,https://www.ncbi.nlm.nih.gov/pubmed/32008178
12964,31912784,Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial,Ann Oncol. 2020 Jan;31(1):115-122. doi: 10.1016/j.annonc.2019.09.002.,Poort H,https://www.ncbi.nlm.nih.gov/pubmed/31912784
12965,32122345,"Comparison of (18)F-sodium fluoride PET/CT, (18)F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France",BMC Med Imaging. 2020 Mar 2;20(1):25. doi: 10.1186/s12880-020-00425-y.,Gauthé M,https://www.ncbi.nlm.nih.gov/pubmed/32122345
12969,32240651,PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling,Biochem Pharmacol. 2020 Jul;177:113943. doi: 10.1016/j.bcp.2020.113943. Epub 2020 Mar 30.,Verma A,https://www.ncbi.nlm.nih.gov/pubmed/32240651
12970,32469184,"Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer",N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29.,Sternberg CN,https://www.ncbi.nlm.nih.gov/pubmed/32469184
12972,32909467,Exercise Adherence and Effect of Self-Regulatory Behavior Change Techniques in Patients Undergoing Curative Cancer Treatment: Secondary Analysis from the Phys-Can Randomized Controlled Trial,Integr Cancer Ther. 2020 Jan-Dec;19:1534735420946834. doi: 10.1177/1534735420946834.,Mazzoni AS,https://www.ncbi.nlm.nih.gov/pubmed/32909467
12974,32080309,68Ga-labeled PSMA-11 (68Ga-isoPROtrace-11) synthesized with ready to use kit: normal biodistribution and uptake characteristics of tumour lesions,Sci Rep. 2020 Feb 20;10(1):3109. doi: 10.1038/s41598-020-60099-y.,Kurash MM,https://www.ncbi.nlm.nih.gov/pubmed/32080309
12979,31580249,Integrative Exome Sequencing Analysis in Castration-Resistant Prostate Cancer in Chinese Population,Curr Pharm Biotechnol. 2020;21(2):140-148. doi: 10.2174/1389201019666191003142119.,Hao L,https://www.ncbi.nlm.nih.gov/pubmed/31580249
12980,32128670,Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma,Clin J Gastroenterol. 2020 Oct;13(5):860-866. doi: 10.1007/s12328-020-01107-6. Epub 2020 Mar 3.,Suoh M,https://www.ncbi.nlm.nih.gov/pubmed/32128670
12984,32241960,"Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer",Mol Pharmacol. 2020 Jun;97(6):409-422. doi: 10.1124/mol.119.118539. Epub 2020 Apr 2.,Liao VWY,https://www.ncbi.nlm.nih.gov/pubmed/32241960
12985,31854294,Association between malignancy and methotrexate and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis,Int J Clin Pharmacol Ther. 2020 Mar;58(3):131-138. doi: 10.5414/CP203604.,Inose R,https://www.ncbi.nlm.nih.gov/pubmed/31854294
12986,32392097,Quantitative Imaging Informatics for Cancer Research,JCO Clin Cancer Inform. 2020 May;4:444-453. doi: 10.1200/CCI.19.00165.,Fedorov A,https://www.ncbi.nlm.nih.gov/pubmed/32392097
12988,32385647,Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [(68)Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients,Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):123-133. doi: 10.1007/s00259-020-04846-3. Epub 2020 May 8.,Uprimny C,https://www.ncbi.nlm.nih.gov/pubmed/32385647
12989,31929761,"HCRP-1 regulates cell migration, invasion and angiogenesis via Src/ FAK signaling in human prostate cancer",Int J Biol Sci. 2020 Jan 1;16(2):342-352. doi: 10.7150/ijbs.38112. eCollection 2020.,Chen F,https://www.ncbi.nlm.nih.gov/pubmed/31929761
12991,32170339,Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis,Cell Mol Life Sci. 2021 Jan;78(1):249-270. doi: 10.1007/s00018-020-03491-1. Epub 2020 Mar 13.,Xie J,https://www.ncbi.nlm.nih.gov/pubmed/32170339
12992,31706019,Regulation of cell cycle by MDM2 in prostate cancer cells through Aurora Kinase-B and p21WAF1(/CIP1) mediated pathways,Cell Signal. 2020 Feb;66:109435. doi: 10.1016/j.cellsig.2019.109435. Epub 2019 Nov 6.,Kanagasabai T,https://www.ncbi.nlm.nih.gov/pubmed/31706019
12993,32407231,Urology nurses lead the way in adopting an innovative prostate biopsy technique,Br J Nurs. 2020 May 14;29(9):S4. doi: 10.12968/bjon.2020.29.9.S4.,Rusere J,https://www.ncbi.nlm.nih.gov/pubmed/32407231
12995,32060711,(68)Ga-PSMA-11 dose reduction for dedicated pelvic imaging with simultaneous PET/MR using TOF BSREM reconstructions,Eur Radiol. 2020 Jun;30(6):3188-3197. doi: 10.1007/s00330-020-06667-2. Epub 2020 Feb 14.,Svirydenka H,https://www.ncbi.nlm.nih.gov/pubmed/32060711
12997,32626918,Mechanism of Notch1?saRNA?1480 reversing androgen sensitivity in human metastatic castration?resistant prostate cancer,Int J Mol Med. 2020 Jul;46(1):265-279. doi: 10.3892/ijmm.2020.4597. Epub 2020 May 8.,Ma L,https://www.ncbi.nlm.nih.gov/pubmed/32626918
12998,31935861,Structural and Biophysical Analyses of Human N-Myc Downstream-Regulated Gene 3 (NDRG3) Protein,Biomolecules. 2020 Jan 6;10(1):90. doi: 10.3390/biom10010090.,Kim KR,https://www.ncbi.nlm.nih.gov/pubmed/31935861
12999,31808135,Contribution of 5th minute and 2nd hour images to standard imaging in ((68)Ga)PSMA 11 PET/CT,Ann Nucl Med. 2020 Mar;34(3):163-173. doi: 10.1007/s12149-019-01428-8. Epub 2019 Dec 5.,Can C,https://www.ncbi.nlm.nih.gov/pubmed/31808135
13000,31914691,PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer,FASEB J. 2020 Jan;34(1):1304-1318. doi: 10.1096/fj.201901205RR. Epub 2019 Nov 29.,Wang C,https://www.ncbi.nlm.nih.gov/pubmed/31914691
13001,31712394,Therapeutic Targeting of MDR1 Expression by ROR? Antagonists Resensitizes Cross-Resistant CRPC to Taxane via Coordinated Induction of Cell Death Programs,Mol Cancer Ther. 2020 Feb;19(2):364-374. doi: 10.1158/1535-7163.MCT-19-0327. Epub 2019 Nov 11.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/31712394
13004,31713499,Rational Identification of Hsp90 Inhibitors as Anticancer Lead Molecules by Structure Based Drug Designing Approach,Anticancer Agents Med Chem. 2020;20(3):369-385. doi: 10.2174/1871520619666191111152050.,Gupta SD,https://www.ncbi.nlm.nih.gov/pubmed/31713499
13005,32089741,(68)Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study,Theranostics. 2020 Jan 12;10(5):2273-2283. doi: 10.7150/thno.38501. eCollection 2020.,van Boxtel W,https://www.ncbi.nlm.nih.gov/pubmed/32089741
13011,31338642,Promoting integrated care in prostate cancer through online prostate cancer-specific holistic needs assessment: a feasibility study in primary care,Support Care Cancer. 2020 Apr;28(4):1817-1827. doi: 10.1007/s00520-019-04967-y. Epub 2019 Jul 23.,Clarke AL,https://www.ncbi.nlm.nih.gov/pubmed/31338642
13015,32239572,Anticancer properties and mechanism of action of the quassinoid ailanthone,Phytother Res. 2020 Sep;34(9):2203-2213. doi: 10.1002/ptr.6681. Epub 2020 Apr 1.,Bailly C,https://www.ncbi.nlm.nih.gov/pubmed/32239572
13021,31844184,Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment,Br J Cancer. 2020 Feb;122(4):517-527. doi: 10.1038/s41416-019-0681-5. Epub 2019 Dec 17.,Rushworth LK,https://www.ncbi.nlm.nih.gov/pubmed/31844184
13024,31983266,"Pairing Microwell Arrays with an Affordable, Semiautomated Single-Cell Aspirator for the Interrogation of Circulating Tumor Cell Heterogeneity",SLAS Technol. 2020 Apr;25(2):162-176. doi: 10.1177/2472630319898146. Epub 2020 Jan 26.,Tokar JJ,https://www.ncbi.nlm.nih.gov/pubmed/31983266
13025,32122315,"A protocol for a multicentre, parallel-group, pragmatic randomised controlled trial to evaluate the NEVERMIND system in preventing and treating depression in patients with severe somatic conditions",BMC Psychiatry. 2020 Mar 2;20(1):93. doi: 10.1186/s12888-020-02494-3.,Carli V,https://www.ncbi.nlm.nih.gov/pubmed/32122315
13031,32399200,Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden,F1000Res. 2020 Jan 28;9:58. doi: 10.12688/f1000research.19260.1. eCollection 2020.,Styrke J,https://www.ncbi.nlm.nih.gov/pubmed/32399200
13038,32350416,Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types,Mod Pathol. 2020 Sep;33(9):1753-1763. doi: 10.1038/s41379-020-0550-z. Epub 2020 Apr 29.,Zhu MMT,https://www.ncbi.nlm.nih.gov/pubmed/32350416
13039,32112276,Racial differences in user experiences and perceived value of electronic symptom monitoring in a cohort of black and white bladder and prostate cancer patients,Qual Life Res. 2021 Nov;30(11):3213-3227. doi: 10.1007/s11136-020-02442-4. Epub 2020 Feb 28.,Samuel CA,https://www.ncbi.nlm.nih.gov/pubmed/32112276
13049,32413024,Estrogen receptor ? exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity,PLoS One. 2020 May 15;15(5):e0226057. doi: 10.1371/journal.pone.0226057. eCollection 2020.,Chaurasiya S,https://www.ncbi.nlm.nih.gov/pubmed/32413024
13050,30783886,A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach,J Robot Surg. 2020 Feb;14(1):69-74. doi: 10.1007/s11701-019-00929-y. Epub 2019 Feb 19.,Miah S,https://www.ncbi.nlm.nih.gov/pubmed/30783886
13051,32614730,Partnerships and Collaborations: The Right Alliances for Clinical Trials in Africa,JCO Glob Oncol. 2020 Jun;6:954-958. doi: 10.1200/JGO.19.00194.,Solarin O,https://www.ncbi.nlm.nih.gov/pubmed/32614730
13056,31986186,"Thymidine phosphorylase and prostrate cancer cell proliferation inhibitory activities of synthetic 4-hydroxybenzohydrazides: In vitro, kinetic, and in silico studies",PLoS One. 2020 Jan 27;15(1):e0227549. doi: 10.1371/journal.pone.0227549. eCollection 2020.,Javaid S,https://www.ncbi.nlm.nih.gov/pubmed/31986186
13082,31661167,Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth,Prostate. 2020 Jan;80(1):88-98. doi: 10.1002/pros.23921. Epub 2019 Oct 29.,Carbonetti G,https://www.ncbi.nlm.nih.gov/pubmed/31661167
13089,33326447,Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence,PLoS One. 2020 Dec 16;15(12):e0242970. doi: 10.1371/journal.pone.0242970. eCollection 2020.,Dahl HC,https://www.ncbi.nlm.nih.gov/pubmed/33326447
13095,32301013,Current Landscape of Immunotherapy in Genitourinary Malignancies,Adv Exp Med Biol. 2020;1244:107-147. doi: 10.1007/978-3-030-41008-7_6.,Alhalabi O,https://www.ncbi.nlm.nih.gov/pubmed/32301013
13102,32102520,"Progesterone Receptor Expression in the Benign Prostatic Hyperplasia and Prostate Cancer Tissues, Relation with Transcription, Growth Factors, Hormone Reception and Components of the AKT/mTOR Signaling Pathway",Asian Pac J Cancer Prev. 2020 Feb 1;21(2):423-429. doi: 10.31557/APJCP.2020.21.2.423.,Spirina LV,https://www.ncbi.nlm.nih.gov/pubmed/32102520
13106,31932416,Temporal Trends in Population-Level Cure of Cancer: The Australian Context,Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):625-635. doi: 10.1158/1055-9965.EPI-19-0693. Epub 2020 Jan 13.,Kou K,https://www.ncbi.nlm.nih.gov/pubmed/31932416
13132,32201141,"Validating the Transfer of Skills Acquired on a Prostate Biopsy Simulator: A Prospective, Randomized, Controlled Study",J Surg Educ. 2020 Jul-Aug;77(4):953-960. doi: 10.1016/j.jsurg.2020.01.008. Epub 2020 Mar 20.,Fiard G,https://www.ncbi.nlm.nih.gov/pubmed/32201141
13144,32197412,Single Nucleotide Polymorphisms in 25-Hydroxyvitamin D3 1-Alpha-Hydroxylase (CYP27B1) Gene: The Risk of Malignant Tumors and Other Chronic Diseases,Nutrients. 2020 Mar 18;12(3):801. doi: 10.3390/nu12030801.,Latacz M,https://www.ncbi.nlm.nih.gov/pubmed/32197412
13155,31357198,"Magnetic Resonance Sentinel Lymph Node Imaging and Magnetometer-Guided Intraoperative Detection in Penile Cancer, using Superparamagnetic Iron Oxide Nanoparticles: First Results",Urol Int. 2020;104(3-4):177-180. doi: 10.1159/000502017. Epub 2019 Jul 29.,Winter A,https://www.ncbi.nlm.nih.gov/pubmed/31357198
13163,32036478,Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers,Curr Oncol Rep. 2020 Feb 8;22(3):21. doi: 10.1007/s11912-020-0890-3.,Wong RL,https://www.ncbi.nlm.nih.gov/pubmed/32036478
13164,32042192,Using human genetics to understand the disease impacts of testosterone in men and women,Nat Med. 2020 Feb;26(2):252-258. doi: 10.1038/s41591-020-0751-5. Epub 2020 Feb 10.,Ruth KS,https://www.ncbi.nlm.nih.gov/pubmed/32042192
13166,32021165,A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy,Int J Nanomedicine. 2020 Jan 8;15:65-80. doi: 10.2147/IJN.S230237. eCollection 2020.,Xu C,https://www.ncbi.nlm.nih.gov/pubmed/32021165
13171,31885347,Advances in research on the interaction between inflammation and cancer,J Int Med Res. 2020 Apr;48(4):300060519895347. doi: 10.1177/0300060519895347. Epub 2019 Dec 29.,Song XD,https://www.ncbi.nlm.nih.gov/pubmed/31885347
13183,32184283,Health system costs for cancer medications and radiation treatment in Ontario for the 4 most common cancers: a retrospective cohort study,CMAJ Open. 2020 Mar 16;8(1):E191-E198. doi: 10.9778/cmajo.20190114. Print 2020 Jan-Mar.,Mittmann N,https://www.ncbi.nlm.nih.gov/pubmed/32184283
13184,32197731,Exploratory Factor Analysis of a Patient-Centered Cancer Care Measure to Support Improved Assessment of Patients' Experiences,Value Health. 2020 Mar;23(3):351-361. doi: 10.1016/j.jval.2019.10.004. Epub 2019 Dec 9.,Mitchell KR,https://www.ncbi.nlm.nih.gov/pubmed/32197731
13197,31771896,Prostatic Artery Embolization Using 100-300-?m Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up,J Vasc Interv Radiol. 2020 Jan;31(1):99-107. doi: 10.1016/j.jvir.2019.08.005. Epub 2019 Nov 23.,Ayyagari R,https://www.ncbi.nlm.nih.gov/pubmed/31771896
13198,32273249,Functional results and survival after surgery for peripheral skeletal metastasis: A 434-case multicenter retrospective series,Orthop Traumatol Surg Res. 2020 Oct;106(6):997-1003. doi: 10.1016/j.otsr.2019.10.024. Epub 2020 Apr 6.,Bonnevialle P,https://www.ncbi.nlm.nih.gov/pubmed/32273249
13205,31736473,Management of urethral atrophy after implantation of artificial urinary sphincter: what are the weaknesses?,Asian J Androl. 2020 Jan-Feb;22(1):60-63. doi: 10.4103/aja.aja_110_19.,Heah NH,https://www.ncbi.nlm.nih.gov/pubmed/31736473
13208,32620366,"COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor",Prog Urol. 2020 Sep;30(10):484-487. doi: 10.1016/j.purol.2020.05.007. Epub 2020 May 22.,Mjaess G,https://www.ncbi.nlm.nih.gov/pubmed/32620366
13209,32062806,Age-related urologic problems in the complex urologic patient,World J Urol. 2021 Apr;39(4):1037-1044. doi: 10.1007/s00345-020-03111-4. Epub 2020 Feb 15.,Faure Walker N,https://www.ncbi.nlm.nih.gov/pubmed/32062806
13212,32398947,"B7-H3, a checkpoint molecule, as a target for cancer immunotherapy",Int J Biol Sci. 2020 Mar 25;16(11):1767-1773. doi: 10.7150/ijbs.41105. eCollection 2020.,Yang S,https://www.ncbi.nlm.nih.gov/pubmed/32398947
13224,31930774,Significance of desmoglein-2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer,Kaohsiung J Med Sci. 2020 May;36(5):336-343. doi: 10.1002/kjm2.12182. Epub 2020 Jan 13.,Zhou BX,https://www.ncbi.nlm.nih.gov/pubmed/31930774
13227,32232838,Clinician Perspectives on Overscreening for Cancer in Older Adults With Limited Life Expectancy,J Am Geriatr Soc. 2020 Jul;68(7):1462-1468. doi: 10.1111/jgs.16415. Epub 2020 Mar 31.,Schoenborn NL,https://www.ncbi.nlm.nih.gov/pubmed/32232838
13229,32404086,Prospective monitoring of imaging guideline adherence by physicians in a surgical collaborative: comparison of statistical process control methods for detecting outlying performance,BMC Med Inform Decis Mak. 2020 May 13;20(1):89. doi: 10.1186/s12911-020-1126-z.,Inadomi M,https://www.ncbi.nlm.nih.gov/pubmed/32404086
13240,32042329,Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity,Theranostics. 2020 Jan 1;10(4):1678-1693. doi: 10.7150/thno.40482. eCollection 2020.,Deberle LM,https://www.ncbi.nlm.nih.gov/pubmed/32042329
13246,32401342,The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types,Cancer. 2020 Jul 15;126(14):3192-3201. doi: 10.1002/cncr.32909. Epub 2020 May 13.,Einsele H,https://www.ncbi.nlm.nih.gov/pubmed/32401342
13252,31463762,"Concentration-Dependent Effects of Zinc Sulfate on DU-145 Human Prostate Cancer Cell Line: Oxidative, Apoptotic, Inflammatory, and Morphological Analyzes",Biol Trace Elem Res. 2020 Jun;195(2):436-444. doi: 10.1007/s12011-019-01879-0. Epub 2019 Aug 28.,Hacioglu C,https://www.ncbi.nlm.nih.gov/pubmed/31463762
13253,32128987,miR-451a is downregulated and targets PSMB8 in prostate cancer,Kaohsiung J Med Sci. 2020 Jul;36(7):494-500. doi: 10.1002/kjm2.12196. Epub 2020 Mar 3.,Liu Y,https://www.ncbi.nlm.nih.gov/pubmed/32128987
13255,31576529,Methods for Evaluation of a Snake Venom-Derived Disintegrin in Animal Models of Human Cancer,Methods Mol Biol. 2020;2068:185-204. doi: 10.1007/978-1-4939-9845-6_10.,Swenson SD,https://www.ncbi.nlm.nih.gov/pubmed/31576529
13258,32141938,Developments in the follow-up of nonmuscle invasive bladder cancer: what did we learn in the last 24 months: a critical review,Curr Opin Urol. 2020 May;30(3):387-391. doi: 10.1097/MOU.0000000000000741.,Witjes JA,https://www.ncbi.nlm.nih.gov/pubmed/32141938
13261,32255313,Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer,Arch Ital Urol Androl. 2020 Apr 6;92(1):1-6. doi: 10.4081/aiua.2020.1.1.,Avci S,https://www.ncbi.nlm.nih.gov/pubmed/32255313
13273,32430241,Low Testosterone in Male Cancer Patients and Survivors,Sex Med Rev. 2021 Jan;9(1):133-142. doi: 10.1016/j.sxmr.2020.03.004. Epub 2020 May 17.,Xu P,https://www.ncbi.nlm.nih.gov/pubmed/32430241
13281,32345533,Possible effects of low testosterone levels on olfactory function in males,Braz J Otorhinolaryngol. 2021 Nov-Dec;87(6):702-710. doi: 10.1016/j.bjorl.2020.03.001. Epub 2020 Apr 11.,K?rgezen T,https://www.ncbi.nlm.nih.gov/pubmed/32345533
13282,31600414,Internet-delivered mindfulness-based cognitive therapy for anxiety and depression in cancer survivors: A randomized controlled trial,Psychooncology. 2020 Jan;29(1):68-75. doi: 10.1002/pon.5237. Epub 2019 Nov 1.,Nissen ER,https://www.ncbi.nlm.nih.gov/pubmed/31600414
13283,32412125,Androgen sensitivity gateway to COVID-19 disease severity,Drug Dev Res. 2020 Nov;81(7):771-776. doi: 10.1002/ddr.21688. Epub 2020 May 15.,Wambier CG,https://www.ncbi.nlm.nih.gov/pubmed/32412125
13287,32170918,Propagation of human prostate tissue from induced pluripotent stem cells,Stem Cells Transl Med. 2020 Jul;9(7):734-745. doi: 10.1002/sctm.19-0286. Epub 2020 Mar 14.,Hepburn AC,https://www.ncbi.nlm.nih.gov/pubmed/32170918
13292,30611645,Urologic conditions associated with malignancy,Urol Oncol. 2020 Jan;38(1):23-30. doi: 10.1016/j.urolonc.2018.12.018. Epub 2019 Jan 2.,Lo EM,https://www.ncbi.nlm.nih.gov/pubmed/30611645
13295,32118296,Green tea (Camellia sinensis) for the prevention of cancer,Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD005004. doi: 10.1002/14651858.CD005004.pub3.,Filippini T,https://www.ncbi.nlm.nih.gov/pubmed/32118296
13306,31892555,Prognostic Significance of ZKSCAN3 (ZNF306) Expression in Gastric Carcinoma,Anticancer Res. 2020 Jan;40(1):81-86. doi: 10.21873/anticanres.13928.,Takano Y,https://www.ncbi.nlm.nih.gov/pubmed/31892555
13314,31481575,Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction,J Nucl Med. 2020 Feb;61(2):234-241. doi: 10.2967/jnumed.119.233064. Epub 2019 Sep 3.,Hensbergen AW,https://www.ncbi.nlm.nih.gov/pubmed/31481575
13325,32274747,Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database,Adv Ther. 2020 May;37(5):2236-2245. doi: 10.1007/s12325-020-01322-0. Epub 2020 Apr 9.,Zhong M,https://www.ncbi.nlm.nih.gov/pubmed/32274747
13338,32304294,"Chemical composition, antioxidant, anti-inflammatory and antiproliferative activities of the essential oil of Cymbopogon nardus, a plant used in traditional medicine",Biomol Concepts. 2020 Apr 15;11(1):86-96. doi: 10.1515/bmc-2020-0007.,Bayala B,https://www.ncbi.nlm.nih.gov/pubmed/32304294
13344,32038497,Aspirin and Its Potential Preventive Role in Cancer: An Umbrella Review,Front Endocrinol (Lausanne). 2020 Jan 23;11:3. doi: 10.3389/fendo.2020.00003. eCollection 2020.,Song Y,https://www.ncbi.nlm.nih.gov/pubmed/32038497
13345,32271699,Future Oncotargets: Targeting Overexpressed Conserved Protein Targets in Androgen Independent Prostate Cancer Cell Lines,Anticancer Agents Med Chem. 2020;20(8):1017-1027. doi: 10.2174/1871520620666200409142239.,Baig AM,https://www.ncbi.nlm.nih.gov/pubmed/32271699
13347,31889184,Identification of altered biological processes in heterogeneous RNA-sequencing data by discretization of expression profiles,Nucleic Acids Res. 2020 Feb 28;48(4):1730-1747. doi: 10.1093/nar/gkz1208.,Lauria A,https://www.ncbi.nlm.nih.gov/pubmed/31889184
13358,32306543,The genetic landscapes of urological cancers and their clinical implications in the era of high-throughput genome analysis,BJU Int. 2020 Jul;126(1):26-54. doi: 10.1111/bju.15084. Epub 2020 May 22.,Light A,https://www.ncbi.nlm.nih.gov/pubmed/32306543
13374,32015291,Prostate Benign Diseases,Top Magn Reson Imaging. 2020 Feb;29(1):1-16. doi: 10.1097/RMR.0000000000000227.,Guimaraes CTS,https://www.ncbi.nlm.nih.gov/pubmed/32015291
13379,32394162,Augmented deep learning model for improved quantitative accuracy of MR-based PET attenuation correction in PSMA PET-MRI prostate imaging,Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):9-20. doi: 10.1007/s00259-020-04816-9. Epub 2020 May 11.,Pozaruk A,https://www.ncbi.nlm.nih.gov/pubmed/32394162
13392,31938965,Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values,Qual Life Res. 2020 Jun;29(6):1483-1494. doi: 10.1007/s11136-020-02420-w. Epub 2020 Jan 14.,van Gelder T,https://www.ncbi.nlm.nih.gov/pubmed/31938965
13402,31727674,"Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation",Drug Metab Dispos. 2020 Feb;48(2):75-84. doi: 10.1124/dmd.119.088229. Epub 2019 Nov 14.,Vaillancourt J,https://www.ncbi.nlm.nih.gov/pubmed/31727674
13411,32206965,Introduction to special section on: current topics in cancer survivorship and work,J Cancer Surviv. 2020 Apr;14(2):101-105. doi: 10.1007/s11764-020-00868-w. Epub 2020 Mar 23.,de Boer AGEM,https://www.ncbi.nlm.nih.gov/pubmed/32206965
13423,31402639,Provoked venous thromboembolism during ten-year follow up at the Clinical Centre University of Sarajevo,Med Glas (Zenica). 2020 Feb 1;17(1):54-58. doi: 10.17392/1038-20.,Mla?o A,https://www.ncbi.nlm.nih.gov/pubmed/31402639
13426,31744788,Role of (18)F-FDG PET/CT in the detection of primary malignancy in patients with bone metastasis of unknown origin,Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jan-Feb;39(1):14-19. doi: 10.1016/j.remn.2019.06.002. Epub 2019 Nov 16.,Budak E,https://www.ncbi.nlm.nih.gov/pubmed/31744788
13429,32193900,Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation,J Korean Med Sci. 2020 Mar 23;35(11):e69. doi: 10.3346/jkms.2020.35.e69.,Park GC,https://www.ncbi.nlm.nih.gov/pubmed/32193900
13430,32074455,Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents,Cancer Biother Radiopharm. 2020 May;35(4):284-291. doi: 10.1089/cbr.2019.3079. Epub 2020 Feb 19.,Roy J,https://www.ncbi.nlm.nih.gov/pubmed/32074455
13442,31977481,Prostate-Specific Membrane Antigen Expression in Primary Juvenile Nasal Angiofibroma-A Pilot Study,Clin Nucl Med. 2020 Mar;45(3):195-199. doi: 10.1097/RLU.0000000000002928.,Sakthivel P,https://www.ncbi.nlm.nih.gov/pubmed/31977481
13443,32309911,Mainstream consent programs for genetic counseling in cancer patients: A systematic review,Asia Pac J Clin Oncol. 2021 Jun;17(3):163-177. doi: 10.1111/ajco.13334. Epub 2020 Apr 20.,Scheinberg T,https://www.ncbi.nlm.nih.gov/pubmed/32309911
13446,31645428,Role of transvaginal ultrasound-guided biopsy in gynecology,Int J Gynecol Cancer. 2020 Jan;30(1):128-132. doi: 10.1136/ijgc-2019-000734. Epub 2019 Oct 23.,Mascilini F,https://www.ncbi.nlm.nih.gov/pubmed/31645428
13448,32529799,Triple Selection Strategy for In Situ Labeling of Circulating Tumor Cells with High Purity and Viability toward Preclinical Personalized Drug Sensitivity Analysis,Adv Biosyst. 2020 Jun;4(6):e2000013. doi: 10.1002/adbi.202000013. Epub 2020 Apr 8.,Mu HY,https://www.ncbi.nlm.nih.gov/pubmed/32529799
13449,32305231,Health expenditures and financial burden among patients with major gastrointestinal cancers relative to other common cancers in the United States,Surgery. 2020 Jun;167(6):985-990. doi: 10.1016/j.surg.2020.02.029. Epub 2020 Apr 15.,Rice DR,https://www.ncbi.nlm.nih.gov/pubmed/32305231
13462,31955140,SOX7 is involved in polyphyllin D-induced G0/G1 cell cycle arrest through down-regulation of cyclin D1,Acta Pharm. 2020 Jun 1;70(2):191-200. doi: 10.2478/acph-2020-0017.,Zheng B,https://www.ncbi.nlm.nih.gov/pubmed/31955140
13464,31434793,Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer,Oncologist. 2020 Jan;25(1):21-e15. doi: 10.1634/theoncologist.2019-0564. Epub 2019 Aug 21.,Lu Q,https://www.ncbi.nlm.nih.gov/pubmed/31434793
13467,31905375,Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians,Ann Intern Med. 2020 Jan 21;172(2):105-118. doi: 10.7326/M19-0830. Epub 2020 Jan 7.,Diem SJ,https://www.ncbi.nlm.nih.gov/pubmed/31905375
13469,32026626,"European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology",Andrology. 2020 Sep;8(5):970-987. doi: 10.1111/andr.12770. Epub 2020 Mar 20.,Corona G,https://www.ncbi.nlm.nih.gov/pubmed/32026626
13474,31256390,Multifarious Pharmacological Applications of Green Routed Eco-Friendly Iron Nanoparticles Synthesized by Streptomyces Sp. (SRT12),Biol Trace Elem Res. 2020 Mar;194(1):273-283. doi: 10.1007/s12011-019-01777-5. Epub 2019 Jun 29.,Rajeswaran S,https://www.ncbi.nlm.nih.gov/pubmed/31256390
13483,32297435,"The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the ""Real-World"": Results from the Population-Based PROFILES Registry",Oncologist. 2020 Apr;25(4):e722-e732. doi: 10.1634/theoncologist.2019-0348. Epub 2019 Oct 31.,Husson O,https://www.ncbi.nlm.nih.gov/pubmed/32297435
13484,31839209,Beyond urate lowering: Analgesic and anti-inflammatory properties of allopurinol,Semin Arthritis Rheum. 2020 Jun;50(3):444-450. doi: 10.1016/j.semarthrit.2019.11.009. Epub 2019 Nov 15.,Schlesinger N,https://www.ncbi.nlm.nih.gov/pubmed/31839209
13488,32319535,Downregulation of c?FLIP and upregulation of DR?5 by cantharidin sensitizes TRAIL?mediated apoptosis in prostate cancer cells via autophagy flux,Int J Mol Med. 2020 Jul;46(1):280-288. doi: 10.3892/ijmm.2020.4566. Epub 2020 Apr 6.,Nazim UM,https://www.ncbi.nlm.nih.gov/pubmed/32319535
13497,32525701,"Effects of Inorganic Arsenic on Human Prostate Stem-Progenitor Cell Transformation, Autophagic Flux Blockade, and NRF2 Pathway Activation",Environ Health Perspect. 2020 Jun;128(6):67008. doi: 10.1289/EHP6471. Epub 2020 Jun 11.,Xie L,https://www.ncbi.nlm.nih.gov/pubmed/32525701
13507,32384017,Food Insecurity and Forgone Medical Care Among Cancer Survivors,JCO Oncol Pract. 2020 Sep;16(9):e922-e932. doi: 10.1200/JOP.19.00736. Epub 2020 May 8.,McDougall JA,https://www.ncbi.nlm.nih.gov/pubmed/32384017
13510,31920119,Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population,Acta Oncol. 2020 Apr;59(4):376-383. doi: 10.1080/0284186X.2019.1711167. Epub 2020 Jan 10.,Thøgersen H,https://www.ncbi.nlm.nih.gov/pubmed/31920119
13522,32227458,Visceral Metastasis: A Prognostic Factor of Survival in Patients with Spinal Metastases,Orthop Surg. 2020 Apr;12(2):552-560. doi: 10.1111/os.12657. Epub 2020 Mar 29.,Lun DX,https://www.ncbi.nlm.nih.gov/pubmed/32227458
13527,31573889,The Cold Case of Metabotropic Glutamate Receptor 6: Unjust Detention in the Retina?,Curr Neuropharmacol. 2020;18(2):120-125. doi: 10.2174/1570159X17666191001141849.,Palazzo E,https://www.ncbi.nlm.nih.gov/pubmed/31573889
13530,32193737,Assessment of the antioxidant and anticancer potential of different isolated strains of cyanobacteria and microalgae from soil and agriculture drain water,Environ Sci Pollut Res Int. 2020 May;27(15):18463-18474. doi: 10.1007/s11356-020-08332-z. Epub 2020 Mar 19.,Senousy HH,https://www.ncbi.nlm.nih.gov/pubmed/32193737
13532,31734055,miR-452 promotes the development of gastric cancer via targeting EPB41L3,Pathol Res Pract. 2020 Jan;216(1):152725. doi: 10.1016/j.prp.2019.152725. Epub 2019 Oct 31.,He X,https://www.ncbi.nlm.nih.gov/pubmed/31734055
13534,33329395,"Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function",Front Endocrinol (Lausanne). 2020 Nov 23;11:591217. doi: 10.3389/fendo.2020.591217. eCollection 2020.,Rouhimoghadam M,https://www.ncbi.nlm.nih.gov/pubmed/33329395
13540,31911188,Exposing Hidden Targets: Combining epigenetic and immunotherapy to overcome cancer resistance,Semin Cancer Biol. 2020 Oct;65:114-122. doi: 10.1016/j.semcancer.2020.01.001. Epub 2020 Jan 3.,Olino K,https://www.ncbi.nlm.nih.gov/pubmed/31911188
13546,31986417,SNHG7: A novel vital oncogenic lncRNA in human cancers,Biomed Pharmacother. 2020 Apr;124:109921. doi: 10.1016/j.biopha.2020.109921. Epub 2020 Jan 24.,Zhou Y,https://www.ncbi.nlm.nih.gov/pubmed/31986417
13547,32285917,MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression,Biosci Rep. 2020 May 29;40(5):BSR20193295. doi: 10.1042/BSR20193295.,Wu J,https://www.ncbi.nlm.nih.gov/pubmed/32285917
13551,31998832,"Triangular correlation (TrC) between cancer aggressiveness, cell uptake capability, and cell deformability",Sci Adv. 2020 Jan 15;6(3):eaax2861. doi: 10.1126/sciadv.aax2861. eCollection 2020 Jan.,Brill-Karniely Y,https://www.ncbi.nlm.nih.gov/pubmed/31998832
13552,32375797,Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study,World J Surg Oncol. 2020 May 6;18(1):88. doi: 10.1186/s12957-020-01868-x.,Shen C,https://www.ncbi.nlm.nih.gov/pubmed/32375797
13560,31904711,Early Impact of the Affordable Care Act and Medicaid Expansion on Racial and Socioeconomic Disparities in Cancer Care,Am J Clin Oncol. 2020 Mar;43(3):163-167. doi: 10.1097/COC.0000000000000588.,Mahal AR,https://www.ncbi.nlm.nih.gov/pubmed/31904711
13561,31696760,STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo,Cancer Biol Ther. 2020;21(3):278-291. doi: 10.1080/15384047.2019.1685290. Epub 2019 Nov 7.,Yang Q,https://www.ncbi.nlm.nih.gov/pubmed/31696760
13566,32502216,Effects of castration on atherosclerosis in Yucatan minipigs with genetic hypercholesterolemia,PLoS One. 2020 Jun 5;15(6):e0234131. doi: 10.1371/journal.pone.0234131. eCollection 2020.,Shim JT,https://www.ncbi.nlm.nih.gov/pubmed/32502216
13580,31393814,The Association between Popular Diets and Serum Testosterone among Men in the United States,J Urol. 2020 Feb;203(2):398-404. doi: 10.1097/JU.0000000000000482. Epub 2019 Aug 8.,Fantus RJ,https://www.ncbi.nlm.nih.gov/pubmed/31393814
13582,32237034,Identification of kinesin family member 3B (KIF3B) as a molecular target for gastric cancer,Kaohsiung J Med Sci. 2020 Jul;36(7):515-522. doi: 10.1002/kjm2.12206. Epub 2020 Apr 1.,Yao FZ,https://www.ncbi.nlm.nih.gov/pubmed/32237034
13596,31732654,Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas,Cancer Res. 2020 Jan 15;80(2):304-318. doi: 10.1158/0008-5472.CAN-18-3539. Epub 2019 Nov 15.,Navas T,https://www.ncbi.nlm.nih.gov/pubmed/31732654
13597,32190895,Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer,Biosci Rep. 2020 Apr 30;40(4):BSR20192457. doi: 10.1042/BSR20192457.,Feng L,https://www.ncbi.nlm.nih.gov/pubmed/32190895
13598,31775567,DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients,Epigenetics. 2020 Apr;15(4):419-430. doi: 10.1080/15592294.2019.1695333. Epub 2019 Nov 27.,Vrba L,https://www.ncbi.nlm.nih.gov/pubmed/31775567
13599,31938049,"Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity",Theranostics. 2020 Jan 1;10(3):1033-1045. doi: 10.7150/thno.38137. eCollection 2020.,Wang B,https://www.ncbi.nlm.nih.gov/pubmed/31938049
13613,32098891,Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database,Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):807-815. doi: 10.1158/1055-9965.EPI-19-0912. Epub 2020 Feb 25.,Hanson HA,https://www.ncbi.nlm.nih.gov/pubmed/32098891
13617,32114419,PCAT1/miR-129/ABCB1 axis confers chemoresistance in non-small cell lung cancer,Front Biosci (Landmark Ed). 2020 Mar 1;25(5):948-960. doi: 10.2741/4842.,Tian R,https://www.ncbi.nlm.nih.gov/pubmed/32114419
13619,32165246,Immunoselective algorithm to devise multi-epitope subunit vaccine fighting against human cytomegalovirus infection,Infect Genet Evol. 2020 Aug;82:104282. doi: 10.1016/j.meegid.2020.104282. Epub 2020 Mar 10.,Pandey RK,https://www.ncbi.nlm.nih.gov/pubmed/32165246
13633,32333795,"Tumour-suppressive effect of oestrogen receptor ? in colorectal cancer patients, colon cancer cells, and a zebrafish model",J Pathol. 2020 Jul;251(3):297-309. doi: 10.1002/path.5453. Epub 2020 May 15.,Topi G,https://www.ncbi.nlm.nih.gov/pubmed/32333795
13634,31873309,Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma,Nat Med. 2020 Jan;26(1):39-46. doi: 10.1038/s41591-019-0694-x. Epub 2019 Dec 23.,Goswami S,https://www.ncbi.nlm.nih.gov/pubmed/31873309
13637,32245019,Three-Component Reaction of Diamines with Triethyl Orthoformate and Diethyl Phosphite and Anti-Proliferative and Antiosteoporotic Activities of the Products,Molecules. 2020 Mar 20;25(6):1424. doi: 10.3390/molecules25061424.,Petruczynik P,https://www.ncbi.nlm.nih.gov/pubmed/32245019
13655,31712791,Injection molded open microfluidic well plate inserts for user-friendly coculture and microscopy,Lab Chip. 2020 Jan 7;20(1):107-119. doi: 10.1039/c9lc00706g. Epub 2019 Nov 12.,Day JH,https://www.ncbi.nlm.nih.gov/pubmed/31712791
13656,32113162,BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma,EBioMedicine. 2020 Mar;53:102685. doi: 10.1016/j.ebiom.2020.102685. Epub 2020 Feb 27.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/32113162
13686,32467172,Telomere DNA Damage Signaling Regulates Prostate Cancer Tumorigenesis,Mol Cancer Res. 2020 Sep;18(9):1326-1339. doi: 10.1158/1541-7786.MCR-19-1129. Epub 2020 May 28.,Wu J,https://www.ncbi.nlm.nih.gov/pubmed/32467172
13693,32526394,Label-free detection of multiple genitourinary cancers from urine by surface-enhanced Raman spectroscopy,Spectrochim Acta A Mol Biomol Spectrosc. 2020 Oct 15;240:118543. doi: 10.1016/j.saa.2020.118543. Epub 2020 May 28.,Cui X,https://www.ncbi.nlm.nih.gov/pubmed/32526394
13700,33254188,"Propiedades psicométricas de la Escala de Evaluación Funcional para el Tratamiento del Cáncer, versión próstata (FACT-P), en pacientes mexicanos",Cir Cir. 2020;88(6):745-752. doi: 10.24875/CIRU.19001755.,Espinoza-Bello M,https://www.ncbi.nlm.nih.gov/pubmed/33254188
13701,31765638,Very high levels of PSA in patients with cardiogenic shock: Report of four clinical cases,Clin Biochem. 2020 Feb;76:42-44. doi: 10.1016/j.clinbiochem.2019.11.002. Epub 2019 Nov 22.,Fernández-Galán E,https://www.ncbi.nlm.nih.gov/pubmed/31765638
13703,32212077,Polymorphism of glutathione S-transferase in the population of Polish patients with carcinoma of the prostate,Environ Sci Pollut Res Int. 2020 Jun;27(16):19375-19382. doi: 10.1007/s11356-020-08435-7. Epub 2020 Mar 24.,Drozdz-Afelt JM,https://www.ncbi.nlm.nih.gov/pubmed/32212077
13709,31662480,Just caring: screening needs limits,J Med Ethics. 2020 Apr;46(4):253-254. doi: 10.1136/medethics-2019-105884. Epub 2019 Oct 29.,Fleck LM,https://www.ncbi.nlm.nih.gov/pubmed/31662480
13710,32424251,"Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib",Cell Death Dis. 2020 May 18;11(5):380. doi: 10.1038/s41419-020-2588-8.,Florent R,https://www.ncbi.nlm.nih.gov/pubmed/32424251
13711,32394497,Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK/JNK activation,J Food Biochem. 2020 Jul;44(7):e13253. doi: 10.1111/jfbc.13253. Epub 2020 May 11.,Erdogan S,https://www.ncbi.nlm.nih.gov/pubmed/32394497
13712,30862408,"Impact of androgen deprivation therapy on mood, cognition, and risk for AD",Urol Oncol. 2020 Feb;38(2):53-61. doi: 10.1016/j.urolonc.2019.01.021. Epub 2019 Mar 9.,Cherrier MM,https://www.ncbi.nlm.nih.gov/pubmed/30862408
13713,32030542,Could the kinetin riboside be used to inhibit human prostate cell epithelial-mesenchymal transition?,Med Oncol. 2020 Feb 6;37(3):17. doi: 10.1007/s12032-020-1338-1.,Duli?ska-Litewka J,https://www.ncbi.nlm.nih.gov/pubmed/32030542
13714,32368176,Immune checkpoint inhibitors in genitourinary malignancies,Curr Oncol. 2020 Apr;27(Suppl 2):S69-S77. doi: 10.3747/co.27.5121. Epub 2020 Apr 1.,Thana M,https://www.ncbi.nlm.nih.gov/pubmed/32368176
13715,31994171,A Bayesian multi-risks survival (MRS) model in the presence of double censorings,Biometrics. 2020 Dec;76(4):1297-1309. doi: 10.1111/biom.13228. Epub 2020 Feb 6.,de Castro M,https://www.ncbi.nlm.nih.gov/pubmed/31994171
13717,33775083,Morphological and cytophysiological changes in selected lines of normal and cancer human cells under the influence of a radio-frequency electromagnetic field,Ann Agric Environ Med. 2021 Mar 18;28(1):163-171. doi: 10.26444/aaem/118260. Epub 2020 Mar 17.,Górski R,https://www.ncbi.nlm.nih.gov/pubmed/33775083
13719,31714274,Heterogeneous 68Ga-Prostate-Specific Membrane Antigen Uptake in the Left Upper Abdomen: Mesenchymal Tumor,Clin Nucl Med. 2020 Feb;45(2):e108-e109. doi: 10.1097/RLU.0000000000002793.,Arçay A,https://www.ncbi.nlm.nih.gov/pubmed/31714274
13720,31901811,Unraveling the electrochemical properties of lanthanum cobaltite decorated halloysite nanotube nanocomposite: An advanced electrocatalyst for determination of flutamide in environmental samples,Ecotoxicol Environ Saf. 2020 Mar 1;190:110098. doi: 10.1016/j.ecoenv.2019.110098. Epub 2020 Jan 2.,Suvina V,https://www.ncbi.nlm.nih.gov/pubmed/31901811
13721,32142289,HILIC-MRM-MS for Linkage-Specific Separation of Sialylated Glycopeptides to Quantify Prostate-Specific Antigen Proteoforms,J Proteome Res. 2020 Jul 2;19(7):2708-2716. doi: 10.1021/acs.jproteome.0c00050. Epub 2020 Mar 18.,van der Burgt YEM,https://www.ncbi.nlm.nih.gov/pubmed/32142289
13724,32199776,Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy,J Geriatr Oncol. 2020 May;11(4):579-585. doi: 10.1016/j.jgo.2020.03.001. Epub 2020 Mar 19.,Lu-Yao G,https://www.ncbi.nlm.nih.gov/pubmed/32199776
13725,31321650,"Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403",Mol Imaging Biol. 2020 Apr;22(2):274-284. doi: 10.1007/s11307-019-01404-8.,Ling X,https://www.ncbi.nlm.nih.gov/pubmed/31321650
13726,32313135,Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis,Sci Rep. 2020 Apr 20;10(1):6649. doi: 10.1038/s41598-020-62845-8.,Monga J,https://www.ncbi.nlm.nih.gov/pubmed/32313135
13727,31892604,"Review of Recent Advances in Understanding the Role of Vitamin D in Reducing Cancer Risk: Breast, Colorectal, Prostate, and Overall Cancer",Anticancer Res. 2020 Jan;40(1):491-499. doi: 10.21873/anticanres.13977.,Grant WB,https://www.ncbi.nlm.nih.gov/pubmed/31892604
13732,32294598,PTEN and PHLPP crosstalk in cancer cells and in TGF?-activated stem cells,Biomed Pharmacother. 2020 Jul;127:110112. doi: 10.1016/j.biopha.2020.110112. Epub 2020 Apr 12.,Ghalali A,https://www.ncbi.nlm.nih.gov/pubmed/32294598
13733,32053377,"Accelerated Protein Biomarker Discovery from FFPE Tissue Samples Using Single-Shot, Short Gradient Microflow SWATH MS",J Proteome Res. 2020 Jul 2;19(7):2732-2741. doi: 10.1021/acs.jproteome.9b00671. Epub 2020 Feb 13.,Sun R,https://www.ncbi.nlm.nih.gov/pubmed/32053377
13735,32083799,Discovery of a Class of Potent and Selective Non-competitive Sentrin-Specific Protease 1 Inhibitors,ChemMedChem. 2020 Apr 20;15(8):675-679. doi: 10.1002/cmdc.202000067. Epub 2020 Mar 18.,Lindenmann U,https://www.ncbi.nlm.nih.gov/pubmed/32083799
13736,30927317,ETS transcription factors as emerging drug targets in cancer,Med Res Rev. 2020 Jan;40(1):413-430. doi: 10.1002/med.21575. Epub 2019 Mar 29.,Hsing M,https://www.ncbi.nlm.nih.gov/pubmed/30927317
13737,31604021,Do we underestimate maximal oxygen uptake in cancer survivors? Findings from a supramaximal verification test,Appl Physiol Nutr Metab. 2020 May;45(5):486-492. doi: 10.1139/apnm-2019-0560. Epub 2019 Oct 11.,Schneider J,https://www.ncbi.nlm.nih.gov/pubmed/31604021
13738,32430351,Immune checkpoint inhibitor induced large vessel vasculitis,BMJ Case Rep. 2020 May 18;13(5):e233496. doi: 10.1136/bcr-2019-233496.,Henderson D,https://www.ncbi.nlm.nih.gov/pubmed/32430351
13739,31985089,A causal framework for classical statistical estimands in failure-time settings with competing events,Stat Med. 2020 Apr 15;39(8):1199-1236. doi: 10.1002/sim.8471. Epub 2020 Jan 27.,Young JG,https://www.ncbi.nlm.nih.gov/pubmed/31985089
13741,32062757,Silymarin inhibited DU145 cells by activating SLIT2 protein and suppressing expression of CXCR4,Med Oncol. 2020 Feb 15;37(3):18. doi: 10.1007/s12032-020-1343-4.,Kacar S,https://www.ncbi.nlm.nih.gov/pubmed/32062757
13742,32059077,Apigenin as an anticancer agent,Phytother Res. 2020 Aug;34(8):1812-1828. doi: 10.1002/ptr.6647. Epub 2020 Feb 14.,Imran M,https://www.ncbi.nlm.nih.gov/pubmed/32059077
13743,32498552,Incidence and mortality of cancer in the Volta Region of Ghana,Exp Biol Med (Maywood). 2020 Jun;245(12):1058-1065. doi: 10.1177/1535370220931514. Epub 2020 Jun 4.,Adadey SM,https://www.ncbi.nlm.nih.gov/pubmed/32498552
13745,32114360,"Novel androgen receptor antagonist identified by structure-based virtual screening, structural optimization, and biological evaluation",Eur J Med Chem. 2020 Apr 15;192:112156. doi: 10.1016/j.ejmech.2020.112156. Epub 2020 Feb 21.,Tang Q,https://www.ncbi.nlm.nih.gov/pubmed/32114360
13747,32115964,"Apoptotic effects of thymol, a novel monoterpene phenol, on different types of cancer",Bratisl Lek Listy. 2020;121(2):122-128. doi: 10.4149/BLL_2020_016.,Elbe H,https://www.ncbi.nlm.nih.gov/pubmed/32115964
13748,32106949,A novel fluorescent assay based on DNAzyme-assisted detection of prostate specific antigen for signal amplification,Anal Chim Acta. 2020 Apr 1;1104:172-179. doi: 10.1016/j.aca.2020.01.014. Epub 2020 Jan 9.,Yan Y,https://www.ncbi.nlm.nih.gov/pubmed/32106949
13749,32312453,Highly sensitive impedimetric immunosensor for determination of interleukin 6 as a cancer biomarker by using conjugated polymer containing epoxy side groups modified disposable ITO electrode,Talanta. 2020 Aug 1;215:120909. doi: 10.1016/j.talanta.2020.120909. Epub 2020 Mar 12.,Ayd?n EB,https://www.ncbi.nlm.nih.gov/pubmed/32312453
13750,32290402,Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers,Int J Mol Sci. 2020 Apr 11;21(8):2663. doi: 10.3390/ijms21082663.,Mukai S,https://www.ncbi.nlm.nih.gov/pubmed/32290402
13751,31955292,Anti-Cancer and Anti-Inflammatory Activities of Bromo- and Cyano-Substituted Azulene Derivatives,Inflammation. 2020 Jun;43(3):1009-1018. doi: 10.1007/s10753-020-01186-0.,Ayaz F,https://www.ncbi.nlm.nih.gov/pubmed/31955292
13752,32277685,"ERCC2 Lys751Gln rs13181 and XRCC2 Arg188His rs3218536 Gene Polymorphisms Contribute to Subsceptibility of Colon, Gastric, HCC, Lung And Prostate Cancer",J BUON. 2020 Jan-Feb;25(1):574-581.,Balkan E,https://www.ncbi.nlm.nih.gov/pubmed/32277685
13753,31495243,How can biomarkers assist the prognosis of urologic malignancies?,Expert Rev Mol Diagn. 2020 Feb;20(2):131-133. doi: 10.1080/14737159.2019.1665506. Epub 2019 Sep 9.,Falzarano SM,https://www.ncbi.nlm.nih.gov/pubmed/31495243
13754,32106365,A comprehensive review of the role of long non-coding RNAs in organs with an endocrine function,Biomed Pharmacother. 2020 May;125:110027. doi: 10.1016/j.biopha.2020.110027. Epub 2020 Feb 25.,Ghafouri-Fard S,https://www.ncbi.nlm.nih.gov/pubmed/32106365
13755,31730793,N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications,Prog Neurobiol. 2020 Jan;184:101722. doi: 10.1016/j.pneurobio.2019.101722. Epub 2019 Nov 12.,Neale JH,https://www.ncbi.nlm.nih.gov/pubmed/31730793
13756,33113544,CYP24A1 rs1570669 Variant Has a Protective Effect against Tumors of the Urinary System,Public Health Genomics. 2020;23(5-6):200-209. doi: 10.1159/000509190. Epub 2020 Oct 28.,Sun Y,https://www.ncbi.nlm.nih.gov/pubmed/33113544
13757,32611993,Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis,Chem Pharm Bull (Tokyo). 2020;68(7):560-566. doi: 10.1248/cpb.c20-00017.,Katsumi H,https://www.ncbi.nlm.nih.gov/pubmed/32611993
13758,31309882,"Gonadotropin-Releasing Hormone and GnRH Receptor: Structure, Function and Drug Development",Curr Med Chem. 2020;27(36):6136-6158. doi: 10.2174/0929867326666190712165444.,Tzoupis H,https://www.ncbi.nlm.nih.gov/pubmed/31309882
13763,31928918,Testosterone Therapy: What We Have Learned From Trials,J Sex Med. 2020 Mar;17(3):447-460. doi: 10.1016/j.jsxm.2019.11.270. Epub 2020 Jan 9.,Corona G,https://www.ncbi.nlm.nih.gov/pubmed/31928918
13764,32849263,Bisphenol A-Induced Epigenetic Changes and Its Effects on the Male Reproductive System,Front Endocrinol (Lausanne). 2020 Jul 30;11:453. doi: 10.3389/fendo.2020.00453. eCollection 2020.,Cariati F,https://www.ncbi.nlm.nih.gov/pubmed/32849263
13767,31857722,Syncope as a sign of occult cancers: a population-based cohort study,Br J Cancer. 2020 Feb;122(4):595-600. doi: 10.1038/s41416-019-0692-2. Epub 2019 Dec 20.,Lorenzen MOB,https://www.ncbi.nlm.nih.gov/pubmed/31857722
13768,32598271,Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship,Rev Recent Clin Trials. 2020;15(3):164-177. doi: 10.2174/1574887115666200628143015.,Caprio GG,https://www.ncbi.nlm.nih.gov/pubmed/32598271
13770,31970706,Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high,Ann Nucl Med. 2020 Mar;34(3):200-211. doi: 10.1007/s12149-020-01435-0. Epub 2020 Jan 22.,Koizumi M,https://www.ncbi.nlm.nih.gov/pubmed/31970706
13771,31324710,Can the Injected Dose Be Reduced in (68)Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?,J Nucl Med. 2020 Feb;61(2):189-193. doi: 10.2967/jnumed.119.227207. Epub 2019 Jul 19.,Rauscher I,https://www.ncbi.nlm.nih.gov/pubmed/31324710
13772,31977457,Advanced Case of Achalasia That Appeared on 68Ga-Prostate-Specific Membrane Antigen PET/CT,Clin Nucl Med. 2020 Apr;45(4):301-302. doi: 10.1097/RLU.0000000000002881.,Shakeri S,https://www.ncbi.nlm.nih.gov/pubmed/31977457
13773,32507667,Chronic hepatitis C virus infection and genitourinary cancers: A case-control study,Semin Oncol. 2020 Apr-Jun;47(2-3):165-167. doi: 10.1053/j.seminoncol.2020.04.005. Epub 2020 May 21.,Angelidakis G,https://www.ncbi.nlm.nih.gov/pubmed/32507667
13775,32334022,"Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3'RACE and high-throughput sequencing",Gene. 2020 Jul 30;749:144708. doi: 10.1016/j.gene.2020.144708. Epub 2020 Apr 22.,Adamopoulos PG,https://www.ncbi.nlm.nih.gov/pubmed/32334022
13777,32169115,Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings,Cancer Imaging. 2020 Mar 14;20(1):23. doi: 10.1186/s40644-020-00300-7.,de Galiza Barbosa F,https://www.ncbi.nlm.nih.gov/pubmed/32169115
13778,32275493,Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines,Anticancer Agents Med Chem. 2020;20(8):1009-1016. doi: 10.2174/1871520620666200410075558.,Azizi R,https://www.ncbi.nlm.nih.gov/pubmed/32275493
13779,32090322,Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors study,Cancer. 2020 Jan 1;126(9):1987-1994. doi: 10.1002/cncr.32725. Epub 2020 Feb 24.,Beebe-Dimmer JL,https://www.ncbi.nlm.nih.gov/pubmed/32090322
13785,32469149,Resolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization,J Cell Mol Med. 2020 Jul;24(14):8045-8056. doi: 10.1111/jcmm.15436. Epub 2020 May 29.,Shan K,https://www.ncbi.nlm.nih.gov/pubmed/32469149
13786,31122873,Healthcare providers' discussions of physical activity with older survivors of cancer: Potential missed opportunities for health promotion,J Geriatr Oncol. 2020 Apr;11(3):437-443. doi: 10.1016/j.jgo.2019.05.007. Epub 2019 May 20.,Siembida EJ,https://www.ncbi.nlm.nih.gov/pubmed/31122873
13787,32959621,The Increasing Trends in Cases of the Most Common Cancers in Saudi Arabia,J Epidemiol Glob Health. 2020 Dec;10(4):258-262. doi: 10.2991/jegh.k.200515.001. Epub 2020 May 22.,Chaudhri E,https://www.ncbi.nlm.nih.gov/pubmed/32959621
13788,31929112,Association between SOD2 V16A variant and urological cancer risk,Aging (Albany NY). 2020 Jan 12;12(1):825-843. doi: 10.18632/aging.102658. Epub 2020 Jan 12.,Zhang LF,https://www.ncbi.nlm.nih.gov/pubmed/31929112
13790,31952963,"Neutral analogs of the heat shock protein 70 (Hsp70) inhibitor, JG-98",Bioorg Med Chem Lett. 2020 Mar 1;30(5):126954. doi: 10.1016/j.bmcl.2020.126954. Epub 2020 Jan 11.,Shao H,https://www.ncbi.nlm.nih.gov/pubmed/31952963
13791,33119881,Mast Cells in the Tumor Microenvironment,Adv Exp Med Biol. 2020;1273:159-173. doi: 10.1007/978-3-030-49270-0_9.,Aponte-López A,https://www.ncbi.nlm.nih.gov/pubmed/33119881
13792,32276264,AR-dependent phosphorylation and phospho-proteome targets in prostate cancer,Endocr Relat Cancer. 2020 Jun;27(6):R193-R210. doi: 10.1530/ERC-20-0048.,Venkadakrishnan VB,https://www.ncbi.nlm.nih.gov/pubmed/32276264
13793,31837908,Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers,Trends Endocrinol Metab. 2020 Mar;31(3):256-268. doi: 10.1016/j.tem.2019.11.005. Epub 2019 Dec 11.,Gomaraschi M,https://www.ncbi.nlm.nih.gov/pubmed/31837908
13794,31846828,Development of selective mono or dual PROTAC degrader probe of CDK isoforms,Eur J Med Chem. 2020 Feb 1;187:111952. doi: 10.1016/j.ejmech.2019.111952. Epub 2019 Dec 6.,Zhou F,https://www.ncbi.nlm.nih.gov/pubmed/31846828
13795,32329861,Non-AIDS defining cancers: a comprehensive update on diagnosis and management,Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3849-3875. doi: 10.26355/eurrev_202004_20852.,Ceccarelli M,https://www.ncbi.nlm.nih.gov/pubmed/32329861
13797,31897876,Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors,J Cancer Surviv. 2020 Jun;14(3):316-321. doi: 10.1007/s11764-019-00846-x. Epub 2020 Jan 2.,Pophali PA,https://www.ncbi.nlm.nih.gov/pubmed/31897876
13798,31901746,"Expansion of chemical space based on a pyrrolo[1,2-a]pyrazine core: Synthesis and its anticancer activity in prostate cancer and breast cancer cells",Eur J Med Chem. 2020 Feb 15;188:111988. doi: 10.1016/j.ejmech.2019.111988. Epub 2019 Dec 20.,Seo Y,https://www.ncbi.nlm.nih.gov/pubmed/31901746
13799,32918214,Vitamin D Receptor Polymorphisms and Cancer,Adv Exp Med Biol. 2020;1268:53-114. doi: 10.1007/978-3-030-46227-7_4.,Gnagnarella P,https://www.ncbi.nlm.nih.gov/pubmed/32918214
13800,32374450,Automated synthesis of (68) Ga/(177) Lu-PSMA on the Trasis miniAllinOne,J Labelled Comp Radiopharm. 2020 Jun 30;63(8):393-403. doi: 10.1002/jlcr.3846. Epub 2020 Jun 1.,Sørensen MA,https://www.ncbi.nlm.nih.gov/pubmed/32374450
13801,32472342,"""Katz activities of daily living disability in older cancer survivors by age, stage, and cancer type""",J Cancer Surviv. 2020 Dec;14(6):769-778. doi: 10.1007/s11764-020-00891-x. Epub 2020 May 30.,Blackwood J,https://www.ncbi.nlm.nih.gov/pubmed/32472342
13803,31463517,Cancer incidence among Swedish firefighters: an extended follow-up of the NOCCA study,Int Arch Occup Environ Health. 2020 Feb;93(2):197-204. doi: 10.1007/s00420-019-01472-x. Epub 2019 Aug 28.,Bigert C,https://www.ncbi.nlm.nih.gov/pubmed/31463517
13804,32306177,Cancer risks of firefighters: a systematic review and meta-analysis of secular trends and region-specific differences,Int Arch Occup Environ Health. 2020 Oct;93(7):839-852. doi: 10.1007/s00420-020-01539-0. Epub 2020 Apr 18.,Casjens S,https://www.ncbi.nlm.nih.gov/pubmed/32306177
13805,31715250,Quantitative susceptibility mapping of prostate with separate calculations for water and fat regions for reducing shading artifacts,Magn Reson Imaging. 2020 Feb;66:22-29. doi: 10.1016/j.mri.2019.11.006. Epub 2019 Nov 9.,Sato R,https://www.ncbi.nlm.nih.gov/pubmed/31715250
13810,32169785,Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists,Eur J Med Chem. 2020 Apr 15;192:112196. doi: 10.1016/j.ejmech.2020.112196. Epub 2020 Mar 5.,Xu X,https://www.ncbi.nlm.nih.gov/pubmed/32169785
13811,31834941,Recreational football is medicine against non-communicable diseases: A systematic review,Scand J Med Sci Sports. 2020 Apr;30(4):618-637. doi: 10.1111/sms.13611. Epub 2019 Dec 25.,Sarmento H,https://www.ncbi.nlm.nih.gov/pubmed/31834941
13812,32189442,"Hyperpolarized (13) C MRI data acquisition and analysis in prostate and brain at University of California, San Francisco",NMR Biomed. 2021 May;34(5):e4280. doi: 10.1002/nbm.4280. Epub 2020 Mar 19.,Crane JC,https://www.ncbi.nlm.nih.gov/pubmed/32189442
13814,32012885,Targeting the Immune system and Epigenetic Landscape of Urological Tumors,Int J Mol Sci. 2020 Jan 28;21(3):829. doi: 10.3390/ijms21030829.,Lobo J,https://www.ncbi.nlm.nih.gov/pubmed/32012885
13815,31855065,Relationship between body mass index and concentrations of prostate specific antigen: a cross-sectional study,Scand J Clin Lab Invest. 2020 Feb-Apr;80(2):162-167. doi: 10.1080/00365513.2019.1703217. Epub 2019 Dec 19.,Zhao Y,https://www.ncbi.nlm.nih.gov/pubmed/31855065
13816,32332318,Increased Prostate-Specific Membrane Antigen Uptake in Neurofibromatosis,Clin Nucl Med. 2020 Jun;45(6):465-467. doi: 10.1097/RLU.0000000000003039.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32332318
13817,31678135,Estimation of the inhibiting impact of abiraterone D4A metabolite on human steroid 21-monooxygenase (CYP21A2),Steroids. 2020 Feb;154:108528. doi: 10.1016/j.steroids.2019.108528. Epub 2019 Oct 31.,Masamrekh R,https://www.ncbi.nlm.nih.gov/pubmed/31678135
13818,31987217,Enzyme-free sandwich-type electrochemical immunosensor for highly sensitive prostate specific antigen based on conjugation of quantum dots and antibody on surface of modified glassy carbon electrode with core-shell magnetic metal-organic frameworks,Talanta. 2020 Apr 1;210:120641. doi: 10.1016/j.talanta.2019.120641. Epub 2019 Dec 10.,Ehzari H,https://www.ncbi.nlm.nih.gov/pubmed/31987217
13819,31183632,Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor,Invest New Drugs. 2020 Apr;38(2):525-532. doi: 10.1007/s10637-019-00799-z. Epub 2019 Jun 10.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/31183632
13820,32332302,18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer,Clin Nucl Med. 2020 Jun;45(6):e276-e278. doi: 10.1097/RLU.0000000000003013.,Marafi F,https://www.ncbi.nlm.nih.gov/pubmed/32332302
13821,32233464,Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands,J Am Chem Soc. 2020 Apr 15;142(15):6970-6982. doi: 10.1021/jacs.9b13159. Epub 2020 Apr 1.,Liu X,https://www.ncbi.nlm.nih.gov/pubmed/32233464
13822,32005121,Contribution of Pyk2 pathway and reactive oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic acid (EPA) in PC3 prostate cancer cells,Lipids Health Dis. 2020 Jan 31;19(1):15. doi: 10.1186/s12944-019-1122-4.,Oono K,https://www.ncbi.nlm.nih.gov/pubmed/32005121
13823,32252254,The Number and Position of Orai3 Units within Heteromeric Store-Operated Ca(2+) Channels Alter the Pharmacology of I(CRAC),Int J Mol Sci. 2020 Apr 2;21(7):2458. doi: 10.3390/ijms21072458.,Kappel S,https://www.ncbi.nlm.nih.gov/pubmed/32252254
13824,32493190,Antiproliferative Activity of 8-methoxy Ciprofloxacin-Hydrozone/Acylhydrazone Scaffolds,Curr Top Med Chem. 2020;20(21):1911-1915. doi: 10.2174/1568026620666200603105644.,Wang LP,https://www.ncbi.nlm.nih.gov/pubmed/32493190
13825,32189590,"Synthesis, Antitumor Activity and Molecular Docking Studies on Seven Novel Thiazacridine Derivatives",Comb Chem High Throughput Screen. 2020;23(5):359-368. doi: 10.2174/1386207323666200319105239.,Almeida ML,https://www.ncbi.nlm.nih.gov/pubmed/32189590
13826,32000810,"Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study",J Transl Med. 2020 Jan 30;18(1):39. doi: 10.1186/s12967-020-02228-9.,Aurisicchio L,https://www.ncbi.nlm.nih.gov/pubmed/32000810
13827,32659681,Are vitamins relevant to cancer risks? A Mendelian randomization investigation,Nutrition. 2020 Oct;78:110870. doi: 10.1016/j.nut.2020.110870. Epub 2020 May 29.,Cheng WW,https://www.ncbi.nlm.nih.gov/pubmed/32659681
13828,31755396,"Design, Synthesis and Evaluation of Novel Substituted (5-methyl-1H-pyrazol-3-yl)- 1,3,4-oxadiazole as Potent Androgen Receptor Antagonist",Anticancer Agents Med Chem. 2020;20(1):84-93. doi: 10.2174/1871520619666191121095720.,Andavar S,https://www.ncbi.nlm.nih.gov/pubmed/31755396
13829,31232182,Structure-activity relationship analysis of 3-phenylpyrazole derivatives as androgen receptor antagonists,J Biomol Struct Dyn. 2020 Jun;38(9):2582-2591. doi: 10.1080/07391102.2019.1635913. Epub 2019 Jul 5.,Han W,https://www.ncbi.nlm.nih.gov/pubmed/31232182
13830,31818479,Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors,Bioorg Chem. 2020 Jan;94:103462. doi: 10.1016/j.bioorg.2019.103462. Epub 2019 Dec 2.,Gumede NJ,https://www.ncbi.nlm.nih.gov/pubmed/31818479
13832,32779172,Radiolabelled PSMA PET/CT in breast cancer. A systematic review,Nucl Med Rev Cent East Eur. 2020;23(1):32-35. doi: 10.5603/NMR.2020.0004.,Bertagna F,https://www.ncbi.nlm.nih.gov/pubmed/32779172
13833,31538772,Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model,Chem Res Toxicol. 2020 Jan 21;33(1):211-222. doi: 10.1021/acs.chemrestox.9b00247. Epub 2019 Oct 9.,Ji C,https://www.ncbi.nlm.nih.gov/pubmed/31538772
13834,32128929,Artificial intelligence as the next step towards precision pathology,J Intern Med. 2020 Jul;288(1):62-81. doi: 10.1111/joim.13030. Epub 2020 Mar 3.,Acs B,https://www.ncbi.nlm.nih.gov/pubmed/32128929
13835,32239063,A dual-round signal amplification strategy for colorimetric/photoacoustic/fluorescence triple read-out detection of prostate specific antigen,Chem Commun (Camb). 2020 May 5;56(36):4942-4945. doi: 10.1039/d0cc01086c.,Jiang C,https://www.ncbi.nlm.nih.gov/pubmed/32239063
13836,32849585,The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion,Front Immunol. 2020 Jul 30;11:1680. doi: 10.3389/fimmu.2020.01680. eCollection 2020.,De Cicco P,https://www.ncbi.nlm.nih.gov/pubmed/32849585
13837,32179703,"Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study",Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1107-1119. doi: 10.1158/1055-9965.EPI-19-1623. Epub 2020 Mar 16.,Peila R,https://www.ncbi.nlm.nih.gov/pubmed/32179703
13838,31626910,The 11?-hydroxyandrostenedione pathway and C11-oxy C(21) backdoor pathway are active in benign prostatic hyperplasia yielding 11keto-testosterone and 11keto-progesterone,J Steroid Biochem Mol Biol. 2020 Feb;196:105497. doi: 10.1016/j.jsbmb.2019.105497. Epub 2019 Oct 15.,du Toit T,https://www.ncbi.nlm.nih.gov/pubmed/31626910
13839,31912902,"Cancer statistics, 2020",CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.,Siegel RL,https://www.ncbi.nlm.nih.gov/pubmed/31912902
13840,31295109,3D APA-Net: 3D Adversarial Pyramid Anisotropic Convolutional Network for Prostate Segmentation in MR Images,IEEE Trans Med Imaging. 2020 Feb;39(2):447-457. doi: 10.1109/TMI.2019.2928056. Epub 2019 Jul 11.,Jia H,https://www.ncbi.nlm.nih.gov/pubmed/31295109
13842,31499007,Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies,Expert Rev Mol Diagn. 2020 Feb;20(2):151-167. doi: 10.1080/14737159.2019.1665998. Epub 2019 Sep 18.,Zeuschner P,https://www.ncbi.nlm.nih.gov/pubmed/31499007
13843,31906362,Occupational Class and Cancer Survival in Korean Men: Follow-Up Study of Nation-Wide Working Population,Int J Environ Res Public Health. 2020 Jan 1;17(1):303. doi: 10.3390/ijerph17010303.,Lee HE,https://www.ncbi.nlm.nih.gov/pubmed/31906362
13845,33384976,Association Between Folate and Health Outcomes: An Umbrella Review of Meta-Analyses,Front Public Health. 2020 Dec 15;8:550753. doi: 10.3389/fpubh.2020.550753. eCollection 2020.,Bo Y,https://www.ncbi.nlm.nih.gov/pubmed/33384976
13847,31302306,Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases,Clin Gastroenterol Hepatol. 2020 Apr;18(4):872-880.e1. doi: 10.1016/j.cgh.2019.06.042. Epub 2019 Jul 11.,Axelrad JE,https://www.ncbi.nlm.nih.gov/pubmed/31302306
13848,32366528,Systemic Immune Response and Cancer Risk: Filling the Missing Piece of Immuno-Oncology,Cancer Res. 2020 May 1;80(9):1801-1803. doi: 10.1158/0008-5472.CAN-20-0730.,Song M,https://www.ncbi.nlm.nih.gov/pubmed/32366528
13849,32213156,PD1/PD-L1 Axis in Uro-oncology,Curr Drug Targets. 2020;21(13):1293-1300. doi: 10.2174/1389450121666200326123700.,Junker K,https://www.ncbi.nlm.nih.gov/pubmed/32213156
13850,32043130,Perspectives on Spinal Precautions in Patients Who Have Cancer and Spinal Metastasis,Phys Ther. 2020 Mar 10;100(3):554-563. doi: 10.1093/ptj/pzz178.,Guo Y,https://www.ncbi.nlm.nih.gov/pubmed/32043130
13852,31626397,Development and usability testing of the e-EXCELS tool to guide cancer survivorship follow-up care,Psychooncology. 2020 Jan;29(1):123-131. doi: 10.1002/pon.5222. Epub 2019 Oct 18.,O'Malley DM,https://www.ncbi.nlm.nih.gov/pubmed/31626397
13853,32285614,Association between cancer-specific adverse event triggers and mortality: A validation study,Cancer Med. 2020 Jun;9(12):4447-4459. doi: 10.1002/cam4.3033. Epub 2020 Apr 13.,Weingart SN,https://www.ncbi.nlm.nih.gov/pubmed/32285614
13854,31387396,Anticancer Characteristics of Fomitopsis pinicola Extract in a Xenograft Mouse Model-a Preliminary Study,Nutr Cancer. 2020;72(4):645-652. doi: 10.1080/01635581.2019.1648693. Epub 2019 Aug 7.,Kao CHJ,https://www.ncbi.nlm.nih.gov/pubmed/31387396
13855,32276007,Development of fast deep learning quantification for magnetic resonance fingerprinting in vivo,Magn Reson Imaging. 2020 Jul;70:81-90. doi: 10.1016/j.mri.2020.03.009. Epub 2020 Apr 7.,Cao P,https://www.ncbi.nlm.nih.gov/pubmed/32276007
13856,31504442,Mortality among Italian male workers in the construction industry: a census-based cohort study,Eur J Public Health. 2020 Apr 1;30(2):247-252. doi: 10.1093/eurpub/ckz129.,Alicandro G,https://www.ncbi.nlm.nih.gov/pubmed/31504442
13857,32400187,"Euphopanes A-C, three new diterpenoids from Euphorbia pekinensis",Nat Prod Res. 2022 Jan;36(1):114-121. doi: 10.1080/14786419.2020.1765342. Epub 2020 May 13.,Yan XL,https://www.ncbi.nlm.nih.gov/pubmed/32400187
13858,32398099,Relative survival in early-stage cancers in the Netherlands: a population-based study,J Hematol Oncol. 2020 May 12;13(1):49. doi: 10.1186/s13045-020-00888-0.,Dinmohamed AG,https://www.ncbi.nlm.nih.gov/pubmed/32398099
13860,32157920,Theranostic approaches in nuclear medicine: current status and future prospects,Expert Rev Med Devices. 2020 Apr;17(4):331-343. doi: 10.1080/17434440.2020.1741348. Epub 2020 Mar 19.,Filippi L,https://www.ncbi.nlm.nih.gov/pubmed/32157920
13861,32446600,Reviewing the Evidence on Vitamin D Supplementation in the Management of Testosterone Status and Its Effects on Male Reproductive System (Testis and Prostate): Mechanistically Dazzling but Clinically Disappointing,Clin Ther. 2020 Jun;42(6):e101-e114. doi: 10.1016/j.clinthera.2020.03.016. Epub 2020 May 21.,Santos HO,https://www.ncbi.nlm.nih.gov/pubmed/32446600
13862,31858624,Estimating the magnitude of cancer overdiagnosis in Australia,Med J Aust. 2020 Mar;212(4):163-168. doi: 10.5694/mja2.50455. Epub 2019 Dec 19.,Glasziou PP,https://www.ncbi.nlm.nih.gov/pubmed/31858624
13863,32307270,Quantitative Characterization of the Prostatic Urethra Using MRI: Implications for Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia,Acad Radiol. 2021 May;28(5):664-670. doi: 10.1016/j.acra.2020.03.017. Epub 2020 Apr 16.,Sanford TH,https://www.ncbi.nlm.nih.gov/pubmed/32307270
13864,31884798,"miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review",Neoplasma. 2020 Mar;67(2):215-228. doi: 10.4149/neo_2019_190401N282. Epub 2019 Dec 23.,Guo CM,https://www.ncbi.nlm.nih.gov/pubmed/31884798
13865,31660812,Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action,Mini Rev Med Chem. 2020;20(8):638-661. doi: 10.2174/1389557519666191029130310.,Shakya B,https://www.ncbi.nlm.nih.gov/pubmed/31660812
13866,32485310,An update on vitamin D signaling and cancer,Semin Cancer Biol. 2022 Feb;79:217-230. doi: 10.1016/j.semcancer.2020.05.018. Epub 2020 May 30.,Carlberg C,https://www.ncbi.nlm.nih.gov/pubmed/32485310
13867,31996368,TRPV6 as a Putative Genomic Susceptibility Locus Influencing Racial Disparities in Cancer,Cancer Prev Res (Phila). 2020 May;13(5):423-428. doi: 10.1158/1940-6207.CAPR-19-0351. Epub 2020 Jan 29.,Francis-Lyon PA,https://www.ncbi.nlm.nih.gov/pubmed/31996368
13868,33778711,High-Resolution Photoacoustic Tomography for Early-Stage Cancer Detection and Its Clinical Translation,Radiol Imaging Cancer. 2020 May 22;2(3):e190030. doi: 10.1148/rycan.2020190030. eCollection 2020 May.,Zhang J,https://www.ncbi.nlm.nih.gov/pubmed/33778711
13869,32360170,"A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial",Urol Oncol. 2020 Aug;38(8):683.e1-683.e10. doi: 10.1016/j.urolonc.2020.03.011. Epub 2020 Apr 30.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32360170
13871,31072247,Affinity-based measures of biomarker performance evaluation,Stat Methods Med Res. 2020 Mar;29(3):837-853. doi: 10.1177/0962280219846157. Epub 2019 May 10.,Carvalho M,https://www.ncbi.nlm.nih.gov/pubmed/31072247
13872,31924727,Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine,J Nucl Med. 2020 Mar;61(3):311-318. doi: 10.2967/jnumed.118.220665. Epub 2020 Jan 10.,Solnes LB,https://www.ncbi.nlm.nih.gov/pubmed/31924727
13873,31910619,Paclitaxel-Potentiated Photodynamic Theranostics for Synergistic Tumor Ablation and Precise Anticancer Efficacy Monitoring,ACS Appl Mater Interfaces. 2020 Feb 5;12(5):5476-5487. doi: 10.1021/acsami.9b19073. Epub 2020 Jan 22.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/31910619
13874,32527682,Patients' Perspective on Digital Technologies in Advanced Genitourinary Cancers,Clin Genitourin Cancer. 2021 Feb;19(1):76-82.e6. doi: 10.1016/j.clgc.2020.03.018. Epub 2020 Apr 7.,Rodler S,https://www.ncbi.nlm.nih.gov/pubmed/32527682
13875,32423699,Changes in chronic medication adherence in older adults with cancer versus matched cancer-free cohorts,J Geriatr Oncol. 2021 Jan;12(1):72-79. doi: 10.1016/j.jgo.2020.04.012. Epub 2020 May 15.,Lund JL,https://www.ncbi.nlm.nih.gov/pubmed/32423699
13876,33376561,TRPV2: A Cancer Biomarker and Potential Therapeutic Target,Dis Markers. 2020 Dec 10;2020:8892312. doi: 10.1155/2020/8892312. eCollection 2020.,Siveen KS,https://www.ncbi.nlm.nih.gov/pubmed/33376561
13879,31580497,Changes in internet use and wishes of cancer survivors: A comparison between 2005 and 2017,Cancer. 2020 Jan 15;126(2):408-415. doi: 10.1002/cncr.32524. Epub 2019 Oct 3.,van Eenbergen MCHJ,https://www.ncbi.nlm.nih.gov/pubmed/31580497
13880,32075798,Circulating Immune Cell Composition and Cancer Risk: A Prospective Study Using Epigenetic Cell Count Measures,Cancer Res. 2020 May 1;80(9):1885-1892. doi: 10.1158/0008-5472.CAN-19-3178. Epub 2020 Feb 19.,Le Cornet C,https://www.ncbi.nlm.nih.gov/pubmed/32075798
13881,31883923,Structure-dependent retention of steroid hormones by common laboratory materials,J Steroid Biochem Mol Biol. 2020 Apr;198:105572. doi: 10.1016/j.jsbmb.2019.105572. Epub 2019 Dec 26.,McManus JM,https://www.ncbi.nlm.nih.gov/pubmed/31883923
13882,31819165,Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy,Oncogene. 2020 Mar;39(11):2231-2242. doi: 10.1038/s41388-019-1138-2. Epub 2019 Dec 9.,Dong X,https://www.ncbi.nlm.nih.gov/pubmed/31819165
13883,32168548,"Determining the Drug-Like Properties of Ailanthone, a Novel Chinese Medicine Monomer with Anti-CRPC Activity",Planta Med. 2020 May;86(7):482-488. doi: 10.1055/a-1125-0385. Epub 2020 Mar 13.,Hu P,https://www.ncbi.nlm.nih.gov/pubmed/32168548
13885,32470346,Background-free cell surface glycan analysis using persistent luminescence nanoparticle as an optical probe,Anal Biochem. 2020 Jul 15;601:113780. doi: 10.1016/j.ab.2020.113780. Epub 2020 May 26.,He N,https://www.ncbi.nlm.nih.gov/pubmed/32470346
13887,31030314,"Anticancer activity, apoptosis and a structure-activity analysis of a series of 1,4-naphthoquinone-2,3-bis-sulfides",Invest New Drugs. 2020 Apr;38(2):274-286. doi: 10.1007/s10637-019-00775-7. Epub 2019 Apr 27.,Wellington KW,https://www.ncbi.nlm.nih.gov/pubmed/31030314
13888,31688914,Network-based multi-task learning models for biomarker selection and cancer outcome prediction,Bioinformatics. 2020 Mar 1;36(6):1814-1822. doi: 10.1093/bioinformatics/btz809.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/31688914
13891,32683879,Complete Response to Chemotherapy in Metastatic Pancreatic Carcinoma Associated with Double Heterozygous Germline Mutation in BRCA2 and CHEK2 Genes - a Case Report,Klin Onkol. 2020 Spring;33(3):220-225. doi: 10.14735/amko2020220.,Pazderová N,https://www.ncbi.nlm.nih.gov/pubmed/32683879
13893,31863763,"The molecular mechanisms associated with PIN7, a protein-protein interaction network of seven pleiotropic proteins",J Theor Biol. 2020 Feb 21;487:110124. doi: 10.1016/j.jtbi.2019.110124. Epub 2019 Dec 18.,Nahálková J,https://www.ncbi.nlm.nih.gov/pubmed/31863763
13894,32423612,Testosterone deficiency syndrome: Diagnosis and treatment,Actas Urol Esp (Engl Ed). 2020 Jun;44(5):294-300. doi: 10.1016/j.acuro.2019.10.009. Epub 2020 May 15.,García-Cruz E,https://www.ncbi.nlm.nih.gov/pubmed/32423612
13895,32108698,Myelodysplastic Syndrome Presenting With Diffuse Bone Marrow Uptake on 68Ga-PSMA PET/CT,Clin Nucl Med. 2020 Apr;45(4):330-333. doi: 10.1097/RLU.0000000000002964.,Arslan ?,https://www.ncbi.nlm.nih.gov/pubmed/32108698
13899,31625482,Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas,Curr Radiopharm. 2020;13(2):94-98. doi: 10.2174/1874471012666191017093721.,Bertagna F,https://www.ncbi.nlm.nih.gov/pubmed/31625482
13900,31833725,Artificial intelligence and neural networks in urology: current clinical applications,Minerva Urol Nefrol. 2020 Feb;72(1):49-57. doi: 10.23736/S0393-2249.19.03613-0. Epub 2019 Dec 12.,Checcucci E,https://www.ncbi.nlm.nih.gov/pubmed/31833725
13902,31952272,Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights,Molecules. 2020 Jan 15;25(2):358. doi: 10.3390/molecules25020358.,Anestis A,https://www.ncbi.nlm.nih.gov/pubmed/31952272
13904,32338091,Recent progress on the role and molecular mechanism of chicken ovalbumin upstream promoter-transcription factor II in cancer,J Int Med Res. 2020 Apr;48(4):300060520919236. doi: 10.1177/0300060520919236.,Yun SH,https://www.ncbi.nlm.nih.gov/pubmed/32338091
13905,31273910,Advances of In Vivo Flow Cytometry on Cancer Studies,Cytometry A. 2020 Jan;97(1):15-23. doi: 10.1002/cyto.a.23851. Epub 2019 Jul 5.,Suo Y,https://www.ncbi.nlm.nih.gov/pubmed/31273910
13906,32335090,Establishment of age-related prostate-specific antigen (PSA) reference limits in the Algerian population: A comparison of four indirect methods,Clin Chim Acta. 2020 Aug;507:149-155. doi: 10.1016/j.cca.2020.04.021. Epub 2020 Apr 23.,Mohamed Mokhtar K,https://www.ncbi.nlm.nih.gov/pubmed/32335090
13907,31827264,Extracellular vesicles in urological malignancies: an update,Nat Rev Urol. 2020 Jan;17(1):11-27. doi: 10.1038/s41585-019-0261-8. Epub 2019 Dec 11.,Linxweiler J,https://www.ncbi.nlm.nih.gov/pubmed/31827264
13908,31810566,Three-dimensional (3D) hierarchical oxygen plasma micro/nanostructured polymeric substrates for selective enrichment of cancer cells from mixtures with normal ones,Colloids Surf B Biointerfaces. 2020 Mar;187:110675. doi: 10.1016/j.colsurfb.2019.110675. Epub 2019 Nov 26.,Kanioura A,https://www.ncbi.nlm.nih.gov/pubmed/31810566
13909,31504186,DeepCOP: deep learning-based approach to predict gene regulating effects of small molecules,Bioinformatics. 2020 Feb 1;36(3):813-818. doi: 10.1093/bioinformatics/btz645.,Woo G,https://www.ncbi.nlm.nih.gov/pubmed/31504186
13912,32252965,Anti-Müllerian hormone levels and risk of cancer: A systematic review,Maturitas. 2020 May;135:53-67. doi: 10.1016/j.maturitas.2020.03.002. Epub 2020 Mar 9.,Verdiesen RMG,https://www.ncbi.nlm.nih.gov/pubmed/32252965
13913,31996469,"Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer",Mol Cancer Res. 2020 Apr;18(4):517-528. doi: 10.1158/1541-7786.MCR-19-0768. Epub 2020 Jan 29.,Oliveira KCS,https://www.ncbi.nlm.nih.gov/pubmed/31996469
13914,32142162,Cancer in Mozambique: Results from two population-based cancer registries,Int J Cancer. 2020 Sep 15;147(6):1629-1637. doi: 10.1002/ijc.32953. Epub 2020 Mar 18.,Lorenzoni CF,https://www.ncbi.nlm.nih.gov/pubmed/32142162
13915,32034500,Challenges facing the urologist in low- and middle-income countries,World J Urol. 2020 Nov;38(11):2987-2994. doi: 10.1007/s00345-020-03101-6. Epub 2020 Feb 7.,Metzler I,https://www.ncbi.nlm.nih.gov/pubmed/32034500
13916,32380649,"Phage Display Selection, Identification, and Characterization of Novel Pancreatic Cancer Targeting Peptides",Biomolecules. 2020 May 5;10(5):714. doi: 10.3390/biom10050714.,Asar MC,https://www.ncbi.nlm.nih.gov/pubmed/32380649
13918,31598632,Single-sample landscape entropy reveals the imminent phase transition during disease progression,Bioinformatics. 2020 Mar 1;36(5):1522-1532. doi: 10.1093/bioinformatics/btz758.,Liu R,https://www.ncbi.nlm.nih.gov/pubmed/31598632
13919,32246432,Psychometric properties of the FACT-G quality of life scale for family caregivers of cancer patients,Qual Life Res. 2020 Aug;29(8):2241-2252. doi: 10.1007/s11136-020-02477-7. Epub 2020 Apr 3.,Song L,https://www.ncbi.nlm.nih.gov/pubmed/32246432
13921,32091879,Alkaline Phosphatase-Triggered in Situ Formation of Silicon-Containing Nanoparticles for a Fluorometric and Colorimetric Dual-Channel Immunoassay,Anal Chem. 2020 Mar 17;92(6):4639-4646. doi: 10.1021/acs.analchem.0c00224. Epub 2020 Mar 5.,Chen C,https://www.ncbi.nlm.nih.gov/pubmed/32091879
13922,31937922,Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival,Br J Cancer. 2020 Mar;122(6):801-811. doi: 10.1038/s41416-019-0726-9. Epub 2020 Jan 15.,Nanou A,https://www.ncbi.nlm.nih.gov/pubmed/31937922
13924,31977478,Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging,Clin Nucl Med. 2020 Mar;45(3):e176-e177. doi: 10.1097/RLU.0000000000002922.,Erhamamci S,https://www.ncbi.nlm.nih.gov/pubmed/31977478
13925,32349323,Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy,Int J Mol Sci. 2020 Apr 27;21(9):3085. doi: 10.3390/ijms21093085.,Sanfilippo V,https://www.ncbi.nlm.nih.gov/pubmed/32349323
13926,31625663,Prostate diffusion MRI with minimal echo time using eddy current nulled convex optimized diffusion encoding,J Magn Reson Imaging. 2020 May;51(5):1526-1539. doi: 10.1002/jmri.26960. Epub 2019 Oct 18.,Zhang Z,https://www.ncbi.nlm.nih.gov/pubmed/31625663
13927,33178195,Cutibacterium acnes Infection Induces Type I Interferon Synthesis Through the cGAS-STING Pathway,Front Immunol. 2020 Oct 15;11:571334. doi: 10.3389/fimmu.2020.571334. eCollection 2020.,Fischer K,https://www.ncbi.nlm.nih.gov/pubmed/33178195
13928,31655351,Fully automated preparation of (68)Ga-PSMA-11?at?curie level quantity using cyclotron-produced (68)Ga for clinical applications,Appl Radiat Isot. 2020 Jan;155:108936. doi: 10.1016/j.apradiso.2019.108936. Epub 2019 Oct 11.,Lin M,https://www.ncbi.nlm.nih.gov/pubmed/31655351
13930,31767345,Post-enrichment circulating tumor cell detection and enumeration via deformability impedance cytometry,Biosens Bioelectron. 2020 Feb 15;150:111868. doi: 10.1016/j.bios.2019.111868. Epub 2019 Nov 11.,Ghassemi P,https://www.ncbi.nlm.nih.gov/pubmed/31767345
13932,31913499,Fear of cancer recurrence promotes cancer screening behaviors among family caregivers of cancer survivors,Cancer. 2020 Apr 15;126(8):1784-1792. doi: 10.1002/cncr.32701. Epub 2020 Jan 8.,Takeuchi E,https://www.ncbi.nlm.nih.gov/pubmed/31913499
13933,31855692,Exogenous hormones and hereditary angioedema,Int Immunopharmacol. 2020 Jan;78:106080. doi: 10.1016/j.intimp.2019.106080. Epub 2019 Dec 16.,Gompel A,https://www.ncbi.nlm.nih.gov/pubmed/31855692
13934,33453868,Advances in lung cancer biomarkers: The role of (metal-) metabolites and selenoproteins,Adv Clin Chem. 2021;100:91-137. doi: 10.1016/bs.acc.2020.04.003. Epub 2020 May 23.,Callejón-Leblic B,https://www.ncbi.nlm.nih.gov/pubmed/33453868
13935,33043705,COVID-19 in Cancer Patients From New York City: A Comparative Single Center Retrospective Analysis,Cancer Control. 2020 Jan-Dec;27(1):1073274820960457. doi: 10.1177/1073274820960457.,Ramachandran P,https://www.ncbi.nlm.nih.gov/pubmed/33043705
13936,32017918,Management of Hsp90-Dependent Protein Folding by Small Molecules Targeting the Aha1 Co-Chaperone,Cell Chem Biol. 2020 Mar 19;27(3):292-305.e6. doi: 10.1016/j.chembiol.2020.01.008. Epub 2020 Feb 3.,Singh JK,https://www.ncbi.nlm.nih.gov/pubmed/32017918
13937,32369335,Nanostructured Architectures Promote the Mesenchymal-Epithelial Transition for Invasive Cells,ACS Nano. 2020 May 26;14(5):5324-5336. doi: 10.1021/acsnano.9b07350. Epub 2020 May 11.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/32369335
13938,32143309,Beneficial Properties of Green Tea Catechins,Int J Mol Sci. 2020 Mar 4;21(5):1744. doi: 10.3390/ijms21051744.,Musial C,https://www.ncbi.nlm.nih.gov/pubmed/32143309
13939,31648651,Dietary Phenolic Acids and Flavonoids as Potential Anti-Cancer Agents: Current State of the Art and Future Perspectives,Anticancer Agents Med Chem. 2020;20(1):29-48. doi: 10.2174/1871520619666191019112712.,Bonta RK,https://www.ncbi.nlm.nih.gov/pubmed/31648651
13940,32048067,Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy,Curr Oncol Rep. 2020 Feb 11;22(3):23. doi: 10.1007/s11912-020-0891-2.,Samuels N,https://www.ncbi.nlm.nih.gov/pubmed/32048067
13941,33081658,Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature,Curr Med Imaging. 2020;16(8):957-966. doi: 10.2174/1573405615666191210103452.,Frantellizzi V,https://www.ncbi.nlm.nih.gov/pubmed/33081658
13942,31742328,Glycoxidative profile of cancer patient serum: A clinical result to associate glycation to cancer,Glycobiology. 2020 Feb 19;30(3):152-158. doi: 10.1093/glycob/cwz093.,Khan H,https://www.ncbi.nlm.nih.gov/pubmed/31742328
13943,31882366,Recent cancer incidence trends in Ukraine and short-term predictions to 2022,Cancer Epidemiol. 2020 Apr;65:101663. doi: 10.1016/j.canep.2019.101663. Epub 2019 Dec 24.,Ryzhov A,https://www.ncbi.nlm.nih.gov/pubmed/31882366
13944,32040502,A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells,PLoS Comput Biol. 2020 Feb 10;16(2):e1007619. doi: 10.1371/journal.pcbi.1007619. eCollection 2020 Feb.,Tripathi S,https://www.ncbi.nlm.nih.gov/pubmed/32040502
13945,31889220,Drugs Causing Bone Loss,Handb Exp Pharmacol. 2020;262:475-497. doi: 10.1007/164_2019_340.,Vestergaard P,https://www.ncbi.nlm.nih.gov/pubmed/31889220
13947,31862804,Radiohybrid Ligands: A Novel Tracer Concept Exemplified by (18)F- or (68)Ga-Labeled rhPSMA Inhibitors,J Nucl Med. 2020 May;61(5):735-742. doi: 10.2967/jnumed.119.234922. Epub 2019 Dec 20.,Wurzer A,https://www.ncbi.nlm.nih.gov/pubmed/31862804
13949,31645015,Neoplastic metastases to the endocrine glands,Endocr Relat Cancer. 2020 Jan;27(1):R1-R20. doi: 10.1530/ERC-19-0263.,Angelousi A,https://www.ncbi.nlm.nih.gov/pubmed/31645015
13950,30588834,"Straightforward synthesis, characterization, and cytotoxicity evaluation of hybrids of natural alkaloid evodiamine/rutaecarpine and thieno[2,3-d]pyrimidinones",J Asian Nat Prod Res. 2020 Jan;22(1):69-82. doi: 10.1080/10286020.2018.1540599. Epub 2018 Dec 27.,Nie LF,https://www.ncbi.nlm.nih.gov/pubmed/30588834
13952,32464498,The effects of shift work and sleep duration on cancer incidence in Alberta`s Tomorrow Project cohort,Cancer Epidemiol. 2020 Aug;67:101729. doi: 10.1016/j.canep.2020.101729. Epub 2020 May 25.,McNeil J,https://www.ncbi.nlm.nih.gov/pubmed/32464498
13953,31200028,Identification of novel alternative transcripts of the human Ribonuclease ? (RNASEK) gene using 3' RACE and high-throughput sequencing approaches,Genomics. 2020 Jan;112(1):943-951. doi: 10.1016/j.ygeno.2019.06.010. Epub 2019 Jun 11.,Adamopoulos PG,https://www.ncbi.nlm.nih.gov/pubmed/31200028
13954,31653969,The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature,Lab Invest. 2020 Feb;100(2):186-198. doi: 10.1038/s41374-019-0333-7. Epub 2019 Oct 25.,Santoni G,https://www.ncbi.nlm.nih.gov/pubmed/31653969
13955,32018227,Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis,Aging (Albany NY). 2020 Feb 4;12(3):2142-2155. doi: 10.18632/aging.102731. Epub 2020 Feb 4.,Jin BR,https://www.ncbi.nlm.nih.gov/pubmed/32018227
13957,31985200,Extended Recognition of the Histone H3 Tail by Histone Demethylase KDM5A,Biochemistry. 2020 Feb 11;59(5):647-651. doi: 10.1021/acs.biochem.9b01036. Epub 2020 Jan 30.,Petronikolou N,https://www.ncbi.nlm.nih.gov/pubmed/31985200
13959,32090545,DNA Framework-Mediated Electrochemical Biosensing Platform for Amplification-Free MicroRNA Analysis,Anal Chem. 2020 Mar 17;92(6):4498-4503. doi: 10.1021/acs.analchem.9b05616. Epub 2020 Mar 3.,Wen Y,https://www.ncbi.nlm.nih.gov/pubmed/32090545
13960,31586605,"Anti-androgenic effect of 6-formylindolo[3,2-b]carbazole (FICZ) in LNCaP cells is mediated by the aryl hydrocarbon-androgen receptors cross-talk",Steroids. 2020 Jan;153:108508. doi: 10.1016/j.steroids.2019.108508. Epub 2019 Oct 3.,Arabnezhad MR,https://www.ncbi.nlm.nih.gov/pubmed/31586605
13963,32474842,Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug,Cancer Chemother Pharmacol. 2020 Jun;85(6):1153-1163. doi: 10.1007/s00280-020-04041-z. Epub 2020 May 30.,Juarez M,https://www.ncbi.nlm.nih.gov/pubmed/32474842
13964,31504082,Dried Fruit Intake and Cancer: A Systematic Review of Observational Studies,Adv Nutr. 2020 Mar 1;11(2):237-250. doi: 10.1093/advances/nmz085.,Mossine VV,https://www.ncbi.nlm.nih.gov/pubmed/31504082
13966,31812467,"Synthesis and anticancer activity of novel 9,13-disubstituted berberine derivatives",Bioorg Med Chem Lett. 2020 Jan 15;30(2):126821. doi: 10.1016/j.bmcl.2019.126821. Epub 2019 Nov 16.,Wang ZC,https://www.ncbi.nlm.nih.gov/pubmed/31812467
13967,32039820,Silencing of long non-coding RNA PCAT6 restrains gastric cancer cell proliferation and epithelial-mesenchymal transition by targeting microRNA-15a,Gen Physiol Biophys. 2020 Jan;39(1):1-12. doi: 10.4149/gpb_2019044.,Dong D,https://www.ncbi.nlm.nih.gov/pubmed/32039820
13968,31204609,Ligand screening to pre-miRNA 149 G-quadruplex investigated by molecular dynamics,J Biomol Struct Dyn. 2020 May;38(8):2276-2286. doi: 10.1080/07391102.2019.1632743. Epub 2019 Jul 5.,Carvalho J,https://www.ncbi.nlm.nih.gov/pubmed/31204609
13971,31820173,Gonadal Hormones and Bone,Handb Exp Pharmacol. 2020;262:65-91. doi: 10.1007/164_2019_327.,Yoshida T,https://www.ncbi.nlm.nih.gov/pubmed/31820173
13972,31988307,The transcription elongation factor TCEA3 induces apoptosis in rhabdomyosarcoma,Cell Death Dis. 2020 Jan 27;11(1):67. doi: 10.1038/s41419-020-2258-x.,Kazim N,https://www.ncbi.nlm.nih.gov/pubmed/31988307
13973,32020713,Consequences of physical inactivity in older adults: A systematic review of reviews and meta-analyses,Scand J Med Sci Sports. 2020 May;30(5):816-827. doi: 10.1111/sms.13616. Epub 2020 Feb 4.,Cunningham C,https://www.ncbi.nlm.nih.gov/pubmed/32020713
13974,32923127,The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines,Oncoimmunology. 2020 Jun 1;9(1):1771142. doi: 10.1080/2162402X.2020.1771142.,Weis-Banke SE,https://www.ncbi.nlm.nih.gov/pubmed/32923127
13975,32466280,Fractalkine/CX3CL1 in Neoplastic Processes,Int J Mol Sci. 2020 May 25;21(10):3723. doi: 10.3390/ijms21103723.,Korbecki J,https://www.ncbi.nlm.nih.gov/pubmed/32466280
13976,31622214,Discovering Therapeutic Protein Targets for Bladder Cancer Using Proteomic Data Analysis,Curr Mol Pharmacol. 2020;13(2):150-172. doi: 10.2174/1874467212666191016124935.,Bahrami S,https://www.ncbi.nlm.nih.gov/pubmed/31622214
13977,30955459,Cancer Diagnosis and Suicide Mortality: A Systematic Review and Meta-Analysis,Arch Suicide Res. 2020;24(sup2):S94-S112. doi: 10.1080/13811118.2019.1596182. Epub 2019 May 9.,Amiri S,https://www.ncbi.nlm.nih.gov/pubmed/30955459
13978,30955466,The impact of new cancer drug therapies on site specialised cancer treatment activity in a UK cancer network 2014-2018,J Oncol Pharm Pract. 2020 Jan;26(1):93-98. doi: 10.1177/1078155219839445. Epub 2019 Apr 7.,Bhimani J,https://www.ncbi.nlm.nih.gov/pubmed/30955466
13979,30497305,The effects of multidisciplinary psychosocial interventions on adult cancer patients: a systematic review and meta-analysis(),Disabil Rehabil. 2020 Apr;42(8):1062-1070. doi: 10.1080/09638288.2018.1515265. Epub 2018 Nov 29.,Myrhaug HT,https://www.ncbi.nlm.nih.gov/pubmed/30497305
13981,31199182,Dairy foods and health: an umbrella review of observational studies,Int J Food Sci Nutr. 2020 Mar;71(2):138-151. doi: 10.1080/09637486.2019.1625035. Epub 2019 Jun 14.,Godos J,https://www.ncbi.nlm.nih.gov/pubmed/31199182
13982,32245899,Molecular Imaging of Bone Metastases and Their Response to Therapy,J Nucl Med. 2020 Jun;61(6):799-806. doi: 10.2967/jnumed.119.234260. Epub 2020 Apr 3.,Cook GJR,https://www.ncbi.nlm.nih.gov/pubmed/32245899
13984,32444914,Society of skeletal radiology member utilization and performance of whole-body MRI in adults,Skeletal Radiol. 2020 Nov;49(11):1731-1736. doi: 10.1007/s00256-020-03471-3. Epub 2020 May 22.,Feldhaus JM,https://www.ncbi.nlm.nih.gov/pubmed/32444914
13986,31884084,Polyphotosensitizer nanogels for GSH-responsive histone deacetylase inhibitors delivery and enhanced cancer photodynamic therapy,Colloids Surf B Biointerfaces. 2020 Apr;188:110753. doi: 10.1016/j.colsurfb.2019.110753. Epub 2019 Dec 23.,Liu N,https://www.ncbi.nlm.nih.gov/pubmed/31884084
13988,32457453,Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer,Sci Rep. 2020 May 26;10(1):8710. doi: 10.1038/s41598-020-65536-6.,Sui Y,https://www.ncbi.nlm.nih.gov/pubmed/32457453
13989,32237745,"MEDICASCY: A Machine Learning Approach for Predicting Small-Molecule Drug Side Effects, Indications, Efficacy, and Modes of Action",Mol Pharm. 2020 May 4;17(5):1558-1574. doi: 10.1021/acs.molpharmaceut.9b01248. Epub 2020 Apr 13.,Zhou H,https://www.ncbi.nlm.nih.gov/pubmed/32237745
13990,32000647,"Synthesis, Biological and Computational Evaluation of Novel 2,3-dihydro-2-aryl-4-(4- isobutylphenyl)-1,5-benzothiazepine Derivatives as Anticancer and Anti-EGFR Tyrosine Kinase Agents",Anticancer Agents Med Chem. 2020;20(9):1115-1128. doi: 10.2174/1871520620666200130091142.,Shaik AB,https://www.ncbi.nlm.nih.gov/pubmed/32000647
13991,31767348,3D printed microfluidic devices for circulating tumor cells (CTCs) isolation,Biosens Bioelectron. 2020 Feb 15;150:111900. doi: 10.1016/j.bios.2019.111900. Epub 2019 Nov 16.,Chen J,https://www.ncbi.nlm.nih.gov/pubmed/31767348
13992,31889654,Risk of Ischemic Stroke and Major Bleeding in Patients with Atrial Fibrillation and Cancer,J Stroke Cerebrovasc Dis. 2020 Mar;29(3):104560. doi: 10.1016/j.jstrokecerebrovasdis.2019.104560. Epub 2019 Dec 27.,Aspberg S,https://www.ncbi.nlm.nih.gov/pubmed/31889654
13993,32199690,Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors,Bioorg Med Chem. 2020 May 1;28(9):115433. doi: 10.1016/j.bmc.2020.115433. Epub 2020 Mar 13.,Donkor IO,https://www.ncbi.nlm.nih.gov/pubmed/32199690
13994,31496392,"Employment Outcomes, Financial Burden, Anxiety, and Depression Among Caregivers of African American Cancer Survivors",JCO Oncol Pract. 2020 Mar;16(3):e221-e233. doi: 10.1200/JOP.19.00410. Epub 2019 Sep 7.,Hastert TA,https://www.ncbi.nlm.nih.gov/pubmed/31496392
13995,31759851,"Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug",Bioorg Med Chem Lett. 2020 Jan 1;30(1):126744. doi: 10.1016/j.bmcl.2019.126744. Epub 2019 Nov 8.,Shimizu T,https://www.ncbi.nlm.nih.gov/pubmed/31759851
13996,31937175,Identification of key genes involved in the pathogenesis of cutaneous melanoma using bioinformatics analysis,J Int Med Res. 2020 Jan;48(1):300060519895867. doi: 10.1177/0300060519895867.,Chen J,https://www.ncbi.nlm.nih.gov/pubmed/31937175
13997,32097010,Novel ?- and ?-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen,J Med Chem. 2020 Mar 26;63(6):3261-3273. doi: 10.1021/acs.jmedchem.9b02022. Epub 2020 Mar 9.,Kim K,https://www.ncbi.nlm.nih.gov/pubmed/32097010
13998,32485892,"Synthesis, Characterization and Biological Evaluation of Metal Adamantyl 2-Pyridylhydrazone Complexes",Molecules. 2020 May 29;25(11):2530. doi: 10.3390/molecules25112530.,Shehadi IA,https://www.ncbi.nlm.nih.gov/pubmed/32485892
13999,32403965,Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases,Int J Surg Pathol. 2020 Oct;28(7):728-734. doi: 10.1177/1066896920918289. Epub 2020 May 13.,Zhou L,https://www.ncbi.nlm.nih.gov/pubmed/32403965
14000,31612408,Expression and function of FRA1 protein in tumors,Mol Biol Rep. 2020 Jan;47(1):737-752. doi: 10.1007/s11033-019-05123-9. Epub 2019 Oct 14.,Jiang X,https://www.ncbi.nlm.nih.gov/pubmed/31612408
14002,31767266,Synthesis of novel 4-Boc-piperidone chalcones and evaluation of their cytotoxic activity against highly-metastatic cancer cells,Bioorg Med Chem Lett. 2020 Jan 1;30(1):126760. doi: 10.1016/j.bmcl.2019.126760. Epub 2019 Oct 28.,Ocasio-Malavé C,https://www.ncbi.nlm.nih.gov/pubmed/31767266
14005,31498176,NKX3.1 and Prostein Expression in Testicular Tissue and Sex Cord-stromal Tumors,Am J Surg Pathol. 2020 Jan;44(1):61-67. doi: 10.1097/PAS.0000000000001367.,Arnesen C,https://www.ncbi.nlm.nih.gov/pubmed/31498176
14006,32633365,LncRNA SNHG15 promotes the proliferation of nasopharyngeal carcinoma via sponging miR-141-3p to upregulate KLF9,Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6744-6751. doi: 10.26355/eurrev_202006_21662.,Yi TW,https://www.ncbi.nlm.nih.gov/pubmed/32633365
14008,31970768,Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening,Int J Cancer. 2020 Jul 1;147(1):9-13. doi: 10.1002/ijc.32885. Epub 2020 Feb 26.,Ponti A,https://www.ncbi.nlm.nih.gov/pubmed/31970768
14009,32417531,A Hungatella effluvii isolate in blood culture of a patient with hematochezia,Anaerobe. 2020 Jun;63:102211. doi: 10.1016/j.anaerobe.2020.102211. Epub 2020 May 15.,Park JH,https://www.ncbi.nlm.nih.gov/pubmed/32417531
14010,32233402,Mechanical-Bond-Induced Exciplex Fluorescence in an Anthracene-Based Homo[2]catenane,J Am Chem Soc. 2020 Apr 29;142(17):7956-7967. doi: 10.1021/jacs.0c02128. Epub 2020 Apr 15.,Garci A,https://www.ncbi.nlm.nih.gov/pubmed/32233402
14011,32282203,"Discovery of Ubiquitin-Specific Protease 7 (USP7) Inhibitors with Novel Scaffold Structures by Virtual Screening, Molecular Dynamics Simulation, and Biological Evaluation",J Chem Inf Model. 2020 Jun 22;60(6):3255-3264. doi: 10.1021/acs.jcim.0c00154. Epub 2020 Apr 23.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/32282203
14013,31123862,Oral bovine colostrum supplementation does not increase circulating insulin-like growth factor-1 concentration in healthy adults: results from short- and long-term administration studies,Eur J Nutr. 2020 Jun;59(4):1473-1479. doi: 10.1007/s00394-019-02004-6. Epub 2019 May 23.,Davison G,https://www.ncbi.nlm.nih.gov/pubmed/31123862
14014,32475354,Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis,Lipids Health Dis. 2020 May 31;19(1):118. doi: 10.1186/s12944-020-01288-6.,Liu SS,https://www.ncbi.nlm.nih.gov/pubmed/32475354
14016,32376840,Discovering the hidden messages within cell trajectories using a deep learning approach for in vitro evaluation of cancer drug treatments,Sci Rep. 2020 May 6;10(1):7653. doi: 10.1038/s41598-020-64246-3.,Mencattini A,https://www.ncbi.nlm.nih.gov/pubmed/32376840
14017,31655380,Interfacial charge regulation of protein blocking layers in transistor biosensor for direct measurement in serum,Biosens Bioelectron. 2020 Jan 1;147:111737. doi: 10.1016/j.bios.2019.111737. Epub 2019 Oct 10.,Park S,https://www.ncbi.nlm.nih.gov/pubmed/31655380
14019,31674073,Long noncoding RNA PCAT-1 knockdown prevents the development of ovarian cancer cells via microRNA-124-3p,J Cell Biochem. 2020 Feb;121(2):1963-1972. doi: 10.1002/jcb.29431. Epub 2019 Oct 31.,Min F,https://www.ncbi.nlm.nih.gov/pubmed/31674073
14020,31165385,Imaging Sigma-1 Receptor (S1R) Expression Using Iodine-124-Labeled 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine ([(124)I]IPAG),Mol Imaging Biol. 2020 Apr;22(2):358-366. doi: 10.1007/s11307-019-01369-8.,Gangangari KK,https://www.ncbi.nlm.nih.gov/pubmed/31165385
14021,32028540,An Automatable Hydrogel Culture Platform for Evaluating Efficacy of Antibody-Based Therapeutics in Overcoming Chemoresistance,Biotechnol J. 2020 May;15(5):e1900439. doi: 10.1002/biot.201900439. Epub 2020 Feb 24.,Kletzmayr A,https://www.ncbi.nlm.nih.gov/pubmed/32028540
14022,32511720,Assessment of Clinician Decision-making on Cancer Screening Cessation in Older Adults With Limited Life Expectancy,JAMA Netw Open. 2020 Jun 1;3(6):e206772. doi: 10.1001/jamanetworkopen.2020.6772.,Schoenborn NL,https://www.ncbi.nlm.nih.gov/pubmed/32511720
14023,31892693,Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect,Med Sci Monit. 2020 Jan 1;26:e918520. doi: 10.12659/MSM.918520.,He R,https://www.ncbi.nlm.nih.gov/pubmed/31892693
14024,31956202,Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate,Intern Med. 2020 May 1;59(9):1163-1166. doi: 10.2169/internalmedicine.3805-19. Epub 2020 Jan 17.,Yamauchi R,https://www.ncbi.nlm.nih.gov/pubmed/31956202
14025,31604113,Lupiwighteone induces caspase-dependent and -independent apoptosis on human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway,Food Chem Toxicol. 2020 Jan;135:110863. doi: 10.1016/j.fct.2019.110863. Epub 2019 Oct 8.,Won YS,https://www.ncbi.nlm.nih.gov/pubmed/31604113
14026,32324396,"p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators",J Med Chem. 2020 Sep 24;63(18):10135-10157. doi: 10.1021/acs.jmedchem.9b02038. Epub 2020 May 5.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32324396
14027,33344645,Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances,Biomed Res Int. 2020 Dec 1;2020:6940953. doi: 10.1155/2020/6940953. eCollection 2020.,Yin Z,https://www.ncbi.nlm.nih.gov/pubmed/33344645
14029,31165158,Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification,J Natl Cancer Inst. 2020 Mar 1;112(3):278-285. doi: 10.1093/jnci/djz113.,Pal Choudhury P,https://www.ncbi.nlm.nih.gov/pubmed/31165158
14030,32162465,Effect of hemolysis on Fourier transform infrared and Raman spectra of blood plasma,J Biophotonics. 2020 Jul;13(7):e201960173. doi: 10.1002/jbio.201960173. Epub 2020 Apr 7.,Medipally DKR,https://www.ncbi.nlm.nih.gov/pubmed/32162465
14031,31948939,Towards Multidrug Adaptive Therapy,Cancer Res. 2020 Apr 1;80(7):1578-1589. doi: 10.1158/0008-5472.CAN-19-2669. Epub 2020 Jan 16.,West J,https://www.ncbi.nlm.nih.gov/pubmed/31948939
14033,32209458,Multi-scale Predictions of Drug Resistance Epidemiology Identify Design Principles for Rational Drug Design,Cell Rep. 2020 Mar 24;30(12):3951-3963.e4. doi: 10.1016/j.celrep.2020.02.108.,Leighow SM,https://www.ncbi.nlm.nih.gov/pubmed/32209458
14034,32398042,A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer,J Exp Clin Cancer Res. 2020 May 12;39(1):87. doi: 10.1186/s13046-020-01564-4.,Zhou Y,https://www.ncbi.nlm.nih.gov/pubmed/32398042
14035,31955144,Synthesis of bioactive quinazolin-4(3H)-one derivatives via microwave activation tailored by phase-transfer catalysis,Acta Pharm. 2020 Jun 1;70(2):161-178. doi: 10.2478/acph-2020-0001.,El-Badry YA,https://www.ncbi.nlm.nih.gov/pubmed/31955144
14037,31298944,Dairy Products and Cancer Risk in a Northern Sweden Population,Nutr Cancer. 2020;72(3):409-420. doi: 10.1080/01635581.2019.1637441. Epub 2019 Jul 12.,Nilsson LM,https://www.ncbi.nlm.nih.gov/pubmed/31298944
14039,31841869,Development and evaluation of a harmonized whole body physiologically based pharmacokinetic (PBPK) model for flutamide in rats and its extrapolation to humans,Environ Res. 2020 Mar;182:108948. doi: 10.1016/j.envres.2019.108948. Epub 2019 Nov 26.,Sharma RP,https://www.ncbi.nlm.nih.gov/pubmed/31841869
14040,32866190,Gene panel screening for insight towards breast cancer susceptibility in different ethnicities,PLoS One. 2020 Aug 31;15(8):e0238295. doi: 10.1371/journal.pone.0238295. eCollection 2020.,Bishop MR,https://www.ncbi.nlm.nih.gov/pubmed/32866190
14041,31536360,Electrochemical Detection of Tumor-Derived Extracellular Vesicles on Nanointerdigitated Electrodes,Nano Lett. 2020 Feb 12;20(2):820-828. doi: 10.1021/acs.nanolett.9b02741. Epub 2019 Sep 26.,Mathew DG,https://www.ncbi.nlm.nih.gov/pubmed/31536360
14042,31321600,Mycobacterium smegmatis alters the production of secondary metabolites by marine-derived Aspergillus niger,J Nat Med. 2020 Jan;74(1):76-82. doi: 10.1007/s11418-019-01345-0. Epub 2019 Jul 18.,Jomori T,https://www.ncbi.nlm.nih.gov/pubmed/31321600
14043,31790770,"New flavonoids, emarginin A-C from Vaccinium emarginatum Hayata",Fitoterapia. 2020 Mar;141:104446. doi: 10.1016/j.fitote.2019.104446. Epub 2019 Nov 29.,Tu PC,https://www.ncbi.nlm.nih.gov/pubmed/31790770
14044,32111912,Genomic alterations and abnormal expression of APE2 in multiple cancers,Sci Rep. 2020 Feb 28;10(1):3758. doi: 10.1038/s41598-020-60656-5.,Jensen KA,https://www.ncbi.nlm.nih.gov/pubmed/32111912
14045,32034265,"Post-mortem Plasma Cell-Free DNA Sequencing: Proof-of-Concept Study for the ""Liquid Autopsy""",Sci Rep. 2020 Feb 7;10(1):2120. doi: 10.1038/s41598-020-59193-y.,Takai E,https://www.ncbi.nlm.nih.gov/pubmed/32034265
14049,32111826,Macropinocytosis confers resistance to therapies targeting cancer anabolism,Nat Commun. 2020 Feb 28;11(1):1121. doi: 10.1038/s41467-020-14928-3.,Jayashankar V,https://www.ncbi.nlm.nih.gov/pubmed/32111826
14050,32726790,Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features,Oncology. 2020;98(10):734-742. doi: 10.1159/000508688. Epub 2020 Jul 29.,Horie K,https://www.ncbi.nlm.nih.gov/pubmed/32726790
14053,32312759,Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials,Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1329-1334. doi: 10.1158/1055-9965.EPI-20-0187. Epub 2020 Apr 20.,Huang J,https://www.ncbi.nlm.nih.gov/pubmed/32312759
14056,32427108,User Experiences of an Internet-Based Stepped-Care Intervention for Individuals With Cancer and Concurrent Symptoms of Anxiety or Depression (the U-CARE AdultCan Trial): Qualitative Study,J Med Internet Res. 2020 May 19;22(5):e16604. doi: 10.2196/16604.,Igelström H,https://www.ncbi.nlm.nih.gov/pubmed/32427108
14058,32437150,Exploring the Sequence Diversity of Cyclotides from Vietnamese Viola Species,J Nat Prod. 2020 Jun 26;83(6):1817-1828. doi: 10.1021/acs.jnatprod.9b01218. Epub 2020 May 21.,Dang TT,https://www.ncbi.nlm.nih.gov/pubmed/32437150
14059,32802191,Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to reality,Theranostics. 2020 Jul 23;10(20):9268-9279. doi: 10.7150/thno.46341. eCollection 2020.,Rochow H,https://www.ncbi.nlm.nih.gov/pubmed/32802191
14060,31883786,Molecular mechanism of C-phycocyanin induced apoptosis in LNCaP cells,Bioorg Med Chem. 2020 Feb 1;28(3):115272. doi: 10.1016/j.bmc.2019.115272. Epub 2019 Dec 18.,Kaur P,https://www.ncbi.nlm.nih.gov/pubmed/31883786
14061,32321026,Characterization and in vitro antitumor activity of polymeric nanoparticles loaded with Uncaria tomentosa extract,An Acad Bras Cienc. 2020 Apr 17;92(1):e20190336. doi: 10.1590/0001-3765202020190336. eCollection 2020.,Ribeiro AF,https://www.ncbi.nlm.nih.gov/pubmed/32321026
14063,33031426,Cancer survivorship needs in Brazil: Patient and family perspective,PLoS One. 2020 Oct 8;15(10):e0239811. doi: 10.1371/journal.pone.0239811. eCollection 2020.,Santos ATCD,https://www.ncbi.nlm.nih.gov/pubmed/33031426
14065,33613529,Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer,Front Immunol. 2021 Feb 3;11:607881. doi: 10.3389/fimmu.2020.607881. eCollection 2020.,Tezcan G,https://www.ncbi.nlm.nih.gov/pubmed/33613529
14066,31874372,Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework,Soc Sci Med. 2020 Feb;246:112595. doi: 10.1016/j.socscimed.2019.112595. Epub 2019 Oct 15.,Angelis A,https://www.ncbi.nlm.nih.gov/pubmed/31874372
14067,32367771,Evaluation of cytotoxic and anticancer effect of Orobanche crenata methanolic extract on cancer cell lines,Tumour Biol. 2020 May;42(5):1010428320918685. doi: 10.1177/1010428320918685.,Hegazy MG,https://www.ncbi.nlm.nih.gov/pubmed/32367771
14068,31678743,Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates,Eur J Med Chem. 2020 Jan 1;185:111810. doi: 10.1016/j.ejmech.2019.111810. Epub 2019 Oct 25.,Chrzanowska A,https://www.ncbi.nlm.nih.gov/pubmed/31678743
14069,32865920,"Comparative Study on Bioactivities from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), Gives an Insight into the Fermentation Broth Showing Greater Antioxidative Activities",Int J Med Mushrooms. 2020;22(7):627-639. doi: 10.1615/IntJMedMushrooms.2020035042.,Xie C,https://www.ncbi.nlm.nih.gov/pubmed/32865920
14070,31902120,Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET/CT,Ann Nucl Med. 2020 Mar;34(3):192-199. doi: 10.1007/s12149-019-01433-x. Epub 2020 Jan 4.,Witkowska-Patena E,https://www.ncbi.nlm.nih.gov/pubmed/31902120
14072,32364082,"Anticancer Properties of Asian Water Monitor Lizard (Varanus salvator), Python (Malayopython reticulatus) and Tortoise (Cuora kamaroma amboinensis)",Anticancer Agents Med Chem. 2020;20(13):1558-1570. doi: 10.2174/1871520620666200504103056.,Jeyamogan S,https://www.ncbi.nlm.nih.gov/pubmed/32364082
14077,32106038,"Synthesis, (18)F-radiolabeling and apoptosis inducing studies of novel 4, 7-disubstituted coumarins",Bioorg Chem. 2020 Apr;97:103663. doi: 10.1016/j.bioorg.2020.103663. Epub 2020 Feb 25.,Goud NS,https://www.ncbi.nlm.nih.gov/pubmed/32106038
14078,32392663,Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea,Korean J Intern Med. 2020 May;35(3):641-651. doi: 10.3904/kjim.2017.402. Epub 2018 Sep 3.,Kim SK,https://www.ncbi.nlm.nih.gov/pubmed/32392663
14079,32092307,Biological activity and apoptotic signaling pathway of C(11)-functionalized cephalostatin 1 analogues,Steroids. 2020 Jun;158:108602. doi: 10.1016/j.steroids.2020.108602. Epub 2020 Feb 22.,Nawasreh MM,https://www.ncbi.nlm.nih.gov/pubmed/32092307
14080,32865781,Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers,Methods Mol Biol. 2020;2176:49-56. doi: 10.1007/978-1-0716-0771-8_3.,Maruyama R,https://www.ncbi.nlm.nih.gov/pubmed/32865781
14081,31629898,High bisphenol A concentrations augment the invasiveness of tumor cells through Snail-1/Cx43/ERR?-dependent epithelial-mesenchymal transition,Toxicol In Vitro. 2020 Feb;62:104676. doi: 10.1016/j.tiv.2019.104676. Epub 2019 Oct 17.,Ryszawy D,https://www.ncbi.nlm.nih.gov/pubmed/31629898
14085,31943757,New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity,Chem Biodivers. 2020 Mar;17(3):e1900670. doi: 10.1002/cbdv.201900670. Epub 2020 Feb 4.,Huan LC,https://www.ncbi.nlm.nih.gov/pubmed/31943757
14086,31779733,Association of supplemental calcium and dairy milk intake with all-cause and cause-specific mortality in the UK Biobank: a prospective cohort study,Br J Nutr. 2020 Mar 14;123(5):574-582. doi: 10.1017/S0007114519003076. Epub 2019 Nov 29.,Stasinopoulos LC,https://www.ncbi.nlm.nih.gov/pubmed/31779733
14087,30320505,Anticancer and antibacterial potential of Rhus punjabensis and CuO nanoparticles,Nat Prod Res. 2020 Mar;34(5):720-725. doi: 10.1080/14786419.2018.1495633. Epub 2018 Oct 15.,Naz S,https://www.ncbi.nlm.nih.gov/pubmed/30320505
14088,32162012,Tumor-derived exosomes in the regulation of macrophage polarization,Inflamm Res. 2020 May;69(5):435-451. doi: 10.1007/s00011-020-01318-0. Epub 2020 Mar 11.,Baig MS,https://www.ncbi.nlm.nih.gov/pubmed/32162012
14089,31956271,"Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1",Exp Mol Med. 2020 Jan;52(1):79-91. doi: 10.1038/s12276-019-0360-x. Epub 2020 Jan 20.,Park HK,https://www.ncbi.nlm.nih.gov/pubmed/31956271
14091,32223238,Multistep Binding of the Non-Steroidal Inhibitors Orteronel and Seviteronel to Human Cytochrome P450 17A1 and Relevance to Inhibition of Enzyme Activity,J Med Chem. 2020 Jun 25;63(12):6513-6522. doi: 10.1021/acs.jmedchem.9b01849. Epub 2020 Apr 9.,Child SA,https://www.ncbi.nlm.nih.gov/pubmed/32223238
14093,31755208,Increased cancer rates in patients with chronic hepatitis C,Liver Int. 2020 Mar;40(3):685-693. doi: 10.1111/liv.14305. Epub 2019 Dec 22.,Nyberg AH,https://www.ncbi.nlm.nih.gov/pubmed/31755208
14096,31478258,PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2,J Cell Biochem. 2020 Feb;121(2):1353-1361. doi: 10.1002/jcb.29370. Epub 2019 Sep 3.,Li H,https://www.ncbi.nlm.nih.gov/pubmed/31478258
14098,32319648,"Association between aberrant dynein cytoplasmic 1 light intermediate chain 1 expression levels, mucins and chemosensitivity in colorectal cancer",Mol Med Rep. 2020 Jul;22(1):185-192. doi: 10.3892/mmr.2020.11086. Epub 2020 Apr 22.,Chang CC,https://www.ncbi.nlm.nih.gov/pubmed/32319648
14099,31778881,Triterpenoids from the barks of Juglans hopeiensis,Phytochemistry. 2020 Feb;170:112201. doi: 10.1016/j.phytochem.2019.112201. Epub 2019 Nov 25.,Peng X,https://www.ncbi.nlm.nih.gov/pubmed/31778881
14100,32114934,Evaluation of seeds ethanolic extracts of Triplaris gardneriana Wedd. using in vitro and in vivo toxicological methods,J Toxicol Environ Health A. 2020 Feb 16;83(4):135-152. doi: 10.1080/15287394.2020.1731035. Epub 2020 Mar 2.,Almeida TS,https://www.ncbi.nlm.nih.gov/pubmed/32114934
14102,32142855,POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway,Exp Cell Res. 2020 May 1;390(1):111933. doi: 10.1016/j.yexcr.2020.111933. Epub 2020 Mar 3.,Xu Q,https://www.ncbi.nlm.nih.gov/pubmed/32142855
14105,32081849,Data from a terminated study on iron oxide nanoparticle magnetic resonance imaging for head and neck tumors,Sci Data. 2020 Feb 21;7(1):63. doi: 10.1038/s41597-020-0392-z.,Elhalawani H,https://www.ncbi.nlm.nih.gov/pubmed/32081849
14106,32114592,"Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials",Br J Cancer. 2020 Apr;122(8):1260-1270. doi: 10.1038/s41416-020-0761-6. Epub 2020 Feb 29.,Hanson S,https://www.ncbi.nlm.nih.gov/pubmed/32114592
14107,32147637,"In silico systems for predicting chemical-induced side effects using known and potential chemical protein interactions, enabling mechanism estimation",J Toxicol Sci. 2020;45(3):137-149. doi: 10.2131/jts.45.137.,Amano Y,https://www.ncbi.nlm.nih.gov/pubmed/32147637
14108,31993970,Trichothecene and tremulane sesquiterpenes from a hallucinogenic mushroom Gymnopilus junonius and their cytotoxicity,Arch Pharm Res. 2020 Feb;43(2):214-223. doi: 10.1007/s12272-020-01213-6. Epub 2020 Jan 29.,Lee S,https://www.ncbi.nlm.nih.gov/pubmed/31993970
14109,31761037,Near-infrared ratiometric probe with a self-immolative spacer for rapid and sensitive detection of alkaline phosphatase activity and imaging in vivo,Anal Chim Acta. 2020 Jan 15;1094:113-121. doi: 10.1016/j.aca.2019.10.001. Epub 2019 Oct 7.,Zhang X,https://www.ncbi.nlm.nih.gov/pubmed/31761037
14110,32066756,Machine Learning and Bioinformatics Models to Identify Pathways that Mediate Influences of Welding Fumes on Cancer Progression,Sci Rep. 2020 Feb 17;10(1):2795. doi: 10.1038/s41598-020-57916-9.,Rana HK,https://www.ncbi.nlm.nih.gov/pubmed/32066756
14111,32407408,"Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study",PLoS One. 2020 May 14;15(5):e0233238. doi: 10.1371/journal.pone.0233238. eCollection 2020.,Kunovszki P,https://www.ncbi.nlm.nih.gov/pubmed/32407408
14113,31601697,"Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonistic and Antagonistic Constructs",J Nucl Med. 2020 Mar;61(3):443-450. doi: 10.2967/jnumed.119.231282. Epub 2019 Oct 10.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/31601697
14114,32963636,"6,12-Diphenyl-3, 9-diazatetraasterane-1, 5, 7, 11-tetracarboxylate Inhibits Proliferation, Migration and Promotes Apoptosis in Ovarian Cancer Cells",Dis Markers. 2020 Sep 3;2020:5068067. doi: 10.1155/2020/5068067. eCollection 2020.,Chen P,https://www.ncbi.nlm.nih.gov/pubmed/32963636
14115,32146506,Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy,Arch Virol. 2020 May;165(5):1089-1097. doi: 10.1007/s00705-020-04585-8. Epub 2020 Mar 7.,Jin SY,https://www.ncbi.nlm.nih.gov/pubmed/32146506
14116,31994464,"Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities",Curr Top Med Chem. 2020;20(16):1461-1467. doi: 10.2174/1568026620666200128144825.,Yang M,https://www.ncbi.nlm.nih.gov/pubmed/31994464
14119,31945665,Design and synthesis of ?-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation,Eur J Med Chem. 2020 Mar 1;189:112028. doi: 10.1016/j.ejmech.2019.112028. Epub 2020 Jan 2.,Zhou L,https://www.ncbi.nlm.nih.gov/pubmed/31945665
14120,31836956,Automated measurement of bone scan index from a whole-body bone scintigram,Int J Comput Assist Radiol Surg. 2020 Mar;15(3):389-400. doi: 10.1007/s11548-019-02105-x. Epub 2019 Dec 13.,Shimizu A,https://www.ncbi.nlm.nih.gov/pubmed/31836956
14122,31364885,Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States,J Med Econ. 2020 Jan;23(1):37-47. doi: 10.1080/13696998.2019.1651122. Epub 2019 Aug 26.,Stopeck A,https://www.ncbi.nlm.nih.gov/pubmed/31364885
14123,32438269,Nickel and zinc complexes of testosterone N4-substituted thiosemicarbazone: Selective cytotoxicity towards human colorectal carcinoma cell line HCT 116 and their cell death mechanisms,J Inorg Biochem. 2020 Jul;208:111097. doi: 10.1016/j.jinorgbio.2020.111097. Epub 2020 May 4.,Heng MP,https://www.ncbi.nlm.nih.gov/pubmed/32438269
14126,31943322,Long-term testosterone undecanoate replacement therapy: Impact of ethnicity,Clin Endocrinol (Oxf). 2020 May;92(5):428-433. doi: 10.1111/cen.14157. Epub 2020 Jan 29.,Kempegowda P,https://www.ncbi.nlm.nih.gov/pubmed/31943322
14127,32387288,"Peptides derived from small mitochondrial open reading frames: Genomic, biological, and therapeutic implications",Exp Cell Res. 2020 Aug 15;393(2):112056. doi: 10.1016/j.yexcr.2020.112056. Epub 2020 May 6.,Miller B,https://www.ncbi.nlm.nih.gov/pubmed/32387288
14128,32187204,"Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice",PLoS One. 2020 Mar 18;15(3):e0229290. doi: 10.1371/journal.pone.0229290. eCollection 2020.,Buss LA,https://www.ncbi.nlm.nih.gov/pubmed/32187204
14129,31773466,(18)F-Fluciclovine ((18)F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas,Ann Nucl Med. 2020 Feb;34(2):81-86. doi: 10.1007/s12149-019-01426-w. Epub 2019 Nov 26.,Albano D,https://www.ncbi.nlm.nih.gov/pubmed/31773466
14130,32208223,Structure-activity relationships of triazole-benzodioxine inhibitors of cathepsin X,Eur J Med Chem. 2020 May 1;193:112218. doi: 10.1016/j.ejmech.2020.112218. Epub 2020 Mar 12.,Fonovi? UP,https://www.ncbi.nlm.nih.gov/pubmed/32208223
14131,32349696,Primary care service use by end-of-life cancer patients: a nationwide population-based cohort study in the United Kingdom,BMC Fam Pract. 2020 Apr 29;21(1):76. doi: 10.1186/s12875-020-01127-8.,Gao W,https://www.ncbi.nlm.nih.gov/pubmed/32349696
14133,32164672,First referral to an integrated onco-palliative care program: a retrospective analysis of its timing,BMC Palliat Care. 2020 Mar 12;19(1):31. doi: 10.1186/s12904-020-0539-x.,Barth C,https://www.ncbi.nlm.nih.gov/pubmed/32164672
14134,33378353,DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden,PLoS One. 2020 Dec 30;15(12):e0244558. doi: 10.1371/journal.pone.0244558. eCollection 2020.,Riggs MJ,https://www.ncbi.nlm.nih.gov/pubmed/33378353
14137,32073198,Curcumin stimulates angiogenesis through VEGF and expression of HLA-G in first-trimester human placental trophoblasts,Cell Biol Int. 2020 May;44(5):1237-1251. doi: 10.1002/cbin.11324. Epub 2020 Feb 26.,Basak S,https://www.ncbi.nlm.nih.gov/pubmed/32073198
14139,31963237,Health Care Costs and Savings Associated with Increased Dairy Consumption among Adults in the United States,Nutrients. 2020 Jan 16;12(1):233. doi: 10.3390/nu12010233.,Scrafford CG,https://www.ncbi.nlm.nih.gov/pubmed/31963237
14141,32031122,Expression of alpha-methylacyl-CoA racemase in vaginal gastric-type adenocarcinoma and uterine clear cell carcinoma,Indian J Pathol Microbiol. 2020 Jan-Mar;63(1):49-52. doi: 10.4103/IJPM.IJPM_525_19.,Hu J,https://www.ncbi.nlm.nih.gov/pubmed/32031122
14142,32468675,Suppression of TRPM7 enhances TRAIL-induced apoptosis in triple-negative breast cancer cells,J Cell Physiol. 2020 Dec;235(12):10037-10050. doi: 10.1002/jcp.29820. Epub 2020 May 29.,Song C,https://www.ncbi.nlm.nih.gov/pubmed/32468675
14143,32047166,Programming bulk enzyme heterojunctions for biosensor development with tetrahedral DNA framework,Nat Commun. 2020 Feb 11;11(1):838. doi: 10.1038/s41467-020-14664-8.,Song P,https://www.ncbi.nlm.nih.gov/pubmed/32047166
14144,31797547,"Identification of Vaccinia-H1 Related Phosphatase as an Anticancer Target for 1,2,3,4,6-O-Pentagalloylglucose",Chem Biodivers. 2020 Feb;17(2):e1900414. doi: 10.1002/cbdv.201900414. Epub 2020 Jan 7.,Yoon SY,https://www.ncbi.nlm.nih.gov/pubmed/31797547
14145,32540605,Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with (18)F-Fluorocholine PET/CT?,Med Hypotheses. 2020 Nov;144:109885. doi: 10.1016/j.mehy.2020.109885. Epub 2020 May 27.,Savelli G,https://www.ncbi.nlm.nih.gov/pubmed/32540605
14147,32286142,Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539,Cell Cycle. 2020 May;19(10):1122-1131. doi: 10.1080/15384101.2020.1748949. Epub 2020 Apr 14.,Wang R,https://www.ncbi.nlm.nih.gov/pubmed/32286142
14149,32173197,"Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors",Bioorg Med Chem Lett. 2020 May 1;30(9):127061. doi: 10.1016/j.bmcl.2020.127061. Epub 2020 Feb 25.,Hou Z,https://www.ncbi.nlm.nih.gov/pubmed/32173197
14150,32348940,Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method,J Mol Graph Model. 2020 Sep;99:107599. doi: 10.1016/j.jmgm.2020.107599. Epub 2020 Apr 10.,Takaya D,https://www.ncbi.nlm.nih.gov/pubmed/32348940
14151,33027304,"The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies",PLoS One. 2020 Oct 7;15(10):e0240169. doi: 10.1371/journal.pone.0240169. eCollection 2020.,Noto FK,https://www.ncbi.nlm.nih.gov/pubmed/33027304
14156,31937834,The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness,Sci Rep. 2020 Jan 14;10(1):218. doi: 10.1038/s41598-019-57076-5.,Mus LM,https://www.ncbi.nlm.nih.gov/pubmed/31937834
14157,32362498,"Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective",Eur Urol. 2020 Jul;78(1):16-20. doi: 10.1016/j.eururo.2020.04.055. Epub 2020 Apr 27.,Boehm K,https://www.ncbi.nlm.nih.gov/pubmed/32362498
14158,32279036,Synthesis of fluorescent G-quadruplex DNA binding ligands for the comparison of terminal group effects in molecular interaction: Phenol versus methoxybenzene,Bioorg Chem. 2020 Jun;99:103821. doi: 10.1016/j.bioorg.2020.103821. Epub 2020 Apr 6.,Jin J,https://www.ncbi.nlm.nih.gov/pubmed/32279036
14161,32139259,LncRNA TMPO-AS1 up-regulates the expression of HIF-1? and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p,Pathol Res Pract. 2020 Apr;216(4):152853. doi: 10.1016/j.prp.2020.152853. Epub 2020 Feb 5.,Peng X,https://www.ncbi.nlm.nih.gov/pubmed/32139259
14166,32199733,"Synthesis and evaluation of anti-tumor activity of novel triazolo[1,5-a] pyrimidine on cancer cells by induction of cellular apoptosis and inhibition of epithelial-to-mesenchymal transition process",Bioorg Med Chem Lett. 2020 May 15;30(10):127111. doi: 10.1016/j.bmcl.2020.127111. Epub 2020 Mar 17.,Safari F,https://www.ncbi.nlm.nih.gov/pubmed/32199733
14171,32339330,PCAT6 mediates cellular biological functions in gastrointestinal stromal tumor via upregulation of PRDX5 and activation of Wnt pathway,Mol Carcinog. 2020 Jun;59(6):661-669. doi: 10.1002/mc.23199. Epub 2020 Apr 27.,Bai F,https://www.ncbi.nlm.nih.gov/pubmed/32339330
14173,31592686,"An Examination of John Henryism, Trust, and Medication Adherence Among African Americans With Hypertension",Health Educ Behav. 2020 Feb;47(1):162-169. doi: 10.1177/1090198119878778. Epub 2019 Oct 8.,Cuffee YL,https://www.ncbi.nlm.nih.gov/pubmed/31592686
14175,32229283,Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery,Int J Pharm. 2020 May 15;581:119275. doi: 10.1016/j.ijpharm.2020.119275. Epub 2020 Mar 27.,Tahir N,https://www.ncbi.nlm.nih.gov/pubmed/32229283
14178,32114665,Epidemiology and biological characteristics of male breast cancer in Italy,Breast Cancer. 2020 Jul;27(4):724-731. doi: 10.1007/s12282-020-01068-1. Epub 2020 Feb 29.,Mangone L,https://www.ncbi.nlm.nih.gov/pubmed/32114665
14179,32520202,lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma,Braz J Med Biol Res. 2020 Jun 5;53(7):e9271. doi: 10.1590/1414-431X20209271. eCollection 2020.,Xu Z,https://www.ncbi.nlm.nih.gov/pubmed/32520202
14180,31926774,PEGylated leuprolide with improved pharmacokinetic properties,Bioorg Med Chem. 2020 Feb 15;28(4):115306. doi: 10.1016/j.bmc.2020.115306. Epub 2020 Jan 7.,Fu M,https://www.ncbi.nlm.nih.gov/pubmed/31926774
14184,32486108,1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents,Molecules. 2020 May 29;25(11):2547. doi: 10.3390/molecules25112547.,Sirazhetdinova NS,https://www.ncbi.nlm.nih.gov/pubmed/32486108
14186,29076352,Ethnic disparities in cancer incidence and survival among the oldest old in the United States,Ethn Health. 2020 Jan;25(1):79-92. doi: 10.1080/13557858.2017.1395818. Epub 2017 Oct 27.,Krok-Schoen JL,https://www.ncbi.nlm.nih.gov/pubmed/29076352
14188,32121640,Ginseng Gintonin Contains Ligands for GPR40 and GPR55,Molecules. 2020 Mar 2;25(5):1102. doi: 10.3390/molecules25051102.,Cho YJ,https://www.ncbi.nlm.nih.gov/pubmed/32121640
14189,32208661,Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation,Inorg Chem. 2020 Apr 6;59(7):5072-5085. doi: 10.1021/acs.inorgchem.0c00319. Epub 2020 Mar 25.,Cunha BN,https://www.ncbi.nlm.nih.gov/pubmed/32208661
14190,32319550,Long non?coding RNA PRNCR1 exerts oncogenic effects in tongue squamous cell carcinoma in vitro and in vivo by sponging microRNA?944 and thereby increasing HOXB5 expression,Int J Mol Med. 2020 Jul;46(1):119-130. doi: 10.3892/ijmm.2020.4581. Epub 2020 Apr 16.,Lin C,https://www.ncbi.nlm.nih.gov/pubmed/32319550
14192,32354903,Sunitinib Treatment-elicited Distinct Tumor Microenvironment Dramatically Compensated the Reduction of Myeloid-derived Suppressor Cells,In Vivo. 2020 May-Jun;34(3):1141-1152. doi: 10.21873/invivo.11886.,Fu SY,https://www.ncbi.nlm.nih.gov/pubmed/32354903
14193,31595574,SNP rs710886 A>G in long noncoding RNA PCAT1 is associated with the risk of endometriosis by modulating expression of multiple stemness-related genes via microRNA-145 signaling pathway,J Cell Biochem. 2020 Feb;121(2):1703-1715. doi: 10.1002/jcb.29406. Epub 2019 Oct 8.,Wang L,https://www.ncbi.nlm.nih.gov/pubmed/31595574
14195,31381204,A novel PTPRZ1-ETV1 fusion in gliomas,Brain Pathol. 2020 Mar;30(2):226-234. doi: 10.1111/bpa.12776. Epub 2019 Aug 27.,Matjaši? A,https://www.ncbi.nlm.nih.gov/pubmed/31381204
14196,31779937,"Photodynamic Therapy for Photodamage, Actinic Keratosis, and Acne in the Cosmetic Practice",Facial Plast Surg Clin North Am. 2020 Feb;28(1):135-148. doi: 10.1016/j.fsc.2019.09.012.,Moy LS,https://www.ncbi.nlm.nih.gov/pubmed/31779937
14201,31992477,VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents,Bioorg Med Chem. 2020 Mar 1;28(5):115328. doi: 10.1016/j.bmc.2020.115328. Epub 2020 Jan 21.,Ahmed EY,https://www.ncbi.nlm.nih.gov/pubmed/31992477
14211,32045361,Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis,Endocr Relat Cancer. 2020 Apr;27(4):245-259. doi: 10.1530/ERC-19-0417.,Tran TV,https://www.ncbi.nlm.nih.gov/pubmed/32045361
14212,32341516,Brightfield multiplex immunohistochemistry with multispectral imaging,Lab Invest. 2020 Aug;100(8):1124-1136. doi: 10.1038/s41374-020-0429-0. Epub 2020 Apr 27.,Morrison LE,https://www.ncbi.nlm.nih.gov/pubmed/32341516
14214,31896509,AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis,Redox Biol. 2020 Feb;30:101413. doi: 10.1016/j.redox.2019.101413. Epub 2019 Dec 26.,Chen TC,https://www.ncbi.nlm.nih.gov/pubmed/31896509
14215,31901857,PRAS40 hyperexpression promotes hepatocarcinogenesis,EBioMedicine. 2020 Jan;51:102604. doi: 10.1016/j.ebiom.2019.102604. Epub 2020 Jan 3.,Qi Z,https://www.ncbi.nlm.nih.gov/pubmed/31901857
14224,31746291,Therapeutic Potential of Medicinal Plant Proteins: Present Status and Future Perspectives,Curr Protein Pept Sci. 2020;21(5):443-487. doi: 10.2174/1389203720666191119095624.,Wani SS,https://www.ncbi.nlm.nih.gov/pubmed/31746291
14233,32403414,Bicalutamide Elicits Renal Damage by Causing Mitochondrial Dysfunction via ROS Damage and Upregulation of HIF-1,Int J Mol Sci. 2020 May 11;21(9):3400. doi: 10.3390/ijms21093400.,Chen KC,https://www.ncbi.nlm.nih.gov/pubmed/32403414
14254,30924024,Emodin induced necroptosis in the glioma cell line U251 via the TNF-?/RIP1/RIP3 pathway,Invest New Drugs. 2020 Feb;38(1):50-59. doi: 10.1007/s10637-019-00764-w. Epub 2019 Mar 28.,Zhou J,https://www.ncbi.nlm.nih.gov/pubmed/30924024
14260,32181976,PMEPA1/TMEPAI isoforms function via its PY and Smad-interaction motifs for tumorigenic activities of breast cancer cells,Genes Cells. 2020 Jun;25(6):375-390. doi: 10.1111/gtc.12766. Epub 2020 Apr 29.,Puteri MU,https://www.ncbi.nlm.nih.gov/pubmed/32181976
14285,31900312,"Discovery of Small Molecules That Target the Phosphatidylinositol (3,4,5) Trisphosphate (PIP(3))-Dependent Rac Exchanger 1 (P-Rex1) PIP(3)-Binding Site and Inhibit P-Rex1-Dependent Functions in Neutrophils",Mol Pharmacol. 2020 Mar;97(3):226-236. doi: 10.1124/mol.119.117556. Epub 2020 Jan 3.,Cash JN,https://www.ncbi.nlm.nih.gov/pubmed/31900312
14330,31814116,Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan,Cancer. 2020 Mar 1;126(5):1031-1040. doi: 10.1002/cncr.32590. Epub 2019 Dec 9.,Zaitsu M,https://www.ncbi.nlm.nih.gov/pubmed/31814116
14338,33295593,Cancer mortality in the Capitals and in the interior of Brazil: a four-decade analysis,Rev Saude Publica. 2020 Dec 4;54:126. doi: 10.11606/s1518-8787.2020054002255. eCollection 2020.,Silva GAE,https://www.ncbi.nlm.nih.gov/pubmed/33295593
14354,32171470,Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes,Ann Endocrinol (Paris). 2021 Jun;82(3-4):132-133. doi: 10.1016/j.ando.2020.02.008. Epub 2020 Feb 29.,Salem JE,https://www.ncbi.nlm.nih.gov/pubmed/32171470
14358,31287738,The Role of Polyphenol (Flavonoids) Compounds in the Treatment of Cancer Cells,Nutr Cancer. 2020;72(3):386-397. doi: 10.1080/01635581.2019.1637006. Epub 2019 Jul 9.,Hazafa A,https://www.ncbi.nlm.nih.gov/pubmed/31287738
14372,33232371,Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles,PLoS One. 2020 Nov 24;15(11):e0242780. doi: 10.1371/journal.pone.0242780. eCollection 2020.,Tegally H,https://www.ncbi.nlm.nih.gov/pubmed/33232371
14373,32344050,Dietary carotenoids in cancer chemoprevention and chemotherapy: A review of emerging evidence,Pharmacol Res. 2020 Jul;157:104830. doi: 10.1016/j.phrs.2020.104830. Epub 2020 Apr 25.,Saini RK,https://www.ncbi.nlm.nih.gov/pubmed/32344050
14393,31915305,A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies,Sci Transl Med. 2020 Jan 8;12(525):eaaw7888. doi: 10.1126/scitranslmed.aaw7888.,Skokos D,https://www.ncbi.nlm.nih.gov/pubmed/31915305
14425,32407843,CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker,Life Sci. 2020 Aug 1;254:117774. doi: 10.1016/j.lfs.2020.117774. Epub 2020 May 11.,Amini M,https://www.ncbi.nlm.nih.gov/pubmed/32407843
14427,32285169,"JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice",Calcif Tissue Int. 2020 Jul;107(1):72-85. doi: 10.1007/s00223-020-00689-0. Epub 2020 Apr 13.,Marino S,https://www.ncbi.nlm.nih.gov/pubmed/32285169
14476,32098890,Harnessing Population Pedigree Data and Machine Learning Methods to Identify Patterns of Familial Bladder Cancer Risk,Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):918-926. doi: 10.1158/1055-9965.EPI-19-0681. Epub 2020 Feb 25.,Hanson HA,https://www.ncbi.nlm.nih.gov/pubmed/32098890
14482,32172132,Therapeutic opportunities for PLK1 inhibitors: Spotlight on BRCA1-deficiency and triple negative breast cancers,Mutat Res. 2020 May-Dec;821:111693. doi: 10.1016/j.mrfmmm.2020.111693. Epub 2020 Feb 25.,García IA,https://www.ncbi.nlm.nih.gov/pubmed/32172132
14484,31978092,Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression-An in vitro study,PLoS One. 2020 Jan 24;15(1):e0228024. doi: 10.1371/journal.pone.0228024. eCollection 2020.,Ayyagari VN,https://www.ncbi.nlm.nih.gov/pubmed/31978092
14490,32141170,Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study,J Biochem Mol Toxicol. 2020 Jun;34(6):e22487. doi: 10.1002/jbt.22487. Epub 2020 Mar 5.,Urbaniak A,https://www.ncbi.nlm.nih.gov/pubmed/32141170
14506,32109420,De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders,Am J Hum Genet. 2020 Mar 5;106(3):405-411. doi: 10.1016/j.ajhg.2020.02.001. Epub 2020 Feb 27.,Nabais Sá MJ,https://www.ncbi.nlm.nih.gov/pubmed/32109420
14517,32078847,Binding patterns and structure-activity relationship of CDK8 inhibitors,Bioorg Chem. 2020 Mar;96:103624. doi: 10.1016/j.bioorg.2020.103624. Epub 2020 Jan 25.,Ma D,https://www.ncbi.nlm.nih.gov/pubmed/32078847
14539,32232956,"Proteomic and genomic biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 antitrypsin",Cancer Med. 2020 Jun;9(11):3974-3982. doi: 10.1002/cam4.3019. Epub 2020 Mar 30.,Najafi Z,https://www.ncbi.nlm.nih.gov/pubmed/32232956
14561,32951576,Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases,Curr Protein Pept Sci. 2020;21(11):1103-1142. doi: 10.2174/1389203721666200918152511.,Singh S,https://www.ncbi.nlm.nih.gov/pubmed/32951576
14577,33172724,"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent",Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.,Mottet N,https://www.ncbi.nlm.nih.gov/pubmed/33172724
14578,32593798,"Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",Ann Oncol. 2020 Sep;31(9):1119-1134. doi: 10.1016/j.annonc.2020.06.011. Epub 2020 Jun 25.,Parker C,https://www.ncbi.nlm.nih.gov/pubmed/32593798
14579,33309278,A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER),Eur Urol. 2021 Sep;80(3):280-292. doi: 10.1016/j.eururo.2020.11.010. Epub 2020 Dec 11.,Valle LF,https://www.ncbi.nlm.nih.gov/pubmed/33309278
14580,32875999,An overview of biomarkers in the diagnosis and management of prostate cancer,Can J Urol. 2020 Aug;27(S3):24-27.,Uhr A,https://www.ncbi.nlm.nih.gov/pubmed/32875999
14581,33002431,Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data,Lancet. 2020 Oct 31;396(10260):1422-1431. doi: 10.1016/S0140-6736(20)31952-8. Epub 2020 Sep 28.,Vale CL,https://www.ncbi.nlm.nih.gov/pubmed/33002431
14582,33039206,EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer,Eur Urol. 2021 Feb;79(2):263-282. doi: 10.1016/j.eururo.2020.09.046. Epub 2020 Oct 7.,Cornford P,https://www.ncbi.nlm.nih.gov/pubmed/33039206
14583,33002429,"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial",Lancet. 2020 Oct 31;396(10260):1413-1421. doi: 10.1016/S0140-6736(20)31553-1. Epub 2020 Sep 28.,Parker CC,https://www.ncbi.nlm.nih.gov/pubmed/33002429
14584,33002437,"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial",Lancet Oncol. 2020 Oct;21(10):1331-1340. doi: 10.1016/S1470-2045(20)30456-3.,Kneebone A,https://www.ncbi.nlm.nih.gov/pubmed/33002437
14585,31788708,Post-treatment prostate MRI,Abdom Radiol (NY). 2020 Jul;45(7):2184-2197. doi: 10.1007/s00261-019-02348-x.,Potretzke TA,https://www.ncbi.nlm.nih.gov/pubmed/31788708
14586,33067016,"Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates",Eur Urol. 2021 Aug;80(2):213-221. doi: 10.1016/j.eururo.2020.09.044. Epub 2020 Oct 14.,Wagaskar VG,https://www.ncbi.nlm.nih.gov/pubmed/33067016
14587,33002438,"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial",Lancet Oncol. 2020 Oct;21(10):1341-1352. doi: 10.1016/S1470-2045(20)30454-X.,Sargos P,https://www.ncbi.nlm.nih.gov/pubmed/33002438
14588,32731747,A Comparative Analysis of Surgical Scar Cosmesis Based on Operative Approach for Radical Prostatectomy,J Endourol. 2021 Feb;35(2):138-143. doi: 10.1089/end.2020.0649. Epub 2020 Sep 15.,Huang MM,https://www.ncbi.nlm.nih.gov/pubmed/32731747
14589,33171199,Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer,Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1232-1242. doi: 10.1016/j.ijrobp.2020.11.003. Epub 2020 Nov 7.,Gogineni E,https://www.ncbi.nlm.nih.gov/pubmed/33171199
14590,33158775,Relapse patterns after low-dose-rate prostate brachytherapy,Brachytherapy. 2021 Mar-Apr;20(2):291-295. doi: 10.1016/j.brachy.2020.09.013. Epub 2020 Nov 3.,Lamb DS,https://www.ncbi.nlm.nih.gov/pubmed/33158775
14591,33173205,"Surgical management of high-risk, localized prostate cancer",Nat Rev Urol. 2020 Dec;17(12):679-690. doi: 10.1038/s41585-020-00384-7. Epub 2020 Nov 10.,Wilkins LJ,https://www.ncbi.nlm.nih.gov/pubmed/33173205
14593,32203071,Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):573-580. doi: 10.1038/s41391-020-0225-3. Epub 2020 Mar 18.,Rosiello G,https://www.ncbi.nlm.nih.gov/pubmed/32203071
14594,33225759,Current and emerging therapies for localized high-risk prostate cancer,Expert Rev Anticancer Ther. 2021 Mar;21(3):267-282. doi: 10.1080/14737140.2021.1852932. Epub 2020 Dec 22.,Moris L,https://www.ncbi.nlm.nih.gov/pubmed/33225759
14595,32719354,Effects of high-intensity interval training compared with resistance training in prostate cancer patients undergoing radiotherapy: a randomized controlled trial,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):156-165. doi: 10.1038/s41391-020-0259-6. Epub 2020 Jul 27.,Piraux E,https://www.ncbi.nlm.nih.gov/pubmed/32719354
14597,32452998,Treatment of the primary in metastatic prostate cancer,Curr Opin Urol. 2020 Jul;30(4):566-575. doi: 10.1097/MOU.0000000000000779.,Gîngu C,https://www.ncbi.nlm.nih.gov/pubmed/32452998
14598,32588203,Metastatic hormone sensitive prostate cancer: local treatment strategies,World J Urol. 2021 Feb;39(2):327-337. doi: 10.1007/s00345-020-03296-8. Epub 2020 Jun 25.,Walz J,https://www.ncbi.nlm.nih.gov/pubmed/32588203
14599,32715604,Prostate cancer screening and treatment: where have we come from and where are we going?,BJU Int. 2020 Aug;126(2):218-224. doi: 10.1111/bju.15153. Epub 2020 Jul 27.,Albertsen PC,https://www.ncbi.nlm.nih.gov/pubmed/32715604
14602,32157345,Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients,Strahlenther Onkol. 2020 Jul;196(7):647-656. doi: 10.1007/s00066-020-01596-x. Epub 2020 Mar 10.,Böckelmann F,https://www.ncbi.nlm.nih.gov/pubmed/32157345
14603,33316361,Influence of Geography on Prostate Cancer Treatment,Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1286-1295. doi: 10.1016/j.ijrobp.2020.11.055. Epub 2020 Dec 13.,Tang C,https://www.ncbi.nlm.nih.gov/pubmed/33316361
14604,33216272,Treatment Options in Oligometastatic Disease in Prostate Cancer: Thinking Outside the Box,Curr Treat Options Oncol. 2020 Nov 20;22(1):2. doi: 10.1007/s11864-020-00798-w.,Fleming CW,https://www.ncbi.nlm.nih.gov/pubmed/33216272
14605,32999435,Erectile function after focal therapy for localized prostate cancer: a systematic review,Int J Impot Res. 2021 May;33(4):418-427. doi: 10.1038/s41443-020-00357-9. Epub 2020 Sep 30.,Fallara G,https://www.ncbi.nlm.nih.gov/pubmed/32999435
14606,32475688,Radical retropubic prostatectomy: Origins and evolution of the technique,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):408-416. doi: 10.1016/j.acuro.2020.03.003. Epub 2020 May 29.,Herranz-Amo F,https://www.ncbi.nlm.nih.gov/pubmed/32475688
14607,33218585,"Retzius-Sparing Robot-Assisted Robotic Prostatectomy: Past, Present, and Future",Urol Clin North Am. 2021 Feb;48(1):11-23. doi: 10.1016/j.ucl.2020.09.012. Epub 2020 Nov 5.,Davis M,https://www.ncbi.nlm.nih.gov/pubmed/33218585
14608,32691544,MRI-Targeted Prostate Biopsy: What Radiologists Should Know,Korean J Radiol. 2020 Sep;21(9):1087-1094. doi: 10.3348/kjr.2019.0817.,Das CJ,https://www.ncbi.nlm.nih.gov/pubmed/32691544
14609,32248258,Imaging assessment of local recurrence of prostate cancer after radical prostatectomy,Abdom Radiol (NY). 2020 Dec;45(12):4073-4083. doi: 10.1007/s00261-020-02505-7.,Magnetta MJ,https://www.ncbi.nlm.nih.gov/pubmed/32248258
14610,33318637,Neglected side effects to curative prostate cancer treatments,Int J Impot Res. 2021 May;33(4):428-438. doi: 10.1038/s41443-020-00386-4. Epub 2020 Dec 14.,Nolsøe AB,https://www.ncbi.nlm.nih.gov/pubmed/33318637
14611,32390076,Extraprostatic extension in prostate cancer: primer for radiologists,Abdom Radiol (NY). 2020 Dec;45(12):4040-4051. doi: 10.1007/s00261-020-02555-x.,Shieh AC,https://www.ncbi.nlm.nih.gov/pubmed/32390076
14612,32495338,Radical prostatectomy versus deferred treatment for localised prostate cancer,Cochrane Database Syst Rev. 2020 Jun 4;6(6):CD006590. doi: 10.1002/14651858.CD006590.pub3.,Vernooij RW,https://www.ncbi.nlm.nih.gov/pubmed/32495338
14613,33360326,The multiple effects of aspirin in prostate cancer patients,Cancer Treat Res Commun. 2021;26:100267. doi: 10.1016/j.ctarc.2020.100267. Epub 2020 Dec 8.,Joshi SN,https://www.ncbi.nlm.nih.gov/pubmed/33360326
14614,32461073,Techniques and Outcomes of Salvage Robot-Assisted Radical Prostatectomy (sRARP),Eur Urol. 2020 Dec;78(6):885-892. doi: 10.1016/j.eururo.2020.05.003. Epub 2020 May 24.,De Groote R,https://www.ncbi.nlm.nih.gov/pubmed/32461073
14615,33043572,Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer,BJU Int. 2021 Jul;128(1):46-56. doi: 10.1111/bju.15269. Epub 2020 Nov 4.,Exterkate L,https://www.ncbi.nlm.nih.gov/pubmed/33043572
14616,32638084,Focal HIFU therapy for anterior compared to posterior prostate cancer lesions,World J Urol. 2021 Apr;39(4):1115-1119. doi: 10.1007/s00345-020-03297-7. Epub 2020 Jul 7.,Huber PM,https://www.ncbi.nlm.nih.gov/pubmed/32638084
14617,33249083,Newly Diagnosed Oligometastatic Prostate Cancer: Current Controversies and Future Developments,Eur Urol Oncol. 2022 Oct;5(5):587-600. doi: 10.1016/j.euo.2020.11.001. Epub 2020 Nov 25.,Fossati N,https://www.ncbi.nlm.nih.gov/pubmed/33249083
14618,32124531,Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy,BJU Int. 2020 Jul;126(1):91-96. doi: 10.1111/bju.15042. Epub 2020 Apr 1.,Ahlering TE,https://www.ncbi.nlm.nih.gov/pubmed/32124531
14619,32442822,A biochemical definition of cure after brachytherapy for prostate cancer,Radiother Oncol. 2020 Aug;149:64-69. doi: 10.1016/j.radonc.2020.04.038. Epub 2020 Apr 27.,Crook JM,https://www.ncbi.nlm.nih.gov/pubmed/32442822
14620,33021440,Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer,J Urol. 2021 Mar;205(3):769-779. doi: 10.1097/JU.0000000000001362. Epub 2020 Oct 6.,Klotz L,https://www.ncbi.nlm.nih.gov/pubmed/33021440
14621,33186616,Proton Therapy for Localized Prostate Cancer: Long-Term Results From a Single-Center Experience,Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):964-974. doi: 10.1016/j.ijrobp.2020.11.007. Epub 2020 Nov 10.,Takagi M,https://www.ncbi.nlm.nih.gov/pubmed/33186616
14622,32402143,Transvesical robot-assisted radical prostatectomy: initial experience and surgical outcomes,BJU Int. 2020 Aug;126(2):300-308. doi: 10.1111/bju.15111. Epub 2020 Jun 1.,Zhou X,https://www.ncbi.nlm.nih.gov/pubmed/32402143
14623,33358229,Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response,Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):237-248. doi: 10.1016/j.ijrobp.2020.09.054. Epub 2020 Dec 22.,Wang K,https://www.ncbi.nlm.nih.gov/pubmed/33358229
14624,32846099,Multiparametric prostate MRI-based intensity-modulated radiation therapy guided by prostatic calcifications,Br J Radiol. 2020 Dec 1;93(1116):20200571. doi: 10.1259/bjr.20200571. Epub 2020 Aug 26.,Kao J,https://www.ncbi.nlm.nih.gov/pubmed/32846099
14625,33008763,Implementation of high-dose-rate brachytherapy for prostatic carcinoma in an unshielded operating room facility,Brachytherapy. 2021 Jan-Feb;20(1):58-65. doi: 10.1016/j.brachy.2020.08.015. Epub 2020 Sep 30.,Elangovan A,https://www.ncbi.nlm.nih.gov/pubmed/33008763
14626,33214044,Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer,Clin Oncol (R Coll Radiol). 2021 Mar;33(3):172-180. doi: 10.1016/j.clon.2020.10.019. Epub 2020 Nov 16.,Telkhade T,https://www.ncbi.nlm.nih.gov/pubmed/33214044
14627,32487352,Oncological control following partial gland ablation for intermediate-risk prostate cancer,Urol Oncol. 2020 Aug;38(8):671-677. doi: 10.1016/j.urolonc.2020.04.017. Epub 2020 May 31.,Becher E,https://www.ncbi.nlm.nih.gov/pubmed/32487352
14628,33350857,Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review,J Urol. 2021 Apr;205(4):967-976. doi: 10.1097/JU.0000000000001578. Epub 2020 Dec 22.,Wilt TJ,https://www.ncbi.nlm.nih.gov/pubmed/33350857
14629,32533247,Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer,World J Urol. 2021 Apr;39(4):1121-1129. doi: 10.1007/s00345-020-03301-0. Epub 2020 Jun 12.,Westhoff N,https://www.ncbi.nlm.nih.gov/pubmed/32533247
14630,31836862,Sexual function outcomes following interventions for prostate cancer: are contemporary reports on functional outcomes misleading?,Int J Impot Res. 2020 Sep;32(5):495-502. doi: 10.1038/s41443-019-0220-1. Epub 2019 Dec 13.,Lovegrove CE,https://www.ncbi.nlm.nih.gov/pubmed/31836862
14631,33352164,"Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment",Urology. 2021 Mar;149:103-109. doi: 10.1016/j.urology.2020.12.008. Epub 2020 Dec 19.,McMahon S,https://www.ncbi.nlm.nih.gov/pubmed/33352164
14633,32447414,Magnetic resonance imaging of the prostate after focal therapy with high-intensity focused ultrasound,Abdom Radiol (NY). 2020 Nov;45(11):3882-3895. doi: 10.1007/s00261-020-02577-5.,Ghafoor S,https://www.ncbi.nlm.nih.gov/pubmed/32447414
14634,33096165,"Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival",Radiother Oncol. 2021 Feb;155:33-41. doi: 10.1016/j.radonc.2020.10.022. Epub 2020 Oct 21.,Fosså SD,https://www.ncbi.nlm.nih.gov/pubmed/33096165
14635,31728517,Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis,J Natl Cancer Inst. 2020 Aug 1;112(8):847-854. doi: 10.1093/jnci/djz221.,Liauw SL,https://www.ncbi.nlm.nih.gov/pubmed/31728517
14636,32960679,Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I,J Urol. 2021 Jan;205(1):14-21. doi: 10.1097/JU.0000000000001375. Epub 2020 Sep 22.,Lowrance WT,https://www.ncbi.nlm.nih.gov/pubmed/32960679
14637,32960678,Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II,J Urol. 2021 Jan;205(1):22-29. doi: 10.1097/JU.0000000000001376. Epub 2020 Sep 22.,Lowrance WT,https://www.ncbi.nlm.nih.gov/pubmed/32960678
14638,33317857,Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy,Eur Urol. 2021 Apr;79(4):537-544. doi: 10.1016/j.eururo.2020.11.012. Epub 2020 Dec 11.,Knipper S,https://www.ncbi.nlm.nih.gov/pubmed/33317857
14639,32488359,Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE),World J Urol. 2021 Apr;39(4):1107-1114. doi: 10.1007/s00345-020-03275-z. Epub 2020 Jun 2.,Blazevski A,https://www.ncbi.nlm.nih.gov/pubmed/32488359
14640,33885246,Prospective evaluation of probabilistic dose-escalated IMRT in prostate cancer,Radiol Oncol. 2020 Dec 22;55(1):88-96. doi: 10.2478/raon-2020-0075.,Wegener D,https://www.ncbi.nlm.nih.gov/pubmed/33885246
14642,33289846,Surgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate Cancer,JAMA Netw Open. 2020 Dec 1;3(12):e2028320. doi: 10.1001/jamanetworkopen.2020.28320.,Xia L,https://www.ncbi.nlm.nih.gov/pubmed/33289846
14643,32550632,Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review,Minerva Urol Nefrol. 2020 Oct;72(5):531-542. doi: 10.23736/S0393-2249.20.03779-0. Epub 2020 Jun 16.,Miura N,https://www.ncbi.nlm.nih.gov/pubmed/32550632
14644,32756597,Dr. Answer AI for prostate cancer: Clinical outcome prediction model and service,PLoS One. 2020 Aug 5;15(8):e0236553. doi: 10.1371/journal.pone.0236553. eCollection 2020.,Rho MJ,https://www.ncbi.nlm.nih.gov/pubmed/32756597
14645,33268854,Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):514-523. doi: 10.1038/s41391-020-00307-y. Epub 2020 Dec 2.,Boeri L,https://www.ncbi.nlm.nih.gov/pubmed/33268854
14647,33051866,(169) Yb-based rotating shield brachytherapy for prostate cancer,Med Phys. 2020 Dec;47(12):6430-6439. doi: 10.1002/mp.14533. Epub 2020 Nov 1.,Adams Q,https://www.ncbi.nlm.nih.gov/pubmed/33051866
14648,33189734,Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH,Urology. 2021 Mar;149:181-186. doi: 10.1016/j.urology.2020.10.043. Epub 2020 Nov 12.,Guerrios-Rivera L,https://www.ncbi.nlm.nih.gov/pubmed/33189734
14649,33359493,Patient Satisfaction and Regret After Robot-assisted Radical Prostatectomy: A Decision Regret Analysis,Urology. 2021 Mar;149:122-128. doi: 10.1016/j.urology.2020.12.015. Epub 2020 Dec 24.,Lindsay J,https://www.ncbi.nlm.nih.gov/pubmed/33359493
14650,32619598,Outpatient Extraperitoneal Single-Port Robotic Radical Prostatectomy,Urology. 2020 Oct;144:142-146. doi: 10.1016/j.urology.2020.06.029. Epub 2020 Jun 30.,Wilson CA,https://www.ncbi.nlm.nih.gov/pubmed/32619598
14652,32921553,Patient-specific radiotherapy quality assurance for estimating actual treatment dose,Med Dosim. 2021 Spring;46(1):e5-e10. doi: 10.1016/j.meddos.2020.08.003. Epub 2020 Sep 11.,Tanabe Y,https://www.ncbi.nlm.nih.gov/pubmed/32921553
14653,33189532,External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA,Urol Oncol. 2021 Feb;39(2):131.e1-131.e7. doi: 10.1016/j.urolonc.2020.10.011. Epub 2020 Nov 11.,Stolzenbach LF,https://www.ncbi.nlm.nih.gov/pubmed/33189532
14654,32628305,The relationship between pre-radiation therapy testosterone levels and prostate cancer aggressiveness,Andrologia. 2020 Nov;52(10):e13731. doi: 10.1111/and.13731. Epub 2020 Jul 6.,Taussky D,https://www.ncbi.nlm.nih.gov/pubmed/32628305
14656,33207133,Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings,J Urol. 2021 Apr;205(4):1055-1062. doi: 10.1097/JU.0000000000001474. Epub 2020 Nov 18.,Wibmer AG,https://www.ncbi.nlm.nih.gov/pubmed/33207133
14657,32814843,Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):186-192. doi: 10.1038/s41391-020-00265-5. Epub 2020 Aug 19.,Nair SM,https://www.ncbi.nlm.nih.gov/pubmed/32814843
14658,32909471,Prostate re-irradiation: current concerns and future perspectives,Expert Rev Anticancer Ther. 2020 Nov;20(11):947-956. doi: 10.1080/14737140.2020.1822742. Epub 2020 Sep 29.,Cuccia F,https://www.ncbi.nlm.nih.gov/pubmed/32909471
14659,31823175,Modified simple prostatectomy: an approach to address large volume BPH and associated prostate cancers,J Robot Surg. 2020 Aug;14(4):543-548. doi: 10.1007/s11701-019-01038-6. Epub 2019 Dec 10.,Moschovas MC,https://www.ncbi.nlm.nih.gov/pubmed/31823175
14660,32664981,Stereotactic body radiotherapy for localized prostate cancer - 5-year efficacy results,Radiat Oncol. 2020 Jul 14;15(1):173. doi: 10.1186/s13014-020-01608-1.,Vuolukka K,https://www.ncbi.nlm.nih.gov/pubmed/32664981
14661,32833036,Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis,Strahlenther Onkol. 2021 Feb;197(2):124-132. doi: 10.1007/s00066-020-01678-w. Epub 2020 Aug 24.,Tamihardja J,https://www.ncbi.nlm.nih.gov/pubmed/32833036
14662,33252300,Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer,J Urol. 2021 Mar;205(3):761-768. doi: 10.1097/JU.0000000000001423. Epub 2020 Nov 30.,Stone BV,https://www.ncbi.nlm.nih.gov/pubmed/33252300
14663,32418156,Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer,Clin Transl Oncol. 2020 Dec;22(12):2236-2243. doi: 10.1007/s12094-020-02364-0. Epub 2020 May 16.,Ingrosso G,https://www.ncbi.nlm.nih.gov/pubmed/32418156
14664,32736934,Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes,Urol Oncol. 2020 Dec;38(12):930.e23-930.e32. doi: 10.1016/j.urolonc.2020.06.022. Epub 2020 Jul 29.,Huelster HL,https://www.ncbi.nlm.nih.gov/pubmed/32736934
14665,32674975,Pelvic Floor Muscle Training in Radical Prostatectomy and Recent Understanding of the Male Continence Mechanism: A Review,Semin Oncol Nurs. 2020 Aug;36(4):151050. doi: 10.1016/j.soncn.2020.151050. Epub 2020 Jul 14.,Sayner A,https://www.ncbi.nlm.nih.gov/pubmed/32674975
14666,33160757,Comparison between laparoscopic and open prostatectomy: Oncological progression analysis,Actas Urol Esp (Engl Ed). 2021 Mar;45(2):139-145. doi: 10.1016/j.acuro.2020.09.008. Epub 2020 Nov 5.,Martínez-Holguín E,https://www.ncbi.nlm.nih.gov/pubmed/33160757
14668,32623822,Early outcomes of single-port robot-assisted radical prostatectomy: lessons learned from the learning-curve experience,BJU Int. 2021 Jan;127(1):114-121. doi: 10.1111/bju.15158. Epub 2020 Aug 2.,Covas Moschovas M,https://www.ncbi.nlm.nih.gov/pubmed/32623822
14669,33279304,Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies,Eur Urol. 2021 Feb;79(2):298-306. doi: 10.1016/j.eururo.2020.11.015. Epub 2020 Dec 3.,Ranasinghe W,https://www.ncbi.nlm.nih.gov/pubmed/33279304
14670,33097398,"Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomy",Urol Oncol. 2021 Apr;39(4):234.e1-234.e7. doi: 10.1016/j.urolonc.2020.10.010. Epub 2020 Oct 20.,Stolzenbach LF,https://www.ncbi.nlm.nih.gov/pubmed/33097398
14671,31821615,Prostate cancer assessment using MR elastography of fresh prostatectomy specimens at 9.4 T,Magn Reson Med. 2020 Jul;84(1):396-404. doi: 10.1002/mrm.28127. Epub 2019 Dec 10.,Reiter R,https://www.ncbi.nlm.nih.gov/pubmed/31821615
14672,32548712,The Prostate Cancer Outcomes (PCO) study in prostate cancer centres certified by the German Cancer Society,Strahlenther Onkol. 2021 Feb;197(2):116-117. doi: 10.1007/s00066-020-01655-3. Epub 2020 Jun 16.,Kowalski C,https://www.ncbi.nlm.nih.gov/pubmed/32548712
14673,32167866,Prospective Evaluation of Focal High Intensity Focused Ultrasound for Localized Prostate Cancer,J Urol. 2020 Sep;204(3):483-489. doi: 10.1097/JU.0000000000001015. Epub 2020 Mar 13.,Nahar B,https://www.ncbi.nlm.nih.gov/pubmed/32167866
14674,32234553,Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial,Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):530-538. doi: 10.1016/j.ijrobp.2020.03.014. Epub 2020 Mar 29.,Keall P,https://www.ncbi.nlm.nih.gov/pubmed/32234553
14675,32969548,"Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?",BJU Int. 2021 Apr;127(4):454-462. doi: 10.1111/bju.15228. Epub 2020 Sep 25.,Marvaso G,https://www.ncbi.nlm.nih.gov/pubmed/32969548
14676,33075391,Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapy,Radiother Oncol. 2021 Feb;155:42-47. doi: 10.1016/j.radonc.2020.10.021. Epub 2020 Oct 17.,Smith WH,https://www.ncbi.nlm.nih.gov/pubmed/33075391
14678,32791508,Prediction of Radioresistant Prostate Cancer Based on Differentially Expressed Proteins,Urol Int. 2021;105(3-4):316-327. doi: 10.1159/000509447. Epub 2020 Aug 13.,Nestler T,https://www.ncbi.nlm.nih.gov/pubmed/32791508
14679,33357990,Robot-assisted Radical Prostatectomy Using Single-port Perineal Approach: Technique and Single-surgeon Matched-paired Comparative Outcomes,Eur Urol. 2021 Mar;79(3):384-392. doi: 10.1016/j.eururo.2020.12.013. Epub 2020 Dec 21.,Lenfant L,https://www.ncbi.nlm.nih.gov/pubmed/33357990
14680,33144456,Predicting Biochemical Failure in Irradiated Patients With Prostate Cancer by Tumour Volume Measured by Multiparametric MRI,In Vivo. 2020 Nov-Dec;34(6):3473-3481. doi: 10.21873/invivo.12187.,Oerther B,https://www.ncbi.nlm.nih.gov/pubmed/33144456
14681,33152695,Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients,J Natl Compr Canc Netw. 2020 Nov 2;18(11):1492-1499. doi: 10.6004/jnccn.2020.7580. Print 2020 Nov.,Stolzenbach LF,https://www.ncbi.nlm.nih.gov/pubmed/33152695
14682,32996611,Differences in treatment choices for localised prostate cancer diagnosed in private and public health services,Med J Aust. 2020 Nov;213(9):411-417. doi: 10.5694/mja2.50794. Epub 2020 Sep 30.,Te Marvelde L,https://www.ncbi.nlm.nih.gov/pubmed/32996611
14683,33251811,Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer,Acta Radiol. 2021 Dec;62(12):1687-1695. doi: 10.1177/0284185120976931. Epub 2020 Nov 28.,Mäkelä P,https://www.ncbi.nlm.nih.gov/pubmed/33251811
14684,31894469,The ongoing dilemma in pelvic lymph node dissection during radical prostatectomy: who should decide and in which patients?,J Robot Surg. 2020 Aug;14(4):549-558. doi: 10.1007/s11701-019-01041-x. Epub 2020 Jan 1.,Onol FF,https://www.ncbi.nlm.nih.gov/pubmed/31894469
14685,32994534,Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [(68)Ga]Ga-PSMA ligand PET/CT(MRI),Prostate Cancer Prostatic Dis. 2021 Jun;24(2):439-447. doi: 10.1038/s41391-020-00294-0. Epub 2020 Sep 29.,Grubmüller B,https://www.ncbi.nlm.nih.gov/pubmed/32994534
14686,30594487,Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based Study,Eur Urol Focus. 2020 Nov 15;6(6):1213-1219. doi: 10.1016/j.euf.2018.12.006. Epub 2018 Dec 26.,Preisser F,https://www.ncbi.nlm.nih.gov/pubmed/30594487
14687,33060732,Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer,Sci Rep. 2020 Oct 15;10(1):17471. doi: 10.1038/s41598-020-74562-3.,Reverberi C,https://www.ncbi.nlm.nih.gov/pubmed/33060732
14688,32898975,High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series,J Urol. 2020 Oct;204(4):741-747. doi: 10.1097/JU.0000000000001126. Epub 2020 Sep 8.,Abreu AL,https://www.ncbi.nlm.nih.gov/pubmed/32898975
14689,32359937,COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation,Brachytherapy. 2020 Jul-Aug;19(4):401-411. doi: 10.1016/j.brachy.2020.04.005. Epub 2020 Apr 21.,Williams VM,https://www.ncbi.nlm.nih.gov/pubmed/32359937
14690,32798180,Salvage low-dose-rate brachytherapy for local recurrences after prostatectomy and adjuvant or salvage external beam irradiation: Feasibility study on five patients and literature review,Brachytherapy. 2021 Jan-Feb;20(1):19-28. doi: 10.1016/j.brachy.2020.07.001. Epub 2020 Aug 12.,Le Roy C,https://www.ncbi.nlm.nih.gov/pubmed/32798180
14691,31375427,"Consulting ""Dr. Google"" for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis",Eur Urol Oncol. 2020 Aug;3(4):481-488. doi: 10.1016/j.euo.2019.07.002. Epub 2019 Jul 31.,Cacciamani GE,https://www.ncbi.nlm.nih.gov/pubmed/31375427
14692,32814844,Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):193-201. doi: 10.1038/s41391-020-00266-4. Epub 2020 Aug 19.,Preisser F,https://www.ncbi.nlm.nih.gov/pubmed/32814844
14694,31932660,GLUT1 expression in high-risk prostate cancer: correlation with (18)F-FDG-PET/CT and clinical outcome,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):441-448. doi: 10.1038/s41391-020-0202-x. Epub 2020 Jan 13.,Meziou S,https://www.ncbi.nlm.nih.gov/pubmed/31932660
14696,33227441,Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial,Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1254-1262. doi: 10.1016/j.ijrobp.2020.11.009. Epub 2020 Nov 21.,Wages NA,https://www.ncbi.nlm.nih.gov/pubmed/33227441
14697,32229268,Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis,Clin Genitourin Cancer. 2020 Oct;18(5):e517-e522. doi: 10.1016/j.clgc.2020.02.011. Epub 2020 Mar 4.,Lysenko I,https://www.ncbi.nlm.nih.gov/pubmed/32229268
14698,33346091,Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial,Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1263-1270. doi: 10.1016/j.ijrobp.2020.12.020. Epub 2020 Dec 17.,Leite ETT,https://www.ncbi.nlm.nih.gov/pubmed/33346091
14699,32453443,Patterns of metastases of prostatic ductal adenocarcinoma,Cancer. 2020 Aug 15;126(16):3667-3673. doi: 10.1002/cncr.32957. Epub 2020 May 26.,Ranasinghe WKB,https://www.ncbi.nlm.nih.gov/pubmed/32453443
14700,33021441,Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?,J Urol. 2021 Mar;205(3):791-799. doi: 10.1097/JU.0000000000001382. Epub 2020 Oct 6.,Ribeiro L,https://www.ncbi.nlm.nih.gov/pubmed/33021441
14702,33006025,Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity,Strahlenther Onkol. 2021 Feb;197(2):133-140. doi: 10.1007/s00066-020-01691-z. Epub 2020 Oct 1.,Franzese C,https://www.ncbi.nlm.nih.gov/pubmed/33006025
14703,32248613,Single-port robot-assisted radical prostatectomy: a systematic review and pooled analysis of the preliminary experiences,BJU Int. 2020 Jul;126(1):55-64. doi: 10.1111/bju.15069. Epub 2020 May 1.,Checcucci E,https://www.ncbi.nlm.nih.gov/pubmed/32248613
14704,32220567,Outcomes for Young Men With Localized Intermediate-Risk Prostate Cancer: An Analysis of the NCDB,Clin Genitourin Cancer. 2020 Oct;18(5):e531-e542. doi: 10.1016/j.clgc.2020.02.002. Epub 2020 Feb 22.,Chua S,https://www.ncbi.nlm.nih.gov/pubmed/32220567
14705,33132070,"The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance",Brachytherapy. 2020 Nov-Dec;19(6):787-793. doi: 10.1016/j.brachy.2020.10.001. Epub 2020 Oct 29.,Frank SJ,https://www.ncbi.nlm.nih.gov/pubmed/33132070
14706,33234408,Risk factors for urethral stricture following external beam radiotherapy and HDR brachytherapy for prostate cancer,Brachytherapy. 2021 Mar-Apr;20(2):302-306. doi: 10.1016/j.brachy.2020.10.002. Epub 2020 Nov 21.,Groom N,https://www.ncbi.nlm.nih.gov/pubmed/33234408
14708,32999466,Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):423-430. doi: 10.1038/s41391-020-00292-2. Epub 2020 Sep 30.,Privé BM,https://www.ncbi.nlm.nih.gov/pubmed/32999466
14709,32930036,Impact of biopsy perineural invasion on younger prostate cancer patients after radical prostatectomy,Scand J Urol. 2020 Dec;54(6):475-480. doi: 10.1080/21681805.2020.1817143. Epub 2020 Sep 15.,Lin SX,https://www.ncbi.nlm.nih.gov/pubmed/32930036
14710,33203549,A DROP-IN Gamma Probe for Robot-assisted Radioguided Surgery of Lymph Nodes During Radical Prostatectomy,Eur Urol. 2021 Jan;79(1):124-132. doi: 10.1016/j.eururo.2020.10.031. Epub 2020 Nov 14.,Dell'Oglio P,https://www.ncbi.nlm.nih.gov/pubmed/33203549
14711,32926761,Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?,BJU Int. 2021 Jun;127(6):654-664. doi: 10.1111/bju.15236. Epub 2020 Sep 26.,Goldberg H,https://www.ncbi.nlm.nih.gov/pubmed/32926761
14712,32948129,Survival outcomes in men with a positive family history of prostate cancer: a registry based study,BMC Cancer. 2020 Sep 18;20(1):894. doi: 10.1186/s12885-020-07174-9.,Ang M,https://www.ncbi.nlm.nih.gov/pubmed/32948129
14713,31900431,Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatment,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):435-440. doi: 10.1038/s41391-019-0199-1. Epub 2020 Jan 3.,Falzarano SM,https://www.ncbi.nlm.nih.gov/pubmed/31900431
14714,33074376,Improved oncological outcome after radical prostatectomy in patients staged with (68)Ga-PSMA-11 PET: a single-center retrospective cohort comparison,Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1219-1228. doi: 10.1007/s00259-020-05058-5. Epub 2020 Oct 19.,Ferraro DA,https://www.ncbi.nlm.nih.gov/pubmed/33074376
14715,33159608,Salvage Pelvic Lymph Node Dissection and Current State of Imaging for Recurrent Prostate Cancer: Does a Standard Exist?,Curr Urol Rep. 2020 Nov 7;21(12):62. doi: 10.1007/s11934-020-01011-z.,McCloskey H,https://www.ncbi.nlm.nih.gov/pubmed/33159608
14716,33002923,Long-term Oncologic Impact of Positive Anterior and Posterior Surgical Margins After Radical Prostatectomy,Am J Clin Oncol. 2020 Dec 1;43(12):872-879. doi: 10.1097/COC.0000000000000765.,Wu S,https://www.ncbi.nlm.nih.gov/pubmed/33002923
14717,32826171,Real-world dosimetric comparison between CyberKnife SBRT and HDR brachytherapy for the treatment of prostate cancer,Brachytherapy. 2021 Jan-Feb;20(1):44-49. doi: 10.1016/j.brachy.2020.07.011. Epub 2020 Aug 18.,Chatzikonstantinou G,https://www.ncbi.nlm.nih.gov/pubmed/32826171
14718,32542758,Deep learning applications in automatic needle segmentation in ultrasound-guided prostate brachytherapy,Med Phys. 2020 Sep;47(9):3797-3805. doi: 10.1002/mp.14328. Epub 2020 Jul 16.,Wang F,https://www.ncbi.nlm.nih.gov/pubmed/32542758
14719,32686748,Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients,Mod Pathol. 2021 Jan;34(1):184-193. doi: 10.1038/s41379-020-0625-x. Epub 2020 Jul 20.,Hollemans E,https://www.ncbi.nlm.nih.gov/pubmed/32686748
14720,33303244,Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer,Eur Urol. 2022 Apr;81(4):325-330. doi: 10.1016/j.eururo.2020.11.038. Epub 2020 Dec 7.,Yamoah K,https://www.ncbi.nlm.nih.gov/pubmed/33303244
14721,32750234,Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer,Cancer Med. 2020 Sep;9(18):6629-6637. doi: 10.1002/cam4.2985. Epub 2020 Aug 4.,Tsuchida K,https://www.ncbi.nlm.nih.gov/pubmed/32750234
14722,32591157,Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer,J Formos Med Assoc. 2021 Jan;120(1 Pt 2):483-491. doi: 10.1016/j.jfma.2020.06.021. Epub 2020 Jun 23.,Lu YC,https://www.ncbi.nlm.nih.gov/pubmed/32591157
14723,32600282,An agent-based model of prostate Cancer bone metastasis progression and response to Radium223,BMC Cancer. 2020 Jun 29;20(1):605. doi: 10.1186/s12885-020-07084-w.,Casarin S,https://www.ncbi.nlm.nih.gov/pubmed/32600282
14724,32776243,Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic,World J Urol. 2021 Jun;39(6):1789-1796. doi: 10.1007/s00345-020-03402-w. Epub 2020 Aug 10.,Diamand R,https://www.ncbi.nlm.nih.gov/pubmed/32776243
14725,32712028,Dosimetric evaluation of MRI-to-ultrasound automated image registration algorithms for prostate brachytherapy,Brachytherapy. 2020 Sep-Oct;19(5):599-606. doi: 10.1016/j.brachy.2020.06.014. Epub 2020 Jul 22.,Shaaer A,https://www.ncbi.nlm.nih.gov/pubmed/32712028
14726,32526316,Predicting patient specific Pareto fronts from patient anatomy only,Radiother Oncol. 2020 Sep;150:46-50. doi: 10.1016/j.radonc.2020.05.050. Epub 2020 Jun 8.,van der Bijl E,https://www.ncbi.nlm.nih.gov/pubmed/32526316
14727,32966843,Estimating acute urinary retention risk post prostate high dose-rate (HDR) brachytherapy: A clinical-based recursive partitioning analysis,Radiother Oncol. 2021 Jan;154:118-122. doi: 10.1016/j.radonc.2020.09.023. Epub 2020 Sep 20.,Mendez LC,https://www.ncbi.nlm.nih.gov/pubmed/32966843
14728,32684512,Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study),Urol Oncol. 2021 Mar;39(3):191.e1-191.e8. doi: 10.1016/j.urolonc.2020.06.019. Epub 2020 Jul 17.,Kodama H,https://www.ncbi.nlm.nih.gov/pubmed/32684512
14729,33129714,Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancer,Brachytherapy. 2021 Jan-Feb;20(1):1-9. doi: 10.1016/j.brachy.2020.09.005. Epub 2020 Oct 29.,King MT,https://www.ncbi.nlm.nih.gov/pubmed/33129714
14730,32091305,Perioperative Outcomes of Single vs Multi-Port Robotic Assisted Radical Prostatectomy: A Single Institutional Experience,J Urol. 2020 Sep;204(3):490-495. doi: 10.1097/JU.0000000000000811. Epub 2020 Feb 24.,Saidian A,https://www.ncbi.nlm.nih.gov/pubmed/32091305
14731,33185707,Longitudinal analysis of trifecta outcome in Japanese patients with prostate cancer following robot-assisted laparoscopic radical prostatectomy,World J Urol. 2022 Aug;40(8):2009-2015. doi: 10.1007/s00345-020-03515-2. Epub 2020 Nov 13.,Inoue S,https://www.ncbi.nlm.nih.gov/pubmed/33185707
14732,33081804,Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition,Radiat Oncol. 2020 Oct 20;15(1):242. doi: 10.1186/s13014-020-01683-4.,Sachpazidis I,https://www.ncbi.nlm.nih.gov/pubmed/33081804
14733,33226309,"Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer",J Urol. 2021 Feb;205(2):426-433. doi: 10.1097/JU.0000000000001385. Epub 2020 Nov 23.,DeWitt-Foy ME,https://www.ncbi.nlm.nih.gov/pubmed/33226309
14734,33031318,The primary treatment of prostate cancer with high-intensity focused ultrasound: A systematic review and meta-analysis,Medicine (Baltimore). 2020 Oct 9;99(41):e22610. doi: 10.1097/MD.0000000000022610.,He Y,https://www.ncbi.nlm.nih.gov/pubmed/33031318
14735,32151470,Comparison between laparoscopic and open prostatectomy: Postoperative urinary continence analysis,Actas Urol Esp (Engl Ed). 2020 Oct;44(8):535-541. doi: 10.1016/j.acuro.2019.10.002. Epub 2020 Mar 6.,Martínez-Holguín E,https://www.ncbi.nlm.nih.gov/pubmed/32151470
14736,31679064,"Radical prostatectomy after previous transurethral resection of the prostate: oncological, surgical and functional outcomes-a meta-analysis",World J Urol. 2020 Aug;38(8):1919-1932. doi: 10.1007/s00345-019-02986-2. Epub 2019 Nov 2.,Liao H,https://www.ncbi.nlm.nih.gov/pubmed/31679064
14737,32916021,Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial,BJU Int. 2021 Mar;127(3):361-368. doi: 10.1111/bju.15238. Epub 2020 Sep 29.,Nyberg M,https://www.ncbi.nlm.nih.gov/pubmed/32916021
14738,32034499,Functional and perioperative outcomes in elderly men after robotic-assisted radical prostatectomy for prostate cancer,World J Urol. 2020 Nov;38(11):2791-2798. doi: 10.1007/s00345-020-03096-0. Epub 2020 Feb 7.,Traboulsi SL,https://www.ncbi.nlm.nih.gov/pubmed/32034499
14739,32278731,The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy,Urol Oncol. 2020 Oct;38(10):794.e17-794.e27. doi: 10.1016/j.urolonc.2020.03.004. Epub 2020 Apr 9.,Bargão Santos P,https://www.ncbi.nlm.nih.gov/pubmed/32278731
14741,33016054,Prostate cancer with cribriform pattern: Exclusion criterion for active surveillance?,Arch Ital Urol Androl. 2020 Oct 2;92(3). doi: 10.4081/aiua.2020.3.235.,Bernardino RM,https://www.ncbi.nlm.nih.gov/pubmed/33016054
14742,32843291,"Prostate cancer presentation, treatment selection, and outcomes among men with HIV/AIDS: A clinical stage, race, and age-matched contemporary analysis",Urol Oncol. 2021 Jan;39(1):73.e19-73.e25. doi: 10.1016/j.urolonc.2020.07.027. Epub 2020 Aug 23.,Ruden M,https://www.ncbi.nlm.nih.gov/pubmed/32843291
14743,31668713,Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer,Eur Urol Oncol. 2020 Dec;3(6):748-755. doi: 10.1016/j.euo.2019.09.006. Epub 2019 Oct 23.,Zelefsky MJ,https://www.ncbi.nlm.nih.gov/pubmed/31668713
14745,33384275,Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis,Eur Urol Oncol. 2021 Aug;4(4):519-528. doi: 10.1016/j.euo.2020.11.008. Epub 2020 Dec 28.,Stabile A,https://www.ncbi.nlm.nih.gov/pubmed/33384275
14746,32532513,Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus,Eur Urol. 2020 Sep;78(3):371-378. doi: 10.1016/j.eururo.2020.05.018. Epub 2020 Jun 10.,Lebastchi AH,https://www.ncbi.nlm.nih.gov/pubmed/32532513
14747,32624405,Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer,Brachytherapy. 2020 Sep-Oct;19(5):557-566. doi: 10.1016/j.brachy.2020.05.007. Epub 2020 Jul 3.,Fischer-Valuck BW,https://www.ncbi.nlm.nih.gov/pubmed/32624405
14748,32696091,(68)Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer,Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):477-482. doi: 10.1007/s00259-020-04944-2. Epub 2020 Jul 22.,Roberts MJ,https://www.ncbi.nlm.nih.gov/pubmed/32696091
14749,32562045,National trends in the management of patients with positive surgical margins at radical prostatectomy,World J Urol. 2021 Apr;39(4):1141-1151. doi: 10.1007/s00345-020-03298-6. Epub 2020 Jun 19.,Ghabili K,https://www.ncbi.nlm.nih.gov/pubmed/32562045
14750,33128858,Trends in prostatectomy utilization: Increasing upfront prostatectomy and postprostatectomy radiotherapy for high-risk prostate cancer,Cancer Med. 2020 Dec;9(23):8754-8764. doi: 10.1002/cam4.3482. Epub 2020 Oct 31.,Kaps B,https://www.ncbi.nlm.nih.gov/pubmed/33128858
14751,32747200,Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy,Eur Urol. 2020 Oct;78(4):583-591. doi: 10.1016/j.eururo.2020.07.017. Epub 2020 Aug 1.,Martini A,https://www.ncbi.nlm.nih.gov/pubmed/32747200
14752,32920006,Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer,Radiother Oncol. 2021 Jan;154:255-259. doi: 10.1016/j.radonc.2020.09.009. Epub 2020 Sep 11.,Bartkowiak D,https://www.ncbi.nlm.nih.gov/pubmed/32920006
14753,32506179,Suprapubic Versus Urethral Catheter for Urinary Drainage After Robot-Assisted Radical Prostatectomy,Curr Urol Rep. 2020 Jun 6;21(8):30. doi: 10.1007/s11934-020-00982-3.,Xia L,https://www.ncbi.nlm.nih.gov/pubmed/32506179
14754,32654363,Complications after open and robot-assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trial,BJU Int. 2021 Feb;127(2):190-197. doi: 10.1111/bju.15172. Epub 2020 Aug 17.,Huang MM,https://www.ncbi.nlm.nih.gov/pubmed/32654363
14755,33119421,Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence,J Urol. 2021 Jan;205(1):129-136. doi: 10.1097/JU.0000000000001327. Epub 2020 Aug 17.,Borges RC,https://www.ncbi.nlm.nih.gov/pubmed/33119421
14756,32940059,Managing Patients with Prostate Cancer During COVID-19 Pandemic: The Experience of a High-Volume Robotic Surgery Center,J Endourol. 2021 Mar;35(3):305-311. doi: 10.1089/end.2020.0751. Epub 2020 Nov 24.,Moschovas MC,https://www.ncbi.nlm.nih.gov/pubmed/32940059
14757,32773013,"Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT",Health Technol Assess. 2020 Aug;24(37):1-176. doi: 10.3310/hta24370.,Hamdy FC,https://www.ncbi.nlm.nih.gov/pubmed/32773013
14758,32935562,"Acceptance, Indications and Chances of Focal Therapy in Localized Prostate Cancer: A Real-World Perspective of Urologists in Germany",J Endourol. 2021 Apr;35(4):444-450. doi: 10.1089/end.2020.0774. Epub 2020 Oct 21.,Wenzel M,https://www.ncbi.nlm.nih.gov/pubmed/32935562
14759,33358891,Improving the Stratification of Patients With Intermediate-risk Prostate Cancer,Clin Genitourin Cancer. 2021 Apr;19(2):e120-e128. doi: 10.1016/j.clgc.2020.11.003. Epub 2020 Nov 10.,Stolzenbach LF,https://www.ncbi.nlm.nih.gov/pubmed/33358891
14760,32748620,Retzius-sparing robot-assisted radical prostatectomy versus open retropubic radical prostatectomy: a prospective comparative study with 19-month follow-up,Minerva Urol Nefrol. 2020 Oct;72(5):586-594. doi: 10.23736/S0393-2249.20.03830-8. Epub 2020 Aug 4.,Abdel Raheem A,https://www.ncbi.nlm.nih.gov/pubmed/32748620
14761,32641738,The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):622-629. doi: 10.1038/s41391-020-0248-9. Epub 2020 Jul 8.,Goldberg H,https://www.ncbi.nlm.nih.gov/pubmed/32641738
14762,32687658,Identifying and treating ROBO1(-ve) /DOCK1(+ve) prostate cancer: An aggressive cancer subtype prevalent in African American patients,Prostate. 2020 Sep;80(13):1045-1057. doi: 10.1002/pros.24018. Epub 2020 Jul 20.,Ferrari MG,https://www.ncbi.nlm.nih.gov/pubmed/32687658
14763,32540218,Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy,Eur Urol Oncol. 2021 Dec;4(6):955-962. doi: 10.1016/j.euo.2020.05.001. Epub 2020 Jun 12.,Weiner AB,https://www.ncbi.nlm.nih.gov/pubmed/32540218
14764,32575490,Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer,Int J Mol Sci. 2020 Jun 19;21(12):4373. doi: 10.3390/ijms21124373.,Waldbillig F,https://www.ncbi.nlm.nih.gov/pubmed/32575490
14765,32595074,A Nationwide Persistent Underutilization of Adjuvant Radiotherapy in North American Prostate Cancer Patients,Clin Genitourin Cancer. 2020 Dec;18(6):489-499.e6. doi: 10.1016/j.clgc.2020.05.001. Epub 2020 May 16.,Rakic N,https://www.ncbi.nlm.nih.gov/pubmed/32595074
14767,32580211,Updated evidence on oncological outcomes of surgery versus external beam radiotherapy for localized prostate cancer,Jpn J Clin Oncol. 2020 Sep 5;50(9):963-969. doi: 10.1093/jjco/hyaa105.,Taguchi S,https://www.ncbi.nlm.nih.gov/pubmed/32580211
14768,32782182,Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry,Urol Oncol. 2020 Oct;38(10):793.e1-793.e11. doi: 10.1016/j.urolonc.2020.07.012. Epub 2020 Aug 8.,Borno HT,https://www.ncbi.nlm.nih.gov/pubmed/32782182
14769,33095670,Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity,Br J Radiol. 2021 Jan 1;94(1117):20200696. doi: 10.1259/bjr.20200696. Epub 2020 Oct 29.,Ugurluer G,https://www.ncbi.nlm.nih.gov/pubmed/33095670
14770,32320130,"Pelvic exenteration surgery in patients with locally advanced castration-naïve and castration-resistant, symptomatic prostate cancer",BJU Int. 2020 Sep;126(3):342-349. doi: 10.1111/bju.15088. Epub 2020 May 16.,Heidenreich A,https://www.ncbi.nlm.nih.gov/pubmed/32320130
14771,33080255,Early Effects of High-intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer on Fecal Continence and Anorectal Physiology,Urology. 2021 Feb;148:211-216. doi: 10.1016/j.urology.2020.10.009. Epub 2020 Oct 17.,de Almeida RVS,https://www.ncbi.nlm.nih.gov/pubmed/33080255
14772,33011207,Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results,Radiother Oncol. 2021 Jan;154:214-219. doi: 10.1016/j.radonc.2020.09.047. Epub 2020 Oct 2.,Hoskin PJ,https://www.ncbi.nlm.nih.gov/pubmed/33011207
14773,32813279,Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer,Cochrane Database Syst Rev. 2020 Aug 18;8(8):CD013641. doi: 10.1002/14651858.CD013641.pub2.,Rosenberg JE,https://www.ncbi.nlm.nih.gov/pubmed/32813279
14774,32889832,Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study,Am J Clin Oncol. 2020 Sep;43(9):628-635. doi: 10.1097/COC.0000000000000721.,D'Agostino GR,https://www.ncbi.nlm.nih.gov/pubmed/32889832
14775,33109583,Longitudinal Changes in Health-related Quality of Life After (125)I Low-dose-rate Brachytherapy for Localized Prostate Cancer,Anticancer Res. 2020 Nov;40(11):6443-6456. doi: 10.21873/anticanres.14666.,Ogasawara N,https://www.ncbi.nlm.nih.gov/pubmed/33109583
14777,31559475,Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy,World J Urol. 2020 Jul;38(7):1749-1756. doi: 10.1007/s00345-019-02970-w. Epub 2019 Sep 26.,Matsumoto K,https://www.ncbi.nlm.nih.gov/pubmed/31559475
14778,32612164,Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome,Sci Rep. 2020 Jul 1;10(1):10704. doi: 10.1038/s41598-020-67320-y.,Strand SH,https://www.ncbi.nlm.nih.gov/pubmed/32612164
14779,32917193,"(Dis)concordance of comorbidity data and cancer status across administrative datasets, medical charts, and self-reports",BMC Health Serv Res. 2020 Sep 11;20(1):858. doi: 10.1186/s12913-020-05713-5.,Sheriffdeen A,https://www.ncbi.nlm.nih.gov/pubmed/32917193
14780,32524295,Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer,Med Oncol. 2020 Jun 10;37(7):60. doi: 10.1007/s12032-020-01385-7.,Reyes DK,https://www.ncbi.nlm.nih.gov/pubmed/32524295
14781,32748617,Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review,Minerva Urol Nefrol. 2020 Oct;72(5):563-578. doi: 10.23736/S0393-2249.20.03783-2. Epub 2020 Aug 4.,Mantica G,https://www.ncbi.nlm.nih.gov/pubmed/32748617
14782,32972877,"Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy",Clin Genitourin Cancer. 2021 Jun;19(3):255-266.e7. doi: 10.1016/j.clgc.2020.08.009. Epub 2020 Aug 28.,Liu Y,https://www.ncbi.nlm.nih.gov/pubmed/32972877
14785,32620655,Retzius-sparing Robotic-assisted Radical Prostatectomy Facilitates Early Continence Regardless of Neurovascular Bundle Sparing,Anticancer Res. 2020 Jul;40(7):4075-4080. doi: 10.21873/anticanres.14405.,Liao PC,https://www.ncbi.nlm.nih.gov/pubmed/32620655
14786,32693961,Inconclusive Bone Scan in Men with Intermediate and High-risk Prostate Cancer: What next?,Semin Oncol Nurs. 2020 Aug;36(4):151046. doi: 10.1016/j.soncn.2020.151046. Epub 2020 Jul 18.,Primeau C,https://www.ncbi.nlm.nih.gov/pubmed/32693961
14787,32593646,Long-term results of a protocol-based ultrasound-guided salvage brachytherapy as re-irradiation for local recurrent prostate cancer,Radiother Oncol. 2020 Sep;150:201-205. doi: 10.1016/j.radonc.2020.06.031. Epub 2020 Jun 25.,Schönle N,https://www.ncbi.nlm.nih.gov/pubmed/32593646
14788,33026448,Association of State-Level Medicaid Expansion With Treatment of Patients With Higher-Risk Prostate Cancer,JAMA Netw Open. 2020 Oct 1;3(10):e2015198. doi: 10.1001/jamanetworkopen.2020.15198.,Liu W,https://www.ncbi.nlm.nih.gov/pubmed/33026448
14789,32727308,Predictors of ISUP score upgrade in patients with low-risk prostate cancer,Tumori. 2021 Jun;107(3):254-260. doi: 10.1177/0300891620943953. Epub 2020 Jul 30.,Haberal HB,https://www.ncbi.nlm.nih.gov/pubmed/32727308
14790,31971494,Nerve Sparing during Robot-Assisted Radical Prostatectomy Increases the Risk of Ipsilateral Positive Surgical Margins,J Urol. 2020 Jul;204(1):91-95. doi: 10.1097/JU.0000000000000760. Epub 2020 Jan 23.,Soeterik TFW,https://www.ncbi.nlm.nih.gov/pubmed/31971494
14791,32614411,Leukocyte telomere length is associated with aggressive prostate cancer in localized African American prostate cancer patients,Carcinogenesis. 2020 Sep 24;41(9):1213-1218. doi: 10.1093/carcin/bgaa070.,Tsai CW,https://www.ncbi.nlm.nih.gov/pubmed/32614411
14792,32356508,Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic,J Urol. 2020 Oct;204(4):720-725. doi: 10.1097/JU.0000000000001089. Epub 2020 May 1.,Ginsburg KB,https://www.ncbi.nlm.nih.gov/pubmed/32356508
14793,32755167,Postoperative Biochemical Failure in Patients With PI-RADS Category 4 or 5 Prostate Cancers: Risk Stratification According to Zonal Location of an Index Lesion,AJR Am J Roentgenol. 2020 Oct;215(4):913-919. doi: 10.2214/AJR.19.22653. Epub 2020 Jul 8.,Shin N,https://www.ncbi.nlm.nih.gov/pubmed/32755167
14794,32647353,The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):135-139. doi: 10.1038/s41391-020-0249-8. Epub 2020 Jul 9.,Nickols NG,https://www.ncbi.nlm.nih.gov/pubmed/32647353
14795,33023952,Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response,Clin Cancer Res. 2021 Jan 15;27(2):429-437. doi: 10.1158/1078-0432.CCR-20-2344. Epub 2020 Oct 6.,Karzai F,https://www.ncbi.nlm.nih.gov/pubmed/33023952
14796,33040249,"Evidence-based evolution of our robot-assisted laparoscopic prostatectomy (RALP) technique through 13,000 cases",J Robot Surg. 2021 Aug;15(4):651-660. doi: 10.1007/s11701-020-01157-5. Epub 2020 Oct 10.,Bhat KRS,https://www.ncbi.nlm.nih.gov/pubmed/33040249
14797,32763123,Survival Outcomes for Metastatic Prostate Cancer Patients Treated With Radical Prostatectomy or Radiation Therapy: A SEER-based Study,Clin Genitourin Cancer. 2020 Dec;18(6):e705-e722. doi: 10.1016/j.clgc.2020.05.005. Epub 2020 May 11.,Jin K,https://www.ncbi.nlm.nih.gov/pubmed/32763123
14798,32427011,Clinical implications of variable relative biological effectiveness in proton therapy for prostate cancer,Acta Oncol. 2020 Oct;59(10):1171-1177. doi: 10.1080/0284186X.2020.1762928. Epub 2020 May 19.,Bertolet A,https://www.ncbi.nlm.nih.gov/pubmed/32427011
14801,32815034,Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome,Virchows Arch. 2021 Feb;478(2):249-256. doi: 10.1007/s00428-020-02902-9. Epub 2020 Aug 20.,van der Slot MA,https://www.ncbi.nlm.nih.gov/pubmed/32815034
14802,32505609,"Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective Trial",Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):905-913. doi: 10.1016/j.ijrobp.2020.05.032. Epub 2020 Jun 4.,Kollmeier MA,https://www.ncbi.nlm.nih.gov/pubmed/32505609
14803,32989262,Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patients,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):414-422. doi: 10.1038/s41391-020-00291-3. Epub 2020 Sep 28.,Miccio JA,https://www.ncbi.nlm.nih.gov/pubmed/32989262
14804,32660504,Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI,Radiat Oncol. 2020 Jul 13;15(1):172. doi: 10.1186/s13014-020-01568-6.,Her EJ,https://www.ncbi.nlm.nih.gov/pubmed/32660504
14805,32484573,Automatic multi-catheter detection using deeply supervised convolutional neural network in MRI-guided HDR prostate brachytherapy,Med Phys. 2020 Sep;47(9):4115-4124. doi: 10.1002/mp.14307. Epub 2020 Jun 15.,Dai X,https://www.ncbi.nlm.nih.gov/pubmed/32484573
14807,32632897,Concordance Between Biopsy and Radical Prostatectomy Gleason Scores: Evaluation of Determinants in a Large-Scale Study of Patients Undergoing RARP in Belgium,Pathol Oncol Res. 2020 Oct;26(4):2605-2612. doi: 10.1007/s12253-020-00860-w. Epub 2020 Jul 6.,Soenens C,https://www.ncbi.nlm.nih.gov/pubmed/32632897
14808,32265129,A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806),Clin Genitourin Cancer. 2020 Aug;18(4):e410-e415. doi: 10.1016/j.clgc.2019.12.020. Epub 2020 Jan 8.,Isfahanian N,https://www.ncbi.nlm.nih.gov/pubmed/32265129
14809,32591899,Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group,World J Urol. 2021 Apr;39(4):1161-1170. doi: 10.1007/s00345-020-03315-8. Epub 2020 Jun 26.,Bardoscia L,https://www.ncbi.nlm.nih.gov/pubmed/32591899
14810,33085799,High intratumoral CD8(+) T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy,Prostate. 2021 Jan;81(1):20-28. doi: 10.1002/pros.24068. Epub 2020 Oct 21.,Yang Y,https://www.ncbi.nlm.nih.gov/pubmed/33085799
14811,32900561,Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer,Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):227-236. doi: 10.1016/j.ijrobp.2020.08.014. Epub 2020 Sep 6.,Royce TJ,https://www.ncbi.nlm.nih.gov/pubmed/32900561
14812,32883625,Real-time Augmented Reality Three-dimensional Guided Robotic Radical Prostatectomy: Preliminary Experience and Evaluation of the Impact on Surgical Planning,Eur Urol Focus. 2021 Nov;7(6):1260-1267. doi: 10.1016/j.euf.2020.08.004. Epub 2020 Sep 1.,Schiavina R,https://www.ncbi.nlm.nih.gov/pubmed/32883625
14813,31959548,Technical Modifications Necessary to Implement the da Vinci Single-port Robotic System,Eur Urol. 2020 Sep;78(3):415-423. doi: 10.1016/j.eururo.2020.01.005. Epub 2020 Jan 17.,Covas Moschovas M,https://www.ncbi.nlm.nih.gov/pubmed/31959548
14814,33109205,"A novel ""three-port"" trocar placement technique for laparoscopic radical prostatectomy",World J Surg Oncol. 2020 Oct 27;18(1):279. doi: 10.1186/s12957-020-02051-y.,Xu B,https://www.ncbi.nlm.nih.gov/pubmed/33109205
14815,32500621,Geriatric 8 screening of frailty in patients with prostate cancer,Int J Urol. 2020 Aug;27(8):642-648. doi: 10.1111/iju.14256. Epub 2020 Jun 4.,Momota M,https://www.ncbi.nlm.nih.gov/pubmed/32500621
14816,33160848,Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for (18)F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease,Urol Oncol. 2021 Jun;39(6):365.e9-365.e16. doi: 10.1016/j.urolonc.2020.10.017. Epub 2020 Nov 5.,Kim EH,https://www.ncbi.nlm.nih.gov/pubmed/33160848
14817,33030972,Clinical iterative model development improves knowledge-based plan quality for high-risk prostate cancer with four integrated dose levels,Acta Oncol. 2021 Feb;60(2):237-244. doi: 10.1080/0284186X.2020.1828619. Epub 2020 Oct 8.,Hundvin JA,https://www.ncbi.nlm.nih.gov/pubmed/33030972
14818,32994091,Impact of Concomitant Medications on Biochemical Outcome in Localised Prostate Cancer Treated with Radiotherapy and Androgen Deprivation Therapy,Clin Oncol (R Coll Radiol). 2021 Mar;33(3):181-190. doi: 10.1016/j.clon.2020.09.005. Epub 2020 Sep 29.,Roy S,https://www.ncbi.nlm.nih.gov/pubmed/32994091
14819,33227302,Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective,Urology. 2021 Feb;148:88-92. doi: 10.1016/j.urology.2020.11.021. Epub 2020 Nov 21.,Etafy MH,https://www.ncbi.nlm.nih.gov/pubmed/33227302
14820,32943260,Technical Refinements in Superextended Robot-assisted Radical Prostatectomy for Locally Advanced Prostate Cancer Patients at Multiparametric Magnetic Resonance Imaging,Eur Urol. 2021 Jul;80(1):104-112. doi: 10.1016/j.eururo.2020.09.009. Epub 2020 Sep 14.,Mazzone E,https://www.ncbi.nlm.nih.gov/pubmed/32943260
14821,32972895,Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy,Eur Urol Oncol. 2022 Jun;5(3):328-337. doi: 10.1016/j.euo.2020.08.008. Epub 2020 Sep 22.,Soeterik TFW,https://www.ncbi.nlm.nih.gov/pubmed/32972895
14822,32777242,Online-adaptive versus robust IMPT for prostate cancer: How much can we gain?,Radiother Oncol. 2020 Oct;151:228-233. doi: 10.1016/j.radonc.2020.07.054. Epub 2020 Aug 7.,Jagt TZ,https://www.ncbi.nlm.nih.gov/pubmed/32777242
14823,32537666,Oncological and functional outcomes in patients over 70 years of age treated with robotic radical prostatectomy: a propensity-matched analysis,World J Urol. 2021 Apr;39(4):1131-1140. doi: 10.1007/s00345-020-03304-x. Epub 2020 Jun 14.,Gurung PMS,https://www.ncbi.nlm.nih.gov/pubmed/32537666
14825,32931133,Effects of nerve-sparing procedures on bowel function after robot-assisted radical prostatectomy: A longitudinal study,Int J Med Robot. 2020 Dec;16(6):1-10. doi: 10.1002/rcs.2156. Epub 2020 Oct 8.,Nishikawa R,https://www.ncbi.nlm.nih.gov/pubmed/32931133
14826,33121914,Pathologic nodal downstaging in men with clinically involved lymph nodes undergoing radical prostatectomy: Implications for definitive locoregional therapy,Urol Oncol. 2021 Feb;39(2):130.e1-130.e7. doi: 10.1016/j.urolonc.2020.08.035. Epub 2020 Oct 26.,Ghali F,https://www.ncbi.nlm.nih.gov/pubmed/33121914
14827,33127301,Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer,Urol Oncol. 2021 Feb;39(2):131.e9-131.e15. doi: 10.1016/j.urolonc.2020.09.026. Epub 2020 Oct 27.,Aizawa R,https://www.ncbi.nlm.nih.gov/pubmed/33127301
14828,32651467,"Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis",Prostate Cancer Prostatic Dis. 2021 Mar;24(1):140-149. doi: 10.1038/s41391-020-0254-y. Epub 2020 Jul 10.,Yuan Z,https://www.ncbi.nlm.nih.gov/pubmed/32651467
14829,33075390,Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: A national population-based study,Radiother Oncol. 2021 Feb;155:48-55. doi: 10.1016/j.radonc.2020.10.019. Epub 2020 Oct 17.,Parry MG,https://www.ncbi.nlm.nih.gov/pubmed/33075390
14830,33358558,Sexual Satisfaction in Men Suffering From Erectile Dysfunction After Robot-Assisted Radical Prostatectomy for Prostate Cancer: An Observational Study,J Sex Med. 2021 Feb;18(2):339-346. doi: 10.1016/j.jsxm.2020.11.011. Epub 2020 Dec 24.,Albers LF,https://www.ncbi.nlm.nih.gov/pubmed/33358558
14831,32211942,PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis,Strahlenther Onkol. 2020 Jul;196(7):637-646. doi: 10.1007/s00066-020-01605-z. Epub 2020 Mar 24.,Schmidt-Hegemann NS,https://www.ncbi.nlm.nih.gov/pubmed/32211942
14832,32928177,"Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial",BMC Cancer. 2020 Sep 14;20(1):884. doi: 10.1186/s12885-020-07386-z.,Privé BM,https://www.ncbi.nlm.nih.gov/pubmed/32928177
14833,32938266,Current Mental Distress Among Men With a History of Radical Prostatectomy and Related Adverse Correlates,Am J Mens Health. 2020 Sep-Oct;14(5):1557988320957535. doi: 10.1177/1557988320957535.,Ilie G,https://www.ncbi.nlm.nih.gov/pubmed/32938266
14834,32873530,Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy-A Feasibility Study,Eur Urol Oncol. 2022 Jun;5(3):357-361. doi: 10.1016/j.euo.2020.08.004. Epub 2020 Aug 29.,Darr C,https://www.ncbi.nlm.nih.gov/pubmed/32873530
14837,32851440,"Is there a clinical benefit from prostate cancer center certification? An evaluation of functional and oncologic outcomes from 22,649 radical prostatectomy patients",World J Urol. 2021 Jan;39(1):5-10. doi: 10.1007/s00345-020-03411-9. Epub 2020 Aug 26.,Butea-Bocu MC,https://www.ncbi.nlm.nih.gov/pubmed/32851440
14838,32453596,Knockdown of FBP1 enhances radiosensitivity in prostate cancer cells by activating autophagy,Neoplasma. 2020 Sep;67(5):982-991. doi: 10.4149/neo_2020_190807N728. Epub 2020 May 26.,Li XR,https://www.ncbi.nlm.nih.gov/pubmed/32453596
14839,32852750,PROACTA: a survey on the actual attitude of the Italian radiation oncologists in the management and prescription of hormonal therapy in prostate cancer patients,Radiol Med. 2021 Mar;126(3):460-465. doi: 10.1007/s11547-020-01264-1. Epub 2020 Aug 27.,Fersino S,https://www.ncbi.nlm.nih.gov/pubmed/32852750
14840,33075151,"Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer",Prostate. 2021 Feb;81(2):102-108. doi: 10.1002/pros.24085. Epub 2020 Oct 19.,Washington SL 3rd,https://www.ncbi.nlm.nih.gov/pubmed/33075151
14841,32143901,Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study,Clin Oncol (R Coll Radiol). 2020 Aug;32(8):501-508. doi: 10.1016/j.clon.2020.02.004. Epub 2020 Mar 3.,Sujenthiran A,https://www.ncbi.nlm.nih.gov/pubmed/32143901
14842,32843292,"Validation of ""patient-reported outcomes via online questionnaire"" as a urinary continence assessment and quality improvement tool following radical prostatectomy",Urol Oncol. 2021 Jan;39(1):72.e15-72.e20. doi: 10.1016/j.urolonc.2020.07.001. Epub 2020 Aug 22.,Huynh LM,https://www.ncbi.nlm.nih.gov/pubmed/32843292
14843,30691961,Association Between Preoperative Magnetic Resonance Imaging-based Urethral Parameters and Continence Recovery Following Robot-assisted Radical Prostatectomy,Eur Urol Focus. 2020 Sep 15;6(5):1013-1020. doi: 10.1016/j.euf.2019.01.011. Epub 2019 Jan 25.,Kim LHC,https://www.ncbi.nlm.nih.gov/pubmed/30691961
14844,32557744,Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve-sparing surgery in prostate cancer patients (NeuroSAFE),Histopathology. 2020 Oct;77(4):539-547. doi: 10.1111/his.14184. Epub 2020 Sep 3.,van der Slot MA,https://www.ncbi.nlm.nih.gov/pubmed/32557744
14845,32497131,Comparison of perioperative outcomes in elderly (age ? 75 years) vs. younger men undergoing robot-assisted radical prostatectomy,PLoS One. 2020 Jun 4;15(6):e0234113. doi: 10.1371/journal.pone.0234113. eCollection 2020.,Yamada Y,https://www.ncbi.nlm.nih.gov/pubmed/32497131
14846,32822547,Stereotactic body radiotherapy (SBRT) in metachronous oligometastatic prostate cancer: a systematic review and meta-analysis on the current prospective evidence,Br J Radiol. 2020 Dec 1;93(1116):20200496. doi: 10.1259/bjr.20200496. Epub 2020 Sep 4.,Yan M,https://www.ncbi.nlm.nih.gov/pubmed/32822547
14847,33242634,Comparative Analysis of 5-Year Clinical Outcomes and Patterns of Failure of Proton Beam Therapy Versus Intensity Modulated Radiation therapy for Prostate Cancer in the Postoperative Setting,Pract Radiat Oncol. 2021 Mar-Apr;11(2):e195-e202. doi: 10.1016/j.prro.2020.11.005. Epub 2020 Nov 24.,Barsky AR,https://www.ncbi.nlm.nih.gov/pubmed/33242634
14848,33030959,Partial prostate re-irradiation for the treatment of isolated local recurrence of prostate cancer in patients previously treated with primary external beam radiotherapy: short-term results of a monocentric study,Neoplasma. 2021 Jan;68(1):216-226. doi: 10.4149/neo_2020_200622N651. Epub 2020 Oct 7.,Matrone F,https://www.ncbi.nlm.nih.gov/pubmed/33030959
14849,32918235,The comparison of the survival outcome between robotic-assisted radical prostatectomy and radiation therapy for localized prostate cancer in men over 70 years: Korean Nationwide Observational Study,J Robot Surg. 2021 Aug;15(4):585-592. doi: 10.1007/s11701-020-01144-w. Epub 2020 Sep 11.,Ko YH,https://www.ncbi.nlm.nih.gov/pubmed/32918235
14850,32683462,Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies,World J Urol. 2021 Jun;39(6):1861-1867. doi: 10.1007/s00345-020-03368-9. Epub 2020 Jul 18.,Ferro M,https://www.ncbi.nlm.nih.gov/pubmed/32683462
14851,33106941,Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years' experience from a large Canadian academic center,World J Urol. 2021 Aug;39(8):2913-2919. doi: 10.1007/s00345-020-03496-2. Epub 2020 Oct 27.,Zakaria AS,https://www.ncbi.nlm.nih.gov/pubmed/33106941
14852,33040689,Does radical prostatectomy result in lower urinary tract symptom improvement in high-risk and locally advanced prostate cancer? A Single-center experience,Urologia. 2021 May;88(2):110-114. doi: 10.1177/0391560320964611. Epub 2020 Oct 10.,Papadopoulos G,https://www.ncbi.nlm.nih.gov/pubmed/33040689
14853,32945701,Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy,Acta Oncol. 2021 Feb;60(2):215-221. doi: 10.1080/0284186X.2020.1821090. Epub 2020 Sep 18.,Nicosia L,https://www.ncbi.nlm.nih.gov/pubmed/32945701
14854,32918971,Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost,Radiother Oncol. 2021 Jan;154:29-35. doi: 10.1016/j.radonc.2020.09.007. Epub 2020 Sep 10.,Alayed Y,https://www.ncbi.nlm.nih.gov/pubmed/32918971
14855,32568605,Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study,J Urol. 2020 Dec;204(6):1236-1241. doi: 10.1097/JU.0000000000001198. Epub 2020 Jun 22.,Reisz PA,https://www.ncbi.nlm.nih.gov/pubmed/32568605
14857,33069598,Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score-matched analysis,Brachytherapy. 2021 Jan-Feb;20(1):10-18. doi: 10.1016/j.brachy.2020.08.023. Epub 2020 Oct 14.,Sutani S,https://www.ncbi.nlm.nih.gov/pubmed/33069598
14858,32807046,The role of bedside assistant during robot assisted radical prostatectomy: Is more experience better? Analysis on perioperative and clinical outcomes,Urologia. 2021 Feb;88(1):9-13. doi: 10.1177/0391560320951085. Epub 2020 Aug 17.,Mangano MS,https://www.ncbi.nlm.nih.gov/pubmed/32807046
14859,32642874,Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects,Strahlenther Onkol. 2021 Feb;197(2):118-123. doi: 10.1007/s00066-020-01657-1. Epub 2020 Jul 8.,Moll M,https://www.ncbi.nlm.nih.gov/pubmed/32642874
14860,33160849,Computed tomography versus magnetic resonance imaging in high-dose-rate prostate brachytherapy planning: The impact on patient-reported health-related quality of life,Brachytherapy. 2021 Jan-Feb;20(1):66-74. doi: 10.1016/j.brachy.2020.09.002. Epub 2020 Nov 5.,Harris AA,https://www.ncbi.nlm.nih.gov/pubmed/33160849
14861,32648416,Comparison and trend of perioperative outcomes between robot-assisted radical prostatectomy and open radical prostatectomy: nationwide inpatient sample 2009-2014,Int Braz J Urol. 2020 Sep-Oct;46(5):754-771. doi: 10.1590/S1677-5538.IBJU.2019.0420.,Qin Y,https://www.ncbi.nlm.nih.gov/pubmed/32648416
14862,32633027,High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term androgen deprivation therapy for very high-risk prostate cancer,Int J Urol. 2020 Sep;27(9):800-806. doi: 10.1111/iju.14305. Epub 2020 Jul 7.,Kasahara T,https://www.ncbi.nlm.nih.gov/pubmed/32633027
14863,32602076,"Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series",Clin Transl Oncol. 2021 Feb;23(2):364-371. doi: 10.1007/s12094-020-02427-2. Epub 2020 Jun 29.,Francolini G,https://www.ncbi.nlm.nih.gov/pubmed/32602076
14867,32843034,Radiation oncologists' attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer,BMC Health Serv Res. 2020 Aug 26;20(1):796. doi: 10.1186/s12913-020-05656-x.,Jacobs BL,https://www.ncbi.nlm.nih.gov/pubmed/32843034
14868,33223371,Primary lymph-node staging with (68)Ga-PSMA PET in high-risk prostate cancer: pathologic correlation with extended pelvic lymphadenectomy specimens,Urol Oncol. 2021 Aug;39(8):494.e1-494.e6. doi: 10.1016/j.urolonc.2020.10.074. Epub 2020 Nov 19.,Corona-Montes VE,https://www.ncbi.nlm.nih.gov/pubmed/33223371
14869,32298794,Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data,Pract Radiat Oncol. 2020 Jul-Aug;10(4):282-292. doi: 10.1016/j.prro.2020.02.014. Epub 2020 Apr 13.,Tang C,https://www.ncbi.nlm.nih.gov/pubmed/32298794
14870,33293077,Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial,Eur Urol. 2021 May;79(5):595-604. doi: 10.1016/j.eururo.2020.11.040. Epub 2020 Dec 5.,Lestingi JFP,https://www.ncbi.nlm.nih.gov/pubmed/33293077
14871,32723224,Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study,Acta Oncol. 2020 Aug;59(8):904-910. doi: 10.1080/0284186X.2020.1759824.,Draulans C,https://www.ncbi.nlm.nih.gov/pubmed/32723224
14872,32978014,Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial,Eur Urol. 2021 Feb;79(2):188-197. doi: 10.1016/j.eururo.2020.08.023. Epub 2020 Sep 22.,Boevé L,https://www.ncbi.nlm.nih.gov/pubmed/32978014
14873,32886212,Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial),J Cancer Res Clin Oncol. 2021 Jan;147(1):235-242. doi: 10.1007/s00432-020-03327-2. Epub 2020 Sep 4.,Wiegel T,https://www.ncbi.nlm.nih.gov/pubmed/32886212
14874,33199175,The impact of a rectal hydrogel spacer on dosimetric and toxicity outcomes among patients undergoing combination therapy with external beam radiotherapy and low-dose-rate brachytherapy,Brachytherapy. 2021 Mar-Apr;20(2):296-301. doi: 10.1016/j.brachy.2020.09.018. Epub 2020 Nov 13.,Nehlsen AD,https://www.ncbi.nlm.nih.gov/pubmed/33199175
14876,32933887,Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review,Eur Urol Oncol. 2020 Oct;3(5):565-581. doi: 10.1016/j.euo.2020.08.005. Epub 2020 Sep 12.,Marra G,https://www.ncbi.nlm.nih.gov/pubmed/32933887
14877,32317241,Conventional vs machine learning-based treatment planning in prostate brachytherapy: Results of a Phase I randomized controlled trial,Brachytherapy. 2020 Jul-Aug;19(4):470-476. doi: 10.1016/j.brachy.2020.03.004. Epub 2020 Apr 19.,Nicolae A,https://www.ncbi.nlm.nih.gov/pubmed/32317241
14878,32930971,"Patient reported outcome measures concerning urinary incontinence after robot assisted radical prostatectomy: development and validation of an online prediction model using clinical parameters, lower urinary tract symptoms and surgical experience",J Robot Surg. 2021 Aug;15(4):593-602. doi: 10.1007/s11701-020-01145-9. Epub 2020 Sep 15.,Collette ERP,https://www.ncbi.nlm.nih.gov/pubmed/32930971
14879,32717361,"Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada",Radiother Oncol. 2020 Nov;152:42-48. doi: 10.1016/j.radonc.2020.07.036. Epub 2020 Jul 24.,Corkum MT,https://www.ncbi.nlm.nih.gov/pubmed/32717361
14880,32929627,A prospective comparative study of routine versus deferred pelvic drain placement after radical prostatectomy: impact on complications and opioid use,World J Urol. 2021 Jun;39(6):1845-1851. doi: 10.1007/s00345-020-03439-x. Epub 2020 Sep 14.,Huang MM,https://www.ncbi.nlm.nih.gov/pubmed/32929627
14881,32619133,A comparison of side-effects and quality-of-life in patients operated on for prostate cancer with and without salvage radiation therapy,Scand J Urol. 2020 Oct;54(5):393-400. doi: 10.1080/21681805.2020.1782980. Epub 2020 Jul 3.,Braide K,https://www.ncbi.nlm.nih.gov/pubmed/32619133
14882,32621208,Patterns of treatment failure in patients with prostate cancer treated with 76-80 Gy radiotherapy to the prostate and seminal vesicles?±?hormonotherapy,Clin Transl Oncol. 2021 Mar;23(3):481-490. doi: 10.1007/s12094-020-02437-0. Epub 2020 Jul 3.,López-Torrecilla J,https://www.ncbi.nlm.nih.gov/pubmed/32621208
14883,31977261,Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy,J Urol. 2020 Jul;204(1):82-90. doi: 10.1097/JU.0000000000000774. Epub 2020 Jan 24.,Falagario UG,https://www.ncbi.nlm.nih.gov/pubmed/31977261
14884,33279595,"Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based Study",Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1219-1229. doi: 10.1016/j.ijrobp.2020.11.023. Epub 2020 Dec 3.,Parry MG,https://www.ncbi.nlm.nih.gov/pubmed/33279595
14885,33037765,Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study,BJU Int. 2021 May;127(5):544-552. doi: 10.1111/bju.15268. Epub 2020 Nov 1.,Nair SM,https://www.ncbi.nlm.nih.gov/pubmed/33037765
14886,33357994,Comparing the Approach to Radical Prostatectomy Using the Multiport da Vinci Xi and da Vinci SP Robots: A Propensity Score Analysis of Perioperative Outcomes,Eur Urol. 2021 Mar;79(3):393-404. doi: 10.1016/j.eururo.2020.11.042. Epub 2020 Dec 24.,Moschovas MC,https://www.ncbi.nlm.nih.gov/pubmed/33357994
14887,32935652,Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis,J Urol. 2021 Feb;205(2):356-369. doi: 10.1097/JU.0000000000001369. Epub 2020 Sep 16.,Crocerossa F,https://www.ncbi.nlm.nih.gov/pubmed/32935652
14888,32524748,Histological comparison between predictive value of preoperative 3-T multiparametric MRI and (68) Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer,BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.,Franklin A,https://www.ncbi.nlm.nih.gov/pubmed/32524748
14889,33385496,Stereotactic Body Radiation Therapy and High-Dose-Rate Brachytherapy Boost in Combination With Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched Analysis,Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):429-437. doi: 10.1016/j.ijrobp.2020.12.034. Epub 2020 Dec 30.,Chen WC,https://www.ncbi.nlm.nih.gov/pubmed/33385496
14891,32734728,Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy,Yonsei Med J. 2020 Aug;61(8):652-659. doi: 10.3349/ymj.2020.61.8.652.,Ahn HK,https://www.ncbi.nlm.nih.gov/pubmed/32734728
14892,32463973,Delayed coloanal anastomosis: an alternative option for restorative rectal cancer surgery after high-dose pelvic radiotherapy for prostate cancer,Colorectal Dis. 2020 Nov;22(11):1545-1552. doi: 10.1111/codi.15144. Epub 2020 Jul 8.,François MO,https://www.ncbi.nlm.nih.gov/pubmed/32463973
14893,32536488,Retzius-sparing Robot-assisted Radical Prostatectomy Leads to Durable Improvement in Urinary Function and Quality of Life Versus Standard Robot-assisted Radical Prostatectomy Without Compromise on Oncologic Efficacy: Single-surgeon Series and Step-by-step Guide,Eur Urol. 2021 Jun;79(6):839-857. doi: 10.1016/j.eururo.2020.05.010. Epub 2020 Jun 11.,Egan J,https://www.ncbi.nlm.nih.gov/pubmed/32536488
14894,33096166,Multivariate normal tissue complication probability models for rectal and bladder morbidity in prostate cancer patients treated with proton therapy,Radiother Oncol. 2020 Dec;153:279-288. doi: 10.1016/j.radonc.2020.10.025. Epub 2020 Oct 21.,Pedersen J,https://www.ncbi.nlm.nih.gov/pubmed/33096166
14895,33016145,Effect of Smoking on Oncological Outcome among Prostate Cancer Patients after Radical Prostatectomy with Neoadjuvant Hormonal Therapy,Cancer Invest. 2020 Nov;38(10):559-564. doi: 10.1080/07357907.2020.1833212. Epub 2020 Oct 12.,Sato N,https://www.ncbi.nlm.nih.gov/pubmed/33016145
14896,32476081,Survival outcomes of Asian younger men (<?55 years) undergoing radical prostatectomy: a review of prostate cancer database in a tertiary hospital in Singapore,Int Urol Nephrol. 2020 Oct;52(10):1885-1891. doi: 10.1007/s11255-020-02518-7. Epub 2020 May 31.,Lu Y,https://www.ncbi.nlm.nih.gov/pubmed/32476081
14897,32383303,Anatomical and dosimetric assessment of the prostate apex: A pilot comparison of image-guided transperineal ultrasound to conventional computed tomography simulation,J Med Imaging Radiat Oncol. 2020 Dec;64(6):839-844. doi: 10.1111/1754-9485.13045. Epub 2020 May 7.,Shanker MD,https://www.ncbi.nlm.nih.gov/pubmed/32383303
14898,32680820,Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study,Urol Oncol. 2020 Sep;38(9):735.e17-735.e25. doi: 10.1016/j.urolonc.2020.05.022. Epub 2020 Jul 15.,Vernooij RWM,https://www.ncbi.nlm.nih.gov/pubmed/32680820
14899,33037017,Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer,Clin Cancer Res. 2021 Jan 1;27(1):320-329. doi: 10.1158/1078-0432.CCR-20-2925. Epub 2020 Oct 9.,Awasthi S,https://www.ncbi.nlm.nih.gov/pubmed/33037017
14900,32846773,Comparing effectiveness of radical prostatectomy versus external beam radiotherapy in patients with locally advanced prostate cancer: A population-based analysis,Medicine (Baltimore). 2020 Aug 21;99(34):e21642. doi: 10.1097/MD.0000000000021642.,Zhou X,https://www.ncbi.nlm.nih.gov/pubmed/32846773
14901,32416376,Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT),Radiother Oncol. 2020 Aug;149:8-13. doi: 10.1016/j.radonc.2020.04.039. Epub 2020 Apr 27.,Alayed Y,https://www.ncbi.nlm.nih.gov/pubmed/32416376
14903,33493001,Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer,J Urol. 2021 Apr;205(4):1047-1054. doi: 10.1097/JU.0000000000001484. Epub 2020 Dec 1.,Cullen J,https://www.ncbi.nlm.nih.gov/pubmed/33493001
14904,33034733,Oncological safety and functional outcomes of testosterone replacement therapy in symptomatic adult-onset hypogonadal prostate cancer patients following robot-assisted radical prostatectomy,World J Urol. 2021 Sep;39(9):3223-3229. doi: 10.1007/s00345-020-03475-7. Epub 2020 Oct 9.,Shahine H,https://www.ncbi.nlm.nih.gov/pubmed/33034733
14905,32993278,Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer,Minerva Urol Nephrol. 2021 Oct;73(5):610-615. doi: 10.23736/S2724-6051.20.03938-7. Epub 2020 Sep 29.,Quhal F,https://www.ncbi.nlm.nih.gov/pubmed/32993278
14906,32696130,Detectable Prostate-specific antigen value between 0.01 and 0.1 ng/ml following robotic-assisted radical prostatectomy (RARP): does it correlate with future biochemical recurrence?,World J Urol. 2021 Jun;39(6):1853-1860. doi: 10.1007/s00345-020-03367-w. Epub 2020 Jul 21.,Zakaria AS,https://www.ncbi.nlm.nih.gov/pubmed/32696130
14907,32367010,Exposure to direct-to-consumer advertising is associated with overestimation of benefits regarding ultrahypofractionated radiation therapy for prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):670-679. doi: 10.1038/s41391-020-0234-2. Epub 2020 May 4.,Caputo JM,https://www.ncbi.nlm.nih.gov/pubmed/32367010
14908,32562839,Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer,Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):930-935. doi: 10.1016/j.ijrobp.2020.06.010. Epub 2020 Jun 17.,Parikh NR,https://www.ncbi.nlm.nih.gov/pubmed/32562839
14909,32852528,Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic Review,JAMA Oncol. 2020 Nov 1;6(11):1793-1800. doi: 10.1001/jamaoncol.2020.2832.,Sachdev S,https://www.ncbi.nlm.nih.gov/pubmed/32852528
14910,31964317,"Is ""extreme"" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure?",Urologia. 2020 Aug;87(3):149-154. doi: 10.1177/0391560319899253. Epub 2020 Jan 22.,Dal Moro F,https://www.ncbi.nlm.nih.gov/pubmed/31964317
14911,32896583,Comparison of Perioperative and Pathologic Outcomes Between Single-port and Standard Robot-assisted Radical Prostatectomy: An Analysis of a High-volume Center and the Pooled World Experience,Urology. 2021 Jan;147:223-229. doi: 10.1016/j.urology.2020.08.046. Epub 2020 Sep 5.,Huang MM,https://www.ncbi.nlm.nih.gov/pubmed/32896583
14913,33109589,Simultaneous Integrated Radiotherapy Boost to the Dominant Intraprostatic Lesion: Final Results of a Phase I/II Trial,Anticancer Res. 2020 Nov;40(11):6499-6503. doi: 10.21873/anticanres.14672.,Buwenge M,https://www.ncbi.nlm.nih.gov/pubmed/33109589
14914,33198555,The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?,J Urol. 2021 Jan;205(1):109-114. doi: 10.1097/JU.0000000000001339. Epub 2020 Nov 17.,Chu CE,https://www.ncbi.nlm.nih.gov/pubmed/33198555
14915,32673683,Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence,Hum Pathol. 2020 Oct;104:96-104. doi: 10.1016/j.humpath.2020.07.005. Epub 2020 Jul 13.,Wu S,https://www.ncbi.nlm.nih.gov/pubmed/32673683
14916,32738465,Long-Term Results of Moderate Hypofractionation to Prostate and Pelvic Nodes Plus Androgen Suppression in High-Risk Prostate Cancer,Pract Radiat Oncol. 2020 Nov-Dec;10(6):e514-e520. doi: 10.1016/j.prro.2020.06.012. Epub 2020 Jul 29.,Faria S,https://www.ncbi.nlm.nih.gov/pubmed/32738465
14917,32894109,Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer,BMC Urol. 2020 Sep 7;20(1):144. doi: 10.1186/s12894-020-00711-5.,Novak V,https://www.ncbi.nlm.nih.gov/pubmed/32894109
14918,32542746,Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens,Histopathology. 2020 Nov;77(5):742-748. doi: 10.1111/his.14179. Epub 2020 Sep 11.,Rijstenberg LL,https://www.ncbi.nlm.nih.gov/pubmed/32542746
14919,33172830,Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study,Radiother Oncol. 2021 Feb;155:80-85. doi: 10.1016/j.radonc.2020.10.029. Epub 2020 Oct 24.,Wang H,https://www.ncbi.nlm.nih.gov/pubmed/33172830
14920,32591903,Specific spatial distribution patterns of tumor foci are associated with a low risk of biochemical recurrence in pT2pN0R0 prostate cancer,World J Urol. 2021 May;39(5):1499-1507. doi: 10.1007/s00345-020-03323-8. Epub 2020 Jun 26.,Eminaga O,https://www.ncbi.nlm.nih.gov/pubmed/32591903
14921,32179961,Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [(68)Ga]PSMA-PET-guided metastasis-directed therapy,Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2328-2338. doi: 10.1007/s00259-020-04760-8. Epub 2020 Mar 16.,Vogel MME,https://www.ncbi.nlm.nih.gov/pubmed/32179961
14922,32611411,"Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation",BMC Urol. 2020 Jul 1;20(1):81. doi: 10.1186/s12894-020-00656-9.,Thompson JE,https://www.ncbi.nlm.nih.gov/pubmed/32611411
14923,32553790,Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice,Urol Oncol. 2020 Nov;38(11):848.e1-848.e7. doi: 10.1016/j.urolonc.2020.04.019. Epub 2020 Jun 16.,Sanmamed N,https://www.ncbi.nlm.nih.gov/pubmed/32553790
14924,32690386,Low-cost 3D print-based phantom fabrication to facilitate interstitial prostate brachytherapy training program,Brachytherapy. 2020 Nov-Dec;19(6):800-811. doi: 10.1016/j.brachy.2020.06.015. Epub 2020 Jul 18.,Chiu T,https://www.ncbi.nlm.nih.gov/pubmed/32690386
14927,32597109,The pathological and clinical features of anterior lesions of prostate cancer: Evaluation in a single cohort of patients,Arch Ital Urol Androl. 2020 Jun 23;92(2). doi: 10.4081/aiua.2020.2.102.,D'Agostino D,https://www.ncbi.nlm.nih.gov/pubmed/32597109
14928,32161996,The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy,World J Urol. 2020 Dec;38(12):3091-3099. doi: 10.1007/s00345-020-03147-6. Epub 2020 Mar 11.,Meissner VH,https://www.ncbi.nlm.nih.gov/pubmed/32161996
14929,32552894,Clinical efficacy of enhanced recovery after surgery (ERAS) program in patients undergoing radical prostatectomy: a systematic review and meta-analysis,World J Surg Oncol. 2020 Jun 17;18(1):131. doi: 10.1186/s12957-020-01897-6.,Zhao Y,https://www.ncbi.nlm.nih.gov/pubmed/32552894
14930,32416115,Assessment of Long-term Changes in Lower Urinary Tract Symptoms in Patients With Prostate Cancer Who Underwent Low-dose-rate Prostate Brachytherapy,Urology. 2020 Aug;142:213-220. doi: 10.1016/j.urology.2020.04.106. Epub 2020 May 13.,Iinuma K,https://www.ncbi.nlm.nih.gov/pubmed/32416115
14932,33066781,Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?,Radiat Oncol. 2020 Oct 16;15(1):239. doi: 10.1186/s13014-020-01681-6.,Byun DJ,https://www.ncbi.nlm.nih.gov/pubmed/33066781
14933,32410119,The impact of surgical margin status on prostate cancer-specific mortality after radical prostatectomy: a systematic review and meta-analysis,Clin Transl Oncol. 2020 Nov;22(11):2087-2096. doi: 10.1007/s12094-020-02358-y. Epub 2020 May 14.,Zhang B,https://www.ncbi.nlm.nih.gov/pubmed/32410119
14934,32525077,The 17-Gene Genomic Prostate Score Test as a Predictor of Outcomes in Men with Unfavorable Intermediate Risk Prostate Cancer,Urology. 2020 Sep;143:103-111. doi: 10.1016/j.urology.2020.05.045. Epub 2020 Jun 7.,Cullen J,https://www.ncbi.nlm.nih.gov/pubmed/32525077
14935,33148738,"Assessing the safety and feasibility of neoadjuvant hormone and radiation therapy followed by robot-assisted radical prostatectomy for treating locally advanced prostate cancer: protocol for an open-label, dose-escalation, single-centre, phase I clinical trial",BMJ Open. 2020 Nov 3;10(11):e038678. doi: 10.1136/bmjopen-2020-038678.,Xiao YT,https://www.ncbi.nlm.nih.gov/pubmed/33148738
14936,32717261,Toxicity of Pelvic Lymph Node Irradiation With Intensity Modulated Radiation Therapy for High-Risk and Locally Advanced Prostate Cancer: A National Population-Based Study Using Patient-Reported Outcomes,Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1196-1203. doi: 10.1016/j.ijrobp.2020.07.031. Epub 2020 Jul 24.,Parry MG,https://www.ncbi.nlm.nih.gov/pubmed/32717261
14937,32706639,"Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer",J Clin Oncol. 2020 Sep 10;38(26):3042-3050. doi: 10.1200/JCO.20.00315. Epub 2020 Jul 24.,Eastham JA,https://www.ncbi.nlm.nih.gov/pubmed/32706639
14938,32311600,Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy,Radiother Oncol. 2020 Jul;148:44-50. doi: 10.1016/j.radonc.2020.04.007. Epub 2020 Apr 9.,Yoon S,https://www.ncbi.nlm.nih.gov/pubmed/32311600
14939,31603140,The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis,Asian J Androl. 2020 Jul-Aug;22(4):383-389. doi: 10.4103/aja.aja_111_19.,Cheng X,https://www.ncbi.nlm.nih.gov/pubmed/31603140
14940,31444604,Using video review to understand the technical variation of robot-assisted radical prostatectomy in a statewide surgical collaborative,World J Urol. 2020 Jul;38(7):1607-1613. doi: 10.1007/s00345-019-02906-4. Epub 2019 Aug 23.,Wu RC,https://www.ncbi.nlm.nih.gov/pubmed/31444604
14941,32619455,Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis,Radiother Oncol. 2020 Sep;150:195-200. doi: 10.1016/j.radonc.2020.06.039. Epub 2020 Jun 30.,Mendez LC,https://www.ncbi.nlm.nih.gov/pubmed/32619455
14942,32597202,The Use of Cumulative Sum Analysis to Derive Institutional and Surgeon-Specific Learning Curves for Robot-Assisted Radical Prostatectomy,J Endourol. 2020 Sep;34(9):969-973. doi: 10.1089/end.2020.0310. Epub 2020 Jul 31.,Ohwaki K,https://www.ncbi.nlm.nih.gov/pubmed/32597202
14943,32632083,Cause of Mortality after Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-institutional Study in Korea,Cancer Res Treat. 2020 Oct;52(4):1242-1250. doi: 10.4143/crt.2020.286. Epub 2020 Jul 3.,Pak S,https://www.ncbi.nlm.nih.gov/pubmed/32632083
14944,32888035,The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy,J Radiat Res. 2020 Nov 16;61(6):908-919. doi: 10.1093/jrr/rraa074.,Ishikawa H,https://www.ncbi.nlm.nih.gov/pubmed/32888035
14945,32750229,Increased curative treatment is associated with decreased prostate cancer-specific and overall mortality in senior adults with high-risk prostate cancer; results from a national registry-based cohort study,Cancer Med. 2020 Sep;9(18):6646-6657. doi: 10.1002/cam4.3297. Epub 2020 Aug 4.,Aas K,https://www.ncbi.nlm.nih.gov/pubmed/32750229
14946,32663537,"Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients",Radiother Oncol. 2020 Oct;151:26-32. doi: 10.1016/j.radonc.2020.07.014. Epub 2020 Jul 11.,Levin-Epstein R,https://www.ncbi.nlm.nih.gov/pubmed/32663537
14947,32524704,Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study,Cancer Med. 2020 Aug;9(15):5416-5424. doi: 10.1002/cam4.3197. Epub 2020 Jun 10.,Adam S,https://www.ncbi.nlm.nih.gov/pubmed/32524704
14948,32666822,Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial,Future Oncol. 2020 Sep;16(27):2035-2044. doi: 10.2217/fon-2020-0390. Epub 2020 Jul 15.,Berghen C,https://www.ncbi.nlm.nih.gov/pubmed/32666822
14950,32701978,Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: Medium-term results from a single centre,PLoS One. 2020 Jul 23;15(7):e0236026. doi: 10.1371/journal.pone.0236026. eCollection 2020.,Wu YT,https://www.ncbi.nlm.nih.gov/pubmed/32701978
14951,32152758,"Indoleamine 2,3-dioxygenase expression in the prognosis of the localized prostate cancer",Int Urol Nephrol. 2020 Aug;52(8):1477-1482. doi: 10.1007/s11255-020-02414-0. Epub 2020 Mar 9.,Ferreira JM,https://www.ncbi.nlm.nih.gov/pubmed/32152758
14952,32396488,Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials,J Clin Oncol. 2020 Sep 10;38(26):3024-3031. doi: 10.1200/JCO.19.03217. Epub 2020 May 12.,Jackson WC,https://www.ncbi.nlm.nih.gov/pubmed/32396488
14953,32349020,Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study,Am J Clin Oncol. 2020 Jul;43(7):469-476. doi: 10.1097/COC.0000000000000693.,Parsai S,https://www.ncbi.nlm.nih.gov/pubmed/32349020
14954,32556840,Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes,Int J Clin Oncol. 2020 Oct;25(10):1844-1853. doi: 10.1007/s10147-020-01723-9. Epub 2020 Jun 17.,Shoji S,https://www.ncbi.nlm.nih.gov/pubmed/32556840
14955,32822127,Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center,Int Braz J Urol. 2020 Nov-Dec;46(6):984-992. doi: 10.1590/S1677-5538.IBJU.2019.0682.,Sivaraman A,https://www.ncbi.nlm.nih.gov/pubmed/32822127
14956,32130477,Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis,World J Urol. 2020 Dec;38(12):3075-3083. doi: 10.1007/s00345-020-03144-9. Epub 2020 Mar 4.,Kretschmer A,https://www.ncbi.nlm.nih.gov/pubmed/32130477
14957,32931662,Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer,Cancer Med. 2020 Nov;9(21):7925-7934. doi: 10.1002/cam4.3414. Epub 2020 Sep 15.,Bai M,https://www.ncbi.nlm.nih.gov/pubmed/32931662
14958,32500468,Predicting factors for progression to castration resistance prostate cancer after biochemical recurrence in patients with clinically localized prostate cancer who underwent radical prostatectomy,Int J Clin Oncol. 2020 Sep;25(9):1704-1710. doi: 10.1007/s10147-020-01716-8. Epub 2020 Jun 4.,Hashimoto T,https://www.ncbi.nlm.nih.gov/pubmed/32500468
14959,32139288,"A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy",Urol Oncol. 2020 Oct;38(10):794.e1-794.e9. doi: 10.1016/j.urolonc.2020.02.007. Epub 2020 Mar 3.,Caumont F,https://www.ncbi.nlm.nih.gov/pubmed/32139288
14960,32888359,Stability of daily rectal movement and effectiveness of replanning protocols for sparing rectal doses based on the daily CT images during proton treatment for prostate cancer,J Appl Clin Med Phys. 2020 Oct;21(10):109-121. doi: 10.1002/acm2.13015. Epub 2020 Sep 5.,Maeda Y,https://www.ncbi.nlm.nih.gov/pubmed/32888359
14961,32715451,The Efficiency and Safety of Transperitoneal versus Extraperitoneal Robotic-Assisted Radical Prostatectomy for Patients with Prostate Cancer: A Single Center Experience with 1-year Follow-up,Urol J. 2020 Jul 21;17(5):480-485. doi: 10.22037/uj.v16i7.5475.,Yang Y,https://www.ncbi.nlm.nih.gov/pubmed/32715451
14962,32697048,Clinicopathological characteristics of localized prostate cancer in younger men aged ? 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta-analysis,Cancer Med. 2020 Sep;9(18):6473-6484. doi: 10.1002/cam4.3320. Epub 2020 Jul 22.,Zheng Y,https://www.ncbi.nlm.nih.gov/pubmed/32697048
14963,32583860,Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer,J Radiat Res. 2020 Jul 6;61(4):622-628. doi: 10.1093/jrr/rraa044.,Sato GE,https://www.ncbi.nlm.nih.gov/pubmed/32583860
14964,32444261,The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series,Eur Urol. 2020 Aug;78(2):155-160. doi: 10.1016/j.eururo.2020.04.068. Epub 2020 May 19.,Stabile A,https://www.ncbi.nlm.nih.gov/pubmed/32444261
14965,32331976,"Acute patient-reported bowel quality of life and rectal bleeding with the combination of prostate external beam radiation, low-dose-rate brachytherapy boost, and SpaceOAR",Brachytherapy. 2020 Jul-Aug;19(4):477-483. doi: 10.1016/j.brachy.2020.03.006. Epub 2020 Apr 21.,Patel AK,https://www.ncbi.nlm.nih.gov/pubmed/32331976
14966,31916185,Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy,Pathol Oncol Res. 2020 Oct;26(4):2115-2121. doi: 10.1007/s12253-019-00762-6. Epub 2020 Jan 8.,Oikawa M,https://www.ncbi.nlm.nih.gov/pubmed/31916185
14967,32891600,Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials,Eur Urol Oncol. 2020 Oct;3(5):582-593. doi: 10.1016/j.euo.2020.07.004. Epub 2020 Sep 3.,Connor MJ,https://www.ncbi.nlm.nih.gov/pubmed/32891600
14968,31838560,Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery,World J Urol. 2020 Oct;38(10):2493-2500. doi: 10.1007/s00345-019-03053-6. Epub 2019 Dec 14.,Ploussard G,https://www.ncbi.nlm.nih.gov/pubmed/31838560
14969,32595092,Survival analysis of patients with prostate cancer and unfavorable risk factors treated with radical prostatectomy and salvage radiotherapy after biochemical recurrence and persistence,Actas Urol Esp (Engl Ed). 2020 Dec;44(10):701-707. doi: 10.1016/j.acuro.2020.02.001. Epub 2020 Jun 25.,Barbas Bernardos G,https://www.ncbi.nlm.nih.gov/pubmed/32595092
14970,32035187,Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study,Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):635-643. doi: 10.1016/j.ijrobp.2020.01.026. Epub 2020 Feb 6.,Dinh TT,https://www.ncbi.nlm.nih.gov/pubmed/32035187
14971,32259466,Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy?,J Urol. 2020 Sep;204(3):476-482. doi: 10.1097/JU.0000000000001070. Epub 2020 Apr 7.,Ahmad AE,https://www.ncbi.nlm.nih.gov/pubmed/32259466
14972,32738549,Relationship between robotic-assisted radical prostatectomy and retropubic radical prostatectomy in the learning curve of a single surgeon as a novice in radical prostatectomy: A retrospective cohort study,Int J Surg. 2020 Sep;81:74-79. doi: 10.1016/j.ijsu.2020.07.006. Epub 2020 Jul 29.,Song W,https://www.ncbi.nlm.nih.gov/pubmed/32738549
14973,32757442,Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer-A population-based cohort study,Cancer Med. 2020 Oct;9(19):6946-6953. doi: 10.1002/cam4.3341. Epub 2020 Aug 5.,Matta R,https://www.ncbi.nlm.nih.gov/pubmed/32757442
14974,32763013,I-125 or Pd-103 for brachytherapy boost in men with high-risk prostate cancer: A comparison of survival and morbidity outcomes,Brachytherapy. 2020 Sep-Oct;19(5):567-573. doi: 10.1016/j.brachy.2020.06.001. Epub 2020 Aug 3.,Stone NN,https://www.ncbi.nlm.nih.gov/pubmed/32763013
14975,32068483,A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank Specimens,J Urol. 2020 Aug;204(2):289-295. doi: 10.1097/JU.0000000000000808. Epub 2020 Feb 18.,Woon DTS,https://www.ncbi.nlm.nih.gov/pubmed/32068483
14976,32922383,"The Prognostic Value of Indoleamine-2,3-Dioxygenase Gene Expression in Urine of Prostate Cancer Patients Undergoing Radical Prostatectomy as First Treatment of Choice",Front Immunol. 2020 Aug 14;11:1244. doi: 10.3389/fimmu.2020.01244. eCollection 2020.,Thüring M,https://www.ncbi.nlm.nih.gov/pubmed/32922383
14979,32531840,(68) Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer,BJU Int. 2020 Dec;126(6):679-683. doi: 10.1111/bju.15135. Epub 2020 Aug 4.,Pfister D,https://www.ncbi.nlm.nih.gov/pubmed/32531840
14980,32327702,African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):581-588. doi: 10.1038/s41391-020-0230-6. Epub 2020 Apr 23.,Deka R,https://www.ncbi.nlm.nih.gov/pubmed/32327702
14981,32698712,The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis,J Urol. 2020 Nov;204(5):909-917. doi: 10.1097/JU.0000000000001290. Epub 2020 Jul 23.,Miura N,https://www.ncbi.nlm.nih.gov/pubmed/32698712
14982,32157427,"Interobserver variability, detection rate, and lesion patterns of (68)Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy",Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2339-2347. doi: 10.1007/s00259-020-04718-w. Epub 2020 Mar 10.,Miksch J,https://www.ncbi.nlm.nih.gov/pubmed/32157427
14983,32573779,"Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial",Cancer. 2020 Sep 1;126(17):3961-3971. doi: 10.1002/cncr.33034. Epub 2020 Jun 23.,Ito K,https://www.ncbi.nlm.nih.gov/pubmed/32573779
14984,31920063,"Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)",Minerva Urol Nefrol. 2020 Oct;72(5):595-604. doi: 10.23736/S0393-2249.19.03637-3. Epub 2020 Jan 7.,Antonelli A,https://www.ncbi.nlm.nih.gov/pubmed/31920063
14985,33028540,Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study,BMJ. 2020 Oct 7;371:m3503. doi: 10.1136/bmj.m3503.,Mazariego CG,https://www.ncbi.nlm.nih.gov/pubmed/33028540
14986,32881424,Predictive value of Prostate Specific Antigen variations in the last week of salvage radiotherapy for biochemical recurrence of prostate cancer after surgery: A practical approach,Cancer Rep (Hoboken). 2020 Dec;3(6):e1285. doi: 10.1002/cnr2.1285. Epub 2020 Sep 3.,Vigna-Taglianti R,https://www.ncbi.nlm.nih.gov/pubmed/32881424
14987,32098731,"Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation",Eur Urol. 2020 Aug;78(2):248-255. doi: 10.1016/j.eururo.2020.02.007. Epub 2020 Feb 22.,Laviana AA,https://www.ncbi.nlm.nih.gov/pubmed/32098731
14988,32447033,"Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life",Radiother Oncol. 2020 Aug;149:240-245. doi: 10.1016/j.radonc.2020.05.029. Epub 2020 May 22.,Sanmamed N,https://www.ncbi.nlm.nih.gov/pubmed/32447033
14989,31260602,Detection and localisation of primary prostate cancer using (68) gallium prostate-specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology,BJU Int. 2020 Jul;126(1):83-90. doi: 10.1111/bju.14858.,Kalapara AA,https://www.ncbi.nlm.nih.gov/pubmed/31260602
14990,32847747,Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy,Eur Urol Oncol. 2020 Dec;3(6):739-747. doi: 10.1016/j.euo.2020.07.008. Epub 2020 Aug 23.,Gandaglia G,https://www.ncbi.nlm.nih.gov/pubmed/32847747
14991,33258324,A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up,Investig Clin Urol. 2021 Jan;62(1):32-38. doi: 10.4111/icu.20200206. Epub 2020 Nov 18.,Song SH,https://www.ncbi.nlm.nih.gov/pubmed/33258324
14992,33090219,Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate,JAMA Oncol. 2020 Dec 1;6(12):1912-1920. doi: 10.1001/jamaoncol.2020.4922.,Dess RT,https://www.ncbi.nlm.nih.gov/pubmed/33090219
14995,32103332,(68)Ga-PSMA PET/CT based primary staging and histological correlation after extended pelvic lymph node dissection at radical prostatectomy,World J Urol. 2020 Dec;38(12):3085-3090. doi: 10.1007/s00345-020-03131-0. Epub 2020 Feb 26.,Kopp J,https://www.ncbi.nlm.nih.gov/pubmed/32103332
14996,32152901,Are we failing to consent to an increasingly common complication? Incisional hernias at robotic prostatectomy,J Robot Surg. 2020 Dec;14(6):861-864. doi: 10.1007/s11701-020-01063-w. Epub 2020 Mar 9.,Timm B,https://www.ncbi.nlm.nih.gov/pubmed/32152901
14997,32804916,Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20?ng/mL,Nucl Med Commun. 2020 Nov;41(11):1178-1182. doi: 10.1097/MNM.0000000000001266.,Telo S,https://www.ncbi.nlm.nih.gov/pubmed/32804916
14998,32496160,Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?,J Urol. 2020 Dec;204(6):1187-1194. doi: 10.1097/JU.0000000000001157. Epub 2020 Jun 4.,Deniffel D,https://www.ncbi.nlm.nih.gov/pubmed/32496160
15001,30683530,Atlas of Ex Vivo Prostate Tissue and Cancer Images Using Confocal Laser Endomicroscopy: A Project for Intraoperative Positive Surgical Margin Detection During Radical Prostatectomy,Eur Urol Focus. 2020 Sep 15;6(5):941-958. doi: 10.1016/j.euf.2019.01.004. Epub 2019 Jan 23.,Panarello D,https://www.ncbi.nlm.nih.gov/pubmed/30683530
15002,32737768,Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity,Jpn J Radiol. 2020 Dec;38(12):1197-1208. doi: 10.1007/s11604-020-01023-2. Epub 2020 Jul 31.,Sakurai T,https://www.ncbi.nlm.nih.gov/pubmed/32737768
15003,32588515,Biochemical control of the combination of cyclooxygenase-2 inhibitor and (125) I-brachytherapy for prostate cancer: Post hoc analysis of an open-label controlled randomized trial,Int J Urol. 2020 Sep;27(9):755-759. doi: 10.1111/iju.14294. Epub 2020 Jun 26.,Nakai Y,https://www.ncbi.nlm.nih.gov/pubmed/32588515
15004,32464368,(18)F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE,Pract Radiat Oncol. 2020 Sep-Oct;10(5):354-362. doi: 10.1016/j.prro.2020.05.007. Epub 2020 May 25.,Solanki AA,https://www.ncbi.nlm.nih.gov/pubmed/32464368
15005,32335059,"Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy",Clin Genitourin Cancer. 2020 Aug;18(4):274-283.e5. doi: 10.1016/j.clgc.2019.11.023. Epub 2020 Mar 19.,Tward JD,https://www.ncbi.nlm.nih.gov/pubmed/32335059
15006,32594901,Can we define reliable risk factors for anastomotic strictures following radical prostatectomy?,Urologia. 2020 Nov;87(4):170-174. doi: 10.1177/0391560320933024. Epub 2020 Jun 27.,Spek A,https://www.ncbi.nlm.nih.gov/pubmed/32594901
15007,31787570,Intraoperative Frozen Section for Margin Evaluation During Radical Prostatectomy: A Systematic Review,Eur Urol Focus. 2020 Jul 15;6(4):664-673. doi: 10.1016/j.euf.2019.11.009. Epub 2019 Nov 29.,Dinneen EP,https://www.ncbi.nlm.nih.gov/pubmed/31787570
15008,31844180,Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):419-428. doi: 10.1038/s41391-019-0197-3. Epub 2019 Dec 16.,Howard LE,https://www.ncbi.nlm.nih.gov/pubmed/31844180
15009,33028256,"Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial",BMC Cancer. 2020 Oct 7;20(1):971. doi: 10.1186/s12885-020-07276-4.,Sanghera S,https://www.ncbi.nlm.nih.gov/pubmed/33028256
15010,32593529,Modified Apical Dissection and Lateral Prostatic Fascia Preservation Improves Early Postoperative Functional Recovery in Robotic-assisted Laparoscopic Radical Prostatectomy: Results from a Propensity Score-matched Analysis,Eur Urol. 2020 Dec;78(6):875-884. doi: 10.1016/j.eururo.2020.05.041. Epub 2020 Jun 24.,Covas Moschovas M,https://www.ncbi.nlm.nih.gov/pubmed/32593529
15011,32641023,Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors,BMC Cancer. 2020 Jul 8;20(1):635. doi: 10.1186/s12885-020-07112-9.,Wollersheim BM,https://www.ncbi.nlm.nih.gov/pubmed/32641023
15012,32624281,Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series,Eur Urol. 2020 Dec;78(6):779-782. doi: 10.1016/j.eururo.2020.06.047. Epub 2020 Jul 2.,Bravi CA,https://www.ncbi.nlm.nih.gov/pubmed/32624281
15013,31875247,Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis,World J Urol. 2020 Oct;38(10):2477-2484. doi: 10.1007/s00345-019-03056-3. Epub 2019 Dec 24.,Hayashi N,https://www.ncbi.nlm.nih.gov/pubmed/31875247
15015,32576406,Usefulness of (18)F-Choline Positron Emission Tomography - Computed Tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):437-443. doi: 10.1016/j.acuro.2020.05.004. Epub 2020 Jun 20.,López Rodríguez E,https://www.ncbi.nlm.nih.gov/pubmed/32576406
15016,30843451,Perineural invasion on biopsy specimen as predictor of tumor progression in aging male treated with radical prostatectomy. Could we use it for pre-surgical screening?,Aging Male. 2020 Dec;23(5):720-725. doi: 10.1080/13685538.2019.1581758. Epub 2019 Mar 7.,Vukovic M,https://www.ncbi.nlm.nih.gov/pubmed/30843451
15017,32928485,Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boost,Brachytherapy. 2020 Sep-Oct;19(5):584-588. doi: 10.1016/j.brachy.2020.06.017.,Ben Aicha I,https://www.ncbi.nlm.nih.gov/pubmed/32928485
15018,32388444,Dosimetric predictors of patient-reported toxicity after prostate stereotactic body radiotherapy: Analysis of full range of the dose-volume histogram using ensemble machine learning,Radiother Oncol. 2020 Jul;148:181-188. doi: 10.1016/j.radonc.2020.04.013. Epub 2020 Apr 17.,Pan X,https://www.ncbi.nlm.nih.gov/pubmed/32388444
15019,33358241,Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Sexual Function - A Randomized Clinical Trial,J Sex Med. 2021 Feb;18(2):327-338. doi: 10.1016/j.jsxm.2020.11.003. Epub 2020 Dec 23.,Siltari A,https://www.ncbi.nlm.nih.gov/pubmed/33358241
15021,33036579,Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial,BMC Cancer. 2020 Oct 9;20(1):978. doi: 10.1186/s12885-020-07490-0.,Mendez LC,https://www.ncbi.nlm.nih.gov/pubmed/33036579
15022,32677927,Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer,BMC Urol. 2020 Jul 16;20(1):100. doi: 10.1186/s12894-020-00659-6.,Zhao HW,https://www.ncbi.nlm.nih.gov/pubmed/32677927
15023,33081748,Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution,BMC Urol. 2020 Oct 20;20(1):163. doi: 10.1186/s12894-020-00734-y.,Lourenço DB,https://www.ncbi.nlm.nih.gov/pubmed/33081748
15024,32617620,Treatment outcomes of metastasis-directed treatment using (68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002),Strahlenther Onkol. 2020 Nov;196(11):1034-1043. doi: 10.1007/s00066-020-01660-6. Epub 2020 Jul 2.,Hurmuz P,https://www.ncbi.nlm.nih.gov/pubmed/32617620
15025,32303782,Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer : Long-term results and factors predictive for outcome and toxicity,Strahlenther Onkol. 2020 Jul;196(7):608-616. doi: 10.1007/s00066-020-01619-7. Epub 2020 Apr 17.,Franzese C,https://www.ncbi.nlm.nih.gov/pubmed/32303782
15026,33032643,"Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)",Radiat Oncol. 2020 Oct 8;15(1):234. doi: 10.1186/s13014-020-01665-6.,Kim YJ,https://www.ncbi.nlm.nih.gov/pubmed/33032643
15027,33121858,Retzius-sparing robot-assisted laparoscopic prostatectomy: An initial short-term experience,Asian J Surg. 2020 Dec;43(12):1203-1204. doi: 10.1016/j.asjsur.2020.09.020. Epub 2020 Oct 26.,Kang SH,https://www.ncbi.nlm.nih.gov/pubmed/33121858
15028,33371950,Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens,Eur J Surg Oncol. 2021 May;47(5):1172-1178. doi: 10.1016/j.ejso.2020.12.014. Epub 2020 Dec 24.,Mori K,https://www.ncbi.nlm.nih.gov/pubmed/33371950
15029,33160844,"""Robotic fatigue?"" - The impact of case order on positive surgical margins in robotic-assisted laparoscopic prostatectomy",Urol Oncol. 2021 Jun;39(6):365.e17-365.e23. doi: 10.1016/j.urolonc.2020.10.071. Epub 2020 Nov 5.,Bukavina L,https://www.ncbi.nlm.nih.gov/pubmed/33160844
15030,32068488,"Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of (68)Ga-PSMA and (11)C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections",J Urol. 2020 Aug;204(2):296-302. doi: 10.1097/JU.0000000000000800. Epub 2020 Feb 18.,Fossati N,https://www.ncbi.nlm.nih.gov/pubmed/32068488
15031,32741099,"Retzius-sparing robot-assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single-blind trial with a 1-year follow-up",BJU Int. 2020 Nov;126(5):633-640. doi: 10.1111/bju.15195. Epub 2020 Aug 17.,Qiu X,https://www.ncbi.nlm.nih.gov/pubmed/32741099
15032,33054804,Temporary pacemaker insertion for severe bradycardia following pneumoperitoneum during robot-assisted radical prostatectomy: a case report,BMC Surg. 2020 Oct 14;20(1):238. doi: 10.1186/s12893-020-00902-9.,Yamabe F,https://www.ncbi.nlm.nih.gov/pubmed/33054804
15033,32519046,"The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial",Clin Exp Metastasis. 2020 Aug;37(4):551-560. doi: 10.1007/s10585-020-10043-1. Epub 2020 Jun 9.,Joshi A,https://www.ncbi.nlm.nih.gov/pubmed/32519046
15034,32676784,Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features,Eur Radiol. 2020 Dec;30(12):6757-6769. doi: 10.1007/s00330-020-07064-5. Epub 2020 Jul 16.,Bernatz S,https://www.ncbi.nlm.nih.gov/pubmed/32676784
15035,32891599,Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging Findings,Eur Urol Oncol. 2022 Apr;5(2):187-194. doi: 10.1016/j.euo.2020.08.001. Epub 2020 Sep 3.,Lantz A,https://www.ncbi.nlm.nih.gov/pubmed/32891599
15036,30477971,Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy,Eur Urol Focus. 2020 Nov 15;6(6):1205-1212. doi: 10.1016/j.euf.2018.11.004. Epub 2018 Nov 23.,Nyarangi-Dix J,https://www.ncbi.nlm.nih.gov/pubmed/30477971
15037,32879900,Texture Analysis of F-18 Fluciclovine PET/CT to Predict Biochemically Recurrent Prostate Cancer: Initial Results,Tomography. 2020 Sep;6(3):301-307. doi: 10.18383/j.tom.2020.00029.,Kang H,https://www.ncbi.nlm.nih.gov/pubmed/32879900
15038,32002591,Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study,Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1852-1863. doi: 10.1007/s00259-020-04708-y. Epub 2020 Jan 30.,Schmidt-Hegemann NS,https://www.ncbi.nlm.nih.gov/pubmed/32002591
15039,32796479,Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level ?0.5?ng/mL,Nucl Med Commun. 2020 Sep;41(9):906-915. doi: 10.1097/MNM.0000000000001228.,Teyateeti A,https://www.ncbi.nlm.nih.gov/pubmed/32796479
15042,33277862,Efficacy of brachytherapy combined with endocrine therapy and external beam radiotherapy in the treatment of intermediate and high-risk localized prostate cancer,J BUON. 2020 Sep-Oct;25(5):2405-2411.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/33277862
15043,32970153,"Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer",JAMA Netw Open. 2020 Sep 1;3(9):e2017144. doi: 10.1001/jamanetworkopen.2020.17144.,Nguyen KA,https://www.ncbi.nlm.nih.gov/pubmed/32970153
15044,33386288,Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome,Eur Urol Focus. 2021 Mar;7(2):238-240. doi: 10.1016/j.euf.2020.12.009. Epub 2020 Dec 30.,Calais J,https://www.ncbi.nlm.nih.gov/pubmed/33386288
15045,32868191,Development of a technique for evaluating the presence of malignant cells in prostatic fluid during robotic prostatectomy,Urol Oncol. 2021 Mar;39(3):192.e1-192.e6. doi: 10.1016/j.urolonc.2020.08.007. Epub 2020 Aug 29.,Lyon TD,https://www.ncbi.nlm.nih.gov/pubmed/32868191
15046,32713779,Evaluating the impact of real-time multicriteria optimizers integrated with interactive plan navigation tools for HDR brachytherapy,Brachytherapy. 2020 Sep-Oct;19(5):607-617. doi: 10.1016/j.brachy.2020.06.016. Epub 2020 Jul 23.,Bélanger C,https://www.ncbi.nlm.nih.gov/pubmed/32713779
15048,32945234,Clinical implications of transversus abdominis plane block (TAP-block) for robot assisted laparoscopic radical prostatectomy: A single-institute analysis,Urologia. 2021 Feb;88(1):25-29. doi: 10.1177/0391560320957226. Epub 2020 Sep 18.,Chiancone F,https://www.ncbi.nlm.nih.gov/pubmed/32945234
15049,33216696,"Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?",J Urol. 2021 Apr;205(4):1063-1068. doi: 10.1097/JU.0000000000001519. Epub 2020 Nov 20.,Stonier T,https://www.ncbi.nlm.nih.gov/pubmed/33216696
15050,32521115,Randomised comparison of techniques for control of the dorsal venous complex during robot-assisted laparoscopic radical prostatectomy,BJU Int. 2020 Nov;126(5):586-594. doi: 10.1111/bju.15133. Epub 2020 Sep 2.,Feng T,https://www.ncbi.nlm.nih.gov/pubmed/32521115
15052,32665124,A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome,Urol Oncol. 2020 Dec;38(12):932.e1-932.e7. doi: 10.1016/j.urolonc.2020.06.015. Epub 2020 Jul 12.,Ashcraft KA,https://www.ncbi.nlm.nih.gov/pubmed/32665124
15053,32869150,Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3?+?4,World J Urol. 2021 Jun;39(6):1825-1830. doi: 10.1007/s00345-020-03421-7. Epub 2020 Aug 31.,Kim H,https://www.ncbi.nlm.nih.gov/pubmed/32869150
15054,33317509,The use of hyperbaric oxygen to treat actinic rectal fistula after SpaceOAR use and radiotherapy for prostate cancer: a case report,BMC Urol. 2020 Dec 14;20(1):196. doi: 10.1186/s12894-020-00767-3.,Kashihara T,https://www.ncbi.nlm.nih.gov/pubmed/33317509
15056,32976872,Challenges influencing the utilization of prostate brachytherapy in the United States,Radiother Oncol. 2021 Jan;154:123-124. doi: 10.1016/j.radonc.2020.09.025. Epub 2020 Sep 22.,Odei B,https://www.ncbi.nlm.nih.gov/pubmed/32976872
15059,32997878,Combination of total length of Gleason pattern 4 and number of Gleason score 3 + 4 = 7 cores detects similar outcome group to Gleason score 6 cancers among cases with ?5% of Gleason pattern 4,Pathol Int. 2020 Dec;70(12):992-998. doi: 10.1111/pin.13026. Epub 2020 Sep 30.,Sato S,https://www.ncbi.nlm.nih.gov/pubmed/32997878
15062,32558720,Ureteral Metastasis From Prostate Cancer: A PSMA PET Pitfall,Clin Nucl Med. 2020 Sep;45(9):689-691. doi: 10.1097/RLU.0000000000003136.,Chaussé G,https://www.ncbi.nlm.nih.gov/pubmed/32558720
15064,32848525,Detection Rate of (18)F-Fluorethylcholine-PET/CT in relation to PSA Value in PCA Patients Referred with Biochemical Relapse,Contrast Media Mol Imaging. 2020 Aug 11;2020:4320178. doi: 10.1155/2020/4320178. eCollection 2020.,Takesh M,https://www.ncbi.nlm.nih.gov/pubmed/32848525
15066,32706990,The implementation of an empty bladder filling protocol for localised prostate volumetric modulated arctherapy (VMAT): early results of a single institution service evaluation,Br J Radiol. 2020 Oct 1;93(1114):20200548. doi: 10.1259/bjr.20200548. Epub 2020 Jul 31.,Chetiyawardana G,https://www.ncbi.nlm.nih.gov/pubmed/32706990
15067,32787797,Impact on quality of life 3?years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study,BMC Cancer. 2020 Aug 12;20(1):757. doi: 10.1186/s12885-020-07244-y.,Houédé N,https://www.ncbi.nlm.nih.gov/pubmed/32787797
15068,31538242,Contrast media kinetics in multiparametric magnetic resonance imaging before radical prostatectomy predicts the probability of postoperative incontinence,World J Urol. 2020 Jul;38(7):1741-1748. doi: 10.1007/s00345-019-02952-y. Epub 2019 Sep 19.,Schmid FA,https://www.ncbi.nlm.nih.gov/pubmed/31538242
15073,32913066,Case of prostate stromal tumour of uncertain malignant potential where positron emission tomography with 18F-fluorodeoxyglucose was useful for surgical planning,BMJ Case Rep. 2020 Sep 10;13(9):e235738. doi: 10.1136/bcr-2020-235738.,Suzuki I,https://www.ncbi.nlm.nih.gov/pubmed/32913066
15077,33301015,Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy,JAMA Netw Open. 2020 Dec 1;3(12):e2025143. doi: 10.1001/jamanetworkopen.2020.25143.,Patel SA,https://www.ncbi.nlm.nih.gov/pubmed/33301015
15080,32980498,Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study,Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):614-625. doi: 10.1016/j.ijrobp.2020.09.040. Epub 2020 Sep 24.,Sanders JW,https://www.ncbi.nlm.nih.gov/pubmed/32980498
15081,31103393,"Establishment of Novel Intraoperative Monitoring and Mapping Method for the Cavernous Nerve During Robot-assisted Radical Prostatectomy: Results of the Phase I/II, First-in-human, Feasibility Study",Eur Urol. 2020 Aug;78(2):221-228. doi: 10.1016/j.eururo.2019.04.042. Epub 2019 May 16.,Song WH,https://www.ncbi.nlm.nih.gov/pubmed/31103393
15083,32211965,Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes,Eur Radiol. 2020 Aug;30(8):4251-4261. doi: 10.1007/s00330-020-06725-9. Epub 2020 Mar 24.,Abreu-Gomez J,https://www.ncbi.nlm.nih.gov/pubmed/32211965
15084,32078119,Sensitivity of CE-MRI in detecting local recurrence after radical prostatectomy,Radiol Med. 2020 Jul;125(7):683-690. doi: 10.1007/s11547-020-01149-3. Epub 2020 Feb 20.,Coppola A,https://www.ncbi.nlm.nih.gov/pubmed/32078119
15085,32527134,"Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis",Ann Palliat Med. 2020 Jul;9(4):1708-1717. doi: 10.21037/apm-19-414. Epub 2020 May 30.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/32527134
15087,32536574,Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer,Eur Urol Oncol. 2021 Jun;4(3):447-455. doi: 10.1016/j.euo.2020.05.004. Epub 2020 Jun 11.,Deek MP,https://www.ncbi.nlm.nih.gov/pubmed/32536574
15088,33132024,Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy,Urol Oncol. 2021 Feb;39(2):130.e9-130.e15. doi: 10.1016/j.urolonc.2020.09.027. Epub 2020 Oct 31.,Prabhu N,https://www.ncbi.nlm.nih.gov/pubmed/33132024
15090,32950271,Impact of organ confined prostate cancer treatment on quality of life,Actas Urol Esp (Engl Ed). 2020 Nov;44(9):630-636. doi: 10.1016/j.acuro.2020.05.002. Epub 2020 Sep 17.,Alvarez-Ossorio-Rodal A,https://www.ncbi.nlm.nih.gov/pubmed/32950271
15092,32497282,"Obesity, race, and long-term prostate cancer outcomes",Cancer. 2020 Aug 15;126(16):3733-3741. doi: 10.1002/cncr.32906. Epub 2020 Jun 4.,Vidal AC,https://www.ncbi.nlm.nih.gov/pubmed/32497282
15093,32532578,Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy,Cancer Radiother. 2020 Jul;24(4):323-331. doi: 10.1016/j.canrad.2020.03.008. Epub 2020 Jun 10.,Karahissarlian V,https://www.ncbi.nlm.nih.gov/pubmed/32532578
15094,32399639,Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy,Strahlenther Onkol. 2020 Nov;196(11):1006-1017. doi: 10.1007/s00066-020-01629-5. Epub 2020 May 12.,Henkenberens C,https://www.ncbi.nlm.nih.gov/pubmed/32399639
15095,32231245,Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):646-653. doi: 10.1038/s41391-020-0226-2. Epub 2020 Mar 30.,Tosoian JJ,https://www.ncbi.nlm.nih.gov/pubmed/32231245
15096,32542009,Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomy,PLoS One. 2020 Jun 15;15(6):e0234264. doi: 10.1371/journal.pone.0234264. eCollection 2020.,Shin D,https://www.ncbi.nlm.nih.gov/pubmed/32542009
15097,33095659,Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes,Br J Radiol. 2021 Jan 1;94(1117):20200848. doi: 10.1259/bjr.20200848. Epub 2020 Nov 2.,Alongi F,https://www.ncbi.nlm.nih.gov/pubmed/33095659
15098,32891570,Minimal channel GreenLight photovaporization before permanent implant prostate brachytherapy for patients with obstructive symptoms: Technically feasible and safe,Brachytherapy. 2021 Jan-Feb;20(1):50-57. doi: 10.1016/j.brachy.2020.08.003. Epub 2020 Sep 3.,Peigne C,https://www.ncbi.nlm.nih.gov/pubmed/32891570
15099,32108029,A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2),Clin Cancer Res. 2020 Jun 15;26(12):3035-3043. doi: 10.1158/1078-0432.CCR-19-3873. Epub 2020 Feb 27.,Freedland SJ,https://www.ncbi.nlm.nih.gov/pubmed/32108029
15100,31788875,Transrectal high-intensity focused ultrasound (HIFU) for management of rectosigmoid deep infiltrating endometriosis: results of Phase-I clinical trial,Ultrasound Obstet Gynecol. 2020 Sep;56(3):431-442. doi: 10.1002/uog.21937.,Philip CA,https://www.ncbi.nlm.nih.gov/pubmed/31788875
15101,32634543,Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy,Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1292-1303. doi: 10.1016/j.ijrobp.2020.06.076. Epub 2020 Jul 4.,Sanders JW,https://www.ncbi.nlm.nih.gov/pubmed/32634543
15104,32865572,Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US,JAMA Netw Open. 2020 Aug 3;3(8):e2014674. doi: 10.1001/jamanetworkopen.2020.14674.,Agrawal V,https://www.ncbi.nlm.nih.gov/pubmed/32865572
15106,32739124,Radical retropubic prostatectomy: Preservation of urinary continence,Actas Urol Esp (Engl Ed). 2020 Dec;44(10):674-681. doi: 10.1016/j.acuro.2020.06.006. Epub 2020 Jul 30.,Herranz-Amo F,https://www.ncbi.nlm.nih.gov/pubmed/32739124
15109,32583236,PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO),J Cancer Res Clin Oncol. 2020 Sep;146(9):2311-2317. doi: 10.1007/s00432-020-03297-5. Epub 2020 Jun 24.,Zerini D,https://www.ncbi.nlm.nih.gov/pubmed/32583236
15110,32500469,Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy,Int J Clin Oncol. 2020 Sep;25(9):1711-1717. doi: 10.1007/s10147-020-01713-x. Epub 2020 Jun 5.,Taniguchi T,https://www.ncbi.nlm.nih.gov/pubmed/32500469
15111,32602770,Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy,J Urol. 2020 Nov;204(5):950-955. doi: 10.1097/JU.0000000000001201. Epub 2020 Jun 30.,Kanthabalan A,https://www.ncbi.nlm.nih.gov/pubmed/32602770
15112,33283763,Fast mixed integer optimization (FMIO) for high dose rate brachytherapy,Phys Med Biol. 2020 Dec 7;65(21):215005. doi: 10.1088/1361-6560/aba317.,Antaki M,https://www.ncbi.nlm.nih.gov/pubmed/33283763
15113,32400122,"Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression",Cancer Med. 2020 Jul;9(13):4667-4675. doi: 10.1002/cam4.3087. Epub 2020 May 13.,Gutiontov SI,https://www.ncbi.nlm.nih.gov/pubmed/32400122
15114,33041230,Radiation protection and dosimetry issues for patients with prostate cancer after I-125 low-dose-rate brachytherapy permanent implant,Brachytherapy. 2021 Jan-Feb;20(1):272-278. doi: 10.1016/j.brachy.2020.09.003. Epub 2020 Oct 9.,Licciardello T,https://www.ncbi.nlm.nih.gov/pubmed/33041230
15115,32166451,Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer,Strahlenther Onkol. 2020 Jul;196(7):617-627. doi: 10.1007/s00066-020-01590-3. Epub 2020 Mar 12.,Campostrini F,https://www.ncbi.nlm.nih.gov/pubmed/32166451
15116,33125156,ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer,Oncol Rep. 2020 Dec;44(6):2735-2745. doi: 10.3892/or.2020.7811. Epub 2020 Oct 15.,Shimizu K,https://www.ncbi.nlm.nih.gov/pubmed/33125156
15117,32421259,Particle therapy toxicity outcomes: A systematic review,J Med Imaging Radiat Oncol. 2020 Oct;64(5):725-737. doi: 10.1111/1754-9485.13036. Epub 2020 May 18.,Hwang EJ,https://www.ncbi.nlm.nih.gov/pubmed/32421259
15118,32783280,Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low-dose-rate brachytherapy: A randomized controlled study,Int J Urol. 2020 Nov;27(11):1013-1017. doi: 10.1111/iju.14349. Epub 2020 Aug 11.,Tanaka N,https://www.ncbi.nlm.nih.gov/pubmed/32783280
15119,32464369,Adaptive Strategy for External Beam Radiation Therapy in Prostate Cancer: Management of the Geometrical Uncertainties With Robust Optimization,Pract Radiat Oncol. 2020 Nov-Dec;10(6):e521-e528. doi: 10.1016/j.prro.2020.05.006. Epub 2020 May 25.,Ferrara E,https://www.ncbi.nlm.nih.gov/pubmed/32464369
15120,31617093,Effects of Retzius sparing on robot-assisted laparoscopic prostatectomy: a systematic review with meta-analysis,Surg Endosc. 2020 Sep;34(9):4020-4029. doi: 10.1007/s00464-019-07190-2. Epub 2019 Oct 15.,Tai TE,https://www.ncbi.nlm.nih.gov/pubmed/31617093
15121,32423621,Clinical Outcomes of Stereotactic Body Radiotherapy With Immediate Versus Delayed Hormone Therapy in Men With Oligometastatic Recurrence of Prostate Cancer,Clin Oncol (R Coll Radiol). 2020 Aug;32(8):509-517. doi: 10.1016/j.clon.2020.03.008. Epub 2020 May 16.,Chaw CL,https://www.ncbi.nlm.nih.gov/pubmed/32423621
15122,32532530,The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer,Urol Oncol. 2020 Nov;38(11):846.e1-846.e7. doi: 10.1016/j.urolonc.2020.05.010. Epub 2020 Jun 10.,Bacchetta F,https://www.ncbi.nlm.nih.gov/pubmed/32532530
15123,32631078,Is a sampling transition zone important to increase the detection of prostate cancer in systematic prostatic biopsies?,Acta Radiol. 2021 Jun;62(6):815-820. doi: 10.1177/0284185120938363. Epub 2020 Jul 6.,Queiroz MR,https://www.ncbi.nlm.nih.gov/pubmed/32631078
15124,32690870,Management of prostate cancer patients during COVID-19 pandemic,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):398-406. doi: 10.1038/s41391-020-0258-7. Epub 2020 Jul 20.,Obek C,https://www.ncbi.nlm.nih.gov/pubmed/32690870
15126,32647352,Risk of erectile dysfunction after modern radiotherapy for intact prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):128-134. doi: 10.1038/s41391-020-0247-x. Epub 2020 Jul 9.,Hunt AA,https://www.ncbi.nlm.nih.gov/pubmed/32647352
15127,32409202,Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer,Urol Oncol. 2020 Aug;38(8):661-670. doi: 10.1016/j.urolonc.2020.04.008. Epub 2020 May 11.,Lenfant L,https://www.ncbi.nlm.nih.gov/pubmed/32409202
15128,32986884,Association between CD8 and PD-L1 expression and outcomes after radical prostatectomy for localized prostate cancer,Prostate. 2021 Jan;81(1):50-57. doi: 10.1002/pros.24079. Epub 2020 Sep 28.,Vicier C,https://www.ncbi.nlm.nih.gov/pubmed/32986884
15129,32150281,Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers,Int J Cancer. 2020 Jul 15;147(2):575-583. doi: 10.1002/ijc.32957. Epub 2020 Mar 18.,Luebke AM,https://www.ncbi.nlm.nih.gov/pubmed/32150281
15131,32413546,RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning,Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):802-812. doi: 10.1016/j.ijrobp.2020.04.045. Epub 2020 May 12.,Mao X,https://www.ncbi.nlm.nih.gov/pubmed/32413546
15132,33085712,68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer,PLoS One. 2020 Oct 21;15(10):e0240892. doi: 10.1371/journal.pone.0240892. eCollection 2020.,Kalinauskaite G,https://www.ncbi.nlm.nih.gov/pubmed/33085712
15133,32558706,99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate Cancer,Clin Nucl Med. 2020 Aug;45(8):e349-e357. doi: 10.1097/RLU.0000000000003102.,Schmidkonz C,https://www.ncbi.nlm.nih.gov/pubmed/32558706
15134,32399638,Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer,Strahlenther Onkol. 2020 Jul;196(7):628-636. doi: 10.1007/s00066-020-01628-6. Epub 2020 May 12.,Cuccia F,https://www.ncbi.nlm.nih.gov/pubmed/32399638
15136,33327317,"Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer",Medicine (Baltimore). 2020 Dec 11;99(50):e23574. doi: 10.1097/MD.0000000000023574.,Serra M,https://www.ncbi.nlm.nih.gov/pubmed/33327317
15137,33008371,Incidence and risk factors of inguinal hernia occurred after radical prostatectomy-comparisons of different approaches,BMC Surg. 2020 Oct 2;20(1):218. doi: 10.1186/s12893-020-00883-9.,Liu L,https://www.ncbi.nlm.nih.gov/pubmed/33008371
15141,32243242,Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy,J Urol. 2020 Sep;204(3):511-517. doi: 10.1097/JU.0000000000001036. Epub 2020 Apr 3.,Daskivich TJ,https://www.ncbi.nlm.nih.gov/pubmed/32243242
15146,33041188,Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications,Urol Oncol. 2021 May;39(5):296.e1-296.e9. doi: 10.1016/j.urolonc.2020.08.030. Epub 2020 Oct 9.,Diamand R,https://www.ncbi.nlm.nih.gov/pubmed/33041188
15147,32327264,Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique,Eur Urol. 2020 Sep;78(3):424-431. doi: 10.1016/j.eururo.2020.03.032. Epub 2020 Apr 20.,Mattei A,https://www.ncbi.nlm.nih.gov/pubmed/32327264
15148,32655718,FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer,Dis Markers. 2020 Jun 18;2020:3904947. doi: 10.1155/2020/3904947. eCollection 2020.,Cao Z,https://www.ncbi.nlm.nih.gov/pubmed/32655718
15150,32324906,Response to: Bando et al. Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histological and molecular analyses,Prostate. 2020 Jul;80(10):795-796. doi: 10.1002/pros.23987. Epub 2020 Apr 23.,Sebben M,https://www.ncbi.nlm.nih.gov/pubmed/32324906
15151,33455105,Efficacy of radical prostatectomy on prostate cancer patients and analysis of risk factors for biochemical recurrence after radical prostatectomy,J BUON. 2020 Nov-Dec;25(6):2623-2628.,Yang X,https://www.ncbi.nlm.nih.gov/pubmed/33455105
15152,32798608,Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer,Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):387-395. doi: 10.1016/j.ijrobp.2020.08.030. Epub 2020 Aug 14.,Deek MP,https://www.ncbi.nlm.nih.gov/pubmed/32798608
15153,32957339,Cribriform pattern does not have a significant impact in Gleason Score ?7/ISUP Grade ?2 prostate cancers submitted to radical prostatectomy,Medicine (Baltimore). 2020 Sep 18;99(38):e22156. doi: 10.1097/MD.0000000000022156.,Flammia S,https://www.ncbi.nlm.nih.gov/pubmed/32957339
15157,32698843,Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5?T MR-guided stereotactic body radiotherapy,Radiat Oncol. 2020 Jul 22;15(1):178. doi: 10.1186/s13014-020-01622-3.,Cuccia F,https://www.ncbi.nlm.nih.gov/pubmed/32698843
15158,32604918,Combined Robotic Surgery for Double Renal Masses and Prostate Cancer: Myth or Reality?,Medicina (Kaunas). 2020 Jun 26;56(6):318. doi: 10.3390/medicina56060318.,Cochetti G,https://www.ncbi.nlm.nih.gov/pubmed/32604918
15159,30777723,Retzius-sparing Robot-assisted Laparoscopic Radical Prostatectomy: An International Survey on Surgical Details and Worldwide Diffusion,Eur Urol Focus. 2020 Sep 15;6(5):1021-1023. doi: 10.1016/j.euf.2019.02.002. Epub 2019 Feb 15.,Galfano A,https://www.ncbi.nlm.nih.gov/pubmed/30777723
15160,32978635,"Men's sexual help-seeking and care needs after radical prostatectomy or other non-hormonal, active prostate cancer treatments",Support Care Cancer. 2021 May;29(5):2699-2711. doi: 10.1007/s00520-020-05775-5. Epub 2020 Sep 26.,Hyde MK,https://www.ncbi.nlm.nih.gov/pubmed/32978635
15161,33288843,Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer,Br J Cancer. 2021 Mar;124(5):896-900. doi: 10.1038/s41416-020-01200-0. Epub 2020 Dec 8.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/33288843
15162,32078707,Contrast-enhanced ultrasound with dispersion analysis for the localization of prostate cancer: correlation with radical prostatectomy specimens,World J Urol. 2020 Nov;38(11):2811-2818. doi: 10.1007/s00345-020-03103-4. Epub 2020 Feb 20.,Postema AW,https://www.ncbi.nlm.nih.gov/pubmed/32078707
15163,32734463,Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer,World J Urol. 2021 Jun;39(6):1797-1804. doi: 10.1007/s00345-020-03394-7. Epub 2020 Jul 30.,Björnebo L,https://www.ncbi.nlm.nih.gov/pubmed/32734463
15164,32583038,External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients,World J Urol. 2021 May;39(5):1489-1497. doi: 10.1007/s00345-020-03322-9. Epub 2020 Jun 24.,Peilleron N,https://www.ncbi.nlm.nih.gov/pubmed/32583038
15166,32977662,Systemic Inflammatory Markers Are Predictive of the Response to Brachytherapy in the Prostate,Cells. 2020 Sep 23;9(10):2153. doi: 10.3390/cells9102153.,Taussky D,https://www.ncbi.nlm.nih.gov/pubmed/32977662
15167,32535161,Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial,Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1047-1054. doi: 10.1016/j.ijrobp.2020.06.002. Epub 2020 Jun 12.,Jaccard M,https://www.ncbi.nlm.nih.gov/pubmed/32535161
15168,32639580,The benefit of prehabilitation and enhanced recovery in robot-assisted radical prostatectomy and the promising future of these protocols in the field of urologic oncology,Cancer. 2020 Sep 15;126(18):4107-4109. doi: 10.1002/cncr.33059. Epub 2020 Jul 8.,Townsend WB,https://www.ncbi.nlm.nih.gov/pubmed/32639580
15169,32312641,Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions,Urol Oncol. 2020 Sep;38(9):734.e11-734.e17. doi: 10.1016/j.urolonc.2020.03.023. Epub 2020 Apr 17.,Manceau C,https://www.ncbi.nlm.nih.gov/pubmed/32312641
15170,33248139,Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy,Urology. 2021 Feb;148:151-158. doi: 10.1016/j.urology.2020.08.095. Epub 2020 Nov 25.,Kubota M,https://www.ncbi.nlm.nih.gov/pubmed/33248139
15171,35300945,Bladder volume reproducibility after water consumption in patients with prostate cancer undergoing radiotherapy: A systematic review and meta-analysis,Biomed J. 2021 Dec;44(6 Suppl 2):S226-S234. doi: 10.1016/j.bj.2020.11.004. Epub 2020 Nov 4.,Chen HH,https://www.ncbi.nlm.nih.gov/pubmed/35300945
15172,32895938,Racial disparities in mortality for patients with prostate cancer after radical prostatectomy,Cancer. 2021 May 1;127(9):1517-1528. doi: 10.1002/cncr.33152. Epub 2020 Sep 8.,Wen W,https://www.ncbi.nlm.nih.gov/pubmed/32895938
15173,33141207,Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance,JAMA. 2020 Nov 3;324(17):1747-1754. doi: 10.1001/jama.2020.17020.,Deka R,https://www.ncbi.nlm.nih.gov/pubmed/33141207
15174,32893378,Relationship between radiation doses and erectile function deterioration in patients with localized prostate cancer treated with permanent prostate brachytherapy,Int J Urol. 2020 Dec;27(12):1087-1093. doi: 10.1111/iju.14358. Epub 2020 Sep 6.,Shigeta K,https://www.ncbi.nlm.nih.gov/pubmed/32893378
15175,32985908,Machine-Learning Models for Multicenter Prostate Cancer Treatment Plans,J Comput Biol. 2021 Feb;28(2):166-184. doi: 10.1089/cmb.2020.0188. Epub 2020 Sep 25.,Syed K,https://www.ncbi.nlm.nih.gov/pubmed/32985908
15176,32259468,Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer,J Urol. 2020 Oct;204(4):748-753. doi: 10.1097/JU.0000000000001074. Epub 2020 Apr 7.,Ranasinghe W,https://www.ncbi.nlm.nih.gov/pubmed/32259468
15177,32273183,"The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial",Eur Urol. 2020 Aug;78(2):184-192. doi: 10.1016/j.eururo.2020.03.001. Epub 2020 Apr 6.,Dearnaley DP,https://www.ncbi.nlm.nih.gov/pubmed/32273183
15179,33023770,External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy,Eur Urol. 2021 Feb;79(2):180-185. doi: 10.1016/j.eururo.2020.09.037. Epub 2020 Oct 3.,Diamand R,https://www.ncbi.nlm.nih.gov/pubmed/33023770
15180,33009987,Robotically assisted laparoscopic radical prostatectomy induces lower tissue trauma than radical retropubic prostatectomy,J Robot Surg. 2021 Feb;15(1):147-151. doi: 10.1007/s11701-020-01150-y. Epub 2020 Oct 3.,Quinto D,https://www.ncbi.nlm.nih.gov/pubmed/33009987
15181,32873918,External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):253-260. doi: 10.1038/s41391-020-00276-2. Epub 2020 Sep 1.,Stolzenbach LF,https://www.ncbi.nlm.nih.gov/pubmed/32873918
15182,31560121,Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomy,World J Urol. 2020 Jul;38(7):1719-1727. doi: 10.1007/s00345-019-02965-7. Epub 2019 Sep 27.,Branger N,https://www.ncbi.nlm.nih.gov/pubmed/31560121
15184,32665997,Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?,Investig Clin Urol. 2020 Jul;61(4):405-410. doi: 10.4111/icu.2020.61.4.405. Epub 2020 May 25.,Pham DM,https://www.ncbi.nlm.nih.gov/pubmed/32665997
15185,33251703,Objective assessment of intraoperative skills for robot-assisted radical prostatectomy (RARP): results from the ERUS Scientific and Educational Working Groups Metrics Initiative,BJU Int. 2021 Jul;128(1):103-111. doi: 10.1111/bju.15311. Epub 2020 Dec 20.,Mottrie A,https://www.ncbi.nlm.nih.gov/pubmed/33251703
15188,32532912,Pituitary metastasis of prostate cancer presenting as a unilateral third nerve palsy,BMJ Case Rep. 2020 Jun 11;13(6):e234550. doi: 10.1136/bcr-2020-234550.,Ahmad S,https://www.ncbi.nlm.nih.gov/pubmed/32532912
15189,32220891,"Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer",Clin Cancer Res. 2020 Jul 1;26(13):3230-3238. doi: 10.1158/1078-0432.CCR-20-0168. Epub 2020 Mar 27.,Stopsack KH,https://www.ncbi.nlm.nih.gov/pubmed/32220891
15190,33148472,Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes,Eur Urol. 2021 Jan;79(1):141-149. doi: 10.1016/j.eururo.2020.09.003. Epub 2020 Nov 2.,Cooperberg MR,https://www.ncbi.nlm.nih.gov/pubmed/33148472
15192,32096413,Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy,Aging Male. 2020 Dec;23(5):1210-1216. doi: 10.1080/13685538.2020.1731450. Epub 2020 Feb 25.,Kato Y,https://www.ncbi.nlm.nih.gov/pubmed/32096413
15193,32763323,Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making,Urology. 2020 Nov;145:197-203. doi: 10.1016/j.urology.2020.07.040. Epub 2020 Aug 4.,Lamba N,https://www.ncbi.nlm.nih.gov/pubmed/32763323
15196,32555410,Histologic tissue components provide major cues for machine learning-based prostate cancer detection and grading on prostatectomy specimens,Sci Rep. 2020 Jun 18;10(1):9911. doi: 10.1038/s41598-020-66849-2.,Han W,https://www.ncbi.nlm.nih.gov/pubmed/32555410
15197,32372146,Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes,J Cancer Res Clin Oncol. 2020 Sep;146(9):2379-2397. doi: 10.1007/s00432-020-03230-w. Epub 2020 May 5.,Mazzola R,https://www.ncbi.nlm.nih.gov/pubmed/32372146
15198,32651696,Conditional Survival and Time of Biochemical Recurrence of Localized Prostate Cancer in Japanese Patients Undergoing Laparoscopic Radical Prostatectomies,Ann Surg Oncol. 2021 Feb;28(2):1247-1253. doi: 10.1245/s10434-020-08770-6. Epub 2020 Jul 10.,Kawakami M,https://www.ncbi.nlm.nih.gov/pubmed/32651696
15199,32536241,Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review,Acta Oncol. 2020 Oct;59(10):1224-1234. doi: 10.1080/0284186X.2020.1775291. Epub 2020 Jun 13.,Achard V,https://www.ncbi.nlm.nih.gov/pubmed/32536241
15201,32654951,Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer,Urol Oncol. 2020 Sep;38(9):735.e9-735.e15. doi: 10.1016/j.urolonc.2020.05.023. Epub 2020 Jul 10.,Yang DD,https://www.ncbi.nlm.nih.gov/pubmed/32654951
15202,33279855,Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial,Eur J Cancer. 2021 Jan;143:64-74. doi: 10.1016/j.ejca.2020.10.023. Epub 2020 Dec 3.,Nabid A,https://www.ncbi.nlm.nih.gov/pubmed/33279855
15204,32330406,Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer,J Urol. 2020 Nov;204(5):934-940. doi: 10.1097/JU.0000000000001091. Epub 2020 Apr 24.,Detsky JS,https://www.ncbi.nlm.nih.gov/pubmed/32330406
15205,32871139,Suboptimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy,Urology. 2021 Feb;148:217-223. doi: 10.1016/j.urology.2020.08.031. Epub 2020 Aug 29.,Karsiyakali N,https://www.ncbi.nlm.nih.gov/pubmed/32871139
15206,33127733,Unusual cause of Fournier's gangrene: colorectal-genitourinary tract fistulae status post brachytherapy,BMJ Case Rep. 2020 Oct 30;13(10):e235903. doi: 10.1136/bcr-2020-235903.,Saleem N,https://www.ncbi.nlm.nih.gov/pubmed/33127733
15207,33078747,Anesthesia concerns in prostate brachytherapy: An institutional experience,Indian J Cancer. 2020 Oct-Dec;57(4):411-415. doi: 10.4103/ijc.IJC_666_18.,Kumar V,https://www.ncbi.nlm.nih.gov/pubmed/33078747
15208,32926314,Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades,Int Urol Nephrol. 2021 Feb;53(2):241-248. doi: 10.1007/s11255-020-02636-2. Epub 2020 Sep 14.,Waeckel T,https://www.ncbi.nlm.nih.gov/pubmed/32926314
15209,33008340,A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence,BMC Cancer. 2020 Oct 2;20(1):953. doi: 10.1186/s12885-020-07438-4.,Kamdar S,https://www.ncbi.nlm.nih.gov/pubmed/33008340
15210,32946907,Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging,Urology. 2020 Dec;146:183-188. doi: 10.1016/j.urology.2020.07.068. Epub 2020 Sep 16.,Alanee S,https://www.ncbi.nlm.nih.gov/pubmed/32946907
15211,33052718,Utility of (18)F-Fluciclovine PET/MRI for Staging Newly Diagnosed High-Risk Prostate Cancer and Evaluating Response to Initial Androgen Deprivation Therapy: A Prospective Single-Arm Pilot Study,AJR Am J Roentgenol. 2021 Sep;217(3):720-729. doi: 10.2214/AJR.20.24509. Epub 2020 Oct 14.,Galgano SJ,https://www.ncbi.nlm.nih.gov/pubmed/33052718
15213,32863190,Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review,Clin Genitourin Cancer. 2021 Feb;19(1):69-75.e5. doi: 10.1016/j.clgc.2020.08.001. Epub 2020 Aug 7.,Kamitani R,https://www.ncbi.nlm.nih.gov/pubmed/32863190
15214,32729184,Deep learning using preoperative magnetic resonance imaging information to predict early recovery of urinary continence after robot-assisted radical prostatectomy,Int J Urol. 2020 Oct;27(10):922-928. doi: 10.1111/iju.14325. Epub 2020 Jul 30.,Sumitomo M,https://www.ncbi.nlm.nih.gov/pubmed/32729184
15215,33014247,Treatment of localized prostate cancer and use of nomograms among urologists in the West Africa sub-region,Pan Afr Med J. 2020 Aug 6;36:251. doi: 10.11604/pamj.2020.36.251.21419. eCollection 2020.,Kyei MY,https://www.ncbi.nlm.nih.gov/pubmed/33014247
15216,32797322,Effect of general self-efficacy on promoting health-related quality of life during recovery from radical prostatectomy: a 1-year prospective study,Int J Clin Oncol. 2020 Dec;25(12):2122-2129. doi: 10.1007/s10147-020-01765-z. Epub 2020 Aug 14.,Kawaguchi K,https://www.ncbi.nlm.nih.gov/pubmed/32797322
15217,31924715,Impact of (68)Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study,J Nucl Med. 2020 Aug;61(8):1153-1160. doi: 10.2967/jnumed.119.237602. Epub 2020 Jan 10.,Sonni I,https://www.ncbi.nlm.nih.gov/pubmed/31924715
15218,30674232,Reformulating the Worker Identity: Men's Experiences After Radical Prostatectomy,Qual Health Res. 2020 Jul;30(8):1225-1236. doi: 10.1177/1049732318825150. Epub 2019 Jan 24.,Yu Ko WF,https://www.ncbi.nlm.nih.gov/pubmed/30674232
15219,32773255,Indications and Complications of Androgen Deprivation Therapy,Semin Oncol Nurs. 2020 Aug;36(4):151042. doi: 10.1016/j.soncn.2020.151042. Epub 2020 Aug 6.,Fankhauser CD,https://www.ncbi.nlm.nih.gov/pubmed/32773255
15220,32307562,Independent external validation of nomogram to predict extracapsular extension in patients with prostate cancer,Eur Radiol. 2020 Sep;30(9):5004-5010. doi: 10.1007/s00330-020-06839-0. Epub 2020 Apr 19.,Alves JR,https://www.ncbi.nlm.nih.gov/pubmed/32307562
15221,32607958,Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection,Int Urol Nephrol. 2020 Nov;52(11):2097-2105. doi: 10.1007/s11255-020-02554-3. Epub 2020 Jun 30.,Tafuri A,https://www.ncbi.nlm.nih.gov/pubmed/32607958
15222,33157570,The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer,J Urol. 2020 Dec;204(6):1222-1228. doi: 10.1097/JU.0000000000001313. Epub 2020 Nov 6.,Maggi M,https://www.ncbi.nlm.nih.gov/pubmed/33157570
15223,32814663,Time to achieve a prostate-specific antigen nadir of ?0.2 ng/mL and related factors after permanent prostate brachytherapy,Brachytherapy. 2021 Jan-Feb;20(1):29-37. doi: 10.1016/j.brachy.2020.07.006. Epub 2020 Aug 16.,Soyano T,https://www.ncbi.nlm.nih.gov/pubmed/32814663
15224,31531690,Long-term functional outcomes after robotic vs. retropubic radical prostatectomy in routine care: a 6-year follow-up of a large German health services research study,World J Urol. 2020 Jul;38(7):1701-1709. doi: 10.1007/s00345-019-02956-8. Epub 2019 Sep 17.,Baunacke M,https://www.ncbi.nlm.nih.gov/pubmed/31531690
15225,32658588,Active Surveillance for Men with Intermediate Risk Prostate Cancer,J Urol. 2021 Jan;205(1):115-121. doi: 10.1097/JU.0000000000001241. Epub 2020 Jul 13.,Agrawal V,https://www.ncbi.nlm.nih.gov/pubmed/32658588
15226,32333202,Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer,Int J Clin Oncol. 2020 Jul;25(7):1398-1404. doi: 10.1007/s10147-020-01682-1. Epub 2020 Apr 24.,Morizane S,https://www.ncbi.nlm.nih.gov/pubmed/32333202
15227,33109264,Small cell carcinoma of the prostate after low-dose-rate brachytherapy: a case report,J Med Case Rep. 2020 Oct 28;14(1):203. doi: 10.1186/s13256-020-02523-5.,Van Bos E,https://www.ncbi.nlm.nih.gov/pubmed/33109264
15228,32621027,Prognostic performance of magnetic resonance imaging-guided biopsy in defining prostate cancer anterior lesions,World J Urol. 2021 May;39(5):1473-1479. doi: 10.1007/s00345-020-03335-4. Epub 2020 Jul 3.,Porreca A,https://www.ncbi.nlm.nih.gov/pubmed/32621027
15230,32988880,Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate Cancer,Anticancer Res. 2020 Oct;40(10):5567-5575. doi: 10.21873/anticanres.14569.,Yuno T,https://www.ncbi.nlm.nih.gov/pubmed/32988880
15231,33113261,Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology,Int J Clin Pract. 2021 Mar;75(3):e13797. doi: 10.1111/ijcp.13797. Epub 2020 Nov 20.,Aslan G,https://www.ncbi.nlm.nih.gov/pubmed/33113261
15232,32588704,Can we predict the development of symptomatic lymphocele following robot-assisted radical prostatectomy and lymph node dissection? Results from a tertiary referral Centre,Scand J Urol. 2020 Aug;54(4):328-333. doi: 10.1080/21681805.2020.1784270. Epub 2020 Jun 26.,Sforza S,https://www.ncbi.nlm.nih.gov/pubmed/32588704
15233,32883645,Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review,Eur Urol Oncol. 2021 Aug;4(4):558-569. doi: 10.1016/j.euo.2020.08.003. Epub 2020 Aug 31.,Cimadamore A,https://www.ncbi.nlm.nih.gov/pubmed/32883645
15234,32889251,Efficacy of a weight loss program prior to robot assisted radical prostatectomy in overweight and obese men with prostate cancer,Surg Oncol. 2020 Dec;35:182-188. doi: 10.1016/j.suronc.2020.08.006. Epub 2020 Aug 7.,Wilson RL,https://www.ncbi.nlm.nih.gov/pubmed/32889251
15235,32861619,The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study),Urol Oncol. 2021 Mar;39(3):192.e7-192.e14. doi: 10.1016/j.urolonc.2020.08.010. Epub 2020 Aug 26.,Togashi K,https://www.ncbi.nlm.nih.gov/pubmed/32861619
15236,33252117,Do not underestimate anterior prostate cancer,Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Jun;165(2):198-202. doi: 10.5507/bp.2020.054. Epub 2020 Nov 26.,Kudlackova S,https://www.ncbi.nlm.nih.gov/pubmed/33252117
15237,32767683,Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapy,Prostate. 2020 Oct;80(14):1244-1252. doi: 10.1002/pros.24054. Epub 2020 Aug 7.,Di Bella CM,https://www.ncbi.nlm.nih.gov/pubmed/32767683
15238,32433602,"Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment",Br J Cancer. 2020 Aug;123(3):487-494. doi: 10.1038/s41416-020-0859-x. Epub 2020 May 20.,Butler EN,https://www.ncbi.nlm.nih.gov/pubmed/32433602
15239,33059351,Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity,Urol Int. 2021;105(5-6):362-369. doi: 10.1159/000510008. Epub 2020 Oct 15.,Tafuri A,https://www.ncbi.nlm.nih.gov/pubmed/33059351
15240,32873515,The Use of Three-dimensional Visualization Techniques for Prostate Procedures: A Systematic Review,Eur Urol Focus. 2021 Nov;7(6):1274-1286. doi: 10.1016/j.euf.2020.08.002. Epub 2020 Aug 29.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/32873515
15241,31980875,The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy,World J Urol. 2020 Nov;38(11):2799-2809. doi: 10.1007/s00345-020-03094-2. Epub 2020 Jan 24.,Sebben M,https://www.ncbi.nlm.nih.gov/pubmed/31980875
15242,32999464,Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):398-405. doi: 10.1038/s41391-020-00289-x. Epub 2020 Sep 30.,Yaxley WJ,https://www.ncbi.nlm.nih.gov/pubmed/32999464
15244,33206323,Anterior prostate fat resection during prostatectomy: a histopathologic review,J Robot Surg. 2021 Oct;15(5):769-772. doi: 10.1007/s11701-020-01172-6. Epub 2020 Nov 18.,Guy AM,https://www.ncbi.nlm.nih.gov/pubmed/33206323
15245,33135127,Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer,World J Urol. 2021 Jul;39(7):2483-2490. doi: 10.1007/s00345-020-03493-5. Epub 2020 Nov 1.,Surcel C,https://www.ncbi.nlm.nih.gov/pubmed/33135127
15247,32591246,"The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's ""M1|RT Comparison""",Eur Urol Oncol. 2020 Aug;3(4):412-419. doi: 10.1016/j.euo.2020.05.003. Epub 2020 Jun 24.,Ali A,https://www.ncbi.nlm.nih.gov/pubmed/32591246
15248,32902306,Health economic impact of a biopsy-based cell cycle gene expression assay in localized prostate cancer,Future Oncol. 2020 Dec;16(36):3061-3074. doi: 10.2217/fon-2020-0648. Epub 2020 Sep 9.,Gustavsen G,https://www.ncbi.nlm.nih.gov/pubmed/32902306
15249,33258482,Impact of radiation dose on recurrence in high-risk prostate cancer patients,Prostate. 2020 Nov;80(15):1322-1327. doi: 10.1002/pros.24059. Epub 2020 Aug 17.,Deek M,https://www.ncbi.nlm.nih.gov/pubmed/33258482
15250,30040004,Quality of life and sexual health in men with prostate cancer undergoing radical prostatectomy,Aging Male. 2020 Dec;23(5):346-353. doi: 10.1080/13685538.2018.1486397. Epub 2018 Jul 24.,Naccarato AMEP,https://www.ncbi.nlm.nih.gov/pubmed/30040004
15252,32734723,Multi-scale tissue architecture analysis of favorable-risk prostate cancer: Correlation with biochemical recurrence,Investig Clin Urol. 2020 Sep;61(5):482-490. doi: 10.4111/icu.20200018. Epub 2020 Jul 28.,Pukl M,https://www.ncbi.nlm.nih.gov/pubmed/32734723
15253,32601113,Patients' experiences of using an e-Health tool for self-management support after prostate cancer surgery: a deductive interview study explained through the FITT framework,BMJ Open. 2020 Jun 29;10(6):e035024. doi: 10.1136/bmjopen-2019-035024.,Nilsson L,https://www.ncbi.nlm.nih.gov/pubmed/32601113
15254,32976179,"Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate",Am J Clin Oncol. 2020 Dec 1;43(12):865-871. doi: 10.1097/COC.0000000000000763.,Janzen BW,https://www.ncbi.nlm.nih.gov/pubmed/32976179
15256,32417965,Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers,Virchows Arch. 2020 Nov;477(5):625-636. doi: 10.1007/s00428-020-02834-4. Epub 2020 May 16.,Möller K,https://www.ncbi.nlm.nih.gov/pubmed/32417965
15257,32740864,Texture analysis on bi-parametric MRI for evaluation of aggressiveness in patients with prostate cancer,Abdom Radiol (NY). 2020 Dec;45(12):4214-4222. doi: 10.1007/s00261-020-02683-4. Epub 2020 Aug 1.,Baek TW,https://www.ncbi.nlm.nih.gov/pubmed/32740864
15258,33310011,Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking,Radiother Oncol. 2021 Mar;156:145-152. doi: 10.1016/j.radonc.2020.12.013. Epub 2020 Dec 11.,Jaccard M,https://www.ncbi.nlm.nih.gov/pubmed/33310011
15260,33371121,Treating the primary in low burden metastatic prostate cancer: Where do we stand?,Medicine (Baltimore). 2020 Dec 18;99(51):e23715. doi: 10.1097/MD.0000000000023715.,Luo HC,https://www.ncbi.nlm.nih.gov/pubmed/33371121
15263,32564359,Registration of presurgical MRI and histopathology images from radical prostatectomy via RAPSODI,Med Phys. 2020 Sep;47(9):4177-4188. doi: 10.1002/mp.14337. Epub 2020 Jul 18.,Rusu M,https://www.ncbi.nlm.nih.gov/pubmed/32564359
15264,32691640,Preoperative Nutritional Risk Index Predicts Recurrence of Oligometastatic Prostate Cancer in Patients Undergoing Cytoreductive Radical Prostatectomy,Nutr Cancer. 2021;73(8):1440-1447. doi: 10.1080/01635581.2020.1795694. Epub 2020 Jul 21.,Guo Y,https://www.ncbi.nlm.nih.gov/pubmed/32691640
15265,32381585,Management of Active Surveillance-Eligible Prostate Cancer during Pretransplantation Workup of Patients with Kidney Failure: A Simulation Study,Clin J Am Soc Nephrol. 2020 Jun 8;15(6):822-829. doi: 10.2215/CJN.14041119. Epub 2020 May 7.,Bieri U,https://www.ncbi.nlm.nih.gov/pubmed/32381585
15266,31424026,Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer,Asian J Androl. 2020 Jul-Aug;22(4):427-431. doi: 10.4103/aja.aja_77_19.,Chen JR,https://www.ncbi.nlm.nih.gov/pubmed/31424026
15267,32602024,Rethinking the need for overnight admission after robotic-assisted laparoscopic prostatectomy,J Robot Surg. 2020 Dec;14(6):913-915. doi: 10.1007/s11701-020-01115-1. Epub 2020 Jun 29.,Kotamarti S,https://www.ncbi.nlm.nih.gov/pubmed/32602024
15268,32520496,Salvage Therapies After 18F-Fluciclovine Detected Prostate Cancer Recurrences,Clin Nucl Med. 2020 Sep;45(9):668-671. doi: 10.1097/RLU.0000000000003104.,Hwang L,https://www.ncbi.nlm.nih.gov/pubmed/32520496
15269,32628792,miR-196a-mediated downregulation of p27(kip1) protein promotes prostate cancer proliferation and relates to biochemical recurrence after radical prostatectomy,Prostate. 2020 Sep;80(12):1024-1037. doi: 10.1002/pros.24036. Epub 2020 Jul 6.,Zhan B,https://www.ncbi.nlm.nih.gov/pubmed/32628792
15270,33281109,Europa Uomo Patient Reported Outcome Study (EUPROMS): Descriptive Statistics of a Prostate Cancer Survey from Patients for Patients,Eur Urol Focus. 2021 Sep;7(5):987-994. doi: 10.1016/j.euf.2020.11.002. Epub 2020 Dec 4.,Venderbos LDF,https://www.ncbi.nlm.nih.gov/pubmed/33281109
15272,32002569,The role of T2-weighted images in assessing the grade of extraprostatic extension of the prostate carcinoma,Abdom Radiol (NY). 2020 Oct;45(10):3293-3300. doi: 10.1007/s00261-020-02419-4.,Onay A,https://www.ncbi.nlm.nih.gov/pubmed/32002569
15273,32718179,Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy,Acta Radiol. 2021 Jul;62(7):949-958. doi: 10.1177/0284185120943047. Epub 2020 Jul 27.,Giannarini G,https://www.ncbi.nlm.nih.gov/pubmed/32718179
15274,32748296,Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer,Int J Clin Oncol. 2020 Dec;25(12):2115-2121. doi: 10.1007/s10147-020-01758-y. Epub 2020 Aug 3.,Guo XX,https://www.ncbi.nlm.nih.gov/pubmed/32748296
15276,32600928,Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling,Urol Oncol. 2020 Dec;38(12):929.e11-929.e19. doi: 10.1016/j.urolonc.2020.05.027. Epub 2020 Jun 26.,Luzzago S,https://www.ncbi.nlm.nih.gov/pubmed/32600928
15277,32505965,Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials,Radiother Oncol. 2020 Jul;148:235-242. doi: 10.1016/j.radonc.2020.04.037. Epub 2020 Apr 28.,Lehrer EJ,https://www.ncbi.nlm.nih.gov/pubmed/32505965
15278,33035728,Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy,Pathol Res Pract. 2020 Nov;216(11):153235. doi: 10.1016/j.prp.2020.153235. Epub 2020 Oct 1.,Liu H,https://www.ncbi.nlm.nih.gov/pubmed/33035728
15279,30924381,The depressive effects of androgen deprivation therapy in locally advanced or metastatic prostate cancer: a comparative study,Aging Male. 2020 Dec;23(5):733-739. doi: 10.1080/13685538.2019.1586869. Epub 2019 Mar 29.,Ceylan Y,https://www.ncbi.nlm.nih.gov/pubmed/30924381
15280,32368932,Preoperative Predictive Model of Narrow Pelvis in Laparoscopic Radical Prostatectomy Through Computed Tomography,J Endourol. 2020 Jul;34(7):763-769. doi: 10.1089/end.2020.0005. Epub 2020 May 28.,Xie R,https://www.ncbi.nlm.nih.gov/pubmed/32368932
15281,32624288,Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought,Eur Urol. 2020 Nov;78(5):661-669. doi: 10.1016/j.eururo.2020.06.043. Epub 2020 Jul 2.,Bravi CA,https://www.ncbi.nlm.nih.gov/pubmed/32624288
15282,32149575,Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy,J Urol. 2020 Sep;204(3):503-510. doi: 10.1097/JU.0000000000001012. Epub 2020 Mar 9.,Luiting HB,https://www.ncbi.nlm.nih.gov/pubmed/32149575
15283,33048258,No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance,World J Urol. 2021 Jul;39(7):2499-2506. doi: 10.1007/s00345-020-03485-5. Epub 2020 Oct 13.,Herkommer K,https://www.ncbi.nlm.nih.gov/pubmed/33048258
15284,32739147,Comparison between (68)Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy,J Formos Med Assoc. 2021 Jan;120(1 Pt 3):688-696. doi: 10.1016/j.jfma.2020.07.029. Epub 2020 Jul 29.,Tseng JR,https://www.ncbi.nlm.nih.gov/pubmed/32739147
15285,33016030,Comparison of multiple abbreviated multiparametric MRI-derived protocols for the detection of clinically significant prostate cancer,Minerva Urol Nephrol. 2022 Feb;74(1):29-37. doi: 10.23736/S2724-6051.20.03952-1. Epub 2020 Oct 5.,Cereser L,https://www.ncbi.nlm.nih.gov/pubmed/33016030
15286,32933541,Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer,Radiat Oncol. 2020 Sep 15;15(1):217. doi: 10.1186/s13014-020-01658-5.,Patel SA,https://www.ncbi.nlm.nih.gov/pubmed/32933541
15287,33309999,Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer,Radiother Oncol. 2021 Mar;156:69-79. doi: 10.1016/j.radonc.2020.12.009. Epub 2020 Dec 11.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/33309999
15288,32549073,Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols,Int Braz J Urol. 2020 Jul;46(suppl.1):50-61. doi: 10.1590/S1677-5538.IBJU.2020.S106.,Sanchez LR,https://www.ncbi.nlm.nih.gov/pubmed/32549073
15289,32671440,A comparison between (68)Ga-labeled prostate-specific membrane antigen-PET/CT and multiparametric MRI for excluding regional metastases prior to radical prostatectomy,Abdom Radiol (NY). 2020 Dec;45(12):4194-4201. doi: 10.1007/s00261-020-02640-1. Epub 2020 Jul 15.,Frumer M,https://www.ncbi.nlm.nih.gov/pubmed/32671440
15290,32500342,Surgical Management and Outcomes of Rectal Cancer with Synchronous Prostate Cancer: A Multicenter Experience from the GRECCAR Group,Ann Surg Oncol. 2020 Oct;27(11):4286-4293. doi: 10.1245/s10434-020-08683-4. Epub 2020 Jun 4.,Doussot A,https://www.ncbi.nlm.nih.gov/pubmed/32500342
15291,32160050,MRI of the Prostate With and Without Endorectal Coil at 3 T: Correlation With Whole-Mount Histopathologic Gleason Score,AJR Am J Roentgenol. 2020 Jul;215(1):133-141. doi: 10.2214/AJR.19.22094. Epub 2020 Mar 11.,Dhatt R,https://www.ncbi.nlm.nih.gov/pubmed/32160050
15292,32605887,Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer,Eur Urol Oncol. 2022 Jun;5(3):362-365. doi: 10.1016/j.euo.2020.06.005. Epub 2020 Jun 27.,Brastianos HC,https://www.ncbi.nlm.nih.gov/pubmed/32605887
15293,32682778,Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy,Brachytherapy. 2020 Sep-Oct;19(5):574-583. doi: 10.1016/j.brachy.2020.06.011. Epub 2020 Jul 15.,Boyce-Fappiano D,https://www.ncbi.nlm.nih.gov/pubmed/32682778
15296,32519025,Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy,Strahlenther Onkol. 2020 Nov;196(11):1018-1033. doi: 10.1007/s00066-020-01637-5. Epub 2020 Jun 9.,Frey B,https://www.ncbi.nlm.nih.gov/pubmed/32519025
15299,32892105,Fusion of high B-value diffusion-weighted and T2-weighted MR images increases sensitivity for identification of extraprostatic disease in prostate cancer,Clin Imaging. 2020 Dec;68:202-209. doi: 10.1016/j.clinimag.2020.08.022. Epub 2020 Aug 28.,Colvin SD,https://www.ncbi.nlm.nih.gov/pubmed/32892105
15300,32455504,Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases,BJU Int. 2021 Jan;127(1):122-130. doi: 10.1111/bju.15121. Epub 2020 Aug 2.,Marra G,https://www.ncbi.nlm.nih.gov/pubmed/32455504
15301,32886074,Pathological findings in very low risk prostate cancer in surgical specimens,Arch Esp Urol. 2020 Sep;73(7):593-599.,Tamayo-Jover MA,https://www.ncbi.nlm.nih.gov/pubmed/32886074
15302,33321450,A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI,EBioMedicine. 2021 Jan;63:103163. doi: 10.1016/j.ebiom.2020.103163. Epub 2020 Dec 13.,Li L,https://www.ncbi.nlm.nih.gov/pubmed/33321450
15303,32656744,Retrospective dose reconstruction of prostate stereotactic body radiotherapy using cone-beam CT and a log file during VMAT delivery with flattening-filter-free mode,Radiol Phys Technol. 2020 Sep;13(3):238-248. doi: 10.1007/s12194-020-00574-3. Epub 2020 Jul 12.,Imae T,https://www.ncbi.nlm.nih.gov/pubmed/32656744
15304,32574932,MRI of prostatic urethral mucinous urothelial carcinoma: Expanding the differential diagnosis for T2 hyperintense prostatic masses,Clin Imaging. 2020 Dec;68:68-70. doi: 10.1016/j.clinimag.2020.06.012. Epub 2020 Jun 16.,Patel N,https://www.ncbi.nlm.nih.gov/pubmed/32574932
15305,33112984,Retrotrigonal muscular layer sling associated with total anatomical reconstruction in robot-assisted radical prostatectomy and early continence,World J Urol. 2021 Jul;39(7):2475-2481. doi: 10.1007/s00345-020-03500-9. Epub 2020 Oct 28.,Zanoni ML,https://www.ncbi.nlm.nih.gov/pubmed/33112984
15307,32430252,"Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study",Urol Oncol. 2020 Nov;38(11):854.e1-854.e9. doi: 10.1016/j.urolonc.2020.04.029. Epub 2020 May 17.,Lec PM,https://www.ncbi.nlm.nih.gov/pubmed/32430252
15308,33026934,Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings,J Urol. 2021 Feb;205(2):444-451. doi: 10.1097/JU.0000000000001389. Epub 2020 Oct 7.,Pooli A,https://www.ncbi.nlm.nih.gov/pubmed/33026934
15309,32900623,Postoperative membranous urethral length is the single most important surgical factor predicting recovery of postoperative urinary continence,Urol Oncol. 2020 Dec;38(12):930.e7-930.e12. doi: 10.1016/j.urolonc.2020.07.024. Epub 2020 Sep 6.,Cho DS,https://www.ncbi.nlm.nih.gov/pubmed/32900623
15310,33191249,Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis,BMJ Open. 2020 Nov 14;10(11):e035436. doi: 10.1136/bmjopen-2019-035436.,Protopapa E,https://www.ncbi.nlm.nih.gov/pubmed/33191249
15311,31953833,Role of Chronic Inflammation as a Predictor of Upstaging/Upgrading in Prostate Cancer: Finding a New Group Eligible for Active Surveillance,Urol J. 2020 Jun 23;17(4):370-373. doi: 10.22037/uj.v0i0.5375.,Nowroozi MR,https://www.ncbi.nlm.nih.gov/pubmed/31953833
15312,33080549,Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI,Eur J Radiol. 2020 Nov;132:109350. doi: 10.1016/j.ejrad.2020.109350. Epub 2020 Oct 15.,Christophe C,https://www.ncbi.nlm.nih.gov/pubmed/33080549
15313,31033371,Sensitivity and specificity of Briganti nomogram in Turkish patients undergoing radical prostatectomy and pelvic lymph node dissection,Aging Male. 2020 Dec;23(5):836-840. doi: 10.1080/13685538.2019.1601176. Epub 2019 Apr 29.,Sahin A,https://www.ncbi.nlm.nih.gov/pubmed/31033371
15314,32203069,A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):630-637. doi: 10.1038/s41391-020-0221-7. Epub 2020 Mar 13.,Longo J,https://www.ncbi.nlm.nih.gov/pubmed/32203069
15315,32513967,Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):689-695. doi: 10.1038/s41391-020-0241-3. Epub 2020 Jun 8.,Sarkar RR,https://www.ncbi.nlm.nih.gov/pubmed/32513967
15316,32181985,Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy,J Magn Reson Imaging. 2020 Oct;52(4):1239-1248. doi: 10.1002/jmri.27138. Epub 2020 Mar 17.,Zhang GM,https://www.ncbi.nlm.nih.gov/pubmed/32181985
15317,32634854,Impact of indocyanine green-guided extended pelvic lymph node dissection during robot-assisted radical prostatectomy,Int J Urol. 2020 Oct;27(10):845-850. doi: 10.1111/iju.14306. Epub 2020 Jul 7.,Shimbo M,https://www.ncbi.nlm.nih.gov/pubmed/32634854
15318,32500450,"Evaluation of a marker-less, intra-operative, augmented reality guidance system for robot-assisted laparoscopic radical prostatectomy",Int J Comput Assist Radiol Surg. 2020 Jul;15(7):1225-1233. doi: 10.1007/s11548-020-02181-4. Epub 2020 Jun 5.,Kalia M,https://www.ncbi.nlm.nih.gov/pubmed/32500450
15319,31786640,Histologic characterization of the post-radiation urethral stenosis in men treated for prostate cancer,World J Urol. 2020 Sep;38(9):2269-2277. doi: 10.1007/s00345-019-03031-y. Epub 2019 Nov 30.,Hughes M,https://www.ncbi.nlm.nih.gov/pubmed/31786640
15320,32040691,Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities,Strahlenther Onkol. 2020 Jul;196(7):598-607. doi: 10.1007/s00066-020-01589-w. Epub 2020 Feb 10.,Vassis S,https://www.ncbi.nlm.nih.gov/pubmed/32040691
15322,33315115,Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers,JAMA Netw Open. 2020 Dec 1;3(12):e2030072. doi: 10.1001/jamanetworkopen.2020.30072.,Cone EB,https://www.ncbi.nlm.nih.gov/pubmed/33315115
15323,32129857,Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN),J Natl Cancer Inst. 2020 Nov 1;112(11):1098-1104. doi: 10.1093/jnci/djaa032.,Jamaspishvili T,https://www.ncbi.nlm.nih.gov/pubmed/32129857
15324,32681540,Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH,Int J Urol. 2020 Oct;27(10):851-857. doi: 10.1111/iju.14307. Epub 2020 Jul 17.,Nik-Ahd F,https://www.ncbi.nlm.nih.gov/pubmed/32681540
15325,32969085,Periprostatic fat thickness quantified by preoperative magnetic resonance imaging is an independent risk factor for upstaging from cT1/2 to pT3 in robot-assisted radical prostatectomy,Int J Urol. 2020 Dec;27(12):1144-1149. doi: 10.1111/iju.14376. Epub 2020 Sep 24.,Iemura Y,https://www.ncbi.nlm.nih.gov/pubmed/32969085
15326,33257218,"Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer",Urol Oncol. 2021 Jun;39(6):366.e19-366.e28. doi: 10.1016/j.urolonc.2020.11.016. Epub 2020 Nov 27.,Morris DS,https://www.ncbi.nlm.nih.gov/pubmed/33257218
15327,32694154,Genomic and Clinicopathologic Characterization of ATM-deficient Prostate Cancer,Clin Cancer Res. 2020 Sep 15;26(18):4869-4881. doi: 10.1158/1078-0432.CCR-20-0764. Epub 2020 Jul 21.,Kaur H,https://www.ncbi.nlm.nih.gov/pubmed/32694154
15328,32003613,Risk of Postoperative Up Staging or Upgrading among Men with Low Risk Familial Prostate Cancer,J Urol. 2020 Jul;204(1):79-81. doi: 10.1097/JU.0000000000000793. Epub 2020 Jan 31.,Jansson F,https://www.ncbi.nlm.nih.gov/pubmed/32003613
15329,32034057,Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy,J Clin Pathol. 2020 Oct;73(10):630-635. doi: 10.1136/jclinpath-2019-206300. Epub 2020 Feb 7.,Ström P,https://www.ncbi.nlm.nih.gov/pubmed/32034057
15330,32740803,How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study,World J Urol. 2021 May;39(5):1445-1452. doi: 10.1007/s00345-020-03350-5. Epub 2020 Aug 1.,Gacci M,https://www.ncbi.nlm.nih.gov/pubmed/32740803
15332,32607629,Machine learning for the identification of clinically significant prostate cancer on MRI: a meta-analysis,Eur Radiol. 2020 Dec;30(12):6877-6887. doi: 10.1007/s00330-020-07027-w. Epub 2020 Jun 30.,Cuocolo R,https://www.ncbi.nlm.nih.gov/pubmed/32607629
15333,32827589,Histologic validation of auto-contoured dominant intraprostatic lesions on [(18)F] DCFPyL PSMA-PET imaging,Radiother Oncol. 2020 Nov;152:34-41. doi: 10.1016/j.radonc.2020.08.008. Epub 2020 Aug 19.,Alfano R,https://www.ncbi.nlm.nih.gov/pubmed/32827589
15334,33241757,Role of sparing of puboprostatic ligaments on continence recovery after radical prostatectomy: a randomized controlled trial,Scand J Urol. 2021 Feb;55(1):22-26. doi: 10.1080/21681805.2020.1849389. Epub 2020 Nov 26.,Assem A,https://www.ncbi.nlm.nih.gov/pubmed/33241757
15335,32409155,Radical Prostatectomy Without Pelvic Lymph Node Dissection Is Widely Practiced in High-Risk Patients Despite Poorer Survival,Clin Genitourin Cancer. 2020 Oct;18(5):395-401.e8. doi: 10.1016/j.clgc.2020.03.008. Epub 2020 Mar 13.,Kodiyan J,https://www.ncbi.nlm.nih.gov/pubmed/32409155
15336,32060212,Intraoperative (68)Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study,J Nucl Med. 2020 Oct;61(10):1500-1506. doi: 10.2967/jnumed.119.240424. Epub 2020 Feb 14.,Darr C,https://www.ncbi.nlm.nih.gov/pubmed/32060212
15337,33035099,The role of body image in treatment decision-making and post-treatment regret following prostatectomy,Br J Nurs. 2020 Oct 8;29(18):S8-S16. doi: 10.12968/bjon.2020.29.18.S8.,Shiridzinomwa C,https://www.ncbi.nlm.nih.gov/pubmed/33035099
15338,32150328,"A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings",BJU Int. 2020 Jul;126(1):104-113. doi: 10.1111/bju.15048. Epub 2020 Apr 1.,Luzzago S,https://www.ncbi.nlm.nih.gov/pubmed/32150328
15339,32362068,Acute kidney injury and its impact on renal prognosis after robot-assisted laparoscopic radical prostatectomy,Int J Med Robot. 2020 Oct;16(5):1-7. doi: 10.1002/rcs.2117. Epub 2020 Jun 14.,Sato H,https://www.ncbi.nlm.nih.gov/pubmed/32362068
15340,33348961,Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance,Arch Ital Urol Androl. 2020 Dec 18;92(4). doi: 10.4081/aiua.2020.4.330.,Ramos N,https://www.ncbi.nlm.nih.gov/pubmed/33348961
15341,31907632,Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer,World J Urol. 2020 Oct;38(10):2513-2521. doi: 10.1007/s00345-019-03066-1. Epub 2020 Jan 6.,Kaufmann S,https://www.ncbi.nlm.nih.gov/pubmed/31907632
15342,33349912,The Role of 68GA-PSMA PET/CT Scan In Patients with Prostate Adenocarcinoma who Underwent Radical Prostatectomy,Urol J. 2020 Dec 9;18(1):58-65. doi: 10.22037/uj.v16i7.6165.,Gultekin MH,https://www.ncbi.nlm.nih.gov/pubmed/33349912
15343,32929343,Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy,Theranostics. 2020 Sep 2;10(22):10200-10212. doi: 10.7150/thno.48706. eCollection 2020.,Shao L,https://www.ncbi.nlm.nih.gov/pubmed/32929343
15344,32986109,Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018,JAMA Netw Open. 2020 Sep 1;3(9):e2018318. doi: 10.1001/jamanetworkopen.2020.18318.,Parikh RB,https://www.ncbi.nlm.nih.gov/pubmed/32986109
15345,32378362,Correlation between lumbar skeletal muscle size and urinary incontinence after radical prostatectomy,Low Urin Tract Symptoms. 2020 Sep;12(3):245-252. doi: 10.1111/luts.12312. Epub 2020 May 6.,Mitsui Y,https://www.ncbi.nlm.nih.gov/pubmed/32378362
15346,33377614,Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image-guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon,J Appl Clin Med Phys. 2021 Jan;22(1):226-241. doi: 10.1002/acm2.13138. Epub 2020 Dec 30.,Levegrün S,https://www.ncbi.nlm.nih.gov/pubmed/33377614
15347,33046413,Prostate-specific Membrane Antigen Positron Emission Tomography-guided Radiotherapy,Eur Urol Focus. 2021 Mar;7(2):250-253. doi: 10.1016/j.euf.2020.09.020. Epub 2020 Oct 10.,Kishan AU,https://www.ncbi.nlm.nih.gov/pubmed/33046413
15348,31411978,Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution,Eur Urol Oncol. 2020 Aug;3(4):474-480. doi: 10.1016/j.euo.2018.10.007. Epub 2018 Nov 24.,Bravi CA,https://www.ncbi.nlm.nih.gov/pubmed/31411978
15350,33091796,Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time,Phys Med. 2020 Dec;80:34-41. doi: 10.1016/j.ejmp.2020.09.026. Epub 2020 Oct 20.,Ruggieri R,https://www.ncbi.nlm.nih.gov/pubmed/33091796
15351,33112662,Lamin B1 promotes tumor progression and metastasis in primary prostate cancer patients,Future Oncol. 2021 Feb;17(6):663-673. doi: 10.2217/fon-2020-0825. Epub 2020 Oct 28.,Luo F,https://www.ncbi.nlm.nih.gov/pubmed/33112662
15354,32866908,Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness,Eur J Radiol. 2020 Oct;131:109230. doi: 10.1016/j.ejrad.2020.109230. Epub 2020 Aug 20.,Barral M,https://www.ncbi.nlm.nih.gov/pubmed/32866908
15355,32065499,Development and randomised controlled trial of a Continence Product Patient Decision Aid for men postradical prostatectomy,J Clin Nurs. 2020 Jul;29(13-14):2251-2259. doi: 10.1111/jocn.15223. Epub 2020 Mar 3.,Murphy C,https://www.ncbi.nlm.nih.gov/pubmed/32065499
15357,33064316,Cine magnetic resonance imaging provides novel predictors of early continence recovery after radical prostatectomy: Assessment of the dynamics of pelvic floor muscles,Neurourol Urodyn. 2021 Jan;40(1):256-264. doi: 10.1002/nau.24544. Epub 2020 Oct 16.,Shimura H,https://www.ncbi.nlm.nih.gov/pubmed/33064316
15358,32746829,Comparison of Retzius-sparing robot-assisted laparoscopic radical prostatectomy vs standard robot-assisted radical prostatectomy: a meta-analysis,BMC Urol. 2020 Aug 3;20(1):114. doi: 10.1186/s12894-020-00685-4.,Jiang YL,https://www.ncbi.nlm.nih.gov/pubmed/32746829
15359,32822249,Patient-based low dose cone beam CT acquisition settings for prostate image-guided radiotherapy treatments on a Varian TrueBeam linear accelerator,Br J Radiol. 2020 Nov 1;93(1115):20200412. doi: 10.1259/bjr.20200412. Epub 2020 Aug 27.,Piliero MA,https://www.ncbi.nlm.nih.gov/pubmed/32822249
15360,33390282,The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy,Eur Urol. 2021 Apr;79(4):446-452. doi: 10.1016/j.eururo.2020.12.031. Epub 2020 Dec 31.,Hamilton RJ,https://www.ncbi.nlm.nih.gov/pubmed/33390282
15361,32298065,Efficacy of modified radical prostatectomy technique for recovery of urinary incontinence in high-grade prostate cancer,Minerva Urol Nefrol. 2020 Oct;72(5):605-614. doi: 10.23736/S0393-2249.20.03633-4. Epub 2020 Apr 16.,Chung JW,https://www.ncbi.nlm.nih.gov/pubmed/32298065
15362,32777664,Digital application developed to evaluate functional results following robot-assisted radical prostatectomy: App for prostate cancer,Comput Methods Programs Biomed. 2020 Dec;197:105683. doi: 10.1016/j.cmpb.2020.105683. Epub 2020 Aug 3.,Faria LF,https://www.ncbi.nlm.nih.gov/pubmed/32777664
15363,33079250,Detection of prostate cancer with (18)F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial,World J Urol. 2021 Jul;39(7):2439-2446. doi: 10.1007/s00345-020-03490-8. Epub 2020 Oct 20.,Bodar YJL,https://www.ncbi.nlm.nih.gov/pubmed/33079250
15364,32220548,Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer,Urol Oncol. 2020 Oct;38(10):793.e19-793.e25. doi: 10.1016/j.urolonc.2020.02.025. Epub 2020 Mar 25.,Sanguedolce F,https://www.ncbi.nlm.nih.gov/pubmed/32220548
15365,32909210,What factors affect the operative time of robot-assisted laparoscopic radical prostatectomy?,Surg Endosc. 2021 Aug;35(8):4436-4443. doi: 10.1007/s00464-020-07946-1. Epub 2020 Sep 9.,Uchida T,https://www.ncbi.nlm.nih.gov/pubmed/32909210
15366,33036065,Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration,Cancer. 2021 Feb 1;127(3):403-411. doi: 10.1002/cncr.33224. Epub 2020 Oct 9.,McKay RR,https://www.ncbi.nlm.nih.gov/pubmed/33036065
15367,32791998,Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy,World J Surg Oncol. 2020 Aug 13;18(1):201. doi: 10.1186/s12957-020-01977-7.,Lian Z,https://www.ncbi.nlm.nih.gov/pubmed/32791998
15368,32758168,Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study,BMC Cancer. 2020 Aug 5;20(1):723. doi: 10.1186/s12885-020-07192-7.,Donswijk ML,https://www.ncbi.nlm.nih.gov/pubmed/32758168
15369,30685354,Poor Adherence to International Cancer Prevention Recommendations Among Patients With Prostate Cancer: First Results From the MARTINI-Lifestyle Cohort,Eur Urol Focus. 2020 Sep 15;6(5):935-940. doi: 10.1016/j.euf.2019.01.006. Epub 2019 Jan 23.,Thederan I,https://www.ncbi.nlm.nih.gov/pubmed/30685354
15370,31710002,Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer,Asian J Androl. 2020 Sep-Oct;22(5):519-525. doi: 10.4103/aja.aja_117_19.,Zhu S,https://www.ncbi.nlm.nih.gov/pubmed/31710002
15371,31893344,Linear extent of positive surgical margin impacts biochemical recurrence after robot-assisted radical prostatectomy in a high-volume center,J Robot Surg. 2020 Aug;14(4):663-675. doi: 10.1007/s11701-019-01039-5. Epub 2020 Jan 1.,Porcaro AB,https://www.ncbi.nlm.nih.gov/pubmed/31893344
15372,33275823,Longitudinal evaluation of the frequency of sexual intercourse and sexual activity in patients after nerve-sparing robot-assisted laparoscopic radical prostatectomy,BJU Int. 2021 May;127(5):560-566. doi: 10.1111/bju.15317. Epub 2020 Dec 27.,Inoue S,https://www.ncbi.nlm.nih.gov/pubmed/33275823
15373,33204007,Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities,Int J Impot Res. 2021 May;33(4):401-409. doi: 10.1038/s41443-020-00374-8. Epub 2020 Nov 17.,Lima TFN,https://www.ncbi.nlm.nih.gov/pubmed/33204007
15374,32506207,Quantitative measurements of prostate capsule and gland density and their correlation to prostate size: possible clinical implications in prostate cancer,Int Urol Nephrol. 2020 Oct;52(10):1829-1837. doi: 10.1007/s11255-020-02527-6. Epub 2020 Jun 6.,Weaver PE,https://www.ncbi.nlm.nih.gov/pubmed/32506207
15375,32736935,Development of a novel nomogram incorporating platelet-to-lymphocyte ratio for the prediction of lymph node involvement in prostate carcinoma,Urol Oncol. 2020 Dec;38(12):930.e1-930.e6. doi: 10.1016/j.urolonc.2020.05.026. Epub 2020 Jul 28.,Merhe A,https://www.ncbi.nlm.nih.gov/pubmed/32736935
15376,32368959,Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy,Radiology. 2020 Jul;296(1):87-95. doi: 10.1148/radiol.2020192133. Epub 2020 May 5.,Park KJ,https://www.ncbi.nlm.nih.gov/pubmed/32368959
15378,33326414,Analysis of Serum Markers with Regard to Treatment Procedures in Advanced Stage Prostate Cancer Patients,Med Sci Monit. 2020 Dec 16;26:e925860. doi: 10.12659/MSM.925860.,Wolny-Rokicka E,https://www.ncbi.nlm.nih.gov/pubmed/33326414
15379,33275486,Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis,J Clin Oncol. 2021 Jan 10;39(2):136-144. doi: 10.1200/JCO.20.02438. Epub 2020 Dec 4.,Spratt DE,https://www.ncbi.nlm.nih.gov/pubmed/33275486
15380,32285460,Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial,Histopathology. 2020 Aug;77(2):284-292. doi: 10.1111/his.14107. Epub 2020 Jun 18.,Delahunt B,https://www.ncbi.nlm.nih.gov/pubmed/32285460
15381,32727771,Radiotherapy of Prostate Carcinoma: A Comparison of the Predictive Role of EAU Versus NCCN Risk Stratification Systems,Anticancer Res. 2020 Aug;40(8):4413-4418. doi: 10.21873/anticanres.14446.,Buwenge M,https://www.ncbi.nlm.nih.gov/pubmed/32727771
15382,32976785,"Oligometastasis: Past, Present, Future",Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):530-538. doi: 10.1016/j.ijrobp.2020.02.019.,Gutiontov SI,https://www.ncbi.nlm.nih.gov/pubmed/32976785
15383,32981004,Statistical control of processes applied to geometric uncertainties for CTV expansion margins determination in prostate cancer patients treated with VMAT: a prospective study in 57 patients,Clin Transl Oncol. 2021 Jun;23(6):1078-1084. doi: 10.1007/s12094-020-02493-6. Epub 2020 Sep 26.,Pardo J,https://www.ncbi.nlm.nih.gov/pubmed/32981004
15384,32951988,The suggested chemopreventive association of metformin with prostate cancer in diabetic patients,Urol Oncol. 2021 Mar;39(3):191.e17-191.e24. doi: 10.1016/j.urolonc.2020.08.032. Epub 2020 Sep 17.,Goldberg H,https://www.ncbi.nlm.nih.gov/pubmed/32951988
15385,32720178,Clinical impact of psoas muscle volume on the development of inguinal hernia after robot-assisted radical prostatectomy,Surg Endosc. 2021 Jul;35(7):3320-3328. doi: 10.1007/s00464-020-07770-7. Epub 2020 Jul 27.,Otaki T,https://www.ncbi.nlm.nih.gov/pubmed/32720178
15386,32881970,Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients,PLoS One. 2020 Sep 3;15(9):e0238814. doi: 10.1371/journal.pone.0238814. eCollection 2020.,Stroomberg HV,https://www.ncbi.nlm.nih.gov/pubmed/32881970
15387,31806773,Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET,J Nucl Med. 2020 Jul;61(7):1037-1042. doi: 10.2967/jnumed.119.235374. Epub 2019 Dec 5.,Farolfi A,https://www.ncbi.nlm.nih.gov/pubmed/31806773
15388,32957584,Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer,Cells. 2020 Sep 17;9(9):2116. doi: 10.3390/cells9092116.,Saoud R,https://www.ncbi.nlm.nih.gov/pubmed/32957584
15389,31446147,Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies,Pract Radiat Oncol. 2020 Sep-Oct;10(5):324-329. doi: 10.1016/j.prro.2019.08.005. Epub 2019 Aug 22.,Verma V,https://www.ncbi.nlm.nih.gov/pubmed/31446147
15390,33247697,"TP53, SPOP and PIK3CA Genes Status in Prostate Cancer",Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3365-3371. doi: 10.31557/APJCP.2020.21.11.3365.,Al Zoubi MS,https://www.ncbi.nlm.nih.gov/pubmed/33247697
15391,33105568,Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological Factors,Int J Mol Sci. 2020 Oct 22;21(21):7812. doi: 10.3390/ijms21217812.,Rochow H,https://www.ncbi.nlm.nih.gov/pubmed/33105568
15392,32970856,Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume,Prostate. 2020 Dec;80(16):1444-1449. doi: 10.1002/pros.24078. Epub 2020 Sep 24.,Omri N,https://www.ncbi.nlm.nih.gov/pubmed/32970856
15393,32266690,"Evaluation of relationships between the final Gleason score, PI-RADS v2 score, ADC value, PSA level, and tumor diameter in patients that underwent radical prostatectomy due to prostate cancer",Radiol Med. 2020 Sep;125(9):827-837. doi: 10.1007/s11547-020-01183-1. Epub 2020 Apr 7.,Gündo?du E,https://www.ncbi.nlm.nih.gov/pubmed/32266690
15394,32274889,"Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden",BJU Int. 2020 Jul;126(1):142-151. doi: 10.1111/bju.15077. Epub 2020 May 8.,Orrason AW,https://www.ncbi.nlm.nih.gov/pubmed/32274889
15395,32169590,A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer,Pract Radiat Oncol. 2020 Sep-Oct;10(5):345-353. doi: 10.1016/j.prro.2020.02.013. Epub 2020 Mar 10.,Ritter MA,https://www.ncbi.nlm.nih.gov/pubmed/32169590
15398,33008404,Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis,Radiat Oncol. 2020 Oct 2;15(1):231. doi: 10.1186/s13014-020-01679-0.,Yao L,https://www.ncbi.nlm.nih.gov/pubmed/33008404
15399,32374087,Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort,Cancer Med. 2020 Jul;9(13):4613-4621. doi: 10.1002/cam4.3101. Epub 2020 May 6.,Lim J,https://www.ncbi.nlm.nih.gov/pubmed/32374087
15400,32701803,Incidental Finding on 11C-Choline-PET/CT of Hepatocellular Carcinoma Recurrence in a Prostate Cancer Patient With Negative Abdominal CT Scan,Clin Nucl Med. 2020 Sep;45(9):703-704. doi: 10.1097/RLU.0000000000003203.,Guglielmo P,https://www.ncbi.nlm.nih.gov/pubmed/32701803
15402,32525914,Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era,PLoS One. 2020 Jun 11;15(6):e0234391. doi: 10.1371/journal.pone.0234391. eCollection 2020.,Chen MM,https://www.ncbi.nlm.nih.gov/pubmed/32525914
15403,32817141,Diagnostic Accuracy of (18)F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence,J Nucl Med. 2021 Feb;62(2):208-213. doi: 10.2967/jnumed.120.246363. Epub 2020 Aug 17.,Sprute K,https://www.ncbi.nlm.nih.gov/pubmed/32817141
15404,32762539,Review of Radium-223 and Metastatic Castration-Sensitive Prostate Cancer,Cancer Biother Radiopharm. 2020 Sep;35(7):490-496. doi: 10.1089/cbr.2019.3493. Epub 2020 Aug 6.,Dandapani SV,https://www.ncbi.nlm.nih.gov/pubmed/32762539
15406,32448741,Benefits of positron emission tomography scans for the evaluation of radiotherapy,Cancer Radiother. 2020 Aug;24(5):388-397. doi: 10.1016/j.canrad.2020.02.007. Epub 2020 May 21.,Decazes P,https://www.ncbi.nlm.nih.gov/pubmed/32448741
15408,33064325,Spine metastasis in patients with prostate cancer: Survival prognosis assessment,Prostate. 2021 Feb;81(2):91-101. doi: 10.1002/pros.24084. Epub 2020 Oct 16.,Amelot A,https://www.ncbi.nlm.nih.gov/pubmed/33064325
15411,33158904,Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging,J Nucl Med. 2021 Jul 1;62(7):961-967. doi: 10.2967/jnumed.120.252528. Epub 2020 Nov 6.,Meijer D,https://www.ncbi.nlm.nih.gov/pubmed/33158904
15412,32798231,The Discrepancy between Needle Biopsy and Radical Prostatectomy Gleason Score in Patients with Prostate Cancer,Urol J. 2020 Aug 4;18(4):395-399. doi: 10.22037/uj.v16i7.5985.,Abedi AR,https://www.ncbi.nlm.nih.gov/pubmed/32798231
15413,31469340,Characteristics of urodynamic study parameters associated with intermediate-term continence after robot-assisted radical prostatectomy in elderly patients,Aging Male. 2020 Dec;23(5):1039-1045. doi: 10.1080/13685538.2019.1659767. Epub 2019 Aug 30.,Iguchi K,https://www.ncbi.nlm.nih.gov/pubmed/31469340
15415,32830012,Retrospective audit of inter-fraction motion for pelvic node radiotherapy in prostate cancer patients,Radiography (Lond). 2021 May;27(2):266-271. doi: 10.1016/j.radi.2020.08.002. Epub 2020 Aug 20.,Lawes R,https://www.ncbi.nlm.nih.gov/pubmed/32830012
15417,32978525,KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):362-369. doi: 10.1038/s41391-020-00283-3. Epub 2020 Sep 25.,Lunger L,https://www.ncbi.nlm.nih.gov/pubmed/32978525
15420,32467601,A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy,Br J Cancer. 2020 Aug;123(4):604-609. doi: 10.1038/s41416-020-0914-7. Epub 2020 May 29.,Haese A,https://www.ncbi.nlm.nih.gov/pubmed/32467601
15421,32677026,Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions,Pathol Oncol Res. 2020 Oct;26(4):2709-2722. doi: 10.1007/s12253-020-00861-9. Epub 2020 Jul 16.,Bernreuther C,https://www.ncbi.nlm.nih.gov/pubmed/32677026
15422,32402544,Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy,Brachytherapy. 2020 Jul-Aug;19(4):484-490. doi: 10.1016/j.brachy.2020.04.001. Epub 2020 May 10.,Bathala TK,https://www.ncbi.nlm.nih.gov/pubmed/32402544
15425,33263177,Treatment of post-prostatectomy urinary incontinence and erectile dysfunction: there is insufficient utilisation of care in German cancer survivors,World J Urol. 2021 Aug;39(8):2929-2936. doi: 10.1007/s00345-020-03526-z. Epub 2020 Dec 1.,Baunacke M,https://www.ncbi.nlm.nih.gov/pubmed/33263177
15427,32349927,Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial,Clin Genitourin Cancer. 2020 Dec;18(6):444-451. doi: 10.1016/j.clgc.2020.03.017. Epub 2020 Apr 7.,Dumont C,https://www.ncbi.nlm.nih.gov/pubmed/32349927
15428,32828839,Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial,Radiother Oncol. 2020 Oct;151:234-241. doi: 10.1016/j.radonc.2020.08.010. Epub 2020 Aug 20.,Hewson EA,https://www.ncbi.nlm.nih.gov/pubmed/32828839
15429,32703714,A Narrative Overview of Active Surveillance for Clinically Localised Prostate Cancer,Semin Oncol Nurs. 2020 Aug;36(4):151045. doi: 10.1016/j.soncn.2020.151045. Epub 2020 Jul 20.,Bates AS,https://www.ncbi.nlm.nih.gov/pubmed/32703714
15430,32962962,Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate,Eur Urol Focus. 2021 Nov;7(6):1247-1253. doi: 10.1016/j.euf.2020.09.003. Epub 2020 Sep 19.,Kretschmer A,https://www.ncbi.nlm.nih.gov/pubmed/32962962
15432,32797086,Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation,PLoS Med. 2020 Aug 14;17(8):e1003281. doi: 10.1371/journal.pmed.1003281. eCollection 2020 Aug.,Grosset AA,https://www.ncbi.nlm.nih.gov/pubmed/32797086
15433,32999046,Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor,Mol Cancer Ther. 2020 Dec;19(12):2598-2611. doi: 10.1158/1535-7163.MCT-20-0410. Epub 2020 Sep 30.,Ganaie AA,https://www.ncbi.nlm.nih.gov/pubmed/32999046
15434,32808077,False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial,Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):501-508. doi: 10.1007/s00259-020-04945-1. Epub 2020 Aug 17.,Fendler WP,https://www.ncbi.nlm.nih.gov/pubmed/32808077
15435,33119944,A knowledge-based quantitative approach to characterize treatment plan quality: Application to prostate VMAT planning,Med Phys. 2021 Jan;48(1):94-104. doi: 10.1002/mp.14564. Epub 2020 Nov 21.,Alnaalwa B,https://www.ncbi.nlm.nih.gov/pubmed/33119944
15436,32469248,Pharmacotherapeutic strategies for castrate-resistant prostate cancer,Expert Opin Pharmacother. 2020 Aug;21(12):1431-1448. doi: 10.1080/14656566.2020.1767069. Epub 2020 May 29.,Moussa M,https://www.ncbi.nlm.nih.gov/pubmed/32469248
15439,32517958,DNA Damage Repair Deficiency in Prostate Cancer,Trends Cancer. 2020 Nov;6(11):974-984. doi: 10.1016/j.trecan.2020.05.011. Epub 2020 Jun 6.,Burdak-Rothkamm S,https://www.ncbi.nlm.nih.gov/pubmed/32517958
15440,32447004,The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study,Int J Surg. 2020 Jul;79:217-221. doi: 10.1016/j.ijsu.2020.05.025. Epub 2020 May 21.,He G,https://www.ncbi.nlm.nih.gov/pubmed/32447004
15441,32430253,Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer,Urol Oncol. 2020 Oct;38(10):795.e1-795.e8. doi: 10.1016/j.urolonc.2020.04.032. Epub 2020 May 17.,Sekino Y,https://www.ncbi.nlm.nih.gov/pubmed/32430253
15442,32672827,"Evaluation of Use of Shorter Radiation Regimens for Breast and Prostate Cancer in the US, 2015-2017",JAMA Netw Open. 2020 Jul 1;3(7):e2010519. doi: 10.1001/jamanetworkopen.2020.10519.,Gillespie EF,https://www.ncbi.nlm.nih.gov/pubmed/32672827
15443,32736286,A review of dose calculation approaches with cone beam CT in photon and proton therapy,Phys Med. 2020 Aug;76:243-276. doi: 10.1016/j.ejmp.2020.06.017. Epub 2020 Jul 28.,Giacometti V,https://www.ncbi.nlm.nih.gov/pubmed/32736286
15444,32740806,Athermal versus ultrasonic nerve-sparing laparoscopic radical prostatectomy: a comparison of functional and oncological outcomes,World J Urol. 2021 May;39(5):1453-1462. doi: 10.1007/s00345-020-03351-4. Epub 2020 Aug 1.,Pagliarulo V,https://www.ncbi.nlm.nih.gov/pubmed/32740806
15445,32320063,Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance,Cancer. 2020 Jul 1;126(13):2986-2990. doi: 10.1002/cncr.32821. Epub 2020 Apr 22.,Shoag JE,https://www.ncbi.nlm.nih.gov/pubmed/32320063
15446,32826958,"Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4-5 index lesions undergoing radical prostatectomy",Prostate Cancer Prostatic Dis. 2021 Mar;24(1):202-209. doi: 10.1038/s41391-020-00270-8. Epub 2020 Aug 21.,Koseoglu E,https://www.ncbi.nlm.nih.gov/pubmed/32826958
15447,32536428,Retzius-sparing robot-assisted radical prostatectomy: Perioperative and immediate continence outcomes of an initial series,Actas Urol Esp (Engl Ed). 2020 Oct;44(8):542-548. doi: 10.1016/j.acuro.2020.02.002. Epub 2020 Jun 11.,Algarra R,https://www.ncbi.nlm.nih.gov/pubmed/32536428
15448,33301049,Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer,Strahlenther Onkol. 2021 Feb;197(2):89-96. doi: 10.1007/s00066-020-01723-8. Epub 2020 Dec 10.,Wolf F,https://www.ncbi.nlm.nih.gov/pubmed/33301049
15449,33374332,MYC DNA Methylation in Prostate Tumor Tissue Is Associated with Gleason Score,Genes (Basel). 2020 Dec 24;12(1):12. doi: 10.3390/genes12010012.,Barry KH,https://www.ncbi.nlm.nih.gov/pubmed/33374332
15450,32956915,Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: Proposal for further pT3 prostate cancer subclassification,Ann Diagn Pathol. 2020 Dec;49:151611. doi: 10.1016/j.anndiagpath.2020.151611. Epub 2020 Aug 24.,Rehman A,https://www.ncbi.nlm.nih.gov/pubmed/32956915
15451,32776244,A-blockers for the management of lower urinary tract symptoms in patients with prostate cancer treated with external beam radiotherapy: a randomized controlled study,World J Urol. 2021 Jun;39(6):1805-1813. doi: 10.1007/s00345-020-03398-3. Epub 2020 Aug 10.,Tsirkas K,https://www.ncbi.nlm.nih.gov/pubmed/32776244
15452,33207140,Can (68)Ga-PSMA-11 Positron Emission Tomography/Computerized Tomography Predict Pathological Response of Primary Prostate Cancer to Neoadjuvant Androgen Deprivation Therapy? A Pilot Study,J Urol. 2021 Apr;205(4):1082-1089. doi: 10.1097/JU.0000000000001481. Epub 2020 Nov 18.,Chen M,https://www.ncbi.nlm.nih.gov/pubmed/33207140
15454,32488311,Dosimetric evaluation of phantoms including metal objects with high atomic number for use in intensity modulated radiation therapy,Radiat Environ Biophys. 2020 Aug;59(3):503-510. doi: 10.1007/s00411-020-00851-0. Epub 2020 Jun 1.,Inal A,https://www.ncbi.nlm.nih.gov/pubmed/32488311
15456,33386122,Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy,Pathology. 2021 Feb;53(2):199-204. doi: 10.1016/j.pathol.2020.10.009. Epub 2020 Dec 29.,Franklin A,https://www.ncbi.nlm.nih.gov/pubmed/33386122
15457,32997692,Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer,PLoS One. 2020 Sep 30;15(9):e0239686. doi: 10.1371/journal.pone.0239686. eCollection 2020.,Carlson AS,https://www.ncbi.nlm.nih.gov/pubmed/32997692
15458,33243663,A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?,Eur Urol Oncol. 2021 Oct;4(5):745-754. doi: 10.1016/j.euo.2020.10.010. Epub 2020 Nov 23.,Heidegger I,https://www.ncbi.nlm.nih.gov/pubmed/33243663
15459,32201958,Multi-atlas-based auto-segmentation for prostatic urethra using novel prediction of deformable image registration accuracy,Med Phys. 2020 Jul;47(7):3023-3031. doi: 10.1002/mp.14154. Epub 2020 Apr 27.,Takagi H,https://www.ncbi.nlm.nih.gov/pubmed/32201958
15461,32958451,Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study,Eur Urol Oncol. 2022 Oct;5(5):544-552. doi: 10.1016/j.euo.2020.08.012. Epub 2020 Sep 18.,Lenis AT,https://www.ncbi.nlm.nih.gov/pubmed/32958451
15462,33020024,Dosimetric evaluation of image-guided radiation therapy for prostate cancer,Med Dosim. 2021 Summer;46(2):117-126. doi: 10.1016/j.meddos.2020.09.007. Epub 2020 Oct 2.,Shan G,https://www.ncbi.nlm.nih.gov/pubmed/33020024
15464,31797075,Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer,World J Urol. 2020 Oct;38(10):2501-2511. doi: 10.1007/s00345-019-03038-5. Epub 2019 Dec 4.,Kimura S,https://www.ncbi.nlm.nih.gov/pubmed/31797075
15465,32871826,Prediction of Results of Radiotherapy With Ku70 Expression and an Artificial Neural Network,In Vivo. 2020 Sep-Oct;34(5):2865-2872. doi: 10.21873/invivo.12114.,Hasegawa T,https://www.ncbi.nlm.nih.gov/pubmed/32871826
15466,32632128,Exercise modulation of tumour perfusion and hypoxia to improve radiotherapy response in prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):1-14. doi: 10.1038/s41391-020-0245-z. Epub 2020 Jul 6.,Schumacher O,https://www.ncbi.nlm.nih.gov/pubmed/32632128
15468,32277993,A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men,Urology. 2020 Aug;142:166-173. doi: 10.1016/j.urology.2020.01.052. Epub 2020 Apr 8.,Murphy AB,https://www.ncbi.nlm.nih.gov/pubmed/32277993
15470,32552276,"Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation",J Clin Oncol. 2020 Sep 10;38(26):3032-3041. doi: 10.1200/JCO.19.03114. Epub 2020 Jun 18.,Xie W,https://www.ncbi.nlm.nih.gov/pubmed/32552276
15471,33098927,Dose prediction with deep learning for prostate cancer radiation therapy: Model adaptation to different treatment planning practices,Radiother Oncol. 2020 Dec;153:228-235. doi: 10.1016/j.radonc.2020.10.027. Epub 2020 Oct 22.,Kandalan RN,https://www.ncbi.nlm.nih.gov/pubmed/33098927
15472,33057024,A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists,Sci Rep. 2020 Oct 14;10(1):17177. doi: 10.1038/s41598-020-73524-z.,Carmona Echeverria LM,https://www.ncbi.nlm.nih.gov/pubmed/33057024
15473,32821953,The role of radiomics in prostate cancer radiotherapy,Strahlenther Onkol. 2020 Oct;196(10):900-912. doi: 10.1007/s00066-020-01679-9. Epub 2020 Aug 21.,Delgadillo R,https://www.ncbi.nlm.nih.gov/pubmed/32821953
15474,32920666,"Prospective evaluation of (68)Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA level",Med Oncol. 2020 Sep 12;37(10):89. doi: 10.1007/s12032-020-01412-7.,Dong L,https://www.ncbi.nlm.nih.gov/pubmed/32920666
15476,32739320,Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials,Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1304-1318. doi: 10.1016/j.ijrobp.2020.07.030. Epub 2020 Jul 30.,Marcello M,https://www.ncbi.nlm.nih.gov/pubmed/32739320
15477,32869940,Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion,BJU Int. 2021 Mar;127(3):318-325. doi: 10.1111/bju.15220. Epub 2020 Sep 19.,Oderda M,https://www.ncbi.nlm.nih.gov/pubmed/32869940
15478,32266979,Secondary bladder and rectal cancer risk estimates following standard fractionated and moderately hypofractionated VMAT for prostate carcinoma,Med Phys. 2020 Jul;47(7):2805-2813. doi: 10.1002/mp.14169. Epub 2020 Apr 30.,Mazonakis M,https://www.ncbi.nlm.nih.gov/pubmed/32266979
15479,33220396,Exercise Therapy and Radiation Therapy for Cancer: A Systematic Review,Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):973-983. doi: 10.1016/j.ijrobp.2020.11.024. Epub 2020 Nov 19.,Zaorsky NG,https://www.ncbi.nlm.nih.gov/pubmed/33220396
15481,32748613,"Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study",Minerva Urol Nephrol. 2021 Aug;73(4):489-497. doi: 10.23736/S2724-6051.20.03723-6. Epub 2020 Aug 4.,Gacci M,https://www.ncbi.nlm.nih.gov/pubmed/32748613
15482,32536573,Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study,Eur Urol Oncol. 2021 Aug;4(4):628-634. doi: 10.1016/j.euo.2020.05.007. Epub 2020 Jun 12.,Tetar SU,https://www.ncbi.nlm.nih.gov/pubmed/32536573
15483,31932995,Duration-dependent margins for prostate radiotherapy-a practical motion mitigation strategy,Strahlenther Onkol. 2020 Jul;196(7):657-663. doi: 10.1007/s00066-019-01558-y. Epub 2020 Jan 13.,Pang EPP,https://www.ncbi.nlm.nih.gov/pubmed/31932995
15484,32413530,Cranberry capsules are not superior to placebo capsules in managing acute non-haemorrhagic radiation cystitis in prostate cancer patients: A phase III double blinded randomised placebo controlled clinical trial,Radiother Oncol. 2020 Aug;149:117-123. doi: 10.1016/j.radonc.2020.05.006. Epub 2020 May 13.,Herst PM,https://www.ncbi.nlm.nih.gov/pubmed/32413530
15486,32686433,A huge rectal ulcer due to argon plasma coagulation in a patient with radiation proctitis,Rev Esp Enferm Dig. 2020 Aug;112(8):661-662. doi: 10.17235/reed.2020.6798/2019.,Viso Vidal D,https://www.ncbi.nlm.nih.gov/pubmed/32686433
15487,32461072,Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer,Eur Urol. 2020 Sep;78(3):327-332. doi: 10.1016/j.eururo.2020.05.009. Epub 2020 May 24.,Kishan AU,https://www.ncbi.nlm.nih.gov/pubmed/32461072
15489,33115461,Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report,BMC Urol. 2020 Oct 28;20(1):171. doi: 10.1186/s12894-020-00738-8.,Williams SG,https://www.ncbi.nlm.nih.gov/pubmed/33115461
15490,32071439,Copy number alterations are associated with metastatic-lethal progression in prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):494-506. doi: 10.1038/s41391-020-0212-8. Epub 2020 Feb 18.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/32071439
15492,32808018,Comparison of prostate verification with implanted gold markers in tissue surrounding the prostate and pelvic bony anatomy for external beam radiation therapy following low-dose-rate brachytherapy: a prospective clinical trial,J Radiat Res. 2020 Sep 8;61(5):784-790. doi: 10.1093/jrr/rraa063.,Kaneda T,https://www.ncbi.nlm.nih.gov/pubmed/32808018
15493,32361572,Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer,Radiother Oncol. 2020 Jul;148:126-132. doi: 10.1016/j.radonc.2020.04.020. Epub 2020 Apr 21.,Fiandra C,https://www.ncbi.nlm.nih.gov/pubmed/32361572
15494,32718204,The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance,J Urol. 2021 Jan;205(1):122-128. doi: 10.1097/JU.0000000000001321. Epub 2020 Jul 27.,Gregg JR,https://www.ncbi.nlm.nih.gov/pubmed/32718204
15497,32763409,"Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples",J Mol Diagn. 2020 Oct;22(10):1246-1263. doi: 10.1016/j.jmoldx.2020.07.003. Epub 2020 Aug 4.,Ebrahimizadeh W,https://www.ncbi.nlm.nih.gov/pubmed/32763409
15498,32671989,Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation,J Appl Clin Med Phys. 2020 Sep;21(9):82-89. doi: 10.1002/acm2.12972. Epub 2020 Jul 16.,Haciislamoglu E,https://www.ncbi.nlm.nih.gov/pubmed/32671989
15499,32902647,Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial,JAMA Netw Open. 2020 Sep 1;3(9):e2015083. doi: 10.1001/jamanetworkopen.2020.15083.,Zumsteg ZS,https://www.ncbi.nlm.nih.gov/pubmed/32902647
15500,32140802,Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617,Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2322-2327. doi: 10.1007/s00259-020-04723-z. Epub 2020 Mar 5.,Ferdinandus J,https://www.ncbi.nlm.nih.gov/pubmed/32140802
15501,32527944,A Prospective Trial of (68)Ga-PSMA and (18)F-FDG PET/CT in Nonmetastatic Prostate Cancer Patients with an Early PSA Progression During Castration,Clin Cancer Res. 2020 Sep 1;26(17):4551-4558. doi: 10.1158/1078-0432.CCR-20-0587. Epub 2020 Jun 11.,Wang B,https://www.ncbi.nlm.nih.gov/pubmed/32527944
15502,32819814,Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients,Urol Oncol. 2021 Jan;39(1):77.e1-77.e8. doi: 10.1016/j.urolonc.2020.06.030. Epub 2020 Aug 17.,Smith AB,https://www.ncbi.nlm.nih.gov/pubmed/32819814
15507,33308973,Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer,Urol Oncol. 2021 Jul;39(7):432.e1-432.e10. doi: 10.1016/j.urolonc.2020.11.024. Epub 2020 Dec 9.,Liu Y,https://www.ncbi.nlm.nih.gov/pubmed/33308973
15508,32173650,T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer,Clin Cancer Res. 2020 Jul 1;26(13):3182-3192. doi: 10.1158/1078-0432.CCR-19-3372. Epub 2020 Mar 15.,Obradovic AZ,https://www.ncbi.nlm.nih.gov/pubmed/32173650
15509,32020512,"Robot-assisted orthotopic ""W"" ileal neobladder in male patients: step-by-step video-illustrated technique and preliminary outcomes",J Robot Surg. 2020 Oct;14(5):739-744. doi: 10.1007/s11701-020-01048-9. Epub 2020 Feb 4.,Nouhaud FX,https://www.ncbi.nlm.nih.gov/pubmed/32020512
15511,32619596,Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database,Urology. 2020 Oct;144:117-122. doi: 10.1016/j.urology.2020.06.025. Epub 2020 Jun 30.,Bahler CD,https://www.ncbi.nlm.nih.gov/pubmed/32619596
15512,33388282,Changes in functional status associated with radiation for prostate cancer in older veterans,J Geriatr Oncol. 2021 Jun;12(5):808-812. doi: 10.1016/j.jgo.2020.12.011. Epub 2020 Dec 30.,Ursem C,https://www.ncbi.nlm.nih.gov/pubmed/33388282
15513,32620540,Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non-organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy,Eur Urol Focus. 2021 Nov;7(6):1316-1323. doi: 10.1016/j.euf.2020.06.016. Epub 2020 Jun 30.,Eineluoto JT,https://www.ncbi.nlm.nih.gov/pubmed/32620540
15514,32333714,Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of life,BJU Int. 2020 Sep;126(3):367-372. doi: 10.1111/bju.15097. Epub 2020 Jun 29.,Seymour ZA,https://www.ncbi.nlm.nih.gov/pubmed/32333714
15515,33270906,Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis,Cochrane Database Syst Rev. 2020 Dec 3;12(12):CD013020. doi: 10.1002/14651858.CD013020.pub2.,Jakob T,https://www.ncbi.nlm.nih.gov/pubmed/33270906
15516,32639601,A combination of enhanced recovery after surgery and prehabilitation pathways improves perioperative outcomes and costs for robotic radical prostatectomy,Cancer. 2020 Sep 15;126(18):4148-4155. doi: 10.1002/cncr.33061. Epub 2020 Jul 8.,Ploussard G,https://www.ncbi.nlm.nih.gov/pubmed/32639601
15517,33106940,Immunotherapy in prostate cancer: new horizon of hurdles and hopes,World J Urol. 2021 May;39(5):1387-1403. doi: 10.1007/s00345-020-03497-1. Epub 2020 Oct 26.,Tsaur I,https://www.ncbi.nlm.nih.gov/pubmed/33106940
15518,32301863,Diagnostic Performance of 68Ga-PSMA-11 Positron-emission-tomography/Computed-tomography in a Large Cohort of Patients with Biochemical Recurrence of Prostate Carcinoma,Health Phys. 2020 Jul;119(1):141-147. doi: 10.1097/HP.0000000000001253.,Hoffmann MA,https://www.ncbi.nlm.nih.gov/pubmed/32301863
15519,32125635,Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients,Radiol Med. 2020 Aug;125(8):777-783. doi: 10.1007/s11547-020-01158-2. Epub 2020 Mar 3.,Onal C,https://www.ncbi.nlm.nih.gov/pubmed/32125635
15520,32404868,Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):680-688. doi: 10.1038/s41391-020-0236-0. Epub 2020 May 13.,Shore N,https://www.ncbi.nlm.nih.gov/pubmed/32404868
15521,33158305,Targeting DNA Damage Response in Prostate and Breast Cancer,Int J Mol Sci. 2020 Nov 4;21(21):8273. doi: 10.3390/ijms21218273.,Wengner AM,https://www.ncbi.nlm.nih.gov/pubmed/33158305
15523,33001184,Utility of a Fifth-Generation Ultrasensitive Prostate-Specific Antigen Assay for Monitoring Prostate Cancer Patients after Radical Prostatectomy with 3 Years of Follow-Up,Clin Chem. 2020 Oct 1;66(10):1329-1338. doi: 10.1093/clinchem/hvaa176.,Ren AH,https://www.ncbi.nlm.nih.gov/pubmed/33001184
15524,32358086,(177)Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer,J Nucl Med. 2020 Dec;61(12):1772-1778. doi: 10.2967/jnumed.120.242263. Epub 2020 May 1.,Zang J,https://www.ncbi.nlm.nih.gov/pubmed/32358086
15525,32245678,Validation of the updated eighth edition of AJCC for prostate cancer: Removal of pT2 substages - Does extent of tumor involvement matter?,Urol Oncol. 2020 Jul;38(7):637.e1-637.e7. doi: 10.1016/j.urolonc.2020.01.005. Epub 2020 Mar 31.,Pompe RS,https://www.ncbi.nlm.nih.gov/pubmed/32245678
15526,32639983,Patient preferences for reducing bowel adverse events following prostate radiotherapy,PLoS One. 2020 Jul 8;15(7):e0235616. doi: 10.1371/journal.pone.0235616. eCollection 2020.,Mishra MV,https://www.ncbi.nlm.nih.gov/pubmed/32639983
15527,32592330,Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging (68) Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant?,BJU Int. 2020 Sep;126(3):396-401. doi: 10.1111/bju.15152. Epub 2020 Jul 28.,Chen MY,https://www.ncbi.nlm.nih.gov/pubmed/32592330
15530,32585335,Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine Tumors,Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):936-940. doi: 10.1016/j.ijrobp.2020.06.024. Epub 2020 Jun 22.,Tabrizi S,https://www.ncbi.nlm.nih.gov/pubmed/32585335
15533,33126124,Assessing the out-of-field dose calculation accuracy by eclipse treatment planning system in sliding window IMRT of prostate cancer patients,Comput Biol Med. 2020 Dec;127:104052. doi: 10.1016/j.compbiomed.2020.104052. Epub 2020 Oct 21.,Faghihi Moghaddam F,https://www.ncbi.nlm.nih.gov/pubmed/33126124
15534,32701808,Radioligand Therapy With 177Lu-Prostate-Specific Membrane Antigen in a Patient With Non-Prostate-Specific Antigen-Secreting Metastatic Prostate Cancer,Clin Nucl Med. 2020 Oct;45(10):789-791. doi: 10.1097/RLU.0000000000003208.,Pirayesh E,https://www.ncbi.nlm.nih.gov/pubmed/32701808
15537,32191583,Short-Term Outcomes of Active Surveillance for Low Risk Prostate Cancer among Men with Germline DNA Repair Gene Mutations,J Urol. 2020 Oct;204(4):707-713. doi: 10.1097/JU.0000000000001027. Epub 2020 Mar 19.,Halstuch D,https://www.ncbi.nlm.nih.gov/pubmed/32191583
15538,32366119,Evaluating Changes in Immune Function and Bone Microenvironment During Radium-223 Treatment of Patients with Castration-Resistant Prostate Cancer,Cancer Biother Radiopharm. 2020 Sep;35(7):485-489. doi: 10.1089/cbr.2019.3397. Epub 2020 May 5.,Dorff TB,https://www.ncbi.nlm.nih.gov/pubmed/32366119
15539,32723519,PSMA PET Scan Era: A Changing Paradigm PSMA PET and Lymph Node Dissection for Prostate Cancer Management,Semin Oncol Nurs. 2020 Aug;36(4):151044. doi: 10.1016/j.soncn.2020.151044. Epub 2020 Jul 25.,Haxhimolla J,https://www.ncbi.nlm.nih.gov/pubmed/32723519
15540,32862068,Margin verification for hypofractionated prostate radiotherapy using a novel dose accumulation workflow and iterative CBCT,Phys Med. 2020 Sep;77:154-159. doi: 10.1016/j.ejmp.2020.08.008. Epub 2020 Aug 28.,Studenski MT,https://www.ncbi.nlm.nih.gov/pubmed/32862068
15541,33124079,Adapting to the motion of multiple independent targets using multileaf collimator tracking for locally advanced prostate cancer: Proof of principle simulation study,Med Phys. 2021 Jan;48(1):114-124. doi: 10.1002/mp.14572. Epub 2020 Nov 23.,Hewson EA,https://www.ncbi.nlm.nih.gov/pubmed/33124079
15542,33095692,Hypofractionated Prostate Radiation Therapy: Adoption and Dosimetric Adherence Through Clinical Pathways in an Integrated Oncology Network,JCO Oncol Pract. 2021 Apr;17(4):e537-e547. doi: 10.1200/OP.20.00508. Epub 2020 Oct 23.,Schad MD,https://www.ncbi.nlm.nih.gov/pubmed/33095692
15543,32523075,Prediction of prostate cancer aggressiveness using (18)F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI,Sci Rep. 2020 Jun 10;10(1):9407. doi: 10.1038/s41598-020-66255-8.,Movahedi P,https://www.ncbi.nlm.nih.gov/pubmed/32523075
15544,32624422,Long-term outcomes of incidental prostate cancer at radical cystectomy,Urol Oncol. 2020 Nov;38(11):848.e17-848.e22. doi: 10.1016/j.urolonc.2020.05.018. Epub 2020 Jul 2.,Packiam VT,https://www.ncbi.nlm.nih.gov/pubmed/32624422
15546,32719916,"(18)F-DCFPyL PET/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary results of treatment efficacy",Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):521-531. doi: 10.1007/s00259-020-04782-2. Epub 2020 Jul 27.,Wondergem M,https://www.ncbi.nlm.nih.gov/pubmed/32719916
15547,33264640,"Dosimetric impact of intrafraction prostate rotation and accuracy of gating, multi-leaf collimator tracking and couch tracking to manage rotation: An end-to-end validation using volumetric film measurements",Radiother Oncol. 2021 Mar;156:10-18. doi: 10.1016/j.radonc.2020.11.031. Epub 2020 Nov 29.,De Roover R,https://www.ncbi.nlm.nih.gov/pubmed/33264640
15549,32333981,Quantifying the Relationship Between Increasing Life Expectancy and Nonprostate Cancer Mortality After Radical Prostatectomy,Urology. 2020 Aug;142:174-178. doi: 10.1016/j.urology.2020.04.053. Epub 2020 Apr 22.,Froehner M,https://www.ncbi.nlm.nih.gov/pubmed/32333981
15550,33039673,Clinical Implementation of Knowledge-Based Automatic Plan Optimization for Helical Tomotherapy,Pract Radiat Oncol. 2021 Mar-Apr;11(2):e236-e244. doi: 10.1016/j.prro.2020.09.012. Epub 2020 Oct 9.,Castriconi R,https://www.ncbi.nlm.nih.gov/pubmed/33039673
15552,33380254,Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysis,Scand J Urol. 2021 Feb;55(1):27-32. doi: 10.1080/21681805.2020.1849390. Epub 2020 Dec 30.,Apfelbeck M,https://www.ncbi.nlm.nih.gov/pubmed/33380254
15554,32410487,Overweight and obesity in men with prostate cancer do not constitute risk factors for biochemical recurrence,Aging Male. 2020 Dec;23(5):1283-1288. doi: 10.1080/13685538.2020.1764523. Epub 2020 May 15.,Leal-García M,https://www.ncbi.nlm.nih.gov/pubmed/32410487
15555,32814720,Expression of Ganglioside Disialosyl Globopentaosyl Ceramide in Prostate Biopsy Specimens as a Predictive Marker for Recurrence after Radical Prostatectomy,Tohoku J Exp Med. 2020 Sep;252(1):1-8. doi: 10.1620/tjem.252.1.,Sato M,https://www.ncbi.nlm.nih.gov/pubmed/32814720
15556,32278839,Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Oct;18(5):e523-e530. doi: 10.1016/j.clgc.2020.03.009. Epub 2020 Mar 13.,Fujita N,https://www.ncbi.nlm.nih.gov/pubmed/32278839
15557,32750548,Mixed-beam approach for high-risk prostate cancer: Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300),Phys Med. 2020 Aug;76:327-336. doi: 10.1016/j.ejmp.2020.07.012. Epub 2020 Aug 2.,Gugliandolo SG,https://www.ncbi.nlm.nih.gov/pubmed/32750548
15558,32347780,[(18)F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer,J Urol. 2020 Oct;204(4):734-740. doi: 10.1097/JU.0000000000001095. Epub 2020 Apr 29.,Alemozaffar M,https://www.ncbi.nlm.nih.gov/pubmed/32347780
15559,32534790,Advanced Prostate Cancer: Treatment Advances and Future Directions,Trends Cancer. 2020 Aug;6(8):702-715. doi: 10.1016/j.trecan.2020.04.010. Epub 2020 Jun 10.,Swami U,https://www.ncbi.nlm.nih.gov/pubmed/32534790
15560,32268944,External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection,Eur Urol. 2020 Aug;78(2):138-142. doi: 10.1016/j.eururo.2020.03.023. Epub 2020 Apr 5.,Gandaglia G,https://www.ncbi.nlm.nih.gov/pubmed/32268944
15562,32986184,Dosimetric evaluation with knowledge-based planning created at different periods in volumetric-modulated arc therapy for prostate cancer: a multi-institution study,Radiol Phys Technol. 2020 Dec;13(4):327-335. doi: 10.1007/s12194-020-00585-0. Epub 2020 Sep 28.,Monzen H,https://www.ncbi.nlm.nih.gov/pubmed/32986184
15563,32845644,Targeted Radiosensitizers for MR-Guided Radiation Therapy of Prostate Cancer,Nano Lett. 2020 Oct 14;20(10):7159-7167. doi: 10.1021/acs.nanolett.0c02487. Epub 2020 Aug 31.,Luo D,https://www.ncbi.nlm.nih.gov/pubmed/32845644
15564,33302278,Impact of Radiotherapy on Prognosis in Patients Diagnosed with Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis,Urol Int. 2021;105(5-6):370-379. doi: 10.1159/000508415. Epub 2020 Dec 10.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/33302278
15566,33147377,Secondary malignancy risk for patients with localized prostate cancer after intensity-modulated radiotherapy with and without flattening filter,J Appl Clin Med Phys. 2020 Dec;21(12):197-205. doi: 10.1002/acm2.13088. Epub 2020 Nov 4.,Treutwein M,https://www.ncbi.nlm.nih.gov/pubmed/33147377
15567,32768351,Comparing the Diagnostic Performance of Multiparametric Prostate MRI Versus 68Ga-PSMA PET-CT in the Evaluation Lymph Node Involvement and Extraprostatic Extension,Acad Radiol. 2022 May;29(5):698-704. doi: 10.1016/j.acra.2020.07.011. Epub 2020 Aug 4.,Arslan A,https://www.ncbi.nlm.nih.gov/pubmed/32768351
15569,32374476,Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer,Cancer. 2020 Jul 15;126(14):3274-3280. doi: 10.1002/cncr.32933. Epub 2020 May 6.,Patel DN,https://www.ncbi.nlm.nih.gov/pubmed/32374476
15570,32621207,"Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding",Clin Transl Oncol. 2021 Feb;23(2):397-404. doi: 10.1007/s12094-020-02433-4. Epub 2020 Jul 3.,Braide K,https://www.ncbi.nlm.nih.gov/pubmed/32621207
15571,32631745,ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer,Eur Urol. 2020 Sep;78(3):452-459. doi: 10.1016/j.eururo.2020.06.001. Epub 2020 Jul 4.,Kreuz M,https://www.ncbi.nlm.nih.gov/pubmed/32631745
15572,33248919,"Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolisation, a Pilot Study",J Vasc Interv Radiol. 2021 Feb;32(2):247-255. doi: 10.1016/j.jvir.2020.10.002. Epub 2020 Nov 25.,Frandon J,https://www.ncbi.nlm.nih.gov/pubmed/33248919
15573,32650811,Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow,Radiat Oncol. 2020 Jul 10;15(1):168. doi: 10.1186/s13014-020-01604-5.,Mannerberg A,https://www.ncbi.nlm.nih.gov/pubmed/32650811
15574,32682337,Technical Note: Efficient and accurate MRI-only based treatment planning of the prostate using bulk density assignment through atlas-based segmentation,Med Phys. 2020 Oct;47(10):4758-4762. doi: 10.1002/mp.14406. Epub 2020 Aug 7.,McCallum HM,https://www.ncbi.nlm.nih.gov/pubmed/32682337
15576,32165153,Value of (18)F-Choline PET/MRI hybrid technique on the therapeutic approach for patients with prostate cancer treated with prostatectomy and rising prostate specific antigen levels below 1 ng/ml,Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jul-Aug;39(4):197-203. doi: 10.1016/j.remn.2020.01.010. Epub 2020 Mar 9.,García JR,https://www.ncbi.nlm.nih.gov/pubmed/32165153
15577,32460527,Gene Expression-Based Immune Cell Infiltration Analyses of Prostate Cancer and Their Associations with Survival Outcome,DNA Cell Biol. 2020 Jul;39(7):1194-1204. doi: 10.1089/dna.2020.5371. Epub 2020 May 27.,Hu P,https://www.ncbi.nlm.nih.gov/pubmed/32460527
15578,32900626,The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?,Urol Oncol. 2020 Dec;38(12):931.e1-931.e7. doi: 10.1016/j.urolonc.2020.08.018. Epub 2020 Sep 6.,Ieiri K,https://www.ncbi.nlm.nih.gov/pubmed/32900626
15580,31967521,Evaluating the Trade-Offs Men with Localized Prostate Cancer Make between the Risks and Benefits of Treatments: The COMPARE Study,J Urol. 2020 Aug;204(2):273-280. doi: 10.1097/JU.0000000000000754. Epub 2020 Jan 22.,Watson V,https://www.ncbi.nlm.nih.gov/pubmed/31967521
15581,33160915,Pure Single-site Robot-assisted Radical Prostatectomy Using Single-port Versus Multiport Robotic Radical Prostatectomy: A Single-institution Comparative Study,Eur Urol Focus. 2021 Sep;7(5):964-972. doi: 10.1016/j.euf.2020.10.006. Epub 2020 Nov 5.,Lenfant L,https://www.ncbi.nlm.nih.gov/pubmed/33160915
15583,32473821,Radical retropubic prostatectomy: Vesicourethral anastomosis,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):423-429. doi: 10.1016/j.acuro.2020.02.004. Epub 2020 May 27.,Herranz-Amo F,https://www.ncbi.nlm.nih.gov/pubmed/32473821
15586,32673785,Rectal and Urethro-Vesical Subregions for Toxicity Prediction After Prostate Cancer Radiation Therapy: Validation of Voxel-Based Models in an Independent Population,Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1189-1195. doi: 10.1016/j.ijrobp.2020.07.019. Epub 2020 Jul 13.,Mylona E,https://www.ncbi.nlm.nih.gov/pubmed/32673785
15587,32687633,Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry,Prostate. 2020 Sep;80(13):1071-1086. doi: 10.1002/pros.24031. Epub 2020 Jul 20.,Angel PM,https://www.ncbi.nlm.nih.gov/pubmed/32687633
15588,33008928,First Clinical Results for PSMA-Targeted ?-Therapy Using (225)Ac-PSMA-I&T in Advanced-mCRPC Patients,J Nucl Med. 2021 May 10;62(5):669-674. doi: 10.2967/jnumed.120.251017. Epub 2020 Oct 2.,Zacherl MJ,https://www.ncbi.nlm.nih.gov/pubmed/33008928
15589,33069628,Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy,Eur Urol Oncol. 2022 Feb;5(1):61-69. doi: 10.1016/j.euo.2020.08.002. Epub 2020 Oct 14.,Fasulo V,https://www.ncbi.nlm.nih.gov/pubmed/33069628
15590,32505458,A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches,Urol Oncol. 2020 Aug;38(8):650-660. doi: 10.1016/j.urolonc.2020.04.005. Epub 2020 Jun 3.,Loy LM,https://www.ncbi.nlm.nih.gov/pubmed/32505458
15591,33259932,Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer,Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1271-1278. doi: 10.1016/j.ijrobp.2020.11.059. Epub 2020 Nov 28.,Koontz BF,https://www.ncbi.nlm.nih.gov/pubmed/33259932
15592,33276019,Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate Cancer,Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1279-1285. doi: 10.1016/j.ijrobp.2020.11.064. Epub 2020 Dec 1.,Dee EC,https://www.ncbi.nlm.nih.gov/pubmed/33276019
15593,32622885,Treatment of Urinary Incontinence in Patients With Erectile Dysfunction,Sex Med Rev. 2021 Oct;9(4):593-604. doi: 10.1016/j.sxmr.2020.04.006. Epub 2020 Jul 2.,Ajay D,https://www.ncbi.nlm.nih.gov/pubmed/32622885
15594,33234327,Correlation of Stiffness of Prostate Cancer Measured by Shear Wave Elastography with Grade Group: A Preliminary Study,Ultrasound Med Biol. 2021 Feb;47(2):288-295. doi: 10.1016/j.ultrasmedbio.2020.10.018. Epub 2020 Nov 21.,Dai WB,https://www.ncbi.nlm.nih.gov/pubmed/33234327
15595,32631777,Single-institution Cost Comparison: Single-port Versus Multiport Robotic Prostatectomy,Eur Urol Focus. 2021 May;7(3):532-536. doi: 10.1016/j.euf.2020.06.010. Epub 2020 Jul 4.,Lenfant L,https://www.ncbi.nlm.nih.gov/pubmed/32631777
15596,33035622,Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control,Radiother Oncol. 2021 Jan;154:207-213. doi: 10.1016/j.radonc.2020.09.053. Epub 2020 Oct 7.,Levin-Epstein RG,https://www.ncbi.nlm.nih.gov/pubmed/33035622
15597,32858066,A combined biological and clinical rationale for evaluating metastasis directed therapy in the management of oligometastatic prostate cancer,Radiother Oncol. 2020 Nov;152:80-88. doi: 10.1016/j.radonc.2020.08.011. Epub 2020 Aug 25.,Kucharczyk MJ,https://www.ncbi.nlm.nih.gov/pubmed/32858066
15598,32863189,Metastasis-directed Therapy (SBRT) Guided by PET-CT (18)F-CHOLINE Versus PET-CT (68)Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness,Clin Genitourin Cancer. 2021 Jun;19(3):230-236. doi: 10.1016/j.clgc.2020.08.002. Epub 2020 Aug 6.,Mazzola R,https://www.ncbi.nlm.nih.gov/pubmed/32863189
15602,33331217,Documenting Horizontal Integration Among Urologists Who Treat Prostate Cancer,Med Care Res Rev. 2022 Feb;79(1):141-150. doi: 10.1177/1077558720980552. Epub 2020 Dec 17.,Mitchell JM,https://www.ncbi.nlm.nih.gov/pubmed/33331217
15603,32507362,Radical retropubic prostatectomy: control of Santorini's venous plexus,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):417-422. doi: 10.1016/j.acuro.2020.04.009. Epub 2020 Jun 2.,Herranz Amo F,https://www.ncbi.nlm.nih.gov/pubmed/32507362
15604,32967771,Prognostic features of Annexin A2 expression in prostate cancer,Pathology. 2021 Feb;53(2):205-213. doi: 10.1016/j.pathol.2020.07.006. Epub 2020 Sep 20.,Tan SH,https://www.ncbi.nlm.nih.gov/pubmed/32967771
15606,31411991,Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group,Eur Urol Oncol. 2020 Aug;3(4):455-463. doi: 10.1016/j.euo.2019.02.007. Epub 2019 Mar 26.,O'Sullivan JM,https://www.ncbi.nlm.nih.gov/pubmed/31411991
15607,33107227,Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL),J Korean Med Sci. 2020 Oct 26;35(41):e342. doi: 10.3346/jkms.2020.35.e342.,Chung JH,https://www.ncbi.nlm.nih.gov/pubmed/33107227
15608,32811748,Supporting health literacy using an interactive app for symptom management during radiotherapy for prostate cancer,Patient Educ Couns. 2021 Feb;104(2):381-386. doi: 10.1016/j.pec.2020.08.003. Epub 2020 Aug 6.,Sundberg K,https://www.ncbi.nlm.nih.gov/pubmed/32811748
15609,32789599,Pelvic lymph-node staging with (18)F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial,Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):509-520. doi: 10.1007/s00259-020-04974-w. Epub 2020 Aug 12.,Jansen BHE,https://www.ncbi.nlm.nih.gov/pubmed/32789599
15610,33188151,Positive Predictive Value and Correct Detection Rate of (18)F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard,J Nucl Med. 2021 Jul 1;62(7):968-974. doi: 10.2967/jnumed.120.255661. Epub 2020 Nov 13.,Chantadisai M,https://www.ncbi.nlm.nih.gov/pubmed/33188151
15611,33351172,"Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with (177)Lu-labeled prostate-specific membrane antigen",Ann Nucl Med. 2021 Mar;35(3):314-320. doi: 10.1007/s12149-020-01567-3. Epub 2020 Dec 22.,Huang K,https://www.ncbi.nlm.nih.gov/pubmed/33351172
15612,32320126,Targeted and systematic cognitive freehand-guided transperineal biopsy: is there still a role for systematic biopsy?,BJU Int. 2020 Aug;126(2):280-285. doi: 10.1111/bju.15092. Epub 2020 May 19.,Neale A,https://www.ncbi.nlm.nih.gov/pubmed/32320126
15613,32080350,Clinicopathological characteristics of glomeruloid architecture in prostate cancer,Mod Pathol. 2020 Aug;33(8):1618-1625. doi: 10.1038/s41379-020-0507-2. Epub 2020 Feb 20.,Hollemans E,https://www.ncbi.nlm.nih.gov/pubmed/32080350
15614,32016908,Endogenous testosterone mirrors prostate cancer aggressiveness: correlation between basal testosterone serum levels and prostate cancer European Urology Association clinical risk classes in a large cohort of Caucasian patients,Int Urol Nephrol. 2020 Jul;52(7):1261-1269. doi: 10.1007/s11255-020-02398-x. Epub 2020 Feb 3.,Tafuri A,https://www.ncbi.nlm.nih.gov/pubmed/32016908
15615,33349092,Value of clinical parameters and MRI with PI-RADS(V2) in predicting seminal vesicle invasion of prostate cancer,Scand J Urol. 2021 Feb;55(1):17-21. doi: 10.1080/21681805.2020.1833981. Epub 2020 Dec 21.,Lim B,https://www.ncbi.nlm.nih.gov/pubmed/33349092
15616,33189049,Dose distribution correction for the influence of magnetic field using a deep convolutional neural network for online MR-guided adaptive radiotherapy,Phys Med. 2020 Dec;80:186-192. doi: 10.1016/j.ejmp.2020.11.002. Epub 2020 Nov 11.,Kajikawa T,https://www.ncbi.nlm.nih.gov/pubmed/33189049
15618,33221091,Need for Systematic Magnetic Resonance Imaging Interpretation and Reporting after Partial Prostate Gland Ablation,Eur Urol. 2021 Feb;79(2):167-169. doi: 10.1016/j.eururo.2020.10.036. Epub 2020 Nov 19.,Hu JC,https://www.ncbi.nlm.nih.gov/pubmed/33221091
15619,32803894,Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression,Prostate. 2020 Oct;80(14):1253-1262. doi: 10.1002/pros.24057. Epub 2020 Aug 17.,Liu W,https://www.ncbi.nlm.nih.gov/pubmed/32803894
15620,33036660,Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study,Cancer Imaging. 2020 Oct 9;20(1):72. doi: 10.1186/s40644-020-00351-w.,Hietikko R,https://www.ncbi.nlm.nih.gov/pubmed/33036660
15621,31989474,"Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)",Clin Transl Oncol. 2020 Aug;22(8):1378-1389. doi: 10.1007/s12094-019-02274-w. Epub 2020 Jan 27.,Valero J,https://www.ncbi.nlm.nih.gov/pubmed/31989474
15622,32116138,Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori,Tumori. 2020 Oct;106(5):406-412. doi: 10.1177/0300891620905646. Epub 2020 Mar 2.,Raimondi A,https://www.ncbi.nlm.nih.gov/pubmed/32116138
15623,32473820,"Prostate cancer, new treatment advances - immunotherapy",Actas Urol Esp (Engl Ed). 2020 Sep;44(7):458-468. doi: 10.1016/j.acuro.2020.01.009. Epub 2020 May 27.,Silva D,https://www.ncbi.nlm.nih.gov/pubmed/32473820
15624,33036061,Reconciling outcomes for Black men with prostate cancer within and outside the Veterans Health Administration,Cancer. 2021 Feb 1;127(3):342-344. doi: 10.1002/cncr.33225. Epub 2020 Oct 9.,Deville C Jr,https://www.ncbi.nlm.nih.gov/pubmed/33036061
15625,32956129,Visceral Metastases as Predictors of Response and Survival Outcomes in Patients of Castration-Resistant Prostate Cancer Treated With 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy: A Systematic Review and Meta-analysis,Clin Nucl Med. 2020 Dec;45(12):935-942. doi: 10.1097/RLU.0000000000003307.,Satapathy S,https://www.ncbi.nlm.nih.gov/pubmed/32956129
15626,32586393,The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer,Trials. 2020 Jun 26;21(1):579. doi: 10.1186/s13063-020-04515-8.,Crippa A,https://www.ncbi.nlm.nih.gov/pubmed/32586393
15627,33156884,Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer,PLoS One. 2020 Nov 6;15(11):e0241636. doi: 10.1371/journal.pone.0241636. eCollection 2020.,Takakusagi Y,https://www.ncbi.nlm.nih.gov/pubmed/33156884
15629,32280037,High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel,Urol Oncol. 2020 Jul;38(7):637.e17-637.e27. doi: 10.1016/j.urolonc.2020.03.001. Epub 2020 Apr 10.,Nientiedt C,https://www.ncbi.nlm.nih.gov/pubmed/32280037
15630,31402242,Results of the York Mason Procedure with and without Concomitant Graciloplasty to Treat Iatrogenic Rectourethral Fistulas,Eur Urol Focus. 2020 Jul 15;6(4):762-769. doi: 10.1016/j.euf.2019.07.005. Epub 2019 Aug 8.,van der Doelen MJ,https://www.ncbi.nlm.nih.gov/pubmed/31402242
15631,32020826,Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis,Aging Male. 2020 Dec;23(5):1182-1193. doi: 10.1080/13685538.2020.1718637. Epub 2020 Feb 5.,Zhou L,https://www.ncbi.nlm.nih.gov/pubmed/32020826
15632,32988249,"Reduction of inter-observer contouring variability in daily clinical practice through a retrospective, evidence-based intervention",Acta Oncol. 2021 Feb;60(2):229-236. doi: 10.1080/0284186X.2020.1825801. Epub 2020 Sep 29.,Patrick HM,https://www.ncbi.nlm.nih.gov/pubmed/32988249
15633,32469606,Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer,Future Oncol. 2020 Jul;16(19):1371-1384. doi: 10.2217/fon-2020-0039. Epub 2020 May 29.,Kuppen MC,https://www.ncbi.nlm.nih.gov/pubmed/32469606
15636,32945017,NeuroSAFE technique-pathological considerations and practical implications for guiding nerve-sparing surgery in prostate cancer patients,Histopathology. 2020 Oct;77(4):536-538. doi: 10.1111/his.14183.,Dinneen E,https://www.ncbi.nlm.nih.gov/pubmed/32945017
15638,32628817,Associations of multimorbidity and patient-reported experiences of care with conservative management among elderly patients with localized prostate cancer,Cancer Med. 2020 Aug;9(16):6051-6061. doi: 10.1002/cam4.3274. Epub 2020 Jul 6.,Fiano RM,https://www.ncbi.nlm.nih.gov/pubmed/32628817
15639,32685021,Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving (177)Lu-PSMA-617 Radioligand Therapy,Theranostics. 2020 Jun 19;10(17):7812-7820. doi: 10.7150/thno.47251. eCollection 2020.,Seifert R,https://www.ncbi.nlm.nih.gov/pubmed/32685021
15642,32565071,Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience,Cancer Radiother. 2020 Dec;24(8):805-811. doi: 10.1016/j.canrad.2020.03.009. Epub 2020 Jun 18.,Ozyigit G,https://www.ncbi.nlm.nih.gov/pubmed/32565071
15643,32629078,Knowledge-Based Assessment of Focal Dose Escalation Treatment Plans in Prostate Cancer,Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1055-1062. doi: 10.1016/j.ijrobp.2020.06.072. Epub 2020 Jul 3.,van Schie MA,https://www.ncbi.nlm.nih.gov/pubmed/32629078
15644,32875372,Cone-beam computed tomography-based radiomics in prostate cancer: a mono-institutional study,Strahlenther Onkol. 2020 Oct;196(10):943-951. doi: 10.1007/s00066-020-01677-x. Epub 2020 Sep 1.,Bosetti DG,https://www.ncbi.nlm.nih.gov/pubmed/32875372
15645,32807168,In regard to Cuccia et al.: impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5?T MR-guided stereotactic body radiotherapy,Radiat Oncol. 2020 Aug 17;15(1):199. doi: 10.1186/s13014-020-01642-z.,Ghaffari H,https://www.ncbi.nlm.nih.gov/pubmed/32807168
15647,32107736,Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy,Appl Health Econ Health Policy. 2020 Oct;18(5):727-737. doi: 10.1007/s40258-020-00564-x.,Edmunds K,https://www.ncbi.nlm.nih.gov/pubmed/32107736
15649,33016042,Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC,Arch Ital Urol Androl. 2020 Oct 1;92(3). doi: 10.4081/aiua.2020.3.196.,Frantellizzi V,https://www.ncbi.nlm.nih.gov/pubmed/33016042
15650,33288372,A scientometric study of the top 100 most-cited publications based on Web-of-Science regarding robotic versus laparoscopic surgery,Asian J Surg. 2021 Feb;44(2):440-451. doi: 10.1016/j.asjsur.2020.10.026. Epub 2020 Dec 4.,Feng LF,https://www.ncbi.nlm.nih.gov/pubmed/33288372
15652,32488362,"Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy",World J Urol. 2021 Apr;39(4):1219-1226. doi: 10.1007/s00345-020-03272-2. Epub 2020 Jun 2.,Deuker M,https://www.ncbi.nlm.nih.gov/pubmed/32488362
15653,31912257,(68)Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is (68)Ga-PSMA PET/CT guided biopsy the future?,Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1843-1851. doi: 10.1007/s00259-019-04620-0. Epub 2020 Jan 7.,Donato P,https://www.ncbi.nlm.nih.gov/pubmed/31912257
15654,33221258,Management of prostate cancer after holmium laser enucleation of the prostate,Urol Oncol. 2021 May;39(5):297.e1-297.e8. doi: 10.1016/j.urolonc.2020.11.003. Epub 2020 Nov 19.,Hutchison D,https://www.ncbi.nlm.nih.gov/pubmed/33221258
15655,32436467,Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer,Acta Oncol. 2020 Aug;59(8):911-917. doi: 10.1080/0284186X.2020.1760349. Epub 2020 May 21.,Outaggarts Z,https://www.ncbi.nlm.nih.gov/pubmed/32436467
15656,32448724,Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer -5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life,Clin Oncol (R Coll Radiol). 2020 Oct;32(10):e177-e187. doi: 10.1016/j.clon.2020.05.002. Epub 2020 May 21.,Jiang XY,https://www.ncbi.nlm.nih.gov/pubmed/32448724
15657,32755355,Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer With Multiparametric MRI,AJR Am J Roentgenol. 2020 Oct;215(4):903-912. doi: 10.2214/AJR.19.22573. Epub 2020 Aug 5.,Mehralivand S,https://www.ncbi.nlm.nih.gov/pubmed/32755355
15658,33337340,Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study,J Med Internet Res. 2020 Dec 18;22(12):e16322. doi: 10.2196/16322.,Chen IA,https://www.ncbi.nlm.nih.gov/pubmed/33337340
15659,32111687,Early Prostate-Specific Antigen Changes and Clinical Outcome After (177)Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer,J Nucl Med. 2020 Oct;61(10):1476-1483. doi: 10.2967/jnumed.119.240242. Epub 2020 Feb 28.,Gafita A,https://www.ncbi.nlm.nih.gov/pubmed/32111687
15660,32949253,Biodistribution and dosimetry of a single dose of albumin-binding ligand [(177)Lu]Lu-PSMA-ALB-56 in patients with mCRPC,Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):893-903. doi: 10.1007/s00259-020-05022-3. Epub 2020 Sep 19.,Kramer V,https://www.ncbi.nlm.nih.gov/pubmed/32949253
15661,33306752,Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received (177)Lu PSMA I&T therapy,Hell J Nucl Med. 2020 Sep-Dec;23(3):229-239. doi: 10.1967/s002449912201. Epub 2020 Dec 14.,Bülbül O,https://www.ncbi.nlm.nih.gov/pubmed/33306752
15664,33285212,The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2,Urology. 2021 Mar;149:174-180. doi: 10.1016/j.urology.2020.11.039. Epub 2020 Dec 5.,Naito H,https://www.ncbi.nlm.nih.gov/pubmed/33285212
15666,33191831,Primary cryotherapy for localized prostate cancer treatment,Aging Male. 2020 Dec;23(5):1460-1466. doi: 10.1080/13685538.2020.1796960. Epub 2020 Nov 16.,Mercader C,https://www.ncbi.nlm.nih.gov/pubmed/33191831
15667,33336265,Prognostic implications of dual tracer PET/CT: PSMA ligand and [(18)F]FDG PET/CT in patients undergoing [(177)Lu]PSMA radioligand therapy,Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2024-2030. doi: 10.1007/s00259-020-05160-8. Epub 2020 Dec 18.,Michalski K,https://www.ncbi.nlm.nih.gov/pubmed/33336265
15672,32404713,Focal 18F-NaF PET Prostate Activity in the Setting of Prostate Adenocarcinoma,Clin Nucl Med. 2020 Jul;45(7):e334-e335. doi: 10.1097/RLU.0000000000003094.,Chiang J,https://www.ncbi.nlm.nih.gov/pubmed/32404713
15674,32711012,The Impact of Performing a 3D Mapping Biopsy Prior to Primary Cryotherapy for the Treatment of Prostate Cancer,Urology. 2020 Oct;144:171-176. doi: 10.1016/j.urology.2020.07.012. Epub 2020 Jul 23.,Barqawi A,https://www.ncbi.nlm.nih.gov/pubmed/32711012
15675,32282629,Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population,Nucl Med Commun. 2020 Jul;41(7):618-628. doi: 10.1097/MNM.0000000000001179.,Thang SP,https://www.ncbi.nlm.nih.gov/pubmed/32282629
15676,32691352,"Single-port versus multi-port: will ""one for all"" ever become a new standard for robot-assisted radical prostatectomy?",J Robot Surg. 2021 Feb;15(1):143-145. doi: 10.1007/s11701-020-01124-0. Epub 2020 Jul 20.,Bertolo R,https://www.ncbi.nlm.nih.gov/pubmed/32691352
15677,33358075,Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature,Eur J Surg Oncol. 2021 Jun;47(6):1252-1257. doi: 10.1016/j.ejso.2020.12.009. Epub 2020 Dec 18.,Clifford RE,https://www.ncbi.nlm.nih.gov/pubmed/33358075
15678,32475745,"Comparative study of surgical orchidectomy and medical castration in treatment efficacy, adverse effects and cost based on a large prospective metastatic prostate cancer registry",Urol Oncol. 2020 Aug;38(8):682.e1-682.e9. doi: 10.1016/j.urolonc.2020.05.005. Epub 2020 May 29.,Tan YG,https://www.ncbi.nlm.nih.gov/pubmed/32475745
15679,33057938,Improvement in early continence after introduction of periurethral suspension stitch in robotic prostatectomy,J Robot Surg. 2021 Oct;15(5):679-686. doi: 10.1007/s11701-020-01156-6. Epub 2020 Oct 14.,Aarsæther E,https://www.ncbi.nlm.nih.gov/pubmed/33057938
15681,33319628,"Plasma, Prostate and Urine Levels of Tocopherols and Metabolites in Men after Supplementation with a ?-Tocopherol-Rich Vitamin E Mixture",Nutr Cancer. 2021;73(11-12):2740-2750. doi: 10.1080/01635581.2020.1857412. Epub 2020 Dec 15.,Goodin S,https://www.ncbi.nlm.nih.gov/pubmed/33319628
15684,32360049,Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study,Eur Urol. 2020 Sep;78(3):443-451. doi: 10.1016/j.eururo.2020.03.035. Epub 2020 Apr 30.,Stavrinides V,https://www.ncbi.nlm.nih.gov/pubmed/32360049
15685,33172323,"Pasotuxizumab, a BiTE((R)) immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings",Immunotherapy. 2021 Feb;13(2):125-141. doi: 10.2217/imt-2020-0256. Epub 2020 Nov 10.,Hummel HD,https://www.ncbi.nlm.nih.gov/pubmed/33172323
15688,32213206,Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223,Int Braz J Urol. 2020 Jul-Aug;46(4):599-611. doi: 10.1590/S1677-5538.IBJU.2019.0343. Epub 2020 Mar 15.,Vidal M,https://www.ncbi.nlm.nih.gov/pubmed/32213206
15689,32466877,External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study,Urol Oncol. 2020 Nov;38(11):847.e9-847.e16. doi: 10.1016/j.urolonc.2020.04.011. Epub 2020 May 26.,Diamand R,https://www.ncbi.nlm.nih.gov/pubmed/32466877
15690,33128131,Prediction of response and survival after standardized treatment with 7400 MBq (177)Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer,Eur J Nucl Med Mol Imaging. 2021 May;48(5):1650-1657. doi: 10.1007/s00259-020-05082-5. Epub 2020 Oct 30.,Rasul S,https://www.ncbi.nlm.nih.gov/pubmed/33128131
15691,32281092,Diagnostic Utility of Lutetium-177 (Lu 177) Prostate-Specific Membrane Antigen (PSMA) Scintigraphy In Prostate Cancer Patients With PSA Rise And Negative Conventional Imaging,Urol J. 2020 Jun 23;17(4):374-378. doi: 10.22037/uj.v0i0.5451.,Ghodsirad MA,https://www.ncbi.nlm.nih.gov/pubmed/32281092
15692,32791030,Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT,Cancer Biol Ther. 2020 Sep 1;21(9):782-784. doi: 10.1080/15384047.2020.1796195. Epub 2020 Aug 13.,Handy WF,https://www.ncbi.nlm.nih.gov/pubmed/32791030
15693,33339518,Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer,BMC Cancer. 2020 Dec 18;20(1):1220. doi: 10.1186/s12885-020-07682-8.,Freytag M,https://www.ncbi.nlm.nih.gov/pubmed/33339518
15696,32488655,Influence of previous laparo-endoscopic inguinal hernia repair on performing radical prostatectomy: a nationwide survey among urological surgeons,Surg Endosc. 2021 Jun;35(6):2583-2591. doi: 10.1007/s00464-020-07676-4. Epub 2020 Jun 2.,Bakker WJ,https://www.ncbi.nlm.nih.gov/pubmed/32488655
15698,32816908,Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer,Cancer Res. 2020 Nov 15;80(22):4892-4903. doi: 10.1158/0008-5472.CAN-20-1216. Epub 2020 Aug 19.,Schonhoft JD,https://www.ncbi.nlm.nih.gov/pubmed/32816908
15699,32430954,A Retrospective Analysis of the Safety and Activity of Lutetium-177-Prostate-Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration-Resistant Prostate Cancer,Oncologist. 2020 Sep;25(9):787-792. doi: 10.1634/theoncologist.2020-0100. Epub 2020 Jun 10.,Leibowitz R,https://www.ncbi.nlm.nih.gov/pubmed/32430954
15701,31992480,Effect of Echo Times on Prostate Cancer Detection on T2-Weighted Images,Acad Radiol. 2020 Nov;27(11):1555-1563. doi: 10.1016/j.acra.2019.12.014. Epub 2020 Jan 26.,Chatterjee A,https://www.ncbi.nlm.nih.gov/pubmed/31992480
15703,33098372,Modified J-CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy,Cancer Med. 2020 Dec;9(24):9346-9352. doi: 10.1002/cam4.3548. Epub 2020 Oct 24.,Lim J,https://www.ncbi.nlm.nih.gov/pubmed/33098372
15704,32814846,Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):210-219. doi: 10.1038/s41391-020-00271-7. Epub 2020 Aug 19.,McKay RR,https://www.ncbi.nlm.nih.gov/pubmed/32814846
15705,33246846,"Safety, Efficacy, and Impact on Quality of Life of Palliative Robotic Cystectomy for Advanced Prostate Cancer",Clin Genitourin Cancer. 2021 Apr;19(2):e129-e134. doi: 10.1016/j.clgc.2020.09.008. Epub 2020 Nov 2.,Bhanvadia RR,https://www.ncbi.nlm.nih.gov/pubmed/33246846
15706,32474391,Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis,Crit Rev Oncol Hematol. 2020 Jul;151:102992. doi: 10.1016/j.critrevonc.2020.102992. Epub 2020 May 23.,Buonerba C,https://www.ncbi.nlm.nih.gov/pubmed/32474391
15708,32544574,Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer,Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):917-926. doi: 10.1016/j.ijrobp.2020.06.009. Epub 2020 Jun 13.,Parikh NR,https://www.ncbi.nlm.nih.gov/pubmed/32544574
15709,33118115,The EPIC-26 domain scores after radical prostatectomy are associated with the personality trait of neuroticism,Int Urol Nephrol. 2021 Apr;53(4):691-698. doi: 10.1007/s11255-020-02688-4. Epub 2020 Oct 28.,Dahl AA,https://www.ncbi.nlm.nih.gov/pubmed/33118115
15710,33367303,Is (177)Lu-PSMA an effective treatment modality for mCRPC patients with bone and visceral metastasis?,Hell J Nucl Med. 2020 Sep-Dec;23(3):312-320. doi: 10.1967/s002449912219.,Gupta M,https://www.ncbi.nlm.nih.gov/pubmed/33367303
15711,32515205,Exploring Biologic Correlates of Cancer-Related Fatigue in Men With Prostate Cancer: Cell Damage Pathways and Oxidative Stress,Biol Res Nurs. 2020 Oct;22(4):514-519. doi: 10.1177/1099800420933347. Epub 2020 Jun 9.,Dickinson K,https://www.ncbi.nlm.nih.gov/pubmed/32515205
15712,32534903,Candidates to salvage therapy after external-beam radiotherapy of prostate cancer: Predictors of local recurrence volume and metastasis-free survival,Diagn Interv Imaging. 2021 Feb;102(2):93-100. doi: 10.1016/j.diii.2020.05.007. Epub 2020 Jun 10.,Maoui M,https://www.ncbi.nlm.nih.gov/pubmed/32534903
15713,32786087,A systematic review of irreversible electroporation in localised prostate cancer treatment,Andrologia. 2020 Nov;52(10):e13789. doi: 10.1111/and.13789. Epub 2020 Aug 12.,Morozov A,https://www.ncbi.nlm.nih.gov/pubmed/32786087
15715,33260535,Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis,Int J Mol Sci. 2020 Nov 28;21(23):9054. doi: 10.3390/ijms21239054.,von Eyben FE,https://www.ncbi.nlm.nih.gov/pubmed/33260535
15716,33016047,Expression of miR-132 and miR-212 in prostate cancer and metastatic lymph node: Case report and revision of the literature,Arch Ital Urol Androl. 2020 Oct 1;92(3). doi: 10.4081/aiua.2020.3.209.,Salemi M,https://www.ncbi.nlm.nih.gov/pubmed/33016047
15717,32444264,Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial,Eur Urol. 2020 Sep;78(3):360-368. doi: 10.1016/j.eururo.2020.05.001. Epub 2020 May 19.,Patel HD,https://www.ncbi.nlm.nih.gov/pubmed/32444264
15718,32759241,Ethnographic investigation of patient-provider communication among African American men newly diagnosed with prostate cancer: a study protocol,BMJ Open. 2020 Aug 5;10(8):e035032. doi: 10.1136/bmjopen-2019-035032.,Palmer NR,https://www.ncbi.nlm.nih.gov/pubmed/32759241
15719,32732622,Clinical impact of PET imaging in prostate cancer management,Curr Opin Urol. 2020 Sep;30(5):649-653. doi: 10.1097/MOU.0000000000000795.,Emmett L,https://www.ncbi.nlm.nih.gov/pubmed/32732622
15720,32924093,"Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer",Invest New Drugs. 2021 Apr;39(2):499-508. doi: 10.1007/s10637-020-00993-4. Epub 2020 Sep 13.,Gartrell BA,https://www.ncbi.nlm.nih.gov/pubmed/32924093
15722,32682582,Improving Physical and Mental Health in Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy: Strategies to Promote and Improve Physical Activity Quality and Quantity,Semin Oncol Nurs. 2020 Aug;36(4):151051. doi: 10.1016/j.soncn.2020.151051. Epub 2020 Jul 15.,Toohey K,https://www.ncbi.nlm.nih.gov/pubmed/32682582
15723,33235072,Psychological nursing intervention on anxiety and depression in patients with urinary incontinence after radical prostatectomy: A randomized controlled study protocol,Medicine (Baltimore). 2020 Nov 25;99(48):e23127. doi: 10.1097/MD.0000000000023127.,Yang L,https://www.ncbi.nlm.nih.gov/pubmed/33235072
15724,32109140,The Relationship Between Total Lesion Activity on (18)F Choline Positron Emission Tomography-Computed Tomography and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Bone Metastases Treated with (223)Radium,Cancer Biother Radiopharm. 2020 Aug;35(6):398-403. doi: 10.1089/cbr.2019.3188. Epub 2020 Feb 28.,Filippi L,https://www.ncbi.nlm.nih.gov/pubmed/32109140
15725,33046366,"The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy",Urol Oncol. 2021 May;39(5):296.e11-296.e19. doi: 10.1016/j.urolonc.2020.09.005. Epub 2020 Oct 9.,Szarvas T,https://www.ncbi.nlm.nih.gov/pubmed/33046366
15726,32614434,The interplay of growth differentiation factor 15 (GDF15) expression and M2 macrophages during prostate carcinogenesis,Carcinogenesis. 2020 Aug 12;41(8):1074-1082. doi: 10.1093/carcin/bgaa065.,Sadasivan SM,https://www.ncbi.nlm.nih.gov/pubmed/32614434
15727,32559353,Prostate-specific membrane antigen theranostics in advanced prostate cancer: an evolving option,BJU Int. 2020 Nov;126(5):525-535. doi: 10.1111/bju.15143. Epub 2020 Aug 12.,Mayor N,https://www.ncbi.nlm.nih.gov/pubmed/32559353
15728,32663140,Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study,J Med Internet Res. 2020 Aug 10;22(8):e17058. doi: 10.2196/17058.,Crafoord MT,https://www.ncbi.nlm.nih.gov/pubmed/32663140
15729,32249345,Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223,Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2633-2638. doi: 10.1007/s00259-020-04796-w. Epub 2020 Apr 5.,Caffo O,https://www.ncbi.nlm.nih.gov/pubmed/32249345
15730,32353391,Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 Prostate Cancers,Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):982-985. doi: 10.1016/j.ijrobp.2020.04.025. Epub 2020 Apr 27.,Abu-Gheida I,https://www.ncbi.nlm.nih.gov/pubmed/32353391
15731,31862185,Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer-A Pilot Study,Acad Radiol. 2020 Oct;27(10):1432-1439. doi: 10.1016/j.acra.2019.10.017. Epub 2019 Dec 18.,Fennessy FM,https://www.ncbi.nlm.nih.gov/pubmed/31862185
15734,32542695,Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial,J Bone Miner Res. 2020 Oct;35(10):1871-1880. doi: 10.1002/jbmr.4106. Epub 2020 Jul 6.,Cheung AS,https://www.ncbi.nlm.nih.gov/pubmed/32542695
15735,33288585,Biweekly Cabazitaxel Is a Safe Treatment Option for Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients After Docetaxel - A Final Analysis of the Prosty II Trial,Anticancer Res. 2020 Dec;40(12):6915-6921. doi: 10.21873/anticanres.14715. Epub 2020 Dec 7.,Kellokumpu-Lehtinen PL,https://www.ncbi.nlm.nih.gov/pubmed/33288585
15736,31549211,Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2,Abdom Radiol (NY). 2020 Jul;45(7):2225-2234. doi: 10.1007/s00261-019-02234-6.,Afshari Mirak S,https://www.ncbi.nlm.nih.gov/pubmed/31549211
15737,33333364,Machine learning and statistical prediction of patient quality-of-life after prostate radiation therapy,Comput Biol Med. 2021 Feb;129:104127. doi: 10.1016/j.compbiomed.2020.104127. Epub 2020 Nov 28.,Yang Z,https://www.ncbi.nlm.nih.gov/pubmed/33333364
15738,32940881,The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients,J Cancer Educ. 2022 Jun;37(3):675-682. doi: 10.1007/s13187-020-01867-2. Epub 2020 Sep 17.,Ihrig A,https://www.ncbi.nlm.nih.gov/pubmed/32940881
15739,32938283,Gene expression analysis reveals a pitfall in the molecular research of prostate tumors relevant to Gleason score,J Bioinform Comput Biol. 2020 Oct;18(5):2050032. doi: 10.1142/S0219720020500328. Epub 2020 Sep 16.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/32938283
15740,33315505,Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer,J Urol. 2021 Apr;205(4):1090-1099. doi: 10.1097/JU.0000000000001567. Epub 2020 Dec 14.,Orczyk C,https://www.ncbi.nlm.nih.gov/pubmed/33315505
15741,32908142,Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion,Nat Commun. 2020 Sep 9;11(1):4498. doi: 10.1038/s41467-020-18313-y.,Cioni B,https://www.ncbi.nlm.nih.gov/pubmed/32908142
15742,32778478,The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings-Implications for the COVID-19 era,Urol Oncol. 2021 Jan;39(1):73.e1-73.e8. doi: 10.1016/j.urolonc.2020.07.009. Epub 2020 Aug 7.,Savin Z,https://www.ncbi.nlm.nih.gov/pubmed/32778478
15743,31612251,Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study,World J Urol. 2020 Jul;38(7):1735-1740. doi: 10.1007/s00345-019-02973-7. Epub 2019 Oct 14.,Ploussard G,https://www.ncbi.nlm.nih.gov/pubmed/31612251
15745,33091718,Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer,Eur J Cancer. 2020 Nov;140:140-146. doi: 10.1016/j.ejca.2020.09.018. Epub 2020 Oct 20.,Caffo O,https://www.ncbi.nlm.nih.gov/pubmed/33091718
15746,32772805,Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center,Scand J Urol. 2020 Oct;54(5):382-386. doi: 10.1080/21681805.2020.1798503. Epub 2020 Aug 10.,Di Trapani E,https://www.ncbi.nlm.nih.gov/pubmed/32772805
15748,33032611,Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing,Mol Cancer. 2020 Oct 8;19(1):147. doi: 10.1186/s12943-020-01264-9.,Ma X,https://www.ncbi.nlm.nih.gov/pubmed/33032611
15750,32767444,Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility,Int J Urol. 2020 Oct;27(10):882-889. doi: 10.1111/iju.14321. Epub 2020 Aug 6.,Aydin AM,https://www.ncbi.nlm.nih.gov/pubmed/32767444
15751,32144767,Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced insulin-like growth factor-1 secretion by prostate stromal cells,Int J Cancer. 2020 Jun 15;146(12):3474-3484. doi: 10.1002/ijc.32959. Epub 2020 Mar 19.,Ohishi T,https://www.ncbi.nlm.nih.gov/pubmed/32144767
15752,32169910,Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study,J Nucl Med. 2020 Nov;61(11):1602-1606. doi: 10.2967/jnumed.120.241588. Epub 2020 Mar 13.,Derlin T,https://www.ncbi.nlm.nih.gov/pubmed/32169910
15753,32604105,Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?,Clin Nucl Med. 2020 Sep;45(9):672-678. doi: 10.1097/RLU.0000000000003122.,Teyateeti A,https://www.ncbi.nlm.nih.gov/pubmed/32604105
15754,32456482,Isolated Intraductal Carcinoma of the Prostate in Prostatectomy Specimens: Report of 2 Cases and Review of the Literature,Int J Surg Pathol. 2020 Dec;28(8):918-924. doi: 10.1177/1066896920920357. Epub 2020 May 26.,Grypari IM,https://www.ncbi.nlm.nih.gov/pubmed/32456482
15755,32777369,Overtreatment and Underutilization of Watchful Waiting in Men With Limited Life Expectancy: An Analysis of the Michigan Urological Surgery Improvement Collaborative Registry,Urology. 2020 Nov;145:190-196. doi: 10.1016/j.urology.2020.07.047. Epub 2020 Aug 7.,Singhal U,https://www.ncbi.nlm.nih.gov/pubmed/32777369
15757,33150763,Kallikrein gene family as biomarkers for recurrent prostate cancer,Croat Med J. 2020 Oct 31;61(5):450-456. doi: 10.3325/cmj.2020.61.450.,Boyukozer FB,https://www.ncbi.nlm.nih.gov/pubmed/33150763
15758,32587285,Risk of Ischemic Heart Disease and Stroke in Prostate Cancer Survivors: A Nationwide Study in South Korea,Sci Rep. 2020 Jun 25;10(1):10313. doi: 10.1038/s41598-020-67029-y.,Shin DW,https://www.ncbi.nlm.nih.gov/pubmed/32587285
15762,32997897,Patient perceptions and preferences about prostate fiducial markers and ultrasound motion monitoring procedures in radiation therapy treatment,J Med Radiat Sci. 2021 Mar;68(1):37-43. doi: 10.1002/jmrs.438. Epub 2020 Sep 30.,Brown A,https://www.ncbi.nlm.nih.gov/pubmed/32997897
15763,32997261,Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer,World J Urol. 2021 Jul;39(7):2621-2626. doi: 10.1007/s00345-020-03444-0. Epub 2020 Sep 30.,Lambert E,https://www.ncbi.nlm.nih.gov/pubmed/32997261
15764,33293356,Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome,J Immunother Cancer. 2020 Dec;8(2):e001535. doi: 10.1136/jitc-2020-001535.,Tiraboschi C,https://www.ncbi.nlm.nih.gov/pubmed/33293356
15766,33369661,Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US,JAMA Netw Open. 2020 Dec 1;3(12):e2031349. doi: 10.1001/jamanetworkopen.2020.31349.,Washington SL 3rd,https://www.ncbi.nlm.nih.gov/pubmed/33369661
15767,32412639,Androgen receptor variants: RNA-based mechanisms and therapeutic targets,Hum Mol Genet. 2020 Sep 30;29(R1):R19-R26. doi: 10.1093/hmg/ddaa089.,Tietz KT,https://www.ncbi.nlm.nih.gov/pubmed/32412639
15768,32500304,A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer,World J Urol. 2021 Feb;39(2):297-306. doi: 10.1007/s00345-020-03265-1. Epub 2020 Jun 4.,Holmes A,https://www.ncbi.nlm.nih.gov/pubmed/32500304
15769,32593644,Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification?,Radiother Oncol. 2020 Sep;150:184-190. doi: 10.1016/j.radonc.2020.06.029. Epub 2020 Jun 25.,Franzese C,https://www.ncbi.nlm.nih.gov/pubmed/32593644
15770,33075177,Optimized MRI Assessment for Clinically Significant Prostate Cancer: A STARD-Compliant Two-Center Study,J Magn Reson Imaging. 2021 Apr;53(4):1210-1219. doi: 10.1002/jmri.27394. Epub 2020 Oct 19.,Bao J,https://www.ncbi.nlm.nih.gov/pubmed/33075177
15771,32383524,"Challenges, applications and future directions of precision medicine in prostate cancer - the role of organoids and patient-derived xenografts",BJU Int. 2020 Jul;126(1):65-72. doi: 10.1111/bju.15103. Epub 2020 May 30.,Joshi A,https://www.ncbi.nlm.nih.gov/pubmed/32383524
15773,33200896,The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study,Minerva Urol Nephrol. 2022 Feb;74(1):38-48. doi: 10.23736/S2724-6051.20.03925-9. Epub 2020 Nov 17.,Gacci M,https://www.ncbi.nlm.nih.gov/pubmed/33200896
15774,33129868,Multiparametric Magnetic Resonance Imaging Should Be Preferred Over Digital Rectal Examination for Prostate Cancer Local Staging and Disease Risk Classification,Urology. 2021 Jan;147:205-212. doi: 10.1016/j.urology.2020.08.089. Epub 2020 Oct 28.,Soeterik TFW,https://www.ncbi.nlm.nih.gov/pubmed/33129868
15776,32921069,Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review,Ann Palliat Med. 2021 May;10(5):5954-5968. doi: 10.21037/apm-20-1128. Epub 2020 Sep 10.,Kent CL,https://www.ncbi.nlm.nih.gov/pubmed/32921069
15778,31653439,A Systematic Review of Sexual Satisfaction in Prostate Cancer Patients,Sex Med Rev. 2020 Jul;8(3):450-465. doi: 10.1016/j.sxmr.2019.09.001. Epub 2019 Oct 23.,Santos-Iglesias P,https://www.ncbi.nlm.nih.gov/pubmed/31653439
15779,33277393,Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer,J Nucl Med. 2021 Jul 1;62(7):989-995. doi: 10.2967/jnumed.120.256263. Epub 2020 Dec 4.,Stuparu AD,https://www.ncbi.nlm.nih.gov/pubmed/33277393
15781,32985924,Hemigland Cryoablation of Clinically Significant Prostate Cancer: Intermediate-Term Followup via Magnetic Resonance Imaging Guided Biopsy,J Urol. 2020 Nov;204(5):941-949. doi: 10.1097/JU.0000000000001133. Epub 2020 Sep 28.,Chuang R,https://www.ncbi.nlm.nih.gov/pubmed/32985924
15782,32897169,Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer,Scand J Urol. 2020 Dec;54(6):481-486. doi: 10.1080/21681805.2020.1814857. Epub 2020 Sep 8.,Anttinen M,https://www.ncbi.nlm.nih.gov/pubmed/32897169
15783,32020032,Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):457-464. doi: 10.1038/s41391-019-0200-z. Epub 2020 Feb 4.,Newton RU,https://www.ncbi.nlm.nih.gov/pubmed/32020032
15784,32060214,Multiphasic (68)Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients,J Nucl Med. 2020 Oct;61(10):1484-1490. doi: 10.2967/jnumed.119.238071. Epub 2020 Feb 14.,Beheshti M,https://www.ncbi.nlm.nih.gov/pubmed/32060214
15785,32665085,Treating De Novo Metastatic Castration-Sensitive Prostate Cancer With Visceral Metastases: An Evolving Issue,Clin Genitourin Cancer. 2021 Feb;19(1):83-86. doi: 10.1016/j.clgc.2020.06.001. Epub 2020 Jun 10.,Roviello G,https://www.ncbi.nlm.nih.gov/pubmed/32665085
15786,32814172,The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer,Pharmacol Res. 2020 Nov;161:105145. doi: 10.1016/j.phrs.2020.105145. Epub 2020 Aug 16.,Matos B,https://www.ncbi.nlm.nih.gov/pubmed/32814172
15787,33058720,Development of an automated radiotherapy dose accumulation workflow for locally advanced high-risk prostate cancer - A technical report,J Med Radiat Sci. 2021 Jun;68(2):203-210. doi: 10.1002/jmrs.442. Epub 2020 Oct 15.,Ong A,https://www.ncbi.nlm.nih.gov/pubmed/33058720
15789,32883962,MicroRNA-107 enhances radiosensitivity by suppressing granulin in PC-3 prostate cancer cells,Sci Rep. 2020 Sep 3;10(1):14584. doi: 10.1038/s41598-020-71128-1.,Lo HC,https://www.ncbi.nlm.nih.gov/pubmed/32883962
15791,32614152,Absence of prostate oedema obviates the need for delay between fiducial marker insertion and radiotherapy simulation,J Med Radiat Sci. 2020 Dec;67(4):302-309. doi: 10.1002/jmrs.412. Epub 2020 Jul 2.,Patel D,https://www.ncbi.nlm.nih.gov/pubmed/32614152
15792,33877047,Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study,Eur Urol Focus. 2021 Sep;7(5):1002-1010. doi: 10.1016/j.euf.2020.09.015. Epub 2020 Oct 24.,von Hardenberg J,https://www.ncbi.nlm.nih.gov/pubmed/33877047
15793,32529451,"Making a case ""against"" focal therapy for intermediate-risk prostate cancer",World J Urol. 2021 Mar;39(3):719-728. doi: 10.1007/s00345-020-03303-y. Epub 2020 Jun 11.,Gontero P,https://www.ncbi.nlm.nih.gov/pubmed/32529451
15794,32360668,Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?,Biochim Biophys Acta Mol Cell Res. 2020 Sep;1867(9):118731. doi: 10.1016/j.bbamcr.2020.118731. Epub 2020 Apr 29.,Braglia L,https://www.ncbi.nlm.nih.gov/pubmed/32360668
15795,32823294,Improving quality of life in patients with metastatic prostate cancer following one cycle of 177Lu-PSMA-617 radioligand therapy: a pilot study,Nuklearmedizin. 2020 Dec;59(6):409-414. doi: 10.1055/a-1234-5891. Epub 2020 Aug 21.,Marinova M,https://www.ncbi.nlm.nih.gov/pubmed/32823294
15797,32633674,Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI,Radiology. 2020 Sep;296(3):564-572. doi: 10.1148/radiol.2020192018. Epub 2020 Jul 7.,Lindenberg L,https://www.ncbi.nlm.nih.gov/pubmed/32633674
15798,32905286,Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer,Curr Oncol. 2020 Aug;27(4):220-224. doi: 10.3747/co.27.6631. Epub 2020 Aug 1.,Southcott D,https://www.ncbi.nlm.nih.gov/pubmed/32905286
15799,33328218,Exercise intervention and sexual function in advanced prostate cancer: a randomised controlled trial,BMJ Support Palliat Care. 2022 Mar;12(1):29-32. doi: 10.1136/bmjspcare-2020-002706. Epub 2020 Dec 16.,Galvão DA,https://www.ncbi.nlm.nih.gov/pubmed/33328218
15800,32510662,The Impact of Geographic Location on Saskatchewan Prostate Cancer Patient Treatment Choices: A Multilevel and Spatial Analysis,J Rural Health. 2020 Sep;36(4):564-576. doi: 10.1111/jrh.12471. Epub 2020 Jun 8.,Andkhoie M,https://www.ncbi.nlm.nih.gov/pubmed/32510662
15801,32852590,MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218),Eur Radiol. 2021 Feb;31(2):716-728. doi: 10.1007/s00330-020-07105-z. Epub 2020 Aug 27.,Gugliandolo SG,https://www.ncbi.nlm.nih.gov/pubmed/32852590
15802,32564173,Comparing the effect of positioning on cerebral autoregulation during radical prostatectomy: a prospective observational study,J Clin Monit Comput. 2021 Aug;35(4):891-901. doi: 10.1007/s10877-020-00549-0. Epub 2020 Jun 20.,Beck S,https://www.ncbi.nlm.nih.gov/pubmed/32564173
15803,31468153,Apical periurethral transition zone lesions: MRI and histology findings,Abdom Radiol (NY). 2020 Oct;45(10):3258-3264. doi: 10.1007/s00261-019-02194-x.,Tuncer S,https://www.ncbi.nlm.nih.gov/pubmed/31468153
15804,33260255,The management of sexual dysfunction resulting from radiotherapy and androgen deprivation therapy to treat prostate cancer: A comparison of uro-oncology practice according to disease stage,Int J Clin Pract. 2021 Apr;75(4):e13873. doi: 10.1111/ijcp.13873. Epub 2020 Dec 28.,Kinnaird W,https://www.ncbi.nlm.nih.gov/pubmed/33260255
15805,32552088,"An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer",Expert Rev Mol Diagn. 2020 Aug;20(8):841-850. doi: 10.1080/14737159.2020.1785288. Epub 2020 Jun 25.,Brönimann S,https://www.ncbi.nlm.nih.gov/pubmed/32552088
15806,32593527,Active surveillance in prostate cancer is possible for Afro-Caribbean population: Comparison of oncological outcomes with a Caucasian cohort,Prog Urol. 2020 Sep;30(10):532-540. doi: 10.1016/j.purol.2020.05.006. Epub 2020 Jun 24.,Percot M,https://www.ncbi.nlm.nih.gov/pubmed/32593527
15808,32980380,"Comment on: Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, by Onal C et al",Radiother Oncol. 2021 Feb;155:e13-e14. doi: 10.1016/j.radonc.2020.09.031. Epub 2020 Sep 24.,Goyal S,https://www.ncbi.nlm.nih.gov/pubmed/32980380
15809,32646877,Immune-Checkpoint Blockade Enhances (225)Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer,J Nucl Med. 2021 Feb;62(2):228-231. doi: 10.2967/jnumed.120.246041. Epub 2020 Jul 9.,Czernin J,https://www.ncbi.nlm.nih.gov/pubmed/32646877
15810,33190809,Resected atypical meningioma relapsed to anaplastic meningioma during luteinizing hormone-releasing hormone agonist therapy,Neurochirurgie. 2021 Apr;67(2):193-197. doi: 10.1016/j.neuchi.2020.10.002. Epub 2020 Oct 22.,Nicosia L,https://www.ncbi.nlm.nih.gov/pubmed/33190809
15811,33259087,CT-based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration-naïve oligometastatic prostate cancer,Prostate. 2021 Feb;81(2):127-134. doi: 10.1002/pros.24088. Epub 2020 Dec 1.,Sheikhbahaei S,https://www.ncbi.nlm.nih.gov/pubmed/33259087
15812,32900629,"Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update",Urol Oncol. 2021 Jan;39(1):34-40. doi: 10.1016/j.urolonc.2020.08.019. Epub 2020 Sep 6.,Powell IJ,https://www.ncbi.nlm.nih.gov/pubmed/32900629
15813,32597270,Mental distress and need for psychosocial support in prostate cancer patients: An observational cross-sectional study,Int J Psychiatry Med. 2021 Jan;56(1):51-63. doi: 10.1177/0091217420938896. Epub 2020 Jun 27.,Baba N,https://www.ncbi.nlm.nih.gov/pubmed/32597270
15815,32068492,Tumor Location and Pathological Features of Latent and Incidental Prostate Cancer in Contemporary Japanese Men,J Urol. 2020 Aug;204(2):267-272. doi: 10.1097/JU.0000000000000804. Epub 2020 Feb 18.,Inaba H,https://www.ncbi.nlm.nih.gov/pubmed/32068492
15816,33166036,The impact of racial residential segregation on prostate cancer diagnosis and treatment,BJU Int. 2021 Jun;127(6):636-644. doi: 10.1111/bju.15293. Epub 2020 Dec 1.,Poulson MR,https://www.ncbi.nlm.nih.gov/pubmed/33166036
15817,32883013,5-(N-Trifluoromethylcarboxy)aminouracil as a Potential DNA Radiosensitizer and Its Radiochemical Conversion into N-Uracil-5-yloxamic Acid,Int J Mol Sci. 2020 Sep 1;21(17):6352. doi: 10.3390/ijms21176352.,Spisz P,https://www.ncbi.nlm.nih.gov/pubmed/32883013
15818,33129718,Resetting the Bar of Castration Resistance - Understanding Androgen Dynamics in Therapy Resistance and Treatment Choice in Prostate Cancer,Clin Genitourin Cancer. 2021 Jun;19(3):199-207. doi: 10.1016/j.clgc.2020.08.008. Epub 2020 Aug 29.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/33129718
15820,33184050,Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial,J Immunother Cancer. 2020 Nov;8(2):e001157. doi: 10.1136/jitc-2020-001157.,Schuhmacher J,https://www.ncbi.nlm.nih.gov/pubmed/33184050
15821,32669231,An Exploration of the Rs of Radiobiology in Prostate Cancer,Semin Oncol Nurs. 2020 Aug;36(4):151054. doi: 10.1016/j.soncn.2020.151054. Epub 2020 Jul 12.,Roberts C,https://www.ncbi.nlm.nih.gov/pubmed/32669231
15822,32592689,Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression,Mol Ther. 2020 Nov 4;28(11):2473-2487. doi: 10.1016/j.ymthe.2020.06.013. Epub 2020 Jun 15.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/32592689
15824,31278659,Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative,J Cancer Educ. 2020 Dec;35(6):1141-1148. doi: 10.1007/s13187-019-01572-9.,Cuypers M,https://www.ncbi.nlm.nih.gov/pubmed/31278659
15825,32521568,Not all prostate cancer is the same - patient perceptions: an Asia-Pacific region study,BJU Int. 2020 Sep;126 Suppl 1:38-45. doi: 10.1111/bju.15129. Epub 2020 Aug 2.,Akakura K,https://www.ncbi.nlm.nih.gov/pubmed/32521568
15826,32783629,Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer,Br J Radiol. 2020 Oct 1;93(1114):20200028. doi: 10.1259/bjr.20200028. Epub 2020 Aug 12.,Schumacher LD,https://www.ncbi.nlm.nih.gov/pubmed/32783629
15827,33214693,TP53 alterations of hormone-naïve prostate cancer in the Chinese population,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):482-491. doi: 10.1038/s41391-020-00302-3. Epub 2020 Nov 19.,Liu Z,https://www.ncbi.nlm.nih.gov/pubmed/33214693
15830,32847699,When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities,Eur Urol. 2021 May;79(5):565-567. doi: 10.1016/j.eururo.2020.07.029. Epub 2020 Aug 23.,Sundahl N,https://www.ncbi.nlm.nih.gov/pubmed/32847699
15831,33338276,"Promoting cell proliferation, cell cycle progression, and glycolysis: Glycometabolism-related genes act as prognostic signatures for prostate cancer",Prostate. 2021 Feb;81(3):157-169. doi: 10.1002/pros.24092. Epub 2020 Dec 18.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/33338276
15832,33408046,The role of prostate-specific antigen in light of new scientific evidence: An update in 2020,Actas Urol Esp (Engl Ed). 2021 Jan-Feb;45(1):21-29. doi: 10.1016/j.acuro.2020.09.005. Epub 2020 Oct 24.,Cózar JM,https://www.ncbi.nlm.nih.gov/pubmed/33408046
15833,32963332,Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer,Sci Rep. 2020 Sep 22;10(1):15415. doi: 10.1038/s41598-020-72088-2.,Trone JC,https://www.ncbi.nlm.nih.gov/pubmed/32963332
15835,32250727,Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on (18)F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer,J Urol. 2020 Sep;204(3):496-502. doi: 10.1097/JU.0000000000001064. Epub 2020 Apr 6.,Markowski MC,https://www.ncbi.nlm.nih.gov/pubmed/32250727
15836,33274851,Patient-Derived Prostate Cancer Explants: A Clinically Relevant Model to Assess siRNA-Based Nanomedicines,Adv Healthc Mater. 2021 Mar;10(6):e2001594. doi: 10.1002/adhm.202001594. Epub 2020 Dec 4.,Tieu T,https://www.ncbi.nlm.nih.gov/pubmed/33274851
15837,33222581,Prostatic dystrophic calcification following salvage cryotherapy for prostate cancer - an under-reported entity?,Scand J Urol. 2021 Feb;55(1):33-35. doi: 10.1080/21681805.2020.1849388. Epub 2020 Nov 23.,Lavi A,https://www.ncbi.nlm.nih.gov/pubmed/33222581
15838,33341358,The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy,Urol Oncol. 2021 May;39(5):297.e9-297.e16. doi: 10.1016/j.urolonc.2020.11.041. Epub 2020 Dec 17.,Perrin A,https://www.ncbi.nlm.nih.gov/pubmed/33341358
15839,32715593,Tumour-capsule interface measured on 18F-DCFPyL PSMA positron emission tomography/CT imaging comparable to multi-parametric MRI in predicting extra-prostatic extension of prostate cancer at initial staging,J Med Imaging Radiat Oncol. 2020 Dec;64(6):829-838. doi: 10.1111/1754-9485.13084. Epub 2020 Jul 27.,Brauchli D,https://www.ncbi.nlm.nih.gov/pubmed/32715593
15840,33372564,Identifying Risk Profiles of Malignant Prostate Cancer Surgical Delay Using a Person-Centered Approach to Understand Prostate Cancer Disparities: The Constellation of Health Determinants Using Latent Class Analysis on Cancer Registry Data,Am J Mens Health. 2020 Nov-Dec;14(6):1557988320984282. doi: 10.1177/1557988320984282.,Montiel Ishino FA,https://www.ncbi.nlm.nih.gov/pubmed/33372564
15842,32938571,Hospital-level Effects Contribute to Variations in Prostate Cancer Quality of Care,Eur Urol Oncol. 2021 Jun;4(3):494-497. doi: 10.1016/j.euo.2020.08.010. Epub 2020 Sep 13.,Lawson KA,https://www.ncbi.nlm.nih.gov/pubmed/32938571
15843,32701725,An up-to-date catalogue of urinary markers for the management of prostate cancer,Curr Opin Urol. 2020 Sep;30(5):684-688. doi: 10.1097/MOU.0000000000000807.,Brönimann S,https://www.ncbi.nlm.nih.gov/pubmed/32701725
15845,32956765,Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications,Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188424. doi: 10.1016/j.bbcan.2020.188424. Epub 2020 Sep 18.,Carpenter VJ,https://www.ncbi.nlm.nih.gov/pubmed/32956765
15847,32865575,Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan,JAMA Netw Open. 2020 Aug 3;3(8):e2015189. doi: 10.1001/jamanetworkopen.2020.15189.,Huang WK,https://www.ncbi.nlm.nih.gov/pubmed/32865575
15848,33616071,The Role of Radiotherapy Among Patients With Prostate Ductal Adenocarcinoma,Clin Genitourin Cancer. 2021 Feb;19(1):e41-e50. doi: 10.1016/j.clgc.2020.07.004. Epub 2020 Aug 3.,Patel M,https://www.ncbi.nlm.nih.gov/pubmed/33616071
15849,32627817,National survey of radiation oncologists' practice patterns regarding hormone-naïve prostate cancer with bone metastases,Jpn J Clin Oncol. 2020 Sep 28;50(10):1188-1194. doi: 10.1093/jjco/hyaa111.,Nakamura K,https://www.ncbi.nlm.nih.gov/pubmed/32627817
15850,32096678,Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer,J Urol. 2020 Sep;204(3):416-426. doi: 10.1097/JU.0000000000000809. Epub 2020 Feb 25.,Saad F,https://www.ncbi.nlm.nih.gov/pubmed/32096678
15851,33000457,The Effect of Single-port Transvesical Laparoscopic Radical Prostatectomy on Erectile Function and Urinary Continence Compared to Intrafascial Endoscopic Extraperitoneal Radical Prostatectomy,Urol J. 2020 Oct 1;17(6):592-596. doi: 10.22037/uj.v16i7.6355.,Yang Y,https://www.ncbi.nlm.nih.gov/pubmed/33000457
15852,32700143,Risk of fracture incidence in prostate cancer survivors: a nationwide cohort study in South Korea,Arch Osteoporos. 2020 Jul 22;15(1):110. doi: 10.1007/s11657-020-00785-6.,Shin HB,https://www.ncbi.nlm.nih.gov/pubmed/32700143
15855,33004037,Can (68)Ga-prostate specific membrane antigen positron emission tomography/computerized tomography provide an accurate lymph node staging for patients with medium/high risk prostate cancer? A diagnostic meta-analysis,Radiat Oncol. 2020 Oct 1;15(1):227. doi: 10.1186/s13014-020-01675-4.,Peng L,https://www.ncbi.nlm.nih.gov/pubmed/33004037
15856,32989259,MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):406-413. doi: 10.1038/s41391-020-00290-4. Epub 2020 Sep 28.,Luzzago S,https://www.ncbi.nlm.nih.gov/pubmed/32989259
15857,33373705,Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary,Urology. 2021 Sep;155:165-171. doi: 10.1016/j.urology.2020.12.021. Epub 2020 Dec 26.,Hofmann MR,https://www.ncbi.nlm.nih.gov/pubmed/33373705
15858,32525248,Effect of Treatment Sequencing on the Tumor Response to Combined Treatment With Ultrasound-Stimulated Microbubbles and Radiotherapy,J Ultrasound Med. 2020 Dec;39(12):2415-2425. doi: 10.1002/jum.15363. Epub 2020 Jun 11.,Klein J,https://www.ncbi.nlm.nih.gov/pubmed/32525248
15859,33079329,Long-term follow-up 3 years after a randomized rehabilitation study among radiated prostate cancer survivors,J Cancer Surviv. 2021 Oct;15(5):668-676. doi: 10.1007/s11764-020-00958-9. Epub 2020 Oct 20.,Dieperink KB,https://www.ncbi.nlm.nih.gov/pubmed/33079329
15860,32606361,Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer,Nat Rev Urol. 2020 Aug;17(8):469-481. doi: 10.1038/s41585-020-0335-7. Epub 2020 Jun 30.,Perera M,https://www.ncbi.nlm.nih.gov/pubmed/32606361
15861,34092288,Intraocular metastasis as a systemic presentation of neuroendocrine differentiation of prostate carcinoma,Arch Soc Esp Oftalmol (Engl Ed). 2021 Jun;96(6):332-336. doi: 10.1016/j.oftale.2020.05.033. Epub 2020 Sep 29.,Valentín Bravo FJ,https://www.ncbi.nlm.nih.gov/pubmed/34092288
15862,32950833,Simple low-cost approaches to semantic segmentation in radiation therapy planning for prostate cancer using deep learning with non-contrast planning CT images,Phys Med. 2020 Oct;78:93-100. doi: 10.1016/j.ejmp.2020.09.004. Epub 2020 Sep 17.,Nemoto T,https://www.ncbi.nlm.nih.gov/pubmed/32950833
15863,33385701,ProsRegNet: A deep learning framework for registration of MRI and histopathology images of the prostate,Med Image Anal. 2021 Feb;68:101919. doi: 10.1016/j.media.2020.101919. Epub 2020 Dec 17.,Shao W,https://www.ncbi.nlm.nih.gov/pubmed/33385701
15864,31846064,Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer,Int J Cancer. 2020 Aug 15;147(4):1228-1234. doi: 10.1002/ijc.32832. Epub 2020 Jan 2.,Ersvaer E,https://www.ncbi.nlm.nih.gov/pubmed/31846064
15865,33309298,Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients,Urol Oncol. 2021 Feb;39(2):130.e17-130.e24. doi: 10.1016/j.urolonc.2020.09.033. Epub 2020 Dec 9.,Sun M,https://www.ncbi.nlm.nih.gov/pubmed/33309298
15866,32705287,Long non?coding RNA BCYRN1 promotes prostate cancer progression via elevation of HDAC11,Oncol Rep. 2020 Sep;44(3):1233-1245. doi: 10.3892/or.2020.7680. Epub 2020 Jul 7.,Huo W,https://www.ncbi.nlm.nih.gov/pubmed/32705287
15867,32451781,Transient renal dysfunction due to rhabdomyolysis after robot-assisted radical prostatectomy,Int Urol Nephrol. 2020 Oct;52(10):1877-1884. doi: 10.1007/s11255-020-02500-3. Epub 2020 May 25.,Onagi A,https://www.ncbi.nlm.nih.gov/pubmed/32451781
15868,32062682,Radioligand therapy using [(177)Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis,Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2106-2112. doi: 10.1007/s00259-020-04703-3. Epub 2020 Feb 16.,Seifert R,https://www.ncbi.nlm.nih.gov/pubmed/32062682
15869,32159858,Intratumoral heterogeneity and genetic characteristics of prostate cancer,Int J Cancer. 2020 Jun 15;146(12):3369-3378. doi: 10.1002/ijc.32961. Epub 2020 Mar 25.,Wu B,https://www.ncbi.nlm.nih.gov/pubmed/32159858
15871,32314028,(68)Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy,Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2804-2815. doi: 10.1007/s00259-020-04809-8. Epub 2020 Apr 20.,Deandreis D,https://www.ncbi.nlm.nih.gov/pubmed/32314028
15872,29730957,Homeostasis: apoptosis and cell cycle in normal and pathological prostate,Aging Male. 2020 Dec;23(5):335-345. doi: 10.1080/13685538.2018.1470233. Epub 2018 May 6.,Torrealba N,https://www.ncbi.nlm.nih.gov/pubmed/29730957
15873,32504818,Lipid droplets in prostate cancer cells and effect of irradiation studied by Raman microspectroscopy,Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158753. doi: 10.1016/j.bbalip.2020.158753. Epub 2020 Jun 3.,Roman M,https://www.ncbi.nlm.nih.gov/pubmed/32504818
15874,30723050,Prostate Cancer Survival Estimates by the General Public Using Unrestricted Internet Searches and Online Nomograms,Eur Urol Focus. 2020 Sep 15;6(5):959-966. doi: 10.1016/j.euf.2019.01.012. Epub 2019 Feb 2.,Campagna JP,https://www.ncbi.nlm.nih.gov/pubmed/30723050
15875,32569513,Utility of (18)F-Fluciclovine PET/CT for Detecting Prostate Cancer Recurrence in Patients With Low (< 1 ng/mL) or Very Low (< 0.3 ng/mL) Prostate-Specific Antigen Levels,AJR Am J Roentgenol. 2020 Oct;215(4):997-1001. doi: 10.2214/AJR.19.22180. Epub 2020 Jun 22.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32569513
15876,33119791,Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review,Support Care Cancer. 2021 Apr;29(4):1811-1824. doi: 10.1007/s00520-020-05830-1. Epub 2020 Oct 29.,Bressi B,https://www.ncbi.nlm.nih.gov/pubmed/33119791
15877,32067075,Buccal mucosal graft urethroplasty for radiation-induced urethral strictures: an evaluation using the extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM),World J Urol. 2020 Nov;38(11):2863-2872. doi: 10.1007/s00345-020-03102-5. Epub 2020 Feb 18.,Vetterlein MW,https://www.ncbi.nlm.nih.gov/pubmed/32067075
15878,33334759,Cauda equina compression in metastatic prostate cancer,BMJ Case Rep. 2020 Dec 17;13(12):e237779. doi: 10.1136/bcr-2020-237779.,Siddiqui RS,https://www.ncbi.nlm.nih.gov/pubmed/33334759
15879,33374960,The Role of Gold Nanorods in the Response of Prostate Cancer and Normal Prostate Cells to Ionizing Radiation-In Vitro Model,Int J Mol Sci. 2020 Dec 22;22(1):16. doi: 10.3390/ijms22010016.,Musielak M,https://www.ncbi.nlm.nih.gov/pubmed/33374960
15880,32716640,Knockdown of Circ_CCNB2 Sensitizes Prostate Cancer to Radiation Through Repressing Autophagy by the miR-30b-5p/KIF18A Axis,Cancer Biother Radiopharm. 2022 Aug;37(6):480-493. doi: 10.1089/cbr.2019.3538. Epub 2020 Jul 23.,Cai F,https://www.ncbi.nlm.nih.gov/pubmed/32716640
15881,32516165,Predictors of resistance to abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer in post-docetaxel setting: a single-center cohort study,Anticancer Drugs. 2020 Aug;31(7):742-746. doi: 10.1097/CAD.0000000000000945.,Omr?en T,https://www.ncbi.nlm.nih.gov/pubmed/32516165
15882,33135402,Complementing the active surveillance criteria with multiparametric magnetic resonance imaging,Investig Clin Urol. 2020 Nov;61(6):573-581. doi: 10.4111/icu.20200159.,Kim TU,https://www.ncbi.nlm.nih.gov/pubmed/33135402
15883,33172774,"Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of (177)Lu-PSMA-617 Prior to Prostatectomy",Eur Urol Focus. 2021 Mar;7(2):234-237. doi: 10.1016/j.euf.2020.09.021. Epub 2020 Nov 7.,Dhiantravan N,https://www.ncbi.nlm.nih.gov/pubmed/33172774
15885,33171313,Pharmacologic management of metastatic bone disease,Bone. 2022 May;158:115735. doi: 10.1016/j.bone.2020.115735. Epub 2020 Nov 7.,Schwartz E,https://www.ncbi.nlm.nih.gov/pubmed/33171313
15886,32201320,Electromagnetic Transponder Localization and Real-Time Tracking for Prostate Cancer Radiation Therapy: Clinical Impact of Metallic Hip Prostheses,Pract Radiat Oncol. 2020 Nov-Dec;10(6):e538-e542. doi: 10.1016/j.prro.2020.03.003. Epub 2020 Mar 19.,Bottero M,https://www.ncbi.nlm.nih.gov/pubmed/32201320
15887,32847482,Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?,J Oncol Pharm Pract. 2021 Sep;27(6):1388-1394. doi: 10.1177/1078155220951612. Epub 2020 Aug 26.,Dülgar Ö,https://www.ncbi.nlm.nih.gov/pubmed/32847482
15891,32583529,Effect of reoxygenation on hypofractionated radiotherapy of prostate cancer,Med Phys. 2020 Oct;47(10):5383-5391. doi: 10.1002/mp.14343. Epub 2020 Sep 3.,Kuperman VY,https://www.ncbi.nlm.nih.gov/pubmed/32583529
15892,32966797,Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases,Cell Rep. 2020 Sep 22;32(12):108181. doi: 10.1016/j.celrep.2020.108181.,Canesin G,https://www.ncbi.nlm.nih.gov/pubmed/32966797
15893,32891133,Clinical outcome of surgical management for symptomatic metastatic spinal cord compression from prostate cancer,BMC Urol. 2020 Sep 5;20(1):143. doi: 10.1186/s12894-020-00713-3.,Miyoshi Y,https://www.ncbi.nlm.nih.gov/pubmed/32891133
15895,32347457,Identification and Design of a Next-Generation Multi Epitopes Bases Peptide Vaccine Candidate Against Prostate Cancer: An In Silico Approach,Cell Biochem Biophys. 2020 Dec;78(4):495-509. doi: 10.1007/s12013-020-00912-7. Epub 2020 Apr 28.,Patra P,https://www.ncbi.nlm.nih.gov/pubmed/32347457
15896,33303404,An Artificial Intelligence-based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies,Eur Urol Focus. 2021 Sep;7(5):995-1001. doi: 10.1016/j.euf.2020.11.001. Epub 2020 Dec 7.,Marginean F,https://www.ncbi.nlm.nih.gov/pubmed/33303404
15897,32716685,PI-RADS(R) Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance,J Urol. 2020 Dec;204(6):1229-1235. doi: 10.1097/JU.0000000000001307. Epub 2020 Jul 27.,Wang AZ,https://www.ncbi.nlm.nih.gov/pubmed/32716685
15898,32978518,A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotype,Oncogene. 2020 Oct;39(44):6871-6878. doi: 10.1038/s41388-020-01476-9. Epub 2020 Sep 25.,Qian K,https://www.ncbi.nlm.nih.gov/pubmed/32978518
15899,32516029,A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging,J Urol. 2020 Dec;204(6):1195-1201. doi: 10.1097/JU.0000000000001184. Epub 2020 Sep 9.,Connor MJ,https://www.ncbi.nlm.nih.gov/pubmed/32516029
15901,32784507,Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level,Cells. 2020 Aug 8;9(8):1863. doi: 10.3390/cells9081863.,Rangel-Pozzo A,https://www.ncbi.nlm.nih.gov/pubmed/32784507
15903,33283584,The targeted inhibition of prostate cancer by iron-based nanoparticles based on bioinformatics,J Biomater Appl. 2021 Jul;36(1):3-14. doi: 10.1177/0885328220975249. Epub 2020 Dec 6.,Xiao F,https://www.ncbi.nlm.nih.gov/pubmed/33283584
15904,33160001,Mini review: Personalization of the radiation therapy management of prostate cancer using MRI-based radiomics,Cancer Lett. 2021 Feb 1;498:210-216. doi: 10.1016/j.canlet.2020.10.033. Epub 2020 Nov 4.,Leech M,https://www.ncbi.nlm.nih.gov/pubmed/33160001
15905,32634447,The Clinical Application and Potential Roles of Circulating Tumor Cells in Bladder Cancer and Prostate Cancer,Urology. 2020 Nov;145:30-37. doi: 10.1016/j.urology.2020.06.039. Epub 2020 Jul 4.,Yan H,https://www.ncbi.nlm.nih.gov/pubmed/32634447
15909,32811715,Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors,Eur Urol. 2020 Dec;78(6):822-830. doi: 10.1016/j.eururo.2020.07.032. Epub 2020 Aug 15.,Fizazi K,https://www.ncbi.nlm.nih.gov/pubmed/32811715
15910,31875956,A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population,Int J Cancer. 2020 Aug 15;147(4):1143-1151. doi: 10.1002/ijc.32851. Epub 2020 Jan 21.,Badrising SK,https://www.ncbi.nlm.nih.gov/pubmed/31875956
15912,32219979,Tumour location determined by preoperative MRI is an independent predictor for positive surgical margin status after Retzius-sparing robot-assisted radical prostatectomy,BJU Int. 2020 Jul;126(1):152-158. doi: 10.1111/bju.15060. Epub 2020 Apr 17.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32219979
15913,32427630,Systemic treatment options for metastatic hormone-sensitive prostate cancer: making sense of the data,Curr Opin Urol. 2020 Jul;30(4):576-583. doi: 10.1097/MOU.0000000000000778.,Baston C,https://www.ncbi.nlm.nih.gov/pubmed/32427630
15914,32621789,Using deep learning to predict beam-tunable Pareto optimal dose distribution for intensity-modulated radiation therapy,Med Phys. 2020 Sep;47(9):3898-3912. doi: 10.1002/mp.14374. Epub 2020 Aug 2.,Bohara G,https://www.ncbi.nlm.nih.gov/pubmed/32621789
15915,32515678,Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology,Radiology. 2020 Aug;296(2):348-355. doi: 10.1148/radiol.2020192330. Epub 2020 Jun 9.,Zhang Z,https://www.ncbi.nlm.nih.gov/pubmed/32515678
15916,33457094,Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen,Oncoimmunology. 2020 Sep 6;9(1):1809926. doi: 10.1080/2162402X.2020.1809926.,Lopez-Bujanda ZA,https://www.ncbi.nlm.nih.gov/pubmed/33457094
15917,33182844,Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate Cancer,Int J Mol Sci. 2020 Nov 10;21(22):8447. doi: 10.3390/ijms21228447.,Zamagni A,https://www.ncbi.nlm.nih.gov/pubmed/33182844
15918,33164217,Inter- and intra-fractional stability of rectal gas in pelvic cancer patients during MRIgRT,Med Phys. 2021 Jan;48(1):414-426. doi: 10.1002/mp.14586. Epub 2020 Nov 30.,Shortall J,https://www.ncbi.nlm.nih.gov/pubmed/33164217
15919,32319003,Percutaneous nephrostomy in obstructing pelvic malignancy does not facilitate further oncological treatment,Int Urol Nephrol. 2020 Sep;52(9):1625-1628. doi: 10.1007/s11255-020-02466-2. Epub 2020 Apr 22.,Folkard SS,https://www.ncbi.nlm.nih.gov/pubmed/32319003
15920,32969171,Radiotherapy for prostate cancer: Effect of gold fiducial markers on diffusion-weighted magnetic resonance imaging,Asia Pac J Clin Oncol. 2021 Feb;17(1):79-83. doi: 10.1111/ajco.13409. Epub 2020 Sep 24.,Tanaka O,https://www.ncbi.nlm.nih.gov/pubmed/32969171
15922,32565318,Impact of Sequencing of Androgen Suppression and Radiation Therapy on Testosterone Recovery in Localized Prostate Cancer,Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1179-1188. doi: 10.1016/j.ijrobp.2020.06.017. Epub 2020 Jun 18.,Roy S,https://www.ncbi.nlm.nih.gov/pubmed/32565318
15924,32407168,Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/?-Catenin Pathway,Cancer Biother Radiopharm. 2020 Nov;35(9):682-695. doi: 10.1089/cbr.2019.3479. Epub 2020 May 14.,Song X,https://www.ncbi.nlm.nih.gov/pubmed/32407168
15925,32876839,"T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology",Eur Radiol. 2021 Mar;31(3):1336-1346. doi: 10.1007/s00330-020-07214-9. Epub 2020 Sep 2.,Shiradkar R,https://www.ncbi.nlm.nih.gov/pubmed/32876839
15926,32549522,Serum paraoxonase 1 and 3 activities in benign and malignant diseases of the prostate and changes in levels following robotic-assisted laparoscopic radical prostatectomy,Turk J Med Sci. 2020 Dec 17;50(8):1872-1878. doi: 10.3906/sag-2004-353.,Bedir F,https://www.ncbi.nlm.nih.gov/pubmed/32549522
15927,32620459,Prostate imaging: Contribution of PET PSMA and MRI,Cancer Radiother. 2020 Aug;24(5):423-428. doi: 10.1016/j.canrad.2020.06.002. Epub 2020 Jun 30.,Abecassis JP,https://www.ncbi.nlm.nih.gov/pubmed/32620459
15928,33370412,The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients,PLoS One. 2020 Dec 28;15(12):e0244663. doi: 10.1371/journal.pone.0244663. eCollection 2020.,Gevaert T,https://www.ncbi.nlm.nih.gov/pubmed/33370412
15929,33137623,Feasibility of image quality improvement for high-speed CBCT imaging using deep convolutional neural network for image-guided radiotherapy in prostate cancer,Phys Med. 2020 Dec;80:84-91. doi: 10.1016/j.ejmp.2020.10.012. Epub 2020 Nov 1.,Kurosawa T,https://www.ncbi.nlm.nih.gov/pubmed/33137623
15930,32814442,Efficacy and Safety of Surgery for Benign Prostatic Obstruction in Patients with Preoperative Urinary Catheter,J Endourol. 2021 Jan;35(1):102-108. doi: 10.1089/end.2020.0704. Epub 2020 Sep 23.,Gondran-Tellier B,https://www.ncbi.nlm.nih.gov/pubmed/32814442
15931,33207137,A Comparison of Prostate Cancer Detection between Visual Estimation (Cognitive Registration) and Image Fusion (Software Registration) Targeted Transperineal Prostate Biopsy,J Urol. 2021 Apr;205(4):1075-1081. doi: 10.1097/JU.0000000000001476. Epub 2020 Nov 18.,Khoo CC,https://www.ncbi.nlm.nih.gov/pubmed/33207137
15934,33380323,"Cerebral oxygenation in 45-degree trendelenburg position for robot-assisted radical prostatectomy: a single-center, open, controlled pilot study",BMC Urol. 2020 Dec 30;20(1):198. doi: 10.1186/s12894-020-00774-4.,Wiesinger C,https://www.ncbi.nlm.nih.gov/pubmed/33380323
15935,33346019,Development of generalized time-dependent TCP model and the investigation of the effect of repopulation and weekend breaks in fractionated external beam therapy,J Theor Biol. 2021 Mar 7;512:110565. doi: 10.1016/j.jtbi.2020.110565. Epub 2020 Dec 18.,Lee TK,https://www.ncbi.nlm.nih.gov/pubmed/33346019
15936,32681926,YB-1: The key to personalised prostate cancer management?,Cancer Lett. 2020 Oct 10;490:66-75. doi: 10.1016/j.canlet.2020.07.006. Epub 2020 Jul 16.,Bates M,https://www.ncbi.nlm.nih.gov/pubmed/32681926
15937,32242253,(68)Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series,Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2624-2632. doi: 10.1007/s00259-020-04783-1. Epub 2020 Apr 2.,Olde Heuvel J,https://www.ncbi.nlm.nih.gov/pubmed/32242253
15938,31758511,Application of [(68)Ga]PSMA PET/CT in Diagnosis and Management of Prostate Cancer Patients,Mol Imaging Biol. 2020 Aug;22(4):1062-1069. doi: 10.1007/s11307-019-01445-z.,Dadgar H,https://www.ncbi.nlm.nih.gov/pubmed/31758511
15939,32725779,Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy,Thorac Cancer. 2020 Sep;11(9):2639-2649. doi: 10.1111/1759-7714.13596. Epub 2020 Jul 29.,Liang JA,https://www.ncbi.nlm.nih.gov/pubmed/32725779
15940,32631766,Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?,Clin Genitourin Cancer. 2020 Dec;18(6):425-428. doi: 10.1016/j.clgc.2020.05.003. Epub 2020 May 11.,Adashek JJ,https://www.ncbi.nlm.nih.gov/pubmed/32631766
15941,32669672,"The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer",Br J Cancer. 2020 Sep;123(7):1063-1070. doi: 10.1038/s41416-020-0978-4. Epub 2020 Jul 16.,Noble SM,https://www.ncbi.nlm.nih.gov/pubmed/32669672
15942,33068792,Impact of Treating Physician on Radiation Therapy Related Severe Toxicities in Men with Prostate Cancer,Pract Radiat Oncol. 2021 May-Jun;11(3):e292-e300. doi: 10.1016/j.prro.2020.09.013. Epub 2020 Oct 14.,Roy S,https://www.ncbi.nlm.nih.gov/pubmed/33068792
15943,31618113,Comparison of prostate cancer detection rates between the Vienna nomogram and the 10-core biopsy protocol,Urologia. 2020 Aug;87(3):155-159. doi: 10.1177/0391560319882224. Epub 2019 Oct 16.,Arda E,https://www.ncbi.nlm.nih.gov/pubmed/31618113
15944,33323452,Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods study,BMJ Open. 2020 Dec 15;10(12):e045500. doi: 10.1136/bmjopen-2020-045500.,Fiard G,https://www.ncbi.nlm.nih.gov/pubmed/33323452
15945,32941092,Robust treatment planning of dose painting for prostate cancer based on ADC-to-Gleason score mappings - what is the potential to increase the tumor control probability?,Acta Oncol. 2021 Feb;60(2):199-206. doi: 10.1080/0284186X.2020.1817547. Epub 2020 Sep 17.,Grönlund E,https://www.ncbi.nlm.nih.gov/pubmed/32941092
15946,32737518,Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer,Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):340-349. doi: 10.1007/s00259-020-04971-z. Epub 2020 Jul 31.,Cysouw MCF,https://www.ncbi.nlm.nih.gov/pubmed/32737518
15947,32641865,Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model,Br J Cancer. 2020 Sep;123(7):1089-1100. doi: 10.1038/s41416-020-0956-x. Epub 2020 Jul 9.,Philippou Y,https://www.ncbi.nlm.nih.gov/pubmed/32641865
15948,32605859,Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials,Eur Urol. 2021 Jan;79(1):44-53. doi: 10.1016/j.eururo.2020.06.002. Epub 2020 Jun 27.,Abufaraj M,https://www.ncbi.nlm.nih.gov/pubmed/32605859
15949,33000302,Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort,Eur Radiol. 2021 Mar;31(3):1644-1655. doi: 10.1007/s00330-020-07256-z. Epub 2020 Sep 30.,Giganti F,https://www.ncbi.nlm.nih.gov/pubmed/33000302
15950,32081564,Lower postoperative natural killer cell activity is associated with positive surgical margins after radical prostatectomy,J Formos Med Assoc. 2020 Nov;119(11):1673-1683. doi: 10.1016/j.jfma.2019.12.015. Epub 2020 Feb 17.,Lu YC,https://www.ncbi.nlm.nih.gov/pubmed/32081564
15951,31784699,Risk of dementia following androgen deprivation therapy for treatment of prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):410-418. doi: 10.1038/s41391-019-0189-3. Epub 2019 Nov 29.,Krasnova A,https://www.ncbi.nlm.nih.gov/pubmed/31784699
15952,33382378,"Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial",J Med Internet Res. 2020 Dec 31;22(12):e19238. doi: 10.2196/19238.,Chan JM,https://www.ncbi.nlm.nih.gov/pubmed/33382378
15953,32167075,Orgasm-associated urinary incontinence (climacturia) following radical prostatectomy: a review of pathophysiology and current treatment options,Asian J Androl. 2020 Nov-Dec;22(6):549-554. doi: 10.4103/aja.aja_145_19.,Kannady C,https://www.ncbi.nlm.nih.gov/pubmed/32167075
15954,33234494,Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review,J Geriatr Oncol. 2021 Jun;12(5):687-695. doi: 10.1016/j.jgo.2020.11.002. Epub 2020 Nov 22.,Batra A,https://www.ncbi.nlm.nih.gov/pubmed/33234494
15955,32907896,Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial,BMJ Open. 2020 Sep 9;10(9):e036024. doi: 10.1136/bmjopen-2019-036024.,Wade J,https://www.ncbi.nlm.nih.gov/pubmed/32907896
15956,32098770,"Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators",Clin Cancer Res. 2020 Jul 1;26(13):3079-3090. doi: 10.1158/1078-0432.CCR-19-2744. Epub 2020 Feb 25.,Huh JW,https://www.ncbi.nlm.nih.gov/pubmed/32098770
15957,32924096,"Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis",Int J Clin Oncol. 2020 Nov;25(11):1892-1900. doi: 10.1007/s10147-020-01777-9. Epub 2020 Sep 14.,Mori K,https://www.ncbi.nlm.nih.gov/pubmed/32924096
15958,32852532,Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability,JAMA Oncol. 2020 Oct 1;6(10):e203187. doi: 10.1001/jamaoncol.2020.3187. Epub 2020 Oct 8.,Cooperberg MR,https://www.ncbi.nlm.nih.gov/pubmed/32852532
15959,32094489,Androgen receptor variant-driven prostate cancer II: advances in clinical investigation,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):367-380. doi: 10.1038/s41391-020-0215-5. Epub 2020 Feb 24.,Brown LC,https://www.ncbi.nlm.nih.gov/pubmed/32094489
15960,32387546,Improving 3D ultrasound prostate localisation in radiotherapy through increased automation of interfraction matching,Radiother Oncol. 2020 Aug;149:134-141. doi: 10.1016/j.radonc.2020.04.044. Epub 2020 May 6.,Grimwood A,https://www.ncbi.nlm.nih.gov/pubmed/32387546
15961,33341915,Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [(68)Ga]Ga-PSMA-11 PET/MRI,Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1795-1805. doi: 10.1007/s00259-020-05140-y. Epub 2020 Dec 19.,Papp L,https://www.ncbi.nlm.nih.gov/pubmed/33341915
15962,33254278,Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients,Oral Dis. 2022 Jan;28(1):182-192. doi: 10.1111/odi.13737. Epub 2020 Dec 14.,Wei LY,https://www.ncbi.nlm.nih.gov/pubmed/33254278
15963,33160846,Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings,Urol Oncol. 2021 Jul;39(7):432.e11-432.e19. doi: 10.1016/j.urolonc.2020.10.016. Epub 2020 Nov 5.,Morote J,https://www.ncbi.nlm.nih.gov/pubmed/33160846
15964,33207020,"Technical Note: ADAM PETer - An anthropomorphic, deformable and multimodality pelvis phantom with positron emission tomography extension for radiotherapy",Med Phys. 2021 Apr;48(4):1624-1632. doi: 10.1002/mp.14597. Epub 2020 Dec 13.,Gillmann C,https://www.ncbi.nlm.nih.gov/pubmed/33207020
15965,33141104,Mobile Health App for Prostate Cancer Patients on Androgen Deprivation Therapy: Qualitative Usability Study,JMIR Mhealth Uhealth. 2020 Nov 3;8(11):e20224. doi: 10.2196/20224.,Nabi J,https://www.ncbi.nlm.nih.gov/pubmed/33141104
15966,32576002,Acinar with ductal and mucinous adenocarcinoma of prostate cancer complicated with lung metastasis: a case report and literature review,Ann Palliat Med. 2021 Feb;10(2):2366-2370. doi: 10.21037/apm-20-386. Epub 2020 Jun 23.,Cui Y,https://www.ncbi.nlm.nih.gov/pubmed/32576002
15967,32609585,Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation,JCO Oncol Pract. 2020 Dec;16(12):e1524-e1531. doi: 10.1200/OP.20.00122. Epub 2020 Jul 1.,Kouzy R,https://www.ncbi.nlm.nih.gov/pubmed/32609585
15968,33284845,Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool,PLoS One. 2020 Dec 7;15(12):e0240039. doi: 10.1371/journal.pone.0240039. eCollection 2020.,Frendl DM,https://www.ncbi.nlm.nih.gov/pubmed/33284845
15969,33079283,Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study),Int J Clin Oncol. 2021 Jan;26(1):199-206. doi: 10.1007/s10147-020-01798-4. Epub 2020 Oct 16.,Hamaya T,https://www.ncbi.nlm.nih.gov/pubmed/33079283
15970,31919032,Real World Experience With Pembrolizumab in Recurrent or Advanced Prostate Cancer,Clin Genitourin Cancer. 2020 Aug;18(4):e397-e401. doi: 10.1016/j.clgc.2019.12.009. Epub 2019 Dec 13.,Higa J,https://www.ncbi.nlm.nih.gov/pubmed/31919032
15971,33340388,"Prostate SBRT using O-Ring Halcyon Linac - Plan quality, delivery efficiency, and accuracy",J Appl Clin Med Phys. 2021 Jan;22(1):68-75. doi: 10.1002/acm2.13105. Epub 2020 Dec 19.,Pokhrel D,https://www.ncbi.nlm.nih.gov/pubmed/33340388
15972,32986870,Impact of spironolactone exposure on prostate cancer incidence amongst men with heart failure: A Pharmacoepidemiological study,Br J Clin Pharmacol. 2021 Apr;87(4):1801-1813. doi: 10.1111/bcp.14568. Epub 2020 Nov 20.,Hiebert BM,https://www.ncbi.nlm.nih.gov/pubmed/32986870
15974,32863151,The Impact of Placement Errors on the Tumor Coverage in MRI-Guided Focal Cryoablation of Prostate Cancer,Acad Radiol. 2021 Jun;28(6):841-848. doi: 10.1016/j.acra.2020.07.013. Epub 2020 Aug 27.,Moreira P,https://www.ncbi.nlm.nih.gov/pubmed/32863151
15975,32620539,The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer,Eur Urol Focus. 2021 May;7(3):537-545. doi: 10.1016/j.euf.2020.06.005. Epub 2020 Jun 30.,Goldberg H,https://www.ncbi.nlm.nih.gov/pubmed/32620539
15976,32557725,Can ultrasound irradiation be a therapeutic option for prostate cancer?,Prostate. 2020 Sep;80(12):986-992. doi: 10.1002/pros.24030. Epub 2020 Jun 18.,Maeshige N,https://www.ncbi.nlm.nih.gov/pubmed/32557725
15977,33093594,Effect of androgen deprivation therapy on cardiovascular function in Chinese patients with advanced prostate cancer: a prospective cohort study,Sci Rep. 2020 Oct 22;10(1):18060. doi: 10.1038/s41598-020-75139-w.,Ng CF,https://www.ncbi.nlm.nih.gov/pubmed/33093594
15978,33079252,Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN,World J Urol. 2021 Jul;39(7):2491-2497. doi: 10.1007/s00345-020-03494-4. Epub 2020 Oct 20.,Hirama H,https://www.ncbi.nlm.nih.gov/pubmed/33079252
15979,32895442,Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study,Sci Rep. 2020 Sep 7;10(1):14713. doi: 10.1038/s41598-020-71715-2.,Kim YJ,https://www.ncbi.nlm.nih.gov/pubmed/32895442
15980,32604113,Dose Calculations and Dose-Effect Relationships in 177Lu-PSMA I&T Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer,Clin Nucl Med. 2020 Sep;45(9):661-667. doi: 10.1097/RLU.0000000000003157.,Barna S,https://www.ncbi.nlm.nih.gov/pubmed/32604113
15981,32683066,Targeted Focal Cryoablation for Prostate Cancer With Real-time Transrectal Ultrasound-guided Free-hands Technique: A Step-by-step Technique,Urology. 2020 Oct;144:261-262. doi: 10.1016/j.urology.2020.07.005. Epub 2020 Jul 17.,Matsugasumi T,https://www.ncbi.nlm.nih.gov/pubmed/32683066
15983,33022649,Contemporary Population-Based Analysis of Bone Mineral Density Testing in Men Initiating Androgen Deprivation Therapy for Prostate Cancer,J Natl Compr Canc Netw. 2020 Oct 1;18(10):1374-1381. doi: 10.6004/jnccn.2020.7576. Print 2020 Oct.,Hu J,https://www.ncbi.nlm.nih.gov/pubmed/33022649
15985,32285285,National trends in the management of low-risk prostate cancer: analyzing the impact of Medicaid expansion in the United States,Int Urol Nephrol. 2020 Sep;52(9):1611-1615. doi: 10.1007/s11255-020-02463-5. Epub 2020 Apr 13.,Chipollini J,https://www.ncbi.nlm.nih.gov/pubmed/32285285
15986,32727885,Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer,Clin Cancer Res. 2020 Sep 1;26(17):4616-4624. doi: 10.1158/1078-0432.CCR-19-2303. Epub 2020 Jul 29.,Guan X,https://www.ncbi.nlm.nih.gov/pubmed/32727885
15987,32877750,DNA polymerase theta repression enhances the docetaxel responsiveness in metastatic castration-resistant prostate cancer,Biochim Biophys Acta Mol Basis Dis. 2020 Dec 1;1866(12):165954. doi: 10.1016/j.bbadis.2020.165954. Epub 2020 Aug 30.,Kuei CH,https://www.ncbi.nlm.nih.gov/pubmed/32877750
15988,33069487,Pelvic lymph node dissection in prostate cancer: Laparoscopy is not dead,Actas Urol Esp (Engl Ed). 2020 Dec;44(10):682-691. doi: 10.1016/j.acuro.2020.06.013. Epub 2020 Oct 14.,Semaan A,https://www.ncbi.nlm.nih.gov/pubmed/33069487
15989,33234060,Relative position of bladder neck to pubic symphysis on cystogram is a strong and reproducible predictor of early urinary continence recovery following radical prostatectomy,Urologia. 2021 May;88(2):115-121. doi: 10.1177/0391560320974891. Epub 2020 Nov 24.,Rossanese M,https://www.ncbi.nlm.nih.gov/pubmed/33234060
15990,33126125,Improving prostate cancer classification in H&E tissue micro arrays using Ki67 and P63 histopathology,Comput Biol Med. 2020 Dec;127:104053. doi: 10.1016/j.compbiomed.2020.104053. Epub 2020 Oct 14.,Shao Y,https://www.ncbi.nlm.nih.gov/pubmed/33126125
15991,32989773,A generative adversarial network-based (GAN-based) architecture for automatic fiducial marker detection in prostate MRI-only radiotherapy simulation images,Med Phys. 2020 Dec;47(12):6405-6413. doi: 10.1002/mp.14498. Epub 2020 Oct 19.,Singhrao K,https://www.ncbi.nlm.nih.gov/pubmed/32989773
15992,33144576,Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity,Nat Commun. 2020 Nov 3;11(1):5549. doi: 10.1038/s41467-020-19328-1.,Cyrta J,https://www.ncbi.nlm.nih.gov/pubmed/33144576
15993,32678818,Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study,PLoS One. 2020 Jul 17;15(7):e0234927. doi: 10.1371/journal.pone.0234927. eCollection 2020.,Hong S,https://www.ncbi.nlm.nih.gov/pubmed/32678818
15994,32561036,Shielding implications on secondary radiation doses in prostate cancer treatment,Appl Radiat Isot. 2020 Sep;163:109163. doi: 10.1016/j.apradiso.2020.109163. Epub 2020 Apr 4.,Medeiros MPC,https://www.ncbi.nlm.nih.gov/pubmed/32561036
15995,32725443,"Phase II prospective trial ""Give Me Five"" short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218)",Med Oncol. 2020 Jul 28;37(8):74. doi: 10.1007/s12032-020-01397-3.,Marvaso G,https://www.ncbi.nlm.nih.gov/pubmed/32725443
15996,32190957,Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration-Sensitive Prostate Cancer,Oncologist. 2020 Jul;25(7):e1042-e1050. doi: 10.1634/theoncologist.2019-0495. Epub 2020 Mar 19.,Wei Y,https://www.ncbi.nlm.nih.gov/pubmed/32190957
15997,33179610,Development and evaluation of a deep learning based artificial intelligence for automatic identification of gold fiducial markers in an MRI-only prostate radiotherapy workflow,Phys Med Biol. 2020 Nov 12;65(22):225011. doi: 10.1088/1361-6560/abb0f9.,Gustafsson CJ,https://www.ncbi.nlm.nih.gov/pubmed/33179610
15999,32555554,ONS GuidelinesTM for Cancer Treatment-Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer,Oncol Nurs Forum. 2020 Jul 1;47(4):374-399. doi: 10.1188/20.ONF.374-399.,Kaplan M,https://www.ncbi.nlm.nih.gov/pubmed/32555554
16000,32366674,"Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFN?, Resulting in Pronounced Antitumor Systemic Immune Responses",Mol Cancer Res. 2020 Aug;18(8):1232-1243. doi: 10.1158/1541-7786.MCR-19-0836. Epub 2020 May 4.,Udayakumar TS,https://www.ncbi.nlm.nih.gov/pubmed/32366674
16001,33022812,Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance,Prostate. 2021 Jan;81(1):58-71. doi: 10.1002/pros.24081. Epub 2020 Oct 6.,Ding Y,https://www.ncbi.nlm.nih.gov/pubmed/33022812
16002,32470965,Accurate 3D-dose-based generation of MLC segments for robotic radiotherapy,Phys Med Biol. 2020 Aug 31;65(17):175011. doi: 10.1088/1361-6560/ab97e7.,Schipaanboord BWK,https://www.ncbi.nlm.nih.gov/pubmed/32470965
16003,32901611,Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT,Health Technol Assess. 2020 Sep;24(41):1-96. doi: 10.3310/hta24410.,Worthington J,https://www.ncbi.nlm.nih.gov/pubmed/32901611
16006,32945940,CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone,Cancer Chemother Pharmacol. 2020 Oct;86(4):527-533. doi: 10.1007/s00280-020-04133-w. Epub 2020 Sep 18.,Crucitta S,https://www.ncbi.nlm.nih.gov/pubmed/32945940
16008,31414399,Neuroendocrine Cancer of the Prostate,Pathol Oncol Res. 2020 Jul;26(3):1447-1450. doi: 10.1007/s12253-019-00712-2. Epub 2019 Aug 14.,Kránitz N,https://www.ncbi.nlm.nih.gov/pubmed/31414399
16009,32789489,Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic,JAMA Oncol. 2020 Oct 1;6(10):1630-1632. doi: 10.1001/jamaoncol.2020.3545.,Dee EC,https://www.ncbi.nlm.nih.gov/pubmed/32789489
16010,32807235,Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression,Genome Med. 2020 Aug 17;12(1):72. doi: 10.1186/s13073-020-00770-1.,Lau E,https://www.ncbi.nlm.nih.gov/pubmed/32807235
16012,32663888,Estimation of [177Lu]PSMA-617 tumor uptake based on voxel-wise 3D Monte Carlo tumor dosimetry in patients with metastasized castration resistant prostate cancer,Nuklearmedizin. 2020 Sep;59(5):365-374. doi: 10.1055/a-1204-9932. Epub 2020 Jul 14.,Götz TI,https://www.ncbi.nlm.nih.gov/pubmed/32663888
16014,32583039,Role of multiparametric prostate MRI in the management of prostate cancer,World J Urol. 2021 Mar;39(3):651-659. doi: 10.1007/s00345-020-03310-z. Epub 2020 Jun 24.,O'Connor LP,https://www.ncbi.nlm.nih.gov/pubmed/32583039
16016,32589458,Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals in Diagnosis and Therapy of Prostate Cancer: Current Status and Future Perspectives,Cancer Biother Radiopharm. 2021 Apr;36(3):237-251. doi: 10.1089/cbr.2020.3603. Epub 2020 Jun 23.,Lin M,https://www.ncbi.nlm.nih.gov/pubmed/32589458
16018,30973040,TGF-?/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer,Aging Male. 2020 Dec;23(5):801-811. doi: 10.1080/13685538.2019.1597840. Epub 2019 Apr 11.,Torrealba N,https://www.ncbi.nlm.nih.gov/pubmed/30973040
16019,34085047,A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance,Nat Cancer. 2020 Nov;1(11):1082-1096. doi: 10.1038/s43018-020-00125-0. Epub 2020 Oct 19.,Arriaga JM,https://www.ncbi.nlm.nih.gov/pubmed/34085047
16020,33132108,Switching Cancers: A Systematic Review Assessing the Role of Androgen Suppressive Therapy in Bladder Cancer,Eur Urol Focus. 2021 Sep;7(5):1044-1051. doi: 10.1016/j.euf.2020.10.002. Epub 2020 Oct 31.,Kourbanhoussen K,https://www.ncbi.nlm.nih.gov/pubmed/33132108
16021,33191572,The Utilization of Poly(2-ethyl-2-oxazoline)-b-Poly(?-caprolactone) Ellipsoidal Particles for Intracellular BIKDDA Delivery to Prostate Cancer,Macromol Biosci. 2021 Feb;21(2):e2000287. doi: 10.1002/mabi.202000287. Epub 2020 Nov 16.,Kocak P,https://www.ncbi.nlm.nih.gov/pubmed/33191572
16022,32555559,The Ecology of Patients' Sexual Health Adjustment After Prostate Cancer Treatment: The Influence of the Social and Healthcare Environment,Oncol Nurs Forum. 2020 Jul 1;47(4):469-478. doi: 10.1188/20.ONF.469-478.,Smith A,https://www.ncbi.nlm.nih.gov/pubmed/32555559
16023,32881870,"Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells",PLoS One. 2020 Sep 3;15(9):e0226056. doi: 10.1371/journal.pone.0226056. eCollection 2020.,Singh JP,https://www.ncbi.nlm.nih.gov/pubmed/32881870
16024,32964674,Dynamic changes of bone metastasis predict bone-predominant status to benefit from radium-223 dichloride for patients with castration-resistant prostate cancer,Cancer Med. 2020 Nov;9(22):8579-8588. doi: 10.1002/cam4.3459. Epub 2020 Sep 22.,Hashimoto K,https://www.ncbi.nlm.nih.gov/pubmed/32964674
16025,32868190,"Barriers to sexual recovery in men with prostate, bladder and colorectal cancer",Urol Oncol. 2022 Sep;40(9):395-402. doi: 10.1016/j.urolonc.2020.08.005. Epub 2020 Aug 29.,Zhu A,https://www.ncbi.nlm.nih.gov/pubmed/32868190
16026,32593665,"Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells",Eur J Pharmacol. 2020 Sep 5;882:173298. doi: 10.1016/j.ejphar.2020.173298. Epub 2020 Jun 25.,Momeny M,https://www.ncbi.nlm.nih.gov/pubmed/32593665
16028,32699318,The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs,Nat Rev Urol. 2020 Sep;17(9):499-512. doi: 10.1038/s41585-020-0349-1. Epub 2020 Jul 22.,Kouspou MM,https://www.ncbi.nlm.nih.gov/pubmed/32699318
16029,32357283,Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance,BJU Int. 2021 Mar;127(3):340-348. doi: 10.1111/bju.15100. Epub 2020 Jun 29.,Shapiro DD,https://www.ncbi.nlm.nih.gov/pubmed/32357283
16031,32685010,Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving (177)Lu-PSMA-617 Radioligand Therapy,Theranostics. 2020 Jun 18;10(17):7645-7655. doi: 10.7150/thno.44556. eCollection 2020.,Kessel K,https://www.ncbi.nlm.nih.gov/pubmed/32685010
16034,33390340,Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer,Eur Urol Oncol. 2021 Feb;4(1):1-9. doi: 10.1016/j.euo.2020.11.011. Epub 2020 Dec 31.,Loeb S,https://www.ncbi.nlm.nih.gov/pubmed/33390340
16035,33121913,Optimizing the risk threshold of lymph node involvement for performing extended pelvic lymph node dissection in prostate cancer patients: a cost-effectiveness analysis,Urol Oncol. 2021 Jan;39(1):72.e7-72.e14. doi: 10.1016/j.urolonc.2020.09.014. Epub 2020 Oct 26.,Hueting TA,https://www.ncbi.nlm.nih.gov/pubmed/33121913
16036,33246975,Preclinical Evaluation of (213)Bi- and (225)Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer,J Nucl Med. 2021 Jul 1;62(7):980-988. doi: 10.2967/jnumed.120.256388. Epub 2020 Nov 27.,Banerjee SR,https://www.ncbi.nlm.nih.gov/pubmed/33246975
16037,32912840,Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores,Eur Urol Focus. 2021 Nov;7(6):1254-1259. doi: 10.1016/j.euf.2020.08.013. Epub 2020 Sep 8.,Marenco J,https://www.ncbi.nlm.nih.gov/pubmed/32912840
16038,32518372,Development of (177)Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen,Sci Rep. 2020 Jun 9;10(1):9313. doi: 10.1038/s41598-020-66285-2.,Carpanese D,https://www.ncbi.nlm.nih.gov/pubmed/32518372
16039,32643031,"Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts",World J Urol. 2021 May;39(5):1421-1429. doi: 10.1007/s00345-020-03328-3. Epub 2020 Jul 8.,Elghazaly H,https://www.ncbi.nlm.nih.gov/pubmed/32643031
16040,32250729,Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer,J Urol. 2020 Oct;204(4):691-700. doi: 10.1097/JU.0000000000001066. Epub 2020 Apr 6.,Woo J,https://www.ncbi.nlm.nih.gov/pubmed/32250729
16041,33293081,Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA,Eur Urol. 2021 Mar;79(3):343-350. doi: 10.1016/j.eururo.2020.11.013. Epub 2020 Dec 5.,Feuerecker B,https://www.ncbi.nlm.nih.gov/pubmed/33293081
16042,32662309,The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer - results from the SAMS trial,Scand J Urol. 2020 Aug;54(4):318-322. doi: 10.1080/21681805.2020.1788634. Epub 2020 Jul 14.,Carlsson S,https://www.ncbi.nlm.nih.gov/pubmed/32662309
16043,32811873,STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population,Sci Rep. 2020 Aug 18;10(1):13958. doi: 10.1038/s41598-020-70948-5.,Canesin G,https://www.ncbi.nlm.nih.gov/pubmed/32811873
16044,32634759,Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer,Eur J Cancer. 2020 Sep;136:16-24. doi: 10.1016/j.ejca.2020.05.001. Epub 2020 Jul 4.,van der Doelen MJ,https://www.ncbi.nlm.nih.gov/pubmed/32634759
16045,33386290,"The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases",Eur Urol Focus. 2021 Mar;7(2):241-244. doi: 10.1016/j.euf.2020.12.010. Epub 2020 Dec 29.,Zilli T,https://www.ncbi.nlm.nih.gov/pubmed/33386290
16046,32666150,Multiparametric magnetic resonance imaging and multiparametric magnetic resonance imaging-guided biopsy in the diagnostic pathway of prostate cancer,Radiologe. 2020 Nov;60(Suppl 1):63-69. doi: 10.1007/s00117-020-00716-z.,Chaloupka M,https://www.ncbi.nlm.nih.gov/pubmed/32666150
16047,33287897,Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report,J Med Case Rep. 2020 Dec 8;14(1):239. doi: 10.1186/s13256-020-02578-4.,Aluisio G,https://www.ncbi.nlm.nih.gov/pubmed/33287897
16049,32057714,Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States,Clin Genitourin Cancer. 2020 Aug;18(4):284-294. doi: 10.1016/j.clgc.2019.12.019. Epub 2020 Jan 7.,George DJ,https://www.ncbi.nlm.nih.gov/pubmed/32057714
16050,33144063,Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group,Cancer Radiother. 2020 Dec;24(8):892-897. doi: 10.1016/j.canrad.2020.03.014. Epub 2020 Nov 2.,Belkacemi Y,https://www.ncbi.nlm.nih.gov/pubmed/33144063
16051,33125581,"Efficacy, safety, and perioperative outcomes of holmium laser enucleation of the prostate-a comparison of patients with lower urinary tract symptoms and urinary retention",Lasers Med Sci. 2021 Sep;36(7):1397-1402. doi: 10.1007/s10103-020-03170-4. Epub 2020 Oct 30.,Trotsenko P,https://www.ncbi.nlm.nih.gov/pubmed/33125581
16053,30295140,Over expression of PI3K-AkT reduces apoptosis and increases prostate size in benign prostatic hyperplasia,Aging Male. 2020 Dec;23(5):440-446. doi: 10.1080/13685538.2018.1519014. Epub 2018 Oct 6.,Sreenivasulu K,https://www.ncbi.nlm.nih.gov/pubmed/30295140
16054,32768524,Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity,Cancer Lett. 2020 Dec 28;495:100-111. doi: 10.1016/j.canlet.2020.07.040. Epub 2020 Aug 6.,Chen D,https://www.ncbi.nlm.nih.gov/pubmed/32768524
16055,33219368,A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk,Prostate Cancer Prostatic Dis. 2021 Sep;24(3):596-611. doi: 10.1038/s41391-020-00298-w. Epub 2020 Nov 20.,Bass EJ,https://www.ncbi.nlm.nih.gov/pubmed/33219368
16059,33245058,Microdosimetry-based determination of tumour control probability curves for treatments with (225)Ac-PSMA of metastatic castration resistant prostate cancer,Phys Med Biol. 2020 Nov 27;65(23):235012. doi: 10.1088/1361-6560/abbc81.,Mínguez Gabiña P,https://www.ncbi.nlm.nih.gov/pubmed/33245058
16060,32313185,Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer,Mod Pathol. 2020 Sep;33(9):1802-1810. doi: 10.1038/s41379-020-0543-y. Epub 2020 Apr 20.,Chan E,https://www.ncbi.nlm.nih.gov/pubmed/32313185
16061,33876734,Evaluation of a urology specialist therapeutic radiographer implemented radiotherapy pathway for prostate cancer patients,Radiography (Lond). 2021 May;27(2):430-436. doi: 10.1016/j.radi.2020.10.006. Epub 2020 Oct 24.,Alexander SE,https://www.ncbi.nlm.nih.gov/pubmed/33876734
16062,32646850,Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial,Eur Urol Oncol. 2020 Oct;3(5):615-619. doi: 10.1016/j.euo.2020.06.007. Epub 2020 Jul 6.,Giganti F,https://www.ncbi.nlm.nih.gov/pubmed/32646850
16067,30826284,Modelling Study with an Interactive Model Assessing the Cost-effectiveness of (68)Ga Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Nano Magnetic Resonance Imaging for the Detection of Pelvic Lymph Node Metastases in Patients with Primary Prostate Cancer,Eur Urol Focus. 2020 Sep 15;6(5):967-974. doi: 10.1016/j.euf.2019.02.013. Epub 2019 Feb 28.,Scholte M,https://www.ncbi.nlm.nih.gov/pubmed/30826284
16068,32424106,"Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance",Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12315-12323. doi: 10.1073/pnas.1922207117. Epub 2020 May 18.,Alumkal JJ,https://www.ncbi.nlm.nih.gov/pubmed/32424106
16071,32860339,Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision-making processes,Cancer Med. 2020 Oct;9(20):7524-7536. doi: 10.1002/cam4.3419. Epub 2020 Aug 28.,Long X,https://www.ncbi.nlm.nih.gov/pubmed/32860339
16072,33053272,miRNAs and radiotherapy response in prostate cancer,Andrology. 2021 Mar;9(2):529-545. doi: 10.1111/andr.12921. Epub 2020 Nov 3.,Konoshenko MY,https://www.ncbi.nlm.nih.gov/pubmed/33053272
16073,32920937,Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis,FASEB J. 2020 Nov;34(11):14150-14159. doi: 10.1096/fj.202001466R. Epub 2020 Sep 13.,Norris JM,https://www.ncbi.nlm.nih.gov/pubmed/32920937
16074,33119677,Prostate cancer survivors with symptoms of radiation cystitis have elevated fibrotic and vascular proteins in urine,PLoS One. 2020 Oct 29;15(10):e0241388. doi: 10.1371/journal.pone.0241388. eCollection 2020.,Zwaans BMM,https://www.ncbi.nlm.nih.gov/pubmed/33119677
16076,32124525,Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study,BJU Int. 2020 Jul;126(1):97-103. doi: 10.1111/bju.15039. Epub 2020 Apr 6.,Berry B,https://www.ncbi.nlm.nih.gov/pubmed/32124525
16077,32366670,"Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study",Clin Cancer Res. 2020 Jul 15;26(14):3517-3524. doi: 10.1158/1078-0432.CCR-19-3402. Epub 2020 May 4.,Posadas EM,https://www.ncbi.nlm.nih.gov/pubmed/32366670
16078,32300836,"Doctor, a patient is on the phone asking about the endorectal coil!",Abdom Radiol (NY). 2020 Dec;45(12):4003-4011. doi: 10.1007/s00261-020-02528-0.,Muglia VF,https://www.ncbi.nlm.nih.gov/pubmed/32300836
16079,32702989,Distinct Metabolic Signatures of Hormone-Sensitive and Castration-Resistant Prostate Cancer Revealed by a (1)H NMR-Based Metabolomics of Biopsy Tissue,J Proteome Res. 2020 Sep 4;19(9):3741-3749. doi: 10.1021/acs.jproteome.0c00282. Epub 2020 Aug 3.,Zheng H,https://www.ncbi.nlm.nih.gov/pubmed/32702989
16081,32654967,Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway,Eur Urol Focus. 2021 Nov;7(6):1292-1299. doi: 10.1016/j.euf.2020.06.022. Epub 2020 Jul 9.,Wiemer L,https://www.ncbi.nlm.nih.gov/pubmed/32654967
16083,33051065,False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS,Eur Urol. 2021 Jan;79(1):20-29. doi: 10.1016/j.eururo.2020.09.043. Epub 2020 Oct 10.,Stavrinides V,https://www.ncbi.nlm.nih.gov/pubmed/33051065
16084,31806772,Radiation Dosimetry in (177)Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors,J Nucl Med. 2020 Jul;61(7):1030-1036. doi: 10.2967/jnumed.119.233411. Epub 2019 Dec 5.,Jackson PA,https://www.ncbi.nlm.nih.gov/pubmed/31806772
16085,31825763,Determination of Gleason score discrepancy for risk stratification in magnetic resonance-ultrasound fusion prostate biopsy,Acta Radiol. 2020 Aug;61(8):1134-1142. doi: 10.1177/0284185119891695. Epub 2019 Dec 11.,Kim SH,https://www.ncbi.nlm.nih.gov/pubmed/31825763
16087,33316417,First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings,Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13.,Ferro M,https://www.ncbi.nlm.nih.gov/pubmed/33316417
16089,33295204,Feasibility of a Weight Management Program Tailored for Overweight Men with Localized Prostate Cancer - A Pilot Study,Nutr Cancer. 2021;73(11-12):2671-2686. doi: 10.1080/01635581.2020.1856890. Epub 2020 Dec 9.,Hamilton-Reeves JM,https://www.ncbi.nlm.nih.gov/pubmed/33295204
16090,32956051,Boundary Coding Representation for Organ Segmentation in Prostate Cancer Radiotherapy,IEEE Trans Med Imaging. 2021 Jan;40(1):310-320. doi: 10.1109/TMI.2020.3025517. Epub 2020 Dec 29.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/32956051
16091,32444177,Rise in serum folate after androgen deprivation associated with worse prostate cancer-specific survival,Urol Oncol. 2020 Aug;38(8):682.e21-682.e27. doi: 10.1016/j.urolonc.2020.04.003. Epub 2020 May 20.,Liss MA,https://www.ncbi.nlm.nih.gov/pubmed/32444177
16092,33446002,Multiparametric MRI-ultrasound fusion prostate biopsy in patients without prior diagnosis of prostate cancer: beyond centers of excellence,Aging Male. 2020 Dec;23(5):1570-1575. doi: 10.1080/13685538.2021.1873263. Epub 2021 Jan 15.,Verma S,https://www.ncbi.nlm.nih.gov/pubmed/33446002
16094,31758324,Effects of a nutrition intervention on acute and late bowel symptoms and health-related quality of life up to 24 months post radiotherapy in patients with prostate cancer: a multicentre randomised controlled trial,Support Care Cancer. 2020 Jul;28(7):3331-3342. doi: 10.1007/s00520-019-05182-5. Epub 2019 Nov 22.,Forslund M,https://www.ncbi.nlm.nih.gov/pubmed/31758324
16095,33000341,Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study,World J Urol. 2021 Jul;39(7):2515-2523. doi: 10.1007/s00345-020-03471-x. Epub 2020 Sep 30.,Herden J,https://www.ncbi.nlm.nih.gov/pubmed/33000341
16096,32464613,Radiodynamic therapy using 15-MV radiation combined with 5-aminolevulinic acid and carbamide peroxide for prostate cancer in vivo,Phys Med Biol. 2020 Aug 19;65(16):165008. doi: 10.1088/1361-6560/ab9776.,Panetta JV,https://www.ncbi.nlm.nih.gov/pubmed/32464613
16098,32779781,Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians,Prostate. 2020 Oct;80(14):1159-1176. doi: 10.1002/pros.24053. Epub 2020 Aug 11.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32779781
16099,32868222,How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound?,Eur Urol Focus. 2021 Nov;7(6):1268-1273. doi: 10.1016/j.euf.2020.08.003. Epub 2020 Aug 28.,Herlemann A,https://www.ncbi.nlm.nih.gov/pubmed/32868222
16100,33070336,Artificial intelligence-based radiotherapy machine parameter optimization using reinforcement learning,Med Phys. 2020 Dec;47(12):6140-6150. doi: 10.1002/mp.14544. Epub 2020 Nov 5.,Hrinivich WT,https://www.ncbi.nlm.nih.gov/pubmed/33070336
16101,32370911,What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort,Eur Urol. 2020 Aug;78(2):163-170. doi: 10.1016/j.eururo.2020.04.029. Epub 2020 May 1.,Norris JM,https://www.ncbi.nlm.nih.gov/pubmed/32370911
16102,33067276,"Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada",BMJ Open. 2020 Oct 16;10(10):e037222. doi: 10.1136/bmjopen-2020-037222.,Vasquez C,https://www.ncbi.nlm.nih.gov/pubmed/33067276
16103,33046412,"The ""Is mpMRI Enough"" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy",Eur Urol Focus. 2021 Sep;7(5):1027-1034. doi: 10.1016/j.euf.2020.09.012. Epub 2020 Oct 10.,Stonier T,https://www.ncbi.nlm.nih.gov/pubmed/33046412
16107,33175360,Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen,Ann Nucl Med. 2020 Dec;34(12):879-883. doi: 10.1007/s12149-020-01549-5. Epub 2020 Nov 11.,Inubushi M,https://www.ncbi.nlm.nih.gov/pubmed/33175360
16108,33164219,Deformable MR-CBCT prostate registration using biomechanically constrained deep learning networks,Med Phys. 2021 Jan;48(1):253-263. doi: 10.1002/mp.14584. Epub 2020 Nov 27.,Fu Y,https://www.ncbi.nlm.nih.gov/pubmed/33164219
16109,32665121,"Combination of NDRG2 overexpression, X-ray radiation and docetaxel enhances apoptosis and inhibits invasiveness properties of LNCaP cells",Urol Oncol. 2020 Nov;38(11):849.e1-849.e9. doi: 10.1016/j.urolonc.2020.06.017. Epub 2020 Jul 12.,Alizadeh Zarei M,https://www.ncbi.nlm.nih.gov/pubmed/32665121
16110,32622779,Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac,Radiother Oncol. 2020 Oct;151:88-94. doi: 10.1016/j.radonc.2020.06.044. Epub 2020 Jul 3.,de Muinck Keizer DM,https://www.ncbi.nlm.nih.gov/pubmed/32622779
16111,32568785,Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer,Am J Clin Oncol. 2020 Oct;43(10):685-689. doi: 10.1097/COC.0000000000000727.,Lehrer S,https://www.ncbi.nlm.nih.gov/pubmed/32568785
16113,32424596,"ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training",Eur Radiol. 2020 Oct;30(10):5404-5416. doi: 10.1007/s00330-020-06929-z. Epub 2020 May 19.,de Rooij M,https://www.ncbi.nlm.nih.gov/pubmed/32424596
16115,33373704,Preserving Well-being in Patients With Advanced and Late Prostate Cancer,Urology. 2021 Sep;155:199-209. doi: 10.1016/j.urology.2020.12.018. Epub 2020 Dec 26.,Handley NR,https://www.ncbi.nlm.nih.gov/pubmed/33373704
16116,32385837,Unmet expectations in prostate cancer patients and their association with decision regret,J Cancer Surviv. 2020 Oct;14(5):731-738. doi: 10.1007/s11764-020-00888-6. Epub 2020 May 8.,Wollersheim BM,https://www.ncbi.nlm.nih.gov/pubmed/32385837
16118,32679272,Combined MRI-targeted Plus Systematic Confirmatory Biopsy Improves Risk Stratification for Patients Enrolling on Active Surveillance for Prostate Cancer,Urology. 2020 Oct;144:164-170. doi: 10.1016/j.urology.2020.06.061. Epub 2020 Jul 15.,O'Connor LP,https://www.ncbi.nlm.nih.gov/pubmed/32679272
16119,32845207,Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational study,Scand J Urol. 2020 Dec;54(6):463-469. doi: 10.1080/21681805.2020.1806354. Epub 2020 Aug 26.,van Santvoort BWH,https://www.ncbi.nlm.nih.gov/pubmed/32845207
16121,33219015,High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors,Clin Cancer Res. 2021 Mar 1;27(5):1505-1515. doi: 10.1158/1078-0432.CCR-20-2293. Epub 2020 Nov 20.,Lin L,https://www.ncbi.nlm.nih.gov/pubmed/33219015
16122,33271756,"Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells",Mar Drugs. 2020 Dec 1;18(12):609. doi: 10.3390/md18120609.,Dyshlovoy SA,https://www.ncbi.nlm.nih.gov/pubmed/33271756
16123,33142234,Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment,Neoplasia. 2020 Dec;22(12):679-688. doi: 10.1016/j.neo.2020.10.001. Epub 2020 Oct 23.,Krishnamachary B,https://www.ncbi.nlm.nih.gov/pubmed/33142234
16124,33034812,Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose,Qual Life Res. 2021 Feb;30(2):437-443. doi: 10.1007/s11136-020-02639-7. Epub 2020 Oct 9.,Pinkawa M,https://www.ncbi.nlm.nih.gov/pubmed/33034812
16127,32758032,The emerging role of PARP inhibitors in prostate cancer,Expert Rev Anticancer Ther. 2020 Aug;20(8):715-726. doi: 10.1080/14737140.2020.1797497. Epub 2020 Aug 6.,Stellato M,https://www.ncbi.nlm.nih.gov/pubmed/32758032
16128,33026927,Application of the PRECISION Trial Biopsy Strategy to a Contemporary Magnetic Resonance Imaging-Targeted Biopsy Cohort-How Many Clinically Significant Prostate Cancers are Missed?,J Urol. 2021 Mar;205(3):740-747. doi: 10.1097/JU.0000000000001406. Epub 2020 Oct 7.,Feuer Z,https://www.ncbi.nlm.nih.gov/pubmed/33026927
16129,32865839,Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting,Prostate. 2020 Nov;80(15):1273-1296. doi: 10.1002/pros.24056. Epub 2020 Aug 31.,Miyahira AK,https://www.ncbi.nlm.nih.gov/pubmed/32865839
16130,32286677,Prognostic value of microRNA-20b expression level in patients with prostate cancer,Histol Histopathol. 2020 Aug;35(8):827-831. doi: 10.14670/HH-18-216. Epub 2020 Apr 14.,Zhang R,https://www.ncbi.nlm.nih.gov/pubmed/32286677
16133,32701718,Where to next prostate-specific membrane antigen PET imaging frontiers?,Curr Opin Urol. 2020 Sep;30(5):672-678. doi: 10.1097/MOU.0000000000000797.,Donswijk ML,https://www.ncbi.nlm.nih.gov/pubmed/32701718
16135,32663819,Quality assurance of IMRT treatment plans for a 1.5 T MR-linac using a 2D ionization chamber array and a static solid phantom,Phys Med Biol. 2020 Aug 13;65(16):16NT01. doi: 10.1088/1361-6560/aba5ec.,Mönnich D,https://www.ncbi.nlm.nih.gov/pubmed/32663819
16140,33128596,Role of prehabilitation following major uro-oncologic surgery: a narrative review,World J Urol. 2022 Jun;40(6):1289-1298. doi: 10.1007/s00345-020-03505-4. Epub 2020 Oct 31.,Minnella EM,https://www.ncbi.nlm.nih.gov/pubmed/33128596
16141,33112008,Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey,Eur J Cancer Care (Engl). 2021 Jan;30(1):e13301. doi: 10.1111/ecc.13301. Epub 2020 Oct 27.,Puneet K,https://www.ncbi.nlm.nih.gov/pubmed/33112008
16142,33219158,Review of Palliative (223)Ra in Metastatic Castration-Resistant Prostate Cancer: Experience at West Virginia University Cancer Center,J Nucl Med Technol. 2021 Mar;49(1):70-74. doi: 10.2967/jnmt.120.254474. Epub 2020 Nov 20.,Arays R,https://www.ncbi.nlm.nih.gov/pubmed/33219158
16143,32701148,Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens,JAMA Oncol. 2020 Sep 1;6(9):1372-1380. doi: 10.1001/jamaoncol.2020.2485.,Nagpal K,https://www.ncbi.nlm.nih.gov/pubmed/32701148
16144,32772613,Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system - the Stavanger experience,Scand J Prim Health Care. 2020 Sep;38(3):315-322. doi: 10.1080/02813432.2020.1802139. Epub 2020 Aug 8.,Viste E,https://www.ncbi.nlm.nih.gov/pubmed/32772613
16146,32861704,Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients,Radiother Oncol. 2020 Oct;151:222-227. doi: 10.1016/j.radonc.2020.08.021. Epub 2020 Aug 28.,Onal C,https://www.ncbi.nlm.nih.gov/pubmed/32861704
16147,32586404,Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells,Stem Cell Res Ther. 2020 Jun 26;11(1):258. doi: 10.1186/s13287-020-01773-w.,Wang L,https://www.ncbi.nlm.nih.gov/pubmed/32586404
16150,33139720,Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer,Cell Death Dis. 2020 Nov 2;11(11):942. doi: 10.1038/s41419-020-02970-4.,Chou FJ,https://www.ncbi.nlm.nih.gov/pubmed/33139720
16151,32844593,Physicochemical damage and early-stage biological response to X-ray radiation studied in prostate cancer cells by Raman spectroscopy,J Biophotonics. 2020 Dec;13(12):e202000252. doi: 10.1002/jbio.202000252. Epub 2020 Sep 18.,Roman M,https://www.ncbi.nlm.nih.gov/pubmed/32844593
16152,33125383,Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2015 and 2019 at the Uganda Cancer Institute,PLoS One. 2020 Oct 30;15(10):e0236458. doi: 10.1371/journal.pone.0236458. eCollection 2020.,Katongole P,https://www.ncbi.nlm.nih.gov/pubmed/33125383
16153,32768356,Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes,Clin Genitourin Cancer. 2020 Dec;18(6):e739-e753. doi: 10.1016/j.clgc.2020.05.008. Epub 2020 May 22.,Enikeev D,https://www.ncbi.nlm.nih.gov/pubmed/32768356
16154,32997342,Impact of 23-valent pneumococcal polysaccharide vaccination on the frequency of pneumonia-related hospitalization and survival in elderly patients with prostate cancer: A seven-year nationwide matched cohort study,Cancer. 2021 Jan 1;127(1):124-136. doi: 10.1002/cncr.33203. Epub 2020 Sep 30.,Li CY,https://www.ncbi.nlm.nih.gov/pubmed/32997342
16155,32870824,Atorvastatin Enhances Effects of Radiotherapy on Prostate Cancer Cells and Xenograft Tumor Mice Through Triggering Interaction Between Bcl-2 and MSH2,Med Sci Monit. 2020 Sep 1;26:e923560. doi: 10.12659/MSM.923560.,He Z,https://www.ncbi.nlm.nih.gov/pubmed/32870824
16156,33149212,Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients,Sci Rep. 2020 Nov 4;10(1):19002. doi: 10.1038/s41598-020-75812-0.,Stanojkovi? TP,https://www.ncbi.nlm.nih.gov/pubmed/33149212
16157,32748714,"Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer",Scand J Urol. 2020 Oct;54(5):401-407. doi: 10.1080/21681805.2020.1798502. Epub 2020 Aug 4.,Linkeviciute-Ulinskiene D,https://www.ncbi.nlm.nih.gov/pubmed/32748714
16159,33171177,Ablation of LGR4 signaling enhances radiation sensitivity of prostate cancer cells,Life Sci. 2021 Jan 15;265:118737. doi: 10.1016/j.lfs.2020.118737. Epub 2020 Nov 7.,Liang F,https://www.ncbi.nlm.nih.gov/pubmed/33171177
16160,32166568,Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naïve patients,Int Urol Nephrol. 2020 Aug;52(8):1483-1490. doi: 10.1007/s11255-020-02426-w. Epub 2020 Mar 12.,Harraz AM,https://www.ncbi.nlm.nih.gov/pubmed/32166568
16161,32917955,Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer,Oncogene. 2020 Oct;39(42):6556-6571. doi: 10.1038/s41388-020-01456-z. Epub 2020 Sep 11.,Wen S,https://www.ncbi.nlm.nih.gov/pubmed/32917955
16162,32609397,Can the combination of biparametric magnetic resonance imaging and PSA-related indicators predict the prostate biopsy outcome?,Andrologia. 2020 Nov;52(10):e13734. doi: 10.1111/and.13734. Epub 2020 Jul 1.,Zhu J,https://www.ncbi.nlm.nih.gov/pubmed/32609397
16163,32657864,223Ra-Dichloride Response Evaluation Using 18F-Fluciclovine PET/CT and Bone Scintigraphy in a Patient With Castration-Resistant Metastatic Prostate Cancer,Clin Nucl Med. 2020 Nov;45(11):e486-e488. doi: 10.1097/RLU.0000000000003168.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32657864
16164,33045468,Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: Novel biomarker and therapeutic target,EBioMedicine. 2020 Nov;61:103059. doi: 10.1016/j.ebiom.2020.103059. Epub 2020 Oct 9.,Sun BL,https://www.ncbi.nlm.nih.gov/pubmed/33045468
16166,33308527,Prostatic Artery Embolization in Refractory Hematuria of Prostatic Origin,Tech Vasc Interv Radiol. 2020 Sep;23(3):100694. doi: 10.1016/j.tvir.2020.100694. Epub 2020 Oct 6.,Kably I,https://www.ncbi.nlm.nih.gov/pubmed/33308527
16167,32890616,Performance of Multiparametric MRI of the Prostate in Biopsy Naïve Men: A Meta-analysis of Prospective Studies,Urology. 2020 Dec;146:189-195. doi: 10.1016/j.urology.2020.06.102. Epub 2020 Sep 2.,Becerra MF,https://www.ncbi.nlm.nih.gov/pubmed/32890616
16171,32975001,One Stop Prostate Clinic': prospective analysis of 1000 men attending a public same-day prostate cancer assessment and/or diagnostic clinic,ANZ J Surg. 2021 Apr;91(4):558-564. doi: 10.1111/ans.16329. Epub 2020 Sep 25.,Hawks C,https://www.ncbi.nlm.nih.gov/pubmed/32975001
16174,32661773,Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models,Mol Cell Biochem. 2020 Oct;473(1-2):263-279. doi: 10.1007/s11010-020-03827-2. Epub 2020 Jul 14.,Borel M,https://www.ncbi.nlm.nih.gov/pubmed/32661773
16175,33593484,The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer,Discov Med. 2020 Nov-Dec;30(161):163-171.,Lehrer S,https://www.ncbi.nlm.nih.gov/pubmed/33593484
16176,33258506,Determining the prognostic significance of IKK? in prostate cancer,Prostate. 2020 Oct;80(14):1188-1202. doi: 10.1002/pros.24045. Epub 2020 Jul 21.,Montes M,https://www.ncbi.nlm.nih.gov/pubmed/33258506
16177,32748295,Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer,Int J Clin Oncol. 2020 Dec;25(12):2130-2137. doi: 10.1007/s10147-020-01756-0. Epub 2020 Aug 3.,Kato M,https://www.ncbi.nlm.nih.gov/pubmed/32748295
16178,33086151,PSMA targeted conjugates based on dextran,Appl Radiat Isot. 2021 Jan;167:109439. doi: 10.1016/j.apradiso.2020.109439. Epub 2020 Oct 2.,Janczewska M,https://www.ncbi.nlm.nih.gov/pubmed/33086151
16179,32946625,Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category,Prostate. 2020 Dec;80(16):1421-1428. doi: 10.1002/pros.24072. Epub 2020 Sep 18.,Greenland NY,https://www.ncbi.nlm.nih.gov/pubmed/32946625
16180,33094433,Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy,Eur J Nucl Med Mol Imaging. 2021 May;48(5):1339-1350. doi: 10.1007/s00259-020-05057-6. Epub 2020 Oct 23.,Ruigrok EAM,https://www.ncbi.nlm.nih.gov/pubmed/33094433
16181,32613373,Training prostate cancer survivors and caregivers to be peer navigators: a blended online/in-person competency-based training program,Support Care Cancer. 2021 Mar;29(3):1235-1244. doi: 10.1007/s00520-020-05586-8. Epub 2020 Jul 2.,Bender JL,https://www.ncbi.nlm.nih.gov/pubmed/32613373
16182,33053515,Deep learning-based inverse mapping for fluence map prediction,Phys Med Biol. 2020 Nov 27;65(23):10.1088/1361-6560/abc12c. doi: 10.1088/1361-6560/abc12c.,Ma L,https://www.ncbi.nlm.nih.gov/pubmed/33053515
16184,33341285,Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial,Eur Urol. 2021 Mar;79(3):413-418. doi: 10.1016/j.eururo.2020.11.043. Epub 2020 Dec 16.,de Feria Cardet RE,https://www.ncbi.nlm.nih.gov/pubmed/33341285
16185,32253231,Mechanistic Insights for Optimizing PSMA Radioligand Therapy,Clin Cancer Res. 2020 Jun 15;26(12):2774-2776. doi: 10.1158/1078-0432.CCR-20-0209. Epub 2020 Apr 6.,Ravi Kumar AS,https://www.ncbi.nlm.nih.gov/pubmed/32253231
16186,31501082,Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study,Eur Urol Oncol. 2020 Oct;3(5):648-656. doi: 10.1016/j.euo.2019.08.008. Epub 2019 Sep 6.,Knaapila J,https://www.ncbi.nlm.nih.gov/pubmed/31501082
16188,32620600,Review of the Role of Radiomics in Tumour Risk Classification and Prognosis of Cancer,Anticancer Res. 2020 Jul;40(7):3605-3618. doi: 10.21873/anticanres.14350.,Li Wen Y,https://www.ncbi.nlm.nih.gov/pubmed/32620600
16189,32690501,Prediction models for prostate cancer to be used in the primary care setting: a systematic review,BMJ Open. 2020 Jul 19;10(7):e034661. doi: 10.1136/bmjopen-2019-034661.,Aladwani M,https://www.ncbi.nlm.nih.gov/pubmed/32690501
16190,32201312,NF-?B signaling promotes castration-resistant prostate cancer initiation and progression,Pharmacol Ther. 2020 Jul;211:107538. doi: 10.1016/j.pharmthera.2020.107538. Epub 2020 Mar 19.,Thomas-Jardin SE,https://www.ncbi.nlm.nih.gov/pubmed/32201312
16192,31997148,Decreasing the prospect of upper extremity neuropraxia during robotic assisted laparoscopic prostatectomy: a novel technique,J Robot Surg. 2020 Oct;14(5):733-738. doi: 10.1007/s11701-020-01047-w. Epub 2020 Jan 29.,Watson MJ,https://www.ncbi.nlm.nih.gov/pubmed/31997148
16193,32628099,"Pain in Men Undergoing Transperineal Free-Hand Multiparametric Magnetic Resonance Imaging Fusion Targeted Biopsies under Local Anesthesia: Outcomes and Predictors from a Multicenter Study of 1,008 Patients",J Urol. 2020 Dec;204(6):1209-1215. doi: 10.1097/JU.0000000000001234. Epub 2020 Jul 6.,Marra G,https://www.ncbi.nlm.nih.gov/pubmed/32628099
16194,33151620,ARPM-net: A novel CNN-based adversarial method with Markov random field enhancement for prostate and organs at risk segmentation in pelvic CT images,Med Phys. 2021 Jan;48(1):227-237. doi: 10.1002/mp.14580. Epub 2020 Nov 24.,Zhang Z,https://www.ncbi.nlm.nih.gov/pubmed/33151620
16195,32880475,A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer,Br J Radiol. 2020 Nov 1;93(1115):20200775. doi: 10.1259/bjr.20200775. Epub 2020 Sep 3.,Alshehri AHD,https://www.ncbi.nlm.nih.gov/pubmed/32880475
16196,33369476,Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model,Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3743-3749. doi: 10.31557/APJCP.2020.21.12.3743.,Onishi K,https://www.ncbi.nlm.nih.gov/pubmed/33369476
16198,32166495,Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice,Eur Radiol. 2020 Jul;30(7):4039-4049. doi: 10.1007/s00330-020-06782-0. Epub 2020 Mar 12.,Zawaideh JP,https://www.ncbi.nlm.nih.gov/pubmed/32166495
16199,32630281,DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity,Cells. 2020 Jul 1;9(7):1593. doi: 10.3390/cells9071593.,Malaquin N,https://www.ncbi.nlm.nih.gov/pubmed/32630281
16200,33098158,"Negative first follow-up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment",BJU Int. 2021 Jul;128(1):72-78. doi: 10.1111/bju.15281. Epub 2020 Nov 15.,Singh S,https://www.ncbi.nlm.nih.gov/pubmed/33098158
16201,33112397,Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations,JAMA Netw Open. 2020 Oct 1;3(10):e2021692. doi: 10.1001/jamanetworkopen.2020.21692.,Schmid S,https://www.ncbi.nlm.nih.gov/pubmed/33112397
16202,33127625,Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies,J Nucl Med. 2021 Jul 1;62(7):1006-1011. doi: 10.2967/jnumed.120.254656. Epub 2020 Oct 30.,Hou X,https://www.ncbi.nlm.nih.gov/pubmed/33127625
16203,32875513,Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases,Int J Clin Oncol. 2021 Jan;26(1):192-198. doi: 10.1007/s10147-020-01776-w. Epub 2020 Sep 1.,Yamamoto Y,https://www.ncbi.nlm.nih.gov/pubmed/32875513
16204,32862251,Deep Learning in Radiation Oncology Treatment Planning for Prostate Cancer: A Systematic Review,J Med Syst. 2020 Aug 30;44(10):179. doi: 10.1007/s10916-020-01641-3.,Almeida G,https://www.ncbi.nlm.nih.gov/pubmed/32862251
16205,32952095,"Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study",Eur Urol Oncol. 2021 Oct;4(5):784-791. doi: 10.1016/j.euo.2020.08.009. Epub 2020 Sep 18.,Rocco B,https://www.ncbi.nlm.nih.gov/pubmed/32952095
16206,32861620,Evaluation of the clinical use of PET/CT with (68)Ga-PSMA for the assessment of biochemical recurrence of low or intermediate-risk prostate cancer,Urol Oncol. 2021 Jan;39(1):73.e9-73.e18. doi: 10.1016/j.urolonc.2020.07.010. Epub 2020 Aug 27.,Ribeiro AMB,https://www.ncbi.nlm.nih.gov/pubmed/32861620
16209,32034111,(68)Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results,J Nucl Med. 2020 Sep;61(9):1314-1319. doi: 10.2967/jnumed.119.235333. Epub 2020 Feb 7.,Liu C,https://www.ncbi.nlm.nih.gov/pubmed/32034111
16210,32804008,A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside?,Cancer Invest. 2020 Sep;38(8-9):486-492. doi: 10.1080/07357907.2020.1811301. Epub 2020 Sep 14.,Gupta M,https://www.ncbi.nlm.nih.gov/pubmed/32804008
16211,32902661,Nonsuspicious prebiopsy multiparametric MRI: is prostate biopsy still necessary?,Abdom Radiol (NY). 2020 Dec;45(12):4160-4165. doi: 10.1007/s00261-020-02728-8. Epub 2020 Sep 9.,Anastay V,https://www.ncbi.nlm.nih.gov/pubmed/32902661
16212,32859466,"PET and MRI guided adaptive radiotherapy: Rational, feasibility and benefit",Cancer Radiother. 2020 Oct;24(6-7):635-644. doi: 10.1016/j.canrad.2020.06.017. Epub 2020 Aug 25.,Thureau S,https://www.ncbi.nlm.nih.gov/pubmed/32859466
16213,32701855,The evolving options in metastatic castration-sensitive prostate cancer,Curr Opin Support Palliat Care. 2020 Sep;14(3):270-275. doi: 10.1097/SPC.0000000000000507.,Hamilou Z,https://www.ncbi.nlm.nih.gov/pubmed/32701855
16214,33069070,The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells,Bioorg Med Chem. 2020 Oct 15;28(20):115712. doi: 10.1016/j.bmc.2020.115712. Epub 2020 Aug 18.,Melnyk JE,https://www.ncbi.nlm.nih.gov/pubmed/33069070
16215,32350606,Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication,J Cancer Res Clin Oncol. 2020 Jul;146(7):1701-1709. doi: 10.1007/s00432-020-03221-x. Epub 2020 Apr 30.,Abdelsalam RA,https://www.ncbi.nlm.nih.gov/pubmed/32350606
16217,33443072,"Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using (19)F/(177)Lu-rhPSMA-7.3 and (177)Lu-PSMA I&T",J Nucl Med. 2021 Aug 1;62(8):1106-1111. doi: 10.2967/jnumed.120.254516. Epub 2020 Dec 18.,Yusufi N,https://www.ncbi.nlm.nih.gov/pubmed/33443072
16218,32948345,"Advances in urologic oncology ""OncoForum"": The best of 2019",Actas Urol Esp (Engl Ed). 2020 Nov;44(9):586-596. doi: 10.1016/j.acuro.2020.06.007. Epub 2020 Sep 15.,Gómez-Veiga F,https://www.ncbi.nlm.nih.gov/pubmed/32948345
16219,32173766,Exercise intensity prescription in cancer survivors: ventilatory and lactate thresholds are useful submaximal alternatives to VO(2peak),Support Care Cancer. 2020 Nov;28(11):5521-5528. doi: 10.1007/s00520-020-05407-y. Epub 2020 Mar 16.,Schneider J,https://www.ncbi.nlm.nih.gov/pubmed/32173766
16220,32599662,Ethnic and socio-economic disparities in prostate cancer screening: lessons from New Zealand,BJU Int. 2021 Dec;128 Suppl 3:11-17. doi: 10.1111/bju.15155. Epub 2020 Aug 7.,Matti B,https://www.ncbi.nlm.nih.gov/pubmed/32599662
16222,32685011,TGF-? causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization,Theranostics. 2020 Jun 18;10(17):7656-7670. doi: 10.7150/thno.44567. eCollection 2020.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32685011
16223,32537698,Size of pelvic bone metastasis as a significant prognostic factor for metastatic prostate cancer patients,Jpn J Radiol. 2020 Oct;38(10):993-996. doi: 10.1007/s11604-020-01004-5. Epub 2020 Jun 14.,Hayakawa T,https://www.ncbi.nlm.nih.gov/pubmed/32537698
16225,33287379,Focused Ultrasound-Induced Cavitation Sensitizes Cancer Cells to Radiation Therapy and Hyperthermia,Cells. 2020 Dec 3;9(12):2595. doi: 10.3390/cells9122595.,Hu S,https://www.ncbi.nlm.nih.gov/pubmed/33287379
16226,32813687,"Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series study",PLoS One. 2020 Aug 19;15(8):e0236480. doi: 10.1371/journal.pone.0236480. eCollection 2020.,Li AH,https://www.ncbi.nlm.nih.gov/pubmed/32813687
16228,33165954,Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States,Cancer. 2021 Jan 15;127(2):249-256. doi: 10.1002/cncr.33239. Epub 2020 Nov 9.,Nguyen DD,https://www.ncbi.nlm.nih.gov/pubmed/33165954
16229,32555329,AR and ERG drive the expression of prostate cancer specific long noncoding RNAs,Oncogene. 2020 Jul;39(30):5241-5251. doi: 10.1038/s41388-020-1365-6. Epub 2020 Jun 17.,Kohvakka A,https://www.ncbi.nlm.nih.gov/pubmed/32555329
16230,33045822,Peptide and pseudo-peptide,Q J Nucl Med Mol Imaging. 2020 Dec;64(4):364-370. doi: 10.23736/S1824-4785.20.03311-7. Epub 2020 Oct 12.,Mirzaei S,https://www.ncbi.nlm.nih.gov/pubmed/33045822
16231,32660838,Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy,Eur Urol Focus. 2021 Nov;7(6):1300-1307. doi: 10.1016/j.euf.2020.06.020. Epub 2020 Jul 11.,Tschirdewahn S,https://www.ncbi.nlm.nih.gov/pubmed/32660838
16232,32816023,Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma,JAMA Oncol. 2020 Oct 1;6(10):1555-1562. doi: 10.1001/jamaoncol.2020.3172.,Nguyen AT,https://www.ncbi.nlm.nih.gov/pubmed/32816023
16233,32166452,Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer,Strahlenther Onkol. 2020 Jul;196(7):589-597. doi: 10.1007/s00066-020-01598-9. Epub 2020 Mar 12.,Ghadjar P,https://www.ncbi.nlm.nih.gov/pubmed/32166452
16234,32536468,Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk Calculator,Urol Oncol. 2020 Nov;38(11):847.e1-847.e8. doi: 10.1016/j.urolonc.2020.05.011. Epub 2020 Jun 12.,"Presti J Jr,",https://www.ncbi.nlm.nih.gov/pubmed/32536468
16235,33074066,Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study,Int J Radiat Biol. 2020 Dec;96(12):1608-1613. doi: 10.1080/09553002.2020.1838655. Epub 2020 Nov 3.,Frantellizzi V,https://www.ncbi.nlm.nih.gov/pubmed/33074066
16236,32468165,Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng/ml improves its performance,Int Urol Nephrol. 2020 Oct;52(10):1811-1819. doi: 10.1007/s11255-020-02517-8. Epub 2020 May 28.,Stojadinovic M,https://www.ncbi.nlm.nih.gov/pubmed/32468165
16238,32319143,ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer,Mol Carcinog. 2020 Aug;59(8):897-907. doi: 10.1002/mc.23201. Epub 2020 Apr 22.,Chen G,https://www.ncbi.nlm.nih.gov/pubmed/32319143
16240,33108189,Synthesis and Evaluation of (68)Ga- and (177)Lu-Labeled (R)- vs (S)-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives,Mol Pharm. 2020 Dec 7;17(12):4589-4602. doi: 10.1021/acs.molpharmaceut.0c00777. Epub 2020 Oct 27.,Zhao R,https://www.ncbi.nlm.nih.gov/pubmed/33108189
16242,33093035,Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis,BMJ Open. 2020 Oct 22;10(10):e039735. doi: 10.1136/bmjopen-2020-039735.,Norris JM,https://www.ncbi.nlm.nih.gov/pubmed/33093035
16243,32215555,Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer,Carcinogenesis. 2020 Aug 12;41(8):1057-1064. doi: 10.1093/carcin/bgaa026.,Deng Y,https://www.ncbi.nlm.nih.gov/pubmed/32215555
16244,33878842,"KRAS, BRAF, PIK3CA mutation frequency of radical prostatectomy samples and review of the literature",Aging Male. 2020 Dec;23(5):1627-1641. doi: 10.1080/13685538.2021.1901274.,Bahcivan A,https://www.ncbi.nlm.nih.gov/pubmed/33878842
16245,32068491,Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate,J Urol. 2020 Jul;204(1):71-78. doi: 10.1097/JU.0000000000000803. Epub 2020 Feb 18.,Stuopelyte K,https://www.ncbi.nlm.nih.gov/pubmed/32068491
16247,32972896,Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD),Eur Urol Oncol. 2021 Dec;4(6):971-979. doi: 10.1016/j.euo.2020.08.014. Epub 2020 Sep 21.,Falagario UG,https://www.ncbi.nlm.nih.gov/pubmed/32972896
16249,31995472,Iterative Label Denoising Network: Segmenting Male Pelvic Organs in CT From 3D Bounding Box Annotations,IEEE Trans Biomed Eng. 2020 Oct;67(10):2710-2720. doi: 10.1109/TBME.2020.2969608. Epub 2020 Jan 27.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/31995472
16250,32871104,DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3? and WEE1,Mol Cell. 2020 Sep 17;79(6):1008-1023.e4. doi: 10.1016/j.molcel.2020.07.028. Epub 2020 Aug 31.,Hong Z,https://www.ncbi.nlm.nih.gov/pubmed/32871104
16251,33131949,Tomato and lycopene and multiple health outcomes: Umbrella review,Food Chem. 2021 May 1;343:128396. doi: 10.1016/j.foodchem.2020.128396. Epub 2020 Oct 15.,Li N,https://www.ncbi.nlm.nih.gov/pubmed/33131949
16252,32645691,Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis,Aging (Albany NY). 2020 Jul 9;12(13):13255-13280. doi: 10.18632/aging.103432. Epub 2020 Jul 9.,Shi J,https://www.ncbi.nlm.nih.gov/pubmed/32645691
16253,32495472,Self-perceived burden and its associations with health-related quality of life among urologic cancer patients,Eur J Cancer Care (Engl). 2020 Jul;29(4):e13248. doi: 10.1111/ecc.13248. Epub 2020 Jun 3.,Ting CY,https://www.ncbi.nlm.nih.gov/pubmed/32495472
16254,33073649,A novel DNA methylation 10-CpG prognostic signature of disease-free survival reveal that MYBL2 is associated with high risk in prostate cancer,Expert Rev Anticancer Ther. 2020 Dec;20(12):1107-1119. doi: 10.1080/14737140.2020.1838280. Epub 2020 Nov 5.,Hou X,https://www.ncbi.nlm.nih.gov/pubmed/33073649
16257,33306251,Prospective validation of microseminoprotein-? added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort,BJU Int. 2021 Aug;128(2):218-224. doi: 10.1111/bju.15320. Epub 2020 Dec 28.,Lonergan PE,https://www.ncbi.nlm.nih.gov/pubmed/33306251
16258,32744426,Effectiveness of a couple-based psychosocial intervention on patients with prostate cancer and their partners: A quasi-experimental study,J Adv Nurs. 2020 Oct;76(10):2572-2585. doi: 10.1111/jan.14471. Epub 2020 Aug 3.,Chien CH,https://www.ncbi.nlm.nih.gov/pubmed/32744426
16260,32631746,Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study,Eur Urol. 2021 Apr;79(4):456-465. doi: 10.1016/j.eururo.2020.06.041. Epub 2020 Jul 3.,Salami SS,https://www.ncbi.nlm.nih.gov/pubmed/32631746
16261,32220760,Performance of PI-RADS v2 assessment categories assigned prior to MR-US fusion biopsy in a new fusion biopsy program,Clin Imaging. 2020 Aug;64:29-34. doi: 10.1016/j.clinimag.2020.03.004. Epub 2020 Mar 13.,Trent GP,https://www.ncbi.nlm.nih.gov/pubmed/32220760
16262,33371032,What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review,BMJ Open. 2020 Dec 18;10(12):e040965. doi: 10.1136/bmjopen-2020-040965.,Kawa SM,https://www.ncbi.nlm.nih.gov/pubmed/33371032
16263,32980383,In response to Goyal et al,Radiother Oncol. 2021 Feb;155:e15. doi: 10.1016/j.radonc.2020.09.030. Epub 2020 Sep 24.,Onal C,https://www.ncbi.nlm.nih.gov/pubmed/32980383
16265,32476206,Predictors of prostate-specific antigen testing in men aged ?55 years: A cross-sectional study based on patient-reported outcomes,Int J Urol. 2020 Sep;27(9):711-718. doi: 10.1111/iju.14276. Epub 2020 May 31.,Leong JY,https://www.ncbi.nlm.nih.gov/pubmed/32476206
16266,33210965,"Investigation of LOY in Prostate, Pancreatic, and Colorectal Cancers in males: A case-control study",Expert Rev Mol Diagn. 2020 Dec;20(12):1259-1263. doi: 10.1080/14737159.2020.1853528. Epub 2020 Dec 29.,Asim A,https://www.ncbi.nlm.nih.gov/pubmed/33210965
16267,32312543,Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study,Eur Urol. 2020 Oct;78(4):503-511. doi: 10.1016/j.eururo.2020.03.002. Epub 2020 Apr 18.,Bosaily AE,https://www.ncbi.nlm.nih.gov/pubmed/32312543
16273,33230156,Identification of transcription factor co-regulators that drive prostate cancer progression,Sci Rep. 2020 Nov 23;10(1):20332. doi: 10.1038/s41598-020-77055-5.,Siddappa M,https://www.ncbi.nlm.nih.gov/pubmed/33230156
16275,32860010,The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):35-48. doi: 10.1038/s41391-020-00273-5. Epub 2020 Aug 28.,Bigaran A,https://www.ncbi.nlm.nih.gov/pubmed/32860010
16279,33047355,Understanding the diagnosis of prostate cancer,Med J Aust. 2020 Nov;213(9):424-429. doi: 10.5694/mja2.50820. Epub 2020 Oct 13.,Ong XRS,https://www.ncbi.nlm.nih.gov/pubmed/33047355
16280,33026210,The emerging value of 64Cu for molecular imaging and therapy,Q J Nucl Med Mol Imaging. 2020 Dec;64(4):329-337. doi: 10.23736/S1824-4785.20.03292-6. Epub 2020 Oct 7.,Bolzati C,https://www.ncbi.nlm.nih.gov/pubmed/33026210
16281,32342192,Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients,Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2796-2803. doi: 10.1007/s00259-020-04827-6. Epub 2020 Apr 28.,Spohn S,https://www.ncbi.nlm.nih.gov/pubmed/32342192
16282,32960990,"(18) F-labeled 1,2,3-triazole-linked Glu-urea-Lys-based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate cancer",Prostate. 2020 Dec;80(16):1383-1393. doi: 10.1002/pros.24062. Epub 2020 Sep 22.,Lee BS,https://www.ncbi.nlm.nih.gov/pubmed/32960990
16283,32239451,Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice,Endocrine. 2020 Jul;69(1):204-211. doi: 10.1007/s12020-020-02277-6. Epub 2020 Apr 1.,Mazziotti G,https://www.ncbi.nlm.nih.gov/pubmed/32239451
16285,32139878,Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):381-397. doi: 10.1038/s41391-020-0217-3. Epub 2020 Mar 5.,Lu C,https://www.ncbi.nlm.nih.gov/pubmed/32139878
16286,32485222,Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer,Cancer Lett. 2020 Sep 28;488:40-49. doi: 10.1016/j.canlet.2020.05.027. Epub 2020 May 30.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/32485222
16287,32715550,Natural killer cell mobilization and egress following acute exercise in men with prostate cancer,Exp Physiol. 2020 Sep;105(9):1524-1539. doi: 10.1113/EP088627. Epub 2020 Jul 26.,Hanson ED,https://www.ncbi.nlm.nih.gov/pubmed/32715550
16288,32856962,The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis,J Urol. 2021 Jan;205(1):60-67. doi: 10.1097/JU.0000000000001341. Epub 2020 Aug 28.,Sari Motlagh R,https://www.ncbi.nlm.nih.gov/pubmed/32856962
16289,33068878,Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database,Cancer Epidemiol. 2020 Dec;69:101833. doi: 10.1016/j.canep.2020.101833. Epub 2020 Oct 14.,Thurin NH,https://www.ncbi.nlm.nih.gov/pubmed/33068878
16291,33009489,Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):448-456. doi: 10.1038/s41391-020-00295-z. Epub 2020 Oct 2.,Haas NB,https://www.ncbi.nlm.nih.gov/pubmed/33009489
16292,32579873,Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trial,Future Oncol. 2020 Jul;16(21):1511-1524. doi: 10.2217/fon-2019-0509. Epub 2020 Jun 24.,Norz V,https://www.ncbi.nlm.nih.gov/pubmed/32579873
16293,33051982,Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study,Asia Pac J Clin Oncol. 2021 Dec;17(6):462-470. doi: 10.1111/ajco.13479. Epub 2020 Oct 13.,Zhou T,https://www.ncbi.nlm.nih.gov/pubmed/33051982
16295,32957385,Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy,Medicine (Baltimore). 2020 Sep 18;99(38):e22287. doi: 10.1097/MD.0000000000022287.,Sraieb M,https://www.ncbi.nlm.nih.gov/pubmed/32957385
16296,33323968,Regucalcin promotes dormancy of prostate cancer,Oncogene. 2021 Feb;40(5):1012-1026. doi: 10.1038/s41388-020-01565-9. Epub 2020 Dec 15.,Sharma S,https://www.ncbi.nlm.nih.gov/pubmed/33323968
16297,32414626,Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic,Eur Urol. 2020 Jul;78(1):29-42. doi: 10.1016/j.eururo.2020.04.063. Epub 2020 May 3.,Wallis CJD,https://www.ncbi.nlm.nih.gov/pubmed/32414626
16299,32914890,Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels,Prostate. 2020 Dec;80(16):1405-1412. doi: 10.1002/pros.24070. Epub 2020 Sep 11.,Li W,https://www.ncbi.nlm.nih.gov/pubmed/32914890
16301,32278840,A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Oct;18(5):343-350. doi: 10.1016/j.clgc.2020.02.005. Epub 2020 Mar 6.,Hird AE,https://www.ncbi.nlm.nih.gov/pubmed/32278840
16302,32900177,"Copper, PET/CT and prostate cancer: a systematic review of the literature",Q J Nucl Med Mol Imaging. 2020 Dec;64(4):382-392. doi: 10.23736/S1824-4785.20.03277-X. Epub 2020 Sep 9.,Piccardo A,https://www.ncbi.nlm.nih.gov/pubmed/32900177
16303,32574991,Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes,Cancer Treat Rev. 2020 Aug;88:102057. doi: 10.1016/j.ctrv.2020.102057. Epub 2020 Jun 10.,Claps M,https://www.ncbi.nlm.nih.gov/pubmed/32574991
16304,32620120,A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort,BMC Med Inform Decis Mak. 2020 Jul 3;20(1):148. doi: 10.1186/s12911-020-01174-2.,Jalali A,https://www.ncbi.nlm.nih.gov/pubmed/32620120
16306,31310271,Biomechanical Leg Muscle Function During Stair Ambulation in Men Receiving Androgen Deprivation Therapy,J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1715-1722. doi: 10.1093/gerona/glz169.,Cheung AS,https://www.ncbi.nlm.nih.gov/pubmed/31310271
16307,32800727,Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer,Eur Urol. 2021 Mar;79(3):353-361. doi: 10.1016/j.eururo.2020.07.038. Epub 2020 Aug 14.,Schaid DJ,https://www.ncbi.nlm.nih.gov/pubmed/32800727
16308,32404709,PSMA Expression in the Neovasculature Associated With Rectal Adenocarcinoma: A Potential Stromal Target for Nuclear Theranostics,Clin Nucl Med. 2020 Jul;45(7):e309-e310. doi: 10.1097/RLU.0000000000003066.,Sonni I,https://www.ncbi.nlm.nih.gov/pubmed/32404709
16312,33342672,The Relationship Between Health Literacy and Nonrecommended Cancer Screening,Am J Prev Med. 2021 Feb;60(2):e69-e72. doi: 10.1016/j.amepre.2020.08.018. Epub 2020 Dec 17.,Rutan MC,https://www.ncbi.nlm.nih.gov/pubmed/33342672
16313,33068791,Phase 2 Clinical Trial of Stereotactic Body Radiation Therapy for Painful Nonspine Bone Metastases,Pract Radiat Oncol. 2021 Mar-Apr;11(2):e139-e145. doi: 10.1016/j.prro.2020.10.003. Epub 2020 Oct 14.,Ito K,https://www.ncbi.nlm.nih.gov/pubmed/33068791
16315,32978369,The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer,Cell Death Dis. 2020 Sep 25;11(9):807. doi: 10.1038/s41419-020-02932-w.,Liu B,https://www.ncbi.nlm.nih.gov/pubmed/32978369
16316,33146243,Prostate examination among adult and elderly subjects in southern Brazil: a cross-sectional population-based study,Sao Paulo Med J. 2020 Nov-Dec;138(6):483-489. doi: 10.1590/1516-3180.2020.0197.R1.03092020.,Meneghini KFD,https://www.ncbi.nlm.nih.gov/pubmed/33146243
16318,31691084,"Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases",World J Urol. 2020 Aug;38(8):1959-1968. doi: 10.1007/s00345-019-02982-6. Epub 2019 Nov 6.,Gontero P,https://www.ncbi.nlm.nih.gov/pubmed/31691084
16321,32469183,Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer,N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32469183
16323,33546905,Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era,Actas Urol Esp (Engl Ed). 2021 Apr;45(3):207-214. doi: 10.1016/j.acuro.2020.11.001. Epub 2020 Nov 7.,García-Rojo E,https://www.ncbi.nlm.nih.gov/pubmed/33546905
16324,32768881,Cytotoxic effects of a triterpene-enriched fraction of Cecropia pachystachya on the human hormone-refractory prostate cancer PC3 cell line,Biomed Pharmacother. 2020 Oct;130:110551. doi: 10.1016/j.biopha.2020.110551. Epub 2020 Aug 5.,Rosa HH,https://www.ncbi.nlm.nih.gov/pubmed/32768881
16327,33109268,Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels,Cancer Imaging. 2020 Oct 27;20(1):77. doi: 10.1186/s40644-020-00350-x.,Pricolo P,https://www.ncbi.nlm.nih.gov/pubmed/33109268
16328,32846465,Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trials,Cancer Med. 2020 Oct;9(20):7363-7374. doi: 10.1002/cam4.3335. Epub 2020 Aug 26.,Mouillet G,https://www.ncbi.nlm.nih.gov/pubmed/32846465
16329,32787923,Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?,Cancer Imaging. 2020 Aug 12;20(1):58. doi: 10.1186/s40644-020-00333-y.,de Leiris N,https://www.ncbi.nlm.nih.gov/pubmed/32787923
16330,32430583,Dosimetry and safety of (177)Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients,Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3008-3017. doi: 10.1007/s00259-020-04856-1. Epub 2020 May 20.,Paganelli G,https://www.ncbi.nlm.nih.gov/pubmed/32430583
16331,33070989,Update and optimization of active surveillance in prostate cancer in 2021,Actas Urol Esp (Engl Ed). 2021 Jan-Feb;45(1):1-7. doi: 10.1016/j.acuro.2020.09.002. Epub 2020 Oct 16.,Rubio-Briones J,https://www.ncbi.nlm.nih.gov/pubmed/33070989
16332,33309149,Assessment of the radiation exposure of relatives and caregivers of patients treated with Ra-223 - Results of a German multicenter study,Z Med Phys. 2021 Feb;31(1):58-64. doi: 10.1016/j.zemedi.2020.09.002. Epub 2020 Dec 10.,Wanke C,https://www.ncbi.nlm.nih.gov/pubmed/33309149
16333,32556682,Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases,Clin Exp Metastasis. 2020 Oct;37(5):565-573. doi: 10.1007/s10585-020-10047-x. Epub 2020 Jun 15.,Franzese C,https://www.ncbi.nlm.nih.gov/pubmed/32556682
16334,33008495,Immunotherapy for Localized Prostate Cancer: The Next Frontier?,Urol Clin North Am. 2020 Nov;47(4):443-456. doi: 10.1016/j.ucl.2020.07.008. Epub 2020 Sep 9.,Patel D,https://www.ncbi.nlm.nih.gov/pubmed/33008495
16335,32315265,Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel,Radiology. 2020 Jul;296(1):76-84. doi: 10.1148/radiol.2020190646. Epub 2020 Apr 21.,Westphalen AC,https://www.ncbi.nlm.nih.gov/pubmed/32315265
16337,32616555,A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone,J Immunother Cancer. 2020 Jul;8(2):e000642. doi: 10.1136/jitc-2020-000642.,Graff JN,https://www.ncbi.nlm.nih.gov/pubmed/32616555
16340,31964201,Whole grain consumption and human health: an umbrella review of observational studies,Int J Food Sci Nutr. 2020 Sep;71(6):668-677. doi: 10.1080/09637486.2020.1715354. Epub 2020 Jan 21.,Tieri M,https://www.ncbi.nlm.nih.gov/pubmed/31964201
16342,32052276,Stereotactic robot-assisted transperineal prostate biopsy under local anaesthesia and sedation: moving robotic biopsy from operating theatre to clinic,J Robot Surg. 2020 Oct;14(5):767-772. doi: 10.1007/s11701-020-01052-z. Epub 2020 Feb 12.,Yang X,https://www.ncbi.nlm.nih.gov/pubmed/32052276
16343,32438463,Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy,BJU Int. 2020 Nov;126(5):568-576. doi: 10.1111/bju.15118. Epub 2020 Sep 14.,Lee AYM,https://www.ncbi.nlm.nih.gov/pubmed/32438463
16344,32255671,Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy,Cancer Biother Radiopharm. 2020 Sep;35(7):497-510. doi: 10.1089/cbr.2020.3568. Epub 2020 Apr 7.,Hagemann UB,https://www.ncbi.nlm.nih.gov/pubmed/32255671
16345,33328650,Genomic and phenotypic heterogeneity in prostate cancer,Nat Rev Urol. 2021 Feb;18(2):79-92. doi: 10.1038/s41585-020-00400-w. Epub 2020 Dec 16.,Haffner MC,https://www.ncbi.nlm.nih.gov/pubmed/33328650
16347,33105713,The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer,Cells. 2020 Oct 22;9(11):2342. doi: 10.3390/cells9112342.,Turnham DJ,https://www.ncbi.nlm.nih.gov/pubmed/33105713
16348,32452656,Association between lactate dehydrogenase levels and oncologic outcomes in metastatic prostate cancer: A meta-analysis,Cancer Med. 2020 Oct;9(19):7341-7351. doi: 10.1002/cam4.3108. Epub 2020 May 26.,Li F,https://www.ncbi.nlm.nih.gov/pubmed/32452656
16350,32453003,The role of taxane-based chemotherapy in the treatment of prostate cancer,Curr Opin Urol. 2020 Jul;30(4):527-533. doi: 10.1097/MOU.0000000000000784.,Huebner NA,https://www.ncbi.nlm.nih.gov/pubmed/32453003
16352,32745485,Prostate Cancer Risk and Prognostic Influence Among Users of 5-Alpha-Reductase Inhibitors and Alpha-Blockers: A Systematic Review and Meta-Analysis,Urology. 2020 Nov;145:216-223. doi: 10.1016/j.urology.2020.05.105. Epub 2020 Jul 31.,Wu Y,https://www.ncbi.nlm.nih.gov/pubmed/32745485
16353,32088746,Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results,World J Urol. 2020 Dec;38(12):3101-3111. doi: 10.1007/s00345-020-03127-w. Epub 2020 Feb 22.,Shore N,https://www.ncbi.nlm.nih.gov/pubmed/32088746
16354,32719353,Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):589-595. doi: 10.1038/s41391-020-0260-0. Epub 2020 Jul 27.,Liu H,https://www.ncbi.nlm.nih.gov/pubmed/32719353
16355,33143905,Gleason grade 5 prostate cancer: sub-patterns and prognosis,Pathology. 2021 Jan;53(1):3-11. doi: 10.1016/j.pathol.2020.09.016. Epub 2020 Nov 2.,Atallah C,https://www.ncbi.nlm.nih.gov/pubmed/33143905
16357,33008499,Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options,Urol Clin North Am. 2020 Nov;47(4):487-510. doi: 10.1016/j.ucl.2020.07.010. Epub 2020 Sep 28.,Chakravarty D,https://www.ncbi.nlm.nih.gov/pubmed/33008499
16358,32599976,"The Fear of Cancer from the Standpoint of Oneself, the Opposite Sex and the Fear of Side Effects of Cancer Treatment",Cancer Res Treat. 2020 Oct;52(4):993-1001. doi: 10.4143/crt.2020.285. Epub 2020 Jun 24.,Park K,https://www.ncbi.nlm.nih.gov/pubmed/32599976
16359,32866512,Germline HSD3B1 Genetics and Prostate Cancer Outcomes,Urology. 2020 Nov;145:13-21. doi: 10.1016/j.urology.2020.08.028. Epub 2020 Aug 28.,Thomas L,https://www.ncbi.nlm.nih.gov/pubmed/32866512
16360,32946908,Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance,Urology. 2021 Jan;147:213-222. doi: 10.1016/j.urology.2020.07.067. Epub 2020 Sep 15.,Ginsburg KB,https://www.ncbi.nlm.nih.gov/pubmed/32946908
16361,33126157,Facing life-prolonging treatment: The perspectives of men with advanced metastatic prostate cancer - An interview study,Eur J Oncol Nurs. 2020 Dec;49:101859. doi: 10.1016/j.ejon.2020.101859. Epub 2020 Oct 16.,Doveson S,https://www.ncbi.nlm.nih.gov/pubmed/33126157
16363,32367009,PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):549-560. doi: 10.1038/s41391-020-0233-3. Epub 2020 May 4.,Ratta R,https://www.ncbi.nlm.nih.gov/pubmed/32367009
16364,31974659,Can multiparametric magnetic resonance of the prostate avoid biopsies in patients with elevated PSA and surgical indication for benign prostatic enlargement?,Abdom Radiol (NY). 2020 Oct;45(10):3278-3282. doi: 10.1007/s00261-020-02411-y.,Wroclawski ML,https://www.ncbi.nlm.nih.gov/pubmed/31974659
16365,33317523,"Shared decision making, physicians' explanations, and treatment satisfaction: a cross-sectional survey of prostate cancer patients",BMC Med Inform Decis Mak. 2020 Dec 14;20(1):334. doi: 10.1186/s12911-020-01355-z.,Nakayama K,https://www.ncbi.nlm.nih.gov/pubmed/33317523
16366,32951005,Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration,Cell Death Dis. 2020 Sep 19;11(9):779. doi: 10.1038/s41419-020-02973-1.,Long X,https://www.ncbi.nlm.nih.gov/pubmed/32951005
16368,33008496,The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer,Urol Clin North Am. 2020 Nov;47(4):457-467. doi: 10.1016/j.ucl.2020.07.004.,Bilusic M,https://www.ncbi.nlm.nih.gov/pubmed/33008496
16369,33046797,Molecular tracing of prostate cancer lethality,Oncogene. 2020 Dec;39(50):7225-7238. doi: 10.1038/s41388-020-01496-5. Epub 2020 Oct 12.,Wang YA,https://www.ncbi.nlm.nih.gov/pubmed/33046797
16370,32732624,mpMRI-targeted biopsy versus systematic biopsy for clinically significant prostate cancer diagnosis: a systematic review and metaanalysis,Curr Opin Urol. 2020 Sep;30(5):711-719. doi: 10.1097/MOU.0000000000000801.,Baccaglini W,https://www.ncbi.nlm.nih.gov/pubmed/32732624
16371,33554033,Psychiatric Disorders and Cardiovascular Diseases During the Diagnostic Workup of Suspected Prostate Cancer,JNCI Cancer Spectr. 2020 Nov 7;5(1):pkaa108. doi: 10.1093/jncics/pkaa108. eCollection 2021 Feb.,Shen Q,https://www.ncbi.nlm.nih.gov/pubmed/33554033
16372,33256740,Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up,BMC Med. 2020 Dec 1;18(1):376. doi: 10.1186/s12916-020-01834-0.,Johnson H,https://www.ncbi.nlm.nih.gov/pubmed/33256740
16373,32054151,Diagnostic Accuracy and Value of Magnetic Resonance Imaging-Ultrasound Fusion Transperineal Targeted and Template Systematic Prostate Biopsy Based on Bi-parametric Magnetic Resonance Imaging,Cancer Res Treat. 2020 Jul;52(3):714-721. doi: 10.4143/crt.2019.716. Epub 2020 Feb 10.,Noh TI,https://www.ncbi.nlm.nih.gov/pubmed/32054151
16374,32389443,Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence,Eur Urol. 2020 Sep;78(3):304-306. doi: 10.1016/j.eururo.2020.04.016. Epub 2020 May 7.,Vickers A,https://www.ncbi.nlm.nih.gov/pubmed/32389443
16375,32493443,Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups,Radiat Oncol. 2020 Jun 3;15(1):140. doi: 10.1186/s13014-020-01579-3.,Vordermark D,https://www.ncbi.nlm.nih.gov/pubmed/32493443
16376,32785769,T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy,Eur Radiol. 2021 Jan;31(1):325-332. doi: 10.1007/s00330-020-07127-7. Epub 2020 Aug 12.,Sun C,https://www.ncbi.nlm.nih.gov/pubmed/32785769
16377,32716687,Risk Stratification of Prostate Cancer According to PI-RADS(R) Version 2 Categories: Meta-Analysis for Prospective Studies,J Urol. 2020 Dec;204(6):1141-1149. doi: 10.1097/JU.0000000000001306. Epub 2020 Jul 27.,Park KJ,https://www.ncbi.nlm.nih.gov/pubmed/32716687
16378,33421975,A Predictive Model Based on Bi-parametric Magnetic Resonance Imaging and Clinical Parameters for Clinically Significant Prostate Cancer in the Korean Population,Cancer Res Treat. 2021 Oct;53(4):1148-1155. doi: 10.4143/crt.2020.1068. Epub 2020 Dec 31.,Noh TI,https://www.ncbi.nlm.nih.gov/pubmed/33421975
16380,32543237,An evaluation of apalutamide for the treatment of prostate cancer,Expert Opin Pharmacother. 2020 Sep;21(13):1537-1546. doi: 10.1080/14656566.2020.1770726. Epub 2020 Jun 16.,Boukovala M,https://www.ncbi.nlm.nih.gov/pubmed/32543237
16381,32516030,The Role of Opioids and Their Receptors in Urological Malignancy: A Review,J Urol. 2020 Dec;204(6):1150-1159. doi: 10.1097/JU.0000000000001156. Epub 2020 Jun 9.,Lec PM,https://www.ncbi.nlm.nih.gov/pubmed/32516030
16382,33141329,HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer,Cancer Chemother Pharmacol. 2021 Jan;87(1):103-112. doi: 10.1007/s00280-020-04192-z. Epub 2020 Nov 3.,Han FF,https://www.ncbi.nlm.nih.gov/pubmed/33141329
16383,33008498,Application of Single-Cell Sequencing to Immunotherapy,Urol Clin North Am. 2020 Nov;47(4):475-485. doi: 10.1016/j.ucl.2020.07.005. Epub 2020 Sep 9.,Beaumont KG,https://www.ncbi.nlm.nih.gov/pubmed/33008498
16384,31659445,"Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study",Support Care Cancer. 2020 Jul;28(7):3093-3101. doi: 10.1007/s00520-019-05079-3. Epub 2019 Oct 28.,Burbridge C,https://www.ncbi.nlm.nih.gov/pubmed/31659445
16386,32970925,Treatment outcomes for patients with metastatic castrate-resistant prostate cancer following docetaxel for hormone-sensitive disease,Asia Pac J Clin Oncol. 2021 Feb;17(1):36-42. doi: 10.1111/ajco.13447. Epub 2020 Sep 24.,Schmidt A,https://www.ncbi.nlm.nih.gov/pubmed/32970925
16387,32709485,Prostate Cancer Prehabilitation and the Importance of Multimodal Interventions for Person-centred Care and Recovery,Semin Oncol Nurs. 2020 Aug;36(4):151048. doi: 10.1016/j.soncn.2020.151048. Epub 2020 Jul 21.,Paterson C,https://www.ncbi.nlm.nih.gov/pubmed/32709485
16388,32624276,Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer,Eur Urol. 2020 Nov;78(5):652-656. doi: 10.1016/j.eururo.2020.06.033. Epub 2020 Jul 2.,Swami U,https://www.ncbi.nlm.nih.gov/pubmed/32624276
16389,32638611,Religious Coping and Quality of Life Among Black and White Men With Prostate Cancer,Cancer Control. 2020 Jul-Aug;27(3):1073274820936288. doi: 10.1177/1073274820936288.,Bruce MA,https://www.ncbi.nlm.nih.gov/pubmed/32638611
16390,32951178,Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study,Int J Clin Pharm. 2020 Dec;42(6):1433-1439. doi: 10.1007/s11096-020-01143-9. Epub 2020 Sep 20.,Wu YH,https://www.ncbi.nlm.nih.gov/pubmed/32951178
16391,33008718,What to expect from a non-suspicious prostate MRI? A review,Prog Urol. 2020 Dec;30(16):986-999. doi: 10.1016/j.purol.2020.09.012. Epub 2020 Sep 29.,Fiard G,https://www.ncbi.nlm.nih.gov/pubmed/33008718
16392,33338321,Immune response drives outcomes in prostate cancer: implications for immunotherapy,Mol Oncol. 2021 May;15(5):1358-1375. doi: 10.1002/1878-0261.12887. Epub 2020 Dec 29.,Meng J,https://www.ncbi.nlm.nih.gov/pubmed/33338321
16393,32504311,Power Doppler Sonography (PDS) and Modified TRUS Systematic Biopsies - Can this Combination Adequately Replace Multiparametric Prostate Magnetic Resonance Imaging (mp-MRI) in Candidates for Re Biopsies Who cannot Undergo mp-MRI,Pathol Oncol Res. 2020 Oct;26(4):2357-2361. doi: 10.1007/s12253-020-00824-0. Epub 2020 Jun 5.,Kravchick S,https://www.ncbi.nlm.nih.gov/pubmed/32504311
16394,32561811,Multi-colour extrusion fused deposition modelling: a low-cost 3D printing method for anatomical prostate cancer models,Sci Rep. 2020 Jun 19;10(1):10004. doi: 10.1038/s41598-020-67082-7.,Chen MY,https://www.ncbi.nlm.nih.gov/pubmed/32561811
16395,32882325,Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer,Genomics. 2020 Nov;112(6):4980-4992. doi: 10.1016/j.ygeno.2020.08.034. Epub 2020 Sep 1.,Gao L,https://www.ncbi.nlm.nih.gov/pubmed/32882325
16397,32192907,Standardization of acquisition protocols using PET/CT with (18)F-Choline in prostate cancer,Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jul-Aug;39(4):204-211. doi: 10.1016/j.remn.2020.01.007. Epub 2020 Mar 16.,Garcia JR,https://www.ncbi.nlm.nih.gov/pubmed/32192907
16398,33290157,Noncontrast Magnetic Resonance Lymphography in Secondary Lymphedema Due to Prostate Cancer,Lymphat Res Biol. 2021 Aug;19(4):355-361. doi: 10.1089/lrb.2020.0034. Epub 2020 Dec 7.,Cellina M,https://www.ncbi.nlm.nih.gov/pubmed/33290157
16400,33384271,Clinical Translation of Positive Metastases Identified on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging in the Management of De Novo Synchronous Oligometastatic Prostate Cancer,Eur Urol Focus. 2021 Sep;7(5):951-954. doi: 10.1016/j.euf.2020.12.002. Epub 2020 Dec 28.,Connor MJ,https://www.ncbi.nlm.nih.gov/pubmed/33384271
16401,32694638,Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer,Sci Rep. 2020 Jul 21;10(1):12016. doi: 10.1038/s41598-020-68868-5.,Raittinen P,https://www.ncbi.nlm.nih.gov/pubmed/32694638
16402,33056955,"Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity - United States, 2001-2017",MMWR Morb Mortal Wkly Rep. 2020 Oct 16;69(41):1473-1480. doi: 10.15585/mmwr.mm6941a1.,Siegel DA,https://www.ncbi.nlm.nih.gov/pubmed/33056955
16403,32604118,Whole-Body 177Lu-Prostate-Specific Membrane Antigen Scan Pattern With Excess Free 177Lu-Chloride in a Metastatic Castration-Resistant Prostate Cancer Patient,Clin Nucl Med. 2020 Oct;45(10):805-807. doi: 10.1097/RLU.0000000000003167.,Askari E,https://www.ncbi.nlm.nih.gov/pubmed/32604118
16404,33289358,Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance,Korean J Radiol. 2021 Apr;22(4):559-567. doi: 10.3348/kjr.2020.0852. Epub 2020 Nov 26.,Salguero J,https://www.ncbi.nlm.nih.gov/pubmed/33289358
16405,33118296,Incidental finding of ileal gastrointestinal stromal tumour during prostate cancer staging with prostate-specific membrane antigen scan,J Med Imaging Radiat Oncol. 2021 Feb;65(1):89-91. doi: 10.1111/1754-9485.13113. Epub 2020 Oct 28.,Lee DJW,https://www.ncbi.nlm.nih.gov/pubmed/33118296
16406,32463977,Detection of clinically significant cancer in the anterior prostate by transperineal biopsy,BJU Int. 2020 Sep;126 Suppl 1:33-37. doi: 10.1111/bju.15124. Epub 2020 Aug 4.,Cowan T,https://www.ncbi.nlm.nih.gov/pubmed/32463977
16407,33100063,The role of immune PSA complex (iXip) in the prediction of prostate cancer,Biomarkers. 2021 Feb;26(1):26-30. doi: 10.1080/1354750X.2020.1841294. Epub 2020 Nov 23.,Lombardo R,https://www.ncbi.nlm.nih.gov/pubmed/33100063
16408,32744242,Management changes for patients with endocrine-related cancers in the COVID-19 pandemic,Endocr Relat Cancer. 2020 Sep;27(9):R357-R374. doi: 10.1530/ERC-20-0229.,Raghavan D,https://www.ncbi.nlm.nih.gov/pubmed/32744242
16409,32620227,MRI in the Management of Prostate Cancer,Semin Ultrasound CT MR. 2020 Aug;41(4):366-372. doi: 10.1053/j.sult.2020.04.003. Epub 2020 May 7.,Stempel CV,https://www.ncbi.nlm.nih.gov/pubmed/32620227
16410,32104968,Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy,BJU Int. 2020 Sep;126 Suppl 1:6-11. doi: 10.1111/bju.14974. Epub 2020 Feb 27.,Franklin A,https://www.ncbi.nlm.nih.gov/pubmed/32104968
16412,33487007,Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance,J Urol. 2021 Apr;205(4):1069-1074. doi: 10.1097/JU.0000000000001523. Epub 2020 Dec 1.,Meyer AR,https://www.ncbi.nlm.nih.gov/pubmed/33487007
16415,32970933,Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of patients with castration-resistant prostate cancer: A local experience of a multicenter retrospective study,Asia Pac J Clin Oncol. 2021 Jun;17(3):238-244. doi: 10.1111/ajco.13441. Epub 2020 Sep 24.,Takai M,https://www.ncbi.nlm.nih.gov/pubmed/32970933
16416,33099450,Screening for Prostate Cancer,Med Clin North Am. 2020 Nov;104(6):1051-1062. doi: 10.1016/j.mcna.2020.08.007. Epub 2020 Sep 16.,Carlsson SV,https://www.ncbi.nlm.nih.gov/pubmed/33099450
16417,32191614,Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?,Int J Circumpolar Health. 2020 Dec;79(1):1742520. doi: 10.1080/22423982.2020.1742520.,Nieder C,https://www.ncbi.nlm.nih.gov/pubmed/32191614
16419,32146725,Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression,J Diabetes Investig. 2020 Sep;11(5):1137-1149. doi: 10.1111/jdi.13247. Epub 2020 Apr 9.,Shigeoka T,https://www.ncbi.nlm.nih.gov/pubmed/32146725
16420,33306857,The characteristics and spatial distributions of prostate cancer in autopsy specimens,Prostate. 2021 Feb;81(2):135-141. doi: 10.1002/pros.24091. Epub 2020 Dec 11.,Zhou Y,https://www.ncbi.nlm.nih.gov/pubmed/33306857
16421,32542812,Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer,Prostate. 2020 Sep;80(12):926-937. doi: 10.1002/pros.24015. Epub 2020 Jun 16.,Begemann D,https://www.ncbi.nlm.nih.gov/pubmed/32542812
16422,32945736,A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy,J Urol. 2021 Feb;205(2):420-425. doi: 10.1097/JU.0000000000001374. Epub 2020 Sep 18.,Kohaar I,https://www.ncbi.nlm.nih.gov/pubmed/32945736
16423,33374303,"Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy",Cells. 2020 Dec 24;10(1):20. doi: 10.3390/cells10010020.,Montironi R,https://www.ncbi.nlm.nih.gov/pubmed/33374303
16424,32775459,Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection,Biomed Res Int. 2020 Jul 21;2020:9872146. doi: 10.1155/2020/9872146. eCollection 2020.,Barisiene M,https://www.ncbi.nlm.nih.gov/pubmed/32775459
16425,32710725,Comprehensive analysis of m6A regulators prognostic value in prostate cancer,Aging (Albany NY). 2020 Jul 25;12(14):14863-14884. doi: 10.18632/aging.103549. Epub 2020 Jul 25.,Ji G,https://www.ncbi.nlm.nih.gov/pubmed/32710725
16426,31912363,Subcapsular orchiectomy versus total orchiectomy and LHRH analogue in the treatment of hormone-sensitive metastatic prostate cancer: a different perspective in evaluation of the psychosocial effects,Support Care Cancer. 2020 Sep;28(9):4313-4326. doi: 10.1007/s00520-019-05266-2. Epub 2020 Jan 7.,Selvi I,https://www.ncbi.nlm.nih.gov/pubmed/31912363
16427,33228130,Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer,Int J Environ Res Public Health. 2020 Nov 19;17(22):8603. doi: 10.3390/ijerph17228603.,Hsieh CY,https://www.ncbi.nlm.nih.gov/pubmed/33228130
16428,33189555,Should we perform systematic biopsies in case of suspicious MRI for prostate cancer in 2020? A review of literature,Prog Urol. 2021 Mar;31(3):147-157. doi: 10.1016/j.purol.2020.09.025. Epub 2020 Nov 12.,Vesval Q,https://www.ncbi.nlm.nih.gov/pubmed/33189555
16429,32504131,Tips to start an MR-US fusion biopsy program,Abdom Radiol (NY). 2020 Dec;45(12):4023-4027. doi: 10.1007/s00261-020-02606-3. Epub 2020 Jun 5.,Sheridan A,https://www.ncbi.nlm.nih.gov/pubmed/32504131
16430,32988673,"Multiparametric Ultrasound for Targeting Prostate Cancer: Combining ARFI, SWEI, QUS and B-Mode",Ultrasound Med Biol. 2020 Dec;46(12):3426-3439. doi: 10.1016/j.ultrasmedbio.2020.08.022. Epub 2020 Sep 28.,Morris DC,https://www.ncbi.nlm.nih.gov/pubmed/32988673
16431,33247498,Current experimental human tissue-derived models for prostate cancer research,Int J Urol. 2021 Feb;28(2):150-162. doi: 10.1111/iju.14441. Epub 2020 Nov 27.,Kato M,https://www.ncbi.nlm.nih.gov/pubmed/33247498
16432,31720770,Prostate cancer and the role of biomarkers,Abdom Radiol (NY). 2020 Jul;45(7):2120-2132. doi: 10.1007/s00261-019-02305-8.,Nevo A,https://www.ncbi.nlm.nih.gov/pubmed/31720770
16433,33039808,"A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancer",Comput Biol Med. 2020 Nov;126:104020. doi: 10.1016/j.compbiomed.2020.104020. Epub 2020 Sep 30.,Lakshmanan VK,https://www.ncbi.nlm.nih.gov/pubmed/33039808
16435,32803471,Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning,Curr Urol Rep. 2020 Aug 17;21(10):38. doi: 10.1007/s11934-020-00987-y.,Eldred-Evans D,https://www.ncbi.nlm.nih.gov/pubmed/32803471
16437,31156017,Prostate cancer incidence and diagnosis in men with PSA levels >20?ng/ml: is it possible to decrease the number of biopsy cores?,Aging Male. 2020 Dec;23(5):893-900. doi: 10.1080/13685538.2019.1620204. Epub 2019 Jun 1.,Ozorak A,https://www.ncbi.nlm.nih.gov/pubmed/31156017
16438,32963329,Validated prognostic significance of YB-1 genetic variation in metastatic prostate cancer,Pharmacogenomics J. 2021 Feb;21(1):102-105. doi: 10.1038/s41397-020-00188-3. Epub 2020 Sep 22.,Shiota M,https://www.ncbi.nlm.nih.gov/pubmed/32963329
16439,33099949,miR-19a promotes the metastasis and EMT through CUL5 in prostate cancer cell line PC3,J BUON. 2020 Jul-Aug;25(4):2028-2035.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/33099949
16440,32314932,Prostate Mapping for Cancer Diagnosis: The Madrid Protocol. Transperineal Prostate Biopsies Using Multiparametric Magnetic Resonance Imaging Fusion and Micro-Ultrasound Guided Biopsies,J Urol. 2020 Oct;204(4):726-733. doi: 10.1097/JU.0000000000001083. Epub 2020 Apr 21.,Rodríguez Socarrás ME,https://www.ncbi.nlm.nih.gov/pubmed/32314932
16441,32453086,Metastatic Parathyroid Hormone-Secreting Prostate Adenocarcinoma Mimicking Ectopic Parathyroid Adenoma Demonstrated on 99mTc-MIBI Image,Clin Nucl Med. 2020 Jul;45(7):555-556. doi: 10.1097/RLU.0000000000003064.,Chen YH,https://www.ncbi.nlm.nih.gov/pubmed/32453086
16442,32008343,Histogram analysis in prostate cancer: a comparison of diffusion kurtosis imaging model versus monoexponential model,Acta Radiol. 2020 Oct;61(10):1431-1440. doi: 10.1177/0284185120901504. Epub 2020 Feb 2.,Jiang Y,https://www.ncbi.nlm.nih.gov/pubmed/32008343
16443,33029725,A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer,Adv Ther. 2020 Dec;37(12):4910-4929. doi: 10.1007/s12325-020-01509-5. Epub 2020 Oct 7.,McKay RR,https://www.ncbi.nlm.nih.gov/pubmed/33029725
16444,32762625,Prostate-specific Membrane Antigen PET: Therapy Response Assessment in Metastatic Prostate Cancer,Radiographics. 2020 Sep-Oct;40(5):1412-1430. doi: 10.1148/rg.2020200058. Epub 2020 Aug 7.,Barbosa FG,https://www.ncbi.nlm.nih.gov/pubmed/32762625
16445,30409717,Prostate Cancer Screening Guidelines for African American Veterans: A New Perspective,J Natl Med Assoc. 2020 Oct;112(5):448-453. doi: 10.1016/j.jnma.2018.10.010. Epub 2018 Nov 6.,Reddy A,https://www.ncbi.nlm.nih.gov/pubmed/30409717
16447,33342177,Acquired Darier disease in a patient with metastatic prostate cancer: a paraneoplastic process?,Dermatol Online J. 2020 Nov 15;26(11):13030/qt40z3v8vq.,Pararajasingam A,https://www.ncbi.nlm.nih.gov/pubmed/33342177
16449,32690473,Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician,Eur Urol Focus. 2020 Nov 15;6(6):1170-1179. doi: 10.1016/j.euf.2020.05.014. Epub 2020 Jul 18.,Siebert AL,https://www.ncbi.nlm.nih.gov/pubmed/32690473
16450,32901094,The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):335-340. doi: 10.1038/s41391-020-00279-z. Epub 2020 Sep 8.,Naha U,https://www.ncbi.nlm.nih.gov/pubmed/32901094
16451,32113858,Histomorphological analysis of false positive PI-RADS 4 and 5 lesions,Urol Oncol. 2020 Jul;38(7):636.e7-636.e12. doi: 10.1016/j.urolonc.2020.01.017. Epub 2020 Feb 27.,Hupe MC,https://www.ncbi.nlm.nih.gov/pubmed/32113858
16452,32965775,Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment,Cancer Med. 2020 Nov;9(22):8530-8539. doi: 10.1002/cam4.3471. Epub 2020 Sep 23.,Slezak JM,https://www.ncbi.nlm.nih.gov/pubmed/32965775
16453,32949185,Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805),Prostate. 2020 Dec;80(16):1429-1437. doi: 10.1002/pros.24074. Epub 2020 Sep 19.,Harshman LC,https://www.ncbi.nlm.nih.gov/pubmed/32949185
16454,33241594,Simulation model of disease incidence driven by diagnostic activity,Stat Med. 2021 Feb 28;40(5):1172-1188. doi: 10.1002/sim.8833. Epub 2020 Nov 25.,Westerberg M,https://www.ncbi.nlm.nih.gov/pubmed/33241594
16456,32072326,Adopting a collaborative approach in developing a prehabilitation program for patients with prostate cancer utilising experience-based co-design methodology,Support Care Cancer. 2020 Nov;28(11):5195-5202. doi: 10.1007/s00520-020-05341-z. Epub 2020 Feb 18.,Tang CY,https://www.ncbi.nlm.nih.gov/pubmed/32072326
16457,31710001,"Association between 5?-reductase inhibitors therapy and incidence, cancer-specific mortality, and progression of prostate cancer: evidence from a meta-analysis",Asian J Androl. 2020 Sep-Oct;22(5):532-538. doi: 10.4103/aja.aja_112_19.,Luo LM,https://www.ncbi.nlm.nih.gov/pubmed/31710001
16458,33241520,A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis,Eur Radiol. 2021 Jun;31(6):4386-4389. doi: 10.1007/s00330-020-07527-9. Epub 2020 Nov 25.,Padhani AR,https://www.ncbi.nlm.nih.gov/pubmed/33241520
16459,31897683,Prostate MRI-TRUS fusion biopsy: a review of the state of the art procedure,Abdom Radiol (NY). 2020 Jul;45(7):2176-2183. doi: 10.1007/s00261-019-02391-8.,Das CJ,https://www.ncbi.nlm.nih.gov/pubmed/31897683
16460,32479105,Comparison of Likert and PI-RADS version 2 MRI scoring systems for the detection of clinically significant prostate cancer,Br J Radiol. 2020 Aug;93(1112):20200298. doi: 10.1259/bjr.20200298. Epub 2020 Jun 11.,Zawaideh JP,https://www.ncbi.nlm.nih.gov/pubmed/32479105
16461,32249349,MRI/TRUS fusion vs. systematic biopsy: intra-patient comparison of diagnostic accuracy for prostate cancer using PI-RADS v2,Abdom Radiol (NY). 2020 Jul;45(7):2235-2243. doi: 10.1007/s00261-020-02481-y.,Labra A,https://www.ncbi.nlm.nih.gov/pubmed/32249349
16462,32307329,Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population,Urol Oncol. 2020 Oct;38(10):794.e11-794.e16. doi: 10.1016/j.urolonc.2020.03.024. Epub 2020 Apr 17.,Zahalka AH,https://www.ncbi.nlm.nih.gov/pubmed/32307329
16463,32900250,Advances in the diagnostic options for prostate cancer,Postgrad Med. 2020 Dec;132(sup4):52-62. doi: 10.1080/00325481.2020.1822067. Epub 2020 Oct 18.,French WW,https://www.ncbi.nlm.nih.gov/pubmed/32900250
16464,33219369,What is the minimal dose for resistance exercise effectiveness in prostate cancer patients? Systematic review and meta-analysis on patient-reported outcomes,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):465-481. doi: 10.1038/s41391-020-00301-4. Epub 2020 Nov 20.,Lopez P,https://www.ncbi.nlm.nih.gov/pubmed/33219369
16466,32899006,Association of long-chain non-coding RNA GAS5 gene polymorphisms with prostate cancer risk and prognosis in Chinese Han population,Medicine (Baltimore). 2020 Sep 4;99(36):e21790. doi: 10.1097/MD.0000000000021790.,Zhao L,https://www.ncbi.nlm.nih.gov/pubmed/32899006
16467,32812797,A 3D-2D Hybrid U-Net Convolutional Neural Network Approach to Prostate Organ Segmentation of Multiparametric MRI,AJR Am J Roentgenol. 2021 Jan;216(1):111-116. doi: 10.2214/AJR.19.22168. Epub 2020 Nov 10.,Ushinsky A,https://www.ncbi.nlm.nih.gov/pubmed/32812797
16470,32466878,Apalutamide in combination with autophagy inhibitors improves treatment effects in prostate cancer cells,Urol Oncol. 2020 Aug;38(8):683.e19-683.e26. doi: 10.1016/j.urolonc.2020.04.030. Epub 2020 May 25.,Eberli D,https://www.ncbi.nlm.nih.gov/pubmed/32466878
16471,33197890,Immune-related biomarker risk score predicts prognosis in prostate cancer,Aging (Albany NY). 2020 Nov 10;12(22):22776-22793. doi: 10.18632/aging.103921. Epub 2020 Nov 10.,Liu Z,https://www.ncbi.nlm.nih.gov/pubmed/33197890
16472,32428663,GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers,Cancer Lett. 2020 Aug 10;485:45-55. doi: 10.1016/j.canlet.2020.05.007. Epub 2020 May 16.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32428663
16473,32748618,The role of metabolic syndrome in high grade prostate cancer: development of a clinical nomogram,Minerva Urol Nefrol. 2020 Dec;72(6):729-736. doi: 10.23736/S0393-2249.20.03797-2. Epub 2020 Aug 4.,De Nunzio C,https://www.ncbi.nlm.nih.gov/pubmed/32748618
16474,32873277,A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy,BMC Urol. 2020 Sep 1;20(1):138. doi: 10.1186/s12894-020-00712-4.,McKiernan J,https://www.ncbi.nlm.nih.gov/pubmed/32873277
16476,32911806,Is There a Role for Immunotherapy in Prostate Cancer?,Cells. 2020 Sep 8;9(9):2051. doi: 10.3390/cells9092051.,Rizzo A,https://www.ncbi.nlm.nih.gov/pubmed/32911806
16477,33380869,Presenting stage and risk group in men dying of prostate cancer,Curr Oncol. 2020 Dec;27(6):e547-e551. doi: 10.3747/co.27.6385. Epub 2020 Dec 1.,Parimi S,https://www.ncbi.nlm.nih.gov/pubmed/33380869
16478,32716686,How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy?,J Urol. 2020 Dec;204(6):1202-1208. doi: 10.1097/JU.0000000000001302. Epub 2020 Jul 27.,Song G,https://www.ncbi.nlm.nih.gov/pubmed/32716686
16479,32717359,Toxicity in combination immune checkpoint inhibitor and radiation therapy: A systematic review and meta-analysis,Radiother Oncol. 2020 Oct;151:141-148. doi: 10.1016/j.radonc.2020.07.035. Epub 2020 Jul 24.,Sha CM,https://www.ncbi.nlm.nih.gov/pubmed/32717359
16480,32898525,An overview of advances in multi-omics analysis in prostate cancer,Life Sci. 2020 Nov 1;260:118376. doi: 10.1016/j.lfs.2020.118376. Epub 2020 Sep 6.,Zhang E,https://www.ncbi.nlm.nih.gov/pubmed/32898525
16482,32313142,Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):638-645. doi: 10.1038/s41391-020-0231-5. Epub 2020 Apr 20.,Martini A,https://www.ncbi.nlm.nih.gov/pubmed/32313142
16483,33119142,Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk,Cancer. 2021 Jan 15;127(2):203-208. doi: 10.1002/cncr.33241. Epub 2020 Oct 29.,Filson CP,https://www.ncbi.nlm.nih.gov/pubmed/33119142
16485,32941663,Heart transplantation in patients with localized prostate cancer-Are we denying a life-saving therapy due to an indolent tumor?,Clin Transplant. 2020 Nov;34(11):e14080. doi: 10.1111/ctr.14080. Epub 2020 Sep 28.,Raikhelkar J,https://www.ncbi.nlm.nih.gov/pubmed/32941663
16488,32761380,The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy,World J Urol. 2021 Jun;39(6):1889-1895. doi: 10.1007/s00345-020-03397-4. Epub 2020 Aug 6.,Stejskal J,https://www.ncbi.nlm.nih.gov/pubmed/32761380
16489,32852902,Optimizing skeletal-related events prevention in patients with advanced prostate cancer,Asia Pac J Clin Oncol. 2020 Sep;16 Suppl 3:4-6. doi: 10.1111/ajco.13315.,Leung AK,https://www.ncbi.nlm.nih.gov/pubmed/32852902
16491,33318295,The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients,Aging (Albany NY). 2020 Dec 9;13(2):2279-2293. doi: 10.18632/aging.202248. Epub 2020 Dec 9.,Shen H,https://www.ncbi.nlm.nih.gov/pubmed/33318295
16492,32404644,18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies,Nucl Med Commun. 2020 Jul;41(7):674-681. doi: 10.1097/MNM.0000000000001189.,Jiménez Londoño GA,https://www.ncbi.nlm.nih.gov/pubmed/32404644
16493,32779258,Changes in lifestyle among prostate cancer survivors: A nationwide population-based study,Psychooncology. 2020 Oct;29(10):1713-1719. doi: 10.1002/pon.5513. Epub 2020 Sep 1.,Bergengren O,https://www.ncbi.nlm.nih.gov/pubmed/32779258
16494,33008497,"Immunotherapy for Prostate Cancer: Treatments for the ""Lethal"" Phenotype",Urol Clin North Am. 2020 Nov;47(4):469-474. doi: 10.1016/j.ucl.2020.07.007. Epub 2020 Sep 10.,Slovin SF,https://www.ncbi.nlm.nih.gov/pubmed/33008497
16495,32591887,Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study,Eur Radiol. 2020 Nov;30(11):6042-6051. doi: 10.1007/s00330-020-06997-1. Epub 2020 Jun 26.,Ullrich T,https://www.ncbi.nlm.nih.gov/pubmed/32591887
16497,32860373,Diagnostic performance of prostate health index (PHI) in predicting prostate cancer on prostate biopsy,Malays J Pathol. 2020 Aug;42(2):209-214.,Othman H,https://www.ncbi.nlm.nih.gov/pubmed/32860373
16498,32372384,Improving detection of prostate cancer foci via information fusion of MRI and temporal enhanced ultrasound,Int J Comput Assist Radiol Surg. 2020 Jul;15(7):1215-1223. doi: 10.1007/s11548-020-02172-5. Epub 2020 May 5.,Sedghi A,https://www.ncbi.nlm.nih.gov/pubmed/32372384
16499,33077762,A novel nomogram predicting the risk of positive biopsy for patients in the diagnostic gray area of prostate cancer,Sci Rep. 2020 Oct 19;10(1):17675. doi: 10.1038/s41598-020-74703-8.,Hou GD,https://www.ncbi.nlm.nih.gov/pubmed/33077762
16500,31749145,Metronomic cyclophosphamide induces regulatory T cells depletion and PSA-specific T cells reactivation in patients with biochemical recurrent prostate cancer,Int J Cancer. 2020 Aug 15;147(4):1199-1205. doi: 10.1002/ijc.32803. Epub 2019 Dec 11.,Laheurte C,https://www.ncbi.nlm.nih.gov/pubmed/31749145
16501,33107101,Diagnosis of prostate cancer in one day: The benefits of cytology in tumour detection,Cytopathology. 2021 Mar;32(2):211-216. doi: 10.1111/cyt.12930. Epub 2020 Dec 22.,Compérat E,https://www.ncbi.nlm.nih.gov/pubmed/33107101
16502,31522234,Validating the European randomised study for screening of prostate cancer (ERSPC) risk calculator in a contemporary South African cohort,World J Urol. 2020 Jul;38(7):1711-1718. doi: 10.1007/s00345-019-02947-9. Epub 2019 Sep 14.,Kowlessur B,https://www.ncbi.nlm.nih.gov/pubmed/31522234
16503,33070957,Benign mimics of prostate cancer,Pathology. 2021 Jan;53(1):26-35. doi: 10.1016/j.pathol.2020.08.006. Epub 2020 Oct 16.,Egevad L,https://www.ncbi.nlm.nih.gov/pubmed/33070957
16504,32500650,Long-term health-related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer,Cancer Med. 2020 Aug;9(15):5643-5654. doi: 10.1002/cam4.3181. Epub 2020 Jun 4.,Talala K,https://www.ncbi.nlm.nih.gov/pubmed/32500650
16505,32341031,Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer,Clin Cancer Res. 2020 Aug 1;26(15):4143-4153. doi: 10.1158/1078-0432.CCR-19-4100. Epub 2020 Apr 27.,Malihi PD,https://www.ncbi.nlm.nih.gov/pubmed/32341031
16506,32248987,Study structure may compromise understanding of longitudinal decision regret stability: A systematic review,Patient Educ Couns. 2020 Aug;103(8):1507-1517. doi: 10.1016/j.pec.2020.03.011. Epub 2020 Mar 12.,Aarhus RT,https://www.ncbi.nlm.nih.gov/pubmed/32248987
16507,32842649,PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer,Biomolecules. 2020 Aug 22;10(9):1221. doi: 10.3390/biom10091221.,Sharad S,https://www.ncbi.nlm.nih.gov/pubmed/32842649
16508,32812795,PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review,AJR Am J Roentgenol. 2021 Jan;216(1):3-19. doi: 10.2214/AJR.20.24268. Epub 2020 Nov 19.,Schoots IG,https://www.ncbi.nlm.nih.gov/pubmed/32812795
16510,31701190,Prostate magnetic resonance imaging technique,Abdom Radiol (NY). 2020 Jul;45(7):2109-2119. doi: 10.1007/s00261-019-02308-5.,Mussi TC,https://www.ncbi.nlm.nih.gov/pubmed/31701190
16511,32576165,DNA methylation signatures of Prostate Cancer in peripheral T-cells,BMC Cancer. 2020 Jun 23;20(1):588. doi: 10.1186/s12885-020-07078-8.,Mehdi A,https://www.ncbi.nlm.nih.gov/pubmed/32576165
16512,34394251,Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?,Afr Health Sci. 2020 Dec;20(4):1870-1874. doi: 10.4314/ahs.v20i4.43.,Amin HS,https://www.ncbi.nlm.nih.gov/pubmed/34394251
16513,33242853,Who Can Avoid Biopsy of Magnetic Resonance Imaging-Negative Lobes without Compromising Significant Cancer Detection among Men with Unilateral Magnetic Resonance Imaging-Positive Lobes?,Urol Int. 2021;105(5-6):386-393. doi: 10.1159/000511636. Epub 2020 Nov 26.,Nakanishi Y,https://www.ncbi.nlm.nih.gov/pubmed/33242853
16514,32660451,Real-world efficacy and safety of two doses of cabazitaxel (20 or 25?mg/m(2)) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study,BMC Cancer. 2020 Jul 13;20(1):649. doi: 10.1186/s12885-020-07131-6.,Matsuyama H,https://www.ncbi.nlm.nih.gov/pubmed/32660451
16515,33135121,How Fast Can We Go: Abbreviated Prostate MR Protocols,Curr Urol Rep. 2020 Nov 2;21(12):59. doi: 10.1007/s11934-020-01008-8.,Udayakumar N,https://www.ncbi.nlm.nih.gov/pubmed/33135121
16516,31235395,Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer,Eur Urol Oncol. 2020 Oct;3(5):640-647. doi: 10.1016/j.euo.2019.05.005. Epub 2019 Jun 22.,Olsson H,https://www.ncbi.nlm.nih.gov/pubmed/31235395
16517,32480269,Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives,Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24.,Leone G,https://www.ncbi.nlm.nih.gov/pubmed/32480269
16518,33025681,Funding of prostate magnetic resonance imaging leads to fewer biopsies and potential savings to health systems in the management of prostate cancer,BJU Int. 2021 May;127 Suppl 1:6-12. doi: 10.1111/bju.15231. Epub 2020 Oct 6.,Whish-Wilson T,https://www.ncbi.nlm.nih.gov/pubmed/33025681
16519,32918577,Comparison of PI-RADS version 2.1 and PI-RADS version 2 regarding interreader variability and diagnostic accuracy for transition zone prostate cancer,Abdom Radiol (NY). 2020 Dec;45(12):4133-4141. doi: 10.1007/s00261-020-02738-6. Epub 2020 Sep 12.,Xu L,https://www.ncbi.nlm.nih.gov/pubmed/32918577
16520,32614123,Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1,J Magn Reson Imaging. 2021 Jan;53(1):283-291. doi: 10.1002/jmri.27283. Epub 2020 Jul 2.,Tamada T,https://www.ncbi.nlm.nih.gov/pubmed/32614123
16521,33154293,Survey of prostate biopsy practices among urologists in Nigeria,Niger Postgrad Med J. 2020 Oct-Dec;27(4):377-383. doi: 10.4103/npmj.npmj_297_20.,Jeje EA,https://www.ncbi.nlm.nih.gov/pubmed/33154293
16522,32356003,Delivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosis,Abdom Radiol (NY). 2020 Dec;45(12):4012-4022. doi: 10.1007/s00261-020-02547-x.,Schoots IG,https://www.ncbi.nlm.nih.gov/pubmed/32356003
16523,32614257,Risk of Prostate Cancer after a Negative Magnetic Resonance Imaging Guided Biopsy,J Urol. 2020 Dec;204(6):1180-1186. doi: 10.1097/JU.0000000000001232. Epub 2020 Jul 2.,Kinnaird A,https://www.ncbi.nlm.nih.gov/pubmed/32614257
16524,32823970,Deep Learning Modeling of Androgen Receptor Responses to Prostate Cancer Therapies,Int J Mol Sci. 2020 Aug 14;21(16):5847. doi: 10.3390/ijms21165847.,Snow O,https://www.ncbi.nlm.nih.gov/pubmed/32823970
16525,32999465,Sectoral cancer detection and tolerability of freehand transperineal prostate biopsy under local anaesthesia,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):431-438. doi: 10.1038/s41391-020-00293-1. Epub 2020 Sep 30.,Chiu PK,https://www.ncbi.nlm.nih.gov/pubmed/32999465
16526,33296173,Noninvasive Precision Screening of Prostate Cancer by Urinary Multimarker Sensor and Artificial Intelligence Analysis,ACS Nano. 2021 Mar 23;15(3):4054-4065. doi: 10.1021/acsnano.0c06946. Epub 2020 Dec 9.,Kim H,https://www.ncbi.nlm.nih.gov/pubmed/33296173
16527,32755166,3-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy,AJR Am J Roentgenol. 2020 Sep;215(3):660-666. doi: 10.2214/AJR.19.22455. Epub 2020 Jul 8.,Hosseiny M,https://www.ncbi.nlm.nih.gov/pubmed/32755166
16529,33191117,The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial,Urol Oncol. 2021 Jul;39(7):433.e1-433.e7. doi: 10.1016/j.urolonc.2020.10.018. Epub 2020 Nov 13.,Schiavina R,https://www.ncbi.nlm.nih.gov/pubmed/33191117
16530,32791510,Clinical Experience of Steroid Switch from Prednisone to Dexamethasone in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate,Urol Int. 2021;105(5-6):380-385. doi: 10.1159/000509882. Epub 2020 Aug 13.,Fang WY,https://www.ncbi.nlm.nih.gov/pubmed/32791510
16532,30849262,Factors affecting the diagnosis of prostate cancer through 12 quadrant guided prostate biopsy,Aging Male. 2020 Dec;23(5):663-668. doi: 10.1080/13685538.2019.1573219. Epub 2019 Mar 8.,Kocan H,https://www.ncbi.nlm.nih.gov/pubmed/30849262
16533,32496317,"In Vivo Quantification of Water Diffusion, Stiffness, and Tissue Fluidity in Benign Prostatic Hyperplasia and Prostate Cancer",Invest Radiol. 2020 Aug;55(8):524-530. doi: 10.1097/RLI.0000000000000685.,Asbach P,https://www.ncbi.nlm.nih.gov/pubmed/32496317
16534,32640738,Hypoxia Promotes Prostate Cancer Aggressiveness by Upregulating EMT-Activator Zeb1 and SK3 Channel Expression,Int J Mol Sci. 2020 Jul 6;21(13):4786. doi: 10.3390/ijms21134786.,Bery F,https://www.ncbi.nlm.nih.gov/pubmed/32640738
16535,33404002,"Prostate cancer age-standardised incidence increase between 2006 and 2016 in Gauteng Province, South Africa: A laboratory data-based analysis",S Afr Med J. 2020 Dec 14;111(1):26-32. doi: 10.7196/SAMJ.2020.v111i1.14850.,Cassim N,https://www.ncbi.nlm.nih.gov/pubmed/33404002
16536,32957106,"Molecular Origin, Expression Regulation, and Biological Function of Androgen Receptor Splicing Variant 7 in Prostate Cancer",Urol Int. 2021;105(5-6):337-353. doi: 10.1159/000510124. Epub 2020 Sep 21.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32957106
16538,32487321,Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer,Eur Urol. 2020 Aug;78(2):173-180. doi: 10.1016/j.eururo.2020.03.044. Epub 2020 May 30.,Fettke H,https://www.ncbi.nlm.nih.gov/pubmed/32487321
16539,32728885,"Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review",World J Urol. 2021 Mar;39(3):677-686. doi: 10.1007/s00345-020-03366-x. Epub 2020 Jul 29.,Yamada Y,https://www.ncbi.nlm.nih.gov/pubmed/32728885
16540,33101546,Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer,Dis Markers. 2020 Oct 9;2020:8860788. doi: 10.1155/2020/8860788. eCollection 2020.,Liu B,https://www.ncbi.nlm.nih.gov/pubmed/33101546
16541,33186519,Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis,Cancer Cell. 2021 Jan 11;39(1):68-82.e9. doi: 10.1016/j.ccell.2020.10.012. Epub 2020 Nov 12.,Guccini I,https://www.ncbi.nlm.nih.gov/pubmed/33186519
16542,33155063,Differences between rural and urban prostate cancer patients,World J Urol. 2021 Jul;39(7):2507-2514. doi: 10.1007/s00345-020-03483-7. Epub 2020 Nov 5.,Stolzenbach LF,https://www.ncbi.nlm.nih.gov/pubmed/33155063
16543,34018917,Redefining masculinity - Men's repair work in the aftermath of prostate cancer treatment,Health Sociol Rev. 2021 Jul;30(2):143-156. doi: 10.1080/14461242.2020.1820367. Epub 2020 Sep 22.,Brüggemann J,https://www.ncbi.nlm.nih.gov/pubmed/34018917
16544,33305678,Prostate Cancer Treatment and Work: A Scoping Review,Am J Mens Health. 2020 Nov-Dec;14(6):1557988320979257. doi: 10.1177/1557988320979257.,Yu Ko WF,https://www.ncbi.nlm.nih.gov/pubmed/33305678
16545,31775579,"A castrate-resistant metastatic prostate cancer patient with severe pancytopenia, successfully treated with docetaxel chemotherapy",J Oncol Pharm Pract. 2020 Jul;26(5):1254-1258. doi: 10.1177/1078155219890653. Epub 2019 Nov 27.,Kunthur A,https://www.ncbi.nlm.nih.gov/pubmed/31775579
16546,33227304,Trends for Stage and Grade Group of Prostate Cancer in the US (2010-2016),Urology. 2021 Mar;149:110-116. doi: 10.1016/j.urology.2020.11.022. Epub 2020 Nov 21.,Schmanke K,https://www.ncbi.nlm.nih.gov/pubmed/33227304
16547,32530556,Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer,Cancer Sci. 2020 Aug;111(8):3020-3031. doi: 10.1111/cas.14525. Epub 2020 Jul 9.,Zhao J,https://www.ncbi.nlm.nih.gov/pubmed/32530556
16548,32556919,Tracking and visualization of the sensing area for a tethered laparoscopic gamma probe,Int J Comput Assist Radiol Surg. 2020 Aug;15(8):1389-1397. doi: 10.1007/s11548-020-02205-z. Epub 2020 Jun 16.,Huang B,https://www.ncbi.nlm.nih.gov/pubmed/32556919
16549,32696126,Who can safely evade a magnetic resonance imaging fusion-targeted biopsy (MRIFTB) for prostate imaging reporting and data system (PI-RADS) 3 lesion?,World J Urol. 2021 May;39(5):1463-1471. doi: 10.1007/s00345-020-03352-3. Epub 2020 Jul 21.,Kim M,https://www.ncbi.nlm.nih.gov/pubmed/32696126
16550,33002371,Impact of PI-RADS Category 3 lesions on the diagnostic accuracy of MRI for detecting prostate cancer and the prevalence of prostate cancer within each PI-RADS category: A systematic review and meta-analysis,Br J Radiol. 2021 Feb 1;94(1118):20191050. doi: 10.1259/bjr.20191050. Epub 2020 Oct 22.,Wadera A,https://www.ncbi.nlm.nih.gov/pubmed/33002371
16551,33103532,Vitamin D levels and the risk of prostate cancer and prostate cancer mortality,Acta Oncol. 2021 Mar;60(3):316-322. doi: 10.1080/0284186X.2020.1837391. Epub 2020 Oct 24.,Stroomberg HV,https://www.ncbi.nlm.nih.gov/pubmed/33103532
16552,33203873,The use of prostate specific antigen density to predict clinically significant prostate cancer,Sci Rep. 2020 Nov 17;10(1):20015. doi: 10.1038/s41598-020-76786-9.,Yusim I,https://www.ncbi.nlm.nih.gov/pubmed/33203873
16553,32574722,HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies,Ann Oncol. 2020 Sep;31(9):1186-1197. doi: 10.1016/j.annonc.2020.06.006. Epub 2020 Jun 20.,Khalaf DJ,https://www.ncbi.nlm.nih.gov/pubmed/32574722
16554,31940221,Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline,J Clin Oncol. 2020 Jun 10;38(17):1963-1996. doi: 10.1200/JCO.19.02757. Epub 2020 Jan 15.,Trabulsi EJ,https://www.ncbi.nlm.nih.gov/pubmed/31940221
16555,33290430,Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer,PLoS One. 2020 Dec 8;15(12):e0243386. doi: 10.1371/journal.pone.0243386. eCollection 2020.,Cunningham J,https://www.ncbi.nlm.nih.gov/pubmed/33290430
16556,31605196,Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort,World J Urol. 2020 Jul;38(7):1757-1764. doi: 10.1007/s00345-019-02974-6. Epub 2019 Oct 12.,Ferriero M,https://www.ncbi.nlm.nih.gov/pubmed/31605196
16557,33402973,Prostate hyperplasia in St Mary's Hospital Lacor: utility of prostate specific antigen in screening for prostate malignancy,Afr Health Sci. 2020 Sep;20(3):1259-1263. doi: 10.4314/ahs.v20i3.30.,Okidi R,https://www.ncbi.nlm.nih.gov/pubmed/33402973
16558,33247633,Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer,Cancer Med. 2021 Jan;10(1):62-69. doi: 10.1002/cam4.3555. Epub 2020 Nov 28.,Borno HT,https://www.ncbi.nlm.nih.gov/pubmed/33247633
16559,32597118,The importance of PSA-Density in active surveillance for prostate cancer,Arch Ital Urol Androl. 2020 Jun 24;92(2). doi: 10.4081/aiua.2020.2.136.,Ediz C,https://www.ncbi.nlm.nih.gov/pubmed/32597118
16560,31812576,Tracking Changes in Clinical Practice Patterns Following Prebiopsy Biparametric Prostate MRI,Acad Radiol. 2020 Sep;27(9):1255-1260. doi: 10.1016/j.acra.2019.10.033. Epub 2019 Dec 4.,Choi MH,https://www.ncbi.nlm.nih.gov/pubmed/31812576
16561,32488548,Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer,Int J Clin Oncol. 2020 Sep;25(9):1695-1703. doi: 10.1007/s10147-020-01712-y. Epub 2020 Jun 2.,Fukuokaya W,https://www.ncbi.nlm.nih.gov/pubmed/32488548
16562,32284527,Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide,Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.,Buttigliero C,https://www.ncbi.nlm.nih.gov/pubmed/32284527
16563,32948433,Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey,Urol Oncol. 2021 May;39(5):295.e1-295.e8. doi: 10.1016/j.urolonc.2020.08.027. Epub 2020 Sep 15.,Fine SW,https://www.ncbi.nlm.nih.gov/pubmed/32948433
16564,32531720,Optimizing size thresholds for detection of clinically significant prostate cancer on MRI: Peripheral zone cancers are smaller and more predictable than transition zone tumors,Eur J Radiol. 2020 Aug;129:109071. doi: 10.1016/j.ejrad.2020.109071. Epub 2020 May 17.,Mahjoub S,https://www.ncbi.nlm.nih.gov/pubmed/32531720
16565,32705314,Robotic-assisted transrectal MRI-guided biopsy. Technical feasibility and role in the current diagnosis of prostate cancer: an initial single-center experience,Abdom Radiol (NY). 2020 Dec;45(12):4150-4159. doi: 10.1007/s00261-020-02665-6. Epub 2020 Jul 23.,Vilanova JC,https://www.ncbi.nlm.nih.gov/pubmed/32705314
16566,33293078,A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer,Eur Urol. 2021 Mar;79(3):374-383. doi: 10.1016/j.eururo.2020.11.021. Epub 2020 Dec 5.,Jairath NK,https://www.ncbi.nlm.nih.gov/pubmed/33293078
16567,32873856,"Impact of rescanning and normalization on convolutional neural network performance in multi-center, whole-slide classification of prostate cancer",Sci Rep. 2020 Sep 1;10(1):14398. doi: 10.1038/s41598-020-71420-0.,Swiderska-Chadaj Z,https://www.ncbi.nlm.nih.gov/pubmed/32873856
16568,32576470,A rare case of penile metastases from small cell prostate cancer,Rev Int Androl. 2020 Oct-Dec;18(4):164-168. doi: 10.1016/j.androl.2019.11.003. Epub 2020 Jun 20.,Garrido-Abad P,https://www.ncbi.nlm.nih.gov/pubmed/32576470
16569,33017413,Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: Impact on diagnostic accuracy and inter-reader agreement,PLoS One. 2020 Oct 5;15(10):e0239975. doi: 10.1371/journal.pone.0239975. eCollection 2020.,Hötker AM,https://www.ncbi.nlm.nih.gov/pubmed/33017413
16570,32940669,The silent presence of Mycoplasma hominis in patients with prostate cancer,Pathog Dis. 2020 Oct 7;78(7):ftaa037. doi: 10.1093/femspd/ftaa037.,Saadat S,https://www.ncbi.nlm.nih.gov/pubmed/32940669
16571,31925552,Long short-term memory artificial neural network model for prediction of prostate cancer survival outcomes according to initial treatment strategy: development of an online decision-making support system,World J Urol. 2020 Oct;38(10):2469-2476. doi: 10.1007/s00345-020-03080-8. Epub 2020 Jan 10.,Koo KC,https://www.ncbi.nlm.nih.gov/pubmed/31925552
16572,32882394,Time-range based sequential mining for survival prediction in prostate cancer,J Biomed Inform. 2020 Oct;110:103550. doi: 10.1016/j.jbi.2020.103550. Epub 2020 Sep 1.,Kaur I,https://www.ncbi.nlm.nih.gov/pubmed/32882394
16573,32777370,Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice,Urology. 2020 Nov;145:204-210. doi: 10.1016/j.urology.2020.07.042. Epub 2020 Aug 8.,Lebastchi AH,https://www.ncbi.nlm.nih.gov/pubmed/32777370
16575,32301002,Surgical management of acquired rectourethral fistula: a retrospective analysis of 52 consecutive patients,Tech Coloproctol. 2020 Sep;24(9):927-933. doi: 10.1007/s10151-020-02214-9. Epub 2020 Apr 16.,Bislenghi G,https://www.ncbi.nlm.nih.gov/pubmed/32301002
16576,32991446,Increasing incidence of prostate cancer in Taiwan: A study of related factors using a nationwide health and welfare database,Medicine (Baltimore). 2020 Sep 25;99(39):e22336. doi: 10.1097/MD.0000000000022336.,Lin PH,https://www.ncbi.nlm.nih.gov/pubmed/32991446
16577,32997518,"PI-RADS Version 2.1: A Critical Review, From the AJR Special Series on Radiology Reporting and Data Systems",AJR Am J Roentgenol. 2021 Jan;216(1):20-32. doi: 10.2214/AJR.20.24495. Epub 2020 Nov 19.,Purysko AS,https://www.ncbi.nlm.nih.gov/pubmed/32997518
16578,32532512,Efficacy and Safety of (177)Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study,Eur Urol. 2020 Aug;78(2):148-154. doi: 10.1016/j.eururo.2020.05.004. Epub 2020 Jun 10.,Gafita A,https://www.ncbi.nlm.nih.gov/pubmed/32532512
16579,32191585,Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive Disease,J Urol. 2020 Sep;204(3):466-475. doi: 10.1097/JU.0000000000001020. Epub 2020 Mar 19.,Wang WW,https://www.ncbi.nlm.nih.gov/pubmed/32191585
16580,32872551,Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies,Int J Mol Sci. 2020 Aug 29;21(17):6265. doi: 10.3390/ijms21176265.,Singh K,https://www.ncbi.nlm.nih.gov/pubmed/32872551
16581,32802197,Efficacy and safety of (225)Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients,Theranostics. 2020 Jul 23;10(20):9364-9377. doi: 10.7150/thno.48107. eCollection 2020.,Yadav MP,https://www.ncbi.nlm.nih.gov/pubmed/32802197
16582,33356529,Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses,J Urol. 2021 May;205(5):1361-1371. doi: 10.1097/JU.0000000000001568. Epub 2020 Dec 28.,Armstrong AJ,https://www.ncbi.nlm.nih.gov/pubmed/33356529
16583,32954481,Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones,Hum Cell. 2021 Jan;34(1):211-218. doi: 10.1007/s13577-020-00435-6. Epub 2020 Sep 20.,Leung JK,https://www.ncbi.nlm.nih.gov/pubmed/32954481
16584,32317221,(18)F-fluciclovine PET CT detection of biochemical recurrent prostate cancer at specific PSA thresholds after definitive treatment,Urol Oncol. 2020 Jul;38(7):636.e1-636.e6. doi: 10.1016/j.urolonc.2020.03.021. Epub 2020 Apr 18.,Armstrong JM,https://www.ncbi.nlm.nih.gov/pubmed/32317221
16585,33080153,Negative Prebiopsy Magnetic Resonance Imaging and Risk of Significant Prostate Cancer: Baseline and Long-Term Followup Results,J Urol. 2021 Mar;205(3):725-731. doi: 10.1097/JU.0000000000001414. Epub 2020 Oct 20.,Buisset J,https://www.ncbi.nlm.nih.gov/pubmed/33080153
16586,31602045,Cancer detection rates and inter-examiner variability of MRI/TRUS fusion targeted biopsy and systematic transrectal biopsy,Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Sep;164(3):314-319. doi: 10.5507/bp.2019.050. Epub 2019 Oct 10.,Zalesky M,https://www.ncbi.nlm.nih.gov/pubmed/31602045
16587,32694594,Rethinking prostate cancer screening: could MRI be an alternative screening test?,Nat Rev Urol. 2020 Sep;17(9):526-539. doi: 10.1038/s41585-020-0356-2. Epub 2020 Jul 21.,Eldred-Evans D,https://www.ncbi.nlm.nih.gov/pubmed/32694594
16588,33289381,Prostate Cancer Diagnosis in the Clinic Using an 8-Protein Biomarker Panel,Anal Chem. 2021 Jan 19;93(2):1059-1067. doi: 10.1021/acs.analchem.0c04034. Epub 2020 Dec 8.,Jones AL,https://www.ncbi.nlm.nih.gov/pubmed/33289381
16590,33336418,Diagnostic performance of prostate cancer antigen 3 and the Prostate Health Index in detecting overall and clinically significant prostate cancer in men at first biopsy: A meta-analysis,Int J Urol. 2021 Mar;28(3):315-325. doi: 10.1111/iju.14464. Epub 2020 Dec 18.,Jia W,https://www.ncbi.nlm.nih.gov/pubmed/33336418
16592,32674954,Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration,Urol Oncol. 2020 Sep;38(9):734.e1-734.e10. doi: 10.1016/j.urolonc.2020.05.015. Epub 2020 Jul 13.,Sohlberg EM,https://www.ncbi.nlm.nih.gov/pubmed/32674954
16593,32763294,Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC),Life Sci. 2020 Oct 15;259:118208. doi: 10.1016/j.lfs.2020.118208. Epub 2020 Aug 4.,Jonnalagadda B,https://www.ncbi.nlm.nih.gov/pubmed/32763294
16595,32996795,Use of Prostate Systematic and Targeted Biopsy on the Basis of Bi-Parametric Magnetic Resonance Imaging in Biopsy-Naïve Patients,J Invest Surg. 2022 Jan;35(1):92-97. doi: 10.1080/08941939.2020.1825884. Epub 2020 Sep 30.,Cheng Y,https://www.ncbi.nlm.nih.gov/pubmed/32996795
16596,33355185,Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer,Cancer Prev Res (Phila). 2021 Apr;14(4):463-470. doi: 10.1158/1940-6207.CAPR-20-0250. Epub 2020 Dec 22.,Joshu CE,https://www.ncbi.nlm.nih.gov/pubmed/33355185
16598,32147365,Combination of Multiparametric Magnetic Resonance Imaging With Elastic-fusion Biopsy Has a High Sensitivity in Detecting Clinically Significant Prostate Cancer in Daily Practice,Clin Genitourin Cancer. 2020 Oct;18(5):e501-e509. doi: 10.1016/j.clgc.2020.02.006. Epub 2020 Feb 8.,Cecchini S,https://www.ncbi.nlm.nih.gov/pubmed/32147365
16599,33132109,Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives,Eur Urol Focus. 2021 Sep;7(5):955-963. doi: 10.1016/j.euf.2020.10.007. Epub 2020 Oct 31.,Zong Y,https://www.ncbi.nlm.nih.gov/pubmed/33132109
16600,33245067,Software-assisted US/MRI fusion-targeted biopsy for prostate cancer,Acta Biomed. 2020 Sep 23;91(10-S):e2020006. doi: 10.23750/abm.v91i10-S.10273.,Angileri SA,https://www.ncbi.nlm.nih.gov/pubmed/33245067
16602,32606435,The cost-effectiveness of prostate health index for prostate cancer detection in Chinese men,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):615-621. doi: 10.1038/s41391-020-0243-1. Epub 2020 Jun 30.,Teoh JY,https://www.ncbi.nlm.nih.gov/pubmed/32606435
16603,32387923,Accuracy of ADC ratio in discriminating true and false positives in multiparametric prostatic MRI,Eur J Radiol. 2020 Jul;128:109024. doi: 10.1016/j.ejrad.2020.109024. Epub 2020 Apr 27.,Falaschi Z,https://www.ncbi.nlm.nih.gov/pubmed/32387923
16604,32321689,Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer,Urol Oncol. 2020 Sep;38(9):734.e19-734.e25. doi: 10.1016/j.urolonc.2020.03.020. Epub 2020 Apr 19.,Watts KL,https://www.ncbi.nlm.nih.gov/pubmed/32321689
16605,32965028,Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer,Int J Cancer. 2021 Jan 15;148(2):385-395. doi: 10.1002/ijc.33306. Epub 2020 Oct 3.,Slootbeek PHJ,https://www.ncbi.nlm.nih.gov/pubmed/32965028
16606,32921565,Efficacy of 3T Multiparametric MR Imaging followed by 3T in-Bore MR-Guided Biopsy for Detection of Clinically Significant Prostate Cancer Based on PIRADSv2.1 Score,J Vasc Interv Radiol. 2020 Oct;31(10):1619-1626. doi: 10.1016/j.jvir.2020.03.002. Epub 2020 Sep 10.,Hosseiny M,https://www.ncbi.nlm.nih.gov/pubmed/32921565
16608,32488882,Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer,J Clin Lab Anal. 2020 Sep;34(9):e23403. doi: 10.1002/jcla.23403. Epub 2020 Jun 2.,Yan Y,https://www.ncbi.nlm.nih.gov/pubmed/32488882
16610,33321757,Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications,Cells. 2020 Dec 10;9(12):2653. doi: 10.3390/cells9122653.,Aurilio G,https://www.ncbi.nlm.nih.gov/pubmed/33321757
16611,32306717,"While Urine and Plasma Decorin Remain Unchanged in Prostate Cancer, Prostatic Tissue Decorin Has a Prognostic Value",Iran Biomed J. 2020 Jul;24(4):229-35. doi: 10.29252/ibj.24.4.229. Epub 2020 Apr 19.,Rezaie R,https://www.ncbi.nlm.nih.gov/pubmed/32306717
16612,33328604,Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer,Commun Biol. 2020 Dec 16;3(1):778. doi: 10.1038/s42003-020-01476-1.,Dong B,https://www.ncbi.nlm.nih.gov/pubmed/33328604
16613,33215787,Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer,Oncologist. 2021 Feb;26(2):e270-e278. doi: 10.1002/onco.13601. Epub 2020 Dec 3.,Sena LA,https://www.ncbi.nlm.nih.gov/pubmed/33215787
16614,32551913,Bad neighbours: hypoxia and genomic instability in prostate cancer,Br J Radiol. 2020 Nov 1;93(1115):20200087. doi: 10.1259/bjr.20200087. Epub 2020 Jun 18.,Ashton J,https://www.ncbi.nlm.nih.gov/pubmed/32551913
16615,32807727,Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial,Eur Urol Oncol. 2020 Dec;3(6):717-724. doi: 10.1016/j.euo.2020.07.001. Epub 2020 Aug 15.,Bryce AH,https://www.ncbi.nlm.nih.gov/pubmed/32807727
16616,32687727,The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer,Future Oncol. 2020 Oct;16(30):2421-2432. doi: 10.2217/fon-2020-0330. Epub 2020 Jul 20.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32687727
16618,33029516,The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer,Biomed Res Int. 2020 Sep 24;2020:5395312. doi: 10.1155/2020/5395312. eCollection 2020.,Xiang Q,https://www.ncbi.nlm.nih.gov/pubmed/33029516
16619,33356482,Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy,J Urol. 2021 May;205(5):1344-1351. doi: 10.1097/JU.0000000000001559. Epub 2020 Dec 24.,Punnen S,https://www.ncbi.nlm.nih.gov/pubmed/33356482
16621,32219507,Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer,Eur Radiol. 2020 Aug;30(8):4262-4271. doi: 10.1007/s00330-020-06773-1. Epub 2020 Mar 26.,Rudolph MM,https://www.ncbi.nlm.nih.gov/pubmed/32219507
16623,32958357,Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening,Ann Oncol. 2020 Nov;31(11):1545-1552. doi: 10.1016/j.annonc.2020.06.025. Epub 2020 Sep 18.,Segal N,https://www.ncbi.nlm.nih.gov/pubmed/32958357
16624,32455477,Development and validation of an explainable artificial intelligence-based decision-supporting tool for prostate biopsy,BJU Int. 2020 Dec;126(6):694-703. doi: 10.1111/bju.15122. Epub 2020 Aug 4.,Suh J,https://www.ncbi.nlm.nih.gov/pubmed/32455477
16625,33316419,The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives,Crit Rev Oncol Hematol. 2021 Jan;157:103199. doi: 10.1016/j.critrevonc.2020.103199. Epub 2020 Dec 13.,Brighi N,https://www.ncbi.nlm.nih.gov/pubmed/33316419
16626,31464205,Initial experience with a novel method for cognitive transperineal magnetic resonance imaging-targeted prostate biopsy,Asian J Androl. 2020 Jul-Aug;22(4):432-436. doi: 10.4103/aja.aja_83_19.,Wang HF,https://www.ncbi.nlm.nih.gov/pubmed/31464205
16627,32529950,Comparing the clinical efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis,J Oncol Pharm Pract. 2021 Apr;27(3):614-622. doi: 10.1177/1078155220929414. Epub 2020 Jun 12.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/32529950
16629,31749179,No time for reflection: Patient experiences with treatment-related decision-making in advanced prostate cancer,Scand J Caring Sci. 2020 Dec;34(4):880-888. doi: 10.1111/scs.12794. Epub 2019 Nov 21.,Netsey-Afedo MML,https://www.ncbi.nlm.nih.gov/pubmed/31749179
16630,33371093,Superb microvascular imaging in guiding targeted biopsy of prostate cancer: A protocol for systematic review and meta analysis,Medicine (Baltimore). 2020 Dec 18;99(51):e23604. doi: 10.1097/MD.0000000000023604.,Wang C,https://www.ncbi.nlm.nih.gov/pubmed/33371093
16631,33300224,Use of the prostate health index in the detection of prostate cancer at all PSA levels (use of prostate health index in prostate cancer),Int J Clin Pract. 2021 Apr;75(4):e13922. doi: 10.1111/ijcp.13922. Epub 2020 Dec 20.,Akdogan N,https://www.ncbi.nlm.nih.gov/pubmed/33300224
16632,33336582,Diagnostic Yield of Incremental Biopsy Cores and Second Lesion Sampling for In-Gantry MRI-Guided Prostate Biopsy,AJR Am J Roentgenol. 2021 Oct;217(4):908-918. doi: 10.2214/AJR.20.24918. Epub 2020 Dec 18.,Seyfried N,https://www.ncbi.nlm.nih.gov/pubmed/33336582
16633,32713070,Diagnostic accuracy of multiparametric magnetic resonance imaging combined with clinical parameters in the detection of clinically significant prostate cancer: A novel diagnostic model,Int J Urol. 2020 Oct;27(10):866-873. doi: 10.1111/iju.14316. Epub 2020 Jul 25.,Ippolito D,https://www.ncbi.nlm.nih.gov/pubmed/32713070
16634,32928793,Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models,Clin Cancer Res. 2020 Dec 1;26(23):6387-6398. doi: 10.1158/1078-0432.CCR-20-3182. Epub 2020 Sep 14.,Bordini J,https://www.ncbi.nlm.nih.gov/pubmed/32928793
16635,32152436,Racial disparity in the utilization of multiparametric MRI-ultrasound fusion biopsy for the detection of prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):567-572. doi: 10.1038/s41391-020-0223-5. Epub 2020 Mar 9.,Hoge C,https://www.ncbi.nlm.nih.gov/pubmed/32152436
16636,33257219,Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia,Urol Oncol. 2021 Jul;39(7):432.e1-432.e7. doi: 10.1016/j.urolonc.2020.11.009. Epub 2020 Nov 27.,Jacewicz M,https://www.ncbi.nlm.nih.gov/pubmed/33257219
16637,33196886,MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance,Eur Radiol. 2021 May;31(5):2696-2705. doi: 10.1007/s00330-020-07336-0. Epub 2020 Nov 16.,Caglic I,https://www.ncbi.nlm.nih.gov/pubmed/33196886
16638,32758400,Phase I/II Trial of the Combination of (177)Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN),Eur Urol Oncol. 2021 Dec;4(6):963-970. doi: 10.1016/j.euo.2020.07.002. Epub 2020 Aug 3.,Crumbaker M,https://www.ncbi.nlm.nih.gov/pubmed/32758400
16639,33380212,Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells,Hum Exp Toxicol. 2021 Jul;40(7):1122-1129. doi: 10.1177/0960327120984209. Epub 2020 Dec 31.,Guney Eskiler G,https://www.ncbi.nlm.nih.gov/pubmed/33380212
16642,32722632,"Understanding the Mechanisms of Diet and Outcomes in Colon, Prostate, and Breast Cancer; Malignant Gliomas; and Cancer Patients on Immunotherapy",Nutrients. 2020 Jul 26;12(8):2226. doi: 10.3390/nu12082226.,Mann S DO,https://www.ncbi.nlm.nih.gov/pubmed/32722632
16643,32278319,MRI-targeted prostate biopsy: key considerations for pathologists,Histopathology. 2020 Jul;77(1):18-25. doi: 10.1111/his.14113. Epub 2020 Jun 7.,Gordetsky JB,https://www.ncbi.nlm.nih.gov/pubmed/32278319
16644,33322720,Extracellular Vesicles-Mediated Transfer of miRNA Let-7b from PC3 Cells to Macrophages,Genes (Basel). 2020 Dec 12;11(12):1495. doi: 10.3390/genes11121495.,Costanzi E,https://www.ncbi.nlm.nih.gov/pubmed/33322720
16647,33153920,Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ? 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience,Clin Genitourin Cancer. 2021 Aug;19(4):275-279. doi: 10.1016/j.clgc.2020.09.006. Epub 2020 Oct 13.,Sterling J,https://www.ncbi.nlm.nih.gov/pubmed/33153920
16648,31411975,"Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups",Eur Urol Oncol. 2020 Oct;3(5):631-639. doi: 10.1016/j.euo.2019.03.003. Epub 2019 Mar 29.,Preisser F,https://www.ncbi.nlm.nih.gov/pubmed/31411975
16649,33272865,The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature,Eur Urol Oncol. 2021 Jun;4(3):370-395. doi: 10.1016/j.euo.2020.11.002. Epub 2020 Dec 4.,Abrams-Pompe RS,https://www.ncbi.nlm.nih.gov/pubmed/33272865
16650,32661959,Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone,Target Oncol. 2020 Aug;15(4):477-483. doi: 10.1007/s11523-020-00734-w.,Sheng IY,https://www.ncbi.nlm.nih.gov/pubmed/32661959
16652,31318579,Consecutive transperineal prostatic template biopsies employing cognitive and systematic approach: a single center study,Aging Male. 2020 Dec;23(5):953-957. doi: 10.1080/13685538.2019.1641796. Epub 2019 Jul 18.,Bhat Z,https://www.ncbi.nlm.nih.gov/pubmed/31318579
16654,32588205,The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates,World J Urol. 2021 May;39(5):1481-1487. doi: 10.1007/s00345-020-03321-w. Epub 2020 Jun 25.,Magistro G,https://www.ncbi.nlm.nih.gov/pubmed/32588205
16655,33083892,Factors Associated with Cancer Screening Among Hopi Men,J Cancer Educ. 2022 Aug;37(4):915-923. doi: 10.1007/s13187-020-01900-4. Epub 2020 Oct 20.,Batai K,https://www.ncbi.nlm.nih.gov/pubmed/33083892
16656,32350862,Overall and abdominal obesity and prostate cancer risk in a West African population: An analysis of the Ghana Prostate Study,Int J Cancer. 2020 Nov 15;147(10):2669-2676. doi: 10.1002/ijc.33026. Epub 2020 May 6.,Hurwitz LM,https://www.ncbi.nlm.nih.gov/pubmed/32350862
16658,33217456,A 4Kscore Cut-off of 7.5% for Prostate Biopsy Decisions Provides High Sensitivity and Negative Predictive Value for Significant Prostate Cancer,Urology. 2021 Feb;148:53-58. doi: 10.1016/j.urology.2020.11.008. Epub 2020 Nov 18.,Bhattu AS,https://www.ncbi.nlm.nih.gov/pubmed/33217456
16659,32865086,Real life data of MRI-targeted biopsy - experience from a single nonacademic centre using cognitive fusion and 1.5 tesla scanning,Scand J Urol. 2020 Oct;54(5):387-392. doi: 10.1080/21681805.2020.1812713. Epub 2020 Aug 31.,Novaes MAS,https://www.ncbi.nlm.nih.gov/pubmed/32865086
16660,32631097,A Comparison of Cancer Detection Rates Between Template Systematic Biopsies Obtained Using Magnetic Resonance Imaging-Ultrasound Fusion Machine and Freehand Transrectal Ultrasound-Guided Systematic Biopsies,J Endourol. 2020 Oct;34(10):1095-1098. doi: 10.1089/end.2020.0299. Epub 2020 Sep 21.,Hoge C,https://www.ncbi.nlm.nih.gov/pubmed/32631097
16661,33148474,Multiparametric MR imaging of the prostate at 1.5-T without endorectal coil using an 8 channel pelvic phased array: Is it still a viable option?,Radiography (Lond). 2021 May;27(2):459-463. doi: 10.1016/j.radi.2020.10.011. Epub 2020 Nov 2.,Pierro A,https://www.ncbi.nlm.nih.gov/pubmed/33148474
16662,32501559,Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients,Prostate. 2020 Aug;80(11):850-858. doi: 10.1002/pros.24016. Epub 2020 Jun 5.,Rii J,https://www.ncbi.nlm.nih.gov/pubmed/32501559
16664,32902659,PI-RADS version 2.1 scoring system is superior in detecting transition zone prostate cancer: a diagnostic study,Abdom Radiol (NY). 2020 Dec;45(12):4142-4149. doi: 10.1007/s00261-020-02724-y. Epub 2020 Sep 9.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/32902659
16666,32776050,A protein corona sensor array detects breast and prostate cancers,Nanoscale. 2020 Aug 20;12(32):16697-16704. doi: 10.1039/d0nr03439h.,Digiacomo L,https://www.ncbi.nlm.nih.gov/pubmed/32776050
16667,33198956,The Psychometric Properties of Taiwanese Version of the Memorial Anxiety Scale for Prostate Cancer,J Pain Symptom Manage. 2021 Apr;61(4):824-830. doi: 10.1016/j.jpainsymman.2020.10.013. Epub 2020 Oct 24.,Chou MC,https://www.ncbi.nlm.nih.gov/pubmed/33198956
16669,32358793,Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies,Histopathology. 2020 Sep;77(3):503-507. doi: 10.1111/his.14132. Epub 2020 Jul 28.,Chen-Maxwell D,https://www.ncbi.nlm.nih.gov/pubmed/32358793
16670,32714984,Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study,Biomed Res Int. 2020 Jul 1;2020:7804932. doi: 10.1155/2020/7804932. eCollection 2020.,Kawahara T,https://www.ncbi.nlm.nih.gov/pubmed/32714984
16672,33003518,Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials,Nutrients. 2020 Sep 29;12(10):2985. doi: 10.3390/nu12102985.,Grammatikopoulou MG,https://www.ncbi.nlm.nih.gov/pubmed/33003518
16673,33000273,N?Myc induces the tumor progression of prostate cancer by regulating FSCN1,Oncol Rep. 2020 Nov;44(5):2265-2274. doi: 10.3892/or.2020.7775. Epub 2020 Sep 22.,He G,https://www.ncbi.nlm.nih.gov/pubmed/33000273
16674,32380831,(1)H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer,J Proteome Res. 2020 Jun 5;19(6):2419-2428. doi: 10.1021/acs.jproteome.0c00091. Epub 2020 May 18.,Bruzzone C,https://www.ncbi.nlm.nih.gov/pubmed/32380831
16675,32188988,"Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study",Jpn J Clin Oncol. 2020 Jul 9;50(7):810-820. doi: 10.1093/jjco/hyaa030.,Suzuki H,https://www.ncbi.nlm.nih.gov/pubmed/32188988
16676,33370963,Primary diffuse large B cell lymphoma (DLBCL) of the prostate presenting with lower urinary tract symptoms (LUTS),BMJ Case Rep. 2020 Dec 22;13(12):e236280. doi: 10.1136/bcr-2020-236280.,Nusrat A,https://www.ncbi.nlm.nih.gov/pubmed/33370963
16677,32867754,Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study,BMC Urol. 2020 Aug 31;20(1):135. doi: 10.1186/s12894-020-00706-2.,Fang CW,https://www.ncbi.nlm.nih.gov/pubmed/32867754
16679,32512071,Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer,Toxicol Appl Pharmacol. 2020 Aug 15;401:115102. doi: 10.1016/j.taap.2020.115102. Epub 2020 Jun 6.,Dasgupta P,https://www.ncbi.nlm.nih.gov/pubmed/32512071
16680,32699997,The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review,Support Care Cancer. 2020 Dec;28(12):5661-5671. doi: 10.1007/s00520-020-05637-0. Epub 2020 Jul 22.,Edmunds K,https://www.ncbi.nlm.nih.gov/pubmed/32699997
16681,32833249,Sleep quality and prostate cancer aggressiveness: Results from the REDUCE trial,Prostate. 2020 Nov;80(15):1304-1313. doi: 10.1002/pros.24052. Epub 2020 Aug 24.,Wiggins EK,https://www.ncbi.nlm.nih.gov/pubmed/32833249
16682,32681273,Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy,World J Urol. 2021 Jun;39(6):1869-1877. doi: 10.1007/s00345-020-03359-w. Epub 2020 Jul 17.,Busetto GM,https://www.ncbi.nlm.nih.gov/pubmed/32681273
16683,32701219,Risk stratification for the prediction of overall survival could assist treatment decision-making at diagnosis of castration-resistant prostate cancer: a multicentre collaborative study in Japan,BJU Int. 2021 Feb;127(2):212-221. doi: 10.1111/bju.15187. Epub 2020 Aug 10.,Uchimoto T,https://www.ncbi.nlm.nih.gov/pubmed/32701219
16684,32910231,Yield of concurrent systemic biopsy during MRI-targeted biopsy according to Prostate Imaging Reporting and Data System version 2 in patients with suspected prostate cancer,Eur Radiol. 2021 Mar;31(3):1667-1675. doi: 10.1007/s00330-020-07167-z. Epub 2020 Sep 10.,Kim CH,https://www.ncbi.nlm.nih.gov/pubmed/32910231
16685,33314020,Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer,Cochrane Database Syst Rev. 2020 Dec 12;12(12):CD013245. doi: 10.1002/14651858.CD013245.pub2.,Sathianathen NJ,https://www.ncbi.nlm.nih.gov/pubmed/33314020
16686,32600058,A Comparative Study of Prostate Cancer Detection Rate Between Transperineal COG-TB and Transperineal FUS-TB in Patients with PSA ?20?ng/mL,J Endourol. 2020 Oct;34(10):1008-1014. doi: 10.1089/end.2020.0276. Epub 2020 Jul 31.,Liang L,https://www.ncbi.nlm.nih.gov/pubmed/32600058
16687,32839133,Accuracy of MRI-guided Versus Systematic Prostate Biopsy in Patients Under Active Surveillance: A Systematic Review and Meta-analysis,Clin Genitourin Cancer. 2021 Feb;19(1):3-11.e1. doi: 10.1016/j.clgc.2020.06.008. Epub 2020 Jul 2.,Baccaglini W,https://www.ncbi.nlm.nih.gov/pubmed/32839133
16688,32470903,Automated gleason grading on prostate biopsy slides by statistical representations of homology profile,Comput Methods Programs Biomed. 2020 Oct;194:105528. doi: 10.1016/j.cmpb.2020.105528. Epub 2020 May 26.,Yan C,https://www.ncbi.nlm.nih.gov/pubmed/32470903
16689,32675592,Targeting defective DNA repair in prostate cancer,Curr Opin Oncol. 2020 Sep;32(5):503-509. doi: 10.1097/CCO.0000000000000654.,Carmichael J,https://www.ncbi.nlm.nih.gov/pubmed/32675592
16690,32580469,New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?,Cells. 2020 Jun 22;9(6):1522. doi: 10.3390/cells9061522.,Aurilio G,https://www.ncbi.nlm.nih.gov/pubmed/32580469
16692,32203070,Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):705-713. doi: 10.1038/s41391-020-0224-4. Epub 2020 Mar 18.,Du M,https://www.ncbi.nlm.nih.gov/pubmed/32203070
16693,32950397,Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates,Urol Oncol. 2021 Jan;39(1):74.e1-74.e7. doi: 10.1016/j.urolonc.2020.08.012. Epub 2020 Sep 17.,Collà Ruvolo C,https://www.ncbi.nlm.nih.gov/pubmed/32950397
16694,32315112,"Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy",BJU Int. 2020 Oct;126(4):481-493. doi: 10.1111/bju.15093. Epub 2020 May 13.,Mannaerts CK,https://www.ncbi.nlm.nih.gov/pubmed/32315112
16695,33127298,Optimizing MRI-targeted prostate biopsy: the diagnostic benefit of additional targeted biopsy cores,Urol Oncol. 2021 Mar;39(3):193.e1-193.e6. doi: 10.1016/j.urolonc.2020.09.019. Epub 2020 Oct 27.,Tracy CR,https://www.ncbi.nlm.nih.gov/pubmed/33127298
16697,31012363,Quality of life among patients after cystoprostatectomy as the treatment for locally advanced prostate cancer with bladder invasion,Aging Male. 2020 Dec;23(5):847-853. doi: 10.1080/13685538.2019.1604653. Epub 2019 Apr 23.,Yuan P,https://www.ncbi.nlm.nih.gov/pubmed/31012363
16699,33273988,Systematic Investigation of mRNA N (6)-Methyladenosine Machinery in Primary Prostate Cancer,Dis Markers. 2020 Nov 12;2020:8833438. doi: 10.1155/2020/8833438. eCollection 2020.,Jiang M,https://www.ncbi.nlm.nih.gov/pubmed/33273988
16700,32726517,Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1,IUBMB Life. 2020 Sep;72(9):1960-1975. doi: 10.1002/iub.2327. Epub 2020 Jul 29.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/32726517
16701,32119574,Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors,Can J Physiol Pharmacol. 2020 Jul;98(7):477-481. doi: 10.1139/cjpp-2019-0668. Epub 2020 Mar 2.,Bakrania A,https://www.ncbi.nlm.nih.gov/pubmed/32119574
16702,32531869,Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance,BJU Int. 2021 Jan;127(1):96-107. doi: 10.1111/bju.15136. Epub 2020 Aug 1.,Tomer A,https://www.ncbi.nlm.nih.gov/pubmed/32531869
16703,32919755,Diagnostic yields in patients with suspected prostate cancer undergoing MRI as the first-line investigation in routine practice,Clin Radiol. 2020 Dec;75(12):950-956. doi: 10.1016/j.crad.2020.08.011. Epub 2020 Sep 9.,Sokhi HK,https://www.ncbi.nlm.nih.gov/pubmed/32919755
16705,32358695,Central adiposity at diagnosis may reduce prostate cancer-specific mortality in African-Caribbean men with prostate cancer: 10-year follow-up of participants in a case-control study,Cancer Causes Control. 2020 Jul;31(7):651-662. doi: 10.1007/s10552-020-01306-z. Epub 2020 May 1.,Jackson MD,https://www.ncbi.nlm.nih.gov/pubmed/32358695
16706,32701720,Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer,Curr Opin Urol. 2020 Sep;30(5):628-634. doi: 10.1097/MOU.0000000000000799.,Ravi Kumar AS,https://www.ncbi.nlm.nih.gov/pubmed/32701720
16707,32387417,Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype,Ann Oncol. 2020 Sep;31(9):1178-1185. doi: 10.1016/j.annonc.2020.04.473. Epub 2020 May 5.,Lu C,https://www.ncbi.nlm.nih.gov/pubmed/32387417
16708,32576498,Ex Vivo Radiation Leads to Opposing Neurite Growth in Whole Ganglia vs Dissociated Cultured Pelvic Neurons,J Sex Med. 2020 Aug;17(8):1423-1433. doi: 10.1016/j.jsxm.2020.04.385. Epub 2020 Jun 20.,Randolph JT,https://www.ncbi.nlm.nih.gov/pubmed/32576498
16709,32894795,Interactive effect of TLR SNPs and exposure to sexually transmitted infections on prostate cancer risk in Jamaican men,Prostate. 2020 Nov;80(15):1365-1372. doi: 10.1002/pros.24067. Epub 2020 Sep 7.,Dubey B,https://www.ncbi.nlm.nih.gov/pubmed/32894795
16710,32886176,Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents,J Bone Miner Metab. 2021 Mar;39(2):295-301. doi: 10.1007/s00774-020-01151-9. Epub 2020 Sep 4.,Nakai Y,https://www.ncbi.nlm.nih.gov/pubmed/32886176
16711,32885994,Apalutamide for the treatment of metastatic castration-sensitive prostate cancer,Future Oncol. 2020 Dec;16(35):2905-2916. doi: 10.2217/fon-2020-0557. Epub 2020 Sep 4.,Dror CM,https://www.ncbi.nlm.nih.gov/pubmed/32885994
16712,32306078,Manual prostate cancer segmentation in MRI: interreader agreement and volumetric correlation with transperineal template core needle biopsy,Eur Radiol. 2020 Sep;30(9):4806-4815. doi: 10.1007/s00330-020-06786-w. Epub 2020 Apr 19.,Liechti MR,https://www.ncbi.nlm.nih.gov/pubmed/32306078
16713,32955923,Prostate cancer measurements on serial MRI during active surveillance: it's time to be PRECISE,Br J Radiol. 2020 Dec 1;93(1116):20200819. doi: 10.1259/bjr.20200819. Epub 2020 Sep 21.,Giganti F,https://www.ncbi.nlm.nih.gov/pubmed/32955923
16714,32553107,MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans,Elife. 2020 Jun 18;9:e53600. doi: 10.7554/eLife.53600.,VanOpstall C,https://www.ncbi.nlm.nih.gov/pubmed/32553107
16715,32914895,The clinical benefit of sequential therapy with androgen receptor axis-targeted agents alone in patients with castration-resistant prostate cancer: A propensity score-matched comparison study,Prostate. 2020 Nov;80(15):1373-1380. doi: 10.1002/pros.24069. Epub 2020 Sep 11.,Naito Y,https://www.ncbi.nlm.nih.gov/pubmed/32914895
16716,32816374,Low reduction of prostate volume is a significant predictor of prostate cancer at subsequent biopsy in patients with dutasteride: A retrospective study,Andrologia. 2020 Dec;52(11):e13810. doi: 10.1111/and.13810. Epub 2020 Aug 20.,Obinata D,https://www.ncbi.nlm.nih.gov/pubmed/32816374
16718,31967522,Predictive Factors of Missed Clinically Significant Prostate Cancers in Men with Negative Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis,J Urol. 2020 Jul;204(1):24-32. doi: 10.1097/JU.0000000000000757. Epub 2020 Jan 22.,Pagniez MA,https://www.ncbi.nlm.nih.gov/pubmed/31967522
16719,33103942,Performance of Prostate Health Index in Biopsy Naïve Black Men,J Urol. 2021 Mar;205(3):718-724. doi: 10.1097/JU.0000000000001453. Epub 2020 Oct 26.,Babajide R,https://www.ncbi.nlm.nih.gov/pubmed/33103942
16720,31397038,"PI-RADS: Past, present, and future",J Magn Reson Imaging. 2020 Jul;52(1):33-53. doi: 10.1002/jmri.26896. Epub 2019 Aug 8.,Gupta RT,https://www.ncbi.nlm.nih.gov/pubmed/31397038
16721,32917647,Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer,Cancer Prev Res (Phila). 2020 Dec;13(12):979-988. doi: 10.1158/1940-6207.CAPR-20-0186. Epub 2020 Sep 11.,Burkhart DL,https://www.ncbi.nlm.nih.gov/pubmed/32917647
16722,31907633,External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers,World J Urol. 2020 Oct;38(10):2555-2561. doi: 10.1007/s00345-019-03058-1. Epub 2020 Jan 6.,Cindolo L,https://www.ncbi.nlm.nih.gov/pubmed/31907633
16723,33360667,"""More men die with prostate cancer than because of it"" - an old adage that still holds true in the 21st century",Cancer Treat Res Commun. 2021;26:100225. doi: 10.1016/j.ctarc.2020.100225. Epub 2020 Oct 16.,C J,https://www.ncbi.nlm.nih.gov/pubmed/33360667
16724,32810511,Hsa_circ_0007494 suppresses prostate cancer progression via miR-616/PTEN axis,Exp Cell Res. 2020 Oct 15;395(2):112233. doi: 10.1016/j.yexcr.2020.112233. Epub 2020 Aug 15.,Zhang S,https://www.ncbi.nlm.nih.gov/pubmed/32810511
16725,32776387,Prognostic significance of p16 expression in high-grade prostate adenocarcinoma,Pathol Int. 2020 Oct;70(10):743-751. doi: 10.1111/pin.12997. Epub 2020 Aug 9.,Takahara T,https://www.ncbi.nlm.nih.gov/pubmed/32776387
16726,32894541,MiR-34a affects G2 arrest in prostate cancer PC3 cells via Wnt pathway and inhibits cell growth and migration,Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8349-8358. doi: 10.26355/eurrev_202008_22631.,Dong B,https://www.ncbi.nlm.nih.gov/pubmed/32894541
16727,32382078,Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10?ng/mL,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):607-614. doi: 10.1038/s41391-020-0237-z. Epub 2020 May 7.,Tutrone R,https://www.ncbi.nlm.nih.gov/pubmed/32382078
16728,32681155,PI-RADS score v.2 in predicting malignancy in patients undergoing 5?-reductase inhibitor therapy,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):150-155. doi: 10.1038/s41391-020-0256-9. Epub 2020 Jul 17.,Forte V,https://www.ncbi.nlm.nih.gov/pubmed/32681155
16729,33356479,Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer,J Urol. 2021 May;205(5):1352-1360. doi: 10.1097/JU.0000000000001547. Epub 2020 Dec 24.,Yerram NK,https://www.ncbi.nlm.nih.gov/pubmed/33356479
16730,31961049,Luminal Water Imaging: Comparison With Diffusion-Weighted Imaging (DWI) and PI-RADS for Characterization of Prostate Cancer Aggressiveness,J Magn Reson Imaging. 2020 Jul;52(1):271-279. doi: 10.1002/jmri.27050. Epub 2020 Jan 21.,Hectors SJ,https://www.ncbi.nlm.nih.gov/pubmed/31961049
16731,32067047,Lifetime Benefits and Harms of Prostate-Specific Antigen-Based Risk-Stratified Screening for Prostate Cancer,J Natl Cancer Inst. 2020 Oct 1;112(10):1013-1020. doi: 10.1093/jnci/djaa001.,Heijnsdijk EAM,https://www.ncbi.nlm.nih.gov/pubmed/32067047
16734,32641739,Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):120-127. doi: 10.1038/s41391-020-0250-2. Epub 2020 Jul 8.,Vigneswaran HT,https://www.ncbi.nlm.nih.gov/pubmed/32641739
16735,32592040,Imaging assisted evaluation of antitumor efficacy of a new histone deacetylase inhibitor in the castration-resistant prostate cancer,Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):53-66. doi: 10.1007/s00259-020-04896-7. Epub 2020 Jun 26.,Chen Z,https://www.ncbi.nlm.nih.gov/pubmed/32592040
16737,32930958,Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer,Drugs. 2020 Oct;80(15):1579-1585. doi: 10.1007/s40265-020-01401-0.,Hoy SM,https://www.ncbi.nlm.nih.gov/pubmed/32930958
16738,31072170,Does plasma thiol and disulphide be a new marker for prostate cancer in prostate-specific antigen level between 10 and 20?ng/ml?,Aging Male. 2020 Dec;23(5):860-864. doi: 10.1080/13685538.2019.1608519. Epub 2019 May 10.,Topakta? R,https://www.ncbi.nlm.nih.gov/pubmed/31072170
16739,32441162,The role of insulin-like growth factors in the development of prostate cancer,Expert Rev Endocrinol Metab. 2020 Jul;15(4):237-250. doi: 10.1080/17446651.2020.1764844. Epub 2020 May 22.,Holly JMP,https://www.ncbi.nlm.nih.gov/pubmed/32441162
16740,32406325,How can we predict the active surveillance candidates meeting all Epstein criteria prior to prostate biopsy to avoid overdiagnosis?,Aging Male. 2020 Dec;23(5):1289-1295. doi: 10.1080/13685538.2020.1764524. Epub 2020 May 14.,Avci S,https://www.ncbi.nlm.nih.gov/pubmed/32406325
16741,33054607,"A non-randomized prospective study on the diagnostic performance of perineal prostatic biopsy, directed via diffusion nuclear resonance, in patients with suspected prostate cancer and previous negative transrectal prostate biopsy",Urologia. 2021 Feb;88(1):69-76. doi: 10.1177/0391560320962888. Epub 2020 Oct 14.,Castellucci R,https://www.ncbi.nlm.nih.gov/pubmed/33054607
16742,31549212,Differentiation of prostate cancer and benign prostatic hyperplasia: comparisons of the histogram analysis of intravoxel incoherent motion and monoexponential model with in-bore MR-guided biopsy as pathological reference,Abdom Radiol (NY). 2020 Oct;45(10):3265-3277. doi: 10.1007/s00261-019-02227-5.,Cui Y,https://www.ncbi.nlm.nih.gov/pubmed/31549212
16743,32724081,Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model,Sci Rep. 2020 Jul 28;10(1):12575. doi: 10.1038/s41598-020-69424-x.,Linxweiler J,https://www.ncbi.nlm.nih.gov/pubmed/32724081
16744,32594578,Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images,Int J Urol. 2020 Sep;27(9):760-766. doi: 10.1111/iju.14295. Epub 2020 Jun 27.,Matsuoka Y,https://www.ncbi.nlm.nih.gov/pubmed/32594578
16745,32389459,Negative Biopsy Histology in Men With PI-RADS Score 5 in Daily Clinical Practice: Incidence of Granulomatous Prostatitis,Clin Genitourin Cancer. 2020 Dec;18(6):e684-e687. doi: 10.1016/j.clgc.2020.04.001. Epub 2020 Apr 14.,Pepe P,https://www.ncbi.nlm.nih.gov/pubmed/32389459
16746,32972894,Can the Use of Serial Multiparametric Magnetic Resonance Imaging During Active Surveillance of Prostate Cancer Avoid the Need for Prostate Biopsies?-A Systematic Diagnostic Test Accuracy Review,Eur Urol Oncol. 2021 Jun;4(3):426-436. doi: 10.1016/j.euo.2020.09.002. Epub 2020 Sep 21.,Hettiarachchi D,https://www.ncbi.nlm.nih.gov/pubmed/32972894
16747,32529956,Two new Cu(II)-based coordination polymers: inhibitory activity on prostate cancer by reducing EGF-R expression and HIPPO signaling pathway activation,J Biomater Sci Polym Ed. 2020 Sep;31(13):1741-1755. doi: 10.1080/09205063.2020.1775057. Epub 2020 Jun 12.,Wang XY,https://www.ncbi.nlm.nih.gov/pubmed/32529956
16748,32006051,Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer,Cell Mol Life Sci. 2020 Oct;77(19):3693-3710. doi: 10.1007/s00018-020-03459-1. Epub 2020 Jan 31.,Jafari S,https://www.ncbi.nlm.nih.gov/pubmed/32006051
16749,33154308,High expression of lncRNA SNHG1 in prostate cancer patients and inhibition of SNHG1 suppresses cell proliferation and promotes apoptosis,Indian J Pathol Microbiol. 2020 Oct-Dec;63(4):575-580. doi: 10.4103/IJPM.IJPM_612_19.,Tang Q,https://www.ncbi.nlm.nih.gov/pubmed/33154308
16751,32539712,"Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)",BMC Med. 2020 Jun 16;18(1):139. doi: 10.1186/s12916-020-01606-w.,Thurtle D,https://www.ncbi.nlm.nih.gov/pubmed/32539712
16752,33070560,External Validation of the Long Short-Term Memory Artificial Neural Network-Based SCaP Survival Calculator for Prediction of Prostate Cancer Survival,Cancer Res Treat. 2021 Apr;53(2):558-566. doi: 10.4143/crt.2020.637. Epub 2020 Oct 6.,Lim B,https://www.ncbi.nlm.nih.gov/pubmed/33070560
16754,32448502,Examining the association of health literacy and numeracy with prostate-related knowledge and prostate cancer treatment regret,Urol Oncol. 2020 Aug;38(8):682.e11-682.e19. doi: 10.1016/j.urolonc.2020.04.007. Epub 2020 May 21.,Joyce DD,https://www.ncbi.nlm.nih.gov/pubmed/32448502
16755,32735712,Adding carboplatin to chemotherapy regimens for metastatic castrate-resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes,Prostate. 2020 Oct;80(14):1216-1222. doi: 10.1002/pros.24048. Epub 2020 Jul 31.,Ahmed ME,https://www.ncbi.nlm.nih.gov/pubmed/32735712
16756,31929198,Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China,Asian J Androl. 2020 Sep-Oct;22(5):539-543. doi: 10.4103/aja.aja_136_19.,Huang D,https://www.ncbi.nlm.nih.gov/pubmed/31929198
16757,33144873,Evaluation of Multimodal Algorithms for the Segmentation of Multiparametric MRI Prostate Images,Comput Math Methods Med. 2020 Oct 20;2020:8861035. doi: 10.1155/2020/8861035. eCollection 2020.,Nai YH,https://www.ncbi.nlm.nih.gov/pubmed/33144873
16758,32499554,Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China,Sci Rep. 2020 Jun 4;10(1):9104. doi: 10.1038/s41598-020-64073-6.,Liu D,https://www.ncbi.nlm.nih.gov/pubmed/32499554
16759,32855410,Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer,Nat Commun. 2020 Aug 27;11(1):4279. doi: 10.1038/s41467-020-17645-z.,Vykoukal J,https://www.ncbi.nlm.nih.gov/pubmed/32855410
16761,31980309,"The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations",Eur Urol. 2020 Sep;78(3):335-344. doi: 10.1016/j.eururo.2020.01.009. Epub 2020 Jan 21.,Jeong CW,https://www.ncbi.nlm.nih.gov/pubmed/31980309
16764,32931774,Mitochondria membrane transformations in colon and prostate cancer and their biological implications,Biochim Biophys Acta Biomembr. 2021 Jan 1;1863(1):183471. doi: 10.1016/j.bbamem.2020.183471. Epub 2020 Sep 12.,Zichri SB,https://www.ncbi.nlm.nih.gov/pubmed/32931774
16765,32055002,Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):486-493. doi: 10.1038/s41391-020-0210-x. Epub 2020 Feb 13.,Wong RL,https://www.ncbi.nlm.nih.gov/pubmed/32055002
16766,32597106,Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsy,Arch Ital Urol Androl. 2020 Jun 23;92(2). doi: 10.4081/aiua.2020.2.89.,Pepe P,https://www.ncbi.nlm.nih.gov/pubmed/32597106
16767,33242160,Affirming Care for Sexual and Gender Minority Prostate Cancer Survivors: Results from an Online Training,J Cancer Educ. 2022 Aug;37(4):1137-1143. doi: 10.1007/s13187-020-01930-y. Epub 2020 Nov 26.,Pratt-Chapman ML,https://www.ncbi.nlm.nih.gov/pubmed/33242160
16768,32819446,Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival,BMC Med Genomics. 2020 Aug 20;13(1):116. doi: 10.1186/s12920-020-00765-2.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32819446
16769,32856605,Asian Race and Risk of Prostate Cancer: Results from the REDUCE Study,Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2165-2170. doi: 10.1158/1055-9965.EPI-20-0646. Epub 2020 Aug 20.,Vidal AC,https://www.ncbi.nlm.nih.gov/pubmed/32856605
16770,32503813,Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions,Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1374-1380. doi: 10.1158/1055-9965.EPI-19-1616. Epub 2020 Jun 5.,Rencsok EM,https://www.ncbi.nlm.nih.gov/pubmed/32503813
16771,32783772,Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer,Expert Opin Pharmacother. 2020 Dec;21(17):2091-2099. doi: 10.1080/14656566.2020.1803281. Epub 2020 Aug 12.,Altavilla A,https://www.ncbi.nlm.nih.gov/pubmed/32783772
16772,32740863,A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions,Abdom Radiol (NY). 2020 Dec;45(12):4223-4234. doi: 10.1007/s00261-020-02678-1. Epub 2020 Aug 1.,Hou Y,https://www.ncbi.nlm.nih.gov/pubmed/32740863
16773,32662187,Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer,Int J Urol. 2020 Oct;27(10):830-837. doi: 10.1111/iju.14303. Epub 2020 Jul 13.,Van Poppel H,https://www.ncbi.nlm.nih.gov/pubmed/32662187
16774,33002843,Influence of deprivation and rurality on patient-reported outcomes of men living with and beyond prostate cancer diagnosis in the UK: A population-based study,Cancer Epidemiol. 2020 Dec;69:101830. doi: 10.1016/j.canep.2020.101830. Epub 2020 Sep 28.,Smith L,https://www.ncbi.nlm.nih.gov/pubmed/33002843
16775,32719332,Stabilization of ADAM9 by N-?-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer,Cell Death Dis. 2020 Jul 27;11(7):591. doi: 10.1038/s41419-020-02786-2.,Lin YW,https://www.ncbi.nlm.nih.gov/pubmed/32719332
16776,32663466,"Prostate Cancer 2020: ""The Times They Are a'Changing""",Cancer Cell. 2020 Jul 13;38(1):25-27. doi: 10.1016/j.ccell.2020.06.008.,Paschalis A,https://www.ncbi.nlm.nih.gov/pubmed/32663466
16777,33368738,Measuring psychosocial outcomes of men living with prostate cancer: feasibility of regular assessment of patient-reported outcomes,Eur J Cancer Care (Engl). 2021 Jul;30(4):e13393. doi: 10.1111/ecc.13393. Epub 2020 Dec 26.,Ettridge K,https://www.ncbi.nlm.nih.gov/pubmed/33368738
16780,32755155,The Negative Predictive Value of a PI-RADS Version 2 Score of 1 on Prostate MRI and the Factors Associated With a False-Negative MRI Study,AJR Am J Roentgenol. 2020 Sep;215(3):667-672. doi: 10.2214/AJR.20.22784. Epub 2020 Jul 1.,Ma HY,https://www.ncbi.nlm.nih.gov/pubmed/32755155
16781,33159431,Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies,Cancer Med. 2020 Dec;9(24):9611-9619. doi: 10.1002/cam4.3549. Epub 2020 Nov 6.,Li W,https://www.ncbi.nlm.nih.gov/pubmed/33159431
16782,32519915,Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer,J Urol. 2020 Dec;204(6):1216-1221. doi: 10.1097/JU.0000000000001186. Epub 2020 Jun 10.,Lonergan PE,https://www.ncbi.nlm.nih.gov/pubmed/32519915
16783,32409115,A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry,Eur Urol. 2020 Sep;78(3):316-320. doi: 10.1016/j.eururo.2020.04.060. Epub 2020 May 12.,Darst BF,https://www.ncbi.nlm.nih.gov/pubmed/32409115
16785,32776718,High B7-H3 expression is linked to increased risk of prostate cancer progression,Pathol Int. 2020 Oct;70(10):733-742. doi: 10.1111/pin.12999. Epub 2020 Aug 10.,Bonk S,https://www.ncbi.nlm.nih.gov/pubmed/32776718
16787,33031638,The FABP12/PPAR? pathway promotes metastatic transformation by inducing epithelial-to-mesenchymal transition and lipid-derived energy production in prostate cancer cells,Mol Oncol. 2020 Dec;14(12):3100-3120. doi: 10.1002/1878-0261.12818. Epub 2020 Oct 23.,Liu RZ,https://www.ncbi.nlm.nih.gov/pubmed/33031638
16788,32985040,Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion,Int J Urol. 2021 Jan;28(1):47-52. doi: 10.1111/iju.14385. Epub 2020 Sep 27.,Falagario UG,https://www.ncbi.nlm.nih.gov/pubmed/32985040
16789,33348972,Primitive small cell carcinoma of the prostate. Case report and revision of the literature,Arch Ital Urol Androl. 2020 Dec 21;92(4). doi: 10.4081/aiua.2020.4.390.,Pepe P,https://www.ncbi.nlm.nih.gov/pubmed/33348972
16790,32700021,Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps,Eur Radiol. 2021 Jan;31(1):379-391. doi: 10.1007/s00330-020-07065-4. Epub 2020 Jul 23.,Hiremath A,https://www.ncbi.nlm.nih.gov/pubmed/32700021
16791,32878811,Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-resistant Prostate Cancer,Anticancer Res. 2020 Sep;40(9):5229-5235. doi: 10.21873/anticanres.14526.,Minami H,https://www.ncbi.nlm.nih.gov/pubmed/32878811
16794,33095939,A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance,Prostate. 2021 Jan;81(1):41-49. doi: 10.1002/pros.24076. Epub 2020 Oct 23.,Jarrard D,https://www.ncbi.nlm.nih.gov/pubmed/33095939
16795,33184097,Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancer,ESMO Open. 2020 Nov;5(6):e000943. doi: 10.1136/esmoopen-2020-000943.,Rao A,https://www.ncbi.nlm.nih.gov/pubmed/33184097
16797,32771334,"Performing Precise Biopsy in Naive Patients With Equivocal PI-RADS, Version 2, Score 3, Lesions: An MRI-based Nomogram to Avoid Unnecessary Surgical Intervention",Clin Genitourin Cancer. 2020 Oct;18(5):367-377. doi: 10.1016/j.clgc.2019.11.011. Epub 2019 Dec 5.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/32771334
16798,33245071,In-bore MRI targeted biopsy,Acta Biomed. 2020 Sep 23;91(10-S):e2020012. doi: 10.23750/abm.v91i10-S.10251.,Gurgitano M,https://www.ncbi.nlm.nih.gov/pubmed/33245071
16799,32796921,Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype,Commun Biol. 2020 Aug 14;3(1):440. doi: 10.1038/s42003-020-01175-x.,Simpson BS,https://www.ncbi.nlm.nih.gov/pubmed/32796921
16800,32725580,Gain-loss framing and patients' decisions: a linguistic examination of information framing in physician-patient conversations,J Behav Med. 2021 Feb;44(1):38-52. doi: 10.1007/s10865-020-00171-0. Epub 2020 Jul 28.,Fridman I,https://www.ncbi.nlm.nih.gov/pubmed/32725580
16801,31960124,Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer,Support Care Cancer. 2020 Oct;28(10):4687-4695. doi: 10.1007/s00520-020-05311-5. Epub 2020 Jan 20.,Banna GL,https://www.ncbi.nlm.nih.gov/pubmed/31960124
16804,32725755,Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatment,Cancer Med. 2020 Sep;9(18):6586-6596. doi: 10.1002/cam4.3321. Epub 2020 Jul 29.,Srinivas S,https://www.ncbi.nlm.nih.gov/pubmed/32725755
16805,32341037,Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance,Cancer Res. 2020 Jul 1;80(13):2927-2939. doi: 10.1158/0008-5472.CAN-19-2549. Epub 2020 Apr 27.,Wu H,https://www.ncbi.nlm.nih.gov/pubmed/32341037
16806,33198356,Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review,Int J Mol Sci. 2020 Nov 12;21(22):8540. doi: 10.3390/ijms21228540.,Ahn HK,https://www.ncbi.nlm.nih.gov/pubmed/33198356
16807,33080150,Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach,J Urol. 2021 Mar;205(3):732-739. doi: 10.1097/JU.0000000000001430. Epub 2020 Oct 20.,Tosoian JJ,https://www.ncbi.nlm.nih.gov/pubmed/33080150
16808,33084023,Access denied: The relationship between patient insurance status and access to high-volume hospitals,Cancer. 2021 Feb 15;127(4):577-585. doi: 10.1002/cncr.33237. Epub 2020 Oct 21.,Nabi J,https://www.ncbi.nlm.nih.gov/pubmed/33084023
16809,32826248,Unique Features of Prostate Cancer in African American and West Indian Patients Including Diagnosis of High Grade Cancers Using Only Elevated Serum Levels of Prostate Specific Antigen,Ann Clin Lab Sci. 2020 Jul;50(4):504-511.,Seydafkan S,https://www.ncbi.nlm.nih.gov/pubmed/32826248
16810,33135335,Differences in survival of prostate cancer Gleason 8-10 disease and the establishment of a new Gleason survival grading system,Cancer Med. 2021 Jan;10(1):87-97. doi: 10.1002/cam4.3571. Epub 2020 Nov 1.,Zhou Y,https://www.ncbi.nlm.nih.gov/pubmed/33135335
16813,32605736,Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis,Urol Oncol. 2020 Nov;38(11):826-834. doi: 10.1016/j.urolonc.2020.03.022. Epub 2020 Jun 28.,Kumar J,https://www.ncbi.nlm.nih.gov/pubmed/32605736
16814,32247852,Metabolically stable diphenylamine derivatives suppress androgen receptor and BET protein in prostate cancer,Biochem Pharmacol. 2020 Jul;177:113946. doi: 10.1016/j.bcp.2020.113946. Epub 2020 Apr 2.,Yu J,https://www.ncbi.nlm.nih.gov/pubmed/32247852
16815,32125228,Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years,J Urol. 2020 Aug;204(2):281-288. doi: 10.1097/JU.0000000000001007. Epub 2020 Mar 3.,Vertosick EA,https://www.ncbi.nlm.nih.gov/pubmed/32125228
16816,30482583,Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (AeonoseTM): A Preliminary Report,Eur Urol Focus. 2020 Nov 15;6(6):1220-1225. doi: 10.1016/j.euf.2018.11.006. Epub 2018 Nov 24.,Waltman CG,https://www.ncbi.nlm.nih.gov/pubmed/30482583
16817,32953881,Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients,Biomed Res Int. 2020 Sep 1;2020:4264291. doi: 10.1155/2020/4264291. eCollection 2020.,Cai J,https://www.ncbi.nlm.nih.gov/pubmed/32953881
16818,32067844,Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative,Urol Oncol. 2020 Jul;38(7):636.e13-636.e19. doi: 10.1016/j.urolonc.2020.01.011. Epub 2020 Feb 14.,Eyrich NW,https://www.ncbi.nlm.nih.gov/pubmed/32067844
16819,33168966,Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):301-309. doi: 10.1038/s41391-020-00299-9. Epub 2020 Nov 9.,Labriola MK,https://www.ncbi.nlm.nih.gov/pubmed/33168966
16820,32529651,Prostate-specific membrane antigen expression in melanoma metastases,J Cutan Pathol. 2020 Dec;47(12):1115-1122. doi: 10.1111/cup.13774. Epub 2020 Jul 6.,Snow H,https://www.ncbi.nlm.nih.gov/pubmed/32529651
16821,32360240,Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea,Curr Probl Cancer. 2020 Dec;44(6):100578. doi: 10.1016/j.currproblcancer.2020.100578. Epub 2020 Apr 25.,Kang J,https://www.ncbi.nlm.nih.gov/pubmed/32360240
16823,33338056,"Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial",PLoS One. 2020 Dec 18;15(12):e0243928. doi: 10.1371/journal.pone.0243928. eCollection 2020.,Brady L,https://www.ncbi.nlm.nih.gov/pubmed/33338056
16824,32499542,Thiol Groups as a Biomarker for the Diagnosis and Prognosis of Prostate Cancer,Sci Rep. 2020 Jun 4;10(1):9093. doi: 10.1038/s41598-020-65918-w.,Koike A,https://www.ncbi.nlm.nih.gov/pubmed/32499542
16826,32413498,Effects of estrogen receptor signaling on prostate cancer carcinogenesis,Transl Res. 2020 Aug;222:56-66. doi: 10.1016/j.trsl.2020.04.003. Epub 2020 May 12.,Qu LG,https://www.ncbi.nlm.nih.gov/pubmed/32413498
16828,33109107,miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1,BMC Cancer. 2020 Oct 27;20(1):1028. doi: 10.1186/s12885-020-07472-2.,Meng Y,https://www.ncbi.nlm.nih.gov/pubmed/33109107
16829,32563976,"An unusual case of ""sterile"" abscess within low-grade meningioma during anti androgenic therapy and LH-releasing hormone agonist treatment for prostate cancer",Clin Neurol Neurosurg. 2020 Sep;196:105993. doi: 10.1016/j.clineuro.2020.105993. Epub 2020 Jun 6.,Fabbri VP,https://www.ncbi.nlm.nih.gov/pubmed/32563976
16830,31548130,"Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators",Eur Urol Oncol. 2020 Oct;3(5):700-704. doi: 10.1016/j.euo.2019.08.015. Epub 2019 Sep 20.,Falagario UG,https://www.ncbi.nlm.nih.gov/pubmed/31548130
16831,32929792,Impact of antiandrogen withdrawal syndrome in castration-resistant prostate cancer patients treated with abiraterone or enzalutamide,Int J Urol. 2020 Dec;27(12):1109-1115. doi: 10.1111/iju.14366. Epub 2020 Sep 15.,Shiota M,https://www.ncbi.nlm.nih.gov/pubmed/32929792
16833,33179868,Fusion US/MRI prostate biopsy using a computer aided diagnostic (CAD) system,Minerva Urol Nephrol. 2021 Oct;73(5):616-624. doi: 10.23736/S2724-6051.20.04008-4. Epub 2020 Nov 12.,Ferriero M,https://www.ncbi.nlm.nih.gov/pubmed/33179868
16835,33034050,Thyroid and androgen receptor signaling are antagonized by ?-Crystallin in prostate cancer,Int J Cancer. 2021 Feb 1;148(3):731-747. doi: 10.1002/ijc.33332. Epub 2020 Oct 31.,Aksoy O,https://www.ncbi.nlm.nih.gov/pubmed/33034050
16837,31691082,"Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer",World J Urol. 2020 Oct;38(10):2329-2347. doi: 10.1007/s00345-019-03000-5. Epub 2019 Nov 5.,Suarez-Ibarrola R,https://www.ncbi.nlm.nih.gov/pubmed/31691082
16838,32393768,Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies,Mod Pathol. 2020 Oct;33(10):2058-2066. doi: 10.1038/s41379-020-0551-y. Epub 2020 May 11.,Raciti P,https://www.ncbi.nlm.nih.gov/pubmed/32393768
16839,32926495,Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival,J Cell Mol Med. 2020 Oct;24(20):12188-12198. doi: 10.1111/jcmm.15876. Epub 2020 Sep 14.,Nalairndran G,https://www.ncbi.nlm.nih.gov/pubmed/32926495
16840,32609927,Modulating tumor reactive stroma by extracorporeal shock waves to control prostate cancer progression,Prostate. 2020 Sep;80(13):1087-1096. doi: 10.1002/pros.24037. Epub 2020 Jul 1.,Rinella L,https://www.ncbi.nlm.nih.gov/pubmed/32609927
16841,33109543,In Vitro Effect and Mechanism of Action of Ergot Alkaloid Dihydroergocristine in Chemoresistant Prostate Cancer Cells,Anticancer Res. 2020 Nov;40(11):6051-6062. doi: 10.21873/anticanres.14626.,Bai L,https://www.ncbi.nlm.nih.gov/pubmed/33109543
16842,34258585,Accelerating precision medicine in metastatic prostate cancer,Nat Cancer. 2020 Nov;1(11):1041-1053. doi: 10.1038/s43018-020-00141-0. Epub 2020 Nov 17.,Mateo J,https://www.ncbi.nlm.nih.gov/pubmed/34258585
16843,31884093,Whole-genome sequencing of prostate cancer reveals novel mutation-driven processes and molecular subgroups,Life Sci. 2020 Aug 1;254:117218. doi: 10.1016/j.lfs.2019.117218. Epub 2019 Dec 26.,Liang C,https://www.ncbi.nlm.nih.gov/pubmed/31884093
16844,31943737,On evaluating how well a biomarker can predict treatment response with survival data,Pharm Stat. 2020 Jul;19(4):410-423. doi: 10.1002/pst.2002. Epub 2020 Jan 13.,Mboup B,https://www.ncbi.nlm.nih.gov/pubmed/31943737
16846,32767102,Simulated clinical deployment of fully automatic deep learning for clinical prostate MRI assessment,Eur Radiol. 2021 Jan;31(1):302-313. doi: 10.1007/s00330-020-07086-z. Epub 2020 Aug 7.,Schelb P,https://www.ncbi.nlm.nih.gov/pubmed/32767102
16847,31679065,Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results,World J Urol. 2020 Aug;38(8):1943-1949. doi: 10.1007/s00345-019-02992-4. Epub 2019 Nov 2.,Gorin MA,https://www.ncbi.nlm.nih.gov/pubmed/31679065
16849,32406054,Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms with Susceptibility to Prostate Cancer: a Comprehensive Systematic Review and Meta-Analysis,Urol J. 2020 Jun 24;17(4):329-337. doi: 10.22037/uj.v0i0.5445.,Abedinzadeh M,https://www.ncbi.nlm.nih.gov/pubmed/32406054
16850,32588090,Clinical value of negative (68)Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients,Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):87-94. doi: 10.1007/s00259-020-04914-8. Epub 2020 Jun 26.,Celli M,https://www.ncbi.nlm.nih.gov/pubmed/32588090
16851,32488048,Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers,Sci Rep. 2020 Jun 2;10(1):8916. doi: 10.1038/s41598-020-65772-w.,Marx A,https://www.ncbi.nlm.nih.gov/pubmed/32488048
16852,32161964,Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia,Lab Med. 2020 Nov 2;51(6):566-573. doi: 10.1093/labmed/lmaa008.,Markin PA,https://www.ncbi.nlm.nih.gov/pubmed/32161964
16853,32737771,Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-?B system,Mol Cell Biochem. 2020 Nov;474(1-2):199-208. doi: 10.1007/s11010-020-03845-0. Epub 2020 Jul 31.,Yang B,https://www.ncbi.nlm.nih.gov/pubmed/32737771
16854,31522235,Novices in MRI-targeted prostate biopsy benefit from structured reporting of MRI findings,World J Urol. 2020 Jul;38(7):1729-1734. doi: 10.1007/s00345-019-02953-x. Epub 2019 Sep 14.,Wetterauer C,https://www.ncbi.nlm.nih.gov/pubmed/31522235
16855,33009820,Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2,J Pathol. 2021 Jan;253(1):106-118. doi: 10.1002/path.5557. Epub 2020 Nov 5.,Liu Q,https://www.ncbi.nlm.nih.gov/pubmed/33009820
16856,32907777,Apalutamide and Overall Survival in Prostate Cancer,Eur Urol. 2021 Jan;79(1):150-158. doi: 10.1016/j.eururo.2020.08.011. Epub 2020 Sep 6.,Smith MR,https://www.ncbi.nlm.nih.gov/pubmed/32907777
16857,33023053,The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics,Int J Environ Res Public Health. 2020 Oct 3;17(19):7247. doi: 10.3390/ijerph17197247.,Chou YE,https://www.ncbi.nlm.nih.gov/pubmed/33023053
16858,33351221,"Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in patients with newly diagnosed prostate cancer referred to androgen-deprivation therapy",Cancer. 2021 May 1;127(9):1495-1506. doi: 10.1002/cncr.33387. Epub 2020 Dec 22.,R Buskbjerg C,https://www.ncbi.nlm.nih.gov/pubmed/33351221
16859,33166542,Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer,Urology. 2021 Feb;148:203-210. doi: 10.1016/j.urology.2020.09.044. Epub 2020 Nov 7.,Greenberg JW,https://www.ncbi.nlm.nih.gov/pubmed/33166542
16861,32437994,Right Parietal Skull Xanthoma Characterized as a Metastatic Deposit,World Neurosurg. 2020 Aug;140:56-59. doi: 10.1016/j.wneu.2020.05.015. Epub 2020 May 11.,Jain S,https://www.ncbi.nlm.nih.gov/pubmed/32437994
16862,33448521,Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses,Psychooncology. 2020 Nov;29(11):1772-1785. doi: 10.1002/pon.5522. Epub 2020 Sep 3.,Abrahams HJG,https://www.ncbi.nlm.nih.gov/pubmed/33448521
16863,33377264,Ancillary imaging and clinical features for the characterization of prostate lesions: A proposed approach to reduce false positives,J Magn Reson Imaging. 2021 Jun;53(6):1887-1897. doi: 10.1002/jmri.27491. Epub 2020 Dec 29.,Lee CM,https://www.ncbi.nlm.nih.gov/pubmed/33377264
16864,32410514,Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients,Aging Male. 2020 Dec;23(5):1333-1338. doi: 10.1080/13685538.2020.1766013. Epub 2020 May 15.,Kincius M,https://www.ncbi.nlm.nih.gov/pubmed/32410514
16865,33306762,PET/CT imaging of prostate cancer in the era of small molecule prostate specific membrane antigen targeted tracers,Hell J Nucl Med. 2020 Sep-Dec;23(3):339-345. doi: 10.1967/s002449912211. Epub 2020 Dec 14.,Vrachimis A,https://www.ncbi.nlm.nih.gov/pubmed/33306762
16866,32493676,The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?,Clin Genitourin Cancer. 2020 Dec;18(6):e698-e704. doi: 10.1016/j.clgc.2020.04.006. Epub 2020 May 4.,Roscigno M,https://www.ncbi.nlm.nih.gov/pubmed/32493676
16867,32970524,Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer,JCO Oncol Pract. 2021 Feb;17(2):e204-e216. doi: 10.1200/OP.20.00399. Epub 2020 Sep 24.,Scheinberg T,https://www.ncbi.nlm.nih.gov/pubmed/32970524
16868,32316763,Comparison of Real-Time Virtual Sonography Navigation Versus BioJet Navigation on Magnetic Resonance Imaging-Guided Prostate Needle Biopsy: A Single Institutional Analysis,J Endourol. 2020 Jul;34(7):739-745. doi: 10.1089/end.2020.0042. Epub 2020 Jun 25.,Nagai T,https://www.ncbi.nlm.nih.gov/pubmed/32316763
16869,32619406,SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways,Cancer Cell. 2020 Sep 14;38(3):350-365.e7. doi: 10.1016/j.ccell.2020.05.022. Epub 2020 Jul 2.,Yuan H,https://www.ncbi.nlm.nih.gov/pubmed/32619406
16870,32701811,Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate Cancer,Clin Nucl Med. 2020 Dec;45(12):e525-e527. doi: 10.1097/RLU.0000000000003207.,Abiodun-Ojo OA,https://www.ncbi.nlm.nih.gov/pubmed/32701811
16871,32706988,Biomarkers in the setting of benign prostatic hyperplasia-induced lower urinary tract symptoms: what an interventional radiologist needs to know,Br J Radiol. 2020 Oct 1;93(1114):20200484. doi: 10.1259/bjr.20200484. Epub 2020 Aug 6.,Young S,https://www.ncbi.nlm.nih.gov/pubmed/32706988
16872,33867045,Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance,Eur Urol Oncol. 2021 Apr;4(2):227-234. doi: 10.1016/j.euo.2020.09.004. Epub 2020 Oct 21.,O'Connor LP,https://www.ncbi.nlm.nih.gov/pubmed/33867045
16874,32277006,"Prostate Cancer Incidence and Aggressiveness in Appalachia versus Non-Appalachia Populations in Pennsylvania by Urban-Rural Regions, 2004-2014",Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1365-1373. doi: 10.1158/1055-9965.EPI-19-1232. Epub 2020 Apr 10.,McDonald AC,https://www.ncbi.nlm.nih.gov/pubmed/32277006
16875,32686918,BRCA2 c.8827C>T pathogenic mutation in a consanguineous Chinese family with hereditary breast cancer,Mol Genet Genomic Med. 2020 Sep;8(9):e1411. doi: 10.1002/mgg3.1411. Epub 2020 Jul 20.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32686918
16876,32681382,Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis,Int J Clin Oncol. 2020 Nov;25(11):1881-1891. doi: 10.1007/s10147-020-01747-1. Epub 2020 Jul 17.,Miura N,https://www.ncbi.nlm.nih.gov/pubmed/32681382
16877,32328763,High spatiotemporal resolution dynamic contrast-enhanced MRI improves the image-based discrimination of histopathology risk groups of peripheral zone prostate cancer: a supervised machine learning approach,Eur Radiol. 2020 Sep;30(9):4828-4837. doi: 10.1007/s00330-020-06849-y. Epub 2020 Apr 23.,Winkel DJ,https://www.ncbi.nlm.nih.gov/pubmed/32328763
16878,32238875,Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization,Mod Pathol. 2020 Sep;33(9):1791-1801. doi: 10.1038/s41379-020-0525-0. Epub 2020 Apr 1.,Dedigama-Arachchige P,https://www.ncbi.nlm.nih.gov/pubmed/32238875
16879,32628300,Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer,Prostate. 2020 Sep;80(13):1097-1107. doi: 10.1002/pros.24038. Epub 2020 Jul 6.,Bonk S,https://www.ncbi.nlm.nih.gov/pubmed/32628300
16880,33215539,A Rare Case of Prostate Carcinoma Metastasis in the Orbital Apex,Ear Nose Throat J. 2022 Nov;101(9):571-574. doi: 10.1177/0145561320973783. Epub 2020 Nov 20.,Wada K,https://www.ncbi.nlm.nih.gov/pubmed/33215539
16881,33023785,A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer,Eur J Cancer. 2021 Jan;142:132-140. doi: 10.1016/j.ejca.2020.08.019. Epub 2020 Oct 3.,Clemons M,https://www.ncbi.nlm.nih.gov/pubmed/33023785
16882,32705477,Evaluating the efficacy of a low-cost cognitive MRI-targeted prostate biopsy protocol: is there still a role for lower volume centers in the Prostate Imaging Reporting and Data System (PI-RADS) version 2 era?,Int Urol Nephrol. 2020 Nov;52(11):2043-2050. doi: 10.1007/s11255-020-02533-8. Epub 2020 Jul 23.,Takeshima Y,https://www.ncbi.nlm.nih.gov/pubmed/32705477
16883,32516092,Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019,J Clin Oncol. 2020 Aug 20;38(24):2798-2811. doi: 10.1200/JCO.20.00046. Epub 2020 Jun 9.,Giri VN,https://www.ncbi.nlm.nih.gov/pubmed/32516092
16884,32928794,Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer,Clin Cancer Res. 2020 Nov 15;26(22):6064-6074. doi: 10.1158/1078-0432.CCR-20-1682. Epub 2020 Sep 14.,Armstrong CM,https://www.ncbi.nlm.nih.gov/pubmed/32928794
16885,32338768,Rare germline genetic variants and risk of aggressive prostate cancer,Int J Cancer. 2020 Oct 15;147(8):2142-2149. doi: 10.1002/ijc.33024. Epub 2020 May 8.,Nguyen-Dumont T,https://www.ncbi.nlm.nih.gov/pubmed/32338768
16886,32513836,"Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer",Clin Cancer Res. 2020 Oct 1;26(19):5162-5171. doi: 10.1158/1078-0432.CCR-20-0945. Epub 2020 Jun 8.,Kyriakopoulos CE,https://www.ncbi.nlm.nih.gov/pubmed/32513836
16888,32630372,"The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling",Int J Mol Sci. 2020 Jun 25;21(12):4507. doi: 10.3390/ijms21124507.,Shorning BY,https://www.ncbi.nlm.nih.gov/pubmed/32630372
16889,32901351,PET/MRI in prostate cancer: a systematic review and meta-analysis,Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):859-873. doi: 10.1007/s00259-020-05025-0. Epub 2020 Sep 8.,Evangelista L,https://www.ncbi.nlm.nih.gov/pubmed/32901351
16890,32789680,PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer,Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):493-500. doi: 10.1007/s00259-020-04981-x. Epub 2020 Aug 13.,Santos A,https://www.ncbi.nlm.nih.gov/pubmed/32789680
16891,32591889,Using decision curve analysis to benchmark performance of a magnetic resonance imaging-based deep learning model for prostate cancer risk assessment,Eur Radiol. 2020 Dec;30(12):6867-6876. doi: 10.1007/s00330-020-07030-1. Epub 2020 Jun 26.,Deniffel D,https://www.ncbi.nlm.nih.gov/pubmed/32591889
16892,32778912,Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study,World J Urol. 2021 Jun;39(6):1879-1887. doi: 10.1007/s00345-020-03393-8. Epub 2020 Aug 10.,Falagario U,https://www.ncbi.nlm.nih.gov/pubmed/32778912
16893,31838732,Is Movember synonymous with moustaches or men's health? An examination of internet search activity for prostate and testicular cancer during the campaign,Ir J Med Sci. 2020 Aug;189(3):811-815. doi: 10.1007/s11845-019-02142-0. Epub 2019 Dec 14.,Khan JS,https://www.ncbi.nlm.nih.gov/pubmed/31838732
16894,32485038,Identification of castration-resistant prostate cancer-related hub genes using weighted gene co-expression network analysis,J Cell Mol Med. 2020 Jul;24(14):8006-8017. doi: 10.1111/jcmm.15432. Epub 2020 Jun 2.,Cheng Y,https://www.ncbi.nlm.nih.gov/pubmed/32485038
16895,32027071,Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI,J Magn Reson Imaging. 2020 Aug;52(2):552-564. doi: 10.1002/jmri.27075. Epub 2020 Feb 6.,Cui Y,https://www.ncbi.nlm.nih.gov/pubmed/32027071
16896,32111923,Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):517-526. doi: 10.1038/s41391-020-0213-7. Epub 2020 Feb 28.,Sartor O,https://www.ncbi.nlm.nih.gov/pubmed/32111923
16897,32679108,Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer,Cancer Cell. 2020 Aug 10;38(2):279-296.e9. doi: 10.1016/j.ccell.2020.06.005. Epub 2020 Jul 16.,Zhang Z,https://www.ncbi.nlm.nih.gov/pubmed/32679108
16899,32739405,Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate Cancer,Eur Urol Focus. 2021 Nov;7(6):1287-1291. doi: 10.1016/j.euf.2020.07.001. Epub 2020 Jul 29.,Fettke H,https://www.ncbi.nlm.nih.gov/pubmed/32739405
16900,31617061,Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials,Clin Transl Oncol. 2020 Jul;22(7):1033-1039. doi: 10.1007/s12094-019-02228-2. Epub 2019 Oct 15.,Roviello G,https://www.ncbi.nlm.nih.gov/pubmed/31617061
16901,32926841,"Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study",Lancet Oncol. 2020 Nov;21(11):1513-1525. doi: 10.1016/S1470-2045(20)30449-6. Epub 2020 Sep 11.,Fizazi K,https://www.ncbi.nlm.nih.gov/pubmed/32926841
16902,32448679,Sexual Motivators and Endorsement of Models Describing Sexual Response of Men Undergoing Androgen Deprivation Therapy for Advanced Prostate Cancer,J Sex Med. 2020 Aug;17(8):1538-1543. doi: 10.1016/j.jsxm.2020.04.006. Epub 2020 May 21.,Fode M,https://www.ncbi.nlm.nih.gov/pubmed/32448679
16903,32524222,Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation,Eur Radiol. 2020 Nov;30(11):6274-6284. doi: 10.1007/s00330-020-06958-8. Epub 2020 Jun 10.,Kan Y,https://www.ncbi.nlm.nih.gov/pubmed/32524222
16904,33195694,Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence,Biomed Res Int. 2020 Oct 28;2020:5845374. doi: 10.1155/2020/5845374. eCollection 2020.,Kind S,https://www.ncbi.nlm.nih.gov/pubmed/33195694
16905,31897680,MRI-targeted biopsy versus standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis of randomized controlled trials,Abdom Radiol (NY). 2020 Oct;45(10):3283-3292. doi: 10.1007/s00261-019-02370-z.,Hu X,https://www.ncbi.nlm.nih.gov/pubmed/31897680
16906,31997782,"How do we define ""castration"" in men on androgen deprivation therapy?",Asian J Androl. 2020 Sep-Oct;22(5):441-446. doi: 10.4103/aja.aja_139_19.,Itty S,https://www.ncbi.nlm.nih.gov/pubmed/31997782
16907,33064355,Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expression,Cancer Sci. 2021 Jan;112(1):323-330. doi: 10.1111/cas.14695. Epub 2020 Nov 24.,Shiota M,https://www.ncbi.nlm.nih.gov/pubmed/33064355
16911,33087165,Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression,J Exp Clin Cancer Res. 2020 Oct 21;39(1):223. doi: 10.1186/s13046-020-01735-3.,Du C,https://www.ncbi.nlm.nih.gov/pubmed/33087165
16912,32787509,YB-1 variant and androgen receptor axis-targeted agents in metastatic castration-resistant prostate cancer patients,Pharmacogenomics. 2020 Aug;21(13):919-928. doi: 10.2217/pgs-2020-0008. Epub 2020 Aug 13.,Afonso A,https://www.ncbi.nlm.nih.gov/pubmed/32787509
16914,32892496,Efficacy of abiraterone acetate in castration-resistant metastatic prostate cancer: A real-world data analysis,Asia Pac J Clin Oncol. 2021 Oct;17(5):e201-e207. doi: 10.1111/ajco.13426. Epub 2020 Sep 5.,Oyman A,https://www.ncbi.nlm.nih.gov/pubmed/32892496
16915,32909877,Patient Reported vs Claims Based Measures of Health for Modeling Life Expectancy in Men with Prostate Cancer,J Urol. 2021 Feb;205(2):434-440. doi: 10.1097/JU.0000000000001355. Epub 2020 Sep 10.,Tan HJ,https://www.ncbi.nlm.nih.gov/pubmed/32909877
16916,33036953,Changing the Prostate Cancer Detection Paradigm: Clinical Application of European Association of Urology Guideline-recommended Magnetic Resonance Imaging-based Risk Stratification in Men with Suspected Prostate Cancer,Eur Urol Focus. 2021 Sep;7(5):1011-1018. doi: 10.1016/j.euf.2020.09.014. Epub 2020 Oct 7.,Tully KH,https://www.ncbi.nlm.nih.gov/pubmed/33036953
16917,32350662,MRI-directed high-frequency (29MhZ) TRUS-guided biopsies: initial results of a single-center study,Eur Radiol. 2020 Sep;30(9):4838-4846. doi: 10.1007/s00330-020-06882-x. Epub 2020 Apr 29.,Cornud F,https://www.ncbi.nlm.nih.gov/pubmed/32350662
16918,33080149,Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study,J Urol. 2021 Mar;205(3):755-760. doi: 10.1097/JU.0000000000001407. Epub 2020 Oct 20.,Naha U,https://www.ncbi.nlm.nih.gov/pubmed/33080149
16919,32152435,Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):539-548. doi: 10.1038/s41391-020-0222-6. Epub 2020 Mar 9.,Mori K,https://www.ncbi.nlm.nih.gov/pubmed/32152435
16920,32314873,Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone,EMBO Rep. 2020 Jun 4;21(6):e50162. doi: 10.15252/embr.202050162. Epub 2020 Apr 21.,Owen KL,https://www.ncbi.nlm.nih.gov/pubmed/32314873
16921,32294481,Concordance and Performance of 4Kscore and SelectMDx for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer,Urology. 2020 Jul;141:119-124. doi: 10.1016/j.urology.2020.02.032. Epub 2020 Apr 12.,Wysock JS,https://www.ncbi.nlm.nih.gov/pubmed/32294481
16922,32444265,Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis,Eur Urol. 2020 Sep;78(3):402-414. doi: 10.1016/j.eururo.2020.03.048. Epub 2020 May 20.,Sathianathen NJ,https://www.ncbi.nlm.nih.gov/pubmed/32444265
16925,31768690,Efficacy and outcome of holmium laser enucleation of prostate in patients with urinary retention due to advanced prostate cancer,Lasers Med Sci. 2020 Aug;35(6):1307-1313. doi: 10.1007/s10103-019-02913-2. Epub 2019 Nov 25.,Tang M,https://www.ncbi.nlm.nih.gov/pubmed/31768690
16926,32303599,Factors Predicting Metastatic Disease in (68)Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer,J Nucl Med. 2020 Dec;61(12):1779-1785. doi: 10.2967/jnumed.119.241174. Epub 2020 Apr 17.,Chiu LW,https://www.ncbi.nlm.nih.gov/pubmed/32303599
16927,32925739,"Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study",Medicine (Baltimore). 2020 Sep 11;99(37):e22059. doi: 10.1097/MD.0000000000022059.,Porreca A,https://www.ncbi.nlm.nih.gov/pubmed/32925739
16929,32498368,Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer,Cells. 2020 Jun 2;9(6):1382. doi: 10.3390/cells9061382.,Montagner IM,https://www.ncbi.nlm.nih.gov/pubmed/32498368
16930,33704114,Out-of-Pocket Costs and Perceived Financial Burden Associated with Prostate Cancer Treatment in a Quebec Remote Area: A Cross-Sectional Study,Curr Oncol. 2020 Nov 30;28(1):26-39. doi: 10.3390/curroncol28010005.,El-Haouly A,https://www.ncbi.nlm.nih.gov/pubmed/33704114
16933,32232921,Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?,BJU Int. 2020 Jul;126(1):124-132. doi: 10.1111/bju.15065. Epub 2020 Apr 22.,Osses DF,https://www.ncbi.nlm.nih.gov/pubmed/32232921
16934,32986127,Antioxidant functions of DHHC3 suppress anti-cancer drug activities,Cell Mol Life Sci. 2021 Mar;78(5):2341-2353. doi: 10.1007/s00018-020-03635-3. Epub 2020 Sep 28.,Sharma C,https://www.ncbi.nlm.nih.gov/pubmed/32986127
16935,32811161,LncRNA AC245100.4 binds HSP90 to promote the proliferation of prostate cancer,Epigenomics. 2020 Aug;12(15):1257-1271. doi: 10.2217/epi-2020-0270. Epub 2020 Aug 19.,Cui R,https://www.ncbi.nlm.nih.gov/pubmed/32811161
16936,33279680,Diagnostic molecular markers predicting aggressive potential in low-grade prostate cancer,Transl Res. 2021 May;231:92-101. doi: 10.1016/j.trsl.2020.11.014. Epub 2020 Dec 3.,Saran U,https://www.ncbi.nlm.nih.gov/pubmed/33279680
16937,31940282,The influence of hypoxia on the prostate cancer proteome,Clin Chem Lab Med. 2020 Jun 25;58(6):980-993. doi: 10.1515/cclm-2019-0626.,Ross JA,https://www.ncbi.nlm.nih.gov/pubmed/31940282
16938,33144585,MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis,Cell Death Dis. 2020 Nov 3;11(11):949. doi: 10.1038/s41419-020-03138-w.,Zhu Z,https://www.ncbi.nlm.nih.gov/pubmed/33144585
16942,32681305,Social and medical risk factors associated with supportive needs in the first year following localized prostate cancer treatment,J Cancer Surviv. 2021 Feb;15(1):110-118. doi: 10.1007/s11764-020-00916-5. Epub 2020 Jul 18.,Tagai EK,https://www.ncbi.nlm.nih.gov/pubmed/32681305
16944,32440915,Latest progress in molecular biology and treatment in genitourinary tumours,Clin Transl Oncol. 2020 Dec;22(12):2175-2195. doi: 10.1007/s12094-020-02373-z. Epub 2020 May 21.,González-Del-Alba A,https://www.ncbi.nlm.nih.gov/pubmed/32440915
16945,32544805,Magnetic resonance imaging/transrectal ultrasonography fusion guided seed placement in a phantom: Accuracy between 2-seed versus 1-seed strategies,Eur J Radiol. 2020 Aug;129:109126. doi: 10.1016/j.ejrad.2020.109126. Epub 2020 Jun 10.,Li Q,https://www.ncbi.nlm.nih.gov/pubmed/32544805
16946,33348956,Attitudes and perceptions towards multiparametric magnetic resonance imaging of the prostate: A national survey among Italian urologists,Arch Ital Urol Androl. 2020 Dec 17;92(4). doi: 10.4081/aiua.2020.4.291.,Stanzione A,https://www.ncbi.nlm.nih.gov/pubmed/33348956
16947,32839920,Development of Convolutional Neural Networks to identify bone metastasis for prostate cancer patients in bone scintigraphy,Ann Nucl Med. 2020 Nov;34(11):824-832. doi: 10.1007/s12149-020-01510-6. Epub 2020 Aug 24.,Papandrianos N,https://www.ncbi.nlm.nih.gov/pubmed/32839920
16949,33128273,Thymoquinone inhibits IL-7-induced tumor progression and metastatic invasion in prostate cancer cells by attenuating matrix metalloproteinase activity and Akt/NF-?B signaling,Biotechnol Appl Biochem. 2021 Dec;68(6):1403-1411. doi: 10.1002/bab.2062. Epub 2020 Nov 11.,Alshyarba M,https://www.ncbi.nlm.nih.gov/pubmed/33128273
16950,32430485,Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer,Mol Cancer Ther. 2020 Aug;19(8):1708-1718. doi: 10.1158/1535-7163.MCT-20-0015. Epub 2020 May 19.,Zhao J,https://www.ncbi.nlm.nih.gov/pubmed/32430485
16952,33002388,Imaging quality and prostate MR: it is time to improve,Br J Radiol. 2021 Feb 1;94(1118):20200934. doi: 10.1259/bjr.20200934. Epub 2020 Nov 11.,Giganti F,https://www.ncbi.nlm.nih.gov/pubmed/33002388
16953,32556091,Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer,Carcinogenesis. 2020 Jul 14;41(7):904-908. doi: 10.1093/carcin/bgaa061.,Stopsack KH,https://www.ncbi.nlm.nih.gov/pubmed/32556091
16954,32169916,(68)Ga-PSMA-Guided Bone Biopsies for Molecular Diagnostics in Patients with Metastatic Prostate Cancer,J Nucl Med. 2020 Nov;61(11):1607-1614. doi: 10.2967/jnumed.119.241109. Epub 2020 Mar 13.,de Jong AC,https://www.ncbi.nlm.nih.gov/pubmed/32169916
16955,32911988,Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT,Nutr Cancer. 2021;73(10):1882-1889. doi: 10.1080/01635581.2020.1819348. Epub 2020 Sep 11.,Inglis JE,https://www.ncbi.nlm.nih.gov/pubmed/32911988
16958,32930425,African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer,Int J Cancer. 2021 Jan 1;148(1):99-105. doi: 10.1002/ijc.33282. Epub 2020 Sep 24.,Karunamuni RA,https://www.ncbi.nlm.nih.gov/pubmed/32930425
16960,33270126,"Changes in Racial Disparities in Mortality After Cancer Surgery in the US, 2007-2016",JAMA Netw Open. 2020 Dec 1;3(12):e2027415. doi: 10.1001/jamanetworkopen.2020.27415.,Lam MB,https://www.ncbi.nlm.nih.gov/pubmed/33270126
16962,32814769,Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer,Nat Commun. 2020 Aug 19;11(1):4153. doi: 10.1038/s41467-020-18013-7.,Vatapalli R,https://www.ncbi.nlm.nih.gov/pubmed/32814769
16963,32213209,Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy,Int Braz J Urol. 2020 Jul-Aug;46(4):557-562. doi: 10.1590/S1677-5538.IBJU.2019.0154.,Demirta? A,https://www.ncbi.nlm.nih.gov/pubmed/32213209
16964,33178832,Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis,Biomed Res Int. 2020 Oct 29;2020:6037434. doi: 10.1155/2020/6037434. eCollection 2020.,Sun Y,https://www.ncbi.nlm.nih.gov/pubmed/33178832
16965,32584473,Orphan nuclear receptor ROR? confers doxorubicin resistance in prostate cancer,Cell Biol Int. 2020 Oct;44(10):2170-2176. doi: 10.1002/cbin.11411. Epub 2020 Jul 7.,Gao M,https://www.ncbi.nlm.nih.gov/pubmed/32584473
16966,32502696,Simple structural indocyanine green-loaded microbubbles for dual-modality imaging and multi-synergistic photothermal therapy in prostate cancer,Nanomedicine. 2020 Aug;28:102229. doi: 10.1016/j.nano.2020.102229. Epub 2020 Jun 2.,Yin T,https://www.ncbi.nlm.nih.gov/pubmed/32502696
16968,32555553,Comparing Interventions for Management of Hot Flashes in Patients With Breast and Prostate Cancer: A Systematic Review With Meta-Analyses,Oncol Nurs Forum. 2020 Jul 1;47(4):E86-E106. doi: 10.1188/20.ONF.E86-E106.,Hutton B,https://www.ncbi.nlm.nih.gov/pubmed/32555553
16970,32319592,Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10?AS1/CBP/FOXM1 signaling pathway,Int J Oncol. 2020 Jul;57(1):314-324. doi: 10.3892/ijo.2020.5036. Epub 2020 Apr 1.,Zhou Y,https://www.ncbi.nlm.nih.gov/pubmed/32319592
16971,32095882,Infectious complications of prostate biopsy: winning battles but not war,World J Urol. 2020 Nov;38(11):2743-2753. doi: 10.1007/s00345-020-03112-3. Epub 2020 Feb 24.,Derin O,https://www.ncbi.nlm.nih.gov/pubmed/32095882
16973,32743740,Adolescent dairy product and calcium intake in relation to later prostate cancer risk and mortality in the NIH-AARP Diet and Health Study,Cancer Causes Control. 2020 Oct;31(10):891-904. doi: 10.1007/s10552-020-01330-z. Epub 2020 Aug 2.,Lan T,https://www.ncbi.nlm.nih.gov/pubmed/32743740
16975,32970216,PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [(177)Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis,Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1200-1210. doi: 10.1007/s00259-020-05040-1. Epub 2020 Sep 24.,Seifert R,https://www.ncbi.nlm.nih.gov/pubmed/32970216
16976,32739228,Concordance of confirmatory prostate biopsy in active surveillance with national guidelines: An analysis from the multi-institutional PURC cohort,Urol Oncol. 2020 Nov;38(11):846.e17-846.e22. doi: 10.1016/j.urolonc.2020.07.008. Epub 2020 Jul 29.,Talwar R,https://www.ncbi.nlm.nih.gov/pubmed/32739228
16977,32994502,Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer,Sci Rep. 2020 Sep 29;10(1):15982. doi: 10.1038/s41598-020-72544-z.,Rudolph MM,https://www.ncbi.nlm.nih.gov/pubmed/32994502
16978,32439702,Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression,Mol Cancer Res. 2020 Aug;18(8):1244-1254. doi: 10.1158/1541-7786.MCR-20-0060. Epub 2020 May 21.,Sullivan C,https://www.ncbi.nlm.nih.gov/pubmed/32439702
16979,33326672,C-reactive protein and procalcitonin levels in prostate cancer,Int J Clin Pract. 2021 Apr;75(4):e13935. doi: 10.1111/ijcp.13935. Epub 2020 Dec 30.,Ilktac A,https://www.ncbi.nlm.nih.gov/pubmed/33326672
16981,32219665,Cross-sectional associations between angiotensin-converting enzyme inhibitor use and cancer diagnosis in US adults,Clin Exp Med. 2020 Aug;20(3):409-416. doi: 10.1007/s10238-020-00622-7. Epub 2020 Mar 26.,Smith L,https://www.ncbi.nlm.nih.gov/pubmed/32219665
16982,32175798,The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility,Cancer Biol Ther. 2020 Jun 2;21(6):533-540. doi: 10.1080/15384047.2020.1736481. Epub 2020 Mar 16.,Zacharopoulou N,https://www.ncbi.nlm.nih.gov/pubmed/32175798
16983,33235229,The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T(1) relaxometry in patients with prostate cancer,Sci Rep. 2020 Nov 24;10(1):20475. doi: 10.1038/s41598-020-77331-4.,Sushentsev N,https://www.ncbi.nlm.nih.gov/pubmed/33235229
16984,32552816,Prognostic factors for overall survival in patients with spinal metastasis secondary to prostate cancer: a systematic review and meta-analysis,BMC Musculoskelet Disord. 2020 Jun 17;21(1):388. doi: 10.1186/s12891-020-03412-0.,Gao ZY,https://www.ncbi.nlm.nih.gov/pubmed/32552816
16985,32594208,Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI,Eur Radiol. 2020 Dec;30(12):6582-6592. doi: 10.1007/s00330-020-07008-z. Epub 2020 Jun 27.,Arif M,https://www.ncbi.nlm.nih.gov/pubmed/32594208
16986,32795228,Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration,J Clin Oncol. 2020 Nov 10;38(32):3763-3772. doi: 10.1200/JCO.20.01035. Epub 2020 Aug 14.,Abida W,https://www.ncbi.nlm.nih.gov/pubmed/32795228
16987,32734457,(68)Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study,Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):483-492. doi: 10.1007/s00259-020-04863-2. Epub 2020 Jul 30.,Zhang LL,https://www.ncbi.nlm.nih.gov/pubmed/32734457
16988,32385116,The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population,Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1381-1388. doi: 10.1158/1055-9965.EPI-19-1560. Epub 2020 May 8.,Darst BF,https://www.ncbi.nlm.nih.gov/pubmed/32385116
16990,33115829,Distinct Genomic Alterations in Prostate Tumors Derived from African American Men,Mol Cancer Res. 2020 Dec;18(12):1815-1824. doi: 10.1158/1541-7786.MCR-20-0648. Epub 2020 Oct 28.,Liu W,https://www.ncbi.nlm.nih.gov/pubmed/33115829
16992,32737545,Comparison of biopsy strategies for prostate biopsy according to lesion size and PSA density in MRI-directed biopsy pathway,Abdom Radiol (NY). 2020 Dec;45(12):4166-4177. doi: 10.1007/s00261-020-02667-4. Epub 2020 Jul 31.,Park MY,https://www.ncbi.nlm.nih.gov/pubmed/32737545
16995,33431343,Influence of prostate cancer status on the prevalence of medication-related osteonecrosis of the jaw,Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 Mar;131(3):312-318. doi: 10.1016/j.oooo.2020.12.018. Epub 2020 Dec 26.,Yasui T,https://www.ncbi.nlm.nih.gov/pubmed/33431343
16996,32336645,"Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study",Eur Urol. 2020 Oct;78(4):603-614. doi: 10.1016/j.eururo.2020.03.019. Epub 2020 Apr 23.,Stenzl A,https://www.ncbi.nlm.nih.gov/pubmed/32336645
16998,32273182,"""PSA Surveillance in the Septuagenarian"": A Proposed New Terminology for Clinical Follow-up to Assess Risk of Prostate Cancer in Men Aged 70 Years and Older",Eur Urol. 2020 Aug;78(2):136-137. doi: 10.1016/j.eururo.2020.03.028. Epub 2020 Apr 6.,Carlsson SV,https://www.ncbi.nlm.nih.gov/pubmed/32273182
16999,33010985,Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer Monitoring,Eur Urol. 2020 Dec;78(6):847-853. doi: 10.1016/j.eururo.2020.08.025. Epub 2020 Oct 1.,Saad F,https://www.ncbi.nlm.nih.gov/pubmed/33010985
17001,32330514,The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells,Cancer Lett. 2020 Jul 28;483:12-21. doi: 10.1016/j.canlet.2020.03.030. Epub 2020 Apr 21.,Siddiqui S,https://www.ncbi.nlm.nih.gov/pubmed/32330514
17002,32653263,Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment,Eur Urol Focus. 2021 Nov;7(6):1308-1315. doi: 10.1016/j.euf.2020.06.018. Epub 2020 Jul 9.,Tsaur I,https://www.ncbi.nlm.nih.gov/pubmed/32653263
17003,33191830,"The relationship of diffuse idiopathic skeletal hyperostosis, visceral fat accumulation, and other age-related diseases with the prevalent vertebral fractures in elderly men with castration-naïve prostate cancer",Aging Male. 2020 Dec;23(5):1512-1517. doi: 10.1080/13685538.2020.1815694. Epub 2020 Nov 16.,Watanabe D,https://www.ncbi.nlm.nih.gov/pubmed/33191830
17004,33237577,Laboratory-wide association study of survival with prostate cancer,Cancer. 2021 Apr 1;127(7):1102-1113. doi: 10.1002/cncr.33341. Epub 2020 Nov 25.,Sohlberg EM,https://www.ncbi.nlm.nih.gov/pubmed/33237577
17005,32701721,PET imaging in urology: a rapidly growing successful collaboration,Curr Opin Urol. 2020 Sep;30(5):623-627. doi: 10.1097/MOU.0000000000000800.,Farolfi A,https://www.ncbi.nlm.nih.gov/pubmed/32701721
17006,33074558,HALP score and albumin levels in men with prostate cancer and benign prostate hyperplasia,Int J Clin Pract. 2021 Mar;75(3):e13766. doi: 10.1111/ijcp.13766. Epub 2020 Nov 9.,Kaya C,https://www.ncbi.nlm.nih.gov/pubmed/33074558
17010,32433882,Sub-zeptomole Detection of Biomarker Proteins Using a Microfluidic Immunoarray with Nanostructured Sensors,Anal Chem. 2020 Jun 16;92(12):8021-8025. doi: 10.1021/acs.analchem.0c01507. Epub 2020 May 27.,Dhanapala L,https://www.ncbi.nlm.nih.gov/pubmed/32433882
17011,33295007,"Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study",Int J Urol. 2021 Mar;28(3):280-287. doi: 10.1111/iju.14447. Epub 2020 Dec 8.,Uemura H,https://www.ncbi.nlm.nih.gov/pubmed/33295007
17013,32856855,Identification of Potential Genes for Benign Prostatic Hyperplasia and Prostate Cancer Susceptibility in Four X-chromosome Regions with High Frequency of Microvariant Alleles,Asian Pac J Cancer Prev. 2020 Aug 1;21(8):2271-2280. doi: 10.31557/APJCP.2020.21.8.2271.,Albujja MH,https://www.ncbi.nlm.nih.gov/pubmed/32856855
17014,32289380,Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer,Ann Oncol. 2020 Jul;31(7):930-941. doi: 10.1016/j.annonc.2020.03.309. Epub 2020 Apr 11.,Halabi S,https://www.ncbi.nlm.nih.gov/pubmed/32289380
17015,33070141,Transarterial Embolization in the Management of Intractable Haemorrhage,Urol Int. 2021;105(1-2):95-99. doi: 10.1159/000511123. Epub 2020 Oct 16.,Comploj E,https://www.ncbi.nlm.nih.gov/pubmed/33070141
17018,33037973,"Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan",Target Oncol. 2020 Oct;15(5):635-643. doi: 10.1007/s11523-020-00759-1.,Fujiwara M,https://www.ncbi.nlm.nih.gov/pubmed/33037973
17021,32527692,Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial,Eur Urol. 2020 Sep;78(3):347-357. doi: 10.1016/j.eururo.2020.04.061. Epub 2020 Jun 9.,Armstrong AJ,https://www.ncbi.nlm.nih.gov/pubmed/32527692
17022,32202923,Targeted ?-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies,Cancer Biother Radiopharm. 2020 Sep;35(7):475-484. doi: 10.1089/cbr.2019.3340. Epub 2020 Mar 23.,Jadvar H,https://www.ncbi.nlm.nih.gov/pubmed/32202923
17023,32617978,Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer,J Pathol. 2020 Oct;252(2):101-113. doi: 10.1002/path.5495. Epub 2020 Aug 28.,Tang DE,https://www.ncbi.nlm.nih.gov/pubmed/32617978
17025,32770391,Role of the parasympathetic nervous system in cancer initiation and progression,Clin Transl Oncol. 2021 Apr;23(4):669-681. doi: 10.1007/s12094-020-02465-w. Epub 2020 Aug 8.,Tibensky M,https://www.ncbi.nlm.nih.gov/pubmed/32770391
17026,32660355,Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells,Epigenetics. 2021 Mar;16(3):289-299. doi: 10.1080/15592294.2020.1795601. Epub 2020 Jul 27.,Shafiee-Kermani F,https://www.ncbi.nlm.nih.gov/pubmed/32660355
17027,33067297,"Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma",BMJ Open. 2020 Oct 16;10(10):e039639. doi: 10.1136/bmjopen-2020-039639.,Heitmann JS,https://www.ncbi.nlm.nih.gov/pubmed/33067297
17028,32546840,Prostate carcinogenesis: inflammatory storms,Nat Rev Cancer. 2020 Aug;20(8):455-469. doi: 10.1038/s41568-020-0267-9. Epub 2020 Jun 16.,de Bono JS,https://www.ncbi.nlm.nih.gov/pubmed/32546840
17031,32535678,Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review,Support Care Cancer. 2021 Feb;29(2):925-943. doi: 10.1007/s00520-020-05556-0. Epub 2020 Jun 13.,Ng TL,https://www.ncbi.nlm.nih.gov/pubmed/32535678
17032,32737420,Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):177-185. doi: 10.1038/s41391-020-0264-9. Epub 2020 Jul 31.,Margel D,https://www.ncbi.nlm.nih.gov/pubmed/32737420
17033,33368414,"Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a",Prostate. 2021 Feb;81(3):147-156. doi: 10.1002/pros.24090. Epub 2020 Dec 24.,Imamura R,https://www.ncbi.nlm.nih.gov/pubmed/33368414
17035,32605059,"Dietary Patterns Are Associated with Risk of Prostate Cancer in a Population-Based Case-Control Study in Montreal, Canada",Nutrients. 2020 Jun 27;12(7):1907. doi: 10.3390/nu12071907.,Trudeau K,https://www.ncbi.nlm.nih.gov/pubmed/32605059
17036,32747980,PSA-based machine learning model improves prostate cancer risk stratification in a screening population,World J Urol. 2021 Jun;39(6):1897-1902. doi: 10.1007/s00345-020-03392-9. Epub 2020 Aug 3.,Perera M,https://www.ncbi.nlm.nih.gov/pubmed/32747980
17037,32904490,Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer,Biomed Res Int. 2020 Aug 20;2020:7586521. doi: 10.1155/2020/7586521. eCollection 2020.,Li S,https://www.ncbi.nlm.nih.gov/pubmed/32904490
17038,32985144,"Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study",Investig Clin Urol. 2020 Nov;61(6):588-593. doi: 10.4111/icu.20200214. Epub 2020 Sep 8.,Byeon S,https://www.ncbi.nlm.nih.gov/pubmed/32985144
17040,33223264,"Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable ""click"" oxime bond tethers and preclinical evaluation against prostate cancer",Eur J Med Chem. 2021 Feb 5;211:113018. doi: 10.1016/j.ejmech.2020.113018. Epub 2020 Nov 12.,Vrettos EI,https://www.ncbi.nlm.nih.gov/pubmed/33223264
17041,32801692,Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer,Int J Nanomedicine. 2020 Jul 29;15:5333-5344. doi: 10.2147/IJN.S258856. eCollection 2020.,Wan Z,https://www.ncbi.nlm.nih.gov/pubmed/32801692
17043,33370378,Observational study on time on treatment with abiraterone and enzalutamide,PLoS One. 2020 Dec 28;15(12):e0244462. doi: 10.1371/journal.pone.0244462. eCollection 2020.,Fallara G,https://www.ncbi.nlm.nih.gov/pubmed/33370378
17044,32455471,Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID-19 using local anaesthesia transperineal biopsy,BJU Int. 2020 Sep;126(3):329-332. doi: 10.1111/bju.15120. Epub 2020 Aug 5.,Popert R,https://www.ncbi.nlm.nih.gov/pubmed/32455471
17045,32653747,Going deeper through the Gleason scoring scale: An automatic end-to-end system for histology prostate grading and cribriform pattern detection,Comput Methods Programs Biomed. 2020 Oct;195:105637. doi: 10.1016/j.cmpb.2020.105637. Epub 2020 Jul 4.,Silva-Rodríguez J,https://www.ncbi.nlm.nih.gov/pubmed/32653747
17047,32560654,Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy,BMC Urol. 2020 Jun 19;20(1):71. doi: 10.1186/s12894-020-00627-0.,Hamid ARAH,https://www.ncbi.nlm.nih.gov/pubmed/32560654
17048,32575429,Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer,Cells. 2020 Jun 19;9(6):1495. doi: 10.3390/cells9061495.,Cimadamore A,https://www.ncbi.nlm.nih.gov/pubmed/32575429
17049,32289552,Trends in Radiation Fractionation for Bone Metastases: A Contemporary Nationwide Analysis,Pract Radiat Oncol. 2020 Nov-Dec;10(6):402-408. doi: 10.1016/j.prro.2020.03.009. Epub 2020 Apr 11.,Wegner RE,https://www.ncbi.nlm.nih.gov/pubmed/32289552
17050,32973149,Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients,Nat Commun. 2020 Sep 24;11(1):4822. doi: 10.1038/s41467-020-18649-5.,Daisley BA,https://www.ncbi.nlm.nih.gov/pubmed/32973149
17051,32669958,The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer,Int J Med Sci. 2020 Jun 21;17(11):1550-1560. doi: 10.7150/ijms.46780. eCollection 2020.,Geng X,https://www.ncbi.nlm.nih.gov/pubmed/32669958
17052,32885272,[(68) Ga]Ga-Prostate-Specific Membrane Antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma,Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):883-892. doi: 10.1007/s00259-020-05017-0. Epub 2020 Sep 3.,Kunikowska J,https://www.ncbi.nlm.nih.gov/pubmed/32885272
17053,32616405,Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?,Eur Urol. 2020 Dec;78(6):786-811. doi: 10.1016/j.eururo.2020.06.025. Epub 2020 Jun 18.,Novara G,https://www.ncbi.nlm.nih.gov/pubmed/32616405
17054,32692888,The role of the androgen receptor in prostate cancer-induced platelet aggregation and platelet-induced invasion,J Thromb Haemost. 2020 Nov;18(11):2976-2986. doi: 10.1111/jth.15020. Epub 2020 Aug 24.,Rudzinski JK,https://www.ncbi.nlm.nih.gov/pubmed/32692888
17055,33081478,Efficacy and safety of docetaxel and prednisolone chemotherapy in very elderly men with metastatic castration-resistant prostate cancer (mCRPC) in real world: a single institute experience,Ann Palliat Med. 2021 Feb;10(2):1438-1444. doi: 10.21037/apm-20-573a. Epub 2020 Oct 15.,Wang KY,https://www.ncbi.nlm.nih.gov/pubmed/33081478
17056,32522924,"Severe Visceral Obesity, Fatty Liver and Diabetes after Orchiectomy for Prostate Cancer",Intern Med. 2020 Sep 15;59(18):2281-2285. doi: 10.2169/internalmedicine.4653-20. Epub 2020 Jun 9.,Kajitani N,https://www.ncbi.nlm.nih.gov/pubmed/32522924
17057,32952813,Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer,Pan Afr Med J. 2020 Jul 9;36:169. doi: 10.11604/pamj.2020.36.169.21038. eCollection 2020.,Tolani MA,https://www.ncbi.nlm.nih.gov/pubmed/32952813
17058,32969563,Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer,BJU Int. 2021 Apr;127(4):435-444. doi: 10.1111/bju.15227. Epub 2020 Oct 23.,Madan RA,https://www.ncbi.nlm.nih.gov/pubmed/32969563
17060,33463373,Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a review,Future Oncol. 2021 Jan;17(1):91-102. doi: 10.2217/fon-2020-0672. Epub 2020 Dec 2.,Pobel C,https://www.ncbi.nlm.nih.gov/pubmed/33463373
17063,32873828,Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer,Sci Rep. 2020 Sep 1;10(1):14380. doi: 10.1038/s41598-020-71263-9.,Luszczak S,https://www.ncbi.nlm.nih.gov/pubmed/32873828
17065,32094488,Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):507-516. doi: 10.1038/s41391-020-0214-6. Epub 2020 Feb 24.,Gupta S,https://www.ncbi.nlm.nih.gov/pubmed/32094488
17067,32556680,A clinician's guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer,J Cancer Res Clin Oncol. 2020 Aug;146(8):2067-2075. doi: 10.1007/s00432-020-03286-8. Epub 2020 Jun 17.,Veen KM,https://www.ncbi.nlm.nih.gov/pubmed/32556680
17068,32561663,Efficacy and Safety Exposure-Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer,Clin Cancer Res. 2020 Sep 1;26(17):4460-4467. doi: 10.1158/1078-0432.CCR-20-1041. Epub 2020 Jun 19.,Perez-Ruixo C,https://www.ncbi.nlm.nih.gov/pubmed/32561663
17069,32581112,"A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data",Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1731-1738. doi: 10.1158/1055-9965.EPI-19-1527. Epub 2020 Jun 24.,Huynh-Le MP,https://www.ncbi.nlm.nih.gov/pubmed/32581112
17072,32916128,Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial,Cancer Cell. 2020 Oct 12;38(4):489-499.e3. doi: 10.1016/j.ccell.2020.08.007. Epub 2020 Sep 10.,Sharma P,https://www.ncbi.nlm.nih.gov/pubmed/32916128
17073,33168599,Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum,Mol Cancer Res. 2021 Mar;19(3):475-484. doi: 10.1158/1541-7786.MCR-20-0548. Epub 2020 Nov 9.,Penney KL,https://www.ncbi.nlm.nih.gov/pubmed/33168599
17075,32929801,Vaccinium myrtillus L. extract and its native polyphenol-recombined mixture have anti-proliferative and pro-apoptotic effects on human prostate cancer cell lines,Phytother Res. 2021 Feb;35(2):1089-1098. doi: 10.1002/ptr.6879. Epub 2020 Sep 14.,Del Bubba M,https://www.ncbi.nlm.nih.gov/pubmed/32929801
17076,33210239,"Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in (68)GaPSMA-11 PET images of patients with primary prostate cancer",Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1987-1997. doi: 10.1007/s00259-020-05111-3. Epub 2020 Nov 18.,Zamboglou C,https://www.ncbi.nlm.nih.gov/pubmed/33210239
17077,32857787,Inadequate tissue mineralization promotes cancer cell attachment,PLoS One. 2020 Aug 28;15(8):e0237116. doi: 10.1371/journal.pone.0237116. eCollection 2020.,Sariisik E,https://www.ncbi.nlm.nih.gov/pubmed/32857787
17078,32761950,A hemi-spleen injection model of liver metastasis for prostate cancer,Prostate. 2020 Oct;80(14):1263-1269. doi: 10.1002/pros.24055. Epub 2020 Aug 6.,Simons BW,https://www.ncbi.nlm.nih.gov/pubmed/32761950
17080,33135506,An up-to-date evaluation of darolutamide for the treatment of prostate cancer,Expert Opin Pharmacother. 2021 Mar;22(4):397-402. doi: 10.1080/14656566.2020.1845650. Epub 2020 Nov 9.,Moussa M,https://www.ncbi.nlm.nih.gov/pubmed/33135506
17081,32284318,An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer,Clin Cancer Res. 2020 Sep 15;26(18):4717-4722. doi: 10.1158/1078-0432.CCR-19-3835. Epub 2020 Apr 13.,Brave M,https://www.ncbi.nlm.nih.gov/pubmed/32284318
17082,32759979,Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists,Mod Pathol. 2021 Mar;34(3):660-671. doi: 10.1038/s41379-020-0640-y. Epub 2020 Aug 5.,Bulten W,https://www.ncbi.nlm.nih.gov/pubmed/32759979
17085,33153817,Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment,Eur Urol. 2021 Jun;79(6):722-733. doi: 10.1016/j.eururo.2020.10.001. Epub 2020 Nov 3.,Ruiz de Porras V,https://www.ncbi.nlm.nih.gov/pubmed/33153817
17086,32542445,Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading,Virchows Arch. 2020 Dec;477(6):777-786. doi: 10.1007/s00428-020-02858-w. Epub 2020 Jun 15.,Egevad L,https://www.ncbi.nlm.nih.gov/pubmed/32542445
17087,32739230,"Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer",Urol Oncol. 2020 Dec;38(12):930.e13-930.e21. doi: 10.1016/j.urolonc.2020.07.002. Epub 2020 Jul 30.,Freedland SJ,https://www.ncbi.nlm.nih.gov/pubmed/32739230
17089,33247977,Posttraumatic stress disorder and suicide among veterans with prostate cancer,Psychooncology. 2021 Apr;30(4):581-590. doi: 10.1002/pon.5605. Epub 2020 Dec 13.,Aboumrad M,https://www.ncbi.nlm.nih.gov/pubmed/33247977
17090,32594155,Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment,J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3293-9. doi: 10.1210/clinem/dgaa412.,de Nie I,https://www.ncbi.nlm.nih.gov/pubmed/32594155
17091,32770439,The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study,Int J Clin Oncol. 2020 Dec;25(12):2107-2114. doi: 10.1007/s10147-020-01761-3. Epub 2020 Aug 8.,Tohi Y,https://www.ncbi.nlm.nih.gov/pubmed/32770439
17093,32897830,Exploring Spatial-Temporal Changes in (18)F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide,J Clin Oncol. 2020 Nov 1;38(31):3662-3671. doi: 10.1200/JCO.20.00348. Epub 2020 Sep 8.,Kyriakopoulos CE,https://www.ncbi.nlm.nih.gov/pubmed/32897830
17094,32847934,Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling,Clin Cancer Res. 2020 Nov 1;26(21):5720-5734. doi: 10.1158/1078-0432.CCR-20-1569. Epub 2020 Aug 26.,Muniyan S,https://www.ncbi.nlm.nih.gov/pubmed/32847934
17095,33062666,Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer,Biomed Res Int. 2020 Sep 29;2020:1269624. doi: 10.1155/2020/1269624. eCollection 2020.,Han C,https://www.ncbi.nlm.nih.gov/pubmed/33062666
17096,32760956,Signalling molecular recognition nanocavities with multiple functional groups prepared by molecular imprinting and sequential post-imprinting modifications for prostate cancer biomarker glycoprotein detection,J Mater Chem B. 2020 Sep 21;8(35):7987-7993. doi: 10.1039/d0tb00685h. Epub 2020 Aug 6.,Saeki T,https://www.ncbi.nlm.nih.gov/pubmed/32760956
17097,32879887,The Potential Diagnostic Value of Exosomal Long Noncoding RNAs in Solid Tumors: A Meta-Analysis and Systematic Review,Biomed Res Int. 2020 Aug 15;2020:6786875. doi: 10.1155/2020/6786875. eCollection 2020.,Wu Z,https://www.ncbi.nlm.nih.gov/pubmed/32879887
17103,33004739,CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials,J Cancer Res Ther. 2020 Sep;16(5):990-1001. doi: 10.4103/jcrt.JCRT_295_18.,Cao Q,https://www.ncbi.nlm.nih.gov/pubmed/33004739
17111,33326257,"Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)",J Clin Oncol. 2021 Jan 20;39(3):190-201. doi: 10.1200/JCO.20.01576. Epub 2020 Dec 16.,Crabb SJ,https://www.ncbi.nlm.nih.gov/pubmed/33326257
17112,33141615,Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer,J Manag Care Spec Pharm. 2021 Feb;27(2):166-174. doi: 10.18553/jmcp.2020.20330. Epub 2020 Nov 3.,Appukkuttan S,https://www.ncbi.nlm.nih.gov/pubmed/33141615
17114,33090917,Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data,J Urol. 2021 Feb;205(2):554-560. doi: 10.1097/JU.0000000000001392. Epub 2020 Oct 22.,Crawford ED,https://www.ncbi.nlm.nih.gov/pubmed/33090917
17116,32902124,The AKR1C3/AR-V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression,J Cell Mol Med. 2020 Oct;24(20):12032-12043. doi: 10.1111/jcmm.15831. Epub 2020 Sep 9.,Wang B,https://www.ncbi.nlm.nih.gov/pubmed/32902124
17117,33061374,PSMA-Targeting Reduction-Cleavable Hyperbranched Polyamide-Amine Gene Delivery System to Treat the Bone Metastases of Prostate Cancer,Int J Nanomedicine. 2020 Sep 28;15:7173-7184. doi: 10.2147/IJN.S268398. eCollection 2020.,Ye Y,https://www.ncbi.nlm.nih.gov/pubmed/33061374
17119,31790614,Plasmatic exosomes from prostate cancer patients show increased carbonic anhydrase IX expression and activity and low pH,J Enzyme Inhib Med Chem. 2020 Dec;35(1):280-288. doi: 10.1080/14756366.2019.1697249.,Logozzi M,https://www.ncbi.nlm.nih.gov/pubmed/31790614
17120,32859160,A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer,BMC Cancer. 2020 Aug 28;20(1):820. doi: 10.1186/s12885-020-07318-x.,Cario CL,https://www.ncbi.nlm.nih.gov/pubmed/32859160
17121,31833723,Persistence and adherence to androgen deprivation therapy in men with prostate cancer: an administrative database study,Minerva Urol Nefrol. 2020 Oct;72(5):615-621. doi: 10.23736/S0393-2249.19.03595-1. Epub 2019 Dec 12.,Cindolo L,https://www.ncbi.nlm.nih.gov/pubmed/31833723
17122,32506665,The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial,Prostate. 2020 Aug;80(11):895-905. doi: 10.1002/pros.24023. Epub 2020 Jun 7.,Chadid S,https://www.ncbi.nlm.nih.gov/pubmed/32506665
17123,32989253,Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors,Oncogene. 2020 Nov;39(45):6935-6949. doi: 10.1038/s41388-020-01479-6. Epub 2020 Sep 28.,Zhu Y,https://www.ncbi.nlm.nih.gov/pubmed/32989253
17125,33204005,Psychosocial contributors to patients' and partners' postprostate cancer sexual recovery: 10 evidence-based and practical considerations,Int J Impot Res. 2021 May;33(4):464-472. doi: 10.1038/s41443-020-00369-5. Epub 2020 Nov 17.,Walker LM,https://www.ncbi.nlm.nih.gov/pubmed/33204005
17132,33257388,Status epilepticus from GABA(B)R antibody positive encephalitis due to de novo mixed small cell and adenocarcinoma of the prostate,BMJ Case Rep. 2020 Nov 30;13(11):e238172. doi: 10.1136/bcr-2020-238172.,Kwan C,https://www.ncbi.nlm.nih.gov/pubmed/33257388
17133,32508311,COVID-19 and androgen-targeted therapy for prostate cancer patients,Endocr Relat Cancer. 2020 Sep;27(9):R281-R292. doi: 10.1530/ERC-20-0165.,Bhowmick NA,https://www.ncbi.nlm.nih.gov/pubmed/32508311
17134,33191799,AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence,Expert Opin Investig Drugs. 2021 Jan;30(1):5-11. doi: 10.1080/13543784.2021.1849140. Epub 2020 Dec 3.,McCarthy PM,https://www.ncbi.nlm.nih.gov/pubmed/33191799
17135,32985524,SV-HotSpot: detection and visualization of hotspots targeted by structural variants associated with gene expression,Sci Rep. 2020 Sep 28;10(1):15890. doi: 10.1038/s41598-020-71168-7.,Eteleeb AM,https://www.ncbi.nlm.nih.gov/pubmed/32985524
17136,33245955,"Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancer",J Control Release. 2021 Jan 10;329:76-86. doi: 10.1016/j.jconrel.2020.11.040. Epub 2020 Nov 24.,Hadi MM,https://www.ncbi.nlm.nih.gov/pubmed/33245955
17138,33000703,Sources of Information for Learning and Decision-Making in Men With Localized Prostate Cancer,Am J Mens Health. 2020 Sep-Oct;14(5):1557988320945461. doi: 10.1177/1557988320945461.,Chhatre S,https://www.ncbi.nlm.nih.gov/pubmed/33000703
17140,33036903,Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists,Urol Oncol. 2020 Dec;38(12):929.e1-929.e10. doi: 10.1016/j.urolonc.2020.09.015. Epub 2020 Oct 7.,Rosenzweig B,https://www.ncbi.nlm.nih.gov/pubmed/33036903
17141,32599279,Clinical Evaluation of Deep Learning and Atlas-Based Auto-Contouring of Bladder and Rectum for Prostate Radiation Therapy,Pract Radiat Oncol. 2021 Jan-Feb;11(1):e80-e89. doi: 10.1016/j.prro.2020.05.013. Epub 2020 Jun 27.,Zabel WJ,https://www.ncbi.nlm.nih.gov/pubmed/32599279
17145,33309270,Controversies in Testosterone Therapy,Sex Med Rev. 2021 Jan;9(1):149-159. doi: 10.1016/j.sxmr.2020.09.004. Epub 2020 Dec 9.,Twitchell DK,https://www.ncbi.nlm.nih.gov/pubmed/33309270
17149,32822128,"Anxiety and depression associated with a positive prostate biopsy result: A comparative, prospective cohort study",Int Braz J Urol. 2020 Nov-Dec;46(6):993-1005. doi: 10.1590/S1677-5538.IBJU.2019.0719.,Sefik E,https://www.ncbi.nlm.nih.gov/pubmed/32822128
17152,33226524,Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial,Int J Clin Oncol. 2021 Mar;26(3):578-590. doi: 10.1007/s10147-020-01824-5. Epub 2020 Nov 23.,Uemura H,https://www.ncbi.nlm.nih.gov/pubmed/33226524
17154,32522195,Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma,Lipids Health Dis. 2020 Jun 10;19(1):133. doi: 10.1186/s12944-020-01305-8.,Albuquerque CP,https://www.ncbi.nlm.nih.gov/pubmed/32522195
17156,31939351,Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment,Asian J Androl. 2020 Sep-Oct;22(5):454-458. doi: 10.4103/aja.aja_138_19.,Chelly S,https://www.ncbi.nlm.nih.gov/pubmed/31939351
17157,32514134,The effect of sample size on polygenic hazard models for prostate cancer,Eur J Hum Genet. 2020 Oct;28(10):1467-1475. doi: 10.1038/s41431-020-0664-2. Epub 2020 Jun 8.,Karunamuni RA,https://www.ncbi.nlm.nih.gov/pubmed/32514134
17158,32559345,Novel small-molecule LG1836 inhibits the in vivo growth of castration-resistant prostate cancer,Prostate. 2020 Sep;80(12):993-1005. doi: 10.1002/pros.24032. Epub 2020 Jun 19.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32559345
17161,33277398,Radiation Dosimetry of (99m)Tc-PSMA I&S: A Single-Center Prospective Study,J Nucl Med. 2021 Aug 1;62(8):1075-1081. doi: 10.2967/jnumed.120.253476. Epub 2020 Dec 4.,Urbán S,https://www.ncbi.nlm.nih.gov/pubmed/33277398
17162,33378392,Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study,PLoS One. 2020 Dec 30;15(12):e0244660. doi: 10.1371/journal.pone.0244660. eCollection 2020.,Shim M,https://www.ncbi.nlm.nih.gov/pubmed/33378392
17163,32979106,A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer,Med Oncol. 2020 Sep 26;37(10):95. doi: 10.1007/s12032-020-01420-7.,Laber DA,https://www.ncbi.nlm.nih.gov/pubmed/32979106
17165,32631311,Sarcoma epidemiology and cancer-related hospitalisation in Western Australia from 1982 to 2016: a descriptive study using linked administrative data,BMC Cancer. 2020 Jul 6;20(1):625. doi: 10.1186/s12885-020-07103-w.,Wright CM,https://www.ncbi.nlm.nih.gov/pubmed/32631311
17166,32267200,Receipt of Survivorship Care Plans and Self-Reported Health Status among Patients with Genitourinary Malignancy,J Urol. 2020 Sep;204(3):564-569. doi: 10.1097/JU.0000000000001032. Epub 2020 Apr 8.,Linscott JA,https://www.ncbi.nlm.nih.gov/pubmed/32267200
17168,33201234,Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis,JAMA Netw Open. 2020 Nov 2;3(11):e2025826. doi: 10.1001/jamanetworkopen.2020.25826.,Myint ZW,https://www.ncbi.nlm.nih.gov/pubmed/33201234
17175,33243690,"Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve Injury",J Sex Med. 2021 Jan;18(1):17-28. doi: 10.1016/j.jsxm.2020.10.015. Epub 2020 Nov 24.,Yin GN,https://www.ncbi.nlm.nih.gov/pubmed/33243690
17176,32694156,A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer,Clin Cancer Res. 2020 Oct 15;26(20):5338-5347. doi: 10.1158/1078-0432.CCR-20-1707. Epub 2020 Jul 21.,Aggarwal RR,https://www.ncbi.nlm.nih.gov/pubmed/32694156
17177,33431146,Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients,Value Health. 2021 Jan;24(1):121-128. doi: 10.1016/j.jval.2020.04.1838. Epub 2020 Sep 11.,Ten Ham RMT,https://www.ncbi.nlm.nih.gov/pubmed/33431146
17190,32989230,Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer,Br J Cancer. 2020 Dec;123(12):1715-1719. doi: 10.1038/s41416-020-01105-y. Epub 2020 Sep 29.,Mout L,https://www.ncbi.nlm.nih.gov/pubmed/32989230
17195,32624280,A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts,Eur Urol. 2021 May;79(5):692-699. doi: 10.1016/j.eururo.2020.06.042. Epub 2020 Jul 2.,Markowski MC,https://www.ncbi.nlm.nih.gov/pubmed/32624280
17196,32636317,Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography,Clin Cancer Res. 2020 Sep 15;26(18):4882-4891. doi: 10.1158/1078-0432.CCR-20-1358. Epub 2020 Jul 7.,Hintz HM,https://www.ncbi.nlm.nih.gov/pubmed/32636317
17201,32532924,Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted ?-particle therapy,Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15172-15181. doi: 10.1073/pnas.1918744117. Epub 2020 Jun 12.,Bicak M,https://www.ncbi.nlm.nih.gov/pubmed/32532924
17207,32696762,Phospholipase C? Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway,Med Sci Monit. 2020 Jul 22;26:e924328. doi: 10.12659/MSM.924328.,Zheng Y,https://www.ncbi.nlm.nih.gov/pubmed/32696762
17209,31602515,Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve,Surg Endosc. 2020 Sep;34(9):4101-4109. doi: 10.1007/s00464-019-07172-4. Epub 2019 Oct 10.,D'Andrea AP,https://www.ncbi.nlm.nih.gov/pubmed/31602515
17212,32565390,RhoA/ROCK pathway inhibitor ameliorates erectile dysfunction induced by radiation therapy in rats,Radiother Oncol. 2020 Sep;150:174-180. doi: 10.1016/j.radonc.2020.06.021. Epub 2020 Jun 19.,Mahmood J,https://www.ncbi.nlm.nih.gov/pubmed/32565390
17219,32956872,PEG-PLGA nanospheres loaded with nanoscintillators and photosensitizers for radiation-activated photodynamic therapy,Acta Biomater. 2020 Nov;117:335-348. doi: 10.1016/j.actbio.2020.09.029. Epub 2020 Sep 19.,Dinakaran D,https://www.ncbi.nlm.nih.gov/pubmed/32956872
17230,32449811,Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals,Prostate. 2020 Jul;80(10):742-752. doi: 10.1002/pros.23988. Epub 2020 May 25.,Tang M,https://www.ncbi.nlm.nih.gov/pubmed/32449811
17233,32453002,Novel therapies for advanced urologic cancers,Curr Opin Urol. 2020 Jul;30(4):594-601. doi: 10.1097/MOU.0000000000000775.,Heidenreich A,https://www.ncbi.nlm.nih.gov/pubmed/32453002
17234,33122083,Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing,Gene. 2021 Feb 5;768:145265. doi: 10.1016/j.gene.2020.145265. Epub 2020 Oct 26.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/33122083
17241,32535711,Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study),Int J Clin Oncol. 2020 Oct;25(10):1835-1843. doi: 10.1007/s10147-020-01721-x. Epub 2020 Jun 13.,Okano N,https://www.ncbi.nlm.nih.gov/pubmed/32535711
17251,32463991,Understanding virtual urology clinics: a systematic review,BJU Int. 2020 Nov;126(5):536-546. doi: 10.1111/bju.15125. Epub 2020 Jul 28.,Edison MA,https://www.ncbi.nlm.nih.gov/pubmed/32463991
17252,32851890,Investigating the Impact of OGT Inhibition on Doxorubicin- and Docetaxel-Induced Cytotoxicity in PC-3 and WPMY-1 Cells,Int J Toxicol. 2020 Nov/Dec;39(6):586-593. doi: 10.1177/1091581820948433. Epub 2020 Aug 27.,Makwana V,https://www.ncbi.nlm.nih.gov/pubmed/32851890
17256,32532703,A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic,Eur Urol Focus. 2020 Sep 15;6(5):1070-1085. doi: 10.1016/j.euf.2020.05.020. Epub 2020 Jun 5.,Heldwein FL,https://www.ncbi.nlm.nih.gov/pubmed/32532703
17273,32890516,COVID's Impact on Radiation Oncology: A Latin American Survey Study,Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):374-378. doi: 10.1016/j.ijrobp.2020.06.058.,Martinez D,https://www.ncbi.nlm.nih.gov/pubmed/32890516
17275,33129674,Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes,Urol Oncol. 2021 May;39(5):258-267. doi: 10.1016/j.urolonc.2020.10.013. Epub 2020 Oct 28.,Mian BM,https://www.ncbi.nlm.nih.gov/pubmed/33129674
17276,33129824,Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells,Toxicol Appl Pharmacol. 2020 Dec 15;409:115308. doi: 10.1016/j.taap.2020.115308. Epub 2020 Oct 29.,Kulkarni P,https://www.ncbi.nlm.nih.gov/pubmed/33129824
17279,32724116,Adipocytes protect fibroblasts from radiation-induced damage by adiponectin secretion,Sci Rep. 2020 Jul 28;10(1):12616. doi: 10.1038/s41598-020-69352-w.,Kosmacek EA,https://www.ncbi.nlm.nih.gov/pubmed/32724116
17321,33078903,Comprehensive review of implications of COVID-19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic,Cancer Med. 2020 Dec;9(24):9205-9218. doi: 10.1002/cam4.3534. Epub 2020 Oct 20.,Madan A,https://www.ncbi.nlm.nih.gov/pubmed/33078903
17326,33142238,ONC201 and imipridones: Anti-cancer compounds with clinical efficacy,Neoplasia. 2020 Dec;22(12):725-744. doi: 10.1016/j.neo.2020.09.005. Epub 2020 Oct 23.,Prabhu VV,https://www.ncbi.nlm.nih.gov/pubmed/33142238
17332,32661416,The DNA methylation landscape of advanced prostate cancer,Nat Genet. 2020 Aug;52(8):778-789. doi: 10.1038/s41588-020-0648-8. Epub 2020 Jul 13.,Zhao SG,https://www.ncbi.nlm.nih.gov/pubmed/32661416
17334,32535158,Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients,Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188383. doi: 10.1016/j.bbcan.2020.188383. Epub 2020 Jun 11.,Muniyan S,https://www.ncbi.nlm.nih.gov/pubmed/32535158
17336,32277721,TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands,Genes Cells. 2020 Jul;25(7):450-465. doi: 10.1111/gtc.12770. Epub 2020 May 5.,Al Mahmud MR,https://www.ncbi.nlm.nih.gov/pubmed/32277721
17353,32361681,"MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses",Redox Biol. 2020 Jul;34:101542. doi: 10.1016/j.redox.2020.101542. Epub 2020 Apr 21.,Chatterjee A,https://www.ncbi.nlm.nih.gov/pubmed/32361681
17354,32535014,Did quality of life for older cancer survivors improve with the turn of the century in the United States?,J Geriatr Oncol. 2021 Jan;12(1):102-105. doi: 10.1016/j.jgo.2020.05.010. Epub 2020 Jun 10.,Mahal AR,https://www.ncbi.nlm.nih.gov/pubmed/32535014
17385,32552031,Targeted Alpha Therapy: Current Clinical Applications,Cancer Biother Radiopharm. 2020 Aug;35(6):404-417. doi: 10.1089/cbr.2020.3576. Epub 2020 Jun 16.,Guerra Liberal FDC,https://www.ncbi.nlm.nih.gov/pubmed/32552031
17396,32356572,Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia,Prostate. 2020 Jul;80(10):731-741. doi: 10.1002/pros.23986. Epub 2020 May 1.,Popovics P,https://www.ncbi.nlm.nih.gov/pubmed/32356572
17411,32692934,Delaying Cancer Cases in Urology during COVID-19: Review of the Literature,J Urol. 2020 Nov;204(5):926-933. doi: 10.1097/JU.0000000000001288. Epub 2020 Jul 25.,Tachibana I,https://www.ncbi.nlm.nih.gov/pubmed/32692934
17433,31967907,Targeted Alpha Therapy with Thorium-227,Cancer Biother Radiopharm. 2020 Aug;35(6):437-445. doi: 10.1089/cbr.2019.3105. Epub 2020 Jan 20.,Frantellizzi V,https://www.ncbi.nlm.nih.gov/pubmed/31967907
17439,32663453,Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review,Biochem Pharmacol. 2020 Nov;181:114149. doi: 10.1016/j.bcp.2020.114149. Epub 2020 Jul 12.,Schönthal AH,https://www.ncbi.nlm.nih.gov/pubmed/32663453
17444,33309430,Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid,J Formos Med Assoc. 2021 Aug;120(8):1572-1580. doi: 10.1016/j.jfma.2020.11.017. Epub 2020 Dec 11.,Wei LY,https://www.ncbi.nlm.nih.gov/pubmed/33309430
17449,32703636,Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable,Urol Oncol. 2020 Oct;38(10):783-792. doi: 10.1016/j.urolonc.2020.06.028. Epub 2020 Jun 26.,Katims AB,https://www.ncbi.nlm.nih.gov/pubmed/32703636
17460,32701160,Association of Inferior Vena Cava Filter Placement With Rates of Pulmonary Embolism in Patients With Cancer and Acute Lower Extremity Deep Venous Thrombosis,JAMA Netw Open. 2020 Jul 1;3(7):e2011079. doi: 10.1001/jamanetworkopen.2020.11079.,Balabhadra S,https://www.ncbi.nlm.nih.gov/pubmed/32701160
17469,33358884,Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy,Eur Urol Focus. 2021 Sep;7(5):980-986. doi: 10.1016/j.euf.2020.11.006. Epub 2020 Dec 24.,Wenzel M,https://www.ncbi.nlm.nih.gov/pubmed/33358884
17479,32861331,Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States,Mayo Clin Proc. 2020 Sep;95(9):1865-1876. doi: 10.1016/j.mayocp.2020.05.044.,Guha A,https://www.ncbi.nlm.nih.gov/pubmed/32861331
17484,32696094,Wee1 kinase inhibitor AZD1775 potentiates CD8+?T cell-dependent antitumour activity via dendritic cell activation following a single high dose of irradiation,Med Oncol. 2020 Jul 21;37(8):66. doi: 10.1007/s12032-020-01390-w.,Wang B,https://www.ncbi.nlm.nih.gov/pubmed/32696094
17485,33085787,The 26th Annual Prostate Cancer Foundation Scientific Retreat Report,Prostate. 2021 Jan;81(1):3-19. doi: 10.1002/pros.24083. Epub 2020 Oct 21.,Miyahira AK,https://www.ncbi.nlm.nih.gov/pubmed/33085787
17486,33049187,Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV,Can J Urol. 2020 Oct;27(5):10352-10362.,Crawford ED,https://www.ncbi.nlm.nih.gov/pubmed/33049187
17489,32669105,"PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment",BMC Med. 2020 Jul 16;18(1):213. doi: 10.1186/s12916-020-01681-z.,Devos G,https://www.ncbi.nlm.nih.gov/pubmed/32669105
17492,33334904,"Vertebroplasty and kyphoplasty in the USA from 2004 to 2017: national inpatient trends, regional variations, associated diagnoses, and outcomes",J Neurointerv Surg. 2021 May;13(5):483-491. doi: 10.1136/neurintsurg-2020-016733. Epub 2020 Dec 17.,Hafezi-Nejad N,https://www.ncbi.nlm.nih.gov/pubmed/33334904
17500,33300403,"Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden",Scand J Urol. 2021 Feb;55(1):1-8. doi: 10.1080/21681805.2020.1851762. Epub 2020 Dec 10.,Svensson J,https://www.ncbi.nlm.nih.gov/pubmed/33300403
17501,32631744,Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer,Eur Urol. 2020 Oct;78(4):515-517. doi: 10.1016/j.eururo.2020.06.030. Epub 2020 Jul 4.,Chu CE,https://www.ncbi.nlm.nih.gov/pubmed/32631744
17510,32471792,Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review,Eur Urol Oncol. 2020 Aug;3(4):400-409. doi: 10.1016/j.euo.2020.03.006. Epub 2020 May 26.,Shevach JW,https://www.ncbi.nlm.nih.gov/pubmed/32471792
17511,32255470,Genome-wide association study of germline copy number variations reveals an association with prostate cancer aggressiveness,Mutagenesis. 2020 Jul 11;35(3):283-290. doi: 10.1093/mutage/geaa010.,Brezina S,https://www.ncbi.nlm.nih.gov/pubmed/32255470
17514,32989500,Cytotoxic and anti-angiogenic effects of zoledronic acid in DU-145 and PC-3 prostate cancer cell lines,Mol Biol Rep. 2020 Oct;47(10):7675-7683. doi: 10.1007/s11033-020-05840-6. Epub 2020 Sep 29.,Gokalp C,https://www.ncbi.nlm.nih.gov/pubmed/32989500
17516,31536012,Computerized Classification of Prostate Cancer Gleason Scores from Whole Slide Images,IEEE/ACM Trans Comput Biol Bioinform. 2020 Nov-Dec;17(6):1871-1882. doi: 10.1109/TCBB.2019.2941195. Epub 2020 Dec 8.,Xu H,https://www.ncbi.nlm.nih.gov/pubmed/31536012
17519,31911085,Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition,Eur Urol Focus. 2020 Nov 15;6(6):1162-1164. doi: 10.1016/j.euf.2019.11.010. Epub 2020 Jan 3.,Izard JP,https://www.ncbi.nlm.nih.gov/pubmed/31911085
17520,33059945,Genetic counseling in prostate cancer: How to implement it in daily clinical practice?,Actas Urol Esp (Engl Ed). 2021 Jan-Feb;45(1):8-20. doi: 10.1016/j.acuro.2020.08.009. Epub 2020 Oct 12.,Borque-Fernando A,https://www.ncbi.nlm.nih.gov/pubmed/33059945
17523,33302594,The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine,Genes (Basel). 2020 Dec 8;11(12):1471. doi: 10.3390/genes11121471.,Lewis DD,https://www.ncbi.nlm.nih.gov/pubmed/33302594
17525,32243243,5?-Reductase Inhibitors and Risk of Prostate Cancer Death,J Urol. 2020 Oct;204(4):714-719. doi: 10.1097/JU.0000000000001038. Epub 2020 Apr 3.,Bonde Miranda T,https://www.ncbi.nlm.nih.gov/pubmed/32243243
17526,33311575,Hypogonadism and its treatment among prostate cancer survivors,Int J Impot Res. 2021 May;33(4):480-487. doi: 10.1038/s41443-020-00387-3. Epub 2020 Dec 12.,Choi EJ,https://www.ncbi.nlm.nih.gov/pubmed/33311575
17528,32709484,Nursing Implications of Recent Changes in Management Practices for Metastatic Prostate Cancer,Semin Oncol Nurs. 2020 Aug;36(4):151047. doi: 10.1016/j.soncn.2020.151047. Epub 2020 Jul 22.,Bennett C,https://www.ncbi.nlm.nih.gov/pubmed/32709484
17529,33164210,Health literacy and shared decision making in prostate cancer screening: Equality versus equity,Cancer. 2021 Jan 15;127(2):181-183. doi: 10.1002/cncr.33235. Epub 2020 Nov 9.,Washington SL 3rd,https://www.ncbi.nlm.nih.gov/pubmed/33164210
17531,32721477,"Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer",Gene. 2020 Oct 30;759:144995. doi: 10.1016/j.gene.2020.144995. Epub 2020 Jul 25.,Ghafouri-Fard S,https://www.ncbi.nlm.nih.gov/pubmed/32721477
17532,33384200,Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission,Eur Urol. 2021 Mar;79(3):327-329. doi: 10.1016/j.eururo.2020.12.010. Epub 2020 Dec 29.,Van Poppel H,https://www.ncbi.nlm.nih.gov/pubmed/33384200
17533,32976977,Kinless hubs are potential target genes in prostate cancer network,Genomics. 2020 Nov;112(6):5227-5239. doi: 10.1016/j.ygeno.2020.09.033. Epub 2020 Sep 23.,Mangangcha IR,https://www.ncbi.nlm.nih.gov/pubmed/32976977
17534,32877009,Steeling' effects in the association between psychological resilience and cancer treatment in prostate cancer patients,Psychooncology. 2021 Jan;30(1):67-73. doi: 10.1002/pon.5537. Epub 2020 Sep 9.,Sharpley CF,https://www.ncbi.nlm.nih.gov/pubmed/32877009
17535,32897803,Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing,J Urol. 2021 Feb;205(2):461-469. doi: 10.1097/JU.0000000000001363. Epub 2020 Sep 8.,Fan L,https://www.ncbi.nlm.nih.gov/pubmed/32897803
17536,32692871,Increased nuclear factor I/B expression in prostate cancer correlates with AR expression,Prostate. 2020 Sep;80(13):1058-1070. doi: 10.1002/pros.24019. Epub 2020 Jul 21.,Nanda JS,https://www.ncbi.nlm.nih.gov/pubmed/32692871
17538,32674976,Changing the Goal Posts: Prostate-specific Membrane Antigen Targeted Theranostics in Prostate Cancer,Semin Oncol Nurs. 2020 Aug;36(4):151052. doi: 10.1016/j.soncn.2020.151052. Epub 2020 Jul 13.,Emmett L,https://www.ncbi.nlm.nih.gov/pubmed/32674976
17539,31721182,Social connectedness and mortality after prostate cancer diagnosis: A prospective cohort study,Int J Cancer. 2020 Aug 1;147(3):766-776. doi: 10.1002/ijc.32786. Epub 2019 Dec 2.,Wu Z,https://www.ncbi.nlm.nih.gov/pubmed/31721182
17543,33216731,Limited improvement in prostate cancer mortality-to-incidence ratios in countries with high health care expenditures,Aging (Albany NY). 2020 Nov 12;12(21):21308-21315. doi: 10.18632/aging.103865. Epub 2020 Nov 12.,Wang SC,https://www.ncbi.nlm.nih.gov/pubmed/33216731
17545,33182828,Curcumin against Prostate Cancer: Current Evidence,Biomolecules. 2020 Nov 10;10(11):1536. doi: 10.3390/biom10111536.,Termini D,https://www.ncbi.nlm.nih.gov/pubmed/33182828
17546,33084183,PARP inhibition in prostate cancer,Genes Chromosomes Cancer. 2021 May;60(5):344-351. doi: 10.1002/gcc.22903. Epub 2020 Oct 28.,Nientiedt C,https://www.ncbi.nlm.nih.gov/pubmed/33084183
17547,32044806,Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer,Am J Surg Pathol. 2020 Jul;44(7):e15-e29. doi: 10.1097/PAS.0000000000001450.,Lotan TL,https://www.ncbi.nlm.nih.gov/pubmed/32044806
17549,32007439,Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis,Clin Genitourin Cancer. 2020 Aug;18(4):e402-e409. doi: 10.1016/j.clgc.2019.12.002. Epub 2019 Dec 13.,Mori K,https://www.ncbi.nlm.nih.gov/pubmed/32007439
17550,31765300,A Clinical Prototype Transrectal Diffuse Optical Tomography (TRDOT) System for In vivo Monitoring of Photothermal Therapy (PTT) of Focal Prostate Cancer,IEEE Trans Biomed Eng. 2020 Jul;67(7):2119-2129. doi: 10.1109/TBME.2019.2955354. Epub 2019 Nov 25.,He J,https://www.ncbi.nlm.nih.gov/pubmed/31765300
17551,32856610,Early-Life Cardiorespiratory Fitness and Long-term Risk of Prostate Cancer,Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2187-2194. doi: 10.1158/1055-9965.EPI-20-0535. Epub 2020 Aug 20.,Crump C,https://www.ncbi.nlm.nih.gov/pubmed/32856610
17552,32733038,Depression and prostate cancer: implications for urologists and oncologists,Nat Rev Urol. 2020 Oct;17(10):571-585. doi: 10.1038/s41585-020-0354-4. Epub 2020 Jul 30.,Sharpley CF,https://www.ncbi.nlm.nih.gov/pubmed/32733038
17553,32701809,18F-Fluciclovine Uptake in Acute Appendicitis,Clin Nucl Med. 2020 Oct;45(10):e453-e454. doi: 10.1097/RLU.0000000000003210.,Ahn GS,https://www.ncbi.nlm.nih.gov/pubmed/32701809
17554,33159603,A Time Scales Approach for Modeling Intermittent Hormone Therapy for Prostate Cancer,Bull Math Biol. 2020 Nov 7;82(11):145. doi: 10.1007/s11538-020-00821-z.,Higgins R,https://www.ncbi.nlm.nih.gov/pubmed/33159603
17555,31412009,Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review,Eur Urol Oncol. 2020 Aug;3(4):489-497. doi: 10.1016/j.euo.2018.12.006. Epub 2019 Jan 23.,Surov A,https://www.ncbi.nlm.nih.gov/pubmed/31412009
17556,32483877,High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancer,Prostate. 2020 Aug;80(11):885-894. doi: 10.1002/pros.24022. Epub 2020 Jun 1.,Itsumi M,https://www.ncbi.nlm.nih.gov/pubmed/32483877
17559,32627306,Prostate cancer survivorship essentials framework: guidelines for practitioners,BJU Int. 2021 Dec;128 Suppl 3(Suppl 3):18-29. doi: 10.1111/bju.15159. Epub 2020 Aug 18.,Dunn J,https://www.ncbi.nlm.nih.gov/pubmed/32627306
17560,32608296,A prospective study of a urine and plasma biomarker test for the prediction of gleason ?3?+?4 prostate cancer in a mixed cohort,Scand J Urol. 2020 Aug;54(4):323-327. doi: 10.1080/21681805.2020.1782979. Epub 2020 Jul 1.,Poulsen MH,https://www.ncbi.nlm.nih.gov/pubmed/32608296
17561,32697345,Risk of invasive prostate cancer and prostate cancer death in relatives of patients with prostatic borderline or in situ neoplasia: A nationwide cohort study,Cancer. 2020 Oct 1;126(19):4371-4378. doi: 10.1002/cncr.33096. Epub 2020 Jul 22.,Xu X,https://www.ncbi.nlm.nih.gov/pubmed/32697345
17565,31705377,"Exploring health behaviors, quality of life, and support needs in African-American prostate cancer survivors: a pilot study to support future interventions",Support Care Cancer. 2020 Jul;28(7):3135-3143. doi: 10.1007/s00520-019-05092-6. Epub 2019 Nov 8.,Stolley MR,https://www.ncbi.nlm.nih.gov/pubmed/31705377
17566,32977723,Differential profiling of prostate tumors versus benign prostatic tissues by using a 2DE-MALDI-TOF-based proteomic approach,Neoplasma. 2021 Jan;68(1):154-164. doi: 10.4149/neo_2020_200611N625. Epub 2020 Sep 24.,Kme?ová Sivo?ová M,https://www.ncbi.nlm.nih.gov/pubmed/32977723
17568,32708810,Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications,Int J Mol Sci. 2020 Jul 16;21(14):5036. doi: 10.3390/ijms21145036.,Brandão A,https://www.ncbi.nlm.nih.gov/pubmed/32708810
17569,32063129,"""One stroke, with twenty-two people"": exploring prostate cancer survivors' participation in dragon boating",J Psychosoc Oncol. 2020 Jul-Aug;38(4):375-388. doi: 10.1080/07347332.2020.1725215. Epub 2020 Feb 17.,Cinà IV,https://www.ncbi.nlm.nih.gov/pubmed/32063129
17570,32585812,Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis,Int J Mol Sci. 2020 Jun 23;21(12):4449. doi: 10.3390/ijms21124449.,Adekoya TO,https://www.ncbi.nlm.nih.gov/pubmed/32585812
17571,33189417,The role of multiparametric magnetic resonance imaging in the selection and follow-up of patients undergoing active surveillance for prostate cancer. An European Section of Uro-Technology (ESUT) review,Actas Urol Esp (Engl Ed). 2021 Apr;45(3):188-197. doi: 10.1016/j.acuro.2020.04.011. Epub 2020 Nov 11.,Gómez Rivas J,https://www.ncbi.nlm.nih.gov/pubmed/33189417
17572,32773352,"The Fallacy of ""Definitive Therapy"" for Prostate Cancer",Eur Urol. 2020 Nov;78(5):650-651. doi: 10.1016/j.eururo.2020.07.013. Epub 2020 Aug 6.,Soloway MS,https://www.ncbi.nlm.nih.gov/pubmed/32773352
17573,32545453,Effect of Palmitic Acid on Exosome-Mediated Secretion and Invasive Motility in Prostate Cancer Cells,Molecules. 2020 Jun 12;25(12):2722. doi: 10.3390/molecules25122722.,Maly IV,https://www.ncbi.nlm.nih.gov/pubmed/32545453
17574,33051756,Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners,J Cancer Surviv. 2021 Aug;15(4):536-545. doi: 10.1007/s11764-020-00947-y. Epub 2020 Oct 13.,Hartung TJ,https://www.ncbi.nlm.nih.gov/pubmed/33051756
17575,32980372,Modeling the effect of immunotherapies on human castration-resistant prostate cancer,J Theor Biol. 2021 Jan 21;509:110500. doi: 10.1016/j.jtbi.2020.110500. Epub 2020 Sep 24.,Coletti R,https://www.ncbi.nlm.nih.gov/pubmed/32980372
17576,32708551,Convergence of Prognostic Gene Signatures Suggests Underlying Mechanisms of Human Prostate Cancer Progression,Genes (Basel). 2020 Jul 16;11(7):802. doi: 10.3390/genes11070802.,Luca BA,https://www.ncbi.nlm.nih.gov/pubmed/32708551
17577,32638007,Cancer survival in kidney transplant recipients in Ireland,Nephrol Dial Transplant. 2020 Oct 1;35(10):1802-1810. doi: 10.1093/ndt/gfaa109.,Murray SL,https://www.ncbi.nlm.nih.gov/pubmed/32638007
17578,33043575,Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer,BJU Int. 2021 Jun;127(6):712-721. doi: 10.1111/bju.15272. Epub 2020 Dec 10.,Fujihara A,https://www.ncbi.nlm.nih.gov/pubmed/33043575
17579,32897802,"Clinical Utility of 4Kscore((R)), ExosomeDxTM and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer",J Urol. 2021 Feb;205(2):452-460. doi: 10.1097/JU.0000000000001361. Epub 2020 Sep 8.,de la Calle CM,https://www.ncbi.nlm.nih.gov/pubmed/32897802
17580,33092896,An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment,Eur Urol. 2021 Jan;79(1):33-41. doi: 10.1016/j.eururo.2020.09.041. Epub 2020 Oct 20.,Cook MB,https://www.ncbi.nlm.nih.gov/pubmed/33092896
17581,33350321,Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial,J Urol. 2021 May;205(5):1372-1378. doi: 10.1097/JU.0000000000001531. Epub 2020 Dec 22.,Pierre-Victor D,https://www.ncbi.nlm.nih.gov/pubmed/33350321
17583,33442662,Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer,JNCI Cancer Spectr. 2020 Oct 26;5(1):pkaa098. doi: 10.1093/jncics/pkaa098. eCollection 2021 Feb.,Nyame YA,https://www.ncbi.nlm.nih.gov/pubmed/33442662
17584,32307327,Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions,Urol Oncol. 2020 Jul;38(7):637.e9-637.e15. doi: 10.1016/j.urolonc.2020.03.019. Epub 2020 Apr 17.,Al Hussein Al Awamlh B,https://www.ncbi.nlm.nih.gov/pubmed/32307327
17585,33257377,Dermatological manifestation of metastatic prostate cancer,BMJ Case Rep. 2020 Nov 30;13(11):e237115. doi: 10.1136/bcr-2020-237115.,Gibb J,https://www.ncbi.nlm.nih.gov/pubmed/33257377
17586,32678368,Hot Flashes: Clinical Summary of the ONS GuidelinesTM for Cancer Treatment-Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer,Clin J Oncol Nurs. 2020 Aug 1;24(4):430-433. doi: 10.1188/20.CJON.430-433.,Kaplan M,https://www.ncbi.nlm.nih.gov/pubmed/32678368
17587,32725550,Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature,Curr Oncol Rep. 2020 Jul 28;22(10):101. doi: 10.1007/s11912-020-00962-3.,Collée GE,https://www.ncbi.nlm.nih.gov/pubmed/32725550
17588,32513898,Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells,Mol Cancer Res. 2020 Sep;18(9):1290-1301. doi: 10.1158/1541-7786.MCR-20-0051. Epub 2020 Jun 8.,Schnepp PM,https://www.ncbi.nlm.nih.gov/pubmed/32513898
17589,33148052,"Association of Prostate Cancer with Nuts, Seeds, Alcohol and Processed Meats: A Worldwide Population-Based Study",Nutr Cancer. 2021;73(11-12):2538-2545. doi: 10.1080/01635581.2020.1841250. Epub 2020 Nov 5.,Ziouziou I,https://www.ncbi.nlm.nih.gov/pubmed/33148052
17590,32497551,A promising therapeutic combination for metastatic prostate cancer: Chloroquine as autophagy inhibitor and palladium(II) barbiturate complex,Biochimie. 2020 Aug;175:159-172. doi: 10.1016/j.biochi.2020.05.010. Epub 2020 Jun 1.,Erkisa M,https://www.ncbi.nlm.nih.gov/pubmed/32497551
17592,33221259,PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?,Urol Oncol. 2021 Jul;39(7):431.e9-431.e13. doi: 10.1016/j.urolonc.2020.11.010. Epub 2020 Nov 19.,Rico L,https://www.ncbi.nlm.nih.gov/pubmed/33221259
17593,32852899,Current status of PSMA PET imaging in prostate cancer,Asia Pac J Clin Oncol. 2020 Sep;16 Suppl 3:7-11. doi: 10.1111/ajco.13313.,Ho CL,https://www.ncbi.nlm.nih.gov/pubmed/32852899
17594,32167077,MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer,Asian J Androl. 2020 Nov-Dec;22(6):616-622. doi: 10.4103/aja.aja_142_19.,Cao Z,https://www.ncbi.nlm.nih.gov/pubmed/32167077
17595,32643549,In silico docking of phytocompounds to identify potent inhibitors of signaling pathways involved in prostate cancer,J Biomol Struct Dyn. 2021 Sep;39(14):5182-5208. doi: 10.1080/07391102.2020.1785944. Epub 2020 Jul 9.,Jonnalagadda B,https://www.ncbi.nlm.nih.gov/pubmed/32643549
17596,32622720,Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer,Urol Oncol. 2020 Dec;38(12):918-928. doi: 10.1016/j.urolonc.2020.06.003. Epub 2020 Jul 1.,Shukla KK,https://www.ncbi.nlm.nih.gov/pubmed/32622720
17597,33279858,Transcriptional network modulated by the prognostic signature transcription factors and their long noncoding RNA partners in primary prostate cancer,EBioMedicine. 2021 Jan;63:103150. doi: 10.1016/j.ebiom.2020.103150. Epub 2020 Dec 3.,Jiang M,https://www.ncbi.nlm.nih.gov/pubmed/33279858
17598,32446375,Wnt/?-catenin signaling contributes to prostate cancer heterogeneity through reciprocal suppression of H3K27 trimethylation,Biochem Biophys Res Commun. 2020 Jun 18;527(1):242-249. doi: 10.1016/j.bbrc.2020.04.112. Epub 2020 May 4.,Wang F,https://www.ncbi.nlm.nih.gov/pubmed/32446375
17600,32700096,Racial Disparity in Response to Prostate Cancer Systemic Therapies,Curr Oncol Rep. 2020 Jul 23;22(9):96. doi: 10.1007/s11912-020-00966-z.,Bitting RL,https://www.ncbi.nlm.nih.gov/pubmed/32700096
17601,32796959,Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer,Oncogene. 2020 Sep;39(36):5839-5854. doi: 10.1038/s41388-020-01418-5. Epub 2020 Aug 14.,Shin SH,https://www.ncbi.nlm.nih.gov/pubmed/32796959
17602,30875031,Prognostic Differences in ISUP Grade Group 4: a Systematic Review and Meta-Analysis,Pathol Oncol Res. 2020 Jul;26(3):1367-1375. doi: 10.1007/s12253-019-00632-1. Epub 2019 Mar 14.,Lu TC,https://www.ncbi.nlm.nih.gov/pubmed/30875031
17604,32701793,Clinical Impact of PET Imaging in Patients With Metastatic Prostate Cancer,Clin Nucl Med. 2020 Oct;45(10):757-764. doi: 10.1097/RLU.0000000000003126.,Tuncel M,https://www.ncbi.nlm.nih.gov/pubmed/32701793
17605,32678362,Metastatic Prostate Cancer: An Update on Treatments and a Review of Patient Symptom Management,Clin J Oncol Nurs. 2020 Aug 1;24(4):369-378. doi: 10.1188/20.CJON.369-378.,Drudge-Coates L,https://www.ncbi.nlm.nih.gov/pubmed/32678362
17606,32358094,Impact of (68)Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial,J Nucl Med. 2020 Dec;61(12):1793-1799. doi: 10.2967/jnumed.120.242180. Epub 2020 May 1.,Fendler WP,https://www.ncbi.nlm.nih.gov/pubmed/32358094
17607,31554922,Dietary inflammatory index and the risk of prostate cancer: a dose-response meta-analysis,Eur J Clin Nutr. 2020 Jul;74(7):1001-1008. doi: 10.1038/s41430-019-0500-3. Epub 2019 Sep 25.,Zhu Y,https://www.ncbi.nlm.nih.gov/pubmed/31554922
17608,32948204,miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer,BMC Med Genomics. 2020 Sep 18;13(Suppl 8):129. doi: 10.1186/s12920-020-00788-9.,Pudova EA,https://www.ncbi.nlm.nih.gov/pubmed/32948204
17609,32556998,Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer,Mamm Genome. 2020 Aug;31(7-8):197-204. doi: 10.1007/s00335-020-09842-4. Epub 2020 Jun 15.,Xiang P,https://www.ncbi.nlm.nih.gov/pubmed/32556998
17610,32808062,Considerations on current and future issues related to reproducibility and accuracy in prostate cancer grading,Virchows Arch. 2021 Feb;478(2):375-377. doi: 10.1007/s00428-020-02913-6. Epub 2020 Aug 17.,Montironi R,https://www.ncbi.nlm.nih.gov/pubmed/32808062
17611,32986533,Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC,JCO Oncol Pract. 2020 Dec;16(12):811-819. doi: 10.1200/OP.20.00431. Epub 2020 Sep 28.,Szymaniak BM,https://www.ncbi.nlm.nih.gov/pubmed/32986533
17612,33290846,Metabolic regulation of prostate cancer heterogeneity and plasticity,Semin Cancer Biol. 2022 Jul;82:94-119. doi: 10.1016/j.semcancer.2020.12.002. Epub 2020 Dec 5.,Peitzsch C,https://www.ncbi.nlm.nih.gov/pubmed/33290846
17613,32636098,DNA Repair and Prostate Cancer: A Field Ripe for Harvest,Eur Urol. 2020 Oct;78(4):486-488. doi: 10.1016/j.eururo.2020.06.020. Epub 2020 Jul 5.,Bryce AH,https://www.ncbi.nlm.nih.gov/pubmed/32636098
17614,32936685,Targeting the BAF complex in advanced prostate cancer,Expert Opin Drug Discov. 2021 Feb;16(2):173-181. doi: 10.1080/17460441.2020.1821644. Epub 2020 Sep 16.,Hartley A,https://www.ncbi.nlm.nih.gov/pubmed/32936685
17615,32799659,Study and detection of potential markers for predicting metastasis into lymph nodes in prostate cancer,Biomark Med. 2020 Oct;14(14):1317-1327. doi: 10.2217/bmm-2020-0372. Epub 2020 Aug 17.,Papasotiriou I,https://www.ncbi.nlm.nih.gov/pubmed/32799659
17616,32169431,Sex After Prostate Cancer in Gay and Bisexual Men: A Review of the Literature,Sex Med Rev. 2020 Jul;8(3):466-472. doi: 10.1016/j.sxmr.2020.01.004. Epub 2020 Mar 10.,McInnis MK,https://www.ncbi.nlm.nih.gov/pubmed/32169431
17617,33003959,The development of apalutamide for the treatment of prostate cancer,Expert Opin Drug Discov. 2021 Mar;16(3):217-226. doi: 10.1080/17460441.2021.1829588. Epub 2020 Oct 12.,Isaacsson Velho P,https://www.ncbi.nlm.nih.gov/pubmed/33003959
17619,32655006,Inflammatory and Insulinemic Dietary Patterns: Influence on Circulating Biomarkers and Prostate Cancer Risk,Cancer Prev Res (Phila). 2020 Oct;13(10):841-852. doi: 10.1158/1940-6207.CAPR-20-0236. Epub 2020 Jul 12.,Aroke D,https://www.ncbi.nlm.nih.gov/pubmed/32655006
17621,32659024,Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities,Prostate. 2020 Sep;80(13):1128-1133. doi: 10.1002/pros.24041. Epub 2020 Jul 13.,Dee EC,https://www.ncbi.nlm.nih.gov/pubmed/32659024
17622,33152137,Early-onset prostate cancer is associated with increased risks of disease progression and cancer-specific mortality,Prostate. 2021 Feb;81(2):118-126. doi: 10.1002/pros.24087. Epub 2020 Nov 5.,Shih HJ,https://www.ncbi.nlm.nih.gov/pubmed/33152137
17623,32648302,Physical activity and advanced cancer: evidence of exercise-sensitive genes regulating prostate cancer cell proliferation and apoptosis,J Physiol. 2020 Sep;598(18):3871-3889. doi: 10.1113/JP279150. Epub 2020 Jul 28.,Schwappacher R,https://www.ncbi.nlm.nih.gov/pubmed/32648302
17625,33335027,Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages,J Immunother Cancer. 2020 Dec;8(2):e001510. doi: 10.1136/jitc-2020-001510.,Potluri HK,https://www.ncbi.nlm.nih.gov/pubmed/33335027
17626,32573466,The role of the androgen receptor as a driver and mitigator of cellular stress,J Mol Endocrinol. 2020 Aug;65(2):R19-R33. doi: 10.1530/JME-20-0057.,Doultsinos D,https://www.ncbi.nlm.nih.gov/pubmed/32573466
17628,32620630,Geographical Differences in Likelihood of Home Death Among Palliative Cancer Patients: A National Population-based Register Study,Anticancer Res. 2020 Jul;40(7):3897-3903. doi: 10.21873/anticanres.14380.,Nilsson J,https://www.ncbi.nlm.nih.gov/pubmed/32620630
17629,32782128,"Fluorine-18 labelled prostate-specific membrane antigen (PSMA)-1007 positron-emission tomography-computed tomography: normal patterns, pearls, and pitfalls",Clin Radiol. 2020 Dec;75(12):903-913. doi: 10.1016/j.crad.2020.06.031. Epub 2020 Aug 8.,Foley RW,https://www.ncbi.nlm.nih.gov/pubmed/32782128
17630,33336540,Evaluation of the safety and effectiveness of prostate-specific antigen (PSA) monitoring in primary care after discharge from hospital-based follow-up following prostate cancer treatment,Eur J Cancer Care (Engl). 2021 Jul;30(4):e13389. doi: 10.1111/ecc.13389. Epub 2020 Dec 18.,Johnson H,https://www.ncbi.nlm.nih.gov/pubmed/33336540
17631,33099951,"MicroRNA-151 regulates the growth, chemosensitivity and metastasis of human prostate cancer cells by targeting PI3K/AKT",J BUON. 2020 Jul-Aug;25(4):2045-2050.,Chen S,https://www.ncbi.nlm.nih.gov/pubmed/33099951
17634,33227392,TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation,Int J Biochem Cell Biol. 2021 Jan;130:105885. doi: 10.1016/j.biocel.2020.105885. Epub 2020 Nov 20.,Niture S,https://www.ncbi.nlm.nih.gov/pubmed/33227392
17635,33159960,Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period,Kidney Int. 2021 Jun;99(6):1430-1438. doi: 10.1016/j.kint.2020.10.018. Epub 2020 Nov 5.,Blosser CD,https://www.ncbi.nlm.nih.gov/pubmed/33159960
17637,32913223,Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids,Sci Rep. 2020 Sep 10;10(1):14931. doi: 10.1038/s41598-020-71925-8.,Pereira MM,https://www.ncbi.nlm.nih.gov/pubmed/32913223
17638,31007118,Awareness of prostate cancer diagnosis and management among Turkish males: a cross sectional study from Çorum,Aging Male. 2020 Sep;23(3):202-205. doi: 10.1080/13685538.2019.1577377. Epub 2019 Apr 22.,Sungur M,https://www.ncbi.nlm.nih.gov/pubmed/31007118
17640,32820256,A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridization,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):220-232. doi: 10.1038/s41391-020-00272-6. Epub 2020 Aug 20.,Eskra JN,https://www.ncbi.nlm.nih.gov/pubmed/32820256
17641,32332147,Semiautomatically Quantified Tumor Volume Using (68)Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer,J Nucl Med. 2020 Dec;61(12):1786-1792. doi: 10.2967/jnumed.120.242057. Epub 2020 Apr 24.,Seifert R,https://www.ncbi.nlm.nih.gov/pubmed/32332147
17643,33069624,Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study,Eur Urol Focus. 2021 Sep;7(5):1019-1026. doi: 10.1016/j.euf.2020.09.013. Epub 2020 Oct 15.,Lughezzani G,https://www.ncbi.nlm.nih.gov/pubmed/33069624
17644,33274720,Emerging Players in Prostate Cancer-Bone Niche Communication,Trends Cancer. 2021 Feb;7(2):112-121. doi: 10.1016/j.trecan.2020.09.006. Epub 2020 Oct 24.,Furesi G,https://www.ncbi.nlm.nih.gov/pubmed/33274720
17648,33369473,Incremental Value of Post Diuretic 68Ga-PSMA-11 PET-CT in Characterization of Indeterminate lLesions in Prostate Cancer,Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3719-3723. doi: 10.31557/APJCP.2020.21.12.3719.,Ghadanfer L,https://www.ncbi.nlm.nih.gov/pubmed/33369473
17649,32620228,The Role of PET-CT Imaging in Prostate Cancer,Semin Ultrasound CT MR. 2020 Aug;41(4):373-391. doi: 10.1053/j.sult.2020.04.004. Epub 2020 May 17.,Subesinghe M,https://www.ncbi.nlm.nih.gov/pubmed/32620228
17651,33287410,"Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling",Int J Mol Sci. 2020 Dec 3;21(23):9233. doi: 10.3390/ijms21239233.,Gilgunn S,https://www.ncbi.nlm.nih.gov/pubmed/33287410
17653,32505838,High hydrostatic pressure enhances the anti-proliferative properties of lotus bee pollen on the human prostate cancer PC-3?cells via increased metabolites,J Ethnopharmacol. 2020 Oct 28;261:113057. doi: 10.1016/j.jep.2020.113057. Epub 2020 Jun 4.,Tuoheti T,https://www.ncbi.nlm.nih.gov/pubmed/32505838
17654,33250303,Prostate Cancer Screening Patterns Among Sexual and Gender Minority Individuals,Eur Urol. 2021 May;79(5):588-592. doi: 10.1016/j.eururo.2020.11.009. Epub 2020 Nov 26.,Ma SJ,https://www.ncbi.nlm.nih.gov/pubmed/33250303
17655,32617640,Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer,Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):469-476. doi: 10.1007/s00259-020-04934-4. Epub 2020 Jul 2.,Fanti S,https://www.ncbi.nlm.nih.gov/pubmed/32617640
17656,32213210,Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients,Int Braz J Urol. 2020 Jul-Aug;46(4):545-556. doi: 10.1590/S1677-5538.IBJU.2019.0146.,Porcaro AB,https://www.ncbi.nlm.nih.gov/pubmed/32213210
17658,33219316,Plectin is a regulator of prostate cancer growth and metastasis,Oncogene. 2021 Jan;40(3):663-676. doi: 10.1038/s41388-020-01557-9. Epub 2020 Nov 20.,Buckup M,https://www.ncbi.nlm.nih.gov/pubmed/33219316
17659,32367635,Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance,BJU Int. 2020 Sep;126(3):373-378. doi: 10.1111/bju.15101. Epub 2020 Jun 2.,Schwen ZR,https://www.ncbi.nlm.nih.gov/pubmed/32367635
17660,32967667,Identification of plasma lipid species as promising diagnostic markers for prostate cancer,BMC Med Inform Decis Mak. 2020 Sep 24;20(Suppl 9):223. doi: 10.1186/s12911-020-01242-7.,Chen X,https://www.ncbi.nlm.nih.gov/pubmed/32967667
17661,32645914,MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?,Int J Mol Sci. 2020 Jul 7;21(13):4796. doi: 10.3390/ijms21134796.,Andl T,https://www.ncbi.nlm.nih.gov/pubmed/32645914
17662,32573960,Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness,Cancer Med. 2020 Aug;9(15):5687-5696. doi: 10.1002/cam4.3082. Epub 2020 Jun 23.,Kamel HFM,https://www.ncbi.nlm.nih.gov/pubmed/32573960
17663,32591248,Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer,Urol Oncol. 2020 Nov;38(11):801-815. doi: 10.1016/j.urolonc.2020.05.025. Epub 2020 Jun 24.,Kafka M,https://www.ncbi.nlm.nih.gov/pubmed/32591248
17664,33024029,Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer,Mol Cancer Ther. 2020 Dec;19(12):2490-2501. doi: 10.1158/1535-7163.MCT-19-0874. Epub 2020 Oct 6.,Kong Y,https://www.ncbi.nlm.nih.gov/pubmed/33024029
17665,32632762,Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative exploration,Support Care Cancer. 2021 Mar;29(3):1317-1325. doi: 10.1007/s00520-020-05594-8. Epub 2020 Jul 6.,Matheson L,https://www.ncbi.nlm.nih.gov/pubmed/32632762
17666,32663571,Prostate cancer liver metastasis: Dormancy and resistance to therapy,Semin Cancer Biol. 2021 Jun;71:2-9. doi: 10.1016/j.semcancer.2020.07.004. Epub 2020 Jul 12.,Ma B,https://www.ncbi.nlm.nih.gov/pubmed/32663571
17667,32674972,Promoting Sexual Well-being for Men and Their Partners Affected by Prostate Cancer,Semin Oncol Nurs. 2020 Aug;36(4):151053. doi: 10.1016/j.soncn.2020.151053. Epub 2020 Jul 13.,Papadopoulou C,https://www.ncbi.nlm.nih.gov/pubmed/32674972
17668,33245666,To treat or not to treat: is it acceptable to avoid active therapies in advanced prostate cancer today?,Expert Rev Anticancer Ther. 2021 Apr;21(4):389-400. doi: 10.1080/14737140.2021.1856661. Epub 2020 Dec 14.,Caffo O,https://www.ncbi.nlm.nih.gov/pubmed/33245666
17669,32521178,PARP inhibitors in prostate cancer: time to narrow patient selection?,Expert Rev Anticancer Ther. 2020 Jul;20(7):523-526. doi: 10.1080/14737140.2020.1781622. Epub 2020 Jul 7.,Markowski MC,https://www.ncbi.nlm.nih.gov/pubmed/32521178
17670,32002539,RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells,Carcinogenesis. 2020 Jul 10;41(6):778-789. doi: 10.1093/carcin/bgaa009.,Kim SH,https://www.ncbi.nlm.nih.gov/pubmed/32002539
17671,32964792,"Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis",Am J Mens Health. 2020 Sep-Oct;14(5):1557988320959984. doi: 10.1177/1557988320959984.,Effah CY,https://www.ncbi.nlm.nih.gov/pubmed/32964792
17672,32805148,Liquid biopsy with cell free DNA: new horizons for prostate cancer,Crit Rev Clin Lab Sci. 2021 Jan;58(1):60-76. doi: 10.1080/10408363.2020.1803789. Epub 2020 Aug 17.,Ponti G,https://www.ncbi.nlm.nih.gov/pubmed/32805148
17673,32535076,"3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review",Urology. 2020 Sep;143:20-32. doi: 10.1016/j.urology.2020.03.066. Epub 2020 Jun 12.,Wake N,https://www.ncbi.nlm.nih.gov/pubmed/32535076
17674,32675591,Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratification,Curr Opin Oncol. 2020 Sep;32(5):527-534. doi: 10.1097/CCO.0000000000000655.,van Dessel LF,https://www.ncbi.nlm.nih.gov/pubmed/32675591
17675,32885704,Genetic testing for the clinician in prostate cancer,Expert Rev Mol Diagn. 2020 Sep;20(9):933-946. doi: 10.1080/14737159.2020.1816170. Epub 2020 Oct 15.,López-Campos F,https://www.ncbi.nlm.nih.gov/pubmed/32885704
17676,33275847,Identifying Synthetic Lectins from a Competitive Screen for the Detection of Prostate Cancer,Bioconjug Chem. 2020 Dec 16;31(12):2750-2758. doi: 10.1021/acs.bioconjchem.0c00526. Epub 2020 Dec 4.,Hollenbeck MG,https://www.ncbi.nlm.nih.gov/pubmed/33275847
17677,32394421,Personalized strategies in population screening for prostate cancer,Int J Cancer. 2020 Dec 1;147(11):2977-2987. doi: 10.1002/ijc.33045. Epub 2020 Jun 3.,Remmers S,https://www.ncbi.nlm.nih.gov/pubmed/32394421
17678,33320438,Silica-Based Nanoparticles as Drug Delivery Vehicles for Prostate Cancer Treatment,Chem Rec. 2021 Jun;21(6):1535-1568. doi: 10.1002/tcr.202000104. Epub 2020 Dec 15.,Tiburcius S,https://www.ncbi.nlm.nih.gov/pubmed/33320438
17679,33219721,The long non-coding RNA PCAL7 promotes prostate cancer by strengthening androgen receptor signaling,J Clin Lab Anal. 2021 Feb;35(2):e23645. doi: 10.1002/jcla.23645. Epub 2020 Nov 21.,Li Z,https://www.ncbi.nlm.nih.gov/pubmed/33219721
17680,31154637,Knowledge and Awareness of Prostate Cancer Among Omani Men Attending a Teaching Hospital,J Cancer Educ. 2020 Oct;35(5):1002-1010. doi: 10.1007/s13187-019-01556-9.,Al-Azri M,https://www.ncbi.nlm.nih.gov/pubmed/31154637
17681,33358543,Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis,Eur Urol Oncol. 2021 Oct;4(5):697-713. doi: 10.1016/j.euo.2020.12.004. Epub 2020 Dec 25.,Mazzone E,https://www.ncbi.nlm.nih.gov/pubmed/33358543
17683,33377281,Knockout of Akt1/2 suppresses the metastasis of human prostate cancer cells CWR22rv1 in vitro and in vivo,J Cell Mol Med. 2021 Feb;25(3):1546-1553. doi: 10.1111/jcmm.16246. Epub 2020 Dec 29.,Su B,https://www.ncbi.nlm.nih.gov/pubmed/33377281
17684,33039351,"Expression, Localization, and Function of the Nucleolar Protein BOP1 in Prostate Cancer Progression",Am J Pathol. 2021 Jan;191(1):168-179. doi: 10.1016/j.ajpath.2020.09.010. Epub 2020 Oct 8.,Vellky JE,https://www.ncbi.nlm.nih.gov/pubmed/33039351
17685,33256058,Preparation and Biological Evaluation of [(99m)Tc]Tc-CNGU as a PSMA-Targeted Radiotracer for the Imaging of Prostate Cancer,Molecules. 2020 Nov 26;25(23):5548. doi: 10.3390/molecules25235548.,Xiao D,https://www.ncbi.nlm.nih.gov/pubmed/33256058
17686,31797025,Prostate MRI with PI-RADS v2.1: initial detection and active surveillance,Abdom Radiol (NY). 2020 Jul;45(7):2133-2142. doi: 10.1007/s00261-019-02346-z.,Lo GC,https://www.ncbi.nlm.nih.gov/pubmed/31797025
17687,32576527,Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer,Urol Oncol. 2020 Nov;38(11):846.e9-846.e16. doi: 10.1016/j.urolonc.2020.05.024. Epub 2020 Jun 21.,Stevens E,https://www.ncbi.nlm.nih.gov/pubmed/32576527
17688,32955663,The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer,Ann Nucl Med. 2020 Dec;34(12):926-931. doi: 10.1007/s12149-020-01524-0. Epub 2020 Sep 21.,Aoki Y,https://www.ncbi.nlm.nih.gov/pubmed/32955663
17689,32391971,Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer,Mol Carcinog. 2020 Aug;59(8):955-966. doi: 10.1002/mc.23214. Epub 2020 May 11.,Shankar E,https://www.ncbi.nlm.nih.gov/pubmed/32391971
17690,33257031,Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis,Eur Urol. 2021 Mar;79(3):419-426. doi: 10.1016/j.eururo.2020.11.014. Epub 2020 Nov 28.,Shi Z,https://www.ncbi.nlm.nih.gov/pubmed/33257031
17691,33137064,Photoacoustic spectral analysis at ultraviolet wavelengths for characterizing the Gleason grades of prostate cancer,Opt Lett. 2020 Nov 1;45(21):6042-6045. doi: 10.1364/OL.409249.,Jo J,https://www.ncbi.nlm.nih.gov/pubmed/33137064
17692,33225866,The Association between Insomnia and Orgasmic Difficulty for Prostate Cancer Patients - Implication to Sex Therapy,J Sex Marital Ther. 2021;47(2):174-185. doi: 10.1080/0092623X.2020.1848947. Epub 2020 Nov 23.,Galvin KT,https://www.ncbi.nlm.nih.gov/pubmed/33225866
17693,32664150,Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis,Medicine (Baltimore). 2020 Jul 10;99(28):e21158. doi: 10.1097/MD.0000000000021158.,Ma Z,https://www.ncbi.nlm.nih.gov/pubmed/32664150
17694,32614483,Decrease of intracellular ROS by arbutin is associated with apoptosis induction and downregulation of IL-1? and TNF-? in LNCaP; prostate cancer,J Food Biochem. 2020 Sep;44(9):e13360. doi: 10.1111/jfbc.13360. Epub 2020 Jul 2.,Safari H,https://www.ncbi.nlm.nih.gov/pubmed/32614483
17695,33103371,"Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl-CoA acetyltransferase 1",J Cell Mol Med. 2020 Dec;24(23):14039-14049. doi: 10.1111/jcmm.16016. Epub 2020 Oct 26.,Guan J,https://www.ncbi.nlm.nih.gov/pubmed/33103371
17696,33219755,Fatherhood status in relation to prostate cancer risks in two large U.S.-based prospective cohort studies,Cancer Med. 2021 Jan;10(1):405-415. doi: 10.1002/cam4.3606. Epub 2020 Nov 21.,Geczik AM,https://www.ncbi.nlm.nih.gov/pubmed/33219755
17697,33217485,Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs,Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188481. doi: 10.1016/j.bbcan.2020.188481. Epub 2020 Nov 17.,Rizzo M,https://www.ncbi.nlm.nih.gov/pubmed/33217485
17698,32047994,Prostate MRI: staging and decision-making,Abdom Radiol (NY). 2020 Jul;45(7):2143-2153. doi: 10.1007/s00261-020-02431-8.,Magnetta MJ,https://www.ncbi.nlm.nih.gov/pubmed/32047994
17699,32768949,Potential inhibitory effect of lycopene on prostate cancer,Biomed Pharmacother. 2020 Sep;129:110459. doi: 10.1016/j.biopha.2020.110459. Epub 2020 Jun 30.,Mirahmadi M,https://www.ncbi.nlm.nih.gov/pubmed/32768949
17700,32584648,A Pilot Study Assessing Aspects of Sexual Function Predicted to Be Important After Treatment for Prostate Cancer in Gay Men: An Underserved Domain Highlighted,LGBT Health. 2020 Jul;7(5):271-276. doi: 10.1089/lgbt.2018.0245. Epub 2020 Jun 23.,Amarasekera C,https://www.ncbi.nlm.nih.gov/pubmed/32584648
17701,33099213,The HOXB13 p.Gly84Glu variant observed in an extended five generation high-risk prostate cancer pedigree supports risk association for multiple cancer sites,Cancer Epidemiol. 2020 Dec;69:101834. doi: 10.1016/j.canep.2020.101834. Epub 2020 Oct 21.,Cannon-Albright LA,https://www.ncbi.nlm.nih.gov/pubmed/33099213
17702,32712140,Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy,Urol Oncol. 2020 Nov;38(11):849.e11-849.e18. doi: 10.1016/j.urolonc.2020.06.033. Epub 2020 Jul 22.,Shiota M,https://www.ncbi.nlm.nih.gov/pubmed/32712140
17703,32280028,Diagnostic Performance of the Prostate Cancer Antigen 3 Test in Prostate Cancer: Systematic Review and Meta-analysis,Clin Genitourin Cancer. 2020 Oct;18(5):402-408.e5. doi: 10.1016/j.clgc.2020.03.005. Epub 2020 Mar 14.,Lee D,https://www.ncbi.nlm.nih.gov/pubmed/32280028
17704,33119808,Analysis of serum glycome by lectin microarrays for prostate cancer patients - a search for aberrant glycoforms,Glycoconj J. 2020 Dec;37(6):703-711. doi: 10.1007/s10719-020-09958-4. Epub 2020 Oct 29.,Bertok T,https://www.ncbi.nlm.nih.gov/pubmed/33119808
17705,32753660,Haptoglobin polymorphism and prostate cancer mortality,Sci Rep. 2020 Aug 4;10(1):13117. doi: 10.1038/s41598-020-69333-z.,Kaiser M,https://www.ncbi.nlm.nih.gov/pubmed/32753660
17707,32873919,Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):261-267. doi: 10.1038/s41391-020-00278-0. Epub 2020 Sep 1.,Weiner AB,https://www.ncbi.nlm.nih.gov/pubmed/32873919
17709,32666408,Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey,Cancer Causes Control. 2020 Sep;31(9):851-860. doi: 10.1007/s10552-020-01326-9. Epub 2020 Jul 14.,Defever K,https://www.ncbi.nlm.nih.gov/pubmed/32666408
17710,32813910,"Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios",Cancer Med. 2020 Oct;9(20):7742-7750. doi: 10.1002/cam4.3395. Epub 2020 Aug 19.,Getaneh AM,https://www.ncbi.nlm.nih.gov/pubmed/32813910
17712,33121737,Interplay between orphan nuclear receptors and androgen receptor-dependent or-independent growth signalings in prostate cancer,Mol Aspects Med. 2021 Apr;78:100921. doi: 10.1016/j.mam.2020.100921. Epub 2020 Oct 26.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/33121737
17716,31705249,Prostate MR: pitfalls and benign lesions,Abdom Radiol (NY). 2020 Jul;45(7):2154-2164. doi: 10.1007/s00261-019-02302-x.,Chatterjee A,https://www.ncbi.nlm.nih.gov/pubmed/31705249
17717,32592757,Deep convolutional neural networks combine Raman spectral signature of serum for prostate cancer bone metastases screening,Nanomedicine. 2020 Oct;29:102245. doi: 10.1016/j.nano.2020.102245. Epub 2020 Jun 25.,Shao X,https://www.ncbi.nlm.nih.gov/pubmed/32592757
17718,32980775,Development and prevalence of castration-resistant prostate cancer subtypes,Neoplasia. 2020 Nov;22(11):566-575. doi: 10.1016/j.neo.2020.09.002. Epub 2020 Sep 25.,Vellky JE,https://www.ncbi.nlm.nih.gov/pubmed/32980775
17719,33107000,Changing Provider PSA Screening Behavior Using Best Practice Advisories: Interventional Study in a Multispecialty Group Practice,J Gen Intern Med. 2020 Nov;35(Suppl 2):796-801. doi: 10.1007/s11606-020-06097-2. Epub 2020 Oct 26.,Presti J Jr,https://www.ncbi.nlm.nih.gov/pubmed/33107000
17722,33388655,"Design, synthesis and biological evaluation of novel thiohydantoin derivatives as potent androgen receptor antagonists for the treatment of prostate cancer",Bioorg Med Chem. 2021 Feb 1;31:115953. doi: 10.1016/j.bmc.2020.115953. Epub 2020 Dec 16.,Wang A,https://www.ncbi.nlm.nih.gov/pubmed/33388655
17723,32764119,Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial,J Nucl Med. 2021 Mar;62(3):354-359. doi: 10.2967/jnumed.120.248120. Epub 2020 Aug 6.,Fosbøl MØ,https://www.ncbi.nlm.nih.gov/pubmed/32764119
17724,32784629,Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer,Mar Drugs. 2020 Aug 7;18(8):415. doi: 10.3390/md18080415.,Sun SQ,https://www.ncbi.nlm.nih.gov/pubmed/32784629
17725,32918578,Structured prostate MRI reporting: how and why,Abdom Radiol (NY). 2020 Dec;45(12):3969-3973. doi: 10.1007/s00261-020-02720-2. Epub 2020 Sep 12.,Shaish H,https://www.ncbi.nlm.nih.gov/pubmed/32918578
17726,31472148,Activated Wnt/?-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer,Life Sci. 2020 Aug 1;254:116816. doi: 10.1016/j.lfs.2019.116816. Epub 2019 Aug 28.,Bian P,https://www.ncbi.nlm.nih.gov/pubmed/31472148
17727,32736710,Snail promotes prostate cancer migration by facilitating SPOP ubiquitination and degradation,Biochem Biophys Res Commun. 2020 Aug 27;529(3):799-804. doi: 10.1016/j.bbrc.2020.05.187. Epub 2020 Jul 20.,Lv W,https://www.ncbi.nlm.nih.gov/pubmed/32736710
17728,32972301,Factors affecting health-related quality of life among prostate cancer patients: A systematic review,J Oncol Pharm Pract. 2020 Dec;26(8):1997-2010. doi: 10.1177/1078155220959414. Epub 2020 Sep 25.,Odeo S,https://www.ncbi.nlm.nih.gov/pubmed/32972301
17729,32661432,Leflunomide triggers synthetic lethality in PTEN-deficient prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):718-723. doi: 10.1038/s41391-020-0251-1. Epub 2020 Jul 13.,Ozturk S,https://www.ncbi.nlm.nih.gov/pubmed/32661432
17730,32072396,On the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer,Arch Sex Behav. 2020 Jul;49(5):1575-1588. doi: 10.1007/s10508-019-01603-y. Epub 2020 Feb 18.,Walker LM,https://www.ncbi.nlm.nih.gov/pubmed/32072396
17731,32607819,Human microbiome and prostate cancer development: current insights into the prevention and treatment,Front Med. 2021 Feb;15(1):11-32. doi: 10.1007/s11684-019-0731-7. Epub 2020 Jun 30.,Ohadian Moghadam S,https://www.ncbi.nlm.nih.gov/pubmed/32607819
17732,33301698,Management of Advanced Prostate Cancer in Clinical Practice: Real-World Answers to Challenging Dilemmas,JCO Oncol Pract. 2020 Dec;16(12):783-789. doi: 10.1200/OP.20.00445.,Mar N,https://www.ncbi.nlm.nih.gov/pubmed/33301698
17733,32600879,Recent trends in prostate cancer in Spain,Actas Urol Esp (Engl Ed). 2020 Sep;44(7):483-488. doi: 10.1016/j.acuro.2020.05.003. Epub 2020 Jun 26.,Cayuela L,https://www.ncbi.nlm.nih.gov/pubmed/32600879
17734,32700624,Perceived susceptibility to developing cancer and screening for colorectal and prostate cancer: A longitudinal analysis of Alberta's Tomorrow Project,J Med Screen. 2021 Jun;28(2):148-157. doi: 10.1177/0969141320941900. Epub 2020 Jul 22.,Gilfoyle M,https://www.ncbi.nlm.nih.gov/pubmed/32700624
17735,33027558,Depression and prostate cancer risk: A Mendelian randomization study,Cancer Med. 2020 Dec;9(23):9160-9167. doi: 10.1002/cam4.3493. Epub 2020 Oct 7.,Chen X,https://www.ncbi.nlm.nih.gov/pubmed/33027558
17737,32323148,Urinary microRNAs expression in prostate cancer diagnosis: a systematic review,Clin Transl Oncol. 2020 Nov;22(11):2061-2073. doi: 10.1007/s12094-020-02349-z. Epub 2020 Apr 22.,Paiva RM,https://www.ncbi.nlm.nih.gov/pubmed/32323148
17738,32778768,Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis,Oncogene. 2020 Sep;39(37):5950-5963. doi: 10.1038/s41388-020-01413-w. Epub 2020 Aug 10.,Ko CJ,https://www.ncbi.nlm.nih.gov/pubmed/32778768
17739,32639616,Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer,Cell Biol Int. 2020 Oct;44(10):2094-2106. doi: 10.1002/cbin.11418. Epub 2020 Jul 20.,Xie M,https://www.ncbi.nlm.nih.gov/pubmed/32639616
17740,33364756,Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis,Int J Nanomedicine. 2020 Dec 15;15:10241-10256. doi: 10.2147/IJN.S283106. eCollection 2020.,Pang B,https://www.ncbi.nlm.nih.gov/pubmed/33364756
17742,32660704,Identification of genetic biomarkers in urine for early detection of prostate cancer,Curr Probl Cancer. 2021 Feb;45(1):100616. doi: 10.1016/j.currproblcancer.2020.100616. Epub 2020 Jul 4.,Kavalci E,https://www.ncbi.nlm.nih.gov/pubmed/32660704
17743,32779392,Clinical factors for predicting malignancy in patients with PSA < 10 ng/mL and PI-RADS 3 lesions,Asia Pac J Clin Oncol. 2021 Apr;17(2):e94-e99. doi: 10.1111/ajco.13347. Epub 2020 Aug 10.,Sonmez G,https://www.ncbi.nlm.nih.gov/pubmed/32779392
17744,32433177,Urinary Reflux Into the Prostate Gland and Seminal Vesicles: A Potential Pitfall in 18F-FDG and 68Ga-PSMA PET/CT,Clin Nucl Med. 2020 Jul;45(7):536-537. doi: 10.1097/RLU.0000000000003069.,Hekimsoy T,https://www.ncbi.nlm.nih.gov/pubmed/32433177
17745,32430927,Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer,Cell Biochem Funct. 2020 Dec;38(8):1006-1016. doi: 10.1002/cbf.3531. Epub 2020 May 19.,Xie Y,https://www.ncbi.nlm.nih.gov/pubmed/32430927
17747,33327545,Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions,Int J Mol Sci. 2020 Dec 14;21(24):9511. doi: 10.3390/ijms21249511.,Fontana F,https://www.ncbi.nlm.nih.gov/pubmed/33327545
17750,32949716,piR-001773 and piR-017184 promote prostate cancer progression by interacting with PCDH9,Cell Signal. 2020 Dec;76:109780. doi: 10.1016/j.cellsig.2020.109780. Epub 2020 Sep 17.,Zhang L,https://www.ncbi.nlm.nih.gov/pubmed/32949716
17751,33234230,Molecular pathology of prostate cancer: a practical approach,Pathology. 2021 Jan;53(1):36-43. doi: 10.1016/j.pathol.2020.10.003. Epub 2020 Nov 21.,Vlajnic T,https://www.ncbi.nlm.nih.gov/pubmed/33234230
17754,33460126,Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study,Int J Cancer. 2020 Nov 1;147(9):2469-2478. doi: 10.1002/ijc.33221. Epub 2020 Aug 12.,Sun X,https://www.ncbi.nlm.nih.gov/pubmed/33460126
17755,33331954,"miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study",Histochem Cell Biol. 2021 Mar;155(3):423-433. doi: 10.1007/s00418-020-01941-2. Epub 2020 Dec 17.,Pe?ka K,https://www.ncbi.nlm.nih.gov/pubmed/33331954
17756,32630092,Smilax glabra Roxb. Inhibits Collagen Induced Adhesion and Migration of PC3 and LNCaP Prostate Cancer Cells through the Inhibition of Beta 1 Integrin Expression,Molecules. 2020 Jun 30;25(13):3006. doi: 10.3390/molecules25133006.,Kwon OY,https://www.ncbi.nlm.nih.gov/pubmed/32630092
17758,32827200,Effect of the exercise programme on the quality of life of prostate cancer survivors: A randomized controlled trial,Int J Nurs Pract. 2021 Apr;27(2):e12883. doi: 10.1111/ijn.12883. Epub 2020 Aug 21.,Mardani A,https://www.ncbi.nlm.nih.gov/pubmed/32827200
17761,32439974,Diagnosing hereditary cancer predisposition in men with prostate cancer,Genet Med. 2020 Sep;22(9):1517-1523. doi: 10.1038/s41436-020-0830-5. Epub 2020 May 22.,Pritzlaff M,https://www.ncbi.nlm.nih.gov/pubmed/32439974
17762,32979229,Impact of (68) Gallium prostate-specific membrane antigen tracers on the management of patients with prostate cancer who experience biochemical recurrence,BJU Int. 2021 Feb;127(2):153-163. doi: 10.1111/bju.15257. Epub 2020 Oct 20.,Diao W,https://www.ncbi.nlm.nih.gov/pubmed/32979229
17763,32909077,"Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study",Cancer Immunol Immunother. 2021 Mar;70(3):701-712. doi: 10.1007/s00262-020-02718-1. Epub 2020 Sep 9.,Wang Q,https://www.ncbi.nlm.nih.gov/pubmed/32909077
17764,32960396,Barriers to Prostate Cancer Screening Among Indo-Guyanese,J Community Health. 2021 Jun;46(3):591-596. doi: 10.1007/s10900-020-00926-5. Epub 2020 Sep 22.,Persaud H,https://www.ncbi.nlm.nih.gov/pubmed/32960396
17765,33294057,GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity,Dis Markers. 2020 Nov 25;2020:8810756. doi: 10.1155/2020/8810756. eCollection 2020.,He S,https://www.ncbi.nlm.nih.gov/pubmed/33294057
17766,32761925,Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells,Prostate. 2020 Oct;80(14):1233-1243. doi: 10.1002/pros.24050. Epub 2020 Aug 6.,Naeem A,https://www.ncbi.nlm.nih.gov/pubmed/32761925
17768,32771969,Prostate cancer screening using chemometric processing of GC-MS profiles obtained in the headspace above urine samples,J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Oct 15;1155:122298. doi: 10.1016/j.jchromb.2020.122298. Epub 2020 Aug 1.,Deev V,https://www.ncbi.nlm.nih.gov/pubmed/32771969
17769,32857520,DNA Framework-Supported Electrochemical Analysis of DNA Methylation for Prostate Cancers,Nano Lett. 2020 Oct 14;20(10):7028-7035. doi: 10.1021/acs.nanolett.0c01898. Epub 2020 Sep 10.,Chen S,https://www.ncbi.nlm.nih.gov/pubmed/32857520
17770,33172003,Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study,Int J Mol Sci. 2020 Nov 6;21(21):8330. doi: 10.3390/ijms21218330.,Davey M,https://www.ncbi.nlm.nih.gov/pubmed/33172003
17771,32847702,The 2019 International Society of Urological Pathology Consensus Conference on Prostate Cancer Grading,Eur Urol. 2021 Jun;79(6):707-709. doi: 10.1016/j.eururo.2020.08.004. Epub 2020 Aug 23.,van Leenders GJLH,https://www.ncbi.nlm.nih.gov/pubmed/32847702
17772,32645410,PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling,Mol Cell Probes. 2020 Oct;53:101642. doi: 10.1016/j.mcp.2020.101642. Epub 2020 Jul 7.,Wang R,https://www.ncbi.nlm.nih.gov/pubmed/32645410
17773,33109563,Association of MDM2 T309G (rs2279744) Polymorphism and Expression Changes With Risk of Prostate Cancer in the Slovak Population,Anticancer Res. 2020 Nov;40(11):6257-6264. doi: 10.21873/anticanres.14646.,Sivonova MK,https://www.ncbi.nlm.nih.gov/pubmed/33109563
17774,33045100,Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer,Int J Cancer. 2021 Feb 1;148(3):748-758. doi: 10.1002/ijc.33344. Epub 2020 Oct 24.,Möller K,https://www.ncbi.nlm.nih.gov/pubmed/33045100
17775,32717855,Role of Mitochondrial Glycerol-3-Phosphate Dehydrogenase in Metabolic Adaptations of Prostate Cancer,Cells. 2020 Jul 23;9(8):1764. doi: 10.3390/cells9081764.,Pecinová A,https://www.ncbi.nlm.nih.gov/pubmed/32717855
17777,32800474,Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage Migration,Clin Genitourin Cancer. 2021 Feb;19(1):e12-e16. doi: 10.1016/j.clgc.2020.06.006. Epub 2020 Jul 11.,Sheng IY,https://www.ncbi.nlm.nih.gov/pubmed/32800474
17778,32358065,Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice,J Biol Chem. 2020 Jun 12;295(24):8252-8261. doi: 10.1074/jbc.RA120.013694. Epub 2020 May 1.,Traughber CA,https://www.ncbi.nlm.nih.gov/pubmed/32358065
17779,32646965,The ERG-Regulated LINC00920 Promotes Prostate Cancer Cell Survival via the 14-3-3?-FOXO Pathway,Mol Cancer Res. 2020 Oct;18(10):1545-1559. doi: 10.1158/1541-7786.MCR-20-0021. Epub 2020 Jul 9.,Angeles AK,https://www.ncbi.nlm.nih.gov/pubmed/32646965
17782,32867229,Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer,Cells. 2020 Aug 27;9(9):1976. doi: 10.3390/cells9091976.,Singh SK,https://www.ncbi.nlm.nih.gov/pubmed/32867229
17783,32772147,Reduced cytoplasmic expression of MAGE-A2 predicts tumor aggressiveness and survival: an immunohistochemical analysis,World J Urol. 2021 Jun;39(6):1831-1843. doi: 10.1007/s00345-020-03395-6. Epub 2020 Aug 9.,Khalvandi A,https://www.ncbi.nlm.nih.gov/pubmed/32772147
17784,32986714,Multi-ethnic transcriptome-wide association study of prostate cancer,PLoS One. 2020 Sep 28;15(9):e0236209. doi: 10.1371/journal.pone.0236209. eCollection 2020.,Fiorica PN,https://www.ncbi.nlm.nih.gov/pubmed/32986714
17785,32876733,Physical activity assessment among men undergoing genetic counseling for inherited prostate cancer: a teachable moment for improved survivorship,Support Care Cancer. 2021 Apr;29(4):2145-2151. doi: 10.1007/s00520-020-05667-8. Epub 2020 Sep 2.,Bruneau M Jr,https://www.ncbi.nlm.nih.gov/pubmed/32876733
17786,32562455,AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer,Cancer Med. 2020 Aug;9(15):5672-5677. doi: 10.1002/cam4.3086. Epub 2020 Jun 20.,Zhou J,https://www.ncbi.nlm.nih.gov/pubmed/32562455
17787,32439935,Racial differences in prostate cancer: does timing of puberty play a role?,Br J Cancer. 2020 Aug;123(3):349-354. doi: 10.1038/s41416-020-0897-4. Epub 2020 May 22.,Hur J,https://www.ncbi.nlm.nih.gov/pubmed/32439935
17789,33327345,Medication utilization evaluation of androgen deprivation therapy for prostate cancer in Taiwan,Medicine (Baltimore). 2020 Dec 11;99(50):e23644. doi: 10.1097/MD.0000000000023644.,Liao KM,https://www.ncbi.nlm.nih.gov/pubmed/33327345
17790,32867540,Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatment,Epigenomics. 2020 Aug;12(15):1317-1332. doi: 10.2217/epi-2020-0173. Epub 2020 Sep 1.,Peter MR,https://www.ncbi.nlm.nih.gov/pubmed/32867540
17793,32576626,The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development,Clin Cancer Res. 2020 Sep 15;26(18):4933-4946. doi: 10.1158/1078-0432.CCR-20-0479. Epub 2020 Jun 23.,Palanisamy N,https://www.ncbi.nlm.nih.gov/pubmed/32576626
17795,32969349,GC-MS-based untargeted metabolomics of plasma and urine to evaluate metabolic changes in prostate cancer,J Breath Res. 2020 Sep 24;14(4):047103. doi: 10.1088/1752-7163/abaeca.,Struck-Lewicka W,https://www.ncbi.nlm.nih.gov/pubmed/32969349
17796,32863055,Precision Oncology for Metastatic Prostate Cancer: Translation into Practice,Eur Urol. 2020 Dec;78(6):771-774. doi: 10.1016/j.eururo.2020.08.021. Epub 2020 Aug 27.,De Santis M,https://www.ncbi.nlm.nih.gov/pubmed/32863055
17797,32801354,Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):24-34. doi: 10.1038/s41391-020-00268-2. Epub 2020 Aug 14.,Sun D,https://www.ncbi.nlm.nih.gov/pubmed/32801354
17798,32208880,Chimeric cytokine receptor enhancing PSMA-CAR-T cell-mediated prostate cancer regression,Cancer Biol Ther. 2020 Jun 2;21(6):570-580. doi: 10.1080/15384047.2020.1739952. Epub 2020 Mar 25.,Weimin S,https://www.ncbi.nlm.nih.gov/pubmed/32208880
17799,33293340,Aspirin Use and Prostate Cancer among African-American Men in the Southern Community Cohort Study,Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):539-544. doi: 10.1158/1055-9965.EPI-19-0792. Epub 2020 Dec 8.,Tang W,https://www.ncbi.nlm.nih.gov/pubmed/33293340
17800,32671604,Novel PET imaging methods for prostate cancer,World J Urol. 2021 Mar;39(3):687-699. doi: 10.1007/s00345-020-03344-3. Epub 2020 Jul 15.,Mena E,https://www.ncbi.nlm.nih.gov/pubmed/32671604
17801,33232539,Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis,Cancer Sci. 2021 Feb;112(2):859-870. doi: 10.1111/cas.14745. Epub 2020 Dec 11.,Cho H,https://www.ncbi.nlm.nih.gov/pubmed/33232539
17802,32552908,Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions,BMC Res Notes. 2020 Jun 17;13(1):295. doi: 10.1186/s13104-020-05138-7.,Ahmed ES,https://www.ncbi.nlm.nih.gov/pubmed/32552908
17803,32896761,Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis,Neoplasia. 2020 Oct;22(10):511-521. doi: 10.1016/j.neo.2020.08.004. Epub 2020 Sep 5.,Frieling JS,https://www.ncbi.nlm.nih.gov/pubmed/32896761
17804,32115854,The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer,BJU Int. 2020 Jul;126(1):191-201. doi: 10.1111/bju.15041. Epub 2020 Mar 29.,Dong L,https://www.ncbi.nlm.nih.gov/pubmed/32115854
17805,32750503,Xenograft-derived mRNA/miR and protein interaction networks of systemic dissemination in human prostate cancer,Eur J Cancer. 2020 Sep;137:93-107. doi: 10.1016/j.ejca.2020.06.025. Epub 2020 Aug 1.,Lange T,https://www.ncbi.nlm.nih.gov/pubmed/32750503
17806,33244038,Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening,Sci Rep. 2020 Nov 26;10(1):20665. doi: 10.1038/s41598-020-77668-w.,Jen HH,https://www.ncbi.nlm.nih.gov/pubmed/33244038
17807,33277863,"Anticancer effects of ovatodiolide on human prostate cancer cells involves cell cycle arrest, apoptosis and blocking of Ras/Raf/MEK/ERK signaling pathway",J BUON. 2020 Sep-Oct;25(5):2412-2417.,Jia D,https://www.ncbi.nlm.nih.gov/pubmed/33277863
17809,33077484,Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer,Mol Cancer Res. 2021 Jan;19(1):124-135. doi: 10.1158/1541-7786.MCR-20-0379. Epub 2020 Oct 19.,Ma Y,https://www.ncbi.nlm.nih.gov/pubmed/33077484
17810,33058520,NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer,FEBS Open Bio. 2020 Dec;10(12):2678-2686. doi: 10.1002/2211-5463.13004. Epub 2020 Nov 8.,Tang L,https://www.ncbi.nlm.nih.gov/pubmed/33058520
17811,32784653,"MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer",Int J Mol Sci. 2020 Aug 7;21(16):5667. doi: 10.3390/ijms21165667.,Ciszkowicz E,https://www.ncbi.nlm.nih.gov/pubmed/32784653
17812,32147352,Results of the spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Update after 21 years of follow-up,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):430-436. doi: 10.1016/j.acuro.2020.01.005. Epub 2020 Mar 5.,Luján Galán M,https://www.ncbi.nlm.nih.gov/pubmed/32147352
17813,32106357,GP experience and understandings of providing follow-up care in prostate cancer survivors in England,Health Soc Care Community. 2020 Sep;28(5):1468-1478. doi: 10.1111/hsc.12969. Epub 2020 Feb 27.,Margariti C,https://www.ncbi.nlm.nih.gov/pubmed/32106357
17814,33352313,Photodynamic therapy for prostate cancer - A narrative review,Photodiagnosis Photodyn Ther. 2021 Mar;33:102158. doi: 10.1016/j.pdpdt.2020.102158. Epub 2020 Dec 19.,Osuchowski M,https://www.ncbi.nlm.nih.gov/pubmed/33352313
17815,32044796,Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61,Anticancer Drugs. 2020 Jul;31(6):609-616. doi: 10.1097/CAD.0000000000000910.,Sahin TK,https://www.ncbi.nlm.nih.gov/pubmed/32044796
17817,33370684,A preliminary study procedure for detection of polyamines in plasma samples as a potential diagnostic tool in prostate cancer,J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jan 1;1162:122468. doi: 10.1016/j.jchromb.2020.122468. Epub 2020 Nov 30.,Coradduzza D,https://www.ncbi.nlm.nih.gov/pubmed/33370684
17818,32683729,Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading,Histopathology. 2020 Dec;77(6):850-861. doi: 10.1111/his.14214. Epub 2020 Sep 13.,van Leenders GJLH,https://www.ncbi.nlm.nih.gov/pubmed/32683729
17819,32703715,Experiences of Unmet Need and Access to Supportive Care for Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Bi-national Study,Semin Oncol Nurs. 2020 Aug;36(4):151049. doi: 10.1016/j.soncn.2020.151049. Epub 2020 Jul 21.,Paterson C,https://www.ncbi.nlm.nih.gov/pubmed/32703715
17820,33132158,SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth,Biochimie. 2021 Jan;180:1-9. doi: 10.1016/j.biochi.2020.10.012. Epub 2020 Oct 24.,Edwards G,https://www.ncbi.nlm.nih.gov/pubmed/33132158
17822,32140766,Round table: arguments against using multiparametric prostate MRI protocols,Abdom Radiol (NY). 2020 Dec;45(12):3997-4002. doi: 10.1007/s00261-020-02456-z.,Ward R,https://www.ncbi.nlm.nih.gov/pubmed/32140766
17823,33158741,Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer,Urol Oncol. 2021 Apr;39(4):233.e9-233.e14. doi: 10.1016/j.urolonc.2020.10.014. Epub 2020 Nov 4.,Borno HT,https://www.ncbi.nlm.nih.gov/pubmed/33158741
17825,33099475,The Association Between the Genetic VDR SNP c.907+75C>T and Prostate Cancer Risk Is Modified by Tanning Potential,Cancer Genomics Proteomics. 2020 Nov-Dec;17(6):739-745. doi: 10.21873/cgp.20228.,Beyene DA,https://www.ncbi.nlm.nih.gov/pubmed/33099475
17826,33382151,Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions,J Magn Reson Imaging. 2022 Mar;55(3):653-680. doi: 10.1002/jmri.27485. Epub 2020 Dec 31.,Van Nieuwenhove S,https://www.ncbi.nlm.nih.gov/pubmed/33382151
17829,32997661,Differential anti-proliferative and apoptotic effects of lichen species on human prostate carcinoma cells,PLoS One. 2020 Sep 30;15(9):e0238303. doi: 10.1371/journal.pone.0238303. eCollection 2020.,Goncu B,https://www.ncbi.nlm.nih.gov/pubmed/32997661
17830,32727149,Drug Repositioning of the ?(1)-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?,Int J Mol Sci. 2020 Jul 27;21(15):5339. doi: 10.3390/ijms21155339.,Florent R,https://www.ncbi.nlm.nih.gov/pubmed/32727149
17832,32943543,Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin,Mol Cancer Ther. 2020 Nov;19(11):2278-2287. doi: 10.1158/1535-7163.MCT-19-1141. Epub 2020 Sep 17.,Yang B,https://www.ncbi.nlm.nih.gov/pubmed/32943543
17833,33043786,Exploring a role for fatty acid synthase in prostate cancer cell migration,Small GTPases. 2021 Jul;12(4):265-272. doi: 10.1080/21541248.2020.1826781. Epub 2020 Oct 12.,De Piano M,https://www.ncbi.nlm.nih.gov/pubmed/33043786
17834,32459381,"CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action",J Cell Mol Med. 2020 Jul;24(13):7239-7253. doi: 10.1111/jcmm.15281. Epub 2020 May 27.,Hu C,https://www.ncbi.nlm.nih.gov/pubmed/32459381
17836,33029258,eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer,Dis Markers. 2020 Sep 22;2020:8847986. doi: 10.1155/2020/8847986. eCollection 2020.,Zhang X,https://www.ncbi.nlm.nih.gov/pubmed/33029258
17837,33274768,Revisiting prostate cancer metabolism: From metabolites to disease and therapy,Med Res Rev. 2021 May;41(3):1499-1538. doi: 10.1002/med.21766. Epub 2020 Dec 4.,Cardoso HJ,https://www.ncbi.nlm.nih.gov/pubmed/33274768
17838,32558033,The miR-1908/SRM regulatory axis contributes to extracellular vesicle secretion in prostate cancer,Cancer Sci. 2020 Sep;111(9):3258-3267. doi: 10.1111/cas.14535. Epub 2020 Jul 18.,Urabe F,https://www.ncbi.nlm.nih.gov/pubmed/32558033
17839,32669400,Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition,Mol Cancer Res. 2020 Oct;18(10):1500-1511. doi: 10.1158/1541-7786.MCR-20-0570. Epub 2020 Jul 15.,Nassar ZD,https://www.ncbi.nlm.nih.gov/pubmed/32669400
17840,33148078,Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy,Immunotherapy. 2021 Feb;13(2):155-175. doi: 10.2217/imt-2020-0066. Epub 2020 Nov 5.,Brennen WN,https://www.ncbi.nlm.nih.gov/pubmed/33148078
17841,32776450,"Case of the month from the Netherlands Cancer Institute, Amsterdam: how to differentiate between benign and malignant prostatic cysts",BJU Int. 2020 Aug;126(2):240-244. doi: 10.1111/bju.15156.,Veerman H,https://www.ncbi.nlm.nih.gov/pubmed/32776450
17842,32888321,Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation,Cancer. 2020 Dec 1;126(23):5114-5123. doi: 10.1002/cncr.33179. Epub 2020 Sep 5.,Kim IE Jr,https://www.ncbi.nlm.nih.gov/pubmed/32888321
17844,32583304,The expression and functional analysis of the sialyl-T antigen in prostate cancer,Glycoconj J. 2020 Aug;37(4):423-433. doi: 10.1007/s10719-020-09927-x. Epub 2020 Jun 24.,Bai R,https://www.ncbi.nlm.nih.gov/pubmed/32583304
17846,32848387,Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer,Int J Nanomedicine. 2020 Aug 5;15:5545-5559. doi: 10.2147/IJN.S257522. eCollection 2020.,Dong W,https://www.ncbi.nlm.nih.gov/pubmed/32848387
17847,33068330,Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk,Cancer Med. 2020 Dec;9(24):9462-9470. doi: 10.1002/cam4.3538. Epub 2020 Oct 17.,Cao D,https://www.ncbi.nlm.nih.gov/pubmed/33068330
17850,30888981,What Are the Experiences of Men Affected by Prostate Cancer Participating in an Ecological Momentary Assessment Study?,Cancer Nurs. 2020 Jul/Aug;43(4):300-310. doi: 10.1097/NCC.0000000000000699.,Paterson C,https://www.ncbi.nlm.nih.gov/pubmed/30888981
17851,33396969,Title Changes in the Mineral Composition of Rat Femoral Bones Induced by Implantation of LNCaP Prostate Cancer Cells and Dietary Supplementation,Nutrients. 2020 Dec 30;13(1):100. doi: 10.3390/nu13010100.,Skrajnowska D,https://www.ncbi.nlm.nih.gov/pubmed/33396969
17852,33380539,Hypokalaemia and peripheral oedema in a Cushingoid patient with metastatic prostate cancer,Neth J Med. 2020 Dec;78(6):401-403.,Schepers LM,https://www.ncbi.nlm.nih.gov/pubmed/33380539
17855,33187966,Conditional Relative Survival and Competing Mortality of Patients with Prostate Cancer in Korea: A Nationwide Cohort Study,Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):326-334. doi: 10.1158/1055-9965.EPI-20-1084. Epub 2020 Nov 13.,Park J,https://www.ncbi.nlm.nih.gov/pubmed/33187966
17856,31745645,Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer,World J Urol. 2020 Sep;38(9):2185-2196. doi: 10.1007/s00345-019-03017-w. Epub 2019 Nov 19.,Kind S,https://www.ncbi.nlm.nih.gov/pubmed/31745645
17857,32764784,Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype,PLoS One. 2020 Aug 7;15(8):e0237222. doi: 10.1371/journal.pone.0237222. eCollection 2020.,Bou-Dargham MJ,https://www.ncbi.nlm.nih.gov/pubmed/32764784
17859,32712753,Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres,J Cancer Res Clin Oncol. 2020 Nov;146(11):2817-2828. doi: 10.1007/s00432-020-03330-7. Epub 2020 Jul 25.,Oh HC,https://www.ncbi.nlm.nih.gov/pubmed/32712753
17861,33347638,O-glycosylated clusterin as a sensitive marker for diagnosing early stages of prostate cancer,Prostate. 2021 Feb;81(3):170-181. doi: 10.1002/pros.24094. Epub 2020 Dec 21.,Kazuno S,https://www.ncbi.nlm.nih.gov/pubmed/33347638
17862,32468018,"TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells",Oncol Rep. 2020 Aug;44(2):747-756. doi: 10.3892/or.2020.7616. Epub 2020 May 19.,Lin M,https://www.ncbi.nlm.nih.gov/pubmed/32468018
17863,32712138,Pseudouridine as a novel biomarker in prostate cancer,Urol Oncol. 2021 Jan;39(1):63-71. doi: 10.1016/j.urolonc.2020.06.026. Epub 2020 Jul 22.,Stockert JA,https://www.ncbi.nlm.nih.gov/pubmed/32712138
17864,32470500,LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation,Mol Cell Probes. 2020 Oct;53:101607. doi: 10.1016/j.mcp.2020.101607. Epub 2020 May 26.,Hu J,https://www.ncbi.nlm.nih.gov/pubmed/32470500
17865,32377739,p53/PGC?1??mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis,Mol Med Rep. 2020 Jul;22(1):155-164. doi: 10.3892/mmr.2020.11121. Epub 2020 May 5.,Li J,https://www.ncbi.nlm.nih.gov/pubmed/32377739
17867,32878613,Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study,BMC Urol. 2020 Sep 2;20(1):139. doi: 10.1186/s12894-020-00689-0.,Uemura H,https://www.ncbi.nlm.nih.gov/pubmed/32878613
17868,33390485,Intracerebral Hemorrhaging Due to Coagulopathy Caused by Latent Advanced Prostate Cancer,Intern Med. 2021 Jun 1;60(11):1763-1767. doi: 10.2169/internalmedicine.5838-20. Epub 2020 Dec 29.,Johno T,https://www.ncbi.nlm.nih.gov/pubmed/33390485
17869,33099950,"MiR-505 inhibits prostate cancer cell invasion, metastasis and epithelial-to-mesenchymal transition through targeting HMGB-1",J BUON. 2020 Jul-Aug;25(4):2036-2044.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/33099950
17870,32831024,Prostate specific antigen test uptake: a cross sectional study on elderly men in Western Iran,BMC Geriatr. 2020 Aug 24;20(1):298. doi: 10.1186/s12877-020-01710-9.,Mirzaei-Alavijeh M,https://www.ncbi.nlm.nih.gov/pubmed/32831024
17871,33217316,Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers,Mol Cell. 2020 Nov 19;80(4):562-577. doi: 10.1016/j.molcel.2020.10.033.,Rubin MA,https://www.ncbi.nlm.nih.gov/pubmed/33217316
17872,32822079,Sensitive identification of prostate-specific antigen by iron oxide nanoparticle antibody conjugates on the gap-finger electrode surface,Biotechnol Appl Biochem. 2021 Aug;68(4):896-901. doi: 10.1002/bab.2012. Epub 2020 Sep 13.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/32822079
17873,31350101,PI-RADS Version 2 Is an Excellent Screening Tool for Clinically Significant Prostate Cancer as Designated by the Validated International Society of Urological Pathology Criteria: A Retrospective Analysis,Curr Probl Diagn Radiol. 2020 Nov-Dec;49(6):407-411. doi: 10.1067/j.cpradiol.2019.06.010. Epub 2019 Jun 29.,Daun M,https://www.ncbi.nlm.nih.gov/pubmed/31350101
17874,32475689,Initial experience with SelectMDx(R) in the diagnosis of prostate cancer in a real-world evidence clinical practice setting,Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):400-407. doi: 10.1016/j.acuro.2020.03.005. Epub 2020 May 29.,Quintana LM,https://www.ncbi.nlm.nih.gov/pubmed/32475689
17875,32003504,Stromal-epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells,J Cell Biochem. 2020 Nov;121(11):4406-4418. doi: 10.1002/jcb.29664. Epub 2020 Jan 31.,Fu S,https://www.ncbi.nlm.nih.gov/pubmed/32003504
17877,33141952,TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer,Prostate. 2021 Feb;81(2):109-117. doi: 10.1002/pros.24086. Epub 2020 Nov 3.,Yamoah K,https://www.ncbi.nlm.nih.gov/pubmed/33141952
17878,32694158,Clinical Evaluation of (4S)-4-(3-[(18)F]Fluoropropyl)-L-glutamate ((18)F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer,Clin Cancer Res. 2020 Oct 15;26(20):5380-5387. doi: 10.1158/1078-0432.CCR-20-0644. Epub 2020 Jul 21.,Park SY,https://www.ncbi.nlm.nih.gov/pubmed/32694158
17879,32743846,Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1,Mol Carcinog. 2020 Oct;59(10):1105-1115. doi: 10.1002/mc.23240. Epub 2020 Aug 3.,Hahm ER,https://www.ncbi.nlm.nih.gov/pubmed/32743846
17882,32222783,Education of prostate MR imaging: commentary,Abdom Radiol (NY). 2020 Dec;45(12):4112-4113. doi: 10.1007/s00261-020-02497-4.,Merritt BA,https://www.ncbi.nlm.nih.gov/pubmed/32222783
17883,33215275,Proteasome inhibitors attenuates mitoxantrone-triggered immunogenic cell death in prostate cancer cells,Med Oncol. 2020 Nov 19;37(12):116. doi: 10.1007/s12032-020-01445-y.,Wei W,https://www.ncbi.nlm.nih.gov/pubmed/33215275
17886,32660148,Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents,Int J Mol Sci. 2020 Jul 9;21(14):4868. doi: 10.3390/ijms21144868.,Wróbel TM,https://www.ncbi.nlm.nih.gov/pubmed/32660148
17887,32800947,Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2,Biochim Biophys Acta Mol Basis Dis. 2020 Dec 1;1866(12):165919. doi: 10.1016/j.bbadis.2020.165919. Epub 2020 Aug 12.,Borel M,https://www.ncbi.nlm.nih.gov/pubmed/32800947
17889,33127624,Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network,J Nucl Med. 2021 Jun 1;62(6):823-828. doi: 10.2967/jnumed.120.254623. Epub 2020 Oct 30.,Kostyszyn D,https://www.ncbi.nlm.nih.gov/pubmed/33127624
17890,33277366,KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer,Cancer Res. 2021 Feb 15;81(4):1026-1039. doi: 10.1158/0008-5472.CAN-20-1965. Epub 2020 Dec 4.,Gao L,https://www.ncbi.nlm.nih.gov/pubmed/33277366
17891,32433780,Does screening for prostate cancer improve cancer-specific mortality in Asian men? Real-world data in Yokosuka City 15 years after introducing PSA-based population screening,Prostate. 2020 Aug;80(11):824-830. doi: 10.1002/pros.23997. Epub 2020 May 20.,Tabei T,https://www.ncbi.nlm.nih.gov/pubmed/32433780
17893,32926991,Application of hierarchical clustering to multi-parametric MR in prostate: Differentiation of tumor and normal tissue with high accuracy,Magn Reson Imaging. 2020 Dec;74:90-95. doi: 10.1016/j.mri.2020.09.011. Epub 2020 Sep 12.,Akamine Y,https://www.ncbi.nlm.nih.gov/pubmed/32926991
17895,32911598,Ranking Series of Cancer-Related Gene Expression Data by Means of the Superposing Significant Interaction Rules Method,Biomolecules. 2020 Sep 8;10(9):1293. doi: 10.3390/biom10091293.,Besalú E,https://www.ncbi.nlm.nih.gov/pubmed/32911598
17897,33174391,HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer,J Cell Mol Med. 2020 Dec;24(24):14539-14548. doi: 10.1111/jcmm.16081. Epub 2020 Nov 10.,Lu W,https://www.ncbi.nlm.nih.gov/pubmed/33174391
17898,32624158,Advances in Prostate Magnetic Resonance Imaging,Magn Reson Imaging Clin N Am. 2020 Aug;28(3):407-414. doi: 10.1016/j.mric.2020.03.006. Epub 2020 Jun 4.,Walker SM,https://www.ncbi.nlm.nih.gov/pubmed/32624158
17899,32967291,Radiomics for Gleason Score Detection through Deep Learning,Sensors (Basel). 2020 Sep 21;20(18):5411. doi: 10.3390/s20185411.,Brunese L,https://www.ncbi.nlm.nih.gov/pubmed/32967291
17900,32940754,Upcoming American College of Radiology prostate MRI designation launching: what to expect,Abdom Radiol (NY). 2020 Dec;45(12):4109-4111. doi: 10.1007/s00261-020-02725-x. Epub 2020 Sep 17.,Tan N,https://www.ncbi.nlm.nih.gov/pubmed/32940754
17902,33277394,Matched-Pair Comparison of (68)Ga-PSMA-11 and (18)F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity,J Nucl Med. 2021 Aug 1;62(8):1082-1088. doi: 10.2967/jnumed.120.251447. Epub 2020 Dec 4.,Kroenke M,https://www.ncbi.nlm.nih.gov/pubmed/33277394
17903,32804046,"Prostate cancer screening in Black men: Screening intention, knowledge, attitudes, and reasons for participation",Soc Work Health Care. 2020 Sep;59(8):543-556. doi: 10.1080/00981389.2020.1808149. Epub 2020 Aug 17.,Miller DB,https://www.ncbi.nlm.nih.gov/pubmed/32804046
17904,32910385,Evaluation of Artificial Tactile Sense in Mass Detection in Silicone Phantom for the Diagnosis of Prostate Tumor,Bull Exp Biol Med. 2020 Aug;169(4):497-503. doi: 10.1007/s10517-020-04917-3. Epub 2020 Sep 10.,Zein S,https://www.ncbi.nlm.nih.gov/pubmed/32910385
17905,32978524,"Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies",Prostate Cancer Prostatic Dis. 2021 Jun;24(2):281-289. doi: 10.1038/s41391-020-00286-0. Epub 2020 Sep 25.,Brunckhorst O,https://www.ncbi.nlm.nih.gov/pubmed/32978524
17906,32322996,Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group,World J Urol. 2020 Oct;38(10):2411-2431. doi: 10.1007/s00345-020-03197-w. Epub 2020 Apr 22.,Jamnadass E,https://www.ncbi.nlm.nih.gov/pubmed/32322996
17907,32393663,A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa,Cancer Res. 2020 Jul 1;80(13):2956-2966. doi: 10.1158/0008-5472.CAN-19-2165. Epub 2020 May 11.,Harlemon M,https://www.ncbi.nlm.nih.gov/pubmed/32393663
17908,32170336,Arguments against using an abbreviated or biparametric prostate MRI protocol,Abdom Radiol (NY). 2020 Dec;45(12):3982-3989. doi: 10.1007/s00261-020-02474-x.,Franco FB,https://www.ncbi.nlm.nih.gov/pubmed/32170336
17909,33090391,"SNHG1 promotes proliferation, invasion and EMT of prostate cancer cells through miR-195-5p",Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):9880-9888. doi: 10.26355/eurrev_202010_23198.,Meng XF,https://www.ncbi.nlm.nih.gov/pubmed/33090391
17910,32872503,"Night Shift Work, Chronotype, Sleep Duration, and Prostate Cancer Risk: CAPLIFE Study",Int J Environ Res Public Health. 2020 Aug 29;17(17):6300. doi: 10.3390/ijerph17176300.,Lozano-Lorca M,https://www.ncbi.nlm.nih.gov/pubmed/32872503
17911,32662543,Pyruvate-lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1-(13) C]pyruvate MRS and [(18) F]FDG-PET,NMR Biomed. 2020 Oct;33(10):e4362. doi: 10.1002/nbm.4362. Epub 2020 Jul 14.,van Heijster FHA,https://www.ncbi.nlm.nih.gov/pubmed/32662543
17912,32681068,MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity,Oncogene. 2020 Aug;39(34):5663-5674. doi: 10.1038/s41388-020-01389-7. Epub 2020 Jul 17.,Whitlock NC,https://www.ncbi.nlm.nih.gov/pubmed/32681068
17913,33446324,Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets,Urol Clin North Am. 2020 Nov;47(4S):e9-e16. doi: 10.1016/j.ucl.2020.10.004. Epub 2020 Dec 9.,Reva BA,https://www.ncbi.nlm.nih.gov/pubmed/33446324
17914,33268134,Prostate MRI: practical guidelines for interpreting and reporting according to PI-RADS version 2.1,Radiologia (Engl Ed). 2020 Nov-Dec;62(6):437-451. doi: 10.1016/j.rx.2020.09.001. Epub 2020 Oct 22.,Sánchez-Oro R,https://www.ncbi.nlm.nih.gov/pubmed/33268134
17915,33446323,The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer,Urol Clin North Am. 2020 Nov;47(4S):e17-e54. doi: 10.1016/j.ucl.2020.10.005.,Nair SS,https://www.ncbi.nlm.nih.gov/pubmed/33446323
17917,33189947,A comparative PET imaging study of (44g)Sc- and (68)Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models,Nucl Med Biol. 2020 Nov-Dec;90-91:74-83. doi: 10.1016/j.nucmedbio.2020.10.005. Epub 2020 Oct 29.,Ferguson S,https://www.ncbi.nlm.nih.gov/pubmed/33189947
17918,32895469,A simple quantitative PCR assay to determine TRAMP transgene zygosity,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):358-361. doi: 10.1038/s41391-020-00282-4. Epub 2020 Sep 7.,Chen R,https://www.ncbi.nlm.nih.gov/pubmed/32895469
17919,32385899,Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer,Mol Oncol. 2020 Aug;14(8):1881-1897. doi: 10.1002/1878-0261.12706. Epub 2020 May 31.,Mazzu YZ,https://www.ncbi.nlm.nih.gov/pubmed/32385899
17920,29696999,Sexual well-being and diurnal cortisol after prostate cancer treatment,J Health Psychol. 2020 Sep;25(10-11):1796-1801. doi: 10.1177/1359105318772655. Epub 2018 Apr 26.,Hoyt MA,https://www.ncbi.nlm.nih.gov/pubmed/29696999
17921,32407712,"Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer",Arch Biochem Biophys. 2020 Jul 30;688:108407. doi: 10.1016/j.abb.2020.108407. Epub 2020 May 12.,Park S,https://www.ncbi.nlm.nih.gov/pubmed/32407712
17922,33245100,Regulation of circGOLPH3 and its binding protein CBX7 on the proliferation and apoptosis of prostate cancer cells,Biosci Rep. 2020 Dec 23;40(12):BSR20200936. doi: 10.1042/BSR20200936.,Gong L,https://www.ncbi.nlm.nih.gov/pubmed/33245100
17923,33176972,Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors,Eur Urol. 2021 Feb;79(2):200-211. doi: 10.1016/j.eururo.2020.10.029. Epub 2020 Nov 8.,Neeb A,https://www.ncbi.nlm.nih.gov/pubmed/33176972
17924,33328331,Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1,Sci Transl Med. 2020 Dec 16;12(574):eabb5647. doi: 10.1126/scitranslmed.abb5647.,Dong B,https://www.ncbi.nlm.nih.gov/pubmed/33328331
17926,32894540,Leptin promotes proliferation and inhibits apoptosis of prostate cancer cells by regulating ERK1/2 signaling pathway,Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8341-8348. doi: 10.26355/eurrev_202008_22630.,Xu CJ,https://www.ncbi.nlm.nih.gov/pubmed/32894540
17927,32000565,Occupation as a predictor of prostate cancer screening behaviour in Canada,J Med Screen. 2020 Dec;27(4):215-222. doi: 10.1177/0969141320902485. Epub 2020 Jan 30.,Peters CE,https://www.ncbi.nlm.nih.gov/pubmed/32000565
17928,32327298,Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants,Clin Breast Cancer. 2020 Aug;20(4):300-306. doi: 10.1016/j.clbc.2020.03.005. Epub 2020 Mar 20.,Abdel-Rahman O,https://www.ncbi.nlm.nih.gov/pubmed/32327298
17929,32912081,Sexual health needs and psychosocial well-being of patients with prostate cancer in a regional cancer Center,Soc Work Health Care. 2020 Sep;59(8):557-574. doi: 10.1080/00981389.2020.1818668. Epub 2020 Sep 10.,Preyde M,https://www.ncbi.nlm.nih.gov/pubmed/32912081
17930,33039058,Dracocephalum palmatum Stephan extract induces apoptosis in human prostate cancer cells via the caspase-8-mediated extrinsic pathway,Chin J Nat Med. 2020 Oct;18(10):793-800. doi: 10.1016/S1875-5364(20)60019-X.,Lee SE,https://www.ncbi.nlm.nih.gov/pubmed/33039058
17931,33138677,LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis,Cancer Biol Ther. 2020 Nov 1;21(11):1072-1080. doi: 10.1080/15384047.2020.1829266. Epub 2020 Nov 3.,Leng W,https://www.ncbi.nlm.nih.gov/pubmed/33138677
17932,32232525,How should radiologists incorporate non-imaging prostate cancer biomarkers into daily practice?,Abdom Radiol (NY). 2020 Dec;45(12):4031-4039. doi: 10.1007/s00261-020-02496-5.,Rajwa P,https://www.ncbi.nlm.nih.gov/pubmed/32232525
17933,33123958,Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions,J Gen Intern Med. 2021 Feb;36(2):447-454. doi: 10.1007/s11606-020-06318-8. Epub 2020 Oct 29.,Radhakrishnan A,https://www.ncbi.nlm.nih.gov/pubmed/33123958
17934,33241737,The Use of Healthcare Services by Prostate Cancer Patients in the Last 12 Months of Life: How Do We Improve the Quality of Care During This Period?,J Palliat Care. 2021 Apr;36(2):93-97. doi: 10.1177/0825859720975944. Epub 2020 Nov 26.,Tien T,https://www.ncbi.nlm.nih.gov/pubmed/33241737
17935,31720802,"Change patterns and determinants of physical activity differ between breast, prostate, and colorectal cancer patients",Support Care Cancer. 2020 Jul;28(7):3207-3218. doi: 10.1007/s00520-019-05097-1. Epub 2019 Nov 13.,Steindorf K,https://www.ncbi.nlm.nih.gov/pubmed/31720802
17936,32933107,Integrated Analysis to Study the Relationship between Tumor-Associated Selenoproteins: Focus on Prostate Cancer,Int J Mol Sci. 2020 Sep 13;21(18):6694. doi: 10.3390/ijms21186694.,Capone F,https://www.ncbi.nlm.nih.gov/pubmed/32933107
17937,32678075,WFDC2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation,Cell Death Dis. 2020 Jul 16;11(7):537. doi: 10.1038/s41419-020-02752-y.,Xiong Y,https://www.ncbi.nlm.nih.gov/pubmed/32678075
17938,32904557,The Significance of Circular RNA DDX17 in Prostate Cancer,Biomed Res Int. 2020 Aug 20;2020:1878431. doi: 10.1155/2020/1878431. eCollection 2020.,Lin Q,https://www.ncbi.nlm.nih.gov/pubmed/32904557
17939,32647229,Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness,Sci Rep. 2020 Jul 9;10(1):11329. doi: 10.1038/s41598-020-68187-9.,Flynn L,https://www.ncbi.nlm.nih.gov/pubmed/32647229
17940,32123316,Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study,Prostate Cancer Prostatic Dis. 2020 Sep;23(3):527-533. doi: 10.1038/s41391-020-0220-8. Epub 2020 Mar 2.,Beckmann K,https://www.ncbi.nlm.nih.gov/pubmed/32123316
17941,32368817,Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study,Prostate. 2020 Jul;80(10):777-781. doi: 10.1002/pros.23991. Epub 2020 May 5.,Lundgren PO,https://www.ncbi.nlm.nih.gov/pubmed/32368817
17942,32598349,Antihypertensive drug use and prostate cancer-specific mortality in Finnish men,PLoS One. 2020 Jun 29;15(6):e0234269. doi: 10.1371/journal.pone.0234269. eCollection 2020.,Siltari A,https://www.ncbi.nlm.nih.gov/pubmed/32598349
17945,32427631,Poly(ADP-ribose) polymerase inhibitors in prostate and urothelial cancer,Curr Opin Urol. 2020 Jul;30(4):519-526. doi: 10.1097/MOU.0000000000000776.,Brönimann S,https://www.ncbi.nlm.nih.gov/pubmed/32427631
17946,33058873,"Small Molecular Inhibitors Block TRPM4 Currents in Prostate Cancer Cells, with Limited Impact on Cancer Hallmark Functions",J Mol Biol. 2021 Aug 20;433(17):166665. doi: 10.1016/j.jmb.2020.09.024. Epub 2020 Oct 12.,Borgström A,https://www.ncbi.nlm.nih.gov/pubmed/33058873
17947,32321776,Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer,Cancer Immunol Res. 2020 Jul;8(7):844-850. doi: 10.1158/2326-6066.CIR-19-0568. Epub 2020 Apr 22.,Wagle MC,https://www.ncbi.nlm.nih.gov/pubmed/32321776
17948,32875501,Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network,J Gen Intern Med. 2021 Jan;36(1):92-99. doi: 10.1007/s11606-020-06124-2. Epub 2020 Sep 1.,Shah A,https://www.ncbi.nlm.nih.gov/pubmed/32875501
17949,32905641,Zingerone suppresses cell proliferation via inducing cellular apoptosis and inhibition of the PI3K/AKT/mTOR signaling pathway in human prostate cancer PC-3 cells,J Biochem Mol Toxicol. 2021 Jan;35(1):e22611. doi: 10.1002/jbt.22611. Epub 2020 Sep 9.,Qian S,https://www.ncbi.nlm.nih.gov/pubmed/32905641
17950,33387886,A novel long non-coding RNA PCLN16 facilitates androgen receptor signaling in prostate cancer,Biochem Biophys Res Commun. 2021 Jan 22;537:78-84. doi: 10.1016/j.bbrc.2020.12.043. Epub 2020 Dec 30.,Shi Z,https://www.ncbi.nlm.nih.gov/pubmed/33387886
17951,32434809,The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane,Cancer Prev Res (Phila). 2020 Aug;13(8):661-672. doi: 10.1158/1940-6207.CAPR-20-0054. Epub 2020 May 20.,Hahm ER,https://www.ncbi.nlm.nih.gov/pubmed/32434809
17952,32539186,The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients,Psychooncology. 2020 Aug;29(8):1338-1346. doi: 10.1002/pon.5442. Epub 2020 Jul 2.,Holtfrerich SKC,https://www.ncbi.nlm.nih.gov/pubmed/32539186
17953,32179174,Association of 5'UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis,Gene. 2020 Jun 5;742:144589. doi: 10.1016/j.gene.2020.144589. Epub 2020 Mar 13.,Ozturk K,https://www.ncbi.nlm.nih.gov/pubmed/32179174
17954,32694611,Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion,Oncogene. 2020 Aug;39(34):5690-5707. doi: 10.1038/s41388-020-1381-6. Epub 2020 Jul 21.,Kohno S,https://www.ncbi.nlm.nih.gov/pubmed/32694611
17955,32924497,Targeted Metabolomics Analyses Reveal Specific Metabolic Alterations in High-Grade Prostate Cancer Patients,J Proteome Res. 2020 Oct 2;19(10):4082-4092. doi: 10.1021/acs.jproteome.0c00493. Epub 2020 Sep 23.,Gómez-Cebrián N,https://www.ncbi.nlm.nih.gov/pubmed/32924497
17956,32519740,LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis,Biosci Rep. 2020 Aug 28;40(8):BSR20193287. doi: 10.1042/BSR20193287.,Xiao S,https://www.ncbi.nlm.nih.gov/pubmed/32519740
17957,32551903,Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management,AJR Am J Roentgenol. 2020 Aug;215(2):267-276. doi: 10.2214/AJR.19.22404. Epub 2020 Jun 17.,Marcus C,https://www.ncbi.nlm.nih.gov/pubmed/32551903
17958,33144536,Is Thiol/Disulphide homeostasis important in prostate cancer diagnosis?,Arch Esp Urol. 2020 Nov;73(9):819-825.,Senel C,https://www.ncbi.nlm.nih.gov/pubmed/33144536
17959,32233011,Integrating the immune microenvironment of prostate cancer induced bone disease,Mol Carcinog. 2020 Jul;59(7):822-829. doi: 10.1002/mc.23192. Epub 2020 Mar 31.,Ihle CL,https://www.ncbi.nlm.nih.gov/pubmed/32233011
17960,33175515,Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells,J Med Chem. 2020 Nov 25;63(22):13861-13877. doi: 10.1021/acs.jmedchem.0c01400. Epub 2020 Nov 11.,Karmakar S,https://www.ncbi.nlm.nih.gov/pubmed/33175515
17961,33082840,Texture Feature-Based Classification on Transrectal Ultrasound Image for Prostatic Cancer Detection,Comput Math Methods Med. 2020 Oct 6;2020:7359375. doi: 10.1155/2020/7359375. eCollection 2020.,Huang X,https://www.ncbi.nlm.nih.gov/pubmed/33082840
17962,33051487,Prostate cancer risk prediction using a polygenic risk score,Sci Rep. 2020 Oct 13;10(1):17075. doi: 10.1038/s41598-020-74172-z.,Sipeky C,https://www.ncbi.nlm.nih.gov/pubmed/33051487
17963,33204318,Urinary glycoproteins associated with aggressive prostate cancer,Theranostics. 2020 Oct 25;10(26):11892-11907. doi: 10.7150/thno.47066. eCollection 2020.,Dong M,https://www.ncbi.nlm.nih.gov/pubmed/33204318
17965,33218973,TIMP1 Determines the Effects of Cellular Senescence in Prostate Cancer,Cancer Discov. 2021 Jan;11(1):12. doi: 10.1158/2159-8290.CD-RW2020-169. Epub 2020 Nov 20.,,https://www.ncbi.nlm.nih.gov/pubmed/33218973
17966,32674955,Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53,Urol Oncol. 2020 Sep;38(9):736.e1-736.e10. doi: 10.1016/j.urolonc.2020.06.016. Epub 2020 Jul 13.,Kaczorowski A,https://www.ncbi.nlm.nih.gov/pubmed/32674955
17967,33280542,Healthcare services expenditures among prostate cancer patients with and without mood disorders in the United States: A propensity score-matched cross-sectional study,J Psychosoc Oncol. 2021;39(2):204-218. doi: 10.1080/07347332.2020.1844842. Epub 2020 Dec 7.,Alsultan MM,https://www.ncbi.nlm.nih.gov/pubmed/33280542
17969,32532514,Prostate Cancer Risk by BRCA2 Genomic Regions,Eur Urol. 2020 Oct;78(4):494-497. doi: 10.1016/j.eururo.2020.05.005. Epub 2020 Jun 10.,Nyberg T,https://www.ncbi.nlm.nih.gov/pubmed/32532514
17970,33149259,Characterisation of the main PSA glycoforms in aggressive prostate cancer,Sci Rep. 2020 Nov 4;10(1):18974. doi: 10.1038/s41598-020-75526-3.,Gratacós-Mulleras A,https://www.ncbi.nlm.nih.gov/pubmed/33149259
17971,32387456,Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532),Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.,Montopoli M,https://www.ncbi.nlm.nih.gov/pubmed/32387456
17972,33013832,Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis,Front Immunol. 2020 Sep 10;11:1820. doi: 10.3389/fimmu.2020.01820. eCollection 2020.,Caputo S,https://www.ncbi.nlm.nih.gov/pubmed/33013832
17975,32317181,Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics,Eur Urol. 2020 Nov;78(5):671-679. doi: 10.1016/j.eururo.2020.03.024. Epub 2020 Apr 19.,Nguyen B,https://www.ncbi.nlm.nih.gov/pubmed/32317181
17977,32988590,Small molecule inhibitors of the prostate cancer target KMT2D,Biochem Biophys Res Commun. 2020 Dec 10;533(3):540-547. doi: 10.1016/j.bbrc.2020.09.004. Epub 2020 Sep 25.,Yu Q,https://www.ncbi.nlm.nih.gov/pubmed/32988590
17978,32452138,Identification of tumor nodule in soft tissue: An inverse finite-element framework based on mechanical characterization,Int J Numer Method Biomed Eng. 2020 Aug;36(8):e3369. doi: 10.1002/cnm.3369. Epub 2020 Jun 15.,Candito A,https://www.ncbi.nlm.nih.gov/pubmed/32452138
17979,32303747,Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer,Jpn J Clin Oncol. 2020 Aug 4;50(8):933-939. doi: 10.1093/jjco/hyaa045.,Ikeda T,https://www.ncbi.nlm.nih.gov/pubmed/32303747
17980,32413384,Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer,Mol Cell Endocrinol. 2020 Jul 1;511:110864. doi: 10.1016/j.mce.2020.110864. Epub 2020 May 13.,Nanni S,https://www.ncbi.nlm.nih.gov/pubmed/32413384
17981,32619361,"Celosiadines A and B, unusual guanidine alkaloids from Iresine diffusa",Nat Prod Res. 2022 Jan;36(1):356-360. doi: 10.1080/14786419.2020.1784174. Epub 2020 Jul 3.,Killian C,https://www.ncbi.nlm.nih.gov/pubmed/32619361
17982,33093161,Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review,Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2454-2462. doi: 10.1158/1055-9965.EPI-20-1104. Epub 2020 Oct 22.,Liss MA,https://www.ncbi.nlm.nih.gov/pubmed/33093161
17983,32047993,Positron emission tomography (PET) radiotracers for prostate cancer imaging,Abdom Radiol (NY). 2020 Jul;45(7):2165-2175. doi: 10.1007/s00261-020-02427-4.,Walker SM,https://www.ncbi.nlm.nih.gov/pubmed/32047993
17984,33341506,Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications,Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27.,Pisano C,https://www.ncbi.nlm.nih.gov/pubmed/33341506
17985,32324216,IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway,Nucleic Acids Res. 2020 Jun 4;48(10):5366-5382. doi: 10.1093/nar/gkaa271.,Bainbridge A,https://www.ncbi.nlm.nih.gov/pubmed/32324216
17986,32385075,Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer,Cancer Discov. 2020 Sep;10(9):1374-1387. doi: 10.1158/2159-8290.CD-19-1352. Epub 2020 May 8.,Zhao D,https://www.ncbi.nlm.nih.gov/pubmed/32385075
17987,33258481,Validation of a prostate cancer polygenic risk score,Prostate. 2020 Nov;80(15):1314-1321. doi: 10.1002/pros.24058. Epub 2020 Aug 17.,Black MH,https://www.ncbi.nlm.nih.gov/pubmed/33258481
17988,33093529,"Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma",Sci Rep. 2020 Oct 22;10(1):18022. doi: 10.1038/s41598-020-75083-9.,Dankert JT,https://www.ncbi.nlm.nih.gov/pubmed/33093529
17990,33035140,Does Baseline Serum Testosterone Influence Androgen Deprivation Therapy Outcomes in Hormone Naïve Patients with Advanced Prostate Cancer?,J Urol. 2021 Mar;205(3):806-811. doi: 10.1097/JU.0000000000001413. Epub 2020 Oct 9.,Patel A,https://www.ncbi.nlm.nih.gov/pubmed/33035140
17992,32928383,Evaluation of prostate cancer based on MALDI-TOF MS fingerprinting of nanoparticle-treated serum proteins/peptides,Talanta. 2020 Dec 1;220:121331. doi: 10.1016/j.talanta.2020.121331. Epub 2020 Jul 7.,Sun J,https://www.ncbi.nlm.nih.gov/pubmed/32928383
17993,32417934,Recent updates and developments in PET imaging of prostate cancer,Abdom Radiol (NY). 2020 Dec;45(12):4063-4072. doi: 10.1007/s00261-020-02570-y.,Rowe SP,https://www.ncbi.nlm.nih.gov/pubmed/32417934
17995,33402974,Frequency of IL-10+CD19+ B cells in patients with prostate cancer compared to patients with benign prostatic hyperplasia,Afr Health Sci. 2020 Sep;20(3):1264-1272. doi: 10.4314/ahs.v20i3.31.,Roya N,https://www.ncbi.nlm.nih.gov/pubmed/33402974
17996,32506642,Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancer,Prostate. 2020 Sep;80(12):1038-1042. doi: 10.1002/pros.24025. Epub 2020 Jun 7.,Carson JJK,https://www.ncbi.nlm.nih.gov/pubmed/32506642
17998,33387600,Increased oxidative stress and cancer biomarkers in the ventral prostate of older rats submitted to maternal malnutrition,Mol Cell Endocrinol. 2021 Mar 1;523:111148. doi: 10.1016/j.mce.2020.111148. Epub 2020 Dec 31.,Portela LM,https://www.ncbi.nlm.nih.gov/pubmed/33387600
18000,33008348,Genetically-regulated transcriptomics & copy number variation of proctitis points to altered mitochondrial and DNA repair mechanisms in individuals of European ancestry,BMC Cancer. 2020 Oct 2;20(1):954. doi: 10.1186/s12885-020-07457-1.,Pathak GA,https://www.ncbi.nlm.nih.gov/pubmed/33008348
18001,32376286,Epigenetic regulation of the ITGB4 gene in prostate cancer,Exp Cell Res. 2020 Jul 15;392(2):112055. doi: 10.1016/j.yexcr.2020.112055. Epub 2020 May 4.,Wilkinson EJ,https://www.ncbi.nlm.nih.gov/pubmed/32376286
18002,33551100,"Ex vivo/in vitro effects of aspirin and ibuprofen, bulk and nano forms, in peripheral lymphocytes of prostate cancer patients and healthy individuals",Mutat Res Genet Toxicol Environ Mutagen. 2021 Jan-Feb;861-862:503306. doi: 10.1016/j.mrgentox.2020.503306. Epub 2020 Dec 25.,Guma A,https://www.ncbi.nlm.nih.gov/pubmed/33551100
18003,32948069,Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery,Int J Mol Sci. 2020 Sep 16;21(18):6806. doi: 10.3390/ijms21186806.,Fontana F,https://www.ncbi.nlm.nih.gov/pubmed/32948069
18005,33334788,Anti-Cancer Effects of RAW 264.7 Cells on Prostate Cancer PC-3 Cells,Ann Clin Lab Sci. 2020 Nov;50(6):739-746.,Nam HW,https://www.ncbi.nlm.nih.gov/pubmed/33334788
18006,32467600,The association of diabetes with risk of prostate cancer defined by clinical and molecular features,Br J Cancer. 2020 Aug;123(4):657-665. doi: 10.1038/s41416-020-0910-y. Epub 2020 May 29.,Feng X,https://www.ncbi.nlm.nih.gov/pubmed/32467600
18007,32790761,The effect of neighborhood social environment on prostate cancer development in black and white men at high risk for prostate cancer,PLoS One. 2020 Aug 13;15(8):e0237332. doi: 10.1371/journal.pone.0237332. eCollection 2020.,Lynch SM,https://www.ncbi.nlm.nih.gov/pubmed/32790761
18008,32838475,"Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study",Int J Cancer. 2021 Feb 15;148(4):876-883. doi: 10.1002/ijc.33267. Epub 2020 Sep 4.,Outzen M,https://www.ncbi.nlm.nih.gov/pubmed/32838475
18009,32529802,Evaluation of the plasma level of long non-coding RNA PCAT1 in prostatic hyperplasia and newly diagnosed prostate cancer patients,J Gene Med. 2020 Oct;22(10):e3239. doi: 10.1002/jgm.3239. Epub 2020 Jul 6.,Rezatabar S,https://www.ncbi.nlm.nih.gov/pubmed/32529802
18010,32946061,"Pioneer of prostate cancer: past, present and the future of FOXA1",Protein Cell. 2021 Jan;12(1):29-38. doi: 10.1007/s13238-020-00786-8. Epub 2020 Sep 18.,Teng M,https://www.ncbi.nlm.nih.gov/pubmed/32946061
18011,32781986,LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression,BMC Cancer. 2020 Aug 11;20(1):749. doi: 10.1186/s12885-020-07141-4.,Chen J,https://www.ncbi.nlm.nih.gov/pubmed/32781986
18012,32879636,An Intelligent Decision-Making Support System for the Detection and Staging of Prostate Cancer in Developing Countries,Comput Math Methods Med. 2020 Aug 17;2020:5363549. doi: 10.1155/2020/5363549. eCollection 2020.,Zhang J,https://www.ncbi.nlm.nih.gov/pubmed/32879636
18014,31705265,A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study,Eur J Nutr. 2020 Oct;59(7):2929-2937. doi: 10.1007/s00394-019-02132-z. Epub 2019 Nov 8.,Papadimitriou N,https://www.ncbi.nlm.nih.gov/pubmed/31705265
18019,32545154,Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis,Medicina (Kaunas). 2020 Jun 11;56(6):285. doi: 10.3390/medicina56060285.,Carli E,https://www.ncbi.nlm.nih.gov/pubmed/32545154
18020,32941257,Impact of radiomics on prostate cancer detection: a systematic review of clinical applications,Curr Opin Urol. 2020 Nov;30(6):754-781. doi: 10.1097/MOU.0000000000000822.,Sugano D,https://www.ncbi.nlm.nih.gov/pubmed/32941257
18021,33159459,Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study,Parasitol Res. 2021 Apr;120(4):1379-1388. doi: 10.1007/s00436-020-06942-7. Epub 2020 Nov 7.,Saleh NE,https://www.ncbi.nlm.nih.gov/pubmed/33159459
18022,32692448,Head to head: should the intraductal component of invasive prostate cancer be graded?,Histopathology. 2021 Jan;78(2):231-239. doi: 10.1111/his.14216. Epub 2020 Sep 12.,Varma M,https://www.ncbi.nlm.nih.gov/pubmed/32692448
18024,32709428,"Molecular imaging of prostate cancer: Review of imaging agents, modalities, and current status",Actas Urol Esp (Engl Ed). 2020 Jul-Aug;44(6):386-399. doi: 10.1016/j.acuro.2019.12.003. Epub 2020 Jul 21.,Quesada-Olarte JM,https://www.ncbi.nlm.nih.gov/pubmed/32709428
18025,32917782,Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study,J Nucl Med. 2021 May 10;62(5):675-678. doi: 10.2967/jnumed.120.246603. Epub 2020 Sep 11.,Farolfi A,https://www.ncbi.nlm.nih.gov/pubmed/32917782
18026,32729384,Potential role of CFTR in bisphenol A-induced malignant transformation of prostate cells via mitochondrial apoptosis,Toxicol Ind Health. 2020 Aug;36(8):531-539. doi: 10.1177/0748233720943750. Epub 2020 Jul 30.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/32729384
18027,33322492,Tensor-Decomposition-Based Unsupervised Feature Extraction Applied to Prostate Cancer Multiomics Data,Genes (Basel). 2020 Dec 11;11(12):1493. doi: 10.3390/genes11121493.,Taguchi YH,https://www.ncbi.nlm.nih.gov/pubmed/33322492
18028,33300812,Magnetic polymeric nanobubbles with optimized core size for MRI/ultrasound bimodal molecular imaging of prostate cancer,Nanomedicine (Lond). 2020 Dec;15(30):2901-2916. doi: 10.2217/nnm-2020-0188. Epub 2020 Dec 10.,Zhu Y,https://www.ncbi.nlm.nih.gov/pubmed/33300812
18029,32704070,Identification of candidate miRNAs in early-onset and late-onset prostate cancer by network analysis,Sci Rep. 2020 Jul 23;10(1):12345. doi: 10.1038/s41598-020-69290-7.,Parra-Medina R,https://www.ncbi.nlm.nih.gov/pubmed/32704070
18030,32303773,Round table: arguments in supporting abbreviated or biparametric MRI of the prostate protocol,Abdom Radiol (NY). 2020 Dec;45(12):3974-3981. doi: 10.1007/s00261-020-02510-w.,Scialpi M,https://www.ncbi.nlm.nih.gov/pubmed/32303773
18031,33208392,Beware Liquid Biopsies to Guide PARP Blockade,Cancer Discov. 2021 Jan;11(1):6. doi: 10.1158/2159-8290.CD-NB2020-105. Epub 2020 Nov 18.,,https://www.ncbi.nlm.nih.gov/pubmed/33208392
18032,32213205,Role of miRNA-182 and miRNA-187 as potential biomarkers in prostate cancer and its correlation with the staging of prostate cancer,Int Braz J Urol. 2020 Jul-Aug;46(4):614-623. doi: 10.1590/S1677-5538.IBJU.2019.0409.,Nayak B,https://www.ncbi.nlm.nih.gov/pubmed/32213205
18033,33221996,A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation,J Cancer Res Clin Oncol. 2021 Feb;147(2):469-480. doi: 10.1007/s00432-020-03455-9. Epub 2020 Nov 21.,Wang F,https://www.ncbi.nlm.nih.gov/pubmed/33221996
18034,32824915,Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study,Int J Mol Sci. 2020 Aug 19;21(17):5949. doi: 10.3390/ijms21175949.,Mercadal M,https://www.ncbi.nlm.nih.gov/pubmed/32824915
18035,33125130,"Effects of zinc finger protein 403 on the proliferation, migration and invasion abilities of prostate cancer cells",Oncol Rep. 2020 Dec;44(6):2455-2464. doi: 10.3892/or.2020.7786. Epub 2020 Oct 1.,Xu X,https://www.ncbi.nlm.nih.gov/pubmed/33125130
18036,33196071,ZIF-C for targeted RNA interference and CRISPR/Cas9 based gene editing in prostate cancer,Chem Commun (Camb). 2020 Dec 21;56(98):15406-15409. doi: 10.1039/d0cc06241c. Epub 2020 Nov 16.,Poddar A,https://www.ncbi.nlm.nih.gov/pubmed/33196071
18037,32561286,Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway,Exp Cell Res. 2020 Sep 1;394(1):112145. doi: 10.1016/j.yexcr.2020.112145. Epub 2020 Jun 16.,Yang T,https://www.ncbi.nlm.nih.gov/pubmed/32561286
18038,32924329,A four-gene signature associated with clinical features can better predict prognosis in prostate cancer,Cancer Med. 2020 Nov;9(21):8202-8215. doi: 10.1002/cam4.3453. Epub 2020 Sep 13.,Yuan P,https://www.ncbi.nlm.nih.gov/pubmed/32924329
18040,32881426,Retinoic acid receptor ? is a therapeutically targetable driver of growth and survival in prostate cancer,Cancer Rep (Hoboken). 2020 Dec;3(6):e1284. doi: 10.1002/cnr2.1284. Epub 2020 Sep 3.,Petrie K,https://www.ncbi.nlm.nih.gov/pubmed/32881426
18041,32705734,"Neuromodulation and the Epidemiology of Magnetic Resonance Utilization for Lung, Breast, Colon, and Prostate Cancer",Neuromodulation. 2020 Oct;23(7):912-921. doi: 10.1111/ner.13224. Epub 2020 Jul 24.,Jotwani R,https://www.ncbi.nlm.nih.gov/pubmed/32705734
18042,32539763,Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression,BMC Cancer. 2020 Jun 15;20(1):555. doi: 10.1186/s12885-020-07049-z.,Li Q,https://www.ncbi.nlm.nih.gov/pubmed/32539763
18043,32796101,Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy,Mol Cancer Ther. 2020 Oct;19(10):2163-2174. doi: 10.1158/1535-7163.MCT-20-0095. Epub 2020 Aug 12.,Werner CK,https://www.ncbi.nlm.nih.gov/pubmed/32796101
18044,32029930,"Associations among statins, preventive care, and prostate cancer mortality",Prostate Cancer Prostatic Dis. 2020 Sep;23(3):475-485. doi: 10.1038/s41391-020-0207-5. Epub 2020 Feb 6.,Kumar A,https://www.ncbi.nlm.nih.gov/pubmed/32029930
18045,33166087,Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss,J Pathol. 2021 Mar;253(3):292-303. doi: 10.1002/path.5587. Epub 2020 Dec 11.,Bastos DC,https://www.ncbi.nlm.nih.gov/pubmed/33166087
18046,32639678,Body mass index trajectories and prostate cancer risk: Results from the EPICAP study,Cancer Med. 2020 Sep;9(17):6421-6429. doi: 10.1002/cam4.3241. Epub 2020 Jul 8.,Lavalette C,https://www.ncbi.nlm.nih.gov/pubmed/32639678
18047,32876473,Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI,AJR Am J Roentgenol. 2021 Aug;217(2):395-403. doi: 10.2214/AJR.20.24370. Epub 2020 Sep 2.,Costa DN,https://www.ncbi.nlm.nih.gov/pubmed/32876473
18048,33144675,Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-? signaling pathway,Exp Mol Med. 2020 Nov;52(11):1809-1822. doi: 10.1038/s12276-020-0431-z. Epub 2020 Nov 4.,Shan G,https://www.ncbi.nlm.nih.gov/pubmed/33144675
18050,31755099,Hormone-related diseases and prostate cancer: An English national record linkage study,Int J Cancer. 2020 Aug 1;147(3):803-810. doi: 10.1002/ijc.32808. Epub 2019 Dec 11.,Watts EL,https://www.ncbi.nlm.nih.gov/pubmed/31755099
18051,32969906,Avid 68Ga-PSMA Uptake in Periappendicular Abscess,Clin Nucl Med. 2020 Nov;45(11):929-930. doi: 10.1097/RLU.0000000000003290.,Christensen MT,https://www.ncbi.nlm.nih.gov/pubmed/32969906
18052,32453079,68Ga-FAPI PET/CT Detects Gastric Signet-Ring Cell Carcinoma in a Patient Previously Treated for Prostate Cancer,Clin Nucl Med. 2020 Aug;45(8):632-635. doi: 10.1097/RLU.0000000000003099.,Pang Y,https://www.ncbi.nlm.nih.gov/pubmed/32453079
18053,32761404,Health disparities and inequities in the utilization of diagnostic imaging for prostate cancer,Abdom Radiol (NY). 2020 Dec;45(12):4090-4096. doi: 10.1007/s00261-020-02657-6. Epub 2020 Aug 6.,Washington C,https://www.ncbi.nlm.nih.gov/pubmed/32761404
18055,32751945,Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review,Int J Mol Sci. 2020 Jul 31;21(15):5484. doi: 10.3390/ijms21155484.,Kim TJ,https://www.ncbi.nlm.nih.gov/pubmed/32751945
18056,32717307,Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell,Gene. 2020 Nov 15;760:144989. doi: 10.1016/j.gene.2020.144989. Epub 2020 Jul 25.,Parvin A,https://www.ncbi.nlm.nih.gov/pubmed/32717307
18057,32759847,Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore,Int J Mol Sci. 2020 Aug 4;21(15):5584. doi: 10.3390/ijms21155584.,Koga H,https://www.ncbi.nlm.nih.gov/pubmed/32759847
18058,32991779,A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery,Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):195-203. doi: 10.1111/bcpt.13499. Epub 2020 Dec 1.,Tian JY,https://www.ncbi.nlm.nih.gov/pubmed/32991779
18059,33263430,DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review,Future Oncol. 2021 Mar;17(7):853-864. doi: 10.2217/fon-2020-0569. Epub 2020 Dec 2.,Armstrong N,https://www.ncbi.nlm.nih.gov/pubmed/33263430
18060,33066102,Identification of Differentially Methylated Regions Associated with a Knockout of SUV39H1 in Prostate Cancer Cells,Genes (Basel). 2020 Oct 13;11(10):1188. doi: 10.3390/genes11101188.,Yan W,https://www.ncbi.nlm.nih.gov/pubmed/33066102
18062,31417010,Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer,Asian J Androl. 2020 Jul-Aug;22(4):422-426. doi: 10.4103/aja.aja_80_19.,Ye C,https://www.ncbi.nlm.nih.gov/pubmed/31417010
18063,33249185,L-theanine suppresses the metastasis of prostate cancer by downregulating MMP9 and Snail,J Nutr Biochem. 2021 Mar;89:108556. doi: 10.1016/j.jnutbio.2020.108556. Epub 2020 Nov 26.,Fan X,https://www.ncbi.nlm.nih.gov/pubmed/33249185
18064,32619574,Bioinformatics analysis of the genes involved in the extension of prostate cancer to adjacent lymph nodes by supervised and unsupervised machine learning methods: The role of SPAG1 and PLEKHF2,Genomics. 2020 Nov;112(6):3871-3882. doi: 10.1016/j.ygeno.2020.06.035. Epub 2020 Jun 30.,Shamsara E,https://www.ncbi.nlm.nih.gov/pubmed/32619574
18065,32179997,Long-term unmet supportive care needs of prostate cancer survivors: 15-year follow-up from the NSW Prostate Cancer Care and Outcomes Study,Support Care Cancer. 2020 Nov;28(11):5511-5520. doi: 10.1007/s00520-020-05389-x. Epub 2020 Mar 16.,Mazariego CG,https://www.ncbi.nlm.nih.gov/pubmed/32179997
18066,32631448,Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing,Genome Biol. 2020 Jul 6;21(1):162. doi: 10.1186/s13059-020-02045-9.,Ramesh N,https://www.ncbi.nlm.nih.gov/pubmed/32631448
18067,33334312,General practitioners' approaches to prostate-specific antigen testing in the north-east of the Netherlands,BMC Fam Pract. 2020 Dec 17;21(1):270. doi: 10.1186/s12875-020-01350-3.,Kappen S,https://www.ncbi.nlm.nih.gov/pubmed/33334312
18068,32475711,Online peer-to-peer support for persons affected by prostate cancer: A systematic review,Patient Educ Couns. 2020 Oct;103(10):2107-2115. doi: 10.1016/j.pec.2020.05.009. Epub 2020 May 12.,Ihrig A,https://www.ncbi.nlm.nih.gov/pubmed/32475711
18072,32440687,The long non-coding RNA LINC00473 contributes to cell proliferation via JAK-STAT3 signaling pathway by regulating miR-195-5p/SEPT2 axis in prostate cancer,Biosci Rep. 2020 Sep 30;40(9):BSR20191850. doi: 10.1042/BSR20191850.,Xing Z,https://www.ncbi.nlm.nih.gov/pubmed/32440687
18073,32969128,Evaluation of long-term living conditions in patients treated for localised prostate cancer,Eur J Cancer Care (Engl). 2021 Jan;30(1):e13333. doi: 10.1111/ecc.13333. Epub 2020 Sep 24.,Xiao D,https://www.ncbi.nlm.nih.gov/pubmed/32969128
18077,32958445,Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer,Urol Oncol. 2021 Jan;39(1):52-62. doi: 10.1016/j.urolonc.2020.08.003. Epub 2020 Sep 18.,Morgans AK,https://www.ncbi.nlm.nih.gov/pubmed/32958445
18078,33288424,Impedimetric aptamer-based glycan PSA score for discrimination of prostate cancer from other prostate diseases,Biosens Bioelectron. 2021 Mar 1;175:112872. doi: 10.1016/j.bios.2020.112872. Epub 2020 Nov 29.,Díaz-Fernández A,https://www.ncbi.nlm.nih.gov/pubmed/33288424
18079,32683077,Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients,Gene. 2020 Oct 20;758:144963. doi: 10.1016/j.gene.2020.144963. Epub 2020 Jul 17.,Gurbuz V,https://www.ncbi.nlm.nih.gov/pubmed/32683077
18081,33303959,Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease,Sci Rep. 2020 Dec 10;10(1):21750. doi: 10.1038/s41598-020-78798-x.,Smith R,https://www.ncbi.nlm.nih.gov/pubmed/33303959
18082,32234541,PKMYT1 is associated with prostate cancer malignancy and may serve as a therapeutic target,Gene. 2020 Jun 20;744:144608. doi: 10.1016/j.gene.2020.144608. Epub 2020 Mar 29.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32234541
18083,32173432,Biosensing of prostate specific antigen (PSA) in human plasma samples using biomacromolecule encapsulation into KCC-1-npr-NH(2): A new platform for prostate cancer detection,Int J Biol Macromol. 2020 Jul 1;154:584-595. doi: 10.1016/j.ijbiomac.2020.03.093. Epub 2020 Mar 13.,Abbasy L,https://www.ncbi.nlm.nih.gov/pubmed/32173432
18084,32718757,An exploration of the Role of the Prostate Cancer Specialist Nurse from Two International Perspectives,Semin Oncol Nurs. 2020 Aug;36(4):151043. doi: 10.1016/j.soncn.2020.151043. Epub 2020 Jul 24.,Fleure L,https://www.ncbi.nlm.nih.gov/pubmed/32718757
18085,33282964,The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis-Mediated Innate Immune Response,J Immunol Res. 2020 Nov 17;2020:8820355. doi: 10.1155/2020/8820355. eCollection 2020.,Fu W,https://www.ncbi.nlm.nih.gov/pubmed/33282964
18086,32672875,PAX3 silencing inhibits prostate cancer progression through the suppression of the TGF-?/Smad signaling axis,Cell Biol Int. 2020 Oct;44(10):2131-2139. doi: 10.1002/cbin.11421. Epub 2020 Jul 28.,Zeng K,https://www.ncbi.nlm.nih.gov/pubmed/32672875
18087,32813978,Astragaloside IV enhanced carboplatin sensitivity in prostate cancer by suppressing AKT/NF-?B signaling pathway,Biochem Cell Biol. 2021 Apr;99(2):214-222. doi: 10.1139/bcb-2020-0026. Epub 2020 Aug 19.,He Y,https://www.ncbi.nlm.nih.gov/pubmed/32813978
18088,32960781,Mechanistic targets for BPH and prostate cancer-a review,Rev Environ Health. 2020 Sep 22;36(2):261-270. doi: 10.1515/reveh-2020-0051. Print 2021 Jun 25.,Shah A,https://www.ncbi.nlm.nih.gov/pubmed/32960781
18089,32938489,IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way,J Exp Clin Cancer Res. 2020 Sep 16;39(1):190. doi: 10.1186/s13046-020-01657-0.,Zhang X,https://www.ncbi.nlm.nih.gov/pubmed/32938489
18090,32552474,Interreader Agreement with Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection: A Systematic Review and Meta-Analysis,J Urol. 2020 Oct;204(4):661-670. doi: 10.1097/JU.0000000000001200. Epub 2020 Jun 18.,Park KJ,https://www.ncbi.nlm.nih.gov/pubmed/32552474
18092,33021980,Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer,PLoS One. 2020 Oct 6;15(10):e0239414. doi: 10.1371/journal.pone.0239414. eCollection 2020.,Meijer D,https://www.ncbi.nlm.nih.gov/pubmed/33021980
18093,31980895,"Pain, fatigue and depression symptom cluster in survivors of prostate cancer",Support Care Cancer. 2020 Oct;28(10):4813-4824. doi: 10.1007/s00520-019-05268-0. Epub 2020 Jan 24.,Baden M,https://www.ncbi.nlm.nih.gov/pubmed/31980895
18094,33310694,3D PBV-Net: An automated prostate MRI data segmentation method,Comput Biol Med. 2021 Jan;128:104160. doi: 10.1016/j.compbiomed.2020.104160. Epub 2020 Dec 7.,Jin Y,https://www.ncbi.nlm.nih.gov/pubmed/33310694
18095,32654366,Use of bisphosphonates and other bone supportive agents in the management of prostate cancer-A UK perspective,Int J Clin Pract. 2020 Nov;74(11):e13611. doi: 10.1111/ijcp.13611. Epub 2020 Jul 27.,Payne H,https://www.ncbi.nlm.nih.gov/pubmed/32654366
18096,33368049,"Prostate Cancer Growth Inhibition by 1-(3,5-Dimethylphenyl)-6-methyl-1H-pyrazolo[4,3-c]pyridin-4(5H)-one via Down-regulation of Phosphorylation PI3K/AKT and STA3/JAK2",Dokl Biochem Biophys. 2020 Nov;495(1):347-353. doi: 10.1134/S160767292006006X.,Xue J,https://www.ncbi.nlm.nih.gov/pubmed/33368049
18097,33028274,Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA <?20 ng/ml,BMC Urol. 2020 Oct 7;20(1):151. doi: 10.1186/s12894-020-00717-z.,Chang TH,https://www.ncbi.nlm.nih.gov/pubmed/33028274
18098,32927797,Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer,Int J Mol Sci. 2020 Sep 10;21(18):6622. doi: 10.3390/ijms21186622.,Tan KN,https://www.ncbi.nlm.nih.gov/pubmed/32927797
18099,32963348,Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank,Br J Cancer. 2020 Dec;123(12):1808-1817. doi: 10.1038/s41416-020-01081-3. Epub 2020 Sep 23.,Perez-Cornago A,https://www.ncbi.nlm.nih.gov/pubmed/32963348
18100,32898989,68Ga-PSMA-11 PET/CT combining ADC value of MRI in the diagnosis of naive prostate cancer: Perspective of radiologist,Medicine (Baltimore). 2020 Sep 4;99(36):e20755. doi: 10.1097/MD.0000000000020755.,Wang L,https://www.ncbi.nlm.nih.gov/pubmed/32898989
18102,33298175,Men's willingness to pay for prostate cancer screening: a systematic review,Syst Rev. 2020 Dec 9;9(1):290. doi: 10.1186/s13643-020-01522-3.,Farabi H,https://www.ncbi.nlm.nih.gov/pubmed/33298175
18103,32805084,LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells,Mol Carcinog. 2020 Oct;59(10):1174-1187. doi: 10.1002/mc.23247. Epub 2020 Aug 17.,Zhao X,https://www.ncbi.nlm.nih.gov/pubmed/32805084
18104,32921062,Germline mutations and prostate cancer: is it time to change treatment algorithms?,Chin Clin Oncol. 2020 Oct;9(5):65. doi: 10.21037/cco-19-207. Epub 2020 Aug 27.,Telvizian T,https://www.ncbi.nlm.nih.gov/pubmed/32921062
18105,32396449,A qualitative exploration of South African men's perceived effects of Androgen Deprivation Therapy (ADT) as a treatment for advanced prostate cancer,Aging Male. 2020 Dec;23(5):1266-1274. doi: 10.1080/13685538.2020.1762075. Epub 2020 May 12.,Gray PB,https://www.ncbi.nlm.nih.gov/pubmed/32396449
18106,32732621,Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence,Curr Opin Urol. 2020 Sep;30(5):635-640. doi: 10.1097/MOU.0000000000000793.,Ferdinandus J,https://www.ncbi.nlm.nih.gov/pubmed/32732621
18107,33070458,Financial toxicity and strain among men receiving prostate cancer care in an equal access healthcare system,Cancer Med. 2020 Dec;9(23):8765-8771. doi: 10.1002/cam4.3484. Epub 2020 Oct 17.,Bauer AG,https://www.ncbi.nlm.nih.gov/pubmed/33070458
18108,32361091,Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism pathway,J Pharm Biomed Anal. 2020 Jul 15;186:113288. doi: 10.1016/j.jpba.2020.113288. Epub 2020 Apr 4.,Wang K,https://www.ncbi.nlm.nih.gov/pubmed/32361091
18110,33054537,Estimation of mandarin peel oil-induced cytotoxicity and genotoxicity in human normal fibroblast and cancerous prostate cell lines,Toxicol Mech Methods. 2021 Feb;31(2):100-106. doi: 10.1080/15376516.2020.1836103. Epub 2020 Nov 1.,Hussien NA,https://www.ncbi.nlm.nih.gov/pubmed/33054537
18111,33059953,Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression,Arch Med Res. 2021 Feb;52(2):174-181. doi: 10.1016/j.arcmed.2020.10.005. Epub 2020 Oct 13.,Yang W,https://www.ncbi.nlm.nih.gov/pubmed/33059953
18114,32343403,Changes in prostate-specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men,Cancer. 2020 Jul 15;126(14):3229-3236. doi: 10.1002/cncr.32930. Epub 2020 Apr 28.,Weiner AB,https://www.ncbi.nlm.nih.gov/pubmed/32343403
18115,33378089,"Circulating interleukin 6, androgen deprivation therapy, and fatigue in prostate cancer: Is inflammation the link?",Cancer. 2021 May 1;127(9):1371-1373. doi: 10.1002/cncr.33398. Epub 2020 Dec 30.,Nazha B,https://www.ncbi.nlm.nih.gov/pubmed/33378089
18116,33120746,Prostate cancer: a risk factor for COVID-19 in males?: A protocol for systematic review and meta analysis,Medicine (Baltimore). 2020 Oct 23;99(43):e22591. doi: 10.1097/MD.0000000000022591.,Mou R,https://www.ncbi.nlm.nih.gov/pubmed/33120746
18118,33279769,Value of MRI texture analysis for predicting high-grade prostate cancer,Clin Imaging. 2021 Apr;72:168-174. doi: 10.1016/j.clinimag.2020.10.028. Epub 2020 Oct 24.,Xiong H,https://www.ncbi.nlm.nih.gov/pubmed/33279769
18119,32912170,GMIEC: a shiny application for the identification of gene-targeted drugs for precision medicine,BMC Genomics. 2020 Sep 10;21(1):619. doi: 10.1186/s12864-020-06996-y.,Malagoli Tagliazucchi G,https://www.ncbi.nlm.nih.gov/pubmed/32912170
18120,32805621,Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells,Phytochemistry. 2020 Nov;179:112478. doi: 10.1016/j.phytochem.2020.112478. Epub 2020 Aug 14.,Huxley C,https://www.ncbi.nlm.nih.gov/pubmed/32805621
18121,33167198,Electrochemical and optical detection and machine learning applied to images of genosensors for diagnosis of prostate cancer with the biomarker PCA3,Talanta. 2021 Jan 15;222:121444. doi: 10.1016/j.talanta.2020.121444. Epub 2020 Aug 7.,Rodrigues VC,https://www.ncbi.nlm.nih.gov/pubmed/33167198
18122,32783410,Comparison of Urologist Satisfaction for Different Types of Prostate MRI Reports: A Large Sample Investigation,Korean J Radiol. 2020 Dec;21(12):1326-1333. doi: 10.3348/kjr.2019.0820. Epub 2020 Aug 11.,Zhong J,https://www.ncbi.nlm.nih.gov/pubmed/32783410
18123,32248259,New prostate MRI techniques and sequences,Abdom Radiol (NY). 2020 Dec;45(12):4052-4062. doi: 10.1007/s00261-020-02504-8.,Chatterjee A,https://www.ncbi.nlm.nih.gov/pubmed/32248259
18124,32511787,Selenium-binding protein 1 alters energy metabolism in prostate cancer cells,Prostate. 2020 Sep;80(12):962-976. doi: 10.1002/pros.24028. Epub 2020 Jun 8.,Elhodaky M,https://www.ncbi.nlm.nih.gov/pubmed/32511787
18125,32901137,EGFR as a stable marker of prostate cancer dissemination to bones,Br J Cancer. 2020 Dec;123(12):1767-1774. doi: 10.1038/s41416-020-01052-8. Epub 2020 Sep 9.,Nasta?y P,https://www.ncbi.nlm.nih.gov/pubmed/32901137
18128,32846021,Inflammatory infiltration is associated with AR expression and poor prognosis in hormone naïve prostate cancer,Prostate. 2020 Nov;80(15):1353-1364. doi: 10.1002/pros.24064. Epub 2020 Aug 26.,McAllister M,https://www.ncbi.nlm.nih.gov/pubmed/32846021
18129,32320704,Identification of cofilin-1 as a novel mediator for the metastatic potentials and chemoresistance of the prostate cancer cells,Eur J Pharmacol. 2020 Aug 5;880:173100. doi: 10.1016/j.ejphar.2020.173100. Epub 2020 Apr 19.,Chen L,https://www.ncbi.nlm.nih.gov/pubmed/32320704
18130,32552802,Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy,BMC Cancer. 2020 Jun 18;20(1):572. doi: 10.1186/s12885-020-07058-y.,Bou-Dargham MJ,https://www.ncbi.nlm.nih.gov/pubmed/32552802
18132,33137624,Selecting proper combination of mpMRI sequences for prostate cancer classification using multi-input convolutional neuronal network,Phys Med. 2020 Dec;80:92-100. doi: 10.1016/j.ejmp.2020.10.013. Epub 2020 Nov 1.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/33137624
18133,32919302,circCRKL suppresses the progression of prostate cancer cells by regulating the miR-141/KLF5 axis,Pathol Res Pract. 2020 Nov;216(11):153182. doi: 10.1016/j.prp.2020.153182. Epub 2020 Aug 23.,Nan C,https://www.ncbi.nlm.nih.gov/pubmed/32919302
18134,33054431,Effect of Methionine on AMD1 Gene Expression in Prostate Cancer Cells,Nutr Cancer. 2021;73(9):1804-1815. doi: 10.1080/01635581.2020.1803931. Epub 2020 Oct 15.,Shen S,https://www.ncbi.nlm.nih.gov/pubmed/33054431
18135,32739231,Specificities of small cell neuroendocrine prostate cancer: Adverse prognostic value of TTF1 expression,Urol Oncol. 2021 Jan;39(1):74.e17-74.e23. doi: 10.1016/j.urolonc.2020.07.007. Epub 2020 Jul 30.,Cancel M,https://www.ncbi.nlm.nih.gov/pubmed/32739231
18136,33065114,"The alpha-1,2 fucosylated tubule system of DU145 prostate cancer cells is derived from a partially fragmented Golgi complex and its formation is actin-dependent",Exp Cell Res. 2020 Nov 15;396(2):112324. doi: 10.1016/j.yexcr.2020.112324. Epub 2020 Oct 13.,Nolfi D,https://www.ncbi.nlm.nih.gov/pubmed/33065114
18137,31924729,Repeatability of Quantitative (18)F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer,J Nucl Med. 2020 Sep;61(9):1320-1325. doi: 10.2967/jnumed.119.236075. Epub 2020 Jan 10.,Jansen BHE,https://www.ncbi.nlm.nih.gov/pubmed/31924729
18138,32560058,High Content Screening Using New U2OS Reporter Cell Models Identifies Harmol Hydrochloride as a Selective and Competitive Antagonist of the Androgen Receptor,Cells. 2020 Jun 16;9(6):1469. doi: 10.3390/cells9061469.,Dellal H,https://www.ncbi.nlm.nih.gov/pubmed/32560058
18139,33152908,Rosemary (Rosmarinus officinalis L.) extract inhibits prostate cancer cell proliferation and survival by targeting Akt and mTOR,Biomed Pharmacother. 2020 Nov;131:110717. doi: 10.1016/j.biopha.2020.110717. Epub 2020 Sep 23.,Jaglanian A,https://www.ncbi.nlm.nih.gov/pubmed/33152908
18140,32713076,Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance,FASEB J. 2020 Sep;34(9):11511-11528. doi: 10.1096/fj.201903167R. Epub 2020 Jul 26.,Lim SC,https://www.ncbi.nlm.nih.gov/pubmed/32713076
18141,32314536,Upregulation of PTTG1 is associated with poor prognosis in prostate cancer,Pathol Int. 2020 Jul;70(7):441-451. doi: 10.1111/pin.12938. Epub 2020 Apr 20.,Fraune C,https://www.ncbi.nlm.nih.gov/pubmed/32314536
18143,33156691,Pharmacokinetic drug-drug interactions: an insight into recent US FDA-approved drugs for prostate cancer,Bioanalysis. 2020 Nov;12(22):1647-1664. doi: 10.4155/bio-2020-0242. Epub 2020 Nov 6.,Rao Gajula SN,https://www.ncbi.nlm.nih.gov/pubmed/33156691
18145,32247806,Self-assembly of amphiphilic phospholipid peptide dendrimer-based nanovectors for effective delivery of siRNA therapeutics in prostate cancer therapy,J Control Release. 2020 Jun 10;322:416-425. doi: 10.1016/j.jconrel.2020.04.003. Epub 2020 Apr 2.,Dong Y,https://www.ncbi.nlm.nih.gov/pubmed/32247806
18146,33236669,The Effect of an Educational Intervention Based on the Health Belief Model on Preventive Behaviors of Prostate Cancer in Military Men,Community Health Equity Res Policy. 2022 Jan;42(2):127-134. doi: 10.1177/0272684X20974196. Epub 2020 Nov 25.,Abhar R,https://www.ncbi.nlm.nih.gov/pubmed/33236669
18147,32988870,Sphere-derived Prostate Cancer Stem Cells Are Resistant to ?? T Cell Cytotoxicity,Anticancer Res. 2020 Oct;40(10):5481-5487. doi: 10.21873/anticanres.14559.,Miyashita M,https://www.ncbi.nlm.nih.gov/pubmed/32988870
18148,33112561,Scorpion and Frog Organ Lysates are Potential Source of Antitumour Activity,Asian Pac J Cancer Prev. 2020 Oct 1;21(10):3011-3018. doi: 10.31557/APJCP.2020.21.10.3011.,Soopramanien M,https://www.ncbi.nlm.nih.gov/pubmed/33112561
18149,32725538,Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients,Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):543-553. doi: 10.1007/s00259-020-04957-x. Epub 2020 Jul 28.,Bogdanovic B,https://www.ncbi.nlm.nih.gov/pubmed/32725538
18150,33048394,Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC),Cancer. 2021 Jan 15;127(2):188-192. doi: 10.1002/cncr.33254. Epub 2020 Oct 13.,Pakarainen T,https://www.ncbi.nlm.nih.gov/pubmed/33048394
18151,32358088,PET Imaging Quantifying (68)Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer,J Nucl Med. 2020 Nov;61(11):1576-1579. doi: 10.2967/jnumed.119.233312. Epub 2020 May 1.,Cuda TJ,https://www.ncbi.nlm.nih.gov/pubmed/32358088
18152,33296690,In search of the correlation between nanomechanical and biomolecular properties of prostate cancer cells with different metastatic potential,Arch Biochem Biophys. 2021 Jan 15;697:108718. doi: 10.1016/j.abb.2020.108718. Epub 2020 Dec 6.,Pogoda K,https://www.ncbi.nlm.nih.gov/pubmed/33296690
18153,31583707,Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study,Int J Cancer. 2020 Jul 1;147(1):84-92. doi: 10.1002/ijc.32718. Epub 2019 Nov 20.,Stikbakke E,https://www.ncbi.nlm.nih.gov/pubmed/31583707
18154,33028943,Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):290-300. doi: 10.1038/s41391-020-00296-y. Epub 2020 Oct 7.,Hussain A,https://www.ncbi.nlm.nih.gov/pubmed/33028943
18155,32674974,Distress Screening for Men with Prostate Cancer,Semin Oncol Nurs. 2020 Aug;36(4):151041. doi: 10.1016/j.soncn.2020.151041. Epub 2020 Jul 14.,Jakimowicz S,https://www.ncbi.nlm.nih.gov/pubmed/32674974
18156,32618118,Grape Powder Supplementation Attenuates Prostate Neoplasia Associated with Pten Haploinsufficiency in Mice Fed High-Fat Diet,Mol Nutr Food Res. 2020 Aug;64(16):e2000326. doi: 10.1002/mnfr.202000326. Epub 2020 Jul 12.,Joshi T,https://www.ncbi.nlm.nih.gov/pubmed/32618118
18157,32330852,Machine learning application for incident prostate adenocarcinomas automatic registration in a French regional cancer registry,Int J Med Inform. 2020 Jul;139:104139. doi: 10.1016/j.ijmedinf.2020.104139. Epub 2020 Apr 9.,Fabacher T,https://www.ncbi.nlm.nih.gov/pubmed/32330852
18158,32665998,A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone,Investig Clin Urol. 2020 Jul;61(4):411-418. doi: 10.4111/icu.2020.61.4.411. Epub 2020 May 29.,Kang HW,https://www.ncbi.nlm.nih.gov/pubmed/32665998
18159,32515225,Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countries,Future Oncol. 2020 Sep;16(25):1889-1901. doi: 10.2217/fon-2020-0315. Epub 2020 Jun 9.,Vassilev ZP,https://www.ncbi.nlm.nih.gov/pubmed/32515225
18160,32712248,Docosahexaenoic acid differentially modulates the cell cycle and metabolism- related genes in tumor and pre-malignant prostate cells,Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Oct;1865(10):158766. doi: 10.1016/j.bbalip.2020.158766. Epub 2020 Jul 23.,Tamarindo GH,https://www.ncbi.nlm.nih.gov/pubmed/32712248
18161,32255528,"Atypical gynecomastia mimicking breast malignancy on mammography, sonography, and 18F-fluciclovine PET/CT in the setting of biochemical recurrence of prostate cancer",Breast J. 2020 Sep;26(9):1805-1807. doi: 10.1111/tbj.13828. Epub 2020 Apr 7.,Winter AM,https://www.ncbi.nlm.nih.gov/pubmed/32255528
18162,32771771,Deep adaptive registration of multi-modal prostate images,Comput Med Imaging Graph. 2020 Sep;84:101769. doi: 10.1016/j.compmedimag.2020.101769. Epub 2020 Jul 31.,Guo H,https://www.ncbi.nlm.nih.gov/pubmed/32771771
18163,31412002,Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials,Eur Urol Oncol. 2020 Aug;3(4):540-543. doi: 10.1016/j.euo.2018.11.006. Epub 2018 Nov 30.,Sonpavde GP,https://www.ncbi.nlm.nih.gov/pubmed/31412002
18165,33063611,The Balance of Patient Involvement: Patients' and Health Professionals' Perspectives on Decision-Making in the Treatment of Advanced Prostate Cancer,Qual Health Res. 2021 Jan;31(1):29-40. doi: 10.1177/1049732320962759. Epub 2020 Oct 16.,Løwe MM,https://www.ncbi.nlm.nih.gov/pubmed/33063611
18166,32998889,Probing single-cell metabolism reveals prognostic value of highly metabolically active circulating stromal cells in prostate cancer,Sci Adv. 2020 Sep 30;6(40):eaaz3849. doi: 10.1126/sciadv.aaz3849. Print 2020 Sep.,Rivello F,https://www.ncbi.nlm.nih.gov/pubmed/32998889
18167,33199826,A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer,Oncogene. 2021 Jan;40(3):592-602. doi: 10.1038/s41388-020-01553-z. Epub 2020 Nov 16.,Singh KB,https://www.ncbi.nlm.nih.gov/pubmed/33199826
18168,32737029,Reimagining Vaccines for Prostate Cancer: Back to the Future,Clin Cancer Res. 2020 Oct 1;26(19):5056-5058. doi: 10.1158/1078-0432.CCR-20-2257. Epub 2020 Jul 31.,Shenderov E,https://www.ncbi.nlm.nih.gov/pubmed/32737029
18169,32571255,"Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: a qualitative study",BMC Cancer. 2020 Jun 22;20(1):577. doi: 10.1186/s12885-020-07076-w.,Knaul FM,https://www.ncbi.nlm.nih.gov/pubmed/32571255
18171,32772143,Coexistence of brown tumors due to secondary hyperparathyroidism and prostate cancer in a patient,Osteoporos Int. 2021 Jan;32(1):205-208. doi: 10.1007/s00198-020-05558-y. Epub 2020 Aug 8.,Abdala R,https://www.ncbi.nlm.nih.gov/pubmed/32772143
18172,32971115,SOX11-induced decrease in vimentin and an increase in prostate cancer cell migration attributed to cofilin activity,Exp Mol Pathol. 2020 Dec;117:104542. doi: 10.1016/j.yexmp.2020.104542. Epub 2020 Sep 21.,Hirokawa YS,https://www.ncbi.nlm.nih.gov/pubmed/32971115
18173,32479339,Paper-based ITP technology: An application to specific cancer-derived exosome detection and analysis,Biosens Bioelectron. 2020 Sep 15;164:112292. doi: 10.1016/j.bios.2020.112292. Epub 2020 May 15.,Guo S,https://www.ncbi.nlm.nih.gov/pubmed/32479339
18174,33235074,A valuable MRI examination method for prostate cancer screening,Medicine (Baltimore). 2020 Nov 25;99(48):e23134. doi: 10.1097/MD.0000000000023134.,Yang X,https://www.ncbi.nlm.nih.gov/pubmed/33235074
18175,32525019,The triphenyltin carboxylate derivative triphenylstannyl 2-(benzylcarbamoyl)benzoate impedes prostate cancer progression via modulation of Akt/FOXO3a signaling,Toxicol Appl Pharmacol. 2020 Aug 15;401:115091. doi: 10.1016/j.taap.2020.115091. Epub 2020 Jun 7.,Waseem D,https://www.ncbi.nlm.nih.gov/pubmed/32525019
18177,32686647,Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis,Elife. 2020 Jul 20;9:e54166. doi: 10.7554/eLife.54166.,Nassar ZD,https://www.ncbi.nlm.nih.gov/pubmed/32686647
18178,32539807,Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study,BMC Cancer. 2020 Jun 15;20(1):551. doi: 10.1186/s12885-020-07036-4.,Lin E,https://www.ncbi.nlm.nih.gov/pubmed/32539807
18179,32606149,Ultrasonographic Follow-up of the Multistep Protocol for Prostate Cancer Induction in Wistar Rats,In Vivo. 2020 Jul-Aug;34(4):1797-1803. doi: 10.21873/invivo.11974.,Faustino-Rocha AI,https://www.ncbi.nlm.nih.gov/pubmed/32606149
18180,33140306,Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer,Hormones (Athens). 2021 Mar;20(1):73-84. doi: 10.1007/s42000-020-00251-5. Epub 2020 Nov 2.,Pyrgidis N,https://www.ncbi.nlm.nih.gov/pubmed/33140306
18181,32371181,A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients,Eur J Radiol. 2020 Jul;128:109020. doi: 10.1016/j.ejrad.2020.109020. Epub 2020 Apr 19.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/32371181
18182,32771333,Synchronous Malignancies Identified by (18)F-fluciclovine Positron Emission Tomography for Prostate Cancer: Case Series and Mini-Review,Clin Genitourin Cancer. 2021 Feb;19(1):e37-e40. doi: 10.1016/j.clgc.2020.07.009. Epub 2020 Jul 16.,Hoyle JM,https://www.ncbi.nlm.nih.gov/pubmed/32771333
18183,31961625,Diagnosis accuracy of PCA3 level in patients with prostate cancer: a systematic review with meta-analysis,Int Braz J Urol. 2020 Sep-Oct;46(5):691-704. doi: 10.1590/S1677-5538.IBJU.2019.0360.,Qin Z,https://www.ncbi.nlm.nih.gov/pubmed/31961625
18184,31876381,Development of an in vitro screening assay for PIP5K1? lipid kinase and identification of potent inhibitors,FEBS J. 2020 Jul;287(14):3042-3064. doi: 10.1111/febs.15194. Epub 2020 Jan 13.,Strätker K,https://www.ncbi.nlm.nih.gov/pubmed/31876381
18187,33111429,Epigenetic modifications in prostate cancer,Int J Urol. 2021 Feb;28(2):140-149. doi: 10.1111/iju.14406. Epub 2020 Oct 27.,Sugiura M,https://www.ncbi.nlm.nih.gov/pubmed/33111429
18188,32520500,Cavernosal Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT,Clin Nucl Med. 2020 Oct;45(10):e449-e450. doi: 10.1097/RLU.0000000000003116.,Nguyen BD,https://www.ncbi.nlm.nih.gov/pubmed/32520500
18189,32963349,"BCAS2, a protein enriched in advanced prostate cancer, interacts with NBS1 to enhance DNA double-strand break repair",Br J Cancer. 2020 Dec;123(12):1796-1807. doi: 10.1038/s41416-020-01086-y. Epub 2020 Sep 23.,Wang LP,https://www.ncbi.nlm.nih.gov/pubmed/32963349
18190,32918383,Etoposide Loaded SPION-PNIPAM Nanoparticles Improve the in vitro Therapeutic Outcome on Metastatic Prostate Cancer Cells via Enhanced Apoptosis,Chem Biodivers. 2020 Nov;17(11):e2000607. doi: 10.1002/cbdv.202000607. Epub 2020 Oct 15.,Erkisa M,https://www.ncbi.nlm.nih.gov/pubmed/32918383
18191,32884240,Cinnamaldehyde Treatment of Prostate Cancer-Associated Fibroblasts Prevents Their Inhibitory Effect on T Cells Through Toll-Like Receptor 4,Drug Des Devel Ther. 2020 Aug 18;14:3363-3372. doi: 10.2147/DDDT.S241410. eCollection 2020.,Mei J,https://www.ncbi.nlm.nih.gov/pubmed/32884240
18192,33328578,GTSE1 promotes prostate cancer cell proliferation via the SP1/FOXM1 signaling pathway,Lab Invest. 2021 May;101(5):554-563. doi: 10.1038/s41374-020-00510-4. Epub 2020 Dec 16.,Lai W,https://www.ncbi.nlm.nih.gov/pubmed/33328578
18194,33332152,Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations,J Urol. 2021 Apr;205(4):977-986. doi: 10.1097/JU.0000000000001570. Epub 2020 Dec 17.,Shore N,https://www.ncbi.nlm.nih.gov/pubmed/33332152
18195,33817716,Prostate carcinomas mimicking a digestive malignancy,Rom J Morphol Embryol. 2020 Jul-Sep;61(3):751-758. doi: 10.47162/RJME.61.3.13.,Dema S,https://www.ncbi.nlm.nih.gov/pubmed/33817716
18198,32702998,How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1,Acta Radiol. 2021 Jun;62(6):839-847. doi: 10.1177/0284185120941831. Epub 2020 Jul 23.,Linhares Moreira AS,https://www.ncbi.nlm.nih.gov/pubmed/32702998
18199,32624421,"Modifiable health behaviors among low-income, uninsured men with prostate cancer",Urol Oncol. 2020 Sep;38(9):735.e1-735.e8. doi: 10.1016/j.urolonc.2020.06.005. Epub 2020 Jul 2.,Haymer M,https://www.ncbi.nlm.nih.gov/pubmed/32624421
18201,32956488,Sudden PSA rise to ?20 ng/ml and prostate cancer diagnosis in the United States: A population-based study,Prostate. 2020 Dec;80(16):1438-1443. doi: 10.1002/pros.24075. Epub 2020 Sep 21.,Vilson FL,https://www.ncbi.nlm.nih.gov/pubmed/32956488
18202,32690869,BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):268-277. doi: 10.1038/s41391-020-0246-y. Epub 2020 Jul 21.,Shafran JS,https://www.ncbi.nlm.nih.gov/pubmed/32690869
18203,32709378,Association between male infertility and male-specific malignancies: systematic review and meta-analysis of population-based retrospective cohort studies,Fertil Steril. 2020 Nov;114(5):984-996. doi: 10.1016/j.fertnstert.2020.04.042. Epub 2020 Jul 22.,Del Giudice F,https://www.ncbi.nlm.nih.gov/pubmed/32709378
18204,33422771,Preclinical evaluation of [(18)F]cabozantinib as a PET imaging agent in a prostate cancer mouse model,Nucl Med Biol. 2021 Feb;93:74-80. doi: 10.1016/j.nucmedbio.2020.12.002. Epub 2020 Dec 23.,Lien VT,https://www.ncbi.nlm.nih.gov/pubmed/33422771
18205,30914279,The role of SOX family members in solid tumours and metastasis,Semin Cancer Biol. 2020 Dec;67(Pt 1):122-153. doi: 10.1016/j.semcancer.2019.03.004. Epub 2019 Mar 23.,Grimm D,https://www.ncbi.nlm.nih.gov/pubmed/30914279
18206,32575748,Spatial Autocorrelation of Breast and Prostate Cancer in Slovakia,Int J Environ Res Public Health. 2020 Jun 20;17(12):4440. doi: 10.3390/ijerph17124440.,Vilinová K,https://www.ncbi.nlm.nih.gov/pubmed/32575748
18207,32298604,Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram,J Comput Biol. 2020 Dec;27(12):1656-1667. doi: 10.1089/cmb.2019.0397. Epub 2020 Apr 16.,Hu M,https://www.ncbi.nlm.nih.gov/pubmed/32298604
18208,33057873,Adiposity over the life course and prostate cancer: unraveling the complexities,Cancer Causes Control. 2020 Dec;31(12):1051-1055. doi: 10.1007/s10552-020-01353-6. Epub 2020 Oct 14.,Giovannucci E,https://www.ncbi.nlm.nih.gov/pubmed/33057873
18209,32401013,Sarcosine Prostate Cancer Biomarker Detection by Controlling Oxygen in NiO(x) Membrane on Vertical Silicon Nanowires in Electrolyte-Insulator-Nanowire Structure,Anal Chem. 2020 Jun 16;92(12):8064-8071. doi: 10.1021/acs.analchem.9b04745. Epub 2020 May 28.,Roy A,https://www.ncbi.nlm.nih.gov/pubmed/32401013
18210,32788235,Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA,J Immunother Cancer. 2020 Aug;8(2):e001065. doi: 10.1136/jitc-2020-001065.,Barata P,https://www.ncbi.nlm.nih.gov/pubmed/32788235
18211,32636623,Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on ?-Glucosidase/Amygdalin,Int J Nanomedicine. 2020 Jun 29;15:4639-4657. doi: 10.2147/IJN.S242359. eCollection 2020.,Zhou J,https://www.ncbi.nlm.nih.gov/pubmed/32636623
18214,32043178,A Weak and Semi-supervised Segmentation Method for Prostate Cancer in TRUS Images,J Digit Imaging. 2020 Aug;33(4):838-845. doi: 10.1007/s10278-020-00323-3.,Han S,https://www.ncbi.nlm.nih.gov/pubmed/32043178
18215,32664160,The association between sleep duration and prostate cancer: A systematic review and meta-analysis,Medicine (Baltimore). 2020 Jul 10;99(28):e21180. doi: 10.1097/MD.0000000000021180.,Liu R,https://www.ncbi.nlm.nih.gov/pubmed/32664160
18216,32897691,Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy,ACS Appl Mater Interfaces. 2020 Sep 23;12(38):42511-42520. doi: 10.1021/acsami.0c11636. Epub 2020 Sep 8.,Hu J,https://www.ncbi.nlm.nih.gov/pubmed/32897691
18217,33166581,Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer,J Pharm Sci. 2021 Feb;110(2):876-887. doi: 10.1016/j.xphs.2020.11.005. Epub 2020 Nov 7.,Yang Q,https://www.ncbi.nlm.nih.gov/pubmed/33166581
18218,33199495,CDK12 Deficiency and the Immune Microenvironment in Prostate Cancer,Clin Cancer Res. 2021 Jan 15;27(2):380-382. doi: 10.1158/1078-0432.CCR-20-3877. Epub 2020 Nov 16.,Lotan TL,https://www.ncbi.nlm.nih.gov/pubmed/33199495
18219,33135403,Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL,Investig Clin Urol. 2020 Nov;61(6):582-587. doi: 10.4111/icu.20200084.,Choi J,https://www.ncbi.nlm.nih.gov/pubmed/33135403
18220,33255593,The Genetic Complexity of Prostate Cancer,Genes (Basel). 2020 Nov 25;11(12):1396. doi: 10.3390/genes11121396.,Compérat E,https://www.ncbi.nlm.nih.gov/pubmed/33255593
18221,32790034,PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA,Oncologist. 2021 Jan;26(1):e115-e129. doi: 10.1634/theoncologist.2020-0697. Epub 2020 Sep 8.,Risdon EN,https://www.ncbi.nlm.nih.gov/pubmed/32790034
18222,33169479,The number of glutamines in the N-terminal of the canine androgen receptor affects signalling intensities,Vet Comp Oncol. 2021 Jun;19(2):399-403. doi: 10.1111/vco.12663. Epub 2020 Nov 16.,Ochiai K,https://www.ncbi.nlm.nih.gov/pubmed/33169479
18223,32588472,Moringa oleifera methanolic leaves extract induces apoptosis and G0/G1 cell cycle arrest via downregulation of Hedgehog Signaling Pathway in human prostate PC-3 cancer cells,J Food Biochem. 2020 Aug;44(8):e13338. doi: 10.1111/jfbc.13338. Epub 2020 Jun 25.,Khan F,https://www.ncbi.nlm.nih.gov/pubmed/32588472
18224,32413672,Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway,Biomed Pharmacother. 2020 Jul;127:110223. doi: 10.1016/j.biopha.2020.110223. Epub 2020 May 12.,Ye J,https://www.ncbi.nlm.nih.gov/pubmed/32413672
18225,32875559,"Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland",Int J Cancer. 2020 Nov 15;147(10):2793-2800. doi: 10.1002/ijc.33272. Epub 2020 Sep 11.,Woko?orczyk D,https://www.ncbi.nlm.nih.gov/pubmed/32875559
18226,32818862,Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure,J Trace Elem Med Biol. 2020 Dec;62:126633. doi: 10.1016/j.jtemb.2020.126633. Epub 2020 Aug 7.,Prajapati A,https://www.ncbi.nlm.nih.gov/pubmed/32818862
18227,33351846,Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort,PLoS One. 2020 Dec 22;15(12):e0244149. doi: 10.1371/journal.pone.0244149. eCollection 2020.,Ishiyama Y,https://www.ncbi.nlm.nih.gov/pubmed/33351846
18228,33347625,Direct interaction of ?-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer,EMBO J. 2021 Feb 15;40(4):e105450. doi: 10.15252/embj.2020105450. Epub 2020 Dec 21.,Pan KF,https://www.ncbi.nlm.nih.gov/pubmed/33347625
18229,32790723,Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer,PLoS One. 2020 Aug 13;15(8):e0237248. doi: 10.1371/journal.pone.0237248. eCollection 2020.,Erb HHH,https://www.ncbi.nlm.nih.gov/pubmed/32790723
18231,33308904,Medical image segmentation and reconstruction of prostate tumor based on 3D AlexNet,Comput Methods Programs Biomed. 2021 Mar;200:105878. doi: 10.1016/j.cmpb.2020.105878. Epub 2020 Nov 27.,Chen J,https://www.ncbi.nlm.nih.gov/pubmed/33308904
18232,33306753,The frequency of thyroid incidental findings and risk of malignancy detected by (68)Ga-labeled prostate-specific membrane antigen PET/CT in prostate cancer,Hell J Nucl Med. 2020 Sep-Dec;23(3):240-245. doi: 10.1967/s002449912202. Epub 2020 Dec 14.,Gossili F,https://www.ncbi.nlm.nih.gov/pubmed/33306753
18234,33349973,The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression,Clin Exp Pharmacol Physiol. 2021 Mar;48(3):422-434. doi: 10.1111/1440-1681.13452. Epub 2020 Dec 21.,Sauer H,https://www.ncbi.nlm.nih.gov/pubmed/33349973
18235,32876551,Body image in men with prostate or laryngeal cancer and their female partners,Z Psychosom Med Psychother. 2020 Sep;66(3):287-301. doi: 10.13109/zptm.2020.66.3.287.,Horschke S,https://www.ncbi.nlm.nih.gov/pubmed/32876551
18236,32606678,"Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer",Int J Nanomedicine. 2020 Jun 17;15:4289-4309. doi: 10.2147/IJN.S243548. eCollection 2020.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32606678
18237,32543166,Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study,Q J Nucl Med Mol Imaging. 2022 Dec;66(4):352-360. doi: 10.23736/S1824-4785.20.03227-6. Epub 2020 Jun 15.,Alongi P,https://www.ncbi.nlm.nih.gov/pubmed/32543166
18238,33069585,Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort,Clin Genitourin Cancer. 2021 Jun;19(3):217-222.e1. doi: 10.1016/j.clgc.2020.07.012. Epub 2020 Aug 22.,Boxley PJ,https://www.ncbi.nlm.nih.gov/pubmed/33069585
18239,33220402,Synthesis and evaluation of new dinitrobenzamide mustards in human prostate cancer,Bioorg Med Chem Lett. 2021 Jan 1;31:127697. doi: 10.1016/j.bmcl.2020.127697. Epub 2020 Nov 18.,Basiri A,https://www.ncbi.nlm.nih.gov/pubmed/33220402
18240,32056383,Late-onset hypogonadism: Prostate safety,Andrology. 2020 Nov;8(6):1606-1613. doi: 10.1111/andr.12772. Epub 2020 Feb 28.,Miranda EP,https://www.ncbi.nlm.nih.gov/pubmed/32056383
18242,31975433,miR-210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells,J Cell Physiol. 2020 Sep;235(9):6194-6203. doi: 10.1002/jcp.29548. Epub 2020 Jan 24.,Angel CZ,https://www.ncbi.nlm.nih.gov/pubmed/31975433
18243,32979134,A pilot feasibility randomized controlled trial adding behavioral counseling to supervised physical activity in prostate cancer survivors: behavior change in prostate cancer survivors trial (BOOST),J Behav Med. 2021 Apr;44(2):172-186. doi: 10.1007/s10865-020-00185-8. Epub 2020 Sep 26.,Trinh L,https://www.ncbi.nlm.nih.gov/pubmed/32979134
18244,33186481,Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases,Int J Cancer. 2021 May 1;148(9):2203-2211. doi: 10.1002/ijc.33397. Epub 2020 Nov 23.,George G,https://www.ncbi.nlm.nih.gov/pubmed/33186481
18247,32704044,Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer,Sci Rep. 2020 Jul 23;10(1):12327. doi: 10.1038/s41598-020-69338-8.,Gheghiani L,https://www.ncbi.nlm.nih.gov/pubmed/32704044
18248,33112829,Adiponectin receptor activation inhibits prostate cancer xenograft growth,Endocr Relat Cancer. 2020 Dec;27(12):711-729. doi: 10.1530/ERC-20-0297.,Philp LK,https://www.ncbi.nlm.nih.gov/pubmed/33112829
18250,33333118,Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo,J Control Release. 2021 Feb 10;330:101-110. doi: 10.1016/j.jconrel.2020.12.017. Epub 2020 Dec 14.,Severic M,https://www.ncbi.nlm.nih.gov/pubmed/33333118
18251,32017073,Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial-mesenchymal transition,J Cell Physiol. 2020 Jul;235(7-8):5602-5612. doi: 10.1002/jcp.29490. Epub 2020 Feb 4.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32017073
18254,32943361,The implementation of a novel patient symptom screening tool: The Odette Cancer Centre (OCC) experience,J Med Imaging Radiat Sci. 2020 Dec;51(4):546-549. doi: 10.1016/j.jmir.2020.08.010. Epub 2020 Sep 14.,Turner A,https://www.ncbi.nlm.nih.gov/pubmed/32943361
18255,32831047,Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells,BMC Cancer. 2020 Aug 24;20(1):802. doi: 10.1186/s12885-020-07310-5.,Igarashi K,https://www.ncbi.nlm.nih.gov/pubmed/32831047
18256,33357453,The Jekyll and Hyde of Senescence in Cancer: TIMP1 Controls the Switch from Tumor-Controlling to Tumor-Promoting Senescence,Cancer Cell. 2021 Jan 11;39(1):13-15. doi: 10.1016/j.ccell.2020.12.013. Epub 2020 Dec 24.,Da Silva-Álvarez S,https://www.ncbi.nlm.nih.gov/pubmed/33357453
18257,32396045,PSMA-targeted Radiotracers versus (18)F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis,Radiology. 2020 Jul;296(1):44-55. doi: 10.1148/radiol.2020191689. Epub 2020 May 12.,Tan N,https://www.ncbi.nlm.nih.gov/pubmed/32396045
18258,32978283,Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center,J Nucl Med. 2021 May 10;62(5):695-699. doi: 10.2967/jnumed.120.251751. Epub 2020 Sep 25.,Bucknor MD,https://www.ncbi.nlm.nih.gov/pubmed/32978283
18259,33116405,"The Impact of Icariside II on Human Prostate Cancer Cell Proliferation, Mobility, and Autophagy via PI3K-AKT-mTOR Signaling Pathway",Drug Des Devel Ther. 2020 Oct 8;14:4169-4178. doi: 10.2147/DDDT.S268524. eCollection 2020.,Li S,https://www.ncbi.nlm.nih.gov/pubmed/33116405
18262,33293372,Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET,Clin Cancer Res. 2021 Mar 1;27(5):1305-1315. doi: 10.1158/1078-0432.CCR-20-3310. Epub 2020 Dec 8.,Wang S,https://www.ncbi.nlm.nih.gov/pubmed/33293372
18263,32378902,Impact of Increased FUT8 Expression on the Extracellular Vesicle Proteome in Prostate Cancer Cells,J Proteome Res. 2020 Jun 5;19(6):2195-2205. doi: 10.1021/acs.jproteome.9b00578. Epub 2020 May 18.,Clark DJ,https://www.ncbi.nlm.nih.gov/pubmed/32378902
18264,32321673,"Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer",Clin Genitourin Cancer. 2020 Dec;18(6):436-443. doi: 10.1016/j.clgc.2020.03.012. Epub 2020 Mar 27.,Yu EY,https://www.ncbi.nlm.nih.gov/pubmed/32321673
18266,32284256,Role of miRNAs in prostate cancer: Do we really know everything?,Urol Oncol. 2020 Jul;38(7):623-635. doi: 10.1016/j.urolonc.2020.03.007. Epub 2020 Apr 10.,Cochetti G,https://www.ncbi.nlm.nih.gov/pubmed/32284256
18267,32734806,PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing,Scand J Urol. 2020 Oct;54(5):376-381. doi: 10.1080/21681805.2020.1797871. Epub 2020 Jul 31.,Enblad AP,https://www.ncbi.nlm.nih.gov/pubmed/32734806
18268,32374071,Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer,ChemMedChem. 2020 Aug 5;15(15):1473-1479. doi: 10.1002/cmdc.202000174. Epub 2020 Jun 30.,Fröhlich T,https://www.ncbi.nlm.nih.gov/pubmed/32374071
18269,33212909,Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer,Cells. 2020 Nov 17;9(11):2494. doi: 10.3390/cells9112494.,Devlies W,https://www.ncbi.nlm.nih.gov/pubmed/33212909
18270,32800724,Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-resistant Prostate Cancer and Risk of Cardiovascular Toxicity: All That Glitters Isn't Gold,Eur Urol. 2020 Nov;78(5):647-649. doi: 10.1016/j.eururo.2020.07.036. Epub 2020 Aug 14.,Di Lorenzo G,https://www.ncbi.nlm.nih.gov/pubmed/32800724
18272,32878799,"Anti-tumor Effect of Hedgehog Signaling Inhibitor, Vismodegib, on Castration-resistant Prostate Cancer",Anticancer Res. 2020 Sep;40(9):5107-5114. doi: 10.21873/anticanres.14514.,Ishii A,https://www.ncbi.nlm.nih.gov/pubmed/32878799
18273,31016492,The Sexual Functioning of Gay and Bisexual Men Following Prostate Cancer Treatment: Results from the Restore Study,Arch Sex Behav. 2020 Jul;49(5):1589-1600. doi: 10.1007/s10508-018-1360-y. Epub 2019 Apr 23.,Rosser BRS,https://www.ncbi.nlm.nih.gov/pubmed/31016492
18274,32806261,Anti-PSMA monoclonal antibody increases the toxicity of paclitaxel carried by carbon nanotubes,Mater Sci Eng C Mater Biol Appl. 2020 Nov;116:111254. doi: 10.1016/j.msec.2020.111254. Epub 2020 Jul 3.,Comparetti EJ,https://www.ncbi.nlm.nih.gov/pubmed/32806261
18275,33025691,PRKAR2B-HIF-1? loop promotes aerobic glycolysis and tumour growth in prostate cancer,Cell Prolif. 2020 Nov;53(11):e12918. doi: 10.1111/cpr.12918. Epub 2020 Oct 7.,Xia L,https://www.ncbi.nlm.nih.gov/pubmed/33025691
18276,31412010,An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer,Eur Urol Oncol. 2020 Aug;3(4):498-508. doi: 10.1016/j.euo.2018.12.005. Epub 2019 Jan 4.,Faugeroux V,https://www.ncbi.nlm.nih.gov/pubmed/31412010
18277,32755168,Prospective Evaluation of (18)F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI,AJR Am J Roentgenol. 2020 Sep;215(3):652-659. doi: 10.2214/AJR.19.22042. Epub 2020 Jul 8.,Gaur S,https://www.ncbi.nlm.nih.gov/pubmed/32755168
18278,33106406,RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance,Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28092-28101. doi: 10.1073/pnas.2008479117. Epub 2020 Oct 26.,Vellky JE,https://www.ncbi.nlm.nih.gov/pubmed/33106406
18280,32833340,Silencing of microRNA-3175 represses cell proliferation and invasion in prostate cancer by targeting the potential tumor-suppressor SCN4B,Kaohsiung J Med Sci. 2021 Jan;37(1):20-26. doi: 10.1002/kjm2.12292. Epub 2020 Aug 24.,Huang H,https://www.ncbi.nlm.nih.gov/pubmed/32833340
18281,33186790,PCLiON: An Ontology for Data Standardization and Sharing of Prostate Cancer Associated Lifestyles,Int J Med Inform. 2021 Jan;145:104332. doi: 10.1016/j.ijmedinf.2020.104332. Epub 2020 Nov 7.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/33186790
18282,33408816,Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner,J Extracell Vesicles. 2020 Dec;10(2):e12042. doi: 10.1002/jev2.12042. Epub 2020 Dec 31.,Henrich SE,https://www.ncbi.nlm.nih.gov/pubmed/33408816
18283,32701717,"Clinical application of Fluciclovine PET, choline PET and gastrin-releasing polypeptide receptor (bombesin) targeting PET in prostate cancer",Curr Opin Urol. 2020 Sep;30(5):641-648. doi: 10.1097/MOU.0000000000000794.,Ceci F,https://www.ncbi.nlm.nih.gov/pubmed/32701717
18284,32634132,LIN28B promotes the development of neuroendocrine prostate cancer,J Clin Invest. 2020 Oct 1;130(10):5338-5348. doi: 10.1172/JCI135373.,Lovnicki J,https://www.ncbi.nlm.nih.gov/pubmed/32634132
18285,33007922,Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status,Biomolecules. 2020 Sep 30;10(10):1393. doi: 10.3390/biom10101393.,Snider AJ,https://www.ncbi.nlm.nih.gov/pubmed/33007922
18286,33309734,Non-coding RNAs regulating androgen receptor signaling pathways in prostate cancer,Clin Chim Acta. 2021 Feb;513:57-63. doi: 10.1016/j.cca.2020.11.027. Epub 2020 Dec 10.,Lu K,https://www.ncbi.nlm.nih.gov/pubmed/33309734
18287,32574928,EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells,Colloids Surf B Biointerfaces. 2020 Oct;194:111185. doi: 10.1016/j.colsurfb.2020.111185. Epub 2020 Jun 6.,Eloy JO,https://www.ncbi.nlm.nih.gov/pubmed/32574928
18288,33106066,Treatment and resistance mechanisms in castration-resistant prostate cancer: new implications for clinical decision making?,Expert Rev Anticancer Ther. 2021 Feb;21(2):149-163. doi: 10.1080/14737140.2021.1843430. Epub 2020 Nov 16.,Norz V,https://www.ncbi.nlm.nih.gov/pubmed/33106066
18289,32086567,Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany,Support Care Cancer. 2020 Nov;28(11):5223-5233. doi: 10.1007/s00520-020-05357-5. Epub 2020 Feb 21.,Diel I,https://www.ncbi.nlm.nih.gov/pubmed/32086567
18291,33155366,BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN,Mol Oncol. 2021 Jan;15(1):279-298. doi: 10.1002/1878-0261.12844. Epub 2020 Nov 20.,Deng R,https://www.ncbi.nlm.nih.gov/pubmed/33155366
18292,33164833,Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells,Life Sci. 2021 Jan 1;264:118638. doi: 10.1016/j.lfs.2020.118638. Epub 2020 Oct 24.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/33164833
18293,32797765,Application of novel pH sensitive isoniazid-heptamethine carbocyanine dye conjugates against prostate cancer cells,Pharmazie. 2020 Sep 1;75(9):412-416. doi: 10.1691/ph.2020.0521.,Yang XG,https://www.ncbi.nlm.nih.gov/pubmed/32797765
18294,32525068,Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models,J Ethnopharmacol. 2020 Oct 5;260:113058. doi: 10.1016/j.jep.2020.113058. Epub 2020 Jun 7.,Zhang ZB,https://www.ncbi.nlm.nih.gov/pubmed/32525068
18295,32796451,Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?,Nucl Med Commun. 2020 Nov;41(11):1183-1188. doi: 10.1097/MNM.0000000000001268.,Raju S,https://www.ncbi.nlm.nih.gov/pubmed/32796451
18297,32962642,Correlation between peripheral blood neutrophil-lymphocyte ratio and CD34 expression in prostate cancer,BMC Cancer. 2020 Sep 22;20(1):900. doi: 10.1186/s12885-020-07382-3.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32962642
18298,32865823,Phototoxic eruption caused by enzalutamide (Xtandi),Contact Dermatitis. 2021 Jan;84(1):64-65. doi: 10.1111/cod.13692. Epub 2020 Sep 18.,Navarro-Triviño FJ,https://www.ncbi.nlm.nih.gov/pubmed/32865823
18299,32185445,PI-RADS: what is new and how to use it,Abdom Radiol (NY). 2020 Dec;45(12):3951-3960. doi: 10.1007/s00261-020-02482-x.,Dutruel SP,https://www.ncbi.nlm.nih.gov/pubmed/32185445
18301,32847976,The Dual Androgen Receptor and Glucocorticoid Receptor Antagonist CB-03-10 as Potential Treatment for Tumors that have Acquired GR-mediated Resistance to AR Blockade,Mol Cancer Ther. 2020 Nov;19(11):2256-2266. doi: 10.1158/1535-7163.MCT-19-1137. Epub 2020 Aug 26.,Rosette C,https://www.ncbi.nlm.nih.gov/pubmed/32847976
18302,33310350,Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer,Nucl Med Biol. 2021 Feb;93:37-45. doi: 10.1016/j.nucmedbio.2020.11.007. Epub 2020 Nov 28.,Kwan KH,https://www.ncbi.nlm.nih.gov/pubmed/33310350
18303,32390303,Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance,FASEB J. 2020 Jul;34(7):9087-9101. doi: 10.1096/fj.201802159RRR. Epub 2020 May 11.,Li T,https://www.ncbi.nlm.nih.gov/pubmed/32390303
18305,32814845,Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):15-23. doi: 10.1038/s41391-020-00267-3. Epub 2020 Aug 19.,Cui H,https://www.ncbi.nlm.nih.gov/pubmed/32814845
18306,33037932,TAp63 and ?Np63 (p40) in prostate adenocarcinomas: ?Np63 associates with a basal-like cancer stem cell population but not with metastasis,Virchows Arch. 2021 Apr;478(4):627-636. doi: 10.1007/s00428-020-02944-z. Epub 2020 Oct 10.,Galoczova M,https://www.ncbi.nlm.nih.gov/pubmed/33037932
18307,33024272,Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM,Br J Cancer. 2021 Jan;124(1):247-258. doi: 10.1038/s41416-020-01091-1. Epub 2020 Oct 7.,Li T,https://www.ncbi.nlm.nih.gov/pubmed/33024272
18308,33169756,Microfluidic Raman biochip detection of exosomes: a promising tool for prostate cancer diagnosis,Lab Chip. 2020 Dec 15;20(24):4632-4637. doi: 10.1039/d0lc00677g.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/33169756
18309,32940630,Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer,JAMA Oncol. 2020 Nov 1;6(11):1773-1777. doi: 10.1001/jamaoncol.2020.3697.,Senft N,https://www.ncbi.nlm.nih.gov/pubmed/32940630
18310,33001270,The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro,J Cancer Res Clin Oncol. 2021 Feb;147(2):339-350. doi: 10.1007/s00432-020-03405-5. Epub 2020 Oct 1.,Yamaguchi M,https://www.ncbi.nlm.nih.gov/pubmed/33001270
18311,32305266,Development and evaluation of the MiCheck test for aggressive prostate cancer,Urol Oncol. 2020 Aug;38(8):683.e11-683.e18. doi: 10.1016/j.urolonc.2020.03.010. Epub 2020 Apr 16.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32305266
18312,32868382,KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis,Cancer Res. 2020 Nov 1;80(21):4633-4643. doi: 10.1158/0008-5472.CAN-20-0505. Epub 2020 Aug 31.,Li G,https://www.ncbi.nlm.nih.gov/pubmed/32868382
18313,33086087,Neuronal calcitonin gene-related peptide promotes prostate tumor growth in the bone microenvironment,Peptides. 2021 Jan;135:170423. doi: 10.1016/j.peptides.2020.170423. Epub 2020 Oct 18.,Zhu W,https://www.ncbi.nlm.nih.gov/pubmed/33086087
18314,32907840,A Deep Learning Framework Identifies Pathogenic Noncoding Somatic Mutations from Personal Prostate Cancer Genomes,Cancer Res. 2020 Nov 1;80(21):4644-4654. doi: 10.1158/0008-5472.CAN-20-1791. Epub 2020 Sep 9.,Wang C,https://www.ncbi.nlm.nih.gov/pubmed/32907840
18315,32360904,Thyroid hormone induces cellular senescence in prostate cancer cells through induction of DEC1,J Steroid Biochem Mol Biol. 2020 Jul;201:105689. doi: 10.1016/j.jsbmb.2020.105689. Epub 2020 May 1.,Kotolloshi R,https://www.ncbi.nlm.nih.gov/pubmed/32360904
18316,33218199,"Sulforaphane Reduces Prostate Cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7",Int J Mol Sci. 2020 Nov 18;21(22):8724. doi: 10.3390/ijms21228724.,Rutz J,https://www.ncbi.nlm.nih.gov/pubmed/33218199
18317,33255879,Therapeutic Potential of Gnetin C in Prostate Cancer: A Pre-Clinical Study,Nutrients. 2020 Nov 26;12(12):3631. doi: 10.3390/nu12123631.,Gadkari K,https://www.ncbi.nlm.nih.gov/pubmed/33255879
18319,33288609,Efficacy and Safety of Enzalutamide in a Real-World Cohort of Japanese Patients With Castration-resistant Prostate Cancer,Anticancer Res. 2020 Dec;40(12):7101-7108. doi: 10.21873/anticanres.14739.,Hori A,https://www.ncbi.nlm.nih.gov/pubmed/33288609
18320,30651026,The relationship between androgen deprivation therapy and depression symptoms in patients with prostate cancer,Aging Male. 2020 Dec;23(5):629-634. doi: 10.1080/13685538.2018.1560404. Epub 2019 Jan 16.,Chen YZ,https://www.ncbi.nlm.nih.gov/pubmed/30651026
18321,33038264,GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells,Int J Cancer. 2021 Jan 15;148(2):469-480. doi: 10.1002/ijc.33335. Epub 2020 Oct 21.,Hao J,https://www.ncbi.nlm.nih.gov/pubmed/33038264
18322,32735933,Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death,Int J Biol Macromol. 2020 Dec 1;164:1461-1474. doi: 10.1016/j.ijbiomac.2020.07.228. Epub 2020 Jul 28.,Faraji Dizaji B,https://www.ncbi.nlm.nih.gov/pubmed/32735933
18323,33352838,Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer,Molecules. 2020 Dec 18;25(24):5993. doi: 10.3390/molecules25245993.,Baun C,https://www.ncbi.nlm.nih.gov/pubmed/33352838
18324,33034258,In silico approach of naringin as potent phosphatase and tensin homolog (PTEN) protein agonist against prostate cancer,J Biomol Struct Dyn. 2022 Mar;40(4):1629-1638. doi: 10.1080/07391102.2020.1830855. Epub 2020 Oct 9.,Muthumanickam S,https://www.ncbi.nlm.nih.gov/pubmed/33034258
18325,32438200,Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer,Eur J Med Chem. 2020 Aug 1;199:112414. doi: 10.1016/j.ejmech.2020.112414. Epub 2020 May 8.,Sanz Del Olmo N,https://www.ncbi.nlm.nih.gov/pubmed/32438200
18326,32717455,Photodynamic therapy on prostate cancer cells involve mitochondria membrane proteins,Photodiagnosis Photodyn Ther. 2020 Sep;31:101933. doi: 10.1016/j.pdpdt.2020.101933. Epub 2020 Jul 24.,Xu DD,https://www.ncbi.nlm.nih.gov/pubmed/32717455
18327,32406844,A 1 MHz Miniaturized Electrical Impedance Tomography System for Prostate Imaging,IEEE Trans Biomed Circuits Syst. 2020 Aug;14(4):787-799. doi: 10.1109/TBCAS.2020.2994297. Epub 2020 May 12.,Rao A,https://www.ncbi.nlm.nih.gov/pubmed/32406844
18329,33176754,"Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis",BMC Cancer. 2020 Nov 11;20(1):1097. doi: 10.1186/s12885-020-07611-9.,Hernández Vargas JA,https://www.ncbi.nlm.nih.gov/pubmed/33176754
18330,33126692,Optimising Web-Based Computer-Tailored Physical Activity Interventions for Prostate Cancer Survivors: A Randomised Controlled Trial Examining the Impact of Website Architecture on User Engagement,Int J Environ Res Public Health. 2020 Oct 28;17(21):7920. doi: 10.3390/ijerph17217920.,Finlay A,https://www.ncbi.nlm.nih.gov/pubmed/33126692
18331,33288345,Separation based characterization methods for the N-glycosylation analysis of prostate-specific antigen,J Pharm Biomed Anal. 2021 Feb 5;194:113797. doi: 10.1016/j.jpba.2020.113797. Epub 2020 Nov 25.,Reider B,https://www.ncbi.nlm.nih.gov/pubmed/33288345
18332,33119680,Prescription-based prediction of baseline mortality risk among older men,PLoS One. 2020 Oct 29;15(10):e0241439. doi: 10.1371/journal.pone.0241439. eCollection 2020.,Gedeborg R,https://www.ncbi.nlm.nih.gov/pubmed/33119680
18337,33198142,Understanding the Relationship between Environmental Arsenic and Prostate Cancer Aggressiveness among African-American and European-American Men in North Carolina,Int J Environ Res Public Health. 2020 Nov 12;17(22):8364. doi: 10.3390/ijerph17228364.,Parada H Jr,https://www.ncbi.nlm.nih.gov/pubmed/33198142
18338,32198642,Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials,Clin Transl Oncol. 2020 Nov;22(11):2126-2129. doi: 10.1007/s12094-020-02334-6. Epub 2020 Mar 20.,Carretero-González A,https://www.ncbi.nlm.nih.gov/pubmed/32198642
18339,33368449,Effect of prostate volume on f/tPSA value: A cross-sectional study,Andrologia. 2021 Mar;53(2):e13851. doi: 10.1111/and.13851. Epub 2020 Dec 25.,Xu XH,https://www.ncbi.nlm.nih.gov/pubmed/33368449
18340,32657143,Combination of Curcumin and Metformin Inhibits Cell Growth and Induces Apoptosis without Affecting the Cell Cycle in LNCaP Prostate Cancer Cell Line,Nutr Cancer. 2021;73(6):1026-1039. doi: 10.1080/01635581.2020.1783327. Epub 2020 Jul 13.,Eslami SS,https://www.ncbi.nlm.nih.gov/pubmed/32657143
18341,32651179,Genomic Profiling of Prostate Cancers from Men with African and European Ancestry,Clin Cancer Res. 2020 Sep 1;26(17):4651-4660. doi: 10.1158/1078-0432.CCR-19-4112. Epub 2020 Jul 10.,Koga Y,https://www.ncbi.nlm.nih.gov/pubmed/32651179
18342,33323969,A detailed characterization of stepwise activation of the androgen receptor variant 7 in prostate cancer cells,Oncogene. 2021 Feb;40(6):1106-1117. doi: 10.1038/s41388-020-01585-5. Epub 2020 Dec 15.,Roggero CM,https://www.ncbi.nlm.nih.gov/pubmed/33323969
18343,32878797,YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression,Anticancer Res. 2020 Sep;40(9):5091-5095. doi: 10.21873/anticanres.14512.,Miyao T,https://www.ncbi.nlm.nih.gov/pubmed/32878797
18344,32329523,Long intergenic noncoding RNA 00844 promotes apoptosis and represses proliferation of prostate cancer cells through upregulating GSTP1 by recruiting EBF1,J Cell Physiol. 2020 Nov;235(11):8472-8485. doi: 10.1002/jcp.29690. Epub 2020 Apr 24.,Qiu K,https://www.ncbi.nlm.nih.gov/pubmed/32329523
18345,33339129,Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics,Int J Mol Sci. 2020 Dec 16;21(24):9568. doi: 10.3390/ijms21249568.,Verma S,https://www.ncbi.nlm.nih.gov/pubmed/33339129
18346,32938488,Mapping the prevalence of the neglected sexual side effects after prostate cancer treatment and the questionnaires used in their screening: a scoping review protocol,Syst Rev. 2020 Sep 17;9(1):214. doi: 10.1186/s13643-020-01473-9.,Röscher P,https://www.ncbi.nlm.nih.gov/pubmed/32938488
18349,32522441,"The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3? pathway in prostate cancer",Exp Cell Res. 2020 Sep 1;394(1):112128. doi: 10.1016/j.yexcr.2020.112128. Epub 2020 Jun 6.,Tian J,https://www.ncbi.nlm.nih.gov/pubmed/32522441
18351,32343676,The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer,J Clin Invest. 2020 Aug 3;130(8):3987-4005. doi: 10.1172/JCI134260.,Ramanand SG,https://www.ncbi.nlm.nih.gov/pubmed/32343676
18352,33455106,Hesperidin induces anticancer effects on human prostate cancer cells via ROS-mediated necrosis like cell death,J BUON. 2020 Nov-Dec;25(6):2629-2634.,Ning L,https://www.ncbi.nlm.nih.gov/pubmed/33455106
18353,33263793,Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?,Eur Radiol. 2021 Jun;31(6):3754-3764. doi: 10.1007/s00330-020-07494-1. Epub 2020 Dec 2.,Huebner NA,https://www.ncbi.nlm.nih.gov/pubmed/33263793
18356,33246977,First Experiences with (177)Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single Patients,J Nucl Med. 2021 Jul 1;62(7):975-978. doi: 10.2967/jnumed.120.249029. Epub 2020 Nov 27.,Prasad V,https://www.ncbi.nlm.nih.gov/pubmed/33246977
18357,32357309,CRISP3 expression drives prostate cancer invasion and progression,Endocr Relat Cancer. 2020 Jul;27(7):415-430. doi: 10.1530/ERC-20-0092.,Volpert M,https://www.ncbi.nlm.nih.gov/pubmed/32357309
18358,32956110,68Ga-PSMA-Avid Small Cell Lung Cancer on PET/CT: Incidental Second Malignancy in Treated Prostate Cancer,Clin Nucl Med. 2020 Dec;45(12):1016-1017. doi: 10.1097/RLU.0000000000003270.,Sharma P,https://www.ncbi.nlm.nih.gov/pubmed/32956110
18361,32855264,Effect of a Prostate Cancer Screening Decision Aid for African-American Men in Primary Care Settings,Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2157-2164. doi: 10.1158/1055-9965.EPI-20-0454. Epub 2020 Aug 27.,Allen JD,https://www.ncbi.nlm.nih.gov/pubmed/32855264
18364,32531951,Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells,Cells. 2020 Jun 10;9(6):1441. doi: 10.3390/cells9061441.,Sánchez BG,https://www.ncbi.nlm.nih.gov/pubmed/32531951
18365,33301988,Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway,Infect Genet Evol. 2021 Mar;88:104669. doi: 10.1016/j.meegid.2020.104669. Epub 2020 Dec 7.,Afshari A,https://www.ncbi.nlm.nih.gov/pubmed/33301988
18366,32662898,Analysis of the expression and association of retinoblastoma binding protein 6 with the JNK signaling pathway in prostate cancers,Cell Biol Int. 2020 Oct;44(10):2107-2119. doi: 10.1002/cbin.11419. Epub 2020 Jul 24.,Guan WY,https://www.ncbi.nlm.nih.gov/pubmed/32662898
18367,33080148,Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer,J Urol. 2021 Mar;205(3):800-805. doi: 10.1097/JU.0000000000001428. Epub 2020 Oct 20.,Xu MC,https://www.ncbi.nlm.nih.gov/pubmed/33080148
18370,33320768,Nutrition Education Seminars for Prostate Cancer-Diet and Prostate Program: Evaluation and Recommendations (DAPPER Study),Can J Diet Pract Res. 2021 Mar 1;82(1):27-31. doi: 10.3148/cjdpr-2020-028. Epub 2020 Dec 15.,Stringer EJ BSc,https://www.ncbi.nlm.nih.gov/pubmed/33320768
18371,32506468,"Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study",Int J Cancer. 2020 Dec 1;147(11):3119-3129. doi: 10.1002/ijc.33139. Epub 2020 Jul 20.,Wendeu-Foyet MG,https://www.ncbi.nlm.nih.gov/pubmed/32506468
18373,33287566,"Obesity, Inflammation, and Advanced Prostate Cancer",Nutr Cancer. 2021;73(11-12):2232-2248. doi: 10.1080/01635581.2020.1856889. Epub 2020 Dec 8.,Olivas A,https://www.ncbi.nlm.nih.gov/pubmed/33287566
18374,32313141,The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):661-669. doi: 10.1038/s41391-020-0229-z. Epub 2020 Apr 20.,Cheng S,https://www.ncbi.nlm.nih.gov/pubmed/32313141
18377,32439453,"Identification of a natural compound, sesamin, as a novel TRPM8 antagonist with inhibitory effects on prostate adenocarcinoma",Fitoterapia. 2020 Sep;145:104631. doi: 10.1016/j.fitote.2020.104631. Epub 2020 May 19.,Sui Y,https://www.ncbi.nlm.nih.gov/pubmed/32439453
18378,32710433,Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression,Cell Oncol (Dordr). 2020 Dec;43(6):1099-1116. doi: 10.1007/s13402-020-00544-2. Epub 2020 Jul 24.,Li C,https://www.ncbi.nlm.nih.gov/pubmed/32710433
18379,33355184,BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression,Cancer Res. 2021 Feb 15;81(4):820-833. doi: 10.1158/0008-5472.CAN-20-1417. Epub 2020 Dec 21.,Alpsoy A,https://www.ncbi.nlm.nih.gov/pubmed/33355184
18380,33383350,Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy,Eur J Cancer. 2021 Feb;144:302-309. doi: 10.1016/j.ejca.2020.11.043. Epub 2020 Dec 29.,Sena LA,https://www.ncbi.nlm.nih.gov/pubmed/33383350
18381,32709978,Crosstalk between COVID-19 and prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):561-563. doi: 10.1038/s41391-020-0262-y. Epub 2020 Jul 24.,Bahmad HF,https://www.ncbi.nlm.nih.gov/pubmed/32709978
18382,32493951,A QSP model of prostate cancer immunotherapy to identify effective combination therapies,Sci Rep. 2020 Jun 3;10(1):9063. doi: 10.1038/s41598-020-65590-0.,Coletti R,https://www.ncbi.nlm.nih.gov/pubmed/32493951
18383,33329538,"Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells",Front Immunol. 2020 Nov 27;11:574046. doi: 10.3389/fimmu.2020.574046. eCollection 2020.,Niespolo C,https://www.ncbi.nlm.nih.gov/pubmed/33329538
18384,31821767,Reporting and handling of equivocal imaging findings in diagnostic studies of bone metastasis in prostate cancer,Acta Radiol. 2020 Aug;61(8):1096-1104. doi: 10.1177/0284185119890087. Epub 2019 Dec 10.,Petersen LJ,https://www.ncbi.nlm.nih.gov/pubmed/31821767
18385,32796246,Inguinal Canal Deposit-An Uncommon Site of Metastases in Carcinoma Prostate Detected on 68Ga-Prostate-Specific Membrane Antigen PET/CT,Clin Nucl Med. 2020 Oct;45(10):e443-e444. doi: 10.1097/RLU.0000000000003225.,Arora S,https://www.ncbi.nlm.nih.gov/pubmed/32796246
18386,33183667,Concomitant botanical medicine use among patients participating in commercial prostate cancer trials,Complement Ther Med. 2020 Nov;54:102549. doi: 10.1016/j.ctim.2020.102549. Epub 2020 Aug 29.,Roydhouse JK,https://www.ncbi.nlm.nih.gov/pubmed/33183667
18387,32358016,Population Differentiation at the PVT1 Gene Locus: Implications for Prostate Cancer,G3 (Bethesda). 2020 Jul 7;10(7):2257-2264. doi: 10.1534/g3.120.401291.,Pal G,https://www.ncbi.nlm.nih.gov/pubmed/32358016
18388,32401357,The association between androgen receptor splice variant 7 status and prognosis of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis,Andrologia. 2020 Aug;52(7):e13642. doi: 10.1111/and.13642. Epub 2020 May 13.,Zhou J,https://www.ncbi.nlm.nih.gov/pubmed/32401357
18389,32421868,THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway,Prostate. 2020 Jul;80(10):753-763. doi: 10.1002/pros.23989. Epub 2020 May 18.,Hou Y,https://www.ncbi.nlm.nih.gov/pubmed/32421868
18390,32900716,Nocardia farcinica masquerading as intracerebral metastases in advanced metastatic prostatic cancer,BMJ Case Rep. 2020 Sep 7;13(9):e233678. doi: 10.1136/bcr-2019-233678.,Livings C,https://www.ncbi.nlm.nih.gov/pubmed/32900716
18391,32562805,Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy,Acta Biomater. 2020 Sep 1;113:501-511. doi: 10.1016/j.actbio.2020.06.019. Epub 2020 Jun 18.,Barve A,https://www.ncbi.nlm.nih.gov/pubmed/32562805
18392,32968784,Soy and isoflavone consumption and subsequent risk of prostate cancer mortality: the Japan Public Health Center-based Prospective Study,Int J Epidemiol. 2020 Oct 1;49(5):1553-1561. doi: 10.1093/ije/dyaa177.,Sawada N,https://www.ncbi.nlm.nih.gov/pubmed/32968784
18393,32804697,Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer,Anticancer Drugs. 2020 Nov;31(10):1099-1102. doi: 10.1097/CAD.0000000000000986.,Koh Y,https://www.ncbi.nlm.nih.gov/pubmed/32804697
18394,32970300,Examining the relationship between diabetes and prostate cancer through changes in screening guidelines,Cancer Causes Control. 2020 Dec;31(12):1105-1113. doi: 10.1007/s10552-020-01347-4. Epub 2020 Sep 24.,Miller EA,https://www.ncbi.nlm.nih.gov/pubmed/32970300
18395,32822124,Effects of Arf6 downregulation on biological characteristics of human prostate cancer cells,Int Braz J Urol. 2020 Nov-Dec;46(6):950-961. doi: 10.1590/S1677-5538.IBJU.2019.0499.,Lei H,https://www.ncbi.nlm.nih.gov/pubmed/32822124
18396,32126630,Pump-Free Glass-Based Capillary Microfluidic Immuno-Assay Chip for Electrochemical Detection of Prostate-Specific Antigen,J Nanosci Nanotechnol. 2020 Aug 1;20(8):4629-4633. doi: 10.1166/jnn.2020.17831.,Lee MJ,https://www.ncbi.nlm.nih.gov/pubmed/32126630
18397,32779056,Stochastic Sequential Modeling: Toward Improved Prostate Cancer Diagnosis Through Temporal-Ultrasound,Ann Biomed Eng. 2021 Feb;49(2):573-584. doi: 10.1007/s10439-020-02585-y. Epub 2020 Aug 10.,Nahlawi L,https://www.ncbi.nlm.nih.gov/pubmed/32779056
18398,32363906,In vivo magnetic resonance imaging of orthotopic prostate cancer,Biotechniques. 2020 Jul;69(1):395-403. doi: 10.2144/btn-2020-0021. Epub 2020 May 2.,Ravoori MK,https://www.ncbi.nlm.nih.gov/pubmed/32363906
18399,33368390,The function of long noncoding RNA HOTAIRM1 in the progression of prostate cancer cells,Andrologia. 2021 Mar;53(2):e13897. doi: 10.1111/and.13897. Epub 2020 Dec 23.,Wang L,https://www.ncbi.nlm.nih.gov/pubmed/33368390
18400,32542727,Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells,Prostate. 2020 Sep;80(12):977-985. doi: 10.1002/pros.24029. Epub 2020 Jun 15.,Wang K,https://www.ncbi.nlm.nih.gov/pubmed/32542727
18401,32835531,Denosumab for cancer-related bone loss,Expert Opin Biol Ther. 2020 Nov;20(11):1261-1274. doi: 10.1080/14712598.2020.1814731. Epub 2020 Sep 9.,Dell'Aquila E,https://www.ncbi.nlm.nih.gov/pubmed/32835531
18402,32696213,Quality Comparison of 3 Tesla multiparametric MRI of the prostate using a flexible surface receiver coil versus conventional surface coil plus endorectal coil setup,Abdom Radiol (NY). 2020 Dec;45(12):4260-4270. doi: 10.1007/s00261-020-02641-0. Epub 2020 Jul 21.,Ullrich T,https://www.ncbi.nlm.nih.gov/pubmed/32696213
18403,31898309,Technology-Based Psychosocial Intervention to Improve Quality of Life and Reduce Symptom Burden in Men with Advanced Prostate Cancer: Results from a Randomized Controlled Trial,Int J Behav Med. 2020 Oct;27(5):490-505. doi: 10.1007/s12529-019-09839-7.,Penedo FJ,https://www.ncbi.nlm.nih.gov/pubmed/31898309
18404,33077351,Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitors,Urol Oncol. 2021 Jun;39(6):365.e1-365.e7. doi: 10.1016/j.urolonc.2020.09.036. Epub 2020 Oct 17.,Machidori A,https://www.ncbi.nlm.nih.gov/pubmed/33077351
18405,33128330,Overexpression of LINC00852 promotes prostate cancer cell proliferation and metastasis,Asia Pac J Clin Oncol. 2021 Dec;17(6):435-441. doi: 10.1111/ajco.13418. Epub 2020 Oct 30.,Yi S,https://www.ncbi.nlm.nih.gov/pubmed/33128330
18406,33388344,White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft,J Nutr Biochem. 2021 Mar;89:108580. doi: 10.1016/j.jnutbio.2020.108580. Epub 2020 Dec 31.,Wang X,https://www.ncbi.nlm.nih.gov/pubmed/33388344
18407,32427627,Urological malignancies in neurogenic patients,Curr Opin Urol. 2020 Jul;30(4):501-506. doi: 10.1097/MOU.0000000000000770.,Liu B,https://www.ncbi.nlm.nih.gov/pubmed/32427627
18409,32493699,Stromal CAVIN1 Controls Prostate Cancer Microenvironment and Metastasis by Modulating Lipid Distribution and Inflammatory Signaling,Mol Cancer Res. 2020 Sep;18(9):1414-1426. doi: 10.1158/1541-7786.MCR-20-0364. Epub 2020 Jun 3.,Low JY,https://www.ncbi.nlm.nih.gov/pubmed/32493699
18410,32681360,Effects of resistance exercise in prostate cancer patients : A systematic review update as of March 2020,Wien Klin Wochenschr. 2020 Aug;132(15-16):452-463. doi: 10.1007/s00508-020-01713-x. Epub 2020 Jul 17.,Zdravkovic A,https://www.ncbi.nlm.nih.gov/pubmed/32681360
18411,32198311,"(18)F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smoothing Filter, and Partial-Volume Correction on PROMISE Criteria",J Nucl Med. 2020 Nov;61(11):1615-1620. doi: 10.2967/jnumed.120.241737. Epub 2020 Mar 20.,Ortega C,https://www.ncbi.nlm.nih.gov/pubmed/32198311
18413,32859632,Characterization of Kinase Expression Related to Increased Migration of PC-3M Cells Using Global Comparative Phosphoproteome Analysis,Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):543-553. doi: 10.21873/cgp.20210.,Gao Y,https://www.ncbi.nlm.nih.gov/pubmed/32859632
18414,32810385,"Variability in accuracy of prostate cancer segmentation among radiologists, urologists, and scientists",Cancer Med. 2020 Oct;9(19):7172-7182. doi: 10.1002/cam4.3386. Epub 2020 Aug 18.,Chen MY,https://www.ncbi.nlm.nih.gov/pubmed/32810385
18415,32965517,Comparison of diagnostic performance between diffusion kurtosis imaging parameters and mono-exponential ADC for determination of clinically significant cancer in patients with prostate cancer,Abdom Radiol (NY). 2020 Dec;45(12):4235-4243. doi: 10.1007/s00261-020-02776-0. Epub 2020 Sep 23.,Park H,https://www.ncbi.nlm.nih.gov/pubmed/32965517
18416,33334906,Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors,Clin Cancer Res. 2021 Mar 15;27(6):1792-1806. doi: 10.1158/1078-0432.CCR-20-2483. Epub 2020 Dec 17.,Chakraborty G,https://www.ncbi.nlm.nih.gov/pubmed/33334906
18420,32705237,"MicroRNA?16?5p regulates cell survival, cell cycle and apoptosis by targeting AKT3 in prostate cancer cells",Oncol Rep. 2020 Sep;44(3):1282-1292. doi: 10.3892/or.2020.7682. Epub 2020 Jul 9.,Wang F,https://www.ncbi.nlm.nih.gov/pubmed/32705237
18421,32882608,"Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer",Eur J Med Chem. 2020 Dec 1;207:112695. doi: 10.1016/j.ejmech.2020.112695. Epub 2020 Aug 18.,Sanz Del Olmo N,https://www.ncbi.nlm.nih.gov/pubmed/32882608
18422,32622250,(68)Ga-PSMA PET/MRI for the diagnosis of primary and biochemically recurrent prostate cancer: A meta-analysis,Eur J Radiol. 2020 Sep;130:109131. doi: 10.1016/j.ejrad.2020.109131. Epub 2020 Jun 20.,Wang R,https://www.ncbi.nlm.nih.gov/pubmed/32622250
18423,32611550,Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9,Mol Cancer Res. 2020 Oct;18(10):1512-1521. doi: 10.1158/1541-7786.MCR-20-0339. Epub 2020 Jul 1.,Itkonen HM,https://www.ncbi.nlm.nih.gov/pubmed/32611550
18424,33036464,Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study,Genes (Basel). 2020 Oct 7;11(10):1174. doi: 10.3390/genes11101174.,Franko A,https://www.ncbi.nlm.nih.gov/pubmed/33036464
18426,31932969,The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancer,Med Mol Morphol. 2020 Sep;53(3):156-167. doi: 10.1007/s00795-020-00243-9. Epub 2020 Jan 13.,Umemori M,https://www.ncbi.nlm.nih.gov/pubmed/31932969
18428,32928910,?2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1,Mol Cancer Res. 2020 Dec;18(12):1839-1848. doi: 10.1158/1541-7786.MCR-19-1037. Epub 2020 Sep 14.,Hassan S,https://www.ncbi.nlm.nih.gov/pubmed/32928910
18430,32573810,Ethanol-extracted Cameroonian propolis: Antiproliferative effects and potential mechanism of action in prostate cancer,Andrologia. 2020 Oct;52(9):e13698. doi: 10.1111/and.13698. Epub 2020 Jun 23.,Zingue S,https://www.ncbi.nlm.nih.gov/pubmed/32573810
18431,32753032,Fusion transcript detection using spatial transcriptomics,BMC Med Genomics. 2020 Aug 4;13(1):110. doi: 10.1186/s12920-020-00738-5.,Friedrich S,https://www.ncbi.nlm.nih.gov/pubmed/32753032
18432,31959023,The influence of androgen deprivation therapy on hip geometric properties and bone mineral density in Japanese men with prostate cancer and its relationship with the visceral fat accumulation,Aging Male. 2020 Dec;23(5):1158-1164. doi: 10.1080/13685538.2020.1713741. Epub 2020 Jan 20.,Watanabe D,https://www.ncbi.nlm.nih.gov/pubmed/31959023
18434,32889239,"The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in Prostate cancer",Int Immunopharmacol. 2020 Nov;88:106913. doi: 10.1016/j.intimp.2020.106913. Epub 2020 Sep 1.,Sadri Nahand J,https://www.ncbi.nlm.nih.gov/pubmed/32889239
18435,33021139,Genetic biomarkers to guide poly(ADP-ribose) polymerase inhibitor precision treatment of prostate cancer,Pharmacogenomics. 2020 Oct;21(15):1101-1115. doi: 10.2217/pgs-2020-0019. Epub 2020 Oct 6.,Varnai R,https://www.ncbi.nlm.nih.gov/pubmed/33021139
18436,31865534,"Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau)",World J Urol. 2020 Oct;38(10):2485-2491. doi: 10.1007/s00345-019-03054-5. Epub 2019 Dec 21.,Prause LW,https://www.ncbi.nlm.nih.gov/pubmed/31865534
18437,33049715,Identification of potential molecular pathways involved in prostate carcinogenesis in offspring exposed to maternal malnutrition,Aging (Albany NY). 2020 Oct 13;12(20):19954-19978. doi: 10.18632/aging.104093. Epub 2020 Oct 13.,Santos SAA,https://www.ncbi.nlm.nih.gov/pubmed/33049715
18438,33241957,Psychosocial consequences of potential overdiagnosis in prostate cancer a qualitative interview study,Scand J Prim Health Care. 2020 Dec;38(4):439-446. doi: 10.1080/02813432.2020.1843826. Epub 2020 Nov 26.,Nielsen SB,https://www.ncbi.nlm.nih.gov/pubmed/33241957
18441,32738396,Mitochondrial functional and structural impairment is involved in the antitumor activity of ?-tocotrienol in prostate cancer cells,Free Radic Biol Med. 2020 Nov 20;160:376-390. doi: 10.1016/j.freeradbiomed.2020.07.009. Epub 2020 Jul 29.,Fontana F,https://www.ncbi.nlm.nih.gov/pubmed/32738396
18442,33047850,Androgen receptor signaling-targeted therapy and taxane chemotherapy induce visceral metastasis in castration-resistant prostate cancer,Prostate. 2021 Jan;81(1):72-80. doi: 10.1002/pros.24082. Epub 2020 Oct 13.,Iwamoto H,https://www.ncbi.nlm.nih.gov/pubmed/33047850
18443,33049204,Dual Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancer: Just a Gambit or Real CheckMate?,Cancer Cell. 2020 Oct 12;38(4):438-440. doi: 10.1016/j.ccell.2020.09.009.,Wilson BE,https://www.ncbi.nlm.nih.gov/pubmed/33049204
18446,33121495,YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer,Mol Cancer. 2020 Oct 29;19(1):152. doi: 10.1186/s12943-020-01267-6.,Li J,https://www.ncbi.nlm.nih.gov/pubmed/33121495
18447,32545675,"Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor In Vitro and In Vivo",Molecules. 2020 Jun 12;25(12):2737. doi: 10.3390/molecules25122737.,Mapoung S,https://www.ncbi.nlm.nih.gov/pubmed/32545675
18448,32531722,Prostate MRI radiomics: A systematic review and radiomic quality score assessment,Eur J Radiol. 2020 Aug;129:109095. doi: 10.1016/j.ejrad.2020.109095. Epub 2020 May 30.,Stanzione A,https://www.ncbi.nlm.nih.gov/pubmed/32531722
18449,33000338,Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients with prostate cancer? A nationwide population-based cohort study,J Cancer Res Clin Oncol. 2021 Apr;147(4):1217-1226. doi: 10.1007/s00432-020-03412-6. Epub 2020 Sep 30.,Kim DK,https://www.ncbi.nlm.nih.gov/pubmed/33000338
18450,32979741,Differential expression of NKX 3.1 and HOXB 13 in bone metastases originating from prostatic carcinoma among the Egyptian males,Pathol Res Pract. 2020 Oct;216(10):153221. doi: 10.1016/j.prp.2020.153221. Epub 2020 Sep 17.,Abouhashem NS,https://www.ncbi.nlm.nih.gov/pubmed/32979741
18451,32614141,Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype Determination,Proteomics Clin Appl. 2020 Nov;14(6):e2000012. doi: 10.1002/prca.202000012. Epub 2020 Jul 9.,Otto JJ,https://www.ncbi.nlm.nih.gov/pubmed/32614141
18452,32791134,Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer,Clin Chim Acta. 2020 Nov;510:437-441. doi: 10.1016/j.cca.2020.08.007. Epub 2020 Aug 10.,Yu M,https://www.ncbi.nlm.nih.gov/pubmed/32791134
18453,32901562,"Prostatitis, the Great Mimicker of Prostate Cancer: Can We Differentiate Them Quantitatively With Multiparametric MRI?",AJR Am J Roentgenol. 2020 Nov;215(5):1104-1112. doi: 10.2214/AJR.20.22843. Epub 2020 Sep 9.,Uysal A,https://www.ncbi.nlm.nih.gov/pubmed/32901562
18454,33261611,"Genetically proxied milk consumption and risk of colorectal, bladder, breast, and prostate cancer: a two-sample Mendelian randomization study",BMC Med. 2020 Dec 2;18(1):370. doi: 10.1186/s12916-020-01839-9.,Larsson SC,https://www.ncbi.nlm.nih.gov/pubmed/33261611
18455,32212356,Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics,J Magn Reson Imaging. 2020 Oct;52(4):1102-1109. doi: 10.1002/jmri.27132. Epub 2020 Mar 25.,Gong L,https://www.ncbi.nlm.nih.gov/pubmed/32212356
18456,33131186,Improved Characterization of Diffusion in Normal and Cancerous Prostate Tissue Through Optimization of Multicompartmental Signal Models,J Magn Reson Imaging. 2021 Feb;53(2):628-639. doi: 10.1002/jmri.27393. Epub 2020 Oct 31.,Conlin CC,https://www.ncbi.nlm.nih.gov/pubmed/33131186
18457,32705219,MDM2 as a target for ellagic acid?mediated suppression of prostate cancer cells in vitro,Oncol Rep. 2020 Sep;44(3):1255-1265. doi: 10.3892/or.2020.7664. Epub 2020 Jun 26.,Mohammed Saleem YI,https://www.ncbi.nlm.nih.gov/pubmed/32705219
18458,32333502,Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation,Mol Oncol. 2020 Sep;14(9):2022-2039. doi: 10.1002/1878-0261.12693. Epub 2020 Jun 5.,Baumgart SJ,https://www.ncbi.nlm.nih.gov/pubmed/32333502
18460,33064229,Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey,J Community Health. 2021 Apr;46(2):389-398. doi: 10.1007/s10900-020-00923-8. Epub 2020 Oct 16.,Johnson JA,https://www.ncbi.nlm.nih.gov/pubmed/33064229
18461,32771000,PIM1 accelerates prostate cancer cell motility by phosphorylating actin capping proteins,Cell Commun Signal. 2020 Aug 8;18(1):121. doi: 10.1186/s12964-020-00618-6.,Santio NM,https://www.ncbi.nlm.nih.gov/pubmed/32771000
18462,33288559,Mir-139 Regulates Autophagy in Prostate Cancer Cells Through Beclin-1 and mTOR Signaling Proteins,Anticancer Res. 2020 Dec;40(12):6649-6663. doi: 10.21873/anticanres.14689. Epub 2020 Dec 7.,Nam RK,https://www.ncbi.nlm.nih.gov/pubmed/33288559
18464,33251599,Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression,J Cell Physiol. 2021 May;236(5):3979-3990. doi: 10.1002/jcp.30150. Epub 2020 Nov 29.,Wang SW,https://www.ncbi.nlm.nih.gov/pubmed/33251599
18465,32715453,Comparison of the Diagnostic Performance of PI-RADS V1 and PI-RADS V2 for the Detection of Prostate Cancer: A Meta-Analysis,Urol J. 2020 Jul 21;18(1):51-57. doi: 10.22037/uj.v16i7.5532.,He Y,https://www.ncbi.nlm.nih.gov/pubmed/32715453
18466,32817335,Evaluation of active Rac1 levels in cancer cells: A case of misleading conclusions from immunofluorescence analysis,J Biol Chem. 2020 Oct 2;295(40):13698-13710. doi: 10.1074/jbc.RA120.013919. Epub 2020 Aug 14.,Baker MJ,https://www.ncbi.nlm.nih.gov/pubmed/32817335
18467,32550630,Prostate specific membrane antigen positron emission tomography/computed tomography and staging high risk prostate cancer: a non-systematic review of high clinical impact literature,Minerva Urol Nephrol. 2021 Feb;73(1):32-41. doi: 10.23736/S2724-6051.20.03739-X. Epub 2020 Jun 16.,Morigi JJ,https://www.ncbi.nlm.nih.gov/pubmed/32550630
18468,33141299,The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer,Eur Radiol. 2021 May;31(5):2747-2753. doi: 10.1007/s00330-020-07363-x. Epub 2020 Nov 3.,Ottosson F,https://www.ncbi.nlm.nih.gov/pubmed/33141299
18469,33461737,Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate Cancer,Eur Urol. 2021 Feb;79(2):177-179. doi: 10.1016/j.eururo.2020.09.048. Epub 2020 Oct 21.,Jiang DM,https://www.ncbi.nlm.nih.gov/pubmed/33461737
18471,33033143,Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network,Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):158-165. doi: 10.1158/1055-9965.EPI-20-1005. Epub 2020 Oct 8.,Seraphin TP,https://www.ncbi.nlm.nih.gov/pubmed/33033143
18472,33355018,Lycopene Does Not Affect Prostate-Specific Antigen in Men with Non-Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,Nutr Cancer. 2021;73(11-12):2796-2807. doi: 10.1080/01635581.2020.1862254. Epub 2020 Dec 23.,Sadeghian M,https://www.ncbi.nlm.nih.gov/pubmed/33355018
18473,33345371,"A systematic review of tools used to assess body image, masculinity and self-esteem in men with prostate cancer",Psychooncology. 2020 Nov;29(11):1761-1771. doi: 10.1002/pon.5518. Epub 2020 Sep 1.,Bowie J,https://www.ncbi.nlm.nih.gov/pubmed/33345371
18475,32820253,Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing,Oncogene. 2020 Sep;39(39):6172-6189. doi: 10.1038/s41388-020-01429-2. Epub 2020 Aug 20.,Shah K,https://www.ncbi.nlm.nih.gov/pubmed/32820253
18477,32891565,Differences in Use of Aggressive Therapy for Localized Prostate Cancer in New York City,Clin Genitourin Cancer. 2021 Feb;19(1):e55-e62. doi: 10.1016/j.clgc.2020.08.005. Epub 2020 Aug 13.,Smigelski M,https://www.ncbi.nlm.nih.gov/pubmed/32891565
18479,33106334,Activatable Zymography Probes Enable In Situ Localization of Protease Dysregulation in Cancer,Cancer Res. 2021 Jan 1;81(1):213-224. doi: 10.1158/0008-5472.CAN-20-2410. Epub 2020 Oct 26.,Soleimany AP,https://www.ncbi.nlm.nih.gov/pubmed/33106334
18481,32851058,Inhibition of Specificity Protein 1 Is Involved in Phloretin-Induced Suppression of Prostate Cancer,Biomed Res Int. 2020 Aug 10;2020:1358674. doi: 10.1155/2020/1358674. eCollection 2020.,Kang D,https://www.ncbi.nlm.nih.gov/pubmed/32851058
18482,32615369,"Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression",J Nutr Biochem. 2020 Oct;84:108444. doi: 10.1016/j.jnutbio.2020.108444. Epub 2020 Jun 2.,Jang YG,https://www.ncbi.nlm.nih.gov/pubmed/32615369
18483,32879898,Dedicated Verification of an Accessory Parotid Gland via Minimal-Activity PSMA-PET/CT,Tomography. 2020 Sep;6(3):288-289. doi: 10.18383/j.tom.2020.00030.,Gühne F,https://www.ncbi.nlm.nih.gov/pubmed/32879898
18484,33648246,"Bioactive compounds, antioxidant activity and antiproliferative effects in prostate cancer cells of green and roasted coffee extracts obtained by microwave-assisted extraction (MAE)",Food Res Int. 2021 Feb;140:110014. doi: 10.1016/j.foodres.2020.110014. Epub 2020 Dec 15.,Montenegro J,https://www.ncbi.nlm.nih.gov/pubmed/33648246
18485,33162934,Osteocytes and Bone Metastasis,Front Endocrinol (Lausanne). 2020 Oct 14;11:567844. doi: 10.3389/fendo.2020.567844. eCollection 2020.,Riquelme MA,https://www.ncbi.nlm.nih.gov/pubmed/33162934
18486,32619716,"Pheophorbide a-mediated sonodynamic, photodynamic and sonophotodynamic therapies against prostate cancer",Photodiagnosis Photodyn Ther. 2020 Sep;31:101909. doi: 10.1016/j.pdpdt.2020.101909. Epub 2020 Jun 30.,Aksel M,https://www.ncbi.nlm.nih.gov/pubmed/32619716
18488,32461304,Targeting RET Kinase in Neuroendocrine Prostate Cancer,Mol Cancer Res. 2020 Aug;18(8):1176-1188. doi: 10.1158/1541-7786.MCR-19-1245. Epub 2020 May 27.,VanDeusen HR,https://www.ncbi.nlm.nih.gov/pubmed/32461304
18490,33058923,A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells,J Ethnopharmacol. 2021 Mar 1;267:113467. doi: 10.1016/j.jep.2020.113467. Epub 2020 Oct 13.,Wei MM,https://www.ncbi.nlm.nih.gov/pubmed/33058923
18491,32839916,Racial and ethnic differences in risk of second primary cancers among prostate cancer survivors,Cancer Causes Control. 2020 Nov;31(11):1011-1019. doi: 10.1007/s10552-020-01336-7. Epub 2020 Aug 24.,Withrow DR,https://www.ncbi.nlm.nih.gov/pubmed/32839916
18492,32844710,"Exploiting defects in homologous recombination repair for metastatic, castration-resistant prostate cancer",Cancer Biol Ther. 2020 Oct 2;21(10):884-887. doi: 10.1080/15384047.2020.1809913. Epub 2020 Aug 26.,Chau V,https://www.ncbi.nlm.nih.gov/pubmed/32844710
18494,33172930,Turnover Modulates the Need for a Cost of Resistance in Adaptive Therapy,Cancer Res. 2021 Feb 15;81(4):1135-1147. doi: 10.1158/0008-5472.CAN-20-0806. Epub 2020 Nov 10.,Strobl MAR,https://www.ncbi.nlm.nih.gov/pubmed/33172930
18496,33165815,"Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer",Mol Biol Rep. 2020 Dec;47(12):9373-9383. doi: 10.1007/s11033-020-05968-5. Epub 2020 Nov 9.,Kiani A,https://www.ncbi.nlm.nih.gov/pubmed/33165815
18497,32495153,Pelvic lymph node distribution and metastases of prostate and bladder cancer: a systematic literature review and template proposal,World J Urol. 2021 Mar;39(3):751-759. doi: 10.1007/s00345-020-03281-1. Epub 2020 Jun 3.,Grivas N,https://www.ncbi.nlm.nih.gov/pubmed/32495153
18498,32501618,Forensic Autopsies can Determine Latent Prostate Cancer Prevalence,J Forensic Sci. 2020 Sep;65(5):1557-1562. doi: 10.1111/1556-4029.14472. Epub 2020 Jun 5.,Takaso M,https://www.ncbi.nlm.nih.gov/pubmed/32501618
18499,32740694,Cumulative financial stress as a potential risk factor for cancer-related fatigue among prostate cancer survivors,J Cancer Surviv. 2021 Feb;15(1):1-13. doi: 10.1007/s11764-020-00906-7. Epub 2020 Aug 1.,Lu L,https://www.ncbi.nlm.nih.gov/pubmed/32740694
18500,32808078,"Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na(+)/K(+)-ATPase-density",Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):532-542. doi: 10.1007/s00259-020-04998-2. Epub 2020 Aug 18.,Jochumsen MR,https://www.ncbi.nlm.nih.gov/pubmed/32808078
18503,32651468,The prognostic value of pain in castration-sensitive prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):654-660. doi: 10.1038/s41391-020-0255-x. Epub 2020 Jul 10.,Iacovelli R,https://www.ncbi.nlm.nih.gov/pubmed/32651468
18506,32553281,Prostate Volume Estimation on MRI: Accuracy and Effects of Ellipsoid and Bullet-Shaped Measurements on PSA Density,Acad Radiol. 2021 Aug;28(8):e219-e226. doi: 10.1016/j.acra.2020.05.014. Epub 2020 Jun 15.,Stanzione A,https://www.ncbi.nlm.nih.gov/pubmed/32553281
18507,32522824,p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer,Cancer Res. 2020 Aug 1;80(15):3074-3087. doi: 10.1158/0008-5472.CAN-20-0233. Epub 2020 Jun 10.,Xu S,https://www.ncbi.nlm.nih.gov/pubmed/32522824
18508,32967941,Autoantibody Landscape in Patients with Advanced Prostate Cancer,Clin Cancer Res. 2020 Dec 1;26(23):6204-6214. doi: 10.1158/1078-0432.CCR-20-1966. Epub 2020 Sep 23.,Chen WS,https://www.ncbi.nlm.nih.gov/pubmed/32967941
18509,32598461,Sister Mary Joseph Nodule in a Patient With Advanced Prostate Cancer,J Am Osteopath Assoc. 2020 Jul 1;120(7):476-478. doi: 10.7556/jaoa.2020.075.,Chahin M,https://www.ncbi.nlm.nih.gov/pubmed/32598461
18510,33010988,Inflammatory markers as prognostic factors in metastatic castration-resistant prostate cancer,Actas Urol Esp (Engl Ed). 2020 Dec;44(10):692-700. doi: 10.1016/j.acuro.2020.08.001. Epub 2020 Oct 1.,Donate-Moreno MJ,https://www.ncbi.nlm.nih.gov/pubmed/33010988
18511,32457180,Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank,Cancer Epidemiol Biomarkers Prev. 2020 Aug;29(8):1615-1626. doi: 10.1158/1055-9965.EPI-19-1525. Epub 2020 May 26.,Watts EL,https://www.ncbi.nlm.nih.gov/pubmed/32457180
18513,32842786,Oleuropein: A Potential Inhibitor for Prostate Cancer Cell Motility by Blocking Voltage-Gated Sodium Channels,Nutr Cancer. 2021;73(9):1758-1767. doi: 10.1080/01635581.2020.1807575. Epub 2020 Aug 26.,Aktas HG,https://www.ncbi.nlm.nih.gov/pubmed/32842786
18514,32830795,Understanding Men's Experiences With Prostate Cancer Stigma: A Qualitative Study,Oncol Nurs Forum. 2020 Sep 1;47(5):577-585. doi: 10.1188/20.ONF.577-585.,Buote R,https://www.ncbi.nlm.nih.gov/pubmed/32830795
18515,33299664,Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression,Oncoimmunology. 2020 Dec 1;9(1):1851950. doi: 10.1080/2162402X.2020.1851950.,Vittrant B,https://www.ncbi.nlm.nih.gov/pubmed/33299664
18516,31718853,Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis,J Formos Med Assoc. 2020 Jul;119(7):1201-1210. doi: 10.1016/j.jfma.2019.10.016. Epub 2019 Nov 11.,Chen CH,https://www.ncbi.nlm.nih.gov/pubmed/31718853
18517,32453205,Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria,Nucl Med Commun. 2020 Aug;41(8):759-767. doi: 10.1097/MNM.0000000000001219.,Demirci E,https://www.ncbi.nlm.nih.gov/pubmed/32453205
18518,33032653,Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition,J Exp Clin Cancer Res. 2020 Oct 8;39(1):213. doi: 10.1186/s13046-020-01723-7.,Iannelli F,https://www.ncbi.nlm.nih.gov/pubmed/33032653
18520,33075425,A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells,Cancer Lett. 2021 Jan 28;497:54-65. doi: 10.1016/j.canlet.2020.10.003. Epub 2020 Oct 16.,Song J,https://www.ncbi.nlm.nih.gov/pubmed/33075425
18521,32658367,Risk and associated factors of depression and anxiety in men with prostate cancer: Results from a German multicenter study,Psychooncology. 2020 Oct;29(10):1604-1612. doi: 10.1002/pon.5471. Epub 2020 Jul 29.,Esser P,https://www.ncbi.nlm.nih.gov/pubmed/32658367
18523,32830375,Protein kinase A inhibitor proteins (PKIs) divert GPCR-G?s-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth,FASEB J. 2020 Oct;34(10):13900-13917. doi: 10.1096/fj.202001515R. Epub 2020 Aug 24.,Hoy JJ,https://www.ncbi.nlm.nih.gov/pubmed/32830375
18525,32552120,Abiraterone acetate in combination with prednisone in the treatment of prostate cancer: safety and efficacy,Expert Rev Anticancer Ther. 2020 Aug;20(8):629-638. doi: 10.1080/14737140.2020.1785289. Epub 2020 Jun 25.,Manceau C,https://www.ncbi.nlm.nih.gov/pubmed/32552120
18526,33323379,MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells,Cancer Res. 2021 Feb 15;81(4):1111-1122. doi: 10.1158/0008-5472.CAN-20-2588. Epub 2020 Dec 15.,Hagiwara M,https://www.ncbi.nlm.nih.gov/pubmed/33323379
18527,33121290,Evaluation of the Effects of Nobiletin on Toll-Like Receptor 3 Signaling Pathways in Prostate Cancer In Vitro,Nutr Cancer. 2021;73(7):1138-1144. doi: 10.1080/01635581.2020.1841247. Epub 2020 Oct 29.,Ozkan AD,https://www.ncbi.nlm.nih.gov/pubmed/33121290
18528,32357310,MINDIN secretion by prostate tumors induces premetastatic changes in bone via ?-catenin,Endocr Relat Cancer. 2020 Jul;27(7):441-456. doi: 10.1530/ERC-20-0116.,Ardura JA,https://www.ncbi.nlm.nih.gov/pubmed/32357310
18530,32282370,In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe2 and NHC*-Au-S-GLUC against advanced prostate cancer PC3,Anticancer Drugs. 2020 Aug;31(7):672-683. doi: 10.1097/CAD.0000000000000930.,Walther W,https://www.ncbi.nlm.nih.gov/pubmed/32282370
18531,32108505,Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients,Acta Radiol. 2020 Nov;61(11):1570-1579. doi: 10.1177/0284185120905066. Epub 2020 Feb 28.,Losnegård A,https://www.ncbi.nlm.nih.gov/pubmed/32108505
18532,32859606,Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone Microenvironment,Cancer Res. 2021 Jan 15;81(2):371-383. doi: 10.1158/0008-5472.CAN-20-0571. Epub 2020 Aug 28.,Dhimolea E,https://www.ncbi.nlm.nih.gov/pubmed/32859606
18534,32371590,Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor,Mol Cancer Ther. 2020 Jul;19(7):1436-1447. doi: 10.1158/1535-7163.MCT-19-0936. Epub 2020 May 5.,Adelaiye-Ogala R,https://www.ncbi.nlm.nih.gov/pubmed/32371590
18535,32704143,Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors,Commun Biol. 2020 Jul 23;3(1):393. doi: 10.1038/s42003-020-01120-y.,Takayama KI,https://www.ncbi.nlm.nih.gov/pubmed/32704143
18538,32900627,Update on cardiovascular and metabolic risk profiles of hormonal agents used in managing advanced prostate cancer,Urol Oncol. 2020 Dec;38(12):912-917. doi: 10.1016/j.urolonc.2020.07.004. Epub 2020 Sep 6.,Higano CS,https://www.ncbi.nlm.nih.gov/pubmed/32900627
18539,32388678,Therapeutic ISCOMATRIXTM adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer,Cancer Immunol Immunother. 2020 Oct;69(10):1959-1972. doi: 10.1007/s00262-020-02597-6. Epub 2020 May 9.,Barr AM,https://www.ncbi.nlm.nih.gov/pubmed/32388678
18540,33020300,Estrogen receptor ? regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3,Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26347-26355. doi: 10.1073/pnas.2007160117. Epub 2020 Oct 5.,Chaurasiya S,https://www.ncbi.nlm.nih.gov/pubmed/33020300
18541,32310634,Isoenzyme-Selective Inhibitors of Human Neuraminidases Reveal Distinct Effects on Cell Migration,ACS Chem Biol. 2020 Jun 19;15(6):1328-1339. doi: 10.1021/acschembio.9b00975. Epub 2020 May 6.,Howlader MA,https://www.ncbi.nlm.nih.gov/pubmed/32310634
18544,33443076,Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB,J Med Genet. 2022 Mar;59(3):243-247. doi: 10.1136/jmedgenet-2020-107286. Epub 2020 Dec 21.,Wei J,https://www.ncbi.nlm.nih.gov/pubmed/33443076
18545,32467000,Diagnostic utility and therapeutic impact of PET/CT [(18)F]F-Fluoromethylcholine -Choline in the biochemical recurrence of prostate cancer,Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Sep-Oct;39(5):284-291. doi: 10.1016/j.remn.2020.03.010. Epub 2020 May 25.,Sánchez N,https://www.ncbi.nlm.nih.gov/pubmed/32467000
18546,32801300,LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression,Cell Death Dis. 2020 Aug 15;11(8):638. doi: 10.1038/s41419-020-02856-5.,Yao M,https://www.ncbi.nlm.nih.gov/pubmed/32801300
18547,33333048,Protective effect of procyanidin A-type dimers against H(2)O(2)-induced oxidative stress in prostate DU145 cells through the MAPKs signaling pathway,Life Sci. 2021 Feb 1;266:118908. doi: 10.1016/j.lfs.2020.118908. Epub 2020 Dec 15.,Yan F,https://www.ncbi.nlm.nih.gov/pubmed/33333048
18548,32640729,"Myxovirus Resistance Protein 1 (MX1), a Novel HO-1 Interactor, Tilts the Balance of Endoplasmic Reticulum Stress towards Pro-Death Events in Prostate Cancer",Biomolecules. 2020 Jul 6;10(7):1005. doi: 10.3390/biom10071005.,Ortiz E,https://www.ncbi.nlm.nih.gov/pubmed/32640729
18549,31806776,Quantitative Test-Retest Measurement of (68)Ga-PSMA-HBED-CC in Tumor and Normal Tissue,J Nucl Med. 2020 Aug;61(8):1145-1152. doi: 10.2967/jnumed.119.236083. Epub 2019 Dec 5.,Pollard JH,https://www.ncbi.nlm.nih.gov/pubmed/31806776
18551,32480236,Stable isotope resolved metabolomics classification of prostate cancer cells using hyperpolarized NMR data,J Magn Reson. 2020 Jul;316:106750. doi: 10.1016/j.jmr.2020.106750. Epub 2020 May 20.,Frahm AB,https://www.ncbi.nlm.nih.gov/pubmed/32480236
18553,32525555,"Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category",Int J Cancer. 2020 Dec 15;147(12):3328-3338. doi: 10.1002/ijc.33150. Epub 2020 Jun 25.,Jochems SHJ,https://www.ncbi.nlm.nih.gov/pubmed/32525555
18555,33383128,Sample sizes of prediction model studies in prostate cancer were rarely justified and often insufficient,J Clin Epidemiol. 2021 May;133:53-60. doi: 10.1016/j.jclinepi.2020.12.011. Epub 2020 Dec 28.,Collins SD,https://www.ncbi.nlm.nih.gov/pubmed/33383128
18556,32863961,Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer,Theranostics. 2020 Aug 2;10(21):9808-9829. doi: 10.7150/thno.43631. eCollection 2020.,Wu D,https://www.ncbi.nlm.nih.gov/pubmed/32863961
18557,32454055,"Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis",Toxicol Appl Pharmacol. 2020 Aug 15;401:115071. doi: 10.1016/j.taap.2020.115071. Epub 2020 May 23.,Samy ALPA,https://www.ncbi.nlm.nih.gov/pubmed/32454055
18558,33146200,"A novel nano copper complex: potentiometry, DFT and application as a cancer prostatic biomarker for the ultrasensitive detection of human PSA",Dalton Trans. 2020 Nov 17;49(44):15769-15778. doi: 10.1039/d0dt03318a.,Akl MA,https://www.ncbi.nlm.nih.gov/pubmed/33146200
18559,32935192,Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study,Eur Radiol. 2021 Mar;31(3):1760-1769. doi: 10.1007/s00330-020-07227-4. Epub 2020 Sep 16.,Hu L,https://www.ncbi.nlm.nih.gov/pubmed/32935192
18560,33037089,Measurement of PET Quantitative Bias In Vivo,J Nucl Med. 2021 May 10;62(5):732-737. doi: 10.2967/jnumed.120.251397. Epub 2020 Oct 9.,Lodge MA,https://www.ncbi.nlm.nih.gov/pubmed/33037089
18561,32884236,Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study,Drug Des Devel Ther. 2020 Aug 13;14:3315-3324. doi: 10.2147/DDDT.S261027. eCollection 2020.,Zare-Zardini H,https://www.ncbi.nlm.nih.gov/pubmed/32884236
18562,32571276,Physician preferences for non-metastatic castration-resistant prostate cancer treatment,BMC Urol. 2020 Jun 22;20(1):73. doi: 10.1186/s12894-020-00631-4.,Srinivas S,https://www.ncbi.nlm.nih.gov/pubmed/32571276
18563,32511873,"Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non-small cell lung cancer",Cancer Med. 2020 Aug;9(15):5362-5380. doi: 10.1002/cam4.3109. Epub 2020 Jun 8.,Aghdam N,https://www.ncbi.nlm.nih.gov/pubmed/32511873
18565,32815480,"African Immigrant Health: Prostate Cancer Attitudes, Perceptions, and Barriers",Am J Mens Health. 2020 Jul-Aug;14(4):1557988320945465. doi: 10.1177/1557988320945465.,Malika N,https://www.ncbi.nlm.nih.gov/pubmed/32815480
18566,33372710,An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer,EMBO Mol Med. 2021 Feb 5;13(2):e11902. doi: 10.15252/emmm.201911902. Epub 2020 Dec 29.,Zekri L,https://www.ncbi.nlm.nih.gov/pubmed/33372710
18568,32717179,Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data,Elife. 2020 Jul 28;9:e50936. doi: 10.7554/eLife.50936.,Hood SP,https://www.ncbi.nlm.nih.gov/pubmed/32717179
18570,32770600,Voxel-based supervised machine learning of peripheral zone prostate cancer using noncontrast multiparametric MRI,J Appl Clin Med Phys. 2020 Oct;21(10):179-191. doi: 10.1002/acm2.12992. Epub 2020 Aug 8.,Gholizadeh N,https://www.ncbi.nlm.nih.gov/pubmed/32770600
18571,33302312,"Multiparametric MRI in the Diagnosis of Prostate Cancer: Physical Foundations, Limitations, and Prospective Advances of Diffusion-Weighted MRI",Rofo. 2021 Apr;193(4):399-409. doi: 10.1055/a-1276-1773. Epub 2020 Dec 10.,Wichtmann BD,https://www.ncbi.nlm.nih.gov/pubmed/33302312
18572,32610116,DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions,Pharmacol Ther. 2020 Nov;215:107617. doi: 10.1016/j.pharmthera.2020.107617. Epub 2020 Jun 28.,Medová M,https://www.ncbi.nlm.nih.gov/pubmed/32610116
18574,33416179,Long non?coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA?145?5p/RBBP5 axis,Oncol Rep. 2021 Feb;45(2):619-629. doi: 10.3892/or.2020.7894. Epub 2020 Dec 10.,Xie H,https://www.ncbi.nlm.nih.gov/pubmed/33416179
18575,32894788,?(2) -adrenergic receptor signaling drives prostate cancer progression by targeting the Sonic hedgehog-Gli1 signaling activation,Prostate. 2020 Nov;80(15):1328-1340. doi: 10.1002/pros.24060. Epub 2020 Sep 7.,Zhang M,https://www.ncbi.nlm.nih.gov/pubmed/32894788
18576,33115805,Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone,Cancer Res. 2021 Jan 1;81(1):50-63. doi: 10.1158/0008-5472.CAN-20-1708. Epub 2020 Oct 28.,Sawant Dessai A,https://www.ncbi.nlm.nih.gov/pubmed/33115805
18577,33355407,Gold nanoparticles regulate the antitumor secretome and have potent cytotoxic effects against prostate cancer cells,J Appl Toxicol. 2021 Aug;41(8):1286-1303. doi: 10.1002/jat.4117. Epub 2020 Dec 23.,Hao Y,https://www.ncbi.nlm.nih.gov/pubmed/33355407
18578,32648618,Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer,Prostate. 2020 Sep;80(12):950-961. doi: 10.1002/pros.24027. Epub 2020 Jul 10.,Abudurexiti M,https://www.ncbi.nlm.nih.gov/pubmed/32648618
18579,32913135,Multiplex Immunofluorescence in Formalin-Fixed Paraffin-Embedded Tumor Tissue to Identify Single-Cell-Level PI3K Pathway Activation,Clin Cancer Res. 2020 Nov 15;26(22):5903-5913. doi: 10.1158/1078-0432.CCR-20-2000. Epub 2020 Sep 10.,Stopsack KH,https://www.ncbi.nlm.nih.gov/pubmed/32913135
18580,32406953,Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer,J Cell Physiol. 2020 Dec;235(12):9729-9742. doi: 10.1002/jcp.29784. Epub 2020 May 14.,Guan H,https://www.ncbi.nlm.nih.gov/pubmed/32406953
18581,32570599,Deep Learning Approach for the Development of a Novel Predictive Model for Prostate Cancer,Stud Health Technol Inform. 2020 Jun 16;270:1241-1242. doi: 10.3233/SHTI200382.,Islam M,https://www.ncbi.nlm.nih.gov/pubmed/32570599
18583,32582990,"E2F7, regulated by miR?30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells",Oncol Rep. 2020 Sep;44(3):849-862. doi: 10.3892/or.2020.7659. Epub 2020 Jun 24.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32582990
18584,33095584,Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer,J Med Chem. 2020 Nov 12;63(21):12642-12665. doi: 10.1021/acs.jmedchem.0c00943. Epub 2020 Oct 23.,He Y,https://www.ncbi.nlm.nih.gov/pubmed/33095584
18586,33293427,"A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility",Cancer Res. 2021 Apr 1;81(7):1695-1703. doi: 10.1158/0008-5472.CAN-20-2635. Epub 2020 Dec 8.,Emami NC,https://www.ncbi.nlm.nih.gov/pubmed/33293427
18587,32669676,Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer,Br J Cancer. 2020 Sep;123(6):982-987. doi: 10.1038/s41416-020-0969-5. Epub 2020 Jul 16.,Conteduca V,https://www.ncbi.nlm.nih.gov/pubmed/32669676
18588,32492656,Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines,Aging (Albany NY). 2020 Jun 3;12(11):10194-10210. doi: 10.18632/aging.103377. Epub 2020 Jun 3.,Chappell WH,https://www.ncbi.nlm.nih.gov/pubmed/32492656
18589,31738404,Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM,Carcinogenesis. 2020 Jul 14;41(7):865-874. doi: 10.1093/carcin/bgz191.,Voss G,https://www.ncbi.nlm.nih.gov/pubmed/31738404
18590,32557113,Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells,Biol Trace Elem Res. 2021 Apr;199(4):1316-1331. doi: 10.1007/s12011-020-02255-z. Epub 2020 Jun 18.,Singh SP,https://www.ncbi.nlm.nih.gov/pubmed/32557113
18593,33094617,11-Keto-testosterone and other androgens of adrenal origin,Physiol Res. 2020 Sep 30;69(Suppl 2):S187-S192. doi: 10.33549/physiolres.934516.,Stárka L,https://www.ncbi.nlm.nih.gov/pubmed/33094617
18594,32361089,"Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [(68)Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies",Nucl Med Biol. 2020 Jul-Aug;86-87:1-8. doi: 10.1016/j.nucmedbio.2020.04.002. Epub 2020 Apr 20.,Doot RK,https://www.ncbi.nlm.nih.gov/pubmed/32361089
18595,33085048,Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line,Mol Biol Rep. 2020 Nov;47(11):8727-8737. doi: 10.1007/s11033-020-05918-1. Epub 2020 Oct 21.,Deezagi A,https://www.ncbi.nlm.nih.gov/pubmed/33085048
18596,33034643,A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation,Integr Biol (Camb). 2020 Oct 16;12(10):250-262. doi: 10.1093/intbio/zyaa020.,Kerr SC,https://www.ncbi.nlm.nih.gov/pubmed/33034643
18597,33223523,microRNA-211-mediated targeting of the INHBA-TGF-? axis suppresses prostate tumor formation and growth,Cancer Gene Ther. 2021 May;28(5):514-528. doi: 10.1038/s41417-020-00237-w. Epub 2020 Nov 22.,Zhao Z,https://www.ncbi.nlm.nih.gov/pubmed/33223523
18599,31673716,Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies,Abdom Radiol (NY). 2020 Jul;45(7):2198-2212. doi: 10.1007/s00261-019-02285-9.,O'Shea A,https://www.ncbi.nlm.nih.gov/pubmed/31673716
18600,32614237,Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer,Neoplasma. 2020 Nov;67(6):1314-1318. doi: 10.4149/neo_2020_191130N1234. Epub 2020 Jul 1.,Li W,https://www.ncbi.nlm.nih.gov/pubmed/32614237
18601,32449815,RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer,Prostate. 2020 Aug;80(11):799-810. doi: 10.1002/pros.23994. Epub 2020 May 25.,Linder A,https://www.ncbi.nlm.nih.gov/pubmed/32449815
18602,32858191,Annexin A1 promotes the nuclear localization of the epidermal growth factor receptor in castration-resistant prostate cancer,Int J Biochem Cell Biol. 2020 Oct;127:105838. doi: 10.1016/j.biocel.2020.105838. Epub 2020 Aug 25.,Mota STS,https://www.ncbi.nlm.nih.gov/pubmed/32858191
18604,32558711,10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients,Clin Nucl Med. 2020 Aug;45(8):594-603. doi: 10.1097/RLU.0000000000003125.,Zattoni F,https://www.ncbi.nlm.nih.gov/pubmed/32558711
18605,32546299,A critical update on the strategies towards modulators targeting androgen receptors,Bioorg Med Chem. 2020 Jul 1;28(13):115554. doi: 10.1016/j.bmc.2020.115554. Epub 2020 May 12.,Luan H,https://www.ncbi.nlm.nih.gov/pubmed/32546299
18606,32593155,Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer,Int Immunopharmacol. 2020 Sep;86:106709. doi: 10.1016/j.intimp.2020.106709. Epub 2020 Jun 24.,Luo C,https://www.ncbi.nlm.nih.gov/pubmed/32593155
18607,32389660,Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate,Hum Pathol. 2020 Jul;101:70-79. doi: 10.1016/j.humpath.2020.04.014. Epub 2020 May 7.,Heaphy CM,https://www.ncbi.nlm.nih.gov/pubmed/32389660
18609,32570663,Primary Care Prostate Cancer Case Ascertainment,Stud Health Technol Inform. 2020 Jun 16;270:1369-1370. doi: 10.3233/SHTI200446.,Lemanska A,https://www.ncbi.nlm.nih.gov/pubmed/32570663
18610,33288740,Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors,Cell Death Dis. 2020 Dec 7;11(12):1039. doi: 10.1038/s41419-020-03256-5.,Alaimo A,https://www.ncbi.nlm.nih.gov/pubmed/33288740
18611,32698845,Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study,BMC Med. 2020 Jul 23;18(1):187. doi: 10.1186/s12916-020-01655-1.,Röhnisch HE,https://www.ncbi.nlm.nih.gov/pubmed/32698845
18613,32865335,Macrophages expedite cell proliferation of prostate intraepithelial neoplasia through their downstream target ERK,FEBS J. 2021 Mar;288(6):1871-1886. doi: 10.1111/febs.15541. Epub 2020 Sep 25.,Thomas MU,https://www.ncbi.nlm.nih.gov/pubmed/32865335
18614,33107155,Comprehensive role of prostate-specific antigen identified with proteomic analysis in prostate cancer,J Cell Mol Med. 2020 Sep;24(17):10202-10215. doi: 10.1111/jcmm.15634. Epub 2020 Jul 27.,Li H,https://www.ncbi.nlm.nih.gov/pubmed/33107155
18615,33015770,Long non-coding RNA LINC00173 serves as sponge for miR-338-3p to promote prostate cancer progression via regulating Rab25,Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9290-9302. doi: 10.26355/eurrev_202009_23011.,Hu CH,https://www.ncbi.nlm.nih.gov/pubmed/33015770
18617,33262291,Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity,Mol Cancer Res. 2021 Mar;19(3):516-527. doi: 10.1158/1541-7786.MCR-20-0316. Epub 2020 Dec 1.,Gevariya N,https://www.ncbi.nlm.nih.gov/pubmed/33262291
18618,33300453,Epidemiological study of granulomatous prostatitis in a tertiary hospital: Associated risk factors and relationship with prostate cancer,Urologia. 2022 May;89(2):257-260. doi: 10.1177/0391560320979859. Epub 2020 Dec 10.,Coello Torà I,https://www.ncbi.nlm.nih.gov/pubmed/33300453
18619,33348384,PI-RADS 2.1 - Image Interpretation: The Most Important Updates and Their Clinical Implications,Rofo. 2021 Jul;193(7):787-796. doi: 10.1055/a-1324-4010. Epub 2020 Dec 21.,Beyer T,https://www.ncbi.nlm.nih.gov/pubmed/33348384
18620,32319597,Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo,Int J Oncol. 2020 Jul;57(1):139-150. doi: 10.3892/ijo.2020.5043. Epub 2020 Apr 13.,Yu F,https://www.ncbi.nlm.nih.gov/pubmed/32319597
18621,33113419,Nanomaterial based aptasensing of prostate specific antigen (PSA): Recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine,Biomed Pharmacother. 2020 Dec;132:110878. doi: 10.1016/j.biopha.2020.110878. Epub 2020 Oct 28.,Farshchi F,https://www.ncbi.nlm.nih.gov/pubmed/33113419
18623,32827147,Association of Long Non-Coding RNA MEG3 Polymorphisms and Risk of Prostate Cancer in Chinese Han Population,Urol J. 2020 Aug 22;18(2):176-180. doi: 10.22037/uj.v16i7.5585.,Xu B,https://www.ncbi.nlm.nih.gov/pubmed/32827147
18624,32052752,Comparison of double inversion recovery magnetic resonance imaging (DIR-MRI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in detection of prostate cancer: A pilot study,Radiography (Lond). 2020 Aug;26(3):234-239. doi: 10.1016/j.radi.2019.12.012. Epub 2020 Jan 6.,Onwuharine EN,https://www.ncbi.nlm.nih.gov/pubmed/32052752
18625,32506803,Machine learning of diffraction image patterns for accurate classification of cells modeled with different nuclear sizes,J Biophotonics. 2020 Sep;13(9):e202000036. doi: 10.1002/jbio.202000036. Epub 2020 Jul 3.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/32506803
18626,32562504,"Pharmacokinetic and pharmacodynamic modeling of the metastin/kisspeptin analog, TAK-448, for its anti-tumor efficacy in a rat xenograft model",Biopharm Drug Dispos. 2020 Jul;41(7):283-294. doi: 10.1002/bdd.2245. Epub 2020 Jul 16.,Kogame A,https://www.ncbi.nlm.nih.gov/pubmed/32562504
18627,32872192,The Impact of Ang-(1-9) and Ang-(3-7) on the Biological Properties of Prostate Cancer Cells by Modulation of Inflammatory and Steroidogenesis Pathway Genes,Int J Mol Sci. 2020 Aug 28;21(17):6227. doi: 10.3390/ijms21176227.,Domi?ska K,https://www.ncbi.nlm.nih.gov/pubmed/32872192
18628,33174661,Dietary intake of polyphenols and total antioxidant capacity and risk of prostate cancer: A case-control study in Iranian men,Eur J Cancer Care (Engl). 2021 Mar;30(2):e13364. doi: 10.1111/ecc.13364. Epub 2020 Nov 11.,Ghanavati M,https://www.ncbi.nlm.nih.gov/pubmed/33174661
18629,33004290,Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria,Eur Urol Oncol. 2021 Feb;4(1):93-101. doi: 10.1016/j.euo.2020.09.001. Epub 2020 Sep 28.,Valenberg FJPV,https://www.ncbi.nlm.nih.gov/pubmed/33004290
18631,33006028,[(18)F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer,Mol Imaging Biol. 2021 Apr;23(2):277-286. doi: 10.1007/s11307-020-01546-0. Epub 2020 Oct 1.,Dietlein F,https://www.ncbi.nlm.nih.gov/pubmed/33006028
18632,33185915,Epigenetic modification-dependent androgen receptor occupancy facilitates the ectopic TSPY1 expression in prostate cancer cells,Cancer Sci. 2021 Feb;112(2):691-702. doi: 10.1111/cas.14731. Epub 2020 Dec 7.,Leng X,https://www.ncbi.nlm.nih.gov/pubmed/33185915
18634,32143995,Effects of six months of aerobic and resistance training on metabolic markers and bone mineral density in older men on androgen deprivation therapy for prostate cancer,J Geriatr Oncol. 2020 Sep;11(7):1074-1077. doi: 10.1016/j.jgo.2020.02.013. Epub 2020 Mar 3.,Papadopoulos E,https://www.ncbi.nlm.nih.gov/pubmed/32143995
18635,32442375,Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer,J Med Chem. 2020 Jul 23;63(14):7601-7615. doi: 10.1021/acs.jmedchem.0c00418. Epub 2020 Jun 8.,Rosenfeld L,https://www.ncbi.nlm.nih.gov/pubmed/32442375
18639,32371391,The role of the histone H3 variant CENPA in prostate cancer,J Biol Chem. 2020 Jun 19;295(25):8537-8549. doi: 10.1074/jbc.RA119.010080. Epub 2020 May 5.,Saha AK,https://www.ncbi.nlm.nih.gov/pubmed/32371391
18640,33288765,Quantifying the influence of mutation detection on tumour subclonal reconstruction,Nat Commun. 2020 Dec 7;11(1):6247. doi: 10.1038/s41467-020-20055-w.,Liu LY,https://www.ncbi.nlm.nih.gov/pubmed/33288765
18641,33676639,Aptamer-based approaches to detect nucleolin in prostate cancer,Talanta. 2021 May 1;226:122037. doi: 10.1016/j.talanta.2020.122037. Epub 2020 Dec 31.,Miranda A,https://www.ncbi.nlm.nih.gov/pubmed/33676639
18642,33297237,Chronic exposure to microcystin-LR increases the risk of prostate cancer and induces malignant transformation of human prostate epithelial cells,Chemosphere. 2021 Jan;263:128295. doi: 10.1016/j.chemosphere.2020.128295. Epub 2020 Sep 10.,Pan C,https://www.ncbi.nlm.nih.gov/pubmed/33297237
18643,32859704,(177)Lu-Labeled Albumin-Binder-Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio,J Nucl Med. 2021 Apr;62(4):521-527. doi: 10.2967/jnumed.120.250738. Epub 2020 Aug 28.,Kuo HT,https://www.ncbi.nlm.nih.gov/pubmed/32859704
18644,32698628,Leptin Promotes Prostate Cancer Proliferation and Migration by Stimulating STAT3 Pathway,Nutr Cancer. 2021;73(7):1217-1227. doi: 10.1080/01635581.2020.1792946. Epub 2020 Jul 22.,Gorrab A,https://www.ncbi.nlm.nih.gov/pubmed/32698628
18645,32250715,"Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer",J Clin Oncol. 2020 Jun 20;38(18):2018-2027. doi: 10.1200/JCO.19.02185. Epub 2020 Apr 6.,Troeschel AN,https://www.ncbi.nlm.nih.gov/pubmed/32250715
18646,32658591,The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer,Future Oncol. 2020 Sep;16(27):2029-2033. doi: 10.2217/fon-2020-0571. Epub 2020 Jul 13.,Mollica V,https://www.ncbi.nlm.nih.gov/pubmed/32658591
18647,32932010,"Exploring the experiences of patients, general practitioners and oncologists of prostate cancer follow-up: A qualitative interview study",Eur J Oncol Nurs. 2020 Oct;48:101820. doi: 10.1016/j.ejon.2020.101820. Epub 2020 Aug 1.,Taylor S,https://www.ncbi.nlm.nih.gov/pubmed/32932010
18648,32878054,The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?,Nutrients. 2020 Aug 31;12(9):2648. doi: 10.3390/nu12092648.,Crocetto F,https://www.ncbi.nlm.nih.gov/pubmed/32878054
18649,32303533,"Racial/Ethnic Disparities in Prostate Cancer Incidence, Distant Stage Diagnosis, and Mortality by U.S. Census Region and Age Group, 2012-2015",Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1357-1364. doi: 10.1158/1055-9965.EPI-19-1344. Epub 2020 Apr 17.,Iyengar S,https://www.ncbi.nlm.nih.gov/pubmed/32303533
18650,32816532,Reprogramming Prostate Cancer Cells into Induced Pluripotent Stem Cells: a Promising Model of Prostate Cancer Stem Cell Research,Cell Reprogram. 2020 Oct;22(5):262-268. doi: 10.1089/cell.2020.0032. Epub 2020 Aug 18.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/32816532
18651,33064976,"Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of DAB1",Cell Cycle. 2020 Nov;19(21):2793-2810. doi: 10.1080/15384101.2020.1823730. Epub 2020 Oct 16.,Li L,https://www.ncbi.nlm.nih.gov/pubmed/33064976
18652,32166512,Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer,Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2562-2576. doi: 10.1007/s00259-020-04721-1. Epub 2020 Mar 12.,Konopka CJ,https://www.ncbi.nlm.nih.gov/pubmed/32166512
18653,32892030,"Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway",Biomed Pharmacother. 2020 Nov;131:110689. doi: 10.1016/j.biopha.2020.110689. Epub 2020 Sep 4.,Zhan K,https://www.ncbi.nlm.nih.gov/pubmed/32892030
18654,33237495,Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer,Target Oncol. 2020 Dec;15(6):791-799. doi: 10.1007/s11523-020-00779-x.,Scott LJ,https://www.ncbi.nlm.nih.gov/pubmed/33237495
18655,32736696,Therapeutic efficacy of modified anti-miR21 in metastatic prostate cancer,Biochem Biophys Res Commun. 2020 Aug 27;529(3):707-713. doi: 10.1016/j.bbrc.2020.05.215. Epub 2020 Jul 18.,Kim K,https://www.ncbi.nlm.nih.gov/pubmed/32736696
18656,32901864,Functional classification of prostate cancer?associated miRNAs through CRISPR/Cas9?mediated gene knockout,Mol Med Rep. 2020 Nov;22(5):3777-3784. doi: 10.3892/mmr.2020.11491. Epub 2020 Sep 7.,Jiang FN,https://www.ncbi.nlm.nih.gov/pubmed/32901864
18659,32527560,Production of (64)Cu-labeled monobody for imaging of human EphA2-expressing tumors,Bioorg Med Chem Lett. 2020 Jul 15;30(14):127262. doi: 10.1016/j.bmcl.2020.127262. Epub 2020 May 15.,Pyo A,https://www.ncbi.nlm.nih.gov/pubmed/32527560
18660,33110136,Modulation of complement activation by pentraxin-3 in prostate cancer,Sci Rep. 2020 Oct 27;10(1):18400. doi: 10.1038/s41598-020-75376-z.,Stallone G,https://www.ncbi.nlm.nih.gov/pubmed/33110136
18661,33249427,FRMD6 has tumor suppressor functions in prostate cancer,Oncogene. 2021 Jan;40(4):763-776. doi: 10.1038/s41388-020-01548-w. Epub 2020 Nov 28.,Haldrup J,https://www.ncbi.nlm.nih.gov/pubmed/33249427
18662,32433169,"Peyronie Disease as an Example of Nononcological, Inflammatory Uptake of 18F-Fluorocholine in Patient With Prostate Cancer",Clin Nucl Med. 2020 Jul;45(7):575-576. doi: 10.1097/RLU.0000000000003082.,Cegla P,https://www.ncbi.nlm.nih.gov/pubmed/32433169
18663,33136217,B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer,Med Oncol. 2020 Nov 2;37(11):107. doi: 10.1007/s12032-020-01433-2.,Lian T,https://www.ncbi.nlm.nih.gov/pubmed/33136217
18665,32860375,CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue m?croarray study,Malays J Pathol. 2020 Aug;42(2):227-236.,Celikden SG,https://www.ncbi.nlm.nih.gov/pubmed/32860375
18667,32418347,Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study,Int J Urol. 2020 Jul;27(7):610-617. doi: 10.1111/iju.14258. Epub 2020 May 16.,Hatakeyama S,https://www.ncbi.nlm.nih.gov/pubmed/32418347
18669,33137125,LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production,PLoS One. 2020 Nov 2;15(11):e0240801. doi: 10.1371/journal.pone.0240801. eCollection 2020.,Han C,https://www.ncbi.nlm.nih.gov/pubmed/33137125
18670,32701800,68Ga-Prostate-Specific Membrane Antigen PET-Positive Paget Bone Disease With Metastatic Prostatic Carcinoma,Clin Nucl Med. 2020 Sep;45(9):e425-e426. doi: 10.1097/RLU.0000000000003198.,Engur CO,https://www.ncbi.nlm.nih.gov/pubmed/32701800
18671,33256668,Spatio-temporal mapping of breast and prostate cancers in South Iran from 2014 to 2017,BMC Cancer. 2020 Nov 30;20(1):1170. doi: 10.1186/s12885-020-07674-8.,Montazeri M,https://www.ncbi.nlm.nih.gov/pubmed/33256668
18672,32661433,Temporal trends in the number of men electing for conservative management for low-risk prostate cancer in the United States,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):714-717. doi: 10.1038/s41391-020-0252-0. Epub 2020 Jul 13.,Al Hussein Al Awamlh B,https://www.ncbi.nlm.nih.gov/pubmed/32661433
18674,33446322,Double-Stranded RNA Immunomodulators in Prostate Cancer,Urol Clin North Am. 2020 Nov;47(4S):e1-e8. doi: 10.1016/j.ucl.2020.10.003.,Salazar AM,https://www.ncbi.nlm.nih.gov/pubmed/33446322
18675,32331836,Markers of malignant prostate cancer cells: Golgi localization of ?-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface,Biochem Biophys Res Commun. 2020 Jun 25;527(2):406-410. doi: 10.1016/j.bbrc.2020.03.168. Epub 2020 Apr 22.,Cheng PW,https://www.ncbi.nlm.nih.gov/pubmed/32331836
18678,32002708,Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain,Cell Biol Toxicol. 2020 Oct;36(5):399-416. doi: 10.1007/s10565-020-09511-x. Epub 2020 Jan 30.,Peng S,https://www.ncbi.nlm.nih.gov/pubmed/32002708
18679,32556947,Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data,Cancer Causes Control. 2020 Sep;31(9):861-867. doi: 10.1007/s10552-020-01324-x. Epub 2020 Jun 17.,Frendl DM,https://www.ncbi.nlm.nih.gov/pubmed/32556947
18683,33118292,Protective effects of natural compounds against oxidative stress in ischemic diseases and cancers via activating the Nrf2 signaling pathway: A mini review,J Biochem Mol Toxicol. 2021 Mar;35(3):e22658. doi: 10.1002/jbt.22658. Epub 2020 Oct 28.,Li W,https://www.ncbi.nlm.nih.gov/pubmed/33118292
18684,31833561,Learning-based biomarker-assisted rules for optimized clinical benefit under a risk constraint,Biometrics. 2020 Sep;76(3):853-862. doi: 10.1111/biom.13199. Epub 2019 Dec 25.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/31833561
18686,33251708,Inflammation driven tumor-like signaling in prostatic epithelial cells by sexually transmitted Trichomonas vaginalis,Int J Urol. 2021 Feb;28(2):225-240. doi: 10.1111/iju.14431. Epub 2020 Nov 30.,Kushwaha B,https://www.ncbi.nlm.nih.gov/pubmed/33251708
18687,33317606,Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis,J Exp Clin Cancer Res. 2020 Dec 14;39(1):282. doi: 10.1186/s13046-020-01761-1.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/33317606
18688,32975741,Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT,Ann Nucl Med. 2020 Dec;34(12):932-941. doi: 10.1007/s12149-020-01529-9. Epub 2020 Sep 25.,Caglar M,https://www.ncbi.nlm.nih.gov/pubmed/32975741
18691,33012578,Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib,Eur Urol. 2021 Apr;79(4):442-445. doi: 10.1016/j.eururo.2020.09.024. Epub 2020 Oct 1.,Stopsack KH,https://www.ncbi.nlm.nih.gov/pubmed/33012578
18692,32770813,Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow,Cancer Sci. 2020 Oct;111(10):3600-3612. doi: 10.1111/cas.14606. Epub 2020 Aug 28.,Wang C,https://www.ncbi.nlm.nih.gov/pubmed/32770813
18693,32917666,Radiomics Improves Cancer Screening and Early Detection,Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2556-2567. doi: 10.1158/1055-9965.EPI-20-0075. Epub 2020 Sep 11.,Gillies RJ,https://www.ncbi.nlm.nih.gov/pubmed/32917666
18694,33321358,Geospatial and temporal variation of prostate cancer incidence,Public Health. 2021 Jan;190:7-15. doi: 10.1016/j.puhe.2020.10.032. Epub 2020 Dec 13.,Wah W,https://www.ncbi.nlm.nih.gov/pubmed/33321358
18695,32386317,"E2F5 promotes prostate cancer cell migration and invasion through regulation of TFPI2, MMP-2 and MMP-9",Carcinogenesis. 2020 Dec 31;41(12):1767-1780. doi: 10.1093/carcin/bgaa043.,Karmakar D,https://www.ncbi.nlm.nih.gov/pubmed/32386317
18697,32839796,New copper(I) complexes selective for prostate cancer cells,Dalton Trans. 2020 Sep 15;49(35):12273-12286. doi: 10.1039/d0dt02157a.,Machado JF,https://www.ncbi.nlm.nih.gov/pubmed/32839796
18699,32691147,"Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients",World J Urol. 2021 Jun;39(6):1815-1823. doi: 10.1007/s00345-020-03363-0. Epub 2020 Jul 20.,Ma MW,https://www.ncbi.nlm.nih.gov/pubmed/32691147
18700,32708644,Exploring Drug Treatment Patterns Based on the Action of Drug and Multilayer Network Model,Int J Mol Sci. 2020 Jul 16;21(14):5014. doi: 10.3390/ijms21145014.,Yu L,https://www.ncbi.nlm.nih.gov/pubmed/32708644
18701,31902713,METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Aug;18(4):e391-e396. doi: 10.1016/j.clgc.2019.12.010. Epub 2019 Dec 14.,Yoshida S,https://www.ncbi.nlm.nih.gov/pubmed/31902713
18702,32614484,Discussing the effects of prostate cancer beyond biographical disruption and new normalcy: the experiences of men with prostate cancer in Germany,Sociol Health Illn. 2020 Jul;42(6):1359-1378. doi: 10.1111/1467-9566.13113. Epub 2020 Jul 2.,Schultze M,https://www.ncbi.nlm.nih.gov/pubmed/32614484
18703,32830255,Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimates,Int J Epidemiol. 2020 Aug 1;49(4):1294-1306. doi: 10.1093/ije/dyaa078.,Uhry Z,https://www.ncbi.nlm.nih.gov/pubmed/32830255
18705,32941451,Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study,PLoS One. 2020 Sep 17;15(9):e0238928. doi: 10.1371/journal.pone.0238928. eCollection 2020.,Aladwani M,https://www.ncbi.nlm.nih.gov/pubmed/32941451
18707,33010982,The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis,Semin Oncol Nurs. 2020 Oct;36(5):151067. doi: 10.1016/j.soncn.2020.151067. Epub 2020 Sep 30.,Logan L,https://www.ncbi.nlm.nih.gov/pubmed/33010982
18709,33200227,A randomized phase III trial of personalized peptide vaccination for castration?resistant prostate cancer progressing after docetaxel,Oncol Rep. 2021 Jan;45(1):159-168. doi: 10.3892/or.2020.7847. Epub 2020 Nov 11.,Noguchi M,https://www.ncbi.nlm.nih.gov/pubmed/33200227
18711,33143724,The awareness of women on prostate cancer: a mixed-methods systematic review protocol,Syst Rev. 2020 Nov 3;9(1):253. doi: 10.1186/s13643-020-01513-4.,Wiafe E,https://www.ncbi.nlm.nih.gov/pubmed/33143724
18713,32797099,Bone metastasis classification using whole body images from prostate cancer patients based on convolutional neural networks application,PLoS One. 2020 Aug 14;15(8):e0237213. doi: 10.1371/journal.pone.0237213. eCollection 2020.,Papandrianos N,https://www.ncbi.nlm.nih.gov/pubmed/32797099
18714,32869960,Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis,Adv Clin Exp Med. 2020 Aug;29(8):1001-1009. doi: 10.17219/acem/121521.,Li H,https://www.ncbi.nlm.nih.gov/pubmed/32869960
18715,33189461,A Comparison of Genitourinary Society Pathology and International Society of Urological Pathology Prostate Cancer Guidelines,Eur Urol. 2021 Jan;79(1):3-5. doi: 10.1016/j.eururo.2020.10.033. Epub 2020 Nov 12.,Epstein JI,https://www.ncbi.nlm.nih.gov/pubmed/33189461
18717,32579110,AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR-CHK2 interaction and prostate cancer survival,Elife. 2020 Jun 24;9:e51378. doi: 10.7554/eLife.51378.,Ta HQ,https://www.ncbi.nlm.nih.gov/pubmed/32579110
18718,32860869,Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI,Magn Reson Imaging. 2020 Nov;73:118-124. doi: 10.1016/j.mri.2020.08.019. Epub 2020 Aug 27.,Park S,https://www.ncbi.nlm.nih.gov/pubmed/32860869
18719,32730114,The FGF/FGFR system in the physiopathology of the prostate gland,Physiol Rev. 2021 Apr 1;101(2):569-610. doi: 10.1152/physrev.00005.2020. Epub 2020 Jul 30.,Giacomini A,https://www.ncbi.nlm.nih.gov/pubmed/32730114
18721,32396050,The Impact of Race and Age on Distribution of Metastases in Patients with Prostate Cancer,J Urol. 2020 Nov;204(5):962-968. doi: 10.1097/JU.0000000000001131. Epub 2020 May 12.,Stolzenbach LF,https://www.ncbi.nlm.nih.gov/pubmed/32396050
18722,32315455,Germline and somatic DNA repair gene alterations in prostate cancer,Cancer. 2020 Jul 1;126(13):2980-2985. doi: 10.1002/cncr.32908. Epub 2020 Apr 21.,Dall'Era MA,https://www.ncbi.nlm.nih.gov/pubmed/32315455
18724,32544780,Segmentation of prostate zones using probabilistic atlas-based method with diffusion-weighted MR images,Comput Methods Programs Biomed. 2020 Nov;196:105572. doi: 10.1016/j.cmpb.2020.105572. Epub 2020 Jun 2.,Singh D,https://www.ncbi.nlm.nih.gov/pubmed/32544780
18725,33302945,"Selective cytotoxic and anti-metastatic activity in DU-145 prostate cancer cells induced by Annona muricata L. bark extract and phytochemical, annonacin",BMC Complement Med Ther. 2020 Dec 10;20(1):375. doi: 10.1186/s12906-020-03130-z.,Foster K,https://www.ncbi.nlm.nih.gov/pubmed/33302945
18726,32654949,Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studies,Urol Oncol. 2020 Nov;38(11):816-825. doi: 10.1016/j.urolonc.2020.04.028. Epub 2020 Jul 9.,Santella C,https://www.ncbi.nlm.nih.gov/pubmed/32654949
18727,32451180,Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer,Eur Urol. 2020 Dec;78(6):834-844. doi: 10.1016/j.eururo.2020.04.058. Epub 2020 May 22.,Herberts C,https://www.ncbi.nlm.nih.gov/pubmed/32451180
18728,32897764,Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2,J Urol. 2021 Feb;205(2):441-443. doi: 10.1097/JU.0000000000001338. Epub 2020 Sep 8.,Klein EA,https://www.ncbi.nlm.nih.gov/pubmed/32897764
18730,28337641,Inhibition of Proliferation of Prostate Cancer Cell Line DU-145 in vitro and in vivo Using Salvia miltiorrhiza Bunge,Chin J Integr Med. 2020 Jul;26(7):533-538. doi: 10.1007/s11655-017-2801-5. Epub 2017 Mar 23.,Bae WJ,https://www.ncbi.nlm.nih.gov/pubmed/28337641
18731,33376323,Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer,Int J Nanomedicine. 2020 Dec 17;15:10305-10320. doi: 10.2147/IJN.S282107. eCollection 2020.,Tai Z,https://www.ncbi.nlm.nih.gov/pubmed/33376323
18732,32641750,Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer,Commun Biol. 2020 Jul 8;3(1):374. doi: 10.1038/s42003-020-1088-9.,Chakravarty D,https://www.ncbi.nlm.nih.gov/pubmed/32641750
18733,32915889,#ERROR!,PLoS One. 2020 Sep 11;15(9):e0238999. doi: 10.1371/journal.pone.0238999. eCollection 2020.,Nicholas TR,https://www.ncbi.nlm.nih.gov/pubmed/32915889
18734,32993106,New Uses for the Personal Glucose Meter: Detection of Nucleic Acid Biomarkers for Prostate Cancer Screening,Sensors (Basel). 2020 Sep 26;20(19):5514. doi: 10.3390/s20195514.,Abardía-Serrano C,https://www.ncbi.nlm.nih.gov/pubmed/32993106
18735,33063780,Illness Uncertainty and Its Antecedents for Patients With Prostate Cancer and Their Partners,Oncol Nurs Forum. 2020 Nov 1;47(6):721-731. doi: 10.1188/20.ONF.721-731.,Guan T,https://www.ncbi.nlm.nih.gov/pubmed/33063780
18737,33106584,Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer,Br J Cancer. 2021 Feb;124(3):552-563. doi: 10.1038/s41416-020-01114-x. Epub 2020 Oct 27.,Lozano R,https://www.ncbi.nlm.nih.gov/pubmed/33106584
18739,33022763,CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage,Prostate. 2021 Jan;81(1):81-88. doi: 10.1002/pros.24080. Epub 2020 Oct 6.,Zhu Y,https://www.ncbi.nlm.nih.gov/pubmed/33022763
18740,33325316,"Lower thiol, glutathione, and glutathione peroxidase levels in prostate cancer: a meta-analysis study",Aging Male. 2020 Dec;23(5):1533-1544. doi: 10.1080/13685538.2020.1858048. Epub 2020 Dec 16.,Sajjaboontawee N,https://www.ncbi.nlm.nih.gov/pubmed/33325316
18742,32571877,Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target,J Biol Chem. 2020 Aug 14;295(33):11656-11668. doi: 10.1074/jbc.RA120.013695. Epub 2020 Jun 22.,Škerlová J,https://www.ncbi.nlm.nih.gov/pubmed/32571877
18743,31422041,Protein expression information of prostate infection based on data mining,J Infect Public Health. 2020 Oct;13(10):1533-1536. doi: 10.1016/j.jiph.2019.07.019. Epub 2019 Aug 14.,Abula A,https://www.ncbi.nlm.nih.gov/pubmed/31422041
18744,33182594,Deciphering Fatty Acid Synthase Inhibition-Triggered Metabolic Flexibility in Prostate Cancer Cells through Untargeted Metabolomics,Cells. 2020 Nov 10;9(11):2447. doi: 10.3390/cells9112447.,Oh JE,https://www.ncbi.nlm.nih.gov/pubmed/33182594
18745,32690948,Prostate cancer reactivates developmental epigenomic programs during metastatic progression,Nat Genet. 2020 Aug;52(8):790-799. doi: 10.1038/s41588-020-0664-8. Epub 2020 Jul 20.,Pomerantz MM,https://www.ncbi.nlm.nih.gov/pubmed/32690948
18746,32546700,KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1,Cell Death Dis. 2020 Jun 16;11(6):466. doi: 10.1038/s41419-020-2671-1.,Ma JB,https://www.ncbi.nlm.nih.gov/pubmed/32546700
18748,32804765,Para-aortal Ganglion Mimicking a Lymph Node Metastases on 68Ga-PSMA PET/CT,Clin Nucl Med. 2020 Nov;45(11):883-885. doi: 10.1097/RLU.0000000000003247.,Schweighofer Zwink G,https://www.ncbi.nlm.nih.gov/pubmed/32804765
18752,32009207,Perspective: a critical assessment of PI-RADS 2.1,Abdom Radiol (NY). 2020 Dec;45(12):3961-3968. doi: 10.1007/s00261-020-02424-7.,Ullrich T,https://www.ncbi.nlm.nih.gov/pubmed/32009207
18754,32791988,ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21,J Hematol Oncol. 2020 Aug 13;13(1):112. doi: 10.1186/s13045-020-00943-w.,Cosi I,https://www.ncbi.nlm.nih.gov/pubmed/32791988
18755,31542824,Complications of the urinary incontinence system ATOMS: description of risk factors and how to prevent these pitfalls,World J Urol. 2020 Jul;38(7):1795-1803. doi: 10.1007/s00345-019-02962-w. Epub 2019 Sep 21.,Mühlstädt S,https://www.ncbi.nlm.nih.gov/pubmed/31542824
18756,32941547,"Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience",PLoS One. 2020 Sep 17;15(9):e0239469. doi: 10.1371/journal.pone.0239469. eCollection 2020.,Groarke A,https://www.ncbi.nlm.nih.gov/pubmed/32941547
18757,32045072,Direct Comparison of PI-RADS Version 2 and 2.1 in Transition Zone Lesions for Detection of Prostate Cancer: Preliminary Experience,J Magn Reson Imaging. 2020 Aug;52(2):577-586. doi: 10.1002/jmri.27080. Epub 2020 Feb 11.,Byun J,https://www.ncbi.nlm.nih.gov/pubmed/32045072
18758,32807506,Association Between the Overall Risk of Prostate Cancer and Use of Calcium Channel Blockers: A Systematic Review and Meta-analysis,Clin Ther. 2020 Sep;42(9):1715-1727.e2. doi: 10.1016/j.clinthera.2020.06.021. Epub 2020 Aug 15.,Yang H,https://www.ncbi.nlm.nih.gov/pubmed/32807506
18759,32412310,The management of patients with metastatic prostate cancer during the COVID-19 pandemic,Future Oncol. 2020 Jul;16(20):1455-1461. doi: 10.2217/fon-2020-0361. Epub 2020 May 15.,Assi T,https://www.ncbi.nlm.nih.gov/pubmed/32412310
18760,32681304,"Enhancing survivorship care planning for patients with localized prostate cancer using a couple-focused web-based, mHealth program: the results of a pilot feasibility study",J Cancer Surviv. 2021 Feb;15(1):99-108. doi: 10.1007/s11764-020-00914-7. Epub 2020 Jul 17.,Song L,https://www.ncbi.nlm.nih.gov/pubmed/32681304
18761,32229215,CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancer,Nanomedicine. 2020 Jul;27:102192. doi: 10.1016/j.nano.2020.102192. Epub 2020 Mar 27.,Tan H,https://www.ncbi.nlm.nih.gov/pubmed/32229215
18762,32590296,Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer,Eur J Cancer. 2020 Aug;135:173-182. doi: 10.1016/j.ejca.2020.04.036. Epub 2020 Jun 23.,Mastelic-Gavillet B,https://www.ncbi.nlm.nih.gov/pubmed/32590296
18763,32808201,Intra-hepatic Abscopal Effect Following Radioembolization of Hepatic Metastases,Cardiovasc Intervent Radiol. 2020 Nov;43(11):1641-1649. doi: 10.1007/s00270-020-02612-4. Epub 2020 Aug 17.,Powerski M,https://www.ncbi.nlm.nih.gov/pubmed/32808201
18764,32556481,"Deep learning detection of prostate cancer recurrence with (18)F-FACBC (fluciclovine, Axumin(R)) positron emission tomography",Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):2992-2997. doi: 10.1007/s00259-020-04912-w. Epub 2020 Jun 17.,Lee JJ,https://www.ncbi.nlm.nih.gov/pubmed/32556481
18765,33263645,A duplex probe-directed recombinase amplification assay for detection of single nucleotide polymorphisms on 8q24 associated with prostate cancer,Braz J Med Biol Res. 2020 Nov 27;54(2):e9549. doi: 10.1590/1414-431X20209549. eCollection 2020.,Duan Q,https://www.ncbi.nlm.nih.gov/pubmed/33263645
18768,33290947,Mechanobiological evaluation of prostate cancer metastasis to bone using an in vitro prostate cancer testbed,J Biomech. 2021 Jan 4;114:110142. doi: 10.1016/j.jbiomech.2020.110142. Epub 2020 Nov 21.,Molla MS,https://www.ncbi.nlm.nih.gov/pubmed/33290947
18769,33377531,A potential therapeutic strategy for prostatic disease by targeting the oral microbiome,Med Res Rev. 2021 May;41(3):1812-1834. doi: 10.1002/med.21778. Epub 2020 Dec 30.,Fang C,https://www.ncbi.nlm.nih.gov/pubmed/33377531
18770,33277864,"Research on the association of plasma TGF-?1 level and blood lymphocyte/monocyte ratio with pathological grade, clinical stage and prognosis of prostate cancer",J BUON. 2020 Sep-Oct;25(5):2418-2423.,Wang Q,https://www.ncbi.nlm.nih.gov/pubmed/33277864
18771,32242968,Using Card Games to study cultural differences in men's social talk about prostate cancer,J Adv Nurs. 2020 Jul;76(7):1840-1849. doi: 10.1111/jan.14373. Epub 2020 Apr 25.,Fry SL,https://www.ncbi.nlm.nih.gov/pubmed/32242968
18772,32299729,Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Aug;18(4):332-339.e2. doi: 10.1016/j.clgc.2019.10.019. Epub 2020 Mar 7.,Smith DC,https://www.ncbi.nlm.nih.gov/pubmed/32299729
18773,32620790,Comparison of (68)Ga-PSMA-617 PET/CT with mpMRI for the detection of PCa in patients with a PSA level of 4-20 ng/ml before the initial biopsy,Sci Rep. 2020 Jul 3;10(1):10963. doi: 10.1038/s41598-020-67385-9.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32620790
18775,32484346,"Design and Synthesis of a Trifunctional Molecular System ""Programmed"" to Block Epidermal Growth Factor Receptor Tyrosine Kinase, Induce High Levels of DNA Damage, and Inhibit the DNA Repair Enzyme (Poly(ADP-ribose) Polymerase) in Prostate Cancer Cells",J Med Chem. 2020 Jun 11;63(11):5752-5762. doi: 10.1021/acs.jmedchem.9b02008. Epub 2020 Jun 2.,Schmitt J,https://www.ncbi.nlm.nih.gov/pubmed/32484346
18776,33144478,Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients,In Vivo. 2020 Nov-Dec;34(6):3631-3638. doi: 10.21873/invivo.12209.,Moritz J,https://www.ncbi.nlm.nih.gov/pubmed/33144478
18780,32512818,Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development,Cells. 2020 Jun 4;9(6):1398. doi: 10.3390/cells9061398.,Ci X,https://www.ncbi.nlm.nih.gov/pubmed/32512818
18784,32777521,Carbonic anhydrase III is a new target of HIF1? in prostate cancer model,Gene. 2020 Dec 15;762:145034. doi: 10.1016/j.gene.2020.145034. Epub 2020 Aug 8.,Okuyan D,https://www.ncbi.nlm.nih.gov/pubmed/32777521
18785,33037409,MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer,Oncogene. 2020 Dec;39(49):7209-7223. doi: 10.1038/s41388-020-01493-8. Epub 2020 Oct 9.,Bhagirath D,https://www.ncbi.nlm.nih.gov/pubmed/33037409
18786,32887685,Reconstruction of clone- and haplotype-specific cancer genome karyotypes from bulk tumor samples,Genome Res. 2020 Sep;30(9):1274-1290. doi: 10.1101/gr.256701.119. Epub 2020 Sep 4.,Aganezov S,https://www.ncbi.nlm.nih.gov/pubmed/32887685
18788,32794165,"Effect of serum 25-hydroxyvitamin D level on lung, breast, colorectal and prostate cancers: a nested case-control study",East Mediterr Health J. 2020 Jul 23;26(7):794-802. doi: 10.26719/emhj.20.035.,Acikgoz A,https://www.ncbi.nlm.nih.gov/pubmed/32794165
18789,32736078,"2H-1,2,3-Triazole-chalcones as novel cytotoxic agents against prostate cancer",Bioorg Med Chem Lett. 2020 Oct 1;30(19):127454. doi: 10.1016/j.bmcl.2020.127454. Epub 2020 Jul 28.,Pinheiro S,https://www.ncbi.nlm.nih.gov/pubmed/32736078
18791,33463130,Epigallocatechin-3-gallate Enhances the Efficacy of MicroRNA-34a Mimic and MicroRNA-93 Inhibitor Co-transfection in Prostate Cancer Cell Line,Iran J Allergy Asthma Immunol. 2020 Dec 19;19(6):612-623. doi: 10.18502/ijaai.v19i6.4930.,Mokhtari H,https://www.ncbi.nlm.nih.gov/pubmed/33463130
18792,33317623,Convergent network effects along the axis of gene expression during prostate cancer progression,Genome Biol. 2020 Dec 14;21(1):302. doi: 10.1186/s13059-020-02188-9.,Charmpi K,https://www.ncbi.nlm.nih.gov/pubmed/33317623
18795,32565538,Androgen receptor-induced integrin ?6?1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer,Oncogene. 2020 Jul;39(31):5390-5404. doi: 10.1038/s41388-020-1370-9. Epub 2020 Jun 21.,Nollet EA,https://www.ncbi.nlm.nih.gov/pubmed/32565538
18796,32628318,Patterns of stemness-associated markers in the development of castration-resistant prostate cancer,Prostate. 2020 Sep;80(13):1108-1117. doi: 10.1002/pros.24039. Epub 2020 Jul 6.,Federer-Gsponer JR,https://www.ncbi.nlm.nih.gov/pubmed/32628318
18797,33368465,Knowledge of prostate cancer among African American men: A systematic review,Prostate. 2021 Feb;81(3):202-213. doi: 10.1002/pros.24097. Epub 2020 Dec 23.,Coughlin SS,https://www.ncbi.nlm.nih.gov/pubmed/33368465
18802,32691745,"Polyacrylamide-punicic acid conjugate-based micelles for flutamide delivery in PC3 cells of prostate cancer: synthesis, characterisation and cytotoxicity studies",IET Nanobiotechnol. 2020 Jul;14(5):417-422. doi: 10.1049/iet-nbt.2020.0014.,Mirsafaei R,https://www.ncbi.nlm.nih.gov/pubmed/32691745
18803,32535819,Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study,Radiol Phys Technol. 2020 Sep;13(3):219-229. doi: 10.1007/s12194-020-00571-6. Epub 2020 Jun 13.,Motegi K,https://www.ncbi.nlm.nih.gov/pubmed/32535819
18804,33012006,Interactions of galeterone and its 3-keto-?4 metabolite (D4G) with one of the key enzymes of corticosteroid biosynthesis - steroid 21-monooxygenase (CYP21A2),Fundam Clin Pharmacol. 2021 Apr;35(2):423-431. doi: 10.1111/fcp.12607. Epub 2020 Oct 27.,Masamrekh RA,https://www.ncbi.nlm.nih.gov/pubmed/33012006
18805,33115529,Novel therapies are changing treatment paradigms in metastatic prostate cancer,J Hematol Oncol. 2020 Oct 28;13(1):144. doi: 10.1186/s13045-020-00978-z.,Powers E,https://www.ncbi.nlm.nih.gov/pubmed/33115529
18806,33039867,"ROS-mediated genotoxic stress is involved in NaAsO(2)-induced cell cycle arrest, stemness enhancement and chemoresistance of prostate cancer cells in a p53-independent manner",Ecotoxicol Environ Saf. 2021 Jan 15;208:111436. doi: 10.1016/j.ecoenv.2020.111436. Epub 2020 Oct 9.,Zhang ZH,https://www.ncbi.nlm.nih.gov/pubmed/33039867
18809,32931488,Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors,PLoS One. 2020 Sep 15;15(9):e0224414. doi: 10.1371/journal.pone.0224414. eCollection 2020.,Baio G,https://www.ncbi.nlm.nih.gov/pubmed/32931488
18812,32979908,An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus,Arch Iran Med. 2020 Sep 1;23(9):614-620. doi: 10.34172/aim.2020.72.,Yeo J,https://www.ncbi.nlm.nih.gov/pubmed/32979908
18813,32948911,Semi-automatic evaluation of baseline whole-body tumor burden as an imaging biomarker of (68)Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer,Abdom Radiol (NY). 2020 Dec;45(12):4202-4213. doi: 10.1007/s00261-020-02745-7. Epub 2020 Sep 18.,Zou Q,https://www.ncbi.nlm.nih.gov/pubmed/32948911
18814,32534106,Alternative splicing regulation by the androgen receptor in prostate cancer cells,J Steroid Biochem Mol Biol. 2020 Sep;202:105710. doi: 10.1016/j.jsbmb.2020.105710. Epub 2020 Jun 11.,Germain L,https://www.ncbi.nlm.nih.gov/pubmed/32534106
18815,32903025,Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis,Acta Radiol. 2021 Sep;62(9):1238-1247. doi: 10.1177/0284185120956269. Epub 2020 Sep 9.,Yang L,https://www.ncbi.nlm.nih.gov/pubmed/32903025
18816,32673068,Machine Learning-Based Interpretation and Visualization of Nonlinear Interactions in Prostate Cancer Survival,JCO Clin Cancer Inform. 2020 Jul;4:637-646. doi: 10.1200/CCI.20.00002.,Li R,https://www.ncbi.nlm.nih.gov/pubmed/32673068
18817,33518028,Cost-Effectiveness of Providing the Depression Care for People With Cancer Program to Patients With Prostate Cancer in the United States,Value Health. 2021 Feb;24(2):216-226. doi: 10.1016/j.jval.2020.09.008. Epub 2020 Oct 31.,Erim DO,https://www.ncbi.nlm.nih.gov/pubmed/33518028
18819,32376773,Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis,Cancer Discov. 2020 Jul;10(7):1038-1057. doi: 10.1158/2159-8290.CD-19-1242. Epub 2020 May 6.,Leibold J,https://www.ncbi.nlm.nih.gov/pubmed/32376773
18820,32447485,"SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis",J Cancer Res Clin Oncol. 2020 Aug;146(8):1953-1969. doi: 10.1007/s00432-020-03247-1. Epub 2020 May 23.,Xu N,https://www.ncbi.nlm.nih.gov/pubmed/32447485
18821,32650128,"Advanced diffusion weighted imaging of the prostate: Comparison of readout-segmented multi-shot, parallel-transmit and single-shot echo-planar imaging",Eur J Radiol. 2020 Sep;130:109161. doi: 10.1016/j.ejrad.2020.109161. Epub 2020 Jul 2.,Klingebiel M,https://www.ncbi.nlm.nih.gov/pubmed/32650128
18822,33233569,"Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target",Cells. 2020 Nov 20;9(11):2511. doi: 10.3390/cells9112511.,He J,https://www.ncbi.nlm.nih.gov/pubmed/33233569
18823,33174061,TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR?155,Mol Med Rep. 2020 Dec;22(6):5209-5218. doi: 10.3892/mmr.2020.11623. Epub 2020 Oct 21.,Chen W,https://www.ncbi.nlm.nih.gov/pubmed/33174061
18824,32321698,Direct in vivo comparison of [(18)F]PSMA-1007 with [(68)Ga]Ga-PSMA-11 and [(18)F]AlF-PSMA-11 in mice bearing PSMA-expressing xenografts,Appl Radiat Isot. 2020 Jul;161:109164. doi: 10.1016/j.apradiso.2020.109164. Epub 2020 Apr 2.,Ioppolo JA,https://www.ncbi.nlm.nih.gov/pubmed/32321698
18825,32691595,Synthesis of a Unique Psammaplysin F Library and Functional Evaluation in Prostate Cancer Cells by Multiparametric Quantitative Single Cell Imaging,J Nat Prod. 2020 Aug 28;83(8):2357-2366. doi: 10.1021/acs.jnatprod.0c00121. Epub 2020 Jul 21.,Kumar R,https://www.ncbi.nlm.nih.gov/pubmed/32691595
18826,33001740,Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy,JCO Glob Oncol. 2020 Oct;6:1481-1489. doi: 10.1200/GO.20.00290.,Bassey IE,https://www.ncbi.nlm.nih.gov/pubmed/33001740
18827,32460179,Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer,Eur J Cancer. 2020 Jul;134:29-40. doi: 10.1016/j.ejca.2020.04.013. Epub 2020 May 24.,Zhou T,https://www.ncbi.nlm.nih.gov/pubmed/32460179
18828,32666419,African-American survivors of prostate cancer: a meta-synthesis of qualitative studies,J Cancer Surviv. 2021 Feb;15(1):40-53. doi: 10.1007/s11764-020-00909-4. Epub 2020 Jul 14.,Okoro FO,https://www.ncbi.nlm.nih.gov/pubmed/32666419
18829,32994029,"LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer",Mater Sci Eng C Mater Biol Appl. 2020 Sep;114:111035. doi: 10.1016/j.msec.2020.111035. Epub 2020 May 1.,Shitole AA,https://www.ncbi.nlm.nih.gov/pubmed/32994029
18830,32534879,A Multimodal Theranostic Nanoformulation That Dramatically Enhances Docetaxel Efficacy Against Castration Resistant Prostate Cancer,J Pharm Sci. 2020 Sep;109(9):2874-2883. doi: 10.1016/j.xphs.2020.06.004. Epub 2020 Jun 11.,Bulmahn JC,https://www.ncbi.nlm.nih.gov/pubmed/32534879
18831,32654508,Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay,Biotechniques. 2020 Aug;69(2):133-140. doi: 10.2144/btn-2020-0045. Epub 2020 Jul 13.,Fettke H,https://www.ncbi.nlm.nih.gov/pubmed/32654508
18834,32628304,Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway,Prostate. 2020 Sep;80(13):1134-1144. doi: 10.1002/pros.24042. Epub 2020 Jul 6.,Qin C,https://www.ncbi.nlm.nih.gov/pubmed/32628304
18835,33150960,Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it,Br J Pharmacol. 2021 Jan;178(2):239-261. doi: 10.1111/bph.15300. Epub 2020 Dec 14.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/33150960
18836,33144490,"Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy",In Vivo. 2020 Nov-Dec;34(6):3723-3730. doi: 10.21873/invivo.12221.,Pollard BS,https://www.ncbi.nlm.nih.gov/pubmed/33144490
18837,33029095,Potential risk of certain cancers among patients with Periodontitis: a supplementary meta-analysis of a large-scale population,Int J Med Sci. 2020 Sep 12;17(16):2531-2543. doi: 10.7150/ijms.46812. eCollection 2020.,Ma H,https://www.ncbi.nlm.nih.gov/pubmed/33029095
18839,32770085,Update analysis on the association between Methionine synthase rs1805087 A/G variant and risk of prostate cancer,Sci Rep. 2020 Aug 7;10(1):13384. doi: 10.1038/s41598-020-70223-7.,Zhang W,https://www.ncbi.nlm.nih.gov/pubmed/32770085
18840,32820953,The potential of PSMA-targeted alpha therapy in the management of prostate cancer,Expert Rev Anticancer Ther. 2020 Oct;20(10):823-829. doi: 10.1080/14737140.2020.1814151. Epub 2020 Sep 3.,Filippi L,https://www.ncbi.nlm.nih.gov/pubmed/32820953
18841,31747816,Editor's Choice: Deliberative and non-deliberative effects of descriptive and injunctive norms on cancer screening behaviors among African Americans,Psychol Health. 2020 Jul;35(7):774-794. doi: 10.1080/08870446.2019.1691725. Epub 2019 Nov 20.,Manning M,https://www.ncbi.nlm.nih.gov/pubmed/31747816
18842,31894360,Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells,Cell Mol Life Sci. 2020 Nov;77(22):4663-4673. doi: 10.1007/s00018-019-03429-2. Epub 2020 Jan 1.,Song IS,https://www.ncbi.nlm.nih.gov/pubmed/31894360
18843,33188147,SLX4IP Promotes Telomere Maintenance in Androgen Receptor-Independent Castration-Resistant Prostate Cancer through ALT-like Telomeric PML Localization,Mol Cancer Res. 2021 Feb;19(2):301-316. doi: 10.1158/1541-7786.MCR-20-0314. Epub 2020 Nov 13.,Mangosh TL,https://www.ncbi.nlm.nih.gov/pubmed/33188147
18845,33230201,Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):499-506. doi: 10.1038/s41391-020-00304-1. Epub 2020 Nov 23.,Oeyen S,https://www.ncbi.nlm.nih.gov/pubmed/33230201
18846,33044685,"Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data",Target Oncol. 2020 Dec;15(6):709-722. doi: 10.1007/s11523-020-00756-4.,Sigorski D,https://www.ncbi.nlm.nih.gov/pubmed/33044685
18847,32576177,Does increased body mass index lead to elevated prostate cancer risk? It depends on waist circumference,BMC Cancer. 2020 Jun 23;20(1):589. doi: 10.1186/s12885-020-07089-5.,Choi JB,https://www.ncbi.nlm.nih.gov/pubmed/32576177
18848,32678070,Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer,Aging (Albany NY). 2020 Jul 17;12(14):14699-14717. doi: 10.18632/aging.103530. Epub 2020 Jul 17.,Huang H,https://www.ncbi.nlm.nih.gov/pubmed/32678070
18849,32275943,HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression,Cell Signal. 2020 Aug;72:109631. doi: 10.1016/j.cellsig.2020.109631. Epub 2020 Apr 7.,Lei X,https://www.ncbi.nlm.nih.gov/pubmed/32275943
18850,32567118,Group analysis of distance matrices,Genet Epidemiol. 2020 Sep;44(6):620-628. doi: 10.1002/gepi.22329. Epub 2020 Jun 21.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32567118
18851,33239676,miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition,Br J Cancer. 2021 Mar;124(5):982-994. doi: 10.1038/s41416-020-01187-8. Epub 2020 Nov 26.,Zhao Z,https://www.ncbi.nlm.nih.gov/pubmed/33239676
18852,32283033,"Incarnatapeptins A and B, Nonribosomal Peptides Discovered Using Genome Mining and (1)H/(15)N HSQC-TOCSY",Org Lett. 2020 Jun 5;22(11):4053-4057. doi: 10.1021/acs.orglett.0c00818. Epub 2020 Apr 13.,Morgan KD,https://www.ncbi.nlm.nih.gov/pubmed/32283033
18854,33290408,A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer,PLoS Genet. 2020 Dec 8;16(12):e1009218. doi: 10.1371/journal.pgen.1009218. eCollection 2020 Dec.,Ray D,https://www.ncbi.nlm.nih.gov/pubmed/33290408
18856,33074658,Glass Fiber-Supported Hybrid Monolithic Spin Tip for Enrichment of Phosphopeptides from Urinary Extracellular Vesicles,Anal Chem. 2020 Nov 3;92(21):14790-14797. doi: 10.1021/acs.analchem.0c03557. Epub 2020 Oct 19.,Zhang H,https://www.ncbi.nlm.nih.gov/pubmed/33074658
18859,32078741,The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer,J Racial Ethn Health Disparities. 2020 Oct;7(5):996-1002. doi: 10.1007/s40615-020-00724-8. Epub 2020 Feb 20.,Zuniga KB,https://www.ncbi.nlm.nih.gov/pubmed/32078741
18860,32319599,Gli2 mediates the development of castration?resistant prostate cancer,Int J Oncol. 2020 Jul;57(1):100-112. doi: 10.3892/ijo.2020.5044. Epub 2020 Apr 13.,Xia L,https://www.ncbi.nlm.nih.gov/pubmed/32319599
18861,32976649,Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study),Int J Cancer. 2021 Mar 15;148(6):1360-1371. doi: 10.1002/ijc.33310. Epub 2020 Oct 7.,Weitzer J,https://www.ncbi.nlm.nih.gov/pubmed/32976649
18862,32649013,Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance,Prostate. 2020 Sep;80(12):1012-1023. doi: 10.1002/pros.24035. Epub 2020 Jul 10.,Kaur H,https://www.ncbi.nlm.nih.gov/pubmed/32649013
18863,30791725,Health Literacy Among Canadian Men Experiencing Prostate Cancer,Health Promot Pract. 2020 Nov;21(6):1004-1011. doi: 10.1177/1524839919827576. Epub 2019 Feb 21.,Seaton CL,https://www.ncbi.nlm.nih.gov/pubmed/30791725
18864,32630147,Epigenetic Regulation of Gfi1 in Endocrine-Related Cancers: a Role Regulating Tumor Growth,Int J Mol Sci. 2020 Jun 30;21(13):4687. doi: 10.3390/ijms21134687.,Ashour N,https://www.ncbi.nlm.nih.gov/pubmed/32630147
18865,32606146,Germline Mutations in DNA Repair Genes in Patients With Metastatic Castration-resistant Prostate Cancer,In Vivo. 2020 Jul-Aug;34(4):1773-1778. doi: 10.21873/invivo.11971.,Holeckova K,https://www.ncbi.nlm.nih.gov/pubmed/32606146
18866,32935296,MAGE-C2/CT10 promotes growth and metastasis through upregulating c-Myc expression in prostate cancer,Mol Cell Biochem. 2021 Jan;476(1):1-10. doi: 10.1007/s11010-020-03814-7. Epub 2020 Jul 6.,Qiu J,https://www.ncbi.nlm.nih.gov/pubmed/32935296
18867,32216035,A critical review of graphics for subgroup analyses in clinical trials,Pharm Stat. 2020 Sep;19(5):541-560. doi: 10.1002/pst.2012. Epub 2020 Mar 25.,Ballarini NM,https://www.ncbi.nlm.nih.gov/pubmed/32216035
18868,32814685,When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials,Eur Urol Oncol. 2020 Oct;3(5):594-611. doi: 10.1016/j.euo.2020.07.005. Epub 2020 Aug 17.,Antonarakis ES,https://www.ncbi.nlm.nih.gov/pubmed/32814685
18869,33339207,The Impact of [C16Pyr][Amp] on the Aggressiveness in Breast and Prostate Cancer Cell Lines,Int J Mol Sci. 2020 Dec 16;21(24):9584. doi: 10.3390/ijms21249584.,Vieira FQ,https://www.ncbi.nlm.nih.gov/pubmed/33339207
18870,33068124,"New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis",Cell Mol Life Sci. 2021 Mar;78(6):2893-2910. doi: 10.1007/s00018-020-03679-5. Epub 2020 Oct 17.,Castillo AF,https://www.ncbi.nlm.nih.gov/pubmed/33068124
18871,33038052,CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression,Cancer Sci. 2020 Dec;111(12):4652-4655. doi: 10.1111/cas.14672. Epub 2020 Oct 23.,Yanai Y,https://www.ncbi.nlm.nih.gov/pubmed/33038052
18872,33149131,Pan-cancer landscape of homologous recombination deficiency,Nat Commun. 2020 Nov 4;11(1):5584. doi: 10.1038/s41467-020-19406-4.,Nguyen L,https://www.ncbi.nlm.nih.gov/pubmed/33149131
18874,33107671,Prostate cancer-secreted CCN3 uses the GSK3? and ?-catenin pathways to enhance osteogenic factor levels in osteoblasts,Environ Toxicol. 2021 Mar;36(3):425-432. doi: 10.1002/tox.23048. Epub 2020 Oct 27.,Chen PC,https://www.ncbi.nlm.nih.gov/pubmed/33107671
18876,33273553,Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance,Sci Rep. 2020 Dec 3;10(1):21015. doi: 10.1038/s41598-020-78058-y.,Sharma V,https://www.ncbi.nlm.nih.gov/pubmed/33273553
18878,32626928,MicroRNA?137 regulates hypoxia?mediated migration and epithelial?mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway,Int J Oncol. 2020 Aug;57(2):540-549. doi: 10.3892/ijo.2020.5064. Epub 2020 May 14.,Zhang H,https://www.ncbi.nlm.nih.gov/pubmed/32626928
18879,32413665,Endosulfan triggers epithelial-mesenchymal transition via PTP4A3-mediated TGF-? signaling pathway in prostate cancer cells,Sci Total Environ. 2020 Aug 20;731:139234. doi: 10.1016/j.scitotenv.2020.139234. Epub 2020 May 7.,Wang Y,https://www.ncbi.nlm.nih.gov/pubmed/32413665
18880,32304760,RETRACTED: MicroRNA-381 facilitates autophagy and apoptosis in prostate cancer cells via inhibiting the RELN-mediated PI3K/AKT/mTOR signaling pathway,Life Sci. 2020 Aug 1;254:117672. doi: 10.1016/j.lfs.2020.117672. Epub 2020 Apr 15.,Liao W,https://www.ncbi.nlm.nih.gov/pubmed/32304760
18881,32595026,Assessment of the role of Ga-68 PSMA I&T PET/CT in response evaluation to docetaxel therapy in castration resistant prostate cancer patients,Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Sep-Oct;39(5):292-298. doi: 10.1016/j.remn.2020.01.004. Epub 2020 Jun 25.,Özülker T,https://www.ncbi.nlm.nih.gov/pubmed/32595026
18882,32909380,Therapeutic prognosis of prostate cancer using surface-enhanced Raman scattering of patient urine and multivariate statistical analysis,J Biophotonics. 2021 Jan;14(1):e202000275. doi: 10.1002/jbio.202000275. Epub 2020 Sep 28.,Ma Y,https://www.ncbi.nlm.nih.gov/pubmed/32909380
18883,32924610,Chemoprevention of Prostate Cancer Cells by Vitamin C plus Quercetin: role of Nrf2 in Inducing Oxidative Stress,Nutr Cancer. 2021;73(10):2003-2013. doi: 10.1080/01635581.2020.1819346. Epub 2020 Sep 14.,Abbasi A,https://www.ncbi.nlm.nih.gov/pubmed/32924610
18884,32968952,The experiences and needs of couples affected by prostate cancer aged 65 and under: a qualitative study,J Cancer Surviv. 2021 Apr;15(2):358-366. doi: 10.1007/s11764-020-00936-1. Epub 2020 Sep 24.,Collaço N,https://www.ncbi.nlm.nih.gov/pubmed/32968952
18886,30457028,Assessing the impact of sexual function on perceptions of masculinity among prostate cancer survivors in the United States: findings from the prostate cancer registry,Aging Male. 2020 Dec;23(5):496-500. doi: 10.1080/13685538.2018.1535582. Epub 2018 Nov 20.,Richards AB,https://www.ncbi.nlm.nih.gov/pubmed/30457028
18887,32327394,Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment,Clin Genitourin Cancer. 2020 Aug;18(4):258-267.e1. doi: 10.1016/j.clgc.2019.11.002. Epub 2020 Mar 29.,Madan RA,https://www.ncbi.nlm.nih.gov/pubmed/32327394
18888,32988877,Mxi-2 Dependent Regulation of p53 in Prostate Cancer,Anticancer Res. 2020 Oct;40(10):5539-5544. doi: 10.21873/anticanres.14566.,KÖditz B,https://www.ncbi.nlm.nih.gov/pubmed/32988877
18889,32828802,Role of nitric oxide in the response to photooxidative stress in prostate cancer cells,Biochem Pharmacol. 2020 Dec;182:114205. doi: 10.1016/j.bcp.2020.114205. Epub 2020 Aug 20.,D'Este F,https://www.ncbi.nlm.nih.gov/pubmed/32828802
18894,33204367,CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer,Dis Markers. 2020 Nov 1;2020:8899924. doi: 10.1155/2020/8899924. eCollection 2020.,Ma Z,https://www.ncbi.nlm.nih.gov/pubmed/33204367
18895,32304618,Riluzole: Anti-invasive effects on rat prostate cancer cells under normoxic and hypoxic conditions,Basic Clin Pharmacol Toxicol. 2020 Oct;127(4):254-264. doi: 10.1111/bcpt.13417. Epub 2020 Jun 19.,Rizaner N,https://www.ncbi.nlm.nih.gov/pubmed/32304618
18896,33199493,Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer,Clin Cancer Res. 2021 Feb 1;27(3):759-774. doi: 10.1158/1078-0432.CCR-20-3396. Epub 2020 Nov 16.,DeLucia DC,https://www.ncbi.nlm.nih.gov/pubmed/33199493
18898,33308223,Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine,Mol Cancer. 2020 Dec 12;19(1):171. doi: 10.1186/s12943-020-01293-4.,Wen S,https://www.ncbi.nlm.nih.gov/pubmed/33308223
18899,33405276,Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank,Int J Cancer. 2021 Feb 15;148(4):825-834. doi: 10.1002/ijc.33255. Epub 2020 Sep 11.,Monroy-Iglesias MJ,https://www.ncbi.nlm.nih.gov/pubmed/33405276
18900,33258507,AKR1C3 mediates pan-AR antagonist resistance in castration-resistant prostate cancer,Prostate. 2020 Oct;80(14):1223-1232. doi: 10.1002/pros.24049. Epub 2020 Jul 31.,Hertzog JR,https://www.ncbi.nlm.nih.gov/pubmed/33258507
18902,32198082,Cabazitaxel in patients aged ?80?years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan,J Geriatr Oncol. 2020 Sep;11(7):1067-1073. doi: 10.1016/j.jgo.2020.02.014. Epub 2020 Mar 18.,Matsubara N,https://www.ncbi.nlm.nih.gov/pubmed/32198082
18903,33347778,"Patterns of Current Cigarette Smoking, Quit Attempts and Cessation Counseling among Survivors of Smoking-Related and Nonsmoking-Related Urological Malignancies: A Nationally Representative Cross-Sectional Analysis",J Urol. 2021 May;205(5):1444-1451. doi: 10.1097/JU.0000000000001483. Epub 2020 Dec 21.,Matulewicz RS,https://www.ncbi.nlm.nih.gov/pubmed/33347778
18904,32781041,Microenvironment-Mediated Resistance to Anti-Androgen Therapy,Cancer Cell. 2020 Aug 10;38(2):155-157. doi: 10.1016/j.ccell.2020.07.007.,Orme JJ,https://www.ncbi.nlm.nih.gov/pubmed/32781041
18905,32967912,Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T,Cancer Immunol Res. 2020 Dec;8(12):1496-1507. doi: 10.1158/2326-6066.CIR-20-0252. Epub 2020 Sep 23.,Zhang L,https://www.ncbi.nlm.nih.gov/pubmed/32967912
18906,32517184,Dietary Diversity and Prostate Cancer in a Spanish Adult Population: CAPLIFE Study,Nutrients. 2020 Jun 6;12(6):1694. doi: 10.3390/nu12061694.,Cano-Ibáñez N,https://www.ncbi.nlm.nih.gov/pubmed/32517184
18907,32094298,Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors,Cancer Res. 2020 Jun 15;80(12):2427-2436. doi: 10.1158/0008-5472.CAN-19-3447. Epub 2020 Feb 24.,Hankey W,https://www.ncbi.nlm.nih.gov/pubmed/32094298
18908,32960365,Cinnamaldehyde induces endogenous apoptosis of the prostate cancer-associated fibroblasts via interfering the Glutathione-associated mitochondria function,Med Oncol. 2020 Sep 22;37(10):91. doi: 10.1007/s12032-020-01417-2.,Han L,https://www.ncbi.nlm.nih.gov/pubmed/32960365
18910,33035382,DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer,Environ Toxicol. 2021 Mar;36(3):308-319. doi: 10.1002/tox.23036. Epub 2020 Oct 9.,Zhu X,https://www.ncbi.nlm.nih.gov/pubmed/33035382
18911,33255236,Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer,Cells. 2020 Nov 24;9(12):2535. doi: 10.3390/cells9122535.,Verma S,https://www.ncbi.nlm.nih.gov/pubmed/33255236
18912,32678004,Pluripotent stem cell differentiation as an emerging model to study human prostate development,Stem Cell Res Ther. 2020 Jul 16;11(1):285. doi: 10.1186/s13287-020-01801-9.,Yu Y,https://www.ncbi.nlm.nih.gov/pubmed/32678004
18914,32434918,Enzyme-mediated depletion of serum l-Met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity,Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):13000-13011. doi: 10.1073/pnas.1917362117. Epub 2020 May 20.,Lu WC,https://www.ncbi.nlm.nih.gov/pubmed/32434918
18915,32600929,Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ((177)Lu-J591) for metastatic castration-resistant prostate cancer,Urol Oncol. 2020 Nov;38(11):848.e9-848.e16. doi: 10.1016/j.urolonc.2020.05.028. Epub 2020 Jun 27.,Batra JS,https://www.ncbi.nlm.nih.gov/pubmed/32600929
18917,32618200,LncRNA HORAS5 promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanism,Epigenomics. 2020 Jul;12(13):1123-1138. doi: 10.2217/epi-2019-0316. Epub 2020 Jul 3.,Pucci P,https://www.ncbi.nlm.nih.gov/pubmed/32618200
18918,32268314,"Design, evaluation and comparison of endorectal coils for hybrid MR-PET imaging of the prostate",Phys Med Biol. 2020 Jun 9;65(11):115005. doi: 10.1088/1361-6560/ab87f8.,Choi CH,https://www.ncbi.nlm.nih.gov/pubmed/32268314
18919,33311589,Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer,Br J Cancer. 2021 Mar;124(5):995-1008. doi: 10.1038/s41416-020-01197-6. Epub 2020 Dec 14.,Nikhil K,https://www.ncbi.nlm.nih.gov/pubmed/33311589
18923,32719513,Tracking the expression of therapeutic protein targets in rare cells by antibody-mediated nanoparticle labelling and magnetic sorting,Nat Biomed Eng. 2021 Jan;5(1):41-52. doi: 10.1038/s41551-020-0590-1. Epub 2020 Jul 27.,Labib M,https://www.ncbi.nlm.nih.gov/pubmed/32719513
18924,33098043,In Vitro Evaluation and Biodistribution Studies of HPMA Copolymers Targeting the Gastrin Releasing Peptide Receptor in Prostate Cancer,Pharm Res. 2020 Oct 23;37(11):229. doi: 10.1007/s11095-020-02952-3.,Alshehri S,https://www.ncbi.nlm.nih.gov/pubmed/33098043
18925,33227916,In Vitro Study of Calcium Microsecond Electroporation of Prostate Adenocarcinoma Cells,Molecules. 2020 Nov 19;25(22):5406. doi: 10.3390/molecules25225406.,Kie?bik A,https://www.ncbi.nlm.nih.gov/pubmed/33227916
18926,32789600,Detection of metastases in newly diagnosed prostate cancer by using 68Ga-PSMA PET/CT and its relationship with modified D'Amico risk classification,Eur J Nucl Med Mol Imaging. 2021 May;48(5):1639-1649. doi: 10.1007/s00259-020-04995-5. Epub 2020 Aug 13.,Simsek DH,https://www.ncbi.nlm.nih.gov/pubmed/32789600
18927,32868907,Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer,Nat Genet. 2020 Oct;52(10):1011-1017. doi: 10.1038/s41588-020-0681-7. Epub 2020 Aug 31.,Gao S,https://www.ncbi.nlm.nih.gov/pubmed/32868907
18928,32931887,Negative cross talk between LIMK2 and PTEN promotes castration resistant prostate cancer pathogenesis in cells and in vivo,Cancer Lett. 2021 Feb 1;498:1-18. doi: 10.1016/j.canlet.2020.09.010. Epub 2020 Sep 12.,Nikhil K,https://www.ncbi.nlm.nih.gov/pubmed/32931887
18929,33303880,Cell-free DNA promotes malignant transformation in non-tumor cells,Sci Rep. 2020 Dec 10;10(1):21674. doi: 10.1038/s41598-020-78766-5.,Souza AG,https://www.ncbi.nlm.nih.gov/pubmed/33303880
18930,33236334,Association between Marital Status and Prognosis in Patients with Prostate Cancer: A Meta-Analysis of Observational Studies,Urol J. 2020 Nov 23;18(4):371-379. doi: 10.22037/uj.v16i7.6197.,Guo Z,https://www.ncbi.nlm.nih.gov/pubmed/33236334
18931,33069922,Cellular plasticity in bone metastasis,Bone. 2022 May;158:115693. doi: 10.1016/j.bone.2020.115693. Epub 2020 Oct 15.,Fang C,https://www.ncbi.nlm.nih.gov/pubmed/33069922
18937,31630355,"Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+?4/CD44+?prostate cancer stem cells",Clin Transl Oncol. 2020 Jul;22(7):1040-1048. doi: 10.1007/s12094-019-02229-1. Epub 2019 Oct 19.,Binal Z,https://www.ncbi.nlm.nih.gov/pubmed/31630355
18938,32853947,Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis,Pathol Res Pract. 2020 Oct;216(10):153109. doi: 10.1016/j.prp.2020.153109. Epub 2020 Jul 13.,Wu YP,https://www.ncbi.nlm.nih.gov/pubmed/32853947
18939,32675047,"A Prospective Comparison of (18)F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE)",Eur Urol Oncol. 2021 Aug;4(4):635-644. doi: 10.1016/j.euo.2020.06.012. Epub 2020 Jul 13.,Anttinen M,https://www.ncbi.nlm.nih.gov/pubmed/32675047
18940,32724813,Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database,Biomed Res Int. 2020 Jul 16;2020:8341097. doi: 10.1155/2020/8341097. eCollection 2020.,Zheng L,https://www.ncbi.nlm.nih.gov/pubmed/32724813
18943,32804986,FeAture Explorer (FAE): A tool for developing and comparing radiomics models,PLoS One. 2020 Aug 17;15(8):e0237587. doi: 10.1371/journal.pone.0237587. eCollection 2020.,Song Y,https://www.ncbi.nlm.nih.gov/pubmed/32804986
18944,32525981,Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer,Nucleic Acids Res. 2020 Nov 4;48(19):11130-11145. doi: 10.1093/nar/gkaa494.,Ptacek J,https://www.ncbi.nlm.nih.gov/pubmed/32525981
18946,33308974,Referral pattern for urologic malignancies before and during the COVID-19 pandemic,Urol Oncol. 2021 May;39(5):268-276. doi: 10.1016/j.urolonc.2020.11.027. Epub 2020 Dec 8.,Maganty A,https://www.ncbi.nlm.nih.gov/pubmed/33308974
18948,32781474,Britanin Exhibits Potential Inhibitory Activity on Human Prostate Cancer Cell Lines Through PI3K/Akt/NF-?B Signaling Pathways,Planta Med. 2020 Dec;86(18):1401-1410. doi: 10.1055/a-1211-4656. Epub 2020 Aug 11.,Zeng Q,https://www.ncbi.nlm.nih.gov/pubmed/32781474
18949,32414694,Low-Dose Enzalutamide in Late-Elderly Patients (? 75 Years Old) Presenting With Metastatic Castration-Resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Dec;18(6):e660-e668. doi: 10.1016/j.clgc.2020.03.019. Epub 2020 Apr 7.,Vinh-Hung V,https://www.ncbi.nlm.nih.gov/pubmed/32414694
18951,32624161,MR Imaging Texture Analysis in the Abdomen and Pelvis,Magn Reson Imaging Clin N Am. 2020 Aug;28(3):447-456. doi: 10.1016/j.mric.2020.03.009. Epub 2020 Jun 6.,Thomas JV,https://www.ncbi.nlm.nih.gov/pubmed/32624161
18952,32925793,Stepwise local stitching ultrasound image algorithms based on adaptive iterative threshold Harris corner features,Medicine (Baltimore). 2020 Sep 11;99(37):e22189. doi: 10.1097/MD.0000000000022189.,Sun H,https://www.ncbi.nlm.nih.gov/pubmed/32925793
18953,33378113,Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings,Cancer. 2021 May 1;127(9):1476-1482. doi: 10.1002/cncr.33397. Epub 2020 Dec 30.,Hoogland AI,https://www.ncbi.nlm.nih.gov/pubmed/33378113
18954,32991011,Diagnosis and prognosis potential of four gene promoter hypermethylation in prostate cancer,Cell Biol Int. 2021 Jan;45(1):117-126. doi: 10.1002/cbin.11474. Epub 2020 Oct 8.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32991011
18955,32979057,Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice,World J Urol. 2021 Feb;39(2):307-315. doi: 10.1007/s00345-020-03433-3. Epub 2020 Sep 26.,Davey P,https://www.ncbi.nlm.nih.gov/pubmed/32979057
18956,32592133,Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium,Lasers Med Sci. 2021 Jun;36(4):743-750. doi: 10.1007/s10103-020-03076-1. Epub 2020 Jun 27.,Akter S,https://www.ncbi.nlm.nih.gov/pubmed/32592133
18957,32719369,Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells,Sci Rep. 2020 Jul 27;10(1):12505. doi: 10.1038/s41598-020-68668-x.,White EZ,https://www.ncbi.nlm.nih.gov/pubmed/32719369
18959,32703994,MAGPEL: an autoMated pipeline for inferring vAriant-driven Gene PanEls from the full-length biomedical literature,Sci Rep. 2020 Jul 23;10(1):12365. doi: 10.1038/s41598-020-68649-0.,Saberian N,https://www.ncbi.nlm.nih.gov/pubmed/32703994
18960,32376689,Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity,J Biol Chem. 2020 Jun 19;295(25):8550-8559. doi: 10.1074/jbc.RA120.013794. Epub 2020 May 6.,Cinar B,https://www.ncbi.nlm.nih.gov/pubmed/32376689
18961,32383180,PLC? regulates metabolism and metastasis signaling via HIF-1?/MEK/ERK pathway in prostate cancer,J Cell Physiol. 2020 Nov;235(11):8546-8557. doi: 10.1002/jcp.29698. Epub 2020 May 7.,Fan Y,https://www.ncbi.nlm.nih.gov/pubmed/32383180
18964,33148111,Cultural Adaptation of Evidence-Based Lifestyle Interventions for African American Men With Prostate Cancer: A Dyadic Approach,Am J Mens Health. 2020 Nov-Dec;14(6):1557988320945449. doi: 10.1177/1557988320945449.,Cho D,https://www.ncbi.nlm.nih.gov/pubmed/33148111
18965,32358577,Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer,Prostate Cancer Prostatic Dis. 2020 Dec;23(4):596-606. doi: 10.1038/s41391-020-0235-1. Epub 2020 May 1.,McAllister MJ,https://www.ncbi.nlm.nih.gov/pubmed/32358577
18966,32624423,Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer,Urol Oncol. 2020 Dec;38(12):931.e9-931.e16. doi: 10.1016/j.urolonc.2020.06.002. Epub 2020 Jul 2.,Kwon DH,https://www.ncbi.nlm.nih.gov/pubmed/32624423
18967,32717903,Alcohol Consumption and the Risk of Prostate Cancer: A Dose-Response Meta-Analysis,Nutrients. 2020 Jul 23;12(8):2188. doi: 10.3390/nu12082188.,Hong S,https://www.ncbi.nlm.nih.gov/pubmed/32717903
18968,33033260,Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy,Nat Commun. 2020 Oct 8;11(1):5070. doi: 10.1038/s41467-020-18843-5.,Woodcock DJ,https://www.ncbi.nlm.nih.gov/pubmed/33033260
18969,33273603,Intra-individual dynamic comparison of (18)F-PSMA-11 and (68)Ga-PSMA-11 in LNCaP xenograft bearing mice,Sci Rep. 2020 Dec 3;10(1):21068. doi: 10.1038/s41598-020-78273-7.,Piron S,https://www.ncbi.nlm.nih.gov/pubmed/33273603
18970,33220811,Surgical Management of Genitourinary Cancer Liver Metastases,Surg Oncol Clin N Am. 2021 Jan;30(1):89-102. doi: 10.1016/j.soc.2020.08.003. Epub 2020 Oct 28.,Martel G,https://www.ncbi.nlm.nih.gov/pubmed/33220811
18971,32399975,"Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study",Int J Cancer. 2020 Nov 15;147(10):2735-2742. doi: 10.1002/ijc.33048. Epub 2020 May 29.,Meyers TJ,https://www.ncbi.nlm.nih.gov/pubmed/32399975
18973,32500781,Hematologic parameters are not predictors of upgrading or treatment in a racially diverse prospective study of men with prostate cancer on active surveillance,Aging Male. 2020 Dec;23(5):1400-1408. doi: 10.1080/13685538.2020.1772227. Epub 2020 Jun 5.,Shelton TM,https://www.ncbi.nlm.nih.gov/pubmed/32500781
18975,32680982,A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer,Nat Commun. 2020 Jul 17;11(1):3598. doi: 10.1038/s41467-020-17325-y.,Walavalkar K,https://www.ncbi.nlm.nih.gov/pubmed/32680982
18976,32668495,IL-17F facilitates prostate cancer cell malignant phenotypes via activation of the PI3K/AKT signalling pathway,Andrologia. 2020 Nov;52(10):e13750. doi: 10.1111/and.13750. Epub 2020 Jul 15.,Zhu X,https://www.ncbi.nlm.nih.gov/pubmed/32668495
18977,32963351,EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer,Oncogene. 2020 Oct;39(44):6757-6775. doi: 10.1038/s41388-020-01468-9. Epub 2020 Sep 22.,Lin SR,https://www.ncbi.nlm.nih.gov/pubmed/32963351
18978,33086276,The Change of 68Ga-Prostate-Specific Membrane Antigen Uptake in Myeloma After Chemotherapy in a Patient With Multiple Myeloma and Concurrent Prostate Cancer,Clin Nucl Med. 2020 Dec;45(12):1013-1015. doi: 10.1097/RLU.0000000000003339.,Pan Q,https://www.ncbi.nlm.nih.gov/pubmed/33086276
18979,33296507,Late mortality in people with cancer: a population-based Australian study,Med J Aust. 2021 Apr;214(7):318-323. doi: 10.5694/mja2.50879. Epub 2020 Dec 9.,Koczwara B,https://www.ncbi.nlm.nih.gov/pubmed/33296507
18980,32931739,SETting Up for Epigenetic Regulation of Advanced Prostate Cancer,Cancer Cell. 2020 Sep 14;38(3):309-311. doi: 10.1016/j.ccell.2020.08.009.,Thienger P,https://www.ncbi.nlm.nih.gov/pubmed/32931739
18981,32712517,Maintenance of sexual activity following androgen deprivation in males,Crit Rev Oncol Hematol. 2020 Sep;153:103064. doi: 10.1016/j.critrevonc.2020.103064. Epub 2020 Jul 15.,Duthie CJ,https://www.ncbi.nlm.nih.gov/pubmed/32712517
18984,32781066,Epigallocatechin-3-gallate mobilizes intracellular Ca(2+) in prostate cancer cells through combined Ca(2+) entry and Ca(2+)-induced Ca(2+) release,Life Sci. 2020 Oct 1;258:118232. doi: 10.1016/j.lfs.2020.118232. Epub 2020 Aug 8.,Marchetti C,https://www.ncbi.nlm.nih.gov/pubmed/32781066
18985,32356608,CD4(+) T helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion,Prostate. 2020 Jul;80(10):764-776. doi: 10.1002/pros.23990. Epub 2020 May 1.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/32356608
18986,32955174,Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer,N Engl J Med. 2020 Dec 10;383(24):2345-2357. doi: 10.1056/NEJMoa2022485. Epub 2020 Sep 20.,Hussain M,https://www.ncbi.nlm.nih.gov/pubmed/32955174
18987,32371099,"Small molecule DTDQ exerts anti-metastatic effects in DU145 human castration-resistant prostate cancer cells via modulations of ERK, JNK, p38 and c-Myc signaling pathways",Bioorg Med Chem Lett. 2020 Jul 1;30(13):127223. doi: 10.1016/j.bmcl.2020.127223. Epub 2020 Apr 27.,Son J,https://www.ncbi.nlm.nih.gov/pubmed/32371099
18988,33179662,"Water soluble ionic Co(II), Cu(II) and Zn(II) diimine-glycinate complexes targeted to tRNA: structural description, in vitro comparative binding, cleavage and cytotoxic studies towards chemoresistant prostate cancer cells",Dalton Trans. 2020 Dec 8;49(46):16830-16848. doi: 10.1039/d0dt02657c.,Zehra S,https://www.ncbi.nlm.nih.gov/pubmed/33179662
18990,32803984,Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy,Mol Pharm. 2020 Sep 8;17(9):3392-3402. doi: 10.1021/acs.molpharmaceut.0c00457. Epub 2020 Aug 17.,Huang CT,https://www.ncbi.nlm.nih.gov/pubmed/32803984
18991,32275162,"Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer",Cancer Biother Radiopharm. 2020 Nov;35(9):661-672. doi: 10.1089/cbr.2019.3123. Epub 2020 Apr 9.,Ma T,https://www.ncbi.nlm.nih.gov/pubmed/32275162
18992,32881725,Pathomics in urology,Curr Opin Urol. 2020 Nov;30(6):823-831. doi: 10.1097/MOU.0000000000000813.,Schuettfort VM,https://www.ncbi.nlm.nih.gov/pubmed/32881725
18994,32929382,LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network,Theranostics. 2020 Aug 29;10(23):10823-10837. doi: 10.7150/thno.47830. eCollection 2020.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/32929382
18995,33296752,Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow,Neoplasia. 2021 Jan;23(1):102-111. doi: 10.1016/j.neo.2020.11.009. Epub 2020 Dec 6.,Jung Y,https://www.ncbi.nlm.nih.gov/pubmed/33296752
18996,33189994,"Prodrugs for nitroreductase based cancer therapy-4: Towards prostate cancer targeting: Synthesis of N-heterocyclic nitro prodrugs, Ssap-NtrB enzymatic activation and anticancer evaluation",Bioorg Chem. 2020 Dec;105:104450. doi: 10.1016/j.bioorg.2020.104450. Epub 2020 Nov 4.,Güngör T,https://www.ncbi.nlm.nih.gov/pubmed/33189994
18997,32449823,Prostate penile metastasis: Incidence and imaging pattern on (68) Ga-PSMA PET/CT,J Med Imaging Radiat Oncol. 2020 Aug;64(4):499-504. doi: 10.1111/1754-9485.13052. Epub 2020 May 25.,Tatkovic A,https://www.ncbi.nlm.nih.gov/pubmed/32449823
18999,32619556,Glycolysis inhibition and apoptosis induction in human prostate cancer cells by FV-429-mediated regulation of AR-AKT-HK2 signaling network,Food Chem Toxicol. 2020 Sep;143:111517. doi: 10.1016/j.fct.2020.111517. Epub 2020 Jun 30.,Chen X,https://www.ncbi.nlm.nih.gov/pubmed/32619556
19000,32556373,Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis,Cell Mol Life Sci. 2020 Dec;77(24):5149-5169. doi: 10.1007/s00018-020-03572-1. Epub 2020 Jun 16.,Hu W,https://www.ncbi.nlm.nih.gov/pubmed/32556373
19001,32595202,"Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer",Med Sci Monit. 2020 Jun 17;26:e922346. doi: 10.12659/MSM.922346.,Zhu J,https://www.ncbi.nlm.nih.gov/pubmed/32595202
19002,32759830,Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy,Int J Mol Sci. 2020 Aug 4;21(15):5571. doi: 10.3390/ijms21155571.,Verde V,https://www.ncbi.nlm.nih.gov/pubmed/32759830
19003,33387627,Ethnicity as modifier of risk for Vitamin D receptors polymorphisms: Comprehensive meta-analysis of all cancer sites,Crit Rev Oncol Hematol. 2021 Feb;158:103202. doi: 10.1016/j.critrevonc.2020.103202. Epub 2020 Dec 30.,Gnagnarella P,https://www.ncbi.nlm.nih.gov/pubmed/33387627
19007,32475774,Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer,Clin Genitourin Cancer. 2020 Oct;18(5):416-422. doi: 10.1016/j.clgc.2020.02.015. Epub 2020 Apr 18.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32475774
19011,32520514,Incidental COVID-19 Pneumonia on 18F-Fluorocholine PET/CT,Clin Nucl Med. 2020 Aug;45(8):e376-e377. doi: 10.1097/RLU.0000000000003189.,García Vicente AM,https://www.ncbi.nlm.nih.gov/pubmed/32520514
19012,32873700,Gene of the month: TMPRSS2 (transmembrane serine protease 2),J Clin Pathol. 2020 Dec;73(12):773-776. doi: 10.1136/jclinpath-2020-206987. Epub 2020 Sep 1.,Thunders M,https://www.ncbi.nlm.nih.gov/pubmed/32873700
19014,31993719,"A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosumab (PROMADE) study",Osteoporos Int. 2020 Jul;31(7):1251-1259. doi: 10.1007/s00198-019-05271-5. Epub 2020 Jan 28.,Yoshida T,https://www.ncbi.nlm.nih.gov/pubmed/31993719
19016,32394269,Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?,Ann Nucl Med. 2020 Jul;34(7):476-485. doi: 10.1007/s12149-020-01474-7. Epub 2020 May 11.,Simsek DH,https://www.ncbi.nlm.nih.gov/pubmed/32394269
19018,32416561,"Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles",Biomed Pharmacother. 2020 Jul;127:110181. doi: 10.1016/j.biopha.2020.110181. Epub 2020 May 13.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32416561
19019,32909849,Synthesis of PEGylated nanographene oxide as a nanocarrier for docetaxel drugs and anticancer activity on prostate cancer cell lines,Hum Exp Toxicol. 2021 Jan;40(1):172-182. doi: 10.1177/0960327120950008. Epub 2020 Sep 10.,Tas A,https://www.ncbi.nlm.nih.gov/pubmed/32909849
19024,32361788,The near-infrared fluorescent dye IR-780 was coupled with cabazitaxel for castration-resistant prostate cancer imaging and therapy,Invest New Drugs. 2020 Dec;38(6):1641-1652. doi: 10.1007/s10637-020-00934-1. Epub 2020 May 2.,Zheng Y,https://www.ncbi.nlm.nih.gov/pubmed/32361788
19026,32503460,Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck,BMC Cancer. 2020 Jun 5;20(1):519. doi: 10.1186/s12885-020-06847-9.,Klein Nulent TJW,https://www.ncbi.nlm.nih.gov/pubmed/32503460
19030,32554858,Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer,Aging (Albany NY). 2020 Jun 17;12(12):11500-11516. doi: 10.18632/aging.103236. Epub 2020 Jun 17.,Sun F,https://www.ncbi.nlm.nih.gov/pubmed/32554858
19032,33015692,Material properties of disulfide-crosslinked hyaluronic acid hydrogels influence prostate cancer cell growth and metabolism,J Mater Chem B. 2020 Nov 4;8(42):9718-9733. doi: 10.1039/d0tb01570a.,Tam NW,https://www.ncbi.nlm.nih.gov/pubmed/33015692
19033,32279449,(99m) Tc-(EDDA/tricine)-HYNIC-GnRH analogue as a potential imaging probe for diagnosis of prostate cancer,Chem Biol Drug Des. 2020 Aug;96(2):850-860. doi: 10.1111/cbdd.13693. Epub 2020 Apr 28.,Masteri Farahani A,https://www.ncbi.nlm.nih.gov/pubmed/32279449
19034,33019427,Herpes zoster and the subsequent risk of prostate cancer in an Asian population: A nationwide population-based cohort study,Medicine (Baltimore). 2020 Oct 2;99(40):e22441. doi: 10.1097/MD.0000000000022441.,Tsao YH,https://www.ncbi.nlm.nih.gov/pubmed/33019427
19037,32338345,"Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer",Clin Pharmacokinet. 2020 Sep;59(9):1135-1148. doi: 10.1007/s40262-020-00882-2.,Duran I,https://www.ncbi.nlm.nih.gov/pubmed/32338345
19039,32752241,The Spectrum of Design Solutions for Improving the Activity-Selectivity Product of Peptide Antibiotics against Multidrug-Resistant Bacteria and Prostate Cancer PC-3 Cells,Molecules. 2020 Aug 1;25(15):3526. doi: 10.3390/molecules25153526.,Jureti? D,https://www.ncbi.nlm.nih.gov/pubmed/32752241
19040,32852205,Development of PSMA-1007-Related Series of (18)F-Labeled Glu-Ureido-Type PSMA Inhibitors,J Med Chem. 2020 Oct 8;63(19):10897-10907. doi: 10.1021/acs.jmedchem.9b01479. Epub 2020 Sep 22.,Cardinale J,https://www.ncbi.nlm.nih.gov/pubmed/32852205
19041,32497056,Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging,PLoS One. 2020 Jun 4;15(6):e0233443. doi: 10.1371/journal.pone.0233443. eCollection 2020.,Rikkert LG,https://www.ncbi.nlm.nih.gov/pubmed/32497056
19042,33197601,"Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer",Pharmacol Res. 2021 Feb;164:105305. doi: 10.1016/j.phrs.2020.105305. Epub 2020 Nov 14.,Zhou X,https://www.ncbi.nlm.nih.gov/pubmed/33197601
19044,32480094,3D porous chitosan-chondroitin sulfate scaffolds promote epithelial to mesenchymal transition in prostate cancer cells,Biomaterials. 2020 Sep;254:120126. doi: 10.1016/j.biomaterials.2020.120126. Epub 2020 May 22.,Xu K,https://www.ncbi.nlm.nih.gov/pubmed/32480094
19046,32721517,A Clinical Reminder Order Check Intervention to Improve Guideline-concordant Imaging Practices for Men With Prostate Cancer: A Pilot Study,Urology. 2020 Nov;145:113-119. doi: 10.1016/j.urology.2020.05.101. Epub 2020 Jul 25.,Ciprut SE,https://www.ncbi.nlm.nih.gov/pubmed/32721517
19047,33229135,Synthesis and evaluation of a UMI-77-based fluorescent probe for selective detecting Mcl-1 protein and imaging in living cancer cells,Bioorg Med Chem. 2021 Jan 1;29:115850. doi: 10.1016/j.bmc.2020.115850. Epub 2020 Nov 7.,Li J,https://www.ncbi.nlm.nih.gov/pubmed/33229135
19049,33260619,Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer,Toxins (Basel). 2020 Nov 28;12(12):753. doi: 10.3390/toxins12120753.,Fischer A,https://www.ncbi.nlm.nih.gov/pubmed/33260619
19050,33298586,Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro,Mol Cancer Ther. 2021 Feb;20(2):398-409. doi: 10.1158/1535-7163.MCT-20-0244. Epub 2020 Dec 9.,Kohrt SE,https://www.ncbi.nlm.nih.gov/pubmed/33298586
19053,32639612,"Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases",Histopathology. 2020 Dec;77(6):890-899. doi: 10.1111/his.14205. Epub 2020 Sep 13.,Alhamar M,https://www.ncbi.nlm.nih.gov/pubmed/32639612
19054,32713607,Understanding How Much TV is Too Much: A Nonlinear Analysis of the Association Between Television Viewing Time and Adverse Health Outcomes,Mayo Clin Proc. 2020 Nov;95(11):2429-2441. doi: 10.1016/j.mayocp.2020.04.035. Epub 2020 Jul 23.,Foster HME,https://www.ncbi.nlm.nih.gov/pubmed/32713607
19058,32884090,Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases,Prostate Cancer Prostatic Dis. 2021 Jun;24(2):341-348. doi: 10.1038/s41391-020-00280-6. Epub 2020 Sep 3.,McGregor B,https://www.ncbi.nlm.nih.gov/pubmed/32884090
19060,32905676,"Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide",N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342.,Fizazi K,https://www.ncbi.nlm.nih.gov/pubmed/32905676
19062,32581009,Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial,Cancer Prev Res (Phila). 2020 Oct;13(10):853-862. doi: 10.1158/1940-6207.CAPR-19-0450. Epub 2020 Jun 24.,Hurwitz LM,https://www.ncbi.nlm.nih.gov/pubmed/32581009
19063,32721059,AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis,Oncologist. 2020 Dec;25(12):e1990-e1995. doi: 10.1634/theoncologist.2020-0043. Epub 2020 Aug 19.,Pacheco-Orozco RA,https://www.ncbi.nlm.nih.gov/pubmed/32721059
19068,32855270,Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2,Mol Cancer Ther. 2020 Oct;19(10):2023-2033. doi: 10.1158/1535-7163.MCT-20-0250. Epub 2020 Aug 27.,Li Q,https://www.ncbi.nlm.nih.gov/pubmed/32855270
19069,32879302,PLC? maintains the functionality of AR signaling in prostate cancer via an autophagy-dependent mechanism,Cell Death Dis. 2020 Sep 2;11(8):716. doi: 10.1038/s41419-020-02917-9.,Quan Z,https://www.ncbi.nlm.nih.gov/pubmed/32879302
19070,32500236,Rectal gas-induced susceptibility artefacts on prostate diffusion-weighted MRI with epi read-out at 3.0 T: does a preparatory micro-enema improve image quality?,Abdom Radiol (NY). 2020 Dec;45(12):4244-4251. doi: 10.1007/s00261-020-02600-9. Epub 2020 Jun 4.,Plodeck V,https://www.ncbi.nlm.nih.gov/pubmed/32500236
19076,33145877,FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate Cancer,Oncologist. 2021 Feb;26(2):139-146. doi: 10.1002/onco.13585. Epub 2020 Nov 17.,Anscher MS,https://www.ncbi.nlm.nih.gov/pubmed/33145877
19077,32388358,"Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer",Sci Total Environ. 2020 Aug 15;730:138314. doi: 10.1016/j.scitotenv.2020.138314. Epub 2020 Apr 30.,Martinez-Gonzalez LJ,https://www.ncbi.nlm.nih.gov/pubmed/32388358
19078,32229267,Quality of Life and Pain During Treatment of Metastatic Castration-resistant Prostate Cancer With Cabazitaxel In Routine Clinical Practice,Clin Genitourin Cancer. 2020 Oct;18(5):e510-e516. doi: 10.1016/j.clgc.2020.02.003. Epub 2020 Mar 6.,Joly F,https://www.ncbi.nlm.nih.gov/pubmed/32229267
19079,32816187,Levels of plasma glycan-binding auto-IgG biomarkers improve the accuracy of prostate cancer diagnosis,Mol Cell Biochem. 2021 Jan;476(1):13-22. doi: 10.1007/s11010-020-03876-7. Epub 2020 Aug 20.,Dos Santos JM,https://www.ncbi.nlm.nih.gov/pubmed/32816187
19082,32957168,Possible role of the receptor of advanced glycation end products (RAGE) in the clinical course of prostate neoplasia in patients with and without type 2 diabetes mellitus,Int J Clin Pract. 2021 Mar;75(3):e13723. doi: 10.1111/ijcp.13723. Epub 2020 Oct 13.,Akkus G,https://www.ncbi.nlm.nih.gov/pubmed/32957168
19083,32722221,Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours,Molecules. 2020 Jul 24;25(15):3363. doi: 10.3390/molecules25153363.,Chilug LE,https://www.ncbi.nlm.nih.gov/pubmed/32722221
19085,33252839,"Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200?000 men in UK Biobank",Int J Cancer. 2021 May 1;148(9):2274-2288. doi: 10.1002/ijc.33416. Epub 2020 Dec 11.,Watts EL,https://www.ncbi.nlm.nih.gov/pubmed/33252839
19087,33201204,Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma,JAMA. 2020 Nov 17;324(19):1957-1969. doi: 10.1001/jama.2020.20457.,AlDubayan SH,https://www.ncbi.nlm.nih.gov/pubmed/33201204
19088,32459967,Hydroxylated Rotenoids Selectively Inhibit the Proliferation of Prostate Cancer Cells,J Nat Prod. 2020 Jun 26;83(6):1829-1845. doi: 10.1021/acs.jnatprod.9b01224. Epub 2020 May 27.,Russell DA,https://www.ncbi.nlm.nih.gov/pubmed/32459967
19089,32727756,Comparison of Tolerability Between 2-Weekly and 3-Weekly Docetaxel Regimen in Castration-resistant Prostate Cancer,Anticancer Res. 2020 Aug;40(8):4291-4297. doi: 10.21873/anticanres.14431.,Shimura Y,https://www.ncbi.nlm.nih.gov/pubmed/32727756
19091,32436081,Protein kinase CK2 impact on intracellular calcium homeostasis in prostate cancer,Mol Cell Biochem. 2020 Jul;470(1-2):131-143. doi: 10.1007/s11010-020-03752-4. Epub 2020 May 20.,Afzal M,https://www.ncbi.nlm.nih.gov/pubmed/32436081
19093,32433170,The Effect of Various ? Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization Algorithm,Clin Nucl Med. 2020 Jul;45(7):506-513. doi: 10.1097/RLU.0000000000003075.,Baratto L,https://www.ncbi.nlm.nih.gov/pubmed/32433170
19094,32149481,Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastases of prostate cancer,J Pathol Clin Res. 2020 Jul;6(3):171-177. doi: 10.1002/cjp2.160. Epub 2020 Mar 9.,Wen J,https://www.ncbi.nlm.nih.gov/pubmed/32149481
19096,32786229,Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer,J Med Chem. 2020 Sep 10;63(17):9258-9270. doi: 10.1021/acs.jmedchem.0c00291. Epub 2020 Aug 13.,Noor A,https://www.ncbi.nlm.nih.gov/pubmed/32786229
19097,32764609,An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk,Nat Commun. 2020 Aug 6;11(1):3905. doi: 10.1038/s41467-020-17673-9.,Wu L,https://www.ncbi.nlm.nih.gov/pubmed/32764609
19098,32739353,"A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer",J Geriatr Oncol. 2021 Mar;12(2):305-311. doi: 10.1016/j.jgo.2020.07.014. Epub 2020 Jul 29.,Ramsey SD,https://www.ncbi.nlm.nih.gov/pubmed/32739353
19102,33185677,Association Between Alzheimer Disease and Cancer With Evaluation of Study Biases: A Systematic Review and Meta-analysis,JAMA Netw Open. 2020 Nov 2;3(11):e2025515. doi: 10.1001/jamanetworkopen.2020.25515.,Ospina-Romero M,https://www.ncbi.nlm.nih.gov/pubmed/33185677
19103,33050597,Imipramine Inhibits Migration and Invasion in Metastatic Castration-Resistant Prostate Cancer PC-3 Cells via AKT-Mediated NF-?B Signaling Pathway,Molecules. 2020 Oct 11;25(20):4619. doi: 10.3390/molecules25204619.,Lim EY,https://www.ncbi.nlm.nih.gov/pubmed/33050597
19105,32556890,"Association of KLK3, VAMP8 and MDM4 Genetic Variants within microRNA Binding Sites with Prostate Cancer: Evidence from Serbian Population",Pathol Oncol Res. 2020 Oct;26(4):2409-2423. doi: 10.1007/s12253-020-00839-7. Epub 2020 Jun 17.,Kotarac N,https://www.ncbi.nlm.nih.gov/pubmed/32556890
19112,32148070,Heme-Oxygenase-1,Antioxid Redox Signal. 2020 Jun 10;32(17):1239-1242. doi: 10.1089/ars.2020.8065.,Facchinetti MM,https://www.ncbi.nlm.nih.gov/pubmed/32148070
19113,32630532,The (+)-Brevipolide H Displays Anticancer Activity against Human Castration-Resistant Prostate Cancer: The Role of Oxidative Stress and Akt/mTOR/p70S6K-Dependent Pathways in G1 Checkpoint Arrest and Apoptosis,Molecules. 2020 Jun 25;25(12):2929. doi: 10.3390/molecules25122929.,Sheng YH,https://www.ncbi.nlm.nih.gov/pubmed/32630532
19114,33153849,The impact of graphene oxide on androgen receptor signalling in prostate cancer cells,Chemosphere. 2021 Apr;269:128759. doi: 10.1016/j.chemosphere.2020.128759. Epub 2020 Oct 30.,Ženata O,https://www.ncbi.nlm.nih.gov/pubmed/33153849
19115,33112350,Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects,J Mater Chem B. 2020 Dec 7;8(45):10416-10427. doi: 10.1039/d0tb01733g. Epub 2020 Oct 28.,Chen ML,https://www.ncbi.nlm.nih.gov/pubmed/33112350
19116,32737628,Automated reference tissue normalization of T2-weighted MR images of the prostate using object recognition,MAGMA. 2021 Apr;34(2):309-321. doi: 10.1007/s10334-020-00871-3. Epub 2020 Jul 31.,Sunoqrot MRS,https://www.ncbi.nlm.nih.gov/pubmed/32737628
19121,32947020,"Perlecan, a modular instructive proteoglycan with diverse functional properties",Int J Biochem Cell Biol. 2020 Nov;128:105849. doi: 10.1016/j.biocel.2020.105849. Epub 2020 Sep 16.,Melrose J,https://www.ncbi.nlm.nih.gov/pubmed/32947020
19122,33025453,User-Centered Development and Patient Acceptability Testing of a Health-Coaching Intervention to Enhance Cancer Survivorship Follow-up in Primary Care,J Cancer Educ. 2022 Jun;37(3):788-797. doi: 10.1007/s13187-020-01883-2. Epub 2020 Oct 7.,O'Malley DM,https://www.ncbi.nlm.nih.gov/pubmed/33025453
19123,33277441,Cabozantinib Unlocks Efficient In Vivo Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate Tumors,Mol Cancer Ther. 2021 Feb;20(2):438-449. doi: 10.1158/1535-7163.MCT-20-0167. Epub 2020 Dec 4.,Chaudagar KK,https://www.ncbi.nlm.nih.gov/pubmed/33277441
19124,32551898,Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis,Genet Test Mol Biomarkers. 2020 Jul;24(7):399-408. doi: 10.1089/gtmb.2020.0009. Epub 2020 Jun 16.,Ma JB,https://www.ncbi.nlm.nih.gov/pubmed/32551898
19125,32796891,Chemogenomic screening identifies the Hsp70 co-chaperone DNAJA1 as a hub for anticancer drug resistance,Sci Rep. 2020 Aug 14;10(1):13831. doi: 10.1038/s41598-020-70764-x.,Nitika,https://www.ncbi.nlm.nih.gov/pubmed/32796891
19127,32525968,Aspartate ?-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1?/GSK3? crosstalk,Carcinogenesis. 2020 Sep 24;41(9):1246-1252. doi: 10.1093/carcin/bgaa053.,Barboro P,https://www.ncbi.nlm.nih.gov/pubmed/32525968
19128,33137837,An in silico study on the effect of the radionuclide half-life on PET/CT imaging with PSMA-targeting radioligands,Nuklearmedizin. 2021 Feb;60(1):33-37. doi: 10.1055/a-1253-1535. Epub 2020 Oct 16.,Begum NJ,https://www.ncbi.nlm.nih.gov/pubmed/33137837
19130,32743881,Slice profile effects on quantitative analysis of hyperpolarized pyruvate,NMR Biomed. 2020 Oct;33(10):e4373. doi: 10.1002/nbm.4373. Epub 2020 Aug 2.,Walker CM,https://www.ncbi.nlm.nih.gov/pubmed/32743881
19131,33302918,A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells,BMC Cancer. 2020 Dec 10;20(1):1214. doi: 10.1186/s12885-020-07562-1.,Lund ME,https://www.ncbi.nlm.nih.gov/pubmed/33302918
19134,31858434,Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer,Clin Transl Oncol. 2020 Aug;22(8):1321-1328. doi: 10.1007/s12094-019-02257-x. Epub 2019 Dec 19.,Papageorgiou I,https://www.ncbi.nlm.nih.gov/pubmed/31858434
19140,33086103,Human papillomavirus and prostate cancer: The role of viral expressed proteins in the inhibition of anoikis and induction of metastasis,Microb Pathog. 2021 Mar;152:104576. doi: 10.1016/j.micpath.2020.104576. Epub 2020 Oct 18.,Fatemipour M,https://www.ncbi.nlm.nih.gov/pubmed/33086103
19144,32883330,Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer,J Nanobiotechnology. 2020 Sep 3;18(1):121. doi: 10.1186/s12951-020-00650-1.,Lan M,https://www.ncbi.nlm.nih.gov/pubmed/32883330
19146,33148544,"Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer",ESMO Open. 2020 Nov;5(Suppl 4):e000796. doi: 10.1136/esmoopen-2020-000796.,Mederos N,https://www.ncbi.nlm.nih.gov/pubmed/33148544
19148,33167327,Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer,Int J Mol Sci. 2020 Nov 5;21(21):8277. doi: 10.3390/ijms21218277.,Ton AT,https://www.ncbi.nlm.nih.gov/pubmed/33167327
19150,32897127,An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells,Autophagy. 2021 Sep;17(9):2200-2216. doi: 10.1080/15548627.2020.1820787. Epub 2020 Sep 20.,Ariotti N,https://www.ncbi.nlm.nih.gov/pubmed/32897127
19151,32694570,Computational analysis of androgen receptor (AR) variants to decipher the relationship between protein stability and related-diseases,Sci Rep. 2020 Jul 21;10(1):12101. doi: 10.1038/s41598-020-68731-7.,Chen F,https://www.ncbi.nlm.nih.gov/pubmed/32694570
19153,32977754,A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment,BMC Cancer. 2020 Sep 25;20(1):919. doi: 10.1186/s12885-020-07410-2.,Kawahara T,https://www.ncbi.nlm.nih.gov/pubmed/32977754
19156,32976691,Artificial intelligence-based detection of lymph node metastases by PET/CT predicts prostate cancer-specific survival,Clin Physiol Funct Imaging. 2021 Jan;41(1):62-67. doi: 10.1111/cpf.12666. Epub 2020 Oct 18.,Borrelli P,https://www.ncbi.nlm.nih.gov/pubmed/32976691
19158,32484838,The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells,PLoS One. 2020 Jun 2;15(6):e0234078. doi: 10.1371/journal.pone.0234078. eCollection 2020.,Sennoune SR,https://www.ncbi.nlm.nih.gov/pubmed/32484838
19163,31682457,Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer,J Proteome Res. 2020 Jul 2;19(7):2631-2642. doi: 10.1021/acs.jproteome.9b00587. Epub 2019 Nov 18.,Mantsiou A,https://www.ncbi.nlm.nih.gov/pubmed/31682457
19164,33275817,Targeted inhibition of ER? signaling and PIP5K1?/Akt pathways in castration-resistant prostate cancer,Mol Oncol. 2021 Apr;15(4):968-986. doi: 10.1002/1878-0261.12873. Epub 2020 Dec 16.,Semenas J,https://www.ncbi.nlm.nih.gov/pubmed/33275817
19165,32932591,Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional Characterization,Int J Mol Sci. 2020 Sep 12;21(18):6672. doi: 10.3390/ijms21186672.,Novakova Z,https://www.ncbi.nlm.nih.gov/pubmed/32932591
19166,32733447,Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy,Front Immunol. 2020 Jul 8;11:1333. doi: 10.3389/fimmu.2020.01333. eCollection 2020.,Qin L,https://www.ncbi.nlm.nih.gov/pubmed/32733447
19167,33006389,Prevalence of comprehensive DNA damage repair gene germline mutations in Chinese prostate cancer patients,Int J Cancer. 2021 Feb 1;148(3):673-681. doi: 10.1002/ijc.33324. Epub 2020 Oct 16.,Wu J,https://www.ncbi.nlm.nih.gov/pubmed/33006389
19169,31805186,Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer,Carcinogenesis. 2020 Aug 12;41(8):1145-1157. doi: 10.1093/carcin/bgz193.,Naiki-Ito A,https://www.ncbi.nlm.nih.gov/pubmed/31805186
19173,33050986,"MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1",BMB Rep. 2020 Dec;53(12):634-639. doi: 10.5483/BMBRep.2020.53.12.162.,Lee KH,https://www.ncbi.nlm.nih.gov/pubmed/33050986
19174,32943461,Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib,Clin Cancer Res. 2020 Dec 1;26(23):6122-6131. doi: 10.1158/1078-0432.CCR-20-2306. Epub 2020 Sep 17.,Tripathi A,https://www.ncbi.nlm.nih.gov/pubmed/32943461
19177,32627909,"Design, synthesis, and biological evaluation of imidazopyridine-linked thiazolidinone as potential anticancer agents",Arch Pharm (Weinheim). 2020 Oct;353(10):e2000071. doi: 10.1002/ardp.202000071. Epub 2020 Jul 6.,Iqbal MA,https://www.ncbi.nlm.nih.gov/pubmed/32627909
19178,32734688,Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer,Mol Oncol. 2020 Oct;14(10):2455-2470. doi: 10.1002/1878-0261.12770. Epub 2020 Aug 9.,Hirayama Y,https://www.ncbi.nlm.nih.gov/pubmed/32734688
19179,32998089,"Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives",Eur J Med Chem. 2020 Dec 15;208:112841. doi: 10.1016/j.ejmech.2020.112841. Epub 2020 Sep 16.,Birgül K,https://www.ncbi.nlm.nih.gov/pubmed/32998089
19181,32847363,Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer,J Med Chem. 2020 Sep 24;63(18):10396-10411. doi: 10.1021/acs.jmedchem.0c00939. Epub 2020 Sep 9.,Endo S,https://www.ncbi.nlm.nih.gov/pubmed/32847363
19185,32283060,"Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line",Eur J Pharmacol. 2020 Jul 5;878:173102. doi: 10.1016/j.ejphar.2020.173102. Epub 2020 Apr 10.,Eftekhari S,https://www.ncbi.nlm.nih.gov/pubmed/32283060
19187,32723991,Two-weekly docetaxel in treatment of advanced breast cancer: A preliminary study,Med J Malaysia. 2020 Jul;75(4):338-341.,Lee DW,https://www.ncbi.nlm.nih.gov/pubmed/32723991
19192,33375977,Autodisplay of human PIP5K1? lipid kinase on Escherichia coli and inhibitor testing,Enzyme Microb Technol. 2021 Feb;143:109717. doi: 10.1016/j.enzmictec.2020.109717. Epub 2020 Nov 24.,Strätker K,https://www.ncbi.nlm.nih.gov/pubmed/33375977
19195,32763322,Risk of Genitourinary Malignancy in the Renal Transplant Patient,Urology. 2020 Nov;145:152-158. doi: 10.1016/j.urology.2020.06.077. Epub 2020 Aug 5.,Jiang S,https://www.ncbi.nlm.nih.gov/pubmed/32763322
19197,32988971,Characterizing CDK12-Mutated Prostate Cancers,Clin Cancer Res. 2021 Jan 15;27(2):566-574. doi: 10.1158/1078-0432.CCR-20-2371. Epub 2020 Sep 28.,Rescigno P,https://www.ncbi.nlm.nih.gov/pubmed/32988971
19198,32847933,Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study,Clin Cancer Res. 2020 Nov 1;26(21):5609-5620. doi: 10.1158/1078-0432.CCR-20-0855. Epub 2020 Aug 26.,Autio KA,https://www.ncbi.nlm.nih.gov/pubmed/32847933
19200,33242948,Comparing the risk of cardiovascular disease following GnRH agonist and GnRH antagonist therapy for patient with prostate cancer: a systematic review and meta-analysis,Minerva Urol Nephrol. 2021 Jun;73(3):276-282. doi: 10.23736/S2724-6051.20.03756-X. Epub 2020 Nov 27.,Ma C,https://www.ncbi.nlm.nih.gov/pubmed/33242948
19202,32008178,"Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells",Invest New Drugs. 2020 Oct;38(5):1292-1302. doi: 10.1007/s10637-020-00901-w. Epub 2020 Feb 1.,Qu F,https://www.ncbi.nlm.nih.gov/pubmed/32008178
19203,33305380,"Integrin ?2?1 inhibition attenuates prostate cancer cell proliferation by cell cycle arrest, promoting apoptosis and reducing epithelial-mesenchymal transition",J Cell Physiol. 2021 Jul;236(7):4954-4965. doi: 10.1002/jcp.30202. Epub 2020 Dec 10.,Salemi Z,https://www.ncbi.nlm.nih.gov/pubmed/33305380
19206,31748962,Spanish validation of Charlson index applied to prostate cancer,Clin Transl Oncol. 2020 Jul;22(7):1187-1192. doi: 10.1007/s12094-019-02246-0. Epub 2019 Nov 20.,Casas Duran F,https://www.ncbi.nlm.nih.gov/pubmed/31748962
19208,32572763,Whole-body magnetic resonance imaging (WB-MRI) in oncology: an Italian survey,Radiol Med. 2021 Feb;126(2):299-305. doi: 10.1007/s11547-020-01242-7. Epub 2020 Jun 22.,Albano D,https://www.ncbi.nlm.nih.gov/pubmed/32572763
19212,33031282,Incidental detection of primary hepatocellular carcinoma on 18F-prostate-specific membrane antigen-1007 positron emission tomography/computed tomography imaging in a patient with prostate cancer: A case report,Medicine (Baltimore). 2020 Oct 9;99(41):e22486. doi: 10.1097/MD.0000000000022486.,Zhao H,https://www.ncbi.nlm.nih.gov/pubmed/33031282
19214,32546687,In Pursuit of Stability Enhancement of a Prostate Cancer Targeting Antibody Derived from a Transgenic Animal Platform,Sci Rep. 2020 Jun 16;10(1):9722. doi: 10.1038/s41598-020-66636-z.,Venkataramani S,https://www.ncbi.nlm.nih.gov/pubmed/32546687
19222,32240651,PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling,Biochem Pharmacol. 2020 Jul;177:113943. doi: 10.1016/j.bcp.2020.113943. Epub 2020 Mar 30.,Verma A,https://www.ncbi.nlm.nih.gov/pubmed/32240651
19223,32469184,"Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer",N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29.,Sternberg CN,https://www.ncbi.nlm.nih.gov/pubmed/32469184
19231,32128670,Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma,Clin J Gastroenterol. 2020 Oct;13(5):860-866. doi: 10.1007/s12328-020-01107-6. Epub 2020 Mar 3.,Suoh M,https://www.ncbi.nlm.nih.gov/pubmed/32128670
19237,33046892,Targetable gene fusions and aberrations in genitourinary oncology,Nat Rev Urol. 2020 Nov;17(11):613-625. doi: 10.1038/s41585-020-00379-4. Epub 2020 Oct 12.,Pederzoli F,https://www.ncbi.nlm.nih.gov/pubmed/33046892
19243,32943549,Microparticle Encapsulation of a Prostate-targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-resistant Prostate Cancer,Mol Cancer Ther. 2020 Nov;19(11):2353-2362. doi: 10.1158/1535-7163.MCT-20-0227. Epub 2020 Sep 17.,Rogers OC,https://www.ncbi.nlm.nih.gov/pubmed/32943549
19244,32626918,Mechanism of Notch1?saRNA?1480 reversing androgen sensitivity in human metastatic castration?resistant prostate cancer,Int J Mol Med. 2020 Jul;46(1):265-279. doi: 10.3892/ijmm.2020.4597. Epub 2020 May 8.,Ma L,https://www.ncbi.nlm.nih.gov/pubmed/32626918
19246,33130548,Association of steroid use with survival in solid tumours,Eur J Cancer. 2020 Dec;141:105-114. doi: 10.1016/j.ejca.2020.09.020. Epub 2020 Oct 30.,Petrelli F,https://www.ncbi.nlm.nih.gov/pubmed/33130548
19248,33313973,BRCA testing delay during the COVID-19 pandemic: How to act?,Mol Biol Rep. 2021 Jan;48(1):983-987. doi: 10.1007/s11033-020-06060-8. Epub 2020 Dec 12.,Minucci A,https://www.ncbi.nlm.nih.gov/pubmed/33313973
19250,33011214,"""Vicarious thinking"" was a key driver of score change in Delphi surveys for COS development and is facilitated by feedback of results",J Clin Epidemiol. 2020 Dec;128:118-129. doi: 10.1016/j.jclinepi.2020.09.028. Epub 2020 Oct 1.,Fish R,https://www.ncbi.nlm.nih.gov/pubmed/33011214
19251,33410260,Study on the pathophysiological mechanism responsible for lower urinary tract symptoms associated with prostate cancer using an animal model,Low Urin Tract Symptoms. 2021 Jul;13(3):390-399. doi: 10.1111/luts.12370. Epub 2020 Dec 31.,Hsu LN,https://www.ncbi.nlm.nih.gov/pubmed/33410260
19254,32579780,The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe,Mol Oncol. 2020 Oct;14(10):2487-2503. doi: 10.1002/1878-0261.12756. Epub 2020 Jul 16.,Drápela S,https://www.ncbi.nlm.nih.gov/pubmed/32579780
19257,33111427,"Design, Synthesis and Cytotoxicity Evaluation of Novel Indole Derivatives Containing Benzoic Acid Group as Potential AKR1C3 Inhibitors",Chem Biodivers. 2020 Dec;17(12):e2000519. doi: 10.1002/cbdv.202000519. Epub 2020 Nov 24.,Sun M,https://www.ncbi.nlm.nih.gov/pubmed/33111427
19258,33471653,Understanding Osteoporosis Screening Practices in Men: A Nationwide Physician Survey,Endocr Pract. 2020 Nov;26(11):1237-1243. doi: 10.4158/EP-2020-0123. Epub 2020 Jun 23.,Choksi P,https://www.ncbi.nlm.nih.gov/pubmed/33471653
19260,32239572,Anticancer properties and mechanism of action of the quassinoid ailanthone,Phytother Res. 2020 Sep;34(9):2203-2213. doi: 10.1002/ptr.6681. Epub 2020 Apr 1.,Bailly C,https://www.ncbi.nlm.nih.gov/pubmed/32239572
19261,32884130,High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts,Mod Pathol. 2021 Feb;34(2):478-489. doi: 10.1038/s41379-020-00674-w. Epub 2020 Sep 3.,Harmon SA,https://www.ncbi.nlm.nih.gov/pubmed/32884130
19269,32926427,Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer,Cancer. 2020 Dec 1;126(23):5050-5059. doi: 10.1002/cncr.33176. Epub 2020 Sep 14.,Caram MEV,https://www.ncbi.nlm.nih.gov/pubmed/32926427
19286,33368314,LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway,J Cell Physiol. 2021 Jul;236(7):5253-5264. doi: 10.1002/jcp.30229. Epub 2020 Dec 23.,Jung YY,https://www.ncbi.nlm.nih.gov/pubmed/33368314
19287,33232788,Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy,Cancer Lett. 2021 Feb 28;499:279-289. doi: 10.1016/j.canlet.2020.11.022. Epub 2020 Nov 21.,Llopiz D,https://www.ncbi.nlm.nih.gov/pubmed/33232788
19288,32350416,Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types,Mod Pathol. 2020 Sep;33(9):1753-1763. doi: 10.1038/s41379-020-0550-z. Epub 2020 Apr 29.,Zhu MMT,https://www.ncbi.nlm.nih.gov/pubmed/32350416
19290,32909456,Liquidambar orientalis Mill. gum extract induces autophagy via PI3K/Akt/mTOR signaling pathway in prostate cancer cells,Int J Environ Health Res. 2022 May;32(5):1011-1019. doi: 10.1080/09603123.2020.1818187. Epub 2020 Sep 10.,Atmaca H,https://www.ncbi.nlm.nih.gov/pubmed/32909456
19291,32860011,Abiraterone and enzalutamide had different adverse effects on the cardiovascular system: a systematic review with pairwise and network meta-analyses,Prostate Cancer Prostatic Dis. 2021 Mar;24(1):244-252. doi: 10.1038/s41391-020-00275-3. Epub 2020 Aug 28.,Lee HY,https://www.ncbi.nlm.nih.gov/pubmed/32860011
19297,32650130,Targeting lactate production and efflux in prostate cancer,Biochim Biophys Acta Mol Basis Dis. 2020 Nov 1;1866(11):165894. doi: 10.1016/j.bbadis.2020.165894. Epub 2020 Jul 8.,Pereira-Nunes A,https://www.ncbi.nlm.nih.gov/pubmed/32650130
19307,31758510,SUV(95th) as a Reliable Alternative to SUV(max) for Determining Renal Uptake in [(68)Ga] PSMA PET/CT,Mol Imaging Biol. 2020 Aug;22(4):1070-1077. doi: 10.1007/s11307-019-01451-1.,Baiocco S,https://www.ncbi.nlm.nih.gov/pubmed/31758510
19317,33090259,Comparison of risk-calculator and MRI and consecutive pathways as upfront stratification for prostate biopsy,World J Urol. 2021 Jul;39(7):2453-2461. doi: 10.1007/s00345-020-03488-2. Epub 2020 Oct 22.,Reesink DJ,https://www.ncbi.nlm.nih.gov/pubmed/33090259
19319,32764580,Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer properties,Sci Rep. 2020 Aug 6;10(1):13178. doi: 10.1038/s41598-020-69751-z.,Dyshlovoy SA,https://www.ncbi.nlm.nih.gov/pubmed/32764580
19326,32805266,Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer,Toxicol Appl Pharmacol. 2020 Oct 1;404:115200. doi: 10.1016/j.taap.2020.115200. Epub 2020 Aug 14.,Shankar E,https://www.ncbi.nlm.nih.gov/pubmed/32805266
19336,32694237,miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling,Aging (Albany NY). 2020 Jul 21;12(14):14418-14433. doi: 10.18632/aging.103485. Epub 2020 Jul 21.,Wang ZC,https://www.ncbi.nlm.nih.gov/pubmed/32694237
19341,33326447,Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence,PLoS One. 2020 Dec 16;15(12):e0242970. doi: 10.1371/journal.pone.0242970. eCollection 2020.,Dahl HC,https://www.ncbi.nlm.nih.gov/pubmed/33326447
19342,32459291,Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa,JAMA Dermatol. 2020 Aug 1;156(8):844-853. doi: 10.1001/jamadermatol.2020.1422.,Jung JM,https://www.ncbi.nlm.nih.gov/pubmed/32459291
19351,31290785,Extramammary Paget Disease of the Scrotum: A Contemporary Clinicopathologic Analysis of 20 Cases in the United States,Appl Immunohistochem Mol Morphol. 2020 Aug;28(7):524-531. doi: 10.1097/PAI.0000000000000789.,Shabihkhani M,https://www.ncbi.nlm.nih.gov/pubmed/31290785
19354,33298014,Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82,BMC Cancer. 2020 Dec 9;20(1):1211. doi: 10.1186/s12885-020-07675-7.,Dodla P,https://www.ncbi.nlm.nih.gov/pubmed/33298014
19355,32712458,TNF-? controls Lipocalin-2 expression in PC-3 prostate cancer cells,Cytokine. 2020 Nov;135:155214. doi: 10.1016/j.cyto.2020.155214. Epub 2020 Jul 24.,Schröder SK,https://www.ncbi.nlm.nih.gov/pubmed/32712458
19362,32694652,Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin,Cell Death Differ. 2021 Jan;28(1):156-169. doi: 10.1038/s41418-020-0590-4. Epub 2020 Jul 21.,Velletri T,https://www.ncbi.nlm.nih.gov/pubmed/32694652
19379,32152959,Evolution of Electrocardiographic Repolarization Parameters During Antiandrogen Therapy in Patients with Prostate Cancer and Hypogonadism,Cardiovasc Toxicol. 2020 Aug;20(4):390-400. doi: 10.1007/s12012-020-09566-6.,Gheorghe ACD,https://www.ncbi.nlm.nih.gov/pubmed/32152959
19394,32201141,"Validating the Transfer of Skills Acquired on a Prostate Biopsy Simulator: A Prospective, Randomized, Controlled Study",J Surg Educ. 2020 Jul-Aug;77(4):953-960. doi: 10.1016/j.jsurg.2020.01.008. Epub 2020 Mar 20.,Fiard G,https://www.ncbi.nlm.nih.gov/pubmed/32201141
19400,33374450,Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer,Molecules. 2020 Dec 24;26(1):56. doi: 10.3390/molecules26010056.,Kandil SB,https://www.ncbi.nlm.nih.gov/pubmed/33374450
19402,32878848,Incidental finding of monoclonal B-cell lymphocytosis in the mandible,BMJ Case Rep. 2020 Sep 2;13(9):e232339. doi: 10.1136/bcr-2019-232339.,Sundaresan PD,https://www.ncbi.nlm.nih.gov/pubmed/32878848
19408,33375030,Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy,Int J Mol Sci. 2020 Dec 22;22(1):21. doi: 10.3390/ijms22010021.,Ide V,https://www.ncbi.nlm.nih.gov/pubmed/33375030
19410,33287214,Betel Nut Arecoline Induces Different Phases of Growth Arrest between Normal and Cancerous Prostate Cells through the Reactive Oxygen Species Pathway,Int J Mol Sci. 2020 Dec 3;21(23):9219. doi: 10.3390/ijms21239219.,Shih LJ,https://www.ncbi.nlm.nih.gov/pubmed/33287214
19412,32988711,Safety evaluation of enzalutamide dose-escalation strategy in patients with castration-resistant prostate cancer,Urol Oncol. 2021 Apr;39(4):233.e15-233.e20. doi: 10.1016/j.urolonc.2020.09.013. Epub 2020 Sep 26.,Miura R,https://www.ncbi.nlm.nih.gov/pubmed/32988711
19422,32762064,Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe),BJU Int. 2020 Nov;126(5):625-632. doi: 10.1111/bju.15198. Epub 2020 Aug 31.,Aljabery F,https://www.ncbi.nlm.nih.gov/pubmed/32762064
19423,32503656,CTCF loss mediates unique DNA hypermethylation landscapes in human cancers,Clin Epigenetics. 2020 Jun 5;12(1):80. doi: 10.1186/s13148-020-00869-7.,Damaschke NA,https://www.ncbi.nlm.nih.gov/pubmed/32503656
19434,32972504,Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis,Chin Med Sci J. 2020 Sep 30;35(3):262-271. doi: 10.24920/003668.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/32972504
19436,32999000,Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer,Cancer Res. 2020 Nov 15;80(22):4904-4917. doi: 10.1158/0008-5472.CAN-20-1228. Epub 2020 Sep 30.,Beketova E,https://www.ncbi.nlm.nih.gov/pubmed/32999000
19459,33017604,ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium,Radiother Oncol. 2020 Dec;153:106-113. doi: 10.1016/j.radonc.2020.09.046. Epub 2020 Oct 2.,Kooreman ES,https://www.ncbi.nlm.nih.gov/pubmed/33017604
19461,32273249,Functional results and survival after surgery for peripheral skeletal metastasis: A 434-case multicenter retrospective series,Orthop Traumatol Surg Res. 2020 Oct;106(6):997-1003. doi: 10.1016/j.otsr.2019.10.024. Epub 2020 Apr 6.,Bonnevialle P,https://www.ncbi.nlm.nih.gov/pubmed/32273249
19462,33225864,Design and experimental study of a novel 7-DOF manipulator for transrectal ultrasound probe,Sci Prog. 2020 Oct-Dec;103(4):36850420970366. doi: 10.1177/0036850420970366.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/33225864
19464,32732981,Strategies to enable large-scale proteomics for reproducible research,Nat Commun. 2020 Jul 30;11(1):3793. doi: 10.1038/s41467-020-17641-3.,Poulos RC,https://www.ncbi.nlm.nih.gov/pubmed/32732981
19471,32620366,"COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor",Prog Urol. 2020 Sep;30(10):484-487. doi: 10.1016/j.purol.2020.05.007. Epub 2020 May 22.,Mjaess G,https://www.ncbi.nlm.nih.gov/pubmed/32620366
19472,32967924,"Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer",Mol Cancer Ther. 2020 Nov;19(11):2235-2244. doi: 10.1158/1535-7163.MCT-20-0116. Epub 2020 Sep 23.,Scribner JA,https://www.ncbi.nlm.nih.gov/pubmed/32967924
19475,32691455,Cocreated internet-based stepped care for individuals with cancer and concurrent symptoms of anxiety and depression: Results from the U-CARE AdultCan randomized controlled trial,Psychooncology. 2020 Dec;29(12):2012-2018. doi: 10.1002/pon.5489. Epub 2020 Sep 22.,Hauffman A,https://www.ncbi.nlm.nih.gov/pubmed/32691455
19485,33050822,Genetic associations between CYP24A1 polymorphisms and predisposition of cancer: A meta-analysis,Int J Biol Markers. 2020 Dec;35(4):71-79. doi: 10.1177/1724600820944408. Epub 2020 Oct 14.,Zhang G,https://www.ncbi.nlm.nih.gov/pubmed/33050822
19499,32232838,Clinician Perspectives on Overscreening for Cancer in Older Adults With Limited Life Expectancy,J Am Geriatr Soc. 2020 Jul;68(7):1462-1468. doi: 10.1111/jgs.16415. Epub 2020 Mar 31.,Schoenborn NL,https://www.ncbi.nlm.nih.gov/pubmed/32232838
19506,32621117,Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics,Mol Biol Rep. 2020 Jul;47(7):5523-5533. doi: 10.1007/s11033-020-05571-8. Epub 2020 Jul 3.,London M,https://www.ncbi.nlm.nih.gov/pubmed/32621117
19507,32819219,Delivery of urological services (telemedicine and urgent surgery) during COVID-19 lockdown: experience and lessons learnt from a university hospital in United Kingdom,Scott Med J. 2020 Nov;65(4):109-111. doi: 10.1177/0036933020951932. Epub 2020 Aug 20.,Somani BK,https://www.ncbi.nlm.nih.gov/pubmed/32819219
19510,32449176,A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network,Med Phys. 2020 Sep;47(9):4077-4086. doi: 10.1002/mp.14255. Epub 2020 Jun 12.,Zong W,https://www.ncbi.nlm.nih.gov/pubmed/32449176
19513,32565177,New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma,Pharmacol Ther. 2020 Oct;214:107611. doi: 10.1016/j.pharmthera.2020.107611. Epub 2020 Jun 18.,Lu KH,https://www.ncbi.nlm.nih.gov/pubmed/32565177
19514,32878814,Cabazitaxel - A Treatment Option in Recurrent Platinum-resistant Ovarian Cancer,Anticancer Res. 2020 Sep;40(9):5255-5261. doi: 10.21873/anticanres.14529.,Madsen CV,https://www.ncbi.nlm.nih.gov/pubmed/32878814
19516,33007114,Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status,Cancer. 2021 Feb 1;127(3):354-358. doi: 10.1002/cncr.33238. Epub 2020 Oct 2.,Bergerot CD,https://www.ncbi.nlm.nih.gov/pubmed/33007114
19517,32401342,The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types,Cancer. 2020 Jul 15;126(14):3192-3201. doi: 10.1002/cncr.32909. Epub 2020 May 13.,Einsele H,https://www.ncbi.nlm.nih.gov/pubmed/32401342
19520,33140261,The Roles of ZnT1 and ZnT4 in Glucose-Stimulated Zinc Secretion in Prostate Epithelial Cells,Mol Imaging Biol. 2021 Apr;23(2):230-240. doi: 10.1007/s11307-020-01557-x. Epub 2020 Nov 2.,Lo ST,https://www.ncbi.nlm.nih.gov/pubmed/33140261
19524,31912882,"Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis",Biosci Rep. 2020 Jul 31;40(7):BSR20193153. doi: 10.1042/BSR20193153.,Guo R,https://www.ncbi.nlm.nih.gov/pubmed/31912882
19528,32128987,miR-451a is downregulated and targets PSMB8 in prostate cancer,Kaohsiung J Med Sci. 2020 Jul;36(7):494-500. doi: 10.1002/kjm2.12196. Epub 2020 Mar 3.,Liu Y,https://www.ncbi.nlm.nih.gov/pubmed/32128987
19534,33028968,Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study,Int J Impot Res. 2022 Jan;34(1):50-54. doi: 10.1038/s41443-020-00361-z. Epub 2020 Oct 7.,Thirumavalavan N,https://www.ncbi.nlm.nih.gov/pubmed/33028968
19540,32796815,Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer,Cell Death Dis. 2020 Aug 14;11(8):625. doi: 10.1038/s41419-020-02869-0.,Tang X,https://www.ncbi.nlm.nih.gov/pubmed/32796815
19542,33026920,Erectile Dysfunction is a Transient Complication of Prostate Biopsy: A Systematic Review and Meta-Analysis,J Urol. 2021 Mar;205(3):664-670. doi: 10.1097/JU.0000000000001398. Epub 2020 Oct 7.,Fainberg J,https://www.ncbi.nlm.nih.gov/pubmed/33026920
19543,32535974,Oncological Surgery During the COVID-19 Pandemic: The Need for Deep and Lasting Measures,Oncologist. 2020 Sep;25(9):e1424-e1425. doi: 10.1634/theoncologist.2020-0360. Epub 2020 Jun 23.,Souadka A,https://www.ncbi.nlm.nih.gov/pubmed/32535974
19549,33063668,Effects of lifelong testosterone exposure on health and disease using Mendelian randomization,Elife. 2020 Oct 16;9:e58914. doi: 10.7554/eLife.58914.,Mohammadi-Shemirani P,https://www.ncbi.nlm.nih.gov/pubmed/33063668
19550,33451934,Systemic therapy and COVID19: Immunotherapy and chemotherapy,Urol Oncol. 2021 Apr;39(4):213-220. doi: 10.1016/j.urolonc.2020.12.022. Epub 2020 Dec 26.,Gulati S,https://www.ncbi.nlm.nih.gov/pubmed/33451934
19552,32412125,Androgen sensitivity gateway to COVID-19 disease severity,Drug Dev Res. 2020 Nov;81(7):771-776. doi: 10.1002/ddr.21688. Epub 2020 May 15.,Wambier CG,https://www.ncbi.nlm.nih.gov/pubmed/32412125
19554,32170918,Propagation of human prostate tissue from induced pluripotent stem cells,Stem Cells Transl Med. 2020 Jul;9(7):734-745. doi: 10.1002/sctm.19-0286. Epub 2020 Mar 14.,Hepburn AC,https://www.ncbi.nlm.nih.gov/pubmed/32170918
19555,32902162,Reflections on the T Trials,Andrology. 2020 Nov;8(6):1512-1518. doi: 10.1111/andr.12901. Epub 2020 Oct 17.,Swerdloff R,https://www.ncbi.nlm.nih.gov/pubmed/32902162
19557,33305617,Predicting future cancer burden in the United States by artificial neural networks,Future Oncol. 2021 Jan;17(2):159-168. doi: 10.2217/fon-2020-0359. Epub 2020 Dec 11.,Piva F,https://www.ncbi.nlm.nih.gov/pubmed/33305617
19579,32825947,"LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis",Pathol Res Pract. 2020 Sep;216(9):153074. doi: 10.1016/j.prp.2020.153074. Epub 2020 Jun 18.,Wang W,https://www.ncbi.nlm.nih.gov/pubmed/32825947
19591,32706352,"Near-IR light-induced photorelease of nitric oxide (NO) on ruthenium nitrosyl complexes: formation, reactivity, and biological effects",Dalton Trans. 2020 Aug 11;49(31):10772-10785. doi: 10.1039/d0dt01788d.,Giri B,https://www.ncbi.nlm.nih.gov/pubmed/32706352
19602,33236530,"miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2",Kaohsiung J Med Sci. 2021 Apr;37(4):294-304. doi: 10.1002/kjm2.12323. Epub 2020 Nov 24.,Li XL,https://www.ncbi.nlm.nih.gov/pubmed/33236530
19603,33228126,Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies,Molecules. 2020 Nov 19;25(22):5417. doi: 10.3390/molecules25225417.,Nogueira L,https://www.ncbi.nlm.nih.gov/pubmed/33228126
19606,33380874,Primary care use after cancer treatment: an analysis of linked administrative data,Curr Oncol. 2020 Dec;27(6):e590-e595. doi: 10.3747/co.27.5993. Epub 2020 Dec 1.,Urquhart R,https://www.ncbi.nlm.nih.gov/pubmed/33380874
19619,32449677,Inappropriate antidiuretic hormone secretion in amyotrophic lateral sclerosis,Clin Neuropathol. 2020 Nov/Dec;39(6):275-281. doi: 10.5414/NP301280.,Douglas A,https://www.ncbi.nlm.nih.gov/pubmed/32449677
19620,33136241,Rural-urban differences in health-related quality of life: patterns for cancer survivors compared to other older adults,Qual Life Res. 2021 Apr;30(4):1131-1143. doi: 10.1007/s11136-020-02683-3. Epub 2020 Nov 2.,Moss JL,https://www.ncbi.nlm.nih.gov/pubmed/33136241
19629,33354760,Implications of androgen receptor and FUS expression on tumor progression in urothelial carcinoma,Histol Histopathol. 2021 Mar;36(3):325-337. doi: 10.14670/HH-18-295. Epub 2020 Dec 23.,Abd Raboh NM,https://www.ncbi.nlm.nih.gov/pubmed/33354760
19630,33039986,Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007-2017,BMJ Open. 2020 Oct 10;10(10):e036341. doi: 10.1136/bmjopen-2019-036341.,Huang SY,https://www.ncbi.nlm.nih.gov/pubmed/33039986
19631,33212129,Endocrine-disrupting effects of bisphenols on urological cancers,Environ Res. 2021 Apr;195:110485. doi: 10.1016/j.envres.2020.110485. Epub 2020 Nov 16.,Pellerin E,https://www.ncbi.nlm.nih.gov/pubmed/33212129
19641,32306543,The genetic landscapes of urological cancers and their clinical implications in the era of high-throughput genome analysis,BJU Int. 2020 Jul;126(1):26-54. doi: 10.1111/bju.15084. Epub 2020 May 22.,Light A,https://www.ncbi.nlm.nih.gov/pubmed/32306543
19644,32704074,Hematospermia is rarely related to genitourinary cancer: lessons learned from 15 years of experience with 342 cases,Int J Impot Res. 2021 Sep;33(6):627-633. doi: 10.1038/s41443-020-0330-9. Epub 2020 Jul 23.,Efesoy O,https://www.ncbi.nlm.nih.gov/pubmed/32704074
19655,33145996,miR-30d-5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma,FEBS Open Bio. 2021 Feb;11(2):529-540. doi: 10.1002/2211-5463.13025. Epub 2020 Dec 19.,Liang L,https://www.ncbi.nlm.nih.gov/pubmed/33145996
19658,33256104,Cancer Prevention by Natural Products Introduced into the Diet-Selected Cyclitols,Int J Mol Sci. 2020 Nov 26;21(23):8988. doi: 10.3390/ijms21238988.,Wi?niewski K,https://www.ncbi.nlm.nih.gov/pubmed/33256104
19675,33203731,"TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors",Mol Cancer Ther. 2021 Jan;20(1):109-120. doi: 10.1158/1535-7163.MCT-20-0061. Epub 2020 Nov 17.,Austin RJ,https://www.ncbi.nlm.nih.gov/pubmed/33203731
19690,32610057,TRPM8 channels: A review of distribution and clinical role,Eur J Pharmacol. 2020 Sep 5;882:173312. doi: 10.1016/j.ejphar.2020.173312. Epub 2020 Jun 28.,Liu Y,https://www.ncbi.nlm.nih.gov/pubmed/32610057
19692,32530319,Dietary Intake of N-3 and N-6 Polyunsaturated Fatty Acids and Risk of Cancer: Meta-Analysis of Data from 32 Studies,Nutr Cancer. 2021;73(6):901-913. doi: 10.1080/01635581.2020.1779321. Epub 2020 Jun 12.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/32530319
19704,32652651,A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in human plasma,Biomed Chromatogr. 2020 Nov;34(11):e4947. doi: 10.1002/bmc.4947. Epub 2020 Aug 7.,Weiss TLD,https://www.ncbi.nlm.nih.gov/pubmed/32652651
19720,32769870,Interventions to facilitate shared decision-making using decision aids with patients in Primary Health Care: A systematic review,Medicine (Baltimore). 2020 Aug 7;99(32):e21389. doi: 10.1097/MD.0000000000021389.,Coronado-Vázquez V,https://www.ncbi.nlm.nih.gov/pubmed/32769870
19741,33125146,Long non?coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression,Oncol Rep. 2020 Dec;44(6):2465-2474. doi: 10.3892/or.2020.7813. Epub 2020 Oct 16.,Guan X,https://www.ncbi.nlm.nih.gov/pubmed/33125146
19742,33225684,Electrochemically Controlled ATRP for Cleavage-Based Electrochemical Detection of the Prostate-Specific Antigen at Femtomolar Level Concentrations,Anal Chem. 2020 Dec 15;92(24):15982-15988. doi: 10.1021/acs.analchem.0c03467. Epub 2020 Nov 22.,Hu Q,https://www.ncbi.nlm.nih.gov/pubmed/33225684
19743,33226445,Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA),Calcif Tissue Int. 2021 Mar;108(3):346-353. doi: 10.1007/s00223-020-00780-6. Epub 2020 Nov 23.,Hagelstein-Rotman M,https://www.ncbi.nlm.nih.gov/pubmed/33226445
19745,32866725,Facile fluorescent aptasensor using aggregation-induced emission luminogens for exosomal proteins profiling towards liquid biopsy,Biosens Bioelectron. 2020 Nov 15;168:112520. doi: 10.1016/j.bios.2020.112520. Epub 2020 Aug 16.,Li B,https://www.ncbi.nlm.nih.gov/pubmed/32866725
19753,32989226,First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours,Br J Cancer. 2020 Dec;123(12):1730-1736. doi: 10.1038/s41416-020-01077-z. Epub 2020 Sep 29.,Ameratunga M,https://www.ncbi.nlm.nih.gov/pubmed/32989226
19771,32211916,State-of-the-art imaging for diagnosis of metastatic bone disease,Radiologe. 2020 Nov;60(Suppl 1):1-16. doi: 10.1007/s00117-020-00666-6.,Isaac A,https://www.ncbi.nlm.nih.gov/pubmed/32211916
19772,33097628,Dynamic (68)Ga-PSMA-11 PET/CT for the Primary Evaluation of Localized Renal Mass: A Prospective Study,J Nucl Med. 2021 Jun 1;62(6):773-778. doi: 10.2967/jnumed.120.251272. Epub 2020 Oct 23.,Golan S,https://www.ncbi.nlm.nih.gov/pubmed/33097628
19773,32968992,Hyperfibrinolysis in Patients with Solid Malignant Neoplasms: A Systematic Review,Semin Thromb Hemost. 2021 Jul;47(5):581-588. doi: 10.1055/s-0040-1715795. Epub 2020 Sep 23.,Winther-Larsen A,https://www.ncbi.nlm.nih.gov/pubmed/32968992
19774,33130424,Acknowledging cancer as a family disease: A systematic review of family care in the cancer setting,Eur J Oncol Nurs. 2020 Dec;49:101841. doi: 10.1016/j.ejon.2020.101841. Epub 2020 Oct 14.,Coyne E,https://www.ncbi.nlm.nih.gov/pubmed/33130424
19782,32026626,"European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology",Andrology. 2020 Sep;8(5):970-987. doi: 10.1111/andr.12770. Epub 2020 Mar 20.,Corona G,https://www.ncbi.nlm.nih.gov/pubmed/32026626
19783,33034761,"The prostate-specific membrane antigen (PSMA)-targeted radiotracer (18)F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer",Med Oncol. 2020 Oct 9;37(11):98. doi: 10.1007/s12032-020-01427-0.,Santhanam P,https://www.ncbi.nlm.nih.gov/pubmed/33034761
19787,33305886,Assessing the Effectiveness of Cancer Screening Interventions Targeting Appalachian Populations: A Systematic Review,J Rural Health. 2021 Jun;37(3):602-623. doi: 10.1111/jrh.12550. Epub 2020 Dec 11.,Robertson NM,https://www.ncbi.nlm.nih.gov/pubmed/33305886
19810,33132079,A potential treatment option for elderly non-Hodgkin lymphoma patients with multiple comorbidities: Two case reports and literature review,Explore (NY). 2021 May-Jun;17(3):265-269. doi: 10.1016/j.explore.2020.10.004. Epub 2020 Oct 21.,Lee S,https://www.ncbi.nlm.nih.gov/pubmed/33132079
19812,32778095,Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment,BMC Cancer. 2020 Aug 10;20(1):748. doi: 10.1186/s12885-020-07253-x.,Fumet JD,https://www.ncbi.nlm.nih.gov/pubmed/32778095
19814,32319535,Downregulation of c?FLIP and upregulation of DR?5 by cantharidin sensitizes TRAIL?mediated apoptosis in prostate cancer cells via autophagy flux,Int J Mol Med. 2020 Jul;46(1):280-288. doi: 10.3892/ijmm.2020.4566. Epub 2020 Apr 6.,Nazim UM,https://www.ncbi.nlm.nih.gov/pubmed/32319535
19822,31711931,Male Sexual and Reproductive Health-Does the Urologist Have a Role in Addressing Gender Inequality in Life Expectancy?,Eur Urol Focus. 2020 Jul 15;6(4):791-800. doi: 10.1016/j.euf.2019.10.009. Epub 2019 Nov 9.,Tharakan T,https://www.ncbi.nlm.nih.gov/pubmed/31711931
19836,32384017,Food Insecurity and Forgone Medical Care Among Cancer Survivors,JCO Oncol Pract. 2020 Sep;16(9):e922-e932. doi: 10.1200/JOP.19.00736. Epub 2020 May 8.,McDougall JA,https://www.ncbi.nlm.nih.gov/pubmed/32384017
19837,32827681,rs2274911 polymorphism in GPRC6A associated with serum E2 and PSA in a Southern Chinese male population,Gene. 2020 Dec 30;763:145067. doi: 10.1016/j.gene.2020.145067. Epub 2020 Aug 19.,Qi N,https://www.ncbi.nlm.nih.gov/pubmed/32827681
19844,33278378,Pneumocystis pneumonia can complicate medical treatment of hypercortisolism even in outpatients with Cushing's disease,Ann Endocrinol (Paris). 2020 Dec;81(6):551-560. doi: 10.1016/j.ando.2020.11.002. Epub 2020 Dec 2.,Cristante J,https://www.ncbi.nlm.nih.gov/pubmed/33278378
19853,33179220,Sex differences in COVID-19: the role of androgens in disease severity and progression,Endocrine. 2021 Jan;71(1):3-8. doi: 10.1007/s12020-020-02536-6. Epub 2020 Nov 11.,Mohamed MS,https://www.ncbi.nlm.nih.gov/pubmed/33179220
19856,33225921,In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116,BMC Complement Med Ther. 2020 Nov 23;20(1):355. doi: 10.1186/s12906-020-03118-9.,Nelson VK,https://www.ncbi.nlm.nih.gov/pubmed/33225921
19857,32923150,Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer,Oncoimmunology. 2020 Jun 30;9(1):1788252. doi: 10.1080/2162402X.2020.1788252.,Chen H,https://www.ncbi.nlm.nih.gov/pubmed/32923150
19866,33124118,The rising worldwide impact of benign prostatic hyperplasia,BJU Int. 2021 Jun;127(6):722-728. doi: 10.1111/bju.15286. Epub 2020 Nov 21.,Launer BM,https://www.ncbi.nlm.nih.gov/pubmed/33124118
19867,33329395,"Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function",Front Endocrinol (Lausanne). 2020 Nov 23;11:591217. doi: 10.3389/fendo.2020.591217. eCollection 2020.,Rouhimoghadam M,https://www.ncbi.nlm.nih.gov/pubmed/33329395
19870,31911188,Exposing Hidden Targets: Combining epigenetic and immunotherapy to overcome cancer resistance,Semin Cancer Biol. 2020 Oct;65:114-122. doi: 10.1016/j.semcancer.2020.01.001. Epub 2020 Jan 3.,Olino K,https://www.ncbi.nlm.nih.gov/pubmed/31911188
19874,33090394,LncRNA PCAT6 aggravates the progression of bladder cancer cells by targeting miR-513a-5p,Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):9908-9914. doi: 10.26355/eurrev_202010_23201.,Xia W,https://www.ncbi.nlm.nih.gov/pubmed/33090394
19878,31567483,Transcriptomic analysis reveals that heat shock protein 90? is a potential diagnostic and prognostic biomarker for cancer,Eur J Cancer Prev. 2020 Jul;29(4):357-364. doi: 10.1097/CEJ.0000000000000549.,Chen W,https://www.ncbi.nlm.nih.gov/pubmed/31567483
19879,33055265,Epigenetics/Epigenomics and Prevention of Early Stages of Cancer by Isothiocyanates,Cancer Prev Res (Phila). 2021 Feb;14(2):151-164. doi: 10.1158/1940-6207.CAPR-20-0217. Epub 2020 Oct 14.,Hudlikar R,https://www.ncbi.nlm.nih.gov/pubmed/33055265
19880,33159561,Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and ?-catenin,Cancer Chemother Pharmacol. 2021 Jan;87(1):85-93. doi: 10.1007/s00280-020-04195-w. Epub 2020 Nov 7.,Xu Y,https://www.ncbi.nlm.nih.gov/pubmed/33159561
19891,32502216,Effects of castration on atherosclerosis in Yucatan minipigs with genetic hypercholesterolemia,PLoS One. 2020 Jun 5;15(6):e0234131. doi: 10.1371/journal.pone.0234131. eCollection 2020.,Shim JT,https://www.ncbi.nlm.nih.gov/pubmed/32502216
19892,33331234,Biophysical binding profile with ct-DNA and cytotoxic studies of a modulated nanoconjugate of umbelliferone cobalt oxide loaded on graphene oxide (GO) as drug carrier,J Biomol Struct Dyn. 2022 Jul;40(10):4558-4569. doi: 10.1080/07391102.2020.1860821. Epub 2020 Dec 17.,Yousuf S,https://www.ncbi.nlm.nih.gov/pubmed/33331234
19893,33128214,Methylation of RILP in lung cancer promotes tumor cell proliferation and invasion,Mol Cell Biochem. 2021 Feb;476(2):853-861. doi: 10.1007/s11010-020-03950-0. Epub 2020 Oct 30.,Lin J,https://www.ncbi.nlm.nih.gov/pubmed/33128214
19913,32908134,M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2,Cell Death Dis. 2020 Sep 9;11(9):728. doi: 10.1038/s41419-020-02926-8.,Dong F,https://www.ncbi.nlm.nih.gov/pubmed/32908134
19914,33348026,Dendritic cell vaccine therapy for colorectal cancer,Pharmacol Res. 2021 Feb;164:105374. doi: 10.1016/j.phrs.2020.105374. Epub 2020 Dec 28.,Wooster AL,https://www.ncbi.nlm.nih.gov/pubmed/33348026
19915,32237034,Identification of kinesin family member 3B (KIF3B) as a molecular target for gastric cancer,Kaohsiung J Med Sci. 2020 Jul;36(7):515-522. doi: 10.1002/kjm2.12206. Epub 2020 Apr 1.,Yao FZ,https://www.ncbi.nlm.nih.gov/pubmed/32237034
19921,33256726,"Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer",BMC Med. 2020 Dec 1;18(1):372. doi: 10.1186/s12916-020-01830-4.,Joshy G,https://www.ncbi.nlm.nih.gov/pubmed/33256726
19939,33277858,GATA6 activated long non-coding RNA PCAT1 maintains stemness of non-small cell lung cancer by mediating FRK,J BUON. 2020 Sep-Oct;25(5):2371-2381.,Zang Q,https://www.ncbi.nlm.nih.gov/pubmed/33277858
19940,32891935,Ultra-efficient sequencing of T Cell receptor repertoires reveals shared responses in muscle from patients with Myositis,EBioMedicine. 2020 Sep;59:102972. doi: 10.1016/j.ebiom.2020.102972. Epub 2020 Sep 3.,Montagne JM,https://www.ncbi.nlm.nih.gov/pubmed/32891935
19943,32843649,Inferring clonal composition from multiple tumor biopsies,NPJ Syst Biol Appl. 2020 Aug 25;6(1):27. doi: 10.1038/s41540-020-00147-5.,Manica M,https://www.ncbi.nlm.nih.gov/pubmed/32843649
19944,32868648,Long noncoding RNA TTTY15 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging microRNA-337-3p to upregulate the expression of JAK2,Anticancer Drugs. 2020 Nov;31(10):1038-1045. doi: 10.1097/CAD.0000000000000960.,Wang W,https://www.ncbi.nlm.nih.gov/pubmed/32868648
19946,33135400,Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist,Investig Clin Urol. 2020 Nov;61(6):539-554. doi: 10.4111/icu.20200317.,Kim J,https://www.ncbi.nlm.nih.gov/pubmed/33135400
19956,33346025,Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2(+) breast cancer cells by attenuating nuclear factor-?B signaling,J Ethnopharmacol. 2021 Apr 6;269:113705. doi: 10.1016/j.jep.2020.113705. Epub 2020 Dec 18.,Xu G,https://www.ncbi.nlm.nih.gov/pubmed/33346025
19958,33094328,Age-related changes in human Leydig cell status,Hum Reprod. 2020 Dec 1;35(12):2663-2676. doi: 10.1093/humrep/deaa271.,Mularoni V,https://www.ncbi.nlm.nih.gov/pubmed/33094328
19960,32165246,Immunoselective algorithm to devise multi-epitope subunit vaccine fighting against human cytomegalovirus infection,Infect Genet Evol. 2020 Aug;82:104282. doi: 10.1016/j.meegid.2020.104282. Epub 2020 Mar 10.,Pandey RK,https://www.ncbi.nlm.nih.gov/pubmed/32165246
19977,32333795,"Tumour-suppressive effect of oestrogen receptor ? in colorectal cancer patients, colon cancer cells, and a zebrafish model",J Pathol. 2020 Jul;251(3):297-309. doi: 10.1002/path.5453. Epub 2020 May 15.,Topi G,https://www.ncbi.nlm.nih.gov/pubmed/32333795
19979,33200894,"Screening for cancer: the economic, medical, and psychosocial issues",Am J Manag Care. 2020 Nov;26(14 Suppl):S300-S306. doi: 10.37765/ajmc.2020.88534.,Brill JV,https://www.ncbi.nlm.nih.gov/pubmed/33200894
20015,32829037,Conventional finite element models estimate the strength of metastatic human vertebrae despite alterations of the bone's tissue and structure,Bone. 2020 Dec;141:115598. doi: 10.1016/j.bone.2020.115598. Epub 2020 Aug 20.,Stadelmann MA,https://www.ncbi.nlm.nih.gov/pubmed/32829037
20018,32810394,"Mobile cancer prevention and early detection outreach in Uganda: Partnering with communities toward bridging the cancer health disparities through ""asset-based community development model""",Cancer Med. 2020 Oct;9(19):7317-7329. doi: 10.1002/cam4.3387. Epub 2020 Aug 18.,Jatho A,https://www.ncbi.nlm.nih.gov/pubmed/32810394
20026,32597485,Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk,Biosci Rep. 2020 Jul 31;40(7):BSR20191825. doi: 10.1042/BSR20191825.,Qi GH,https://www.ncbi.nlm.nih.gov/pubmed/32597485
20032,32467172,Telomere DNA Damage Signaling Regulates Prostate Cancer Tumorigenesis,Mol Cancer Res. 2020 Sep;18(9):1326-1339. doi: 10.1158/1541-7786.MCR-19-1129. Epub 2020 May 28.,Wu J,https://www.ncbi.nlm.nih.gov/pubmed/32467172
20035,31925432,Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review,Mil Med. 2020 Jun 8;185(5-6):e864-e869. doi: 10.1093/milmed/usz386.,White LJ,https://www.ncbi.nlm.nih.gov/pubmed/31925432
20037,32972898,Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient Outcomes,Eur Urol Focus. 2021 Mar;7(2):229-230. doi: 10.1016/j.euf.2020.09.005. Epub 2020 Sep 21.,Hadaschik BA,https://www.ncbi.nlm.nih.gov/pubmed/32972898
20038,32526394,Label-free detection of multiple genitourinary cancers from urine by surface-enhanced Raman spectroscopy,Spectrochim Acta A Mol Biomol Spectrosc. 2020 Oct 15;240:118543. doi: 10.1016/j.saa.2020.118543. Epub 2020 May 28.,Cui X,https://www.ncbi.nlm.nih.gov/pubmed/32526394
20041,32590746,Cumulative evidence of relationships between multiple variants in 8q24 region and cancer incidence,Medicine (Baltimore). 2020 Jun 26;99(26):e20716. doi: 10.1097/MD.0000000000020716.,Tong Y,https://www.ncbi.nlm.nih.gov/pubmed/32590746
20046,32514122,Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases,Nat Genet. 2020 Jul;52(7):669-679. doi: 10.1038/s41588-020-0640-3. Epub 2020 Jun 8.,Ishigaki K,https://www.ncbi.nlm.nih.gov/pubmed/32514122
20051,33250425,Rapid rise in the cost of targeted cancer therapies for Medicare patients with solid tumors from 2006 to 2015,J Geriatr Oncol. 2021 Apr;12(3):375-380. doi: 10.1016/j.jgo.2020.11.007. Epub 2020 Nov 27.,Wilson LE,https://www.ncbi.nlm.nih.gov/pubmed/33250425
20057,32875998,Controversies with testosterone therapy,Can J Urol. 2020 Aug;27(S3):20-23.,Khera M,https://www.ncbi.nlm.nih.gov/pubmed/32875998
20058,32614706,Bispecific antibodies: a novel approach for targeting prominent biomarkers,Hum Vaccin Immunother. 2020 Nov 1;16(11):2831-2839. doi: 10.1080/21645515.2020.1738167. Epub 2020 Jul 2.,Gupta A,https://www.ncbi.nlm.nih.gov/pubmed/32614706
20059,32433166,Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET,Clin Nucl Med. 2020 Jul;45(7):561-562. doi: 10.1097/RLU.0000000000003081.,Arçay A,https://www.ncbi.nlm.nih.gov/pubmed/32433166
20060,32445497,Small interfering RNA target for long noncoding RNA PCGEM1 increases the sensitivity of LNCaP cells to baicalein,Anat Rec (Hoboken). 2020 Aug;303(8):2077-2085. doi: 10.1002/ar.24454. Epub 2020 Jul 2.,Han Z,https://www.ncbi.nlm.nih.gov/pubmed/32445497
20061,32394497,Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK/JNK activation,J Food Biochem. 2020 Jul;44(7):e13253. doi: 10.1111/jfbc.13253. Epub 2020 May 11.,Erdogan S,https://www.ncbi.nlm.nih.gov/pubmed/32394497
20062,33050243,Synthesis of Prostate MR Images for Classification Using Capsule Network-Based GAN Model,Sensors (Basel). 2020 Oct 9;20(20):5736. doi: 10.3390/s20205736.,Yu H,https://www.ncbi.nlm.nih.gov/pubmed/33050243
20063,32749684,"Patterns of cancer family history and genetic counseling eligibility among African Americans with breast, prostate, lung, and colorectal cancers: A Detroit Research on Cancer Survivors cohort study",Cancer. 2020 Nov 1;126(21):4744-4752. doi: 10.1002/cncr.33126. Epub 2020 Aug 4.,Purrington KS,https://www.ncbi.nlm.nih.gov/pubmed/32749684
20064,33297583,2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors,Molecules. 2020 Dec 7;25(23):5778. doi: 10.3390/molecules25235778.,Wanyan Y,https://www.ncbi.nlm.nih.gov/pubmed/33297583
20065,31994171,A Bayesian multi-risks survival (MRS) model in the presence of double censorings,Biometrics. 2020 Dec;76(4):1297-1309. doi: 10.1111/biom.13228. Epub 2020 Feb 6.,de Castro M,https://www.ncbi.nlm.nih.gov/pubmed/31994171
20069,32504685,Skene's Gland Adenocarcinoma: Borrowing From Prostate Cancer Experience for the Evaluation and Management of a Rare Malignancy,Urology. 2021 May;151:182-187. doi: 10.1016/j.urology.2020.05.032. Epub 2020 Jun 3.,Kaufman ME,https://www.ncbi.nlm.nih.gov/pubmed/32504685
20070,32369771,Fibroblast growth factors signaling in bone metastasis,Endocr Relat Cancer. 2020 Jul;27(7):R255-R265. doi: 10.1530/ERC-19-0472.,Labanca E,https://www.ncbi.nlm.nih.gov/pubmed/32369771
20071,32778506,Outcomes With Liver-Directed Therapy for Genitourinary Malignancies: Single-Institution Experience,Clin Genitourin Cancer. 2021 Feb;19(1):87-91. doi: 10.1016/j.clgc.2020.07.010. Epub 2020 Jul 16.,Pierro M,https://www.ncbi.nlm.nih.gov/pubmed/32778506
20074,32400098,Role of Pd(II)-chitooligosaccharides-Gboxin analog in oxidative phosphorylation inhibition and energy depletion: Targeting mitochondrial dynamics,Chem Biol Drug Des. 2020 Oct;96(4):1148-1161. doi: 10.1111/cbdd.13703. Epub 2020 Aug 19.,Elbehairi SEI,https://www.ncbi.nlm.nih.gov/pubmed/32400098
20075,32945248,My wife is my doctor at home': A qualitative study exploring the challenges of home-based palliative care in a resource-poor setting,Palliat Med. 2021 Jan;35(1):97-108. doi: 10.1177/0269216320951107. Epub 2020 Sep 18.,Salifu Y,https://www.ncbi.nlm.nih.gov/pubmed/32945248
20076,33233128,Antiproliferative and apoptotic effects of probiotic whey dairy beverages in human prostate cell lines,Food Res Int. 2020 Nov;137:109450. doi: 10.1016/j.foodres.2020.109450. Epub 2020 Jun 17.,Rosa LS,https://www.ncbi.nlm.nih.gov/pubmed/33233128
20077,32600281,"MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours",BMC Cancer. 2020 Jun 29;20(1):606. doi: 10.1186/s12885-020-07098-4.,Ishihara M,https://www.ncbi.nlm.nih.gov/pubmed/32600281
20078,32142289,HILIC-MRM-MS for Linkage-Specific Separation of Sialylated Glycopeptides to Quantify Prostate-Specific Antigen Proteoforms,J Proteome Res. 2020 Jul 2;19(7):2708-2716. doi: 10.1021/acs.jproteome.0c00050. Epub 2020 Mar 18.,van der Burgt YEM,https://www.ncbi.nlm.nih.gov/pubmed/32142289
20079,32624155,PET/Magnetic Resonance Imaging Applications in Abdomen and Pelvis,Magn Reson Imaging Clin N Am. 2020 Aug;28(3):369-380. doi: 10.1016/j.mric.2020.03.010.,Panda A,https://www.ncbi.nlm.nih.gov/pubmed/32624155
20081,31156005,Three different urogenital carcinoma in an aging patient: a rare case presentation,Aging Male. 2020 Dec;23(5):911-913. doi: 10.1080/13685538.2019.1621834. Epub 2019 Jun 1.,Yildirim C,https://www.ncbi.nlm.nih.gov/pubmed/31156005
20082,33340989,Synergistic effect of Zataria Multiflora essential oil on doxorubicin-induced growth inhibition of PC3 cancer cells and apoptosis,Complement Ther Clin Pract. 2021 Feb;42:101286. doi: 10.1016/j.ctcp.2020.101286. Epub 2020 Dec 8.,Zare E,https://www.ncbi.nlm.nih.gov/pubmed/33340989
20084,32681769,Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis,Clin Chem Lab Med. 2020 Jul 20;59(1):11-26. doi: 10.1515/cclm-2020-0145.,Bernal-Soriano MC,https://www.ncbi.nlm.nih.gov/pubmed/32681769
20085,30710326,In vivo comparison of the proangiogenic properties of chlordecone and three of its dechlorinated derivatives formed by in situ chemical reduction,Environ Sci Pollut Res Int. 2020 Nov;27(33):40953-40962. doi: 10.1007/s11356-019-04353-5. Epub 2019 Feb 1.,Alabed Alibrahim E,https://www.ncbi.nlm.nih.gov/pubmed/30710326
20091,32294598,PTEN and PHLPP crosstalk in cancer cells and in TGF?-activated stem cells,Biomed Pharmacother. 2020 Jul;127:110112. doi: 10.1016/j.biopha.2020.110112. Epub 2020 Apr 12.,Ghalali A,https://www.ncbi.nlm.nih.gov/pubmed/32294598
20092,32053377,"Accelerated Protein Biomarker Discovery from FFPE Tissue Samples Using Single-Shot, Short Gradient Microflow SWATH MS",J Proteome Res. 2020 Jul 2;19(7):2732-2741. doi: 10.1021/acs.jproteome.9b00671. Epub 2020 Feb 13.,Sun R,https://www.ncbi.nlm.nih.gov/pubmed/32053377
20093,32619771,Investigation of spectroscopic and proteomic alterations underlying prostate carcinogenesis,J Proteomics. 2020 Aug 30;226:103888. doi: 10.1016/j.jprot.2020.103888. Epub 2020 Jun 30.,Felgueiras J,https://www.ncbi.nlm.nih.gov/pubmed/32619771
20094,33266506,Recent Discoveries on the Involvement of Krüppel-Like Factor 4 in the Most Common Cancer Types,Int J Mol Sci. 2020 Nov 22;21(22):8843. doi: 10.3390/ijms21228843.,Taracha-Wisniewska A,https://www.ncbi.nlm.nih.gov/pubmed/33266506
20098,33114768,Proteomic Profiling of Two Distinct Populations of Extracellular Vesicles Isolated from Human Seminal Plasma,Int J Mol Sci. 2020 Oct 26;21(21):7957. doi: 10.3390/ijms21217957.,Zhang X,https://www.ncbi.nlm.nih.gov/pubmed/33114768
20099,33378540,"37-year incidence and mortality time trends of common cancer types by sex, age, and stage in the canton of Zurich",Swiss Med Wkly. 2020 Dec 14;150:w20388. doi: 10.4414/smw.2020.20388. eCollection 2020 Dec 14.,Wanner M,https://www.ncbi.nlm.nih.gov/pubmed/33378540
20100,32948609,Q&A: John Carpten on Cancer Disparities,Cancer Discov. 2020 Nov;10(11):1620. doi: 10.1158/2159-8290.CD-ND2020-015. Epub 2020 Sep 18.,,https://www.ncbi.nlm.nih.gov/pubmed/32948609
20102,33090762,Nanoparticles Yield Increased Drug Uptake and Therapeutic Efficacy upon Sequential Near-Infrared Irradiation,ACS Nano. 2020 Nov 24;14(11):15193-15203. doi: 10.1021/acsnano.0c05425. Epub 2020 Oct 22.,Luo D,https://www.ncbi.nlm.nih.gov/pubmed/33090762
20104,32503330,Evaluation of Deep Neural Networks for Semantic Segmentation of Prostate in T2W MRI,Sensors (Basel). 2020 Jun 3;20(11):3183. doi: 10.3390/s20113183.,Khan Z,https://www.ncbi.nlm.nih.gov/pubmed/32503330
20105,33354936,The association between gout and the risk of urological cancers: A pooled analysis of population-based studies,Int J Rheum Dis. 2021 Feb;24(2):281-283. doi: 10.1111/1756-185X.14044. Epub 2020 Dec 23.,Feng D,https://www.ncbi.nlm.nih.gov/pubmed/33354936
20106,32533855,Graph-convolutional-network-based interactive prostate segmentation in MR images,Med Phys. 2020 Sep;47(9):4164-4176. doi: 10.1002/mp.14327. Epub 2020 Jul 13.,Tian Z,https://www.ncbi.nlm.nih.gov/pubmed/32533855
20108,32877783,Label-free characterization and real-time monitoring of cell uptake of extracellular vesicles,Biosens Bioelectron. 2020 Nov 15;168:112510. doi: 10.1016/j.bios.2020.112510. Epub 2020 Aug 15.,Koponen A,https://www.ncbi.nlm.nih.gov/pubmed/32877783
20109,31598754,Smartphone technology and its applications in urology: a review of the literature,World J Urol. 2020 Oct;38(10):2393-2410. doi: 10.1007/s00345-019-02960-y. Epub 2019 Oct 9.,Tapiero S,https://www.ncbi.nlm.nih.gov/pubmed/31598754
20110,32736229,"The design, synthesis and anti-tumor mechanism study of new androgen receptor degrader",Eur J Med Chem. 2020 Oct 15;204:112512. doi: 10.1016/j.ejmech.2020.112512. Epub 2020 Jul 10.,Xie H,https://www.ncbi.nlm.nih.gov/pubmed/32736229
20111,33104910,Associations between daily aspirin use and cancer risk across strata of major cancer risk factors in two large U.S. cohorts,Cancer Causes Control. 2021 Jan;32(1):57-65. doi: 10.1007/s10552-020-01357-2. Epub 2020 Oct 26.,Hurwitz LM,https://www.ncbi.nlm.nih.gov/pubmed/33104910
20113,32059077,Apigenin as an anticancer agent,Phytother Res. 2020 Aug;34(8):1812-1828. doi: 10.1002/ptr.6647. Epub 2020 Feb 14.,Imran M,https://www.ncbi.nlm.nih.gov/pubmed/32059077
20116,33277442,"Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen Therapy",Mol Cancer Ther. 2021 Mar;20(3):490-499. doi: 10.1158/1535-7163.MCT-20-0417. Epub 2020 Dec 4.,Lee GT,https://www.ncbi.nlm.nih.gov/pubmed/33277442
20117,33218704,Anisotropic 3D Multi-Stream CNN for Accurate Prostate Segmentation from Multi-Planar MRI,Comput Methods Programs Biomed. 2021 Mar;200:105821. doi: 10.1016/j.cmpb.2020.105821. Epub 2020 Nov 4.,Meyer A,https://www.ncbi.nlm.nih.gov/pubmed/33218704
20118,32299262,Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors,J Enzyme Inhib Med Chem. 2020 Dec;35(1):1050-1059. doi: 10.1080/14756366.2020.1753721.,Fu DJ,https://www.ncbi.nlm.nih.gov/pubmed/32299262
20119,31711933,Distress and Quality of Life Among Patients with Advanced Genitourinary Cancers,Eur Urol Focus. 2020 Nov 15;6(6):1150-1154. doi: 10.1016/j.euf.2019.10.014. Epub 2019 Nov 9.,Bergerot CD,https://www.ncbi.nlm.nih.gov/pubmed/31711933
20120,32312453,Highly sensitive impedimetric immunosensor for determination of interleukin 6 as a cancer biomarker by using conjugated polymer containing epoxy side groups modified disposable ITO electrode,Talanta. 2020 Aug 1;215:120909. doi: 10.1016/j.talanta.2020.120909. Epub 2020 Mar 12.,Ayd?n EB,https://www.ncbi.nlm.nih.gov/pubmed/32312453
20121,33334587,Structure-activity relationship studies of dipeptide-based hepsin inhibitors with Arg bioisosteres,Bioorg Chem. 2021 Feb;107:104521. doi: 10.1016/j.bioorg.2020.104521. Epub 2020 Nov 28.,Kwon H,https://www.ncbi.nlm.nih.gov/pubmed/33334587
20123,32211946,Implementation and design of artificial intelligence in abdominal imaging,Abdom Radiol (NY). 2020 Dec;45(12):4084-4089. doi: 10.1007/s00261-020-02471-0.,Choi HH,https://www.ncbi.nlm.nih.gov/pubmed/32211946
20124,33153765,"Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells",Eur J Med Chem. 2021 Jan 15;210:112970. doi: 10.1016/j.ejmech.2020.112970. Epub 2020 Oct 29.,He ZX,https://www.ncbi.nlm.nih.gov/pubmed/33153765
20125,33011530,Structure-activity relationship studies of prostate-specific membrane antigen (PSMA) inhibitors derived from ?-amino acid with (S)- or (R)-configuration at P1' region,Bioorg Chem. 2020 Nov;104:104304. doi: 10.1016/j.bioorg.2020.104304. Epub 2020 Sep 24.,Kwon H,https://www.ncbi.nlm.nih.gov/pubmed/33011530
20126,32594815,The immunotherapy revolution in genitourinary malignancies,Immunotherapy. 2020 Aug;12(11):819-831. doi: 10.2217/imt-2020-0054. Epub 2020 Jun 29.,U Gandhy S,https://www.ncbi.nlm.nih.gov/pubmed/32594815
20127,32407457,iSOM-GSN: an integrative approach for transforming multi-omic data into gene similarity networks via self-organizing maps,Bioinformatics. 2020 Aug 1;36(15):4248-4254. doi: 10.1093/bioinformatics/btaa500.,Fatima N,https://www.ncbi.nlm.nih.gov/pubmed/32407457
20131,32849263,Bisphenol A-Induced Epigenetic Changes and Its Effects on the Male Reproductive System,Front Endocrinol (Lausanne). 2020 Jul 30;11:453. doi: 10.3389/fendo.2020.00453. eCollection 2020.,Cariati F,https://www.ncbi.nlm.nih.gov/pubmed/32849263
20136,32562083,Interleukin-23 Represses the Level of Cell Senescence Induced by the Androgen Receptor Antagonists Enzalutamide and Darolutamide in Castration-Resistant Prostate Cancer Cells,Horm Cancer. 2020 Aug;11(3-4):182-190. doi: 10.1007/s12672-020-00391-5. Epub 2020 Jun 20.,Gupta S,https://www.ncbi.nlm.nih.gov/pubmed/32562083
20137,32546843,Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk,Sci Rep. 2020 Jun 16;10(1):9688. doi: 10.1038/s41598-020-65665-y.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/32546843
20139,33290052,Peptide Cleavage-Mediated and Environmentally Friendly Photocurrent Polarity Switching System for Prostate-Specific Antigen Assay,Anal Chem. 2021 Jan 19;93(2):1076-1083. doi: 10.1021/acs.analchem.0c04086. Epub 2020 Dec 8.,Fu Y,https://www.ncbi.nlm.nih.gov/pubmed/33290052
20140,32607649,Interpreting body MRI cases: classic findings in pelvic MRI,Abdom Radiol (NY). 2020 Sep;45(9):2916-2930. doi: 10.1007/s00261-020-02615-2. Epub 2020 Jun 30.,Kania LM,https://www.ncbi.nlm.nih.gov/pubmed/32607649
20141,33284011,Electrical Cartridge Sensor Enables Reliable and Direct Identification of MicroRNAs in Urine of Patients,ACS Sens. 2021 Mar 26;6(3):833-841. doi: 10.1021/acssensors.0c01870. Epub 2020 Dec 7.,Kim S,https://www.ncbi.nlm.nih.gov/pubmed/33284011
20143,33090317,Current Knowledge and Opinions of Medical Trainees Regarding PSA Screening,J Cancer Educ. 2022 Aug;37(4):942-949. doi: 10.1007/s13187-020-01904-0. Epub 2020 Oct 22.,Sheetz T,https://www.ncbi.nlm.nih.gov/pubmed/33090317
20144,32621266,Incidental pulmonary embolism in oncologic patients-a systematic review and meta-analysis,Support Care Cancer. 2021 Mar;29(3):1293-1302. doi: 10.1007/s00520-020-05601-y. Epub 2020 Jul 4.,Meyer HJ,https://www.ncbi.nlm.nih.gov/pubmed/32621266
20145,32725840,Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma,J Mass Spectrom. 2020 Oct;55(10):e4584. doi: 10.1002/jms.4584.,Bhatnagar A,https://www.ncbi.nlm.nih.gov/pubmed/32725840
20146,32529857,Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice,Expert Opin Drug Saf. 2020 Aug;19(8):1041-1048. doi: 10.1080/14740338.2020.1781089. Epub 2020 Jun 22.,Escudero-Vilaplana V,https://www.ncbi.nlm.nih.gov/pubmed/32529857
20147,32334022,"Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3'RACE and high-throughput sequencing",Gene. 2020 Jul 30;749:144708. doi: 10.1016/j.gene.2020.144708. Epub 2020 Apr 22.,Adamopoulos PG,https://www.ncbi.nlm.nih.gov/pubmed/32334022
20150,32306447,FAM35A/SHLD2/RINN2: A novel determinant of double strand break repair pathway choice and genome stability in cancer,Environ Mol Mutagen. 2020 Aug;61(7):709-715. doi: 10.1002/em.22379. Epub 2020 Jul 3.,Fackrell K,https://www.ncbi.nlm.nih.gov/pubmed/32306447
20151,32822118,Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort,Cancer Med. 2020 Oct;9(20):7763-7771. doi: 10.1002/cam4.3368. Epub 2020 Aug 21.,Malburg CM,https://www.ncbi.nlm.nih.gov/pubmed/32822118
20152,32498320,A Scoping Review of Interactions between Omega-3 Long-Chain Polyunsaturated Fatty Acids and Genetic Variation in Relation to Cancer Risk,Nutrients. 2020 Jun 2;12(6):1647. doi: 10.3390/nu12061647.,Yurko-Mauro K,https://www.ncbi.nlm.nih.gov/pubmed/32498320
20156,33009488,De novo induction of lineage plasticity from human prostate luminal epithelial cells by activated AKT1 and c-Myc,Oncogene. 2020 Nov;39(48):7142-7151. doi: 10.1038/s41388-020-01487-6. Epub 2020 Oct 2.,Kwon OJ,https://www.ncbi.nlm.nih.gov/pubmed/33009488
20157,33052518,Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis,Int Urol Nephrol. 2021 Mar;53(3):471-477. doi: 10.1007/s11255-020-02659-9. Epub 2020 Oct 14.,Li H,https://www.ncbi.nlm.nih.gov/pubmed/33052518
20158,33367450,Recent advances in nanomaterials for colorimetric cancer detection,J Mater Chem B. 2021 Jan 28;9(4):921-938. doi: 10.1039/d0tb02163f. Epub 2020 Dec 24.,Wang H,https://www.ncbi.nlm.nih.gov/pubmed/33367450
20159,32469149,Resolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization,J Cell Mol Med. 2020 Jul;24(14):8045-8056. doi: 10.1111/jcmm.15436. Epub 2020 May 29.,Shan K,https://www.ncbi.nlm.nih.gov/pubmed/32469149
20160,32506842,Blood-derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs,Mol Oncol. 2020 Sep;14(9):2111-2123. doi: 10.1002/1878-0261.12738. Epub 2020 Jun 22.,Zhang Y,https://www.ncbi.nlm.nih.gov/pubmed/32506842
20161,32959621,The Increasing Trends in Cases of the Most Common Cancers in Saudi Arabia,J Epidemiol Glob Health. 2020 Dec;10(4):258-262. doi: 10.2991/jegh.k.200515.001. Epub 2020 May 22.,Chaudhri E,https://www.ncbi.nlm.nih.gov/pubmed/32959621
20162,32989765,Distortion-free 3D diffusion imaging of the prostate using a multishot diffusion-prepared phase-cycled acquisition and dictionary matching,Magn Reson Med. 2021 Mar;85(3):1441-1454. doi: 10.1002/mrm.28527. Epub 2020 Sep 28.,Roccia E,https://www.ncbi.nlm.nih.gov/pubmed/32989765
20163,33027706,"Measuring progress against cancer in the Azores, Portugal: Incidence, survival, and mortality trends and projections to 2025",Cancer Epidemiol. 2020 Dec;69:101810. doi: 10.1016/j.canep.2020.101810. Epub 2020 Oct 4.,Forjaz G,https://www.ncbi.nlm.nih.gov/pubmed/33027706
20166,32560347,Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells,Nutrients. 2020 Jun 17;12(6):1798. doi: 10.3390/nu12061798.,Negri M,https://www.ncbi.nlm.nih.gov/pubmed/32560347
20167,33048309,Reactor produced [(64)Cu]CuCl(2) as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic,Ann Nucl Med. 2020 Dec;34(12):899-910. doi: 10.1007/s12149-020-01522-2. Epub 2020 Oct 13.,Chakravarty R,https://www.ncbi.nlm.nih.gov/pubmed/33048309
20168,32374450,Automated synthesis of (68) Ga/(177) Lu-PSMA on the Trasis miniAllinOne,J Labelled Comp Radiopharm. 2020 Jun 30;63(8):393-403. doi: 10.1002/jlcr.3846. Epub 2020 Jun 1.,Sørensen MA,https://www.ncbi.nlm.nih.gov/pubmed/32374450
20169,32472342,"""Katz activities of daily living disability in older cancer survivors by age, stage, and cancer type""",J Cancer Surviv. 2020 Dec;14(6):769-778. doi: 10.1007/s11764-020-00891-x. Epub 2020 May 30.,Blackwood J,https://www.ncbi.nlm.nih.gov/pubmed/32472342
20170,32961381,Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras,Eur J Med Chem. 2020 Dec 15;208:112769. doi: 10.1016/j.ejmech.2020.112769. Epub 2020 Aug 26.,Takwale AD,https://www.ncbi.nlm.nih.gov/pubmed/32961381
20171,32306177,Cancer risks of firefighters: a systematic review and meta-analysis of secular trends and region-specific differences,Int Arch Occup Environ Health. 2020 Oct;93(7):839-852. doi: 10.1007/s00420-020-01539-0. Epub 2020 Apr 18.,Casjens S,https://www.ncbi.nlm.nih.gov/pubmed/32306177
20172,33159289,Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies,Drug Deliv Transl Res. 2021 Oct;11(5):1806-1817. doi: 10.1007/s13346-020-00868-4. Epub 2020 Nov 6.,Verco S,https://www.ncbi.nlm.nih.gov/pubmed/33159289
20173,33322746,CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate,Cells. 2020 Dec 12;9(12):2675. doi: 10.3390/cells9122675.,Stolarova L,https://www.ncbi.nlm.nih.gov/pubmed/33322746
20174,32623317,Development of a reliable bioanalytical method based on prostate specific antigen trapping on the cavity of molecular imprinted polymer towards sensing of PSA using binding affinity of PSA-MIP receptor: A novel biosensor,J Pharm Biomed Anal. 2020 Sep 5;188:113447. doi: 10.1016/j.jpba.2020.113447. Epub 2020 Jun 26.,Abbasy L,https://www.ncbi.nlm.nih.gov/pubmed/32623317
20176,32865287,Effect of myeloperoxidase on the anticoagulant activity of low molecular weight heparin and rivaroxaban in an in vitro tumor model,J Thromb Haemost. 2020 Dec;18(12):3267-3279. doi: 10.1111/jth.15075. Epub 2020 Sep 25.,Voigtlaender M,https://www.ncbi.nlm.nih.gov/pubmed/32865287
20177,33302880,Variable selection in social-environmental data: sparse regression and tree ensemble machine learning approaches,BMC Med Res Methodol. 2020 Dec 10;20(1):302. doi: 10.1186/s12874-020-01183-9.,Handorf E,https://www.ncbi.nlm.nih.gov/pubmed/33302880
20180,32701807,"68Ga-Prostate-Specific Membrane Antigen-11-Avid Cardiac Metastases in a Patient With Adenoid Cystic Carcinoma, A Rare Presentation of a Rare Cancer",Clin Nucl Med. 2020 Sep;45(9):716-718. doi: 10.1097/RLU.0000000000003204.,Uijen MJM,https://www.ncbi.nlm.nih.gov/pubmed/32701807
20181,32992306,Characterization of B(0)-field fluctuations in prostate MRI,Phys Med Biol. 2020 Nov 5;65(21):21NT01. doi: 10.1088/1361-6560/abbc7f.,Shrestha Kakkar L,https://www.ncbi.nlm.nih.gov/pubmed/32992306
20182,33319508,Capacity building for cancer prevention and early detection in the Ugandan primary healthcare facilities: Working toward reducing the unmet needs of cancer control services,Cancer Med. 2021 Jan;10(2):745-756. doi: 10.1002/cam4.3659. Epub 2020 Dec 14.,Jatho A,https://www.ncbi.nlm.nih.gov/pubmed/33319508
20183,32531293,Roles of OCT4 in pathways of embryonic development and cancer progression,Mech Ageing Dev. 2020 Jul;189:111286. doi: 10.1016/j.mad.2020.111286. Epub 2020 Jun 9.,Patra SK,https://www.ncbi.nlm.nih.gov/pubmed/32531293
20184,31792837,The Effect of Chirality on the Application of 5-[(18)F]Fluoro-Aminosuberic Acid ([(18)F]FASu) for Oxidative Stress Imaging,Mol Imaging Biol. 2020 Aug;22(4):873-882. doi: 10.1007/s11307-019-01450-2.,?olovi? M,https://www.ncbi.nlm.nih.gov/pubmed/31792837
20185,32956764,Targeting protein tyrosine kinase 6 in cancer,Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188432. doi: 10.1016/j.bbcan.2020.188432. Epub 2020 Sep 18.,Gilic MB,https://www.ncbi.nlm.nih.gov/pubmed/32956764
20186,32926324,Sympathetic and parasympathetic innervation in cancer: therapeutic implications,Clin Auton Res. 2021 Apr;31(2):165-178. doi: 10.1007/s10286-020-00724-y. Epub 2020 Sep 14.,Kamiya A,https://www.ncbi.nlm.nih.gov/pubmed/32926324
20188,32868355,Trends in cancer incidence and survival in the Augsburg study region-results from the Augsburg cancer registry,BMJ Open. 2020 Aug 30;10(8):e036176. doi: 10.1136/bmjopen-2019-036176.,Grundmann N,https://www.ncbi.nlm.nih.gov/pubmed/32868355
20189,32706737,Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis,JMIR Mhealth Uhealth. 2020 Jul 23;8(7):e17609. doi: 10.2196/17609.,Amor-García MÁ,https://www.ncbi.nlm.nih.gov/pubmed/32706737
20190,32840146,Culturally Responsive Health Promotion to Address Health Disparities in African American Men: A Program Impact Evaluation,Am J Mens Health. 2020 Jul-Aug;14(4):1557988320951321. doi: 10.1177/1557988320951321.,Okoro ON,https://www.ncbi.nlm.nih.gov/pubmed/32840146
20191,32676854,Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer,Support Care Cancer. 2021 Mar;29(3):1423-1431. doi: 10.1007/s00520-020-05623-6. Epub 2020 Jul 16.,Batra A,https://www.ncbi.nlm.nih.gov/pubmed/32676854
20192,32659681,Are vitamins relevant to cancer risks? A Mendelian randomization investigation,Nutrition. 2020 Oct;78:110870. doi: 10.1016/j.nut.2020.110870. Epub 2020 May 29.,Cheng WW,https://www.ncbi.nlm.nih.gov/pubmed/32659681
20193,31760521,Moderate-to-vigorous intensity physical activity is associated with modified fatigue during and after cancer treatment,Support Care Cancer. 2020 Jul;28(7):3343-3350. doi: 10.1007/s00520-019-05176-3. Epub 2019 Nov 23.,Nilsson M,https://www.ncbi.nlm.nih.gov/pubmed/31760521
20194,32661092,"Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell-Mediated Immune Suppression and Tumor Progression",Cancer Immunol Res. 2020 Sep;8(9):1215-1227. doi: 10.1158/2326-6066.CIR-19-0371. Epub 2020 Jul 13.,Consiglio CR,https://www.ncbi.nlm.nih.gov/pubmed/32661092
20195,32497271,Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019,Cancer. 2020 Aug 15;126(16):3742-3749. doi: 10.1002/cncr.32997. Epub 2020 Jun 4.,Desai AP,https://www.ncbi.nlm.nih.gov/pubmed/32497271
20196,33052780,The role of circular RNAs in therapy resistance of patients with solid tumors,Per Med. 2020 Nov;17(6):469-490. doi: 10.2217/pme-2020-0103. Epub 2020 Oct 14.,Papatsirou M,https://www.ncbi.nlm.nih.gov/pubmed/33052780
20197,33328104,"Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis",Eur J Med Chem. 2021 Jan 1;209:112942. doi: 10.1016/j.ejmech.2020.112942. Epub 2020 Oct 15.,Faraji A,https://www.ncbi.nlm.nih.gov/pubmed/33328104
20198,32128929,Artificial intelligence as the next step towards precision pathology,J Intern Med. 2020 Jul;288(1):62-81. doi: 10.1111/joim.13030. Epub 2020 Mar 3.,Acs B,https://www.ncbi.nlm.nih.gov/pubmed/32128929
20199,33228208,Dysregulation of Transcription Factor Activity During Formation of Cancer-Associated Fibroblasts,Int J Mol Sci. 2020 Nov 19;21(22):8749. doi: 10.3390/ijms21228749.,Kapusta P,https://www.ncbi.nlm.nih.gov/pubmed/33228208
20200,33086204,Differentiating cancer types using a urine test for volatile organic compounds,J Breath Res. 2020 Dec 3;15(1):017102. doi: 10.1088/1752-7163/abc36b.,Bannaga AS,https://www.ncbi.nlm.nih.gov/pubmed/33086204
20201,32930133,Heme oxygenase-1 in osteosarcoma,J Cancer Res Ther. 2020 Jul-Sep;16(4):874-877. doi: 10.4103/jcrt.JCRT_419_17.,Kharb S,https://www.ncbi.nlm.nih.gov/pubmed/32930133
20202,32849585,The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion,Front Immunol. 2020 Jul 30;11:1680. doi: 10.3389/fimmu.2020.01680. eCollection 2020.,De Cicco P,https://www.ncbi.nlm.nih.gov/pubmed/32849585
20204,32944394,Zinc dysregulation in cancers and its potential as a therapeutic target,Cancer Biol Med. 2020 Aug 15;17(3):612-625. doi: 10.20892/j.issn.2095-3941.2020.0106.,Wang J,https://www.ncbi.nlm.nih.gov/pubmed/32944394
20205,32517780,Association between periodontitis and all-cause and cancer mortality: retrospective elderly community cohort study,BMC Oral Health. 2020 Jun 9;20(1):168. doi: 10.1186/s12903-020-01156-w.,Chung PC,https://www.ncbi.nlm.nih.gov/pubmed/32517780
20206,32961226,The Clinical Implication of Incidental Prostatic Amyloidosis,Urology. 2020 Nov;145:253-257. doi: 10.1016/j.urology.2020.08.053. Epub 2020 Sep 19.,Nevo A,https://www.ncbi.nlm.nih.gov/pubmed/32961226
20207,31845006,Cancer and end of life: the management provided during the year and the month preceding death in 2015 and causes of death in France,Support Care Cancer. 2020 Aug;28(8):3877-3887. doi: 10.1007/s00520-019-05188-z. Epub 2019 Dec 16.,Melac AT,https://www.ncbi.nlm.nih.gov/pubmed/31845006
20208,33384976,Association Between Folate and Health Outcomes: An Umbrella Review of Meta-Analyses,Front Public Health. 2020 Dec 15;8:550753. doi: 10.3389/fpubh.2020.550753. eCollection 2020.,Bo Y,https://www.ncbi.nlm.nih.gov/pubmed/33384976
20209,33379017,12-Plex UHPLC-MS/MS analysis of sarcosine in human urine using integrated principle of multiplex tags chemical isotope labeling and selective imprint enriching,Talanta. 2021 Mar 1;224:121788. doi: 10.1016/j.talanta.2020.121788. Epub 2020 Oct 19.,Chen SE,https://www.ncbi.nlm.nih.gov/pubmed/33379017
20210,33261132,Analysis of the Circulating Tumor Cell Capture Ability of a Slit Filter-Based Method in Comparison to a Selection-Free Method in Multiple Cancer Types,Int J Mol Sci. 2020 Nov 27;21(23):9031. doi: 10.3390/ijms21239031.,Takagi H,https://www.ncbi.nlm.nih.gov/pubmed/33261132
20211,32984948,Aspirin and the risk of nondigestive tract cancers: An updated meta-analysis to 2019,Int J Cancer. 2021 Mar 15;148(6):1372-1382. doi: 10.1002/ijc.33311. Epub 2020 Oct 6.,Santucci C,https://www.ncbi.nlm.nih.gov/pubmed/32984948
20213,33131268,Ciliary neurotrophic factor (CNTF) and its receptor (CNTFR?) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study,Eur J Histochem. 2020 Oct 19;64(4):3147. doi: 10.4081/ejh.2020.3147.,Fantone S,https://www.ncbi.nlm.nih.gov/pubmed/33131268
20214,31926877,Prevalence and factors associated with potentially inappropriate medication use in older medicare beneficiaries with cancer,Res Social Adm Pharm. 2020 Oct;16(10):1459-1471. doi: 10.1016/j.sapharm.2019.12.018. Epub 2019 Dec 26.,Feng X,https://www.ncbi.nlm.nih.gov/pubmed/31926877
20215,33090770,Powerful Chemiluminescence Probe for Rapid Detection of Prostate Specific Antigen Proteolytic Activity: Forensic Identification of Human Semen,Bioconjug Chem. 2020 Nov 18;31(11):2488-2493. doi: 10.1021/acs.bioconjchem.0c00500. Epub 2020 Oct 22.,Gutkin S,https://www.ncbi.nlm.nih.gov/pubmed/33090770
20216,32860827,Recognition of nucleolin through interaction with RNA G-quadruplex,Biochem Pharmacol. 2021 Jul;189:114208. doi: 10.1016/j.bcp.2020.114208. Epub 2020 Aug 27.,Santos T,https://www.ncbi.nlm.nih.gov/pubmed/32860827
20218,32555265,Analysis of risk factors for post-bacillus Calmette-Guerin-induced prostatitis in patients with non-muscle invasive bladder cancer,Sci Rep. 2020 Jun 17;10(1):9763. doi: 10.1038/s41598-020-66952-4.,Kim TJ,https://www.ncbi.nlm.nih.gov/pubmed/32555265
20219,32276007,Development of fast deep learning quantification for magnetic resonance fingerprinting in vivo,Magn Reson Imaging. 2020 Jul;70:81-90. doi: 10.1016/j.mri.2020.03.009. Epub 2020 Apr 7.,Cao P,https://www.ncbi.nlm.nih.gov/pubmed/32276007
20221,32783257,"A novel series of substituted 1,2,3-triazoles as cancer stem cell inhibitors: Synthesis and biological evaluation",Drug Dev Res. 2021 Feb;82(1):68-85. doi: 10.1002/ddr.21723. Epub 2020 Aug 12.,Padhariya KN,https://www.ncbi.nlm.nih.gov/pubmed/32783257
20222,32899792,Novel ANO1 Inhibitor from Mallotus apelta Extract Exerts Anticancer Activity through Downregulation of ANO1,Int J Mol Sci. 2020 Sep 4;21(18):6470. doi: 10.3390/ijms21186470.,Seo Y,https://www.ncbi.nlm.nih.gov/pubmed/32899792
20223,32758683,Identifying and ranking potential cancer drivers using representation learning on attributed network,Methods. 2021 Aug;192:13-24. doi: 10.1016/j.ymeth.2020.07.013. Epub 2020 Aug 3.,Peng W,https://www.ncbi.nlm.nih.gov/pubmed/32758683
20225,32814638,Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age,Eur Urol. 2021 Feb;79(2):234-240. doi: 10.1016/j.eururo.2020.08.001. Epub 2020 Aug 17.,Boeri L,https://www.ncbi.nlm.nih.gov/pubmed/32814638
20226,33144696,Insights into the role of sialylation in cancer progression and metastasis,Br J Cancer. 2021 Jan;124(1):76-90. doi: 10.1038/s41416-020-01126-7. Epub 2020 Nov 4.,Dobie C,https://www.ncbi.nlm.nih.gov/pubmed/33144696
20227,32729651,MicroRNAs and gene regulation in breast cancer,J Biochem Mol Toxicol. 2020 Nov;34(11):e22567. doi: 10.1002/jbt.22567. Epub 2020 Jul 30.,Abdalla F,https://www.ncbi.nlm.nih.gov/pubmed/32729651
20229,33321758,Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A(2) (sPLA(2)) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells,Int J Mol Sci. 2020 Dec 10;21(24):9396. doi: 10.3390/ijms21249396.,Najahi-Missaoui W,https://www.ncbi.nlm.nih.gov/pubmed/33321758
20230,32740175,Problem-solving in technology-rich environments and cancer screening in later life,Eur J Cancer Prev. 2020 Sep;29(5):474-480. doi: 10.1097/CEJ.0000000000000570.,Sahoo S,https://www.ncbi.nlm.nih.gov/pubmed/32740175
20231,32897058,"A Selective ERR?/? Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer Cells",ACS Chem Biol. 2020 Sep 18;15(9):2338-2345. doi: 10.1021/acschembio.0c00670. Epub 2020 Sep 8.,Schoepke E,https://www.ncbi.nlm.nih.gov/pubmed/32897058
20232,33212541,Comparison of Prostate MRI Lesion Segmentation Agreement Between Multiple Radiologists and a Fully Automatic Deep Learning System,Rofo. 2021 May;193(5):559-573. doi: 10.1055/a-1290-8070. Epub 2020 Nov 19.,Schelb P,https://www.ncbi.nlm.nih.gov/pubmed/33212541
20234,32662797,Fe(iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents,Org Biomol Chem. 2020 Aug 7;18(29):5571-5576. doi: 10.1039/d0ob01241f. Epub 2020 Jul 14.,Samanta S,https://www.ncbi.nlm.nih.gov/pubmed/32662797
20237,32593151,Analysis of 52 C(19) and C(21) steroids by UPC(2)-MS/MS: Characterising the C11-oxy steroid metabolome in serum,J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Sep 1;1152:122243. doi: 10.1016/j.jchromb.2020.122243. Epub 2020 Jun 13.,du Toit T,https://www.ncbi.nlm.nih.gov/pubmed/32593151
20238,32674614,Cancer screening and follow-up in general practice: A French nationwide cross-sectional study,Eur J Gen Pract. 2020 Dec;26(1):95-101. doi: 10.1080/13814788.2020.1784875.,Lamort-Bouché M,https://www.ncbi.nlm.nih.gov/pubmed/32674614
20239,32360170,"A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial",Urol Oncol. 2020 Aug;38(8):683.e1-683.e10. doi: 10.1016/j.urolonc.2020.03.011. Epub 2020 Apr 30.,Shore ND,https://www.ncbi.nlm.nih.gov/pubmed/32360170
20240,32969164,Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*,Chembiochem. 2021 Feb 2;22(3):496-500. doi: 10.1002/cbic.202000577. Epub 2020 Nov 4.,Sasaki K,https://www.ncbi.nlm.nih.gov/pubmed/32969164
20241,32833288,Paying the price for standing tall: Fluid mechanics of prostate pathology,Prostate. 2020 Nov;80(15):1297-1303. doi: 10.1002/pros.24051. Epub 2020 Aug 24.,Gat Y,https://www.ncbi.nlm.nih.gov/pubmed/32833288
20242,32918849,Instrumental activities of daily living and neuropsychological functioning among patients with different types of cancer,Eur J Neurol. 2021 Jan;28(1):66-70. doi: 10.1111/ene.14522. Epub 2020 Oct 6.,Megari K,https://www.ncbi.nlm.nih.gov/pubmed/32918849
20244,33376561,TRPV2: A Cancer Biomarker and Potential Therapeutic Target,Dis Markers. 2020 Dec 10;2020:8892312. doi: 10.1155/2020/8892312. eCollection 2020.,Siveen KS,https://www.ncbi.nlm.nih.gov/pubmed/33376561
20245,33065626,False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma,Clin Nucl Med. 2020 Dec;45(12):960-961. doi: 10.1097/RLU.0000000000003310.,Panagiotidis E,https://www.ncbi.nlm.nih.gov/pubmed/33065626
20246,32576579,Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model,Cancer Genomics Proteomics. 2020 Jul-Aug;17(4):335-350. doi: 10.21873/cgp.20193.,Divella R,https://www.ncbi.nlm.nih.gov/pubmed/32576579
20248,33222075,Finding incident cancer cases through outpatient oncology clinic claims data and integration into a state cancer registry,Cancer Causes Control. 2021 Feb;32(2):199-202. doi: 10.1007/s10552-020-01368-z. Epub 2020 Nov 22.,Cogle CR,https://www.ncbi.nlm.nih.gov/pubmed/33222075
20249,32470346,Background-free cell surface glycan analysis using persistent luminescence nanoparticle as an optical probe,Anal Biochem. 2020 Jul 15;601:113780. doi: 10.1016/j.ab.2020.113780. Epub 2020 May 26.,He N,https://www.ncbi.nlm.nih.gov/pubmed/32470346
20250,33264718,Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies,Crit Rev Oncol Hematol. 2021 Jan;157:103177. doi: 10.1016/j.critrevonc.2020.103177. Epub 2020 Nov 13.,Michels N,https://www.ncbi.nlm.nih.gov/pubmed/33264718
20252,32592976,"Diversity-oriented generation and biological evaluation of new chemical scaffolds bearing a 2,2-dimethyl-2H-chromene unit: Discovery of novel potent ANO1 inhibitors",Bioorg Chem. 2020 Aug;101:104000. doi: 10.1016/j.bioorg.2020.104000. Epub 2020 Jun 8.,Seo Y,https://www.ncbi.nlm.nih.gov/pubmed/32592976
20253,32529410,Sacituzumab Govitecan: First Approval,Drugs. 2020 Jul;80(10):1019-1025. doi: 10.1007/s40265-020-01337-5.,Syed YY,https://www.ncbi.nlm.nih.gov/pubmed/32529410
20254,32943359,Perceptions of care coordination among older adult cancer survivors: A SEER-CAHPS study,J Geriatr Oncol. 2021 Apr;12(3):446-452. doi: 10.1016/j.jgo.2020.09.003. Epub 2020 Sep 15.,Mollica MA,https://www.ncbi.nlm.nih.gov/pubmed/32943359
20255,32717139,Insulin-like growth factor-1 and site-specific cancers: A Mendelian randomization study,Cancer Med. 2020 Sep;9(18):6836-6842. doi: 10.1002/cam4.3345. Epub 2020 Jul 27.,Larsson SC,https://www.ncbi.nlm.nih.gov/pubmed/32717139
20256,33128527,In vitro effect of dibenzyl trisulfide on the p50 of the oxygen haemoglobin dissociation curve,J Basic Clin Physiol Pharmacol. 2020 Nov 2;32(3):279-282. doi: 10.1515/jbcpp-2020-0125.,Pepple DJ,https://www.ncbi.nlm.nih.gov/pubmed/33128527
20258,32755976,Cross-Sectional Analysis of the Associations Between Four Common Cancers and Disability,J Natl Compr Canc Netw. 2020 Aug;18(8):1031-1044. doi: 10.6004/jnccn.2020.7551.,Iezzoni LI,https://www.ncbi.nlm.nih.gov/pubmed/32755976
20259,33874825,Frontiers of metal-coordinating drug design,Expert Opin Drug Discov. 2021 May;16(5):497-511. doi: 10.1080/17460441.2021.1851188. Epub 2020 Dec 1.,Palermo G,https://www.ncbi.nlm.nih.gov/pubmed/33874825
20260,33289351,Clinical utility of circulating tumor cells: an update,Mol Oncol. 2021 Jun;15(6):1647-1666. doi: 10.1002/1878-0261.12869. Epub 2020 Dec 25.,Vasseur A,https://www.ncbi.nlm.nih.gov/pubmed/33289351
20262,32701947,"Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants",PLoS Med. 2020 Jul 23;17(7):e1003178. doi: 10.1371/journal.pmed.1003178. eCollection 2020 Jul.,Larsson SC,https://www.ncbi.nlm.nih.gov/pubmed/32701947
20264,32762299,The Delivery Materials with Chemotherapy Drugs for Treatment of the Positive Margin in Solid Tumors,Tissue Eng Part A. 2021 May;27(9-10):536-548. doi: 10.1089/ten.TEA.2020.0076. Epub 2020 Sep 21.,Zhu Y,https://www.ncbi.nlm.nih.gov/pubmed/32762299
20265,33114598,Development of HPLC Method for Quantification of Sinigrin from Raphanus sativus Roots and Evaluation of Its Anticancer Potential,Molecules. 2020 Oct 26;25(21):4947. doi: 10.3390/molecules25214947.,Nair AB,https://www.ncbi.nlm.nih.gov/pubmed/33114598
20266,32998722,Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth,BMC Cancer. 2020 Oct 1;20(1):941. doi: 10.1186/s12885-020-07370-7.,Metz EP,https://www.ncbi.nlm.nih.gov/pubmed/32998722
20267,33099962,Follow-up protocol for oncological patients at risk of developing multiple primary neoplasms,J BUON. 2020 Jul-Aug;25(4):2117-2122.,Nemes A,https://www.ncbi.nlm.nih.gov/pubmed/33099962
20268,33297851,Concordance probability as a meaningful contrast across disparate survival times,Stat Methods Med Res. 2021 Mar;30(3):816-825. doi: 10.1177/0962280220973694. Epub 2020 Dec 9.,Devlin SM,https://www.ncbi.nlm.nih.gov/pubmed/33297851
20269,33096244,iODA: An integrated tool for analysis of cancer pathway consistency from heterogeneous multi-omics data,J Biomed Inform. 2020 Dec;112:103605. doi: 10.1016/j.jbi.2020.103605. Epub 2020 Oct 20.,Yu C,https://www.ncbi.nlm.nih.gov/pubmed/33096244
20270,32561524,"Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology",J Clin Pathol. 2021 Mar;74(3):187-189. doi: 10.1136/jclinpath-2020-206833. Epub 2020 Jun 19.,De Vincentiis L,https://www.ncbi.nlm.nih.gov/pubmed/32561524
20271,32335090,Establishment of age-related prostate-specific antigen (PSA) reference limits in the Algerian population: A comparison of four indirect methods,Clin Chim Acta. 2020 Aug;507:149-155. doi: 10.1016/j.cca.2020.04.021. Epub 2020 Apr 23.,Mohamed Mokhtar K,https://www.ncbi.nlm.nih.gov/pubmed/32335090
20272,33351717,"Days Spent at Home before Death from Cancer for Immigrants and Long-Term Residents in Ontario, Canada",J Palliat Med. 2021 Apr;24(4):593-598. doi: 10.1089/jpm.2020.0287. Epub 2020 Dec 22.,Engelhart S,https://www.ncbi.nlm.nih.gov/pubmed/33351717
20274,32984907,Cancer cure for 32 cancer types: results from the EUROCARE-5 study,Int J Epidemiol. 2020 Oct 1;49(5):1517-1525. doi: 10.1093/ije/dyaa128.,Dal Maso L,https://www.ncbi.nlm.nih.gov/pubmed/32984907
20277,33357963,Creating a priority list of non-communicable diseases to support health research funding decision-making,Health Policy. 2021 Feb;125(2):221-228. doi: 10.1016/j.healthpol.2020.12.003. Epub 2020 Dec 10.,Babashahi S,https://www.ncbi.nlm.nih.gov/pubmed/33357963
20278,33385391,"PFAS and cancer, a scoping review of the epidemiologic evidence",Environ Res. 2021 Mar;194:110690. doi: 10.1016/j.envres.2020.110690. Epub 2020 Dec 30.,Steenland K,https://www.ncbi.nlm.nih.gov/pubmed/33385391
20279,32828885,Nerve input to tumours: Pathophysiological consequences of a dynamic relationship,Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188411. doi: 10.1016/j.bbcan.2020.188411. Epub 2020 Aug 21.,Hutchings C,https://www.ncbi.nlm.nih.gov/pubmed/32828885
20280,33089436,The added value of new covariates to the brier score in cox survival models,Lifetime Data Anal. 2021 Jan;27(1):1-14. doi: 10.1007/s10985-020-09509-x. Epub 2020 Oct 22.,Heller G,https://www.ncbi.nlm.nih.gov/pubmed/33089436
20282,33124957,A 5-Year Single-Institution Experience Integrating Telehealth Into Urologic Care Delivery,Telemed J E Health. 2021 Sep;27(9):997-1002. doi: 10.1089/tmj.2020.0267. Epub 2020 Oct 30.,Nourian A,https://www.ncbi.nlm.nih.gov/pubmed/33124957
20283,32586210,Perceived importance of affective forecasting in cancer treatment decision making,J Psychosoc Oncol. 2020 Nov-Dec;38(6):687-701. doi: 10.1080/07347332.2020.1768198. Epub 2020 Jun 26.,Perry LM,https://www.ncbi.nlm.nih.gov/pubmed/32586210
20284,32555901,An in vitro tumor swamp model of heterogeneous cellular and chemotherapeutic landscapes,Lab Chip. 2020 Jul 14;20(14):2453-2464. doi: 10.1039/d0lc00131g.,Lin KC,https://www.ncbi.nlm.nih.gov/pubmed/32555901
20285,33067731,Indirectly radioiodinated exendin-4 as an analytical tool for in vivo detection of glucagon-like peptide-1 receptor in a disease setting,Ann Nucl Med. 2021 Jan;35(1):83-91. doi: 10.1007/s12149-020-01540-0. Epub 2020 Oct 16.,Kondo N,https://www.ncbi.nlm.nih.gov/pubmed/33067731
20286,32777484,A Machine Learning method for relabeling arbitrary DICOM structure sets to TG-263 defined labels,J Biomed Inform. 2020 Sep;109:103527. doi: 10.1016/j.jbi.2020.103527. Epub 2020 Aug 8.,Sleeman Iv WC,https://www.ncbi.nlm.nih.gov/pubmed/32777484
20287,32924698,"Education, income and risk of cancer: results from a Norwegian registry-based study",Acta Oncol. 2020 Nov;59(11):1300-1307. doi: 10.1080/0284186X.2020.1817548. Epub 2020 Sep 14.,Larsen IK,https://www.ncbi.nlm.nih.gov/pubmed/32924698
20288,32142162,Cancer in Mozambique: Results from two population-based cancer registries,Int J Cancer. 2020 Sep 15;147(6):1629-1637. doi: 10.1002/ijc.32953. Epub 2020 Mar 18.,Lorenzoni CF,https://www.ncbi.nlm.nih.gov/pubmed/32142162
20289,32820240,Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence,Eur J Clin Nutr. 2021 Jun;75(6):865-876. doi: 10.1038/s41430-020-00710-7. Epub 2020 Aug 20.,Abe SK,https://www.ncbi.nlm.nih.gov/pubmed/32820240
20290,32034500,Challenges facing the urologist in low- and middle-income countries,World J Urol. 2020 Nov;38(11):2987-2994. doi: 10.1007/s00345-020-03101-6. Epub 2020 Feb 7.,Metzler I,https://www.ncbi.nlm.nih.gov/pubmed/32034500
20291,32791747,Identification of key genes and pathways in IgA nephropathy using bioinformatics analysis,Medicine (Baltimore). 2020 Jul 24;99(30):e21372. doi: 10.1097/MD.0000000000021372.,Hu SL,https://www.ncbi.nlm.nih.gov/pubmed/32791747
20292,32246432,Psychometric properties of the FACT-G quality of life scale for family caregivers of cancer patients,Qual Life Res. 2020 Aug;29(8):2241-2252. doi: 10.1007/s11136-020-02477-7. Epub 2020 Apr 3.,Song L,https://www.ncbi.nlm.nih.gov/pubmed/32246432
20295,33284127,Using Social Media Data to Understand Consumers' Information Needs and Emotions Regarding Cancer: Ontology-Based Data Analysis Study,J Med Internet Res. 2020 Dec 7;22(12):e18767. doi: 10.2196/18767.,Lee J,https://www.ncbi.nlm.nih.gov/pubmed/33284127
20296,33091561,A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance,Ann Oncol. 2021 Jan;32(1):103-112. doi: 10.1016/j.annonc.2020.10.470. Epub 2020 Oct 19.,Tobalina L,https://www.ncbi.nlm.nih.gov/pubmed/33091561
20297,33347954,Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3,Mol Cell Endocrinol. 2021 Feb 15;522:111136. doi: 10.1016/j.mce.2020.111136. Epub 2020 Dec 25.,Massah S,https://www.ncbi.nlm.nih.gov/pubmed/33347954
20298,32845627,Lab-on-Membrane Platform Coupled with Paper Spray Ionization for Analysis of Prostate-Specific Antigen in Clinical Settings,Anal Chem. 2020 Oct 6;92(19):13298-13304. doi: 10.1021/acs.analchem.0c02554. Epub 2020 Sep 4.,Chen R,https://www.ncbi.nlm.nih.gov/pubmed/32845627
20299,33178195,Cutibacterium acnes Infection Induces Type I Interferon Synthesis Through the cGAS-STING Pathway,Front Immunol. 2020 Oct 15;11:571334. doi: 10.3389/fimmu.2020.571334. eCollection 2020.,Fischer K,https://www.ncbi.nlm.nih.gov/pubmed/33178195
20301,32646039,Anticancer Potential and Capsianosides Identification in Lipophilic Fraction of Sweet Pepper (Capsicum annuum L.),Molecules. 2020 Jul 7;25(13):3097. doi: 10.3390/molecules25133097.,Chilczuk B,https://www.ncbi.nlm.nih.gov/pubmed/32646039
20302,32709735,Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank,Cancer Res. 2020 Sep 15;80(18):4014-4021. doi: 10.1158/0008-5472.CAN-20-1281. Epub 2020 Jul 24.,Knuppel A,https://www.ncbi.nlm.nih.gov/pubmed/32709735
20303,33397596,Nucleic acid sensing via electrochemical oligonucleotide-templated reactions,Biosens Bioelectron. 2021 Mar 15;176:112891. doi: 10.1016/j.bios.2020.112891. Epub 2020 Dec 15.,Gillespie P,https://www.ncbi.nlm.nih.gov/pubmed/33397596
20304,32838739,Data integration by fuzzy similarity-based hierarchical clustering,BMC Bioinformatics. 2020 Aug 21;21(Suppl 10):350. doi: 10.1186/s12859-020-03567-6.,Ciaramella A,https://www.ncbi.nlm.nih.gov/pubmed/32838739
20306,32534450,Aberrantly glycosylated integrin ?3?1 is a unique urinary biomarker for the diagnosis of bladder cancer,Aging (Albany NY). 2020 Jun 13;12(11):10844-10862. doi: 10.18632/aging.103297. Epub 2020 Jun 13.,Jin D,https://www.ncbi.nlm.nih.gov/pubmed/32534450
20309,32709853,Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells,Cell Death Dis. 2020 Jul 24;11(7):577. doi: 10.1038/s41419-020-02780-8.,Zhai B,https://www.ncbi.nlm.nih.gov/pubmed/32709853
20310,32929645,Assessment of cancer screening effectiveness in the era of screening programs,Eur J Epidemiol. 2020 Oct;35(10):891-897. doi: 10.1007/s10654-020-00684-7. Epub 2020 Sep 14.,Adami HO,https://www.ncbi.nlm.nih.gov/pubmed/32929645
20311,32875374,"Patient competence in the context of cancer: its dimensions and their relationships with coping, coping self-efficacy, fear of progression, and depression",Support Care Cancer. 2021 Apr;29(4):2133-2143. doi: 10.1007/s00520-020-05699-0. Epub 2020 Sep 2.,Giesler JM,https://www.ncbi.nlm.nih.gov/pubmed/32875374
20312,32741068,"Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms",Mol Oncol. 2021 Mar;15(3):790-800. doi: 10.1002/1878-0261.12772. Epub 2020 Aug 18.,Friedenreich CM,https://www.ncbi.nlm.nih.gov/pubmed/32741068
20313,27595182,"New advances in our understanding of the ""unique"" RNase L in host pathogen interaction and immune signaling",Cytokine. 2020 Sep;133:153847. doi: 10.1016/j.cyto.2016.08.009. Epub 2016 Aug 29.,Gusho E,https://www.ncbi.nlm.nih.gov/pubmed/27595182
20315,33077837,Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method,Sci Rep. 2020 Oct 19;10(1):17628. doi: 10.1038/s41598-020-74705-6.,Lucchetta M,https://www.ncbi.nlm.nih.gov/pubmed/33077837
20316,31647397,Birth size and cancer prognosis: a systematic review and meta-analysis,J Dev Orig Health Dis. 2020 Aug;11(4):309-316. doi: 10.1017/S2040174419000631. Epub 2019 Oct 24.,Sharma S,https://www.ncbi.nlm.nih.gov/pubmed/31647397
20320,32710191,Measuring the temporal prognostic utility of a baseline risk score,Lifetime Data Anal. 2020 Oct;26(4):856-871. doi: 10.1007/s10985-020-09503-3. Epub 2020 Jul 24.,Devlin SM,https://www.ncbi.nlm.nih.gov/pubmed/32710191
20323,32903142,Revisiting same day administration of pegfilgrastim in the age of biosimilars: A review of literature,J Oncol Pharm Pract. 2020 Dec;26(8):1970-1976. doi: 10.1177/1078155220956305. Epub 2020 Sep 9.,Gerberich AJ,https://www.ncbi.nlm.nih.gov/pubmed/32903142
20327,32464498,The effects of shift work and sleep duration on cancer incidence in Alberta`s Tomorrow Project cohort,Cancer Epidemiol. 2020 Aug;67:101729. doi: 10.1016/j.canep.2020.101729. Epub 2020 May 25.,McNeil J,https://www.ncbi.nlm.nih.gov/pubmed/32464498
20328,31760519,Hospice enrollment among cancer patients in Texas covered by Medicare managed care and traditional fee-for-service plans: a statewide population-based study,Support Care Cancer. 2020 Jul;28(7):3351-3359. doi: 10.1007/s00520-019-05142-z. Epub 2019 Nov 23.,Elting LS,https://www.ncbi.nlm.nih.gov/pubmed/31760519
20329,32801055,"Synthesis, characterization and in vitro biological evaluation of novel organotin(IV) compounds with derivatives of 2-(5-arylidene-2,4-dioxothiazolidin-3-yl)propanoic acid",J Inorg Biochem. 2020 Oct;211:111207. doi: 10.1016/j.jinorgbio.2020.111207. Epub 2020 Jul 26.,Panteli? N?,https://www.ncbi.nlm.nih.gov/pubmed/32801055
20330,32975661,How can we combat multicenter variability in MR radiomics? Validation of a correction procedure,Eur Radiol. 2021 Apr;31(4):2272-2280. doi: 10.1007/s00330-020-07284-9. Epub 2020 Sep 25.,Orlhac F,https://www.ncbi.nlm.nih.gov/pubmed/32975661
20332,32828957,Exposure to organophosphorus insecticides and increased risks of health and cancer in US women,Environ Toxicol Pharmacol. 2020 Nov;80:103474. doi: 10.1016/j.etap.2020.103474. Epub 2020 Aug 20.,Sun H,https://www.ncbi.nlm.nih.gov/pubmed/32828957
20333,32217475,Synthetic Elastography Using B-Mode Ultrasound Through a Deep Fully Convolutional Neural Network,IEEE Trans Ultrason Ferroelectr Freq Control. 2020 Dec;67(12):2640-2648. doi: 10.1109/TUFFC.2020.2983099. Epub 2020 Nov 24.,Wildeboer RR,https://www.ncbi.nlm.nih.gov/pubmed/32217475
20334,33226844,Genetic Polymorphisms of PRNCR1 and Lung Cancer Risk in Chinese Northeast Population: A Case-Control Study and Meta-Analysis,DNA Cell Biol. 2021 Jan;40(1):132-144. doi: 10.1089/dna.2020.6194. Epub 2020 Nov 23.,Li N,https://www.ncbi.nlm.nih.gov/pubmed/33226844
20335,33187970,Premature Years of Life Lost Due to Cancer in the United States in 2017,Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2591-2598. doi: 10.1158/1055-9965.EPI-20-0782. Epub 2020 Nov 13.,Song M,https://www.ncbi.nlm.nih.gov/pubmed/33187970
20337,32576339,Anticancer Activity of Novel NF-kappa B Inhibitor DHMEQ by Intraperitoneal Administration,Oncol Res. 2020 Dec 10;28(5):541-550. doi: 10.3727/096504020X15929100013698. Epub 2020 Jun 23.,Umezawa K,https://www.ncbi.nlm.nih.gov/pubmed/32576339
20338,33046779,Deep neural network based artificial intelligence assisted diagnosis of bone scintigraphy for cancer bone metastasis,Sci Rep. 2020 Oct 12;10(1):17046. doi: 10.1038/s41598-020-74135-4.,Zhao Z,https://www.ncbi.nlm.nih.gov/pubmed/33046779
20340,33027717,Cell-penetrating peptides in oncologic pharmacotherapy: A review,Pharmacol Res. 2020 Dec;162:105231. doi: 10.1016/j.phrs.2020.105231. Epub 2020 Oct 4.,Vale N,https://www.ncbi.nlm.nih.gov/pubmed/33027717
20341,32651353,Underlying Mechanism of Insulin Resistance: A Bioinformatics Analysis Based on Validated Related-Genes from Public Disease Databases,Med Sci Monit. 2020 Jul 11;26:e924334. doi: 10.12659/MSM.924334.,Gao P,https://www.ncbi.nlm.nih.gov/pubmed/32651353
20342,32853479,Report of a germline double heterozygote in MSH2 and PALB2,Mol Genet Genomic Med. 2020 Oct;8(10):e1242. doi: 10.1002/mgg3.1242. Epub 2020 Aug 27.,Agiannitopoulos K,https://www.ncbi.nlm.nih.gov/pubmed/32853479
20343,32632269,An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway,Cancer Gene Ther. 2021 Feb;28(1-2):112-125. doi: 10.1038/s41417-020-0190-y. Epub 2020 Jul 7.,Chen J,https://www.ncbi.nlm.nih.gov/pubmed/32632269
20344,33167207,Fabrication of electrochemical immunosensor based on acid-substituted poly(pyrrole) polymer modified disposable ITO electrode for sensitive detection of CCR4 cancer biomarker in human serum,Talanta. 2021 Jan 15;222:121487. doi: 10.1016/j.talanta.2020.121487. Epub 2020 Aug 7.,Ayd?n EB,https://www.ncbi.nlm.nih.gov/pubmed/33167207
20346,33160761,Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges,Eur J Med Chem. 2021 Jan 15;210:112981. doi: 10.1016/j.ejmech.2020.112981. Epub 2020 Oct 31.,Zeng S,https://www.ncbi.nlm.nih.gov/pubmed/33160761
20347,32609659,A Network Pharmacology Approach to Explore the Potential Mechanisms of Huangqin-Baishao Herb Pair in Treatment of Cancer,Med Sci Monit. 2020 Jul 1;26:e923199. doi: 10.12659/MSM.923199.,Xu T,https://www.ncbi.nlm.nih.gov/pubmed/32609659
20350,32948029,The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity,Int J Mol Sci. 2020 Sep 16;21(18):6805. doi: 10.3390/ijms21186805.,Park KC,https://www.ncbi.nlm.nih.gov/pubmed/32948029
20351,32887764,Renal Cortical (68)Ga-PSMA-11 PET and (99m)Tc-DMSA Images,J Nucl Med Technol. 2021 Mar;49(1):30-33. doi: 10.2967/jnmt.120.248922. Epub 2020 Sep 4.,Sarikaya I,https://www.ncbi.nlm.nih.gov/pubmed/32887764
20354,32441924,Paper-Based Acoustofluidics for Separating Particles and Cells,Anal Chem. 2020 Jun 16;92(12):8569-8578. doi: 10.1021/acs.analchem.0c01496. Epub 2020 Jun 5.,Zhou J,https://www.ncbi.nlm.nih.gov/pubmed/32441924
20355,32990903,The EphA2 and cancer connection: potential for immune-based interventions,Mol Biol Rep. 2020 Oct;47(10):8037-8048. doi: 10.1007/s11033-020-05767-y. Epub 2020 Sep 29.,London M,https://www.ncbi.nlm.nih.gov/pubmed/32990903
20356,33323967,Men1 disruption in Nkx3.1-deficient mice results in AR(low)/CD44(+) microinvasive carcinoma development with the dysregulated AR pathway,Oncogene. 2021 Feb;40(6):1118-1127. doi: 10.1038/s41388-020-01589-1. Epub 2020 Dec 15.,Teinturier R,https://www.ncbi.nlm.nih.gov/pubmed/33323967
20357,30990075,Terpenoids and phenolics of Micromeria persica,Nat Prod Res. 2020 Oct;34(20):2913-2918. doi: 10.1080/14786419.2019.1598988. Epub 2019 Apr 16.,Kalaki Kordkolaei S,https://www.ncbi.nlm.nih.gov/pubmed/30990075
20359,32737339,Anticancer properties of Tulbaghia violacea regulate the expression of p53-dependent mechanisms in cancer cell lines,Sci Rep. 2020 Jul 31;10(1):12924. doi: 10.1038/s41598-020-69722-4.,Motadi LR,https://www.ncbi.nlm.nih.gov/pubmed/32737339
20360,32696989,"Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems",J Pharm Pharmacol. 2020 Nov;72(11):1491-1512. doi: 10.1111/jphp.13339. Epub 2020 Jul 22.,Luan F,https://www.ncbi.nlm.nih.gov/pubmed/32696989
20362,32798360,Beyond diabetes mellitus: role of metformin in non-muscle-invasive bladder cancer,Singapore Med J. 2022 Apr;63(4):209-213. doi: 10.11622/smedj.2020121. Epub 2020 Aug 17.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/32798360
20363,32942035,Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases,Autoimmun Rev. 2020 Nov;19(11):102658. doi: 10.1016/j.autrev.2020.102658. Epub 2020 Sep 14.,Szekanecz Z,https://www.ncbi.nlm.nih.gov/pubmed/32942035
20364,32697592,Glycopolymers for Efficient Inhibition of Galectin-3: In Vitro Proof of Efficacy Using Suppression of T Lymphocyte Apoptosis and Tumor Cell Migration,Biomacromolecules. 2020 Aug 10;21(8):3122-3133. doi: 10.1021/acs.biomac.0c00515. Epub 2020 Jul 22.,Filipová M,https://www.ncbi.nlm.nih.gov/pubmed/32697592
20365,32515474,STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway,Biosci Rep. 2020 Jun 26;40(6):BSR20193169. doi: 10.1042/BSR20193169.,Huo SF,https://www.ncbi.nlm.nih.gov/pubmed/32515474
20366,32665992,Clinical correlation among male infertility and overall male health: A systematic review of the literature,Investig Clin Urol. 2020 Jul;61(4):355-371. doi: 10.4111/icu.2020.61.4.355. Epub 2020 Jun 8.,Del Giudice F,https://www.ncbi.nlm.nih.gov/pubmed/32665992
20369,31621027,A cohort study of banana plantation workers in the French West Indies: first mortality analysis (2000-2015),Environ Sci Pollut Res Int. 2020 Nov;27(33):41014-41022. doi: 10.1007/s11356-019-06481-4. Epub 2019 Oct 16.,Luce D,https://www.ncbi.nlm.nih.gov/pubmed/31621027
20370,32974961,KRAS 117N positive Rosai-Dorfman disease with atypical features,J Cutan Pathol. 2021 Jan;48(1):147-150. doi: 10.1111/cup.13883. Epub 2020 Oct 9.,Jafri ZA,https://www.ncbi.nlm.nih.gov/pubmed/32974961
20372,33189835,Aerobic exercise ameliorates benign prostatic hyperplasia in obese mice through downregulating the AR/androgen/PI3K/AKT signaling pathway,Exp Gerontol. 2021 Jan;143:111152. doi: 10.1016/j.exger.2020.111152. Epub 2020 Nov 13.,Wang SS,https://www.ncbi.nlm.nih.gov/pubmed/33189835
20373,32444914,Society of skeletal radiology member utilization and performance of whole-body MRI in adults,Skeletal Radiol. 2020 Nov;49(11):1731-1736. doi: 10.1007/s00256-020-03471-3. Epub 2020 May 22.,Feldhaus JM,https://www.ncbi.nlm.nih.gov/pubmed/32444914
20374,32800334,"Gephyromycin C, a novel small-molecule inhibitor of heat shock protein Hsp90, induces G2/M cell cycle arrest and apoptosis in PC3 cells in vitro",Biochem Biophys Res Commun. 2020 Oct 20;531(3):377-382. doi: 10.1016/j.bbrc.2020.07.096. Epub 2020 Aug 13.,Ding WJ,https://www.ncbi.nlm.nih.gov/pubmed/32800334
20376,32622013,LncRNA PCGEM1 enhances metastasis and gastric cancer invasion through targeting of miR-129-5p to regulate P4HA2 expression,Exp Mol Pathol. 2020 Oct;116:104487. doi: 10.1016/j.yexmp.2020.104487. Epub 2020 Jul 1.,Zhang T,https://www.ncbi.nlm.nih.gov/pubmed/32622013
20377,31768967,PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade,Pathol Oncol Res. 2020 Oct;26(4):2091-2103. doi: 10.1007/s12253-019-00768-0. Epub 2019 Nov 25.,Molla S,https://www.ncbi.nlm.nih.gov/pubmed/31768967
20378,32814947,Meat intake and cancer risk: prospective analyses in UK Biobank,Int J Epidemiol. 2020 Oct 1;49(5):1540-1552. doi: 10.1093/ije/dyaa142.,Knuppel A,https://www.ncbi.nlm.nih.gov/pubmed/32814947
20380,33348600,Scientific Evidence Supporting the Beneficial Effects of Isoflavones on Human Health,Nutrients. 2020 Dec 17;12(12):3853. doi: 10.3390/nu12123853.,Gómez-Zorita S,https://www.ncbi.nlm.nih.gov/pubmed/33348600
20381,32827761,Improving identification of candidates for lung cancer screening in a high risk population,Lung Cancer. 2020 Oct;148:79-85. doi: 10.1016/j.lungcan.2020.07.036. Epub 2020 Aug 7.,Waddle MR,https://www.ncbi.nlm.nih.gov/pubmed/32827761
20382,32970391,An investigation into the molecular basis of cancer comorbidities in coronavirus infection,FEBS Open Bio. 2020 Nov;10(11):2363-2374. doi: 10.1002/2211-5463.12984. Epub 2020 Oct 12.,Facchiano A,https://www.ncbi.nlm.nih.gov/pubmed/32970391
20383,32403965,Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases,Int J Surg Pathol. 2020 Oct;28(7):728-734. doi: 10.1177/1066896920918289. Epub 2020 May 13.,Zhou L,https://www.ncbi.nlm.nih.gov/pubmed/32403965
20384,33112478,Research progress on the relationship between sex hormone-binding globulin and male reproductive system diseases,Andrologia. 2021 Feb;53(1):e13893. doi: 10.1111/and.13893. Epub 2020 Oct 28.,Wan Q,https://www.ncbi.nlm.nih.gov/pubmed/33112478
20385,32517676,Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review,BMC Endocr Disord. 2020 Jun 9;20(1):83. doi: 10.1186/s12902-020-00566-9.,Gómez-Izquierdo J,https://www.ncbi.nlm.nih.gov/pubmed/32517676
20386,33266025,The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication,Int J Mol Sci. 2020 Nov 30;21(23):9107. doi: 10.3390/ijms21239107.,Wörthmüller J,https://www.ncbi.nlm.nih.gov/pubmed/33266025
20388,33145926,Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study,Respirology. 2021 Feb;26(2):180-187. doi: 10.1111/resp.13911. Epub 2020 Jul 22.,Lee HY,https://www.ncbi.nlm.nih.gov/pubmed/33145926
20396,33045661,Current development of CBP/p300 inhibitors in the last decade,Eur J Med Chem. 2021 Jan 1;209:112861. doi: 10.1016/j.ejmech.2020.112861. Epub 2020 Oct 1.,He ZX,https://www.ncbi.nlm.nih.gov/pubmed/33045661
20397,32692447,Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence,Obes Rev. 2021 Jan;22(1):e13088. doi: 10.1111/obr.13088. Epub 2020 Jul 21.,Silveira EA,https://www.ncbi.nlm.nih.gov/pubmed/32692447
20399,32998383,Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A(2),Molecules. 2020 Sep 28;25(19):4459. doi: 10.3390/molecules25194459.,Kim RR,https://www.ncbi.nlm.nih.gov/pubmed/32998383
20400,31970768,Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening,Int J Cancer. 2020 Jul 1;147(1):9-13. doi: 10.1002/ijc.32885. Epub 2020 Feb 26.,Ponti A,https://www.ncbi.nlm.nih.gov/pubmed/31970768
20401,32957072,Hydrolysis of Schiff bases with phenyl-ethynyl-phenyl system: The importance for biological and physicochemical studies,J Photochem Photobiol B. 2020 Nov;212:112020. doi: 10.1016/j.jphotobiol.2020.112020. Epub 2020 Sep 11.,Senka?a S,https://www.ncbi.nlm.nih.gov/pubmed/32957072
20402,33105836,Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response,Int J Mol Sci. 2020 Oct 22;21(21):7844. doi: 10.3390/ijms21217844.,Stefanski CD,https://www.ncbi.nlm.nih.gov/pubmed/33105836
20403,32602389,Mortality among U.S. military participants at eight aboveground nuclear weapons test series,Int J Radiat Biol. 2022;98(4):679-700. doi: 10.1080/09553002.2020.1787543. Epub 2020 Aug 3.,Boice JD,https://www.ncbi.nlm.nih.gov/pubmed/32602389
20404,32356584,"Design, Synthesis and Bioevaluation of Two Series of 3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones and N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines",Chem Biodivers. 2020 Jul;17(7):e2000290. doi: 10.1002/cbdv.202000290. Epub 2020 Jun 23.,Lan TT,https://www.ncbi.nlm.nih.gov/pubmed/32356584
20405,32463129,Selective Release of Doxorubicin from Cucurbit[8]uril Stabilized Gold Supra-Pyramid Host at pH of Small Intestine,Chemistry. 2020 Nov 26;26(66):15150-15158. doi: 10.1002/chem.202002048. Epub 2020 Oct 6.,Saini M,https://www.ncbi.nlm.nih.gov/pubmed/32463129
20406,32716647,Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters,JCO Clin Cancer Inform. 2020 Jul;4:657-665. doi: 10.1200/CCI.20.00068.,London JW,https://www.ncbi.nlm.nih.gov/pubmed/32716647
20407,33143346,"Teratopyrones A-C, Dimeric Naphtho-?-Pyrones and Other Metabolites from Teratosphaeria sp. AK1128, a Fungal Endophyte of Equisetum arvense",Molecules. 2020 Oct 30;25(21):5058. doi: 10.3390/molecules25215058.,Xu YM,https://www.ncbi.nlm.nih.gov/pubmed/33143346
20408,32885893,"Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions",Oncologist. 2021 Jan;26(1):e78-e89. doi: 10.1634/theoncologist.2020-0509. Epub 2020 Sep 15.,Jardim DL,https://www.ncbi.nlm.nih.gov/pubmed/32885893
20409,32282203,"Discovery of Ubiquitin-Specific Protease 7 (USP7) Inhibitors with Novel Scaffold Structures by Virtual Screening, Molecular Dynamics Simulation, and Biological Evaluation",J Chem Inf Model. 2020 Jun 22;60(6):3255-3264. doi: 10.1021/acs.jcim.0c00154. Epub 2020 Apr 23.,Liu S,https://www.ncbi.nlm.nih.gov/pubmed/32282203
20410,33310788,Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort,Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):554-563. doi: 10.1158/1055-9965.EPI-20-1045. Epub 2020 Dec 11.,Poizot-Martin I,https://www.ncbi.nlm.nih.gov/pubmed/33310788
20412,33338475,Nucleic acids therapeutics using PolyPurine Reverse Hoogsteen hairpins,Biochem Pharmacol. 2021 Jul;189:114371. doi: 10.1016/j.bcp.2020.114371. Epub 2020 Dec 16.,Noé V,https://www.ncbi.nlm.nih.gov/pubmed/33338475
20413,32736230,"Design, synthesis and high antitumor potential of new unsymmetrical bisacridine derivatives towards human solid tumors, specifically pancreatic cancers and their unique ability to stabilize DNA G-quadruplexes",Eur J Med Chem. 2020 Oct 15;204:112599. doi: 10.1016/j.ejmech.2020.112599. Epub 2020 Jul 16.,Paluszkiewicz E,https://www.ncbi.nlm.nih.gov/pubmed/32736230
20415,32691677,"Cytotoxic effects, carbonic anhydrase isoenzymes, ?-glycosidase and acetylcholinesterase inhibitory properties, and molecular docking studies of heteroatom-containing sulfonyl hydrazone derivatives",J Biomol Struct Dyn. 2021 Sep;39(15):5539-5550. doi: 10.1080/07391102.2020.1792345. Epub 2020 Jul 21.,Celebioglu HU,https://www.ncbi.nlm.nih.gov/pubmed/32691677
20416,32552791,Preclinical anticancer studies on the ethyl acetate leaf extracts of Datura stramonium and Datura inoxia,BMC Complement Med Ther. 2020 Jun 17;20(1):188. doi: 10.1186/s12906-020-02975-8.,Nasir B,https://www.ncbi.nlm.nih.gov/pubmed/32552791
20418,33208786,Medicinal potential of mycelium and fruiting bodies of an arboreal mushroom Fomitopsis officinalis in therapy of lifestyle diseases,Sci Rep. 2020 Nov 18;10(1):20081. doi: 10.1038/s41598-020-76899-1.,Fija?kowska A,https://www.ncbi.nlm.nih.gov/pubmed/33208786
20419,33217248,Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone,Annu Rev Med. 2021 Jan 27;72:75-91. doi: 10.1146/annurev-med-050219-034711. Epub 2020 Nov 20.,Rodrigues Dos Santos M,https://www.ncbi.nlm.nih.gov/pubmed/33217248
20420,32809797,Electron Acceptors Co-Regulated Self-Powered Photoelectrochemical Strategy and Its Application for Circulating Tumor Nucleic Acid Detection Coupled with Recombinase Polymerase Amplification,Anal Chem. 2020 Sep 1;92(17):11771-11778. doi: 10.1021/acs.analchem.0c01893. Epub 2020 Aug 18.,Hun X,https://www.ncbi.nlm.nih.gov/pubmed/32809797
20421,33201570,The association between non-alcoholic fatty liver disease (with or without metabolic syndrome) and extrahepatic cancer development,J Gastroenterol Hepatol. 2021 Jul;36(7):1971-1978. doi: 10.1111/jgh.15350. Epub 2020 Dec 13.,Yamamoto K,https://www.ncbi.nlm.nih.gov/pubmed/33201570
20423,32324396,"p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators",J Med Chem. 2020 Sep 24;63(18):10135-10157. doi: 10.1021/acs.jmedchem.9b02038. Epub 2020 May 5.,Chen Y,https://www.ncbi.nlm.nih.gov/pubmed/32324396
20424,33344645,Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances,Biomed Res Int. 2020 Dec 1;2020:6940953. doi: 10.1155/2020/6940953. eCollection 2020.,Yin Z,https://www.ncbi.nlm.nih.gov/pubmed/33344645
20425,32162465,Effect of hemolysis on Fourier transform infrared and Raman spectra of blood plasma,J Biophotonics. 2020 Jul;13(7):e201960173. doi: 10.1002/jbio.201960173. Epub 2020 Apr 7.,Medipally DKR,https://www.ncbi.nlm.nih.gov/pubmed/32162465
20428,33172882,Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment,J Immunother Cancer. 2020 Nov;8(2):e001297. doi: 10.1136/jitc-2020-001297.,Wang Z,https://www.ncbi.nlm.nih.gov/pubmed/33172882
20430,33130549,Identification of nephronectin as a new target for IGF1 action,Eur J Cancer. 2020 Dec;141:115-127. doi: 10.1016/j.ejca.2020.09.034. Epub 2020 Oct 30.,Sarfstein R,https://www.ncbi.nlm.nih.gov/pubmed/33130549
20431,32535900,Two-group Poisson-Dirichlet mixtures for multiple testing,Biometrics. 2021 Jun;77(2):622-633. doi: 10.1111/biom.13314. Epub 2020 Jun 28.,Denti F,https://www.ncbi.nlm.nih.gov/pubmed/32535900
20432,32811566,Aspartate ?-hydroxylase as a target for cancer therapy,J Exp Clin Cancer Res. 2020 Aug 18;39(1):163. doi: 10.1186/s13046-020-01669-w.,Kanwal M,https://www.ncbi.nlm.nih.gov/pubmed/32811566
20433,32866190,Gene panel screening for insight towards breast cancer susceptibility in different ethnicities,PLoS One. 2020 Aug 31;15(8):e0238295. doi: 10.1371/journal.pone.0238295. eCollection 2020.,Bishop MR,https://www.ncbi.nlm.nih.gov/pubmed/32866190
20434,33199044,Genetically predicted plasma phospholipid arachidonic acid concentrations and 10 site-specific cancers in UK biobank and genetic consortia participants: A mendelian randomization study,Clin Nutr. 2021 May;40(5):3332-3337. doi: 10.1016/j.clnu.2020.11.004. Epub 2020 Nov 7.,Larsson SC,https://www.ncbi.nlm.nih.gov/pubmed/33199044
20435,32878791,"Up-regulation of Death Receptor 5/TRAIL-R2 Mediates Apoptosis Induced by N,N'-[(3,4-dimethoxyphenyl)methylene] Biscinnamide in Cancer Cells",Anticancer Res. 2020 Sep;40(9):5035-5041. doi: 10.21873/anticanres.14506.,Hiromi I,https://www.ncbi.nlm.nih.gov/pubmed/32878791
20436,32219380,"Albuminuria, Kidney Function, and Cancer Risk in the Community",Am J Epidemiol. 2020 Sep 1;189(9):942-950. doi: 10.1093/aje/kwaa043.,Mok Y,https://www.ncbi.nlm.nih.gov/pubmed/32219380
20438,32639250,Association Between Outdoor Light-at-night Exposure and Colorectal Cancer in Spain,Epidemiology. 2020 Sep;31(5):718-727. doi: 10.1097/EDE.0000000000001226.,Garcia-Saenz A,https://www.ncbi.nlm.nih.gov/pubmed/32639250
20439,32707118,Endocrine-disrupting chemicals: implications for human health,Lancet Diabetes Endocrinol. 2020 Aug;8(8):703-718. doi: 10.1016/S2213-8587(20)30129-7.,Kahn LG,https://www.ncbi.nlm.nih.gov/pubmed/32707118
20440,32919134,"Targeting EGFR tyrosine kinase: Synthesis, in vitro antitumor evaluation, and molecular modeling studies of benzothiazole-based derivatives",Bioorg Chem. 2020 Nov;104:104259. doi: 10.1016/j.bioorg.2020.104259. Epub 2020 Sep 2.,Mokhtar AM,https://www.ncbi.nlm.nih.gov/pubmed/32919134
20441,32312759,Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials,Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1329-1334. doi: 10.1158/1055-9965.EPI-20-0187. Epub 2020 Apr 20.,Huang J,https://www.ncbi.nlm.nih.gov/pubmed/32312759
20442,32943772,Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression,Pharmacogenomics J. 2021 Feb;21(1):85-93. doi: 10.1038/s41397-020-00186-5. Epub 2020 Sep 17.,Shoaib M,https://www.ncbi.nlm.nih.gov/pubmed/32943772
20444,32410390,"Plumbagin-Serum Albumin Interaction: Spectral, Electrochemical, Structure-Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy",ChemMedChem. 2020 Jul 20;15(14):1338-1347. doi: 10.1002/cmdc.202000157. Epub 2020 Jun 8.,Chrastina A,https://www.ncbi.nlm.nih.gov/pubmed/32410390
20446,32437150,Exploring the Sequence Diversity of Cyclotides from Vietnamese Viola Species,J Nat Prod. 2020 Jun 26;83(6):1817-1828. doi: 10.1021/acs.jnatprod.9b01218. Epub 2020 May 21.,Dang TT,https://www.ncbi.nlm.nih.gov/pubmed/32437150
20447,32802191,Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to reality,Theranostics. 2020 Jul 23;10(20):9268-9279. doi: 10.7150/thno.46341. eCollection 2020.,Rochow H,https://www.ncbi.nlm.nih.gov/pubmed/32802191
20449,32981382,"Design, synthesis, and evaluation of novel N'-substituted-1-(4-chlorobenzyl)-1H-indol-3-carbohydrazides as antitumor agents",J Enzyme Inhib Med Chem. 2020 Dec;35(1):1854-1865. doi: 10.1080/14756366.2020.1816997.,Huan LC,https://www.ncbi.nlm.nih.gov/pubmed/32981382
20450,33017009,An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer,Biosci Rep. 2020 Oct 30;40(10):BSR20192051. doi: 10.1042/BSR20192051.,Moazeni-Roodi A,https://www.ncbi.nlm.nih.gov/pubmed/33017009
20451,33115801,Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential,Cancer Res. 2021 Feb 1;81(3):525-534. doi: 10.1158/0008-5472.CAN-20-2906. Epub 2020 Oct 28.,Strepkos D,https://www.ncbi.nlm.nih.gov/pubmed/33115801
20453,33031426,Cancer survivorship needs in Brazil: Patient and family perspective,PLoS One. 2020 Oct 8;15(10):e0239811. doi: 10.1371/journal.pone.0239811. eCollection 2020.,Santos ATCD,https://www.ncbi.nlm.nih.gov/pubmed/33031426
20454,33141069,Bisphosphonates in veterinary medicine: The new horizon for use,Bone. 2021 Jan;142:115711. doi: 10.1016/j.bone.2020.115711. Epub 2020 Oct 24.,Suva LJ,https://www.ncbi.nlm.nih.gov/pubmed/33141069
20457,33131246,Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis,Haematologica. 2020 Nov 1;105(11):2572-2583. doi: 10.3324/haematol.2019.225763.,Yang S,https://www.ncbi.nlm.nih.gov/pubmed/33131246
20459,32750679,"Design, synthesis and biological evaluation of 3,5-diaryl isoxazole derivatives as potential anticancer agents",Bioorg Med Chem Lett. 2020 Oct 1;30(19):127427. doi: 10.1016/j.bmcl.2020.127427. Epub 2020 Jul 23.,Akta? DA,https://www.ncbi.nlm.nih.gov/pubmed/32750679
20462,32683280,"Physical activity and cancer risk: Findings from the UK Biobank, a large prospective cohort study",Cancer Epidemiol. 2020 Oct;68:101780. doi: 10.1016/j.canep.2020.101780. Epub 2020 Jul 16.,Murray JM,https://www.ncbi.nlm.nih.gov/pubmed/32683280
20464,33584972,"Cancer Incidence in Older Adults in the United States: Characteristics, Specificity, and Completeness of the Data",J Registry Manag. 2020 Fall;47(3):150-160.,Weir HK,https://www.ncbi.nlm.nih.gov/pubmed/33584972
20466,33164907,Use of Social Media to Promote Cancer Screening and Early Diagnosis: Scoping Review,J Med Internet Res. 2020 Nov 9;22(11):e21582. doi: 10.2196/21582.,Plackett R,https://www.ncbi.nlm.nih.gov/pubmed/33164907
20468,32223238,Multistep Binding of the Non-Steroidal Inhibitors Orteronel and Seviteronel to Human Cytochrome P450 17A1 and Relevance to Inhibition of Enzyme Activity,J Med Chem. 2020 Jun 25;63(12):6513-6522. doi: 10.1021/acs.jmedchem.9b01849. Epub 2020 Apr 9.,Child SA,https://www.ncbi.nlm.nih.gov/pubmed/32223238
20472,33247092,In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo,Nat Commun. 2020 Nov 27;11(1):6080. doi: 10.1038/s41467-020-19486-2.,Parayath NN,https://www.ncbi.nlm.nih.gov/pubmed/33247092
20474,32532766,Effect of different communication strategies about stopping cancer screening on screening intention and cancer anxiety: a randomised online trial of older adults in Australia,BMJ Open. 2020 Jun 11;10(6):e034061. doi: 10.1136/bmjopen-2019-034061.,Smith J,https://www.ncbi.nlm.nih.gov/pubmed/32532766
20475,32770356,An updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer,Eur J Nutr. 2021 Apr;60(3):1561-1586. doi: 10.1007/s00394-020-02346-6. Epub 2020 Aug 8.,Morze J,https://www.ncbi.nlm.nih.gov/pubmed/32770356
20476,32319648,"Association between aberrant dynein cytoplasmic 1 light intermediate chain 1 expression levels, mucins and chemosensitivity in colorectal cancer",Mol Med Rep. 2020 Jul;22(1):185-192. doi: 10.3892/mmr.2020.11086. Epub 2020 Apr 22.,Chang CC,https://www.ncbi.nlm.nih.gov/pubmed/32319648
20477,33159501,"Work changes and individual, cancer-related, and work-related predictors of decreased work participation among African American cancer survivors",Cancer Med. 2020 Dec;9(23):9168-9177. doi: 10.1002/cam4.3512. Epub 2020 Nov 7.,Hastert TA,https://www.ncbi.nlm.nih.gov/pubmed/33159501
20478,32566972,Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population,Breast Cancer. 2020 Nov;27(6):1158-1167. doi: 10.1007/s12282-020-01119-7. Epub 2020 Jun 22.,Li D,https://www.ncbi.nlm.nih.gov/pubmed/32566972
20482,33225460,Social needs and health-related quality of life among African American cancer survivors: Results from the Detroit Research on Cancer Survivors study,Cancer. 2021 Feb 1;127(3):467-475. doi: 10.1002/cncr.33286. Epub 2020 Nov 23.,Hastert TA,https://www.ncbi.nlm.nih.gov/pubmed/33225460
20483,32701380,Development of a TEM-cell-integrated CO(2) incubator for cell-based transient electromagnetic field bioeffect study,Electromagn Biol Med. 2020 Oct 1;39(4):290-297. doi: 10.1080/15368378.2020.1793170. Epub 2020 Jul 23.,Peng WY,https://www.ncbi.nlm.nih.gov/pubmed/32701380
20484,32534222,Prevalence and causes of elevated bone mass,Bone. 2020 Sep;138:115476. doi: 10.1016/j.bone.2020.115476. Epub 2020 Jun 11.,Nottez A,https://www.ncbi.nlm.nih.gov/pubmed/32534222
20485,32830201,Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank,Br J Cancer. 2020 Oct;123(9):1356-1359. doi: 10.1038/s41416-020-01036-8. Epub 2020 Aug 24.,Wei J,https://www.ncbi.nlm.nih.gov/pubmed/32830201
20488,33219129,ABHD5 suppresses cancer cell anabolism through lipolysis-dependent activation of the AMPK/mTORC1 pathway,J Biol Chem. 2021 Jan-Jun;296:100104. doi: 10.1074/jbc.RA120.014682. Epub 2020 Nov 27.,Chen G,https://www.ncbi.nlm.nih.gov/pubmed/33219129
20489,33064958,FGF13 interaction with SHCBP1 activates AKT-GSK3?/? signaling and promotes the proliferation of A549 cells,Cancer Biol Ther. 2020 Nov 1;21(11):1014-1024. doi: 10.1080/15384047.2020.1824512. Epub 2020 Oct 16.,Lu H,https://www.ncbi.nlm.nih.gov/pubmed/33064958
20490,33017668,WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1,Biochim Biophys Acta Gene Regul Mech. 2020 Dec;1863(12):194642. doi: 10.1016/j.bbagrm.2020.194642. Epub 2020 Oct 2.,Belali T,https://www.ncbi.nlm.nih.gov/pubmed/33017668
20492,32963636,"6,12-Diphenyl-3, 9-diazatetraasterane-1, 5, 7, 11-tetracarboxylate Inhibits Proliferation, Migration and Promotes Apoptosis in Ovarian Cancer Cells",Dis Markers. 2020 Sep 3;2020:5068067. doi: 10.1155/2020/5068067. eCollection 2020.,Chen P,https://www.ncbi.nlm.nih.gov/pubmed/32963636
20494,32529749,Development of ROS-responsive amino acid-based poly(ester amide) nanoparticle for anticancer drug delivery,J Biomed Mater Res A. 2021 Apr;109(4):524-537. doi: 10.1002/jbm.a.37035. Epub 2020 Jul 30.,Xu Q,https://www.ncbi.nlm.nih.gov/pubmed/32529749
20498,33275876,Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins,Structure. 2021 May 6;29(5):404-412.e4. doi: 10.1016/j.str.2020.11.012. Epub 2020 Dec 3.,Hou C,https://www.ncbi.nlm.nih.gov/pubmed/33275876
20499,33300919,DNA topoisomerases as additional targets for anticancer monofunctional platinum(ii) complexes,Dalton Trans. 2021 Jan 7;50(1):304-310. doi: 10.1039/d0dt02608e. Epub 2020 Dec 10.,Zhang H,https://www.ncbi.nlm.nih.gov/pubmed/33300919
20500,32913330,Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability,Nat Commun. 2020 Sep 10;11(1):4534. doi: 10.1038/s41467-020-18306-x.,Prendergast L,https://www.ncbi.nlm.nih.gov/pubmed/32913330
20501,32624415,Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer,J Geriatr Oncol. 2020 Nov;11(8):1309-1315. doi: 10.1016/j.jgo.2020.06.018. Epub 2020 Jul 3.,Li S,https://www.ncbi.nlm.nih.gov/pubmed/32624415
20502,32987038,"Neprilysin expression and functions in development, ageing and disease",Mech Ageing Dev. 2020 Dec;192:111363. doi: 10.1016/j.mad.2020.111363. Epub 2020 Sep 26.,Nalivaeva NN,https://www.ncbi.nlm.nih.gov/pubmed/32987038
20504,33229626,Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC),Aging (Albany NY). 2020 Nov 20;12(24):25395-25411. doi: 10.18632/aging.104142. Epub 2020 Nov 20.,Mai Q,https://www.ncbi.nlm.nih.gov/pubmed/33229626
20507,32438269,Nickel and zinc complexes of testosterone N4-substituted thiosemicarbazone: Selective cytotoxicity towards human colorectal carcinoma cell line HCT 116 and their cell death mechanisms,J Inorg Biochem. 2020 Jul;208:111097. doi: 10.1016/j.jinorgbio.2020.111097. Epub 2020 May 4.,Heng MP,https://www.ncbi.nlm.nih.gov/pubmed/32438269
20508,33036598,Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis,BMC Pulm Med. 2020 Oct 9;20(1):262. doi: 10.1186/s12890-020-01304-6.,Uno S,https://www.ncbi.nlm.nih.gov/pubmed/33036598
20510,33246003,Capping protein regulator and myosin 1 linker 3 regulates transcription of key cytokines in activated phagocytic cells,Cell Signal. 2021 Feb;78:109848. doi: 10.1016/j.cellsig.2020.109848. Epub 2020 Nov 24.,Zhao N,https://www.ncbi.nlm.nih.gov/pubmed/33246003
20511,32519176,Exosome-transmitted lncRNA PCGEM1 promotes invasive and metastasis in gastric cancer by maintaining the stability of SNAI1,Clin Transl Oncol. 2021 Feb;23(2):246-256. doi: 10.1007/s12094-020-02412-9. Epub 2020 Jun 9.,Piao HY,https://www.ncbi.nlm.nih.gov/pubmed/32519176
20512,32990800,LncRNA PCAT6 Regulated by YY1 Accelerates the Progression of Glioblastoma via miR-513/IGF2BP1,Neurochem Res. 2020 Dec;45(12):2894-2902. doi: 10.1007/s11064-020-03138-4. Epub 2020 Sep 29.,Liu P,https://www.ncbi.nlm.nih.gov/pubmed/32990800
20514,32517237,Highly Oxygenated Constituents from a Marine Alga-Derived Fungus Aspergillus giganteus NTU967,Mar Drugs. 2020 Jun 6;18(6):303. doi: 10.3390/md18060303.,Chen JJ,https://www.ncbi.nlm.nih.gov/pubmed/32517237
20516,32387288,"Peptides derived from small mitochondrial open reading frames: Genomic, biological, and therapeutic implications",Exp Cell Res. 2020 Aug 15;393(2):112056. doi: 10.1016/j.yexcr.2020.112056. Epub 2020 May 6.,Miller B,https://www.ncbi.nlm.nih.gov/pubmed/32387288
20518,32488249,Consumption of Fish and ?-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies,Adv Nutr. 2020 Sep 1;11(5):1134-1149. doi: 10.1093/advances/nmaa055.,Lee KH,https://www.ncbi.nlm.nih.gov/pubmed/32488249
20524,33278516,ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease,Microb Pathog. 2021 Jan;150:104621. doi: 10.1016/j.micpath.2020.104621. Epub 2020 Dec 2.,Singh H,https://www.ncbi.nlm.nih.gov/pubmed/33278516
20525,33075381,Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies,Urology. 2021 Feb;148:134-140. doi: 10.1016/j.urology.2020.08.080. Epub 2020 Oct 16.,Hollenbeck BK,https://www.ncbi.nlm.nih.gov/pubmed/33075381
20527,33130987,Proinflammatory cytokine profile is critical in autocrine GH-triggered curcumin resistance engulf by atiprimod cotreatment in MCF-7 and MDA-MB-231 breast cancer cells,Mol Biol Rep. 2020 Nov;47(11):8797-8808. doi: 10.1007/s11033-020-05928-z. Epub 2020 Oct 31.,Coker-Gurkan A,https://www.ncbi.nlm.nih.gov/pubmed/33130987
20528,32907567,"Anti-trichomonad activities of different compounds from foods, marine products, and medicinal plants: a review",BMC Complement Med Ther. 2020 Sep 9;20(1):271. doi: 10.1186/s12906-020-03061-9.,Friedman M,https://www.ncbi.nlm.nih.gov/pubmed/32907567
20531,33378353,DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden,PLoS One. 2020 Dec 30;15(12):e0244558. doi: 10.1371/journal.pone.0244558. eCollection 2020.,Riggs MJ,https://www.ncbi.nlm.nih.gov/pubmed/33378353
20532,33283516,Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer,J Med Chem. 2020 Dec 24;63(24):15344-15370. doi: 10.1021/acs.jmedchem.0c01344. Epub 2020 Dec 7.,Martin MC,https://www.ncbi.nlm.nih.gov/pubmed/33283516
20533,33839684,The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression,J Biol Chem. 2021 Jan-Jun;296:100220. doi: 10.1074/jbc.RA120.016645. Epub 2020 Dec 25.,Poria DK,https://www.ncbi.nlm.nih.gov/pubmed/33839684
20534,33122620,"An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor",Am J Case Rep. 2020 Oct 30;21:e926728. doi: 10.12659/AJCR.926728.,Ghafouri S,https://www.ncbi.nlm.nih.gov/pubmed/33122620
20535,31302853,"Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors",Mol Divers. 2020 Aug;24(3):673-689. doi: 10.1007/s11030-019-09974-z. Epub 2019 Jul 13.,?enkarde? S,https://www.ncbi.nlm.nih.gov/pubmed/31302853
20536,32521698,"Chrysosplenol d, a Flavonol from Artemisia annua, Induces ERK1/2-Mediated Apoptosis in Triple Negative Human Breast Cancer Cells",Int J Mol Sci. 2020 Jun 8;21(11):4090. doi: 10.3390/ijms21114090.,Lang SJ,https://www.ncbi.nlm.nih.gov/pubmed/32521698
20539,33110062,Structure of human steroid 5?-reductase 2 with the anti-androgen drug finasteride,Nat Commun. 2020 Oct 27;11(1):5430. doi: 10.1038/s41467-020-19249-z.,Xiao Q,https://www.ncbi.nlm.nih.gov/pubmed/33110062
20540,32657284,Dissecting the intracellular signalling and fate of a DNA nanosensor by super-resolution and quantitative microscopy,Nanoscale. 2020 Jul 23;12(28):15402-15413. doi: 10.1039/d0nr03087b.,Glab A,https://www.ncbi.nlm.nih.gov/pubmed/32657284
20543,32468675,Suppression of TRPM7 enhances TRAIL-induced apoptosis in triple-negative breast cancer cells,J Cell Physiol. 2020 Dec;235(12):10037-10050. doi: 10.1002/jcp.29820. Epub 2020 May 29.,Song C,https://www.ncbi.nlm.nih.gov/pubmed/32468675
20545,32540605,Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with (18)F-Fluorocholine PET/CT?,Med Hypotheses. 2020 Nov;144:109885. doi: 10.1016/j.mehy.2020.109885. Epub 2020 May 27.,Savelli G,https://www.ncbi.nlm.nih.gov/pubmed/32540605
20546,32575541,Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone,Int J Mol Sci. 2020 Jun 19;21(12):4378. doi: 10.3390/ijms21124378.,Tsao YC,https://www.ncbi.nlm.nih.gov/pubmed/32575541
20548,32891003,Diterpenoids from Cephalotaxus fortunei var. alpina and their cytotoxic activity,Bioorg Chem. 2020 Oct;103:104226. doi: 10.1016/j.bioorg.2020.104226. Epub 2020 Aug 26.,Li Y,https://www.ncbi.nlm.nih.gov/pubmed/32891003
20550,32348940,Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method,J Mol Graph Model. 2020 Sep;99:107599. doi: 10.1016/j.jmgm.2020.107599. Epub 2020 Apr 10.,Takaya D,https://www.ncbi.nlm.nih.gov/pubmed/32348940
20551,32484436,MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation,Elife. 2020 Jun 2;9:e54954. doi: 10.7554/eLife.54954.,Arai S,https://www.ncbi.nlm.nih.gov/pubmed/32484436
20552,33027304,"The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies",PLoS One. 2020 Oct 7;15(10):e0240169. doi: 10.1371/journal.pone.0240169. eCollection 2020.,Noto FK,https://www.ncbi.nlm.nih.gov/pubmed/33027304
20556,32362498,"Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective",Eur Urol. 2020 Jul;78(1):16-20. doi: 10.1016/j.eururo.2020.04.055. Epub 2020 Apr 27.,Boehm K,https://www.ncbi.nlm.nih.gov/pubmed/32362498
20557,32754750,"Marked Increase in Incident Gynecomastia: A 20-Year National Registry Study, 1998 to 2017",J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa440. doi: 10.1210/clinem/dgaa440.,Koch T,https://www.ncbi.nlm.nih.gov/pubmed/32754750
20559,32615465,"Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects",Bioorg Chem. 2020 Aug;101:104019. doi: 10.1016/j.bioorg.2020.104019. Epub 2020 Jun 17.,Turky A,https://www.ncbi.nlm.nih.gov/pubmed/32615465
20560,32927132,"Design, synthesis and biological evaluation of thieno[3,2-d]pyrimidine derivatives containing aroyl hydrazone or aryl hydrazide moieties for PI3K and mTOR dual inhibition",Bioorg Chem. 2020 Nov;104:104197. doi: 10.1016/j.bioorg.2020.104197. Epub 2020 Aug 28.,Han Y,https://www.ncbi.nlm.nih.gov/pubmed/32927132
20561,33087639,"Preclinical Pharmacokinetics, Tissue Distribution and Primary Safety Evaluation of a Novel Curcumin Analogue H10 Suspension, a Potential 17? Hydroxysteroid Dehydrogenase Type 3 Inhibitor",Chem Pharm Bull (Tokyo). 2021 Jan 1;69(1):52-58. doi: 10.1248/cpb.c20-00242. Epub 2020 Oct 20.,Xiao L,https://www.ncbi.nlm.nih.gov/pubmed/33087639
20564,33047235,A Novel White-to-Blue Colony Formation Assay to Select for Optimized sgRNAs,Mol Biotechnol. 2021 Jan;63(1):1-12. doi: 10.1007/s12033-020-00280-w. Epub 2020 Oct 12.,Wei C,https://www.ncbi.nlm.nih.gov/pubmed/33047235
20565,33142405,Copper (II)-based halogen-substituted chromone antitumor drug entities: Studying biomolecular interactions with ct-DNA mediated by sigma hole formation and cytotoxicity activity,Bioorg Chem. 2020 Nov;104:104327. doi: 10.1016/j.bioorg.2020.104327. Epub 2020 Sep 30.,Arjmand F,https://www.ncbi.nlm.nih.gov/pubmed/33142405
20567,32771992,Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells,J Immunother Cancer. 2020 Aug;8(2):e000515. doi: 10.1136/jitc-2019-000515.,Chen H,https://www.ncbi.nlm.nih.gov/pubmed/32771992
20568,32492651,Assessment of Adaptive Engagement and Support Model for People With Chronic Health Conditions in Online Health Communities: Combined Content Analysis,J Med Internet Res. 2020 Jul 7;22(7):e17338. doi: 10.2196/17338.,Green BM,https://www.ncbi.nlm.nih.gov/pubmed/32492651
20574,32114665,Epidemiology and biological characteristics of male breast cancer in Italy,Breast Cancer. 2020 Jul;27(4):724-731. doi: 10.1007/s12282-020-01068-1. Epub 2020 Feb 29.,Mangone L,https://www.ncbi.nlm.nih.gov/pubmed/32114665
20575,32208781,Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity,J Enzyme Inhib Med Chem. 2020 Dec;35(1):831-839. doi: 10.1080/14756366.2020.1743281.,Al-Rashood ST,https://www.ncbi.nlm.nih.gov/pubmed/32208781
20577,32520202,lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma,Braz J Med Biol Res. 2020 Jun 5;53(7):e9271. doi: 10.1590/1414-431X20209271. eCollection 2020.,Xu Z,https://www.ncbi.nlm.nih.gov/pubmed/32520202
20578,32594454,Onapristone Extended Release: Safety Evaluation from Phase I-II Studies with an Emphasis on Hepatotoxicity,Drug Saf. 2020 Oct;43(10):1045-1055. doi: 10.1007/s40264-020-00964-x.,Lewis JH,https://www.ncbi.nlm.nih.gov/pubmed/32594454
20579,32931884,A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity,Cancer Lett. 2020 Dec 28;495:22-32. doi: 10.1016/j.canlet.2020.08.040. Epub 2020 Sep 12.,Du T,https://www.ncbi.nlm.nih.gov/pubmed/32931884
20589,32319550,Long non?coding RNA PRNCR1 exerts oncogenic effects in tongue squamous cell carcinoma in vitro and in vivo by sponging microRNA?944 and thereby increasing HOXB5 expression,Int J Mol Med. 2020 Jul;46(1):119-130. doi: 10.3892/ijmm.2020.4581. Epub 2020 Apr 16.,Lin C,https://www.ncbi.nlm.nih.gov/pubmed/32319550
20591,33372800,"3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A(2B) Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition",J Med Chem. 2021 Jan 14;64(1):458-480. doi: 10.1021/acs.jmedchem.0c01431. Epub 2020 Dec 29.,Majellaro M,https://www.ncbi.nlm.nih.gov/pubmed/33372800
20595,33229547,Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis,Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31189-31197. doi: 10.1073/pnas.2017152117. Epub 2020 Nov 23.,Yi J,https://www.ncbi.nlm.nih.gov/pubmed/33229547
20598,33216356,"Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies",Cancer. 2021 Mar 15;127(6):840-849. doi: 10.1002/cncr.33328. Epub 2020 Nov 20.,McGregor BA,https://www.ncbi.nlm.nih.gov/pubmed/33216356
20600,32782388,TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation,Nat Commun. 2020 Aug 11;11(1):4012. doi: 10.1038/s41467-020-17802-4.,Kim HK,https://www.ncbi.nlm.nih.gov/pubmed/32782388
20603,33151182,Genetic parkinsonisms and cancer: a systematic review and meta-analysis,Rev Neurosci. 2020 Nov 5;32(2):159-167. doi: 10.1515/revneuro-2020-0083. Print 2021 Feb 23.,Sturchio A,https://www.ncbi.nlm.nih.gov/pubmed/33151182
20606,33032658,The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases,Microbiome. 2020 Oct 8;8(1):145. doi: 10.1186/s40168-020-00923-9.,Xu F,https://www.ncbi.nlm.nih.gov/pubmed/33032658
20607,32580359,"Tumoricidal Potential of Novel Amino-1,10-phenanthroline Derived Imine Ligands: Chemical Preparation, Structure, and Biological Investigations",Molecules. 2020 Jun 22;25(12):2865. doi: 10.3390/molecules25122865.,Prasad KS,https://www.ncbi.nlm.nih.gov/pubmed/32580359
20610,32341516,Brightfield multiplex immunohistochemistry with multispectral imaging,Lab Invest. 2020 Aug;100(8):1124-1136. doi: 10.1038/s41374-020-0429-0. Epub 2020 Apr 27.,Morrison LE,https://www.ncbi.nlm.nih.gov/pubmed/32341516
20613,32967084,"Design, Synthesis and Bioactivity Evaluation of 4,6-Disubstituted Pyrido[3,2-d]pyrimidine Derivatives as Mnk and HDAC Inhibitors",Molecules. 2020 Sep 21;25(18):4318. doi: 10.3390/molecules25184318.,Xing K,https://www.ncbi.nlm.nih.gov/pubmed/32967084
20615,33376014,"Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors",Bioorg Chem. 2021 Mar;108:104563. doi: 10.1016/j.bioorg.2020.104563. Epub 2020 Dec 15.,Panova VA,https://www.ncbi.nlm.nih.gov/pubmed/33376014
20622,32388776,Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms,Endocr Pathol. 2020 Sep;31(3):254-263. doi: 10.1007/s12022-020-09626-1.,Narayanan D,https://www.ncbi.nlm.nih.gov/pubmed/32388776
20629,32889383,"Selective VEGFR-2 inhibitors: Synthesis of pyridine derivatives, cytotoxicity and apoptosis induction profiling",Bioorg Chem. 2020 Oct;103:104222. doi: 10.1016/j.bioorg.2020.104222. Epub 2020 Aug 26.,AbdelHaleem A,https://www.ncbi.nlm.nih.gov/pubmed/32889383
20638,32472945,"Radiosynthesis, in vitro and preliminary biological evaluation of [(18) F]2-amino-4-((2-((3-fluorobenzyl)oxy)benzyl)(2-((3-(fluoromethyl)benzyl)oxy)benzyl)amino)butanoic acid, a novel alanine serine cysteine transporter 2 inhibitor-based positron emission tomography tracer",J Labelled Comp Radiopharm. 2020 Aug;63(10):442-455. doi: 10.1002/jlcr.3863. Epub 2020 Jul 6.,Baguet T,https://www.ncbi.nlm.nih.gov/pubmed/32472945
20641,33091671,"Design and synthesis of novel tranilast analogs: Docking, antiproliferative evaluation and in-silico screening of TGF?R1 inhibitors",Bioorg Chem. 2020 Dec;105:104368. doi: 10.1016/j.bioorg.2020.104368. Epub 2020 Oct 12.,Ismail MMF,https://www.ncbi.nlm.nih.gov/pubmed/33091671
20650,33388654,"Synthesis, anticancer and antimicrobial evaluation of new benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study",Bioorg Med Chem. 2021 Feb 1;31:115976. doi: 10.1016/j.bmc.2020.115976. Epub 2020 Dec 27.,El-Khouly OA,https://www.ncbi.nlm.nih.gov/pubmed/33388654
20652,32669607,Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle,Cell Res. 2021 Jan;31(1):80-93. doi: 10.1038/s41422-020-0372-z. Epub 2020 Jul 15.,Liu J,https://www.ncbi.nlm.nih.gov/pubmed/32669607
20656,33148439,Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study,Brain Behav Immun. 2021 Jan;91:383-392. doi: 10.1016/j.bbi.2020.10.019. Epub 2020 Oct 24.,Zhou J,https://www.ncbi.nlm.nih.gov/pubmed/33148439
20666,33087743,Coffee consumption and cancer risk in African Americans from the Southern Community Cohort Study,Sci Rep. 2020 Oct 21;10(1):17907. doi: 10.1038/s41598-020-72993-6.,Schmit SL,https://www.ncbi.nlm.nih.gov/pubmed/33087743
20692,33126484,NAA10 as a New Prognostic Marker for Cancer Progression,Int J Mol Sci. 2020 Oct 28;21(21):8010. doi: 10.3390/ijms21218010.,Kim SM,https://www.ncbi.nlm.nih.gov/pubmed/33126484
20694,32913128,CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins,J Biol Chem. 2020 Nov 27;295(48):16239-16250. doi: 10.1074/jbc.RA120.013756. Epub 2020 Sep 9.,Langendorf CG,https://www.ncbi.nlm.nih.gov/pubmed/32913128
20695,32581132,Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy,Sci Transl Med. 2020 Jun 24;12(549):eaba2325. doi: 10.1126/scitranslmed.aba2325.,Waite JC,https://www.ncbi.nlm.nih.gov/pubmed/32581132
20721,32882003,Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734,Blood Adv. 2020 Sep 8;4(17):4124-4135. doi: 10.1182/bloodadvances.2020001879.,Spriano F,https://www.ncbi.nlm.nih.gov/pubmed/32882003
20724,32910542,A meta-analysis of microRNA networks regulated by melatonin in cancer: Portrait of potential candidates for breast cancer treatment,J Pineal Res. 2020 Nov;69(4):e12693. doi: 10.1111/jpi.12693. Epub 2020 Sep 19.,Chuffa LGA,https://www.ncbi.nlm.nih.gov/pubmed/32910542
20731,32835767,Nuclear protein 1 imparts oncogenic potential and chemotherapeutic resistance in cancer,Cancer Lett. 2020 Dec 1;494:132-141. doi: 10.1016/j.canlet.2020.08.019. Epub 2020 Aug 22.,Murphy A,https://www.ncbi.nlm.nih.gov/pubmed/32835767
20745,32787343,BReast CAncer (BRCA) gene mutations as an emerging biomarker for the treatment of gastrointestinal malignancies,Chin Clin Oncol. 2020 Oct;9(5):64. doi: 10.21037/cco-2019-ddp-05. Epub 2020 Aug 10.,Premnath N,https://www.ncbi.nlm.nih.gov/pubmed/32787343
20774,32756864,Mechanism and significance of chromosome damage repair by homologous recombination,Essays Biochem. 2020 Oct 26;64(5):779-790. doi: 10.1042/EBC20190093.,Kawale AS,https://www.ncbi.nlm.nih.gov/pubmed/32756864
20782,33153024,Impact of Gene-Environment Interactions on Cancer Development,Int J Environ Res Public Health. 2020 Nov 3;17(21):8089. doi: 10.3390/ijerph17218089.,Mbemi A,https://www.ncbi.nlm.nih.gov/pubmed/33153024
20787,32522979,SHQ1 is an ER stress response gene that facilitates chemotherapeutics-induced apoptosis via sensitizing ER-stress response,Cell Death Dis. 2020 Jun 10;11(6):445. doi: 10.1038/s41419-020-2656-0.,Liu H,https://www.ncbi.nlm.nih.gov/pubmed/32522979
20788,33295593,Cancer mortality in the Capitals and in the interior of Brazil: a four-decade analysis,Rev Saude Publica. 2020 Dec 4;54:126. doi: 10.11606/s1518-8787.2020054002255. eCollection 2020.,Silva GAE,https://www.ncbi.nlm.nih.gov/pubmed/33295593
20816,32948992,Associations between shared care and patient experiences among older cancer survivors,J Cancer Surviv. 2021 Apr;15(2):333-343. doi: 10.1007/s11764-020-00934-3. Epub 2020 Sep 18.,Halpern MT,https://www.ncbi.nlm.nih.gov/pubmed/32948992
20829,33232371,Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles,PLoS One. 2020 Nov 24;15(11):e0242780. doi: 10.1371/journal.pone.0242780. eCollection 2020.,Tegally H,https://www.ncbi.nlm.nih.gov/pubmed/33232371
20830,32344050,Dietary carotenoids in cancer chemoprevention and chemotherapy: A review of emerging evidence,Pharmacol Res. 2020 Jul;157:104830. doi: 10.1016/j.phrs.2020.104830. Epub 2020 Apr 25.,Saini RK,https://www.ncbi.nlm.nih.gov/pubmed/32344050
20862,33022999,"Country-Level Relationships of the Human Intake of N and P, Animal and Vegetable Food, and Alcoholic Beverages with Cancer and Life Expectancy",Int J Environ Res Public Health. 2020 Oct 3;17(19):7240. doi: 10.3390/ijerph17197240.,Penuelas J,https://www.ncbi.nlm.nih.gov/pubmed/33022999
20890,32407843,CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker,Life Sci. 2020 Aug 1;254:117774. doi: 10.1016/j.lfs.2020.117774. Epub 2020 May 11.,Amini M,https://www.ncbi.nlm.nih.gov/pubmed/32407843
20893,32285169,"JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice",Calcif Tissue Int. 2020 Jul;107(1):72-85. doi: 10.1007/s00223-020-00689-0. Epub 2020 Apr 13.,Marino S,https://www.ncbi.nlm.nih.gov/pubmed/32285169
20911,33279671,Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators,Cell Signal. 2021 Feb;78:109871. doi: 10.1016/j.cellsig.2020.109871. Epub 2020 Dec 3.,Ashrafizadeh M,https://www.ncbi.nlm.nih.gov/pubmed/33279671
20940,33375616,"Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy",Genes (Basel). 2020 Dec 25;12(1):19. doi: 10.3390/genes12010019.,Zarubin A,https://www.ncbi.nlm.nih.gov/pubmed/33375616
20949,33002285,Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress,Pathol Int. 2020 Dec;70(12):943-952. doi: 10.1111/pin.13027. Epub 2020 Oct 1.,Katsuya N,https://www.ncbi.nlm.nih.gov/pubmed/33002285
20955,32853681,Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group,Ann Oncol. 2020 Nov;31(11):1491-1505. doi: 10.1016/j.annonc.2020.07.014. Epub 2020 Aug 24.,Mosele F,https://www.ncbi.nlm.nih.gov/pubmed/32853681
20992,33172169,"Design of Anticancer 2,4-Diaminopyrimidines as Novel Anoctamin 1 (ANO1) Ion Channel Blockers",Molecules. 2020 Nov 6;25(21):5180. doi: 10.3390/molecules25215180.,Kim T,https://www.ncbi.nlm.nih.gov/pubmed/33172169
21007,32962891,"Temperature Elevation in an Instrumented Phantom Insonated by B-Mode Imaging, Pulse Doppler and Shear Wave Elastography",Ultrasound Med Biol. 2020 Dec;46(12):3317-3326. doi: 10.1016/j.ultrasmedbio.2020.08.021. Epub 2020 Sep 19.,Issaoui M,https://www.ncbi.nlm.nih.gov/pubmed/32962891
21016,32594651,Paclitaxel induces apoptosis through the TAK1-JNK activation pathway,FEBS Open Bio. 2020 Aug;10(8):1655-1667. doi: 10.1002/2211-5463.12917. Epub 2020 Jul 31.,Yu-Wei D,https://www.ncbi.nlm.nih.gov/pubmed/32594651
